Search Result
Results for "
Antibody
" in MedChemExpress (MCE) Product Catalog:
2120
Inhibitors & Agonists
107
Biochemical Assay Reagents
1288
Inhibitory Antibodies
8
Isotope-Labeled Compounds
Cat. No. |
Product Name |
Target |
Research Areas |
Chemical Structure |
-
- HY-P99018
-
Antibody ANB 020
|
Interleukin Related
|
Cancer
|
Etokimab (Antibody ANB 020) is a humanized monoclonal antibody that targets IL-33. Etokimab can be used for the research of atopic dermatitis .
|
-
-
- HY-P99289
-
Antibody hLL 2; Anti-Human CD22 Recombinant Antibody
|
CD22
|
Inflammation/Immunology
Cancer
|
Epratuzumab (Antibody hLL 2) is an anti-CD22 IgG1 monoclonal antibody. Epratuzumab is also a tumor-imaging agent and an immunomodulatory agent. Epratuzumab can induce CD22 phosphorylation. Epratuzumab has been used to research non-Hodgkin’s lymphomas (NHL) and certain autoimmune diseases .
|
-
-
- HY-P99352
-
Anti-MSLN Antibody
|
Mesothelin
|
Cancer
|
Anetumab (Anti-MSLN Antibody) is an anti-mesothelin (MSLN) antibody. MSLN is a tumor-associated antigen. Anetumab can be used to synthesis Anetumab ravtansine, a MSLN-targeting antibody-drug conjugate (ADC). Anetumab can be used for the research of malignant tumor .
|
-
-
- HY-P99271
-
Anti-Human F3 Recombinant Antibody
|
ADC Antibody
|
Cancer
|
Tisotumab (Anti-Human F3 Recombinant Antibody) is a human IgG1 monoclonal antibody targets tissue factor (TF). Tisotumab can be used for the research of solid tumors .
|
-
-
- HY-P99313
-
Anti-Human NGcGM3 Recombinant Antibody
|
Apoptosis
|
Inflammation/Immunology
|
Quilizumab (Anti-Human NGcGM3 Recombinant Antibody) is a humanized IgG1κ monoclonal antibody. Quilizumab targets the M1-prime segment of membrane-expressed IgE, leading to depletion of IgE-switched and memory B cells. Quilizumab has the potantial for the asthma research .
|
-
-
- HY-P99296
-
CNTO 95; Anti-Human CD51 Recombinant Antibody
|
EGFR
|
Cancer
|
Intetumumab (CNTO 95) is a potent anti-EGFR monoclonal antibody that is glycoengineered for enhanced antibody-dependent cellular cytotoxicity (ADCC). Intetumumab can be used in research of cancer .
|
-
-
- HY-P99324
-
Anti-Human EGFR Recombinant Antibody
|
EGFR
Apoptosis
|
Cancer
|
Tomuzotuximab (Anti-Human EGFR Recombinant Antibody) is a fully human glycoengineered IgG1 monoclonal antibody against EGFR. Tomuzotuximab has anticancer effects .
|
-
-
- HY-P99292
-
HuZAF; Anti-Human IFNG Recombinant Antibody
|
IFNAR
|
Inflammation/Immunology
|
Fontolizumab (HuZAF) is a humanized monoclonal anti-IFN-gamma antibody. Fontolizumab is an immunosuppressive agent. Fontolizumab can be used in research of Crohn’s disease .
|
-
-
- HY-P99310
-
RG4934; Anti-Human IL17A Recombinant Antibody
|
Interleukin Related
|
Inflammation/Immunology
|
Perakizumab (RG4934) is a humanized IgG1κ monoclonal antibody against IL-17A (Interleukin Related). Perakizumab can be uesd for the research of autoimmune diseases, such as psoriatic arthritis .
|
-
-
- HY-P99372
-
Anti-NCAM1/ CD56 Reference Antibody (lorvotuzumab)
|
ADC Antibody
|
Cancer
|
Lorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab)) is a humanized monoclonal antibody that binds CD56 (NCAM1). Lorvotuzumab can be used to synthesize an ADC compound, Lorvotuzumab mertansine .
|
-
-
- HY-P99374
-
Anti-TSPAN26/CD37 Reference Antibody (naratuximab)
|
ADC Antibody
|
Cancer
|
Naratuximab (Anti-TSPAN26/CD37 Reference Antibody (naratuximab)) is a humanized monoclonal antibody that binds CD37 (TSPAN26). Naratuximab can be used to synthesize an ADC compound, Naratuximab emtansine .
|
-
-
- HY-P99295
-
RG 7160; RO 5083945; Anti-EGFR Recombinant Antibody
|
EGFR
|
Cancer
|
Imgatuzumab (RG 7160) is a humanized monoclonal antibody against the EGFR. Imgatuzumab acts as an immunomodulator. Imgatuzumab can be used in research of cancer .
|
-
-
- HY-P99328
-
Anti-EPCAM Recombinant Antibody; huKS-IL2
|
Interleukin Related
|
Inflammation/Immunology
Cancer
|
Tucotuzumab (Anti-EPCAM Recombinant Antibody) is an antigen-specific IgG1 monoclonal antibody that targets human epithelial cell adhesion molecule (EpCAM). Tucotuzumab links two IL-2 molecules and is an immunosuppressant and anti-tumor active molecule .
|
-
-
- HY-P9916
-
Anti-Human IL6Rα, Human Antibody
|
Interleukin Related
|
Inflammation/Immunology
Cancer
|
Sarilumab (Anti-Human IL6Rα, Human Antibody) is a human immunoglobulin G1 monoclonal antibody. Sarilumab, a interleukin-6 (IL-6) receptor antagonist, binds to the IL-6 receptor with high affinity and inhibits cis and trans signaling by IL-6, resulting in reduced inflammation. Sarilumab can be used for the research of Rheumatoid arthritis .
|
-
-
- HY-P99269
-
BIBH 1; Anti-Human FAP Recombinant Antibody
|
FAP
|
Cancer
|
Sibrotuzumab (BIBH 1) is a humanized IgG1 monoclonal antibody targets fibroblast activation protein (FAP). Sibrotuzumab can be used for the research of colorectal cancer and non-small cell lung cancer (NSCLC) .
|
-
-
- HY-P99293
-
IDEC 114; Anti-Human CD80 Recombinant Antibody
|
CD28
|
Cancer
|
Galiximab (IDEC 114) is a primatized immunoglobulin G1 (IgG1) lambda monoclonal antibody directed against the CD80 antigen. Galiximab has variable regions are primatized (cynomologous monkeys), and the constant regions are human. Galiximab can be used in research of B-cell lymphoma .
|
-
-
- HY-P9917
-
Anti-Human IL6R, Humanized Antibody
|
Interleukin Related
|
Inflammation/Immunology
Cancer
|
Tocilizumab (Anti-Human IL6R, Humanized Antibody) is an anti-human interleukin-6 receptor (IL-6R) neutralizing antibody, prevents binding of IL-6 to the IL-6R, thereby inhibiting both classic and trans-signaling. Tocilizumab (Anti-Human IL6R, Humanized Antibody) can be used for the treatment of rheumatoid arthritis . Tocilizumab is remarkablely effective for the study of severe COVID-19 (coronavirus disease) .
|
-
-
- HY-P9914
-
Anti-Human C5, Humanized Antibody
|
Complement System
|
Cardiovascular Disease
|
Eculizumab (Anti-Human C5, Humanized Antibody) is a long-acting humanized monoclonal antibody targeted against complement C5. Eculizumab inhibits the cleavage of C5 into C5a and C5b and hence inhibits deployment of the terminal complement system including the formation of membrane attack complex (MAC). Eculizumab has the potential for haemolysis research .
|
-
-
- HY-P99330
-
Anti-Human VEGFA Recombinant Antibody; RO5520985
|
VEGFR
Tie
|
Cancer
|
Vanucizumab is a first-in-class, bispecific IgG1-like monoclonal antibody that simultaneously blocks VEGF-A and angiopoietin-2 (Ang-2) from interacting with their receptors. Vanucizumab has antiangiogenic and anticancer effects .
|
-
-
- HY-P99263
-
Anti-Human selectin P Recombinant Antibody
|
P-selectin
|
Cardiovascular Disease
|
Inclacumab (Anti-Human selectin P Recombinant Antibody) is a human monoclonal IgG4 antibody selectively targets P-selectin with a Kd value of 9.9 nM. Inclacumab inhibits P-selectin glycoprotein ligand 1 (PSGL-1) mimetic peptide bind with P-selectin with an IC50 value of 1.9 μg/mL and strongly inhibits cell adhesion .
|
-
-
- HY-P99315
-
BG 9588; Anti-Human CD40L Recombinant Antibody
|
TNF Receptor
|
Inflammation/Immunology
|
Ruplizumab (BG 9588) is a humanized monoclonal anti-CD40L (TNF Receptor) IgG1κ antibody. Ruplizumab has the potential for systemic lupus erythematosus disease research .
|
-
-
- HY-P9915
-
Anti-Human CD38, Human Antibody
|
CD38
ADC Antibody
|
Inflammation/Immunology
Cancer
|
Daratumumab (Anti-Human CD38) is the first-in-class human-specific anti-CD38 monoclonal antibody (IgG1). Daratumumab has anti-multiple myeloma (MM) effect. Daratumumab impairs MM cell adhesion, which results in an increased sensitivity of MM to proteasome inhibition .
|
-
-
- HY-P99270
-
CS-1008; Anti-Human TRAIL-R2 Recombinant Antibody
|
Apoptosis
|
Cancer
|
Tigatuzumab (CS-1008) is a humanized IgG1 monoclonal antibody targets death receptor 5 (DR5). Tigatuzumab induces cell apoptosis of cancer cells and inhibits tumor growth in vivo. Tigatuzumab can be used for the research of cancer .
|
-
-
- HY-P99288
-
Pamrevlumab; Anti-Human CTGF Recombinant Antibody
|
Apoptosis
|
Cancer
|
FG-3019 (Pamrevlumab) is a recombinant human antibody that binds to connective tissue growth factor (CTGF). FG-3019 can be used for the research of idiopathic pulmonary fibrosis (IPF) .
|
-
-
- HY-P99275
-
Human Anti-ERBB3 Recombinant Antibody
|
EGFR
Akt
ERK
PARP
Survivin
|
Cancer
|
Patritumab (Human Anti-ERBB3 Recombinant Antibody) is a neutralizing monoclonal antibody to ERBB3. Patritumab shows a synergy with Cetuximab (HY-P9905), potently inhibits the phosphorylation of EGFR, HER2, HER3, ERK, and AKT. Patritumab also induces cell apoptosis and suppresses the growth of pancreatic, non-small cell lung cancer, and colorectal cancer xenograft tumors .
|
-
-
- HY-P99252
-
Anti-Human CD6 Recombinant Antibody
|
CD6
|
Infection
Inflammation/Immunology
|
Itolizumab (Anti-Human CD6 Recombinant Antibody) is a humanized recombinant anti-CD6 monoclonal antibody (MAb) targeting the extracellular SRCR distal domain 1 of CD6. Itolizumab reduces T-cell proliferation and inhibits the production of pro-inflammatory cytokines, such as INF-γ, TNFα and IL-6. Itolizumab can be used in the research of psoriasis, rheumatoid arthritis (RA), COVID-19 .
|
-
-
- HY-P99294
-
AMG 479; Human Anti-IGF1R Recombinant Antibody
|
IGF-1R
|
Cancer
|
Ganitumab (AMG 479) is a recombinant human monoclonal antibody to the human type 1 insulin-like growth factor receptor (IGF1R). Ganitumab recognizes murine IGF1R with sub-nanomolar affinity (KD=0.22 nM) and inhibits the interaction of murine IGF1R with IGF1 and IGF2. Ganitumab can be used in research of cancer .
|
-
-
- HY-P99785
-
HLX20
|
PD-1/PD-L1
|
Cancer
|
Opucolimab is an anti-PD-L1 recombinant human monoclonal antibody. Opucolimab can be used to synthesis antibody agent conjugates. Opucolimab can be used for the research of advanced solid tumors .
|
-
-
- HY-P990055
-
|
EGFR
|
Cancer
|
Nezutatug is an anti-HER3 antibody, and used for cancer research .
|
-
-
- HY-P99256
-
SCH 900222; MK 3222; Anti-Human IL23 Recombinant Antibody
|
Interleukin Related
|
Inflammation/Immunology
|
Tildrakizumab (SCH 900222) is a humanized anti-IL-23 (p19 subunit) monoclonal antibody. IL-23 is a critical cytokine to maintain the Th17 cell phenotype. Tildrakizumab has high-affinity for single-chain IL-23 (Kd: 136 pM). Tildrakizumab is effective against moderate to severe plaque psoriasis .
|
-
-
- HY-P99336
-
BI-RR 0001; Anti-Human IL6 Recombinant Antibody
|
Integrin
|
Neurological Disease
Inflammation/Immunology
|
Enlimomab (BI-RR 0001), a murine IgG2a monoclonal antibody to the human ICAM-1, inhibits leukocyte adhesion to the vascular endothelium, thereby decreasing leukocyte extravasation and inflammatory tissue injury. Enlimomab has anti-inflammatory effects, and can be used for stroke research .
|
-
-
- HY-P99455
-
EMB-01
|
EGFR
c-Met/HGFR
|
Cancer
|
Bafisontamab (EMB-01) is a bispecific antibody targeting EGFR and cMET with antitumor activity .
|
-
-
- HY-P99702
-
BCD-089
|
Interleukin Related
|
Inflammation/Immunology
|
Levilimab (BCD-089) is a fully humanized anti-interleukin-6 receptor (IL-6R) monoclonal antibody. Levilimab is an inflammation-alleviating antibody. Levilimab can be used for the research of rheumatoid .
|
-
-
- HY-P99861
-
BMS-914143
|
IFNAR
|
Others
|
Peginterferon lambda-1a (BMS-914143) is a monoclonal antibody targeting IFNLR1 and consists of IFNL1 conjugated to pegol .
|
-
-
- HY-P99332
-
Anti-Human CD3E Recombinant Antibody; HuM291
|
Apoptosis
|
Inflammation/Immunology
|
Visilizumab (Anti-Human CD3E Recombinant Antibody) is a humanized low-Fc receptor binding anti-CD3 monoclonal IgG2 antibody. Visilizumab can be used for ulcerative colitis and Crohn's disease research .
|
-
-
- HY-P99298
-
RG 7417; TNX 234; Anti-CFD Recombinant Antibody
|
Complement System
|
Inflammation/Immunology
|
Lampalizumab (RG 7417) is a humanised monoclonal antibody targeting complement Factor D in the alternative complement pathway. Lampalizumab binds an exosite and sterically blocks Factor B access to the active site. Lampalizumab can be used for age-related macular degeneration (AMD) research .
|
-
-
- HY-P9997
-
ANB030
|
PD-1/PD-L1
|
Cancer
|
Rosnilimab is a humanized IgG1-κ antibody targeting to PD-1 .
|
-
-
- HY-P9996
-
LY3434172
|
PD-1/PD-L1
|
Cancer
|
Reozalimab is a bispecific antibody targeting to PD-1/PD-L1. Reozalimab mediates antibody-dependent cell cytotoxicity in cancer research .
|
-
-
- HY-P99784
-
|
Filovirus
|
Infection
|
Porgaviximab is a monoclonal antibody that can be used Ebola infection research .
|
-
-
- HY-P9980
-
GSK2857914
|
TNF Receptor
ADC Antibody
|
Cancer
|
Belantamab (GSK2857914) is a humanised IgG1 anti-BCMA (TNFRSF17) monoclonal antibody. Belantamab can be used in the synthesis of antibody-drug conjugate (ADC), Belantamab mafodotin .
|
-
-
- HY-P99376
-
OMS 721; Anti-MASP2 Reference Antibody (narsoplimab)
|
SARS-CoV
|
Infection
|
Narsoplimab (OMS 721) is a high-affinity fully human immunoglobulin gamma 4 (IgG4) monoclonal antibody that binds MASP-2 and blocks lectin pathway activation. Narsoplimab can be used in research of hematopoietic stem-cell transplantation and SARS-CoV-2 .
|
-
-
- HY-P99371
-
AK002; Anti-Siglec-8 Reference Antibody (lirentelimab)
|
Apoptosis
|
Inflammation/Immunology
|
Lirentelimab (AK002) is a humanized IgG1 monoclonal antibody that targets sialic acid-binding Ig-like lectin 8 (SIGLEC8). Lirentelimab induces cell apoptosis of IL-5-activated eosinophils and inhibits IgE-mediated mast cell activation. Lirentelimab can be used for the research of eosinophilic gastritis and duodenitis .
|
-
-
- HY-P99564
-
-
-
- HY-P99230
-
|
Integrin
CD22
|
Cancer
|
Pinatuzumab is a CD22 monoclonal antibody. Pinatuzumab targets the cell-surface antigen CD22. Pinatuzumab can be used for synthesis of antibody agent conjugates (ADCs) to research several diseases including non-Hodgkin lymphoma (NHL) .
|
-
-
- HY-P99234
-
|
Interleukin Related
|
Cancer
|
Pivekimab is a human IgG1 monoclonal antibody targeting interleukin 3 (IL-3) and CD123. Pivekimab can be used in the study of blastocytic plasmacytoid dendritic cell tumor (BPDCN) .
|
-
-
- HY-P99888
-
|
EGFR
|
Others
|
Pimurutamab is a humanized IgG1-κ antibody targeting EGFR. Mainly expressed by CHO-K1 cells .
|
-
-
- HY-P99753
-
BAYX1351
|
TNF Receptor
|
Infection
|
Nerelimomab (BAYX1351) is an anti-TNF-α antibody. Nerelimomab can be used for research of sepsis .
|
-
-
- HY-P99854
-
-
-
- HY-145626
-
BA302
|
ADC Antibody
|
Cancer
|
Ozuriftamab is a naked human IgG1 kappa antibody of receptor tyrosine kinase-like orphan receptor 2 ROR2, can be used to synthesis ADC .
|
-
-
- HY-P99233
-
HuMax-TAC
|
Interleukin Related
|
Cancer
|
Camidanlumab (HuMax-TAC) is a CD25 monoclonal antibody. Camidanlumab targets the cell-surface antigen CD25, which is over-expressed on a variety of hematological tumors and shows limited expression on normal tissues. Camidanlumab can be used for synthesis of antibody agent conjugates (ADCs) to research several diseases including lymphoma and leukemia .
|
-
- HY-P99378
-
ALTB-168; Anti-PSGL1/CD162 Reference Antibody (neihulizumab)
|
Apoptosis
|
Inflammation/Immunology
|
Neihulizumab (ALTB-168) is an immune checkpoint agonistic antibody that binds to human CD162 (PSGL-1), leading to downregulation of activated T-cells. Neihulizumab can be uesd for steroid-refractory acute graft-versus-host-disease (SR-aGVHD), psoriasis, psoriatic arthritis and ulcerative colitis research .
|
-
- HY-P99285
-
hBU 12
|
ADC Antibody
CD19
|
Others
|
Denintuzumab (hBU 12) is a recombinant humanized anti-CD19 monoclonal antibody. Denintuzumab can be used as the antibody moiety (ADC antibody) of antibody-drug conjugates to synthesize ADC, Denintuzumab Mafodotin (SGN-CD19A). Denintuzumab Mafodotin can be used in the research of acute lymphoblastic leukemia .
|
-
- HY-P99808
-
|
VEGFR
|
Cancer
|
Pulocimab is an anti-VEGFR2 monoclonal antibody (mAb). Pulocimab can be used for the research of cancers .
|
-
- HY-P99106
-
-
- HY-P99737
-
LY3074828
|
Interleukin Related
|
Inflammation/Immunology
|
Mirikizumab (LY3074828) is a humanized IgG4 monoclonal antibody targets the p19 subunit of interleukin 23. Mirikizumab can be used for the research of ulcerative colitis .
|
-
- HY-P99232
-
5F9 Monoclonal Antibody
|
Guanylate Cyclase
|
Cancer
|
Indusatumab (5F9 Monoclonal antibody) is an anti-human GUCY2C (Guanylate cyclase 2C) monoclonal antibody .
|
-
- HY-P990002
-
|
c-Kit
|
Cancer
|
Anti-Mouse CD117 Antibody is an IgG2b antibody inhibitor against mouse CD117. Derived from rat.
|
-
- HY-P990001
-
-
- HY-P99586
-
REGN2222
|
RSV
|
Infection
|
Suptavumab (REGN2222) is a human monoclonal antibody. Suptavumab can bind and block a conserved epitope on RSV A and B subtypes. Suptavumab can be used for the research of RSV infection .
|
-
- HY-P99360
-
Anti-AXL/UFO Reference Antibody (enapotamab)
|
TAM Receptor
|
Cancer
|
Enapotamab is an anti-AXL/UFO reference antibody. Enapotamab can be used to synthesis Bcl-xl inhibitor antibody-drug conjugates .
|
-
- HY-157235
-
|
Others
|
Inflammation/Immunology
|
AC Antibody affinity resin is AC commonly used packing. AC Antibody affinity resin has highly cross-linked agarose matrix with 85 μm of average particle size. AC Antibody affinity resin has alkali-resistant protein A derivative (E. coli) ligand. AC Antibody affinity resin can be used for antibody affinity chromatography .
|
-
- HY-P99361
-
PDL192; ABT-361; Anti-TNFRSF12A/TWEAKR/CD266 Reference Antibody (enavatuzumab)
|
TNF Receptor
|
Cancer
|
Enavatuzumab (PDL192; ABT-361) is a humanized IgG1 monoclonal antibody targeting the receptor of TNF-like weak inducer of apoptosis (TWEAK). TWEAK (Fn14; TNFRSF12A), the natural ligand of the TWEAK receptor (TweakR), stimulates multiple cellular responses. Enavatuzumab induces tumor growth inhibition through direct TweakR signaling and antibody dependent cell-mediated cytotoxicity (ADCC). Enavatuzumab can actively recruits and activates myeloid effectors to kill tumor cells. Enavatuzumab inhibits the growth of various human TweakR-positive cancer cell lines and xenografts in vitro and in vivo .
|
-
- HY-P99042
-
|
ADC Antibody
|
Cancer
|
Polatuzumab is a monoclonal antibody, which targets CD79b that is found on the surface of B cells. Polatuzumab sticks to the CD79b protein and delivers the chemotherapy compound into the cell. Polatuzumab can be used to synthesize Polatuzumab Vedotin, which is an antibody-drug conjugate (ADC) targeting CD79b .
|
-
- HY-P9995
-
JNJ-63733657
|
Tau Protein
|
Cancer
|
Posdinemab is a humanized IgG1κ antibody, targeting to microtubule-associated protein tau (MAPT) .
|
-
- HY-P99118
-
HLX 10
|
PD-1/PD-L1
|
Cancer
|
Serplulimab (HLX 10) is humanized monoclonal anti-PD-1 antibody. Serplulimab can be used in research of small cell lung cancer .
|
-
- HY-P99850
-
-
- HY-P99264
-
Humanized Anti-CD22 Recombinant Antibody
|
ADC Antibody
CD22
|
Cancer
|
Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) is a humanized IgG4, κ antibody that targets human CD22. Inotuzumab can be linked to a toxic agent ozogamicin as an antibody-drug conjugate (ADC). Inotuzumab can be used for the research of acute lymphoblastic leukemia and non-Hodgkin lymphoma .
|
-
- HY-P99304
-
Anti-Human ERBB3 Recombinant Antibody
|
EGFR
|
Cancer
|
Lumretuzumab (Anti-Human ERBB3 Recombinant Antibody) is a humanized anti-HER3 (ERBB3) monoclonal antibody that can be used for the research of cancer .
|
-
- HY-P99016
-
|
ADC Antibody
Nectin-4
|
Cancer
|
Enfortumab is a monoclonal antibody targeting Nectin-4. Enfortumab can used for researching urothelial cancer .
|
-
- HY-P99151
-
|
TNF Receptor
|
Cancer
|
Brentuximab is a chimeric antibody targeting CD30. Brentuximab can be used for the research of emerging targeted therapies .
|
-
- HY-P9968
-
|
EGFR
|
Cancer
|
Nimotuzumab is a humanized IgG1 monoclonal antibody targeting EGFR with a KD of 0.21 nM. Nimotuzumab is directed against the extracellular domain of the EGFR blocking the binding to its ligands. Nimotuzumab, a strong antitumor agent, is cytolytic on target tumors by its capacity to cause antibody dependent cell mediated cytotoxicity (ADCC) and complement dependent cytotoxicity (CDC) .
|
-
- HY-P9807
-
SARS-CR3022; SARS-CoV-2 Antibody-CR3022
|
SARS-CoV
|
Infection
Inflammation/Immunology
|
Anti-SARS-CoV-2 Spike mAb (CR3022) is a a CHO cell derived human monoclonal IgG1 antibody. It binds to both S1 domain of SARS-CoV/SARS-CoV-2 Spike protein .
|
-
- HY-P99133
-
-
- HY-P99136
-
|
IFNAR
|
Inflammation/Immunology
|
Anti-Mouse IFN gamma Antibody is an anti-mouse IFN gamma IgG antibody inhibitor derived from host Armenian Hamster.
|
-
- HY-P99123
-
|
CD28
|
Inflammation/Immunology
|
Anti-Mouse CD28 Antibody is an anti-mouse CD28 IgG antibody inhibitor derived from the host Syrian Hamster.
|
-
- HY-P99970
-
|
ADC Antibody
|
Others
|
Lifastuzumab is a humanized anti-NaPi2b monoclonal antibody (IgG1 type). Lifastuzumab can be coupled with monomethyl auristatin E (MMAE) through ADC Linker to form an antibody-drug conjugate (ADC) lifastuzumab vedotin (DNIB0600A) with anticancer activity .
|
-
- HY-P99144
-
-
- HY-P99229
-
|
ADC Antibody
|
Cancer
|
Upifitamab is an ADC Antibody (a naked antibody of upifitamab rilsodotin), which can be used for antibody-coupled agent (ADC) synthesis. Upifitamab rilsodotin is an ADC targeting NaPi2b and is used in ovarian cancer research, particularly in platinum-resistant recurrent ovarian cancer .
|
-
- HY-P99976
-
|
CD19
|
Cancer
|
Anti-Mouse CD19 Antibody (1D3) is an anti-mouse CD19 IgG2a antibody inhibitor.
|
-
- HY-P99855
-
BCD-132
|
CD20
|
Inflammation/Immunology
|
Divozilimab (BCD-132) is a humanised monoclonal antibody against CD20 (CD20). Divozilimab can be used for multiple sclerosis research .
|
-
- HY-P99235
-
|
Interleukin Related
|
Cancer
|
Nadunolimab is a human monoclonal IgG1 antibody targeting IL1RAP. Nadunolimab blocks IL-1α and IL-1β signaling and triggering antibody-dependent cellular cytotoxicity. Nadunolimab can be used in research of cancer .
|
-
- HY-P9803
-
SARS-80R; SARS Antibody-80R
|
SARS-CoV
|
Infection
|
Anti-SARS-80R mAb (SARS-80R) is a human monoclonal IgG1 antibody produced in CHO cells. Anti-SARS-80R mAb can specifically bind to Spike (S1) protein to prevent SARS virus infection of susceptible cells .
|
-
- HY-P9969
-
EMD 72000
|
EGFR
|
Cancer
|
Matuzumab (EMD 72000) is a humanized anti-EGFR monoclonal antibody that blocks EGFR activation and downstream signaling, inhibits tumor growth .
|
-
- HY-P9981
-
XmAb5574; MOR00208; Tafasitamab-cxix
|
Apoptosis
|
Inflammation/Immunology
Cancer
|
Tafasitamab (XmAb5574) is an Fc-modified, humanized monoclonal antibody that binds to the human B-cell surface antigenCD19 .
|
-
- HY-P99616
-
MOR-202
|
CD38
|
Cancer
|
Felzartamab (MOR-202) is a human monoclonal antibody that targets CD38 and can be used in multiple myeloma research .
|
-
- HY-P99999
-
|
HIV
|
Infection
|
Anti-Mouse CD4 Antibody (YTS 191) is anti-mouse CD4 IgG2b antibody inhibitor derived from host Rat.
|
-
- HY-P99287
-
B-E8; Anti-IL-6 MAB B-E8; Anti-Human IL6 Recombinant Antibody
|
Interleukin Related
|
Inflammation/Immunology
Cancer
|
Elsilimomab (B-E8) is a IgG1 monoclonal antibody against interleukin-6 (IL-6), with a KD of 22 pM and an IC50 of 1.4 nM. Elsilimomab can be used for the research of multiple myeloma, renal cell carcinoma, and rheumatoid arthritis (RA) .
|
-
- HY-P9998
-
UB421
|
HIV
|
Cancer
|
Semzuvolimab is a murine IgG1κ antibody, targeting to p55, T cell surface antigen T4/Leu-3 (CD4). Murine CD4 antibodies can neutralize HIV infection and have the potential to inhibit HAART stable HIV infection .
|
-
- HY-P99124
-
-
- HY-P99760
-
BCD-145
|
CTLA-4
|
Cancer
|
Nurulimab (BCD-145) is an anti-cytotoxic T lymphocyte antigen-4 (anti-CTLA-4) human monoclonal antibody. Nurulimab can be can be used in research of melanoma .
|
-
- HY-P990004
-
|
Tim3
|
Cancer
|
Anti-Mouse TIM-3 Antibody (B8.2C12) is an anti-mouse TIM-3 antibody inhibitor. Anti-Mouse TIM-3 Antibody (B8.2C12) is an antibody of rat IgG2a subtype .
|
-
- HY-P99148
-
-
- HY-P99779
-
-
- HY-P9801
-
SARS-CoV-2 (2019-nCoV) Spike RBD Antibody
|
SARS-CoV
|
Infection
|
Anti-Spike-RBD mAb is a CHO cell derived human monoclonal IgG1 antibody. Blocking the interaction of Spike protein and ACE2. Anti-Spike-RBD mAb is a potential therapeutic approach for SARS-CoV-2 treatment .
|
-
- HY-P99149
-
-
- HY-P99132
-
-
- HY-P99478
-
|
IFNAR
|
Inflammation/Immunology
|
Bifarcept is a recombinant antibody of interferon receptor type I (IFN-RI). Bifarcept can bind IFN-β and prolong its serum half-life .
|
-
- HY-P99638
-
-
- HY-P9976
-
|
Apoptosis
|
Cancer
|
Isatuximab is a monoclonal antibody targeting the transmembrane receptor and ectoenzyme CD38, a protein highly expressed on hematological malignant cells, including those in multiple myeloma (MM). Isatuximab has antitumor activity via multiple biological mechanisms, including antibody-dependent cellular-mediated cytotoxicity, complement-dependent cytotoxicity, antibody-dependent cellular phagocytosis, and direct induction of apoptosis without crosslinking. Isatuximab also directly inhibits CD38 ectoenzyme activity, which is implicated in many cellular functions .
|
-
- HY-P9922
-
IMC-3G3; LY3012207
|
PDGFR
|
Cancer
|
Olaratumab (IMC-3G3; LY3012207) is an anti-platelet-derived growth factor receptor alpha (PDGFRα) human monoclonal IgG1 antibody with antitumor activity .
|
-
- HY-D1710
-
|
Microtubule/Tubulin
|
Others
|
Anti-α-Tubulin Antibody, AF555 conjugate is a conjugate of mouse anti-α-tubulin monoclonal antibody and the red fluorescent dye Alexa Fluor 555. Anti-α-Tubulin Antibody, AF555 conjugate can be used for the detection of tubulin (Ex/Em: 554/567 nm) .
|
-
- HY-P99210
-
CDP 6038; OKZ
|
Interleukin Related
|
Inflammation/Immunology
|
Olokizumab (CDP 6038) is a humanized monoclonal antibody targeting the interleukin-6 (IL-6). Olokizumab can be used in research of rheumatoid arthritis (RA) .
|
-
- HY-P99325
-
IDEC-131; Anti-Human CD40 ligand Recombinant Antibody
|
TNF Receptor
|
Inflammation/Immunology
|
Toralizumab (IDEC-131) is a humanized monoclonal antibody (mAb) against CD40L (CD154) comprised of human gamma 1 heavy chains and human kappa light chains. Toralizumab binds specifically to human CD40L on T cells, thereby preventing CD40 signaling. Toralizumab, a immunosuppressive agent, has the potential for active systemic lupus erythematosus (SLE) research .
|
-
- HY-P99138
-
-
- HY-P9805
-
MERS-3A1; MERS Antibody-3A1
|
SARS-CoV
|
Infection
|
Anti-MERS-3A1 mAb (MERS-3A1) is a human monoclonal IgG1 antibody with the high binding affinity produced in CHO cells.
Anti-MERS-3A1 mAb bocks the binding of MERS-CoV spike protein to DPP4 receptor .
|
-
- HY-P99134
-
-
- HY-P99139
-
-
- HY-P99825
-
-
- HY-P9999
-
RG6102; RO-7126209
|
Amyloid-β
|
Neurological Disease
|
Trontinemab is a bispecific and humanizedized IgG1-κ antibody, targeting to amyloid beta A4 precursor protein (APP) and transferrin receptor, p90, CD71 (TFRC). Trontinemab can be used for research on Alzheimer disease (AD) .
|
-
- HY-P99729
-
GSK 3772847; CNTO-7160
|
Interleukin Related
|
Inflammation/Immunology
|
Melrilimab (GSK 3772847) is an IgG2-kappa anti-IL1RL1/ST2/IL33R/DER4/FIT-1 monoclonal antibody. Melrilimab can be used for the research of asthma .
|
-
- HY-P99379
-
CAN04; Anti-IL-1RAP/IL-1R3 Reference Antibody (nidanilimab)
|
Interleukin Related
|
Cancer
|
Nidanilimab (CAN04) is a fully humanized monoclonal anti-IL1RAP antibody with a Kd value of 1.10 pM. Nidanilimab blocks IL1α and IL1β signaling and stimulates the immune system to destroy tumour cells. Nidanilimab can be used in research of non-small lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC) .
|
-
- HY-P99350
-
AMG 910; Anti-Human CD3xClaudin18 2
|
CD3
|
Cancer
|
Gresonitamab (AMG 910) is a half-life extended (HLE) bispecific T-cell engager (BiTE) antibody targets CD3-positive T cells and CLDN18.2-expressing tumor cells. Gresonitamab can be used for the research of adenocarcinoma .
|
-
- HY-P99246
-
-
- HY-P99380
-
ZW 25
|
EGFR
|
Cancer
|
Zanidatamab (ZW25) is a humanised, bispecific monoclonal antibody targeting 2 distinct HER2 epitopes (ECD2 and ECD4). Zanidatamab has anti-tumour activity .
|
-
- HY-P9906
-
Anti-Human VEGF, Humanized Antibody
|
VEGFR
|
Cancer
|
Bevacizumab, a humanized IgG1 monoclonal antibody, specifically binds to all VEGF-A isoforms with high affinity.
|
-
- HY-P9802
-
SARS-CoV-2 (2019-nCoV) Single-Domain Antibodies; Humanized Single Domain Antibody
|
SARS-CoV
|
Infection
|
Anti-Spike-RBD Single Domain mAb is a CHO cell derived Alpaca monoclonal VHH-huFc antibody, specifically binds to SARS-CoV-2 RBD with high affinity .
|
-
- HY-P99140
-
-
- HY-P99628
-
|
EGFR
|
Cancer
|
Futuximab is a chimeric monoclonal antibody targeting non-overlapping epitopes on EGFR. Futuximab has antineoplastic activity .
|
-
- HY-P99022
-
|
Amyloid-β
|
Neurological Disease
|
Gantenerumab is a fully human anti-amyloid-β (Aβ) IgG1 monoclonal antibody demonstrates sustained cerebral amyloid-β binding. Gantenerumab can be used for Alzheimer's disease research .
|
-
- HY-P9902
-
MK-3475; Lambrolizumab
|
PD-1/PD-L1
|
Cancer
|
Pembrolizumab (MK-3475) is a humanized IgG4 antibody inhibiting the programmed cell death 1 (PD-1) receptor, used in cancer immunotherapy.
|
-
- HY-P9938
-
|
CGRP Receptor
|
Others
|
Erenumab is a fully human monoclonal antibody. Erenumab inhibits the calcitonin gene–related peptide (CGRP) receptor. Erenumab can be used for the prevention of episodic migraine .
|
-
- HY-P99695
-
CAT-152
|
TGF-beta/Smad
|
Neurological Disease
|
Lerdelimumab (CAT-152) is an IgG4 human anti-TGF-β2 recombinant monoclonal antibody. Lerdelimumab can be used as an anti-scarring agent for glaucoma research .
|
-
- HY-P99592
-
AMG 110; MT110
|
CD3
|
Cancer
|
Solitomab (AMG 110) is a bispecific anti-CD3 and anti-epithelial-cell-adhesion-molecule (EpCAM) antibody. Solitomab can be used for the research of primary uterine and ovarian carcinosarcoma cancer .
|
-
- HY-108730
-
Anti-Human PD-L1, Human Antibody; MSB 0010718C; MSB0010718C
|
PD-1/PD-L1
|
Inflammation/Immunology
Cancer
|
Avelumab is a fully human IgG1 anti-PD-L1 monoclonal antibody with potential antibody-dependent cell-mediated cytotoxicity.
|
-
- HY-P9908
-
-
- HY-P990107
-
|
Others
|
Inflammation/Immunology
|
Anti-Mouse/Human/Rat/Monkey/Hamster/Canine/Bovine TGF-β Antibody (1D11) is an anti-mouse/human/rat/monkey/hamster/canine/bovine IgG antibody inhibitor of TGF-β .
|
-
- HY-P99205
-
|
ADC Antibody
|
Cancer
|
Glembatumumab is a fully human IgG2 monoclonal antibody directed against the extracellular structural domain of GPNMB expressed in human breast cancer and melanoma. Glembatumumab can be coupled to the microtubule inhibitor monomethyl auristatin E to form glembatumumab vedotin. Glembatumumab vedotin is an antibody-agent coupling (ADC) with antitumor activity .
|
-
- HY-P99556
-
AZD8895
|
SARS-CoV
|
Infection
|
Tixagevimab (AZD8895) is a human monoclonal antibody that targets the SARS-CoV-2 receptor binding domain (RBD). It exhibits neutralizing activity against SARS-CoV-2 by binding to the RBD and the S-glycoprotein ectodomain and blocking S-glycoprotein-mediated binding to the receptor .
|
-
- HY-P99043
-
|
Notch
|
Cancer
|
Rovalpituzumab is a humanized monoclonal antibody against delta-like protein 3 (DLL3). Rovalpituzumab can be used in the synthesis of antibody-drug conjugate (ADC), Rovalpituzumab Tesirine . Rovalpituzumab has activity against small cell lung cancer (SCLC) .
|
-
- HY-P99137
-
|
IFNAR
|
Inflammation/Immunology
|
Anti-Mouse IFNAR1 Antibody (MAR1-5A3) is a neutralizing antibody of IFNAR1. Anti-Mouse IFNAR1 Antibody (MAR1-5A3) reacts with IFNAR1 and inhibits IFNAR1 signaling in vitro and in vivo. Mouse IgG1 kappa, Isotype Control (HY-P99977) is the isotype control of Anti-Mouse IFNAR1 Antibody (MAR1-5A3) .
|
-
- HY-P99017
-
|
CGRP Receptor
|
Others
|
Eptinezumab is a human monoclonal antibody. Eptinezumab binds to calcitonin gene-related peptide (CGRP) and blocks its binding to the receptor. Eptinezumab can be used for the prevention of migraine in adults .
|
-
- HY-P99773
-
-
- HY-P9961
-
|
CD20
|
Cancer
|
Ofatumumab is a fully human anti-CD20 monoclonal antibody that induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity in CD20-expressing B lymphocytes .
|
-
- HY-P99514
-
AGEN1884
|
CTLA-4
|
Cancer
|
Zalifrelimab (AGEN1884) is a fully human IgG1 monoclonal antibody targeting CTLA-4 (CTLA-4). Zalifrelimab antagonizes the inhibitory checkpoints of immune cell activation regulated by CTLA-4 signaling .
|
-
- HY-P99538
-
LFB-R603; TG-1101; TGTX-1101
|
CD20
|
Cancer
|
Ublituximab (LFB-R603; TG-1101; TGTX-1101) is a next-generation, type 1 chimeric monoclonal antibody targeting a unique epitope on the CD20 antigen. Ublituximab has anticancer effects .
|
-
- HY-P99102
-
10-1074
|
HIV
|
Infection
|
Zinlirvimab is a human IgG1-λ2, HIV neutralising antibody targeting to HIV-1 gp120 envelope glycoprotein (IIIB gp120 V3 loop) .
|
-
- HY-P99241
-
PF 06946860
|
TGF-beta/Smad
|
Cancer
|
Ponsegromab (PF 06946860) is a potent and selective humanized anti-GDF15 antibody inhibitor with anti-cachexia activity. Ponsegromab binds to GDF15 and prevents the binding of GDF15 to GFRAL, thereby blocking GDF15/GFRAL-mediated signaling. Ponsegromab can be used in the research of cancers .
|
-
- HY-P99417
-
UCB4144; VR 942
|
Interleukin Related
|
Inflammation/Immunology
|
Abrezekimab (VR 942) contains CDP7766, a humanized, high-affinity, neutralizing, anti-human-IL-13 antibody fragment that binds to IL-13. Abrezekimab prevents binding to the IL-13Rα1 subunit. Abrezekimab can be used in research of asthma .
|
-
- HY-P99027
-
LAG525; IMP701
|
LAG-3
|
Cancer
|
Ieramilimab (LAG525; IMP701) is a humanized IgG4 monoclonal antibody that binds to LAG-3, resulting in inhibition of LAG-3 interaction with MHC-II molecules .
|
-
- HY-P99465
-
BAY 1093884
|
Thrombin
|
Cardiovascular Disease
|
Befovacimab (BAY 1093884) is a fully human monoclonal IgG2 antibody able to bind to tissue factor pathway inhibitor (TFPI). Befovacimab can be used for haemophilia A/B research .
|
-
- HY-P99169
-
TJ004309
|
CD73
|
Cancer
|
Uliledlimab is a potent against CD73 humanizedized monoclonal antibody. Uliledlimab inhibits the conversion of extracellular adenosine monophosphate (AMP) to adenosine. Uliledlimab can be used in research of cancer .
|
-
- HY-P99936
-
LJM716
|
EGFR
|
Cancer
|
Elgemtumab(LJM716) is a fully human IgG monoclonal antibody. Elgemtumab can specifically bind to HER3, block ligand-dependent and independent HER3 signal transduction and cell proliferation, and has good anti-tumor potential .
|
-
- HY-P99355
-
Anti-ACVR2B Reference Antibody; BYM338
|
TGF-β Receptor
|
Metabolic Disease
|
Bimagrumab (Anti-ACVR2B Reference Antibody) is a human monoclonal antibody that blocks activin type II receptor (ActRII), with KDs of 1.7 pM and 434 pM for human ActRIIB and ActRIIA, respectively. Bimagrumab can be used for the research of pathological muscle loss and weakness .
|
-
- HY-P99012
-
|
Interleukin Related
SARS-CoV
|
Infection
Inflammation/Immunology
|
Clazakizumab is a monoclonal antibody with high affinity and specificity for the IL-6 (interleukin-6) cytokine. Clazakizumab may be helpful in inhibiting the cytokine response to SARS-CoV-2 in COVID-19. Clazakizumab can be used for the research of psoriatic arthritis (PsA) and renal antibody-mediated rejection .
|
-
- HY-P99624
-
CR4098
|
RABV
|
Infection
|
Foravirumab (CR4098) is a monoclonal antibody against rabies virus glycoprotein antigenic site III .
|
-
- HY-P99467
-
BMS 4182137; VIR 7832
|
SARS-CoV
|
Infection
|
Beludavimab (BMS 4182137; VIR 7832) is a monoclonal antibody targeting the spike glycoprotein of SARS-CoV-2. Beludavimab binds to recombinant spike protein receptor-binding domain (S-RBD) with an EC50 value of 14.9 ng/mL and a Kd of 0.21 nM .
|
-
- HY-P99904
-
MEDI-507
|
CD2
|
Inflammation/Immunology
|
Siplizumab (MEDI-507) is a humanized IgG1 monoclonal antibody against CD2. Siplizumab depletes T cells, decreases T cell activation, inhibites T cell proliferation and enriches naïve and bona fide regulatory T cells .
|
-
- HY-P9906A
-
Anti-Human VEGF, Humanized Antibody (PBS)
|
VEGFR
|
Cancer
|
Bevacizumab, a humanized IgG1 monoclonal antibody, specifically binds to all VEGF-A isoforms with high affinity .
|
-
- HY-P99889
-
BRII-198
|
SARS-CoV
|
Infection
|
Romlusevimab (BRII-198) is a neutralizing recombinant human IgG1 monoclonal antibody against the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) .
|
-
- HY-P99057
-
CDX-1127
|
TNF Receptor
|
Cancer
|
Varlilumab (CDX-1127) is a first-in-class human IgG1 anti-CD27 monoclonal antibody. Varlilumab has an anti-tumor activity .
|
-
- HY-P99405
-
PRX 002; RG 7935; RO 7046015
|
α-synuclein
|
Neurological Disease
|
Prasinezumab (PRX 002) is a humanized IgG1 monoclonal antibody directed against aggregated α-synuclein. Prasinezumab has the potential for Parkinson's disease research .
|
-
- HY-P99710
-
BI 767551; DZIF-10c
|
SARS-CoV
|
Infection
|
Lomtegovimab (BI 767551) is a human anti-SARS-COV-2 spike glycoprotein monoclonal antibody. Lomtegovimab binds and neutralizes SARS-CoV-2. Lomtegovimab shows antiviral efficacy. Lomtegovimab has the potential for the research of COVID-19 .
|
-
- HY-P99185
-
|
Amyloid-β
|
Neurological Disease
|
Bapineuzumab is an anti-β-amyloid protein (APP) monoclonal antibody. Bapineuzumab can be used for the research of Alzheimer’s disease (AD) .
|
-
- HY-P99119
-
-
- HY-P99474
-
CAT 213; iCo-008
|
CCR
|
Inflammation/Immunology
|
Bertilimumab (CAT 213; iCo-008) is a human monoclonal antibody targeting eotaxin-1 (CCL11). Bertilimumab has the potential for allergic disorders research .
|
-
- HY-P9913
-
Anti-Human CD20 type I, Chimeric Antibody
|
CD20
|
Inflammation/Immunology
Cancer
|
Rituximab is an anti-CD20 chimeric monoclonal antibody used for research of certain autoimmune diseases and cancer.
|
-
- HY-P9940
-
|
Factor VIII
|
Cardiovascular Disease
|
Emicizumab is a bispecific monoclonal antibody that bridges activated factor IX and factor X to replace the function of missing activated factor VIII, thereby restoring hemostasis. Emicizumab can be used for hemophilia A research .
|
-
- HY-P9963
-
Anatumomab
|
CD19
|
Cancer
|
Blinatumomab (Anatumomab) is a bispecific monoclonal antibody which can specifically targets the CD19 antigen present on B cells. Blinatumomab can be used for the research of acute lymphoblastic leukemia .
|
-
- HY-P99025
-
|
Interleukin Related
|
Inflammation/Immunology
|
Lebrikizumab is an IgG4 humanized monoclonal antibody that specifically binds to interleukin-13 (IL-13) and inhibits its function. Lebrikizumab can be used for the research of asthma .
|
-
- HY-P99631
-
CSL312
|
Factor Xa
|
Cardiovascular Disease
|
Garadacimab (CSL312) is a first-in-class, fully human IgG4 monoclonal antibody targeting activated factor XII (FXIIa). Garadacimab has the potential for hereditary angioedema research .
|
-
- HY-P99305
-
-
- HY-P9909
-
-
- HY-P99244
-
ILV 094
|
Interleukin Related
|
Inflammation/Immunology
|
Fezakinumab is an interleukin-22 (IL-22) monoclonal antibody. Fezakinumab can be used for the research of inflammatory disease, such as psoriasis and rheumatoid arthritis .
|
-
- HY-P99891
-
|
Integrin
|
Cardiovascular Disease
|
Rovelizumab is a humanized monoclonal leukointegrin antibody. Rovelizumab is a monoclonal antibody directed against the CD11/CD18 cell adhesion proteins. Rovelizumab can be used for research of multiple sclerosis (MS), hemorrhagic shock, myocardial infarction (MI) and stroke .
|
-
- HY-P99316
-
-
- HY-P99053
-
|
Interleukin Related
|
Inflammation/Immunology
|
Tralokinumab, a fully human IgG4 monoclonal antibody, specifically binds with high affinity to IL-13 alone, preventing its interaction with the receptor and subsequent downstream signalling. Tralokinumab can be used for the research of the atopic dermatitis (AD) .
|
-
- HY-P99364
-
Anti-VEGFR1/FLT1 Reference Antibody; IMC-18F1
|
VEGFR
|
Cancer
|
Icrucumab (Anti-VEGFR1/FLT1 Reference Antibody; IMC-18F1) is a human Anti-VEGFR-1 IgG1 monoclonal antibody. Icrucumab has the potential for the research of advanced solid tumors .
|
-
- HY-P99040
-
JNJ-61610588
|
PD-1/PD-L1
|
Cancer
|
Onvatilimab (JNJ-61610588) is a human IgG1κ anti-VISTA (V-domain Ig Suppressor of T-cell Activation) monoclonal antibody. Onvatilimab has an anti-tumor activity .
|
-
- HY-P99859
-
LY3002813
|
Amyloid-β
|
Neurological Disease
|
Donanemab (LY3002813) is a humanized IgG1 monoclonal antibody directed at an N‐terminal pyroglutamate amyloid beta (Aβ) epitope. Donanemab has the potential for early Alzheimer's disease research .
|
-
- HY-P99589
-
16B5; AB-16B5
|
Apoptosis
|
Cancer
|
Sotevtamab (16B5) is a humanized IgG2 anti-clusterin monoclonal antibody (mAb). Sotevtamab is an inhibitor of the epithelial to mesenchymal transition. Sotevtamab can be used for cancer research .
|
-
- HY-P990106
-
|
VEGFR
|
Cancer
|
Anti-Mouse VEGFR-2 Antibody (DC101) is a potent VEGFR2 inhibitor that can be used for the research of papilloma .
|
-
- HY-P99425
-
-
- HY-P99162
-
CIM331
|
Interleukin Related
|
Inflammation/Immunology
|
Nemolizumab (CIM331) is a humanized antihuman interleukin-31 receptor A monoclonal antibody that inhibits the binding of interleukin-31 (IL-31) to its receptor and subsequent signal transduction. Nemolizumab can used be in research of atopic dermatitis (AD) .
|
-
- HY-P99302
-
Humanized Anti-CD28 Recombinant Antibody
|
CD28
|
Inflammation/Immunology
|
Lulizumab (Humanized Anti-CD28 Recombinant Antibody) is a selective CD28 blockade, Lulizumab prevents T cell activation by selectively targeting CD28 signaling .
|
-
- HY-P99563
-
LY 3090106
|
TNF Receptor
Interleukin Related
|
Inflammation/Immunology
|
Tibulizumab (LY 3090106) is a tetravalent bispecific monoclonal antibody targeting B-cell activating factor (BAFF) and IL-17A with Kd values of 60 pM and 14 pM, respectively. Tibulizumab can be used for autoimmune disease research .
|
-
- HY-P99116
-
RG7716
|
VEGFR
|
Metabolic Disease
|
Faricimab is a bispecific antibody targeting angiopoietin-2 and vascular endothelial growth factor-A (VEGF-A). Faricimab can be used for diabetic macular edema (DME) research .
|
-
- HY-P99166
-
|
PD-1/PD-L1
CTLA-4
|
Inflammation/Immunology
|
Vudalimab is a potent dual PD-1 and CTLA-4 inhibitor as a fully humanized bispecific monoclonal antibody. Vudalimab targets immune checkpoint receptors PD-1 and CTLA-4 and promotes tumor-selective T-cell activation .
|
-
- HY-P99961
-
JS004
|
CD28
|
Cancer
|
Tifcemalimab (JS004) is a humanized anti-BTLA (B and T lymphocyte attenuation factor) monoclonal antibody. Tifcemalimab blocks the interaction of HVEM-BTLA by binding to BTLA, and thus blocks the inhibitory signaling pathway mediated by BTLA. Tifcemalimab can be used in research of cancer .
|
-
- HY-P99117
-
AK104
|
PD-1/PD-L1
|
Cancer
|
Cadonilimab (AK104) is a targeting PD1/CTLA4 IgG1 scaffold Fc-engineered humanized antibody. Cadonilimab can be used for researching metastatic cervical cancer .
|
-
- HY-P99021
-
LY 2951742
|
CGRP Receptor
|
Neurological Disease
|
Galcanezumab (LY 2951742) is a humanized IgG4 monoclonal antibody against the CGRP ligand. Galcanezumab can be used for migraine or cluster headaches research .
|
-
- HY-P9944
-
MEDI 493
|
RSV
|
Infection
|
Palivizumab (MEDI 493), a humanized respiratory syncytial virus monoclonal antibody, reduces respiratory syncytial virus (RSV) infection .
|
-
- HY-P99786
-
REGN3918
|
Complement System
|
Metabolic Disease
|
Pozelimab (REGN3918) is a fully human IgG4 anti-C5 monoclonal antibody. Pozelimab binds to C5 and C5 variants with high affinity and blocks complement-mediated hemolysis. Pozelimab can be used for the research of complement-mediated diseases .
|
-
- HY-P99308
-
AME 133v; LY 2469298; Humanized Anti-MS4A1 Recombinant Antibody
|
CD20
|
Cancer
|
Ocaratuzumab (AME 133v) is an Fc-engineered humanized IgG1 anti-CD20 monoclonal antibody, with a Kd of ~100 pM. Ocaratuzumab exhibits more effective antibody-dependent cell-mediated cytotoxicity (ADCC) .
|
-
- HY-P99356
-
BIIB054; Anti-Alpha-synuclein Reference Antibody (cinpanemab)
|
α-synuclein
|
Neurological Disease
|
Cinpanemab (BIIB054) is a human-derived monoclonal antibody that binds to α-synuclein. Cinpanemab can be used for the research of Parkinson's disease .
|
-
- HY-P990104
-
|
Notch
|
Inflammation/Immunology
Cancer
|
Anti-DLL3 Antibody (anti-DLL3 arm derived from AMG-757) is the anti-DLL3 arm of the bispecific T-cell engager (BiTE) antibody-Tarlatamab (AMG-757) (HY-P99575). Tarlatamab targets both DLL3 and CD3.
|
-
- HY-P99969
-
|
EGFR
|
Cancer
|
Inetetamab is a monoclonal antibody binding to domain IV of HER2 receptor. Inetetamab alone or together with tyrosine kinase inhibitors has antitumor activities .
|
-
- HY-P9993
-
LY-3462817
|
PD-1/PD-L1
|
Cancer
|
Peresolimab is a humanized IgG1-κ antibody targeting to PD-1. Peresolimab potentially stimulates physiological immune inhibitory pathways to restore immune homeostasis .
|
-
- HY-P99326
-
Anti-Human CD20 Recombinant Antibody
|
CD20
|
Cancer
|
Tositumomab is a murine IgG2a lambda monoclonal antibody directed against the CD20 antigen, which is found on the surface of normal and malignant B lymphocytes .
|
-
- HY-P99750
-
CT-P23
|
Influenza Virus
|
Infection
|
Navivumab (CT-P23) is an influenza A virus hemagglutinin HA monoclonal antibody. neutralizes H1, H2, H5, and H9 influenza A viruses by binding to the stem fusion domain in HA2 .
|
-
- HY-P99639
-
APL-501; CBT-501; GB-226
|
PD-1/PD-L1
|
Cancer
|
Geptanolimab (CBT-501) is a humanized IgG4k monoclonal antibody against programmed death-1 (PD-1). Siplizumab inhibits the binding of PD-L1/L2 to PD-1 through a competitive action. Siplizumab can be used in research of cancer .
|
-
- HY-P99274
-
BI 836845; Anti-Human IGF1 and IGF2 Recombinant Antibody
|
IGF-1R
|
Cancer
|
Xentuzumab (Anti-Human IGF1 and IGF2 Recombinant Antibody; BI836845) is a recombinant a human monoclonal antibody that targets IGF ligands IGF1 and IGF2. Xentuzumab inhibits both of IGF1 and IGF2 growth-promoting signalling and suppresses AKT activation .
|
-
- HY-P99632
-
REGN 2477
|
TGF-β Receptor
|
Inflammation/Immunology
|
Garetosmab (REGN 2477) is a fully human IgG4 monoclonal antibody that specifically inhibits activin A. Garetosmab can be used for fibrodysplasia ossificans progressiva (FOP) research .
|
-
- HY-P99357
-
REGN1193; Anti-GCGR Reference Antibody (crotedumab)
|
GCGR
|
Metabolic Disease
|
Crotedumab (REGN1193) is a fully human IgG4 monoclonal antibody that binds and inhibits glucagon receptor (GCGR), with a KD of 0.1 nM. Crotedumab can be used for the research of diabetes .
|
-
- HY-P99103
-
LY-3853113; LY-COV1404
|
SARS-CoV
|
Infection
|
Bebtelovimab a humanized IgG1-λ2 antibody targeting to SARS-CoV-2, especially COVID-19. Bebtelovimab potently neutralizes SARS-CoV-2 variants, and inhibits COVID-19 with mild-to-moderate efficacy .
|
-
- HY-P99399
-
RG 6100; RO7105705; MTAU-9937A
|
Tau Protein
|
Neurological Disease
|
Semorinemab (RG 6100) is an anti-Tau humanized IgG4 monoclonal antibody, targets the N-terminal portion of the Tau protein (amino acid residues 6-23). Semorinemab binds with human Tau with a Kd value of 3.8 nM. Semorinemab can be used for the research of Alzheimer's Disease .
|
-
- HY-P99509
-
-
- HY-P99028
-
TMB-355; TNX-355
|
HIV
|
Infection
|
Ibalizumab (TMB-355) is a humanised IgG4 monoclonal antibody that prevents HIV cell entry by binding to CD4 receptor. Ibalizumab has the potential for HIV-1 infection research .
|
-
- HY-P99038
-
|
CD20
|
Inflammation/Immunology
Cancer
|
Odronextamab is a hinge-stabilised, fully human IgG4-based CD20 × CD3 bispecific antibody that binds CD3 on T cells and CD20 on B cells .
|
-
- HY-P99191
-
NI-0501
|
IFNAR
|
Inflammation/Immunology
|
Emapalumab (NI-0501) is a human monoclonal IgG1 antibody that noncompetitively inhibits IFN-γ. Emapalumab binds with high affinity (Kd= 1.4 pM) to both free IFN-γ as well as IFN-γ bound to its receptor. Emapalumab can be used in research of hemophagocytic lymphohistiocytosis (HLH) .
|
-
- HY-P99280
-
Anti-Human IL17A/IL-17F Recombinant Antibody
|
Interleukin Related
|
Inflammation/Immunology
|
Bimekizumab (Anti-Human IL17A/IL-17F Recombinant Antibody) is a humanised monoclonal antibody, can selectively neutralises IL-17A and IL-17F. Both of them are pro-osteogenic with respect to human periosteum-derived cell (hPDC) differentiation. Thus Bimekizumab blocks the inflammation-driven osteogenic differentiation .
|
-
- HY-P99207
-
KB 003
|
SARS-CoV
|
Cancer
|
Lenzilumab (KB 003) is a human monoclonal antibody targeting CSF2/GM-CSF for COVID-19, chronic myelomonocytic leukemia (CMML) and juvenile myelomonocytic leukemia (JMML) studies .
|
-
- HY-P99471
-
UCB 0107
|
Tau Protein
|
Neurological Disease
|
Bepranemab (UCB 0107) is a humanized, full-length IgG4 monoclonal antibody that binds to a central tau epitope (amino acids 235-250). Bepranemab can be used for Alzheimer’s disease (AD) research .
|
-
- HY-P9907
-
Anti-Human HER2, Humanized Antibody
|
EGFR
ADC Antibody
|
Cancer
|
Trastuzumab is a humanized IgG1 monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab has the potential for HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer research.
|
-
- HY-P99262
-
BAX69; Anti-Human MIF Recombinant Antibody
|
Macrophage migration inhibitory factor (MIF)
|
Cancer
|
Imalumab (BAX69) is a recombinant, human IgG1 monoclonal antibody that targets macrophage inhibitory factor (MIF). Imalumab can be used for the research of ovarian carcinoma, recurrent malignant ascites and cancer .
|
-
- HY-P99023
-
G250; cG250
|
Carbonic Anhydrase
|
Cancer
|
Girentuximab (G250) is a chimeric monoclonal antibody that binds carbonic anhydrase IX (CAIX), a cell surface glycoprotein ubiquitously expressed in clear cell renal cell carcinoma (ccRCC) .
|
-
- HY-P9967
-
BIIB037
|
Amyloid-β
|
Neurological Disease
|
Aducanumab (BIIB037) is a human monoclonal antibody that selectively targets aggregated amyloid-beta (Aβ). Aducanumab shows brain penetration, and can be used for Alzheimer's disease (AD) research .
|
-
- HY-P99656
-
MCDS0593A
|
ADC Antibody
|
Cancer
|
Iladatuzumab (MCDS0593A) is a humanized IgG1 anti-human CD79B monoclonal antibody. Iladatuzumab can be used to synthesize antibody-drug conjugates (ADC) Iladatuzumab vedotin (DCDS0780A; HY-P99657), which has the potential for B-cell non-Hodgkin lymphoma (B-NHL) research .
|
-
- HY-P9910
-
GA101; Anti-Human CD20 type II, Humanized Antibody
|
CD20
|
Cancer
|
Obinutuzumab (GA101) a novel glycoengineered Type II CD20 humanized IgG1 monoclonal antibody in development for non-Hodgkin lymphoma.
|
-
- HY-P99145
-
-
- HY-P99415
-
MAA868
|
Factor Xa
|
Cardiovascular Disease
|
Abelacimab (MAA868) is a fully human IgG1 monoclonal antibody that binds with high affinity to the catalytic structural domain of FXI and locks it in the zymogen conformation, thereby preventing its activation by FXIIa or thrombin. Abelacimab can be used in thromboembolic disease studies .
|
-
- HY-P99442
-
Hu1D10
|
Apoptosis
|
Inflammation/Immunology
|
Apolizumab (Hu1D10) is a humanized monoclonal anti-Human leukocyte antigen-DR beta-chain antibody. Apolizumab can mediate apoptosis of chronic lymphocytic leukemia (CLL) cells in vitro .
|
-
- HY-P99521
-
XmAb14045
|
CD3
|
Cancer
|
Vibecotamab (XmAb14045) is a potent bispecific antibody against CD123 and CD3 that stimulates T cell-mediated targeted killing of CD123-expressing cells. Vibecotamab has antitumor activity and can be used in acute myeloid leukaemia studies .
|
-
- HY-P99846
-
QAX576
|
Interleukin Related
|
Inflammation/Immunology
|
Dectrekumab (QAX576) is a human monoclonal antibody that targets IL-13. Dectrekumab significantly improves intraepithelial esophageal eosinophil counts and dysregulated esophageal disease-related transcripts with Eosinophilic esophagitis (EoE) in a sustained manner and can be used for inflammation and immunology related research .
|
-
- HY-P99422
-
SHR-1316
|
PD-1/PD-L1
Apoptosis
|
Cancer
|
Adebrelimab (SHR-1316) is a humanized IgG4 monoclonal PD-L1 (PD-1/PD-L1) antibody. Adebrelimab has promising antitumor activity in solid tumors including extensive-stage small-cell lung cancer (SCLC) .
|
-
- HY-P99462
-
CDX 0159
|
c-Kit
|
Inflammation/Immunology
|
Barzolvolimab (CDX 0159) is a humanized anti-KIT IgG1 monoclonal antibody. Barzolvolimab specificity and potently inhibits KIT activation by SCF. Barzolvolimab can reduce skin mast cells and disease activity in chronic inducible urticaria .
|
-
- HY-P99156
-
BMS-986016
|
LAG-3
|
Cancer
|
Relatlimab (BMS-986016) is a human monoclonal antibody anti-LAG-3 antibody generated by immunization of transgenic mice bearing human immunoglobulin miniloci with recombinant LAG-3 protein. Relatlimab blocks LAG-3/MHC II interaction with an IC50 value of 0.67 nM and LAG-3/FGL1 interaction with an IC50 value of 0.019 nM. Relatlimab can be used in research of cancer .
|
-
- HY-P9989
-
REGN5458
|
CD3
TNF Receptor
|
Cancer
|
Linvoseltamab is a bispecific antibody targeting to both BCMA (TNFRSF17) and CD3 epsilon. Linvoseltamab shows safety profile and encouraging efficacy in relapsed/refractory multiple myeloma (RRMM) models .
|
-
- HY-P9911
-
Anti-Human lymphocyte α4β7 integrin, Humanized Antibody
|
Integrin
|
Inflammation/Immunology
Cancer
|
Vedolizumab is a humanized IgG1 monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease.
|
-
- HY-P99626
-
LY 3015014
|
Ser/Thr Protease
|
Metabolic Disease
|
Frovocimab (LY 3015014) is a humanized IgG4 monoclonal antibody (mAb) that neutralizes PCSK9. Frovocimab inhibits PCSK9 binding to LDL receptor (LDLR) while permitting the normal proteolytic cleavage of the bound intact PCSK9 .
|
-
- HY-P9918
-
Ticilimumab; CP-675206
|
CTLA-4
|
Inflammation/Immunology
Cancer
|
Tremelimumab (Ticilimumab) is a fully human monoclonal antibody specific for cytotoxic T-lymphocyte antigen-4 (CTLA-4) and can be used for metastatic melanoma research .
|
-
- HY-P99307
-
AMG-203; Anti-Human CSF2 Recombinant Antibody
|
c-Fms
|
Inflammation/Immunology
|
Namilumab (AMG203) is a human IgG1 monoclonal antibody that binds with high affinity to the GM-CSF ligand, potently neutralizing GM-CSF. Namilumab can be used for the research of rheumatoid arthritis .
|
-
- HY-P99141
-
-
- HY-P99039
-
MEDI9447
|
CD73
|
Cancer
|
Oleclumab (MEDI9447) is a human IgG1λ monoclonal antibody targeting CD73 and inhibits the exonuclease activity of the extracellular enzyme CD73. Oleclumab can adjust the composition of bone marrow and lymphoid infiltrating leukocyte populations in the tumor microenvironment and has anti-tumor activity .
|
-
- HY-P99424
-
RG 7624; RO 5553110; NI-1401
|
Interleukin Related
|
Inflammation/Immunology
|
Afasevikumab (RG 7624; RO 5553110; NI-1401) is a fully human monoclonal IgG1κ antibody neutralizing both IL-17A and IL-17F. Afasevikumab has anti-inflammatory activities .
|
-
- HY-P99618
-
IBI-315; BH2950
|
EGFR
PD-1/PD-L1
|
Inflammation/Immunology
Cancer
|
Fidasimtamab (IBI-315; BH2950) is a recombinant human IgG1 bispecific antibody that targets, binds and inhibits both HER2 and PD-1 and their downstream signalling pathways, and links PD-1 expressing T cells to HER2 expressing tumour cells. Fidasimtamab has potential immunosuppressive and antitumor activity .
|
-
- HY-P99301
-
Anti-Canine IL31 Recombinant Antibody
|
Interleukin Related
|
Inflammation/Immunology
|
Lokivetmab (Anti-Canine IL31 Recombinant Antibody) is an anti-canine IL-31 monoclonal antibody that can be used for the research of atopic dermatitis (AD) in dogs .
|
-
- HY-P9988
-
BA301
|
ADC Antibody
TAM Receptor
|
Cancer
|
Mecbotamab is a humanized IgG1-κ antibody targeting to AXL receptor tyrosine kinase (AXL). Mecbotamab can serves as a conditionally active biologic (CAB), which can be conjugated with MMAE (HY-15162) via a cleavable linker, to form ADC Mecbotamab vedotin (BA3011) .
|
-
- HY-P99484
-
AGEN 1181
|
CTLA-4
|
Cancer
|
Botensilimab (AGEN 1181), a human anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4) monoclonal antibody, is an innate and adaptive immune activator. Botensilimab can be used for the research of cancer .
|
-
- HY-P99351
-
Anti-MMP9 Reference Antibody (andecaliximab)
|
MMP
|
Cancer
|
Andecaliximab is a recombinant chimeric IgG4 monoclonal antibody (mAb) targets matrix metalloproteinase 9 (MMP9). Andecaliximab shows the antifibrotic efficacy in idiopathic pulmonary fibrosis mouse models. Andecaliximab can be used for the research of gastric adenocarcinoma and idiopathic pulmonary fibrosis (IPF) .
|
-
- HY-P99323
-
BTT 1023; Anti-Human AOC3 Recombinant Antibody
|
AP-1
|
Inflammation/Immunology
|
Timolumab (BTT1023 ), a recombinant fully human monoclonal antibody that specifically binds VAP-1. Timolumab (BTT1023 ) could be used in the study of chronic inflammatory diseases .
|
-
- HY-P99309
-
BSYX-A 110; Anti-S. Epidermidis LTA Recombinant Antibody
|
Bacterial
|
Infection
|
Pagibaximab is a chimeric IgG1 antibody recognizing the surface component lipoteichoic acid of S. aureus and S. epidermidis. Pagibaximab can be used to prevent staphylococcal sepsis .
|
-
- HY-P99016B
-
-
- HY-P99966
-
|
RANKL/RANK
|
Cancer
|
Narlumosbart (JMT103) is an IgG4κ antibody targeting receptor activator of nuclear factor-κB ligand (RANKL) .
|
-
- HY-P99320
-
OMP 59R5; Anti-Human NOTCH2 Recombinant Antibody
|
Notch
|
Cancer
|
Tarextumab (OMP-59R5) is an anti-Notch2/3 fully human IgG2 monoclonal antibody. Tarextumab shows anti-tumor activity .
|
-
- HY-P99318
-
LT 1009; Anti-Human S1P Recombinant Antibody
|
LPL Receptor
|
Cancer
|
Sonepcizumab (LT 1009) is a fully human anti-S1P monoclonal antibody. Sonepcizumab has the potential for the research of metastatic renal cell carcinoma (mRCC) .
|
-
- HY-P9952
-
LymphoStat B
|
TNF Receptor
|
Inflammation/Immunology
|
Belimumab (LymphoStat B) is a human IgG1λ monoclonal antibody that inhibits B-cell activating factor (BAFF). Belimumab can be used for systemic lupus erythematosus (SLE) research .
|
-
- HY-P99052
-
|
PD-1/PD-L1
|
Inflammation/Immunology
Cancer
|
Tislelizumab, a monoclonal antibody with high binding affinity to the PD-1 receptor, minimizes Fcγ receptor binding on macrophages, thereby abrogating antibody-dependent phagocytosis, a mechanism of T cell clearance and potential resistance to anti-PD-1 research. Tislelizumab can be used for the research of advanced squamous non-small-cell lung cancer .
|
-
- HY-P99507
-
MCLA-128; PB4188; R040517
|
EGFR
|
Cancer
|
Zenocutuzumab (MCLA-128) is a bispecific humanized IgG1 antibody containing two different Fab arms, targeting extracellular domains of HER2 and HER3 .
|
-
- HY-P99475
-
MSB-2311
|
PD-1/PD-L1
|
Cancer
|
Betifisolimab (MSB-2311) is a humanized monoclonal antibody directed against the immunosuppressive ligand PD-L1. Betifisolimab has the potential for advanced solid tumors and hematological malignancies research .
|
-
- HY-P9924
-
LY2439821
|
Interleukin Related
|
Inflammation/Immunology
|
Ixekizumab (LY2439821) is a humanized IgG4 monoclonal antibody that selectively binds and neutralizes interleukin IL-17A (KD<3 pM). Ixekizumab directly blocks IL-17A binding to IL-17RA (IL-17A receptor) but does not bind to other IL-17 family members. Ixekizumab is used for the research of moderate-to-severe plaque psoriasis .
|
-
- HY-P99020
-
GC1008
|
TGF-β Receptor
|
Inflammation/Immunology
Cancer
|
Fresolimumab (GC1008) is a high-affinity fully human monoclonal antibody that neutralizes the active form of human TGFβ1, TGFβ2, and TGFβ3. Fresolimumab can be used for the research of cancer and fibrotic diseases .
|
-
- HY-P99110
-
SHP643; DX-2930
|
Ser/Thr Protease
|
Inflammation/Immunology
|
Lanadelumab (SHP643) is a human IgG1 monoclonal antibody against plasma kallikrein (pKal) with an Ki value of 0.12 nM. Lanadelumab inhibits both free and HMWK (high molecular weight kininogen)-bound pKal. Lanadelumab has the potential for the research of hereditary angioedema .
|
-
- HY-P99322
-
LFG316; Anti-Human C5 Recombinant Antibody
|
Complement System
|
Inflammation/Immunology
|
Tesidolumab (LFG316) is a fully-human IgG1/λ anti-C5 monoclonal antibody of 143 kDa (without glycosylation). Tesidolumab (LFG316) blocks cleavage of C5 and prevents subsequent formation of the membrane attack complex .
|
-
- HY-P9931
-
CNTO 1959
|
Interleukin Related
|
Inflammation/Immunology
|
Guselkumab is a recombinant human IgG1 monoclonal antibody against the IL-23p19 subunit. Guselkumab binds to human and cynomolgus monkey IL-23 with Kd values of 3.3 and 1.9 pmol/L, respectively. Guselkumab inhibits production of cytokines lying downstream of the IL-23 signaling pathway and can be used for psoriatic arthritis research .
|
-
- HY-P99261
-
OMP 21M18; Human Anti-TNFRSF10B Recombinant Antibody
|
Notch
|
Cancer
|
Demcizumab (OMP 21M18) is an anti-DLL4 monoclonal antibody. Demcizumab is a potent inhibitor of the Notch pathway. Demcizumab alone or in combination with chemotherapy is effective in various cancer models .
|
-
- HY-P99272
-
BMS 936564; MDX 1338; Anti-Human CXCR4 Recombinant Antibody
|
CXCR
|
Cancer
|
Ulocuplumab (Anti-Human CXCR4 Recombinant Antibody/BMS-936564/MDX1338) is a fully human IgG4 anti-CXCR4 antibody. Ulocuplumab induces apoptosis and inhibits CXCL12 mediated CXCR4 activation-migration of chronic lymphocytic leukemia (CLL). Ulocuplumab exhibits antitumor activity in established tumors including acute myeloid leukemia (AML), non-Hodgkin lymphoma (NHL), and multiple myeloma xenograft models .
|
-
- HY-P99444
-
MSTT 1041A; RG 6149
|
Interleukin Related
|
Inflammation/Immunology
|
Astegolimab (MSTT 1041A; RG 6149) is a human IgG2 monoclonal antibody that blocks IL-33 signaling by targeting ST2, the IL-33 receptor. Astegolimab has the potential for chronic obstructive pulmonary disease (COPD) research .
|
-
- HY-P9907A
-
Anti-Human HER2, Humanized Antibody (PBS)
|
ADC Antibody
EGFR
|
Cancer
|
Trastuzumab (PBS) is a humanized IgG1 monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab (PBS) has the potential for HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer research.
|
-
- HY-P9951
-
RG-6321
|
VEGFR
|
Cardiovascular Disease
|
Ranibizumab (RG-6321) is a humanized anti-VEGF monoclonal antibody fragment and can recognize all VEGF-A isoforms (VEGF110, VEGF121, and VEGF165) . Ranibizumab slows vision loss in vivo and is used for wet age-related macular degeneration (AMD) research .
|
-
- HY-P99238
-
|
Interleukin Related
|
Inflammation/Immunology
Cancer
|
Rolinsatamab is a potent dual IL-4 and IL-13 inhibitor as a fully humanized bispecific monoclonal antibody. Rolinsatamab chimeric antigen receptor sequence T cell. Rolinsatamab can be used in research of immune disease .
|
-
- HY-P99704
-
OCS-02
|
TNF Receptor
|
Inflammation/Immunology
|
Licaminlimab (OCS-02) is a single-chain anti-TNF alpha antibody fragment. TNF alpha is an inflammatory cytokine produced by macrophages and monocytes during inflammation .
|
-
- HY-P99153
-
MORAb-003
|
Antibiotic
|
Cancer
|
Farletuzumab (MORAb-003) is a potent folate receptor-alpha (FRα) inhibitor. Farletuzumab is a humanized monoclonal antibody with high affinity for FRα. Farletuzumab possesses growth-inhibitory functions on cells overexpressing FRα. Farletuzumab can be used in research of cancer .
|
-
- HY-P9915A
-
Anti-Human CD38, Human Antibody (PBS)
|
ADC Antibody
CD38
|
Cancer
|
Daratumumab (PBS) (Anti-Human CD38) is the first-in-class human-specific anti-CD38 monoclonal antibody (IgG1). Daratumumab (PBS) has anti-multiple myeloma (MM) effect. Daratumumab (PBS) impairs MM cell adhesion, which results in an increased sensitivity of MM to proteasome inhibition .
|
-
- HY-P99820
-
NV-01
|
TNF Receptor
|
Inflammation/Immunology
|
Ranevetmab (NV-01) is a caninised anti-NGF monoclonal antibody (mAb). Ranevetmab can alleviate pain, and is used for the research of degenerative joint disease (DJD) pain .
|
-
- HY-P99317
-
Immunoglobulin G1, anti-(human β-amyloid) (human-mouse monoclonAnti-Human Abeta Recombinant Antibody
|
Amyloid-β
|
Neurological Disease
|
Solanezumab is a humanized monoclonal IgG1 antibody directed against the mid-domain of the amyloid-β (Aβ) peptide. Solanezumab has the potential for the research of Alzheimer’s disease .
|
-
- HY-P99155
-
|
EGFR
|
Cancer
|
Zalutumumab is a high affinity, completely human IgG1 monoclonal antibody targeting EGFR. Zalutumumab binds to domain III of the EGF receptor and acts by blocking the binding of EGF and by sterically interfering with the active conformation of the receptor. Zalutumumab binds with IgG and its Fab fragment with EC50s of 7 and 19 nM, respectively. Zalutumumab can be used for the research of cancer .
|
-
- HY-P99353
-
Anti-ACVRL1 / ALK-1 Reference Antibody (ascrinvacumab); PF-03446962
|
Anaplastic lymphoma kinase (ALK)
|
Cancer
|
Ascrinvacumab (PF-03446962) is a human IgG2 monoclonal antibody targets ALK-1. Ascrinvacumab shows binding efficiency with human ALK1 with a Kd value of 7 nM. Ascrinvacumab can be used for the research of hepatocellular carcinoma (HCC) .
|
-
- HY-P99224
-
IMMU-106; hA20
|
Integrin
|
Cancer
|
Veltuzumab (IMMU-106) is a humanized anti-CD20 monoclonal antibody. Veltuzumab has low EC50 value of 0.08-0.09 μg/mL in the Daudi cell line. Veltuzumab can be used for the research of cancer including non-Hodgkin lymphoma (NHL) .
|
-
- HY-P9951A
-
RG-6321 (anti-VEGF)
|
VEGFR
|
Cardiovascular Disease
|
Ranibizumab (RG-6321) (anti-VEGF) is a humanized anti-VEGF monoclonal antibody fragment and can recognize all VEGF-A isoforms (VEGF110, VEGF121, and VEGF165) . Ranibizumab (anti-VEGF) slows vision loss in vivo and is used for wet age-related macular degeneration (AMD) research .
|
-
- HY-P99041
-
ABX-EGF
|
EGFR
|
Cancer
|
Panitumumab (ABX-EGF) is a fully human IgG2 anti-EGFR monoclonal antibody with anti-tumor activity. Panitumumab inhibits tumor cell proliferation, survival and angiogenesis. Panitumumab can be used in the research of cancers, such as colon cancer .
|
-
- HY-P99291
-
LM 609; MEDI 523; Anti-αvβ3 Integrin Recombinant Antibody
|
Integrin
|
Cancer
|
Etaracizumab (LM 609) is an αvβ3 integrin IgG1 monoclonal antibody. Etaracizumab inhibits angiogenesis and melanoma tumor growth. Etaracizumab can be used to research anticancer .
|
-
- HY-P99199
-
NI-0401
|
CD3
|
Inflammation/Immunology
|
Foralumab (NI-0401) is a potent, orally active human monoclonal antibody targeting the CD3. Foralumab modulates immune responses by human cells in NSG mice that were reconstituted with human hematopoietic stem cells .
|
-
- HY-P99437
-
KN-026
|
EGFR
|
Cancer
|
Anbenitamab (KN-026) is a bispecific antibody simultaneously targeting the extracellular domains II and IV of the human HER2. Anbenitamab blocks both ligand-dependent and ligand-independent HER2 signaling pathway. The IgG1 Fc fragment of Anbenitamab binds FcRγIIIa mediates potent antibody dependent cell-mediated cytotoxicity (ADCC) and inhibits tumor cell proliferation. Anbenitamab has the potential for HER2-positive metastatic breast cancer (MBC) research .
|
-
- HY-P99193
-
MEDI-528
|
Interleukin Related
|
Inflammation/Immunology
|
Enokizumab (MEDI-528) is a monoclonal antibody targeting to interleukin (IL)-9. IL-9 regulates the development of airway inflammation, mucus production, airway hyperresponsiveness, and airway fibrosis largely by increasing mast cell numbers and activity in the airways .
|
-
- HY-P99258
-
OMP 52M51; Anti-Human NOTCH1 Recombinant Antibody
|
Notch
|
Cancer
|
Brontictuzumab (OMP 52M51) is a monoclonal antibody (MAb) that inhibits Notch1 signal. Brontictuzumab selectively binds the negative regulatory region of the Notch1. Brontictuzumab inhibits tumor cell proliferation. Brontictuzumab can be used in the research of leukemia and lymphoma .
|
-
- HY-P9972
-
PDR001
|
PD-1/PD-L1
|
Cancer
|
Spartalizumab (PDR001) is a humanized immunoglobulin 4 monoclonal antibody that binds PD-1 with subnanomolar activity and blocks interaction with PD-L1 and PD-L2. Spartalizumab can be used for the research of anaplastic thyroid carcinoma (ATC) .
|
-
- HY-108810
-
Ilaris; ACZ 885
|
Interleukin Related
|
Inflammation/Immunology
|
Canakinumab (ACZ885) is a recombinant human anti-IL-1β monoclonal antibody. Canakinumab shows IC50 values of 43.6 and 40.8 pM for human and marmoset IL-1β, respectively. The mode of action of canakinumab is based on the neutralization of IL-1β signaling, resulting in suppression of inflammation related to disorders of autoimmune origin .
|
-
- HY-P99286
-
PRO 95780; rhuMAb-DR 5; Anti-Human DR5 Recombinant Antibody
|
Apoptosis
|
Cancer
|
Drozitumab (PRO 95780) is a human agonistic monoclonal antibody which binds the death receptor DR5. Drozitumab has potent antitumor activity against rhabdomyosarcoma .
|
-
- HY-P99184
-
|
Integrin
|
Infection
Inflammation/Immunology
Cancer
|
Abrilumab is a fully human monoclonal antibody directed against α4β7. Abrilumab selectively binds the α4β7 integrin heterodimer. Abrilumab can be used for the research of inflammatory bowel disease (IBD) .
|
-
- HY-P99041A
-
|
EGFR
|
Cancer
|
Panitumumab (anti-EGFR) is a fully human IgG2 anti-EGFR monoclonal antibody with anti-tumor activity. Panitumumab (anti-EGFR) inhibits tumor cell proliferation, survival and angiogenesis. Panitumumab (anti-EGFR) can be used in the research of cancers, such as colon cancer .
|
-
- HY-P99152
-
|
CD3
|
Inflammation/Immunology
Cancer
|
Muromonab is a monoclonal antibody targeting the CD3 receptor. Muromonab can block all cytotoxic T cell function. Muromonab also as an immunosuppressant agent given to reduce acute solid organ transplant rejection .
|
-
- HY-P99938
-
HX008
|
PD-1/PD-L1
|
Cancer
|
Pucotenlimab (HX008) is a humanized immunoglobulin G4 (IgG4) anti programmed cell death protein 1 (anti-PD-1) monoclonal antibody. Pucotenlimab can be used for the research of tumor .
|
-
- HY-156897
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
Val-Cit-amide-Ph-Maytansine is an antibody and bispecific antigen-binding mol. that bind hepatocyte growth factor receptor c-Met (MET) or antibody-drug conjugates (ADCs) .
|
-
- HY-P9962
-
|
Fungal
|
Infection
|
Efungumab is a monoclonal antibody with antifungal activity. Efungumab binds to HSP 90, preventing a conformational change needed for fungal viability. Efungumab can be used for research on invasive candidiasis (IC) .
|
-
- HY-P99031
-
CAM 3001
|
c-Fms
|
Cardiovascular Disease
Inflammation/Immunology
|
Mavrilimumab (CAM 3001) is a monoclonal antibody that binds to the α subunit of the granulocyte-macrophage colony stimulating factor (GM-CSF) receptor and blocks intracellular signalling downstream of GM-CSF. GM-CSF might be a mediator of the hyperactive inflammatory response associated with respiratory failure and death .
|
-
- HY-P99377
-
OMP-305B83; Anti-DLL4 Reference Antibody (navicixizumab)
|
Notch
|
Cancer
|
Navicixizumab (OMP-305B83) is a bispecific anti-VEGF and anti-DLL4 inhibitory antibody. Navicixizumab can combine with Paclitaxel (HY-B0015) for cancer research. Navicixizumab can be used in the research of ovarian, primary peritoneal, or fallopian tube cancer .
|
-
- HY-P9954
-
|
CD3
|
Cancer
|
Catumaxomab, a trifunctional IgG2 antibody, is composed of mouse and rat heavy and light chains and binds to human EpCAM and human CD 3 receptors. The Fc region of Catumaxomab region has binding affinity for FcγR1 (CD 64), FcγRIIA (CD 32a), and FcγRIII (CD 16). Catumaxomab can be used for anti-tumor research, especially epithelial cancers .
|
-
- HY-P9957
-
ABthrax
|
Bacterial
|
Infection
|
Raxibacumab (ABthrax) is a human IgG1 monoclonal antibody against Bacillus anthracis protective antigen (PA). Raxibacumab blocks the toxin’s deleterious effects by preventing binding of the protective antigen component of the anthrax toxin to its receptors in host cells, thereby blocking the toxin’s deleterious effects. Raxibacumab can be used for anti-anthrax research .
|
-
- HY-P99941
-
|
PD-1/PD-L1
|
Cancer
|
Retifanlimab is an anti-programmed cell death protein 1 (anti-PD-1) monoclonal antibody (mAb). Retifanlimab can be used for the research of gastroesophageal adenocarcinoma (GEA) .
|
-
- HY-156896
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
Val-Cit-amide-Cbz-N(Me)-Maytansine is an antibody and bispecific antigen-binding mol. that bind hepatocyte growth factor receptor c-Met (MET) or antibody-drug conjugates (ADCs) .
|
-
- HY-P99613
-
MK-4280
|
LAG-3
|
Cancer
|
Favezelimab (MK-4280) is a humanized anti-LAG-3 monoclonal antibody that blocks the interaction between LAG-3 and its ligand MHC class II. Favezelimab has the potential for colorectal cancer (CRC) research combined with the PD-L1 inhibitor Pembrolizumab (HY-P9902) .
|
-
- HY-P99044
-
MBG453
|
Tim3
|
Inflammation/Immunology
|
Sabatolimab (MBG453) is a high-affinity, humanized, IgG4 (S228P) antibody targeting TIM-3, an inhibitory receptor that regulates adaptive and innate immune responses. Sabatolimab is a potential immunosuppression agent that can target TIM-3 on immune and myeloid cells .
|
-
- HY-P99335
-
Anti-Human IL17A Recombinant Antibody
|
Interleukin Related
|
Inflammation/Immunology
|
Vunakizumab (Anti-Human IL17A Recombinant Antibody) is a recombinant human IgGκ monoclonal antibody that targets IL-17A and inhibits its interaction with the IL-17 receptor. Vunakizumab can be used to study autoimmune diseases such as psoriatic arthritis, ankylosing spondylitis, multiple sclerosis and inflammatory arthritis .
|
-
- HY-P99024
-
RO7082859
|
CD20
|
Cancer
|
Glofitamab (RO7082859) is a T-cell-engaging bispecific antibody possessing a novel 2:1 structure with bivalency for CD20 on B cells and monovalency for CD3 on T cells. Glofitamab leads to T-cell activation, proliferation, and tumor cell killing upon binding to CD20 on malignant cells. Glofitamab induces durable complete remissions in relapsed or refractory B-Cell lymphoma .
|
-
- HY-P99962
-
BGB-A425
|
Mucin
|
Cancer
|
Surzebiclimab (BGB-A425) is a humanized IgG1-variant monoclonal antibody against T-cell immunoglobulin and mucin-domain containing-3 (TIM-3). Surzebiclimab binds to the extracellular domain of human Tim-3 with high affinity (KD=0.36 nM) and specificity. Surzebiclimab can be used in research of cancer .
|
-
- HY-P99614
-
BFKB8488A
|
FGFR
|
Metabolic Disease
|
Fazpilodemab (BFKB8488A) is a humanized, agonistic, bispecific antibody targeting fibroblast growth factor receptor 1c (FGFR1c) and Klothoβ. Fazpilodemab can be used for the research of type 2 diabetes mellitus (T2DM) or nonalcoholic fatty liver disease (NAFLD) .
|
-
- HY-P99201
-
UC-961; Cirmtuzumab
|
ROR
|
Cancer
|
Zilovertamab (UC-961) is a humanised monoclonal antibody against ROR1 that blocks Wnt5a-induced ROR1 signalling .
|
-
- HY-P99321
-
BMS 224819; Chi220; Anti-Human CD40 Recombinant Antibody
|
TNF Receptor
|
Inflammation/Immunology
Cancer
|
Teneliximab (BMS-224819) is a chimeric monoclonal antibody, blocks the CD40-CD40L interaction. Teneliximab (BMS-224819) has partial agonist activity resulting in some signaling through CD40 and peripheral B cell depletion .
|
-
- HY-P99688
-
AL001
|
Neurotensin Receptor
|
Cancer
|
Latozinemab (AL001) is a recombinant human anti-Sortilin monoclonal antibody. Latozinemab effectively binds Sortilin with a high affinity and blocks the interaction between progranulin protein (PGRN) and Sortilin receptor. Latozinemab has the potential for progranulin gene (GRN) mutations causative of Frontotemporal dementia (FTD) (FTD-GRN) research .
|
-
- HY-P99057A
-
|
TNF Receptor
|
Cancer
|
Varlilumab (anti-CD27) is a first-in-class human IgG1 anti-CD27 monoclonal antibody. Varlilumab has an anti-tumor activity .
|
-
- HY-P99172
-
|
Interleukin Related
|
Cancer
|
CC-90002 is a humanized anti-CD47 monoclonal antibody (mAb). CC-90002 has a high affinity for binding to CD47 with a subnanomolar Kd value. CC-90002 can be used for the research of hematologic malignancies and solid tumors .
|
-
- HY-P9978
-
|
PD-1/PD-L1
|
Cancer
|
Toripalimab is the first domestic anti-tumor PD-1 antibody in China. Toripalimab is a selective, recombinant, humanized monoclonal antibody against PD-1. Toripalimab is able to bind to PD-1 and block the interaction with its ligands. Toripalimab has exhibited primary anti-tumor effects in tumors such as melanoma, lung cancer, digestive tract tumors, hepatobiliary and pancreatic tumors, neuroendocrine neoplasms, nasopharyngeal carcinoma and urothelial carcinoma .
|
-
- HY-P9804
-
MERS-2E6; MERS Antibody-2E6
|
SARS-CoV
|
Infection
|
Anti-MERS-2E6 mAb (MERS-2E6; MERS Antibody-2E6), a human neutralizing antibody IgG1 (CHO expressed) that can compete for the binding of the virus Spike protein to the receptor (CD26), thereby inhibiting virus invasion into host cells.
|
-
- HY-P99259
-
FPA 008; Anti-Human CSF1R Recombinant Antibody
|
c-Fms
|
Inflammation/Immunology
Cancer
|
Cabiralizumab (FPA 008) is an anti-CSF1R monoclonal antibody (MAb). Cabiralizumab enhances T cell infiltration and antitumor T cell immune responses. Cabiralizumab inhibits the activation of osteoclasts and blocks bone destruction, and can be used in the research of rheumatoid arthritis (RA). Cabiralizumab can combine with Nivolumab (HY-P9903) for lung cancer research .
|
-
- HY-P99178
-
|
Interleukin Related
|
Inflammation/Immunology
Cancer
|
CTX-471 is a fully human monoclonal antibody of CD137. CTX-471 has bind affinity for recombinant human, cynomolgus macaque CD137 and mouse CD137 with Kd values of 50 nM, 61 nM and 748 nM, respectively. CTX-471 can be used for the research of immunomodulation and cancer .
|
-
- HY-P99963
-
HS636
|
PD-1/PD-L1
|
Cancer
|
Sudubrilimab (HS636) is an Ig G1-kappa monoclonal antibody against PDL1. Sudubrilimab is fused at the C terminus of the heavy chain to a TGF-β1 receptor Ⅱ ectodomain (TGFBR2-ECD), and which can sequester the PD-1/PD-L1 pathway and TGF-β bioactivity in the immunosuppressive tumor microenvironment .
|
-
- HY-P9945
-
SB 240563
|
Interleukin Related
|
Cardiovascular Disease
Inflammation/Immunology
|
Mepolizumab (SB 240563) is a humanized monoclonal antibody that binds to and neutralizes interleukin-5 (IL-5), the major cytokine involved in eosinophil proliferation, activation, and survival. Mepolizumab can be used for the research of eosinophilic granulomatosis with polyangiitis (EGPA) and severe eosinophilic asthma .
|
-
- HY-P9947
-
|
Integrin
|
Others
|
Efalizumab is a targeted T cell modulator, and is a humanized monoclonal antibody of CD11a, the α subunit of LFA-1. Efalizumab inhibits T cell activation, cutaneous T cell trafficking, and T cell adhesion to keratinocytes, can be used for plaque psoriasis research .
|
-
- HY-P99260
-
AMG 655; TRAIL-R2 mAb; Human Anti-TNFRSF10B Recombinant Antibody
|
TNF Receptor
|
Cancer
|
Conatumumab (AMG 655) is a human monoclonal agonist antibody against human death receptor 5 (DR5, TRAILR2) (Kd: 1 nM for the long form of DR5, 0.8 nM for the short form of DR5). Conatumumab induces apoptosis via caspase activation. Conatumumab can be used in the research of cancers.
.
|
-
- HY-P99203
-
|
PD-1/PD-L1
|
Cancer
|
Cemiplimab (Anti-Human PD-1) is a high-affinity programmed death receptor-1 (PD-1) monoclonal IgG4 antibody that blocks PD-1/PD-L1-mediated T-cell suppression. Cemiplimab is commonly used in squamous cell skin cancer research .
|
-
- HY-P99112
-
|
Interleukin Related
|
Inflammation/Immunology
Cancer
|
Satralizumab, a humanized monoclonal antibody, is a potent Interleukine-6 (IL-6) inhibitor. Satralizumab prevents dTAA formation and progression in rattus norvegicus. Satralizumab can be used for neuromyelitis optica spectrum disorder (NMOSD) and descending thoracic aorta aneurysm (dTAA) research .
|
-
- HY-P99687
-
AMG 256
|
PD-1/PD-L1
|
Cancer
|
Latikafusp (AMG 256) is a bifunctional fusion protein comprising a PD-1-targeting antibody and IL-21 mutein designed to deliver IL-21 pathway stimulation to PD-1+ cells. Latikafusp is designed to prime and extend the activity of cytotoxic and memory T cells and induce anti-tumor immunity. Latikafusp has the potential for solid tumors research .Latikafusp may lead to the development of immunogenicity-mediated responses .
|
-
- HY-P9945A
-
|
Interleukin Related
|
Inflammation/Immunology
|
Mepolizumab (anti-IL5) is a humanized monoclonal antibody that binds to and neutralizes interleukin-5 (IL-5), the major cytokine involved in eosinophil proliferation, activation, and survival. Mepolizumab can be used for the research of eosinophilic granulomatosis with polyangiitis (EGPA) and severe eosinophilic asthma .
|
-
- HY-P99033
-
BTCT-4465A
|
CD20
CD3
|
Inflammation/Immunology
Cancer
|
Mosunetuzumab (BTCT-4465A) is a full-length, fully humanized immunoglobulin G1 (IgG1) T-cell-dependent bispecific (TDB) antibody targeting CD20 (B cells) and CD3 (T cells). Mosunetuzumab redirects T cells to engage and eliminate malignant B cells and can be used for the research of relapsed or refractory (R/R) B-cell non-Hodgkin lymphomas (B-NHLs) .
|
-
- HY-P9984
-
rhuMAb Beta7; RG7413; PRO145223
|
Integrin
|
Cancer
|
Etrolizumab (rhuMAb Beta7) is a gut-selective, anti-β7 integrin monoclonal antibody. Etrolizumab is specific targeting of the β7 subunit of α4β7 and αEβ7 integrins with Ki values of 18 nM and 1800 pM for Human α4β7 and Human αEβ7-293, respectively. Etrolizumab can be used in research of inflammatory bowel disease (IBD) .
|
-
- HY-P99744
-
TAK-573
|
CD38
|
Cancer
|
Modakafusp alfa (TAK-573) is a humanized, anti-CD38 IgG4 monoclonal antibody fused to 2 attenuated IFNα2b molecules. Modakafusp alfa can be used in the research of multiple myeloma .
|
-
- HY-108831A
-
|
Integrin
|
Inflammation/Immunology
|
Natalizumab (Solution) is a recombinant, humanized IgG4 monoclonal antibody, binds to α4β1-integrin and blocks its interaction with vascular cell adhesion molecule-1 (VCAM-1). Natalizumab can be used for the treatment of relapsing remitting multiple sclerosis and Crohn's disease. Natalizumab is also the first targeted therapy which blocks an essential mechanism for lymphocyte entry to the CNS and thus prevents acute demyelinating relapses .
|
-
- HY-P99268
-
SAR 256212; MM 121; Anti-Human ERBB3/ErbB 3 Recombinant Antibody
|
EGFR
Apoptosis
|
Cancer
|
Seribantumab (MM 121) is a fully human IgG2 monoclonal antibody that targets HER3. Seribantumab blocks the activation of epidermal growth factor receptor (ErbB) family members and its downstream signal. Seribantumab inhibits neuregulin 1 (NRG1) fusion-dependent tumorigenesis in vitro and in vivo in breast, lung and ovarian patient-derived cancer models .
|
-
- HY-P99359
-
ABT-555; AE12-1Y-QL; Anti-RGMA Reference Antibody (elezanumab)
|
TGF-beta/Smad
|
Metabolic Disease
|
Elezanumab (ABT-555; AE12-1Y-QL) is a human monoclonal antibody that selectively targets repulsive guidance molecule A (RGMa). Elezanumab potently inhibited RGMa mediated BMP signalling via the SMAD1/5/8 pathway, with an IC50 around 97 pM. Elezanumab promotes neuroregeneration and neuroprotection in neuronal injury and demyelination models binds N-terminal RGMa, blocks BMP signaling and lacks RGMc cross-reactivity. elezanumab has neuroregenerative and neuroprotective activities without impact on iron metabolism .
|
-
- HY-P9975
-
TGN1412
|
CD28
|
Inflammation/Immunology
|
Theralizumab (TGN1412) is a humanized lgG4 superagonistic anti-CD28 monoclonal antibody that directly stimulates T cells. Theralizumab can cause cytokine release syndrome (CRS). Theralizumab can be used for the research of rheumatoid arthritis .
|
-
- HY-P9977
-
JNJ-61186372
|
EGFR
|
Cancer
|
Amivantamab (JNJ-61186372) is a human EGFR-MET bispecific antibody with immune anticancer activity. Amivantamab inhibits ligand binding, promotes endocytosis and degradation of receptor-antibody complexes, and induces Fc-dependent cytokinesis in macrophages and antibody-dependent cytotoxicity in natural killer cells .
|
-
- HY-153631
-
|
Others
|
Inflammation/Immunology
|
Sulfo-TAG NHS ester (disodium) is an N-hydroxysuccinimide ester that can be coupled to proteins via primary amine groups. Sulfo-TAG NHS ester (disodium) can be used for antibody labeling .
|
-
- HY-157205
-
|
Others
|
Inflammation/Immunology
|
Zeph is a small chemical group double heterologous hapten of Zep and combines with a specific antibody but lacks antigenicity of its own.
|
-
- HY-P9960
-
Ocrevus
|
CD20
|
Inflammation/Immunology
|
Ocrelizumab is an anti-CD20 antibody that depletes circulating immature and mature B cells but spares CD20-negative plasma cells. The effector mechanisms of Ocrelizumab are complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity. Ocrelizumab is the first monoclonal antibody for secondary primary progressive multiple sclerosis (PPMS) .
|
-
- HY-P99048
-
IBI308
|
PD-1/PD-L1
|
Inflammation/Immunology
Cancer
|
Sintilimab (IBI308) is a fully human IgG4 monoclonal antibody that binds to PD-1, thereby blocking the interaction of PD-1 with its ligands (PD-L1 and PL-L2) and consequently helping to restore the endogenous antitumour T-cell response. Sintilimab can be used for the research of classical Hodgkin's lymphoma, non-small cell lung cancer and oesophageal cancer .
|
-
- HY-P99718
-
BAY 1112623
|
ADC Antibody
|
Cancer
|
Lupartumab (BAY 1112623) is an anti-LYPD3 (C4.4A) monoclonal antibody that can be used for the synthesis of antibody-drug conjugate BAY 1129980 .
|
-
- HY-P99496
-
RPC 4046; ABT 308; CC-93538
|
Interleukin Related
|
Inflammation/Immunology
|
Cendakimab (RPC4046; ABT 308; CC-93538) is a selective, humanized, recombinant monoclonal antibody against the IL-13 molecule. Cendakimab has a high affinity and potency for both human wild-type and variant IL-13 and blocks binding of IL-13 to both IL-13Rα1 and IL-13Rα2 with IC50s of 352 pM and 631 pM by ELISA, respectively. Cendakimab recognizes both wild-type human IL-13 and the common polymorphic variant R110Q, with binding affinities of 52 and 50 pM, respectively. Cendakimab has the potential for IL-13-related allergic/inflammatory diseases (e.g., asthma and eosinophilic esophagitis) .
|
-
- HY-108730A
-
-
- HY-P99245
-
RG 7155; RO 5509554
|
c-Fms
|
Cancer
|
Emactuzumab(RG 7155) is a specific monoclonal antibody that inhibits colonystimulating factor 1 receptor (CSF1R) activation. Emactuzumab has high affinity for CSF-1R with Ki value of 0.2 nM to blocks CSF-1R dimerization. Emactuzumab can be used for the research of several diseases, such as diffuse-type tenosynovial giant cell tumour (dt-GCT) .
|
-
- HY-P9976A
-
|
CD38
|
Cancer
|
Isatuximab (anti-CD38) is a monoclonal antibody targeting the transmembrane receptor and extracellular enzyme CD38.Isatuximab induces tumor cell killing via fragment crystallizable (Fc)-dependent or Fc-independent mechanisms, including antibody-dependent cellular cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP), and complement-dependent cytotoxicity (CDC) .
|
-
- HY-157232
-
|
Others
|
Others
|
AC Antibody purification resin 2 is based on spherical, highly cross-linked agarose beads with a narrow size distribution and high mechanical stability. Used for the separation and purification of complex antibodies such as monoclonal antibody, double antibody, multi-antibody and Fc fusion protein .
Substrate: highly crosslinked agarose microspheres; Particle size: 65μm; Ligand: alkali-resistant recombinant Protein A; ADC purified resin.
|
-
- HY-P99113
-
|
ADC Antibody
CD19
|
Inflammation/Immunology
|
Inebilizumab is an anti-CD19 monoclonal antibody (mAb) with enhanced antibody-dependent cell-mediated cytotoxicity against B cells. Inebilizumab can be used for multiple sclerosis and neuromyelitis optica research .
|
-
- HY-P99712
-
hz208F2-4
|
IGF-1R
ADC Antibody
|
Cancer
|
Lonigutamab (hz208F2-4) is a humanized anti-IGF-1R monoclonal antibody that can be used for the synthesis of antibody–agent conjugates (ADC) .
|
-
- HY-150075
-
|
Others
|
Others
|
STING agonist-19 can be used to synthesize ISAC (immune-stimulating antibody conjugates) molecule.
|
-
- HY-P9928
-
REGN 727; SAR 236553
|
Ser/Thr Protease
|
Cardiovascular Disease
|
Alirocumab (REGN 727) is a human monoclonal antibody inhibitor of PCSK9. Alirocumab is a monoclonal antibody. Alirocumab has anti-inflammatory, antiangiogenic and antioxidant effects. Alirocumab can be used in the study of hypercholesterolemia .
|
-
- HY-P99634
-
PankoMab
|
Mucin
|
Cancer
|
Gatipotuzumab (PankoMab) is a humanized monoclonal antibody which recognizes the tumor-specific epitope of mucin-1 (TA-MUC1). Gatipotuzumab reveals a potent tumor-specific antibody-dependent cell cytotoxicity (ADCC) .
|
-
- HY-P99788
-
|
ADC Antibody
ALCAM/CD166
|
Cancer
|
Praluzatamab is a monoclonal antibody targeting the activated leukocyte cell adhesion molecule (ALCAM/CD116). Praluzatamab can be used to synthesize Praluzatamab ravtansine (antibody-drug conjugates). Praluzatamab can be used for research of cancers .
|
-
- HY-P99953
-
|
Bacterial
|
Infection
|
Rivabazumab is a recombinant antibody against Pseudomonas aeruginosa pcrV .
|
-
- HY-P990038
-
-
- HY-P99250
-
MetMAb
|
c-Met/HGFR
|
Cancer
|
Onartuzumab (MetMAb) is a unique, humanized and affinity-matured monovalent (one-armed) monoclonal antibody against the MET receptor. Onartuzumab potently inhibits HGF binding and receptor phosphorylation and signaling. Onartuzumab has antibody-like pharmacokinetics and antitumor activity .
|
-
- HY-P99971
-
|
ADC Antibody
|
Cancer
|
Gemtuzumab is a monoclonal IgG4-κ antibody targeting CD33 antigen, which present on leukemic myeloblasts of acute myeloid leukemia (AML). Gemtuzumab can be used for synthesis of antibody-drug conjugate (ADC), Gemtuzumab ozogamicin (HY-109539). Gemtuzumab ozogamicin consists of a cytotoxic derivative of Calicheamicin (a cytotoxic antibiotic), and a monoclonal antibody. Gemtuzumab ozogamicin can be used for the research of acute myeloid leukemia .
|
-
- HY-157233
-
|
Others
|
Cardiovascular Disease
|
AC Antibody purification resin 1 is a nano agarose with a particle size of 69μm. AC Antibody purification resin 1 can be used in ADC purification. AC Antibody purification resin 1 contains a ligand: recombinant protein A.
|
-
- HY-131326
-
-
- HY-P990012
-
-
- HY-P99967
-
|
ADC Antibody
|
Cancer
|
Cantuzumab is a monoclonal antibody that can binds the CanAg antigen. Cantuzumab is typically linked to one of several cytotoxic agents, yielding antibody-drug conjugates (ADC), such as Cantuzumab mertansine (HY-P99492) and Cantuzumab ravtansine (HY-P99493) .
|
-
- HY-132180A
-
|
ADC Cytotoxin
|
Inflammation/Immunology
Cancer
|
Seco-DUBA is a duocarmycin (DUBA) prodrug containing two hydroxyl groups, which can each be used for coupling to an antibody via a linker. Seco-DUBA can be used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-P99470
-
GEN1029
|
TNF Receptor
Apoptosis
|
Cancer
|
Benufutamab (GEN1029) is a death receptor 5 (DR5)-specific agonistic antibody. Benufutamab is a mixture of 2 noncompeting DR5-specific IgG1 antibodies, each with an E430G mutation in the Fc domain. Benufutamab has antitumor effects .
|
-
- HY-P99734
-
ADCT-601
|
TAM Receptor
|
Cancer
|
Mipasetamab uzoptirine (ADCT-601) is an AXL-targeted antibody-drug conjugates (ADCs). Mipasetamab uzoptirine consists of a humanized anti-AXL antibody, a cleavable linker and the potent pyrrolobenzodiazepine (PBD) dimer cytotoxin SG3199. Mipasetamab uzoptirine can be used for the research of cancers .
|
-
- HY-P99733
-
|
ADC Antibody
TAM Receptor
|
Cancer
|
Mipasetamab is an IgG1κ antibody targeting to AXL, a tyrosine kinase receptor and an TAM Receptor. Mipasetamab involves in synthesis of ADCT-601 (Mipasetamab uzoptirine), an AXL-targeted antibody-drug conjugate (ADC). ADCT-601 has anti-tumor activity .
|
-
- HY-145674
-
|
Others
|
Cancer
|
HDP 30.1699, the derivative of α-Amanitin, shows considerable cross-links. The cysteine residues of the anti-HER2 THIOMAB antibody are used for conjugation of the cysteine reactive linker–Amanitin compound, HDP 30.1699, with a cleavable linker by maleimide chemistry .
|
-
- HY-P99108
-
-
- HY-P990057
-
-
- HY-P99809
-
MK-1308
|
CTLA-4
|
Cancer
|
Quavonlimab (MK-1308) is a novel anti-CTLA-4 antibody .
|
-
- HY-P99868
-
MGD 011
|
CD19
|
Others
|
Duvortuxizumab (MGD 011) is a chimeric humanized IG antibody targeting CD19 and CD3E .
|
-
- HY-P99014
-
|
Apoptosis
|
Inflammation/Immunology
|
Cusatuzumab is a human αCD70 monoclonal antibody. Cusatuzumab shows cytotoxicity activity with enhanced antibody-dependent cellular. Cusatuzumab reduces leukemia stem cells (LSCs) and triggers gene signatures related to myeloid differentiation and apoptosis. Cusatuzumab has the potential for the research of Acute myeloid leukemia (AML) .
|
-
- HY-P99526
-
-
- HY-P99709
-
LY3300054
|
PD-1/PD-L1
|
Cancer
|
Lodapolimab (LY3300054) is an IgGλ anti-PD-1 monoclonal antibody .
|
-
- HY-P990024
-
-
- HY-P99883
-
SAR156597
|
Interleukin Related
|
Others
|
Romilkimab (SAR156597) is a chimeric humanized IG antibody that specifically targets IL-4 and IL13 .
|
-
- HY-P4020
-
|
HIV
|
Others
|
2F5 epitope, a peptide gp41 (659-671), comprises the entire epitope for one of the three known antibodies capable of neutralizing a broad spectrum of primary HIV-1 isolates and is the only such epitope that is sequential. 2F5 epitope is recognized by broadly neutralizing antibodies 2F5 .
|
-
- HY-P99225
-
M9346A
|
Antifolate
|
Cancer
|
Mirvetuximab (M9346A) is an anti-FOLR1 (folate receptor 1) monoclonal antibody. Mirvetuximab is the antibody moiety of novel folate receptor alpha (FRα)-targeting ADC (Mirvetuximab soravtansine). Mirvetuximab soravtansine can be used in ovarian and other FRα-positive cancer research .
|
-
- HY-P99451
-
-
- HY-P99663
-
|
TNF Receptor
|
Cancer
|
Inezetamab is a bispecific anti-CD40 and anti-MSLN IgG1 monoclonal antibody .
|
-
- HY-P99699
-
-
- HY-P99723
-
BCD-135
|
PD-1/PD-L1
|
Cancer
|
Manelimab is a monoclonal antibody that inhibits programmed death-ligand 1 (PD-L1) .
|
-
- HY-P99862
-
PEG sTNF-RI
|
TNF Receptor
|
Others
|
Pegsunercept (PEG sTNF-RI) is a monoclonal antibody that specifically targets TNFA and is conjugated to a pegol structure .
|
-
- HY-P990058
-
-
- HY-P990011
-
-
- HY-157190
-
|
Others
|
Inflammation/Immunology
|
Fenhexamid-butyric acid (Compound FHo) is a hapten designed based on fenhexamid, which can produce monoclonal antibodies with an IC50 value of 0.66-0.93 nM .
|
-
- HY-P9923
-
MEDI-563; BIW-8405
|
Interleukin Related
Apoptosis
|
Inflammation/Immunology
Cancer
|
Benralizumab (MEDI-563) is an interleukin-5 receptor α (IL-5Rα)-directed cytolytic monoclonal antibody that induces direct, rapid and nearly complete depletion of eosinophils via enhanced antibody-dependent cell-mediated cytotoxicity. Benralizumab can be used for severe eosinophilic asthma .
|
-
- HY-P99015
-
|
TNF Receptor
|
Cancer
|
Dacetuzumab (SGN-40) is a humanized IgG1, anti-CD40 monoclonal antibody with anti-lymphoma activity. Dacetuzumab kills tumor cells via immune effector functions (antibody-dependent cellular cytotoxicity and phagocytosis [ADCC/ADCP]). Dacetuzumab ((SGN-40) can be used for multiple myeloma research .
|
-
- HY-P99253
-
KW-0761
|
CCR
|
Inflammation/Immunology
Cancer
|
Mogamulizumab (KW-0761) is a recombinant anti-CCR4 monoclonal antibody (MAb). Mogamulizumab can eliminate tumor cells by antibody-dependent cellular cytotoxicity (ADCC). Mogamulizumab can be used in the research of cancers, adult T-cell leukemia/lymphoma (ATLL), cutaneous T-cell lymphoma (CTCL) .
|
-
- HY-P99604
-
AZD-1061; COV2-2130
|
SARS-CoV
|
Infection
|
Cilgavimab (AZD-1061; COV2-2130) is a human SARS-CoV-2-neutralizing monoclonal antibody, can compose monoclonal-antibody combination AZD7442 with Tixagevimab (HY-P99556). Cilgavimab shows protective action on mouse models of SARS-CoV-2 infection .
|
-
- HY-P99843
-
|
TROP2
ADC Antibody
|
Cancer
|
Datopotamab (CDP7657) is an antibody targeting to TROP2. Datopotamab can be used to synthesize Datopotamab deruxtecan (HY-141598), TROP2-directed antibody-drug conjugate (ADC). Datopotamab deruxtecan consists of DNA topoisomerase I inhibitor Deruxtecan (HY-13631E) and Datopotamab .
|
-
- HY-P99730
-
TAK-079
|
CD38
|
Cancer
|
Mezagitamab (TAK-079) is a IgG1λ anti-CD38 monoclonal antibody. Mezagitamab depletes tumor cells expressing CD38 through antibody and complement dependent cytotoxicity. Mezagitamab has potential application in relapsed/refractory multiple myeloma (RRMM) and idiopathic thrombocytopenic purpura (ITP) .
|
-
- HY-D0054
-
|
Fluorescent Dye
|
Inflammation/Immunology
|
9-(2-Carboxy-2-cyanovinyl)julolidine is a fluorescent molecular rotor. 9-(2-Carboxy-2-cyanovinyl)julolidine can be used to bind to IgG and Fab, and preparing antibodies .
|
-
- HY-P99211
-
ChAglyCD3; TRX 4
|
CD3
|
Metabolic Disease
|
Otelixizumab (ChAglyCD3) is an anti-human CD3 monoclonal antibody and can be used for the research of type 1 diabetes .
|
-
- HY-P99016A
-
-
- HY-P990027
-
|
ADC Antibody
|
Cancer
|
Izeltabart is a high-affinity humanized antibody targeting ADAM9. Izeltabart can be used as ADC Antibody for site-specific conjugation with Maytansinoid-based DM21-C (a Drug-Linker Conjugates for ADC), to synthesize IMGC936 (Antibody-Drug Conjugates (ADCs)) with strong anti-cancer activity. DM21-C is composed of Maytansinoid (microtubule inhibitor) and a stable tripeptide linker. IMGC936 exhibits cytotoxicity against ADAM9-positive human tumor cell lines and potent antitumor activity in xenograft tumor models .
|
-
- HY-P99457
-
-
- HY-P99937
-
|
HIV
|
Infection
|
Elipovimab is a potent broadly neutralizing HIV-1 antibody for the targeted elimination of HIV-infected cells
|
-
- HY-P9806
-
MERS-D12; MERS Antibody-D12
|
SARS-CoV
|
Infection
|
Anti-MERS-D12 mAb (MERS-D12; MERS Antibody-D12) is a human monoclonal IgG1. Anti-MERS-D12 mAb binds directly to the DPP4 interacting region of the MERS-CoV Spike receptor binding domain (RBD) and effect neutralization by directly blocking receptor binding .
|
-
- HY-P990018
-
MK-5890
|
TNF Receptor
|
Cancer
|
Boserolimab (MK-5890) is a chimeric humanized IgG1κ antibody targeting the mouse signaling regulatory protein CD27.
|
-
- HY-P99675
-
AK112
|
PD-1/PD-L1
VEGFR
|
Cancer
|
Ivonescimab (AK112) is a PD-1/VEGF Bispecific Antibody. Ivonescimab can be used for cancer research .
|
-
- HY-P99679
-
-
- HY-P99558
-
GEXMab73; GT-MAb7.3-GEX; TrastuzuMab-GEX
|
EGFR
|
Cancer
|
Timigutuzumab (GEXMab73) is a humanized monoclonal antibody that targets ErbB2. Timigutuzumab can be used for the research of cancer .
|
-
- HY-P990036
-
|
IFNAR
|
Infection
|
Dazukibart is a mouse-derived, humanized IgG1κ antibody targeting interferon beta 1 (IFNB1) .
|
-
- HY-P990082
-
|
VEGFR
|
Cancer
|
Suvemcitug is a humanized IgG1κ antibody targeting VEGF derived from the African hare (Oryctolagus cuniculus) .
|
-
- HY-P99655
-
KB004
|
Ephrin Receptor
Apoptosis
|
Cancer
|
Ifabotuzumab (KB004) is an IgG1κ antibody targeting EphA3 (KD=610 pM). Ifabotuzumab induces tumor cell apoptosis, activates Antibody-dependent cell mediated cytotoxicity (ADCC), and damages tumor vasculature. Ifabotuzumab reduces human idiopathic pulmonary fibrosis (IPF) CCR10 + cells and improves pulmonary fibrosis .
|
-
- HY-W087027
-
|
Others
|
Cancer
|
Maleimide-NOTA is a chelator for the labeling of peptides and antibodies. Maleimide-NOTA can react with cysteine .
|
-
- HY-P9908A
-
-
- HY-P99347
-
-
- HY-P99684
-
J2898A
|
EGFR
|
Cancer
|
Laprituximab (J2898A) is a humanized IgG1 anti-EGFR antibody that can be used for the synthesis of ADC IMGN289 .
|
-
- HY-P99968
-
|
Mucin
|
Cancer
|
Clivatuzumab is a humanized anti-mucin monoclonal antibody targeting an epitope in the MUC1 antigen expressed in most pancreatic cancers .
|
-
- HY-P99867
-
MEDI 573
|
IGF-1R
|
Others
|
Dusigitumab (MEDI 573) is a human IgG2λ monoclonal antibody that specifically targets IGF2 and IGF1 .
|
-
- HY-P99167
-
HCD122
|
TNF Receptor
|
Cancer
|
Lucatumumab (HCD122) is a fully human anti-CD40 antagonist monoclonal antibody, which blocks CD40/CD40L-mediated signaling. Lucatumumab efficiently mediates antibody-dependent cell-mediated cytotoxicity (ADCC) and clearance of tumor cells, can be used for refractory lymphomas, CLL and multiple myeloma research .
|
-
- HY-P99622
-
IMC-20D7S
|
Tyrosinase
|
Cancer
|
Flanvotumab (IMC-20D7S) is a human monoclonal antibody targeting to tyrosinase-related protein (TYRP1), specifically expressed in melanocytes and melanoma cells. Flanvotumab acts function via natural killing-mediated antibody-dependent cell-mediated cytotoxicity (ADCC). Flanvotumab has potent anti-tumor activity and good tolerance .
|
-
- HY-P99481
-
NEOD001
|
Amyloid-β
|
Neurological Disease
|
Birtamimab (NEOD001) is an investigational monoclonal antibody that specifically and selectively target and clear the amyloid. Birtamimab can be used for the research of light chain amyloidosis .
|
-
- HY-P99892
-
PR-1594407; DC-1630423
|
EGFR
|
Others
|
Serclutamab is a humanized chimeric antibody targeting EGFR IgG1-κ. Mainly expressed by CHO (Chinese Hamster Ovary) cells .
|
-
- HY-P99975
-
-
- HY-P99740
-
|
CD276/B7-H3
|
Cancer
|
Mirzotamab is an IgG1κ antibody targeting to CD276/B7-H3. Mirzotamab can conjugates with Clezutoclax (HY-137774), an BCL inhibitor to form Mirzotamab clezutoclax (HY-P99741), involving in research with taxane research in relapsed/refractory solid tumors. Mirzotamab clezutoclax (ABBV-155) is a targeted antibody drug conjugate (ADC) .
|
-
- HY-P99954
-
|
Bacterial
|
Infection
|
Rivabazumab pegol is a PcrV protein antibody that can be used to study the phase II pegylated Fab of chronic Pseudomonas aeruginosa infection .
|
-
- HY-P9964
-
|
EGFR
|
Cancer
|
Necitumumab is a human IgG monoclonal antibody directed against EGFR. Necitumumab can be used for research of NSCLC, colorectal cancer, etc .
|
-
- HY-P990089
-
-
- HY-P990047
-
|
GLP Receptor
|
Metabolic Disease
|
Maridebart is a human immunoglobulin G1-kappa, anti-GIPR (gastric inhibitory polypeptide receptor) monoclonal antibody .
|
-
- HY-P99539
-
REGN4018
|
CD3
|
Cancer
|
Ubamatamab (REGN4018) is a humanized bispecific antibody targeted against Mucin 16 (MUC16) and CD3. Ubamatamab demonstrates potent antitumor activity .
|
-
- HY-P99517
-
JNJ-63898081
|
CD3
|
Cancer
|
Voxalatamab (JNJ-63898081) is a bispecific IgG4 antibody that binds PSMA and CD3 and has anti-cancer activity for use in prostate cancer research .
|
-
- HY-P9912A
-
|
EGFR
|
Cancer
|
Pertuzumab (PBS), a humanized monoclonal antibody, is a HER2 dimerization inhibitor for the treatment of metastatic HER2-positive breast cancer.
|
-
- HY-P99408
-
-
- HY-145645
-
-
- HY-P99615
-
SB 209763; RSHZ19
|
RSV
|
Infection
|
Felvizumab (SB 209763) is a humanized IgG1κ monoclonal antibody directed to distinct neutralizing epitopes on the F glycoprotein of RSV .
|
-
- HY-P99781
-
MLN-1202
|
CCR
|
Cancer
|
Plozalizumab (MLN-1202) is a specific humanized anti-CCR2 antibody. Plozalizumab can be used for malignant melanoma research .
|
-
- HY-P990035
-
|
PD-1/PD-L1
|
Cancer
|
Benmelstobart is an IgG1κ antibody targeting PD-L1/CD274, derived from mice .
|
-
- HY-P990016
-
-
- HY-P990048
-
|
CTLA-4
|
Cancer
|
Muzastotug is a humanized immunoglobulin G1-kappa, anti-CTLA4 monoclonal antibody. Muzastotug is an immunostimulant and antineoplastic .
|
-
- HY-P99577
-
|
CD19
|
Cancer
|
Taplitumomab paptox is an anti-CD19 monoclonal antibody. Taplitumomab paptox can be used in cancer research.
|
-
- HY-P990306
-
|
c-Met/HGFR
ADC Antibody
|
Cancer
|
ABBV-303 is a multi-specific NK cell antibody targeting c-Met designed based on TriNKET technology for natural killer (NK) cell redirection therapy. The ABBV-303 antibody consists of three functional arms, a single-chain variable fragment (scFV) targeting c-Met, a Fab arm targeting NKG2D, and an Fc fragment targeting NK cell CD16a .
|
-
- HY-P99619
-
SCT-I10A
|
PD-1/PD-L1
|
Cancer
|
Finotonlimab (SCT-I10A) is a recombinant humanised IgG PD-1 antibody. Finotonlimab has the potential for solid tumors or lymphomas research .
|
-
- HY-P99754
-
|
Interleukin Related
|
Inflammation/Immunology
|
Netakimab is an anti-IL-17 monoclonal antibody. Nerelimomab can be used for research of ankylosing spondylitis, psoriatic arthritis, moderate-to-severe plaque psoriasis .
|
-
- HY-156035
-
|
Others
|
Inflammation/Immunology
|
Bz-DTPA is a bifunctional chelator. Bz-DTPA can be used for preparing immunoconjugate of monoclonal antibody 2G3 labeled with indium-111 .
|
-
- HY-P9912
-
|
EGFR
|
Cancer
|
Pertuzumab, a humanized IgG1 monoclonal antibody, is a HER2 dimerization inhibitor for the treatment of metastatic HER2-positive breast cancer.
|
-
- HY-P99198
-
-
- HY-P99402
-
REGN 2176
|
PDGFR
|
Metabolic Disease
|
Rinucumab (REGN 2176), a monoclonal antibody, is a PDGF inhibitor. Rinucumab (REGN 2176) could be used for the study of neovascular age-related macular degeneration .
|
-
- HY-P99501
-
HS006
|
CD20
|
Cancer
|
Zuberitamab (HS006) is a monoclonal antibody that targets CD20 and can be used in cancer research, including diffuse large B-cell lymphoma .
|
-
- HY-P99533
-
SRF-231; SRF231
|
Interleukin Related
|
Cancer
|
Urabrelimab (SRF231) is a fully human anti-CD47 monoclonal antibody that blocks the CD47-SIRP interaction .
|
-
- HY-P99724
-
-
- HY-P99512
-
UCB-7858
|
Glutaminase
|
Inflammation/Immunology
|
Zampilimab (UCB-7858) is a monoclonal antibody against transglutaminase 2 (TG2). Zampilimab has potential application in renal transplant .
|
-
- HY-P99866
-
MEHD-7945A; RG 7597
|
EGFR
|
Others
|
Duligotuzumab (MEHD-7945A; RG 7597) is a humanized IgG-κ monoclonal antibody that specifically targets Her3 (ErbB3) .
|
-
- HY-P990040
-
LVGN-6051
|
TNF Receptor
|
Cancer
|
Exlinkibart (LVGN-6051) targets TNFRSF9 and is an IgG1κ antibody humanized through complementarity-determining region (CDR) grafting technology.
|
-
- HY-P9913A
-
|
CD20
|
Inflammation/Immunology
Cancer
|
Rituximab (anti-CD20) is an anti-CD20 chimeric monoclonal antibody used to treat certain autoimmune diseases and types of cancer .
|
-
- HY-P99343
-
REGN3470
|
Filovirus
|
Infection
|
Atoltivimab (REGN3470), or maftivimab/odesivimab (Inmazeb) is the first Food and agent Administration (FDA)-approved monoclonal antibody to target Zaire ebolavirus (EBOVs) infection .
|
-
- HY-P99383
-
REMD-477; AMG-477
|
GCGR
|
Metabolic Disease
|
Volagidemab is an antagonistic glucagon receptor (GCGR) monoclonal antibody (mAb). Volagidemab can be used in the research of type 1 diabetes (T1D) .
|
-
- HY-P99617
-
REGN3767
|
LAG-3
|
Cancer
|
Fianlimab (REGN3767) is a human monoclonal antibody that targets the immune checkpoint receptor LAG-3 on T cells and has anti-tumour activity .
|
-
- HY-P99578
-
HL036337; HBM9036
|
TNF Receptor
|
Others
|
Tanfanercept (HL036337) is an anti-TNF-α monoclonal antibody. Tanfanercept is effective in ameliorating corneal erosions in a dry eye (DE) mouse model .
|
-
- HY-P99775
-
ART621; CEP-37247; PN0621
|
TNF Receptor
|
Inflammation/Immunology
|
Placulumab (ART621) is an anti-TNF α monoclonal antibody. Placulumab has anti-inflammatory activity and has potential applications in inflammatory diseases such as arthritis .
|
-
- HY-P99865
-
AK-119
|
CD73
|
Others
|
Dresbuxelimab (AK-119) is an IgG-κ monoclonal antibody targeting CD73. The expression system is usually CHO (Chinese Hamster Ovary) cells .
|
-
- HY-P990080
-
|
CTLA-4
|
Cancer
|
Sovipostobart is an immunoglobulin G1-kappa, anti-CTLA-4 human monoclonal antibody with cleavable prodomain. Sovipostobart is an immunostimulant and antineoplastic .
|
-
- HY-P99177
-
|
SARS-CoV
|
Infection
Cardiovascular Disease
|
Enibarcimab is a humanised murine monoclonal immunoglobulin G1 (IgG1) antibody, could be used for acute heart failure, COVID-19 infections and septic shock research .
|
-
- HY-P99404
-
|
CXCR
|
Inflammation/Immunology
Cancer
|
Quetmolimab is a humanized anti-CX3CL1 monoclonal antibody. However, CX3CL1 is a chemokine with a modulating effect on chemotaxis and adhesion .
|
-
- HY-P99115
-
ASC 22; KN 035
|
PD-1/PD-L1
|
Cancer
|
Envafolimab (ASC 22; KN 035) is a recombinant protein of a humanized single-domain anti- PD-L1 antibody. Envafolimab is created by a fusion of the of anti-PD-L1 domain with Fc fragment of human IgG1 antibody. Envafolimab blocks interaction between PD-L1 and PD-1 with an IC50 value of 5.25 nM. Envafolimab has the potential for the research of solid tumors .
|
-
- HY-P9904
-
MPDL3280A
|
PD-1/PD-L1
Apoptosis
Autophagy
|
Cancer
|
Atezolizumab (MPDL3280A) is a selective humanized monoclonal IgG1 antibody against programmed death ligand 1 (PD-L1), used for cancer research.
|
-
- HY-P99187
-
-
- HY-P99555
-
-
- HY-P99625
-
SAR441344; INX-021
|
TNF Receptor
|
Inflammation/Immunology
|
Frexalimab (SAR441344; INX-021) is a monoclonal antibody targeting the CD40 ligand (CD40L). Frexalimab has the potential for multiple sclerosis research .
|
-
- HY-P99686
-
c4G7-N
|
Filovirus
|
Infection
|
Larcaviximab (c4G7-N) is an IgG1 kappa anti-Ebola virus glycoprotein chimeric monoclonal antibody .
|
-
- HY-P99758
-
CS1003
|
PD-1/PD-L1
|
Cancer
|
Nofazinlimab (CS1003) is a humanised IgG4 anti-PD-1 monoclonal antibody. Nofazinlimab can be used for unresectable hepatocellular carcinoma (uHCC) research .
|
-
- HY-P99761
-
XmAb5871
|
CD19
|
Inflammation/Immunology
|
Obexelimab (XmAb5871) is a humanized anti-CD19 antibody Fc-engineered for increased affinity to FcγRIIb. Obexelimab can be used in research of autoimmune .
|
-
- HY-P9948
-
Campath-IH
|
Apoptosis
|
Cancer
|
Alemtuzumab (Campath-IH) is a humanized monoclonal antibody against CD52. Alemtuzumab does not cross-react with murine CD52. Alemtuzumab selectively targets the CD52 antigen to induce profound lymphocyte depletion, followed by recovery of T and B cells with regulatory phenotypes. Alemtuzumab is capable of complement-dependent cytotoxicity and antibody-dependent cell-mediated cytotoxicity (ADCC), as well as induction of apoptosis. Alemtuzumab has the potential for B-cell chronic lymphocytic leukaemia research .
|
-
- HY-132158
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
MC-AAA-NHCH2OCH2COO-7-aminomethyl-10-methyl-11-fluoro camptothecin (compound 21a), a camptothecin payload, can be conjugated to a monoclonal antibody (mAb) for the synthesis of camptothecin antibody-drug conjugate (ADC) .
|
-
- HY-P9903
-
BMS-936558; ONO-4538; MDX-1106
|
PD-1/PD-L1
|
Cancer
|
Nivolumab is a programmed death receptor-1 (PD-1) blocking human IgG4 antibody to treat advanced (metastatic) non-small cell lung cancer.
|
-
- HY-P99642
-
-
- HY-P9929
-
|
Bacterial
|
Infection
Inflammation/Immunology
|
Bezlotoxumab is a human monoclonal antibody directed against C. difficile toxin B. Bezlotoxumab binds to C. difficile toxin B preventing intestinal epithelial damage and colitis .
|
-
- HY-P990041
-
|
CTLA-4
|
Inflammation/Immunology
Cancer
|
Firastotug is an IgG1κ antibody targeting CTLA4. CTLA4 is a cytotoxic T lymphocyte-associated protein and a key immune checkpoint in the fields of autoimmunity and cancer .
|
-
- HY-P990015
-
|
HBV
|
Infection
|
Tobevibart is an IgG1-lambda, anti-HBV (hepatitis B virus) surface envelope protein human monoclonal antibody. Tobevibart shows antiviral activity .
|
-
- HY-P990042
-
ONC-392; BNT 316
|
CTLA-4
|
Cancer
|
Gotistobart (ONC-392) is a humanized anti-CTLA-4 antibody that confers immunotherapeutic effect by selective depletion of regulatory T cells (Treg) in the tumor microenvironment .
|
-
- HY-P99676
-
SI-B001
|
EGFR
|
Cancer
|
Izalontamab (SI-B001) is a bispecific anti-EGFR/HER3 monoclonal antibody with high selectivity for EGFR/HER3 heterodimer. Izalontamab can be used for the research of cancer .
|
-
- HY-P99807
-
BCD-100
|
PD-1/PD-L1
|
Cancer
|
Prolgolimab (BCD-100) is a human IgG1 anti-PD-1 monoclonal antibody containing the Fc-silencing 'LALA' mutation. Prolgolimab can be used for the research of advanced melanoma .
|
-
- HY-160453
-
|
Others
|
Others
|
MC-Gly-Gly-Phe-Gly-NH-CH2-O-cyclopropane-CH2COOH is a camptothecin derivative. MC-Gly-Gly-Phe-Gly-NH-CH2-O-cyclopropane-CH2COOH can be used for antibody drug conjugate (ADC) .
|
-
- HY-156712
-
|
Antibody-Drug Conjugates (ADCs)
|
Cancer
|
Depatuxizumab MMAE is an antibody-drug conjugate (ADC) comprising an anti EGFR monoclonal antibody (Depatuxizumab) and the cytotoxic agent Monomethyl auristatin E (MMAE). Depatuxizumab inhibits the growth of xenograft models of mutant EGFRvIII and wild-type EGFR .
|
-
- HY-P99856
-
|
RABV
|
Infection
|
Docaravimab is an antibody, targeting ERA (Evelyn-Rockitniki-Abelseth) glycoprotein ectodomain epitope G-III. Docaravimab can be used in research of Rabies .
|
-
- HY-P99188
-
CNTO 888
|
CCR
|
Cancer
|
Carlumab (CNTO 888) is a human anti-CCL2 (chemokine ligand 2) antibody with high affinity. Carlumab can be used in cancer research, particularly in prostate cancer .
|
-
- HY-108852
-
CHI 621
|
Interleukin Related
|
Inflammation/Immunology
|
Basiliximab (CHI 621) is a recombinant chimeric murine/human IgG1 monoclonal anti-interleukin-2 receptor antibody. Basiliximab can be used for the research of renal transplantation .
|
-
- HY-P99804
-
MK1654
|
RSV
|
Infection
|
Clesrovimab (MK1654) is a fully human, anti-RSV fusion (RSV F) glycoprotein monoclonal antibody. Clesrovimab has the potential for the research of respiratory syncytial virus infection .
|
-
- HY-P99494
-
TRC105; DE-122
|
TGF-beta/Smad
|
Cancer
|
Carotuximab (TRC105) is a IgG1 monoclonal antibody that blocks endoglin (CD105) and its downstream Smad signaling pathway. Carotuximab has immunomodulatory and antineoplastic actions .
|
-
- HY-P99703
-
17.1.41
|
HBV
|
Infection
|
Libivirumab (17.1.41) is a human anti-HBV monoclonal antibody. Libivirumab shows neutralization activity with IC50s of 35, 130 ng/mL for HBsAg, HBeAg, respectively .
|
-
- HY-P99812
-
INCAGN-1876
|
TNF Receptor
|
Cancer
|
Ragifilimab (INCAGN-1876) is an agonist monoclonal antibody targeting the glucocorticoid-induced TNFR-related protein (GITR). Ragifilimab can be used for advanced or metastatic solid tumors research .
|
-
- HY-P99835
-
MABT 5102A; RG 7412
|
Amyloid-β
|
Neurological Disease
|
Crenezumab (MABT 5102A; RG 7412) is a fully humanized anti-Aβ monoclonal antibody that binds multiple forms of Aβ, such as soluble, oligomeric and fibrillar, for use in Alzheimer's disease research .
|
-
- HY-P99104
-
COVI-AMG; STI-2020
|
SARS-CoV
|
Infection
|
Plutavimab a human IgG1-κ anti-SARS-CoV-2 antibody, targeting to Spike (S) glycoprotein receptor binding domain (RBD) .
|
-
- HY-P99884
-
PF-06801591
|
PD-1/PD-L1
|
Others
|
Sasanlimab (PF-06801591) is a humanized IgG4-κ antibody targeting PD-1. Mainly expressed by CHO (Chinese Hamster Ovary) cells .
|
-
- HY-P990049
-
JMT-101
|
EGFR
|
Cancer
|
Becotatug (JMT-101) is an IgG1 antibody targeting EGFR that can also be conjugated to Afatinib (HY-10261) and Osimertinib (HY-15772) as a synthetic ADC .
|
-
- HY-131955
-
|
ADC Linker
|
Cancer
|
Fmoc-aminooxy-PEG2-NH2 is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-P99849
-
ABT-806
|
EGFR
|
Cancer
|
Depatuxizumab is a brain-penetrant and humanized tumor-specific anti EGFR monoclonal antibody. Depatuxizumab inhibits the growth of xenograft models of mutant EGFRvIII and wild-type EGFR. Depatuxizumab can be used for research on cancer .
|
-
- HY-156514
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
MC-GGFG-AM-(10NH2-11F-Camptothecin) is an antibody drug conjugates (ADC). MC-GGFG-AM-(10NH2-11F-Camptothecin) binds to the anti-TROp-2 antibody sacituzumab via a hydrolysable pH-sensitive linker and has anti-tumor activity. MC-GGFG-AM-(10NH2-11F-Camptothecin) can be used for cancer research .
|
-
- HY-P9905
-
C225
|
EGFR
|
Cancer
|
Cetuximab (C225) is a human IgG1 monoclonal antibody that inhibits epidermal growth factor receptor (EGFR), with a Kd of 0.201 nM for EGFR by SPR. Cetuximab has potent antitumor activity .
|
-
- HY-P99214
-
KBPA101
|
Bacterial
|
Infection
|
Panobacumab (KBPA101) is a fully human IgM/κ monoclonal antibody generated by immortalizing human B lymphocytes against the LPS O polysaccharide of serotype O11 of P. aeruginosa .
|
-
- HY-P99209
-
MEDI-524
|
RSV
|
Infection
|
Motavizumab (MEDI-524) is an anti-human RSV (respiratory syncytial virus) monoclonal antibody. Motavizumab can be used in respiratory syncytial virus infection in high-risk infants research .
|
-
- HY-P99473
-
BI-505
|
Integrin
|
Cancer
|
Bersanlimab (BI-505) is a fully human monoclonal antibody that targets intercellular adhesion molecule-1 (ICAM-1 or CD54). Bersanlimab has anticancer effects .
|
-
- HY-P99576
-
OG1953
|
VEGFR
|
Others
|
Tarcocimab (OG1953) is a humanized anti-VEGFA monoclonal antibody (IgG1 type). Tarcocimab is available for research in retinal vein occlusion (RVO) and wet age-related macular degeneration (AMD).
|
-
- HY-P99832
-
c13C6-FR1
|
Filovirus
|
Infection
|
Cosfroviximab (c13C6-FR1) is a mouse/human chimeric monoclonal antibody against Ebola virus glycoprotein (EBOV-GP) .
|
-
- HY-P99831
-
GB-221
|
EGFR
|
Others
|
Coprelotamab (GB-221) is an IgG-κ monoclonal antibody targeting EGFR2. The commonly used expression system for Coprelotamab is CHO DG44 (Chinese Hamster Ovary) cells .
|
-
- HY-P99870
-
ASLAN004; CSL-334
|
Interleukin Related
|
Others
|
Eblasakimab (ASLAN004; CSL-334) is a human IgG4 antibody that specifically targets IL13RA1 and is primarily expressed by CHO-K1 cells .
|
-
- HY-P990052
-
MAD-0004J08
|
SARS-CoV
|
Infection
|
Simaravibart (MAD-0004J08) is an IgG1κ antibody targeting the SARS-CoV2 spike (S) glycoprotein receptor binding domain .
|
-
- HY-P990073
-
REGN-5093
|
c-Met/HGFR
|
Cancer
|
Davutamig (REGN-5093) is a human immunoglobulin G4-kappa, anti-MET monoclonal antibody targeting two different nonoverlapping epitopes on MET. Davutamig is an antineoplastic .
|
-
- HY-P990084
-
|
IGF-1R
|
Cancer
|
Veligrotug is an IgG1-kappa, anti-IGF1R (insulin-like growth factor 1 receptor, CD221) chimeric monoclonal antibody .
|
-
- HY-P99572
-
BNT-312; DuoBody-CD40x-4-1BB; GEN1042
|
TNF Receptor
|
Inflammation/Immunology
Cancer
|
Tecaginlimab (BNT-312) is a Fc-inert bispecific antibody for dual targeting and conditional stimulation of CD40 and 4-1BB. Tecaginlimab can enhance priming and reactivation of tumor-specific immunity .
|
-
- HY-P99736
-
BI-754111
|
LAG-3
|
Cancer
|
Miptenalimab (BI-754111) is an anti-human LAG-3 antibody (KD: 88.6 nM for h LAG-3). Miptenalimab blocks the interaction of LAG-3 with its ligand MHC-II .
|
-
- HY-147407
-
|
Others
|
Cancer
|
Imbotolimod, immunoglobulin G1-kappa, is a humanized monoclonal antibody with anti-ERBB2 and antineoplastic activity. Imbotolimod is a derivative of telratolimod .
|
-
- HY-145620
-
-
- HY-P99707
-
HH1
|
Apoptosis
|
Cancer
|
Lilotomab (HH1) is a murine anti-CD37 monoclonal antibody. Lilotomab reduces clonogenic survival. Lilotomab shows anti-tumor activity .
|
-
- HY-P99047
-
AB 0024; GS 6624
|
Monoamine Oxidase
|
Inflammation/Immunology
|
Simtuzumab (AB 0024; GS 6624) is a monoclonal antibody directed against Lysyl oxidase like-2 (LOXL2). Simtuzumab can be used for the research of primary sclerosing cholangitis (PSC) .
|
-
- HY-P99706
-
AK 117
|
Interleukin Related
|
Cancer
|
Ligufalimab (AK 117) is a humanized IgG4 anti-CD47 monoclonal antibody. Ligufalimab does not induce RBC hemagglutination, and induces phagocytosis. Ligufalimab shows anti-tumor activity .
|
-
- HY-P99748
-
|
TGF-β Receptor
|
Inflammation/Immunology
|
Nadecnemab is an IgG4κ antibody targeting to GFRA3, glial cell derived neurotrophic factor family receptor alpha 3. Nadecnemab can be used for research of osteoarthritis of the knee/pain .
|
-
- HY-P99871
-
AK102
|
Ser/Thr Protease
|
Others
|
Ebronucimab (AK102) is an IgG1-λ2 antibody targeting PCSK9 and is primarily expressed by CHO DG44 (Chinese Hamster Ovary) cells .
|
-
- HY-P9925
-
AMG 827; KHK4827
|
Interleukin Related
|
Inflammation/Immunology
|
Brodalumab (AMG 827) is a human anti-interleukin-17-receptor IgG2 monoclonal antibody that can be used for the research of moderate-to-severe plaque psoriasis and rheumatoid arthritis .
|
-
- HY-P99649
-
MEDI3902
|
Bacterial
|
Infection
|
Gremubamab (MEDI3902) is a humanized IgG1 kappa anti-PcrV/Psl monoclonal antibody. Gremubamab binds to the PA PcrV protein and Psl exopolysaccharide. Gremubamab has the potential for the research of pseudomonas aeruginosa infections .
|
-
- HY-P990013
-
|
GCGR
|
Metabolic Disease
|
Gulgafafusp alfa is a human IgG2κ antibody targeting the glucagon-like peptide 1 receptor GLP1R .
|
-
- HY-P990054
-
|
CD20
|
Cancer
|
Eramkafusp Alfa is a human IgG1 antibody targeting the mouse B lymphocyte CD20 antigen MS4A1 .
|
-
- HY-P9923A
-
MEDI-563 (anti-IL5RA ); BIW-8405 (anti-IL5RA )
|
Interleukin Related
|
Inflammation/Immunology
|
Benralizumab (anti-IL5RA ) (MEDI-563 (anti-IL5RA ); BIW-8405 (anti-IL5RA )) is an interleukin-5 receptor α (IL-5Rα)-directed cytolytic monoclonal antibody that induces direct, rapid and nearly complete depletion of eosinophils via enhanced antibody-dependent cell-mediated cytotoxicity. Benralizumab can be used for severe eosinophilic asthma study .
|
-
- HY-P99045
-
|
ADC Antibody
|
Cancer
|
Sacituzumab is a humanized IgG1 monoclonal antibody for anti-trophoblast cell-surface antigen 2 (anti-Trop-2). Sacituzumab has the potential for metastatic triple-negative breast cancer research .
|
-
- HY-P9958
-
Immunoglobulin G2; Ranmark
|
NF-κB
|
Cancer
|
Denosumab is a human monoclonal antibody binding to, and inhibiting, the receptor activator of RANKL (TNFSF11). Denosumab can reduce the risk of vertebral, nonvertebral and hip fractures , also has anti-cancer activity .
|
-
- HY-P99181
-
CPI-006
|
CD73
|
Infection
Inflammation/Immunology
|
Mupadolimab (CPI-006) is an IgG1κ humanized FcγR binding-deficient anti-CD73 monoclonal antibody (mAb) that activates CD73 POS B cells .
|
-
- HY-P99337
-
Ansuvimab-zyk; mAb114
|
Filovirus
|
Infection
|
Ansuvimab (Ansuvimab-zyk) is a recombinant human monoclonal IgG1 antibody that exhibits antiviral activity against Zaire ebolavirus. Ansuvimab binds to the glycoprotein on Zaire ebolavirus to block its entry into host cells .
|
-
- HY-P99423
-
ADG 20
|
SARS-CoV
|
Infection
|
Adintrevimab (ADG 20) is a human IgG1 monoclonal SARS-CoV (SARS-CoV) antibody. Adintrevimab inhibits SARS-CoV-2 variants and other SARS-like coronaviruses with pandemic potential .
|
-
- HY-P99670
-
-
- HY-P99947
-
XVR011
|
SARS-CoV
|
Infection
|
Rimteravimab (XVR011) is a bivalent VHH-Fc antibody with potent neutralizing activity with high stability, broad coverage and silenced Fc effector functions against the disease caused by SARS-CoV-2 .
|
-
- HY-145641
-
BMS-986413; C-144-LS
|
SARS-CoV
|
Infection
|
Crexavibart (BMS-986413; C-144-LS) is an IgG1λ2 antibody that targets the SARS-CoV2 spike (S) glycoprotein receptor-binding domain .
|
-
- HY-P990077
-
CT-011; MDV9300
|
PD-1/PD-L1
|
Cancer
|
Pidilizumab (CT-011) is a humanized IgG1k anti-PD-1 monoclonal antibody. Pidilizumab acts as a DLL1 antagonist. Pidilizumab has the potential for hematologic malignancies research .
|
-
- HY-18286
-
|
TSH Receptor
|
Endocrinology
|
NCGC00229600 is an allosteric inverse agonist of thyrotropin receptor (TSHR). NCGC00229600 inhibits both TSH and stimulating antibody activation of TSHRs endogenously expressed in Graves' disease .
|
-
- HY-D0871
-
N-Cyclohexyltaurine
|
Biochemical Assay Reagents
|
Others
|
CHES (N-Cyclohexyltaurine) is a zwitterionic buffer. CHES can bind to hemagglutinin (HA) emulating with sialic acid (SA) and receptor binding site (RBS)-targeting broadly neutralizing antibodies .
|
-
- HY-P99453
-
|
ADC Antibody
|
Cancer
|
Azintuxizumab is a monoclonal, targeting to B-cell maturation antigen (BCMA) and SLAMF7/CRACC/CD319, IgG1 bispecific antibody. Azintuxizumab has the potential for the research of relapsed/refractory multiple myeloma (RRMM) .
|
-
- HY-P99671
-
M-6495
|
ADAMTS
|
Inflammation/Immunology
|
Isecarosmab (M-6495) is an anti-ADAMTS monoclonal antibody (mAb) with a KD value of 3.65 pM. Isecarosmab has chondroprotective and anti-inflammatory activities. Isecarosmab can bind albumin to extend plasma half-life .
|
-
- HY-118870
-
|
Endogenous Metabolite
|
Inflammation/Immunology
|
γ-Globulins from human blood are a class of proteins in the blood. γ-Globulin is a protein fraction of blood serum containing many antibodies that protect against bacterial and viral infectious diseases. γ-Globulins from human blood is used for common variable immunodeficiency
|
-
- HY-P9903A
-
|
PD-1/PD-L1
|
Cancer
|
Nivolumab (anti-PD-1) is a programmed death receptor-1 (PD-1) blocking human IgG4 antibody to treat advanced (metastatic) non-small cell lung cancer .
|
-
- HY-P9956
-
CNTO-328
|
Interleukin Related
|
Cancer
|
Siltuximab is an anti-IL-6 (interleukin-6) monoclonal antibody, and shows antitumor activity. Siltuximab can be used in Multicentric Castleman's Disease (MCD) and COVID-19 research .
|
-
- HY-P99461
-
ISU-104
|
EGFR
|
Cancer
|
Barecetamab (ISU-104) is a fully human anti-ErbB3 monoclonal antibody. Barecetamab can be used for the research of recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) .
|
-
- HY-P99629
-
FHTR 2163; RG 6147; RO 7171009
|
Ser/Thr Protease
|
Neurological Disease
|
Galegenimab (FHTR 2163; RG 6147; RO 7171009), an anti-High-temperature requirement A1 (HTRA1) antibody fragment. Galegenimab can be used for age-related macular degeneration (AMD) research .
|
-
- HY-P99900
-
MSL-109
|
CMV
|
Infection
|
Sevirumab (MSL-109) is a human IgG1 neutralizing monoclonal antibody against cytomegalovirus (CMV). Sevirumab recognizes CMV gH complexes and inhibits CMV replication with an EC50 of 0.3 μg/mL .
|
-
- HY-P99811
-
CR57
|
RABV
|
Infection
|
Rafivirumab (CR57) is an anti-rabies virus monoclonal antibody for the prophylaxis of rabies. Rafivirumab has neutralizing potency against a broad spectrum of RABV variants. Rafivirumab can be used for research of cocktails .
|
-
- HY-P9927A
-
-
- HY-P990009
-
NIS-793
|
TGF-beta/Smad
|
Cancer
|
Nisevokitug (NIS-793) is a human, IgG2λ antibody targeting TGF-β (TGFB1/TGFB2). Nisevokitug is expressed by CHO-K1 cells .
|
-
- HY-P9985
-
RC48
|
Antibody-Drug Conjugates (ADCs)
EGFR
|
Cancer
|
Disitamab vedotin (RC48) is an antibody-drug conjugate (ADC) comprising a monoclonal antibody against human epidermal growth factor receptor 2 (HER2) conjugated via a cleavable linker to the cytotoxic agent Monomethyl auristatin E (MMAE). Disitamab vedotin enhances antitumor immunity .
|
-
- HY-P99489
-
ABBV 181; PR 1648817
|
PD-1/PD-L1
|
Cancer
|
Budigalimab (ABBV 181; PR 1648817) is a humanized IgG1 monoclonal antibody targeting programmed cell death 1 (PD-1) receptor. Budigalimab is Fc mutated thus to reduce Fc receptor interactions and limit effector function .
|
-
- HY-P99652
-
AK 111
|
Interleukin Related
|
Inflammation/Immunology
|
Gumokimab (AK 111) is a monoclonal antibody targeting IL-17A, which can be used in the study of psoriasis, ankylosing spondylitis. Gumokimab competitively blocks the binding of human IL-17A to IL-17R.
|
-
- HY-P99223
-
MEDI-575
|
PDGFR
|
Cancer
|
Tovetumab (MEDI-575) is an anti-PDGFRα monoclonal antibody that selectively blocks the PDGFRα signal transduction. Tovetumab can be used in the research of glioblastoma and non-small cell lung cancer (NSCLC) .
|
-
- HY-P99540
-
PSB-205; QL1706 (iparomlimab/tuvonralimab); PBS105
|
PD-1/PD-L1
CTLA-4
|
Cancer
|
Tuvonralimab (PSB-205; QL1706) is a dual immune checkpoint blockade containing a mixture of anti-PD-1 IgG4 and anti-CTLA-4 IgG1 antibodies, Iparomlimab and Tuvonralimab .
|
-
- HY-P99550
-
MEDI-3506
|
Interleukin Related
|
Inflammation/Immunology
|
Tozorakimab (MEDI-3506) is a human immunoglobulin G1 monoclonal antibody targeting interleukin-33. Tozorakimab reduces inflammation and epithelial dysfunction. Tozorakimab can be used to research chronic obstructive pulmonary disease .
|
-
- HY-P99491
-
AVTX-007; CERC-007; MEDI 2338
|
Interleukin Related
|
Inflammation/Immunology
|
Camoteskimab (AVTX-007) is a fully human, high-affinity anti-IL-18 monoclonal antibody. Camoteskimab has the potential for the autoinflammatory diseases research, including adult-onset Still’s disease (AOSD) .
|
-
- HY-P99895
-
|
PD-1/PD-L1
|
Inflammation/Immunology
Cancer
|
Rulonilimab is a human IgG1 monoclonal antibody against PD-1 that targets, binds and inhibits PD-1 and its downstream signalling pathways with potential immune checkpoint inhibition and anti-tumour activity .
|
-
- HY-P99792
-
NM57; rhRIG
|
RABV
|
Infection
|
Ormutivimab (rhRIG) is a recombinant human monoclonal antibody, targeting rabies virus. Ormutivimab neutralizes a variety of rabies virus strains. Ormutivimab exhibits potent potency against rabies post-exposure prophylaxis (PEP) model .
|
-
- HY-P99853
-
CR6261
|
Influenza Virus
|
Infection
|
Diridavumab is a monoclonal anti-HA stalk antibody. Diridavumab stabilizes the prefusion HA structure and prevents pH-dependent fusion of cellular and viral membranes in endosomes. Diridavumab can be used in research of H2 influenza virus .
|
-
- HY-P99727
-
SYN023
|
RABV
|
Infection
|
Mazorelvimab (SYN023) is a combination of CTB011 and CTB012 humanized monoclonal antibodies cocktail against rabies virus (RABV). Mezagitamab binds to non-overlapping epitopes on RABV glycoprotein (G). Mezagitamab has potential application in the prevention of rabies .
|
-
- HY-P9901
-
MDX-010; BMS-734016
|
CTLA-4
|
Cancer
|
Ipilimumab is a fully human monoclonal antibody IgG1κ that blocks the inhibitory receptor cytotoxic T lymphocyte antigen 4 (CTLA-4) on T cells. Ipilimumab can be used in unresectable or metastatic melanoma (MM) studies .
|
-
- HY-P99196
-
|
c-Met/HGFR
|
Cancer
|
Ficlatuzumab is a monoclonal antibody (McAb) targeting human hepatocyte growth factor (HGF). Ficlatuzumab blocks the activation of the HGF/c-Met signaling pathway, and inhibits c-Met receptor-mediated cancer cell proliferation, migration, and invasion .
|
-
- HY-P99365
-
ALXN1210
|
Complement System
|
Metabolic Disease
|
Ravulizumab (ALXN1210) is a humanized monoclonal antibody that specifically binds with high affinity to the human complement protein C5. Ravulizumab can be used for the research of paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis .
|
-
- HY-P99452
-
SNDX-6352
|
c-Fms
|
Inflammation/Immunology
Cancer
|
Axatilimab (SNDX-6352) is a humanized IgG4 antibody with high affinity to CSF-1R. Axatilimab can be used for the research of chronic graft versus host disease (cGVHD) and neoplastic diseases .
|
-
- HY-P99560
-
C4G1; YM-337
|
Integrin
|
Cardiovascular Disease
|
Tadocizumab (C4G1; YM-337) is a humanized monoclonal antibody tageting integrin αIIbβ3. Tadocizumab has antiplatelet and antithrombotic effects, and can be used for cardiovascular disease research .
|
-
- HY-P99485
-
AMG 139; MEDI2070
|
Interleukin Related
|
Inflammation/Immunology
|
Brazikumab (AMG 139) is a human IgG2 monoclonal antibody, selectively binds the p19 subunit of IL-23, with a KD of 0.138 nM for human IL-23. Brazikumab can be used for the research of Crohn's disease .
|
-
- HY-P99795
-
GSK 3196165; MOR103
|
c-Fms
|
Inflammation/Immunology
|
Otilimab (GSK 3196165) is an anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) human monoclonal antibody. Otilimab neutralises the biological function of GM-CSF by blocking the interaction of GM-CSF with its cell surface receptor .
|
-
- HY-P99764
-
REGN-3471
|
Influenza Virus
|
Infection
|
Odesivimab is a human monoclonal antibody, targeting Ebola virus glycoprotein with a KD value of 7.74 nM for recombinant histidine-tagged Makona strain Ebola virus glycoprotein ectodomain protein. Odesivimab can be used in research of Ebola virus infection .
|
-
- HY-P990095
-
|
CD3
TNF Receptor
|
Cancer
|
Vonsetamig is a humanised immunoglobulin G4-kappa, anti-TNFRSF17 and CD3E monoclonal antibody. Vonsetamig is an antineoplastic .
|
-
- HY-P99931
-
GEN3013
|
CD3
CD20
|
Cancer
|
Epcoritamab (GEN3013) is an bispecific IgG1 antibody redirecting T-cells toward CD3×CD20 + tumor cells. Epcoritamab induces potent T-cell-mediated cytotoxicity towards B-cell NHL cell lines .
|
-
- HY-P99796
-
ATN-103
|
TNF Receptor
|
Inflammation/Immunology
|
Ozoralizumab (ATN-103) is an anti-TNFα humanized antibody. Ozoralizumab is a humanized trivalent nanobody compound that consists of two anti-human TNFα nanobodies and an anti-human serum albumin (HSA) nanobody. Ozoralizumab can be used in research of arthritis .
|
-
- HY-W145690
-
A-Pentasaccharide
|
Others
|
Inflammation/Immunology
|
Blood group A pentasaccharide (A-Pentasaccharide), an oligosaccharide in urine, can inhibit the binding of anti-A antibody to blood group A substance .
|
-
- HY-P99183
-
EMD 525797; DI17E6
|
Integrin
|
Cancer
|
Abituzumab (DI17E6) is a humanised anti-integrin αV monoclonal antibody (IgG2 type). Abituzumab effectively reduces the phosphorylation of FAK, Akt and ERK. Abituzumab can be used in cancer research, particularly in prostate cancer .
|
-
- HY-P99222
-
MGA-031; PRV-031
|
CD3
|
Metabolic Disease
|
Teplizumab (MGA-031) is a Fc receptor non-binding anti-human CD3 monoclonal antibody. Teplizumab reduces the loss of beta-cell function. Teplizumab can be used in the research of type 1 diabetes .
|
-
- HY-P99648
-
BMS-986168; IPN007; BIIB092
|
Tau Protein
|
Neurological Disease
|
Gosuranemab (BMS-986168) is a humanised IgG4 anti-tau monoclonal antibody. Gosuranemab binds to human N-terminal tau residues 15-22. Gosuranemab has the potential for the research of alzheimer’s disease (AD) .
|
-
- HY-P99830
-
KH902
|
VEGFR
|
Others
|
Conbercept (KH902) is a monoclonal antibody targeting VEGFRA fused to the IGHG1 Fc fragment. Conbercept is produced by the fusion of the second C-LIKE of FLT1 and the third and fourth C-LIKE of KDR with IGHG1 Fc. Conbercept .
|
-
- HY-P990008
-
|
TNF Receptor
Apoptosis
|
Inflammation/Immunology
|
Atrosab is a humanized IgG1 antagonistic anti-TNFR1 antibody. Atrosab inhibits TNF-mediated apoptosis induction and IL-6 and IL-8 production. Atrosab can be used for research of inflammatory disease .
|
-
- HY-P990072
-
|
PD-1/PD-L1
|
Cancer
|
Lipustobart is an IgG4-kappa, anti-PDCD1 (programmed cell death 1, PD1, PD-1, CD279) humanized monoclonal antibody. Lipustobart shows immunostimulant and antineoplastic activity .
|
-
- HY-137098
-
|
Fluorescent Dye
|
Others
|
Sulfo-Cy3 maleimide potassium is a fluorescent dye with a maleimide functionality at the end a short alkyl linker. Sulfo-Cy3 maleimide potassium can be used for the labeling of antibodies and other labile proteins .
|
-
- HY-P99007
-
BAY 1179470
|
FGFR
|
Cancer
|
Aprutumab (BAY 1179470) is a fully human FGFR2 monoclonal antibody, which binds to the FGFR2 isoforms FGFR2-IIIb and FGFR2-IIIc. Aprutumab has the potential for solid tumors research .
|
-
- HY-P99010
-
|
FGFR
|
Cancer
|
Bemarituzumab is a first-in-class, humanized IgG1 monoclonal antibody against FGFR2b (a FGF receptor). Bemarituzumab blocks fibroblast growth factors from binding and activating FGFR2b. Bemarituzumab has the potential for cancer research .
|
-
- HY-P99030
-
|
EGFR
|
Cancer
|
Margetuximab (MGAH22) is a chimeric anti-HER2 monoclonal antibody optimized Fc domain, with an EC50 value of 39.33 ng/mL. Margetuximab can be used for researching metastatic HER2-positive breast cancer .
|
-
- HY-P9911A
-
|
Integrin
|
Inflammation/Immunology
|
Vedolizumab (anti-α4β7-integrin) is a humanized IgG1 monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease .
|
-
- HY-P9934
-
C7E3
|
Integrin
|
Cardiovascular Disease
|
Abciximab (C7E3), a chimeric mouse/human monoclonal antibody, is a glycoprotein (GP) IIb/IIIa inhibitor. Abciximab inhibits platelet aggregation and leucocyte adhesion by binding to the glycoprotein IIb/IIIa, vitronectin and Mac-1 receptors .
|
-
- HY-P99219
-
MEDI-545; MDX 1103
|
IFNAR
|
Inflammation/Immunology
|
Sifalimumab (MEDI-545) is an anti-IFNα monoclonal antibody. Sifalimumab suppresses the abnormal immune activity by binding to multiple interferon-alpha (IFNα) subtypes. Sifalimumab can be used in systemic lupus erythematosus (SLE) research .
|
-
- HY-P99354
-
Anti-Human CTLA4xLAG3
|
LAG-3
|
Inflammation/Immunology
Cancer
|
Bavunalimab (Anti-Human CTLA4xLAG3) is a bispecific human anti-CTLA-4/LAG-3 monoclonal antibody. Bavunalimab activates T cells in NSG mice. Bavunalimab can be used for the research of cancer .
|
-
- HY-P99516
-
HLX-06
|
VEGFR
|
Cancer
|
Vulinacimab (HLX-06) is an anti-VEGFR-2 monoclonal antibody (mAb). Vulinacimab can be used in the research of cancers. VEGFR-2, overexpressed in certain tumors, is critical in angiogenesis and the proliferation, survival, migration and differentiation of endothelial cells .
|
-
- HY-P99439
-
IMA-638
|
Interleukin Related
|
Inflammation/Immunology
|
Anrukinzumab (IMA-638) is a humanized anti-IL-13 monoclonal antibody. Anrukinzumab effectively reduces lung inflammation in a cynomolgus monkey model. Anrukinzumab can be used in studies of ulcerative colitis (UC) as well as asthma .
|
-
- HY-P99945
-
-
- HY-P990067
-
ATOR-1017
|
TNF Receptor
|
Cancer
|
Evunzekibart (ATOR-1017) is an Fc-γ receptor conditional 4-1BB agonist and IgG4-type antibody. Evunzekibart can be used as monotherapy or in combination with anti-PD1 to exert anticancer activity.
|
-
- HY-P990014
-
IMC-001; STI-3031
|
PD-1/PD-L1
|
Inflammation/Immunology
Cancer
|
Danburstotug (IMC-001) is an IgG1-lambda anti-CD274 (PDL1, B7 homologue 1, B7H1) human monoclonal antibody. Danburstotug also is immunostimulant and antineoplastic .
|
-
- HY-138200
-
Cyanine5 maleimide
|
DNA Stain
Fluorescent Dye
|
Others
|
Cy5 maleimide is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
|
-
- HY-P99661
-
|
Interleukin Related
|
Cancer
|
Inbakicept is a dimeric human IL-15 receptor alpha (IL-15 Ra) sushi domain/human IgG1 Fc fusion protein and is an IL-15 superagonist complex. Inbakicept is able to form complex N-803 (Nogapendekin alfa inbakicept) with the IL-15 antibody Nogapendekin alfa in a 1:2 ratio. N-803 mimics the function of IL-15 and amplifies anti-CD20 mAb-mediated NK cell responses and antibody-dependent cellular cytotoxicity (ADCC). N-803 also increases degranulation and IFNγ production in cells .
|
-
- HY-P9953
-
Certolizumab; CDP870
|
TNF Receptor
|
Inflammation/Immunology
|
Certolizumab pegol (Certolizumab) is a recombinant, polyethylene glycolylated, antigen-binding fragment of a humanized monoclonal antibody that selectively targets and neutralizes tumour necrosis factor-α (TNF-α). Certolizumab pegol can be used for rheumatoid arthritis and Crohn disease research .
|
-
- HY-P99226
-
MEDI7734; VIB7734
|
SARS-CoV
|
Cancer
|
Daxdilimab is an anti-ILT7 monoclonal antibody, ILT7 is a cell surface molecule specific to the pDC type of dendritic cells. Daxdilimab can be used in acute lung injury (ALI) in patients with COVID-19 infection research .
|
-
- HY-P99216
-
PF-04360365; RN 1219
|
EGFR
|
Neurological Disease
|
Ponezumab (PF-04360365) is a humanised anti-amyloid IgG2 monoclonal antibody. Ponezumab reduces Aβ levels in the central nervous system and improves performance in mice in various models of learning and memory. Ponezumab can be used in study of Alzheimer's disease .
|
-
- HY-P99197
-
CP-751871
|
IGF-1R
|
Cancer
|
Figitumumab (CP-751871) is a potent and fully human monoclonal anti–insulin-like growth factor 1 receptor (IGF1R) antibody. Figitumumab prevents IGF1 from binding to IGF1R with an IC50 of 1.8 nM .
|
-
- HY-P99346
-
CT-P59
|
SARS-CoV
Angiotensin-converting Enzyme (ACE)
|
Infection
|
Regdanvimab (CT-P59) is a human monoclonal antibody that targets the receptor-binding domain of SARS-CoV-2 spike protein, blocking interaction with ACE2 for viral entry. Regdanvimab can be used for the research of COVID-19 .
|
-
- HY-P990046
-
Incagn-02385
|
LAG-3
|
Inflammation/Immunology
|
Tuparstobart (Incagn-02385) is an IgG1κ antibody targeting LAG-3. LAG-3 is an immune checkpoint receptor protein mainly expressed on activated T cells, NK cells, B cells and plasmacytoid dendritic cells .
|
-
- HY-P990070
-
BION-1301
|
TNF Receptor
|
Inflammation/Immunology
|
Zigakibart (BION-1301) is an IgG4-kappa, anti-TNFSF13 (tumor necrosis factor (TNF) superfamily member 13, APRIL, CD256) humanized monoclonal antibody. Zigakibart shows anti-inflammatory activity .
|
-
- HY-P99392
-
|
CD3
|
Cancer
|
Teclistamab is a human bispecific antibody to BCMA and CD3 that recognizes BCMA on target cells and CD3 on T cells and induces T cell-mediated cytotoxicity leading to T cell activation and subsequent target cell lysis. Teclistamab can be used in studies of diseases related to multiple myeloma (MM) .
|
-
- HY-114377
-
|
Others
|
Cancer
|
p-SCN-Bn-DOTA is a bifunctional chelating agent. p-SCN-Bn-DOTA can simultaneously chelate radionuclides and link monoclonal antibody for radioimmunoresearch of tumor .
|
-
- HY-P99659
-
ANB 019
|
Interleukin Related
|
Inflammation/Immunology
|
Imsidolimab (ANB 019) is a high-affinity, humanized monoclonal antibody of anti-IL-36R. Imsidolimab antagonizes IL-36 cytokine signal transduction. Imsidolimab has potential application in generalized pustular psoriasis (GPP) and other inflammatory skin diseases .
|
-
- HY-P9927
-
AIN457
|
Interleukin Related
|
Inflammation/Immunology
Cancer
|
Secukinumab (AIN457) is a high affinity, human monoclonal antibody targeted against interleukin (IL)-17A. Secukinumab is the first-in-class anti-IL-17 agent used for the research of plaque psoriasis, ankylosing spondylitis and psoriatic arthritis .
|
-
- HY-P99217
-
AMG 102
|
c-Met/HGFR
|
Cancer
|
Rilotumumab (AMG 102) is an anti-HGF (anti-hepatocyte growth factor) monoclonal antibody, inhibits HGF/MET-driven signaling. Rilotumumab shows anti-tumor activity, and can be used in castration-resistant prostate cancer (CRPC) and solid tumor research .
|
-
- HY-P99476
-
|
VEGFR
|
Cancer
|
ABP 215 (Bevacizumab-awwb), a Bevacizumab (Bevacizumab (HY-P9906)) biosimilar, is a humanized IgG1 monoclonal antibody targeting VEGFA (VEGFR). ABP 215 has anticancer effects, and can be used metastatic colorectal cancer (mCRC) research .
|
-
- HY-P99701
-
BMS-986004
|
TNF Receptor
|
Inflammation/Immunology
|
Letolizumab (BMS-986004) is a monoclonal antibody targeting CD40L, which is produced to express mutant IgG1 lacking effector function, including Fc binding and complement fixation. Letolizumab reduces rejection, thromboembolism and prolongs the survival time .
|
-
- HY-P99768
-
TTAC-0001
|
VEGFR
|
Cancer
|
Olinvacimab (TTAC-0001) is a fully human anti-VEGFR2 monoclonal antibody. Olinvacimab inhibits VEGF binds to KDR with a Kd value of 0.23 nM. Olinvacimab has antiangiogenic activity. Olinvacimab can be used for the research of recurrent glioblastoma and breast cancer .
|
-
- HY-P99770
-
514-G3
|
Bacterial
|
Infection
|
Omodenbamab is an anti-SpA (Staphylococcal protein A) human monoclonal antibody with a KD value of 0.0467 nM. Omodenbamab circumvents a key S. aureus evasion mechanism by targeting the cell wall moiety Protein A (SpA). Omodenbamab can be used in research of S. aureus bloodstream infection .
|
-
- HY-P990007
-
PRA023; PRA-023
|
TNF Receptor
|
Inflammation/Immunology
|
Tulisokibart (PRA023) is a humanized IgG1-κ monoclonal antibody targeting to TNFSF15/TL1A. Tulisokibart can be used to study a variety of inflammatory/fibrotic diseases, such as Crohn's Disease (CD) .
|
-
- HY-P990037
-
|
CD38
|
Cancer
|
Erzotabart is an IgG1-kappa, anti-CD38 (ADP-ribosyl cyclase 1, cyclic ADP-ribose hydrolase 1, cADPr hydrolase 1, cADPR1) Homo sapiens monoclonal antibody. Erzotabart shows antineoplastic activity .
|
-
- HY-D1389
-
Sulfo-Cyanine5.5 NHS ester tripotassium
|
Fluorescent Dye
|
Others
|
Sulfo-CY-5.5 NHS ester (Sulfo-Cyanine5.5 NHS ester) tripotassium is an amine-reactive ester of sulfonated far-red Cyanine5.5 fluorophore, which can be used to label antibodies, proteins, etc., as well as for in vivo NIR imaging .
|
-
- HY-P99192
-
LY2875358
|
c-Met/HGFR
|
Cancer
|
Emibetuzumab (LY2875358) is a humanized bivalent MET antibody (IgG4 type). Emibetuzumab shows high neutralization and internalization activities, resulting in inhibition of both HGF-dependent and HGF-independent MET pathway activation and tumor growth. Emibetuzumab can be used in study of cancer .
|
-
- HY-P99523
-
AMG 199
|
CD3
|
Cancer
|
Vepsitamab (AMG 199) is an anti-MUC17/CD3 BiTE antibody that binds to CD3 on T cells and MUC17 expressed on tumor cells, mediates redirected tumor cell lysis, and induces T cell activation and proliferation .
|
-
- HY-P99886
-
h5G1. 1-SC
|
Complement System
Apoptosis
|
Cardiovascular Disease
Neurological Disease
|
Pexelizumab (h5G1. 1-SC) is a humanized scFv monoclonal antibody directed against the C5 complement component. Pexelizumab inhibits apoptosis and leukocyte infiltration. Pexelizumab can be used for the research of cerebral IR injury and myocardial infarction .
|
-
- HY-P99827
-
TSR-022; GSK4069889
|
Tim3
|
Cancer
|
Cobolimab (TSR-022) is an anti-TIM-3 monoclonal antibody. Cobolimab mediates the internalization of TIM3 with an IC50 value of 0.4464 nM. Cobolimab has potential application in solid tumors and non-small cell lung cancer (NSCLC) .
|
-
- HY-P990078
-
LY3372993
|
Amyloid-β
|
Neurological Disease
|
Remternetug is a human immunoglobulin G1-kappa, anti-APP (amyloid beta A4 precursor protein) Aβ42 N3pGlu peptide monoclonal antibody. Remternetug recognizes a pyroglutamated form of Aβ that aggregates into amyloid plaques .
|
-
- HY-P99714
-
MGD019
|
PD-1/PD-L1
CTLA-4
|
Cancer
|
Lorigerlimab (MGD019) is a bispecific IgG4 dual-affinity re-targeting antibody (DART). Lorigerlimab can block PD-1 and CTLA-4, and improves T-cell responses. Lorigerlimab can be used for research of metastatic castration-resistant prostate cancer (mCRPC) .
|
-
- HY-P99757
-
Hu3F8-BsAb
|
CD2
CD3
|
Cancer
|
Nivatrotamab (Hu3F8-BsAb) is a humanized anti-GD2/CD3 bispecific antibody. Nivatrotamab is a CD3- and GD2-specific bsAb-based T-cell engager. Nivatrotamab can be used in research of neuroblastoma .
|
-
- HY-148411
-
LJP 394 free base
|
Others
|
Inflammation/Immunology
|
Abetimus (LJP 394 free base) is an immunosuppressant consisting of four double-stranded DNA (dsDNA) oligonucleotides. Abetimus is capable of crosslinking anti-dsDNA antibodies on the surface of B cells, and decreases anti-dsDNA antibodies levels. Abetimus has the potential for research of systemic lupus erythematosus .
|
-
- HY-P9970
-
-
- HY-P99019
-
TEV-48125
|
CGRP Receptor
|
Neurological Disease
|
Fremanezumab (TEV-48125) is a humanized IgG2a monoclonal antibody that selectively and potently binds to calcitonin gene-related peptide (CGRP). CGRP is a 37-amino acid neuropeptide involved in central and peripheral pathophysiological events of migraine. Fremanezumab has the potential for chronic migraine research .
|
-
- HY-P99114
-
|
PD-1/PD-L1
|
Cancer
|
Sugemalimab is a fully human, full length, anti-programmed death ligand 1 (PD-L1) immunoglobulin G4 (IgG4) monoclonal antibody (mAb). Sugemalimab shows anticancer activities and can be used for non-small cell lung cancer research .
|
-
- HY-P99519
-
KPL-716
|
Interleukin Related
|
Inflammation/Immunology
|
Vixarelimab (KPL-716) is a human anti-oncostatin M (OSM) monoclonal antibody that binds to the beta chain of the OSM receptor and inhibits IL-31 and OSM signalling. Vixarelimab can be used in studies of inflammatory skin diseases such as atopic dermatitis and itchy nodular rash .
|
-
- HY-P99450
-
IPH 5401; Anti-C5aR1 mAb
|
Complement System
|
Inflammation/Immunology
Cancer
|
Avdoralimab (IPH 5401) is a fully human IgGκ monoclonal antibody that targets the complement C5a receptor 1 (C5aR1) that prevents its binding to C5a. Avdoralimab can be used for complement-driven inflammatory diseases and solid tumours research .
|
-
- HY-P99711
-
RB4v1.2
|
CD19
|
Cancer
|
Loncastuximab (RB4v1.2) is an anti-CD19 monoclonal antibody. Loncastuximab shows antitumor activity and has potential application in non-Hodgkin's lymphoma (NHL), including diffuse large B-cell lymphoma (DLBCL) .
|
-
- HY-P99794
-
BAY 1213790
|
Factor Xa
|
Cardiovascular Disease
|
Osocimab (BAY 1213790), an anti-FXIa antibody (Ki=2.4 nM; EC50=0.2 nM). FXI inhibition may reduce the risk of thrombosis. Osocimab inhibits thrombin generation, and prolongs activated partial thromboplastin time. Osocimab exhibits anticoagulant effects .
|
-
- HY-P99466
-
SAND-26
|
Dipeptidyl Peptidase
|
Inflammation/Immunology
|
Begelomab (SAND-26) is a murine IgG2b monoclonal antibody against DPP-4/CD26. Begelomab can be used for the research of severe refractory idiopathic inflammatory myopathy .
|
-
- HY-113512
-
|
Others
|
Inflammation/Immunology
|
17-HDHA is a DHA-derived specialized proresolving mediator (SPM). 17-HDHA enhances the antibody-mediated immune response against influenza virus. 17-HDHA enhances the differentiation of B cells toward the CD27 + CD38 + antibody-secreting cell phenotype, thereby strongly increasing IgM and IgG production by activated B cells .
|
-
- HY-P99220
-
LY2127399
|
TNF Receptor
|
Inflammation/Immunology
|
Tabalumab (LY2127399) is a human anti-BAFF (B-cell activating factor) monoclonal antibody (IgG4 type) with neutralising activity against membrane bound and soluble BAFF. Tabalumab can be used in studies of autoimmune diseases such as rheumatoid arthritis, renal failure and systemic lupus erythematosus .
|
-
- HY-P99215
-
Anti-EGFL7; RG 7414
|
VEGFR
|
Cancer
|
Parsatuzumab (Anti-EGFL7; RG 7414) is a humanized monoclonal antibody, acts as an immunomodulator and binds to EGFL7. Parsatuzumab selectively blocks the interaction between EGFL7 and endothelial cells, potentially inhibiting vascular regrowth and reducing vascular endothelial growth factor (VEGF) inhibition .
|
-
- HY-P99368
-
MCS110; Anti-Human B7-H3
|
c-Fms
|
Metabolic Disease
Cancer
|
Lacnotuzumab (MCS110) is a neutralizing humanized IgG1/κ monoclonal antibody targeting CSF-1 that prevents CSF-1 from activating the CSF-1R. Lacnotuzumab can be used for the research of pigmented villonodular synovitis .
|
-
- HY-P99490
-
hzVSF-v13
|
Interleukin Related
SARS-CoV
|
Infection
Inflammation/Immunology
|
Burfiralimab (hzVSF-v13) is a monoclonal IgG4 antibody against vimentin expressed on the surface of virus-infected cells, with broad-spectrum antiviral activity and anti-inflammatory effects against virus-induced inflammation. Burfiralimab can be used in severe COVID-19 studies .
|
-
- HY-P99633
-
BGB-A333
|
PD-1/PD-L1
Apoptosis
|
Cancer
|
Garivulimab (BGB-A333) is a humanized IgG1-variant monoclonal antibody that specifically targets and binds to PD-L1. Garivulimab selectively blocks the interaction of PD-L1 and PD-1. Garivulimab has antitumor activity .
|
-
- HY-P99756
-
MEDI8897
|
RSV
|
Infection
|
Nirsevimab (MEDI8897) is a recombinant human respiratory syncytial virus (RSV) monoclonal antibody with modified Fc region, which can prolong its half-life. Nirsevimab has an affinity for RSV-B with an Kd value of 1.5 nM. Nirsevimab can be used for RSV research .
|
-
- HY-P99776
-
XmAb-13676
|
CD20
CD3
|
Cancer
|
Plamotamab (XmAb-13676) is a human bispecific antibody (bsAb) that binds CD3 and CD20. Plamotamab recruits cytotoxic T cells to kill CD20 + expressing tumor cells. Plamotamab induces a mild hematologic reaction (MR), and results in tumor regression in vivo .
|
-
- HY-P9987
-
|
P-selectin
|
Cardiovascular Disease
|
Crizanlizumab is an anti-P-selectin monoclonal antibody. Crizanlizumab binds to P-selectin and blocks its interaction with P-selectin glycoprotein ligand 1 (PSGL-1). Crizanlizumab prevents vaso-occlusive crises (VOCs) and can be used for research of sickle cell disease .
|
-
- HY-P990086
-
|
Interleukin Related
|
Cancer
|
Vopikitug is an IgG1-kappa, anti-IL2RA (interleukin 2 receptor alpha subunit, IL-2RA, TAC, p55, CD25) homo sapiens monoclonal antibody. Vopikitug shows antineoplastic activity .
|
-
- HY-P99396
-
BI 655130
|
Interleukin Related
|
Inflammation/Immunology
|
Spesolimab (BI 655130) is an anti-IL-36R antibody. IL-36 involves in immune system, as Spesolimab can be used for palmoplantar pustulosis (PPP) research. Spesolimab is associated with the reduction of biomarkers linked to innate, Th1/Th17, and neutrophilic pathways .
|
-
- HY-P99664
-
|
Interleukin Related
|
Inflammation/Immunology
|
Inolimomab is an anti-interleukin-2 receptor (IL-2R) α chain monoclonal antibody. Inolimomab improves the survival rate in the early research of treating acute graft-versus-host disease (aGVHD) .
|
-
- HY-P99562
-
XmAb-18087
|
CD3
|
Cancer
|
Tidutamab (XmAb-18087) is a humanized and affinity-optimized bispecific antibody (bsAb) targeting SSTR2 binding domain and T-cell binding domain (CD3). Tidutamab possesses a full Fc domain to maintain long serum half-life.Tidutamab eliminates SSTR+ tumor cells by stimulating redirected T cellmediated cytotoxicity (RTcC) .
|
-
- HY-156516
-
|
ADC Cytotoxin
Topoisomerase
|
Cancer
|
10NH2-11F-Camptothecin is a Camptothecin (HY-16560) analogue that serves as an ADC cytotoxin for the synthesis of antibody-drug conjugates (ADCs). 10NH2-11F-Camptothecin can inhibit tumor growth and is used in cancer research .
|
-
- HY-400878
-
|
Glucocorticoid Receptor
Drug-Linker Conjugates for ADC
|
Cancer
|
Glucocorticoid receptor agonist-1 phosphate Gly-Glu-Mal, a glucocorticoid receptor agonist, is a drug-linker conjugate for ADC. Glucocorticoid receptor agonist-1 phosphate Gly-Glu-Mal can be used to synthesize the anti-CD40 antibody agent conjugates (WO2019106608A1; example 9) .
|
-
- HY-P9919
-
MEDI 4736
|
PD-1/PD-L1
|
Cancer
|
Durvalumab (MEDI 4736) is an human anti-PD-L1 monoclonal antibody . Durvalumab (MEDI4736) completely blocks the binding of PD-L1 to both PD-1 and CD80, with IC50s of 0.1 and 0.04 nM, respectively .
|
-
- HY-P99218
-
Sch 717454; 19D12
|
IGF-1R
|
Cancer
|
Robatumumab (Sch 717454) is an anti-human IGF-1R (insulin-like growth factor receptor-1) antibody. Robatumumab shows anti-tumor activity and anti-proliferative activity to cancer cells. Robatumumab can be used in osteosarcoma and Ewing sarcoma research .
|
-
- HY-P99544
-
HBM-9167; KL-A167
|
PD-1/PD-L1
|
Cancer
|
Tagitanlimab (HBM-9167) is a humanized anti-PD-L1 antibody (IgG1κ type). Tagitanlimab selectively blocks the interaction of PD-L1 and PD-1. Tagitanlimab has the potential to be studied in recurrent or metastatic nasopharyngeal carcinoma (NPC) .
|
-
- HY-P99541
-
anti-hepatitis B; OST 577; SDZ-OST 577
|
HBV
|
Infection
|
Tuvirumab (OST 577; SDZ-OST 577) is a human IgG1 subclass monoclonal antibody directed against HBV surface antigen (HBsAg). Tuvirumab binds specifically and with high affinity (K=3.6 nM) to HBsAg. Tuvirumab has the potential for chronic hepatitis B research .
|
-
- HY-P99672
-
MM 141; MM-005
|
IGF-1R
EGFR
|
Cancer
|
Istiratumab (M-6495) is bispecific monoclonal antibody targeting IGF-1R and ErbB3. Istiratumab induces IGF-1R and ErbB3 receptor degradation through the proteasome pathway Istiratumab can be used for research of cancers .
|
-
- HY-P99669
-
MDX-060
|
TNF Receptor
|
Cancer
|
Iratumumab (MDX-060) a human anti-CD30 IgG1κ monoclonal antibody. Iratumumab inhibits the growth of CD30-expressing tumor cells. Iratumumab can be used for research of Hodgkin's lymphoma (HL) and anaplastic large-cell lymphoma (ALCL) .
|
-
- HY-P990060
-
Mim8
|
Factor Xa
|
Cardiovascular Disease
|
Denecimig (Mim8) is a novel activated coagulation factor VIII-mimetic human bispecific antibody with anti-FIXa and anti-FX arms that potently stimulates FX activation resulting in efficacious haemostasis in vitro and in vivo .
|
-
- HY-P99822
-
SHR-1209
|
Ser/Thr Protease
|
Metabolic Disease
|
Recaticimab (SHR-1209) is a humanized monoclonal antibody that inhibits PCSK9. Receticimab mediates the degradation of PCSK9 by binding to PCSK9, increasing the level of low-density lipoprotein (LDL) receptors on the surface of hepatocytes, reducing the level of LDL in plasma, and achieving the goal of lowering blood lipids. Recaticimab has potential application in hypercholesterolemia .
|
-
- HY-P99299
-
HGS-ETR 2; ETR2-ST01
|
Apoptosis
|
Cancer
|
Lexatumumab (HGS-ETR 2) is a human agonistic TRAIL receptor 2 (TRAIL-R2, DR5, APO-2) IgG4κ type monoclonal antibody. Lexatumumab induces apoptosis in malignant mesothelioma. Lexatumumab can be used for malignant pleural mesothelioma (MPM) research .
|
-
- HY-P99486
-
ABT-874
|
Interleukin Related
|
Inflammation/Immunology
|
Briakinumab (ABT-874) is a fully human anti-IL-12/23p40 monoclonal antibody. Briakinumab targets and neutralizes IL-12 and IL-23. Briakinumab can be used for the research of rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis .
|
-
- HY-P99680
-
SB-210396; IDEC CE9.1
|
Interleukin Related
|
Cancer
|
Keliximab (SB-210396) is a chimeric human/macaque IgG1 anti-CD4 monoclonal antibody with a Ki value of 1.0 nM for soluble CD4. Keliximab blocks T cell proliferation and inhibits IL-2 production. Keliximab can be used for cancer research .
|
-
- HY-P99697
-
PRO 140
|
CCR
HIV
|
Infection
Cancer
|
Leronlimab (PRO 140) is a humanized IgG4 anti-CCR5 monoclonal antibody. Leronlimab inhibits CCR5-mediated HIV-1 viral and lung metastasis in mouse tumor models. Leronlimab can be used for the research of HIV nonalcoholic steatohepatitis (NASH) and cancer .
|
-
- HY-P99793
-
MLDL1278A
|
LDLR
|
Inflammation/Immunology
|
Orticumab (MLDL1278A) is an antibody targeting to oxidized or malondialdehyde-modified lipoprotein (LDL). Orticumab specifically inhibits oxidized low-density lipoproteins (oxLDL). Orticumab involves in modulation of autoimmune responses against oxLDL, improves atherosclerosis in animal model. Orticumab also can be used for research of psoriasis improvement .
|
-
- HY-P99836
-
IBI101
|
Orexin Receptor (OX Receptor)
|
Inflammation/Immunology
Cancer
|
Cudarolimab (IBI101) is a completely human anti-OX40 (CD134, a co stimulating molecule expressed by activated immune cells) antibody. Cudarolimab inhibits the binding of OX40 to its ligand OX40L. Cudarolimab has antitumor activity and can be used in cancer related research .
|
-
- HY-P99844
-
ALPN-202; CD80 vIgD-Fc
|
CTLA-4
|
Others
|
Davoceticept (ALPN-202; CD80 vIgD-Fc) is a monoclonal antibody targeting CTLA-4. Davoceticept consists of the (1-107) fragment of CD80 linked to IGHG1 Fc via a peptidyl linker. The expression system of Davoceticept is usually CHO (Chinese Hamster Ovary) cells .
|
-
- HY-157257
-
|
Biochemical Assay Reagents
|
Others
|
Trimethoprim fumaric acid (Compound CDI) is a universal hapten for ASGs (Antibacterial synergists) and can be used to design broadly specific monoclonal antibodies (mAbs) against ASGs. The mAb developed by Trimethoprim fumaric acid can be applied in ELISA to detect the residues of ASGs in foods of animal origin .
|
-
- HY-P9920
-
|
VEGFR
|
Cancer
|
Ramucirumab is a human VEGFR-2 antagonist for the treatment of solid tumors. Ramucirumab is a recombinant human immunoglobulin G1 monoclonal antibody that binds to the extracellular binding domain of VEGFR-2 and prevents the binding of VEGFR ligands: VEGF-A, VEGF-C, and VEGF-D. Ramucirumab is also an angiogenesis inhibitor .
|
-
- HY-P99412
-
OSE-127
|
Interleukin Related
|
Cancer
|
Lusvertikimab (OSE-127) is a humanized IL7R monoclonal antibody. Lusvertikimab is not internalized by target cells and prevents IL7R heterodimerization and subsequent downstream signaling. Lusvertikimab has anti-leukemic efficacy and has the potential for B cell precursor acute lymphoblastic leukemia (BCP-ALL) research .
|
-
- HY-P99913
-
|
c-Fms
|
Inflammation/Immunology
|
Eflapegrastim is a human IgG4 monoclonal antibody, is also a granulocyte colony-stimulating factor (G-CSF). Eflapegrastim targets to G-CSF receptor (c-Fms). Eflapegrastim stimulates proliferation and differentiation of neutrophil progenitor cells and maintains stable numbers of mature and functional neutrophils. Eflapegrastim also shortens the duration of neutropenia .
|
-
- HY-P99673
-
REGN-3500; SAR-440340
|
Interleukin Related
NF-κB
|
Inflammation/Immunology
|
Itepekimab (REGN-3500) is an IgG4 monoclonal antibody against IL-33. Itepekimab reduced airway inflammation and related tissue damage in preliminary clinical studies. Itepekimab has potential effects in asthma, chronic obstructive pulmonary disease (COPD), and atopic dermatitis (AD) .
|
-
- HY-P99011
-
|
CD3
|
Cancer
|
Cibisatamab (CEA-TCB), a T cell bispecific antibody, binds Carcino-Embryonic Antigen (CEA) on cancer cells and CD3 on T cells. Cibisatamab (CEA-TCB) triggers T cell killing of cancer cell lines expressing moderate to high levels of CEA at the cell surface. Cibisatamab (CEA-TCB) can be used for colorectal cancer research .
|
-
- HY-P99765
-
anti-LFA1
|
Integrin
|
Inflammation/Immunology
|
Odulimomab (anti-LFA1) is an anti-LFA-1 monoclonal antibody. Odulimomab inhibits proliferation of T lymphocyte and shows protective effects against ischemia and reperfusion injury. Odulimomab can be used for the research of transplant rejection and immunological disease .
|
-
- HY-P99342
-
REGN10987
|
SARS-CoV
|
Infection
|
Imdevimab (REGN10987) is a human monoclonal antibody to target SARS-CoV-2 virus, which causes COVID-19. Imdevimab lacks efficacy against COVID-19 variants. Imdevimab can be used in combination with Casirivimab (HY-P99341), it reduces viral load and improves diseases .
|
-
- HY-P99341
-
REGN10933
|
SARS-CoV
|
Infection
|
Casirivimab (REGN10933) is a human monoclonal antibody to target SARS-CoV-2 virus, which causes COVID-19. Casirivimab lacks efficacy against COVID-19 variants. Casirivimab can be used in combination with Imdevimab (HY-P99342), it reduces viral load and improves diseases .
|
-
- HY-P99637
-
MHAA4549A; RG7745
|
Influenza Virus
|
Infection
|
Gedivumab (MHAA4549A; RG7745) is a human monoclonal antibody that targets influenza A virus (IAV) with high specificity and binds to the highly conserved stem region of the IAV haemagglutinin protein, thereby preventing haemagglutinin maturation and blocking haemagglutinin-mediated membrane fusion in the intranucleosome. Gedivumab can be used in IAV infection disease studies .
|
-
- HY-P99956
-
VLS-101; MK-2140
|
Antibody-Drug Conjugates (ADCs)
Apoptosis
|
Cancer
|
Zilovertamab vedotin (VLS-101) is a novel antibody-drug conjugate comprising the humanized monoclonal antibody zilovertamab and and the anti-microtubule cytotoxin monomethyl vedotin. Zilovertamab vedotin binding to tumor cell ROR1 results in rapid internalization, trafficking to lysosomes, antibody–agent conjugate cleavage, and monomethyl vedotin release. Zilovertamab vedotin induces apoptosis. Zilovertamab vedotin can be used in research of cancer .
|
-
- HY-157813
-
|
Drug-Linker Conjugates for ADC
Topoisomerase
|
Cancer
|
2-MSP-5-HA-GGFG-NH-CH2-O-CH2-CO-Exatecan is a drug-linker conjugates for ADC, consiting of a cleavable linker and Exatecan (HY-13631). 2-MSP-5-HA-GGFG-NH-CH2-O-CH2-CO-Exatecan can be linked to anti-Her3 antibody .
|
-
- HY-P99163
-
ABBV-8E12; C2N-8E12
|
Microtubule/Tubulin
|
Neurological Disease
|
Tilavonemab (ABBV-8E12) is a humanised anti-tau antibody that binds amino acids 25-30 near the N-terminal end of the tau protein. Tilavonemab blocks the ability of human and mouse neurons to take up tau aggregates and reduces brain atrophy. Tilavonemab can be used in the study of Alzheimer's disease .
|
-
- HY-P99344
-
Anti-Human SARS-CoV-2
|
SARS-CoV
|
Infection
|
Bamlanivimab (Anti-Human SARS-CoV-2) is the first COVID-19 monoclonal antibody (mAb) to be granted Emergency Use Authorization (EUA) in November 2020 by the U.S. Food and agent Administration (FDA). However, Bamlanivimab is withdrawn in April 2021 following the rise of SARS-CoV-2 virus variants resistant to Bamlanivimab .
|
-
- HY-P99345
-
TSR-042
|
PD-1/PD-L1
|
Cancer
|
Dostarlimab (TSR-042) is a humanized anti-PD-1 monoclonal antibody. Dostarlimab binds with high affinity to human PD-1 and competitively inhibits its interaction with its ligands, PD-L1 and PD-L2, with IC50s of 1.8 and 1.5 nM, respectively .
|
-
- HY-P99385
-
ALX-0061
|
Interleukin Related
|
Inflammation/Immunology
|
Vobarilizumab (ALX-0061) is an anti-IL-6R monoclonal antibody (mAb) (Kd: 0.19 pM). Vobarilizumab consists of an anti-IL-6R domain and an anti-human serum albumin domain. Vobarilizumab can be used in the research of inflammatory autoimmune diseases, such as rheumatoid arthritis .
|
-
- HY-P99487
-
BR 3FC
|
ADC Antibody
|
Inflammation/Immunology
|
Briobacept (BR 3FC) is a selective human monoclonal antibody targeting to BLyS (BAFF), induces B cells apoptosis. Briobacept is a recombinant glucoprotein, consists of 2 molecules from the BLyS receptor (BR3)and a Fc domain of human IgG1. Briobacept can be used in studies of rheumatoid arthritis (RA) .
|
-
- HY-P99594
-
ZKAB001; STI-1014; STI-A1014
|
PD-1/PD-L1
|
Cancer
|
Socazolimab (ZKAB001) is an anti-PD-L1 monoclonal antibody. Socazolimab has lasting safety and efficacy in the treatment of recurrent or metastatic cervical cancer. Socazolimab also has potential applications in small cell lung cancer, esophageal squamous cell carcinoma (ESCC), advanced urothelial carcinoma and osteosarcoma .
|
-
- HY-P99767
-
ALXN1007
|
Complement System
|
Infection
|
Olendalizumab (ALXN1007) is a mouse-derived and humanized IgG2-G4-κ antibody, targeting to Complement protein C5a (Ki=60 pM). Olendalizumab targets the complement inflammatory pathway. Moreover, Olendalizumab can be used for research of complement mediated disorder caused by corona virus .
|
-
- HY-P990006
-
|
TNF Receptor
|
Inflammation/Immunology
|
Duvakitug is a humanized IgG1-λ2 monoclonal antibody targeting to TNFSF15/TL1A. Duvakitug' main expression system is CHOK1SV cells endogenously expressing glutamine synthetase (GS). Duvakitug can be used in the study of Crohn's Disease (CD) .
|
-
- HY-160180
-
-
- HY-160178
-
-
- HY-P99419
-
GEN1046
|
PD-1/PD-L1
|
Cancer
|
Acasunlimab (GEN1046) is a bispecific antibody (bsAb) targeting PD-L1 and 4-1BB. Acasunlimab enhances T-cell and NK-cell function through conditional 4-1BB stimulation while constitutively blocking the PD-1/PD-L1 inhibitory axis. Acasunlimab can be used in research of cancer .
|
-
- HY-P99668
-
|
PD-1/PD-L1
|
Cancer
|
Iparomlimab is an anti-human PD-1/CD279/PDCD1 IgG4κ antibody. Iparomlimab also targets to human monoclonal PSB103 γ4-chain, disulfided with human monoclonal PSB103 κ-chain to form a dimer. Iparomlimab can be used for Oncology research .
|
-
- HY-P99715
-
ABT-806
|
EGFR
|
Cancer
|
Losatuxizumab (ABT-806) is an anti-EGFR monoclonal antibody. Losatuxizumab binds to EGFR with EC50s of 0.96 nM for EGFR wild-type, 0.09 nM for EGFR C271A,C283A, 0.12 nM for EGFRvIII, 0.66 nM for EGFR1-501. Losatuxizumab can be used for research of EGFR-expressing cancers .
|
-
- HY-138633
-
|
PROTACs
Epigenetic Reader Domain
|
Cancer
|
PROTAC BRD4 Degrader-10 (compound 8b) is a PROTAC connected by ligands for von Hippel-Lindau and BRD4. PROTAC BRD4 Degrader-10 can be conjugated with STEAP1 and CLL1 antibodies to degrade the BRD4 protein in PC3 prostate cancer cells, with a DC50 of 1.3 nM and 18 nM, respectively .
|
-
- HY-138634
-
|
PROTACs
Epigenetic Reader Domain
|
Cancer
|
PROTAC BRD4 Degrader-11 (compound 9a) is a PROTAC connected by ligands for von Hippel-Lindau and BRD4. PROTAC BRD4 Degrader-11 can be conjugated with STEAP1 and CLL1 antibodies to degrade the BRD4 protein in PC3 prostate cancer cells, with a DC50 of 0.23 nM and 0.38 nM, respectively .
|
-
- HY-156517
-
|
ADC Cytotoxin
Topoisomerase
|
Cancer
|
7Ethanol-10NH2-11F-Camptothecin is a Camptothecin (HY-16560) analogue that serves as an ADC cytotoxin for the synthesis of antibody-drug conjugates (ADCs). 7Ethanol-10NH2-11F-Camptothecin can inhibit tumor growth and is used in cancer research .
|
-
- HY-P99161
-
BGB149
|
TAM Receptor
|
Cancer
|
Tilvestamab (BGB149) is a humanized anti-AXL antibody that blocks AXL-mediated cell signaling. Tilvestamab significantly inhibits Gas6-induced AXL activation in 786-0-Luc RCC cells and inhibits downstream AKT phosphorylation. Tilvestamab can be used in cancer research, particularly in AXL overexpressing renal cell carcinomas .
|
-
- HY-P99239
-
HUJ-591
|
PSMA
|
Cancer
|
Rosopatamab (HuJ591) is a humanized antiPSMA IgG1 monoclonal antibody that can be used in cancer research, especially prostate cancer. Rosopatamab can be linked to the low-energy beta-emitting radioisotope lutetium-177 ( 177Lu) through the bifunctional chelator DOTA-NHS ester to obtain a radioimmunoconjugate that targets malignant prostate cells with high efficiency .
|
-
- HY-P99406
-
MCLA 158
|
EGFR
|
Cancer
|
Petosemtamab (MCLA 158) is an anti- EGFR (Kd: 0.22 nM) and anti-LGR5 (Kd: 0.86 nM) monoclonal antibody (mAb). Petosemtamab leads to EGFR signaling blockade and receptor degradation in LGR5+ cancer cells. Petosemtamab can be used in the research of solid tumors, such as head and neck squamous cell carcinoma (HNSCC), metastatic colorectal cancer (CRC) .
|
-
- HY-P99552
-
IBI-306
|
Ser/Thr Protease
|
Cardiovascular Disease
|
Tafolecimab (IBI-306) is a human lgG2 monoclonal antibody that specifically binds PCSK-9 and reduces LDL-C levels by inhibiting PCSK-9-mediated endocytosis of the LDL receptor, which in turn enhances clearance of LDL-C and leads to a reduction in LDL-C levels. Tafolecimab may be used in studies of hypercholesterolaemia .
|
-
- HY-P9920A
-
|
VEGFR
|
Cancer
|
Ramucirumab (anti-VEGFR) is a human VEGFR-2 antagonist for the treatment of solid tumors. Ramucirumab (anti-VEGFR) is a recombinant human immunoglobulin G1 monoclonal antibody that binds to the extracellular binding domain of VEGFR-2 and prevents the binding of VEGFR ligands: VEGF-A, VEGF-C, and VEGF-D. Ramucirumab (anti-VEGFR) is also an angiogenesis inhibitor .
|
-
- HY-P99101
-
AEX-4089
|
ADC Antibody
|
Cancer
|
Vobramitamab is a humanized B7-H3 monoclonal antibody (mAb). Vobramitamab conjugated with prodrug seco-DUBA (HY-132180A) via a cleavable linker, to form antibody-drug conjugate (ADC), the MGC018 .
|
-
- HY-P99395
-
JNJ 56022473; CSL 362
|
Interleukin Related
|
Cancer
|
Talacotuzumab (JNJ 56022473; CSL 362) is an IgG1-type fully humanized, CD123-neutralizing monoclonal antibody containing a modified Fc structure. Talacotuzumab has KDs of 0.43 nM, 188 nM, 46 nM, 16.8 nM for CD123, CD32b/c, CD16-158F, CD16-158V, respectively. Talacotuzumab inhibits IL-3 binding to CD123, antagonizing IL-3 signaling in target cells. Talacotuzumab has mutated the Fc region to increase affinity for CD16 (FcγRIIIa), thereby enhancing antibody-dependent cell-mediated cytotoxicity (ADCC). Talacotuzumab is highly effective in vivo reducing leukemic cell growth in acute myeloid leukemia (AML) xenograft mouse models .
|
-
- HY-N3522
-
|
Others
|
Inflammation/Immunology
|
Platycoside E is a platycodigenin-type saponin isolated from the root of Platycodon grandiflorum with haemolytic activity and adjuvant potential. Platycoside E promotes the production of the sera OVA-specific IgG2a and IgG2b antibody in the ovalbumin (OVA)-immunized mice .
|
-
- HY-P99762
-
MGD009
|
CD3
|
Cancer
|
Obrindatamab is a humanized anti-B7-H3/CD3 bispecific antibody. Obrindatamab binds to B7-H3 and CD3, thereby mediating redirected cytotoxic T-lymphocyte (CTL) activity against B7-H3-expressing cancer cells. Obrindatamab can be used in research of cancer .
|
-
- HY-P9902A
-
|
PD-1/PD-L1
|
Cancer
|
Pembrolizumab (anti-PD-1) is a humanized IgG4 antibody and PD-1 inhibitor. Pembrolizumab produces PD-1 blockade, preventing PD-L1 and PD-L2 from connecting to PD-1. This avoids the uncontrolled regulation of T cells on cells that normally express PD-1 .
|
-
- HY-P9974
-
OMP-18R5
|
Wnt
|
Cancer
|
Vantictumab (OMP-18R5) is a fully human IgG2 monoclonal antibody. Vantictumab inhibits Wnt pathway signaling by binding to FZD1/2/5/7/8 receptors. Vantictumab is being studied against cancers such as metastatic HER2-negative breast cancer and metastatic pancreatic adenocarcinoma .
|
-
- HY-P990093
-
CM310
|
Interleukin Related
|
Inflammation/Immunology
|
Stapokibart (CM310) is a humanised monoclonal antibody targeting IL-4Rα and efficiently blocks the interaction of cytokines IL-4 and IL-13 with their co-receptor subunit IL-4Rα. Stapokibart has the capacity to interact with IL-4Rα in humans, cynomolgus monkeys, and rats .
|
-
- HY-P9919A
-
MEDI 4736 (anti-PD-L1)
|
PD-1/PD-L1
|
Others
|
Durvalumab (anti-PD-L1)(MEDI 4736) is a human anti-PD-L1 protein monoclonal antibody . Durvalumab (anti-PD-L1) completely blocks PD-L1 binding to PD-1 and CD80, IC 50 are 0.1 and 0.04 nM respectively .
|
-
- HY-P99593A
-
DMUC5754A (solution)
|
Antibody-Drug Conjugates (ADCs)
|
Cancer
|
Sofituzumab vedotin (DMUC5754A) (solution) is an antibody-drug conjugate (ADC) that contains the humanized IgG1 anti-MUC16 monoclonal antibody and a potent anti-mitotic agent, monomethyl auristatin E (MMAE), linked through a protease-cleavable linker .
|
-
- HY-P99837
-
SPV-T3a
|
CD3
|
Infection
|
Dafsolimab (SPV-T3a) is an IgG2a murine monoclonal antibody (anti-CD3). Dafsolimab can induce cell death through modulation and activation of the CD3/T cell receptor complex. Dafsolimab can be used for the research of graft-versus-host disease (GVHD) .
|
-
- HY-P9949
-
Sch 55700
|
Interleukin Related
|
Inflammation/Immunology
|
Reslizumab (Sch 55700) is humanized monoclonal antibodies that target interleukin-5 (IL-5) for the treatment of eosinophilic asthma. Reslizumab is effective in neutralizing the function of IL-5. Reslizumab has high binding affinity for human IL-5, with KD values of 109 pM and 4.3 pM in the the Biacore surface plasmon resonance and Kinetic Exclusion Assay, respectively .
|
-
- HY-108738
-
Zenapax; Ro 24-7375
|
Interleukin Related
|
Inflammation/Immunology
|
Daclizumab (Zenapax) is a humanized, monoclonal antibody that blocks CD25 (α-subunit of the high-affinity interleukin-2 receptor (IL-2R-HA)). Daclizumab (Zenapax) reversibly binds to CD25and prevents the interaction of IL-2 with the IL-2R-HA. Daclizumab (Zenapax) can be used for multiple sclerosis research .
|
-
- HY-P99190
-
BMS-936557; MDX-1100
|
CXCR
|
Inflammation/Immunology
|
Eldelumab (BMS-936557) is a human anti-CXCL10 (IP-10) monoclonal antibody (IgG1 type). Eldelumab selectively binds to CXCL10 and blocks CXCL10-induced calcium flux and cell migration. Eldelumab can be used in studies of autoimmune and auto-inflammatory diseases such as rheumatoid arthritis, ulcerative colitis and crohn's disease .
|
-
- HY-P99386
-
MNRP-1685A
|
Complement System
|
Cancer
|
Vesencumab (MNRP-1685A) is IG1 antibody against neuropilin-1 (NRP-1). Vesencumab binds to NRP-1 and prevents the subsequent coupling of NRP-1 to VEGFR-2. Vesencumab has anti-angiogenic and anti-neoplastic activities. Vesencumab can be used in the research of metastatic solid tumors, including ovarian cancer .
|
-
- HY-P99394
-
JNJ-64407564
|
CD3
|
Cancer
|
Talquetamab (JNJ-64407564) is a humanized bispecific antibody that binds to GPRC5D (member of G protein-coupled receptor family C5 group D) and CD3 to induce T cell-mediated killing of GPRC5D-expressing MM cells through T cell recruitment and activation. Talquetamab (JNJ-64407564) has antitumor activity .
|
-
- HY-P99810
-
AVTX-002; AEVI 002; SAR 252067
|
SARS-CoV
|
Cardiovascular Disease
|
Quisovalimab (AVTX-002; AEVI 002; SAR 252067) is a human monoclonal antibody against LIGHT, a tumor necrosis factor (TNF)-related cytokine (TNFSF14) that plays an important role in acute respiratory distress syndrome (ARDS) and cytokine release syndrome (CRS) COVID-19. Quisovalimab can be used in COVID-19 acute respiratory distress syndrome and other studies .
|
-
- HY-P99588
-
MYO-029
|
TGF-β Receptor
|
Metabolic Disease
|
Stamulumab (MYO-029) is a recombinant human IgG1λ antibody that binds to myostatin and neutralizes its activity by preventing binding to its endogenous high-affinity receptor ActRIIB. Stamulumab leads to muscle fiber hypertrophy and not hyperplasia in SCID mice. Stamulumab has the potential for Becker muscular dystrophy (BMD), facioscapulohumeral dystrophy (FSHD), and limb-girdle muscular dystrophy (LGMD) research .
|
-
- HY-P99612
-
MORAb-202
|
Antibody-Drug Conjugates (ADCs)
|
Cancer
|
Farletuzumab ecteribulin (MORAb-202) is an antibody-drug conjugate (ADC), consisting of the humanized anti-human folate receptor alpha (FRA) antibody Farletuzumab (HY-P99153) conjugated via reduced interchain disulfide bonds to Mal-PEG2-Val-Cit-PAB-eribulin. Farletuzumab ecteribulin has a agent-to-antibody ratio of 4.0. Farletuzumab ecteribulin is highly cytotoxic to FRA-positive cells in vitro. Farletuzumab ecteribulin has potent antitumor activity.
|
-
- HY-P9928A
-
REGN 727(anti-PCSK9); SAR 236553(anti-PCSK9)
|
Ser/Thr Protease
|
Cardiovascular Disease
|
Alirocumab (anti-PCSK9) is a human monoclonal antibody inhibiting proprotein convertase subtilisin/kexin type 9 (PCSK9). Alirocumab specifically binds PCSK9, a down regulator of liver low-density lipoprotein (LDL)-receptors, thereby increasing the ability of the liver to bind LDL-cholesterol (LDL-C) and reducing levels of LDL-C in blood. Alirocumab can be used for the research of hypercholesterolemia .
|
-
- HY-P99248
-
Risankizumab rzaa; BI 655066
|
Interleukin Related
|
Inflammation/Immunology
|
Risankizumab (BI 655066) is a humanised IgG monoclonal antibody, targeting IL-23 p19 subunit (Kd <10 pM) and inhibiting IL-17 production induced by human IL-23 in mouse splenocytes (IC50 = 2 pM). Risankizumab can be used to research immunological and inflammatory disorders such as psoriasis vulgaris, psoriatic arthritis, generalized pustular psoriasis and erythrodermic psoriasis .
|
-
- HY-P99387
-
|
LAG-3
|
Cancer
|
TSR-033 is a high affinity human IgG4 antibody targeting LAG-3 (lymphocyte activation gene-3), a co-receptor associated with impaired T cell function and often co-expressed with PD-1, that enhances T cell function and PD-1 blocking activity in vitro and in vivo. TSR-033 has anti-tumor activity .
|
-
- HY-P99520
-
CaCP-29, IFX-1
|
Complement System
SARS-CoV
|
Infection
Inflammation/Immunology
|
Vilobelimab (CaCP-29, IFX-1) is a monoclonal anti-C5a antibody to the allergen C5a, a pro-inflammatory complement division product that plays a central role in mediating organ dysfunction. Vilobelimab acts as a C5a inhibitor, inhibiting neutrophil activation, chemotaxis, and reducing inflammatory signalling, and may be used in studies related to sepsis, COVID-19, etc .
|
-
- HY-P99731
-
hLL1; MEDI-115
|
CD74
|
Cancer
|
Milatuzumab (hLL1; MEDI-115) is a humanized anti-CD74 monoclonal antibody. CD74, a integral membrane protein, is associated with the promotion of B-cell growth and survival. Milatuzumab causes free radical oxygen generation, and loss of mitochondrial membrane potential. Milatuzumaba also decreases CD20/CD74 aggregates and cell adhesion, to lead to cell death .
|
-
- HY-P99333
-
M200; Eos 200-4
|
Integrin
|
Cardiovascular Disease
Cancer
|
Volociximab (M200) is a chimeric human/murine IgG4 antibody IIA1 targeting integrin α5β1 (EC50=0.2 nM). Integrin α5β1 is a major fibronectin receptor involved in angiogenesis. Volociximab has antiangiogenic and antitumor activities and inhibits the proliferation of human umbilical vein vascular endothelial cells (HUVECs) .
|
-
- HY-P99623
-
MGD006; S80880
|
CD3
|
Cancer
|
Flotetuzumab (MGD006; S80880) is an investigational CD123/CD3 bispecific dual-affinity retargeting antibody (DART) molecule. Flotetuzumab reactivates T cells by simultaneously binding to CD123 in target cells and CD3 in effector T cells, leading to T-cell-mediated cytotoxicity in target cells. Flotetuzumab shows inhibitory effect on a mouse model of patient-derived xenograft (PDX) in acute myeloid leukemia (AML) .
|
-
- HY-D2194
-
|
Fluorescent Dye
|
Others
|
AgAuSe-COOH (1000 nm) is a fluorescent quantum dot that emits fluorescence in the near-infrared II region, with an emission peak reaching 1000 nm. AgAuSe-COOH (1000 nm) has the advantages of narrow band gap, large Stokes shift, and good photostability. AgAuSe-COOH (1000 nm) can bind proteins, antibodies, peptides, PEG, etc., and can be widely used in the field of biological imaging.
|
-
- HY-P99390
-
MCLA 117
|
CD3
|
Cancer
|
Tepoditamab (MCLA-117) is a bispecific monoclonal antibody that binds to CLEC12A of myeloid cells and CD3 of cytotoxic T cells. Among others, CLEC12A is a myeloid differentiation antigen. Tepoditamab (MCLA-117) kills AML leukaemia mother cells and AML leukaemia stem cells, induces T cell-mediated proliferative lysis of AML cells and can be used in acute myeloid leukaemia (AML) research .
|
-
- HY-145644
-
C-135-LS; BMS-986414
|
SARS-CoV
|
Infection
|
Ogalvibart (C-135-LS) is a human anti-SARS-CoV-2 monoclonal antibody (IgG1 type). Ogalvibart binds to the spike (S) glycoprotein receptor-binding domain (RBD) of SARS-CoV-2. Ogalvibart in combination with C144LS (1:1 ratio) shows good preventive activity and can effectively block the development of COVID19 in a rhesus monkey disease model .
|
-
- HY-P99551
-
KBSA301; AR-301
|
Antibiotic
|
Infection
|
Tosatoxumab (AR-301; KBSA301) is a human immunoglobulin G1 monoclonal antibody that specifically neutralizes alpha-toxin (alpha-hemolysin; Hla) of S. aureus. Tosatoxumab binds to an N-terminal epitope of alpha-toxin, thereby preventing functional toxin pore oligomerisation. Tosatoxumab has the potential for passive immunotherapy in the S. aureus pneumonia as an adjunctive therapy to standard antibiotic agent .
|
-
- HY-P990091
-
SAR 445088
|
Complement System
|
Inflammation/Immunology
|
Riliprubart (SAR445088) is an anti-C1s humanized monoclonal antibody that inhibits activated C1s in the proximal portion of the classical complement system. Riliprubart selectively inhibits activated C1s and prevents the enzymatic action of C1 on its substrates C4 and C2, thus inhibiting the formation of the classical pathway C3 convertase, C4b2a .
|
-
- HY-P99157
-
|
CD276/B7-H3
|
Cancer
|
Omburtamab is an anti-CD276 (also known as B7-H3) monoclonal antibody, CD276 is a B7/CD28 immunoglobulin superfamily member expressed among solid human tumours. Omburtamab can bind tumor tissues and be used in various cancers research .
|
-
- HY-138636
-
|
PROTACs
Epigenetic Reader Domain
|
Cancer
|
PROTAC BRD4 Degrader-13 (compound 9d) is a PROTAC connected by ligands for von Hippel-Lindau and BRD4. PROTAC BRD4 Degrader-13 can be conjugated with STEAP1 and CLL1 antibodies to degrade the BRD4 protein in PC3 prostate cancer cells, with a DC50 of 0.025 nM and 6.0 nM, respectively .
|
-
- HY-138635
-
|
PROTACs
Epigenetic Reader Domain
|
Cancer
|
PROTAC BRD4 Degrader-12 (compound 9c) is a PROTAC connected by ligands for von Hippel-Lindau and BRD4. PROTAC BRD4 Degrader-12 can be conjugated with STEAP1 and CLL1 antibodies to degrade the BRD4 protein in PC3 prostate cancer cells, with a DC50 of 0.39 nM and 0.24 nM, respectively .
|
-
- HY-157241
-
|
Others
|
Others
|
CEX Cation-exchange resin 1 is an ion exchange chromatography resin based on monodisperse polystyrene/divinylbenzene (PS-DVB). The particle size of CEX Cation-exchange resin 1 is 50μm and the ligand is -CH2CH2CH2SO3-. CEX Cation-exchange resin 1 can be used for the separation and purification of antibodies, VLPs, viruses and proteins .
|
-
- HY-P99340
-
VIR 7831
|
SARS-CoV
|
Infection
|
Sotrovimab (VIR 7831) is a human IgG1κ pan-sarbecovirus monoclonal antibody (mAb), neutralizes SARS-CoV-2, SARS-CoV-1, and multiple other sarbecoviruses. Sotrovimab is developed based on S309, exhibits a long half-life and great bioavailability in the respiratory mucosa. Sotrovimab could result in immune-mediated viral clearance and prevent progression of Covid-19 early in the course of disease .
|
-
- HY-P99583
-
MEDI4893
|
Bacterial
|
Infection
Inflammation/Immunology
|
Suvratoxumab (MEDI4893) is a long-acting, high-affinity human anti-α-toxin monoclonal antibody (IgG1κ type). Suvratoxumab potently neutralizes α-toxin, a key S. aureus virulence factor. Suvratoxumab improves survival and reduces lung injury in an immunocompromised mice model of pneumonia. Suvratoxumab also enhances the antibacterial activity of Vancomycin (HY-B0671) or Linezolid (HY-10394) .
|
-
- HY-P99506
-
SC-003 mAb; SC-Mab003; SC34.28ss1
|
ADC Antibody
|
Cancer
|
Tamrintamab (SC-003 mAb, SC-Mab003, SC34.28ss1) is an ADC Antibody targeting to dipeptidase 3 (DPEP3 or MBD3). DPEP3 is a glycosyl phosphatidylinositol anchored metallopeptidase that is overexpressed in ovarian tumors. Tamrintamab can specifically bind DPEP3-expressing cells to produce cytotoxicity. Tamrintamab can be used in ovarian cancer research .
|
-
- HY-P99833
-
CK-301; TG-1501
|
PD-1/PD-L1
|
Cancer
|
Cosibelimab (CK-301; TG-1501) is a high-affinity, fully human PD-L1-blocking monoclonal antibody that binds PD-L1 and blocks its interaction with PD-1. Cosibelimab has a functional Fc domain and is capable of inducing ADCC and complement-dependent cytotoxicity (CDC)-mediated killing of PD-L1 + cell lines, including lymphoma cells .
|
-
- HY-P99708
-
ABBV-151; ARGX-115
|
TGF-beta/Smad
|
Cancer
|
Livmoniplimab (ABBV-151; ARGX-115) is a potent, humanized monoclonal antibody against the LRRC32 (GARP)/TGFβ1 complex. Livmoniplimab blocks LRRC32-mediated latent TGFβ1 activation and release. Livmoniplimab has potential in cancer research as a single anticancer agent or in combination with an anti-PD-1 mAb to inhibit locally advanced or metastatic solid tumors (NCT03821935) .
|
-
- HY-132253
-
|
Antibody-Drug Conjugates (ADCs)
|
Cancer
|
Polatuzumab vedotin is an antibody-drug conjugate targeting CD79b. It contains a humanized anti-CD79b IgG1 monoclonal antibody linked to monomethyl auristatin E (MMAE), a potent microtubule inhibitor. Polatuzumab vedotin has the potential for the research of Large B-cell lymphomas (LBCL) .
|
-
- HY-P990304
-
-
- HY-W019939
-
|
ADC Linker
|
Cancer
|
Hydroxy-PEG10-Boc is extacted from patent CN108707228 (example 0024) . Hydroxy-PEG10-Boc is a uncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Hydroxy-PEG10-Boc can be conjugated to Paclitaxel (HY-B0015) or docetaxel (HY-B0011) .
|
-
- HY-D0153
-
|
Fluorescent Dye
|
Cancer
|
Tetramethylrhodamine-5-isothiocyanate is a potent fluorescent dye. Tetramethylrhodamine-5-isothiocyanate can be used for label PG-M3 antibody for rapid diagnosis of acute promyelocytic leukemia (APL). Tetramethylrhodamine-5-isothiocyanate can be used as probe to quantify in vivo the biodistribution of PLGA (poly(lactic-co-glycolic) acid) and PLGA/chitosan nanoparticles .
|
-
- HY-108831
-
|
Integrin
|
Inflammation/Immunology
|
Natalizumab is a recombinant, humanized IgG4 monoclonal antibody, binds to α4β1-integrin and blocks its interaction with vascular cell adhesion molecule-1 (VCAM-1). Natalizumab can be used for the treatment of relapsing remitting multiple sclerosis and Crohn's disease. Natalizumab is also the first targeted therapy which blocks an essential mechanism for lymphocyte entry to the CNS and thus prevents acute demyelinating relapses .
|
-
- HY-P99111
-
CNTO-148
|
TNF Receptor
Apoptosis
Interleukin Related
Caspase
|
Inflammation/Immunology
Cancer
|
Golimumab (CNTO-148) is a potent human IgG1 TNFα antagonist monoclonal antibody. Golimumab has anti-inflammation activitity and inhibits IL-6 and IL-1β production. Golimumab acts via targeting and neutralizing TNF to prevent inflammation and destruction of cartilage and bone. Golimumab has the anticancer activity and induces cell apoptosis. Golimumab can be used for rheumatoid arthritis, Crohn's disease and cancer research .
|
-
- HY-P99171
-
|
Interleukin Related
|
Inflammation/Immunology
|
Gevokizumab is a potent anti-IL-1β antibody, negatively modulates IL-1β signaling through an allosteric mechanism. Gevokizumab selectively decreases the binding affinity of IL-1β for the IL-1 receptor type I (IL-1RI) signaling receptor instead of IL-1 counter-regulatory decoy receptor (IL-1 receptor type II) .
|
-
- HY-P99165
-
|
IGF-1R
TSH Receptor
|
Endocrinology
|
Teprotumumab is an IGF-1 receptor (IGF-1R) blocking human monoclonal antibody. Teprotumumab binds to the ligand binding extracellular α-subunit domain of IGF-1R. Teprotumumab inhibits TSH and IGF-1 action in fibrocytes. Teprotumumab attenuates TSH-dependent IL-6 and IL-8 expression and Akt phosphorylation. Teprotumumab can be used for thyroid-associated ophthalmopathy research .
|
-
- HY-P99410
-
AMG 714; PRV-015
|
Interleukin Related
|
Inflammation/Immunology
|
Ordesekimab (AMG 714; PRV-015) is a fully human IgG1κ anti-IL-15 (Interleukin Related) monoclonal antibody. The binding of Ordesekimab to IL-15 inhibits the interaction of IL-15 with the IL-2Rβ and common γ chain of the IL-15 receptor complex, but not with the IL-15Rα chain. Ordesekimab has the potential for study of nonresponsive celiac disease (NRCD) .
|
-
- HY-P99584
-
KD-247
|
HIV
|
Infection
|
Suvizumab (KD-247) is an neutralizing antibody anti-HIV-1. Suvizumab effectively neutralizes HIV-1MN, HIV-1SF2 and HIV-189.6 with IC50 values of 0.1 µg/mL, 1.0 µg/mL and 0.2 µg/mL, respectively. Suvizumab reduces the viral load of HIV. Suvizumab has good tolerance and can be used to prevent HIV infection .
|
-
- HY-P99464
-
IMMU-LL 2
|
CD22
|
Cancer
|
Bectumomab (IMMU-LL 2) is an humanized IgG2a mAb against human CD22 (antigen). Bectumomab is also an anti-lymphoma antibody fragment. Bectumomab can be used for imaging in combination with technetium 99 (Tc99m LL2 Fab). Moreover, Bectumomab examines in the staging of recurrent or newly diagnosed non-Hodgkin's lymphoma (NHL) and to assess targeting before radioimmunoresearch (RIT) .
|
-
- HY-P99813
-
HER3-DXd
|
Antibody-Drug Conjugates (ADCs)
|
Cancer
|
Patritumab deruxtecan (HER3-DXd) is an antibody-drug conjugate (ADC) consisting of a fully human anti-HER3 IgG1 monoclonal antibody Patritumab (HY-P99275) attached to a topoisomerase I inhibitor payload via a tetrapeptide-based cleavable linker. Patritumab deruxtecan shows anticancer activity .
|
-
- HY-P99911
-
-
- HY-P99284
-
MK-0646; h7C10
|
IGF-1R
Apoptosis
|
Cancer
|
Dalotuzumab (MK-0646) is a recombinant humanized monoclonal antibody (IgG1 type) targeting IGF-1R. Dalotuzumab acts by inhibiting IGF-1- and IGF-2-mediated tumor cell proliferation, IGF-1R autophosphorylation, and Akt phosphorylation. Dalotuzumab also induces apoptosis and cycle arrest. Dalotuzumab in combination with other anticancer agents such as statins can enhance the antitumor activity of Dalotuzumab in vitro and in vivo .
|
-
- HY-157236
-
|
Others
|
Others
|
AEX Anion-exchange resin 1 is a strong anion exchange chromatography resin, based on monodisperse polystyrene/divinylbenzene (PS-DVB), with a particle size of 50 μm and an ionic ligand of –CH2N + (CH3)3. AEX Anion-exchange resin 1 can be used for the separation and purification of biological macromolecules such as proteins, antibodies, and viral vaccines.
|
-
- HY-P99957
-
AMG-404
|
PD-1/PD-L1
|
Cancer
|
Zeluvalimab (AMG-404) is a monoclonal antibody targeting the PD-1 receptor that can be used for the research of cancer .
|
-
- HY-P990017
-
CD19-4-1BBL; RO7227166; RG6076
|
CD19
|
Cancer
|
Englumafusp alfa (CD19-4-1BBL; RO7227166) is a fusion construct comprised of a CD19-specific antibody domain fused to a trimerized extracellular domains of human 41BBL. Englumafusp alfa promotes CD19-specific 4-1BB cross-linking on the surface of T and NK cells .
|
-
- HY-P99575
-
AMG-757
|
Notch
|
Inflammation/Immunology
Cancer
|
Tarlatamab (AMG-757) is a bispecific T-cell engager (BiTE) antibody targeting delta-like ligand 3 (DLL3). DLL3 is a target that is selectively expressed in small-cell lung cancer (SCLC) tumors, but with minimal normal tissue expression. Tarlatamab has the KDs of 0.64 nM and 0.50 nM for human and nonhuman primate (NHP) DLL3, respectively. Tarlatamab has the KDs of 14.9 nM and 12 nM for human and NHP CD3, respectively. Tarlatamab is a first-in-class HLE BiTE immuno-oncology therapy targeting DLL3 and has the potential for SCLC research .
|
-
- HY-P990304A
-
-
- HY-P9930
-
AMG 145
|
NF-κB
Ser/Thr Protease
Toll-like Receptor (TLR)
|
Cardiovascular Disease
Metabolic Disease
Inflammation/Immunology
Cancer
|
Evolocumab (AMG 145) is a human monoclonal antibody that inhibits PCSK9. Evolocumab is used in the study of hypercholesterolemia and atherosclerotic cardiovascular disease. Evolocumab binds to circulating PCSK9 protein and inhibits its binding to LDLR. Evolocumab has antioxidant and cytoprotective activities against H2O2-induced oxidative damage to endothelial cells. Evolocumab may also negatively regulate activation of the TLR-4/NF-κB signaling pathway to prevent inflammation .
|
-
- HY-145642
-
ZRC3308-A7
|
SARS-CoV
|
Infection
|
Masavibart (ZRC3308-A7) is an anti-SARS-CoV-2 monoclonal antibody (IgG1 type). Masavibart shows good binding affinity to a non-competing epitope on the RBD of the SARS-CoV-2 spike protein. Masavibart can be used in combination with ZRC3308-B10 (HY-145643) at a ratio of 1:1, which is effective for the prevention of COVID-19 and the early stage of COVID-19 before the development of severe disease .
|
-
- HY-145643
-
ZRC3308-B10
|
SARS-CoV
|
Infection
|
Nepuvibart (ZRC3308-B10) is an anti-SARS-CoV-2 monoclonal antibody (IgG1 type). Nepuvibart shows good binding affinity to a non-competing epitope on the RBD of the SARS-CoV-2 spike protein. Nepuvibart can be used in combination with ZRC3308-A7 (HY-145642) at a ratio of 1:1, which is effective for the prevention of COVID-19 and the early stage of COVID-19 before the development of severe disease .
|
-
- HY-P99620
-
CT-P22; CT120
|
Influenza Virus
|
Infection
|
Firivumab (CT-P22; CT120) is a human IgG1 monoclonal influenza A virus hemagglutinin (Anti-IAV HA) antibody. Firivumab is capable of neutralizing H1N1, H5N1, H6N1, H6N2, H8N4, H8N8, H9N2 and H12N7. Firivumab shows protection against H1N1 virus in mice .
|
-
- HY-P99483
-
AT 004; VT 007
|
CD20
|
Cancer
|
Blontuvetmab (AT 004)is a caninized CD20 monoclonal antibody. Blontuvetmab can be used for the research of Canine B-cell lymphoma .
|
-
- HY-P99542
-
SAR-408701; HuMAb2-3-SPDB-DM4
|
Antibody-Drug Conjugates (ADCs)
Microtubule/Tubulin
|
Cancer
|
Tusamitamab ravtansine (SAR-408701) is a targeted ADC against tumor cells expressing CEACAM5, composed of a humanized anti-CEACAM5 monoclonal antibody covalently linked to the potent cytotoxic agent, maytansinoid DM4 (HY-12454), via a cleavable linker. Tusamitamab ravtansine has an average drug-to-antibody ratio (DAR) of 3.8 .
|
-
- HY-128870
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
Mal-PEG2-VCP-Eribulin consists the ADCs linker (Mal-PEG2-VCP) and Eribulin (HY-13442). Eribulin is a mechanistically unique microtubule inhibitor and Eribulin inhibits the proliferation of cancer cells by binding microtubule proteins and microtubules. Mal-PEG2-VCP-Eribulin is an Eribulin-based agent for antibody conjugates .
|
-
- HY-P9971
-
SHR-1210
|
PD-1/PD-L1
|
Cancer
|
Camrelizumab (SHR-1210) is a potent humanied high-affinity IgG4-κ monoclonal antibody (mAb) to PD-1. Camrelizumab binds PD-1 at a high affinity of 3 nM and inhibits the binding interaction of PD-1 and PD-L1 with an IC50 of 0.70 nM. Camrelizumab acts as anti-PD-1/PD-L1 agent and can be used for cancer research, including NSCLC, ESCC, Hodgkin lymphoma, and advanced HCC et,al .
|
-
- HY-P99109
-
GLS-010; AB-122; WBP-3055
|
PD-1/PD-L1
|
Cancer
|
Zimberelimab (GLS-010) is a fully human IgG4 anti-PD-1 monoclonal antibody with an EC50 of 210 pM for human PD-1. Zimberelimab effectively blocks the binding of PD-L1 and PD-L2 to cell-surface PD-1 in CHO-S cells, with IC50 values of 580 pM and 670 pM, respectively. Zimberelimab shows antitumor activities, and can be used for various cancers research, including cervical cancer, non-small cell lung cancer and classical Hodgkin’s lymphoma .
|
-
- HY-P99925
-
REGN421
|
Notch
|
Metabolic Disease
Cancer
|
Enoticumab (REGN421, SAR153192) is an IgG1κ antibody targeting human Dll4. DLL4 is a ligand of the Notch signaling pathway and regulates fatty acid uptake through non-transcriptional regulation of macropinocytosis-dependent long-chain fatty acid uptake. Specific in vivo activity of Enoticumab in an ovarian xenograft model. EGN421 (2.5 mg/kg once weekly) resulted in 86% and 83% tumor growth inhibition in mouse subcutaneous TOV-112D or intraperitoneal A2780 human tumor xenograft models, respectively .
|
-
- HY-P990090
-
CBP-201
|
Interleukin Related
|
Inflammation/Immunology
|
Rademikibart (CBP-201) is a human monoclonal antibody targeting IL-4Rα with a KD of 20.7 pM when binding to human IL-4Rα epitopes. Rademikibart does not bind to IL-4Rα from other species. Rademikibart inhibits IL-4 and IL-13-mediated STAT6 signaling, TF-1 cell proliferation and TARC production in PBMCs. Rademikibart has the potential for moderate-to-severe Th2 inflammatory diseases research .
|
-
- HY-147207
-
|
Liposome
|
Others
|
Phospholipid-PEG-Biotin (MW 1000) is a phospholipid PEG derivative that has a biotin and a phospholipid bridged by a linear PEG linker. Phospholipid-PEG-Biotin (MW 3400) can interact with avidinylated antibodies. Phospholipid-PEG-Biotin (MW 3400) can be used to modify liposome and cells surface, and pancreatic islets for cell transplantation .
|
-
- HY-147207B
-
|
Liposome
|
Others
|
Phospholipid-PEG-Biotin (MW 3400) is a phospholipid PEG derivative that has a biotin and a phospholipid bridged by a linear PEG linker. Phospholipid-PEG-Biotin (MW 3400) can interact with avidinylated antibodies. Phospholipid-PEG-Biotin (MW 3400) can be used to modify liposome and cells surface, and pancreatic islets for cell transplantation .
|
-
- HY-147207D
-
|
Liposome
|
Others
|
Phospholipid-PEG-Biotin (MW 10000) is a phospholipid PEG derivative that has a biotin and a phospholipid bridged by a linear PEG linker. Phospholipid-PEG-Biotin (MW 3400) can interact with avidinylated antibodies. Phospholipid-PEG-Biotin (MW 3400) can be used to modify liposome and cells surface, and pancreatic islets for cell transplantation .
|
-
- HY-147207E
-
|
Liposome
|
Others
|
Phospholipid-PEG-Biotin (MW 20000) is a phospholipid PEG derivative that has a biotin and a phospholipid bridged by a linear PEG linker. Phospholipid-PEG-Biotin (MW 3400) can interact with avidinylated antibodies. Phospholipid-PEG-Biotin (MW 3400) can be used to modify liposome and cells surface, and pancreatic islets for cell transplantation .
|
-
- HY-151640
-
|
ADC Linker
|
Others
|
Fmoc-DAP-N3 is a click chemistry reagent containing an azide group. Fmoc-DAP-N3 is a short, linear spacer molecule with Fmoc protected amino function. Fmoc-DAP-N3 can be used in click conjugation and amid bond formation either with small molecules or for bioconjugation with proteins and antibodies .
|
-
- HY-P99797
-
JR-141
|
Transferrin Receptor
|
Neurological Disease
|
Pabinafusp alfa (JR-141) is a transferrin receptor-targeting antibody consisting of Iduronate 2-sulfatase (HY-P76399) and an anti-human transferrin receptor antibody. Pabinafusp alfa is blood-brain permeable and prevents heparan sulfate (HS) deposition in the central nervous system of mucopolysaccharidosis II (MPS II) mice. Pabinafusp alfa improves learning and prevents central nervous system neuronal damage in mice .
|
-
- HY-P990304C
-
-
- HY-P99164
-
LY33003560
|
Microtubule/Tubulin
|
Neurological Disease
|
Zagotenemab (LY3303560) is a humanised anti-tau antibody that selectively binds and neutralises tau deposits in the brain. Zagotenemab can be used in Alzheimer's disease research .
|
-
- HY-P99515
-
-
- HY-138632
-
|
PROTACs
Epigenetic Reader Domain
|
Cancer
|
PROTAC BRD4 Degrader-9 (compound 8a) is a PROTAC connected by ligands for von Hippel-Lindau and BRD4. PROTAC BRD4 Degrader-9 can be conjugated with STEAP1 and CLL1 antibodies to degrade the BRD4 protein in PC3 prostate cancer cells, with a DC50 of 0.86 nM and 7.6 nM, respectively .
|
-
- HY-P99606
-
ZTS-00521426
|
TGF-beta/Smad
|
Inflammation/Immunology
|
Cirevetmab (ZTS-00521426) is an immunoglobulin G2-kappa, Canis lupus familiaris TGFB1 caninized monoclonal antibody. Cirevetmab is an immunomodulator .
|
-
- HY-P99641
-
|
PD-1/PD-L1
|
Cancer
|
Gilvetmab is a potent caninized antiPD-1 monoclonal antibody. gilvetmab blocks the interaction between PD-1 and its ligand PDL-1 .
|
-
- HY-P99841
-
AGEN-1423; GS-1423
|
CD73
TGF-β Receptor
|
Inflammation/Immunology
|
Dalutrafusp alfa (AGEN-1423; GS-1423) is a specific bifunctional antibody against CD73 and TGF-β, which is involved in the immunosuppressive pathway .
|
-
- HY-P99573
-
MGD-013
|
LAG-3
|
Inflammation/Immunology
Cancer
|
Tebotelimab (MGD-013) is a humanized IgG4κ bispecific PD-1/LAG-3 dual-affinity re-targeting (DART) antibody. Tebotelimab binds cell-surface expressed PD-1 and LAG-3 with EC50s of 1.65 nM and 0.41 nM in NS0 cells, respectively. Tebotelimab blocks PD-1/PD-L1, PD-1/PD-L2 and LAG-3/HLA (MHC-II) interactions and PD-1 signaling. Tebotelimab restores exhausted T-cell responses and and enhances antitumour immunity .
|
-
- HY-P990304B
-
-
- HY-P99864
-
ZTS-00521505
|
Interleukin Related
|
Others
|
Dovanvetmab (ZTS-00521505) is an IgG1-κ antibody targeting Felcat IL31. Mainly expressed by CHO (Chinese Hamster Ovary) cells .
|
-
- HY-P99965
-
SKY59; RO7112689
|
Complement System
|
Cardiovascular Disease
Metabolic Disease
|
Crovalimab (SKY59; RO7112689) is a novel humanized antibody against C5 in a pH-dependent manner with KDs of 15.2 nM and 16.8 μM at pH 7.4 and 5.8, respectively. Crovalimab binds human FcRn with great affinity (KD: 17 μM at pH 6.0). Crovalimab can block cleavage of C5 by the C5 convertase and inhibite the activity of a C5 variant (p.Arg885His). Crovalimab inhibits C5b-9 formation significantly in all three complement pathways, the classical pathway (CP), lectin pathway (LP), and alternative pathway (AP). Crovalimab has the potential for paroxysmal nocturnal hemoglobinuria (PNH) and complement-mediated diseases research .
|
-
- HY-P3239
-
GSK2857916; Belantamab mafodotin-blm
|
Antibody-Drug Conjugates (ADCs)
|
Cancer
|
Belantamab mafodotin (GSK2857916) is composed of humanized and focused monoclonal antibody against B cell maturation antigen (BCMA) and McMMAF. Belantamab mafodotin has anti-myeloma activity .
|
-
- HY-P9973
-
DLX1008; ESBA 1008; RTH258
|
VEGFR
|
Cancer
|
Brolucizumab (DLX1008) is a single-chain anti-VEGF-A antibody fragment with low picomolar affinity (KD=1.05 pM). Brolucizumab can be used for the research of cancer .
|
-
- HY-P99593
-
DMUC5754A
|
Antibody-Drug Conjugates (ADCs)
|
Cancer
|
Sofituzumab vedotin (DMUC5754A) is a MMAE-containing anti-MUC16 antibody-drug conjugate (ADC) with a protease-cleavable linker. Sofituzumab vedotin can be used for the research of cancer .
|
-
- HY-P99510
-
LY-3127804
|
Tie
|
Inflammation/Immunology
|
Zansecimab (LY-3127804) is an immunoglobulin G4-kappa, a monoclonal antibody against angiopoietin 2 (Ang 2). Zansecimab has potential applications in angiogenesis and immune regulation .
|
-
- HY-P99772
-
L19TNF
|
TNF Receptor
|
Cancer
|
Onfekafusp alfa (L19TNF) is a homotrimer that forms from engineered peptides for the L19 antibody in scFv format fused to human TNF. Onfekafusp alfa can be used for malignant glioma research .
|
-
- HY-152121
-
-
- HY-P99384
-
B-701; MFGR-1877S; RG-7444
|
FGFR
|
Cancer
|
Vofatamab (B-701) is an anti-FGFR3 monoclonal antibody (mAb). Vofatamab blocks activation of both the wildtype and genetically activated receptor. Vofatamab can be used in the research of metastatic urothelial carcinoma (mUC) .
|
-
- HY-P99630
-
MM-302
|
EGFR
|
Cancer
|
Gancotamab (MM-302) is a HER2-targeted antibody-liposomal Doxorubicin conjugate with antitumor activity. Gancotamab encapsulates Doxorubicin to facilitate its delivery to HER2-overexpressing tumor cells .
|
-
- HY-P99581
-
OTSA101-DTPA; OTSA101-DTPA-90Y; OTSA101-SS01
|
Wnt
|
Cancer
|
Tabituximab barzuxetan (exclude Y90) is a radioimmunoconjugate composed of a humanized monoclonal antibody targeting FZD-10 (OTSA-101). Tabituximab barzuxetan shows antineoplastic activity. Tabituximab barzuxetan can be used for synovial sarcoma research .
|
-
- HY-P99505
-
COR-001
|
Interleukin Related
|
Cardiovascular Disease
Inflammation/Immunology
|
Ziltivekimab (COR-001) is a human anti-IL-6 monoclonal antibody that is effective in reducing serum CRP. Ziltivekimab has anti-inflammatory activity and may be used in studies of chronic systemic inflammation and cardiovascular disease associated with CKD .
|
-
- HY-P99530
-
AGT-181; HIRMAb-IDUA
|
Insulin Receptor
|
Metabolic Disease
|
Valanafusp alfa (AGT-181) is a brain penetrating recombinant fusion protein of a chimeric monoclonal antibody against the human insulin receptor (HIR) and human iduronidase (IDUA). Valanafusp alfa can be used for the research of Mucopolysaccharidosis type I (MPS I) .
|
-
- HY-P99902
-
FAP-IL2v
|
Interleukin Related
|
Cancer
|
Simlukafusp alfa (FAP-IL2v) is an immunocytokine comprising an antibody against fibroblast activation protein α (FAPα) and an IL-2 variant that only binds IL-2Rβγ. Isotype: human IgG1 .
|
-
- HY-P99513
-
CTB011; SYN023
|
RABV
|
Infection
|
Zamerovimab (CTB011; SYN023) is a mixture of human monoclonal antibodies consisting of CTB011 and CTB012. Zamerovimab binds to non-overlapping epitopes on rabies virus (RABV) glycoprotein, where CTB011 binds to antigenic site III. Zamerovimab can be used in rabies studies .
|
-
- HY-P99297
-
ZTS-00508841
|
Trk Receptor
|
Inflammation/Immunology
|
Bedinvetmab (ZTS-00508841) is a canine monoclonal antibody (mAb) targeting nerve growth factor (NGF). Bedinvetmab inhibits NGF interaction with tropomyosin receptor kinase A (trkA) and p75 neurotrophin receptor (p75NTR) receptors. Bedinvetmab can be used for the research of osteoarthritis pain in dogs .
|
-
- HY-P99349
-
Loncastuximab tesirine-lpyl; ADCT-402
|
Antibody-Drug Conjugates (ADCs)
Apoptosis
|
Cancer
|
Loncastuximab tesirine is a human cluster of differentiation 19 (CD19)-directed antibody-drug conjugate (ADC). Once bound to CD19 on the cell membrane, loncastuximab tesirine is rapidly internalised and triggers cell death. Loncastuximab tesirin induces cell apoptosis, it can be used for the research of diffuse large B-cell lymphoma .
|
-
- HY-P99493
-
IMGN242; huC242-DM4
|
Antibody-Drug Conjugates (ADCs)
Microtubule/Tubulin
|
Cancer
|
Cantuzumab ravtansine (IMGN242; huC242-DM4), an ADC, is a humanized monoclonal antibody, huC242, covalently linked via a disulfide bond to DM4 (DM4 (HY-12454)). Cantuzumab ravtansine has broad antitumor efficacy against a range of CanAg-positive human tumor xenografts .
|
-
- HY-148346
-
|
Drug-Linker Conjugates for ADC
STING
|
Cancer
|
STING agonist-20-Ala-amide-PEG2-C2-NH2 is an active scaffold comprising a stimulator of interferon genes (STING). STING agonist-20-Ala-amide-PEG2-C2-NH2 can be used to synthesize immune-stimulating antibody conjugate (ISAC). STING agonist-20-Ala-amide-PEG2-C2-NH2 can be used for the research of cancer .
|
-
- HY-P99492
-
SB-408075; huC242-DM1
|
Antibody-Drug Conjugates (ADCs)
Microtubule/Tubulin
|
Cancer
|
Cantuzumab mertansine (SB-408075; huC242-DM1), an ADC, is an immunoconjugate of the potent maytansine derivative (DM1; HY-19792) and the humanized monoclonal antibody (huC242) directed to CanAg. Cantuzumab mertansine has cytotoxic toward colon cancer cells and has broad antitumor efficacy against a range of CanAg-positive human tumor xenografts .
|
-
- HY-148346A
-
|
Drug-Linker Conjugates for ADC
STING
|
Cancer
|
STING agonist-20-Ala-amide-PEG2-C2-NH2 (Compound 30b) TFA is an active scaffold comprising a stimulator of interferon genes (STING). STING agonist-20-Ala-amide-PEG2-C2-NH2 TFA can be used to synthesize immune-stimulating antibody conjugate (ISAC). STING agonist-20-Ala-amide-PEG2-C2-NH2 TFA can be used for the research of cancer .
|
-
- HY-19792
-
DM1; Maytansinoid DM1
|
Microtubule/Tubulin
ADC Cytotoxin
|
Cancer
|
Mertansine (DM1) is a microtubulin inhibitor and is an antibody-conjugatable maytansinoid that is developed to overcome systemic toxicity associated with maytansine and to enhance tumor-specific delivery. Mertansine can be attached to a monoclonal antibody with a linker to create an antibody-drug conjugate (ADC) .
|
-
- HY-P99803
-
VAL-1221
|
Glucosidase
|
Others
|
Clervonafusp alfa (VAL-1221) is a fusion protein targeting both cytosolic and lysosomal glycogen. Clervonafusp alfa is comprised of the Fab portion of a cell-penetrating antibody and recombinant human acid alpha glucosidase (rhGAA), the former utilizing the nucleoside transporter ENT-2 to gain access to the cytosol, and the latter enters lysosomes via mannose-6-phosphate receptors (M6PRs). Clervonafusp alfa can be used for late-onset Pompe disease research .
|
-
- HY-102001
-
|
ADC Cytotoxin
|
Cancer
|
Tomaymycin DM, a DNA alkylator, is a derivative of Tomaymycin, it is a PBD dimer, which is attached to tumor targeting antibodies to create antibody-drug conjugates (ADCs).
|
-
- HY-78932A
-
|
ADC Linker
|
Cancer
|
Dap-NE hydrochloride is a dipeptide hydrochloride and a cleavable ADC Linker.Dap-NE hydrochloride can be used to connect Antibody and toxin molecules (Cytotoxin) to synthesize Antibody-Drug Conjugates (ADCs) .
|
-
- HY-130082
-
|
ADC Cytotoxin
Microtubule/Tubulin
|
Cancer
|
DM4-SMe is a metabolite of antibody-maytansin conjugates (AMCs) and a tubulin inhibitor, and also a cytotoxic moiety of antibody-drug conjugates (ADCs), which can be linked to antibody through disulfide bond or stable thioether bond. DM4-SMe inhibits KB cells with an IC50 of 0.026 nM .
|
-
- HY-145365
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
DGN549-L is a DNA alkylator and can be utilized for antibody conjugation at lysine residues. DGN549-L can be used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-156299
-
|
ADC Linker
|
Cancer
|
NMS-P945 is an ADC linker that can be used in the synthesis of antibody-drug conjugates (ADCs). NMS-P945 is suitable for conjugation to mAbs with reproducible Drug Antibody Ratio (DAR) >3.5 .
|
-
- HY-20336
-
Maleimidocaproyl-L-valine-L-citrulline-p-aminobenzyl alcohol p-nitrophenyl carbonate
|
ADC Linker
|
Others
Inflammation/Immunology
Cancer
|
Mc-Val-Cit-PABC-PNP is a cathepsin cleavable linker for antibody-drug conjugates (ADCs) which couples the antibody element to the effecting compound. Mc-Val-Cit-PABC-PNP can be used in the synthesis of ADCs .
|
-
- HY-W101718
-
|
Isotope-Labeled Compounds
ADC Linker
|
Cancer
|
Fmoc-N-(2-Boc-aminoethyl)-Gly-OH is a Fmoc-protected glycine derivative that can be used in antibody agent coupling (ADC) synthesis. ADC consists of antibodies that are linked to ADC cytotoxins via ADC junctions[1].
|
-
- HY-129365
-
|
ADC Linker
|
Cancer
|
SNPB is a cleavable linker that is used for making antibody-drug conjugate (ADC).
|
-
- HY-130107
-
|
ADC Linker
|
Cancer
|
Ald-Ph-NHS ester is a nonclaevable linker for antibody-agent-conjugation (ADC).
|
-
- HY-160182
-
-
- HY-P5168S
-
|
Isotope-Labeled Compounds
|
Infection
|
GPSVFPLAPSSK- 13C6 is the 13C labeled GPSVFPLAPSSK. GPSVFPLAPSSK is an IgG1 signature peptide of anti-SARS-CoV-2 antibodies. GPSVFPLAPSSK can be used for the quantification of the specific isolation of anti-SARS-CoV-2 antibodies .
|
-
- HY-15581
-
Demethyldolastatin 10; Monomethylauristatin D; Monomethyl Dolastatin 10
|
Microtubule/Tubulin
ADC Cytotoxin
|
Cancer
|
MMAD is a potent tubulin inhibitor, is a toxin payload in antibody agent conjugates (ADCs).
|
-
- HY-129376
-
|
ADC Linker
|
Cancer
|
Sulfo-SNPB is a cleavable linker that is used for making antibody-drug conjugate (ADC).
|
-
- HY-126498
-
|
ADC Linker
|
Cancer
|
PDEC-NB is a disulfide cleavable linker used for the antibody-drug conjugate (ADC).
|
-
- HY-126519
-
|
ADC Linker
|
Cancer
|
PDdEC-NB is a disulfide cleavable linker used for the antibody-drug conjugate (ADC).
|
-
- HY-42146
-
|
ADC Linker
|
Cancer
|
BMPS is a nonclaevable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
|
-
- HY-134797
-
|
Others
|
Others
|
p-SCN-Bn-deferoxamine is a linker used to connect antibodies to materials .
|
-
- HY-141601
-
ABBV-399
|
Antibody-Drug Conjugates (ADCs)
c-Met/HGFR
|
Cancer
|
Telisotuzumab vedotin (ABBV-399) is an antibody-drug conjugate (ADCs) targeting c-Met. Telisotuzumab vedotin consists of Monomethyl Auristatin E (MMAE), Telisotuzumab antibody and a cleavable mc-val-cit-PABC type linker. Telisotuzumab vedotin can be used in cancer research .
|
-
- HY-P99107A
-
|
Antibody-Drug Conjugates (ADCs)
Apoptosis
|
Cancer
|
Brentuximab vedotin solution is the solution form of Brentuximab vedotin (HY-P99107). Brentuximab vedotin (cAC10-vcMMAE) is an antibody-drug conjugate (ADC) comprising an anti-CD30 antibody and the cytotoxic agent Monomethyl auristatin E (MMAE) .
|
-
- HY-12448
-
|
ADC Linker
|
Cancer
|
SPDB is a glutathione cleavable ADC linker used for the antibody-drug conjugate (ADCs) .
|
-
- HY-129375
-
|
ADC Linker
|
Cancer
|
SNPB-sulfo-Me is a cleavable linker that is used for making antibody-drug conjugate (ADC).
|
-
- HY-126667
-
|
ADC Linker
|
Cancer
|
SC-Val-Cit-PAB is a cleavable ADC linker for antibody-drug conjugates (ADCs).
|
-
- HY-129366
-
|
ADC Linker
|
Cancer
|
PDB-Pfp is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
|
-
- HY-129368
-
|
ADC Linker
|
Cancer
|
SPDMV is a glutathione cleavable ADC linker used for the antibody-drug conjugate (ADCs) .
|
-
- HY-129369
-
|
ADC Linker
|
Cancer
|
SPDMB is a glutathione cleavable ADC linker used for the antibody-drug conjugate (ADCs) .
|
-
- HY-129373
-
|
ADC Linker
|
Cancer
|
SPDMV-sulfo is a glutathione cleavable ADC linker used for the antibody-drug conjugate (ADCs).
|
-
- HY-44235
-
|
ADC Linker
|
Cancer
|
MC-Gly-Gly-Phe is a cleavable linker used for antibody-drug conjugates (ADC).
|
-
- HY-126530
-
-
- HY-D0922
-
-
- HY-D0922A
-
-
- HY-160299
-
|
Others
|
Others
|
GDP-Fuc-Biotin is a biotinylated GDP-Fucose that can be used to conjugate antibodies .
|
-
- HY-153793
-
|
DGK
|
Cancer
|
DGKζ-IN-1 (compound 9) is an inhibitor of DGKζ. DGKζ-IN-1 can be used for research in cancer related to immunocyte activation or cancer resistant to anti-PD-1 antibody/anti-PD-L1 antibody .
|
-
- HY-46572
-
|
ADC Linker
|
Cancer
|
Benzyl 2-cyclopropyl-2-hydroxyacetate is an intermediate in the synthesis of ADC linker.The linker composed of Benzyl 2-cyclopropyl-2-hydroxyacetate can be coupled to Exatecan (HY-13631) and combined with antibodies (such as antibody hu2F7) .
|
-
- HY-135682
-
-
- HY-P1783A
-
|
Influenza Virus
|
Infection
|
M2e, human TFA, consisting of the 23 extracellular residues of M2 (the third integral membrane protein of influenza A), has been remarkably conserved in all human influenza A. M2e, human TFA is a valid and versatile vaccine candidate to protect against any strain of human influenza A .
|
-
- HY-P1783
-
|
Influenza Virus
|
Infection
|
M2e, human, consisting of the 23 extracellular residues of M2 (the third integral membrane protein of influenza A), has been remarkably conserved in all human influenza A, which is a valid and versatile vaccine candidate to protect against any strain of human influenza A .
|
-
- HY-101909
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
Val-Cit-PAB-MMAF is a agent-linker conjugate for ADC. Val-Cit-PAB-MMAF contains the ADCs linker (peptide Val-Cit-PAB) and a potent tubulin polymerization inhibitor MMAF (HY-15579)
|
-
- HY-44177
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
Val-Cit-PAB-MMAF sodium is a agent-linker conjugate for ADC. Val-Cit-PAB-MMAF sodium contains the ADCs linker (peptide Val-Cit-PAB) and a potent tubulin polymerization inhibitor MMAF (HY-15579)
|
-
- HY-156513
-
|
ADC Cytotoxin
|
Cancer
|
7-Hydroxyethyl carbamate-(10Me-11F-Camptothecin) is a Camptothecin (HY-16560) analogue. 7-Hydroxyethyl carbamate-(10Me-11F-Camptothecin) is a ADC cytotoxin that can be used for synthesis of ADCs, and for cancer research .
|
-
- HY-157191
-
|
Others
|
Others
|
Fenhexamid-5-hexenoic acidis a hapten that can be coupled with fenhexamid .
|
-
- HY-139909
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
CL2E-SN-38, a highly releasable and structurally stable antibody-SN-38-conjugate, is a part of the antibody drug conjugate (ADC). SN-38, the active metabolite of Irinotecan from camptothecins, is an Topoisomerase I inhibitor .
|
-
- HY-109539
-
|
Antibody-Drug Conjugates (ADCs)
Apoptosis
|
Cancer
|
Gemtuzumab ozogamicin is an antibody-drug conjugate (ADC) consisting of a humanized immunoglobulin (IgG4) antibody directed against CD33 that is conjugated to the cytotoxic drug Calicheamicin (HY-19609). Calicheamicin is a cytotoxic antibiotic. Gemtuzumab ozogamicin can be used for the research of acute myeloid leukemia (AML) .
|
-
- HY-128927
-
|
ADC Linker
|
Cancer
|
Mc-Leu-Gly-Arg is a cleavable ether linker for antibody-drug conjugates (ADC) design.
|
-
- HY-128970
-
|
ADC Linker
|
Cancer
|
Mp-polymer ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-129370
-
|
ADC Linker
|
Cancer
|
SPDB-sulfo is a glutathione cleavable ADC linker used for the antibody-drug conjugate (ADCs) .
|
-
- HY-126531
-
|
ADC Linker
|
Cancer
|
DMAC-PDB is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-114697
-
-
- HY-118759
-
-
- HY-140098
-
|
ADC Linker
|
Cancer
|
Boc-Cystamine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-140014
-
|
ADC Linker
|
Cancer
|
Val-Cit is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-126349
-
|
ADC Linker
|
Cancer
|
DTSSP Crosslinker is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-101151
-
|
ADC Linker
|
Cancer
|
sulfo-SPDB is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-130111
-
|
ADC Linker
|
Cancer
|
DMAC-SPP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-126405
-
|
ADC Linker
|
Cancer
|
SMPT is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-W071006
-
2,5-Dioxopyrrolidin-1-yl 3-(pyridin-2-yldisulfanyl)butanoate
|
ADC Linker
|
Cancer
|
PPC-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-133540
-
-
- HY-133542
-
|
ADC Linker
|
Cancer
|
Dimethylamine-SPDB is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-133543
-
|
ADC Linker
|
Cancer
|
SPDP-sulfo is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-133550
-
|
ADC Linker
|
Cancer
|
DMAC-SPDB is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-19318A
-
|
ADC Linker
|
Cancer
|
Fmoc-D-Val-Cit-PAB is a cleavable linker for antibody-agent-conjugation (ADC) .
|
-
- HY-19318B
-
|
ADC Linker
|
Cancer
|
Fmoc-D-Val-Cit-PAB is a cleavable linker for antibody-agent-conjugation (ADC) .
|
-
- HY-150043A
-
|
ADC Linker
|
Cancer
|
MDTF is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-125305
-
|
ADC Linker
|
Cancer
|
Z-AEVD-FMK is a cleavable ADC linker for the synthesis of antibody active molecule conjugates (ADCs).
|
-
- HY-D2174
-
|
Fluorescent Dye
|
Others
|
AF488 amine is a bright, green-fluorescent dye used for labeling molecule such as antibodies .
|
-
- HY-160157
-
-
- HY-139909A
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
CL2E-SN-38 TFA, a highly releasable and structurally stable antibody-SN-38-conjugate, is a part of the antibody drug conjugate (ADC). SN-38, the active metabolite of Irinotecan from camptothecins, is an Topoisomerase I inhibitor .
|
-
- HY-147021
-
|
ADC Linker
|
Cancer
|
MC-Val-D-Cit-PAB-PNP is a cleavable peptide linker molecule used in the synthesis of antibody-drug conjugates (ADCs). MC-Val-D-Cit-PAB-PNP contains a maleimidocaproyl (Mc) group that can be conjugated to an antibody and a p-nitrophenol (PNP) group that allows the peptide to be linked to antitumor compounds.
|
-
- HY-P99681
-
IMMU 130; hMN-14-SN-38
|
Antibody-Drug Conjugates (ADCs)
|
Cancer
|
Labetuzumab govitecan (IMMU 130) is an Anti-CEACAM5/SN-38 antibody-drug conjugate (ADC). Labetuzumab govitecan consists of the antibody Labetuzumab, SN-38, and a pH-sensitive Linker. Labetuzumab govitecan can be used for research of cancers, such as colorectal cancer .
|
-
- HY-148870
-
|
ADC Cytotoxin
|
Cancer
|
Maytansinoid B is a kind of ADC Cytotoxin. Maytansinoid B can be used to conjugates with antibodies to form antibody-drug conjugates (ADCs). Maytansinoids are known as antimitotic agents, binding to tubulin and inhibiting microtubule assembly. Maytansinoids induces G2/M arrest in the cell cycle to induce apoptosis .
|
-
- HY-20560
-
|
ADC Linker
|
Cancer
|
(Ac)Phe-Lys(Alloc)-PABC-PNP is an useful cleavable chemical linker in antibody drug conjugates.
|
-
- HY-19318
-
|
ADC Linker
|
Cancer
|
Fmoc-Val-Cit-PAB is a cleavable antibody-conjugated active molecule (ADC) commonly used linker.
|
-
- HY-U00265
-
3-Carbethoxypsoralen; 3-Ethoxycarbonylpsoralen
|
Others
|
Infection
|
3-CPs is a serotype capsular polysaccharide which can interfere with antibody-mediated bacterial killing.
|
-
- HY-128929
-
|
ADC Linker
|
Cancer
|
Fmoc-PEA (Example 1-2) is a used as a cleavable linker for antibody-drug conjugates (ADC) .
|
-
- HY-129352
-
|
ADC Linker
|
Cancer
|
Cbz-Phe-(Alloc)Lys-PAB-PNP is an cleavable linker for antibody-drug conjugates (ADC) design.
|
-
- HY-129367
-
|
ADC Linker
|
Cancer
|
NO2-SPP is a cleavable linker that is used for making antibody-drug conjugate (ADC).
|
-
- HY-130099
-
|
ADC Linker
|
Cancer
|
Ald-Ph-amido-PEG2 is a noncleavable ADC linker for antibody-drug conjugate .
|
-
- HY-129353
-
|
ADC Linker
|
Cancer
|
Boc-Phe-(Alloc)Lys-PAB-PNP is a used as a cleavable linker for antibody-drug conjugates (ADC).
|
-
- HY-129360
-
|
ADC Linker
|
Cancer
|
Ala-Ala-Asn-PAB is a peptide cleavable ADC linker for antibody-drug conjugates (ADCs) .
|
-
- HY-126496
-
|
ADC Linker
|
Cancer
|
PEG4-SPDP is a cleavable ADC linker used for the antibody-drug conjugates (ADCs).
|
-
- HY-44221
-
|
ADC Linker
|
Cancer
|
MAC glucuronide linker-1 is a claevable ADC linker for antibody-agent-conjugations (ADCs) .
|
-
- HY-140129
-
|
ADC Linker
|
Cancer
|
NHS-SS-biotin is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-140096
-
|
ADC Linker
|
Cancer
|
Aminoethyl-SS-propionic acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-140987
-
|
ADC Linker
|
Cancer
|
5-Maleimidovaleric acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-140122
-
|
ADC Linker
|
Cancer
|
THP-SS-alcohol is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-126495A
-
|
ADC Linker
|
Cancer
|
Sulfo-LC-SPDP sodium is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-W002213
-
|
ADC Linker
|
Cancer
|
N-Hydroxysulfosuccinimide (sodium) is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-W019543
-
|
ADC Linker
|
Cancer
|
DSS Crosslinker is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-W011541
-
|
ADC Linker
|
Cancer
|
SIA Crosslinker is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-126364
-
|
ADC Linker
|
Cancer
|
Mc- Val- Ala- PAB is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
|
-
- HY-130110
-
|
ADC Linker
|
Cancer
|
Sulfo-DMAC-SPP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-141158
-
|
ADC Linker
|
Cancer
|
N-(Iodoacetamido)-Doxorubicin is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-131084
-
|
ADC Linker
|
Cancer
|
DMAC-SPDB-sulfo is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-D0799
-
|
Fluorescent Dye
|
Others
|
Sulfo-NHS-LC-Biotin sodium is an amine-reactive biotinylation reagent that can be used for antibody labeling .
|
-
- HY-44246
-
|
ADC Linker
|
Cancer
|
MC-Gly-Gly-Phe-Gly is a cleavable ADC linker used for antibody-drug conjugates (ADCs).
|
-
- HY-19318C
-
|
ADC Linker
|
Cancer
|
Fmoc-D-Val-D-Cit-PAB is a cleavable linker for antibody-agent-conjugation (ADC) .
|
-
- HY-138327
-
|
ADC Linker
|
Cancer
|
16-Bismesyloxyhexane is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-W096127
-
|
ADC Linker
|
Cancer
|
Biotin-sar-oh is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-147118
-
|
ADC Linker
|
Cancer
|
NHS-SS-Ph is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-150043
-
|
ADC Linker
|
Cancer
|
MDTF free acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-41919
-
mDPR(boc); (S)-MALEOYL-DPR(BOC)-OH·DCHA
|
|
|
Mal-L-PA-NH-Boc is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
|
-
- HY-44235A
-
|
ADC Linker
|
Cancer
|
MC-Gly-Gly-D-Phe is a cleavable linker used for sythesis of antibody-drug conjugates (ADC).
|
-
- HY-149753
-
|
Others
|
Inflammation/Immunology
|
Methylthiomcresol-succinaldehydic acid is a fenthion hapten that can be used for immunoreagent production (protein conjugates and polyclonal antibodies) .
|
-
- HY-160408
-
|
ADC Linker
|
Cancer
|
Mal-GGG-Bal-NHS ester is an ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-D1840
-
|
Biochemical Assay Reagents
|
Others
|
Tyramide Amplification Buffer is a ready-to-use buffer primarily intended for immunostaining of cells and tissues by the technique of tyramide signal amplification (TSA). TSA Technology is based on a tyrosinase labeling system that reacts a tyrosine-labeled antibody with a fluorescently labeled tyramide using peroxidase to form a highly amplified fluorescent signal. For example, horseradish peroxidase (HRP) can catalyze the reaction of tyrosine and hydrogen peroxide under milder conditions to generate epoxy groups. Epoxy groups promote the binding of tyramide to adjacent amino acids to form fluorescently labeled products .
|
-
- HY-112100
-
|
PROTAC-Linker Conjugates for PAC
Estrogen Receptor/ERR
|
Cancer
|
PROTAC ERα Degrader-5 (compound LP2) consists an ADC linker and a PROTAC, whcih can be conjugated to an antibody to form PACs. PROTAC ERα Degrader-5 conjugated to an antibody is a more marked estrogen receptor-alpha (ERα) degrader compared to PROTAC (without Ab) .
|
-
- HY-130081
-
|
ADC Cytotoxin
Microtubule/Tubulin
|
Cancer
|
DM3-SMe is a maytansine derivative and a tubulin inhibitor, and is a cytotoxic moiety of antibody-drug conjugates (ADCs), which can be linked to antibody through disulfide bond or stable thioether bond. DM3-SMe shows highly cytotoxic activity in vitro with an IC50 of 0.0011 nM .
|
-
- HY-128527
-
|
PROTACs
Estrogen Receptor/ERR
|
Cancer
|
PROTAC ER Degrader-3 is an intermediate for synthesis of PAC. PAC, consists the ADCs linker and PROTACs, conjugated to an antibody. PAC extracts from patent WO2017201449A1, compound LP2. PAC conjugated to an antibody is a more marked estrogen receptor-alpha (ERα) degrader compared to PROTAC (without Ab) .
|
-
- HY-128528
-
|
PROTACs
Estrogen Receptor/ERR
|
Cancer
|
PROTAC ER Degrader-2 is an intermediate for synthesis of PAC. PAC, consists the ADCs linker and PROTACs, conjugated to an antibody. PAC extracts from patent WO2017201449A1, compound LP2. PAC conjugated to an antibody is a more marked estrogen receptor-alpha (ERα) degrader compared to PROTAC (without Ab) .
|
-
- HY-152963
-
|
Antibody-Drug Conjugates (ADCs)
|
Cancer
|
Tisotumab vedotin is an antibody-drug conjugate (ADC) targeting tissue factor (TF). Tisotumab vedotin consists of a fully human monoclonal antibody to tissue factor (TF-011) conjugated to Monomethyl Auristatin E (MMAE). Tisotumab vedotin has good antitumor activity and can be used in the research of advanced or metastatic solid tumors .
|
-
- HY-D0821
-
Sulfo-Cyanine5
|
Fluorescent Dye
|
Others
|
CY5 is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
|
-
- HY-D1054
-
Cyanine2 (iodine)
|
Fluorescent Dye
|
Others
|
Cy2 iodine is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
|
-
- HY-112498
-
Cyanine3 NHS ester
|
Fluorescent Dye
|
Others
|
Cy3 NHS ester is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
|
-
- HY-D0825
-
Sulfo-Cyanine7
|
|
|
CY7 is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
|
-
- HY-D1388
-
|
Fluorescent Dye
|
Others
|
Cy3 NHS ester is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
|
-
- HY-153235
-
|
SARS-CoV
Liposome
|
Infection
|
COVID-19 Spike Protein mRNA-LNP is a lipid nanoparticle (LNP) containing COVID-19 Spike Protein, suitable for detection of RNA delivery, translation efficiency, cell viability, etc. COVID-19 Spike Protein is the novel coronavirus pneumonia spike protein located on the membrane surface. COVID-19 Spike Protein undertakes the functions of virus binding to host cell membrane receptors and membrane fusion, thereby mediating the entry of COVID-19 virus into cells. COVID-19 Spike Protein is an important site of action for host neutralizing antibodies and a key target for vaccine design .
|
-
- HY-130086
-
|
ADC Linker
|
Cancer
|
Bis- PEG4- NHS ester is a nonclaevable 4-unit PEG linker for antibody-agent-conjugation (ADC).
|
-
- HY-129349
-
|
ADC Linker
|
Cancer
|
Phe-Lys(Trt)-PAB is a cathepsin cleavable ADC linker used for the antibody-drug conjugates (ADCs) .
|
-
- HY-129362
-
|
ADC Linker
|
Cancer
|
Phe-Lys(Fmoc)-PAB is a cathepsin cleavable ADC linker used for the antibody-drug conjugates (ADCs) .
|
-
- HY-23641
-
|
ADC Linker
|
Cancer
|
NH-bis(C1-Boc)is a uncleavable linker used for antibody-drug conjugates (ADC).
|
-
- HY-117409
-
|
ADC Linker
|
Cancer
|
Aminoethyl-SS-ethylalcohol is a glutathione cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-135418
-
|
ADC Linker
|
Cancer
|
Fmoc-Asp-NH2 is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
|
-
- HY-W038702
-
|
ADC Linker
|
Cancer
|
Boc-Val-Cit-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-140140
-
|
ADC Linker
|
Cancer
|
PC Mal-NHS carbonate ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-141141
-
|
ADC Linker
|
Cancer
|
Boc-Val-Cit-PAB is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-124329
-
|
ADC Linker
|
Cancer
|
BS3 Crosslinker is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-140138
-
|
ADC Linker
|
Cancer
|
PC SPDP-NHS carbonate ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-W023121
-
|
ADC Linker
|
Cancer
|
Fmoc-Gly-Gly-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-130112
-
NHS-C4-MTS
|
ADC Linker
|
Cancer
|
N-Succinimidyloxycarbonylpropyl methanethiosulfonate is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-101153
-
|
ADC Linker
|
Cancer
|
MC-Val-Ala-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-136102
-
|
ADC Linker
|
Cancer
|
Py-ds-Prp-Osu is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-79129
-
|
ADC Linker
|
Cancer
|
Fmoc-D-Trp(Boc)-OH is a cleavable ADC linker that used in the synthesis of antibody-drug conjugates (ADCs).
|
-
- HY-138322
-
|
ADC Linker
|
Cancer
|
N-trifluoroacetyl-β-alanyl chloride is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-141664
-
|
ADC Linker
|
Cancer
|
PPA is an ADC linker (US20060073528A1). PPA can be used for making antibody-drug conjugate .
|
-
- HY-P3893
-
|
CDK
|
Metabolic Disease
|
PSTAIR is a monoclonal antibody that recognizes the PSTAIR sequence in Cdc28, PSTAIR can be used as loading control .
|
-
- HY-W097109A
-
|
ADC Linker
|
Cancer
|
Fmoc-(D-Phe)-Osu is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-129360A
-
|
ADC Linker
|
Cancer
|
Ala-Ala-Asn-PAB TFA is a peptide cleavable ADC linker for antibody-drug conjugates (ADCs) .
|
-
- HY-135415
-
|
Fluorescent Dye
|
Others
|
Cyanine5.5 NHS ester chloride is a reactive dye for the labeling of proteins, and antibodies and small molecular compounds .
|
-
- HY-400191
-
|
ADC Linker
|
Cancer
|
Fmoc-Gly-Gly-allyl propionate is a cleavable linker that can be used to synthesize Antibody-Drug Conjugates (ADCs).
|
-
- HY-163007
-
|
Others
|
Others
|
Malonylurea-cyclopentene-butanoic acid is a hapten. Malonylurea-cyclopentene-butanoic acid can be used as probe of antibody response and immunorecognition .
|
-
- HY-141604
-
CDX-011; CR011-vcMMAE
|
Antibody-Drug Conjugates (ADCs)
Microtubule/Tubulin
|
Cancer
|
Glembatumumab vedotin (CDX-011) is an ADC (antibody-drug conjugates (ADCs)) comprising a fully human IgG2 monoclonal antibody (CR011) directed against glycoprotein NMB (GPNMB) and conjugated to the potent tubulinbinding cytotoxic agent MMAE via a protease-sensitive vc linker. Glembatumumab vedotin has potent anticancer effects .
|
-
- HY-132258
-
IMGN853
|
Antibody-Drug Conjugates (ADCs)
|
Cancer
|
Mirvetuximab soravtansine (IMGN853) is an antibody drug-conjugate (ADC) consisting of the cytotoxic maytansinoid, DM4, covalently linked to the humanized monoclonal antibody M9346A. Mirvetuximab soravtansine selectively binds to folate receptor 1 (FOLR1). Mirvetuximab soravtansine has an anti-proliferative effect via growth arrest and augmented DNA damage .
|
-
- HY-W250541
-
|
ADC Linker
|
Cancer
|
Fmoc-Gly-NH-CH2-O-Cyclopropane-CH2COOH is an intermediate in the synthesis of ADC linker.The linker composed of Benzyl 2-cyclopropyl-2-hydroxyacetate can be coupled to Exatecan (HY-13631) and combined with antibodies (such as antibody hu2F7) .
|
-
- HY-132258A
-
IMGN853 (solution)
|
Antibody-Drug Conjugates (ADCs)
|
Cancer
|
Mirvetuximab soravtansine (IMGN853) solution is an antibody drug-conjugate (ADC) consisting of the cytotoxic maytansinoid, DM4, covalently linked to the humanized monoclonal antibody M9346A. Mirvetuximab soravtansine selectively binds to folate receptor 1 (FOLR1). Mirvetuximab soravtansine has an anti-proliferative effect via growth arrest and augmented DNA damage .
|
-
- HY-P99601
-
BFCR 4350A; RG 6160; RO 7187797
|
CD3
|
Neurological Disease
Cancer
|
Cevostamab (BFCR4350A; RG6160; RO7187797) is a humanized IgG1-based BsAb that targets membrane-proximal extracellular domain of FcRH5 on multiple myeloma (MM) cells as well as CD3 on T cells. Moreover, Cevostamab facilitates efficient synapse formation, improves killing activity of T cells against MM tumor cells .
|
-
- HY-12454
-
-
- HY-114430
-
|
ADC Linker
|
Others
|
Fmoc-Phe-Lys(Boc)-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
|
-
- HY-126663
-
|
ADC Cytotoxin
|
Cancer
|
N-Me-L-Ala-maytansinol is a hydrophobic, cell permeable payload used for making antibody-drug conjugate (ADC) .
|
-
- HY-44222
-
|
ADC Linker
|
Cancer
|
MAC glucuronide linker-2 is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-44234
-
|
ADC Linker
|
Cancer
|
Fmoc-Gly-Gly-Phe-OtBu is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-126670
-
|
ADC Linker
|
Cancer
|
mDPR(Boc)-Val-Cit-PAB is a cleavable ADC linker used as a linker for antibody-drug conjugates (ADC) .
|
-
- HY-126497
-
|
ADC Linker
|
Cancer
|
LC-PEG8-SPDP is a cleavable ADC linker used for the antibody-drug conjugates (ADCs) .
|
-
- HY-140116
-
|
ADC Linker
|
Cancer
|
Boc-NH-ethyl-SS-propionic acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-140125
-
|
ADC Linker
|
Cancer
|
2-Hydroxyethyl disulfide mono-tosylate is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-140117
-
|
ADC Linker
|
Cancer
|
Boc-aminooxy-ethyl-SS-propanol is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-140120
-
|
ADC Linker
|
Cancer
|
Mal-NH-ethyl-SS-propionic acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-141144
-
|
ADC Linker
|
Cancer
|
OPSS-Val-Cit-PAB-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-141145
-
|
ADC Linker
|
Cancer
|
OPSS-Val-Cit-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-141142
-
|
ADC Linker
|
Cancer
|
Boc-Val-Cit-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-140118
-
|
ADC Linker
|
Cancer
|
Fmoc-NH-ethyl-SS-propionic acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-135975
-
|
ADC Linker
|
Cancer
|
MC-Val-Ala-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-130930
-
|
ADC Linker
|
Cancer
|
Acid-propionylamino-Val-Cit-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-W071007
-
|
ADC Linker
|
Cancer
|
NO2-SPDMV is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-130932
-
|
ADC Linker
|
Cancer
|
Boc-Val-Ala-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-126353
-
|
ADC Linker
|
Cancer
|
Fmoc-Val-Ala-PAB-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-136107
-
|
ADC Linker
|
Cancer
|
Fmoc-Phe-Lys(Trt)-PAB is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-136136
-
|
ADC Linker
|
Cancer
|
Fmoc-Val-Ala-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-130961
-
|
ADC Linker
|
Cancer
|
Boc-Val-Dil-Dap-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-131833
-
|
ADC Linker
|
Cancer
|
Fmoc-Gly-Gly-Phe-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-124329A
-
|
ADC Linker
|
Cancer
|
BS3 Crosslinker disodium is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-139856
-
|
ADC Linker
|
Cancer
|
Mal-Ala-Ala-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-144003
-
-
- HY-139353
-
|
ADC Linker
|
Cancer
|
Fmoc-Phe-Lys(Boc)-PAB is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-135415A
-
|
Fluorescent Dye
|
Others
|
Cyanine5.5 NHS ester chloride TEA is a reactive dye for the labeling of proteins, and antibodies and small molecular compounds .
|
-
- HY-156727
-
|
ADC Linker
|
Cancer
|
Val-Cit-PABC-Ahx-May is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-153209
-
|
Others
|
Others
|
ISATM51 is a vaccine adjuvant that enhances antigen-specific antibody titers and cytotoxic T lymphocyte (CTL) responses .
|
-
- HY-D0824
-
Sulfo-Cyanine7 Succinimidyl Ester
|
Fluorescent Dye
|
Others
|
CY7-SE is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
|
-
- HY-D0826
-
Cyanine2 Succinimidyl Ester (iodine)
|
Fluorescent Dye
|
Others
|
Cy2-SE iodine is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
|
-
- HY-D0824A
-
Sulfo-Cyanine7 Succinimidyl Ester triethylamine
|
Fluorescent Dye
|
Others
|
CY7-SE triethylamine is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
|
-
- HY-D0924
-
Sulfo-Cyanine5.5
|
|
|
Cy5.5 is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
|
-
- HY-D0926
-
|
|
|
Cy7.5 is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
|
-
- HY-D1323
-
Cy5.5 maleimide chloride
|
Fluorescent Dye
|
Others
|
Cyanine5.5 maleimide chloride is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
|
-
- HY-D1566
-
|
Fluorescent Dye
|
Others
|
Sulfo-Cy7.5 maleimide is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
|
-
- HY-D1565
-
|
Fluorescent Dye
|
Others
|
Cy7.5 maleimide is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
|
-
- HY-D0924B
-
Sulfo-Cyanine5.5 TEA
|
Fluorescent Dye
|
Cardiovascular Disease
Neurological Disease
Metabolic Disease
Inflammation/Immunology
Cancer
|
Cy5.5 TEA is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
|
-
- HY-D0924A
-
Sulfo-Cyanine5.5 acetate
|
Fluorescent Dye
|
Cardiovascular Disease
Neurological Disease
Metabolic Disease
Inflammation/Immunology
Cancer
|
Cy5.5 acetate is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
|
-
- HY-156574
-
|
DGK
|
Cancer
|
DGKζ-IN-4 is a DGK-zeta inhibitor. DGKζ-IN-4 can be used as an active component of pharmaceutical compositions. DGKζ-IN-4 is used to treat cancers associated with immune cell activation or cancers resistant to anti-PD-1 antibody/anti-PD-11 antibody treatment .
|
-
- HY-P99050
-
-
- HY-P99852
-
ABT165; PR1283233
|
VEGFR
|
Cancer
|
Dilpacimab (ABT165) is a potent dual-variable domain immunoglobulin, targets both delta-like ligand 4 (DLL4) and VEGF pathways.. Dilpacimab can be used in research of cancer .
|
-
- HY-129378
-
|
ADC Linker
|
Cancer
|
NO2-SPP-sulfo-Me is a cleavable linker that is used for making antibody-drug conjugate (ADC) .
|
-
- HY-130090
-
|
ADC Linker
|
Cancer
|
NHPI-PEG4-C2-Pfp ester is used as a linker for antibody-drug conjugates (ADC).
|
-
- HY-130087
-
|
ADC Linker
|
Cancer
|
Bis-PEG3-NHS ester is a nonclaevable 3-unit PEG linker for antibody-agent-conjugation (ADC).
|
-
- HY-130088
-
|
ADC Linker
|
Cancer
|
Bis-PEG2-NHS ester is a nonclaevable 2-unit PEG linker for antibody-agent-conjugation (ADC).
|
-
- HY-130089
-
|
ADC Linker
|
Cancer
|
Bis-PEG1-NHS ester is a nonclaevable 1-unit PEG linker for antibody-agent-conjugation (ADC).
|
-
- HY-130098
-
|
ADC Linker
|
Cancer
|
Ald-Ph-amido-PEG3-C-COOH is a noncleavable linker used for the antibody-drug conjugate (ADC).
|
-
- HY-129356A
-
-
- HY-W011561
-
|
ADC Linker
|
Cancer
|
Boc-NH-C6-Br is a non-cleavable linker used for antibody-drug conjugates (ADC) .
|
-
- HY-126502
-
|
ADC Linker
|
Cancer
|
Mal-C2-NHS ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-126533
-
|
ADC Linker
|
Cancer
|
PDP-C1-Ph-Val-Cit is a cleavable ADC linker used for antibody-drug conjugates (ADCs).
|
-
- HY-129350
-
|
ADC Linker
|
Cancer
|
Fmoc-Phe-Lys(Trt)-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-W040236
-
-
- HY-140119
-
|
ADC Linker
|
Cancer
|
Fmoc-NH-ethyl-SS-propionic NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-130547
-
|
ADC Linker
|
Cancer
|
BS2G Crosslinker (disodium) is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-130976
-
|
ADC Linker
|
Cancer
|
N-Boc-Val-Dil-Dap-Doe is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-130933
-
|
ADC Linker
|
Cancer
|
Fmoc-Ala-Ala-Asn(Trt)-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-136132
-
|
ADC Linker
|
Cancer
|
MC-VC-PAB-NH2 is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-133547
-
|
ADC Linker
|
Cancer
|
NO2-SPP-sulfo is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-133548
-
|
ADC Linker
|
Cancer
|
NO2-SPDB-sulfo is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-133549
-
|
ADC Linker
|
Cancer
|
NO2-SPDMV-sulfo is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-136329
-
|
ADC Linker
|
Cancer
|
β-D-glucuronide-pNP-carbonate is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-130975
-
|
ADC Linker
|
Cancer
|
Boc-Val-Dil-Dap-Phe-OMe is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-130956
-
|
ADC Linker
|
Cancer
|
Boc-NMe-Val-Val-Dil-Dap-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
|
-
- HY-78921
-
|
ADC Linker
|
Cancer
|
Fmoc-3VVD-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-132251
-
|
ADC Linker
|
Cancer
|
MCC is non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs), such as MCC-DM1 .
|
-
- HY-139441
-
-
- HY-120903
-
|
ADC Linker
|
Cancer
|
DBCO-C3-Acid is a Click Chemistry intermediate used in the synthesis of antibody-drug conjugate (ADC) linker .
|
-
- HY-147164
-
|
ADC Linker
|
Cancer
|
MC-Gly-Gly-Phe-Gly-PAB-PNP is a linker for synthesis anti-human EGFR antibody agent conjugate .
|
-
- HY-136547
-
|
ADC Linker
|
Others
|
Boc-Val-Ala-PAB is a cathepsin cleavable ADC linker that is used for making antibody-drug conjugate (ADCs) .
|
-
- HY-137774
-
-
- HY-145767A
-
|
Others
|
Others
|
SN-38-CO-DMEDA TFA is the intermediate product for synthesizing antibody-conjugated drug LND1035 .
|
-
- HY-156727A
-
|
ADC Linker
|
Cancer
|
Val-Cit-PABC-Ahx-May TFA is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-112099
-
|
ADC Linker
|
Cancer
|
Mc-Val-Cit-PAB-Cl is a cleavable ADC linker. Mc-Val-Cit-PAB-Cl can be used to conjugate MMAE and antibody to form antibody-MC-vc-MMAE (e.g., anti-CD22-MC-VC-PABC-MMAE with IC50s of 3.3 and 0.95 nM for BJAB and WSU cell lines in cytotoxicity assay).
|
-
- HY-P99107
-
|
Antibody-Drug Conjugates (ADCs)
Apoptosis
TNF Receptor
|
Cancer
|
Brentuximab vedotin (cAC10-vcMMAE) is an antibody-drug conjugate (ADC) comprising an anti-CD30 antibody and the cytotoxic agent Monomethyl auristatin E (MMAE). Brentuximab vedotin inhibits CD30-positive cells with an IC50 of 2.5 ng/mL. Brentuximab vedotin can be used for the research of relapsed and refractory Hodgkin lymphoma .
|
-
- HY-147239
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
MC-VA-PABC-MMAE is a agent-linker conjugate for ADC. MC-VA-PABC-MMAE contains the ADCs linker (peptide MC-VA-PABC) and a potent tubulin polymerization inhibitor MMAE (HY-15162) .
|
-
- HY-147392
-
|
CXCR
|
Metabolic Disease
|
CXCR2 antagonist 8 is a potent and selective CXCR2 antagonist. CXCR2 antagonist 8 can be used for insulin resistance research .
|
-
- HY-149689
-
HBA
|
Biochemical Assay Reagents
|
Inflammation/Immunology
|
2-[(4-Oxo-1,2,3-benzotriazin-3-yl)oxy]acetic acid (HBA) is a hapten with a carboxyl group at the end of its spacer arm, suitable for reacting with free amine groups of proteins. 2-[(4-Oxo-1,2,3-benzotriazin-3-yl)oxy]acetic acid can be combined with carrier proteins and used in antigen design .
|
-
- HY-149688
-
MBH
|
Biochemical Assay Reagents
|
Inflammation/Immunology
|
6-[(4-Oxo-1,2,3-benzotriazin-3-yl)methylthio]hexanoic acid (MBH) is a hapten with a carboxyl group at the end of its spacer arm, suitable for reacting with free amine groups of proteins. 6-[(4-Oxo-1,2,3-benzotriazin-3-yl)methylthio]hexanoic acid can be combined with carrier proteins and used in antigen design .
|
-
- HY-149691
-
MFH
|
Biochemical Assay Reagents
|
Inflammation/Immunology
|
6-(N-Phthalimidoylmethylthio)hexanoic acid (MFH) is a hapten with a carboxyl group at the end of its spacer arm, suitable for reacting with free amine groups of proteins. 6-(N-Phthalimidoylmethylthio)hexanoic acid can be combined with carrier proteins and used in antigen design .
|
-
- HY-149690
-
MFA
|
Biochemical Assay Reagents
|
Inflammation/Immunology
|
2-(N-Phthalimidoylmethylthio)acetic acid (MFA) is a hapten with a carboxyl group at the end of its spacer arm, suitable for reacting with free amine groups of proteins. 2-(N-Phthalimidoylmethylthio)acetic acid can be combined with carrier proteins and used in antigen design .
|
-
- HY-149687
-
MBP
|
Biochemical Assay Reagents
|
Inflammation/Immunology
|
3-[(4-Oxo-1,2,3-benzotriazin-3-yl)methylthio]propanoic acid (MBP) is a hapten with a carboxyl group at the end of its spacer arm, suitable for reacting with free amine groups of proteins. 3-[(4-Oxo-1,2,3-benzotriazin-3-yl)methylthio]propanoic acid can be combined with carrier proteins and used in antigen design .
|
-
- HY-W028210
-
|
Biochemical Assay Reagents
|
Inflammation/Immunology
|
6-N-Phthalimidoy hexanoic acid (compound FH) is a hapten with a carboxyl group at the end of its spacer arm, suitable for reacting with free amine groups of proteins. 6-N-Phthalimidoy hexanoic acid can be combined with carrier proteins and used in antigen design .
|
-
- HY-W046063
-
4-Phthalimidobutyric acid
|
Biochemical Assay Reagents
|
Inflammation/Immunology
|
4-(N-Phthalimidoyl)butanoic acid (compound FB) is a hapten with a carboxyl group at the end of its spacer arm, suitable for reacting with free amine groups of proteins. 4-(N-Phthalimidoyl)butanoic acid can be combined with carrier proteins and used in antigen design .
|
-
- HY-W026082
-
|
Biochemical Assay Reagents
|
Inflammation/Immunology
|
4-Ketobenztriazine-CH2COOH (compound BA) is a hapten with a carboxyl group at the end of its spacer arm, suitable for reacting with free amine groups of proteins. 4-Ketobenztriazine-CH2COOH can be combined with carrier proteins and used in antigen design .
|
-
- HY-157194
-
|
Biochemical Assay Reagents
|
Inflammation/Immunology
|
RL-6-Me-7-OH is a hapten that activates human and mouse MAIT cells (EC50=25µM). RL-6-Me-7-OH can be combined with carrier proteins and used in antigen design. RL-6-Me-7-OH can be used in inflammation and immunity research .
|
-
- HY-W474473
-
|
Biochemical Assay Reagents
|
Inflammation/Immunology
|
3-(((1,3-Dioxoisoindolin-2-yl)methyl)thio)propanoic acid (MFP) is a hapten with a carboxyl group at the end of its spacer arm, suitable for reacting with free amine groups of proteins. 3-(((1,3-Dioxoisoindolin-2-yl)methyl)thio)propanoic acid can be combined with carrier proteins and used in antigen design .
|
-
- HY-15943
-
6-TAMRA
1 Publications Verification
6-Carboxytetramethylrhodamine
|
DNA Stain
|
Others
|
6-TAMRA has been a widely used fluorophore for preparing bioconjugates, especially fluorescent antibody and avidin derivatives used in immunochemistry.
|
-
- HY-129351
-
|
ADC Linker
|
Cancer
|
Aloc-D-Ala-Phe-Lys(Aloc)-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
|
-
- HY-140126
-
|
ADC Linker
|
Cancer
|
Bis-Tos-(2-hydroxyethyl disulfide) is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-141143
-
|
ADC Linker
|
Cancer
|
MC(C5)-Val-Cit is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-136154
-
|
ADC Linker
|
Cancer
|
Fmoc-Glu-(Boc)-Val-Cit-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-133584
-
|
ADC Linker
|
Cancer
|
Bis-SS-C3-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-112806
-
-
- HY-112805
-
-
- HY-145488
-
|
ADC Linker
|
Cancer
|
MethylCBI-azaindole-benzamide-MOM-Boc-ethylenediamine-D is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-138651
-
|
ADC Linker
|
Inflammation/Immunology
|
PAB-Val-Lys-Boc is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) for stimulating an immune response .
|
-
- HY-D1941
-
|
Fluorescent Dye
|
Others
|
ATTO 590 Streptavidin is a streptavidin derivative of ATTO 590, it can label protein or antibody, the maximum excitation/emission wavelength: 594/622 nm.
|
-
- HY-D1947
-
|
Fluorescent Dye
|
Others
|
ATTO 700 Streptavidin is a streptavidin derivative of ATTO 700, it can label protein or antibody, the maximum excitation/emission wavelength: 700/716 nm.
|
-
- HY-D1949
-
|
Fluorescent Dye
|
Others
|
ATTO 594 Streptavidin is a streptavidin derivative of ATTO 594, it can label protein or antibody, the maximum excitation/emission wavelength: 603/626 nm.
|
-
- HY-D1962
-
|
Fluorescent Dye
|
Others
|
ATTO 633 Streptavidin is a streptavidin derivative of ATTO 633, it can label protein or antibody, the maximum excitation/emission wavelength: 630/651 nm.
|
-
- HY-D1963
-
|
Fluorescent Dye
|
Others
|
ATTO 565 Streptavidin is a streptavidin derivative of ATTO 565, it can label protein or antibody, the maximum excitation/emission wavelength: 564/590 nm.
|
-
- HY-D1977
-
|
Fluorescent Dye
|
Others
|
ATTO 610 Streptavidin is a streptavidin derivative of ATTO 610, it can label protein or antibody, the maximum excitation/emission wavelength: 616/633 nm.
|
-
- HY-D1985
-
|
Fluorescent Dye
|
Others
|
ATTO 725 Streptavidin is a streptavidin derivative of ATTO 725, it can label protein or antibody, the maximum excitation/emission wavelength: 728/751 nm.
|
-
- HY-D1987
-
|
Fluorescent Dye
|
Others
|
ATTO 620 Streptavidin is a streptavidin derivative of ATTO 620, it can label protein or antibody, the maximum excitation/emission wavelength: 620/642 nm.
|
-
- HY-D1995
-
|
Fluorescent Dye
|
Others
|
ATTO 647 Streptavidin is a streptavidin derivative of ATTO 647, it can label protein or antibody, the maximum excitation/emission wavelength: 630/651 nm.
|
-
- HY-D2075
-
|
Fluorescent Dye
|
Others
|
ATTO 740 streptavidin is a streptavidin derivative of ATTO 740, it can label protein or antibody, the maximum excitation/emission wavelength: 743/763 nm.
|
-
- HY-D2004
-
|
Fluorescent Dye
|
Others
|
ATTO 488 streptavidin is a streptavidin derivative of ATTO 488, it can label protein or antibody, the maximum excitation/emission wavelength: 500/520 nm.
|
-
- HY-D2048
-
|
Fluorescent Dye
|
Others
|
ATTO 532 streptavidin is a streptavidin derivative of ATTO 532, it can label protein or antibody, the maximum excitation/emission wavelength: 532/552 nm.
|
-
- HY-D2024
-
|
Fluorescent Dye
|
Others
|
ATTO 550 streptavidin is a streptavidin derivative of ATTO 550, it can label protein or antibody, the maximum excitation/emission wavelength: 554/576 nm.
|
-
- HY-D2030
-
|
Fluorescent Dye
|
Others
|
ATTO 514 streptavidin is a streptavidin derivative of ATTO 514, it can label protein or antibody, the maximum excitation/emission wavelength: 511/531 nm.
|
-
- HY-D2023
-
|
Fluorescent Dye
|
Others
|
ATTO 665 streptavidin is a streptavidin derivative of ATTO 665, it can label protein or antibody, the maximum excitation/emission wavelength: 663/680 nm.
|
-
- HY-D2064
-
|
Fluorescent Dye
|
Others
|
ATTO 680 streptavidin is a streptavidin derivative of ATTO 680, it can label protein or antibody, the maximum excitation/emission wavelength: 681/698 nm.
|
-
- HY-136132A
-
|
ADC Linker
|
Cancer
|
MC-VC-PAB-NH2 TFA is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-400356
-
|
ADC Linker
|
Cancer
|
Glucocorticoid receptor agonist-1 phosphate Gly-Glu (TFA) is a cleavable linker, that can be used to synthesize Antibody-Drug Conjugates (ADCs).
|
-
- HY-78921AG
-
|
ADC Linker
|
Cancer
|
Fmoc-3VVD-OH (GMP) is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-149752
-
|
Others
|
Inflammation/Immunology
|
Methylthiomcresol-C1-benzoic acid is a fenthion hapten that can be used for immunoreagent production (protein conjugates and polyclonal antibodies) .
|
-
- HY-157244
-
|
Others
|
Others
|
Proteins separation resin is a hydrophobic interaction chromatography resin that can be used in the monoclonal antibody purification (Particle size: 65 μm) .
|
-
- HY-157175
-
|
Others
|
Others
|
Mannosamine-lipoic acid adduct is a hapten. Mannosamine-lipoic acid adduct with hsIgG conjugation significantly reduces the antibody immune response against hsIgG .
|
-
- HY-157173
-
|
Others
|
Inflammation/Immunology
|
Mannosamine–biotin adduct is a hapten. Mannosamine–biotin adduct conjugated to hsIgG significantly reduces antibody immune responses against hsIgG .
|
-
- HY-D0925
-
Cyanine5.5 NHS ester
|
|
|
Cy5.5-SE (Cyanine5.5 NHS ester) is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance . Storage: protect from light.
|
-
- HY-108829
-
CTLA4lg; BMS-188667
|
CTLA-4
|
Inflammation/Immunology
Cancer
|
Abatacept (CTLA4lg) is a soluble fusion protein consisting of the extra-cellular domain of human CTLA4 and a fragment of the Fc portion of human IgG1 (hinge and CH2 and 3 domains) . Abatacept is a selective T-cell co-stimulation modulator and a protein agent for the autoimmune diseases .
|
-
- HY-P9926
-
REGN-668; SAR-231893
|
Interleukin Related
|
Inflammation/Immunology
Cancer
|
Dupilumab (REGN-668) is a fully human mAb to IL-4 receptor α (IL-4Rα) that inhibits both IL-4 and IL-13 signaling, markedly improved moderate-to-severe atopic dermatitis .
|
-
- HY-108847
-
|
TNF Receptor
Bacterial
|
Inflammation/Immunology
Cancer
|
Etanercept, a dimeric fusion protein that binds TNF, acts as a TNF inhibitor. Etanercept competitively inhibits the binding of both TNF-α and TNF-β to cell surface TNF receptors, rendering TNF biologically inactive. Etanercept shows efficacy against rheumatoid arthritis, juvenile idiopathic arthritis, and plaque psoriasis .
|
-
- HY-P99006
-
MORab-009
|
Mesothelin
|
Cancer
|
Amatuximab (MORab-009) is a chimeric, humanized IgG1/k MAb that targets the cell surface mesothelin (MSLN). Mesothelin is a glycosylphosphatidyl inositol (GPI)-anchored membrane glycoprotein, which is present in a restricted set of normal adult tissues such as the mesothelium .
|
-
- HY-P99032
-
IPH2201
|
Checkpoint Kinase (Chk)
IFNAR
|
Inflammation/Immunology
Cancer
|
Monalizumab (IPH2201) is an immune checkpoint inhibitor targeting Natural Killer Group 2A (NKG2A). Monalizumab, a humanized anti-NKG2A blocking mAb, increases IFN-γ production, thereby promoting NK cell effector functions. Monalizumab can be used for the research of head and neck squamous cell carcinoma (HNSCC) .
|
-
- HY-P99056
-
PF 05082566
|
TNF Receptor
|
Inflammation/Immunology
Cancer
|
Utomilumab (PF 05082566) is a fully human IgG2 mAb agonist of the T-cell costimulatory receptor 4-1BB/CD137. Utomilumab can be used for the research of relapsed/refractory follicular lymphoma (FL) and other CD20 + non-Hodgkin lymphomas (NHL) .
|
-
- HY-108801
-
VEGF Trap; VEGF-TRAPR1R2; VEGF-trapR1
|
VEGFR
|
Cardiovascular Disease
Metabolic Disease
|
Aflibercept (VEGF Trap) is a soluble decoy VEGFR constructed by fusing the Ig domains of VEGFR1 and VEGFR2 with the Fc region of human IgG1. Aflibercept inhibits VEGF signaling by reducing VEGF-regulated processes. Aflibercept can be used for thr research of age-related macular degeneration (AMD) and cardiovascular disease .
|
-
- HY-145633
-
OPT 302; VGX-300
|
VEGFR
|
Cardiovascular Disease
|
Sozinibercept (OPT 302; VGX-300) is a soluble form of VEGFR-3, potently inhibits the activity of VEGF-C/D, which are the proangiogenic factors, inhibiting angiogenesis and vascular leakage. Sozinibercept also inhibits diabetic retinal edema in rats .
|
-
- HY-P99420
-
ALPN-101
|
CD28
|
Inflammation/Immunology
|
Acazicolcept (ALPN-101), an Fc fusion protein, is a dual inducible T cell costimulator (ICOS)/CD28 antagonist. Acazicolcept has anti-inflammatory activities .
|
-
- HY-P99397
-
ALX 0761; M 1095
|
Interleukin Related
|
Inflammation/Immunology
|
Sonelokimab (ALX 0761; M 1095) is a trivalent nanobody comprised of monovalent camelid-derived nanobodies specific to human interleukin (IL)-17A, IL-17F, and human serum albumin VHHs. Sonelokimab has the potential for plaque-type psoriasis research .
|
-
- HY-P99433
-
U 85855
|
HIV
|
Infection
|
Alvircept sudotox is a recombinant CD4 derived from Pneumonas aeruginosa exotoxin A. Alvircept sudotox can be used in the research of HIV infections .
|
-
- HY-P99435
-
BRII-196
|
SARS-CoV
|
Infection
|
Amubarvimab (BRII-196) is a human IgG1 mAb that bind to non-competing epitopes on the receptor binding domain (RBD) of spike protein, with a KD of 5.88 nM. Amubarvimab can effectively neutralize SARS-CoV-2 variants .
|
-
- HY-P99440
-
CSL-324
|
c-Fms
|
Inflammation/Immunology
|
Anumigilimab (CSL-324) is an human IgG2a mAb against human granulocyte colony-stimulating factor (G-CSF) receptor. Anumigilimab can be used for increasing numbers of neutrophils at sites of inflammation .
|
-
- HY-P99445
-
APG101; CAN008
|
TNF Receptor
|
Inflammation/Immunology
Cancer
|
Asunercept (APG101; CAN008) is a soluble CD95-Fc fusion protein targeting CD95L. Asunercept disrupts CD95/CD95L signaling by selectively binding to CD95L. Asunercept can be used in the research of glioblastoma multiforme (GBM), myelodysplastic syndrome (MDS), and graft-versus-host disease (GvHD) .
|
-
- HY-P99565
-
ARENEGYR; NGR-TNF; NGR-hTNF
|
TNF Receptor
|
Cancer
|
Tengonermin (ARENEGYR) is a vascular-targeting agent consisting of the human Tumour Necrosis Factor-α (TNF-α) conjugated with the CNGRCG peptide. Tengonermin increases penetration of intratumoral chemotherapy and T-cell infiltration by modifying the tumour microenvironment .
|
-
- HY-P99887
-
JTX-4014
|
PD-1/PD-L1
|
Cancer
|
Pimivalimab (JTX-4014) is a PD-1 inhibitor. Pimivalimab can be used for the research of solid tumor .
|
-
- HY-P99621
-
NPC-21; EV2038
|
CMV
|
Infection
|
Fiztasovimab (NPC-21; EV2038) is a fully human IgG1λ mAb against human cytomegalovirus (hCMV). Fiztasovimab acts neutralizing activity by binding to the antigenic domain 1 of glycoprotein B on hCMV envelope. Fiztasovimab inhibits cell-to-cell transmission of hCMV .
|
-
- HY-P99610
-
BI-754091
|
PD-1/PD-L1
|
Cancer
|
Ezabenlimab (BI-754091) is an anti-PD-1 mAb with binding constant Kd value of 6 nM (CHO cells). Ezabenlimab blocks the interaction of PD-1 with PD-L1 and PD-L2. Ezabenlimab increases interferon-γ secretion in T cells, and inhibits tumor growth in vivo .
|
-
- HY-P99608
-
|
HBV
|
Infection
|
Exbivirumab is an anti-HBV mAb. Exbivirumab enhances the antiviral activity of hepatitis B immunoglobulin (HBIG) .
|
-
- HY-P99536
-
SL-401
|
Interleukin Related
|
Cancer
|
Tagraxofusp (SL-401) is a potent IL-3 receptor inhibitor to inhibits plasmacytoid dendritic cells (pDCs) growth in multiple myeloma (MM) bone marrow (BM) microenvironment. Tagraxofusp has synergistic effect with Bortezomib (HY-10227) and Pomalidomide (HY-10984) to suppress multiple myeloma (MM) .
|
-
- HY-P99499
-
JNJ 63723283; JNJ 3283
|
PD-1/PD-L1
Interleukin Related
TNF Receptor
|
Cancer
|
Cetrelimab (JNJ 63723283; JNJ 3283) is a human IgG4κ mAb targeting PD-1. Cetrelimab binds PD-1 (Kd=1.72 nM, HEK293) to block the interaction of PD-1 with PD-L1 and PD-L2 (IC50s=111.7 ng/mL and 138.6 ng/mL, respectively). Cetrelimab stimulates peripheral T cells, increases IFN-γ, IL-2, TNF-α level and inhibits tumor growth in vivo .
|
-
- HY-P99498
-
CEA-IL2v; RG 7813; RO 6895882
|
Interleukin Related
|
Inflammation/Immunology
Cancer
|
Cergutuzumab amunaleukin (CEA-IL2v) is a monomeric carcinoembryonic antigen (CEA)-targeted IL-2 variant-based immunocytokine. Cergutuzumab amunaleukin has immunostimulating and antineoplastic activities .
|
-
- HY-108822
-
Arcalyst; IL 1 Trap; Interleukin 1 Trap
|
Interleukin Related
|
Inflammation/Immunology
|
Rilonacept (Arcalyst), a dimeric fusion protein, is a interleukin 1 inhibitor. Rilonacept consists of the ligand-binding domains of the extracellular portions of the IL-1R components linked to the Fc portion of human IgG1. Rilonacept can be used for the research of cryopyrin-associated periodic syndromes .
|
-
- HY-P99930
-
|
FGFR
|
Metabolic Disease
|
Efruxifermin is an Fc-FGF21 fusion protein (human IgG1 Fc domain linked to a modified human FGF21). Efruxifermin has prolonged half-life and enhanced receptor affinity compared with native human FGF21. Efruxifermin can be used for the research of non-alcoholic steatohepatitis .
|
-
- HY-P99940
-
ABT-122
|
TNF Receptor
Interleukin Related
|
Inflammation/Immunology
|
Remtolumab (ABT-122) is a dual-variable domain immunoglobulin that neutralises both tumor necrosis factor α (TNFα) and IL-17A. Remtolumab shows dual inhibition of TNFα and IL-17A. Remtolumab can be used for rheumatoid arthritis (RA) research .
|
-
- HY-P99463
-
AVB-S6-500
|
TAM Receptor
|
Cancer
|
Batiraxcept (AVB-S6-500) is a highly potent and specific AXL inhibitor, a recombinant fusion protein dimer containing the extracellular domain of human AXLM and human immunoglobulin G1 heavy chain (Fc). Batiraxcept binds to GAS6 and inhibits the interaction of GAS6 with AXL, thereby substantially reducing AXL signaled invasion and migration of highly metastatic cells in vitro and inhibiting metastatic disease in nonclinical models of aggressive human cancers. Batiraxcept is available for studies in advanced or metastatic clear cell renal cell carcinoma (ccRCC) and platinum sensitive recurrent ovarian cancer .
|
-
- HY-P99645
-
-
- HY-P99952
-
SCT400
|
CD20
|
Cancer
|
Ripertamab (SCT400) is a recombinant, human-mouse chimeric anti-CD20 IgG1κ mAb. Ripertamab can be used for the research of hematological malignancies, including non-Hodgkin’s lymphoma (NHL) .
|
-
- HY-P99692
-
p55TNF-R:Ig; Ro 45-2081; TNFR55-IgG1
|
TNF Receptor
|
Inflammation/Immunology
|
Lenercept (Ro 45-2081) is a recombinant fusion protein that consists of the soluble TNF-receptor (p55) linked to the Fc portion of human IgG1 .
|
-
- HY-P99722
-
REGN3470-3471-3479
|
Filovirus
|
Infection
|
Maftivimab (REGN3470-3471-3479), the inhibitor of Filovirus, is an Food and agent Administration (FDA)-approved agent. Maftivimab, also named as Atoltivimab, Odesivimab (Inmazeb), can be used for research of Zaire ebolavirus infection .
|
-
- HY-P99721
-
ABT-981
|
Interleukin Related
|
Inflammation/Immunology
|
Lutikizumab (ABT-981) is an anti-IL-1α and IL-1β dual variable domain immunoglobulin. Lutikizumab binds and inhibits IL-1α and IL-1β. Lutikizumab can be used for the research of osteoarthritis .
|
-
- HY-P99693
-
GC1102
|
HBV
|
Infection
|
Lenvervimab (GC1102) is a IgG1-type recombinant human hepatitis B Immunoglobulin. Lenvervimab can be used for research of hepatitis B virus infection .
|
-
- HY-P99720
-
ACE-536; luspatercept–aamt
|
TGF-beta/Smad
|
Metabolic Disease
|
Luspatercept (ACE-536) is a recombinant modified ActRIIB fusion protein that binds with transforming growth factor β superfamily ligands. Luspatercept increases the erythrocyte numbers and promotes maturation of erythroid precursors. Luspatercept binds with GDF11 and inhibits Smad2/3 signaling. Luspatercept can be used for the research of anemia .
|
-
- HY-P99667
-
OMP-54F28; FZD8-Fc
|
Wnt
|
Cancer
|
Ipafricept (OMP-54F28; FZD8-Fc) is the first class of recombinant fusion proteins, consisting of the extracellular portion of the human fried-8 receptor fused to the Fc fragment of human IgG1 binding to the Wnt ligand. Ipafricept shows solid tumor inhibition activity, with well tolerance .
|
-
- HY-P99590
-
ACE-011
|
TGF-β Receptor
|
Inflammation/Immunology
Cancer
|
Sotatercept (ACE-011) is a soluble activin receptor 2A (ACVR2A) type IgG Fc fusion protein. Sotatercept combines activin and growth differentiation factor to try to restore the balance between growth promotion and growth inhibition signal pathways. Sotatercept has potential application in pulmonary arterial hypertension, anemia, bone loss, erythropoiesis, multiple myeloma (MM) osteolytic lesions .
|
-
- HY-P99782
-
-
- HY-P99818
-
|
TGF-β Receptor
|
Metabolic Disease
|
Ramatercept is a soluble ActRIIB receptor and can be used as a soluble activin receptor 2 (ACVR2) antagonist. Ramatercept inhibits the signal pathway of muscle growth inhibition and has potential application in muscle atrophy .
|
-
- HY-P99821
-
-
- HY-P99798
-
AMG 420; BI-836909
|
CD3
|
Cancer
|
Pacanalotamab (AMG 420; BI-836909) is a bispecific T-cell engager (BiTE) targeting to BCMA and CD3ɛ. BCMA refers to B cell maturation antigen, as Pacanalotamab redirecting T cells to BCMA expressing cells on the cell surface. Pacanalotamab conducts T-cell redirected lysis of human multiple myeloma (MM) cell lines .
|
-
- HY-P99823
-
TA-46; sFGFR3
|
FGFR
|
Others
|
Recifercept (TA-46) is a soluble, recombinant fibroblast growth factor receptor 3 (FGFR3) molecule. Recifercept can be used as a decoy/ligand trap to decrease the amount of fibroblast growth factors that can bind to mutant FGFR3 receptors. Recifercept can be used for the research of achondroplasia .
|
-
- HY-P99802
-
BAY 2010112; AMG 212
|
CD3
|
Cancer
|
Pasotuxizumab (BAY 2010112) is a PSMA and CD3 bispecific T-cell engager (BiTE). Pasotuxizumab binds to CD3 and PSMA with KDs of 9.4 nM and 47.0 nM for human CD3 and PSMA. Pasotuxizumab can be used for research of metastatic castration-resistant prostate cancer (mCRPC) .
|
-
- HY-P99816
-
-
- HY-P99799
-
CX-072
|
PD-1/PD-L1
|
Cancer
|
Pacmilimab (CX-072) is a potent PD-L1 inhibitor. Pacmilimab shows antitumor activity .
|
-
- HY-P99814
-
AMG-701
|
CD3
|
Inflammation/Immunology
Cancer
|
Pavurutamab (AMG-701) is a bispecific T cell engager molecule that anti-CD3 and anti-B cell maturation antigens (BCMA). Pavurutamab has an extended half-life based on Pacanalotamab (HY-P99798). The Fc of Pavurutamab is coupled to molecules to improve pharmacokinetic parameters. Pavurutamab has potential applications in immune regulation and multiple myeloma (MM) .
|
-
- HY-P99817
-
|
Interleukin Related
HIV
|
Infection
|
Pegaldesleukin is a conjugate of polyethylene glycol and interleukin-2 (PEG-IL2). Pegaldeslukin has antiviral activity and has potential applications in HIV, possibly delaying the progression of HIV infection by retaining the immune repertoire .
|
-
- HY-P99742
-
ADC-1013; JNJ-64457107
|
TNF Receptor
|
Cancer
|
Mitazalimab (ADC-1013; JNJ-64457107) is FcγR-dependent CD40 agonist with tumor-directed activity. Mitazalimab activates antigen-presenting cells, e.g. dendritic cells (DC), to initiate tumor-reactive T cells. Therefore, Mitazalimab induces tumor-specific T cells to infiltrate and kill tumors. Mitazalimab remodels the tumor-infiltrating myeloid microenvironment .
|
-
- HY-P99100
-
CTL-002
|
PD-1/PD-L1
|
Cancer
|
Visugromab is aGDF-15 neutralizing IgG4 mAb. Visugromab exhibits potent effecicacy in PD-1/PD-L1 relapsed/refractory metastatic solid tumors .
|
-
- HY-P9958A
-
|
RANKL/RANK
|
Cancer
|
Denosumab (anti-TNFSF11) is a RANKL inhibitor that is effective against giant cell tumor of bone (GCTB).Denosumab eliminates RANK-positive tumor giant cells and reduces the relative content of proliferative, dense-cell tumor stromal cells .
|
-
- HY-108801A
-
|
VEGFR
|
Cardiovascular Disease
Metabolic Disease
|
Aflibercept (VEGF Trap) is a soluble decoy VEGFR constructed by fusing the Ig domains of VEGFR1 and VEGFR2 with the Fc region of human IgG1. Aflibercept inhibits VEGF signaling by reducing VEGF-regulated processes. Aflibercept can be used for thr research of age-related macular degeneration (AMD) and cardiovascular disease .
|
-
- HY-P990111
-
-
- HY-136287
-
-
- HY-130097
-
|
ADC Linker
|
Cancer
|
Ald-Ph-amido-PEG4-C2-acid is a noncleavable linker used for the antibody-drug conjugate (ADC).
|
-
- HY-141123
-
|
ADC Linker
|
Cancer
|
SPDP-C6-Gly-Leu-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-141353
-
|
ADC Linker
|
Cancer
|
SPDP-PEG12-acid is a cleavable 12 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-141355
-
|
ADC Linker
|
Cancer
|
OPSS-PEG36-acid is a cleavable 36 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-133408
-
|
ADC Linker
|
Cancer
|
4-Methyl-4-(methyldisulfanyl)pentanoic acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-136106
-
|
ADC Linker
|
Cancer
|
Fmoc-Gly3-Val-Cit-PAB is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-W040254
-
|
Fluorescent Dye
|
Others
|
Biotin-LC-LC-NHS is a SMCC cross-linking reagent that can be used to mark antibody and other small molecules, such as Paclitaxel .
|
-
- HY-133585
-
|
ADC Linker
|
Cancer
|
Bis-SS-C3-sulfo-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-D1112
-
|
Fluorescent Dye
|
Others
|
TFAX 546,SE triethylammonium, an amine reactive yellow fluorescent dye, can forms bright and photostable conjugates with proteins and antibodies .
|
-
- HY-145148
-
|
ADC Cytotoxin
|
Cancer
|
Hemiasterlin derivative-1 is a hemiasterlin derivative. Hemiasterlin derivative-1 can be used for the synthesis of the antibody-drug conjugate (ADC) .
|
-
- HY-145367
-
|
ADC Linker
|
Cancer
|
Ala-CO-amide-C4-Boc is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-145489
-
|
ADC Linker
|
Cancer
|
Mal-PEG2-Val-Cit-PABA is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-145066
-
|
ADC Linker
|
Cancer
|
Gly-Gly-Gly-PEG4-azide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-148550
-
|
ADC Linker
|
Cancer
|
MC-PEG2-NH2 is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-144629
-
-
- HY-144630
-
-
- HY-W127793
-
(S)-1-(p-Bromoacetamidobenzyl)ethylenediaminetetraacetic acid
|
Biochemical Assay Reagents
|
Others
|
EDTA-p-Bromoacetamido benzyl ((S)-1-(p-Bromoacetamidobenzyl)ethylenediaminetetraacetic acid) is a compound of EDTA and phenylbromoacetamide that can be coupled to antibodies .
|
-
- HY-B1884
-
|
Fungal
|
Infection
Inflammation/Immunology
|
Procymidone, a pesticide, is an immunogen hapten that can be combined with cOVA (carrier protein) to produce polyclonal antibodies. Procymidone has antifungal activity .
|
-
- HY-157275
-
|
ADC Linker
|
Cancer
|
Gly-Gly-Gly-PEG2-azide is an ADC linker that can be used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-135125
-
|
ADC Cytotoxin
|
Cancer
|
DC4, an ADC cytotoxin, can be used in the synthesis of antibody-drug conjugate (ADC). DC4 can be used for the targeted treatment of cancer .
|
-
- HY-120258
-
-
- HY-126883
-
-
- HY-129311
-
-
- HY-W019793
-
-
- HY-140115
-
|
ADC Linker
|
Cancer
|
Bis-(PEG6-acid)-SS is a cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-140244
-
|
ADC Linker
|
Cancer
|
Gly-PEG3-amine is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-140097
-
|
ADC Linker
|
Cancer
|
Amino-SS-PEG12-acid is a cleavable 12 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-141358
-
|
ADC Linker
|
Cancer
|
SPDP-PEG36-NHS ester is a cleavable 36 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-135961
-
|
ADC Linker
|
Cancer
|
PTAD-PEG4-amine is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-136051
-
|
ADC Linker
|
Cancer
|
Biotin-PEG3-aldehyde is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-116655
-
|
ADC Linker
|
Cancer
|
Hydroxy-PEG1-acid is a non-cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-135964
-
|
ADC Linker
|
Cancer
|
(2-pyridyldithio)-PEG4 acid is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-135974
-
|
ADC Linker
|
Cancer
|
Amino-PEG3-SS-acid is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-136047
-
|
ADC Linker
|
Cancer
|
Methylcyclopropene-PEG3-amine is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-136048
-
|
ADC Linker
|
Cancer
|
Methylcyclopropene-PEG4-NHS is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-131086
-
-
- HY-136127
-
|
ADC Linker
|
Cancer
|
ALD-PEG4-OPFP is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-136309
-
|
ADC Linker
|
Cancer
|
Ald-PEG23-SPDP is a cleavable 23 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-136432
-
Mc-GGFG-PAB-OH
|
ADC Linker
|
Cancer
|
Mc-Gly-Gly-Phe-Gly-PAB-OH (Mc-GGFG-PAB-OH) is a cleavable ADC linker used for antibody-drug conjugates (ADCs).
|
-
- HY-133544
-
|
ADC Linker
|
Cancer
|
Mal-CO-PEG5- NHS ester is a non-cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
|
-
- HY-132086
-
|
ADC Linker
|
Cancer
|
2-Pyridyldithio-PEG6 acid is a cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-138484
-
|
ADC Linker
|
Cancer
|
Folate-PEG3-amine is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-138488
-
|
ADC Linker
|
Cancer
|
Biotin-PEG4-PFP ester is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-132163
-
|
ADC Linker
|
Cancer
|
MP-PEG4-VK(Boc)G-OSu is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-141594
-
|
Microtubule/Tubulin
|
Cancer
|
Modified MMAF, an ADC cytotoxin, can be used in the synthesis of Antibody-drug Conjugate (ADC). Modified MMAF can be used for the targeted research of cancer .
|
-
- HY-131156
-
|
ADC Linker
|
Cancer
|
Mal-PEG2-Val-Cit-PABA-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-140144
-
|
ADC Linker
|
Cancer
|
Mal-PEG1-Val-Cit-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-148463
-
|
ADC Linker
|
Cancer
|
MP-Ala-Ala-PAB is a cleavable ADC linker. Fmoc-Ala-Ala-PAB can be used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-148461
-
|
ADC Linker
|
Cancer
|
Mal-VC-PAB-PNP is a cleavable ADC linker. Mal-VC-PAB-PNP can be used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-148462
-
|
ADC Linker
|
Cancer
|
Fmoc-Ala-Ala-PAB is a cleavable ADC linker. Fmoc-Ala-Ala-PAB can be used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-148464
-
|
ADC Linker
|
Cancer
|
MC-Ala-Ala-PAB is a cleavable ADC linker. Fmoc-Ala-Ala-PAB can be used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-P5276
-
|
PD-1/PD-L1
|
Cancer
|
Human membrane-bound PD-L1 polypeptide can be used as an antigen to induce PD-L1 antibody production .
|
-
- HY-48668
-
|
ADC Linker
|
Cancer
|
AcLys-PABC-VC-Aur0101 intermediate-1 is a cathepsin cleavable ADC linker that is used for making antibody-drug conjugate .
|
-
- HY-D1918
-
|
Fluorescent Dye
|
Others
|
ATTO 390 maleimide is a maleimide ester derivative of ATTO 390, which can be used to label proteins or antibodies. The maximum excitation/emission wavelength: 390/476 nm.
|
-
- HY-D1925
-
|
Fluorescent Dye
|
Others
|
ATTO 425 Maleimide is a maleimide ester derivative of ATTO 425, which can be used to label proteins or antibodies. The maximum excitation emission wavelength: 439/489 nm.
|
-
- HY-D1936
-
|
Fluorescent Dye
|
Others
|
ATTO 465 Maleimid is a maleimide ester derivative of ATTO 465, which can be used to label proteins or antibodies. The maximum excitation/emission wavelength: 453/506 nm.
|
-
- HY-D1948
-
|
Fluorescent Dye
|
Others
|
ATTO 594 Maleimid is a maleimide ester derivative of ATTO 594, which can be used to label proteins or antibodies, with maximum excitation/emission wavelengths: 603/626 nm.
|
-
- HY-D1960
-
|
Fluorescent Dye
|
Others
|
ATTO 633 Maleimid is a maleimide ester derivative of ATTO 633, which can be used to label proteins or antibodies, with maximum excitation/emission wavelengths: 630/651 nm.
|
-
- HY-D1974
-
|
Fluorescent Dye
|
Others
|
ATTO 610 NHS-Ester is an activated ester derivative of ATTO 610, which can directly label proteins or antibodies. The maximum excitation/emission wavelength: 616/633 nm.
|
-
- HY-D1976
-
|
Fluorescent Dye
|
Others
|
ATTO 610 Maleimid is a maleimide ester derivative of ATTO 610, which can be used to label proteins or antibodies, with maximum excitation/emission wavelengths: 616/633 nm.
|
-
- HY-D1979
-
|
Fluorescent Dye
|
Others
|
ATTO 725 NHS-Ester is an activated ester derivative of ATTO 725, which can directly label proteins or antibodies. The maximum excitation/emission wavelength: 728/751 nm.
|
-
- HY-D1982
-
|
Fluorescent Dye
|
Others
|
ATTO 725 Maleimid is a maleimide ester derivative of ATTO 725, which can be used to label proteins or antibodies. The maximum excitation/emission wavelength: 728/751 nm.
|
-
- HY-D1983
-
|
Fluorescent Dye
|
Others
|
ATTO 620 NHS-Ester is an activated ester derivative of ATTO 620, which can directly label proteins or antibodies. The maximum excitation/emission wavelength: 620/642 nm.
|
-
- HY-D1986
-
|
Fluorescent Dye
|
Others
|
ATTO 620 Maleimid is a maleimide ester derivative of ATTO 620, which can be used to label proteins or antibodies, with maximum excitation/emission wavelengths: 620/642 nm.
|
-
- HY-D1994
-
|
Fluorescent Dye
|
Others
|
ATTO 647 Maleimid is a maleimide ester derivative of ATTO 647, which can be used to label proteins or antibodies, with maximum excitation/emission wavelengths: 630/651 nm.
|
-
- HY-D2020
-
|
Fluorescent Dye
|
Others
|
ATTO 665 maleimid is a maleimide ester derivative of ATTO 665, which can be used to label proteins or antibodies. The maximum excitation/emission wavelength: 663/680 nm.
|
-
- HY-D2028
-
|
Fluorescent Dye
|
Others
|
ATTO 514 maleimid is a maleimide ester derivative of ATTO 514, which can be used to label proteins or antibodies. The maximum excitation/emission wavelength: 511/531 nm.
|
-
- HY-W352966
-
|
ADC Linker
|
Cancer
|
Mal-PEG2-CH2COOH is an ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-W426106
-
|
ADC Linker
|
Cancer
|
Gly-NH-CH2-Boc is a cleavable ADC linker that can be used to synthesize antibody-conjugated active molecules (ADC) .
|
-
- HY-D1103
-
|
Fluorescent Dye
|
Others
|
SiR dye 1 is a new silicon rhodamine-like fluorescent probe, and can be conjugated with small molecules, peptides and oligonucleotide aminogroups or proteins with antibodies .
|
-
- HY-157338
-
|
ADC Linker
Kinesin
|
Cancer
|
NHS-Ala-Ala-Asn-active metabolite is a cleavable antibody-drug conjugate (ADC) linker for synthesis of kinesin spindle protein (KSP)inhibitor .
|
-
- HY-P10252
-
|
HIV
|
Inflammation/Immunology
|
HIV gp120 421-438 is HIV antigen fragments, that conjugates with keyhole limpet hemocyanin (KLH) and generates specific anti-HIV antibody .
|
-
- HY-P10250
-
|
HIV
|
Inflammation/Immunology
|
HIV gp120 308-331 is HIV antigen fragments, that conjugates with keyhole limpet hemocyanin (KLH) and generates specific anti-HIV antibody .
|
-
- HY-D0925A
-
Cyanine5.5 NHS ester (DIPEA)
|
DNA Stain
Fluorescent Dye
|
Others
|
Cy5.5-SE (Cyanine5.5 NHS ester) DIPEA is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance . Storage: protect from light.
|
-
- HY-D0925B
-
Cyanine5.5 NHS ester TEA
|
Fluorescent Dye
|
Others
|
Cy5.5-SE TEA (Cyanine5.5 NHS ester TEA) is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance . Storage: protect from light.
|
-
- HY-116392F
-
|
Others
|
Cancer
|
D-threo-PDMP hydrochloride is a glucosylceramide (GlcCer) synthase inhibitor that inhibits glucosylceramide (GlcCer) and lactosylceramide (LacCer) levels in B16 melanoma cells. D-threo-PDMP hydrochloride lacks reactivity to the other two surface antigens anti-melanoma monoclonal antibodies M562 and M622 and the major histocompatibility antigen anti-H-2KbDb monoclonal antibody, so it is specific for B16 melanoma sex .
|
-
- HY-P1449
-
|
ADC Linker
|
Cancer
|
Boc-Gly-Gly-Phe-Gly-OH, a self-assembly of N- and C-protected tetrapeptide, is a protease cleavable linker used for the antibody-drug conjugate (ADC).
|
-
- HY-130080
-
Maytansinoid DM3
|
ADC Cytotoxin
Microtubule/Tubulin
|
Cancer
|
DM3 (Maytansinoid DM3) is a maytansine analog bearing disulfide or thiol groups and a tubulin inhibitor, and is a cytotoxic moiety of antibody-drug conjugates (ADCs) .
|
-
- HY-135660
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
MMAE-SMCC is a agent-linker conjugate for ADC. MMAE-SMCC is composed of a potent mitotic and a tubulin inhibitor MMAE and a linker SMCC to make antibody agent conjugate.
|
-
- HY-112561
-
-
- HY-140124
-
|
ADC Linker
|
Cancer
|
THP-SS-PEG1-Tos is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-140123
-
|
ADC Linker
|
Cancer
|
THP-SS-PEG1-Boc is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-140134
-
|
ADC Linker
|
Cancer
|
PC Biotin-PEG3-NHS ester is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-136037
-
|
ADC Linker
|
Cancer
|
Boc-amino-PEG3-SS-acid is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-135962
-
|
ADC Linker
|
Cancer
|
Boc-Aminooxy-PEG2-bromide is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-136041
-
|
ADC Linker
|
Cancer
|
Boc-amino-PEG3-SSPy is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-136097
-
|
ADC Linker
|
Cancer
|
Maleimide-PEG2-hydrazide (TFA) is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-133545
-
|
ADC Linker
|
Cancer
|
Mal-Ph-CONH-PEG4- NHS ester is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
|
-
- HY-138508
-
|
ADC Linker
|
Cancer
|
Biotin-PEG2-methyl ethanethioate is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-136432A
-
Mc-GGFG-PAB-OH TFA
|
ADC Linker
|
Cancer
|
Mc-Gly-Gly-Phe-Gly-PAB-OH (Mc-GGFG-PAB-OH) TFA is a cleavable ADC linker used for antibody-drug conjugates (ADCs).
|
-
- HY-150074
-
|
Others
|
Cancer
|
STING agonist-18 (compound 1a) can be used for synthesis of antibody-drug conjugates (ADCs), such Trastuzumab (HY-P9907) conjugate .
|
-
- HY-148425
-
|
ADC Linker
|
Cancer
|
Mal-amide-PEG8-Val-Ala-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-153600
-
-
- HY-163014
-
|
Others
|
Inflammation/Immunology
|
Dicamba 1-azidopropane (DCn) is an immunizing and heterologous hapten. Dicamba 1-azidopropane can be used to generate monoclonal antibodies specific of Dicamba .
|
-
- HY-132259
-
ABT-414
|
Antibody-Drug Conjugates (ADCs)
EGFR
|
Cancer
|
Depatuxizumab mafodotin is an antibody-drug conjugate (ADC) that specifically targets the epidermal growth factor receptor (EGFR). Depatuxizumab mafodotin can be used for cancer research .
|
-
- HY-138139A
-
T785 hydrochloride
|
Toll-like Receptor (TLR)
|
Inflammation/Immunology
|
AXC-715 (T785) hydrochloride is a TLR7/TLR8 dual agonist, extracted from patent WO2020168017 A1 . AXC-715, compound D from WO2020190734A1, can be used for synthesis of antibody-adjuvant immunoconjugates, comprising an antibody construct that binds programmed death-ligand 1 (PD-L1) linked to one or more adjuvants .
|
-
- HY-138139B
-
T785 trihydrochloride
|
Toll-like Receptor (TLR)
|
Inflammation/Immunology
|
AXC-715 (T785) trihydrochloride is a TLR7/TLR8 dual agonist, extracted from patent WO2020168017 A1 . AXC-715 trihydrochloride, compound D from WO2020190734A1, can be used for synthesis of antibody-adjuvant immunoconjugates, comprising an antibody construct that binds programmed death-ligand 1 (PD-L1) linked to one or more adjuvants .
|
-
- HY-138298A
-
DS-8201; DS-8201a
|
Antibody-Drug Conjugates (ADCs)
EGFR
|
Cancer
|
Trastuzumab deruxtecan (DS-8201a) is an anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate (ADC). Trastuzumab deruxtecan is composed of a humanized anti-HER2 antibody, an enzymatically cleavable peptide-linker, a topoisomerase I inhibitor (a toxin component of Dxd). Trastuzumab deruxtecan can be used for the research of HER2-positive breast cancer and gastric cancer .
|
-
- HY-128960
-
-
- HY-P1449A
-
|
ADC Linker
|
Cancer
|
Boc-Gly-Gly-Phe-Gly-OH TFA, a self-assembly of N- and C-protected tetrapeptide, is a protease cleavable linker used for the antibody-drug conjugate (ADC).
|
-
- HY-126510
-
|
ADC Linker
|
Cancer
|
MC-PEG2-C2- NHS ester is a nonclaevable 2-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs).
|
-
- HY-140099
-
|
ADC Linker
|
Cancer
|
Amino-ethyl-SS-PEG3-NHBoc is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-141284
-
|
ADC Linker
|
Cancer
|
Gly-Gly-Gly-PEG4-methyltetrazine is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-141292
-
|
ADC Linker
|
Cancer
|
Oleoyl-Gly-Lys-N-(m-PEG11) is a cleavable 11 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-141190
-
|
ADC Linker
|
Cancer
|
Gly-Gly-Gly-PEG3-TCO is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-130962
-
|
ADC Linker
|
Cancer
|
Ald-Ph-amido-PEG23-OPSS is a cleavable 23 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-133459
-
|
ADC Linker
|
Cancer
|
Mal-PEG1-Val-Cit-OH is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-136134
-
|
ADC Linker
|
Cancer
|
SS-bis-amino-PEG4-NHS ester is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-136135
-
|
ADC Linker
|
Cancer
|
(2-pyridyldithio)-PEG1-hydrazine is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-133538
-
|
ADC Linker
|
Cancer
|
4-Succinimidyl-oxycarbonyl-α-(2-pyridyldithio)toluene is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-W096135
-
|
ADC Linker
|
Cancer
|
Biotin-PEG1-NH2 is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-141808
-
|
Others
|
Cancer
|
AZD-CO-Ph-PEG4-Ph-CO-AZD is a bis-β-lactam linker can be used for antibody-siRNA conjugate synthesis .
|
-
- HY-W034595
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Eicosanedioic acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Eicosanedioic acid is also a alkyl chain-based PROTAC linker that can be used in the synthesis
|
-
- HY-117371
-
(-)-Hemiasterlin; Milnamide B
|
ADC Cytotoxin
|
Cancer
|
Hemiasterlin ((-)-Hemiasterlin) is an antimitotic marine natural product with potent anticancer effcts. Hemiasterlin can be used as a cytotoxic payload (ADC Cytotoxin) in antibody-drug conjugates (ADCs) .
|
-
- HY-13218
-
WP-871
|
Others
|
Inflammation/Immunology
|
Acitazanolast is an orally active antiallergic agent, can inhibit histamine release. Acitazanolast can be used in study of type I anaphylaxis (immediate) caused by IgE antibodies .
|
-
- HY-49206
-
|
ADC Linker
|
Cancer
|
CbzNH-PEG8-amide-bis(pentayl-5OBz) is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
|
-
- HY-160179
-
-
- HY-138298
-
DS-8201 (solution); DS-8201a (solution)
|
Antibody-Drug Conjugates (ADCs)
EGFR
|
Cancer
|
Trastuzumab deruxtecan (T-DXd; DS-8201a) (solution) is an anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate (ADC). Trastuzumab deruxtecan is composed of a humanized anti-HER2 antibody, an enzymatically cleavable peptide-linker, a topoisomerase I inhibitor (a toxin component of Dxd). Trastuzumab deruxtecan can be used for the research of HER2-positive breast cancer and gastric cancer .
|
-
- HY-P10091
-
|
PD-1/PD-L1
|
Cancer
|
CD24/Siglec-10 blocking peptide, CSBP can not only block the interaction of CD24/Siglec-10 but also PD-1/PD-L1. CD24/Siglec-10 blocking peptide, CSBP can induce the phagocytosis of tumor cell .
|
-
- HY-130091
-
|
ADC Linker
|
Cancer
|
NHPI-PEG4-C2-NHS ester, example 40 (WO2014185985A1), is used as a linker for antibody-drug conjugates (ADC) .
|
-
- HY-130105
-
|
ADC Linker
|
Cancer
|
Ald-Ph-amido-PEG1-C2-Pfp ester is a nonclaevable 1-unit PEG linker for antibody-agent-conjugation (ADC).
|
-
- HY-130106
-
|
ADC Linker
|
Cancer
|
Ald-Ph-amido-PEG1-C2-NHS ester is a nonclaevable 1-unit PEG linker for antibody-agent-conjugation (ADC).
|
-
- HY-130101
-
|
ADC Linker
|
Cancer
|
Ald-Ph-amido-PEG4-C2-NHS ester is a nonclaevable 4-unit PEG linker for antibody-agent-conjugation (ADC).
|
-
- HY-130092
-
|
ADC Linker
|
Cancer
|
NHPI-PEG3-C2-Pfp ester is a nonclaevable 3-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs).
|
-
- HY-130093
-
|
ADC Linker
|
Cancer
|
NHPI-PEG3-C2-NHS ester is a nonclaevable 3-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs).
|
-
- HY-130094
-
|
ADC Linker
|
Cancer
|
NHPI-PEG2-C2-Pfp ester is a nonclaevable 2-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs).
|
-
- HY-130095
-
|
ADC Linker
|
Cancer
|
NHPI-PEG2-C2-NHS ester is a nonclaevable 2-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs).
|
-
- HY-130103
-
|
ADC Linker
|
Cancer
|
Ald-Ph-amido-PEG2-C2-Pfp ester is a nonclaevable 2-unit PEG linker for antibody-agent-conjugation (ADC).
|
-
- HY-130104
-
|
ADC Linker
|
Cancer
|
Ald-Ph-amido-PEG2-C2-NHS ester is a nonclaevable 2-unit PEG linker for antibody-agent-conjugation (ADC).
|
-
- HY-140112
-
|
ADC Linker
|
Cancer
|
Acid-PEG2-SS-PEG2-acid is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-140113
-
|
ADC Linker
|
Cancer
|
Acid-PEG3-SS-PEG3-acid is a cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-141154
-
-
- HY-140143
-
|
ADC Linker
|
Cancer
|
Mal-PEG4-Val-Cit-PAB-OH is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-140145
-
|
ADC Linker
|
Cancer
|
Mal-PEG4-Val-Cit-PAB-PNP is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-141150
-
|
ADC Linker
|
Cancer
|
Azido-PEG5-Ala-Ala-Asn-PAB is a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-141149
-
|
ADC Linker
|
Cancer
|
Fmoc-PEG4-Ala-Ala-Asn-PAB is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-133409
-
|
ADC Linker
|
Cancer
|
4-Methyl-4-(pyridin-2-yldisulfanyl)pentanoic acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-130941
-
|
ADC Linker
|
Cancer
|
Fmoc-N-bis-PEG3-NH-Boc is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-130944
-
|
ADC Linker
|
Cancer
|
Mal-PEG1-Val-Cit-PABC-OH is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-136108
-
|
ADC Linker
|
Cancer
|
Fmoc-Gly3-Val-Cit-PAB-PNP is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-136157
-
|
ADC Linker
|
Cancer
|
Py-ds-dmBut-amido-PEG4-NHS ester is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-131087
-
|
ADC Linker
|
Cancer
|
Me-triacetyl-β-D-glucopyranuronate-Ph-CH2OH-Fmoc is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-133579
-
|
ADC Linker
|
Cancer
|
Ald-Ph-amido-PEG3-NHS ester is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-112901
-
|
ADC Cytotoxin
|
Cancer
|
DC41 is a DC1 derivative. DC1, a simplified analogue of CC-1065, is an antibody conjugate of cytotoxic DNA alkylators for the targeted treatment of cancer .
|
-
- HY-136286
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
MC-DM1 is a agent-linker conjugate composed of a potent microtubule-disrupting agent DM1 and a linker MC to make antibody agent conjugate (ADC) .
|
-
- HY-P1439
-
-
- HY-P3149
-
|
TNF Receptor
|
Inflammation/Immunology
|
LEESGGGLVQPGGSMK, a proteolysis peptide, is a component of Infliximab. LEESGGGLVQPGGSMK can be used for quantitative analysis of Infliximab. Infliximab is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α .
|
-
- HY-P3149B
-
|
TNF Receptor
|
Inflammation/Immunology
|
LEESGGGLVQPGGSMK acetate, a proteolysis peptide, is a component of Infliximab. LEESGGGLVQPGGSMK acetate can be used for quantitative analysis of Infliximab. Infliximab is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α .
|
-
- HY-132973
-
|
ADC Linker
|
Cancer
|
MC-Val-Cit-PAB-NH-C2-NH-Boc is a cathepsin cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-W034918
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Docosanedioic acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Docosanedioic acid is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.
|
-
- HY-D1546
-
|
Fluorescent Dye
|
Cancer
|
Biotin-C2-maleimide is an antibody conjugate reagent, can bind to many biomolecules without significantly changing the biological activity of the target molecule .
|
-
- HY-153195
-
|
Others
|
Cancer
|
Tetra-O-acetyl-β-D-galactopyranosyl-Ph-CH2OH-Fmoc can be used as conjugates to prepare antibody drug conjugates (ADCs) .
|
-
- HY-163024
-
|
Others
|
Inflammation/Immunology
|
Atrazine-3-mercaptopropanoic acid is a hapten. The IC50 value of polyclonal antibody (PcAb) 1 with coating Atrazine-3-mercaptopropanoic acid is 7.5 ng/mL .
|
-
- HY-W025723A
-
N-(Benzyloxycarbonyl)-D-homoserine
|
Others
|
Cancer
|
N-Carbobenzoxy-D-homoserine (N-(Benzyloxycarbonyl)-D-homoserine) is D-homoserine with N-Carbobenzoxy protecting group, which can be used to synthesize Antibody-Drug Conjugates (ADCs).
|
-
- HY-160097
-
-
- HY-157795
-
|
ADC Cytotoxin
Topoisomerase
|
Cancer
|
Exatecan analogue 1 (Icp-3) is a Exatecan (HY-13631) analogue. Exatecan analogue 1 can be used in the synthesis of antibody-drug conjugates (ADCs)
|
-
- HY-P99034
-
-
- HY-P99611
-
-
- HY-15582
-
|
Microtubule/Tubulin
ADC Cytotoxin
|
Cancer
|
Auristatin E is a cytotoxic tubulin modifier with potent and selective antitumor activity; MMAE analog and cytotoxin in antibody-drug conjugates. Auristatin E inhibits cell division by blocking the polymerisation of tubulin.
|
-
- HY-128871
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
VCP-Eribulin consists the ADCs linker (VCP) and Eribulin . Eribulin is a mechanistically unique microtubule inhibitor for cancer . VCP-Eribulin is an Eribulin-based agent for antibody conjugates .
|
-
- HY-126669
-
|
ADC Linker
|
Cancer
|
Mal-PEG4-VA is a cleavable ADC linker containing a Maleimide group. Mal-PEG4-VA is used for making antibody-drug conjugate.
|
-
- HY-130315
-
-
- HY-126894
-
|
PROTAC Linkers
ADC Linker
|
Cancer
|
Bis- PEG9- acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Bis- PEG9- acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
|
-
- HY-140147
-
|
ADC Linker
|
Cancer
|
Mal-amido-PEG2-Val-Cit-PAB-PNP is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-141146
-
|
ADC Linker
|
Cancer
|
Mal-amido-PEG8-val-gly-PAB-OH is a cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-141151
-
|
ADC Linker
|
Cancer
|
Fmoc-PEG3-Ala-Ala-Asn(Trt)-PAB is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-140146
-
|
ADC Linker
|
Cancer
|
Mal-amido-PEG2-Val-Cit-PAB-OH is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-133572
-
|
ADC Linker
|
Cancer
|
Ald-Ph-amido-PEG11-NH-Boc is a non-cleavable 11 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-133582
-
|
ADC Linker
|
Cancer
|
Mal-amido-PEG3-C1- NHS ester is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
|
-
- HY-W096148
-
|
ADC Linker
|
Cancer
|
Biotin-C4-amide-C5-NH2 is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-132159
-
|
ADC Linker
|
Cancer
|
MC-AAA-NHCH2OCH2COOH (compound 20) is a cleavable ADC linker that is used for making antibody-drug conjugate (ADC) .
|
-
- HY-P3203A
-
|
TNF Receptor
|
Inflammation/Immunology
|
DSTYSLSSTLTLSK TFA is a generic human peptide and can be used for infliximab quantitative detection . Infliximab (Avakine) is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α.
|
-
- HY-139956
-
|
ADC Linker
|
Cancer
|
Mal-amido-PEG9-Val-Ala-PAB-SG3200 is a cleavable ADC linker conjugate used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-132254
-
IMMU-132
|
Antibody-Drug Conjugates (ADCs)
|
Cancer
|
Sacituzumab govitecan (IMMU-132) is an antibody-drug conjugate (ADC) targeting Trop-2 for delivery of SN-38. Sacituzumab govitecan shows anticancer activity .
|
-
- HY-147179
-
|
ADC Cytotoxin
|
Inflammation/Immunology
|
INX-SM-56 is a cytotoxin that can be used for the synthesis of anti-VISTA antibody agent conjugate. VISTA: V-region Immunoglobulin-containing Suppressor of T cell Activation .
|
-
- HY-155494
-
|
Others
|
Inflammation/Immunology
|
trans-Stilbene-NHCO-(CH2)3-acid, a trans-stilbene hapten, can be used to elicit a panel of monoclonal antibodies that display a range of fluorescent spectral behavior .
|
-
- HY-W025723
-
N-(Benzyloxycarbonyl)-L-homoserine
|
Others
|
Cancer
|
N-Carbobenzoxy-L-homoserine (N-(Benzyloxycarbonyl)-L-homoserine) is L-homoserine with N-Carbobenzoxy protecting group, which can be used as a linker (ADC Linker) for the synthesis of Antibody-Drug Conjugates (ADCs).
|
-
- HY-132254A
-
IMMU-132 (solution)
|
Antibody-Drug Conjugates (ADCs)
|
Cancer
|
Sacituzumab govitecan (IMMU-132) is an antibody-drug conjugate (ADC) targeting Trop-2 for delivery of SN-38. Sacituzumab govitecan shows anticancer activity .
|
-
- HY-148460
-
|
Drug-Linker Conjugates for ADC
EGFR
STING
|
Cancer
|
Mal-VC-PAB-(N-Me-amide-C3)-ADU-S100 triethylamine is an immune stimulator antibody conjugate (ISAC) comprising an anti-human epidermal growth factor receptor 2 (HER2) antibody, a STING agonist (ADU-S100) and a linker. Mal-VC-PAB-(N-Me-amide-C3)-ADU-S100 triethylamine can be uesd for cancer research (WO2018200812A1; example 5) .
|
-
- HY-112899
-
|
ADC Cytotoxin
DNA Alkylator/Crosslinker
|
Cancer
|
DC1, an analogue of the minor groove-binding DNA alkylator CC-1065, is a ADC Cytotoxin. DC1 can be used in synthesis of antibody-drug conjugates for the targeted treatment of cancer.
|
-
- HY-128873
-
|
ADC Cytotoxin
DNA Alkylator/Crosslinker
|
Cancer
|
Duocarmycin GA is an antibody agent conjugates (ADCs) toxin. Duocarmycin is a DNA alkylating agent that binds in the minor groove. Duocarmycin GA can be used against multi-agent resistant cell lines.
|
-
- HY-107770
-
|
ADC Cytotoxin
DNA Alkylator/Crosslinker
|
Cancer
|
Duocarmycin MB is an antibody agent conjugates (ADCs) toxin. Duocarmycin is a DNA alkylating agent that binds in the minor groove. Duocarmycin MB can be used against multi-agent resistant cell lines.
|
-
- HY-P1787
-
|
Amyloid-β
|
Neurological Disease
|
β-Amyloid (4-10) is an epitope for the polyclonal anti-Aβ(1-42) antibody, reduces amyloid deposition in a transgenic Alzheimer disease mouse model .
|
-
- HY-18987
-
|
|
|
Duocarmycin MA is an antibody agent conjugates (ADCs) toxin. Duocarmycin is a DNA alkylating agent that binds in the minor groove. Duocarmycin MA can be used against multi-agent resistant cell lines.
|
-
- HY-129526
-
|
ADC Linker
|
Cancer
|
Mal-PEG3-NHS ester is a noncleavable ADC linker containing a Maleimide group. Mal-PEG3-NHS ester is used for making antibody-drug conjugate .
|
-
- HY-140121
-
|
ADC Linker
|
Cancer
|
m-PEG6-SS-PEG6-methyl is a cleavable 12 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-136133
-
|
ADC Linker
|
Cancer
|
NHS-PEG2-SS-PEG2-NHS is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-133581
-
|
ADC Linker
|
Cancer
|
Mal-PEG3-C1-NHS ester is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-P3149A
-
|
TNF Receptor
|
Inflammation/Immunology
|
LEESGGGLVQPGGSMK TFA, a proteolysis peptide, is a component of Infliximab. LEESGGGLVQPGGSMK TFA can be used for quantitative analysis of Infliximab. Infliximab is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α .
|
-
- HY-139957
-
-
- HY-W125504
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
AEEA-AEEA is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). AEEA-AEEA is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.
|
-
- HY-148474
-
|
ADC Linker
|
Cancer
|
Mal-Val-Ala-PABA-cGAMP is a ADC linker that can be connected to a STING agonist. Mal-Val-Ala-PABA-cGAMP can be used for the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-Y0332C
-
Sodium phosphate dihydrate,≥99.0%
|
Biochemical Assay Reagents
|
Others
|
Phosphoric acid (sodium hydrate),≥99.0% is used as a buffer capacity reagent in molecular biology, biochemistry, and chromatography. For the preparation of biological buffers. It is also used to purify antibodies, as a laxative, and in combination with other sodium phosphates
|
-
- HY-153908
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
SMP-93566 is a kind of antibody-drug conjugates (ADCs) with a low payload shedding rate and has in vivo tumor inhibitory effects on ovarian cancer, gastric cancer, and breast cancer .
|
-
- HY-W877850
-
|
ADC Linker
|
Cancer
|
Mal-C5-N-bis(PEG2-C2-acid) is an ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-Y0332G
-
Potassium phosphate monobasic, for molecular biology
|
Biochemical Assay Reagents
|
Others
|
Potassium dihydrogen phosphate (Potassium phosphate monobasic), for molecular biology, ≥ 99% is used as a buffer capacity reagent in molecular biology, biochemistry, and chromatography. For the preparation of biological buffers. It is also used to purify antibodies, and in combination with other sodium phosphates .
|
-
- HY-130083
-
|
ADC Cytotoxin
DNA Alkylator/Crosslinker
|
Cancer
|
Seco-Duocarmycin TM is a DNA alkylator agent belonging to Duocarmycins family that inhibits DNA synthesis. Seco-Duocarmycin TM is a cytotoxic agent, used as the cytotoxic component in antibody-drug conjugates (ADC) [1].
|
-
- HY-W040135
-
-
- HY-W040246
-
-
- HY-W044078
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
N-Boc-diethanolamine is an Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. N-Boc-diethanolamine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-130546
-
|
ADC Linker
|
Cancer
|
Hydroxy-PEG3-SS-PEG3-alcohol is also a cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-130929
-
|
ADC Linker
|
Cancer
|
β-Estradiol-6-CMO-PEG3-biotin is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-101150
-
|
DNA Alkylator/Crosslinker
ADC Cytotoxin
|
Cancer
|
DGN462, a potent DNA-alkylating agent, shows anti-tumor activity, such as acute myeloid leukemia (AML). DGN462 can be used as a cytotoxic component of antibody-drug conjugates (ADCs) .
|
-
- HY-133574
-
|
ADC Linker
|
Cancer
|
Mal-amido-PEG3-C1-PFP ester is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-W010975
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Fmoc-Lys-OH hydrochloride is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-Lys-OH hydrochloride is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.
|
-
- HY-144880
-
|
ADC Cytotoxin
EGFR
Drug Metabolite
|
Cancer
|
SC209, an ADC cytotoxin extracted from patent WO2021247798, is used in synthesis of anti-EGFR antibody-drug conjugate ADC. SC209 is a metabolite of STRO-002 .
|
-
- HY-150402
-
-
- HY-134669
-
N-Cyclopropene-L-Lysine
|
Others
|
Cancer
|
CypK (N-Cyclopropene-L-Lysine), a cyclopropene derivative of lysine, is efficiently incorporated into antibodies through genetic-code expansion. CypK is a minimal bioorthogonal handle for the creation of stable therapeutic protein conjugates .
|
-
- HY-152861
-
TAK-676 free base
|
STING
|
Cancer
|
Dazostinag (TAK-676 free base) is an agonist of stimulator of interferon genes (STING) protein with antineoplastic activity. Dazostinag can serve as a playload to synthesis antibody-drug conjugates (ADCs) .
|
-
- HY-W591317
-
(R)-NODAG
|
Others
|
Cancer
|
(R)-NODAGA-tris(t-Bu ester) ((R)-NODAG) is a NODAGA derivative. (R)-NODAGA-tris(t-Bu ester) can be used to label peptides, antibodies, etc., and subsequently radiolabeled for PET imaging .
|
-
- HY-W755222
-
(S)-NODAG
|
Others
|
Cancer
|
(S)-NODAGA-tris(t-Bu ester) ((S)-NODAG) is a NODAGA derivative. (S)-NODAGA-tris(t-Bu ester) can be used to label peptides, antibodies, etc., and subsequently radiolabeled for PET imaging .
|
-
- HY-D1849
-
|
Fluorescent Dye
|
Others
|
Cy3B NHS ester is a fluorescent dye compound that is commonly used in biomarking and fluorescent labeling experiments, especially for labeling biomolecules containing amino functional groups (amine groups), such as proteins, antibodies or peptides.
|
-
- HY-W598456
-
|
Others
|
Cancer
|
Brigimadlin intermediate-1 is an intermediate of the E3 ubiquitin protein ligase MDM-2 inhibitor Brigimadlin (HY-152859) and can be used to synthesize Antibody-Drug Conjugates (ADCs) .
|
-
- HY-161022A
-
|
ADC Linker
|
Cancer
|
FL118-C3-O-C-amide-C-NH2 format is an ADC linker for the synthesis of synthetic antibody conjugate active molecules (ADCs)..
|
-
- HY-131157
-
|
ADC Linker
|
Cancer
|
Lys(MMT)-PAB-oxydiacetamide-PEG8-N3 is a cleavable antibody agent conjugate linker used in the synthesis of antibody-drug conjugates (ADCs) . Lys(MMT)-PAB-oxydiacetamide-PEG8-N3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-W731085
-
|
ADC Linker
|
Cancer
|
MC-GGFG-NH-CH2-O-CH2-(s-cyclopropane)-COOH is an ADC linker that can be combined with the cytotoxic Camptothecin (HY-16560) to form an ADC-related drug-linker conjugate (Drug- Linker Conjugates for ADC).MC-GGFG-NH-CH2-O-CH2-cyclopropane-COOH is conjugated to Camptothecin, which can further bind to the antibody Trastuzumab (HY-P9907) to form Antibody-Drug Conjugates (ADCs) .
|
-
- HY-49929
-
|
ADC Linker
|
Cancer
|
MC-GGFG-NH-CH2-O-CH2-cyclopropane-COOH is an ADC linker that can be combined with the cytotoxic Camptothecin (HY-16560) to form ADC-related drug-linker conjugates (Drug-Linker Conjugates for ADC ).MC-GGFG-NH-CH2-O-CH2-cyclopropane-COOH is conjugated to Camptothecin, which can further bind to the antibody Trastuzumab (HY-P9907) to form Antibody-Drug Conjugates (ADCs) .
|
-
- HY-128880
-
-
- HY-128881
-
-
- HY-44149
-
|
ADC Linker
|
Cancer
|
m-C-tri(CH2-PEG1-NHS ester) is a non-cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-130978
-
|
DNA Alkylator/Crosslinker
ADC Cytotoxin
|
Cancer
|
Duocarmycin DM, a DNA minor-groove alkylator, is an antibody agent conjugates (ADCs) toxin. Duocarmycin DM is based on its characteristic curved indole structure and a spirocyclopropylcyclohexadienone electrophile to act anticancer activity .
|
-
- HY-131990
-
|
ADC Linker
|
Cancer
|
MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-145449
-
-
- HY-12454S
-
-
- HY-151752
-
|
ADC Linker
|
Others
|
Mal-AMCHC-N-Propargylamide is a click chemistry reagent containing an azide group. Mal-AMCHC-N-Propargylamide can be a bio-conjugation reagent for antibody-agent-conjugate synthesis using Click-Chemistry .
|
-
- HY-148773
-
|
ADC Linker
|
Cancer
|
MC-Gly-Gly-Phe-Boc is involved in the synthesis of antibody-drug conjugates (ADCs) to Trastuzumab (HY-P9907). MC-Gly-Gly-Phe-Boc can participate in cancer research .
|
-
- HY-113736
-
|
Amino Acid Derivatives
|
Others
|
Glycyllysine is a polypeptide that can be used in the synthesis of antibodies and amino acid type gemini surfactants. Glycyllysine has potential applications in modifying plasmid/gemini/lipid (P/G/L) nanoparticles transport carriers .
|
-
- HY-153345
-
-
- HY-153179
-
|
Drug-Linker Conjugates for ADC
Topoisomerase
|
Cancer
|
Mal-Gly-PAB-Exatecan-D-glucuronic acid can be used for Antibody-Drug Conjugates (ADCs) synthesis. Mal-Gly-PAB-Exatecan-D-glucuronic acid can be used for research of tumor research and diagnosis .
|
-
- HY-153236
-
-
- HY-156693
-
-
- HY-156849
-
|
ADC Cytotoxin
Topoisomerase
|
Cancer
|
Exatecan-methylacetamide-OH (compound 6) is a Exatecan derivative with anticancer effects. Exatecan-methylacetamide-OH is an ADC cytotoxin that can be used to synthesize Antibody-Drug Conjugates (ADCs) (CN112125915A; compound 6) .
|
-
- HY-155471
-
|
Others
|
Others
|
IMP 245 is a symmetric di-HSG bivalent hapten. IMP 245 has low toxicity, high affinity binding to available antibodies and absence of cross reactivity or non-specific binding with body components .
|
-
- HY-46225
-
|
Others
|
Inflammation/Immunology
|
DEX-maleimide is a coupling agent that can be used to synthesize conjugates containing single-domain antibodies (VHH) conjugated with antigens and anti-inflammatory agents. DEX-maleimide can be used for research on autoimmune diseases .
|
-
- HY-161022
-
|
ADC Linker
|
Cancer
|
FL118-C3-O-C-amide-C-NH2 (compound 6a) is an ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-P99366A
-
|
Others
|
Inflammation/Immunology
|
Tezepelumab (anti-TSLP) is human monoclonal antibody (IgG2λ) that binds specifically to TSLP, blocking it from interacting with its heterodimeric receptor. Tezepelumab can be used for the research of severe, uncontrolled asthma .
|
-
- HY-P990029
-
|
PD-1/PD-L1
|
Infection
Cancer
|
Eciskafusp alfa is a programmed cell death 1 (PDCD1, best known as PD-1) cis-targeted IL2v immunocytokine. Eciskafusp alfa preferentially targets antigen-specific stem-like PD-1+ TCF-1+ CD8+ T cells and differentiates them towards a novel population of better effectors. Eciskafusp alfa can be used for the research of cancer and chronic infections .
|
-
- HY-P990088
-
|
VEGFR
PD-1/PD-L1
|
Cardiovascular Disease
|
Sotiburafusp alfa is a bispecific fusion protein, which is a humanized VEGFR-1 extracellular domain fragment (129-228, 1-100 in the current sequence) fused via the peptide linker 101GGSGGSGGSGGSGGS 115 to the N-terminus of the heavy chain (116-564) of a humanized IgG1-kappa anti-human PD-L1 heavy chain variant L352>A, L353>A. Sotiburafusp alfa is also an angiogenesis inhibitor .
|
-
- HY-101070
-
DM1-SMCC
|
Drug-Linker Conjugates for ADC
|
Cancer
|
SMCC-DM1 (DM1-SMCC) is a agent-linker conjugate composed of a potent microtubule-disrupting agent DM1 and a linker SMCC to make antibody agent conjugate (ADC) .
|
-
- HY-W007324
-
|
ADC Linker
|
Cancer
|
Maleimide can be used for production of antibody-drug conjugate (ADC) which is used in cancer research. Maleimide also be leveraged for the preparation of fluorogenic probe, which is mainly used for the specific detection of thiol analytes .
|
-
- HY-128954
-
-
- HY-122907
-
|
Influenza Virus
|
Infection
|
JNJ4796 is an oral active fusion inhibitor of influenza virus, neutralizing influenza A group 1 viruses by inhibiting hemagglutinin (HA)-mediated fusion. JNJ4796 mimics the functionality of the broadly neutralizing antibodies (bnAbs) .
|
-
- HY-117050
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Tos-PEG12 is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). PEG12-Tos is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
|
-
- HY-41541
-
Tos-PEG4
|
|
|
Tetraethylene glycol monotosylate is a cleavable and acylhydrazone-based ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetraethylene glycol monotosylate also can be used as a PROTAC linker that can be used in the synthesis of PROTACs.
|
-
- HY-130818
-
|
ADC Linker
|
Cancer
|
N-(5-Hydroxypentyl)maleimide is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs), such as Gemcitabine-O-Si(di-iso)-O-Mc (HY-130812) ) .
|
-
- HY-78931
-
|
ADC Linker
|
Cancer
|
Boc-Dap-NE is an intermediate in the synthesis of Monomethyl auristatin E (HY-15162), which is an inhibitor of tubulin polymerization. Monomethyl auristatin E can be used to synthesize Antibody-Drug Conjugates (ADCs) as ADC Cytotoxin.
|
-
- HY-131085
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
Desmethyl Vc-seco-DUBA consists a cleavable ADC linker (Desmethyl Vc-seco) and a DNA alkylating agent (DUBA). Desmethyl Vc-seco-DUBA can be used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-141663
-
|
ADC Linker
|
Cancer
|
2',3'-cGAMP-C2-SH is a cyclic di-nucleotide (CDN) that can be conjugated to antibodies or antigen-binding fragments targeting specific antigens in the microenvironment of diseased cells or tissue .
|
-
- HY-108379
-
|
ADC Linker
|
Cancer
|
Boc-C2-Urea-bis(Boc)-C4-Urea-4-phenylacetic acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-148067
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
ΧΜΤ-1519 conjugate-1 (compound 31) is a linker for the HER-2 monoclonal antibody XMT-1519, which can be used to synthesize ADC and increase anti-tumor activity .
|
-
- HY-148127
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
TAM558 is a payload molecule used for the synthesis of OMTX705. OMTX705 is a humanized anti-fibroblast-activating protein (FAP) antibody conjugated to the cytolysin TAM470 (HY-148128), with antitumor activity .
|
-
- HY-151764
-
|
ADC Linker
|
Others
|
N3-D-Orn(Boc)-OH is a Boc-protected pentanoic amino acid derivative, can be used as a click chemistry reagent and has been used to synthesis antibody-drug conjugates (ADC) .
|
-
- HY-131990A
-
|
ADC Linker
|
Cancer
|
MC-Gly-Gly-{D-Phe}-Gly-NH-CH2-O-CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-153907
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
SMP-88480 is an Antibody-Drug Conjugates (ADCs). SMP-88480 is stable in mouse, monkey and human plasma and has in vivo tumor inhibitory effects on ovarian cancer, gastric cancer, and breast cancer .
|
-
- HY-19318G
-
|
ADC Linker
|
Cancer
|
Fmoc-Val-Cit-PAB GMP is a GMP grade Fmoc-Val-Cit-PAB (HY-19318). Fmoc-Val-Cit-PAB is a cleavable antibody-conjugated active molecule (ADC) commonly used linker.
|
-
- HY-D2181
-
|
Fluorescent Dye
|
Others
|
Preactivated PE-Cy5.5 Maleimide is a Preactivated PE-Cy5.5 Maleimide, which is a dye that can be used to label molecules such as dye that can be used to label molecules such as antibodies .
|
-
- HY-102090
-
|
CD28
|
Inflammation/Immunology
|
B7/CD28 interaction inhibitor 1 (copmound 6b) is a potent B7.1-CD28 interaction inhibitor with an IC50 of 50 nM .
|
-
- HY-161005
-
|
Others
|
Metabolic Disease
|
TETS-Methyl benzoate(compound 2j) is a haptendirectly conjugated to the carrier protein via carboxylic acid function using the standard activated ester method .
|
-
- HY-131089
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
MC-VC-PABC-C6-alpha-Amanitin is an antibody agent conjugate consisting of an anticancer toxin alpha-Amanitin (HY-19610) and a monoclonal antibody MC-VC-PABC-C6. Among them, alpha-Amanitin is a potent inhibitor of RNA polymerase IIα. MC-VC-PABC-C6-alpha-Amanitin accurately targets HER2 receptors, specifically recognizes HER2-positive tumor cells. It is widely used in breast cancer and gastric cancer research .
|
-
- HY-111605
-
|
ADC Linker
|
Cancer
|
Macropa-NCS can be coupled with antibodies to form tumor-selective carrier molecules, which can be further combined with radionuclides as specific targeting cancer cell carriers, and is a linker-chelating agent in targeted alpha research (TAT) .
|
-
- HY-126893
-
|
PROTAC Linkers
ADC Linker
|
Cancer
|
Bis-PEG8-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Bis-PEG8-acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-140242
-
|
ADC Linker
|
Cancer
|
NH2-PEG4-Lys(Boc)-NH-(m-PEG24) is a cleavable 28 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-133546
-
|
ADC Linker
|
Cancer
|
Ald-Ph-amido-PEG11-C2-NH2 is a non-cleavable 11 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-65039
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Boc-Hyp-OMe is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Boc-Hyp-OMe is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-76043
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
H-Hyp-OMe hydrochloride is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). H-Hyp-OMe hydrochloride is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[1]<
|
-
- HY-79125
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Fmoc-Hyp(Bom)-OH is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-Hyp(Bom)-OH is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs<
|
-
- HY-I0781
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Boc-Hyp-OH is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Boc-Hyp-OH is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[2]
|
-
- HY-W016429
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
H-cis-Hyp-OMe hydrochloride is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). H-cis-Hyp-OMe hydrochloride is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PR
|
-
- HY-W018154
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
H-Glu-OtBu is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). H-Glu-OtBu is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[2
|
-
- HY-151764A
-
|
ADC Linker
|
Others
|
N3-D-Orn(Boc)-OH (CHA) is a Boc-protected pentanoic amino acid derivative, can be used as a click chemistry reagent and has been used to synthesis antibody-drug conjugates (ADC) .
|
-
- HY-141598
-
-
- HY-15579A
-
Monomethylauristatin F hydrochloride
|
Microtubule/Tubulin
ADC Cytotoxin
|
Cancer
|
MMAF (Monomethylauristatin F) hydrochloride is a potent tubulin polymerization inhibitor and is used as a antitumor agent. MMAF hydrochloride is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) such as Vorsetuzumab mafodotin and SGN-CD19A .
|
-
- HY-12693
-
R(+)-IAA-94
|
Chloride Channel
|
Others
|
R(+)-Methylindazone (R(+)-IAA-94) is a potent indanyloxyacetic acid blocker of epithelial chloride channels. R(+)-Methylindazone inhibits Nef-sdAb19 (single-domain antibody) interaction and binds to negative factor (Nef) .
|
-
- HY-136297
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
DGN549-C consists a cleavable ADC linker valine-alanine (va) and PBD dimer. DGN549 is a novel DNA-alkylating cytotoxic payload and can be used in the synthesis of antibody-agent conjugates (ADCs) .
|
-
- HY-126671
-
|
ADC Linker
|
Cancer
|
Mal-Phe-C4-Val-Cit-PAB is a cleavable ADC linker containing a Maleimide group. Mal-Phe-C4-Val-Cit-PAB is used for making antibody-drug conjugate.
|
-
- HY-126668
-
|
ADC Linker
|
Cancer
|
Mal-PEG4-VC-PAB-DMEA is a cleavable ADC linker containing a Maleimide group. Mal-PEG4-VC-PAB-DMEA is used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-126672
-
|
ADC Linker
|
Cancer
|
Mal-PEG4-Val-Cit-PAB is a cleavable ADC linker containing a Maleimide group. Mal-PEG4-Val-Cit-PAB is used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-130166
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Amino-PEG9-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Amino-PEG9-acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-126886
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Mal-PEG1-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Mal-PEG1-NHS ester is PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
|
-
- HY-117519
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Amino-Tri-(carboxyethoxymethyl)-methane is a cleavable PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Amino-Tri-(carboxyethoxymethyl)-methan is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-126892
-
|
PROTAC Linkers
ADC Linker
|
Cancer
|
Bis-PEG7-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Bis-PEG6-propionic acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-141379
-
|
PROTAC Linkers
ADC Linker
|
Cancer
|
N-Bromoacetyl-β-alanine is an alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs . N-Bromoacetyl-β-alanine is also a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-141596
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
Lys-Nε-SPDB-DM4 is a agent-linker conjugate composed of a potent a tubulin inhibitor DM4 and a linker Lys-Nε-SPDB to make antibody agent conjugate (ADC) .
|
-
- HY-W017755
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
(R)-Azetidine-2-carboxylic acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). (R)-Azetidine-2-carboxylic acid is also a alkyl chain-based PROTAC linker that can be
|
-
- HY-117519A
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Amino-Tri-(carboxyethoxymethyl)-methane hydrochloride is a cleavable PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Amino-Tri-(carboxyethoxymethyl)-methan hydrochloride is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-153013
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
SN38-COOH is used for the synthesis of antibody-drug conjugates (ADCs). SN-38 is an active metabolite of the Topoisomerase I inhibitor Irinotecan. SN-38 inhibits DNA and RNA synthesis .
|
-
- HY-153043
-
|
Drug Metabolite
|
Cancer
|
DM-CO-(CH2)5-SMe is an anticancer agent derived from antibody-drug conjugates (ADC) metabolite with cytotoxicity to H1703, H1975, COLO704 and Colo720E cells .
|
-
- HY-D1821
-
VF 750 Carboxylic acid(free acid)
|
Fluorescent Dye
|
Others
|
Vari Fluor 750 Carboxylic acid (VF 750 Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
|
-
- HY-D1822
-
VF 555 Carboxylic acid(free acid)
|
Fluorescent Dye
|
Others
|
Vari Fluor 555 Carboxylic acid (VF 555 Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
|
-
- HY-D1823
-
VF 647A Carboxylic acid(free acid)
|
Fluorescent Dye
|
Others
|
Vari Fluor 647A Carboxylic acid (VF 647A Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
|
-
- HY-D1828
-
VF 640 Carboxylic acid(free acid)
|
Fluorescent Dye
|
Others
|
Vari Fluor 640 Carboxylic acid (VF 640 Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
|
-
- HY-D1824
-
VF 488 Carboxylic acid(free acid)
|
Fluorescent Dye
|
Others
|
Vari Fluor 488 Carboxylic acid (VF 488 Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
|
-
- HY-D1825
-
VF 532 Carboxylic acid(free acid)
|
Fluorescent Dye
|
Others
|
Vari Fluor 532 Carboxylic acid (VF 532 Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
|
-
- HY-D1826
-
VF 594 Carboxylic acid(free acid)
|
Fluorescent Dye
|
Others
|
Vari Fluor 594 Carboxylic acid (VF 594 Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
|
-
- HY-D1827
-
VF 660 Carboxylic acid(free acid)
|
Fluorescent Dye
|
Others
|
Vari Fluor 660 Carboxylic acid (VF 660 Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
|
-
- HY-D1829
-
VF 568 Carboxylic acid(free acid)
|
Fluorescent Dye
|
Others
|
Vari Fluor 568 Carboxylic acid (VF 568 Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
|
-
- HY-D1830
-
VF 680 Carboxylic acid(free acid)
|
Fluorescent Dye
|
Others
|
Vari Fluor 680 Carboxylic acid (VF 680 Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
|
-
- HY-163025
-
|
Others
|
Inflammation/Immunology
|
Cyanazine-3-mercaptopropanoic acid (compound 6), a coating hapten, is a stable carrier-hapten complex. Polyclonal antibody obtained were with a high titer, with the IC50 of 10.2 ng/mL for Cyanazine-3-mercaptopropanoic acid .
|
-
- HY-160247
-
|
Drug-Linker Conjugates for ADC
|
Others
|
Boc-Lys-PEG8-N-bis(D-glucose) (compound 89-5) is a drug linker that can be used in the synthesis of antibody-drug conjugates (ADCs) extracted from patent WO2023280227A2 .
|
-
- HY-136261
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
DM1-(PEG)4-DBCO is a agent-linker conjugate composed of a potent microtubulin inhibitor DM1 and a linker DBCO-PEG4-Ahx to make antibody agent conjugate (ADC). Mertansine (DM1) is a microtubulin inhibitor and is an antibody-conjugatable maytansinoid that is developed to overcome systemic toxicity associated with maytansine and to enhance tumor-specific delivery. DM1-PEG4-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-136260
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
DBCO-PEG4-Ahx-DM1 is a agent-linker conjugate composed of a potent microtubulin inhibitor DM1 and a linker DBCO-PEG4-Ahx to make antibody agent conjugate (ADC). Mertansine (DM1) is a microtubulin inhibitor and is an antibody-conjugatable maytansinoid that is developed to overcome systemic toxicity associated with maytansine and to enhance tumor-specific delivery. DBCO-PEG4-Ahx-DM1 is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-41189
-
|
ADC Linker
|
Cancer
|
Fmoc-Val-Cit-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-Val-Cit-PAB-PNP has superior plasma stability comparable to that of non-cleavable linkers .
|
-
- HY-128915
-
|
DNA Alkylator/Crosslinker
ADC Cytotoxin
|
Cancer
|
Duocarmycin DM free base, a DNA minor-groove alkylator, is an antibody agent conjugates (ADCs) toxin. Duocarmycin DM free base is based on its characteristic curved indole structure and a spirocyclopropylcyclohexadienone electrophile to act anticancer activity .
|
-
- HY-120237
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
m-PEG7-Amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG7-Amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-130408
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
m-PEG6-Amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG6-Amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-130571
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
m-PEG9-Amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG9-Amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-42745
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
m-PEG2-Tos is a uncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). m-PEG2-Tos is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
|
-
- HY-W008429
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
m-PEG2-Amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG2-Amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-W018174
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
m-PEG3-Amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG3-Amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-W040214
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
m-PEG4-Amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG4-Amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-116186
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
m-PEG5-MS is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG5-MS is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-117031
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
m-PEG8-MS is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG8-MS is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-130457
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
m-PEG4-MS is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG4-MS is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-130528
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
m-PEG7-MS is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG7-MS is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-130410
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Bis-PEG6-NHS ester is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Bis-PEG6-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-141167
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
TCO-PEG4-NHS ester is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. TCO-PEG4-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-141170
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
TCO-PEG12-NHS ester is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. TCO-PEG12-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-12489
-
Acid Red 112
|
Fluorescent Dye
|
Others
|
Ponceau S (Acid Red 112) is a non-specific protein dye commonly used as a stain for Western blot. Ponceau S is used in an acidic aqueous solution that is compatible with antibody-antigen binding and dyes the proteins on the membrane red .
|
-
- HY-145397
-
|
ADC Cytotoxin
Topoisomerase
|
Cancer
|
(4-NH2)-Exatecan, a topoisomerase inhibitor, is a derivative of Exatecan. (4-NH2)-Exatecan can be used in the synthesis of antibody-drug conjugates (ADCs) (US20200306243A1, compound A) .
|
-
- HY-W017882
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Boc-trans-D-Hyp-OMe is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Boc-trans-D-Hyp-OMe is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.
|
-
- HY-W019213
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
cis-4-Hydroxy-L-proline hydrochloride is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). cis-4-Hydroxy-L-proline hydrochloride is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
|
-
- HY-40144
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Azetidin-3-ol hydrochloride is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Azetidin-3-ol hydrochloride is also a alkyl chain-based PROTAC linker that can be used in the synthes PROTAC.
|
-
- HY-148128
-
|
Microtubule/Tubulin
ADC Cytotoxin
|
Cancer
|
TAM470 is a novel cytolysin, inhibiting tubulin polymerization and microtubule depolymerization. TAM470 can be used in the synthesis of OMTX705 as payload molecule, OMTX705 is a novel FAP-targeting antibody-drug conjugates (ADCs) with antitumor activity .
|
-
- HY-D0860
-
|
Biochemical Assay Reagents
|
Others
|
Tricine is widely used as a buffer in protein electrophoresis, nucleic acid analysis, and immunology, which can help adjust pH and stabilize chemical reactions. In addition, the compound can also be used in research in certain medical fields, such as in antibody detection and drug screening.
|
-
- HY-153196
-
|
ADC Linker
|
Others
|
Tetra-O-acetyl-β-D-galactopyranosyl-Ph-CH2-(4-nitrophenyl)carbonate-Fmoc (Example 2.28.6) is an ADC linker that can be used to synthesize antibody-conjugated active molecules (ADCs) .
|
-
- HY-400676
-
|
ADC Linker
|
Cancer
|
NH2-PEG4-GGFG-CH2-O-CH2-Cbz is a reactant for the synthesis of ADC linker and is used to synthesize Antibody-Drug Conjugates (ADCs) .
|
-
- HY-156174
-
|
Toll-like Receptor (TLR)
ADC Cytotoxin
|
Cancer
|
E104 (compound 1) is a potent and selective TLR7 agonist. E104 can be delivered by antibody-drug conjugate (ADC) technology to elicit potent anticancer activity. E104 induces the activation of mouse macrophages and hPBMCs .
|
-
- HY-79255
-
|
ADC Cytotoxin
Microtubule/Tubulin
|
Cancer
|
Fmoc-MMAF-OMe is an anticancer agent and tubulin polymerization inhibitor with an Fmoc protecting group. The active ingredient of Fmoc-MMAF-OMe, MMAF (HY-15579), is the cytotoxic (ADC Cytotoxin) component of classic antibody drug conjugates (ADCs) .
|
-
- HY-163010
-
|
Biochemical Assay Reagents
|
Others
|
Dicamba-propionic acid (DCa3) is a heterologous hapten that can be used to develop high-affinity monoclonal antibodies (mAb) against Dicamba. The Dicamba-propionic acid- developed mAb can be used to determine the residual amount of Dicamba in environmental water samples .
|
-
- HY-W047496
-
|
Others
|
Infection
|
AN-12-H5 intermediate-2 is an intermediate of the viral inhibitor AN-12-H5 (HY-120900) and can be used to synthesize Antibody-Drug Conjugates (ADCs).
|
-
- HY-W451820
-
|
Others
|
Infection
|
AN-12-H5 intermediate-3 is an intermediate of the viral inhibitor AN-12-H5 (HY-120900) and can be used to synthesize Antibody-Drug Conjugates (ADCs).
|
-
- HY-W457085
-
|
PD-1/PD-L1
|
Cancer
|
PD-1/PD-L1-IN-29 intermediate-2 is an intermediate of PD-1/PD-L1 inhibitors and can be used to synthesize Antibody-Drug Conjugates (ADCs).
|
-
- HY-48934
-
|
PD-1/PD-L1
|
Cancer
|
PD-1/PD-L1-IN-29 intermediate-1 is an intermediate of PD-1/PD-L1 inhibitors and can be used to synthesize Antibody-Drug Conjugates (ADCs).
|
-
- HY-15579
-
Monomethylauristatin F
|
Microtubule/Tubulin
ADC Cytotoxin
|
Cancer
|
MMAF (Monomethylauristatin F) is a potent tubulin polymerization inhibitor and is used as a antitumor agent. MMAF (Monomethylauristatin F) is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) such as vorsetuzumab mafodotin and SGN-CD19A .
|
-
- HY-D1049
-
6-((2,4-Dinitrophenyl)amino)hexanoic acid
|
Fluorescent Dye
|
Metabolic Disease
|
DNP-X acid (6-((2,4-Dinitrophenyl)amino)hexanoic acid), an amine-reactive building block for developing a probe, can be recognized by anti-DNP antibodies. DNP-X acid is also an excellent amine-reactive FRET quencher paired with Trp or Tyr.
|
-
- HY-15579B
-
Monomethylauristatin F sodium
|
Microtubule/Tubulin
ADC Cytotoxin
|
Cancer
|
MMAF sodium (Monomethylauristatin F sodium) is a potent tubulin polymerization inhibitor and is used as a antitumor agent. MMAF sodium (Monomethylauristatin F sodium) is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) such as Vorsetuzumab mafodotin and SGN-CD19A .
|
-
- HY-126673
-
|
ADC Linker
|
Cancer
|
Mal-C2-Gly3-EDA is a cleavable ADC linker containing a Maleimide group. Mal-C2-Gly3-EDA is used for making antibody-drug conjugate.
|
-
- HY-126674
-
|
ADC Linker
|
Cancer
|
Mal-Phe-C4-Val-Cit-PAB-DMEA is a cleavable ADC linker containing a Maleimide group. Mal-Phe-C4-Val-Cit-PAB-DMEA is used for making antibody-drug conjugate.
|
-
- HY-126958
-
-
- HY-126960
-
-
- HY-W040222
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
m-PEG11-Amino is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). m-PEG11-Amine is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-D1111
-
|
Fluorescent Dye
|
Others
|
TFAX 568, SE is an orange fluorescent dye and exhibits pH-insensitivity over a very broad range (pH in the 4-10). TFAX 568, SE yields exceptionally bright, photostable conjugates with proteins or antibodies (such as goat anti-mouse IgG) .
|
-
- HY-131833A
-
|
ADC Linker
|
Cancer
|
Fmoc-Gly-Gly-D-Phe-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-Gly-Gly-D-Phe-OH is the D-isomer of Fmoc-Gly-Gly-Phe-OH (HY-131833).
|
-
- HY-W011277
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Fmoc-azetidine-3-carboxylic acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-azetidine-3-carboxylic acid is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.
|
-
- HY-D1619
-
|
Fluorescent Dye
|
Others
|
Cyanine3 hydrazide dichloride is a carbonyl reactive dye. Cyanine3 hydrazide dichloride allows the labelling of various carbonyl-containing molecules such as antibodies and other glycoproteins after oxidation by periodate, proteins or reducing sugars after oxidative stress or deamination .
|
-
- HY-400677
-
|
ADC Linker
|
Cancer
|
NH2-PEG4-GGFG-NH-CH2-O-CH2COOH is a reactant for the synthesis of ADC linkers and is used to synthesize Antibody-Drug Conjugates (ADCs) .
|
-
- HY-131833G
-
|
ADC Linker
|
Cancer
|
Fmoc-Gly-Gly-Phe-OH GMP is a GMP grade Fmoc-Gly-Gly-Phe-OH (HY-131833). Fmoc-Gly-Gly-Phe-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-160497
-
|
PROTAC-Linker Conjugates for PAC
|
Cancer
|
MC-(β-Ala)-PABC-(β-D-GlcUA)-amide-PEG1-CH2-CC-885 (Comp Ie) is a neodegrader conjugate, can be used in the synthesis of antibody neoDegrader conjugate (AnDC) .
|
-
- HY-66019
-
Fluorescein 5-isothiocyanate
|
Fluorescent Dye
|
Others
|
FITC (Fluorescein Isothiocyanate), is one of the green fluorescein derivatives widely used in biology. FITC has the characteristics of high absorptivity, excellent fluorescence quantum yield and good water solubility. The isothiocyanate group of FITC can be combined with amino, sulfhydryl, imidazole, tyrosyl, carbonyl and other groups on the protein, so as to achieve protein labeling including antibodies and lectins. In addition to its use as a protein marker, FITC can also be used as a fluorescent protein tracer to rapidly identify pathogens by labeling antibodies, or for microsequencing of proteins and peptides (HPLC). The maximum excitation wavelength of FITC is 494 nm. Once excited, it fluoresces yellow-green at a maximum emission wavelength of 520 nm.
|
-
- HY-15162
-
MMAE; SGD-1010; Vedotin
|
Microtubule/Tubulin
ADC Cytotoxin
Apoptosis
|
Cancer
|
Monomethyl auristatin E (MMAE; SGD-1010) is a synthetic derivative of dolastatin 10 and functions as a potent mitotic inhibitor by inhibiting tubulin polymerization. MMAE is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) to treat several different cancer types.
|
-
- HY-100216
-
SPDP
4 Publications Verification
SPDP Crosslinker
|
ADC Linker
|
Cancer
|
SPDP (SPDP Crosslinker) is a short-chain crosslinker for amine-to-sulfhydryl conjugation via NHS-ester and pyridyldithiol reactive groups that form cleavable (reducible) disulfide bonds with cysteine sulfhydryls. It is a glutathione cleavable ADC linker used for the antibody-drug conjugates (ADCs) .
|
-
- HY-44234A
-
|
ADC Linker
|
Cancer
|
Fmoc-Gly-Gly-D-Phe-OtBu is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-Gly-Gly-D-Phe-OtBu is the R-isomer of Fmoc-Gly-Gly-Phe-OtBu (HY-44234) .
|
-
- HY-130328
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
NH-bis-PEG2 is a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). NH-bis-PEG2 is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
|
-
- HY-116270
-
|
ADC Linker
|
Cancer
|
DBCO-Maleimide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-Maleimide is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-42973
-
|
ADC Linker
|
Cancer
|
DBCO-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-NHS ester is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-W000423
-
|
ADC Linker
|
Cancer
|
DBCO-amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-amine is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-117009
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Bis-PEG9-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Bis-PEG9-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-126889
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Bis-PEG5-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Bis-PEG5-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-126890
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Bis-PEG7-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Bis-PEG7-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-130824
-
|
PROTAC Linkers
ADC Linker
|
Cancer
|
Bis-PEG10-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Bis-PEG10-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-130825
-
|
PROTAC Linkers
ADC Linker
|
Cancer
|
Bis-PEG13-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Bis-PEG13-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-130826
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Bis-PEG17-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Bis-PEG17-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-130827
-
|
PROTAC Linkers
ADC Linker
|
Cancer
|
Bis-PEG21-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Bis-PEG21-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-130828
-
|
PROTAC Linkers
ADC Linker
|
Cancer
|
Bis-PEG25-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Bis-PEG25-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-141385
-
3-(2-Bromoacetamido)propanoic acid NHS ester
|
PROTAC Linkers
ADC Linker
|
Cancer
|
N-Succinimidyl 3-(Bromoacetamido)propionate is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . N-Succinimidyl 3-(Bromoacetamido)propionate is also a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-79584
-
|
ADC Linker
|
Cancer
|
Propargyl-Tos is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-Tos is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-139292
-
|
Amino Acid Derivatives
|
Cancer
|
Fmoc-NH-PEG6-alcohol is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-NH-PEG6-alcohol is extracted from patent WO2016030791, example comp 91 .
|
-
- HY-33615
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Methyl azetidine-3-carboxylate hydrochloride is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Methyl azetidine-3-carboxylate hydrochloride is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs<
|
-
- HY-W034599
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Boc-C14-COOH is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Boc-C14-COOH is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.
|
-
- HY-W045598
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Boc-C16-COOH is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Boc-C16-COOH is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs
|
-
- HY-W045822
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Fmoc-Lys(Pal-Glu-OtBu)-OH is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-Lys(Pal-Glu-OtBu)-OH is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.
|
-
- HY-Y0530
-
|
|
|
Azetidine-3-carboxylic acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Azetidine-3-carboxylic acid is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[2
|
-
- HY-D1885
-
|
Fluorescent Dye
|
Others
|
Vari Fluor 647 Carboxylic acid free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivative is an inactive labeled fluorescent dye, which can be used to label proteins, antibodies, polysaccharides. The use of Vari Fluor carboxylic acid derivatives requires carboxylic acid activation.
|
-
- HY-156617
-
|
ADC Cytotoxin
Topoisomerase
|
Cancer
|
Cyclopropaneacetamide-Exatecan (Compound 2-A) is an ADC Cytotoxin and an Exatecan analogue. Cyclopropaneacetamide-Exatecan can be used in the synthesis of ADC such as anti-B7H3 antibody-Exatecan analogue conjugate (compound ADC-2) .
|
-
- HY-N3622
-
(6S,9S)-Roseoside
|
Others
|
Inflammation/Immunology
|
Corchoionoside C ((6S,9S)-Roseoside), an ionone glucoside, can be isolated from Capparis spinosa. Corchoionoside C inhibits the antigen-antibody reaction induced histamine release from rat peritoneal exudate cells .
|
-
- HY-D2267
-
|
Fluorescent Dye
|
Others
|
JF646-Hoechst is a fluorescent red DNA probe that is an ideal substitute for large oligonucleotide-coupled antibodies used in PAINT experiments, especially for bacterial studies. JF646-Hoechst excitation/emission maximum =655/670 nm .
|
-
- HY-145449A
-
-
- HY-17422
-
Aciclovir; Acycloguanosine
|
HSV
Apoptosis
Antibiotic
Bacterial
|
Infection
Cancer
|
Acyclovir (Aciclovir) is a potent, orally active antiviral agent. Acyclovir has antiherpetic activity with IC50 values of 0.85 μM and 0.86 μM for HSV-1 and HSV-2, respectively. Acyclovir induces cell cycle perturbation and apoptosis. Acyclovir prevents bacterial infections during induction therapy for acute leukaemia .
|
-
- HY-17422A
-
Aciclovir sodium; Acycloguanosine sodium
|
HSV
Apoptosis
Antibiotic
Bacterial
|
Infection
Cancer
|
Acyclovir (Aciclovir) sodium is a potent, orally active antiviral agent. Acyclovir sodium has antiherpetic activity with IC50 values of 0.85 μM and 0.86 μM for HSV-1 and HSV-2, respectively. Acyclovir sodium induces cell cycle perturbation and apoptosis. Acyclovir sodium prevents bacterial infections during induction therapy for acute leukaemia .
|
-
- HY-15941
-
Fluorescein 5(6)-isothiocyanate; Fluorescein isothiocyanate 5- and 6- isomers
|
Fluorescent Dye
|
Others
|
5(6)-FITC (Fluorescein 5(6)-isothiocyanate) is an amine-reactive derivative of fluorescein dye that has wide-ranging applications as a label for antibodies and other probes, for use in fluorescence microscopy, flow cytometry and immunofluorescence-based assays such as Western blotting and ELISA.
|
-
- HY-126686
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
Mal-Phe-C4-VC-PAB-MMAE is made by MMAE conjugated to Mal-Phe-C4-VC-PAB linker. Monomethyl auristatin E (MMAE), a potent tubulin inhibitor, is a toxin payload in antibody agent conjugate.
|
-
- HY-117104
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Hydroxy-PEG4-acid is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Hydroxy-PEG4-acid is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-120845
-
-
- HY-130165
-
-
- HY-126851
-
|
ADC Linker
|
Cancer
|
Fluorescein-DBCO is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Fluorescein-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-141382
-
|
PROTAC Linkers
ADC Linker
|
Cancer
|
Bromoacetamido-PEG4-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Bromoacetamido-PEG4-acid is also a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-136095
-
|
ADC Linker
|
Cancer
|
Tetrazine-biotin is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-biotin is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
-
- HY-136104
-
|
ADC Linker
|
Cancer
|
Methyltetrazine-Maleimide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Methyltetrazine-Maleimide is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
-
- HY-131057
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
Mc-VC-PAB-SN38 consists a cleavable ADC linker (Mc-VC-PAB) and a DNA topoisomerase I inhibitor (SN38). Mc-VC-PAB-SN38 can be used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-D1110
-
|
Fluorescent Dye
|
Others
|
TFAX 594,SE is a red fluorescent dye and exhibits pH-insensitivity over a very broad range (pH in the 4-10). TFAX 594,SE yields exceptionally bright, photostable conjugates with proteins or antibodies (such as goat anti-mouse IgG) .
|
-
- HY-148245
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
OH-Glu-Val-Cit-PAB-MMAE consists a cleavable ADC linker (OH-Glu-Val-Cit-PAB) and a potent tubulin inhibitor (MMAE). SuO-Glu-Val-Cit-PAB-MMAE can be used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-108905
-
Human IGF-I; FK 780
|
IGF-1R
|
Metabolic Disease
|
Mecasermin (Human IGF-I; FK 780) is a recombinant human insulin-like growth factor I (IGF-I). Mecasermin has the potential for the study of the growth failure of growth hormone (GH) insensitivity caused by GH receptor defects or GH-inhibiting antibodies .
|
-
- HY-P4810
-
T140
|
CXCR
|
Infection
|
Polyphemusin II-Derived Peptide (T140), a CXCR4 inhibitor, shows high inhibitory activity against HIV-1 entry and the inhibitory effect on the binding of an anti-CXCR4 monoclonal antibody (12G5) to CXCR4 .
|
-
- HY-153672
-
|
ADC Linker
|
Cancer
|
Amine-PEG3-Lys(PEG3-N3)-PEG3-N3 (compound 5) is a branched linker that can be used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-156810
-
|
ADC Linker
|
Cancer
|
Fmoc-PEG4-GGFG-CH2-O-CH2-Cbz is a cleavable ADC linker containing 4 units of PEG, which can be used to synthesize active antibody conjugation molecules (ADC) .
|
-
- HY-79253
-
|
ADC Cytotoxin
|
Cancer
|
MMAF intermediate 1 is an intermediate in the synthesis of MMAF (HY-15579). MMAF (Monomethylauristatin F) is a potent inhibitor of tubulin polymerization and the cytotoxic (ADC Cytotoxin) component of classic antibody drug conjugates (ADCs), such as Vorsetuzumab mafodotin and SGN-CD19A .
|
-
- HY-79254
-
|
ADC Cytotoxin
|
Cancer
|
MMAF intermediate 2 is an intermediate for the synthesis of MMAF (HY-15579). MMAF (Monomethylauristatin F) is a potent inhibitor of tubulin polymerization and the cytotoxic (ADC Cytotoxin) component of classic antibody drug conjugates (ADCs), such as Vorsetuzumab mafodotin and SGN-CD19A .
|
-
- HY-15578
-
McMMAF
4 Publications Verification
Maleimidocaproyl monomethylauristatin F
|
Drug-Linker Conjugates for ADC
|
Cancer
|
McMMAF is a protective group (maleimidocaproyl)-conjugated MMAF, which is a potent tubulin polymerization inhibitor. McMMAF can be used as a agent-linker for antibody-drug conjugates (ADC). McMMAF is uncleavable, and must be internalized and degraded within a cell, releasing cysteine-McMMAF as the active agent .
|
-
- HY-128945
-
|
ADC Linker
|
Inflammation/Immunology
Cancer
|
CL2A is a claevable complicated PEG8- and triazole-containing PABC-peptide-mc linker. CL2A is cleavable through pH sensitivity, giving rise to bystander effect, and binds the antibody at a cysteine residue via a disulfide bond. Labetuzumab govitecan used this linker .
|
-
- HY-126517
-
|
ADC Linker
|
Cancer
|
Cyclooctyne-O-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Cyclooctyne-O-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-126518
-
|
ADC Linker
|
Cancer
|
Cyclooctyne-O-PFP ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Cyclooctyne-O-PFP ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-W019799
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Amino-PEG8-Boc is a cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Amino-PEG8-Boc is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-120702
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
N-Boc-PEG5-bromide is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. N-Boc-PEG5-bromide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-123687
-
|
ADC Linker
|
Cancer
|
DBCO-Sulfo-NHS ester sodium is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-Sulfo-NHS ester (sodium) is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-130503
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
N-Boc-PEG2-bromide is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. N-Boc-PEG2-bromide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-130505
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
N-Boc-PEG7-alcohol is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. N-Boc-PEG7-alcohol is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-W006445
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
N-Boc-PEG3-bromide is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. N-Boc-PEG3-bromide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-W046471
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
N-Boc-PEG4-bromide is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. N-Boc-PEG4-bromide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-W071583
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
N-Boc-PEG9-alcohol is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. N-Boc-PEG9-alcohol is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-W071584
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
N-Boc-PEG6-alcohol is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. N-Boc-PEG6-alcohol is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-140500
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
m-PEG10-acid is a non-cleavable 10 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . m-PEG10-acid is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-140501
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
m-PEG11-acid is a non-cleavable 11 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . m-PEG11-acid is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-140306
-
|
ADC Linker
|
Cancer
|
Mal-Sulfo-DBCO is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Mal-Sulfo-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-135977
-
|
ADC Linker
|
Cancer
|
DBCO-SS-aldehyde is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-SS-aldehyde is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-135972
-
|
ADC Linker
|
Cancer
|
BCN-SS-amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-SS-amine is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-135973
-
|
ADC Linker
|
Cancer
|
BCN-SS-NHS is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-SS-NHS is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-D1113
-
|
Fluorescent Dye
|
Others
|
TFAX 488,TFP is a green fluorescent dye and exhibits pH-insensitivity over a very broad range (pH in the 4-10). TFAX 488,TFP yields exceptionally bright, photostable conjugates with proteins or antibodies (such as goat anti-mouse IgG, streptavidin) .
|
-
- HY-138506
-
|
ADC Linker
|
Cancer
|
DBCO-S-S-acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-S-S-acid is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-76105
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
D-Proline, 4-hydroxy-, methyl ester hydrochloride is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). D-Proline, 4-hydroxy-, methyl ester hydrochloride is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[2
|
-
- HY-77475
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
1-Cbz-3-Hydroxyazetidine is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). 1-Cbz-3-Hydroxyazetidine is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.
|
-
- HY-76104
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
cis-4-Hydroxy-D-proline hydrochloride is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). cis-4-Hydroxy-D-proline hydrochloride is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.
|
-
- HY-W003511
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
tans-4-Hydroxy-D-proline hydrochloride is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). tans-4-Hydroxy-D-proline hydrochloride is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PR
|
-
- HY-W052600
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Ethyl azetidine-3-carboxylate hydrochloride is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Ethyl azetidine-3-carboxylate hydrochloride is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[2]
|
-
- HY-152916
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
mp-dLAE-PABC-MMAE is a agent-linker conjugate for ADC. mp-dLAE-PABC-MMAE contains a potent tubulin inhibitor Monomethyl auristatin E (HY-15162). mp-dLAE-PABC-MMAE can be used to synthesis antibody-drug conjugates (ADCs) .
|
-
- HY-P10056
-
Human ezrin peptide (324-337)
|
HIV
|
Infection
|
HEP-1 (Human ezrin peptide (324-337)) is an orally active peptide with anti-HIV activity. HEP-1 enhances antibody titers generated by hepatitis B vaccination. HEP-1 has the potential to be studied against viral infections .
|
-
- HY-D2182
-
|
Fluorescent Dye
|
Others
|
Preactivated PE-Cy5 Maleimide is a sulfhydryl reactive dye that reacts with free sulfhydryl groups on proteins. Preactivated APC-Cy5.5 Maleimide binds easily to proteins or antibodies, and does not change the spectral characteristics of APC-Cy/YF after activation.
|
-
- HY-120761
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Amino-PEG10-OH is non-cleavable 10 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Amino-PEG10-OH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-130298
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Amino-PEG11-OH is non-cleavable 11 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Amino-PEG11-OH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-126942
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Amino-PEG6-alcohol is a non-cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Amino-PEG6-alcohol is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-133066
-
|
PROTAC Linkers
ADC Linker
|
Inflammation/Immunology
Cancer
|
m-PEG6-NHS ester is a non-cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). m-PEG6-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs.
|
-
- HY-141395
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
m-PEG4-Boc is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . m-PEG4-Boc is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-136032
-
|
ADC Linker
|
Cancer
|
Tetrazine-SS-NHS is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-SS-NHS is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
-
- HY-136033
-
|
ADC Linker
|
Cancer
|
Methyltetrazine-SS-NHS is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Methyltetrazine-SS-NHS is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
-
- HY-136039
-
|
ADC Linker
|
Cancer
|
TCO-SS-amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . TCO-SS-amine is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
|
-
- HY-130928
-
|
ADC Linker
|
Cancer
|
Tetrazine-Ph-OPSS is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-Ph-OPSS is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
-
- HY-136031
-
|
ADC Linker
|
Cancer
|
Tetrazine-SS-Biotin is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-SS-Biotin is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
-
- HY-W046348
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
22-(tert-Butoxy)-22-oxodocosanoic acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). 22-(tert-Butoxy)-22-oxodocosanoic acid is also a alkyl chain-based PROTAC linker that can be used in t
|
-
- HY-147281
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
BAY 1135626 is used to synthesize BAY 1129980, and use to anti-tumor research. BAY 1129980 is a Auristatin-based anti-C4.4A (LYPD3) antibody–agent conjugate (ADC), is used to non–small cell lung cancer (NSCLC) research .
|
-
- HY-N10510
-
A-Tetrasaccharide
|
Others
|
Others
|
Blood group A antigen tetraose type 5 (A-Tetrasaccharide) is a tetrasaccharide and a blood group specific oligosaccharide, inhibits the binding of anti-A antibody to blood group A substance. Blood group A antigen tetraose type 5 can be isolated from polar bear milk samples .
|
-
- HY-151696
-
|
ADC Linker
|
Others
|
TCO-PEG3-maleimide (TCO-PEG3-NEM) is a click chemistry reagent. TCO-PEG3-maleimide efficiently binds TCO (trans-cyclooctene) moiety to thiol-containing molecules (such as antibodies, cysteine-containing peptides) .
|
-
- HY-P4029
-
|
HCV
|
Infection
|
HCV-1 e2 Protein (484-499) is a peptide consisting of 16 amino acids. HCV-1 e2 Protein (484-499) is derived from the envelope 2 protein of hepatitis C virus in the sera from individuals with antibodies to HCV .
|
-
- HY-D2180
-
|
Fluorescent Dye
|
Others
|
Preactivated APC-Cy5.5 Maleimide is a sulfhydryl reactive dye that reacts with free sulfhydryl groups on proteins. Preactivated APC-Cy5.5 Maleimide binds easily to proteins or antibodies, and does not change the spectral characteristics of APC-Cy/YF after activation.
|
-
- HY-B0199
-
RS 61443; TM-MMF
|
Drug Metabolite
Apoptosis
Endogenous Metabolite
Bacterial
|
Cancer
|
Mycophenolate mofetil (RS 61443) is the morpholinoethylester proagent of Mycophenolic acid. Mycophenolate mofetil inhibits de novo purine synthesis via the inhibition of inosine monophosphate dehydrogenase (IMPDH). Mycophenolate mofetil shows selective lymphocyte antiproliferative effects involve both T and B cells, preventing antibody formation .
|
-
- HY-15583
-
|
ADC Cytotoxin
Microtubule/Tubulin
|
Cancer
|
Auristatin F is a potent cytotoxin in antibo-conjugated agents and an analogue of MMAF. Auristatin F is a potent microtubule inhibitor and vascular damaging agent (VDA). Auristatin F inhibits cell division by preventing tubulin aggregation.Auristatin F can be used in antibody-drug conjugates (ADC) .
|
-
- HY-126511
-
|
ADC Linker
|
Cancer
|
Propargyl-C1-NHS ester is a nonclaevable linker for antibody-agent-conjugation (ADC). Propargyl-C1-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-126512
-
|
ADC Linker
|
Cancer
|
Propargyl-C2-NHS ester is a nonclaevable linker for antibody-agent-conjugation (ADC). Propargyl-C2-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-126918
-
|
PROTAC Linkers
ADC Linker
|
Cancer
|
THP-PEG6-OH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . THP-PEG6-OH is also a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-W008005
-
|
PROTAC Linkers
ADC Linker
|
Cancer
|
Amino-PEG4-alcohol is a PEG-based PROTAC linker can be used in the synthesis of PROTACs . Amino-PEG4-alcohol is also a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-130449
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
N-Boc-N-bis(PEG4-OH) is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. N-Boc-N-bis(PEG4-OH) is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-130810
-
|
ADC Linker
|
Cancer
|
DBCO-Sulfo-Link-biotin is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-Sulfo-Link-biotin is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-124123
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Aminooxy-PEG4-alcohol is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Aminooxy-PEG4-alcohol is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-126951
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Aminooxy-PEG2-alcohol is a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Aminooxy-PEG2-alcohol is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-130222
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Mal-PEG2-Val-Cit-PAB-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Mal-PEG2-Val-Cit-PAB-OH also can be used as a PROTAC linker that can be used in the synthesis of PROTACs.
|
-
- HY-21577
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Tris[[2-(tert-butoxycarbonyl)ethoxy]methyl]methylamine is a cleavable PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Amino-Tri-(t-butoxycarbonylethoxymethyl)-methane is also a PEG/Alkyl/ether-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-W042654
-
-
- HY-140226
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
m-PEG10-amine is a non-cleavable 10 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . m-PEG10-amine is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-140227
-
|
PROTAC Linkers
ADC Linker
|
Cancer
|
m-PEG12-amine is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . m-PEG12-amine is also a non-cleavable 12 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-141220
-
|
PROTAC Linkers
ADC Linker
|
Cancer
|
m-PEG12-OH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . m-PEG12-OH is also a non-cleavable 12 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-114995
-
-
- HY-130935
-
|
ADC Linker
|
Cancer
|
DBCO-Val-Cit-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-Val-Cit-OH is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-D1114
-
|
Fluorescent Dye
|
Others
|
TFAX 488,SE dilithium is a green fluorescent dye and exhibits pH-insensitivity over a very broad range (pH in the 4-10). TFAX 488,SE dilithium yields exceptionally bright, photostable conjugates with proteins or antibodies (such as goat anti-mouse IgG, streptavidin) .
|
-
- HY-135122
-
|
ADC Cytotoxin
DNA Alkylator/Crosslinker
|
Cancer
|
DC10SMe is a DNA alkylator, can be used in the synthesis of antibody-drug conjugate (ADC). DC10SMe exhibits IC50s of 15 pM, 12 pM, and 12 pM for Ramos, Namalwa, and HL60/s cancer cells, respectively .
|
-
- HY-131056
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
Gly3-VC-PAB-MMAE consists a cleavable ADC linker (Gly3-VC-PAB) and a potent tubulin inhibitor (MMAE). Gly3-VC-PAB-MMAE can be used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-126350
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
CL2-SN-38 is a cleavable linker-based agent-Linker conjugate, it can conjugate with the anti-Trop-2-humanized antibody hRS7. CL2-SN-38 can be used for the reasearch of cancer .
|
-
- HY-W006629
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
tans-4-Hydroxy-D-proline methyl ester hydrochloride is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). tans-4-Hydroxy-D-proline methyl ester hydrochloride is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.
|
-
- HY-W034597
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
20-(tert-Butoxy)-20-oxoicosanoic acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). 20-(tert-Butoxy)-20-oxoicosanoic acid is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs
|
-
- HY-40142
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
1-N-Boc-3-hydroxyazetidine is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). 1-N-Boc-3-hydroxyazetidine is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs
|
-
- HY-148459
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
ATAC21, a linker-immune-stimulatory compound that can be formed by conjugating a noncleavable maleimide-PEG4 linker containing a succinimide group with an immune- stimulatory compound. ATAC21 can be combined with SBT-040 (anti-CD40 antibody) to form a conjugate .
|
-
- HY-148819
-
|
ADC Cytotoxin
Topoisomerase
|
Cancer
|
NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT (compound I) is a topoisomerase I inhibitor, which can be delivered to cells through conjugated antibody targeting, and has good ADC activity in vivo and in vitro .
|
-
- HY-148820
-
|
Drug-Linker Conjugates for ADC
Topoisomerase
|
Cancer
|
Br-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT (Formula V) is a agent-linker conjugate that composed of a potent topoisomerase I inhibitor and a linker to make antibody agent conjugate (ADC) .
|
-
- HY-148819A
-
|
ADC Cytotoxin
Topoisomerase
|
Cancer
|
NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT (compound I) hydrochloride is a topoisomerase I inhibitor, which can be delivered to cells through conjugated antibody targeting, and has good ADC activity in vivo and in vitro .
|
-
- HY-33048
-
|
Others
|
Cancer
|
Monomethyl auristatin E intermediate-1 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs) .
|
-
- HY-43146
-
|
Others
|
Cancer
|
Monomethyl auristatin E intermediate-3 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs) .
|
-
- HY-43147
-
|
Others
|
Cancer
|
Monomethyl auristatin E intermediate-4 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs) .
|
-
- HY-43149
-
|
Others
|
Cancer
|
Monomethyl auristatin E intermediate-5 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs) .
|
-
- HY-49413
-
|
Others
|
Cancer
|
Monomethyl auristatin E intermediate-2 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs) .
|
-
- HY-78899
-
|
Others
|
Cancer
|
Monomethyl auristatin E intermediate-6 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs) .
|
-
- HY-78901
-
|
Others
|
Cancer
|
Monomethyl auristatin E intermediate-7 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs) .
|
-
- HY-78901A
-
|
Others
|
Cancer
|
Monomethyl auristatin E intermediate-8 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs) .
|
-
- HY-78903
-
|
Others
|
Cancer
|
Monomethyl auristatin E intermediate-9 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs) .
|
-
- HY-78903A
-
|
Others
|
Cancer
|
Monomethyl auristatin E intermediate-10 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs) .
|
-
- HY-78908
-
|
Others
|
Cancer
|
Monomethyl auristatin E intermediate-11 is an intermediate reactant in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs) .
|
-
- HY-78910
-
|
Others
|
Cancer
|
Monomethyl auristatin E intermediate-12 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs) .
|
-
- HY-78911
-
|
Others
|
Cancer
|
Monomethyl auristatin E intermediate-13 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs) .
|
-
- HY-78913
-
|
Others
|
Cancer
|
Monomethyl auristatin E intermediate-14 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs) .
|
-
- HY-79196
-
|
Others
|
Cancer
|
Monomethyl auristatin E intermediate-15 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs) .
|
-
- HY-79198
-
|
Others
|
Cancer
|
Monomethyl auristatin E intermediate-16 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs) .
|
-
- HY-79205
-
|
Others
|
Cancer
|
Monomethyl auristatin E intermediate-17 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs) .
|
-
- HY-115384
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Amino-PEG5-C2-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Amino-PEG5-C2-acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-112560
-
|
PROTAC Linkers
ADC Linker
|
Cancer
|
Bis-PEG2-PFP ester is also a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Bis-PEG2-PFP ester is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-130150
-
|
PROTAC Linkers
ADC Linker
|
Inflammation/Immunology
Cancer
|
m-PEG5-succinimidyl carbonate is a non-cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). m-PEG5-succinimidyl carbonate is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs.
|
-
- HY-133504
-
|
ADC Linker
|
Cancer
|
Tetrazine-Ph-SS-amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-Ph-SS-amine is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
-
- HY-P9921
-
Ado-Trastuzumab emtansine; PRO132365; T-DM 1
|
Antibody-Drug Conjugates (ADCs)
EGFR
|
Cancer
|
Trastuzumab emtansine (Ado-Trastuzumab emtansine) is an antibody-drug conjugate (ADC) that incorporates the HER2-targeted antitumor properties of trastuzumab with the cytotoxic activity of the microtubule-inhibitory agent DM1 (derivative of maytansine). Trastuzumab emtansine can be used for the research of advanced breast cancer .
|
-
- HY-145951
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
Amidate-VC-PAB-MMAF consists a cleavable ADC linker (Amidate-VC-PAB) and a potent tubulin polymerization inhibitor (MMAF). Amidate-VC-PAB-MMAF can be used in the synthesis of antibody-drug conjugates (ADCs). Amidate-VC-PAB-MMAF reduces off-target cytotoxicity of ADCs .
|
-
- HY-P3028
-
Ficin
|
Biochemical Assay Reagents
|
Others
Metabolic Disease
|
Ficain is an enzyme extract composed of several proteases that can be isolated from Ficus hispida L. and the latex of fig (Ficus carica). Ficain has different specificities in different proportions during fruit ripening. Ficain is widely used in protein hydrolysis, food, production of bioactive peptides and antibody fragments .
|
-
- HY-W043748
-
N-Succinimidyl acrylate
|
Biochemical Assay Reagents
|
Others
|
2,5-Dioxopyrrolidin-1-yl acrylate (N-Succinimidyl acrylate) is a protein crosslinker. 2,5-Dioxopyrrolidin-1-yl acrylate can react with a monoclonal anti-horseradish peroxidase IgG antibody (anti-HRP) to modify lysine residues .
|
-
- HY-161002
-
|
Others
|
Others
|
AMOZ-CHPh-4-O-acid is a hapten, containing 2 carbon and 1 oxygen spacer. AMOZ-CHPh-4-O-acid can be used for antibody production. AMOZ-CHPh-4-O-acid is coupled to BSA for immunogens and coupled to OVA for coating antigens .
|
-
- HY-Y0332L
-
Potassium phosphate monobasic, meets analytical specification of Ph. Eur., NF, E340
|
Biochemical Assay Reagents
|
Others
|
Potassium dihydrogen phosphate (Potassium phosphate monobasic), meets analytical specification of Ph. Eur., NF, E340 is used as a buffer capacity reagent in molecular biology, biochemistry, and chromatography. For the preparation of biological buffers. It is also used to purify antibodies, and in combination with other sodium phosphates, meets analytical specification of Ph. Eur., NF, E340 .
|
-
- HY-P9921A
-
Ado-Trastuzumab emtansine (solution) ; PRO132365 (solution) ; T-DM 1 (solution)
|
Antibody-Drug Conjugates (ADCs)
EGFR
|
Cancer
|
Trastuzumab emtansine (Ado-Trastuzumab emtansine) is an antibody-drug conjugate (ADC) that incorporates the HER2-targeted antitumor properties of trastuzumab with the cytotoxic activity of the microtubule-inhibitory agent DM1 (derivative of maytansine). Trastuzumab emtansine can be used for the research of advanced breast cancer .
|
-
- HY-145736A
-
|
Drug-Linker Conjugates for ADC
Apoptosis
|
Cancer
|
β-Glucuronide-dPBD-PEG5-NH2 TFA is the β-glucuronide-linked pyrrolobenzodiazepine dimer, which binds to the prenylated antibody for synthesis of antibody-drug conjugate (ADC) cIRCR201-dPBD.β-glucuronide-linkage as a cleavable linker. β-Glucuronide-dPBD-PEG5-NH2 TFA, as a proagent of cIRCR201-dPBD, reduces side effects. β-Glucuronide-dPBD-PEG5-NH2 TFA can induce apoptosis and arrest cell cycle. β-Glucuronide-dPBD-PEG5-NH2 TFA has antitumor activity .
|
-
- HY-145736
-
|
Drug-Linker Conjugates for ADC
Apoptosis
|
Cancer
|
β-Glucuronide-dPBD-PEG5-NH2 is the β-glucuronide-linked pyrrolobenzodiazepine dimer, which binds to the prenylated antibody for synthesis of antibody-drug conjugate (ADC) cIRCR201-dPBD. β-glucuronide-linkage as a cleavable linker. β-Glucuronide-dPBD-PEG5-NH2, as a proagent of cIRCR201-dPBD, reduces side effects. β-Glucuronide-dPBD-PEG5-NH2 can induce apoptosis and arrest cell cycle. β-Glucuronide-dPBD-PEG5-NH2 has antitumor activity .
|
-
- HY-153360
-
|
Drug-Linker Conjugates for ADC
Topoisomerase
|
Cancer
|
MC-GGFG-AM-(10Me-11F-Camptothecin) is a linker-payload conjugate used to synthesize ZW251. ZW251 an antibody-drug conjugate (ADC) targeting human GPC3. ZW251 consists of a humanized IgG1 antibody conjugated to a novel camptothecin-based topoisomerase 1 inhibitor, ZD06519, via a linker. The linker is the maleimide anchor and a glycyl glycyl phenylalanyl glycine (GGFG)-aminomethyl (AM) cleavable linker. ZW251 has high affinity with human and cynomolgus monkey GPC3. ZW251 displays rapid internalization in GPC3-expressing HCC cell lines, and bystander-mediated killing of GPC3 negative cancer cells .
|
-
- HY-120775
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Boc-NH-PEG1-CH2CH2COOH is a cleavable (1 unit PEG) ADC linker and also a PEG- and Alkyl/ether-based PROTAC linker can be used in the synthesis of antibody-drug conjugates (ADCs) or PROTACs .
|
-
- HY-W040165
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Amino-PEG3-C2-acid is a cleavable PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Amino-PEG3-C2-acid is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-117079
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
N-Boc-N-bis(PEG2-OH) is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. N-Boc-N-bis(PEG2-OH) is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-130936
-
|
ADC Linker
|
Cancer
|
DBCO-Val-Cit-PABC-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-Val-Cit-PABC-OH is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-130937
-
|
ADC Linker
|
Cancer
|
DBCO-Val-Cit-PABC-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-Val-Cit-PABC-PNP is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-133412
-
|
ADC Linker
|
Cancer
|
DBCO-NHCO-S-S-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-NHCO-S-S-NHS ester is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-133413
-
|
ADC Linker
|
Cancer
|
DBCO-CONH-S-S-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-CONH-S-S-NHS ester is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-W002886
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
N-Boc-cis-4-hydroxy-L-proline is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N-Boc-cis-4-hydroxy-L-proline is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[2
|
-
- HY-40141
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
1-Boc-azetidine-3-carboxylic acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). 1-Boc-azetidine-3-carboxylic acid is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[2]
|
-
- HY-W004868
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
1-Cbz-azetidine-3-carboxylic acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). 1-Cbz-azetidine-3-carboxylic acid is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[1]
|
-
- HY-43564
-
|
ADC Cytotoxin
Topoisomerase
|
|
Exatecan Intermediate 5 is the intermediate of Exatecan (HY-13631) And Exatecan (DX-8951) is a DNA topoisomerase I inhibitor with an IC50 value of 2.2 μM (0.975 μg/mL) that can be used in cancer research. Exatecan Intermediate 5 can be used to synthesize Antibody-Drug Conjugates (ADCs).
|
-
- HY-44369
-
|
ADC Cytotoxin
Topoisomerase
|
|
Exatecan Intermediate 6 is the intermediate of Exatecan (HY-13631) And Exatecan (DX-8951) is a DNA topoisomerase I inhibitor with an IC50 value of 2.2 μM (0.975 μg/mL) that can be used in cancer research. Exatecan Intermediate 6 can be used to synthesize Antibody-Drug Conjugates (ADCs).
|
-
- HY-45157
-
|
ADC Cytotoxin
Topoisomerase
|
|
Exatecan Intermediate 7 is the intermediate of Exatecan (HY-13631) And Exatecan (DX-8951) is a DNA topoisomerase I inhibitor with an IC50 value of 2.2 μM (0.975 μg/mL) that can be used in cancer research. Exatecan Intermediate 7 can be used to synthesize Antibody-Drug Conjugates (ADCs).
|
-
- HY-46081
-
|
ADC Cytotoxin
Topoisomerase
|
|
Exatecan Intermediate 3 is the intermediate of Exatecan (HY-13631) And Exatecan (DX-8951) is a DNA topoisomerase I inhibitor with an IC50 value of 2.2 μM (0.975 μg/mL) that can be used in cancer research. Exatecan Intermediate 3 can be used to synthesize Antibody-Drug Conjugates (ADCs).
|
-
- HY-20336G
-
|
ADC Linker
|
Cancer
|
Mc-Val-Cit-PABC-PNP GMP is a GMP grade Mc-Val-Cit-PABC-PNP (HY-20336). Mc-Val-Cit-PABC-PNP is a cathepsin cleavable ADC linker. Mc-Val-Cit-PABC-PNP can be used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-155470
-
|
Biochemical Assay Reagents
|
Cancer
|
IMP 243 is a symmetric di-HSG (histamine-succinyl-glycine) bivalent hapten containing a Tscg-Cys ligand and two HSG groups. IMP 243 can be radiolabeled with 99mTc-pertechnetate. IMP 243 can be conjugated to other peptides to design bispecific antibodies (bsMAbs) for cancer research .
|
-
- HY-128481
-
|
STING
|
Cancer
|
SB24011 is a STING-TRIM29 interaction inhibitor with a IC50 value of 3.85 μM. SB24011 enhances STING immunity by upregating STING protein levels, thereby enhancing the immunotherapy effect of STING agonists and anti-PD-1 antibodies through systemic anticancer immunity .
|
-
- HY-157937
-
|
IFNAR
|
Cancer
|
VISTA-IN-3 (Compound A4) is a potent VISTA small molecule inhibitor with a KD value of 0.49 μM. VISTA-IN-3 can induce the release of IFN-γ cytokines. VISTA-IN-3 synergistically enhances anti-cancer activity with PD-L1 antibody .
|
-
- HY-13631F
-
|
Drug-Linker Conjugates for ADC
Topoisomerase
|
Cancer
|
Gly-Gly-Phe-Gly-NH-O-CO-Exatecan, as a drug-linker conjugate composed of linker Gly-Gly-Phe-Gly-NH-O-CO and Exatecan, can be used to prepare antibody conjugate drugs. Exatecan is a DNA topoisomerase I inhibitor that can be used in cancer research .
|
-
- HY-160649
-
|
Drug-Linker Conjugates for ADC
Topoisomerase
|
Cancer
|
MC-Gly-Gly-Phe-Gly-GABA-Exatecan is an agent linker conjugate for ADC, with an inhibitor for Topoisomerase Exatecan (HY-13631) with IC50 of 22 μM. MC-Gly-Gly-Phe-Gly-GABA-Exatecan targets various antibodies, exhibits cytotoxic and antitumor efficacy in vitro and in vivo .
|
-
- HY-130989
-
NHS-Glutarate-Val-Cit-PAB-MMAE
|
Drug-Linker Conjugates for ADC
|
Cancer
|
SuO-Glu-Val-Cit-PAB-MMAE (NHS-Glutarate-Val-Cit-PAB-MMAE) consists a cleavable ADC linker (SuO-Glu-Val-Cit-PAB) and a potent tubulin inhibitor (MMAE). SuO-Glu-Val-Cit-PAB-MMAE can be used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-125586
-
|
DNA/RNA Synthesis
ADC Cytotoxin
|
Cancer
|
β-Amanitin is a cyclic peptide toxin in the poisonous Amanita phalloides mushroom. β-Amanitin inhibits inhibits eukaryotic RNA polymerase II and III. β-Amanitin inhibits protein synthesis. β-Amanitin can be used as a cytotoxic component of antibody-drug conjugates (ADCs) .
|
-
- HY-W002887
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
N-Boc-cis-4-Hydroxy-D-proline is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N-Boc-cis-4-Hydroxy-D-proline is also a alkyl chain-based PROTAC linker that can be used in the Synthesis of ADCs or PROTACs.
|
-
- HY-40151
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Methyl 1-Boc-azetidine-3-carboxylate is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Methyl 1-Boc-azetidine-3-carboxylate is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs [1
|
-
- HY-145943
-
-
- HY-112900
-
|
ADC Cytotoxin
|
Cancer
|
DC41SMe, a DC1 derivative, shows cytotoxicity in Ramos, Namalwa, and HL60/s cells with IC50s ranging from 18-25 pM. DC1, a simplified analogue of CC-1065, is an antibody conjugate of cytotoxic DNA alkylators for the targeted treatment of cancer .
|
-
- HY-126513
-
|
ADC Linker
|
Cancer
|
Propargyl-PEG1-NHS ester is a nonclaevable 1-unit PEG linker for antibody-agent-conjugation (ADC). Propargyl-PEG1-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-126516
-
|
ADC Linker
|
Cancer
|
Propargyl-PEG4-NHS ester is a nonclaevable 4-unit PEG linker for antibody-agent-conjugation (ADC). Propargyl-PEG4-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-W019798
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
NH2-PEG8-acid is a non-cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . NH2-PEG8-acid also is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-W040168
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Amino-PEG2-C2-acid is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Amino-PEG2-C2-acid is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-130175
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Fmoc-NH-PEG4-CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-NH-PEG4-CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-130364
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Fmoc-NH-PEG6-CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-NH-PEG6-CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-133062
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Fmoc-NH-PEG5-CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-NH-PEG5-CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-133063
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Fmoc-NH-PEG8-CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-NH-PEG8-CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-W055861
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Fmoc-NH-PEG1-CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-NH-PEG1-CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-120770
-
|
ADC Linker
|
Cancer
|
DBCO-PEG4-Maleimide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG4-Maleimide is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-120537
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
m-PEG5-CH2COOH is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). m-PEG5-CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-42640
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Boc-NH-PEG4-CH2COOH is a cleavable ADC linker used as a linker for antibody-drug conjugates (ADC). Boc-NH-PEG4-CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-141218
-
Decaethylene glycol monomethyl ether
|
ADC Linker
PROTAC Linkers
|
Cancer
|
m-PEG10-alcohol (Decaethylene glycol monomethyl ether) is a non-cleavable 10 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . m-PEG10-alcohol is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-122534
-
|
Mitochondrial Metabolism
ADC Cytotoxin
Apoptosis
|
Cancer
|
Mensacarcin, a highly complex polyketide, strongly inhibits cell growth universally in cancer cell lines and potently induces apoptosis in melanoma cells. Mensacarcin targets to mitochondria, affects energy metabolism in mitochondria, and activates caspase-dependent apoptotic pathways. Mensacarcin, an antibiotic, can be used as a cytotoxic component of antibody-drug conjugates (ADCs) .
|
-
- HY-135971
-
|
ADC Linker
|
Cancer
|
BCN-PEG4-acid is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-PEG4-acid is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-136125
-
|
ADC Linker
|
Cancer
|
BCOT-PEF3-OPFP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCOT-PEF3-OPFP is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-77593
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
N-tert-Butoxycarbonyl-trans-4-hydroxy-D-proline is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N-tert-Butoxycarbonyl-trans-4-hydroxy-D-proline is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.
|
-
- HY-40152
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
1-Boc-azetidine-3-yl-methanol is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). 1-Boc-azetidine-3-yl-methanol is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[1]
|
-
- HY-W019226
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Methyl 1-Cbz-azetidine-3-carboxylate is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Methyl 1-Cbz-azetidine-3-carboxylate is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[1
|
-
- HY-Y0755
-
|
|
|
N-Boc-cis-4-hydroxy-L-proline methyl ester is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N-Boc-cis-4-hydroxy-L-proline methyl ester is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[2
|
-
- HY-145593
-
|
ADC Linker
|
Cancer
|
Aminooxy-PEG2-BCN is a cleavable PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Aminooxy-PEG2-BCN is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-147215
-
|
Toll-like Receptor (TLR)
|
Inflammation/Immunology
|
UC-1V150 is a specific TLR7 (Toll-like receptor) agonist that stimulates cellular immune responses and has anti-tumor activity. UC-1V150 can be used to synthesize ISAC (Immune-Stimulating Antibody Conjugates) molecule .
|
-
- HY-147271
-
|
Drug-Linker Conjugates for ADC
Topoisomerase
|
Cancer
|
Mal-PEG8-Val-Ala-PAB-Exatecan (Compound 9b) is an antibody-drug conjugate linker (ADC linker) that binds to Nectin-4 polypeptides conjugated to chemotherapeutic agents. Mal-PEG8-Val-Ala-PAB-Exatecan can be used for cancer research .
|
-
- HY-147193A
-
|
NAMPT
|
Cancer
|
Nampt-IN-10 trihydrochloride (compound 4) is a Nicotinamide Phosphoribosyltransferase (NAMPT) inhibitor. Nampt-IN-10 trihydrochloride shows cellular potency to A2780 and CORL23 cell lines with IC50 values of 5 and 19 nM, respectively. Nampt-IN-10 trihydrochloride can be used as a novel non-antimitotic payload for antibody-drug conjugate (ADC) .
|
-
- HY-P4042
-
hepatitis B peptide 4980
|
HBV
|
Infection
Inflammation/Immunology
|
Hepatitis B Virus Receptor Binding Fragment (hepatitis B peptide 4980) is a synthetic peptide analog which specifically binds to Hep G2 cells. Hepatitis B Virus Receptor Binding Fragment is a promising immunogen expected to elicit protective antibodies based on the concept of the attachment blockade pathway of virus neutralization .
|
-
- HY-P5201S
-
|
Isotope-Labeled Compounds
|
Others
|
VTSEGAGLQLQK- 13C6, 15N2 is the 13C and 15N labeled VTSEGAGLQLQK. VTSEGAGLQLQK is an amino acid sequence in the C-terminal region of recombinant human alpha-acid glucosidase (rhGAA). VTSEGAGLQLQK can be used to bind anti-drug antibodies (ADA) in plasma and quantitatively analyze the therapeutic effect .
|
-
- HY-153879
-
|
Liposome
|
Infection
|
C12-TLRa is an adjuvant lipidoid. C12-TLRa acts as a structural component of LNP to enhance mRNA delivery. C12-TLRa substitution can increase antigen-specific antibody responses and B cell responses of clinically relevant mRNA-LNP vaccines .
|
-
- HY-P5309
-
|
Biochemical Assay Reagents
|
Inflammation/Immunology
|
(Thr(GalNAc)4,7,15,Ser(GalNAc)9,11)-IgA1 Hinge Region Peptide is a synthetic glycopeptide and can be used for detection of gender difference and epitope specificity of IgG antibody activity against IgA1 hinge portion in IgA nephropathy patients .
|
-
- HY-D1305
-
|
Fluorescent Dye
|
Others
|
ATTO 488 carboxylic acid is a new fluorescent label based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 488 carboxylic acid is a carboxylic acid derivative of ATTO 488, which can be used to label proteins or antibodies.
|
-
- HY-D1917
-
|
Fluorescent Dye
|
Others
|
ATTO 390 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 390 NHS ester is an NHS ester derivative of ATTO 390 that can be used to label proteins or antibodies.
|
-
- HY-D1929
-
|
Fluorescent Dye
|
Others
|
ATTO 594 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 594 NHS ester is an NHS ester derivative of ATTO 594 that can be used to label proteins or antibodies.
|
-
- HY-D1932
-
|
Fluorescent Dye
|
Others
|
ATTO 590 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 590 NHS ester is an NHS ester derivative of ATTO 590 that can be used to label proteins or antibodies.
|
-
- HY-D1933
-
|
Fluorescent Dye
|
Others
|
ATTO 590 maleimide is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 590 maleimide is a maleimide derivative of ATTO 590, which can be used to label proteins or antibodies.
|
-
- HY-D1935
-
|
Fluorescent Dye
|
Others
|
ATTO 465 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 465 NHS ester is an NHS ester derivative of ATTO 465 that can be used to label proteins or antibodies.
|
-
- HY-D1939
-
|
Fluorescent Dye
|
Others
|
ATTO 465 amine is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 465 amine is an amine derivative of ATTO 465 and can be used to label proteins or antibodies.
|
-
- HY-D1946
-
|
Fluorescent Dye
|
Others
|
ATTO 590 alkyne is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 590 alkyne is an alkyne derivative of ATTO 590 and can be used to label proteins or antibodies.
|
-
- HY-D1957
-
|
Fluorescent Dye
|
Others
|
ATTO 633 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 633 NHS ester is an NHS ester derivative of ATTO 633 that can be used to label proteins or antibodies.
|
-
- HY-D1959
-
|
Fluorescent Dye
|
Others
|
ATTO 565 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 565 NHS ester is an NHS ester derivative of ATTO 565 that can be used to label proteins or antibodies.
|
-
- HY-D1961
-
|
Fluorescent Dye
|
Others
|
ATTO 565 maleimide is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 565 maleimide is a maleimide derivative of ATTO 565, which can be used to label proteins or antibodies.
|
-
- HY-D1993
-
|
Fluorescent Dye
|
Others
|
ATTO 647 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 647 NHS ester is an NHS ester derivative of ATTO 647 that can be used to label proteins or antibodies.
|
-
- HY-D1999
-
|
Fluorescent Dye
|
Others
|
ATTO 665 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 665 NHS ester is an NHS ester derivative of ATTO 665 that can be used to label proteins or antibodies.
|
-
- HY-D2001
-
|
Fluorescent Dye
|
Others
|
ATTO 488 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 488 NHS ester is an NHS ester derivative of ATTO 488 that can be used to label proteins or antibodies.
|
-
- HY-D2002
-
|
Fluorescent Dye
|
Others
|
ATTO 488 maleimide is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 488 maleimide is a maleimide derivative of ATTO 488, which can be used to label proteins or antibodies.
|
-
- HY-D2014
-
|
Fluorescent Dye
|
Others
|
ATTO 565 alkyne is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 565 alkyne is an alkyne derivative of ATTO 565 and can be used to label proteins or antibodies.
|
-
- HY-D2015
-
|
Fluorescent Dye
|
Others
|
ATTO 488 alkyne is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 488 alkyne is an alkyne derivative of ATTO 488 and can be used to label proteins or antibodies.
|
-
- HY-153524
-
|
Fluorescent Dye
|
Others
|
ATTO 425 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 425 NHS ester is an NHS ester derivative of ATTO 425 that can be used to label proteins or antibodies.
|
-
- HY-D2016
-
|
Fluorescent Dye
|
Others
|
ATTO 565 cadaverine is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 565 cadaverine is a cadaverine derivative of ATTO 565, which can be used to label proteins or antibodies.
|
-
- HY-D2019
-
|
Fluorescent Dye
|
Others
|
ATTO 550 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 550 NHS ester is an NHS ester derivative of ATTO 550 that can be used to label proteins or antibodies.
|
-
- HY-D2021
-
|
Fluorescent Dye
|
Others
|
ATTO 550 maleimide is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 550 maleimide is a maleimide derivative of ATTO 550, which can be used to label proteins or antibodies.
|
-
- HY-D2026
-
|
Fluorescent Dye
|
Others
|
ATTO 514 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 514 NHS ester is an NHS ester derivative of ATTO 514 that can be used to label proteins or antibodies.
|
-
- HY-D2035
-
|
Fluorescent Dye
|
Others
|
ATTO 514 alkyne is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 514 alkyne is an alkyne derivative of ATTO 514 and can be used to label proteins or antibodies.
|
-
- HY-D2038
-
|
Fluorescent Dye
|
Others
|
ATTO 550 alkyne is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 550 alkyne is an alkyne derivative of ATTO 550 and can be used to label proteins or antibodies.
|
-
- HY-D2046
-
|
Fluorescent Dye
|
Others
|
ATTO 532 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 532 NHS ester is an NHS ester derivative of ATTO 532 that can be used to label proteins or antibodies.
|
-
- HY-D2047
-
|
Fluorescent Dye
|
Others
|
ATTO 532 maleimide is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 532 maleimide is a maleimide derivative of ATTO 532, which can be used to label proteins or antibodies.
|
-
- HY-D2052
-
|
Fluorescent Dye
|
Others
|
ATTO 532 iodacetamid is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 532 iodacetamid is an iodoacetamide derivative of ATTO 532, which can be used to label proteins or antibodies.
|
-
- HY-D2058
-
|
Fluorescent Dye
|
Others
|
ATTO 700 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 700 NHS ester is an NHS ester derivative of ATTO 700 that can be used to label proteins or antibodies.
|
-
- HY-D2059
-
|
Fluorescent Dye
|
Others
|
ATTO 700 maleimide is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 700 maleimide is a maleimide derivative of ATTO 700, which can be used to label proteins or antibodies.
|
-
- HY-D2062
-
|
Fluorescent Dye
|
Others
|
ATTO 740 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 740 NHS ester is an NHS ester derivative of ATTO 740 that can be used to label proteins or antibodies.
|
-
- HY-D2063
-
|
Fluorescent Dye
|
Others
|
ATTO 740 maleimide is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 740 maleimide is a maleimide derivative of ATTO 740, which can be used to label proteins or antibodies.
|
-
- HY-D2073
-
|
Fluorescent Dye
|
Others
|
ATTO 680 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 680 NHS ester is an NHS ester derivative of ATTO 680 that can be used to label proteins or antibodies.
|
-
- HY-D2074
-
|
Fluorescent Dye
|
Others
|
ATTO 680 maleimide is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 680 maleimide is a maleimide derivative of ATTO 680, which can be used to label proteins or antibodies.
|
-
- HY-P5201S1
-
|
Isotope-Labeled Compounds
|
Others
|
VTSEGAGLQLQK- 13C6, 15N2 (TFA) is the 13C- and 15N-labeled VTSEGAGLQLQK. VTSEGAGLQLQK is an amino acid sequence in the C-terminal region of recombinant human alpha-acid glucosidase (rhGAA), which can be used to bind anti-drug antibodies in plasma and quantitatively analyze the therapeutic effect .
|
-
- HY-78931G
-
|
ADC Linker
|
Cancer
|
Boc-Dap-NE (GMP) is Boc-Dap-NE (HY-78931) produced by using GMP guidelines. Boc-Dap-NE is an intermediate in the synthesis of Monomethyl auristatin E (HY-15162), which is an inhibitor of tubulin polymerization. Monomethyl auristatin E can be used to synthesize Antibody-Drug Conjugates (ADCs) as ADC Cytotoxin.
|
-
- HY-15579G
-
Monomethylauristatin F
|
Microtubule/Tubulin
ADC Cytotoxin
|
Cancer
|
MMAF (Monomethylauristatin F) GMP is a GMP grade MMAF (HY-15579). MMAF (Monomethylauristatin F) is a potent tubulin polymerization inhibitor and is used as a antitumor agent. MMAF (Monomethylauristatin F) is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) such as vorsetuzumab mafodotin and SGN-CD19A .
|
-
- HY-15579BG
-
Monomethylauristatin F sodium
|
Microtubule/Tubulin
ADC Cytotoxin
|
Cancer
|
MMAF sodium GMP is a GMP grade MMAF (sodium) (HY-15579B). MMAF sodium (Monomethylauristatin F sodium) is a potent tubulin polymerization inhibitor and is used as a antitumor agent. MMAF sodium (Monomethylauristatin F sodium) is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) such as Vorsetuzumab mafodotin and SGN-CD19A .
|
-
- HY-157186
-
|
Others
|
Inflammation/Immunology
|
(22R)-33,34,35-Trinorbacteriohopan-32-oic acid (compound 2c) is a hapten that can be covalently coupled to a carrier protein. (22R)-33,34,35-Trinorbacteriohopan-32-oic acid can be used in antibody generation and immunoassay .
|
-
- HY-158109
-
|
Others
|
Cancer
|
M3554 is a novel anti-GD2 ADC designed based on humanized ch14.18 anti-GD2 antibody and has anti-tumor activity. The cytotoxicity of M3554 against the GD2-positive neuroblastoma cell line CHP134 was in the subnanomolar IC50 range.
|
-
- HY-NP006
-
SPA
|
Endogenous Metabolite
|
Inflammation/Immunology
|
Protein A (SPA) is an immunoglobulin (Ig) binding protein that exists on the surface of bacteria and can be freely secreted into the extracellular environment. Protein A blocks opsonization and phagocytosis and induces B-cell death in vitro by binding to the Fc region of antibodies and the Fab region of B-cell receptors. Protein A has the ability to inhibit opsonization and phagocytosis in vitro .
|
-
- HY-136170
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
MC-SN38 is a agent-linker conjugate composed of a potent microtubule-disrupting agent SN38 and a non-cleavable MC linker to make antibody agent conjugate (ADC). SN-38, an active metabolite of the Topoisomerase I inhibitor Irinotecan, inhibits DNA synthesis and causes frequent DNA single-strand breaks .
|
-
- HY-114233
-
MC-GGFG-DX8951
|
Drug-Linker Conjugates for ADC
Topoisomerase
|
Cancer
|
MC-GGFG-Exatecan (MC-GGFG-DX8951) is a agent-linker conjugate for ADC. MC-GGFG-Exatecan is a DX8951 (a DNA topoisomerase I inhibitor) derivative with protease cleavable MC-GGFG linker. MC-GGFG-Exatecan shows antitumor activity and can be used to prepare DX8951 antibody conjugate (ADC) .
|
-
- HY-126493
-
|
Drug-Linker Conjugates for ADC
Microtubule/Tubulin
|
Cancer
|
DM4-SPDP is a agent-linker conjugate composed of a potent antitubulin agent DM4 and a linker SMCC to make antibody agent conjugate . SPDP is a short-chain crosslinker for amine-to-sulfhydryl conjugation via NHS-ester and pyridyldithiol reactive groups that form cleavable (reducible) disulfide bonds with cysteine sulfhydryls .
|
-
- HY-129637
-
|
PROTAC Linkers
ADC Linker
|
Cancer
|
NH2-PEG5-OH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . NH2-PEG5-OH is also a non-cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-130486
-
|
PROTAC Linkers
ADC Linker
|
Cancer
|
NH2-PEG6-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . NH2-PEG6-Boc is also a non-cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-130442
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Mal-PEG2-acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Mal-PEG2-acid can be conjugated to Tubulysin (HY-128914) and its derivative cytotoxic molecule . Mal-PEG2-acid is also a PROTAC linker that can be used in the synthesis of PROTACs.
|
-
- HY-136046
-
|
ADC Linker
|
Cancer
|
PTAD-PEG4-alkyne is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . PTAD-PEG4-alkyne is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-136049
-
|
ADC Linker
|
Cancer
|
APN-PEG4-DBCO is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . APN-PEG4-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-136044
-
|
ADC Linker
|
Cancer
|
APN-PEG4-BCN is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . APN-PEG4-BCN is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-130939
-
|
ADC Linker
|
Cancer
|
APN-PEG4-Amine (hydrochloride) is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . APN-PEG4-Amine (hydrochloride) is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-136061
-
|
ADC Linker
|
Cancer
|
BCN-PEG4-HyNic is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-PEG4-HyNic is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-136067
-
|
ADC Linker
|
Cancer
|
DBCO-PEG4-HyNic is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG4-HyNic is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-136075
-
|
ADC Linker
|
Cancer
|
HyNic-PEG4-alkyne is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . HyNic-PEG4-alkyne is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-136101
-
|
ADC Linker
|
Cancer
|
Bocaminooxyacetamide-PEG3-alkyne is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Bocaminooxyacetamide-PEG3-alkyne is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-W002680
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
N-Boc-cis-4-hydroxy-D-proline methyl ester is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N-Boc-cis-4-hydroxy-D-proline methyl ester is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[1
|
-
- HY-137896
-
|
Fluorescent Dye
|
Others
|
4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic acid disodium is a fluorescent dye. 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic acid disodium can be used to demonstrate retrograde axonal transport to label secondary antibodies and as a fluorescent whole cell stain .
|
-
- HY-147236
-
|
Toll-like Receptor (TLR)
|
Inflammation/Immunology
|
TLR7/8 agonist 7 (compound 10) is a TLR7/8 agonist. TLR7/8 agonist 7 activates a variety of immune cells and it can be used to synthesize immune stimulating antibody conjugate (ISAC) molecules. TLR7/8 agonist 7 can be used for the research of immunity .
|
-
- HY-147325
-
|
ADC Linker
|
Others
|
bisSP1 is an antibody agent conjugates linker . bisSP1 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-65039A
-
|
Others
|
Cancer
|
rel-Boc-Hyp-OMe is the isomer of Boc-Hyp-OMe (HY-65039), and can be used as an experimental control. Boc-Hyp-OMe is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Boc-Hyp-OMe is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-78899A
-
|
Others
|
Cancer
|
(4R,5S)-Monomethyl auristatin E intermediate-6 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs) .
|
-
- HY-78931C
-
|
Others
|
Cancer
|
(S,S,R,S,R)-Boc-Dap-NE is an isomer of the dipeptide Boc-Dap-NE (HY-78931). Boc-Dap-NE is an intermediate in the synthesis of Monomethyl auristatin E (HY-15162), which is an inhibitor of tubulin polymerization. Monomethyl auristatin E can be used to synthesize Antibody-Drug Conjugates (ADCs) as ADC Cytotoxin.
|
-
- HY-78931E
-
|
Others
|
Cancer
|
(R,S,R,S,R)-Boc-Dap-NE is an isomer of the dipeptide Boc-Dap-NE (HY-78931). Boc-Dap-NE is an intermediate in the synthesis of Monomethyl auristatin E (HY-15162), which is an inhibitor of tubulin polymerization. Monomethyl auristatin E can be used to synthesize Antibody-Drug Conjugates (ADCs) as ADC Cytotoxin.
|
-
- HY-78931F
-
|
Others
|
Cancer
|
(R,S,S,S,R)-Boc-Dap-NE is an isomer of the dipeptide Boc-Dap-NE (HY-78931). Boc-Dap-NE is an intermediate in the synthesis of Monomethyl auristatin E (HY-15162), which is an inhibitor of tubulin polymerization. Monomethyl auristatin E can be used to synthesize Antibody-Drug Conjugates (ADCs) as ADC Cytotoxin.
|
-
- HY-W000423G
-
|
ADC Linker
|
Cancer
|
DBCO-amine GMP is a GMP grade DBCO-amine (HY-W000423). DBCO-amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-amine is a click chemistry reagent, itcontains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-15578G
-
Maleimidocaproyl monomethylauristatin F
|
Drug-Linker Conjugates for ADC
|
Cancer
|
McMMAF GMP is a GMP grade McMMAF (HY-15578). McMMAF is a protective group (maleimidocaproyl)-conjugated MMAF, which is a potent tubulin polymerization inhibitor. McMMAF can be used as a agent-linker for antibody-drug conjugates (ADC). McMMAF is uncleavable, and must be internalized and degraded within a cell, releasing cysteine-McMMAF as the active agent .
|
-
- HY-156516A
-
|
ADC Cytotoxin
Topoisomerase
|
Cancer
|
10NH2-11F-Camptothecin TFA is a Camptothecin (HY-16560) analogue that serves as an ADC cytotoxin for the synthesis of antibody-drug conjugates (ADCs). 10NH2-11F-Camptothecin TFA has anticancer effects (WO2022246576A1; compound 140) .
|
-
- HY-D2291
-
|
Fluorescent Dye
|
Others
|
BODIPY TMR NHS ester is bright, orange fluorescent dye with Ex/Em of 544/570 nm. The NHS ester (or succinimidyl ester) of BODIPY TMR NHS ester is a popular tool for conjugating the dye to a protein or antibody. NHS esters can be used to label the primary amines (R-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules .
|
-
- HY-158290
-
|
Opioid Receptor
|
Cancer
|
Natrexone/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Natrexone (HY-76711) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-161490
-
|
Antibiotic
|
Infection
|
AMOZ/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of AMOZ (HY-131146) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-115524
-
|
ADC Linker
|
Cancer
|
DBCO-NHS ester 2 is a cleavable linker that is used for making antibody-drug conjugate (ADC). DBCO-NHS ester 2 is a derivative of Dibenzylcyclooctyne (DBCO) used in copper-free click chemistry . DBCO-NHS ester 2 is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-109714
-
|
Others
|
Inflammation/Immunology
|
3,4-Benzocoumarin is a kind of the expanded structure of coumarin derivatives.Coumarin is a chemical compound in the benzopyrone chemical class that can be found in many natural species. Coumarins possess variety of biological activities and unique photophysical properties . 3,4-Benzocoumarin, a AOH‐like compound , has the sensibility of the antibody with an IC50 of 919.2 ng/mL .
|
-
- HY-D1050
-
6-(2,4-Dinitrophenyl)aminohexanoic acid, succinimidyl ester
|
Fluorescent Dye
|
Metabolic Disease
|
DNP-X, SE (6-(2,4-Dinitrophenyl)aminohexanoic acid, succinimidyl ester), the DNP-X acid modified by succinimidyl ester, is an amine-reactive building block for developing a probe, which can be recognized by anti-DNP antibodies. DNP-X, SE (6-(2,4-Dinitrophenyl)aminohexanoic acid, succinimidyl ester) is also an excellent amine-reactive FRET quencher paired with Trp or Tyr.
|
-
- HY-130524
-
|
PROTAC Linkers
ADC Linker
|
Cancer
|
Amino-PEG4-CH2COOH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Amino-PEG4-CH2COOH is also a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-114816
-
C4-HSL; N-Butyryl-L-homoserine lactone
|
ADC Linker
Bacterial
|
Infection
Inflammation/Immunology
|
N-Butanoyl-L-homoserine lactone (C4-HSL) is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N-Butanoyl-L-homoserine lactone has antibacterial activity and is used in antibacterial biofilm . N-Butanoyl-L-homoserine lactone aptamers blocks qurom sensing and inhibits biofilm formation in Pseudomonas aeruginosa .
|
-
- HY-140136
-
|
ADC Linker
|
Cancer
|
PC DBCO-PEG3-biotin is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . PC DBCO-PEG3-biotin is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-140930
-
|
ADC Linker
|
Cancer
|
Diazo Biotin-PEG3-DBCO is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Diazo Biotin-PEG3-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-140108
-
|
ADC Linker
|
Cancer
|
Propargyl-PEG1-SS-alcohol is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG1-SS-alcohol is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-140078
-
|
ADC Linker
|
Cancer
|
bis-PEG2-endo-BCN is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . bis-PEG2-endo-BCN is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-140139
-
|
ADC Linker
|
Cancer
|
PC Alkyne-PEG4-NHS ester is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . PC Alkyne-PEG4-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-140130
-
|
ADC Linker
|
Cancer
|
PC Biotin-PEG3-alkyne is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . PC Biotin-PEG3-alkyne is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-140152
-
|
ADC Linker
|
Cancer
|
BCN-PEG3-VC-PFP ester is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-PEG3-VC-PFP ester is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-135979
-
|
ADC Linker
|
Cancer
|
DBCO-SS-PEG4-Biotin is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-SS-PEG4-Biotin is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-136052
-
|
ADC Linker
|
Cancer
|
Tetrazine-PEG4-oxyamine (hydrochloride) is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-PEG4-oxyamine (hydrochloride) is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
-
- HY-136050
-
|
ADC Linker
|
Cancer
|
TCO-PEG3-Biotin is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . TCO-PEG3-Biotin is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
|
-
- HY-136053
-
|
ADC Linker
|
Cancer
|
Tetrazine-PEG4-biotin is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-PEG4-biotin is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
-
- HY-136056
-
|
ADC Linker
|
Cancer
|
Methyltetrazine-PEG4-oxyamine is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Methyltetrazine-PEG4-oxyamine is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
-
- HY-136045
-
|
ADC Linker
|
Cancer
|
APN-PEG4-tetrazine is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . APN-PEG4-tetrazine is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
-
- HY-133431
-
|
ADC Linker
|
Cancer
|
DBCO-PEG3-SS-NHS ester is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG3-SS-NHS ester is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-130924
-
|
ADC Linker
|
Cancer
|
BCN-PEG3-Biotin is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-PEG3-Biotin is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-130925
-
|
ADC Linker
|
Cancer
|
BCN-PEG4-OH is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-PEG4-OH is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-130926
-
|
ADC Linker
|
Cancer
|
BCN-PEG3-oxyamine is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-PEG3-oxyamine is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-133427
-
|
ADC Linker
|
Cancer
|
Propargyl-PEG4-hydrazide is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG4-hydrazide is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-133429
-
|
ADC Linker
|
Cancer
|
DBCO-PEG3-oxyamine is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG3-oxyamine is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-133430
-
|
ADC Linker
|
Cancer
|
DBCO-PEG4-alkyne is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG4-alkyne is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-130927
-
|
ADC Linker
|
Cancer
|
BCN-PEG4-Ts is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-PEG4-Ts is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-130972
-
|
ADC Linker
|
Cancer
|
Amino-bis-PEG3-DBCO is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Amino-bis-PEG3-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-130977
-
|
ADC Linker
|
Cancer
|
Tetrazine-PEG4-amine (hydrochloride) is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-PEG4-amine (hydrochloride) is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
-
- HY-136074
-
|
ADC Linker
|
Cancer
|
Methyltetrazine-PEG4-aldehyde is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Methyltetrazine-PEG4-aldehyde is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
-
- HY-136077
-
|
ADC Linker
|
Cancer
|
TCO-PEG3-aldehyde is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . TCO-PEG3-aldehyde is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
|
-
- HY-136085
-
|
ADC Linker
|
Cancer
|
Amino-bis-PEG3-BCN is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Amino-bis-PEG3-BCN is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-136086
-
|
ADC Linker
|
Cancer
|
Tetrazine-PEG6-amine (hydrochloride) is a cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-PEG6-amine (hydrochloride) is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
-
- HY-136087
-
|
ADC Linker
|
Cancer
|
Mal-bis-PEG3-DBCO is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Mal-bis-PEG3-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-136096
-
|
ADC Linker
|
Cancer
|
DBCO-PEG3 acetic-EVCit-PAB is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG3 acetic-EVCit-PAB is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-131081
-
|
DNA/RNA Synthesis
ADC Cytotoxin
|
Cancer
|
γ-Amanitin an ADC cytotoxin and isolated from the mushroom. γ-Amanitin inhibits RNA polymerase II and disrupts synthesis of mRNA. γ-Amanitin shows similar effects to α-Amanitin and β-Amanitin. γ-Amanitin competitively binds to monoclonal antibody (mAb), with an IC50 of 163.1 ng/mL .
|
-
- HY-103347
-
|
Apoptosis
|
Inflammation/Immunology
|
M50054 is a potent inhibitor of apoptosis. M50054 inhibits Etoposide-induced caspase-3 activation of U937 cells with an IC50 of 79 μg/mL. M50054 does not directly inhibit the enzymatic activity of caspase-3. M50054 can be used for the research anti-Fas-antibody-induced hepatitis and chemotherapy-induced alopecia .
|
-
- HY-151207
-
|
Apoptosis
ADC Cytotoxin
|
Cancer
|
Anticancer agent 81 (Compound 37b3) is an anticancer agent and can induce tumor cell cycle arrest and apoptosis. Anticancer agent 81 can be used as a payload to conjugate with Trastuzumab (HY-P9907) to obtain the antibody–agent conjugate (ADC) T-PBA. T-PBA maintained its mode of target and internalization ability of Trastuzumab .
|
-
- HY-148211
-
|
ADC Linker
|
Cancer
|
Tetrazine-PEG7-amine hydrochloride is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-PEG7-amine (hydrochloride) is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
-
- HY-148420
-
|
STING
|
Inflammation/Immunology
|
CDN-A is a cyclic di-nucleotide, it can be used to synthesis antibody-drug conjugate (ADC). Cyclic di-nucleotides are potent stimulators of innate and adaptive immune responses. In humans, cyclic di-nucleotide, which are either produced endogenously in response to foreign DNA or by invading bacterial pathogens, trigger the innate immune system by activating the expression of interferon genes .
|
-
- HY-D1800
-
VF 680 SE
|
Fluorescent Dye
|
Others
|
Vari Fluor 680 SE (VF 680 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=680 nm/700 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
|
-
- HY-D1801
-
VF 488 SE
|
Fluorescent Dye
|
Others
|
Vari Fluor 488 SE (VF 488 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=488 nm/513 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
|
-
- HY-D1790
-
VF 640 SE
|
Fluorescent Dye
|
Others
|
Vari Fluor 640 SE (VF 640 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=648 nm/664 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
|
-
- HY-D1802
-
VF 425 SE
|
Fluorescent Dye
|
Others
|
Vari Fluor 425 SE (VF 425 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=430 nm/475 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
|
-
- HY-D1803
-
VF 565 SE
|
Fluorescent Dye
|
Others
|
Vari Fluor 565 SE (VF 565 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=563 nm/594 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
|
-
- HY-D1797
-
VF 660 SE
|
Fluorescent Dye
|
Others
|
Vari Fluor 660 SE (VF 660 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=660 nm/679 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
|
-
- HY-D1798
-
VF 350 SE
|
Fluorescent Dye
|
Others
|
Vari Fluor 350 SE (VF 350 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=350 nm/448 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
|
-
- HY-D1799
-
VF 568 SE
|
Fluorescent Dye
|
Others
|
Vari Fluor 568 SE (VF 568 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=573 nm/595 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
|
-
- HY-D1791
-
VF 750 SE
|
Fluorescent Dye
|
Others
|
Vari Fluor 750 SE (VF 750 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=747 nm/770 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
|
-
- HY-D1792
-
VF 555 SE
|
Fluorescent Dye
|
Others
|
Vari Fluor 555 SE (VF 555 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=550 nm/561 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
|
-
- HY-D1794
-
VF 405 SE
|
Fluorescent Dye
|
Others
|
Vari Fluor 405 SE (VF 405 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=399 nm/421 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
|
-
- HY-D1795
-
VF 532 SE
|
Fluorescent Dye
|
Others
|
Vari Fluor 532 SE (VF 532 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=532 nm/545 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
|
-
- HY-D1796
-
VF 594 SE
|
Fluorescent Dye
|
Others
|
Vari Fluor 594 SE (VF 594 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=585 nm/609 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
|
-
- HY-24144
-
|
DNA Alkylator/Crosslinker
|
Cancer
|
Tesirine intermediate-2 is the intermediate of Tesirine (HY-128952). Tesirine (SG3249), a pyrrole benzodiazepine (PBD) dimer, is a DNA small channel crosslinker with strong cytotoxicity. Tesirine can be used to synthesize Antibody-Drug Conjugates (ADCs), the warhead component of the payload is SG3199 (HY-101161), which has strong anticancer cell activity.
|
-
- HY-47820
-
|
DNA Alkylator/Crosslinker
|
Cancer
|
Tesirine intermediate-1 is the intermediate of Tesirine (HY-128952). Tesirine (SG3249), a pyrrole benzodiazepine (PBD) dimer, is a DNA small channel crosslinker with strong cytotoxicity. Tesirine can be used to synthesize Antibody-Drug Conjugates (ADCs), the warhead component of the payload is SG3199 (HY-101161), which has strong anticancer cell activity.
|
-
- HY-161008
-
|
Others
|
Cancer
|
Heroin-CH2-acid a hapten that can be coupled with bovine serum albumin (BSA). Heroin-CH2-acid vaccine elicited both greater quantities as well as equivalent or higher affinity antibodies towards heroin and 6-AM. Heroin-CH2-acid plays an important role in opioid use disorder .
|
-
- HY-158279
-
|
Antibiotic
Bacterial
|
Infection
|
Gentamicin/OVA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Gentamicin (HY-A0276A) and OVA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-158282
-
|
Antibiotic
Autophagy
Bacterial
|
Infection
|
Pyrazinamide-KLH is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Pyrazinamide (HY-B0271) and KLH. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-158292
-
|
Endogenous Metabolite
Na+/K+ ATPase
|
Cardiovascular Disease
|
Digoxin-OVA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Digoxin (HY-B1049) and OVA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-158296
-
|
Antibiotic
Bacterial
|
Infection
|
Tetracycline/OVA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Tetracycline (HY-A0107) and OVA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-158297
-
|
Endogenous Metabolite
Histamine Receptor
|
Neurological Disease
|
Histamine/OVA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Histamine (HY-B1204) and OVA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-161488
-
|
Reactive Oxygen Species
Ferroptosis
Parasite
Apoptosis
Bacterial
|
Infection
|
Eugenol/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Eugenol (HY-N0337) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-161485
-
|
Bacterial
|
Infection
|
Gentamicin/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Gentamicin (HY-A0276A) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-161487
-
|
Drug Metabolite
|
Metabolic Disease
|
AOZ/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of AOZ (HY-W012982) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-158283
-
|
Antibiotic
Bacterial
|
Infection
|
Ethambutol-BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Ethambutol (HY-B0535) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-161482
-
|
Apoptosis
Endogenous Metabolite
Autophagy
Histamine Receptor
|
Endocrinology
|
Alginic acid/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Alginic acid (HY-W127758) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-161480
-
|
Drug Metabolite
|
Others
|
Melamine/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Melamine (HY-Y1117) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-158289
-
|
Antibiotic
Mitophagy
Autophagy
Bacterial
|
Infection
|
Isoniazid-KLH is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Isoniazid (HY-B0329) and KLH. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-161477
-
|
Endogenous Metabolite
|
Neurological Disease
|
Histamine/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Histamine (HY-B1204) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-158275
-
|
Antibiotic
Influenza Virus
Orthopoxvirus
|
Infection
|
Rifampin/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Rifampin (HY-B0272) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-158276
-
|
Antibiotic
|
Infection
|
Rifampin/KLH is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Rifampin (HY-B0272) and KLH. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-158267
-
|
Antibiotic
Endogenous Metabolite
Bacterial
|
Infection
|
Enrofloxacin/OVA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Enrofloxacin (HY-B0502) and OVA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-158270
-
|
Antibiotic
|
Infection
|
Ethambutol-KLH is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Ethambutol (HY-B0535) and KLH. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-158288
-
|
Autophagy
|
Infection
|
Pyrazinamide-BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Pyrazinamide (HY-B0271) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-161479
-
|
Drug Metabolite
|
Others
|
Melamine/OVA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Melamine (HY-Y1117) and OVA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-161489
-
|
Antibiotic
|
Infection
|
Enrofloxacin/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Enrofloxacin (HY-B0502) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-B0199S
-
|
Isotope-Labeled Compounds
Drug Metabolite
Apoptosis
Endogenous Metabolite
|
Cancer
|
Mycophenolate Mofetil-d4 is the deuterium labeled Mycophenolate Mofetil. Mycophenolate mofetil (RS 61443) is the morpholinoethylester proagent of Mycophenolic acid. Mycophenolate mofetil inhibits de novo purine synthesis via the inhibition of inosine monophosphate dehydrogenase (IMPDH). Mycophenolate mofetil shows selective lymphocyte antiproliferative effects involve both T and B cells, preventing antibody formation[1].
|
-
- HY-121805
-
|
ADC Linker
|
Cancer
|
DBCO-C6-acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). DBCO-C6-acid can be used in the synthesis of carmaphycin analogues . DBCO- C6- acid is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-130151
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
m-PEG7-CH2CH2COOH is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). m-PEG7-CH2CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
|
-
- HY-130185
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
m-PEG7-CH2CH2CHO is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). m-PEG7-CH2CH2CHO is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
|
-
- HY-W067509
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
m-PEG3-CH2CH2COOH is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). m-PEG3-CH2CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
|
-
- HY-W035376
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
m-PEG6-CH2CH2CHO is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). m-PEG6-CH2CH2CHO is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
|
-
- HY-140309
-
|
ADC Linker
|
Cancer
|
Gly-Gly-Gly-PEG4-DBCO is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Gly-Gly-Gly-PEG4-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-136040
-
|
ADC Linker
|
Cancer
|
Tetrazine-PEG4-SS-NHS is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-PEG4-SS-NHS is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
-
- HY-130922
-
|
ADC Linker
|
Cancer
|
BCN-PEG1-Val-Cit-OH is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-PEG1-Val-Cit-OH is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-130945
-
|
ADC Linker
|
Cancer
|
Tetrazine-PEG5-SS-amine is a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-PEG5-SS-amine is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
-
- HY-130947
-
|
ADC Linker
|
Cancer
|
Tetrazine-PEG4-SS-Py is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-PEG4-SS-Py is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
-
- HY-130955
-
|
ADC Linker
|
Cancer
|
Amino-bis-PEG3-TCO is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Amino-bis-PEG3-TCO is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
|
-
- HY-133432
-
|
ADC Linker
|
Cancer
|
DBCO-PEG4-SS-TCO is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG4-SS-TCO is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
|
-
- HY-133466
-
|
ADC Linker
|
Cancer
|
Methyltetrazine-PEG4-SS-NHS ester is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Methyltetrazine-PEG4-SS-NHS ester is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
-
- HY-133435
-
|
ADC Linker
|
Cancer
|
Aminooxy-amido-PEG4-propargyl is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Aminooxy-amido-PEG4-propargyl is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-136035
-
|
ADC Linker
|
Cancer
|
Methyltetrazine-SS-PEG4-Biotin is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Methyltetrazine-SS-PEG4-Biotin is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
-
- HY-136036
-
|
ADC Linker
|
Cancer
|
Tetrazine-SS-PEG4-Biotin is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-SS-PEG4-Biotin is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
-
- HY-136078
-
|
ADC Linker
|
Cancer
|
Tetrazine-diazo-PEG4-biotin is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-diazo-PEG4-biotin is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
-
- HY-136141
-
|
ADC Linker
|
Cancer
|
DBCO-PEG3-propionic EVCit-PAB is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG3-propionic EVCit-PAB is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-D1052
-
|
Fluorescent Dye
|
Cancer
|
Cy7-YNE is a fluorescence labeling agent (Ex=700-770 nm,Em=790 nm). Cyanine dyes are used to label proteins, antibodies, and peptides. Cy7-YNE is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-132161
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
MP-PEG4-Val-Lys-Gly-7-MAD-MDCPT is a Camptothecin-linker compound extracted from patent WO2019195665A1, example 4-1. MP-PEG4-Val-Lys-Gly-7-MAD-MDCPT is a agent-linker conjugate for antibody-drug conjugate (ADC) .
|
-
- HY-110211
-
|
Fluorescent Dye
|
Others
|
BODIPY TMR-X SE is a potent fluorescent dye. BODIPY TMR-X SE can be used to label the primary amines (R-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules. BODIPY TR-X binds to protein or antibody and has bright, orange fluorescent light. (λex=544 nm, λem=570 nm) .
|
-
- HY-150233
-
|
Microtubule/Tubulin
|
Cancer
|
Cys-McMMAF is the released payload of AlMcMMAF, an anti-5T4 humanized A1 antibody conjugated to the microtubule disrupting MMAF (HY-15579) via a maleimidocaproyl linker. Cys-McMMAF has antitumor efficacy in two tumor mouse models (H1975 and MDA-MB-361-DYT2 models) .
|
-
- HY-78931A
-
|
Others
|
Cancer
|
(R,S,S,R,S)-Boc-Dap-NE is the inactive isomer of Boc-Dap-NE (HY-78931), and can be used as an experimental control. Boc-Dap-NE, is an intermediate in the synthesis of Monomethyl auristatin E (HY-15162), which is an inhibitor of tubulin polymerization. Monomethyl auristatin E can be used to synthesize Antibody-Drug Conjugates (ADCs) as ADC Cytotoxin.
|
-
- HY-E70132
-
Endo D
|
Others
|
Metabolic Disease
|
Endo-β-N-acetylglucosaminidase D (Endo D), isolated from Streptococcus pneumoniae. Endo-β-N-acetylglucosaminidase D hydrolyzes Fc N-glycan of intact IgG antibodies after sequential removal of the sialic acid, galactose, and internal GlcNAc residues in the N-glycan. Endo-β-N-acetylglucosaminidase D possesses transglycosylation activity with sugar oxazoline as the donor substrate .
|
-
- HY-400687
-
|
Others
|
Cancer
|
TAM558 intermediate-1 is an intermediate in the synthesis of TAM558 (HY-148127).TAM558 is the payload molecule used in the synthesis of OMTX705.OMTX705 is a humanized anti-fibroblast activation protein (FAP) antibody that binds to the cytolysin TAM470 (HY-148128) and has anti-tumor activity .
|
-
- HY-400688
-
|
Others
|
Cancer
|
TAM558 intermediate-24 is an intermediate in the synthesis of TAM558 (HY-148127).TAM558 is the payload molecule used in the synthesis of OMTX705.OMTX705 is a humanized anti-fibroblast activation protein (FAP) antibody that binds to the cytolysin TAM470 (HY-148128) and has anti-tumor activity .
|
-
- HY-400689
-
|
Others
|
Cancer
|
TAM558 intermediate-34 is an intermediate in the synthesis of TAM558 (HY-148127).TAM558 is the payload molecule used in the synthesis of OMTX705.OMTX705 is a humanized anti-fibroblast activation protein (FAP) antibody that binds to the cytolysin TAM470 (HY-148128) and has anti-tumor activity .
|
-
- HY-400690
-
|
Others
|
Cancer
|
TAM558 intermediate-4 is an intermediate in the synthesis of TAM558 (HY-148127).TAM558 is the payload molecule used in the synthesis of OMTX705.OMTX705 is a humanized anti-fibroblast activation protein (FAP) antibody that binds to the cytolysin TAM470 (HY-148128) and has anti-tumor activity .
|
-
- HY-48564
-
|
ADC Cytotoxin
|
Cancer
|
TAM558 intermediate-54 is an intermediate in the synthesis of TAM558 (HY-148127).TAM558 is the payload molecule used in the synthesis of OMTX705.OMTX705 is a humanized anti-fibroblast activation protein (FAP) antibody that binds to the cytolysin TAM470 (HY-148128) and has anti-tumor activity .
|
-
- HY-78931B
-
|
Others
|
Cancer
|
(S,S,S,S,R)-Boc-Dap-NE is the inactive isomer of Boc-Dap-NE (HY-78931), and can be used as an experimental control. Boc-Dap-NE, is an intermediate in the synthesis of Monomethyl auristatin E (HY-15162), which is an inhibitor of tubulin polymerization. Monomethyl auristatin E can be used to synthesize Antibody-Drug Conjugates (ADCs) as ADC Cytotoxin.
|
-
- HY-15583S
-
|
Isotope-Labeled Compounds
ADC Cytotoxin
Microtubule/Tubulin
|
Cancer
|
Auristatin F-d8 is deuterium labeled Auristatin F (HY-15583). Auristatin F is a potent cytotoxin in antibo-conjugated agents and an analogue of MMAF. Auristatin F is a potent microtubule inhibitor and vascular damaging agent (VDA). Auristatin F inhibits cell division by preventing tubulin aggregation.Auristatin F can be used in antibody-drug conjugates (ADC) .
|
-
- HY-161484
-
|
Bacterial
|
Infection
|
Penicillin G/OVA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Penicillin G (HY-N7139) and OVA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-158268
-
|
Endogenous Metabolite
Aldehyde Dehydrogenase (ALDH)
|
Cancer
|
4-Hydroxynonenal/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of 4-Hydroxynonenal (HY-113466) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-158269
-
|
Thyroid Hormone Receptor
Endogenous Metabolite
|
Endocrinology
|
T4-BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of T4 (HY-18341) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-158284
-
|
Bacterial
|
Infection
|
Penicillin G/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Penicillin G (HY-N7139) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-161481
-
|
Drug Metabolite
|
Others
|
Melamine/bov igG is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Melamine (HY-Y1117) and bov IgG. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-135124
-
|
ADC Cytotoxin
|
Cancer
|
DC44SMe, a phosphate proagent of cytotoxic DNA alkylator DC44, can be used in the synthesis of antibody-drug conjugate (ADC). DC44SMe exhibits IC50s of 2.0 nM, 2.8 nM, and 1.9 nM for Ramos, Namalwa, and HL60/s cancer cells, respectively. DC44SMe can be used for the targeted treatment of cancer .
|
-
- HY-135123
-
|
ADC Cytotoxin
|
Cancer
|
DC4SMe, a phosphate proagent of cytotoxic DNA alkylator DC4, can be used in the synthesis of antibody-drug conjugate (ADC). DC4SMe exhibits IC50s of 1.9 nM, 2.9 nM, and 1.8 nM for Ramos, Namalwa, and HL60/s cancer cells, respectively. DC4SMe can be used for the targeted treatment of cancer .
|
-
- HY-129942
-
|
ADC Linker
|
Cancer
|
S-(1-Hydroxy-2-methylpropan-2-yl) methanesulfonothioate is a glutathione cleavable ADC linker used for the antibody-drug conjugates (ADCs) and refers to the Alkyl-Chain composition. S-(1-Hydroxy-2-methylpropan-2-yl) methanesulfonothioate is the linker portions of the molecules employed for mAb attachment purposes .
|
-
- HY-W000434
-
Fmoc-15-amino-4,7,10,13-tetraoxapentadecanoic acid
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Fmoc-NH-PEG4-CH2CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-NH-PEG4-CH2CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-W040231
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Fmoc-NH-PEG3-CH2CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-NH-PEG3-CH2CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-W040238
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Fmoc-NH-PEG2-CH2CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-NH-PEG2-CH2CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-130167
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Fmoc-NH-PEG9-CH2CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-NH-PEG9-CH2CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-W040244
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Boc-NH-PEG6-CH2CH2COOH is a cleavable ADC linker used as a linker for antibody-drug conjugates (ADC). Boc-NH-PEG6-CH2CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-141147
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
7-O-(Amino-PEG4)-paclitaxel is a PEG-class Drug-linker conjugates for ADC, containing a paclitaxel moiety and a amino group. The amine group is reactive with carboxylic acids, activated NHS esters, carbonyls (ketone, aldehyde) etc. 7-O-(Amino-PEG4)-paclitaxel can be used in the synthesis of Antibody-Drug Conjugates (ADCs) .
|
-
- HY-140104
-
|
ADC Linker
|
Cancer
|
Azidoethyl-SS-ethylamine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azidoethyl-SS-ethylamine is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-140100
-
|
ADC Linker
|
Cancer
|
Azidoethyl-SS-propionic acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azidoethyl-SS-propionic acid is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-140105
-
|
ADC Linker
|
Cancer
|
Azidoethyl-SS-ethylazide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azidoethyl-SS-ethylazide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-133426
-
Ald-benzyl-amide-PEG4-propargyl
|
ADC Linker
|
Cancer
|
Ald-Ph-amido-PEG4-propargyl is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Ald-Ph-amido-PEG4-propargyl is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-133436
-
|
ADC Linker
|
Cancer
|
Boc-aminooxy-amide-PEG4-propargyl is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Boc-aminooxy-amide-PEG4-propargyl is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-130923
-
|
ADC Linker
|
Cancer
|
BCN-PEG1-Val-Cit-PABC-OH is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-PEG1-Val-Cit-PABC-OH is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-130934
-
|
ADC Linker
|
Cancer
|
TCO-PEG1-Val-Cit-OH is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . TCO-PEG1-Val-Cit-OH is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
|
-
- HY-136103
-
|
ADC Linker
|
Cancer
|
DBCO-PEG4-Propionic-Val-Cit-PAB is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG4-Propionic-Val-Cit-PAB is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-136098
-
|
ADC Linker
|
Cancer
|
DBCO-PEG4-acetic-Val-Cit-PAB is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG4-acetic-Val-Cit-PAB is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-133573
-
|
ADC Linker
|
Cancer
|
Cyclooctyne-O-amido-PEG2-PFP ester is a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Cyclooctyne-O-amido-PEG2-PFP ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-133575
-
|
ADC Linker
|
Cancer
|
Cyclooctyne-O-amido-PEG3-PFP ester is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Cyclooctyne-O-amido-PEG3-PFP ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-133576
-
|
ADC Linker
|
Cancer
|
Cyclooctyne-O-amido-PEG4-PFP ester is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Cyclooctyne-O-amido-PEG4-PFP ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-P1439A
-
|
Toll-like Receptor (TLR)
|
Inflammation/Immunology
|
RS 09 TFA is a TLR4 agonist. RS 09 TFA promotes NF-κB nuclear translocation and induces inflammatory cytokine secretion in RAW264.7 macrophages in vitro. RS 09 TFA acts as an adjuvant in vivo; RS 09 TFA enhances X-15 specific antibody serum concentrations, when administered with X-15-KLH in mice.
|
-
- HY-144497
-
-
- HY-110212
-
BODIPY TR-X NHS Ester
|
Fluorescent Dye
|
Others
|
BODIPY TR-X (BODIPY TR-X NHS Ester) is a potent fluorescent dye. BODIPY TR-X can be used to label the primary amines (R-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules. BODIPY TR-X binds to protein or antibody and has bright, red fluorescent light. (λex=545 nm, λem=560 nm) .
|
-
- HY-D1742
-
|
Fluorescent Dye
DNA Stain
|
Others
|
DRAQ5 is a novel cell permeant and far red-fluorescing DNA probe. DRAQ5 excites at a wavelength of 647 nm, close to the Ex, and produces a fluorescence spectrum extending from 665 nm out to beyond 780 nm wavelengths. DRAQ5 fluorescence reflects cellular DNA content. DRAQ5 can be used in combination with FITC and RPE-labelled antibodies, without the need for fluorescence compensation .
|
-
- HY-128355A
-
|
Indoleamine 2,3-Dioxygenase (IDO)
|
Others
|
(R)-IDO/TDO-IN-1 (compound 25) is an indoleamine-2,3-dioxygenase (IDO) inhibitor, with good pharmacokinetic properties. (R)-IDO/TDO-IN-1 exhibits anti-tumor activity in MC38 xenograft model. (R)-IDO/TDO-IN-1 shows synergistic effect with anti-PD-1 monoclonal antibody (SHR-1210) .
|
-
- HY-B0199R
-
RS 61443 (Standard); TM-MMF (Standard)
|
Drug Metabolite
Apoptosis
Endogenous Metabolite
Bacterial
|
Cancer
|
Mycophenolate Mofetil (Standard) is the analytical standard of Mycophenolate Mofetil. This product is intended for research and analytical applications. Mycophenolate mofetil (RS 61443) is the morpholinoethylester proagent of Mycophenolic acid. Mycophenolate mofetil inhibits de novo purine synthesis via the inhibition of inosine monophosphate dehydrogenase (IMPDH). Mycophenolate mofetil shows selective lymphocyte antiproliferative effects involve both T and B cells, preventing antibody formation .
|
-
- HY-158273
-
|
DNA/RNA Synthesis
|
Others
|
2,4-D/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of 2,4-D (HY-18572) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-158287
-
|
DNA/RNA Synthesis
|
Others
|
2,4-D/KLH is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of 2,4-D (HY-18572) and KLH. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-15486
-
|
Phosphatase
HSV
Autophagy
Apoptosis
|
Infection
Inflammation/Immunology
Cancer
|
Salubrinal is a cell-permeable and selective inhibitor of eIF2α dephosphorylation . Salubrinal acts as a dual-specificity phosphatase 2 (Dusp2) inhibitor and suppresses inflammation in anti-collagen antibody-induced arthritis . Salubrinal has antiviral activity against HSV-1 and inhibits dephosphorylation of eIF2α mediated by the HSV-1 protein ICP34.5 .
|
-
- HY-112616
-
|
NAMPT
Drug-Linker Conjugates for ADC
|
Cancer
|
NAMPT inhibitor-linker 2 is a agent-linker conjugates for ADC, composed of an NAMPT inhibitor as a payload, and a linker. ADC-4 consists of an NAMPT inhibitor-linker 2 and an anti-c-Kit monoclonal antibody, exihibits potent activity against c-Kit expressing cell lines such as GIST-T1 and NCI-H526, with IC50s of <7 pM and 40 pM, respectively.
|
-
- HY-42149
-
|
PROTAC Linkers
ADC Linker
|
Cancer
|
NH2-PEG2-C2-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . NH2-PEG2-C2-Boc is also a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-124386
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
DBCO-NHCO-PEG4-amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. DBCO-NHCO-PEG4-amine is a cleavable ADC linker used to conjugate MMAE (HY-15162) and antibody (e.g., DBCO-VCpAB−MMAE and DBCO-TRX−MMAE with EC50s of 280 nM and 22 nM in SKBR3 cells, respectively) .
|
-
- HY-W007713
-
Fmoc-NH-PEG2-CH2COOH
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Fmoc-8-amino-3,6-dioxaoctanoic acid (Fmoc-NH-PEG2-CH2COOH) is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-8-amino-3,6-dioxaoctanoic acid is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-W035378
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Fmoc-N-methyl-PEG3-CH2CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-N-methyl-PEG3-CH2CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-W040132
-
|
PROTAC Linkers
ADC Linker
|
Cancer
|
Boc-NH-PEG4-CH2CH2COOH is a PEG-based PROTAC linker can be used in the synthesis of PROTAC . Boc-NH-PEG4-CH2CH2COOH is also a cleavable ADC linker used as a linker for antibody-drug conjugates (ADC) .
|
-
- HY-130383
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Propargyl-PEG7-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG7-acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG7-acid is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-130386
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Propargyl-PEG6-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG6-acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG6-acid is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-140109
-
|
ADC Linker
|
Cancer
|
Propargyl-PEG1-SS-PEG1-acid is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG1-SS-PEG1-acid is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-140102
-
|
ADC Linker
|
Cancer
|
Azidoethyl-SS-propionic NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azidoethyl-SS-propionic NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-141155
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
endo-BCN-PEG4-Val-Cit-PAB-MMAE is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . endo-BCN-PEG4-Val-Cit-PAB-MMAE is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-130966
-
|
ADC Linker
|
Cancer
|
TCO-PEG1-Val-Cit-PABC-OH is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . TCO-PEG1-Val-Cit-PABC-OH is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
|
-
- HY-136100
-
|
ADC Linker
|
Cancer
|
TCO-PEG1-Val-Cit-PABC-PNP is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . TCO-PEG1-Val-Cit-PABC-PNP is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
|
-
- HY-136131
-
|
ADC Linker
|
Cancer
|
NH2-PEG4-hydrazone-DBCO is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . NH2-PEG4-hydrazone-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-129937
-
|
PROTACs
Epigenetic Reader Domain
|
Cancer
|
(S)-GNE-987 (compound 4), the GNE-987 (a chimeric BET degrader) hydroxy-proline epimer, abrogates binding to von Hippel-Lindau and does not degrade BRD4 protein. (S)-GNE-987 binds to the BRD4 BD1(IC50=4 nM) and BD2 (3.9 nM) bromodomains and can be used to design PROTAC-Antibody Conjugate (PAC) .
|
-
- HY-138387
-
|
ADC Linker
|
Cancer
|
6-Azido-hexylamine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . 6-Azido-hexylamine is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-148424
-
|
ADC Cytotoxin
|
Cancer
|
PBD dimer-2 (compound 2c) is a C8-linked pyrrolobenzodiazepine dimer. PBD dimer-2 can span an extra base pair and cross-link the 5′-Pu-GA(T/A)TC-Py sequence. PBD dimer-2 can be used as a payload for antibody–agent conjugates (ADCs), and it can be used for the research of cancer .
|
-
- HY-D1848
-
|
Fluorescent Dye
|
Others
|
Sulfo-Cy3-NHS disodium is a derivative of Cy3 (Cyanine3) (HY-D0822) dye containing sulfonate ions. Sulfo-Cy3-NHS disodium contains sulfonate ions and has improved water solubility. Sulfo-Cy3-NHS disodium can label biomolecules containing amine groups, such as proteins, antibodies or peptides.
|
-
- HY-D2242
-
|
Fluorescent Dye
|
Others
|
Sulfo-Cy7.5 DBCO is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) bearing a DBCO group. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Sulfo-Cy7.5 DBCO can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples .
|
-
- HY-158278
-
|
Bacterial
|
Cancer
|
Aflatoxin B1/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Aflatoxin B1 (HY-N6615) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-158281
-
|
Bacterial
Endogenous Metabolite
Parasite
|
Cancer
|
Aflatoxin B1/KLH is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Aflatoxin B1 (HY-N6615) and KLH. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-112898
-
|
ADC Cytotoxin
|
Cancer
|
DC1Sme, a DC1 derivative, exhibits IC50 values of 22 pM, 10 pM, 32 pM and 250 pM for Ramos, Namalwa, HL60/s and COLO 205 cancer cells, respectively. DC1, an analogue of the minor groove-binding DNA alkylator CC-1065, is a ADC Cytotoxin. DC1 can be used in synthesis of antibody-drug conjugates for the targeted treatment of cancer.
|
-
- HY-112615
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
NAMPT inhibitor-linker 1 is a agent-linker conjugates for ADC, composed of an NAMPT inhibitor as a payload, and a linker. ADC-3 consists of an NAMPT inhibitor-linker 1 and an anti-c-Kit monoclonal antibody, exihibits potent activity against c-Kit expressing cell lines such as GIST-T1 and NCI-H526 cells, with IC50s of <3 pM and 9 pM, respectively.
|
-
- HY-128930
-
|
ADC Linker
|
Cancer
|
6-O-2-Propyn-1-yl-D-galactose is a nonclaevable glycolinker for the functionalization of cytotoxic agents and applications in antibody-agent conjugation. 6-O-2-Propyn-1-yl-D-galactose is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-115545
-
|
ADC Linker
|
Cancer
|
DBCO-NHS ester 3 (Compound 12) is a cleavable linker that is used for making antibody-drug conjugate (ADC). DBCO-NHS ester 3 is a derivative of Dibenzylcyclooctyne (DBCO) obtained by activation of N-hydroxysuccinimide by the carboxylic acid moiety of both methyl-oxanorbornadiene (MeOND) and dibenzoazacyclooctyne (DIBAC) . DBCO-NHS ester 3 is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-130426
-
Mal-PEG3-acid
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Maleimido-tri(ethylene glycol)-propionic acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Maleimido-tri(ethylene glycol)-propionic acid is used for the preparation of neolymphostin-based ADC precursors for site-specific cysteine mutant trastuzumab-A114C conjugation . Maleimido-tri(ethylene glycol)-propionic acid also can be used as a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
|
-
- HY-140111
-
|
ADC Linker
|
Cancer
|
Propargyl-PEG1-SS-PEG1-propargyl is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG1-SS-PEG1-propargyl is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-140110
-
|
ADC Linker
|
Cancer
|
Propargyl-PEG1-SS-PEG1-PFP ester is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG1-SS-PEG1-PFP ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-140313
-
|
ADC Linker
|
Cancer
|
Methyltetrazine-DBCO is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Methyltetrazine-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups. Methyltetrazine-DBCO also contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
-
- HY-141148
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
7-O-(Cbz-N-amido-PEG4)-paclitaxel is a PEG-class Drug-linker conjugates for ADC, containing a paclitaxel moiety and a amino group. The amine group is reactive with carboxylic acids, activated NHS esters, carbonyls (ketone, aldehyde) etc. 7-O-(Cbz-N-amido-PEG4)-paclitaxel can be used in the synthesis of Antibody-Drug Conjugates (ADCs) .
|
-
- HY-135970
-
|
ADC Linker
|
Cancer
|
Alkyne-PEG4-SS-PEG4-alkyne is a cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Alkyne-PEG4-SS-PEG4-alkyne is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-130968
-
|
ADC Linker
|
Cancer
|
Amino-PEG4-bis-PEG3-propargyl is a cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Amino-PEG4-bis-PEG3-propargyl is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-130971
-
|
ADC Linker
|
Cancer
|
Mal-PEG4-bis-PEG3-DBCO is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Mal-PEG4-bis-PEG3-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-130973
-
|
ADC Linker
|
Cancer
|
Mal-PEG4-bis-PEG4-propargyl is a cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Mal-PEG4-bis-PEG4-propargyl is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-136060
-
|
ADC Linker
|
Cancer
|
Mal-PEG2-bis-PEG3-BCN is a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Mal-PEG2-bis-PEG3-BCN is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-136076
-
|
ADC Linker
|
Cancer
|
TCO-PEG3-CH2-aldehyde is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . TCO-PEG3-CH2-aldehyde is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
|
-
- HY-136088
-
|
ADC Linker
|
Cancer
|
Acid-PEG1-bis-PEG3-BCN is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Acid-PEG1-bis-PEG3-BCN is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-136089
-
|
ADC Linker
|
Cancer
|
Aminooxy-PEG2-bis-PEG3-BCN is a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Aminooxy-PEG2-bis-PEG3-BCN is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-145399
-
SG 3932
|
Drug-Linker Conjugates for ADC
Topoisomerase
|
Cancer
|
Mal-PEG8-amide-Val-Ala-(4-NH2)-Exatecan is a Drug-Linker Conjugates for ADC, which comprises a topoisomerase inhibitor and a linker for ligand unit connecting. Mal-PEG8-amide-Val-Ala-(4-NH2)-Exatecan can be used to synthesis antibody-drug conjugate (ADC) .
|
-
- HY-P3560
-
TV 4710
|
Apoptosis
|
Inflammation/Immunology
|
Edratide (TV 4710) is a synthetic peptide of 19 amino acid based on the complementarity-determining region 1 (CDR1) of a human anti-DNA antibody that expresses a major idiotype denoted 16/6 Id. Edratide reduces the rates of apoptosis (Apoptosis) and down-regulates of caspase-8 and caspase-3, up-regulates Bcl-xL. Edratide has the potential for the research of systemic lupus erythematosus (SLE) .
|
-
- HY-47018
-
|
ADC Linker
|
Others
|
BCN-HS-PEG2-VA-PABC-SG3199 (Compound 4) is a pyrrolobenzodiazepine that can be used as a agent linker of antibody-drug conjugates (ADC) . BCN-HS-PEG2-VA-PABC-SG3199 is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-120255
-
17(R)-HDoHE
|
Others
|
Inflammation/Immunology
|
17(R)-HDHA (17(R)-HDoHE) is a pro-resolving mediator (SPM). 17(R)-HDHA enhances the differentiation of B cells toward the CD27(+)CD38(+) antibody-secreting cell phenotype, thereby strongly increasing IgM and IgG production by activated B cells. 17(R)-HDHA does not affect cell proliferation and is non-toxic to cells .
|
-
- HY-126524
-
|
ADC Linker
|
Cancer
|
N3-Ph-NHS ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N3-Ph-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-125541
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
DBCO-Amide-PEG5-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. DBCO-Amide-PEG5-acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-NHCO-PEG4-acid is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-W021787
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
NH2-PEG4-CH2CH2COOH is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). NH2-PEG4-CH2CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
|
-
- HY-130346
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
DBCO-PEG4-DBCO is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. DBCO-PEG4-DBCO is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG4-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-126976
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Propargyl-PEG5-amine is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Propargyl-PEG5-amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs . Propargyl-PEG5-amine is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-130372
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Propargyl-PEG9-bromide is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG9-bromide is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG9-bromide is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-130377
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Propargyl-PEG8-bromide is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG8-bromide is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG8-bromide is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-130591
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Propargyl-PEG4-Br is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG4-Br is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG4-Br is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-116427
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Propargyl-PEG4-thiol is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG4-thiol is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG4-thiol is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-118808
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Propargyl-PEG2-NHBoc is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Propargyl-PEG2-NHBoc is a PEG-based PROTAC linker can be used in the synthesis of PROTACs . Propargyl-PEG2-NHBoc is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-130387
-
|
PROTAC Linkers
ADC Linker
|
Cancer
|
Propargyl-PEG4-Tos is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG4-Tos is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG4-Tos is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-130943
-
|
ADC Linker
|
Cancer
|
Methyltetrazine-PEG4-SS-PEG4-methyltetrazine is a cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Methyltetrazine-PEG4-SS-PEG4-methyltetrazine is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
-
- HY-130953
-
|
ADC Linker
|
Cancer
|
Mal-PEG4-bis-PEG3-methyltetrazine is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Mal-PEG4-bis-PEG3-methyltetrazine is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
-
- HY-130931
-
|
ADC Linker
|
Cancer
|
Propargyl-NH-PEG3-C2-NHS ester is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-NH-PEG3-C2-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-130967
-
|
ADC Linker
|
Cancer
|
Ald-Ph-PEG4-bis-PEG4-propargyl is a cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Ald-Ph-PEG4-bis-PEG4-propargyl is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-130970
-
|
ADC Linker
|
Cancer
|
Amino-PEG4-bis-PEG3-methyltetrazine is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Amino-PEG4-bis-PEG3-methyltetrazine is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
-
- HY-133539
-
|
ADC Linker
|
Cancer
|
Propargyl-C8-amido-PEG2-NHS ester is a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-C8-amido-PEG2-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-138521
-
|
ADC Linker
|
Cancer
|
Azido-C6-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-C6-OH is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-138535
-
|
ADC Linker
|
Cancer
|
Azide-C2-Azide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azide-C2-Azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-125390
-
CL-087
|
Toll-like Receptor (TLR)
|
Inflammation/Immunology
|
SM-360320 (CL-087) is a potent, orally active TLR7 agonist. SM-360320 is a immuno-modulator and exerts an antitumor effect. SM-360320 can act in synergy with DNA vaccines leading to an enhanced Th1 antibody response . SM-360320 can inhibit HCV replication in hepatocytes via a type I IFN-independent mechanism in addition to its IFN-mediated activity .
|
-
- HY-D1865
-
|
Fluorescent Dye
|
Others
|
Cy3 dimethyl iodide is a dye derivative of Cyanine 3 (Cy3) (HY-D0822) with a dimethyl group in the iodide salt form. The iodide salt form increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy3 is a near-infrared fluorescent dye commonly used in biolabeling and cell imaging. Cy3 dimethyl iodide binds to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
|
-
- HY-22055B
-
(2S,4S)-1-tert-butyl 2-methyl-4-hydroxypiperidine-1,2-dicarboxylate
|
Others
|
Infection
|
AN-12-H5 intermediate-1 ((2S,4S)-1-tert-butyl 2-methyl-4-hydroxypiperidine-1,2-dicarboxylate) is an intermediate of the viral inhibitor AN-12-H5 (HY-120900) and can be used to synthesize Antibody-Drug Conjugates (ADCs).
|
-
- HY-128952
-
SG3249
|
Drug-Linker Conjugates for ADC
DNA Alkylator/Crosslinker
|
Cancer
|
Tesirine (SG3249) is an antibody-drug conjugate (ADC) pyrrolobenzodiazepine (PBD) dimer payload. Tesirine combines potent antitumor activity with desirable physicochemical properties such as favorable hydrophobicity and improved conjugation characteristics. SG3199 (HY-101161) is the released warhead component of the ADC payload Tesirine. SG3199 retains picomolar activity in a panel of cancer cell lines. PBD dimers are highly efficient DNA minor groove cross-linking agents with potent cytotoxicity .
|
-
- HY-126525
-
|
ADC Linker
|
Cancer
|
4-N3Pfp-NHS ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . 4-N3Pfp-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-126677
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Boc-NH-PEG3-C2-triazole-DBCO-PEG4-VC-PAB-DMEA is a double claevable 3-unit and 4-unit PEG linker for antibody-agent-conjugation (ADC). Boc-NH-PEG3-C2-triazole-DBCO-PEG4-VC-PAB-DMEA also is a PROTAC linker that can be used in the synthesis of PROTACs.
|
-
- HY-118764
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Propargyl-PEG2-acid is a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Propargyl-PEG2-acid is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Propargyl-PEG2-acid is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-130161
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
m-PEG4-Br is a cleavable ADC linker used in the synthesis of antibody-drug conjugate (ADC) for Trastuzumab (HY-P9907). m-PEG4-Br is placed distally from the monomethyl auristatin E (MMAE) payload to yield an ADC with altered hydrophilicity, antigen binding, and in vitro potency . m-PEG4-Br also can be used as a PROTAC linker that can be used in the synthesis of PROTACs.
|
-
- HY-42488
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Hydroxy-PEG2-(CH2)2-Boc is a uncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Hydroxy-PEG2-(CH2)2-Boc is extracted from patent WO2004008101A2 (compound 196) . Hydroxy-PEG2-(CH2)2-Boc is also a PROTAC linker that can be used in the synthesis of PROTACs.
|
-
- HY-W008352
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Boc-NH-PEG4-CH2CH2NH2 a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Boc-NH-PEG4-CH2CH2NH2 is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-W039178
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Hydroxy-PEG4-(CH2)2-Boc is a uncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Hydroxy-PEG4-(CH2)2-Boc is extracted from patent WO2004008101A2 (compound 191). Hydroxy-PEG4-(CH2)2-Boc is also a PROTAC linker that can be used in the synthesis of PROTACs.
|
-
- HY-W040257
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
NH2-PEG6-CH2CH2COOH is a cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). NH2-PEG6-CH2CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
|
-
- HY-W067061
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Hydroxy-PEG2-(CH2)2-Boc is a uncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Hydroxy-PEG2-(CH2)2-Boc is extracted from patent WO2004008101A2 (compound 196) . Hydroxy-PEG2-(CH2)2-Boc is also a PROTAC linker that can be used in the synthesis of PROTACs.
|
-
- HY-111456
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
DBCO-NHCO-PEG4-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. DBCO-NHCO-PEG4-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-NHCO-PEG4-NHS ester is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-126885
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
DBCO-PEG5-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. DBCO-PEG5-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG5-NHS ester is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-126974
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Propargyl-PEG3-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG3-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG3-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-130376
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Propargyl-PEG8-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG8-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG8-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-130381
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Propargyl-PEG7-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG7-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG7-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-130385
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Propargyl-PEG6-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG6-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG6-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-130388
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Propargyl-PEG5-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG5-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG5-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-W051634
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Propargyl-PEG2-amine is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Propargyl-PEG2-amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs . Propargyl-PEG2-amine is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-115374
-
|
ADC Linker
|
Inflammation/Immunology
Cancer
|
m-PEG6-azide is a non-cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). m-PEG6-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-140352
-
|
ADC Linker
|
Cancer
|
Azide-PEG5-Tos is a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azide-PEG5-Tos is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-133434
-
|
ADC Linker
|
Cancer
|
Aminoxyacetamide-PEG3-azide is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Aminoxyacetamide-PEG3-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-136038
-
|
ADC Linker
|
Cancer
|
Azido-PEG3-SSPy is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG3-SSPy is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-130974
-
|
ADC Linker
|
Cancer
|
Ald-Ph-PEG4-bis-PEG3-methyltetrazine is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Ald-Ph-PEG4-bis-PEG3-methyltetrazine is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
-
- HY-136099
-
|
ADC Linker
|
Cancer
|
Bocaminooxyacetamide-PEG2-Azido is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Bocaminooxyacetamide-PEG2-Azido is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-W096133
-
|
ADC Linker
|
Cancer
|
Biotin-PEG1-azide is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Biotin-PEG1-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-138745
-
|
ADC Linker
|
Cancer
|
Bis-sulfone-PEG3-Azide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Bis-sulfone-PEG3-Azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-139107
-
|
ADC Linker
|
Cancer
|
Biotin-PEG4-SS-azide is a cleavable, biotin-labeled, ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Biotin-PEG4-SS-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-141662
-
|
STING
Drug-Linker Conjugates for ADC
|
Inflammation/Immunology
Cancer
|
2’,3’-cGAMP-C2-PPA is a cyclic dinucleotide interferon gene-stimulating protein (STING) agonist. 2’,3’-cGAMP-C2-PPA is a drug conjugated conjugate used to target antibody-drug conjugated conjugate (ADC) for the treatment of cancer. 2’,3’-cGAMP-C2-PPA can be used in the study of immune and tumor-related diseases .
|
-
- HY-139859
-
|
ADC Linker
|
Cancer
|
APN-PEG36-tetrazine is an analogue of APN-PEG4-tetrazine. APN-PEG4-tetrazine is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . APN-PEG36-tetrazine is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
-
- HY-114816S
-
|
Isotope-Labeled Compounds
ADC Linker
Bacterial
|
Infection
Inflammation/Immunology
|
N-butyryl-L-Homoserine lactone-d5 is the deuterium labeled N-Butanoyl-L-homoserine lactone. N-Butanoyl-L-homoserine lactone (C4-HSL) is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N-Butanoyl-L-homoserine lactone has antibacterial activity and is used in antibacterial biofilm[1]. N-Butanoyl-L-homoserine lactone aptamers blocks qurom sensing and inhibits biofilm formation in Pseudomonas aeruginosa[2][3].
|
-
- HY-153084
-
|
CD19
|
Inflammation/Immunology
Cancer
|
CD19 CAR mRNA will express CD19 car protein, and can be used in chimeric antigen receptor T cell immunotherapy (CAR-CD19). The CD19 car is a chimeric antigen receptor. Among them, CD19 is a CD molecule expressed by B cells (i.e. leukocyte differentiation antigen), an important membrane antigen involved in B cell proliferation, differentiation, activation and antibody production, and can also promote BCR signal transduction.
|
-
- HY-153085
-
|
CD19
|
Inflammation/Immunology
Cancer
|
CD19 CAR circRNA will express CD19 car protein, and can be used in chimeric antigen receptor T cell immunotherapy (CAR-CD19). The CD19 car is a chimeric antigen receptor. Among them, CD19 is a CD molecule expressed by B cells (i.e. leukocyte differentiation antigen), an important membrane antigen involved in B cell proliferation, differentiation, activation and antibody production, and can also promote BCR signal transduction.
|
-
- HY-126360
-
|
TNF Receptor
Interleukin Related
|
Inflammation/Immunology
|
Oxazolone is a haptenizing agent that induces acute or chronic inflammation of the large intestine and is used to construct models of colitis. Oxazolone can cause Th1/Th2-dependent colitis with weight loss and diarrhea. Oxazolone-induced inflammation can be mitigated by neutralizing anti-IL-4 or anti-TNF-α antibodies or decoy IL-13R2-α-FC proteins .
|
-
- HY-D1317A
-
|
Fluorescent Dye
|
Others
|
Cyanine7.5 carboxylic is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) with carboxylic acid functional groups. Cy7.5 is a near-infrared fluorescent dye commonly used in biomedical research areas such as biomarkers and cell imaging. Cyanine7.5 carboxylic can be covalently bound to some biological molecules (especially antibodies, proteins, etc.) to track their location and dynamic changes in biological samples.
|
-
- HY-D1852
-
|
Fluorescent Dye
|
Others
|
Cy3B amine chloride is a dye derivative of Cyanine 3 (Cy3) (HY-D0822) bearing an amine group. Cy3 is a fluorescent dye with a fluorescence spectrum typically in the green to orange wavelength range. The amine functionality of Sulfo-Cy3 amine can react with carboxyl groups to form covalent bonds. Sulfo-Cy3 amine can bind to biological molecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
|
-
- HY-D1317
-
|
Fluorescent Dye
|
Others
|
Cyanine7.5 carboxylic acid chloride is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) with carboxylic acid functional groups. Cy7.5 is a near-infrared fluorescent dye commonly used in biomedical research areas such as biomarkers and cell imaging. Cyanine7.5 carboxylic acid chloride can be covalently bound to some biological molecules (especially antibodies, proteins, etc.) to track their location and dynamic changes in biological samples.
|
-
- HY-B1610K
-
|
Biochemical Assay Reagents
|
Others
|
Sodium citrate buffer, 0.5M, pH 5.5, is a commonly used buffer with main components are citric acid and sodium hydrogen phosphate. Sodium citrate buffer 0.5M pH 5.5 is used in heat induced epitope retrieval (HIER) methods to reverse the loss of antigenicity that occurs with some epitopes in formalin-fixed paraffin embedded tissues. Sodium citrate buffer 0.5M pH 5.5 is the preferred solution for most antibodies. .
|
-
- HY-B1610M
-
|
Biochemical Assay Reagents
|
Others
|
Sodium citrate buffer, 0.5M, pH 6.5, is a commonly used buffer with main components are citric acid and sodium hydrogen phosphate. Sodium citrate buffer, 0.5M, pH 6.5 is used in heat induced epitope retrieval (HIER) methods to reverse the loss of antigenicity that occurs with some epitopes in formalin-fixed paraffin embedded tissues. Sodium citrate buffer, 0.5M, pH 6.5 is the preferred solution for most antibodies .
|
-
- HY-126520
-
|
ADC Linker
|
Cancer
|
N3-C2-NHS ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N3-C2-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-126521
-
|
ADC Linker
|
Cancer
|
N3-C3-NHS ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N3-C3-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-126522
-
|
ADC Linker
|
Cancer
|
N3-C4-NHS ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N3-C4-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-126523
-
|
ADC Linker
|
Cancer
|
N3-C5-NHS ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N3-C5-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-126514
-
|
ADC Linker
|
Cancer
|
Propargyl-O-C1-amido-PEG2-C2-NHS ester is a nonclaevable 2-unit PEG linker for antibody-agent-conjugation (ADC). Propargyl-O-C1-amido-PEG2-C2-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-126515
-
|
ADC Linker
|
Cancer
|
Propargyl-O-C1-amido-PEG4-C2-NHS ester is a nonclaevable 4-unit PEG linker for antibody-agent-conjugation (ADC). Propargyl-O-C1-amido-PEG4-C2-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-126884
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
DBCO-NHCO-PEG4-NH-Boc is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. DBCO-NHCO-PEG4-NH-Boc is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-NHCO-PEG4-NH-Boc is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-130379
-
|
ADC Linker
PROTAC Linkers
Bacterial
|
Infection
Cancer
|
Propargyl-PEG8-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG8-acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). The ADCs can be used in bacterial infections caused by Gram-negative bacteria . Propargyl-PEG8-acid is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-113764
-
(Rac)-C4-HSL
|
Bacterial
|
Infection
Inflammation/Immunology
|
N-Butanoyl-DL-homoserine lactone ((Rac)-C4-HSL) is a racemic mixture of N-Butanoyl-D-homoserine lactone and N-Butanoyl-L-homoserine lactone. N-Butanoyl-L-homoserine lactone is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N-Butanoyl-L-homoserine lactone has antibacterial activity and is used in antibacterial biofilm. N-Butanoyl-L-homoserine lactone aptamers blocks qurom sensing and inhibits biofilm formation in Pseudomonas aeruginosa .
|
-
- HY-140132
-
|
ADC Linker
|
Cancer
|
PC Biotin-PEG3-azide is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . PC Biotin-PEG3-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-140944
-
|
ADC Linker
|
Cancer
|
Biotin-PEG3-SS-azide is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Biotin-PEG3-SS-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-135966
-
|
ADC Linker
|
Cancer
|
Azido-PEG3-SS-NHS is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG3-SS-NHS is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-130940
-
|
ADC Linker
|
Cancer
|
PTAD-PEG4-N3 is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . PTAD-PEG4-N3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-130954
-
|
ADC Linker
|
Cancer
|
Hynic-PEG3-N3 is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Hynic-PEG3-N3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-136034
-
|
ADC Linker
|
Cancer
|
Azido-PEG1-Val-Cit-OH is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG1-Val-Cit-OH is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-136084
-
|
ADC Linker
|
Cancer
|
Mal-PEG4-(PEG3-DBCO)-(PEG3-TCO) is a cleavable 10 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Mal-PEG4-(PEG3-DBCO)-(PEG3-TCO) is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
|
-
- HY-136130
-
|
ADC Linker
|
Cancer
|
N,N-Bis(PEG2-alkyne)-N-amido-PEG2-thiol is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . N,N-Bis(PEG2-alkyne)-N-amido-PEG2-thiol is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-D0175
-
γ-Aminopropyltriethoxysilane; APTES
|
Biochemical Assay Reagents
|
Others
|
3-Aminopropyltriethoxysilane (APTES) acts as a strong glue to immobilize biomolecules such as antibodies and enzymes to silicon and silicon derivatives such as silicon nitride (Si3N4 )) on. 3-Aminopropyltriethoxysilane also acts as a spacer, providing biomolecules with more spatial freedom during immobilization for higher specific activity. 3-Aminopropyltriethoxysilane can form a more stable, sensitive, and highly biocompatible bioanalytical platform by immobilizing biomolecules onto some solid materials, electrode materials, nanomaterials, and nanocomposites .
|
-
- HY-144012A
-
DPPE-PEG350; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-350] ammonium
|
Liposome
|
Others
|
16:0 PEG350 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-144012B
-
DPPE-PEG550; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-550] ammonium
|
Biochemical Assay Reagents
Liposome
|
Others
|
16:0 PEG550 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-144012C
-
DPPE-PEG750; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-750] ammonium
|
Biochemical Assay Reagents
Liposome
|
Others
|
16:0 PEG750 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-144013A
-
DSPE-mPEG350 ammonium; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-350] ammonium
|
Liposome
|
Others
|
18:0 mPEG350 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-144013B
-
DSPE-mPEG550 ammonium; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-550] ammonium
|
Biochemical Assay Reagents
Liposome
|
Others
|
18:0 mPEG550 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-144013C
-
DSPE-mPEG750 ammonium; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-750] ammonium
|
Biochemical Assay Reagents
Liposome
|
Others
|
18:0 mPEG750 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-144012D
-
DPPE-PEG1000; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-1000] ammonium
|
Liposome
|
Others
|
16:0 PEG1000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-144012E
-
DPPE-PEG3000; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-3000] ammonium
|
Liposome
|
Others
|
16:0 PEG3000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-144012H
-
DPPE-PEG5000; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-5000] ammonium
|
Liposome
|
Others
|
16:0 PEG5000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-144013D
-
DSPE-mPEG1000 ammonium; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-1000] ammonium
|
Liposome
|
Others
|
18:0 mPEG1000 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-144013E
-
DSPE-mPEG3000 ammonium; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-3000] ammonium
|
Liposome
|
Others
|
18:0 mPEG3000 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-144013H
-
DSPE-mPEG5000 ammonium; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-5000] ammonium
|
Liposome
|
Others
|
18:0 mPEG5000 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-155924
-
DMPE-PEG350; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-350] ammonium
|
Liposome
|
Others
|
14:0 PEG350 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-155925
-
DMPE-PEG550; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-550] ammonium
|
Liposome
|
Others
|
14:0 PEG550 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-155926
-
DMPE-PEG750; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-750] ammonium
|
Liposome
|
Others
|
14:0 PEG750 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-155927
-
DMPE-PEG1000; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-1000] ammonium
|
Liposome
|
Others
|
14:0 PEG1000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-155928
-
DMPE-PEG3000; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-3000] ammonium
|
Liposome
|
Others
|
14:0 PEG3000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-155929
-
DMPE-PEG5000; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-5000] ammonium
|
Liposome
|
Others
|
14:0 PEG5000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-155930
-
DOPE-PEG350; 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-350] ammonium
|
Liposome
|
Others
|
18:1 PEG350 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-155931
-
DOPE-PEG550; 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-550] ammonium
|
Liposome
|
Others
|
18:1 PEG550 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-155932
-
DOPE-PEG1000; 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-1000] ammonium
|
Liposome
|
Others
|
18:1 PEG1000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-155933
-
DOPE-PEG3000; 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-3000] ammonium
|
Liposome
|
Others
|
18:1 PEG3000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-155934
-
DOPE-PEG5000; 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-5000] ammonium
|
Liposome
|
Others
|
18:1 PEG5000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-132160
-
|
ADC Cytotoxin
|
Cancer
|
7-Aminomethyl-10-methyl-11-fluoro camptothecin is a cytotoxin of MC-AAA-NHCH2OCH2COO-7-aminomethyl-10-methyl-11-fluoro camptothecin (HY-132158). 7-Aminomethyl-10-methyl-11-fluoro camptothecin can be used for the synthesis of camptothecin antibody-drug conjugate (ADC) .
|
-
- HY-D1846
-
|
Fluorescent Dye
|
Others
|
Sulfo-Cy7.5 dimethyl is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) with a dimethyl group. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy7.5 is a near-infrared fluorescent dye commonly used for biolabeling and cell imaging. Sulfo-Cy7.5 dimethyl binds to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
|
-
- HY-D1851
-
|
Fluorescent Dye
|
Others
|
Cy3B amine chloride is a dye derivative of Cyanine 3 (Cy3) (HY-D0822) bearing an amine group in the disodium salt form. Cy3 is a fluorescent dye with a fluorescence spectrum typically in the green to orange wavelength range. The amine functionality of Sulfo-Cy3 amine can react with carboxyl groups to form covalent bonds. Sulfo-Cy3 amine can bind to biological molecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
|
-
- HY-D1860
-
|
Fluorescent Dye
|
Others
|
Cy3 alkyne chloride is a dye derivative of Cyanine 3 (Cy3) (HY-D0822) containing a sulfonate ion and an alkyne functional group. Cy3 is a fluorescent dye with a fluorescence spectrum typically in the green to orange wavelength range. The alkyne functional group of Cy3 alkyne chloride can react with molecules containing the azide functional group to form covalent bonds. Cy3 alkyne chloride can bind to biological molecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
|
-
- HY-D1868
-
|
Fluorescent Dye
|
Others
|
Cy3 azide plus is a Cyanine 3 (Cy3) (HY-D0822) dye derivative with an azide functional group. Cy3 is a fluorescent dye with a fluorescence spectrum typically in the green to orange wavelength range. The azide group of Cy3 azide plus can react chemically with molecules containing alkyne functionality, such as alkyne or cyclooctyne, to form covalent bonds. Therefore, Cy3 azide plus can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
|
-
- HY-D1871
-
|
Fluorescent Dye
|
Others
|
Cy3 maleimide chloride is a dye derivative of Cyanine 3 (Cy3) (HY-D0822) containing maleimide functional groups. Cy3 is a fluorescent dye with a fluorescence spectrum typically in the green to orange wavelength range. The alkyne functional group of Cy3 maleimide chloride can undergo a "thiol-acrylamide" reaction with molecules containing sulfur-oxygen functional groups to form covalent bonds. Cy3 maleimide chloride can bind to biological molecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
|
-
- HY-155446
-
|
Others
|
Inflammation/Immunology
Cancer
|
di-DTPA-LTL is a bivalent hapten based on tyrosine-containing polypeptide design. di-DTPA-LTL has good hydrophilia and biological distribution. di-DTPA-LTL is labeled with 111In (indium) and 131I (iodine). di-DTPA-LTL achieves tumor radioimmunoimaging in primary colorectal cancer patients with CEA by injecting a fixed low dose (5 mg) of bispecific antibody (anti-CEA x, anti-DTPA) and di-DTPA antigen peptide (labeled 111In) into the patients .
|
-
- HY-132160A
-
|
ADC Cytotoxin
|
Cancer
|
7-Aminomethyl-10-methyl-11-fluoro camptothecin TFA is a cytotoxin of MC-AAA-NHCH2OCH2COO-7-aminomethyl-10-methyl-11-fluoro camptothecin (HY-132158). 7-Aminomethyl-10-methyl-11-fluoro camptothecin TFA can be used for the synthesis of camptothecin antibody-drug conjugate (ADC) .
|
-
- HY-161022S1
-
|
Isotope-Labeled Compounds
ADC Linker
|
Cancer
|
FL118-C3-O-C-amide-C-NH2-d5 formate is a deuterium labeled FL118-C3-O-C-amide-C-NH2 formate. FL118-C3-O-C-amide-C-NH2 formate is an ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-126690
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
DBCO-(PEG2-VC-PAB-MMAE)2 is made by MMAE conjugated to the cleavable DBCO-(PEG2-VC-PAB)2 linker. Monomethyl auristatin E (MMAE), a potent tubulin inhibitor, is a toxin payload in antibody agent conjugate . DBCO-(PEG2-VC-PAB-MMAE)2 is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-128946
-
|
Drug-Linker Conjugates for ADC
|
Inflammation/Immunology
Cancer
|
CL2A-SN-38 is a agent-linker conjugate composed of a potent a DNA Topoisomerase I inhibitor SN-38 and a linker CL2A to make antibody agent conjugate (ADC). CL2A-SN-38 provides significant and specific antitumor effects against a range of human solid tumor types. CL2A-SN-38 uses hydrolyzable linker to deliver active agents within tumor cells and in the tumor microenvironment, resulting in bystander effects .
|
-
- HY-126676
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
DBCO-(PEG2-Val-Cit-PAB)2 is a dual cleavable ADC linker for antibody-drug conjugates (ADCs). DBCO-(PEG2-Val-Cit-PAB)2 is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. DBCO-(PEG2-Val-Cit-PAB)2 is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-130182
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Propargyl-PEG8-NH2 (compound 3b) is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG8-NH2 is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG8-NH2 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-140127
-
|
ADC Linker
|
Cancer
|
Azide-C2-SS-C2-biotin is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azide-C2-SS-C2-biotin is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-140148
-
|
ADC Linker
|
Cancer
|
Azido-PEG3-Val-Cit-PAB-OH is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG3-Val-Cit-PAB-OH is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-140634
-
|
ADC Linker
|
Cancer
|
Ald-CH2-PEG5-azide is a non-cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Ald-CH2-PEG5-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-140081
-
|
PROTAC Linkers
ADC Linker
|
Cancer
|
Boc-gly-PEG3-endo-BCN is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Boc-gly-PEG3-endo-BCN is also a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Boc-gly-PEG3-endo-BCN is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-136054
-
|
ADC Linker
|
Cancer
|
N3-PEG5-aldehyde is a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . N3-PEG5-aldehyde is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-133428
-
|
ADC Linker
|
Cancer
|
DBCO-PEG3-TCO is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG3-TCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups. DBCO-PEG3-TCO also contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
|
-
- HY-136105
-
|
ADC Linker
|
Cancer
|
Azido-PEG1-Val-Cit-PABC-PNP is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG1-Val-Cit-PABC-PNP is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-136137
-
|
ADC Linker
|
Cancer
|
Azide-PEG1-Val-Cit-PABC-OH is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azide-PEG1-Val-Cit-PABC-OH is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-136155
-
|
ADC Linker
|
Cancer
|
Fmoc-NH-Azide-PEG4-L-Lysine-PFP ester is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Fmoc-NH-Azide-PEG4-L-Lysine-PFP ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-131082
-
|
ADC Linker
|
Cancer
|
(R)-8-Azido-2-(Fmoc-amino)octanoic acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . (R)-8-Azido-2-(Fmoc-amino)octanoic acid is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-133583
-
|
ADC Linker
|
Cancer
|
Propargyl-O-C1-amido-PEG3-C2-NHS ester is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-O-C1-amido-PEG3-C2-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-D1847
-
|
Fluorescent Dye
|
Others
|
Cy7.5 tetrazine tetrafluoroborate is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) bearing a tetrazine group. Cy7.5 is a near-infrared fluorescent dye commonly used for biolabeling and cell imaging. Cy7.5 tetrazine tetrafluoroborate can perform efficient click reactions with molecules containing alkyne functional groups (such as alkyne) to form covalent bonds. It can be combined with biological molecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
|
-
- HY-131990G
-
|
ADC Linker
|
Cancer
|
MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH GMP is a GMP grade MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH (HY-131990). MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-108841
-
AMG-719; Anakinra
|
Interleukin Related
|
Inflammation/Immunology
Cancer
|
Raleukin (AMG-719) is a recombinant, nonglycosylated human interleukin-1 receptor (IL-1R) antagonist. Raleukin (AMG-719) is the first biological agent to block the pro-inflammatory effects .
|
-
- HY-119810A
-
Ucb 44212 lithium
|
HIV
|
Neurological Disease
|
Seletracetam (Ucb 44212) lithium, as an analog of the antiepileptic agent Levetiracetam, is a SV2A modulator for the research of epilepsy .
|
-
- HY-103415
-
YM-09151-2; Emonapride
|
Dopamine Receptor
5-HT Receptor
|
Neurological Disease
|
Nemonapride is a highly potent dopamine D2 receptor antagonist with a Ki of 0.06 nM. Nemonapride also activates 5-HT1A receptor with an IC50 of 34 nM. Nemonapride is an antipsychotic that readily passes through the blood brain barrier and exhibits potent neuroleptic effects in animals .
|
-
- HY-145771
-
|
PD-1/PD-L1
|
Cancer
|
PD-1/PD-L1-IN-20 (Example 21) is a small-molecule inhibitor of the PD-1/PD-L1 protein-protein interaction. PD-1/PD-L1-IN-20 blocks PD-1/PD-L1 with the IC50 of 5.29 nM. PD-1/PD-L1-IN-20 can be used for the research of cancers, infectious diseases and autoimmune diseases .
|
-
- HY-118860
-
Org 36286; MK-8962
|
Estrogen Receptor/ERR
|
Endocrinology
|
Corifollitropin alfa (Org 36286) is a long-acting recombinant follicle-stimulating hormone (FSH) analog. Corifollitropin alfa is a FSH Receptor agonist with an EC50 of 5.0 pM. Corifollitropin alfa stimulates ovulation and can be used in the research of infertility .
|
-
- HY-112998
-
|
Factor VIII
|
Others
|
Efmoroctocog alfa is a recombinant human coagulation factor VIII-Fc fusion protein (rFVIIIFc) that can be used for the research of haemophilia A .
|
-
- HY-P99255
-
CAT 8015; HA 22
|
Antibody-Drug Conjugates (ADCs)
CD22
|
Cancer
|
Moxetumomab pasudotox (CAT 8015) is anti-CD22 immunotoxin containing an anti-CD22 Fv and Pseudomonas exotoxin. CD22 is a cell surface receptor expressed on a variety of malignant B-cells. Moxetumomab pasudotox can be used in the research of hairy cell leukemia (HCL) .
|
-
- HY-P99338
-
CTL019
|
CD19
|
Inflammation/Immunology
Cancer
|
Tisagenlecleucel (CTL019) is an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy. Tisagenlecleucel targets and eliminates CD19-expressing B cells. Tisagenlecleucel can be used for the research of refractory aggressive diffuse large B-cell lymphoma .
|
-
- HY-P99339
-
IMCgp100
|
Interleukin Related
TNF Receptor
|
Cancer
|
Tebentafusp (IMCgp100) is a bispecific fusion protein to target gp100 peptide-HLA-A*02:01 (a melanoma-associated antigen). Tebentafusp guides T cells to kill gp100-expressing tumor cells via a high affinity T-cell receptor (TCR) binding domain and an anti-CD3 T-cell engaging domain. Tebentafusp leads to inflammatory cytokines and cytolytic proteins production, resulting in the direct lysis of tumour cells .
|
-
- HY-P99348
-
Ropeginterferon alfa-2b-njft; PEG-proline-interferon alpha-2b
|
Apoptosis
|
Cancer
|
Ropeginterferon alfa-2b (Ropeginterferon alfa-2b-njft) is a monopegylated IFN-α that can be used for the research of myeloproliferative neoplasms .
|
-
- HY-P99416
-
AGN-150998; MP0112
|
VEGFR
|
Cardiovascular Disease
Inflammation/Immunology
|
Abicipar pegol (AGN-150998, MP0112) is an anti-VEGF DARPin molecule, a novel class of small proteins containing ankyrin repeat domains engineered to bind with high specificity and affinity to target proteins. Abicipar pegol effectively inhibits angiogenesis and vascular permeability and is used in the study of diseases related to ocular inflammation by intravitreal injection, reducing mean retinal thickness and leakage area .
|
-
- HY-P99547
-
(vic)-Trastuzumab duocarmazine
|
Antibody-Drug Conjugates (ADCs)
|
Cancer
|
Trastuzumab duocarmazine ((vic)-Trastuzumab duocarmazine) is a HER2-targeting ADC that is recognized and cleaved by histone B in tumor cells and selectively targets tumor cells. Trastuzumab duocarmazine has anti-tumor activity and can be used in cancer research related to uterine and ovarian sarcomas .
|
-
- HY-P99497
-
|
Integrin
HCV
|
Infection
|
Cepeginterferon alfa-2b is a pegylated interferon. And Cepeginterferon alfa-2b has PEG with molecular weight of 20 kDa as a pegylated base. Cepeginterferon alfa-2b can be used for research of various diseases, such as hepatitis C virus (HCV), polycythemia vera (PV) and essential thrombocythemia (ET) .
|
-
- HY-P99917
-
|
STAT
|
Inflammation/Immunology
|
Eflepedocokin alfa is a recombinant fusion protein with potential cell protective activity. Eflepedocokin alfa consists of human IL-22 fused to human IgG2-Fc domain. Eflepedocokin alfa leads to the activation of IL-22/IL-22R-mediated signal transduction pathways as well as STAT3. Eflepedocokin alfa plays a role in immune response and bacterial infection, enhancing intestinal barrier function, intestinal immunity, and tissue repair .
|
-
- HY-P99905
-
|
VEGFR
|
Cardiovascular Disease
Neurological Disease
|
Efdamrofusp alfa is a bispecific fusion protein. Efdamrofusp alfa is capable of neutralizing both VEGF isoforms and C3b/C4b. Efdamrofusp alfa can be used for the research of neovascular age-related macular degeneration (nAMD) and other complement-related ocular conditions .
|
-
- HY-P99919
-
|
Interleukin Related
|
Infection
|
Efmarodocokin alfa is a fusion protein of human IL-22 and the IgG4 crystallizable fragment. Efmarodocokin alfa activates IL-22 signaling. Efmarodocokin alfa can be used for the research of severe COVID-19 pneumonia .
|
-
- HY-P99908
-
NT-17
|
Interleukin Related
|
Cancer
|
Efineptakin alfa (NT-17) is a long-acting recombinant human IL-7. Efineptakin alfa supports the proliferation and survival CD4 + and CD8 + cells in both human and mice. Efineptakin alfa can be used for glioblastoma research .
|
-
- HY-152228
-
|
Histone Methyltransferase
Autophagy
|
Cancer
|
SMYD3-IN-2 is a SMYD3 inhibitor against gastric cancer via inducing lethal autophagy. SMYD3-IN-2 has inhibitory for SMYD3 and BGC823 cells with IC50 values of 0.81 μM and 0.75 μM, respectively. SMYD3-IN-2 can be used for the research of cancer .
|
-
- HY-P99690
-
-
- HY-P99647
-
ALX-0171; VR-465
|
RSV
|
Infection
|
Gontivimab (ALX-0171; VR-465) is a poent anti-RSV prefusion F protein nanobody with a KD value of 0.113 nM. Gontivimab shows antiviral activity. Gontivimab reduces the RSV load in the nose and lung .
|
-
- HY-P99666
-
|
IFNAR
|
Infection
|
Albinterferon alfa-2b is a type I interferon that activates novel genes and exerts potent antiviral and antiproliferative activity on target cells. Signaling by Albinterferon alfa-2b requires receptor-dependent activation of Stat1 and Stat2 to form a heterodimeric STAT that binds to the DNA-binding protein IRF-9 (p48) and forms ISGF-3 (IFN-stimulated gene factor 3). The driver genes are then further activated by ISGF-3 to achieve antiviral function .
|
-
- HY-P99696
-
LIB003
|
Ser/Thr Protease
|
Cardiovascular Disease
Metabolic Disease
|
Lerodalcibep (LIB003) is a recombinant fusion protein of a PCSK9-binding domain (adnectin) and human serum albumin. Lerodalcibep is a Lipid-lowering agent. Lerodalcibep can be used for the research of hypercholesterolemia and cardiovascular diseases .
|
-
- HY-P99665
-
LY-3209590
|
Insulin Receptor
|
Metabolic Disease
|
Insulin efsitora alfa (LY-3209590) is a selective agonist of insulin receptor (IR). Insulin efsitora alfa is a fusion protein composed of human IR agonists fused with the crystallizable (Fc) domain of human immunoglobulin G2 (IgG2) fragment, with a molecular weight of 64.1 kDa. Insulin efsitora alfa is well tolerated and has potential applications in diabetes .
|
-
- HY-P99728
-
RG7835; RO7049665
|
Interleukin Related
|
Inflammation/Immunology
|
Melredableukin alfa (RO-7049665) is a fusion protein that consists of a human IgG1-κ fused to a mutated human interleukin 2 (IL2 mutein) via a peptide linker. Melredableukin alfa can be used for the research of autoimmune hepatitis and ulcerative colitis .
|
-
- HY-P99735
-
|
IFNAR
|
Infection
|
Mipeginterferon alfa-2b is an interferon alpha-2b (IFNA2b) analogue, with an average number of 5 substituted among 11 amino groups (one N-terminal and 10 lysine N6). Mipeginterferon alfa-2b has the relative molecular mass of 40 kDa .
|
-
- HY-P99769
-
SCT-800
|
Factor VIII
|
Metabolic Disease
|
Omfiloctocog alfa (SCT-800) is a recombinant factor VIII (FVIII). FVIII is an essential blood coagulation protein and a key component of the fluid phase blood coagulation system. Omfiloctocog alfa can be used for the research of Hemophilia A .
|
-
- HY-P99933
-
IMP321; LAG-3Ig
|
LAG-3
|
Cancer
|
Eftilagimod alfa (IMP321) is a recombinant LAG-3Ig fusion protein that binds to MHC class II. Eftilagimod alfa mediates antigen-presenting cell (APC) activation followed by CD8 T-cell activation. Eftilagimod alfa can be used for metastatic melanoma and metastatic breast carcinoma research .
|
-
- HY-P99934
-
ABBV-621
|
Apoptosis
|
Cancer
|
Eftozanermin alfa (ABBV-621) is a second-generation tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) agonist. Eftozanermin alfa induces apoptosis in tumor cells by activation of death receptors 4/5. Eftozanermin alfa can be used for the research of multiple solid and heme malignancies .
|
-
- HY-P99944
-
Retlirafusp alfa
|
PD-1/PD-L1
TGF-β Receptor
|
Cancer
|
SHR-1701 (Retlirafusp alfa) is a bifunctional fusion protein targeting PD-L1 and TGF-β for cancer research .
|
-
- HY-P99752
-
ALKS 4230; RDB-1450
|
Interleukin Related
|
Inflammation/Immunology
Cancer
|
Nemvaleukin alfa (ALKS 4230) is a IL-2 fusion protein that selectively binds to intermediate-affinity IL-2R. Nemvaleukin alfa is an activator of NK and effector T cells. Nemvaleukin alfa can be used for research of cancer .
|
-
- HY-108798
-
|
VEGFR
|
Cardiovascular Disease
Cancer
|
Ziv-aflibercept is a soluble inhibitor of vascular endothelial growth factor (VEGF). Ziv-aflibercept is an adaptive variant of Aflibercept (HY-108801), Ziv-aflibercept has a low PH value and high osmotic pressure when compared to Aflibercept. Ziv-aflibercept has potential applications in metastatic colorectal carcinoma and retinal diseases .
|
-
- HY-P99605
-
PRS 343
|
EGFR
TNF Receptor
|
Cancer
|
Cinrebafusp alfa (PRS 343) is a high affinity CD137/HER2 bispecfic anticalin-based drug. Cinrebafusp alfa binds to recombinant human HER2 (Kd=0.3 nM) and human monomeric CD137 (4-1BB; Kd=5 nM). Cinrebafusp alfa facilitates T-cell costimulation by tumor-localized, HER2-dependent 4-1BB clustering and activation, further enhancing T-cell receptor-mediated activity and leading to tumor destruction. Cinrebafusp alfa has the potential for HER2+ solid tumors research .
|
-
- HY-P99480
-
M7824; MSB0011359C
|
TGF-β Receptor
|
Cancer
|
Bintrafusp alfa (M 7824) is a first-in-class bifunctional fusion protein composed of the extracellular domain of TGF-βRII fused to a human IgG1 mAb blocking programmed cell death ligand. Bintrafusp alfa can be used for the research of cancer .
|
-
- HY-P99974
-
|
Microtubule/Tubulin
Apoptosis
Autophagy
|
Cancer
|
Nab-Paclitaxel is an albumin-bound nanoparticle formulation of Paclitaxel (HY-B0015). Nab-Paclitaxel is composed of albumin and the active pharmaceutical ingredient Paclitaxel (Paclitaxel: human albumin=1:9), in which human albumin is used as an excipient to disperse and stabilize particles and carry the main drug. Nab-Paclitaxel was associated with higher response rates and better tolerability, with favorable pharmacokinetic properties .
|
-
- HY-119594
-
|
Parasite
|
Infection
|
Melarsoprol, a melaminophenylarsine-type trivalent organic arsenical, is an important drug for African trypanosomiasis. Melarsoprol is also active against leukemia cell lines and plasma cells from myeloma patients. Melarsoprol increases the biliary output of GSH in rats .
|
-
- HY-108829A
-
CTLA4lg (powder); BMS-188667 (powder)
|
CTLA-4
|
Inflammation/Immunology
Cancer
|
Abatacept (CTLA4lg; BMS-188667) powder is a soluble fusion protein consisting of the extra-cellular domain of human CTLA4 and a fragment of the Fc portion of human IgG1 (hinge and CH2 and 3 domains). Abatacept powder is a selective T-cell co-stimulation modulator and a protein agent for the autoimmune diseases .
|
-
- HY-P99829
-
PF-06647020; ABBV-647; h6M24-vc0101
|
Antibody-Drug Conjugates (ADCs)
Microtubule/Tubulin
|
Cancer
|
Cofetuzumab pelidotin (PF-06647020) is a PTK7-targeting ADC comprising a humanized anti-PTK7 mAb (hu6M024, IgG1) joined to an auristatin microtubule inhibitor payload, auristatin-0101 (Aur0101; HY-12522), by a cleavable valine-citrulline (vc)-based linker. Cofetuzumab pelidotin has a DAR of 4. Cofetuzumab pelidotin binds to cell-surface PTK7 with an EC50 of 1153 pM by flow cytometry. Cofetuzumab pelidotin has the potential for solid tumors research .
|
-
- HY-P990305
-
-
- HY-126526
-
|
ADC Linker
|
Cancer
|
N3-PEG2-C2-NHS ester is a nonclaevable 2-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs). N3-PEG2-C2-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-126527
-
|
ADC Linker
|
Cancer
|
N3-PEG2-C2-PFP ester is a nonclaevable 2-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs). N3-PEG2-C2-PFP ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-126528
-
|
ADC Linker
|
Cancer
|
N3-PEG3-C2-NHS ester is a nonclaevable 3-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs). N3-PEG3-C2-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-126529
-
|
ADC Linker
|
Cancer
|
N3-PEG3-C2-PFP ester is a nonclaevable 3-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs). N3-PEG3-C2-PFP ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-130108
-
|
ADC Linker
|
Cancer
|
N3-PEG4-C2-Pfp ester is a nonclaevable 4-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs). N3-PEG4-C2-Pfp ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-130109
-
|
ADC Linker
|
Cancer
|
N3-PEG4-C2-NHS ester is a nonclaevable 4-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs). N3-PEG4-C2-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-101157
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Propargyl-PEG5-acid is a non-cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Propargyl-PEG5-acid can used to synthesize ADC inhibitors of Galectin-3. Propargyl-PEG5-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Propargyl-PEG5-acid is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-130475
-
|
PROTAC Linkers
ADC Linker
|
Inflammation/Immunology
Cancer
|
Azido-PEG9-acid is a non-cleavable 9 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG9-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Azido-PEG9-acid is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-140454
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Azido-PEG8-acid is a non-cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG8-acid is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG8-acid is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-140133
-
|
ADC Linker
|
Cancer
|
PC-Biotin-PEG4-PEG3-azide is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . PC-Biotin-PEG4-PEG3-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-136058
-
|
ADC Linker
|
Cancer
|
N3-PEG4-amido-Lys(Fmoc)-acid is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . N3-PEG4-amido-Lys(Fmoc)-acid is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-136079
-
|
ADC Linker
|
Cancer
|
Methyltetrazine-PEG4-hydrazone-DBCO is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Methyltetrazine-PEG4-hydrazone-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups. Methyltetrazine-PEG4-hydrazone-DBCO also contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
-
- HY-136318
-
|
ADC Linker
|
Cancer
|
β-D-tetraacetylgalactopyranoside-PEG1-N3 is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . β-D-tetraacetylgalactopyranoside-PEG1-N3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-136288
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
Azide-PEG4-VC-PAB-Doxorubicin is a agent-linker conjugate composed of a cytotoxic anthracycline antibiotic Doxorubicin and a linker Azide-PEG4-VC-PAB to make antibody agent conjugate (ADC) . Azide-PEG4-VC-PAB-Doxorubicin is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-147363
-
|
Drug-Linker Conjugates for ADC
|
Others
|
DIBAC-GGFG-NH2CH2-Dxd (compound LP4), a Camptothecin (HY-16560) derivative, is a linker-payload of protein-agent conjugates . Dxd (HY-13631D) can be used as a payload for the antibody-coupling drug ADC (DS-8201a).DIBAC-GGFG-NH2CH2-Dxd is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-153808A
-
Montanide ISA-51
|
Others
|
Inflammation/Immunology
|
Incomplete Freund's adjuvant (IFA) (Montanide ISA-51) is an immunoadjuvant emulsified with antigen by its discoverer Jules T. Freund. Incomplete Freund's adjuvant (IFA) does not contain inactivated tuberculosis bacilli and consists of petroleum jelly containing lanolin. Incomplete Freund's adjuvant (IFA) induces high antibody titers and long-lasting effector T cell responses with no long-term effects on collagen disease, tumors, or death. Complete Freund's adjuvant (CFA) (HY-153808) is another type of Freund's Adjuvant that stimulates a stronger immune response .
|
-
- HY-D1272
-
Sulfo-Cyanine3 amine
|
Fluorescent Dye
|
Others
|
Sulfo-Cy3 amine is a dye derivative of Cyanine 3 (Cy3) (HY-D0822) bearing an amine group. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy3 is a fluorescent dye with a fluorescence spectrum typically in the green to orange wavelength range. The amine functionality of Sulfo-Cy3 amine can react with carboxyl groups to form covalent bonds. Sulfo-Cy3 amine can bind to biological molecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
|
-
- HY-D1318
-
|
Fluorescent Dye
|
Others
|
Cyanine7.5 azide chloride is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) with an azide functional group. Cy7.5 is a near-infrared fluorescent dye commonly used for biolabeling and cell imaging. The azide group of Cyanine7.5 azide chloride can react chemically with molecules containing alkyne functionality, such as alkyne or cyclooctyne, to form covalent bonds. Therefore, Cyanine7.5 azide chloride can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
|
-
- HY-D1375
-
|
Fluorescent Dye
|
Others
|
Sulfo-Cy5 amine is a dye derivative of Cyanine 5 (Cy5) (HY-D0821) bearing an amine group. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy5 is a near-infrared fluorescent dye commonly used in biolabeling and cell imaging. The amine functionality of Sulfo-Cy5 amine can react with carboxyl groups to form covalent bonds. Sulfo-Cy5 amine can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
|
-
- HY-D1864
-
|
Fluorescent Dye
|
Others
|
Sulfo-Cy7.5 dicarboxylic acid is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) with carboxylic acid and sulfonate functional groups. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy7.5 is a near-infrared fluorescent dye commonly used in biomedical research areas such as biomarkers and cell imaging. Sulfo-Cy7.5 dicarboxylic acid can be covalently bound to some biomolecules (especially antibodies, proteins, etc.) to track their location and dynamic changes in biological samples.
|
-
- HY-B1610N
-
|
Biochemical Assay Reagents
|
Others
|
Sodium citrate buffer, 0.1M, pH 4.0, is a commonly used buffer with main components are citric acid and sodium hydrogen phosphate. Sodium citrate buffer, 0.1M, pH 4.0 is used in heat induced epitope retrieval (HIER) methods to reverse the loss of antigenicity that occurs with some epitopes in formalin-fixed paraffin embedded tissues. Sodium citrate buffer, 0.1M, pH 4.0 is the preferred solution for most antibodies . Sodium citrate buffer, 0.1M, pH 4.0 is used in the hydration of liposome film .
|
-
- HY-130990
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
DBCO-PEG4-Val-Cit-PAB-MMAF consists a cleavable 4 unit PEG ADC linker (DBCO-PEG4-Val-Cit-PAB) and a potent tubulin polymerization inhibitor (MMAF). DBCO-PEG4-Val-Cit-PAB-MMAF can be used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG4-Val-Cit-PAB-MMAF is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-130169
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Azido-PEG9-amine is a non-cleavable 9 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG9-amine is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG9-amine is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-130324
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Azido-PEG7-amine is a non-cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG7-amine is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG7-amine is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-130435
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
DBCO-PEG4-amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. DBCO-PEG4-amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). DBCO-PEG4-amine can be used in the synthesis of FPM-PEG4-DBCO (a homobifunctional azide-to-azide cross-linker) . DBCO-PEG4-amine is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-113931
-
|
PROTAC Linkers
ADC Linker
|
Cancer
|
Aminooxy-PEG2-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Aminooxy-PEG2-azide is also a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Aminooxy-PEG2-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-130211
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Azido-PEG5-alcohol is a non-cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG5-alcohol is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG5-alcohol is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-130537
-
|
PROTAC Linkers
ADC Linker
|
Cancer
|
Azido-PEG6-alcohol is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG6-alcohol is also a non-cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG6-alcohol is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-140004
-
|
PROTAC Linkers
ADC Linker
|
Cancer
|
Azide-PEG3-Tos is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azide-PEG3-Tos is also a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azide-PEG3-Tos is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-140215
-
|
PROTAC Linkers
ADC Linker
|
Cancer
|
Azido-PEG6-amine is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG6-amine is also a non-cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG6-amine is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-140101
-
|
ADC Linker
|
Cancer
|
Azido-C2-SS-PEG2-C2-acid is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-C2-SS-PEG2-C2-acid is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-130957
-
|
ADC Linker
|
Cancer
|
Amino-PEG6-amido-bis-PEG5-N3 is a cleavable 11 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Amino-PEG6-amido-bis-PEG5-N3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-130969
-
|
ADC Linker
|
Cancer
|
Ald-Ph-PEG4-bis-PEG3-N3 is a cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Ald-Ph-PEG4-bis-PEG3-N3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-136090
-
|
ADC Linker
|
Cancer
|
Amino-PEG4-bis-PEG3-N3 is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Amino-PEG4-bis-PEG3-N3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-153083
-
|
SARS-CoV
|
Infection
|
COVID-19 Spike Protein mRNA will express COVID-19 spike protein, and suitable for detection of RNA delivery, translation efficiency, cell viability, etc. COVID-19 spike protein is the novel coronavirus pneumonia spike protein located on the membrane surface. COVID-19 spike protein undertakes the functions of virus binding to host cell membrane receptors and membrane fusion, thereby mediating the entry of COVID-19 virus into cells. COVID-19 spike protein is an important site of action for host neutralizing antibodies and a key target for vaccine design .
|
-
- HY-D1861
-
|
Fluorescent Dye
|
Others
|
Sulfo-Cy3 hydrazide is a Cyanine 3 (Cy3) (HY-D0822) dye derivative with hydrazine functionality. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy3 is a fluorescent dye with a fluorescence spectrum typically in the green to orange wavelength range. The hydrazide group of Sulfo-Cy3 hydrazide can form hydrazinone coupling with molecules containing aldehydes or ketones to form covalent bonds. Therefore, Cy3 azide plus can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
|
-
- HY-D1862
-
|
Fluorescent Dye
|
Others
|
Cy7.5 alkyne chloride is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) containing a sulfonate ion and an alkyne functional group. Cy7.5 is a near-infrared fluorescent dye commonly used for biolabeling and cell imaging. The alkyne functional group of Cy7.5 alkyne chloride can react with molecules containing the azide functional group to form covalent bonds. Cy7.5 alkyne chloride can bind to biological molecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
|
-
- HY-D1866
-
|
Fluorescent Dye
|
Others
|
Sulfo-Cy7.5 carboxylic acid is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) with carboxylic acid and sulfonate ion (sulfonate) functional groups. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy7.5 is a near-infrared fluorescent dye commonly used in biomedical research areas such as biomarkers and cell imaging. Sulfo-Cy7.5 carboxylic acid can be covalently bound to some biomolecules (especially antibodies, proteins, etc.) to track their location and dynamic changes in biological samples.
|
-
- HY-125858B
-
|
Others
|
Others
|
(S,R,S)-MI-1061 is the isomer of MI-1061(HY-125858). (S,R,S)-MI-1061 can used to synthesize Antibody-Drug Conjugates (ADCs). MI-1061 is a potent, orally bioavailable, and chemically stable MDM2 (MDM2-p53 interaction) inhibitor (IC50=4.4 nM; Ki=0.16 nM). MI-1061 potently activates p53 and induces apoptosis in the SJSA-1 xenograft tumor tissue in mice. Anti-tumor activity .
|
-
- HY-B1610J
-
|
Biochemical Assay Reagents
|
Others
|
Sodium citrate buffer, 0.5M, pH 5.0, is a commonly used buffer with main components are citric acid and sodium hydrogen phosphate. Sodium citrate buffer, 0.5M, pH 5.0 is used in heat induced epitope retrieval (HIER) methods to reverse the loss of antigenicity that occurs with some epitopes in formalin-fixed paraffin embedded tissues. Sodium citrate buffer, 0.5M, pH 5.0 is the preferred solution for most antibodies . Sodium citrate buffer, 0.5M, pH 5.0 is used as solution for captisol in animal tumor models .
|
-
- HY-136314
-
|
Drug-Linker Conjugates for ADC
|
Cancer
|
DBCO-PEG4-VC-PAB-MMAE consists a ADC linker (DBCO-PEG4-VC-PAB) and a tubulin polymerization inhibitor MMAE (HY-15162). DBCO-PEG4-VC-PAB-MMAE can be used in the synthesis of antibody-agent conjugates (ADCs). MMAE is a synthetic derivative of dolastatin 10 and functions as a potent mitotic inhibitor by inhibiting tubulin polymerization. DBCO-PEG4-VC-PAB-MMAE is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-130572
-
|
PROTAC Linkers
ADC Linker
|
Inflammation/Immunology
Cancer
|
Azido-PEG5-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs, such as the conjugate CPT-APO (CPT: Camptothecin (HY-16560)). Azido-PEG5-acid is a non-cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG5-acid is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-126949
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Aminooxy-PEG3-azide is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Aminooxy-C2-PEG3-azide is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Aminooxy-PEG3-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-130184
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Azido-PEG8-NHS ester is a cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG8-NHS ester is also a PEG- and Alkyl/ether-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG8-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-130474
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Azido-PEG6-NHS ester is a cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG6-NHS ester is also a PEG- and Alkyl/ether based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG6-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-140310
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
TCO-PEG4-DBCO is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. TCO-PEG4-DBCO is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . TCO-PEG4-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups. TCO-PEG4-DBCO also contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
|
-
- HY-153234
-
|
CD19
Liposome
|
Inflammation/Immunology
Cancer
|
CD19 car circRNA-LNP is a lipid nanoparticle (LNP) containing CD19 car circRNA, suitable for detection of RNA delivery, translation efficiency, cell viability, etc. CD19 car circRNA can be used in chimeric antigen receptor T cell immunotherapy (CAR-CD19). The CD19 car is a chimeric antigen receptor. Among them, CD19 is a CD molecule expressed by B cells (i.e. leukocyte differentiation antigen), an important membrane antigen involved in B cell proliferation, differentiation, activation and antibody production, and can also promote BCR signal transduction .
|
-
- HY-153233
-
|
CD19
Liposome
|
Inflammation/Immunology
Cancer
|
CD19 car mRNA-LNP is a lipid nanoparticle (LNP) containing CD19 car mRNA, suitable for detection of RNA delivery, translation efficiency, cell viability, etc. CD19 car mRNA can be used in chimeric antigen receptor T cell immunotherapy (CAR-CD19). The CD19 car is a chimeric antigen receptor. Among them, CD19 is a CD molecule expressed by B cells (i.e. leukocyte differentiation antigen), an important membrane antigen involved in B cell proliferation, differentiation, activation and antibody production, and can also promote BCR signal transduction .
|
-
- HY-D1867
-
|
Fluorescent Dye
|
Others
|
Sulfo-Cy3-PEG2-TCO disodium is a derivative of Cy3 (Cyanine3) (HY-D0822) dye containing sulfonate and TCO groups. The TCO groups of Sulfo-Cy3-PEG2-TCO disodium react with tetrazine functional groups in highly specific click chemistry to form covalent bonds. Thus, Sulfo-Cy3-PEG2-TCO disodium can be covalently bound to some biomolecules (especially antibodies, proteins, etc.) to track their location and dynamic changes in biological samples.
|
-
- HY-D1863
-
|
Fluorescent Dye
|
Others
|
sulfo-Cy7.5 amine is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) bearing an amine group. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy7.5 is a near-infrared fluorescent dye commonly used for biolabeling and cell imaging. The amine functionality of sulfo-Cy7.5 amine can react with carboxyl groups to form covalent bonds. Sulfo-Cy7.5 amine can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
|
-
- HY-129937A
-
|
PROTACs
Epigenetic Reader Domain
|
Cancer
|
GNE-987 is a PROTAC connected by ligands for von Hippel-Lindau and BRD4. GNE-987 exhibits picomolar cell BRD4 degradation activity (DC50=0.03 nM for EOL-1 AML cell line). GNE-987 binds equipotently to the BD1 and BD2 bromodomains of BRD4 with low nanomolar affinities (IC50=4.7 and 4.4 nM, respectively). GNE-987 incorporates a potent BET binder/inhibitor, a VHL-binding fragment, and a ten methylene spacer moiety. GNE-987 can be used in PROTAC-Antibody Conjugate (PAC) .
|
-
- HY-140149
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Azido-PEG4-Val-Cit-PAB-OH is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG4-Val-Cit-PAB-OH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG4-Val-Cit-PAB-OH is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-140150
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Azido-PEG3-Val-Cit-PAB-PNP is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG3-Val-Cit-PAB-PNP is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG3-Val-Cit-PAB-PNP is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-130690
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Propargyl-PEG1-SS-PEG1-C2-Boc is a Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG1-SS-PEG1-C2-Boc is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG1-SS-PEG1-C2-Boc is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-130485
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Bromo-PEG2-C2-azide is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Bromo-PEG2-C2-azide is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Bromo-PEG2-C2-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-136129
-
|
ADC Linker
|
Cancer
|
N,N-Bis(PEG2-N3)-N-amido-PEG2-thiol is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . N,N-Bis(PEG2-N3)-N-amido-PEG2-thiol is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-D1870
-
|
Fluorescent Dye
|
Others
|
Sulfo-Cy3-PEG3-biotin potassium is a biotin-modified derivative of Cy3 (Cyanine3) (HY-D0822) dye containing a TCO group. The TCO group of Sulfo-Cy3-PEG3-biotin potassium reacts with the tetrazine functional group in highly specific click chemistry to form a covalent bond. Thus, Sulfo-Cy3-PEG3-biotin potassium can be covalently bound to some biomolecules (especially antibodies, proteins, etc.) to track their location and dynamic changes in biological samples. And because it is labeled with biotin, it is often used in affinity chromatography experiments, such as immunoprecipitation.
|
-
- HY-D1859
-
|
Fluorescent Dye
|
Others
|
Sulfo-Cy7.5 alkyne is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) containing a sulfonate ion and an alkyne functional group. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy7.5 is a near-infrared fluorescent dye commonly used for biolabeling and cell imaging. The alkyne functionality of Sulfo-Cy7.5 alkyne can react with molecules containing the azide functionality to form covalent bonds. Sulfo-Cy7.5 alkyne can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
|
-
- HY-130653
-
|
PROTAC Linkers
ADC Linker
|
Inflammation/Immunology
Cancer
|
Azido-PEG4-C2-acid a PEG-based PROTAC linker can be used in the synthesis of vRucaparib-TP4. Azido-PEG4-C2-acid is also a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG4-C2-acid is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-130144
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Ald-CH2-PEG3-azide is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Ald-CH2-PEG3-azide is a PEG-based PROTAC linker can be used in the synthesis of PROTACs . Ald-CH2-PEG3-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-151769
-
|
ADC Linker
|
Others
|
TCO-PEG2-Sulfo-NHS ester-EDC Urea is a click chemistry reagent containing an azide group. TCO-PEG2-Sulfo-NHS ester is a PEG linker containing a TCO moiety and a sulfo-NHS ester moiety. The sulfo group makes this molecule soluble in waqueous buffer. This reagent can be used to label antibodies, proteins and other primary amine-containing macromolecules with TCO moiety. Reagent grade, for research use only . TCO-PEG2-Sulfo-NHS ester-EDC Urea is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
|
-
- HY-D1850
-
|
Fluorescent Dye
|
Others
|
Sulfo-Cy7.5 azide is a Cyanine 7.5 (Cy7.5) (HY-D0926) dye derivative with azide and sulfonate functional groups. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy7.5 is a near-infrared fluorescent dye commonly used for biolabeling and cell imaging. The azide group of Sulfo-Cy7.5 azide can react chemically with molecules containing alkyne functionality, such as alkyne or cyclooctyne, to form covalent bonds. Therefore, Sulfo-Cy7.5 azide can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
|
-
- HY-42618
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Azido-PEG4-CH2-Boc is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG4-CH2-Boc is also a PEG- and Alkyl/ether-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG4-CH2-Boc is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-130946
-
|
ADC Linker
|
Cancer
|
NH2-C5-PEG4-N3-L-Lysine-PEG3-N3 is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . NH2-C5-PEG4-N3-L-Lysine-PEG3-N3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-130194
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
Azido-PEG5-CH2CO2H is a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG5-CH2CO2H is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG5-CH2CO2H is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-42490
-
|
PROTAC Linkers
ADC Linker
|
Inflammation/Immunology
Cancer
|
N3-PEG3-CH2CH2COOH a PEG-based PROTAC linker can be used in the synthesis of BI-3663 (HY-111546), BI-4216 and BI-0319. Azido-PEG3-acid is also a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N3-PEG3-CH2CH2COOH is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-42489
-
|
ADC Linker
PROTAC Linkers
|
Cancer
|
N3-PEG3-CH2CH2-Boc is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . N3-PEG3-CH2CH2-Boc is also a PEG- and Alkyl/ether-based PROTAC linker that can be used in the synthesis of PROTACs . N3-PEG3-CH2CH2-Boc is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-140213
-
N3-PEG2-CH2CH2NH2
|
PROTAC Linkers
ADC Linker
|
Cancer
|
Azido-PEG2-C2-amine (N3-PEG2-CH2CH2NH2) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG2-C2-amine is also a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG2-C2-amine is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
-
-
HY-L177
-
|
21 compounds
|
Antibody inhibitors are compounds with the same activity as the original therapeutic antibodies, which can be used as positive controls for drug efficacy evaluation and other studies. Antibody inhibitors can also assist in verifying the functional activity of the target protein. These antibody inhibitors are active in vivo and can achieve certain physiological functions by blocking or neutralizing target proteins, such as CD20, HER2, EGFR, VEGFR, TNF-α, etc. In drug screening, antibody inhibitor-based screening can be carried out to identify active compounds targeting target proteins and target diseases.
MCE can provide 21 antibody inhibitors that can be used for drug development in cancer, immunity, infection and other hot research areas.
|
-
-
HY-L023
-
|
94 compounds
|
Antibody-Drug Conjugates (ADCs), a new class of treatment for cancer, are composed with a monoclonal antibody, a linker and a cytotoxic agent also referred to as a payload. To date, several ADCs have received market approval and more than 60 ADCs are currently in clinical trials. ADCs are one of the fastest growing classes of oncology drugs worldwide.
The payload or cytotoxic agent is the most important unit in the ADC. ADC has the capability to kill cancer cell depending on the potency of the payload. MCE provides 94 highly potent cytotoxins that contain auristatin derivatives, maytansinoids, calicheamicin, duocarmycin, pyrrolobenzodiazepines (PBDs), etc.
|
-
-
HY-L080
-
|
107 compounds
|
Targeted cancer therapies are drugs or other substances that block the growth and spread of cancer by interfering with specific molecular targets that are involved in the growth, progression, and spread of cancer.
There are several different types of targeted therapy. The most common types are small-molecule drugs and monoclonal antibodies. Small-molecule drugs are small enough to enter cells easily, so they are used for targets that are inside cells, while monoclonal antibodies are usually used for targets that are located outside the cells. Because of high specificity, low side effect and potent anticancer activity, targeted therapy has become the mainstream of new anti-tumor drugs. Various targeted therapies have been approved by FDA and used in the treatment of diseases.
MCE carefully collects a unique of 107 targeted therapy drugs used in cancer treatment. MCE Targeted therapy drug library is a useful tool for the research of targeted therapy.
|
-
-
HY-L031
-
|
494 compounds
|
Immuno-Oncology is a type of immunotherapy that has the specific purpose of treating cancer. It works by stimulating our immune system to fight back. Normally, our immune system is able to destroy cancer cells in our body, however sometimes cancer cells can adapt and mutate, effectively hiding from our immune system. This is when tumors can develop and become a threat to our health. Immuno-oncology involves mobilizing lymphocytes to recognize and eliminate cancer cells using the body’s immune system. There are several immuno-oncology treatments available, including Immune cell therapy (CAR-T), monoclonal antibodies (mABs) and checkpoint inhibitors, cytokines and cancer vaccines.
MCE Small Molecule Immuno-Oncology Compound Library offers 494 bioactive tumor immunology compounds that target some important checkpoints such as PD1/PD-L1, CXCR, Sting, IDO, TLR, etc. This library is a useful tool for Immuno-oncology research.
|
Cat. No. |
Product Name |
Type |
-
- HY-D0871
-
N-Cyclohexyltaurine
|
Dyes
|
CHES (N-Cyclohexyltaurine) is a zwitterionic buffer. CHES can bind to hemagglutinin (HA) emulating with sialic acid (SA) and receptor binding site (RBS)-targeting broadly neutralizing antibodies .
|
-
- HY-138200
-
Cyanine5 maleimide
|
Fluorescent Dyes/Probes
|
Cy5 maleimide is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
|
-
- HY-D1389
-
Sulfo-Cyanine5.5 NHS ester tripotassium
|
Fluorescent Dyes/Probes
|
Sulfo-CY-5.5 NHS ester (Sulfo-Cyanine5.5 NHS ester) tripotassium is an amine-reactive ester of sulfonated far-red Cyanine5.5 fluorophore, which can be used to label antibodies, proteins, etc., as well as for in vivo NIR imaging .
|
-
- HY-137098
-
|
Fluorescent Dyes/Probes
|
Sulfo-Cy3 maleimide potassium is a fluorescent dye with a maleimide functionality at the end a short alkyl linker. Sulfo-Cy3 maleimide potassium can be used for the labeling of antibodies and other labile proteins .
|
-
- HY-D2194
-
|
Fluorescent Dyes/Probes
|
AgAuSe-COOH (1000 nm) is a fluorescent quantum dot that emits fluorescence in the near-infrared II region, with an emission peak reaching 1000 nm. AgAuSe-COOH (1000 nm) has the advantages of narrow band gap, large Stokes shift, and good photostability. AgAuSe-COOH (1000 nm) can bind proteins, antibodies, peptides, PEG, etc., and can be widely used in the field of biological imaging.
|
-
- HY-D0153
-
|
Fluorescent Dyes/Probes
|
Tetramethylrhodamine-5-isothiocyanate is a potent fluorescent dye. Tetramethylrhodamine-5-isothiocyanate can be used for label PG-M3 antibody for rapid diagnosis of acute promyelocytic leukemia (APL). Tetramethylrhodamine-5-isothiocyanate can be used as probe to quantify in vivo the biodistribution of PLGA (poly(lactic-co-glycolic) acid) and PLGA/chitosan nanoparticles .
|
-
- HY-D0922
-
-
- HY-D0922A
-
-
- HY-D2174
-
|
Fluorescent Dyes/Probes
|
AF488 amine is a bright, green-fluorescent dye used for labeling molecule such as antibodies .
|
-
- HY-D1840
-
|
Dyes
|
Tyramide Amplification Buffer is a ready-to-use buffer primarily intended for immunostaining of cells and tissues by the technique of tyramide signal amplification (TSA). TSA Technology is based on a tyrosinase labeling system that reacts a tyrosine-labeled antibody with a fluorescently labeled tyramide using peroxidase to form a highly amplified fluorescent signal. For example, horseradish peroxidase (HRP) can catalyze the reaction of tyrosine and hydrogen peroxide under milder conditions to generate epoxy groups. Epoxy groups promote the binding of tyramide to adjacent amino acids to form fluorescently labeled products .
|
-
- HY-D0821
-
Sulfo-Cyanine5
|
Protein Labeling
|
CY5 is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
|
-
- HY-D1054
-
Cyanine2 (iodine)
|
Fluorescent Dyes/Probes
|
Cy2 iodine is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
|
-
- HY-112498
-
Cyanine3 NHS ester
|
Fluorescent Dyes/Probes
|
Cy3 NHS ester is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
|
-
- HY-D1388
-
|
Fluorescent Dyes/Probes
|
Cy3 NHS ester is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
|
-
- HY-135415
-
|
Fluorescent Dyes/Probes
|
Cyanine5.5 NHS ester chloride is a reactive dye for the labeling of proteins, and antibodies and small molecular compounds .
|
-
- HY-135415A
-
|
Fluorescent Dyes/Probes
|
Cyanine5.5 NHS ester chloride TEA is a reactive dye for the labeling of proteins, and antibodies and small molecular compounds .
|
-
- HY-D0824
-
Sulfo-Cyanine7 Succinimidyl Ester
|
Fluorescent Dyes/Probes
|
CY7-SE is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
|
-
- HY-D0826
-
Cyanine2 Succinimidyl Ester (iodine)
|
Protein Labeling
|
Cy2-SE iodine is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
|
-
- HY-D0824A
-
Sulfo-Cyanine7 Succinimidyl Ester triethylamine
|
Fluorescent Dyes/Probes
|
CY7-SE triethylamine is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
|
-
- HY-D1323
-
Cy5.5 maleimide chloride
|
Dyes
|
Cyanine5.5 maleimide chloride is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
|
-
- HY-D1566
-
|
Fluorescent Dyes/Probes
|
Sulfo-Cy7.5 maleimide is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
|
-
- HY-D1565
-
|
Fluorescent Dyes/Probes
|
Cy7.5 maleimide is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
|
-
- HY-D0924B
-
Sulfo-Cyanine5.5 TEA
|
Fluorescent Dyes/Probes
|
Cy5.5 TEA is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
|
-
- HY-D0924A
-
Sulfo-Cyanine5.5 acetate
|
Fluorescent Dyes/Probes
|
Cy5.5 acetate is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
|
-
- HY-15943
-
6-TAMRA
1 Publications Verification
6-Carboxytetramethylrhodamine
|
Fluorescent Dyes/Probes
|
6-TAMRA has been a widely used fluorophore for preparing bioconjugates, especially fluorescent antibody and avidin derivatives used in immunochemistry.
|
-
- HY-D1941
-
|
Fluorescent Dyes/Probes
|
ATTO 590 Streptavidin is a streptavidin derivative of ATTO 590, it can label protein or antibody, the maximum excitation/emission wavelength: 594/622 nm.
|
-
- HY-D1947
-
|
Fluorescent Dyes/Probes
|
ATTO 700 Streptavidin is a streptavidin derivative of ATTO 700, it can label protein or antibody, the maximum excitation/emission wavelength: 700/716 nm.
|
-
- HY-D1949
-
|
Fluorescent Dyes/Probes
|
ATTO 594 Streptavidin is a streptavidin derivative of ATTO 594, it can label protein or antibody, the maximum excitation/emission wavelength: 603/626 nm.
|
-
- HY-D1962
-
|
Fluorescent Dyes/Probes
|
ATTO 633 Streptavidin is a streptavidin derivative of ATTO 633, it can label protein or antibody, the maximum excitation/emission wavelength: 630/651 nm.
|
-
- HY-D1963
-
|
Fluorescent Dyes/Probes
|
ATTO 565 Streptavidin is a streptavidin derivative of ATTO 565, it can label protein or antibody, the maximum excitation/emission wavelength: 564/590 nm.
|
-
- HY-D1977
-
|
Fluorescent Dyes/Probes
|
ATTO 610 Streptavidin is a streptavidin derivative of ATTO 610, it can label protein or antibody, the maximum excitation/emission wavelength: 616/633 nm.
|
-
- HY-D1985
-
|
Fluorescent Dyes/Probes
|
ATTO 725 Streptavidin is a streptavidin derivative of ATTO 725, it can label protein or antibody, the maximum excitation/emission wavelength: 728/751 nm.
|
-
- HY-D1987
-
|
Fluorescent Dyes/Probes
|
ATTO 620 Streptavidin is a streptavidin derivative of ATTO 620, it can label protein or antibody, the maximum excitation/emission wavelength: 620/642 nm.
|
-
- HY-D1995
-
|
Fluorescent Dyes/Probes
|
ATTO 647 Streptavidin is a streptavidin derivative of ATTO 647, it can label protein or antibody, the maximum excitation/emission wavelength: 630/651 nm.
|
-
- HY-D2075
-
|
Fluorescent Dyes/Probes
|
ATTO 740 streptavidin is a streptavidin derivative of ATTO 740, it can label protein or antibody, the maximum excitation/emission wavelength: 743/763 nm.
|
-
- HY-D2004
-
|
Fluorescent Dyes/Probes
|
ATTO 488 streptavidin is a streptavidin derivative of ATTO 488, it can label protein or antibody, the maximum excitation/emission wavelength: 500/520 nm.
|
-
- HY-D2048
-
|
Fluorescent Dyes/Probes
|
ATTO 532 streptavidin is a streptavidin derivative of ATTO 532, it can label protein or antibody, the maximum excitation/emission wavelength: 532/552 nm.
|
-
- HY-D2024
-
|
Fluorescent Dyes/Probes
|
ATTO 550 streptavidin is a streptavidin derivative of ATTO 550, it can label protein or antibody, the maximum excitation/emission wavelength: 554/576 nm.
|
-
- HY-D2030
-
|
Fluorescent Dyes/Probes
|
ATTO 514 streptavidin is a streptavidin derivative of ATTO 514, it can label protein or antibody, the maximum excitation/emission wavelength: 511/531 nm.
|
-
- HY-D2023
-
|
Fluorescent Dyes/Probes
|
ATTO 665 streptavidin is a streptavidin derivative of ATTO 665, it can label protein or antibody, the maximum excitation/emission wavelength: 663/680 nm.
|
-
- HY-D2064
-
|
Fluorescent Dyes/Probes
|
ATTO 680 streptavidin is a streptavidin derivative of ATTO 680, it can label protein or antibody, the maximum excitation/emission wavelength: 681/698 nm.
|
-
- HY-78921AG
-
|
Fluorescent Dye
|
Fmoc-3VVD-OH (GMP) is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-D1112
-
|
Fluorescent Dyes/Probes
|
TFAX 546,SE triethylammonium, an amine reactive yellow fluorescent dye, can forms bright and photostable conjugates with proteins and antibodies .
|
-
- HY-D1918
-
|
Fluorescent Dyes/Probes
|
ATTO 390 maleimide is a maleimide ester derivative of ATTO 390, which can be used to label proteins or antibodies. The maximum excitation/emission wavelength: 390/476 nm.
|
-
- HY-D1925
-
|
Fluorescent Dyes/Probes
|
ATTO 425 Maleimide is a maleimide ester derivative of ATTO 425, which can be used to label proteins or antibodies. The maximum excitation emission wavelength: 439/489 nm.
|
-
- HY-D1936
-
|
Fluorescent Dyes/Probes
|
ATTO 465 Maleimid is a maleimide ester derivative of ATTO 465, which can be used to label proteins or antibodies. The maximum excitation/emission wavelength: 453/506 nm.
|
-
- HY-D1948
-
|
Fluorescent Dyes/Probes
|
ATTO 594 Maleimid is a maleimide ester derivative of ATTO 594, which can be used to label proteins or antibodies, with maximum excitation/emission wavelengths: 603/626 nm.
|
-
- HY-D1960
-
|
Fluorescent Dyes/Probes
|
ATTO 633 Maleimid is a maleimide ester derivative of ATTO 633, which can be used to label proteins or antibodies, with maximum excitation/emission wavelengths: 630/651 nm.
|
-
- HY-D1974
-
|
Fluorescent Dyes/Probes
|
ATTO 610 NHS-Ester is an activated ester derivative of ATTO 610, which can directly label proteins or antibodies. The maximum excitation/emission wavelength: 616/633 nm.
|
-
- HY-D1976
-
|
Fluorescent Dyes/Probes
|
ATTO 610 Maleimid is a maleimide ester derivative of ATTO 610, which can be used to label proteins or antibodies, with maximum excitation/emission wavelengths: 616/633 nm.
|
- HY-D1979
-
|
Fluorescent Dyes/Probes
|
ATTO 725 NHS-Ester is an activated ester derivative of ATTO 725, which can directly label proteins or antibodies. The maximum excitation/emission wavelength: 728/751 nm.
|
- HY-D1982
-
|
Fluorescent Dyes/Probes
|
ATTO 725 Maleimid is a maleimide ester derivative of ATTO 725, which can be used to label proteins or antibodies. The maximum excitation/emission wavelength: 728/751 nm.
|
- HY-D1983
-
|
Fluorescent Dyes/Probes
|
ATTO 620 NHS-Ester is an activated ester derivative of ATTO 620, which can directly label proteins or antibodies. The maximum excitation/emission wavelength: 620/642 nm.
|
- HY-D1986
-
|
Fluorescent Dyes/Probes
|
ATTO 620 Maleimid is a maleimide ester derivative of ATTO 620, which can be used to label proteins or antibodies, with maximum excitation/emission wavelengths: 620/642 nm.
|
- HY-D1994
-
|
Fluorescent Dyes/Probes
|
ATTO 647 Maleimid is a maleimide ester derivative of ATTO 647, which can be used to label proteins or antibodies, with maximum excitation/emission wavelengths: 630/651 nm.
|
- HY-D2020
-
|
Fluorescent Dyes/Probes
|
ATTO 665 maleimid is a maleimide ester derivative of ATTO 665, which can be used to label proteins or antibodies. The maximum excitation/emission wavelength: 663/680 nm.
|
- HY-D2028
-
|
Fluorescent Dyes/Probes
|
ATTO 514 maleimid is a maleimide ester derivative of ATTO 514, which can be used to label proteins or antibodies. The maximum excitation/emission wavelength: 511/531 nm.
|
- HY-D1103
-
|
Fluorescent Dyes/Probes
|
SiR dye 1 is a new silicon rhodamine-like fluorescent probe, and can be conjugated with small molecules, peptides and oligonucleotide aminogroups or proteins with antibodies .
|
- HY-D0925B
-
Cyanine5.5 NHS ester TEA
|
Fluorescent Dyes/Probes
|
Cy5.5-SE TEA (Cyanine5.5 NHS ester TEA) is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance . Storage: protect from light.
|
- HY-D1546
-
|
Fluorescent Dyes/Probes
|
Biotin-C2-maleimide is an antibody conjugate reagent, can bind to many biomolecules without significantly changing the biological activity of the target molecule .
|
- HY-78932G
-
|
Fluorescent Dye
|
Dap-NE hydrochloride (GMP) is Dap-NE hydrochloride (HY-78932A) produced by using GMP guidelines. Dap-NE hydrochloride is an intermediate used in the synthesis of antibody-drug conjugates (ADCs) .
|
- HY-153209G
-
|
Fluorescent Dye
|
ISATM51 (GMP) is a GMP grade ISATM51. ISATM51 is a vaccine adjuvant that enhances antigen-specific antibody titers and cytotoxic T lymphocyte (CTL) responses .
|
- HY-D1849
-
|
Fluorescent Dyes/Probes
|
Cy3B NHS ester is a fluorescent dye compound that is commonly used in biomarking and fluorescent labeling experiments, especially for labeling biomolecules containing amino functional groups (amine groups), such as proteins, antibodies or peptides.
|
- HY-19318G
-
|
Fluorescent Dye
|
Fmoc-Val-Cit-PAB GMP is a GMP grade Fmoc-Val-Cit-PAB (HY-19318). Fmoc-Val-Cit-PAB is a cleavable antibody-conjugated active molecule (ADC) commonly used linker.
|
- HY-D2181
-
|
Fluorescent Dyes/Probes
|
Preactivated PE-Cy5.5 Maleimide is a Preactivated PE-Cy5.5 Maleimide, which is a dye that can be used to label molecules such as dye that can be used to label molecules such as antibodies .
|
- HY-D1821
-
VF 750 Carboxylic acid(free acid)
|
Dyes
|
Vari Fluor 750 Carboxylic acid (VF 750 Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
|
- HY-D1822
-
VF 555 Carboxylic acid(free acid)
|
Dyes
|
Vari Fluor 555 Carboxylic acid (VF 555 Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
|
- HY-D1823
-
VF 647A Carboxylic acid(free acid)
|
Dyes
|
Vari Fluor 647A Carboxylic acid (VF 647A Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
|
- HY-D1828
-
VF 640 Carboxylic acid(free acid)
|
Dyes
|
Vari Fluor 640 Carboxylic acid (VF 640 Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
|
- HY-D1824
-
VF 488 Carboxylic acid(free acid)
|
Dyes
|
Vari Fluor 488 Carboxylic acid (VF 488 Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
|
- HY-D1825
-
VF 532 Carboxylic acid(free acid)
|
Dyes
|
Vari Fluor 532 Carboxylic acid (VF 532 Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
|
- HY-D1826
-
VF 594 Carboxylic acid(free acid)
|
Dyes
|
Vari Fluor 594 Carboxylic acid (VF 594 Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
|
- HY-D1827
-
VF 660 Carboxylic acid(free acid)
|
Dyes
|
Vari Fluor 660 Carboxylic acid (VF 660 Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
|
- HY-D1829
-
VF 568 Carboxylic acid(free acid)
|
Dyes
|
Vari Fluor 568 Carboxylic acid (VF 568 Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
|
- HY-D1830
-
VF 680 Carboxylic acid(free acid)
|
Dyes
|
Vari Fluor 680 Carboxylic acid (VF 680 Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
|
- HY-12489
-
Acid Red 112
|
Dyes
|
Ponceau S (Acid Red 112) is a non-specific protein dye commonly used as a stain for Western blot. Ponceau S is used in an acidic aqueous solution that is compatible with antibody-antigen binding and dyes the proteins on the membrane red .
|
- HY-D1049
-
6-((2,4-Dinitrophenyl)amino)hexanoic acid
|
Fluorescent Dyes/Probes
|
DNP-X acid (6-((2,4-Dinitrophenyl)amino)hexanoic acid), an amine-reactive building block for developing a probe, can be recognized by anti-DNP antibodies. DNP-X acid is also an excellent amine-reactive FRET quencher paired with Trp or Tyr.
|
- HY-D1111
-
|
Fluorescent Dyes/Probes
|
TFAX 568, SE is an orange fluorescent dye and exhibits pH-insensitivity over a very broad range (pH in the 4-10). TFAX 568, SE yields exceptionally bright, photostable conjugates with proteins or antibodies (such as goat anti-mouse IgG) .
|
- HY-D1619
-
|
Fluorescent Dyes/Probes
|
Cyanine3 hydrazide dichloride is a carbonyl reactive dye. Cyanine3 hydrazide dichloride allows the labelling of various carbonyl-containing molecules such as antibodies and other glycoproteins after oxidation by periodate, proteins or reducing sugars after oxidative stress or deamination .
|
- HY-131833G
-
|
Fluorescent Dye
|
Fmoc-Gly-Gly-Phe-OH GMP is a GMP grade Fmoc-Gly-Gly-Phe-OH (HY-131833). Fmoc-Gly-Gly-Phe-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
- HY-66019
-
FITC
Maximum Cited Publications
37 Publications Verification
Fluorescein 5-isothiocyanate
|
Fluorescent Dyes/Probes
|
FITC (Fluorescein Isothiocyanate), is one of the green fluorescein derivatives widely used in biology. FITC has the characteristics of high absorptivity, excellent fluorescence quantum yield and good water solubility. The isothiocyanate group of FITC can be combined with amino, sulfhydryl, imidazole, tyrosyl, carbonyl and other groups on the protein, so as to achieve protein labeling including antibodies and lectins. In addition to its use as a protein marker, FITC can also be used as a fluorescent protein tracer to rapidly identify pathogens by labeling antibodies, or for microsequencing of proteins and peptides (HPLC). The maximum excitation wavelength of FITC is 494 nm. Once excited, it fluoresces yellow-green at a maximum emission wavelength of 520 nm.
|
- HY-D1885
-
|
Fluorescent Dyes/Probes
|
Vari Fluor 647 Carboxylic acid free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivative is an inactive labeled fluorescent dye, which can be used to label proteins, antibodies, polysaccharides. The use of Vari Fluor carboxylic acid derivatives requires carboxylic acid activation.
|
- HY-D2267
-
|
Fluorescent Dyes/Probes
|
JF646-Hoechst is a fluorescent red DNA probe that is an ideal substitute for large oligonucleotide-coupled antibodies used in PAINT experiments, especially for bacterial studies. JF646-Hoechst excitation/emission maximum =655/670 nm .
|
- HY-15941
-
Fluorescein 5(6)-isothiocyanate; Fluorescein isothiocyanate 5- and 6- isomers
|
Fluorescent Dyes/Probes
|
5(6)-FITC (Fluorescein 5(6)-isothiocyanate) is an amine-reactive derivative of fluorescein dye that has wide-ranging applications as a label for antibodies and other probes, for use in fluorescence microscopy, flow cytometry and immunofluorescence-based assays such as Western blotting and ELISA.
|
- HY-126851
-
|
Dyes
|
Fluorescein-DBCO is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Fluorescein-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-D1110
-
|
Fluorescent Dyes/Probes
|
TFAX 594,SE is a red fluorescent dye and exhibits pH-insensitivity over a very broad range (pH in the 4-10). TFAX 594,SE yields exceptionally bright, photostable conjugates with proteins or antibodies (such as goat anti-mouse IgG) .
|
- HY-123687
-
|
Dyes
|
DBCO-Sulfo-NHS ester sodium is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-Sulfo-NHS ester (sodium) is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-D1113
-
|
Fluorescent Dyes/Probes
|
TFAX 488,TFP is a green fluorescent dye and exhibits pH-insensitivity over a very broad range (pH in the 4-10). TFAX 488,TFP yields exceptionally bright, photostable conjugates with proteins or antibodies (such as goat anti-mouse IgG, streptavidin) .
|
- HY-D2182
-
|
Fluorescent Dyes/Probes
|
Preactivated PE-Cy5 Maleimide is a sulfhydryl reactive dye that reacts with free sulfhydryl groups on proteins. Preactivated APC-Cy5.5 Maleimide binds easily to proteins or antibodies, and does not change the spectral characteristics of APC-Cy/YF after activation.
|
- HY-D2180
-
|
Fluorescent Dyes/Probes
|
Preactivated APC-Cy5.5 Maleimide is a sulfhydryl reactive dye that reacts with free sulfhydryl groups on proteins. Preactivated APC-Cy5.5 Maleimide binds easily to proteins or antibodies, and does not change the spectral characteristics of APC-Cy/YF after activation.
|
- HY-D1114
-
|
Fluorescent Dyes/Probes
|
TFAX 488,SE dilithium is a green fluorescent dye and exhibits pH-insensitivity over a very broad range (pH in the 4-10). TFAX 488,SE dilithium yields exceptionally bright, photostable conjugates with proteins or antibodies (such as goat anti-mouse IgG, streptavidin) .
|
- HY-20336G
-
|
Fluorescent Dye
|
Mc-Val-Cit-PABC-PNP GMP is a GMP grade Mc-Val-Cit-PABC-PNP (HY-20336). Mc-Val-Cit-PABC-PNP is a cathepsin cleavable ADC linker. Mc-Val-Cit-PABC-PNP can be used in the synthesis of antibody-drug conjugates (ADCs) .
|
- HY-D1305
-
|
Fluorescent Dyes/Probes
|
ATTO 488 carboxylic acid is a new fluorescent label based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 488 carboxylic acid is a carboxylic acid derivative of ATTO 488, which can be used to label proteins or antibodies.
|
- HY-D1917
-
|
Fluorescent Dyes/Probes
|
ATTO 390 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 390 NHS ester is an NHS ester derivative of ATTO 390 that can be used to label proteins or antibodies.
|
- HY-D1929
-
|
Fluorescent Dyes/Probes
|
ATTO 594 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 594 NHS ester is an NHS ester derivative of ATTO 594 that can be used to label proteins or antibodies.
|
- HY-D1932
-
|
Fluorescent Dyes/Probes
|
ATTO 590 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 590 NHS ester is an NHS ester derivative of ATTO 590 that can be used to label proteins or antibodies.
|
- HY-D1933
-
|
Fluorescent Dyes/Probes
|
ATTO 590 maleimide is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 590 maleimide is a maleimide derivative of ATTO 590, which can be used to label proteins or antibodies.
|
- HY-D1935
-
|
Fluorescent Dyes/Probes
|
ATTO 465 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 465 NHS ester is an NHS ester derivative of ATTO 465 that can be used to label proteins or antibodies.
|
- HY-D1939
-
|
Fluorescent Dyes/Probes
|
ATTO 465 amine is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 465 amine is an amine derivative of ATTO 465 and can be used to label proteins or antibodies.
|
- HY-D1946
-
|
Fluorescent Dyes/Probes
|
ATTO 590 alkyne is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 590 alkyne is an alkyne derivative of ATTO 590 and can be used to label proteins or antibodies.
|
- HY-D1957
-
|
Fluorescent Dyes/Probes
|
ATTO 633 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 633 NHS ester is an NHS ester derivative of ATTO 633 that can be used to label proteins or antibodies.
|
- HY-D1959
-
|
Fluorescent Dyes/Probes
|
ATTO 565 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 565 NHS ester is an NHS ester derivative of ATTO 565 that can be used to label proteins or antibodies.
|
- HY-D1961
-
|
Fluorescent Dyes/Probes
|
ATTO 565 maleimide is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 565 maleimide is a maleimide derivative of ATTO 565, which can be used to label proteins or antibodies.
|
- HY-D1993
-
|
Fluorescent Dyes/Probes
|
ATTO 647 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 647 NHS ester is an NHS ester derivative of ATTO 647 that can be used to label proteins or antibodies.
|
- HY-D1999
-
|
Fluorescent Dyes/Probes
|
ATTO 665 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 665 NHS ester is an NHS ester derivative of ATTO 665 that can be used to label proteins or antibodies.
|
- HY-D2001
-
|
Fluorescent Dyes/Probes
|
ATTO 488 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 488 NHS ester is an NHS ester derivative of ATTO 488 that can be used to label proteins or antibodies.
|
- HY-D2002
-
|
Fluorescent Dyes/Probes
|
ATTO 488 maleimide is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 488 maleimide is a maleimide derivative of ATTO 488, which can be used to label proteins or antibodies.
|
- HY-D2014
-
|
Fluorescent Dyes/Probes
|
ATTO 565 alkyne is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 565 alkyne is an alkyne derivative of ATTO 565 and can be used to label proteins or antibodies.
|
- HY-D2015
-
|
Fluorescent Dyes/Probes
|
ATTO 488 alkyne is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 488 alkyne is an alkyne derivative of ATTO 488 and can be used to label proteins or antibodies.
|
- HY-153524
-
|
Fluorescent Dyes/Probes
|
ATTO 425 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 425 NHS ester is an NHS ester derivative of ATTO 425 that can be used to label proteins or antibodies.
|
- HY-D2016
-
|
Fluorescent Dyes/Probes
|
ATTO 565 cadaverine is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 565 cadaverine is a cadaverine derivative of ATTO 565, which can be used to label proteins or antibodies.
|
- HY-D2019
-
|
Fluorescent Dyes/Probes
|
ATTO 550 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 550 NHS ester is an NHS ester derivative of ATTO 550 that can be used to label proteins or antibodies.
|
- HY-D2021
-
|
Fluorescent Dyes/Probes
|
ATTO 550 maleimide is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 550 maleimide is a maleimide derivative of ATTO 550, which can be used to label proteins or antibodies.
|
- HY-D2026
-
|
Fluorescent Dyes/Probes
|
ATTO 514 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 514 NHS ester is an NHS ester derivative of ATTO 514 that can be used to label proteins or antibodies.
|
- HY-D2035
-
|
Fluorescent Dyes/Probes
|
ATTO 514 alkyne is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 514 alkyne is an alkyne derivative of ATTO 514 and can be used to label proteins or antibodies.
|
- HY-D2038
-
|
Fluorescent Dyes/Probes
|
ATTO 550 alkyne is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 550 alkyne is an alkyne derivative of ATTO 550 and can be used to label proteins or antibodies.
|
- HY-D2046
-
|
Fluorescent Dyes/Probes
|
ATTO 532 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 532 NHS ester is an NHS ester derivative of ATTO 532 that can be used to label proteins or antibodies.
|
- HY-D2047
-
|
Fluorescent Dyes/Probes
|
ATTO 532 maleimide is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 532 maleimide is a maleimide derivative of ATTO 532, which can be used to label proteins or antibodies.
|
- HY-D2052
-
|
Fluorescent Dyes/Probes
|
ATTO 532 iodacetamid is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 532 iodacetamid is an iodoacetamide derivative of ATTO 532, which can be used to label proteins or antibodies.
|
- HY-D2058
-
|
Fluorescent Dyes/Probes
|
ATTO 700 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 700 NHS ester is an NHS ester derivative of ATTO 700 that can be used to label proteins or antibodies.
|
- HY-D2059
-
|
Fluorescent Dyes/Probes
|
ATTO 700 maleimide is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 700 maleimide is a maleimide derivative of ATTO 700, which can be used to label proteins or antibodies.
|
- HY-D2062
-
|
Fluorescent Dyes/Probes
|
ATTO 740 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 740 NHS ester is an NHS ester derivative of ATTO 740 that can be used to label proteins or antibodies.
|
- HY-D2063
-
|
Fluorescent Dyes/Probes
|
ATTO 740 maleimide is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 740 maleimide is a maleimide derivative of ATTO 740, which can be used to label proteins or antibodies.
|
- HY-D2073
-
|
Fluorescent Dyes/Probes
|
ATTO 680 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 680 NHS ester is an NHS ester derivative of ATTO 680 that can be used to label proteins or antibodies.
|
- HY-D2074
-
|
Fluorescent Dyes/Probes
|
ATTO 680 maleimide is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 680 maleimide is a maleimide derivative of ATTO 680, which can be used to label proteins or antibodies.
|
- HY-78931G
-
|
Fluorescent Dye
|
Boc-Dap-NE (GMP) is Boc-Dap-NE (HY-78931) produced by using GMP guidelines. Boc-Dap-NE is an intermediate in the synthesis of Monomethyl auristatin E (HY-15162), which is an inhibitor of tubulin polymerization. Monomethyl auristatin E can be used to synthesize Antibody-Drug Conjugates (ADCs) as ADC Cytotoxin.
|
- HY-15579G
-
Monomethylauristatin F (GMP)
|
Fluorescent Dye
|
MMAF (Monomethylauristatin F) GMP is a GMP grade MMAF (HY-15579). MMAF (Monomethylauristatin F) is a potent tubulin polymerization inhibitor and is used as a antitumor agent. MMAF (Monomethylauristatin F) is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) such as vorsetuzumab mafodotin and SGN-CD19A .
|
- HY-15579BG
-
Monomethylauristatin F sodium (GMP)
|
Fluorescent Dye
|
MMAF sodium GMP is a GMP grade MMAF (sodium) (HY-15579B). MMAF sodium (Monomethylauristatin F sodium) is a potent tubulin polymerization inhibitor and is used as a antitumor agent. MMAF sodium (Monomethylauristatin F sodium) is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) such as Vorsetuzumab mafodotin and SGN-CD19A .
|
- HY-137896
-
|
Fluorescent Dyes/Probes
|
4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic acid disodium is a fluorescent dye. 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic acid disodium can be used to demonstrate retrograde axonal transport to label secondary antibodies and as a fluorescent whole cell stain .
|
- HY-W000423G
-
|
Fluorescent Dye
|
DBCO-amine GMP is a GMP grade DBCO-amine (HY-W000423). DBCO-amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-amine is a click chemistry reagent, itcontains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-15578G
-
Maleimidocaproyl monomethylauristatin F (GMP)
|
Fluorescent Dye
|
McMMAF GMP is a GMP grade McMMAF (HY-15578). McMMAF is a protective group (maleimidocaproyl)-conjugated MMAF, which is a potent tubulin polymerization inhibitor. McMMAF can be used as a agent-linker for antibody-drug conjugates (ADC). McMMAF is uncleavable, and must be internalized and degraded within a cell, releasing cysteine-McMMAF as the active agent .
|
- HY-D2291
-
|
Fluorescent Dyes/Probes
|
BODIPY TMR NHS ester is bright, orange fluorescent dye with Ex/Em of 544/570 nm. The NHS ester (or succinimidyl ester) of BODIPY TMR NHS ester is a popular tool for conjugating the dye to a protein or antibody. NHS esters can be used to label the primary amines (R-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules .
|
- HY-D1050
-
6-(2,4-Dinitrophenyl)aminohexanoic acid, succinimidyl ester
|
Fluorescent Dyes/Probes
|
DNP-X, SE (6-(2,4-Dinitrophenyl)aminohexanoic acid, succinimidyl ester), the DNP-X acid modified by succinimidyl ester, is an amine-reactive building block for developing a probe, which can be recognized by anti-DNP antibodies. DNP-X, SE (6-(2,4-Dinitrophenyl)aminohexanoic acid, succinimidyl ester) is also an excellent amine-reactive FRET quencher paired with Trp or Tyr.
|
- HY-D1800
-
VF 680 SE
|
Fluorescent Dyes/Probes
|
Vari Fluor 680 SE (VF 680 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=680 nm/700 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
|
- HY-D1801
-
VF 488 SE
|
Dyes
|
Vari Fluor 488 SE (VF 488 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=488 nm/513 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
|
- HY-D1790
-
VF 640 SE
|
Dyes
|
Vari Fluor 640 SE (VF 640 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=648 nm/664 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
|
- HY-D1802
-
VF 425 SE
|
Dyes
|
Vari Fluor 425 SE (VF 425 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=430 nm/475 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
|
- HY-D1803
-
VF 565 SE
|
Dyes
|
Vari Fluor 565 SE (VF 565 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=563 nm/594 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
|
- HY-D1797
-
VF 660 SE
|
Dyes
|
Vari Fluor 660 SE (VF 660 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=660 nm/679 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
|
- HY-D1798
-
VF 350 SE
|
Dyes
|
Vari Fluor 350 SE (VF 350 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=350 nm/448 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
|
- HY-D1799
-
VF 568 SE
|
Dyes
|
Vari Fluor 568 SE (VF 568 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=573 nm/595 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
|
- HY-D1791
-
VF 750 SE
|
Dyes
|
Vari Fluor 750 SE (VF 750 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=747 nm/770 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
|
- HY-D1792
-
VF 555 SE
|
Dyes
|
Vari Fluor 555 SE (VF 555 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=550 nm/561 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
|
- HY-D1794
-
VF 405 SE
|
Dyes
|
Vari Fluor 405 SE (VF 405 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=399 nm/421 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
|
- HY-D1795
-
VF 532 SE
|
Dyes
|
Vari Fluor 532 SE (VF 532 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=532 nm/545 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
|
- HY-D1796
-
VF 594 SE
|
Dyes
|
Vari Fluor 594 SE (VF 594 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=585 nm/609 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
|
- HY-D1052
-
|
Fluorescent Dyes/Probes
|
Cy7-YNE is a fluorescence labeling agent (Ex=700-770 nm,Em=790 nm). Cyanine dyes are used to label proteins, antibodies, and peptides. Cy7-YNE is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-110211
-
|
Protein Labeling
|
BODIPY TMR-X SE is a potent fluorescent dye. BODIPY TMR-X SE can be used to label the primary amines (R-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules. BODIPY TR-X binds to protein or antibody and has bright, orange fluorescent light. (λex=544 nm, λem=570 nm) .
|
- HY-110212
-
BODIPY TR-X NHS Ester
|
Protein Labeling
|
BODIPY TR-X (BODIPY TR-X NHS Ester) is a potent fluorescent dye. BODIPY TR-X can be used to label the primary amines (R-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules. BODIPY TR-X binds to protein or antibody and has bright, red fluorescent light. (λex=545 nm, λem=560 nm) .
|
- HY-D1742
-
|
Fluorescent Dyes/Probes
|
DRAQ5 is a novel cell permeant and far red-fluorescing DNA probe. DRAQ5 excites at a wavelength of 647 nm, close to the Ex, and produces a fluorescence spectrum extending from 665 nm out to beyond 780 nm wavelengths. DRAQ5 fluorescence reflects cellular DNA content. DRAQ5 can be used in combination with FITC and RPE-labelled antibodies, without the need for fluorescence compensation .
|
- HY-D1848
-
|
Fluorescent Dyes/Probes
|
Sulfo-Cy3-NHS disodium is a derivative of Cy3 (Cyanine3) (HY-D0822) dye containing sulfonate ions. Sulfo-Cy3-NHS disodium contains sulfonate ions and has improved water solubility. Sulfo-Cy3-NHS disodium can label biomolecules containing amine groups, such as proteins, antibodies or peptides.
|
- HY-D2242
-
|
Fluorescent Dyes/Probes
|
Sulfo-Cy7.5 DBCO is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) bearing a DBCO group. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Sulfo-Cy7.5 DBCO can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples .
|
- HY-D1865
-
|
Fluorescent Dyes/Probes
|
Cy3 dimethyl iodide is a dye derivative of Cyanine 3 (Cy3) (HY-D0822) with a dimethyl group in the iodide salt form. The iodide salt form increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy3 is a near-infrared fluorescent dye commonly used in biolabeling and cell imaging. Cy3 dimethyl iodide binds to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
|
- HY-D1317A
-
|
Fluorescent Dyes/Probes
|
Cyanine7.5 carboxylic is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) with carboxylic acid functional groups. Cy7.5 is a near-infrared fluorescent dye commonly used in biomedical research areas such as biomarkers and cell imaging. Cyanine7.5 carboxylic can be covalently bound to some biological molecules (especially antibodies, proteins, etc.) to track their location and dynamic changes in biological samples.
|
- HY-D1852
-
|
Fluorescent Dyes/Probes
|
Cy3B amine chloride is a dye derivative of Cyanine 3 (Cy3) (HY-D0822) bearing an amine group. Cy3 is a fluorescent dye with a fluorescence spectrum typically in the green to orange wavelength range. The amine functionality of Sulfo-Cy3 amine can react with carboxyl groups to form covalent bonds. Sulfo-Cy3 amine can bind to biological molecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
|
- HY-D1846
-
|
Fluorescent Dyes/Probes
|
Sulfo-Cy7.5 dimethyl is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) with a dimethyl group. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy7.5 is a near-infrared fluorescent dye commonly used for biolabeling and cell imaging. Sulfo-Cy7.5 dimethyl binds to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
|
- HY-D1851
-
|
Fluorescent Dyes/Probes
|
Cy3B amine chloride is a dye derivative of Cyanine 3 (Cy3) (HY-D0822) bearing an amine group in the disodium salt form. Cy3 is a fluorescent dye with a fluorescence spectrum typically in the green to orange wavelength range. The amine functionality of Sulfo-Cy3 amine can react with carboxyl groups to form covalent bonds. Sulfo-Cy3 amine can bind to biological molecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
|
- HY-D1860
-
|
Fluorescent Dyes/Probes
|
Cy3 alkyne chloride is a dye derivative of Cyanine 3 (Cy3) (HY-D0822) containing a sulfonate ion and an alkyne functional group. Cy3 is a fluorescent dye with a fluorescence spectrum typically in the green to orange wavelength range. The alkyne functional group of Cy3 alkyne chloride can react with molecules containing the azide functional group to form covalent bonds. Cy3 alkyne chloride can bind to biological molecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
|
- HY-D1868
-
|
Fluorescent Dyes/Probes
|
Cy3 azide plus is a Cyanine 3 (Cy3) (HY-D0822) dye derivative with an azide functional group. Cy3 is a fluorescent dye with a fluorescence spectrum typically in the green to orange wavelength range. The azide group of Cy3 azide plus can react chemically with molecules containing alkyne functionality, such as alkyne or cyclooctyne, to form covalent bonds. Therefore, Cy3 azide plus can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
|
- HY-D1871
-
|
Fluorescent Dyes/Probes
|
Cy3 maleimide chloride is a dye derivative of Cyanine 3 (Cy3) (HY-D0822) containing maleimide functional groups. Cy3 is a fluorescent dye with a fluorescence spectrum typically in the green to orange wavelength range. The alkyne functional group of Cy3 maleimide chloride can undergo a "thiol-acrylamide" reaction with molecules containing sulfur-oxygen functional groups to form covalent bonds. Cy3 maleimide chloride can bind to biological molecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
|
- HY-D1847
-
|
Fluorescent Dyes/Probes
|
Cy7.5 tetrazine tetrafluoroborate is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) bearing a tetrazine group. Cy7.5 is a near-infrared fluorescent dye commonly used for biolabeling and cell imaging. Cy7.5 tetrazine tetrafluoroborate can perform efficient click reactions with molecules containing alkyne functional groups (such as alkyne) to form covalent bonds. It can be combined with biological molecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
|
- HY-131990G
-
|
Fluorescent Dye
|
MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH GMP is a GMP grade MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH (HY-131990). MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
- HY-D1272
-
Sulfo-Cyanine3 amine
|
Fluorescent Dyes/Probes
|
Sulfo-Cy3 amine is a dye derivative of Cyanine 3 (Cy3) (HY-D0822) bearing an amine group. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy3 is a fluorescent dye with a fluorescence spectrum typically in the green to orange wavelength range. The amine functionality of Sulfo-Cy3 amine can react with carboxyl groups to form covalent bonds. Sulfo-Cy3 amine can bind to biological molecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
|
- HY-D1318
-
|
Fluorescent Dyes/Probes
|
Cyanine7.5 azide chloride is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) with an azide functional group. Cy7.5 is a near-infrared fluorescent dye commonly used for biolabeling and cell imaging. The azide group of Cyanine7.5 azide chloride can react chemically with molecules containing alkyne functionality, such as alkyne or cyclooctyne, to form covalent bonds. Therefore, Cyanine7.5 azide chloride can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
|
- HY-D1375
-
|
Fluorescent Dyes/Probes
|
Sulfo-Cy5 amine is a dye derivative of Cyanine 5 (Cy5) (HY-D0821) bearing an amine group. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy5 is a near-infrared fluorescent dye commonly used in biolabeling and cell imaging. The amine functionality of Sulfo-Cy5 amine can react with carboxyl groups to form covalent bonds. Sulfo-Cy5 amine can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
|
- HY-D1864
-
|
Fluorescent Dyes/Probes
|
Sulfo-Cy7.5 dicarboxylic acid is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) with carboxylic acid and sulfonate functional groups. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy7.5 is a near-infrared fluorescent dye commonly used in biomedical research areas such as biomarkers and cell imaging. Sulfo-Cy7.5 dicarboxylic acid can be covalently bound to some biomolecules (especially antibodies, proteins, etc.) to track their location and dynamic changes in biological samples.
|
- HY-D1861
-
|
Fluorescent Dyes/Probes
|
Sulfo-Cy3 hydrazide is a Cyanine 3 (Cy3) (HY-D0822) dye derivative with hydrazine functionality. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy3 is a fluorescent dye with a fluorescence spectrum typically in the green to orange wavelength range. The hydrazide group of Sulfo-Cy3 hydrazide can form hydrazinone coupling with molecules containing aldehydes or ketones to form covalent bonds. Therefore, Cy3 azide plus can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
|
- HY-D1862
-
|
Fluorescent Dyes/Probes
|
Cy7.5 alkyne chloride is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) containing a sulfonate ion and an alkyne functional group. Cy7.5 is a near-infrared fluorescent dye commonly used for biolabeling and cell imaging. The alkyne functional group of Cy7.5 alkyne chloride can react with molecules containing the azide functional group to form covalent bonds. Cy7.5 alkyne chloride can bind to biological molecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
|
- HY-D1866
-
|
Fluorescent Dyes/Probes
|
Sulfo-Cy7.5 carboxylic acid is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) with carboxylic acid and sulfonate ion (sulfonate) functional groups. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy7.5 is a near-infrared fluorescent dye commonly used in biomedical research areas such as biomarkers and cell imaging. Sulfo-Cy7.5 carboxylic acid can be covalently bound to some biomolecules (especially antibodies, proteins, etc.) to track their location and dynamic changes in biological samples.
|
- HY-D1867
-
|
Fluorescent Dyes/Probes
|
Sulfo-Cy3-PEG2-TCO disodium is a derivative of Cy3 (Cyanine3) (HY-D0822) dye containing sulfonate and TCO groups. The TCO groups of Sulfo-Cy3-PEG2-TCO disodium react with tetrazine functional groups in highly specific click chemistry to form covalent bonds. Thus, Sulfo-Cy3-PEG2-TCO disodium can be covalently bound to some biomolecules (especially antibodies, proteins, etc.) to track their location and dynamic changes in biological samples.
|
- HY-D1863
-
|
Fluorescent Dyes/Probes
|
sulfo-Cy7.5 amine is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) bearing an amine group. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy7.5 is a near-infrared fluorescent dye commonly used for biolabeling and cell imaging. The amine functionality of sulfo-Cy7.5 amine can react with carboxyl groups to form covalent bonds. Sulfo-Cy7.5 amine can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
|
- HY-D1870
-
|
Dyes
|
Sulfo-Cy3-PEG3-biotin potassium is a biotin-modified derivative of Cy3 (Cyanine3) (HY-D0822) dye containing a TCO group. The TCO group of Sulfo-Cy3-PEG3-biotin potassium reacts with the tetrazine functional group in highly specific click chemistry to form a covalent bond. Thus, Sulfo-Cy3-PEG3-biotin potassium can be covalently bound to some biomolecules (especially antibodies, proteins, etc.) to track their location and dynamic changes in biological samples. And because it is labeled with biotin, it is often used in affinity chromatography experiments, such as immunoprecipitation.
|
- HY-D1859
-
|
Fluorescent Dyes/Probes
|
Sulfo-Cy7.5 alkyne is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) containing a sulfonate ion and an alkyne functional group. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy7.5 is a near-infrared fluorescent dye commonly used for biolabeling and cell imaging. The alkyne functionality of Sulfo-Cy7.5 alkyne can react with molecules containing the azide functionality to form covalent bonds. Sulfo-Cy7.5 alkyne can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
|
- HY-D1850
-
|
Fluorescent Dyes/Probes
|
Sulfo-Cy7.5 azide is a Cyanine 7.5 (Cy7.5) (HY-D0926) dye derivative with azide and sulfonate functional groups. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy7.5 is a near-infrared fluorescent dye commonly used for biolabeling and cell imaging. The azide group of Sulfo-Cy7.5 azide can react chemically with molecules containing alkyne functionality, such as alkyne or cyclooctyne, to form covalent bonds. Therefore, Sulfo-Cy7.5 azide can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
|
Cat. No. |
Product Name |
Type |
-
- HY-D0871
-
N-Cyclohexyltaurine
|
Dyes
|
CHES (N-Cyclohexyltaurine) is a zwitterionic buffer. CHES can bind to hemagglutinin (HA) emulating with sialic acid (SA) and receptor binding site (RBS)-targeting broadly neutralizing antibodies .
|
-
- HY-147207
-
|
Drug Delivery
|
Phospholipid-PEG-Biotin (MW 1000) is a phospholipid PEG derivative that has a biotin and a phospholipid bridged by a linear PEG linker. Phospholipid-PEG-Biotin (MW 3400) can interact with avidinylated antibodies. Phospholipid-PEG-Biotin (MW 3400) can be used to modify liposome and cells surface, and pancreatic islets for cell transplantation .
|
-
- HY-147207B
-
|
Drug Delivery
|
Phospholipid-PEG-Biotin (MW 3400) is a phospholipid PEG derivative that has a biotin and a phospholipid bridged by a linear PEG linker. Phospholipid-PEG-Biotin (MW 3400) can interact with avidinylated antibodies. Phospholipid-PEG-Biotin (MW 3400) can be used to modify liposome and cells surface, and pancreatic islets for cell transplantation .
|
-
- HY-147207D
-
|
Drug Delivery
|
Phospholipid-PEG-Biotin (MW 10000) is a phospholipid PEG derivative that has a biotin and a phospholipid bridged by a linear PEG linker. Phospholipid-PEG-Biotin (MW 3400) can interact with avidinylated antibodies. Phospholipid-PEG-Biotin (MW 3400) can be used to modify liposome and cells surface, and pancreatic islets for cell transplantation .
|
-
- HY-147207E
-
|
Drug Delivery
|
Phospholipid-PEG-Biotin (MW 20000) is a phospholipid PEG derivative that has a biotin and a phospholipid bridged by a linear PEG linker. Phospholipid-PEG-Biotin (MW 3400) can interact with avidinylated antibodies. Phospholipid-PEG-Biotin (MW 3400) can be used to modify liposome and cells surface, and pancreatic islets for cell transplantation .
|
-
- HY-153235
-
|
Drug Delivery
|
COVID-19 Spike Protein mRNA-LNP is a lipid nanoparticle (LNP) containing COVID-19 Spike Protein, suitable for detection of RNA delivery, translation efficiency, cell viability, etc. COVID-19 Spike Protein is the novel coronavirus pneumonia spike protein located on the membrane surface. COVID-19 Spike Protein undertakes the functions of virus binding to host cell membrane receptors and membrane fusion, thereby mediating the entry of COVID-19 virus into cells. COVID-19 Spike Protein is an important site of action for host neutralizing antibodies and a key target for vaccine design .
|
-
- HY-144003
-
|
Drug Delivery
|
BAY-R 1005, an immunoenhancing agent, is a synthetic glycolipid analogue (GLA), which is supposed to modulate antibody synthesis .
|
-
- HY-78921AG
-
|
Biochemical Assay Reagents
|
Fmoc-3VVD-OH (GMP) is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-W127793
-
(S)-1-(p-Bromoacetamidobenzyl)ethylenediaminetetraacetic acid
|
Biochemical Assay Reagents
|
EDTA-p-Bromoacetamido benzyl ((S)-1-(p-Bromoacetamidobenzyl)ethylenediaminetetraacetic acid) is a compound of EDTA and phenylbromoacetamide that can be coupled to antibodies .
|
-
- HY-W539893
-
NODAG
|
Biochemical Assay Reagents
|
NODAGA-tris(t-Bu ester) (NODAG) is a NODAGA derivative. NODAGA-tris(t-Bu ester) can be used to label peptides, antibodies, etc., and subsequently radiolabeled for PET imaging .
|
-
- HY-78932G
-
|
Biochemical Assay Reagents
|
Dap-NE hydrochloride (GMP) is Dap-NE hydrochloride (HY-78932A) produced by using GMP guidelines. Dap-NE hydrochloride is an intermediate used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-153209G
-
|
Biochemical Assay Reagents
|
ISATM51 (GMP) is a GMP grade ISATM51. ISATM51 is a vaccine adjuvant that enhances antigen-specific antibody titers and cytotoxic T lymphocyte (CTL) responses .
|
-
- HY-Y0332C
-
Sodium phosphate dihydrate,≥99.0%
|
Biochemical Assay Reagents
|
Phosphoric acid (sodium hydrate),≥99.0% is used as a buffer capacity reagent in molecular biology, biochemistry, and chromatography. For the preparation of biological buffers. It is also used to purify antibodies, as a laxative, and in combination with other sodium phosphates
|
-
- HY-Y0332G
-
Potassium phosphate monobasic, for molecular biology
|
Buffer Reagents
|
Potassium dihydrogen phosphate (Potassium phosphate monobasic), for molecular biology, ≥ 99% is used as a buffer capacity reagent in molecular biology, biochemistry, and chromatography. For the preparation of biological buffers. It is also used to purify antibodies, and in combination with other sodium phosphates .
|
-
- HY-19318G
-
|
Biochemical Assay Reagents
|
Fmoc-Val-Cit-PAB GMP is a GMP grade Fmoc-Val-Cit-PAB (HY-19318). Fmoc-Val-Cit-PAB is a cleavable antibody-conjugated active molecule (ADC) commonly used linker.
|
-
- HY-D0860
-
|
Biochemical Assay Reagents
|
Tricine is widely used as a buffer in protein electrophoresis, nucleic acid analysis, and immunology, which can help adjust pH and stabilize chemical reactions. In addition, the compound can also be used in research in certain medical fields, such as in antibody detection and drug screening.
|
-
- HY-131833G
-
|
Biochemical Assay Reagents
|
Fmoc-Gly-Gly-Phe-OH GMP is a GMP grade Fmoc-Gly-Gly-Phe-OH (HY-131833). Fmoc-Gly-Gly-Phe-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-P3028
-
Ficin
|
Biochemical Assay Reagents
|
Ficain is an enzyme extract composed of several proteases that can be isolated from Ficus hispida L. and the latex of fig (Ficus carica). Ficain has different specificities in different proportions during fruit ripening. Ficain is widely used in protein hydrolysis, food, production of bioactive peptides and antibody fragments .
|
-
- HY-Y0332L
-
Potassium phosphate monobasic, meets analytical specification of Ph. Eur., NF, E340
|
Buffer Reagents
|
Potassium dihydrogen phosphate (Potassium phosphate monobasic), meets analytical specification of Ph. Eur., NF, E340 is used as a buffer capacity reagent in molecular biology, biochemistry, and chromatography. For the preparation of biological buffers. It is also used to purify antibodies, and in combination with other sodium phosphates, meets analytical specification of Ph. Eur., NF, E340 .
|
-
- HY-20336G
-
|
Biochemical Assay Reagents
|
Mc-Val-Cit-PABC-PNP GMP is a GMP grade Mc-Val-Cit-PABC-PNP (HY-20336). Mc-Val-Cit-PABC-PNP is a cathepsin cleavable ADC linker. Mc-Val-Cit-PABC-PNP can be used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-78931G
-
|
Biochemical Assay Reagents
|
Boc-Dap-NE (GMP) is Boc-Dap-NE (HY-78931) produced by using GMP guidelines. Boc-Dap-NE is an intermediate in the synthesis of Monomethyl auristatin E (HY-15162), which is an inhibitor of tubulin polymerization. Monomethyl auristatin E can be used to synthesize Antibody-Drug Conjugates (ADCs) as ADC Cytotoxin.
|
-
- HY-15579G
-
Monomethylauristatin F (GMP)
|
Biochemical Assay Reagents
|
MMAF (Monomethylauristatin F) GMP is a GMP grade MMAF (HY-15579). MMAF (Monomethylauristatin F) is a potent tubulin polymerization inhibitor and is used as a antitumor agent. MMAF (Monomethylauristatin F) is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) such as vorsetuzumab mafodotin and SGN-CD19A .
|
-
- HY-15579BG
-
Monomethylauristatin F sodium (GMP)
|
Biochemical Assay Reagents
|
MMAF sodium GMP is a GMP grade MMAF (sodium) (HY-15579B). MMAF sodium (Monomethylauristatin F sodium) is a potent tubulin polymerization inhibitor and is used as a antitumor agent. MMAF sodium (Monomethylauristatin F sodium) is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) such as Vorsetuzumab mafodotin and SGN-CD19A .
|
-
- HY-NP006
-
SPA
|
Native Proteins
|
Protein A (SPA) is an immunoglobulin (Ig) binding protein that exists on the surface of bacteria and can be freely secreted into the extracellular environment. Protein A blocks opsonization and phagocytosis and induces B-cell death in vitro by binding to the Fc region of antibodies and the Fab region of B-cell receptors. Protein A has the ability to inhibit opsonization and phagocytosis in vitro .
|
-
- HY-158271
-
|
Biochemical Assay Reagents
|
Methamphetamine/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Methamphetamine () and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-158274
-
|
Biochemical Assay Reagents
|
Gibberellins/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Gibberellins () and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-158295
-
|
Biochemical Assay Reagents
|
IAA/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of IAA () and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-158300
-
|
Biochemical Assay Reagents
|
HCY/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of HCY () and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-161486
-
|
Biochemical Assay Reagents
|
AOZ/OVA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of AOZ () and OVA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-161478
-
|
Biochemical Assay Reagents
|
Phosphoserine/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Phosphoserine () and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-158298
-
|
Biochemical Assay Reagents
|
Penicillin/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Penicillin () and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-W000423G
-
|
Biochemical Assay Reagents
|
DBCO-amine GMP is a GMP grade DBCO-amine (HY-W000423). DBCO-amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-amine is a click chemistry reagent, itcontains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-15578G
-
Maleimidocaproyl monomethylauristatin F (GMP)
|
Biochemical Assay Reagents
|
McMMAF GMP is a GMP grade McMMAF (HY-15578). McMMAF is a protective group (maleimidocaproyl)-conjugated MMAF, which is a potent tubulin polymerization inhibitor. McMMAF can be used as a agent-linker for antibody-drug conjugates (ADC). McMMAF is uncleavable, and must be internalized and degraded within a cell, releasing cysteine-McMMAF as the active agent .
|
-
- HY-158290
-
|
Biochemical Assay Reagents
|
Natrexone/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Natrexone (HY-76711) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-161490
-
|
Biochemical Assay Reagents
|
AMOZ/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of AMOZ (HY-131146) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-158277
-
|
Biochemical Assay Reagents
|
Streptomycin/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Streptomycin (HY-B1906) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-158279
-
|
Biochemical Assay Reagents
|
Gentamicin/OVA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Gentamicin (HY-A0276A) and OVA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-158280
-
|
Biochemical Assay Reagents
|
Streptomycin/KLH is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Streptomycin (HY-B1906) and KLH. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-158282
-
|
Biochemical Assay Reagents
|
Pyrazinamide-KLH is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Pyrazinamide (HY-B0271) and KLH. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-158286
-
|
Biochemical Assay Reagents
|
Streptomycin/OVA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Streptomycin (HY-B1906) and OVA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-158299
-
|
Biochemical Assay Reagents
|
Periplogenin/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Periplogenin (HY-N2414) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-158291
-
|
Biochemical Assay Reagents
|
Periplogenin/KLH is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Periplogenin (HY-N2414) and KLH. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-158292
-
|
Biochemical Assay Reagents
|
Digoxin-OVA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Digoxin (HY-B1049) and OVA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-158293
-
|
Biochemical Assay Reagents
|
Toosendanin/OVA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Toosendanin (HY-N0263) and OVA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-158294
-
|
Biochemical Assay Reagents
|
Toosendanin/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Toosendanin (HY-N0263) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-158296
-
|
Biochemical Assay Reagents
|
Tetracycline/OVA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Tetracycline (HY-A0107) and OVA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-158297
-
|
Biochemical Assay Reagents
|
Histamine/OVA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Histamine (HY-B1204) and OVA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-161488
-
|
Biochemical Assay Reagents
|
Eugenol/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Eugenol (HY-N0337) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-161485
-
|
Biochemical Assay Reagents
|
Gentamicin/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Gentamicin (HY-A0276A) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
-
- HY-161487
-
|
Biochemical Assay Reagents
|
AOZ/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of AOZ (HY-W012982) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
- HY-158283
-
|
Biochemical Assay Reagents
|
Ethambutol-BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Ethambutol (HY-B0535) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
- HY-161482
-
|
Biochemical Assay Reagents
|
Alginic acid/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Alginic acid (HY-W127758) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
- HY-161480
-
|
Biochemical Assay Reagents
|
Melamine/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Melamine (HY-Y1117) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
- HY-158289
-
|
Biochemical Assay Reagents
|
Isoniazid-KLH is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Isoniazid (HY-B0329) and KLH. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
- HY-161477
-
|
Biochemical Assay Reagents
|
Histamine/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Histamine (HY-B1204) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
- HY-158275
-
|
Biochemical Assay Reagents
|
Rifampin/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Rifampin (HY-B0272) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
- HY-158276
-
|
Biochemical Assay Reagents
|
Rifampin/KLH is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Rifampin (HY-B0272) and KLH. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
- HY-158267
-
|
Biochemical Assay Reagents
|
Enrofloxacin/OVA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Enrofloxacin (HY-B0502) and OVA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
- HY-158270
-
|
Biochemical Assay Reagents
|
Ethambutol-KLH is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Ethambutol (HY-B0535) and KLH. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
- HY-158288
-
|
Biochemical Assay Reagents
|
Pyrazinamide-BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Pyrazinamide (HY-B0271) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
- HY-161479
-
|
Biochemical Assay Reagents
|
Melamine/OVA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Melamine (HY-Y1117) and OVA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
- HY-161489
-
|
Biochemical Assay Reagents
|
Enrofloxacin/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Enrofloxacin (HY-B0502) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
- HY-E70068
-
|
Biochemical Assay Reagents
|
Endo-β-N-acetylglucosaminidase (Endo S) is a family 18 glycosyl hydrolase secreted by Streptococcus pyogenes. Endo-β-N-acetylglucosaminidase (Endo S) exclusively hydrolyzes the β-1,4-di-N-acetylchitobiose core of the asparagine-linked complex-type glycan on Asn-297 of the γ-chains of IgG antibody .
|
- HY-161484
-
|
Biochemical Assay Reagents
|
Penicillin G/OVA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Penicillin G (HY-N7139) and OVA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
- HY-158268
-
|
Biochemical Assay Reagents
|
4-Hydroxynonenal/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of 4-Hydroxynonenal (HY-113466) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
- HY-158269
-
|
Biochemical Assay Reagents
|
T4-BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of T4 (HY-18341) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
- HY-158284
-
|
Biochemical Assay Reagents
|
Penicillin G/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Penicillin G (HY-N7139) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
- HY-161481
-
|
Biochemical Assay Reagents
|
Melamine/bov igG is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Melamine (HY-Y1117) and bov IgG. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
- HY-158273
-
|
Biochemical Assay Reagents
|
2,4-D/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of 2,4-D (HY-18572) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
- HY-158287
-
|
Biochemical Assay Reagents
|
2,4-D/KLH is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of 2,4-D (HY-18572) and KLH. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
- HY-158278
-
|
Biochemical Assay Reagents
|
Aflatoxin B1/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Aflatoxin B1 (HY-N6615) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
- HY-158281
-
|
Biochemical Assay Reagents
|
Aflatoxin B1/KLH is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Aflatoxin B1 (HY-N6615) and KLH. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
- HY-158285
-
|
Biochemical Assay Reagents
|
25-OH Vitamin D3/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of 25-OH Vitamin D3 () and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
- HY-B1610K
-
|
Biochemical Assay Reagents
|
Sodium citrate buffer, 0.5M, pH 5.5, is a commonly used buffer with main components are citric acid and sodium hydrogen phosphate. Sodium citrate buffer 0.5M pH 5.5 is used in heat induced epitope retrieval (HIER) methods to reverse the loss of antigenicity that occurs with some epitopes in formalin-fixed paraffin embedded tissues. Sodium citrate buffer 0.5M pH 5.5 is the preferred solution for most antibodies. .
|
- HY-B1610M
-
|
Biochemical Assay Reagents
|
Sodium citrate buffer, 0.5M, pH 6.5, is a commonly used buffer with main components are citric acid and sodium hydrogen phosphate. Sodium citrate buffer, 0.5M, pH 6.5 is used in heat induced epitope retrieval (HIER) methods to reverse the loss of antigenicity that occurs with some epitopes in formalin-fixed paraffin embedded tissues. Sodium citrate buffer, 0.5M, pH 6.5 is the preferred solution for most antibodies .
|
- HY-D0175
-
γ-Aminopropyltriethoxysilane; APTES
|
Biochemical Assay Reagents
|
3-Aminopropyltriethoxysilane (APTES) acts as a strong glue to immobilize biomolecules such as antibodies and enzymes to silicon and silicon derivatives such as silicon nitride (Si3N4 )) on. 3-Aminopropyltriethoxysilane also acts as a spacer, providing biomolecules with more spatial freedom during immobilization for higher specific activity. 3-Aminopropyltriethoxysilane can form a more stable, sensitive, and highly biocompatible bioanalytical platform by immobilizing biomolecules onto some solid materials, electrode materials, nanomaterials, and nanocomposites .
|
- HY-144012A
-
DPPE-PEG350; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-350] ammonium
|
Drug Delivery
|
16:0 PEG350 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
- HY-144012B
-
DPPE-PEG550; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-550] ammonium
|
Drug Delivery
|
16:0 PEG550 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
- HY-144012C
-
DPPE-PEG750; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-750] ammonium
|
Drug Delivery
|
16:0 PEG750 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
- HY-144013A
-
DSPE-mPEG350 ammonium; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-350] ammonium
|
Drug Delivery
|
18:0 mPEG350 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
- HY-144013B
-
DSPE-mPEG550 ammonium; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-550] ammonium
|
Drug Delivery
|
18:0 mPEG550 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
- HY-144013C
-
DSPE-mPEG750 ammonium; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-750] ammonium
|
Drug Delivery
|
18:0 mPEG750 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
- HY-144012D
-
DPPE-PEG1000; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-1000] ammonium
|
Drug Delivery
|
16:0 PEG1000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
- HY-144012E
-
DPPE-PEG3000; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-3000] ammonium
|
Drug Delivery
|
16:0 PEG3000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
- HY-144012H
-
DPPE-PEG5000; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-5000] ammonium
|
Drug Delivery
|
16:0 PEG5000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
- HY-144013D
-
DSPE-mPEG1000 ammonium; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-1000] ammonium
|
Drug Delivery
|
18:0 mPEG1000 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
- HY-144013E
-
DSPE-mPEG3000 ammonium; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-3000] ammonium
|
Drug Delivery
|
18:0 mPEG3000 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
- HY-144013H
-
DSPE-mPEG5000 ammonium; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-5000] ammonium
|
Drug Delivery
|
18:0 mPEG5000 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
- HY-155924
-
DMPE-PEG350; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-350] ammonium
|
Drug Delivery
|
14:0 PEG350 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
- HY-155925
-
DMPE-PEG550; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-550] ammonium
|
Drug Delivery
|
14:0 PEG550 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
- HY-155926
-
DMPE-PEG750; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-750] ammonium
|
Drug Delivery
|
14:0 PEG750 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
- HY-155927
-
DMPE-PEG1000; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-1000] ammonium
|
Drug Delivery
|
14:0 PEG1000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
- HY-155928
-
DMPE-PEG3000; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-3000] ammonium
|
Drug Delivery
|
14:0 PEG3000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
- HY-155929
-
DMPE-PEG5000; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-5000] ammonium
|
Drug Delivery
|
14:0 PEG5000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
- HY-155930
-
DOPE-PEG350; 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-350] ammonium
|
Drug Delivery
|
18:1 PEG350 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
- HY-155931
-
DOPE-PEG550; 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-550] ammonium
|
Drug Delivery
|
18:1 PEG550 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
- HY-155932
-
DOPE-PEG1000; 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-1000] ammonium
|
Drug Delivery
|
18:1 PEG1000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
- HY-155933
-
DOPE-PEG3000; 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-3000] ammonium
|
Drug Delivery
|
18:1 PEG3000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
- HY-155934
-
DOPE-PEG5000; 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-5000] ammonium
|
Drug Delivery
|
18:1 PEG5000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
- HY-P2149A
-
|
Native Proteins
|
Concanavalin A (agarose) consists of Concanavalin A (HY-P2149) coupled to agarose. Concanavalin A is a tetrameric metalloprotein lectin isolated from Canavalia ensiformis (jack bean). Concanavalin A (agarose) is used for the purification of glycoproteins, polysaccharides and glycolipids as it binds molecules containing α-D-mannopyranosyl, α-D-glucopyranosyl and sterically related residues. Concanavalin A (agarose) has also be used in other application areas including purification of enzyme-antibody conjugates, purification of IgM and separation of membrane vesicles .
|
- HY-154818
-
Ac-BSA
|
Native Proteins
|
Bovine Serum Albumin, Acetylated (Ac-BSA) is a polypeptide of known structure with strong antigenicity. Bovine Serum Albumin, Acetylated produced a significant immune response, validating the accuracy and reliability of the experimental method. Bovine Serum Albumin, Acetylated can be used as a positive control substance in ELISA or WB experiments, and can be used in experiments with acetylated lysine monoclonal or polyclonal antibodies. Bovine Serum Albumin, Acetylated also improves encapsulation efficiency at low concentrations of PLGA, a polymer for biopharmaceutical delivery with biocompatibility, degradability, and controlled release properties .
|
- HY-131990G
-
|
Biochemical Assay Reagents
|
MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH GMP is a GMP grade MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH (HY-131990). MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
- HY-161493
-
|
Biochemical Assay Reagents
|
1-(2-Aminoethyl)-1H-pyrazol-4-ylphosphonic acid/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of 1-(2-Aminoethyl)-1H-pyrazol-4-ylphosphonic acid () and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases .
|
- HY-B1610N
-
|
Biochemical Assay Reagents
|
Sodium citrate buffer, 0.1M, pH 4.0, is a commonly used buffer with main components are citric acid and sodium hydrogen phosphate. Sodium citrate buffer, 0.1M, pH 4.0 is used in heat induced epitope retrieval (HIER) methods to reverse the loss of antigenicity that occurs with some epitopes in formalin-fixed paraffin embedded tissues. Sodium citrate buffer, 0.1M, pH 4.0 is the preferred solution for most antibodies . Sodium citrate buffer, 0.1M, pH 4.0 is used in the hydration of liposome film .
|
- HY-B1610J
-
|
Biochemical Assay Reagents
|
Sodium citrate buffer, 0.5M, pH 5.0, is a commonly used buffer with main components are citric acid and sodium hydrogen phosphate. Sodium citrate buffer, 0.5M, pH 5.0 is used in heat induced epitope retrieval (HIER) methods to reverse the loss of antigenicity that occurs with some epitopes in formalin-fixed paraffin embedded tissues. Sodium citrate buffer, 0.5M, pH 5.0 is the preferred solution for most antibodies . Sodium citrate buffer, 0.5M, pH 5.0 is used as solution for captisol in animal tumor models .
|
- HY-153234
-
|
Drug Delivery
|
CD19 car circRNA-LNP is a lipid nanoparticle (LNP) containing CD19 car circRNA, suitable for detection of RNA delivery, translation efficiency, cell viability, etc. CD19 car circRNA can be used in chimeric antigen receptor T cell immunotherapy (CAR-CD19). The CD19 car is a chimeric antigen receptor. Among them, CD19 is a CD molecule expressed by B cells (i.e. leukocyte differentiation antigen), an important membrane antigen involved in B cell proliferation, differentiation, activation and antibody production, and can also promote BCR signal transduction .
|
- HY-153233
-
|
Drug Delivery
|
CD19 car mRNA-LNP is a lipid nanoparticle (LNP) containing CD19 car mRNA, suitable for detection of RNA delivery, translation efficiency, cell viability, etc. CD19 car mRNA can be used in chimeric antigen receptor T cell immunotherapy (CAR-CD19). The CD19 car is a chimeric antigen receptor. Among them, CD19 is a CD molecule expressed by B cells (i.e. leukocyte differentiation antigen), an important membrane antigen involved in B cell proliferation, differentiation, activation and antibody production, and can also promote BCR signal transduction .
|
Cat. No. |
Product Name |
Target |
Research Area |
-
- HY-P5271
-
|
Peptides
|
Others
|
Influenza hemagglutinin (HA) epitope is a polypeptide. Influenza hemagglutinin (HA) epitope is conjugated to keyhole limpet hemocyanin to generate anti-HA polyclonal antibodies following immunization of rabbits .
|
-
- HY-P2171A
-
|
Peptides
|
Inflammation/Immunology
|
CCP peptide TFA is a synthetic cyclic citrullinated peptide (CCP) and used as the substrate for detecting anti-CCP antibodies serologically. CCP peptide TFA functions as a target for autoantibodies with a very high specificity for rheumatoid arthritis (RA) .
|
-
- HY-P4020
-
|
HIV
|
Others
|
2F5 epitope, a peptide gp41 (659-671), comprises the entire epitope for one of the three known antibodies capable of neutralizing a broad spectrum of primary HIV-1 isolates and is the only such epitope that is sequential. 2F5 epitope is recognized by broadly neutralizing antibodies 2F5 .
|
-
- HY-P2171
-
|
Peptides
|
Inflammation/Immunology
|
CCP peptide is a synthetic cyclic citrullinated peptide (CCP) and used as the substrate for detecting anti-CCP antibodies serologically. CCP peptide functions as a target for autoantibodies with a very high specificity for rheumatoid arthritis (RA) .
|
-
- HY-P0085
-
|
Peptides
|
Inflammation/Immunology
|
Splenopentin diacetate is a synthetic immunomodulating pentapeptide corresponding to the residues 32-36 of the splenic hormone splenin. Splenopentin diacetate influences both early T and B cell differentiation, to increase the number of antibody-forming cells in mice after gamma irradiation .
|
-
- HY-P4025
-
|
Peptides
|
Others
|
ELDKWA is the highly conserved amino acids on the ecto-domain of gp41. ELDKWA acts as the epitope of a neutralizing monoclonal antibody 2F5 (mAb 2F5) directed against human immunodeficiency virus type 1 .
|
-
- HY-P1783A
-
|
Influenza Virus
|
Infection
|
M2e, human TFA, consisting of the 23 extracellular residues of M2 (the third integral membrane protein of influenza A), has been remarkably conserved in all human influenza A. M2e, human TFA is a valid and versatile vaccine candidate to protect against any strain of human influenza A .
|
-
- HY-P3893
-
|
CDK
|
Metabolic Disease
|
PSTAIR is a monoclonal antibody that recognizes the PSTAIR sequence in Cdc28, PSTAIR can be used as loading control .
|
-
- HY-136432
-
Mc-GGFG-PAB-OH
|
ADC Linker
|
Cancer
|
Mc-Gly-Gly-Phe-Gly-PAB-OH (Mc-GGFG-PAB-OH) is a cleavable ADC linker used for antibody-drug conjugates (ADCs).
|
-
- HY-P5276
-
|
PD-1/PD-L1
|
Cancer
|
Human membrane-bound PD-L1 polypeptide can be used as an antigen to induce PD-L1 antibody production .
|
-
- HY-P10252
-
|
HIV
|
Inflammation/Immunology
|
HIV gp120 421-438 is HIV antigen fragments, that conjugates with keyhole limpet hemocyanin (KLH) and generates specific anti-HIV antibody .
|
-
- HY-P10250
-
|
HIV
|
Inflammation/Immunology
|
HIV gp120 308-331 is HIV antigen fragments, that conjugates with keyhole limpet hemocyanin (KLH) and generates specific anti-HIV antibody .
|
-
- HY-P1449
-
|
ADC Linker
|
Cancer
|
Boc-Gly-Gly-Phe-Gly-OH, a self-assembly of N- and C-protected tetrapeptide, is a protease cleavable linker used for the antibody-drug conjugate (ADC).
|
-
- HY-136432A
-
Mc-GGFG-PAB-OH TFA
|
ADC Linker
|
Cancer
|
Mc-Gly-Gly-Phe-Gly-PAB-OH (Mc-GGFG-PAB-OH) TFA is a cleavable ADC linker used for antibody-drug conjugates (ADCs).
|
-
- HY-P3727
-
|
Peptides
|
Inflammation/Immunology
|
Lys-Pro-Pro-Thr-Pro-Pro-Pro-Glu-Pro-Glu-Thr is a undecapeptide, corresponding to the carboxy terminus of simian virus 40 large T antigen. Lys-Pro-Pro-Thr-Pro-Pro-Pro-Glu-Pro-Glu-Thr can be targeted by antibodies secreted from three mouse hybridomas, designated KT1, KT3, and KT4, produced antibodies that immunoprecipitated large T antigen .
|
-
- HY-P1449A
-
|
ADC Linker
|
Cancer
|
Boc-Gly-Gly-Phe-Gly-OH TFA, a self-assembly of N- and C-protected tetrapeptide, is a protease cleavable linker used for the antibody-drug conjugate (ADC).
|
-
- HY-P4664
-
|
Peptides
|
Inflammation/Immunology
|
VHLTP is the N-terminal pentapeptide of human hemoglobin beta. VHLTP binds to cell membranes and serves as a ligand for anti-HbA1c antibodies .
|
-
- HY-P10091
-
|
PD-1/PD-L1
|
Cancer
|
CD24/Siglec-10 blocking peptide, CSBP can not only block the interaction of CD24/Siglec-10 but also PD-1/PD-L1. CD24/Siglec-10 blocking peptide, CSBP can induce the phagocytosis of tumor cell .
|
-
- HY-P1439
-
-
- HY-P3149
-
|
TNF Receptor
|
Inflammation/Immunology
|
LEESGGGLVQPGGSMK, a proteolysis peptide, is a component of Infliximab. LEESGGGLVQPGGSMK can be used for quantitative analysis of Infliximab. Infliximab is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α .
|
-
- HY-P3149B
-
|
TNF Receptor
|
Inflammation/Immunology
|
LEESGGGLVQPGGSMK acetate, a proteolysis peptide, is a component of Infliximab. LEESGGGLVQPGGSMK acetate can be used for quantitative analysis of Infliximab. Infliximab is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α .
|
-
- HY-P3203
-
|
Peptides
|
Inflammation/Immunology
|
DSTYSLSSTLTLSK is a generic human peptide and can be used for infliximab quantitative detection . Infliximab (Avakine) is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α.
|
-
- HY-P3203A
-
|
TNF Receptor
|
Inflammation/Immunology
|
DSTYSLSSTLTLSK TFA is a generic human peptide and can be used for infliximab quantitative detection . Infliximab (Avakine) is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α.
|
-
- HY-P0223
-
FLAG peptide
Maximum Cited Publications
9 Publications Verification
|
Peptides
|
Inflammation/Immunology
|
FLAG peptide is an eight amino acids peptide (Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys) with an enterokinase-cleavage site; designed for antibody-mediated identification and purification of recombinant proteins.
|
-
- HY-P1787
-
|
Amyloid-β
|
Neurological Disease
|
β-Amyloid (4-10) is an epitope for the polyclonal anti-Aβ(1-42) antibody, reduces amyloid deposition in a transgenic Alzheimer disease mouse model .
|
-
- HY-P3149A
-
|
TNF Receptor
|
Inflammation/Immunology
|
LEESGGGLVQPGGSMK TFA, a proteolysis peptide, is a component of Infliximab. LEESGGGLVQPGGSMK TFA can be used for quantitative analysis of Infliximab. Infliximab is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α .
|
-
- HY-113736
-
|
Amino Acid Derivatives
|
Others
|
Glycyllysine is a polypeptide that can be used in the synthesis of antibodies and amino acid type gemini surfactants. Glycyllysine has potential applications in modifying plasmid/gemini/lipid (P/G/L) nanoparticles transport carriers .
|
-
- HY-P5812
-
|
Peptides
|
Neurological Disease
|
IDR 1002 is an IPO-38 antibody marker protein. IDR
1002 catalyzes the conversion of arginine to citrulline. IDR 1002 can be used
to study the role of citrullinated modification of protein in cancer biology
.
|
-
- HY-P1509
-
|
Peptides
|
Neurological Disease
|
Rhodopsin Epitope Tag is a 9-amino acid peptide localized within the C-terminal region of bovine rhodopsin . Rhodopsin Epitope Tag is widely used as an epitope tag and can be recognized by a number of anti-rhodopsin antibodies.
|
-
- HY-P5274
-
|
Peptides
|
Others
|
BACE1 (485-501) is the carboxyl terminal of BACE1 (Beta-site APP cleaving enzyme 1). BACE1 (485-501) can be used as antigen to produce anti-BACE1-C antibody .
|
-
- HY-P3332A
-
|
Peptides
|
Others
|
DYKDDDDK peptide (FLAG) is a useful tool for investigating the function and localization of proteins whose antibodies (Abs) are not available. Often it is also used in a 3X FLAG format (3x DYKDDDDK Tag TFA) for purifying difficult proteins that accumulate in low abundance .
|
-
- HY-P3332
-
|
Peptides
|
Others
|
3x DYKDDDDK Tag is a useful tool for investigating the function and localization of proteins whose antibodies (Abs) are not available. Often it is also used in a 3X FLAG format (3x DYKDDDDK Tag) for purifying difficult proteins that accumulate in low abundance .
|
-
- HY-108905
-
Human IGF-I; FK 780
|
IGF-1R
|
Metabolic Disease
|
Mecasermin (Human IGF-I; FK 780) is a recombinant human insulin-like growth factor I (IGF-I). Mecasermin has the potential for the study of the growth failure of growth hormone (GH) insensitivity caused by GH receptor defects or GH-inhibiting antibodies .
|
-
- HY-P4810
-
T140
|
CXCR
|
Infection
|
Polyphemusin II-Derived Peptide (T140), a CXCR4 inhibitor, shows high inhibitory activity against HIV-1 entry and the inhibitory effect on the binding of an anti-CXCR4 monoclonal antibody (12G5) to CXCR4 .
|
-
- HY-P4166
-
|
Peptides
|
Cancer
|
Ac-{Gly(N-me)}-Sar-Sar-Sar-Sar-Sar-Sar-Sar-Sar-Sar is a decapeptide. Ac-{Gly(N-me)}-Sar-Sar-Sar-Sar-Sar-Sar-Sar-Sar-Sar can be used to preparation of antibody-drug conjugate .
|
-
- HY-P10056
-
Human ezrin peptide (324-337)
|
HIV
|
Infection
|
HEP-1 (Human ezrin peptide (324-337)) is an orally active peptide with anti-HIV activity. HEP-1 enhances antibody titers generated by hepatitis B vaccination. HEP-1 has the potential to be studied against viral infections .
|
-
- HY-P4029
-
|
HCV
|
Infection
|
HCV-1 e2 Protein (484-499) is a peptide consisting of 16 amino acids. HCV-1 e2 Protein (484-499) is derived from the envelope 2 protein of hepatitis C virus in the sera from individuals with antibodies to HCV .
|
-
- HY-P5911
-
|
Peptides
|
Inflammation/Immunology
|
GluN1 (359-378) is an anti-N-methyl-D-aspartate
receptor (NMDAR) antibody. GluN1 (359-378) can cross the blood-brain barrier.
GluN1 (359-378) can be used to study anti-NMDAR encephalitis therapy targeting
the immune system .
|
-
- HY-P4042
-
hepatitis B peptide 4980
|
HBV
|
Infection
Inflammation/Immunology
|
Hepatitis B Virus Receptor Binding Fragment (hepatitis B peptide 4980) is a synthetic peptide analog which specifically binds to Hep G2 cells. Hepatitis B Virus Receptor Binding Fragment is a promising immunogen expected to elicit protective antibodies based on the concept of the attachment blockade pathway of virus neutralization .
|
-
- HY-P5309
-
|
Biochemical Assay Reagents
|
Inflammation/Immunology
|
(Thr(GalNAc)4,7,15,Ser(GalNAc)9,11)-IgA1 Hinge Region Peptide is a synthetic glycopeptide and can be used for detection of gender difference and epitope specificity of IgG antibody activity against IgA1 hinge portion in IgA nephropathy patients .
|
-
- HY-P5201S1
-
|
Isotope-Labeled Compounds
|
Others
|
VTSEGAGLQLQK- 13C6, 15N2 (TFA) is the 13C- and 15N-labeled VTSEGAGLQLQK. VTSEGAGLQLQK is an amino acid sequence in the C-terminal region of recombinant human alpha-acid glucosidase (rhGAA), which can be used to bind anti-drug antibodies in plasma and quantitatively analyze the therapeutic effect .
|
-
- HY-P5309A
-
|
Peptides
|
Inflammation/Immunology
|
(Thr(GalNAc)4,7,15,Ser(GalNAc)9,11)-IgA1 Hinge Region Peptide (TFA) (GN5) is a synthetic glycopeptide and can be used for detection of gender difference and epitope specificity of IgG antibody activity against IgA1 hinge portion in IgA nephropathy patients .
|
-
- HY-P0329
-
|
Peptides
|
Others
|
X-press Tag Peptide is a tag peptide used for protein purification. X-press Tag is also an N-terminal leader peptide; this N-terminal peptide contains a polyhistidine sequence, the Xpress epitope (part of bacteriophage T7 gene 10 protein) and an enterokinase cleavage site. Anti-Xpress antibodies recognize the Xpress epitope sequence found in this leader peptide.
|
-
- HY-P3560
-
TV 4710
|
Apoptosis
|
Inflammation/Immunology
|
Edratide (TV 4710) is a synthetic peptide of 19 amino acid based on the complementarity-determining region 1 (CDR1) of a human anti-DNA antibody that expresses a major idiotype denoted 16/6 Id. Edratide reduces the rates of apoptosis (Apoptosis) and down-regulates of caspase-8 and caspase-3, up-regulates Bcl-xL. Edratide has the potential for the research of systemic lupus erythematosus (SLE) .
|
-
- HY-P5413
-
|
Peptides
|
Others
|
[Lys3]-Bombesin is a biological active peptide. (PET (Positron Emission Tomography) imaging of [Lys3]-bombesin is able to detect gastrin-releasing peptide receptor (GRPR) positive prostate cancer. An immunoconjugate of [Lys3]-bombesin and corresponding monoclonal antibody can specifically induce (CD64)-dependent monocyte and neutrophil-mediated lysis of small cell carcinoma.)
|
-
- HY-P10109A
-
hG6PI (325-339) (hydrochloride)
|
Peptides
|
Inflammation/Immunology
|
G6PI 325-339 (human) hydrochloride is an efficient inducer of arthritis in B10.Q mice. G6PI 325-339 (human) hydrochloride primes Th1 and Th17 cells cross-reacted with the murine G6PI protein. G6PI 325-339 (human) hydrochloride induces arthritis model operating through a T and B cell-dependent pathway but without antibody effector mechanisms .
|
-
- HY-P10109
-
hG6PI (325-339)
|
Peptides
|
Inflammation/Immunology
|
G6PI 325-339 (human) is an efficient inducer of arthritis in B10.Q mice. G6PI 325-339 (human) primes Th1 and Th17 cells cross-reacted with the murine G6PI protein. G6PI 325-339 (human) induces arthritis model operating through a T and B cell-dependent pathway but without antibody effector mechanisms .
|
-
- HY-P1240
-
MOG (35-55)
|
Peptides
|
Neurological Disease
Inflammation/Immunology
|
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (MOG (35-55)) is a minor component of CNS myelin. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat has encephalitogenic activity and induces T cell proliferative. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat induces Th1 cytokine response as well as relatively high levels of IgG antibodies. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat produces a relapsing-remitting neurological disease with extensive plaque-like demyelination .
|
-
- HY-P1240B
-
MOG (35-55) (acetate)
|
Peptides
|
Neurological Disease
Inflammation/Immunology
|
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (MOG (35-55)) acetate is a minor component of CNS myelin. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat acetate has encephalitogenic activity and induces T cell proliferative. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat acetate induces Th1 cytokine response as well as relatively high levels of IgG antibodies. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat acetate produces a relapsing-remitting neurological disease with extensive plaque-like demyelination .
|
-
- HY-P1240A
-
MOG (35-55) (TFA)
|
Peptides
|
Neurological Disease
Inflammation/Immunology
|
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (MOG (35-55)) TFA is a minor component of CNS myelin. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat TFA has encephalitogenic activity and induces T cell proliferative. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat TFA induces Th1 cytokine response as well as relatively high levels of IgG antibodies. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat TFA produces a relapsing-remitting neurological disease with extensive plaque-like demyelination .
|
- HY-P3385
-
SCB-313
|
Peptides
|
Others
|
Rilunermin alfa (SCB-313) is an active compound. Rilunermin alfa can be used for various biochemical studies .
|
-
- HY-K0221
-
|
MCE Affinity Chromatography (AC) Columns are designed for purification of recombinant proteins with different tags, enzymes, antibodies, antigens and nucleic acids.
|
-
- HY-K2016
-
|
MCE Protein Transfection Reagent is a cationic lipid mixture for complexation with proteins, peptides, antibodies and other biologically active molecules to allow their direct intracellular delivery.
|
-
- HY-K1005
-
Maximum Cited Publications
47 Publications Verification
|
MCE Ultra High Sensitivity ECL Kit is an ultra-sensitive, luminol-based enhanced chemiluminescent substrate for detecting horseradish peroxidase (HRP) labeled antibodies on western blots.
|
-
- HY-K0213
-
1 Publications Verification
|
MCE Protein A Agarose, a 4% highly cross-linked agarose reagent coupled with recombinant Protein A, effectively purifies mammalian monoclonal and polyclonal antibodies, such as human IgG, IgE, IgM.
|
-
- HY-K0242
-
|
MCE Protein A Plus Magnetic Agarose Beads can be used for the detection and purification of IgG from serum, ascites fluid, cell culture supernatant and other antibody samples.
|
-
- HY-K0243
-
|
MCE Protein G Plus Magnetic Agarose Beads can be used for the detection and purification of IgG from serum, ascites fluid, cell culture supernatant and other antibody samples.
|
-
- HY-K0215
-
|
MCE Protein L Agarose, a 4% highly cross-linked agarose reagent coupled with recombinant Protein L, effectively purifies mammalian monoclonal and polyclonal antibodies which have kappa light chain.
|
-
- HY-K1022
-
1 Publications Verification
|
MCE PBS-T Powder (1 L of 1×) consists of NaCl, KCl, Phosphate and Tween 20, and is widely used in ELISA and Western Blot, and can also be used for antibody dilution and preparation of blocking solution.
|
-
- HY-K1026
-
|
MCE TBS Powder (1 L of 1×) consists of NaCl, KCl and Tris, and is widely used as washing buffer in immunocytochemistry, FISH or ELISA, and can also be used for antibody dilution and preparation of blocking solution.
|
-
- HY-K1027
-
|
MCE Rapid Blocking Buffer (TBS-T) Powder (100 mL of 1×) mainly consists of fish gelatin protein, and is widely used for the antibody blocking step in Western Blot or ELISA within 15 minutes.
|
-
- HY-K0214
-
2 Publications Verification
|
MCE Protein G Agarose, a 4% highly cross-linked agarose reagent coupled with recombinant Protein G, effectively purifies mammalian monoclonal and polyclonal antibodies, such as human IgG3 and rat IgG2a.
|
-
- HY-K1025
-
2 Publications Verification
|
MCE TBS-T Powder (1 L of 1×) consists of NaCl, KCl, Tris and Tween 20, and is widely used as washing buffer in immunocytochemistry, FISH or ELISA, and can also be used for antibody dilution and preparation of blocking solution.
|
-
- HY-K0226
-
|
MCE CHO Magnetic Beads (200 nm, 10 mg/mL) contain CHO functional groups, which react with primary amines on proteins or other molecules to form stable amide linkages,can covalently immobilize proteins for the affinity purification of antibodies, antigens and other biomolecules.
|
-
- HY-K0501A
-
|
MCE SYBR Green qPCR Master Mix (Universal) is compatible with all qPCR instruments. 2× ready-to-use formulations which consist of antibody-mediated hot start polymerase, MgCl2, dNTPs and a proprietary reaction buffer, produce optimal results in qPCR experiments.
|
-
- HY-K0227
-
|
MCE NHS Magnetic Beads (200 nm, 10 mg/mL) contain N-hydroxysuccinimide (NHS) functional groups, which react with primary amines on proteins or
other molecules to form stable amide linkages,can covalently immobilize proteins for the affinity purification of antibodies, antigens and other
biomolecules.
|
-
- HY-K0218A
-
1 Publications Verification
|
MCE Streptavidin Agarose 6FF, a 6% highly cross-linked agarose reagent coupled with recombinant streptavidin, is an affinity chromatography medium for separation and purification of biotinylated peptides, antibodies, lectins, etc. The total binding capacity of Streptavidin Agarose 6FF is more than 200 nmol of D-Biotin/mL settled resin.
|
Cat. No. |
Product Name |
Target |
Research Area |
-
- HY-P99018
-
Antibody ANB 020
|
Interleukin Related
|
Cancer
|
Etokimab (Antibody ANB 020) is a humanized monoclonal antibody that targets IL-33. Etokimab can be used for the research of atopic dermatitis .
|
-
- HY-P99289
-
Antibody hLL 2; Anti-Human CD22 Recombinant Antibody
|
CD22
|
Inflammation/Immunology
Cancer
|
Epratuzumab (Antibody hLL 2) is an anti-CD22 IgG1 monoclonal antibody. Epratuzumab is also a tumor-imaging agent and an immunomodulatory agent. Epratuzumab can induce CD22 phosphorylation. Epratuzumab has been used to research non-Hodgkin’s lymphomas (NHL) and certain autoimmune diseases .
|
-
- HY-P99352
-
Anti-MSLN Antibody
|
Mesothelin
|
Cancer
|
Anetumab (Anti-MSLN Antibody) is an anti-mesothelin (MSLN) antibody. MSLN is a tumor-associated antigen. Anetumab can be used to synthesis Anetumab ravtansine, a MSLN-targeting antibody-drug conjugate (ADC). Anetumab can be used for the research of malignant tumor .
|
-
- HY-P99271
-
Anti-Human F3 Recombinant Antibody
|
ADC Antibody
|
Cancer
|
Tisotumab (Anti-Human F3 Recombinant Antibody) is a human IgG1 monoclonal antibody targets tissue factor (TF). Tisotumab can be used for the research of solid tumors .
|
-
- HY-P99525
-
-
- HY-P99313
-
Anti-Human NGcGM3 Recombinant Antibody
|
Apoptosis
|
Inflammation/Immunology
|
Quilizumab (Anti-Human NGcGM3 Recombinant Antibody) is a humanized IgG1κ monoclonal antibody. Quilizumab targets the M1-prime segment of membrane-expressed IgE, leading to depletion of IgE-switched and memory B cells. Quilizumab has the potantial for the asthma research .
|
-
- HY-P99296
-
CNTO 95; Anti-Human CD51 Recombinant Antibody
|
EGFR
|
Cancer
|
Intetumumab (CNTO 95) is a potent anti-EGFR monoclonal antibody that is glycoengineered for enhanced antibody-dependent cellular cytotoxicity (ADCC). Intetumumab can be used in research of cancer .
|
-
- HY-P99324
-
Anti-Human EGFR Recombinant Antibody
|
EGFR
Apoptosis
|
Cancer
|
Tomuzotuximab (Anti-Human EGFR Recombinant Antibody) is a fully human glycoengineered IgG1 monoclonal antibody against EGFR. Tomuzotuximab has anticancer effects .
|
-
- HY-P99292
-
HuZAF; Anti-Human IFNG Recombinant Antibody
|
IFNAR
|
Inflammation/Immunology
|
Fontolizumab (HuZAF) is a humanized monoclonal anti-IFN-gamma antibody. Fontolizumab is an immunosuppressive agent. Fontolizumab can be used in research of Crohn’s disease .
|
-
- HY-P99310
-
RG4934; Anti-Human IL17A Recombinant Antibody
|
Interleukin Related
|
Inflammation/Immunology
|
Perakizumab (RG4934) is a humanized IgG1κ monoclonal antibody against IL-17A (Interleukin Related). Perakizumab can be uesd for the research of autoimmune diseases, such as psoriatic arthritis .
|
-
- HY-P99278
-
MT 201; Anti-Human EPCAM Recombinant Antibody
|
Inhibitory Antibodies
|
Cancer
|
Adecatumumab (Anti-Human EPCAM Recombinant Antibody; MT201) is a full human monoclonal antibody of the IgG1 isotype, targeting human EpCAM. Adecatumumab is expressed in almost all adenocarcinomas, and its activity is not dependent of K-Ras status .
|
-
- HY-P99372
-
Anti-NCAM1/ CD56 Reference Antibody (lorvotuzumab)
|
ADC Antibody
|
Cancer
|
Lorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab)) is a humanized monoclonal antibody that binds CD56 (NCAM1). Lorvotuzumab can be used to synthesize an ADC compound, Lorvotuzumab mertansine .
|
-
- HY-P99374
-
Anti-TSPAN26/CD37 Reference Antibody (naratuximab)
|
ADC Antibody
|
Cancer
|
Naratuximab (Anti-TSPAN26/CD37 Reference Antibody (naratuximab)) is a humanized monoclonal antibody that binds CD37 (TSPAN26). Naratuximab can be used to synthesize an ADC compound, Naratuximab emtansine .
|
-
- HY-P99329
-
Anti-Human CD33 Recombinant Antibody
|
Inhibitory Antibodies
|
Cancer
|
Vadastuximab is a humanized monoclonal antibody targeting CD33. Vadastuximab can be used to synthesize an ADC compound, Vadastuximab talirine .
|
-
- HY-P99295
-
RG 7160; RO 5083945; Anti-EGFR Recombinant Antibody
|
EGFR
|
Cancer
|
Imgatuzumab (RG 7160) is a humanized monoclonal antibody against the EGFR. Imgatuzumab acts as an immunomodulator. Imgatuzumab can be used in research of cancer .
|
-
- HY-P99328
-
Anti-EPCAM Recombinant Antibody; huKS-IL2
|
Interleukin Related
|
Inflammation/Immunology
Cancer
|
Tucotuzumab (Anti-EPCAM Recombinant Antibody) is an antigen-specific IgG1 monoclonal antibody that targets human epithelial cell adhesion molecule (EpCAM). Tucotuzumab links two IL-2 molecules and is an immunosuppressant and anti-tumor active molecule .
|
-
- HY-P99267
-
RhuMab IFNalpha; Anti-Human IFN alpha Recombinant Antibody
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Rontalizumab is a humanized IgG1 monoclonal antibody targets IFN-α. Rontalizumab can be used for the research of systemic lupus erythematosus[1].
|
-
- HY-P9916
-
Anti-Human IL6Rα, Human Antibody
|
Interleukin Related
|
Inflammation/Immunology
Cancer
|
Sarilumab (Anti-Human IL6Rα, Human Antibody) is a human immunoglobulin G1 monoclonal antibody. Sarilumab, a interleukin-6 (IL-6) receptor antagonist, binds to the IL-6 receptor with high affinity and inhibits cis and trans signaling by IL-6, resulting in reduced inflammation. Sarilumab can be used for the research of Rheumatoid arthritis .
|
-
- HY-P99269
-
BIBH 1; Anti-Human FAP Recombinant Antibody
|
FAP
|
Cancer
|
Sibrotuzumab (BIBH 1) is a humanized IgG1 monoclonal antibody targets fibroblast activation protein (FAP). Sibrotuzumab can be used for the research of colorectal cancer and non-small cell lung cancer (NSCLC) .
|
-
- HY-P99293
-
IDEC 114; Anti-Human CD80 Recombinant Antibody
|
CD28
|
Cancer
|
Galiximab (IDEC 114) is a primatized immunoglobulin G1 (IgG1) lambda monoclonal antibody directed against the CD80 antigen. Galiximab has variable regions are primatized (cynomologous monkeys), and the constant regions are human. Galiximab can be used in research of B-cell lymphoma .
|
-
- HY-P9917
-
Anti-Human IL6R, Humanized Antibody
|
Interleukin Related
|
Inflammation/Immunology
Cancer
|
Tocilizumab (Anti-Human IL6R, Humanized Antibody) is an anti-human interleukin-6 receptor (IL-6R) neutralizing antibody, prevents binding of IL-6 to the IL-6R, thereby inhibiting both classic and trans-signaling. Tocilizumab (Anti-Human IL6R, Humanized Antibody) can be used for the treatment of rheumatoid arthritis . Tocilizumab is remarkablely effective for the study of severe COVID-19 (coronavirus disease) .
|
-
- HY-P9914
-
Anti-Human C5, Humanized Antibody
|
Complement System
|
Cardiovascular Disease
|
Eculizumab (Anti-Human C5, Humanized Antibody) is a long-acting humanized monoclonal antibody targeted against complement C5. Eculizumab inhibits the cleavage of C5 into C5a and C5b and hence inhibits deployment of the terminal complement system including the formation of membrane attack complex (MAC). Eculizumab has the potential for haemolysis research .
|
-
- HY-P99330
-
Anti-Human VEGFA Recombinant Antibody; RO5520985
|
VEGFR
Tie
|
Cancer
|
Vanucizumab is a first-in-class, bispecific IgG1-like monoclonal antibody that simultaneously blocks VEGF-A and angiopoietin-2 (Ang-2) from interacting with their receptors. Vanucizumab has antiangiogenic and anticancer effects .
|
-
- HY-P99263
-
Anti-Human selectin P Recombinant Antibody
|
P-selectin
|
Cardiovascular Disease
|
Inclacumab (Anti-Human selectin P Recombinant Antibody) is a human monoclonal IgG4 antibody selectively targets P-selectin with a Kd value of 9.9 nM. Inclacumab inhibits P-selectin glycoprotein ligand 1 (PSGL-1) mimetic peptide bind with P-selectin with an IC50 value of 1.9 μg/mL and strongly inhibits cell adhesion .
|
-
- HY-P99315
-
BG 9588; Anti-Human CD40L Recombinant Antibody
|
TNF Receptor
|
Inflammation/Immunology
|
Ruplizumab (BG 9588) is a humanized monoclonal anti-CD40L (TNF Receptor) IgG1κ antibody. Ruplizumab has the potential for systemic lupus erythematosus disease research .
|
-
- HY-P9915
-
Anti-Human CD38, Human Antibody
|
CD38
ADC Antibody
|
Inflammation/Immunology
Cancer
|
Daratumumab (Anti-Human CD38) is the first-in-class human-specific anti-CD38 monoclonal antibody (IgG1). Daratumumab has anti-multiple myeloma (MM) effect. Daratumumab impairs MM cell adhesion, which results in an increased sensitivity of MM to proteasome inhibition .
|
-
- HY-P99270
-
CS-1008; Anti-Human TRAIL-R2 Recombinant Antibody
|
Apoptosis
|
Cancer
|
Tigatuzumab (CS-1008) is a humanized IgG1 monoclonal antibody targets death receptor 5 (DR5). Tigatuzumab induces cell apoptosis of cancer cells and inhibits tumor growth in vivo. Tigatuzumab can be used for the research of cancer .
|
-
- HY-P99362
-
Anti-MUC5AC Reference Antibody (ensituximab); NEO-102
|
Inhibitory Antibodies
|
Cancer
|
Ensituximab (NEO-102; NPC-1C) is a chimeric monoclonal IgG1 antibody targeting a variant of MUC5AC. Ensituximab shows specificity to colorectal and pancreatic cancer .
|
-
- HY-P99288
-
Pamrevlumab; Anti-Human CTGF Recombinant Antibody
|
Apoptosis
|
Cancer
|
FG-3019 (Pamrevlumab) is a recombinant human antibody that binds to connective tissue growth factor (CTGF). FG-3019 can be used for the research of idiopathic pulmonary fibrosis (IPF) .
|
-
- HY-P99275
-
Human Anti-ERBB3 Recombinant Antibody
|
EGFR
Akt
ERK
PARP
Survivin
|
Cancer
|
Patritumab (Human Anti-ERBB3 Recombinant Antibody) is a neutralizing monoclonal antibody to ERBB3. Patritumab shows a synergy with Cetuximab (HY-P9905), potently inhibits the phosphorylation of EGFR, HER2, HER3, ERK, and AKT. Patritumab also induces cell apoptosis and suppresses the growth of pancreatic, non-small cell lung cancer, and colorectal cancer xenograft tumors .
|
-
- HY-P99252
-
Anti-Human CD6 Recombinant Antibody
|
CD6
|
Infection
Inflammation/Immunology
|
Itolizumab (Anti-Human CD6 Recombinant Antibody) is a humanized recombinant anti-CD6 monoclonal antibody (MAb) targeting the extracellular SRCR distal domain 1 of CD6. Itolizumab reduces T-cell proliferation and inhibits the production of pro-inflammatory cytokines, such as INF-γ, TNFα and IL-6. Itolizumab can be used in the research of psoriasis, rheumatoid arthritis (RA), COVID-19 .
|
-
- HY-P99294
-
AMG 479; Human Anti-IGF1R Recombinant Antibody
|
IGF-1R
|
Cancer
|
Ganitumab (AMG 479) is a recombinant human monoclonal antibody to the human type 1 insulin-like growth factor receptor (IGF1R). Ganitumab recognizes murine IGF1R with sub-nanomolar affinity (KD=0.22 nM) and inhibits the interaction of murine IGF1R with IGF1 and IGF2. Ganitumab can be used in research of cancer .
|
-
- HY-P99358
-
GSK 2398852; Anti-Serum Amyloid P/SAP Reference Antibody (dezamizumab)
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Dezamizumab (GSK 2398852) is a fully humanized recombinant monoclonal IgG1 anti-serum amyloid P component (SAP) antibody, with potential anti-amyloid activity. Dezamizumab triggers immunotherapeutic clearance of amyloid. Dezamizumab can be used in research of Amyloid light-chain (AL) amyloidosis .
|
-
- HY-P99785
-
HLX20
|
PD-1/PD-L1
|
Cancer
|
Opucolimab is an anti-PD-L1 recombinant human monoclonal antibody. Opucolimab can be used to synthesis antibody agent conjugates. Opucolimab can be used for the research of advanced solid tumors .
|
-
- HY-P990055
-
|
EGFR
|
Cancer
|
Nezutatug is an anti-HER3 antibody, and used for cancer research .
|
-
- HY-P99256
-
SCH 900222; MK 3222; Anti-Human IL23 Recombinant Antibody
|
Interleukin Related
|
Inflammation/Immunology
|
Tildrakizumab (SCH 900222) is a humanized anti-IL-23 (p19 subunit) monoclonal antibody. IL-23 is a critical cytokine to maintain the Th17 cell phenotype. Tildrakizumab has high-affinity for single-chain IL-23 (Kd: 136 pM). Tildrakizumab is effective against moderate to severe plaque psoriasis .
|
-
- HY-P99369
-
IPH 4102; Anti-KIR3DL2/CD158k Reference Antibody (lacutamab)
|
Inhibitory Antibodies
|
Cancer
|
Lacutamab (IPH4102) is a humanizedized monoclonal antibody (mAb) directed against the immune receptor molecule KIR3DL2, produced by recombinant technology in CHO cells. Lacutamab can be used in research of cutaneous T-cell lymphoma .
|
-
- HY-P99251
-
|
Inhibitory Antibodies
|
Others
|
Lodelcizumab is a monoclonal antibody. Lodelcizumab can be used for the research of hypercholesterolemia .
|
-
- HY-P99336
-
BI-RR 0001; Anti-Human IL6 Recombinant Antibody
|
Integrin
|
Neurological Disease
Inflammation/Immunology
|
Enlimomab (BI-RR 0001), a murine IgG2a monoclonal antibody to the human ICAM-1, inhibits leukocyte adhesion to the vascular endothelium, thereby decreasing leukocyte extravasation and inflammatory tissue injury. Enlimomab has anti-inflammatory effects, and can be used for stroke research .
|
-
- HY-P99557
-
-
- HY-P99472
-
-
- HY-P99455
-
EMB-01
|
EGFR
c-Met/HGFR
|
Cancer
|
Bafisontamab (EMB-01) is a bispecific antibody targeting EGFR and cMET with antitumor activity .
|
-
- HY-P99869
-
|
Inhibitory Antibodies
|
Others
|
Ebdarokimab (AK101) is a humanized IgG1-κ antibody, usually expressed in CHO (Chinese Hamster Ovary) cells .
|
-
- HY-P99702
-
BCD-089
|
Interleukin Related
|
Inflammation/Immunology
|
Levilimab (BCD-089) is a fully humanized anti-interleukin-6 receptor (IL-6R) monoclonal antibody. Levilimab is an inflammation-alleviating antibody. Levilimab can be used for the research of rheumatoid .
|
-
- HY-P99861
-
BMS-914143
|
IFNAR
|
Others
|
Peginterferon lambda-1a (BMS-914143) is a monoclonal antibody targeting IFNLR1 and consists of IFNL1 conjugated to pegol .
|
-
- HY-P99001
-
-
- HY-P99242
-
-
- HY-P99332
-
Anti-Human CD3E Recombinant Antibody; HuM291
|
Apoptosis
|
Inflammation/Immunology
|
Visilizumab (Anti-Human CD3E Recombinant Antibody) is a humanized low-Fc receptor binding anti-CD3 monoclonal IgG2 antibody. Visilizumab can be used for ulcerative colitis and Crohn's disease research .
|
-
- HY-P99298
-
RG 7417; TNX 234; Anti-CFD Recombinant Antibody
|
Complement System
|
Inflammation/Immunology
|
Lampalizumab (RG 7417) is a humanised monoclonal antibody targeting complement Factor D in the alternative complement pathway. Lampalizumab binds an exosite and sterically blocks Factor B access to the active site. Lampalizumab can be used for age-related macular degeneration (AMD) research .
|
-
- HY-P99002
-
- HY-P99003
-
- HY-P9997
-
ANB030
|
PD-1/PD-L1
|
Cancer
|
Rosnilimab is a humanized IgG1-κ antibody targeting to PD-1 .
|
- HY-P9996
-
LY3434172
|
PD-1/PD-L1
|
Cancer
|
Reozalimab is a bispecific antibody targeting to PD-1/PD-L1. Reozalimab mediates antibody-dependent cell cytotoxicity in cancer research .
|
- HY-P99784
-
|
Filovirus
|
Infection
|
Porgaviximab is a monoclonal antibody that can be used Ebola infection research .
|
- HY-P990066
-
- HY-P9980
-
GSK2857914
|
TNF Receptor
ADC Antibody
|
Cancer
|
Belantamab (GSK2857914) is a humanised IgG1 anti-BCMA (TNFRSF17) monoclonal antibody. Belantamab can be used in the synthesis of antibody-drug conjugate (ADC), Belantamab mafodotin .
|
- HY-P99376
-
OMS 721; Anti-MASP2 Reference Antibody (narsoplimab)
|
SARS-CoV
|
Infection
|
Narsoplimab (OMS 721) is a high-affinity fully human immunoglobulin gamma 4 (IgG4) monoclonal antibody that binds MASP-2 and blocks lectin pathway activation. Narsoplimab can be used in research of hematopoietic stem-cell transplantation and SARS-CoV-2 .
|
- HY-P99371
-
AK002; Anti-Siglec-8 Reference Antibody (lirentelimab)
|
Apoptosis
|
Inflammation/Immunology
|
Lirentelimab (AK002) is a humanized IgG1 monoclonal antibody that targets sialic acid-binding Ig-like lectin 8 (SIGLEC8). Lirentelimab induces cell apoptosis of IL-5-activated eosinophils and inhibits IgE-mediated mast cell activation. Lirentelimab can be used for the research of eosinophilic gastritis and duodenitis .
|
- HY-P99726
-
- HY-P99564
-
- HY-P99230
-
|
Integrin
CD22
|
Cancer
|
Pinatuzumab is a CD22 monoclonal antibody. Pinatuzumab targets the cell-surface antigen CD22. Pinatuzumab can be used for synthesis of antibody agent conjugates (ADCs) to research several diseases including non-Hodgkin lymphoma (NHL) .
|
- HY-P99234
-
|
Interleukin Related
|
Cancer
|
Pivekimab is a human IgG1 monoclonal antibody targeting interleukin 3 (IL-3) and CD123. Pivekimab can be used in the study of blastocytic plasmacytoid dendritic cell tumor (BPDCN) .
|
- HY-P99888
-
|
EGFR
|
Others
|
Pimurutamab is a humanized IgG1-κ antibody targeting EGFR. Mainly expressed by CHO-K1 cells .
|
- HY-P99753
-
BAYX1351
|
TNF Receptor
|
Infection
|
Nerelimomab (BAYX1351) is an anti-TNF-α antibody. Nerelimomab can be used for research of sepsis .
|
- HY-P99815
-
- HY-P99854
-
- HY-145626
-
BA302
|
ADC Antibody
|
Cancer
|
Ozuriftamab is a naked human IgG1 kappa antibody of receptor tyrosine kinase-like orphan receptor 2 ROR2, can be used to synthesis ADC .
|
- HY-P99233
-
HuMax-TAC
|
Interleukin Related
|
Cancer
|
Camidanlumab (HuMax-TAC) is a CD25 monoclonal antibody. Camidanlumab targets the cell-surface antigen CD25, which is over-expressed on a variety of hematological tumors and shows limited expression on normal tissues. Camidanlumab can be used for synthesis of antibody agent conjugates (ADCs) to research several diseases including lymphoma and leukemia .
|
- HY-P99378
-
ALTB-168; Anti-PSGL1/CD162 Reference Antibody (neihulizumab)
|
Apoptosis
|
Inflammation/Immunology
|
Neihulizumab (ALTB-168) is an immune checkpoint agonistic antibody that binds to human CD162 (PSGL-1), leading to downregulation of activated T-cells. Neihulizumab can be uesd for steroid-refractory acute graft-versus-host-disease (SR-aGVHD), psoriasis, psoriatic arthritis and ulcerative colitis research .
|
- HY-P99285
-
hBU 12
|
ADC Antibody
CD19
|
Others
|
Denintuzumab (hBU 12) is a recombinant humanized anti-CD19 monoclonal antibody. Denintuzumab can be used as the antibody moiety (ADC antibody) of antibody-drug conjugates to synthesize ADC, Denintuzumab Mafodotin (SGN-CD19A). Denintuzumab Mafodotin can be used in the research of acute lymphoblastic leukemia .
|
- HY-P99808
-
|
VEGFR
|
Cancer
|
Pulocimab is an anti-VEGFR2 monoclonal antibody (mAb). Pulocimab can be used for the research of cancers .
|
- HY-P99106
-
- HY-P99737
-
LY3074828
|
Interleukin Related
|
Inflammation/Immunology
|
Mirikizumab (LY3074828) is a humanized IgG4 monoclonal antibody targets the p19 subunit of interleukin 23. Mirikizumab can be used for the research of ulcerative colitis .
|
- HY-P99037
-
M281
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Nipocalimab (M281) is a fully human, recombinant, aglycosylated IgG1 monoclonal antibody. Nipocalimab is a human deglycosylated IgG1 anti-FcRn monoclonal antibody that binds with picomolar affinity to Fc receptor (FcRn) at both endosomal pH 6.0 and extracellular pH 7.6 .
|
- HY-P99232
-
5F9 Monoclonal Antibody
|
Guanylate Cyclase
|
Cancer
|
Indusatumab (5F9 Monoclonal antibody) is an anti-human GUCY2C (Guanylate cyclase 2C) monoclonal antibody .
|
- HY-P99303
-
- HY-P9943
-
- HY-P99535
-
- HY-P990002
-
|
c-Kit
|
Cancer
|
Anti-Mouse CD117 Antibody is an IgG2b antibody inhibitor against mouse CD117. Derived from rat.
|
- HY-P990001
-
- HY-P990301
-
|
Inhibitory Antibodies
|
Others
|
Amyloid-beta Antibody (MOAB-2) is a mouse-derived IgG2b, λ type antibody inhibitor, targeting to Amyloid-beta.
|
- HY-P99586
-
REGN2222
|
RSV
|
Infection
|
Suptavumab (REGN2222) is a human monoclonal antibody. Suptavumab can bind and block a conserved epitope on RSV A and B subtypes. Suptavumab can be used for the research of RSV infection .
|
- HY-P99360
-
Anti-AXL/UFO Reference Antibody (enapotamab)
|
TAM Receptor
|
Cancer
|
Enapotamab is an anti-AXL/UFO reference antibody. Enapotamab can be used to synthesis Bcl-xl inhibitor antibody-drug conjugates .
|
- HY-P99306
-
DS 1024; Sym 004
|
Inhibitory Antibodies
|
Cancer
|
Modotuximab (Anti-Human EGFR Recombinant Antibody) is an IgG1κ-type chimeric antibody targeting human EGFR protein. Modotuximab contains a portion of Futuximab that binds to two independent, non-overlapping epitopes on EGFR. Modotuximab promotes cross-linking of EGFR on the cell surface and promotes EGFR cellular internalization and degradation. Modotuximab has antitumor activity in vivo .
|
- HY-P990069
-
|
Inhibitory Antibodies
|
Cancer
|
Linavonkibart (SRK 181) is a high-affinity, fully human antibody that selectively binds to latent TGFβ1 and inhibits its activation. Linavonkibart plays an important role in cancer .
|
- HY-P99545
-
- HY-P99361
-
PDL192; ABT-361; Anti-TNFRSF12A/TWEAKR/CD266 Reference Antibody (enavatuzumab)
|
TNF Receptor
|
Cancer
|
Enavatuzumab (PDL192; ABT-361) is a humanized IgG1 monoclonal antibody targeting the receptor of TNF-like weak inducer of apoptosis (TWEAK). TWEAK (Fn14; TNFRSF12A), the natural ligand of the TWEAK receptor (TweakR), stimulates multiple cellular responses. Enavatuzumab induces tumor growth inhibition through direct TweakR signaling and antibody dependent cell-mediated cytotoxicity (ADCC). Enavatuzumab can actively recruits and activates myeloid effectors to kill tumor cells. Enavatuzumab inhibits the growth of various human TweakR-positive cancer cell lines and xenografts in vitro and in vivo .
|
- HY-P99042
-
|
ADC Antibody
|
Cancer
|
Polatuzumab is a monoclonal antibody, which targets CD79b that is found on the surface of B cells. Polatuzumab sticks to the CD79b protein and delivers the chemotherapy compound into the cell. Polatuzumab can be used to synthesize Polatuzumab Vedotin, which is an antibody-drug conjugate (ADC) targeting CD79b .
|
- HY-P990245
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse FAP Antibody (73.3) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to mouse FAP.
|
- HY-P990079
-
- HY-P9995
-
JNJ-63733657
|
Tau Protein
|
Cancer
|
Posdinemab is a humanized IgG1κ antibody, targeting to microtubule-associated protein tau (MAPT) .
|
- HY-P990159
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse TCRβ Antibody (HB218) is a Armenian hamster-derived IgG type antibody inhibitor, targeting to mouse TCRβ.
|
- HY-P99118
-
HLX 10
|
PD-1/PD-L1
|
Cancer
|
Serplulimab (HLX 10) is humanized monoclonal anti-PD-1 antibody. Serplulimab can be used in research of small cell lung cancer .
|
- HY-P99850
-
- HY-P99264
-
Humanized Anti-CD22 Recombinant Antibody
|
ADC Antibody
CD22
|
Cancer
|
Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) is a humanized IgG4, κ antibody that targets human CD22. Inotuzumab can be linked to a toxic agent ozogamicin as an antibody-drug conjugate (ADC). Inotuzumab can be used for the research of acute lymphoblastic leukemia and non-Hodgkin lymphoma .
|
- HY-P99304
-
Anti-Human ERBB3 Recombinant Antibody
|
EGFR
|
Cancer
|
Lumretuzumab (Anti-Human ERBB3 Recombinant Antibody) is a humanized anti-HER3 (ERBB3) monoclonal antibody that can be used for the research of cancer .
|
- HY-P990124
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse GITR Antibody (DTA-1) is a rat-derived IgG2b, λ type antibody inhibitor, targeting to mouse GITR.
|
- HY-P99016
-
|
ADC Antibody
Nectin-4
|
Cancer
|
Enfortumab is a monoclonal antibody targeting Nectin-4. Enfortumab can used for researching urothelial cancer .
|
- HY-P99151
-
|
TNF Receptor
|
Cancer
|
Brentuximab is a chimeric antibody targeting CD30. Brentuximab can be used for the research of emerging targeted therapies .
|
- HY-P990284
-
- HY-P990286
-
- HY-P99745
-
- HY-P990023
-
- HY-P9968
-
|
EGFR
|
Cancer
|
Nimotuzumab is a humanized IgG1 monoclonal antibody targeting EGFR with a KD of 0.21 nM. Nimotuzumab is directed against the extracellular domain of the EGFR blocking the binding to its ligands. Nimotuzumab, a strong antitumor agent, is cytolytic on target tumors by its capacity to cause antibody dependent cell mediated cytotoxicity (ADCC) and complement dependent cytotoxicity (CDC) .
|
- HY-P9807
-
SARS-CR3022; SARS-CoV-2 Antibody-CR3022
|
SARS-CoV
|
Infection
Inflammation/Immunology
|
Anti-SARS-CoV-2 Spike mAb (CR3022) is a a CHO cell derived human monoclonal IgG1 antibody. It binds to both S1 domain of SARS-CoV/SARS-CoV-2 Spike protein .
|
- HY-P99133
-
- HY-P99136
-
|
IFNAR
|
Inflammation/Immunology
|
Anti-Mouse IFN gamma Antibody is an anti-mouse IFN gamma IgG antibody inhibitor derived from host Armenian Hamster.
|
- HY-P99123
-
|
CD28
|
Inflammation/Immunology
|
Anti-Mouse CD28 Antibody is an anti-mouse CD28 IgG antibody inhibitor derived from the host Syrian Hamster.
|
- HY-P990145
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse VISTA Antibody (13F3) is a Armenian hamster-derived IgG type antibody inhibitor, targeting to mouse VISTA.
|
- HY-P99970
-
|
ADC Antibody
|
Others
|
Lifastuzumab is a humanized anti-NaPi2b monoclonal antibody (IgG1 type). Lifastuzumab can be coupled with monomethyl auristatin E (MMAE) through ADC Linker to form an antibody-drug conjugate (ADC) lifastuzumab vedotin (DNIB0600A) with anticancer activity .
|
- HY-P99126
-
- HY-P990150
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse TSLP Antibody (28F12) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse TSLP.
|
- HY-P990122
-
- HY-P990155
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse TIGIT Antibody (1G9) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to mouse TIGIT.
|
- HY-P9990
-
BIIB059
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Litifilimab is a humanized IgG1-κ antibody targeting to C-type lectin domain family 4 member C (CLEC4C). Litifilimab can be used for cutaneous lupus erythematosus (CLE) study .
|
- HY-P99144
-
- HY-P99229
-
|
ADC Antibody
|
Cancer
|
Upifitamab is an ADC Antibody (a naked antibody of upifitamab rilsodotin), which can be used for antibody-coupled agent (ADC) synthesis. Upifitamab rilsodotin is an ADC targeting NaPi2b and is used in ovarian cancer research, particularly in platinum-resistant recurrent ovarian cancer .
|
- HY-P99964
-
AGS15C; Ha15-10ac12; Ha15-10ac12.1
|
Inhibitory Antibodies
|
Cancer
|
Sirtratumab is a human Igγ2 monoclonal antibody against SLIT and NTRK-like family 6 (Slitrk6). Sirtratumab can be used in research of cancer .
|
- HY-P990137
-
- HY-P990163
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse Siglec-H Antibody (440c) is a rat-derived IgG2b type antibody inhibitor, targeting to mouse Siglec-H.
|
- HY-P990259
-
- HY-P990139
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD20 Antibody (AISB12) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse CD20.
|
- HY-P990278
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD29 Antibody (KMI6) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse CD29.
|
- HY-P990295
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD103 Antibody (M290) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse CD103.
|
- HY-P990273
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD38 Antibody (NIMR5) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse CD38.
|
- HY-P99976
-
|
CD19
|
Cancer
|
Anti-Mouse CD19 Antibody (1D3) is an anti-mouse CD19 IgG2a antibody inhibitor.
|
- HY-P99855
-
BCD-132
|
CD20
|
Inflammation/Immunology
|
Divozilimab (BCD-132) is a humanised monoclonal antibody against CD20 (CD20). Divozilimab can be used for multiple sclerosis research .
|
- HY-P99235
-
|
Interleukin Related
|
Cancer
|
Nadunolimab is a human monoclonal IgG1 antibody targeting IL1RAP. Nadunolimab blocks IL-1α and IL-1β signaling and triggering antibody-dependent cellular cytotoxicity. Nadunolimab can be used in research of cancer .
|
- HY-P9803
-
SARS-80R; SARS Antibody-80R
|
SARS-CoV
|
Infection
|
Anti-SARS-80R mAb (SARS-80R) is a human monoclonal IgG1 antibody produced in CHO cells. Anti-SARS-80R mAb can specifically bind to Spike (S1) protein to prevent SARS virus infection of susceptible cells .
|
- HY-P9969
-
EMD 72000
|
EGFR
|
Cancer
|
Matuzumab (EMD 72000) is a humanized anti-EGFR monoclonal antibody that blocks EGFR activation and downstream signaling, inhibits tumor growth .
|
- HY-P9981
-
XmAb5574; MOR00208; Tafasitamab-cxix
|
Apoptosis
|
Inflammation/Immunology
Cancer
|
Tafasitamab (XmAb5574) is an Fc-modified, humanized monoclonal antibody that binds to the human B-cell surface antigenCD19 .
|
- HY-P99616
-
MOR-202
|
CD38
|
Cancer
|
Felzartamab (MOR-202) is a human monoclonal antibody that targets CD38 and can be used in multiple myeloma research .
|
- HY-P99999
-
|
HIV
|
Infection
|
Anti-Mouse CD4 Antibody (YTS 191) is anti-mouse CD4 IgG2b antibody inhibitor derived from host Rat.
|
- HY-P990261
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD83 Antibody (Michel-17) is a rat-derived IgG1, κ type antibody inhibitor, targeting to mouse CD83.
|
- HY-P990263
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD73 Antibody (TY/23) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse CD73.
|
- HY-P990135
-
- HY-P990262
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD8 Antibody (HB-129) is a mouse-derived IgG2a, κ type antibody inhibitor, targeting to mouse CD8.
|
- HY-P990264
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD70 Antibody (FR70) is a rat-derived IgG2b, κ type antibody inhibitor, targeting to mouse CD70.
|
- HY-P990285
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD200 Antibody (OX-90) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse CD200.
|
- HY-P99287
-
B-E8; Anti-IL-6 MAB B-E8; Anti-Human IL6 Recombinant Antibody
|
Interleukin Related
|
Inflammation/Immunology
Cancer
|
Elsilimomab (B-E8) is a IgG1 monoclonal antibody against interleukin-6 (IL-6), with a KD of 22 pM and an IC50 of 1.4 nM. Elsilimomab can be used for the research of multiple myeloma, renal cell carcinoma, and rheumatoid arthritis (RA) .
|
- HY-P9998
-
UB421
|
HIV
|
Cancer
|
Semzuvolimab is a murine IgG1κ antibody, targeting to p55, T cell surface antigen T4/Leu-3 (CD4). Murine CD4 antibodies can neutralize HIV infection and have the potential to inhibit HAART stable HIV infection .
|
- HY-P99543
-
OPRX-106; PRX-106; TNFR-Fc
|
Inhibitory Antibodies
|
Cancer
|
Tulinercept (OPRX-106) is a monoclonal antibody. Tulinercept can be used for various biochemical studies .
|
- HY-P99448
-
- HY-P99130
-
- HY-P99124
-
- HY-P99760
-
BCD-145
|
CTLA-4
|
Cancer
|
Nurulimab (BCD-145) is an anti-cytotoxic T lymphocyte antigen-4 (anti-CTLA-4) human monoclonal antibody. Nurulimab can be can be used in research of melanoma .
|
- HY-P990197
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse MAdCAM-1 Antibody (MECA-367) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse MAdCAM-1.
|
- HY-P990223
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse IL-15 Antibody (AIO.3) is a rat-derived IgG2a, λ type antibody inhibitor, targeting to mouse IL-15.
|
- HY-P990004
-
|
Tim3
|
Cancer
|
Anti-Mouse TIM-3 Antibody (B8.2C12) is an anti-mouse TIM-3 antibody inhibitor. Anti-Mouse TIM-3 Antibody (B8.2C12) is an antibody of rat IgG2a subtype .
|
- HY-P99148
-
- HY-P990289
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD172a Antibody (P84) is a rat-derived IgG1, κ type antibody inhibitor, targeting to mouse CD172a.
|
- HY-P990257
-
- HY-P99779
-
- HY-P9801
-
SARS-CoV-2 (2019-nCoV) Spike RBD Antibody
|
SARS-CoV
|
Infection
|
Anti-Spike-RBD mAb is a CHO cell derived human monoclonal IgG1 antibody. Blocking the interaction of Spike protein and ACE2. Anti-Spike-RBD mAb is a potential therapeutic approach for SARS-CoV-2 treatment .
|
- HY-P990158
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse Ter-119 Antibody (TER-119) is a rat-derived IgG2b, κ type antibody inhibitor, targeting to mouse Ter-119.
|
- HY-P99129
-
- HY-P99149
-
- HY-P99132
-
- HY-P990272
-
- HY-P990266
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD48 Antibody (HM48-1) is a Armenian hamster-derived IgG type antibody inhibitor, targeting to mouse CD48.
|
- HY-P990200
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse Ly6C Antibody (Monts 1) is a rat-derived IgG2a type antibody inhibitor, targeting to mouse Ly6C.
|
- HY-P990302
-
|
Inhibitory Antibodies
|
Others
|
Anti-Human/Rat/Fish AChR Antibody (Mab35) is a rat-derived IgG1 type antibody inhibitor, targeting to human/rat/Fish AChR.
|
- HY-P99478
-
|
IFNAR
|
Inflammation/Immunology
|
Bifarcept is a recombinant antibody of interferon receptor type I (IFN-RI). Bifarcept can bind IFN-β and prolong its serum half-life .
|
- HY-P99508
-
IBI939
|
Inhibitory Antibodies
|
Cancer
|
Tamgiblimab (IBI939) is a fully human monoclonal antibody targeting T-cell immunoreceptor with immunoglobulin and ITIM domains (TIGIT). Tamgiblimab has anticancer effects .
|
- HY-P99638
-
- HY-P9976
-
|
Apoptosis
|
Cancer
|
Isatuximab is a monoclonal antibody targeting the transmembrane receptor and ectoenzyme CD38, a protein highly expressed on hematological malignant cells, including those in multiple myeloma (MM). Isatuximab has antitumor activity via multiple biological mechanisms, including antibody-dependent cellular-mediated cytotoxicity, complement-dependent cytotoxicity, antibody-dependent cellular phagocytosis, and direct induction of apoptosis without crosslinking. Isatuximab also directly inhibits CD38 ectoenzyme activity, which is implicated in many cellular functions .
|
- HY-P99700
-
IBI-188
|
Inhibitory Antibodies
|
Cancer
|
Letaplimab (IBI-188) is a human IgG4 anti-CD47 monoclonal antibody. CD47 is overexpressed on cancer cells, it is a ligand for SIRPα. Letaplimab enhances tumor cell phagocytosis .
|
- HY-P9922
-
IMC-3G3; LY3012207
|
PDGFR
|
Cancer
|
Olaratumab (IMC-3G3; LY3012207) is an anti-platelet-derived growth factor receptor alpha (PDGFRα) human monoclonal IgG1 antibody with antitumor activity .
|
- HY-P99143
-
- HY-P990149
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse/Human TYRP1 Antibody (TA99) is a mouse-derived IgG2a, κ type antibody inhibitor, targeting to mouse/human TYRP1.
|
- HY-P990164
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse RGMb Antibody (307.9D1) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse RGMb.
|
- HY-P990283
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD22 Antibody (Cy34.1) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to mouse CD22.
|
- HY-P990177
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse Notch4 Antibody (HMN4-14) is a Armenian hamster-derived IgG, κ type antibody inhibitor, targeting to mouse Notch4.
|
- HY-P990181
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse myeloperoxidase/MPO Antibody (6G4) is a mouse-derived IgG2c, κ type antibody inhibitor, targeting to mouse myeloperoxidase/MPO.
|
- HY-P990208
-
- HY-P990239
-
|
Inhibitory Antibodies
|
Others
|
Anti-Human/Mouse GRP78 Antibody (N88) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to human/mouse GRP78.
|
- HY-P990288
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD18 Antibody (M18/2) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse CD18.
|
- HY-P99120
-
- HY-P99391
-
ABT-700
|
Inhibitory Antibodies
|
Cancer
|
Telisotuzumab (ABT-700) is a human recombinant bivalent antibody, a therapeutic antibody against the hepatocyte growth factor receptor (MET) that binds c-Met with high affinity and inhibits c-Met signaling. Telisotuzumab has antitumor activity .
|
- HY-P99210
-
CDP 6038; OKZ
|
Interleukin Related
|
Inflammation/Immunology
|
Olokizumab (CDP 6038) is a humanized monoclonal antibody targeting the interleukin-6 (IL-6). Olokizumab can be used in research of rheumatoid arthritis (RA) .
|
- HY-P99325
-
IDEC-131; Anti-Human CD40 ligand Recombinant Antibody
|
TNF Receptor
|
Inflammation/Immunology
|
Toralizumab (IDEC-131) is a humanized monoclonal antibody (mAb) against CD40L (CD154) comprised of human gamma 1 heavy chains and human kappa light chains. Toralizumab binds specifically to human CD40L on T cells, thereby preventing CD40 signaling. Toralizumab, a immunosuppressive agent, has the potential for active systemic lupus erythematosus (SLE) research .
|
- HY-P99138
-
- HY-P990282
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD24 Antibody (M1/69) is a rat-derived IgG2b, κ type antibody inhibitor, targeting to mouse CD24.
|
- HY-P990126
-
- HY-P990216
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse IL-25 Antibody (2C3) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to mouse IL-25.
|
- HY-P990243
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse FGL-1 Antibody (177R4) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse FGL-1.
|
- HY-P990121
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse IL-4 Antibody (11B11) is a rat-derived IgG1, κ type antibody inhibitor, targeting to mouse IL-4.
|
- HY-P99128
-
- HY-P9805
-
MERS-3A1; MERS Antibody-3A1
|
SARS-CoV
|
Infection
|
Anti-MERS-3A1 mAb (MERS-3A1) is a human monoclonal IgG1 antibody with the high binding affinity produced in CHO cells.
Anti-MERS-3A1 mAb bocks the binding of MERS-CoV spike protein to DPP4 receptor .
|
- HY-P99134
-
- HY-P99139
-
- HY-P990268
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD45.2 Antibody (104.2) is a mouse-derived IgG2a, κ type antibody inhibitor, targeting to mouse CD45.2.
|
- HY-P990210
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse/Human IL-7 Antibody (M25) is a mouse-derived IgG2b type antibody inhibitor, targeting to mouse/human IL-7.
|
- HY-P990153
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse TIM-2 Antibody (RMT2-29) is a rat-derived Ig2a, λ type antibody inhibitor, targeting to mouse TIM-2.
|
- HY-P990213
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse/Human IL-5 Antibody (TRFK5) is a rat-derived IgG1, κ type antibody inhibitor, targeting to mouse/human IL-5.
|
- HY-P990152
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse TIM-4 Antibody (RMT4-54) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse TIM-4.
|
- HY-P99121
-
- HY-P99122
-
- HY-P99825
-
- HY-P9999
-
RG6102; RO-7126209
|
Amyloid-β
|
Neurological Disease
|
Trontinemab is a bispecific and humanizedized IgG1-κ antibody, targeting to amyloid beta A4 precursor protein (APP) and transferrin receptor, p90, CD71 (TFRC). Trontinemab can be used for research on Alzheimer disease (AD) .
|
- HY-P99729
-
GSK 3772847; CNTO-7160
|
Interleukin Related
|
Inflammation/Immunology
|
Melrilimab (GSK 3772847) is an IgG2-kappa anti-IL1RL1/ST2/IL33R/DER4/FIT-1 monoclonal antibody. Melrilimab can be used for the research of asthma .
|
- HY-P99049
-
- HY-P99447
-
- HY-P99379
-
CAN04; Anti-IL-1RAP/IL-1R3 Reference Antibody (nidanilimab)
|
Interleukin Related
|
Cancer
|
Nidanilimab (CAN04) is a fully humanized monoclonal anti-IL1RAP antibody with a Kd value of 1.10 pM. Nidanilimab blocks IL1α and IL1β signaling and stimulates the immune system to destroy tumour cells. Nidanilimab can be used in research of non-small lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC) .
|
- HY-P99127
-
- HY-P99135
-
- HY-P990242
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse Galectin-9 Antibody (RG9-1) is a rat-derived IgG2b, κ type antibody inhibitor, targeting to mouse Galectin-9.
|
- HY-P99350
-
AMG 910; Anti-Human CD3xClaudin18 2
|
CD3
|
Cancer
|
Gresonitamab (AMG 910) is a half-life extended (HLE) bispecific T-cell engager (BiTE) antibody targets CD3-positive T cells and CLDN18.2-expressing tumor cells. Gresonitamab can be used for the research of adenocarcinoma .
|
- HY-P99246
-
- HY-P99380
-
ZW 25
|
EGFR
|
Cancer
|
Zanidatamab (ZW25) is a humanised, bispecific monoclonal antibody targeting 2 distinct HER2 epitopes (ECD2 and ECD4). Zanidatamab has anti-tumour activity .
|
- HY-P990303
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse 2C TCR Antibody (1B2) is a mouse-derived IgG1 type antibody inhibitor, targeting to mouse 2C TCR.
|
- HY-P990287
-
- HY-P990118
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse Ly6G Antibody (1A8) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse Ly6G.
|
- HY-P990184
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse MHC Class II (βchain) Antibody (KL277) is a hamster/mouse-derived IgG type antibody inhibitor, targeting to mouse MHC Class II.
|
- HY-P9906
-
Bevacizumab
Maximum Cited Publications
25 Publications Verification
Anti-Human VEGF, Humanized Antibody
|
VEGFR
|
Cancer
|
Bevacizumab, a humanized IgG1 monoclonal antibody, specifically binds to all VEGF-A isoforms with high affinity.
|
- HY-P9802
-
SARS-CoV-2 (2019-nCoV) Single-Domain Antibodies; Humanized Single Domain Antibody
|
SARS-CoV
|
Infection
|
Anti-Spike-RBD Single Domain mAb is a CHO cell derived Alpaca monoclonal VHH-huFc antibody, specifically binds to SARS-CoV-2 RBD with high affinity .
|
- HY-P990274
-
|
Inhibitory Antibodies
|
Others
|
Anti-Canine CD34 Antibody (1H6) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to canine CD34.
|
- HY-P99279
-
Anti-Human Phosphatidylserine Recombinant Antibody
|
Inhibitory Antibodies
|
Cancer
|
Bavituximab (Anti-Human Phosphatidylserine Recombinant Antibody) is a phosphatidylserine (PS)-targeting monoclonal antibody, suppresses tumor growth by targeting tumor vasculature and reactivating antitumor immunity. Bavituximab plus Paclitaxel (HY-B0015) and Carboplatin (HY-17393), have enhanced inhibition on non-small-cell lung cancer .
|
- HY-P99140
-
- HY-P990142
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse Vβ4 TCR Antibody (KT4) is a rat-derived IgG2b type antibody inhibitor, targeting to mouse Vβ4 TCR.
|
- HY-P990131
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD47/IAP Antibody (MIAP301) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse CD47/IAP.
|
- HY-P990059
-
|
Inhibitory Antibodies
|
Cancer
|
Puxitatug is an immunoglobulin G1-κ, anti-[Homo sapiens VTCN1 (Vset domain containing T cell activation inhibitor 1, B7 family member H4, B7H4, B7-H4)] Homo sapiens monoclonal antibody .
|
- HY-P99628
-
|
EGFR
|
Cancer
|
Futuximab is a chimeric monoclonal antibody targeting non-overlapping epitopes on EGFR. Futuximab has antineoplastic activity .
|
- HY-P99875
-
- HY-P99131
-
- HY-P990250
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse DKK3 Antibody (DKK3-4.22) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to mouse DKK3.
|
- HY-P990167
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse/Human PrP/prion protein Antibody (TW1) is a mouse-derived IgG2a type antibody inhibitor, targeting to mouse/human PrP/prion protein.
|
- HY-P990265
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD69 Antibody (CD69.2.2) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to mouse CD69.
|
- HY-P99022
-
|
Amyloid-β
|
Neurological Disease
|
Gantenerumab is a fully human anti-amyloid-β (Aβ) IgG1 monoclonal antibody demonstrates sustained cerebral amyloid-β binding. Gantenerumab can be used for Alzheimer's disease research .
|
- HY-P99691
-
- HY-P990233
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse IFNγR/CD119 Antibody (GR-20) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse IFNγR/CD119.
|
- HY-P990206
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse Jagged 2 Antibody (HMJ2-1) is a Armenian hamster-derived IgG type antibody inhibitor, targeting to mouse Jagged 2.
|
- HY-P99266
-
Anti-Human CD4 Recombinant Antibody
|
Inhibitory Antibodies
|
Inflammation/Immunology
Cancer
|
Zanolimumab (Anti-Human CD4 Recombinant Antibody) is a fully human monoclonal antibody targets CD4. Zanolimumab effectively inhibits T-cell receptor (TCR) signal transduction. Zanolimumab can be used for the research of heumatoid arthritis, psoriasis, melanoma, cutaneous and peripheral T-cell lymphoma .
|
- HY-P990298
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse BTLA/CD272 Antibody (6A6) is a Armenian hamster-derived IgG, κ type antibody inhibitor, targeting to mouse BTLA/CD272.
|
- HY-P990160
-
|
Inhibitory Antibodies
|
Others
|
Anti-Rat TCR alpha/beta Antibody (R73) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to rat TCR alpha/beta.
|
- HY-P990136
-
|
Inhibitory Antibodies
|
Others
|
Anti-Monkey/Human CD28 Antibody (CD28.2) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to monkey/human CD28.
|
- HY-P990113
-
|
Inhibitory Antibodies
|
Others
|
Anti-Rat TCR gamma/delta Antibody (V65) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to rat TCR gamma/delta.
|
- HY-P990205
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse/Human KLRG-1 Antibody (2F1) is a Syrian hamster-derived IgG type antibody inhibitor, targeting to mouse/human KLRG-1.
|
- HY-P990231
-
|
Inhibitory Antibodies
|
Others
|
Anti-Rat IgG1 Antibody (RG11/39.4) is a mouse-derived IgG2c, κ type antibody inhibitor, targeting to rat IgG1.
|
- HY-P990138
-
|
Inhibitory Antibodies
|
Others
|
Anti-Monkey/Human CD20 Antibody (2H7) is a mouse-derived IgG2b, κ type antibody inhibitor, targeting to monkey/human CD20.
|
- HY-P990291
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD16.2 Antibody (9E9) is a Armenian hamster-derived IgG type antibody inhibitor, targeting to mouse CD16.2.
|
- HY-P990222
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse IL-17A Antibody (17F3) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to mouse IL-17A.
|
- HY-P990119
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse Kappa Immunoglobulin Light Chain Antibody (HB-58) is a rat-derived IgG1, κ type antibody inhibitor, targeting to mouse Kappa Immunoglobulin Light Chain.
|
- HY-P9902
-
MK-3475; Lambrolizumab
|
PD-1/PD-L1
|
Cancer
|
Pembrolizumab (MK-3475) is a humanized IgG4 antibody inhibiting the programmed cell death 1 (PD-1) receptor, used in cancer immunotherapy.
|
- HY-P99026
-
TJ011133; TJC4
|
Inhibitory Antibodies
|
Cancer
|
Lemzoparlimab (TJ011133; TJC4) is a humanized anti-CD47 IgG4 antibody. Lemzoparlimab has a strong anti-tumor activity .
|
- HY-P9938
-
|
CGRP Receptor
|
Others
|
Erenumab is a fully human monoclonal antibody. Erenumab inhibits the calcitonin gene–related peptide (CGRP) receptor. Erenumab can be used for the prevention of episodic migraine .
|
- HY-108739
-
BI 655075
|
Inhibitory Antibodies
|
Cardiovascular Disease
|
Idarucizumab is a humanized monoclonal antibody fragment. Idarucizumab is first reversal agent for a direct oral anticoagulant (DOAC). Idarucizumab can specifically neutralize the effects of the oral direct thrombin inhibitor in order to restore hemostasis .
|
- HY-P99695
-
CAT-152
|
TGF-beta/Smad
|
Neurological Disease
|
Lerdelimumab (CAT-152) is an IgG4 human anti-TGF-β2 recombinant monoclonal antibody. Lerdelimumab can be used as an anti-scarring agent for glaucoma research .
|
- HY-P99592
-
AMG 110; MT110
|
CD3
|
Cancer
|
Solitomab (AMG 110) is a bispecific anti-CD3 and anti-epithelial-cell-adhesion-molecule (EpCAM) antibody. Solitomab can be used for the research of primary uterine and ovarian carcinosarcoma cancer .
|
- HY-P990277
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD31/PECAM-1 Antibody (390) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse CD31/PECAM-1.
|
- HY-108730
-
Anti-Human PD-L1, Human Antibody; MSB 0010718C; MSB0010718C
|
PD-1/PD-L1
|
Inflammation/Immunology
Cancer
|
Avelumab is a fully human IgG1 anti-PD-L1 monoclonal antibody with potential antibody-dependent cell-mediated cytotoxicity.
|
- HY-P9908
-
- HY-P99205
-
|
ADC Antibody
|
Cancer
|
Glembatumumab is a fully human IgG2 monoclonal antibody directed against the extracellular structural domain of GPNMB expressed in human breast cancer and melanoma. Glembatumumab can be coupled to the microtubule inhibitor monomethyl auristatin E to form glembatumumab vedotin. Glembatumumab vedotin is an antibody-agent coupling (ADC) with antitumor activity .
|
- HY-P990116
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse osteopontin/SPP1 Antibody (100D3) is a mouse-derived IgG2c, κ type antibody inhibitor, targeting to mouse osteopontin/SPP1.
|
- HY-P990237
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse ICOS Antibody (7E.17G9) is a rat-derived IgG2b, κ type antibody inhibitor, targeting to mouse ICOS.
|
- HY-P990123
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse ICOSL/CD275 Antibody (HK5.3) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse ICOSL/CD275.
|
- HY-P990218
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse IL-21R Antibody (4A9) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse IL-21R.
|
- HY-P990165
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse RANKL/CD254 Antibody (IK22/5) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse RANKL/CD254.
|
- HY-P99556
-
AZD8895
|
SARS-CoV
|
Infection
|
Tixagevimab (AZD8895) is a human monoclonal antibody that targets the SARS-CoV-2 receptor binding domain (RBD). It exhibits neutralizing activity against SARS-CoV-2 by binding to the RBD and the S-glycoprotein ectodomain and blocking S-glycoprotein-mediated binding to the receptor .
|
- HY-P99043
-
|
Notch
|
Cancer
|
Rovalpituzumab is a humanized monoclonal antibody against delta-like protein 3 (DLL3). Rovalpituzumab can be used in the synthesis of antibody-drug conjugate (ADC), Rovalpituzumab Tesirine . Rovalpituzumab has activity against small cell lung cancer (SCLC) .
|
- HY-P990276
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD317/BST2 Antibody (927) is a rat-derived IgG2b, κ type antibody inhibitor, targeting to mouse CD317/BST2.
|
- HY-P990147
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse VEGFR-2 Antibody (DC101-CP132) is a mouse-derived IgG2a, κ type antibody inhibitor, targeting to mouse VEGFR-2.
|
- HY-P990211
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse IL-6R Antibody (15A7) is a rat-derived IgG2b, κ type antibody inhibitor, targeting to mouse IL-6R.
|
- HY-P990248
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse E-Cadherin/CD324 Antibody (DECMA-1) is a rat-derived IgG1, κ type antibody inhibitor, targeting to mouse E-Cadherin/CD324.
|
- HY-P990244
-
|
Inhibitory Antibodies
|
Others
|
Anti-Rat FcRn heavy chain heterodimers Antibody (2G3) is a mouse-derived IgG1 type antibody inhibitor, targeting to rat FcRn heavy chain heterodimers.
|
- HY-P990238
-
|
Inhibitory Antibodies
|
Others
|
Anti-Human/Rat HER2 (neu) Antibody (7.16.4) is a mouse-derived IgG2a, κ type antibody inhibitor, targeting to human/rat HER2.
|
- HY-P990230
-
|
Inhibitory Antibodies
|
Others
|
Anti-Rat IgG2a Antibody (RG7/1.30) is a mouse-derived IgG2b, κ type antibody inhibitor, targeting to rat IgG2a.
|
- HY-P990267
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD45RB Antibody (MB23G2) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse CD45RB.
|
- HY-P990125
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CSF1R (CD115) Antibody (AFS98) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse CSF1R.
|
- HY-P99137
-
|
IFNAR
|
Inflammation/Immunology
|
Anti-Mouse IFNAR1 Antibody (MAR1-5A3) is a neutralizing antibody of IFNAR1. Anti-Mouse IFNAR1 Antibody (MAR1-5A3) reacts with IFNAR1 and inhibits IFNAR1 signaling in vitro and in vivo. Mouse IgG1 kappa, Isotype Control (HY-P99977) is the isotype control of Anti-Mouse IFNAR1 Antibody (MAR1-5A3) .
|
- HY-P99017
-
|
CGRP Receptor
|
Others
|
Eptinezumab is a human monoclonal antibody. Eptinezumab binds to calcitonin gene-related peptide (CGRP) and blocks its binding to the receptor. Eptinezumab can be used for the prevention of migraine in adults .
|
- HY-P99773
-
- HY-P990141
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse Vβ8 TCR Antibody (F23.1) is a mouse-derived IgG2a, κ type antibody inhibitor, targeting to mouse Vβ8 TCR.
|
- HY-P990275
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD326/EpCAM Antibody (G8.8) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse CD326/EpCAM.
|
- HY-P990120
-
|
Inhibitory Antibodies
|
Others
|
Anti-Rat Kappa Immunoglobulin Light Chain Antibody (MAR 18.5) is a mouse-derived IgG2a, κ type antibody inhibitor, targeting to rat Kappa Immunoglobulin Light Chain.
|
- HY-P990179
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse NKG2AB6 Antibody (16A11) is a mouse-derived IgG2b, κ type antibody inhibitor, targeting to mouse NKG2AB6.
|
- HY-P990240
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse GITR (LALA-PG) Antibody (DTA-1-CP029) is a mouse-derived IgG2a, κ type antibody inhibitor, targeting to mouse GITR.
|
- HY-P9961
-
|
CD20
|
Cancer
|
Ofatumumab is a fully human anti-CD20 monoclonal antibody that induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity in CD20-expressing B lymphocytes .
|
- HY-P99281
-
BIWA 4; Anti-CD44 Recombinant Antibody
|
Inhibitory Antibodies
|
Cancer
|
Bivatuzumab (Anti-CD44 Recombinant Antibody; BIWA 4) is a humanized monoclonal antibody directed against CD44v6. CD44v6 could acts as a sarcoma target for CAR-redirected CIK cells .
|
- HY-P99363
-
Anti-ICOS/CD278 Reference Antibody (feladilimab); GSK3359609
|
Inhibitory Antibodies
|
Cancer
|
Feladilimab (Anti-ICOS/CD278 Reference Antibody (feladilimab); GSK3359609) is humanized IgG4 anti-ICOS agonist monoclonal antibody. Feladilimab binds to ICOS-expressing T cells. Feladilimab has the potential for the research of cancer .
|
- HY-P99514
-
AGEN1884
|
CTLA-4
|
Cancer
|
Zalifrelimab (AGEN1884) is a fully human IgG1 monoclonal antibody targeting CTLA-4 (CTLA-4). Zalifrelimab antagonizes the inhibitory checkpoints of immune cell activation regulated by CTLA-4 signaling .
|
- HY-P99538
-
LFB-R603; TG-1101; TGTX-1101
|
CD20
|
Cancer
|
Ublituximab (LFB-R603; TG-1101; TGTX-1101) is a next-generation, type 1 chimeric monoclonal antibody targeting a unique epitope on the CD20 antigen. Ublituximab has anticancer effects .
|
- HY-P99102
-
10-1074
|
HIV
|
Infection
|
Zinlirvimab is a human IgG1-λ2, HIV neutralising antibody targeting to HIV-1 gp120 envelope glycoprotein (IIIB gp120 V3 loop) .
|
- HY-P99046
-
|
Inhibitory Antibodies
|
Cancer
|
Selicrelumab is an agonist CD40 antibody, induces changes in the tumor microenvironment. Selicrelumab can be used for the research of pancreatic cance and neoadjuvant study .
|
- HY-P990219
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse IL-2 Antibody (JES6-1A12) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse IL-2.
|
- HY-P990229
-
|
Inhibitory Antibodies
|
Others
|
Anti-Rat IgG2b Antibody (RG7/11.1) is a mouse-derived IgG2b, κ type antibody inhibitor, targeting to rat IgG2b.
|
- HY-P990280
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD27 Antibody (RM27-3E5) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse CD27.
|
- HY-P990271
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD40 Antibody (FGK4.5-CP133) is a mouse-derived IgG2a, κ type antibody inhibitor, targeting to mouse CD40.
|
- HY-P990251
-
|
Inhibitory Antibodies
|
Others
|
Anti-Human/Mouse denatured collagen type-I Antibody (XL313) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to human/mouse denatured collagen type-I.
|
- HY-P990207
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse/Human Integrin β7 Antibody (FIB504) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse/human Integrin β7.
|
- HY-P99277
-
Anti-C. difficile Toxin A Recombinant Antibody
|
Inhibitory Antibodies
|
Infection
|
Actoxumab (Anti-C. difficile Toxin A Recombinant Antibody) is a antitoxin antibody against C. difficile toxin A by neutralizing TcdA. Actoxumab prevents both the damage to the gut wall and the inflammatory response, which are associated with C. difficile. Actoxumab has synergy effect with Bezlotoxumab (HY-P9929) targeting TcdB .
|
- HY-P9979
-
UCB7665
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Rozanolixizumab (UCB7665), a humanized high-affinity anti-human neonatal Fc receptor (FcRn) monoclonal antibody (IgG4P), is used to the research of reducing pathogenic IgG in autoimmune and alloimmune diseases .
|
- HY-P99029
-
Hu5F9-G4
|
Inhibitory Antibodies
|
Cancer
|
Magrolimab (Hu5F9-G4) is a first-in-class humanized anti-CD47 IgG4 antibody with an anti-tumor activity .
|
- HY-P990148
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse VEGF-A Antibody (2G11-2A05) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse VEGF-A.
|
- HY-P990292
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD132 (common γ chain) Antibody (3E12) is a rat-derived IgG2b type antibody inhibitor, targeting to mouse CD132.
|
- HY-P990232
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse IFNγRα/CD119 Antibody (2E2) is a Armenian hamster-derived IgG type antibody inhibitor, targeting to mouse IFNγRα/CD119.
|
- HY-P99860
-
- HY-P99054
-
|
Inhibitory Antibodies
|
Cancer
|
Tusamitamab is an IgG1 monoclonal antibody that targets CEACAM5. Tusamitamab can be used to synthesize Tusamitamab ravtansine (SAR408701), which is a first-in-class humanized antibody-drug conjugate (ADC) that combines Tusamitamab and DM4 (a potent maytansine derivative) .
|
- HY-P990201
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse L-Selectin/CD62L Antibody (Mel-14) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse L-Selectin/CD62L.
|
- HY-P990214
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse IL-3 Antibody (MP2-8F8) is a rat-derived IgG1 type antibody inhibitor, targeting to mouse IL-3.
|
- HY-P990227
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse IL-12 Antibody (R1-5D9) is a rat-derived IgG2a type antibody inhibitor, targeting to mouse IL-12.
|
- HY-P99241
-
PF 06946860
|
TGF-beta/Smad
|
Cancer
|
Ponsegromab (PF 06946860) is a potent and selective humanized anti-GDF15 antibody inhibitor with anti-cachexia activity. Ponsegromab binds to GDF15 and prevents the binding of GDF15 to GFRAL, thereby blocking GDF15/GFRAL-mediated signaling. Ponsegromab can be used in the research of cancers .
|
- HY-P99417
-
UCB4144; VR 942
|
Interleukin Related
|
Inflammation/Immunology
|
Abrezekimab (VR 942) contains CDP7766, a humanized, high-affinity, neutralizing, anti-human-IL-13 antibody fragment that binds to IL-13. Abrezekimab prevents binding to the IL-13Rα1 subunit. Abrezekimab can be used in research of asthma .
|
- HY-P99027
-
LAG525; IMP701
|
LAG-3
|
Cancer
|
Ieramilimab (LAG525; IMP701) is a humanized IgG4 monoclonal antibody that binds to LAG-3, resulting in inhibition of LAG-3 interaction with MHC-II molecules .
|
- HY-P99465
-
BAY 1093884
|
Thrombin
|
Cardiovascular Disease
|
Befovacimab (BAY 1093884) is a fully human monoclonal IgG2 antibody able to bind to tissue factor pathway inhibitor (TFPI). Befovacimab can be used for haemophilia A/B research .
|
- HY-P99146
-
- HY-P990168
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse Podoplanin/glycoprotein 38 Antibody (8.1.1) is a Syrian hamster-derived IgG type antibody inhibitor, targeting to mouse Podoplanin/glycoprotein 38.
|
- HY-P99169
-
TJ004309
|
CD73
|
Cancer
|
Uliledlimab is a potent against CD73 humanizedized monoclonal antibody. Uliledlimab inhibits the conversion of extracellular adenosine monophosphate (AMP) to adenosine. Uliledlimab can be used in research of cancer .
|
- HY-P99236
-
FP-1305
|
Inhibitory Antibodies
|
Inflammation/Immunology
Cancer
|
Bexmarilimab (FP-1305) is a potent humanized anti-CLEVER-1 IgG4-antibody with an IC50 value of 4.51 nM. Bexmarilimab is capable of inducing a phenotypic M2 to M1 immune switch of tumor-associated macrophages. Bexmarilimab can be used in research of cancer .
|
- HY-P990115
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse OX40/CD134 Antibody (OX-86) is a rat-derived IgG1, κ type antibody inhibitor, targeting to mouse OX40/CD134.
|
- HY-P990241
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse GITR (D265A) Antibody (DTA-1-CP027) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to mouse GITR.
|
- HY-P99936
-
LJM716
|
EGFR
|
Cancer
|
Elgemtumab(LJM716) is a fully human IgG monoclonal antibody. Elgemtumab can specifically bind to HER3, block ligand-dependent and independent HER3 signal transduction and cell proliferation, and has good anti-tumor potential .
|
- HY-P990117
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse/Rat/Human Osteopontin/SPP1 Antibody (MPIIIB10) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to mouse/rat/human Osteopontin/SPP1.
|
- HY-P990246
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse F4/80 Antibody (CI:A3-1) is a rat-derived IgG2b, κ type antibody inhibitor, targeting to mouse F4/80.
|
- HY-P990226
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse IL-12 p35 Antibody (C18.2) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse IL-12 p35.
|
- HY-P990212
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse IL-6 Antibody (MP5-20F3) is a rat-derived IgG1, κ type antibody inhibitor, targeting to mouse IL-6.
|
- HY-P990225
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse IL-12 p40 Antibody (C17.8) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse IL-12 p40.
|
- HY-P990217
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse IL-23 p19 Antibody (G23-8) is a rat-derived IgG1, κ type antibody inhibitor, targeting to mouse IL-23 p19.
|
- HY-P990220
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse IL-18 Antibody (YIGIF74-1G7) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse IL-18.
|
- HY-P99901
-
VIS649
|
Inhibitory Antibodies
|
Cancer
|
Sibeprenlimab (VIS649) is a humanized IgG2 monoclonal antibody. Sibeprenlimab can inhibit APRIL. Sibeprenlimab can be used for the research of IgA nephropathy (IgAN) .
|
- HY-P99355
-
Anti-ACVR2B Reference Antibody; BYM338
|
TGF-β Receptor
|
Metabolic Disease
|
Bimagrumab (Anti-ACVR2B Reference Antibody) is a human monoclonal antibody that blocks activin type II receptor (ActRII), with KDs of 1.7 pM and 434 pM for human ActRIIB and ActRIIA, respectively. Bimagrumab can be used for the research of pathological muscle loss and weakness .
|
- HY-P99012
-
|
Interleukin Related
SARS-CoV
|
Infection
Inflammation/Immunology
|
Clazakizumab is a monoclonal antibody with high affinity and specificity for the IL-6 (interleukin-6) cytokine. Clazakizumab may be helpful in inhibiting the cytokine response to SARS-CoV-2 in COVID-19. Clazakizumab can be used for the research of psoriatic arthritis (PsA) and renal antibody-mediated rejection .
|
- HY-P99624
-
CR4098
|
RABV
|
Infection
|
Foravirumab (CR4098) is a monoclonal antibody against rabies virus glycoprotein antigenic site III .
|
- HY-P990189
-
|
Inhibitory Antibodies
|
Others
|
Anti-Monkey/Human MHC class II (HLA-DR) Antibody (L243) is a mouse-derived IgG2a, κ type antibody inhibitor, targeting to monkey/human MHC class II.
|
- HY-P990188
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse MHC class II (I-A) Antibody (Y-3P) is a mouse-derived IgG2a, κ type antibody inhibitor, targeting to mouse MHC class II.
|
- HY-P99467
-
BMS 4182137; VIR 7832
|
SARS-CoV
|
Infection
|
Beludavimab (BMS 4182137; VIR 7832) is a monoclonal antibody targeting the spike glycoprotein of SARS-CoV-2. Beludavimab binds to recombinant spike protein receptor-binding domain (S-RBD) with an EC50 value of 14.9 ng/mL and a Kd of 0.21 nM .
|
- HY-P99904
-
MEDI-507
|
CD2
|
Inflammation/Immunology
|
Siplizumab (MEDI-507) is a humanized IgG1 monoclonal antibody against CD2. Siplizumab depletes T cells, decreases T cell activation, inhibites T cell proliferation and enriches naïve and bona fide regulatory T cells .
|
- HY-P9906A
-
Anti-Human VEGF, Humanized Antibody (PBS)
|
VEGFR
|
Cancer
|
Bevacizumab, a humanized IgG1 monoclonal antibody, specifically binds to all VEGF-A isoforms with high affinity .
|
- HY-P990299
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse B220 Antibody (RA3.3A1/6.1) is a rat-derived IgM type antibody inhibitor, targeting to mouse B220.
|
- HY-P99889
-
BRII-198
|
SARS-CoV
|
Infection
|
Romlusevimab (BRII-198) is a neutralizing recombinant human IgG1 monoclonal antibody against the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) .
|
- HY-P99057
-
CDX-1127
|
TNF Receptor
|
Cancer
|
Varlilumab (CDX-1127) is a first-in-class human IgG1 anti-CD27 monoclonal antibody. Varlilumab has an anti-tumor activity .
|
- HY-P99405
-
PRX 002; RG 7935; RO 7046015
|
α-synuclein
|
Neurological Disease
|
Prasinezumab (PRX 002) is a humanized IgG1 monoclonal antibody directed against aggregated α-synuclein. Prasinezumab has the potential for Parkinson's disease research .
|
- HY-P990143
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse/Rat/Bovine VLDL-R Antibody (IgG-6A6) is a mouse-derived IgG1, λ type antibody inhibitor, targeting to mouse/rat/Bovine VLDL-R.
|
- HY-P990146
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse/Rat/Human v-H-Ras Antibody (Y13-238) is a rat-derived IgG2a type antibody inhibitor, targeting to mouse/rat/human v-H-Ras.
|
- HY-P990194
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse MHC Class I (H-2Kd) Antibody (HB-159)) is a mouse-derived IgG2a, κ type antibody inhibitor, targeting to mouse MHC Class I.
|
- HY-P99123A
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD28 (LALA-PG) Antibody (D665-CP043) is a mouse-derived IgG2a, κ type antibody inhibitor, targeting to mouse CD28.
|
- HY-P99710
-
BI 767551; DZIF-10c
|
SARS-CoV
|
Infection
|
Lomtegovimab (BI 767551) is a human anti-SARS-COV-2 spike glycoprotein monoclonal antibody. Lomtegovimab binds and neutralizes SARS-CoV-2. Lomtegovimab shows antiviral efficacy. Lomtegovimab has the potential for the research of COVID-19 .
|
- HY-P990129
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD71/TfR1 Antibody (8D3) is a rat-derived IgG2a type antibody inhibitor, targeting to mouse CD71/TfR1.
|
- HY-P990140
-
|
Inhibitory Antibodies
|
Others
|
Anti-Rat β-2-Microglobulin Antibody (4C9) is a mouse-derived IgG1 type antibody inhibitor, targeting to rat β-2-Microglobulin.
|
- HY-P990134
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD40L/CD154 Antibody (MR-1) is a Armenian hamster-derived IgG type antibody inhibitor, targeting to mouse CD40L/CD154.
|
- HY-P990132
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse/Rat/Human CD47/IAP Antibody (MIAP410) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to mouse/rat/human CD47/IAP.
|
- HY-P99185
-
|
Amyloid-β
|
Neurological Disease
|
Bapineuzumab is an anti-β-amyloid protein (APP) monoclonal antibody. Bapineuzumab can be used for the research of Alzheimer’s disease (AD) .
|
- HY-P99119
-
- HY-P990254
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CXCR3/CD183 Antibody (CXCR3-173) is a Armenian hamster-derived IgG type antibody inhibitor, targeting to mouse CXCR3/CD183.
|
- HY-P990154
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse TIM-1/CD365 Antibody (3B3) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse TIM-1/CD365.
|
- HY-P990127
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD80/B7-1 Antibody (RM80) is a rat-derived IgG2a type antibody inhibitor, targeting to mouse CD80/B7-1.
|
- HY-P990166
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse PSGL-1/CD162 Antibody (4RA10) is a rat-derived IgG1, κ type antibody inhibitor, targeting to mouse PSGL-1/CD162.
|
- HY-P99474
-
CAT 213; iCo-008
|
CCR
|
Inflammation/Immunology
|
Bertilimumab (CAT 213; iCo-008) is a human monoclonal antibody targeting eotaxin-1 (CCL11). Bertilimumab has the potential for allergic disorders research .
|
- HY-P9913
-
Anti-Human CD20 type I, Chimeric Antibody
|
CD20
|
Inflammation/Immunology
Cancer
|
Rituximab is an anti-CD20 chimeric monoclonal antibody used for research of certain autoimmune diseases and cancer.
|
- HY-P9940
-
|
Factor VIII
|
Cardiovascular Disease
|
Emicizumab is a bispecific monoclonal antibody that bridges activated factor IX and factor X to replace the function of missing activated factor VIII, thereby restoring hemostasis. Emicizumab can be used for hemophilia A research .
|
- HY-P990249
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse DR5/CD262 Antibody (MD5-1) is a Armenian hamster-derived IgG, κ type antibody inhibitor, targeting to mouse DR5/CD262.
|
- HY-P990178
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse NKG2D/CD314 Antibody (CX5) is a rat-derived IgG1, κ type antibody inhibitor, targeting to mouse NKG2D/CD314.
|
- HY-P990196
-
|
Inhibitory Antibodies
|
Others
|
Anti-Monkey/Human MDR-1/CD243 Antibody (UIC2) is a mouse-derived IgG2a, κ type antibody inhibitor, targeting to monkey/human MDR-1/CD243.
|
- HY-P990180
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse NKG2A/C/E Antibody (20D5) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse NKG2A/C/E.
|
- HY-P99389
-
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Tesnatilimab is a human IgG4 monoclonal antibody that acts on the immune activating receptor NKG2D and has potential immunomodulatory and anti-inflammatory activity. Tesnatilimab can be used in the study of inflammatory bowel disease (IBD) .
|
- HY-P99319
-
- HY-P9963
-
Anatumomab
|
CD19
|
Cancer
|
Blinatumomab (Anatumomab) is a bispecific monoclonal antibody which can specifically targets the CD19 antigen present on B cells. Blinatumomab can be used for the research of acute lymphoblastic leukemia .
|
- HY-P99025
-
|
Interleukin Related
|
Inflammation/Immunology
|
Lebrikizumab is an IgG4 humanized monoclonal antibody that specifically binds to interleukin-13 (IL-13) and inhibits its function. Lebrikizumab can be used for the research of asthma .
|
- HY-P99631
-
CSL312
|
Factor Xa
|
Cardiovascular Disease
|
Garadacimab (CSL312) is a first-in-class, fully human IgG4 monoclonal antibody targeting activated factor XII (FXIIa). Garadacimab has the potential for hereditary angioedema research .
|
- HY-P99305
-
- HY-P99276
-
Anti-Human CA-125 Recombinant Antibody
|
Inhibitory Antibodies
|
Cancer
|
Abagovomab (Anti-Human CA-125 Recombinant Antibody) is a murine monoclonal anti-idiotypic antibody, against the tumor-associated antigen, CA-125. Abagovomab is generated by a mouse hybridoma, can imitate the human TAA, CA-125. Abagovomab can elicit humoral and cellular immune responses against ovarian cancer (oc) .
|
- HY-P990198
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse/Human Mac-2/Galectin-3 Antibody (TIB-166) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse/human Mac-2/Galectin-3.
|
- HY-P990260
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD86/B7-2 Antibody (GL-1) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse CD86/B7-2.
|
- HY-P990130
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse/Rat CD71/TfR1 Antibody (OX-26) is a mouse-derived IgG2a, κ type antibody inhibitor, targeting to mouse/rat CD71/TfR1.
|
- HY-P9909
-
- HY-P990247
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse E-selectin/CD62E Antibody (9A9) is a rat-derived IgG2b type antibody inhibitor, targeting to mouse E-selectin/CD62E.
|
- HY-P99244
-
ILV 094
|
Interleukin Related
|
Inflammation/Immunology
|
Fezakinumab is an interleukin-22 (IL-22) monoclonal antibody. Fezakinumab can be used for the research of inflammatory disease, such as psoriasis and rheumatoid arthritis .
|
- HY-P99441
-
SRK-015
|
Inhibitory Antibodies
|
Neurological Disease
|
Apitegromab (SRK-015) is an anti-promyostatin monoclonal antibody. Apitegromab can be used for the research of neuromuscular disease including spinal muscular atrophy .
|
- HY-P99381
-
|
Inhibitory Antibodies
|
Cancer
|
XmAb 5592 is a humanized, Fc-engineered anti-HM1.24 antibody with enhanced binding to FcγRIIIa and FcγRIIa receptors, augments HM1.24-specific multiple myeloma (MM) cells lysis in vitro via antibody-dependent cellular cytotoxicity (ADCC) and antibody dependent cellular phagocytosis (ADCP) .
|
- HY-P99891
-
|
Integrin
|
Cardiovascular Disease
|
Rovelizumab is a humanized monoclonal leukointegrin antibody. Rovelizumab is a monoclonal antibody directed against the CD11/CD18 cell adhesion proteins. Rovelizumab can be used for research of multiple sclerosis (MS), hemorrhagic shock, myocardial infarction (MI) and stroke .
|
- HY-P99893
-
- HY-P99316
-
- HY-P990174
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse Pan-endothelial Cell Antigen/MECA-32 Antibody (MECA-32) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse Pan-endothelial Cell Antigen/MECA-32.
|
- HY-P990258
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CLEC9A/CD370 Antibody (7H11) is a rat-derived IgG1, κ type antibody inhibitor, targeting to mouse CLEC9A/CD370.
|
- HY-P99053
-
|
Interleukin Related
|
Inflammation/Immunology
|
Tralokinumab, a fully human IgG4 monoclonal antibody, specifically binds with high affinity to IL-13 alone, preventing its interaction with the receptor and subsequent downstream signalling. Tralokinumab can be used for the research of the atopic dermatitis (AD) .
|
- HY-P99147
-
- HY-P99364
-
Anti-VEGFR1/FLT1 Reference Antibody; IMC-18F1
|
VEGFR
|
Cancer
|
Icrucumab (Anti-VEGFR1/FLT1 Reference Antibody; IMC-18F1) is a human Anti-VEGFR-1 IgG1 monoclonal antibody. Icrucumab has the potential for the research of advanced solid tumors .
|
- HY-P990255
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CXCL9/MIG Antibody (MIG-2F5.5) is a Armenian hamster-derived IgG, κ type antibody inhibitor, targeting to mouse CXCL9/MIG.
|
- HY-P99040
-
JNJ-61610588
|
PD-1/PD-L1
|
Cancer
|
Onvatilimab (JNJ-61610588) is a human IgG1κ anti-VISTA (V-domain Ig Suppressor of T-cell Activation) monoclonal antibody. Onvatilimab has an anti-tumor activity .
|
- HY-P99859
-
LY3002813
|
Amyloid-β
|
Neurological Disease
|
Donanemab (LY3002813) is a humanized IgG1 monoclonal antibody directed at an N‐terminal pyroglutamate amyloid beta (Aβ) epitope. Donanemab has the potential for early Alzheimer's disease research .
|
- HY-P99589
-
16B5; AB-16B5
|
Apoptosis
|
Cancer
|
Sotevtamab (16B5) is a humanized IgG2 anti-clusterin monoclonal antibody (mAb). Sotevtamab is an inhibitor of the epithelial to mesenchymal transition. Sotevtamab can be used for cancer research .
|
- HY-P990187
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse MHC Class II (I-A/I-E) Antibody (M5/114) is a rat-derived IgG2b type antibody inhibitor, targeting to mouse MHC Class II.
|
- HY-P990106
-
|
VEGFR
|
Cancer
|
Anti-Mouse VEGFR-2 Antibody (DC101) is a potent VEGFR2 inhibitor that can be used for the research of papilloma .
|
- HY-P990128
-
|
Inhibitory Antibodies
|
Others
|
Anti-Rat CD80/B7-1 Antibody (3H5) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to rat CD80/B7-1.
|
- HY-P990294
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD106/VCAM-1 Antibody (M/K-2.7) is a rat-derived IgG1, κ type antibody inhibitor, targeting to mouse CD106/VCAM-1.
|
- HY-P99607
-
IDEC-151
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Clenoliximab (IDEC-151) is a macaque-human chimeric monoclonal antibody (immunoglobulin G4) specific for the CD4 molecule on the surface of T lymphocytes. Clenoliximab can be used for the research of rheumatoid arthritis .
|
- HY-P99425
-
- HY-P99162
-
CIM331
|
Interleukin Related
|
Inflammation/Immunology
|
Nemolizumab (CIM331) is a humanized antihuman interleukin-31 receptor A monoclonal antibody that inhibits the binding of interleukin-31 (IL-31) to its receptor and subsequent signal transduction. Nemolizumab can used be in research of atopic dermatitis (AD) .
|
- HY-P990224
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse IL-12 p75 Antibody (R2-9A5) is a rat-derived IgG2b, κ type antibody inhibitor, targeting to mouse IL-12 p75.
|
- HY-P99302
-
Humanized Anti-CD28 Recombinant Antibody
|
CD28
|
Inflammation/Immunology
|
Lulizumab (Humanized Anti-CD28 Recombinant Antibody) is a selective CD28 blockade, Lulizumab prevents T cell activation by selectively targeting CD28 signaling .
|
- HY-P99563
-
LY 3090106
|
TNF Receptor
Interleukin Related
|
Inflammation/Immunology
|
Tibulizumab (LY 3090106) is a tetravalent bispecific monoclonal antibody targeting B-cell activating factor (BAFF) and IL-17A with Kd values of 60 pM and 14 pM, respectively. Tibulizumab can be used for autoimmune disease research .
|
- HY-P99116
-
RG7716
|
VEGFR
|
Metabolic Disease
|
Faricimab is a bispecific antibody targeting angiopoietin-2 and vascular endothelial growth factor-A (VEGF-A). Faricimab can be used for diabetic macular edema (DME) research .
|
- HY-P9965
-
HuLuc 63; PDL 063; BMS 901608
|
Inhibitory Antibodies
|
Cancer
|
Elotuzumab is a monoclonal antibody directed against the SLAMF7 receptor. Elotuzumab has no significant antimyeloma activity when given as a single agent with relapsed or refractory multiple myeloma (RRMM). Elotuzumab results in improved response and outcome when combined with other antimyeloma agents .
|
- HY-P99166
-
|
PD-1/PD-L1
CTLA-4
|
Inflammation/Immunology
|
Vudalimab is a potent dual PD-1 and CTLA-4 inhibitor as a fully humanized bispecific monoclonal antibody. Vudalimab targets immune checkpoint receptors PD-1 and CTLA-4 and promotes tumor-selective T-cell activation .
|
- HY-P99961
-
JS004
|
CD28
|
Cancer
|
Tifcemalimab (JS004) is a humanized anti-BTLA (B and T lymphocyte attenuation factor) monoclonal antibody. Tifcemalimab blocks the interaction of HVEM-BTLA by binding to BTLA, and thus blocks the inhibitory signaling pathway mediated by BTLA. Tifcemalimab can be used in research of cancer .
|
- HY-P99117
-
AK104
|
PD-1/PD-L1
|
Cancer
|
Cadonilimab (AK104) is a targeting PD1/CTLA4 IgG1 scaffold Fc-engineered humanized antibody. Cadonilimab can be used for researching metastatic cervical cancer .
|
- HY-P99300
-
QGE 031; Anti-IGHE Recombinant Antibody
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Ligelizumab (QGE 031) is a humanized high-affinity monoclonal anti-IgE antibody. Ligelizumab can be used for the research of chronic spontaneous urticarial .
|
- HY-P990133
-
|
Inhibitory Antibodies
|
Others
|
Anti-Monkey/Human CD40L/CD154 Antibody (5C8) is a mouse-derived IgG2a type antibody inhibitor, targeting to monkey/human CD40L/CD154.
|
- HY-P990215
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse IL-27 p28 Antibody (MM27.7B1) is a mouse-derived IgG2a, κ type antibody inhibitor, targeting to mouse IL-27 p28.
|
- HY-P99125
-
- HY-P99021
-
LY 2951742
|
CGRP Receptor
|
Neurological Disease
|
Galcanezumab (LY 2951742) is a humanized IgG4 monoclonal antibody against the CGRP ligand. Galcanezumab can be used for migraine or cluster headaches research .
|
- HY-P9944
-
MEDI 493
|
RSV
|
Infection
|
Palivizumab (MEDI 493), a humanized respiratory syncytial virus monoclonal antibody, reduces respiratory syncytial virus (RSV) infection .
|
- HY-P99398
-
BPS 804
|
Inhibitory Antibodies
|
Inflammation/Immunology
Cancer
|
Setrusumab (BPS 804) is a fully human monoclonal antibody targets sclerostin. Setrusumab efftively improves bone strength. Setrusumab can be used for the resesrch of Osteogenesis Imperfecta (OI) and cancer .
|
- HY-P99786
-
REGN3918
|
Complement System
|
Metabolic Disease
|
Pozelimab (REGN3918) is a fully human IgG4 anti-C5 monoclonal antibody. Pozelimab binds to C5 and C5 variants with high affinity and blocks complement-mediated hemolysis. Pozelimab can be used for the research of complement-mediated diseases .
|
- HY-P99308
-
AME 133v; LY 2469298; Humanized Anti-MS4A1 Recombinant Antibody
|
CD20
|
Cancer
|
Ocaratuzumab (AME 133v) is an Fc-engineered humanized IgG1 anti-CD20 monoclonal antibody, with a Kd of ~100 pM. Ocaratuzumab exhibits more effective antibody-dependent cell-mediated cytotoxicity (ADCC) .
|
- HY-P990170
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse PD-L2/B7-DC Antibody (TY25) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse PD-L2/B7-DC.
|
- HY-P990157
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse Thy1/CD90 Antibody (M5/49.4.1) is a rat-derived IgG2a type antibody inhibitor, targeting to mouse Thy1/CD90.
|
- HY-P990151
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse TL1A/TNFSF15 Antibody (5G4.6) is a Armenian hamster-derived IgG type antibody inhibitor, targeting to mouse TL1A/TNFSF15.
|
- HY-P990175
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse OX40L/CD134L Antibody (RM134L) is a rat-derived IgG2b, κ type antibody inhibitor, targeting to mouse OX40L/CD134L.
|
- HY-P990300
-
|
Inhibitory Antibodies
|
Others
|
anti-Phosphotyrosine Antibody (4G10) is a mouse-derived IgG2b type antibody inhibitor, targeting to Phosphotyrosine.
|
- HY-P99356
-
BIIB054; Anti-Alpha-synuclein Reference Antibody (cinpanemab)
|
α-synuclein
|
Neurological Disease
|
Cinpanemab (BIIB054) is a human-derived monoclonal antibody that binds to α-synuclein. Cinpanemab can be used for the research of Parkinson's disease .
|
- HY-P990104
-
|
Notch
|
Inflammation/Immunology
Cancer
|
Anti-DLL3 Antibody (anti-DLL3 arm derived from AMG-757) is the anti-DLL3 arm of the bispecific T-cell engager (BiTE) antibody-Tarlatamab (AMG-757) (HY-P99575). Tarlatamab targets both DLL3 and CD3.
|
- HY-P990293
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD122/IL-2Rβ Antibody (5H4) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse CD122/IL-2Rβ.
|
- HY-P99969
-
|
EGFR
|
Cancer
|
Inetetamab is a monoclonal antibody binding to domain IV of HER2 receptor. Inetetamab alone or together with tyrosine kinase inhibitors has antitumor activities .
|
- HY-P9993
-
LY-3462817
|
PD-1/PD-L1
|
Cancer
|
Peresolimab is a humanized IgG1-κ antibody targeting to PD-1. Peresolimab potentially stimulates physiological immune inhibitory pathways to restore immune homeostasis .
|
- HY-P99326
-
Anti-Human CD20 Recombinant Antibody
|
CD20
|
Cancer
|
Tositumomab is a murine IgG2a lambda monoclonal antibody directed against the CD20 antigen, which is found on the surface of normal and malignant B lymphocytes .
|
- HY-P99036
-
- HY-P99698
-
LDP
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Lesabelimab (LDP) is an immunoglobulin G1-kappa anti-CD274 monoclonal antibody. CD274 is an immune checkpoint ligand, represses antitumour immunity through the interaction with PDCD1 receptor .
|
- HY-P99750
-
CT-P23
|
Influenza Virus
|
Infection
|
Navivumab (CT-P23) is an influenza A virus hemagglutinin HA monoclonal antibody. neutralizes H1, H2, H5, and H9 influenza A viruses by binding to the stem fusion domain in HA2 .
|
- HY-P990236
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse/Rat/Monkey/Human ICOS/CD278 Antibody (C398.4A) is a Armenian hamster-derived IgG type antibody inhibitor, targeting to mouse/rat/monkey/human ICOS/CD278.
|
- HY-P990234
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse ICOSL/CD275 (LALA-PG) Antibody (HK5.3-CP046) is a mouse-derived IgG2a, κ type antibody inhibitor, targeting to mouse ICOSL/CD275.
|
- HY-P990279
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD276/B7-H3 Antibody (MJ18) is a rat-derived IgG1, κ type antibody inhibitor, targeting to mouse CD276/B7-H3.
|
- HY-P990144
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse/Human VLA-4/CD49d Antibody (PS/2) is a rat-derived IgG2b, κ type antibody inhibitor, targeting to mouse/human VLA-4/CD49d.
|
- HY-P990156
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse Thy1.1/CD90.1 Antibody (19E12) is a mouse-derived IgG2a, κ type antibody inhibitor, targeting to mouse Thy1.1/CD90.1.
|
- HY-P990202
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse/Rat/Human LRP1/CD91 Antibody (11H4) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to mouse/rat/human LRP1/CD91.
|
- HY-P990297
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse/Rat/Human CCL2/MCP-1 Antibody (2H5) is a Armenian hamster-derived IgG, κ type antibody inhibitor, targeting to mouse/rat/human CCL2/MCP-1.
|
- HY-P99639
-
APL-501; CBT-501; GB-226
|
PD-1/PD-L1
|
Cancer
|
Geptanolimab (CBT-501) is a humanized IgG4k monoclonal antibody against programmed death-1 (PD-1). Siplizumab inhibits the binding of PD-L1/L2 to PD-1 through a competitive action. Siplizumab can be used in research of cancer .
|
- HY-P990192
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse MHC Class I (H-2Kk) Antibody (AF3-12.1.3) is a mouse-derived IgG1 type antibody inhibitor, targeting to mouse MHC Class I.
|
- HY-P990195
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse MHC Class I (H-2) Antibody (M1/42.3.9.8) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse MHC Class I.
|
- HY-P99274
-
BI 836845; Anti-Human IGF1 and IGF2 Recombinant Antibody
|
IGF-1R
|
Cancer
|
Xentuzumab (Anti-Human IGF1 and IGF2 Recombinant Antibody; BI836845) is a recombinant a human monoclonal antibody that targets IGF ligands IGF1 and IGF2. Xentuzumab inhibits both of IGF1 and IGF2 growth-promoting signalling and suppresses AKT activation .
|
- HY-P99632
-
REGN 2477
|
TGF-β Receptor
|
Inflammation/Immunology
|
Garetosmab (REGN 2477) is a fully human IgG4 monoclonal antibody that specifically inhibits activin A. Garetosmab can be used for fibrodysplasia ossificans progressiva (FOP) research .
|
- HY-P99357
-
REGN1193; Anti-GCGR Reference Antibody (crotedumab)
|
GCGR
|
Metabolic Disease
|
Crotedumab (REGN1193) is a fully human IgG4 monoclonal antibody that binds and inhibits glucagon receptor (GCGR), with a KD of 0.1 nM. Crotedumab can be used for the research of diabetes .
|
- HY-P990173
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse/Rat/Human PD-L1 Antibody (368A.4H1) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to mouse/rat/human PD-L1.
|
- HY-P990161
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse TCR Vγ1.1/Cr4 Antibody (2.11) is a Armenian hamster-derived IgG type antibody inhibitor, targeting to mouse TCR Vγ1.1/Cr4.
|
- HY-P990296
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CCR3/CD193) Antibody (6S2-19-4) is a rat-derived IgG2b, λ type antibody inhibitor, targeting to mouse CCR3/CD193).
|
- HY-P99103
-
LY-3853113; LY-COV1404
|
SARS-CoV
|
Infection
|
Bebtelovimab a humanized IgG1-λ2 antibody targeting to SARS-CoV-2, especially COVID-19. Bebtelovimab potently neutralizes SARS-CoV-2 variants, and inhibits COVID-19 with mild-to-moderate efficacy .
|
- HY-P99399
-
RG 6100; RO7105705; MTAU-9937A
|
Tau Protein
|
Neurological Disease
|
Semorinemab (RG 6100) is an anti-Tau humanized IgG4 monoclonal antibody, targets the N-terminal portion of the Tau protein (amino acid residues 6-23). Semorinemab binds with human Tau with a Kd value of 3.8 nM. Semorinemab can be used for the research of Alzheimer's Disease .
|
- HY-P99142
-
- HY-P99509
-
- HY-P99028
-
TMB-355; TNX-355
|
HIV
|
Infection
|
Ibalizumab (TMB-355) is a humanised IgG4 monoclonal antibody that prevents HIV cell entry by binding to CD4 receptor. Ibalizumab has the potential for HIV-1 infection research .
|
- HY-P99038
-
|
CD20
|
Inflammation/Immunology
Cancer
|
Odronextamab is a hinge-stabilised, fully human IgG4-based CD20 × CD3 bispecific antibody that binds CD3 on T cells and CD20 on B cells .
|
- HY-P99051
-
- HY-P99191
-
NI-0501
|
IFNAR
|
Inflammation/Immunology
|
Emapalumab (NI-0501) is a human monoclonal IgG1 antibody that noncompetitively inhibits IFN-γ. Emapalumab binds with high affinity (Kd= 1.4 pM) to both free IFN-γ as well as IFN-γ bound to its receptor. Emapalumab can be used in research of hemophagocytic lymphohistiocytosis (HLH) .
|
- HY-P990235
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse ICOSL/CD275 (D265A) Antibody (HK5.3-CP044) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to mouse ICOSL/CD275.
|
- HY-P99280
-
Anti-Human IL17A/IL-17F Recombinant Antibody
|
Interleukin Related
|
Inflammation/Immunology
|
Bimekizumab (Anti-Human IL17A/IL-17F Recombinant Antibody) is a humanised monoclonal antibody, can selectively neutralises IL-17A and IL-17F. Both of them are pro-osteogenic with respect to human periosteum-derived cell (hPDC) differentiation. Thus Bimekizumab blocks the inflammation-driven osteogenic differentiation .
|
- HY-P990209
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse IL-7Rα/CD127 Antibody (A7R34) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse IL-7Rα/CD127.
|
- HY-P99207
-
KB 003
|
SARS-CoV
|
Cancer
|
Lenzilumab (KB 003) is a human monoclonal antibody targeting CSF2/GM-CSF for COVID-19, chronic myelomonocytic leukemia (CMML) and juvenile myelomonocytic leukemia (JMML) studies .
|
- HY-P99471
-
UCB 0107
|
Tau Protein
|
Neurological Disease
|
Bepranemab (UCB 0107) is a humanized, full-length IgG4 monoclonal antibody that binds to a central tau epitope (amino acids 235-250). Bepranemab can be used for Alzheimer’s disease (AD) research .
|
- HY-P9907
-
Anti-Human HER2, Humanized Antibody
|
EGFR
ADC Antibody
|
Cancer
|
Trastuzumab is a humanized IgG1 monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab has the potential for HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer research.
|
- HY-P99262
-
BAX69; Anti-Human MIF Recombinant Antibody
|
Macrophage migration inhibitory factor (MIF)
|
Cancer
|
Imalumab (BAX69) is a recombinant, human IgG1 monoclonal antibody that targets macrophage inhibitory factor (MIF). Imalumab can be used for the research of ovarian carcinoma, recurrent malignant ascites and cancer .
|
- HY-P99023
-
G250; cG250
|
Carbonic Anhydrase
|
Cancer
|
Girentuximab (G250) is a chimeric monoclonal antibody that binds carbonic anhydrase IX (CAIX), a cell surface glycoprotein ubiquitously expressed in clear cell renal cell carcinoma (ccRCC) .
|
- HY-P9967
-
BIIB037
|
Amyloid-β
|
Neurological Disease
|
Aducanumab (BIIB037) is a human monoclonal antibody that selectively targets aggregated amyloid-beta (Aβ). Aducanumab shows brain penetration, and can be used for Alzheimer's disease (AD) research .
|
- HY-P99656
-
MCDS0593A
|
ADC Antibody
|
Cancer
|
Iladatuzumab (MCDS0593A) is a humanized IgG1 anti-human CD79B monoclonal antibody. Iladatuzumab can be used to synthesize antibody-drug conjugates (ADC) Iladatuzumab vedotin (DCDS0780A; HY-P99657), which has the potential for B-cell non-Hodgkin lymphoma (B-NHL) research .
|
- HY-P9910
-
GA101; Anti-Human CD20 type II, Humanized Antibody
|
CD20
|
Cancer
|
Obinutuzumab (GA101) a novel glycoengineered Type II CD20 humanized IgG1 monoclonal antibody in development for non-Hodgkin lymphoma.
|
- HY-P990203
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse LPAM-1/Integrin α4β7 Antibody (DATK32) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse LPAM-1/Integrin α4β7.
|
- HY-P990253
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse Delta-like protein 1/DLL1 Antibody (HMD1-5) is a Armenian hamster-derived IgG, κ type antibody inhibitor, targeting to mouse Delta-like protein 1/DLL1.
|
- HY-P990252
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse Delta-like protein 4/DLL4 Antibody (HMD4-2) is a Armenian hamster-derived IgG, κ type antibody inhibitor, targeting to mouse Delta-like protein 4/DLL4.
|
- HY-P99145
-
- HY-P990199
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse Ly6G/Ly6C Antibody (NIMP-R14) is a rat-derived IgG2b, κ type antibody inhibitor, targeting to mouse Ly6G/Ly6C.
|
- HY-P990281
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD25/IL-2Rα Antibody (PC-61.5.3) is a rat-derived IgG1, λ type antibody inhibitor, targeting to mouse CD25/IL-2Rα.
|
- HY-P99415
-
MAA868
|
Factor Xa
|
Cardiovascular Disease
|
Abelacimab (MAA868) is a fully human IgG1 monoclonal antibody that binds with high affinity to the catalytic structural domain of FXI and locks it in the zymogen conformation, thereby preventing its activation by FXIIa or thrombin. Abelacimab can be used in thromboembolic disease studies .
|
- HY-P99442
-
Hu1D10
|
Apoptosis
|
Inflammation/Immunology
|
Apolizumab (Hu1D10) is a humanized monoclonal anti-Human leukocyte antigen-DR beta-chain antibody. Apolizumab can mediate apoptosis of chronic lymphocytic leukemia (CLL) cells in vitro .
|
- HY-P990228
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse IL-10R/CD210 Antibody (1B1.3A) is a rat-derived IgG1, κ type antibody inhibitor, targeting to mouse IL-10R/CD210.
|
- HY-P990176
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse OX40/CD134 (LALA-PG) Antibody (OX86-CP018) is a mouse-derived IgG2a, κ type antibody inhibitor, targeting to mouse OX40/CD134.
|
- HY-P99460
-
- HY-P990162
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse T15 VH and T15 VL regions of IgM Antibody (HB33) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to mouse T15 VH and T15 VL regions of IgM.
|
- HY-P99521
-
XmAb14045
|
CD3
|
Cancer
|
Vibecotamab (XmAb14045) is a potent bispecific antibody against CD123 and CD3 that stimulates T cell-mediated targeted killing of CD123-expressing cells. Vibecotamab has antitumor activity and can be used in acute myeloid leukaemia studies .
|
- HY-P99846
-
QAX576
|
Interleukin Related
|
Inflammation/Immunology
|
Dectrekumab (QAX576) is a human monoclonal antibody that targets IL-13. Dectrekumab significantly improves intraepithelial esophageal eosinophil counts and dysregulated esophageal disease-related transcripts with Eosinophilic esophagitis (EoE) in a sustained manner and can be used for inflammation and immunology related research .
|
- HY-P99422
-
SHR-1316
|
PD-1/PD-L1
Apoptosis
|
Cancer
|
Adebrelimab (SHR-1316) is a humanized IgG4 monoclonal PD-L1 (PD-1/PD-L1) antibody. Adebrelimab has promising antitumor activity in solid tumors including extensive-stage small-cell lung cancer (SCLC) .
|
- HY-P99462
-
CDX 0159
|
c-Kit
|
Inflammation/Immunology
|
Barzolvolimab (CDX 0159) is a humanized anti-KIT IgG1 monoclonal antibody. Barzolvolimab specificity and potently inhibits KIT activation by SCF. Barzolvolimab can reduce skin mast cells and disease activity in chronic inducible urticaria .
|
- HY-P990169
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse/Human phosphorylated PD-1/CD279 Antibody (407.6G12) is a mouse-derived IgG2a, κ type antibody inhibitor, targeting to mouse/human phosphorylated PD-1/CD279.
|
- HY-P99156
-
BMS-986016
|
LAG-3
|
Cancer
|
Relatlimab (BMS-986016) is a human monoclonal antibody anti-LAG-3 antibody generated by immunization of transgenic mice bearing human immunoglobulin miniloci with recombinant LAG-3 protein. Relatlimab blocks LAG-3/MHC II interaction with an IC50 value of 0.67 nM and LAG-3/FGL1 interaction with an IC50 value of 0.019 nM. Relatlimab can be used in research of cancer .
|
- HY-P9989
-
REGN5458
|
CD3
TNF Receptor
|
Cancer
|
Linvoseltamab is a bispecific antibody targeting to both BCMA (TNFRSF17) and CD3 epsilon. Linvoseltamab shows safety profile and encouraging efficacy in relapsed/refractory multiple myeloma (RRMM) models .
|
- HY-P9911
-
Anti-Human lymphocyte α4β7 integrin, Humanized Antibody
|
Integrin
|
Inflammation/Immunology
Cancer
|
Vedolizumab is a humanized IgG1 monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease.
|
- HY-P9932
-
ETI 204
|
Inhibitory Antibodies
|
Infection
|
Obiltoxaximab is a potent anti-protective antigen (PA) monoclonal antibody. Obiltoxaximab plays a central role in anthrax toxin assembly and target cell intoxication. Obiltoxaximab can be used in animal‐to‐human dose translation for research of inhalational anthrax .
|
- HY-P99626
-
LY 3015014
|
Ser/Thr Protease
|
Metabolic Disease
|
Frovocimab (LY 3015014) is a humanized IgG4 monoclonal antibody (mAb) that neutralizes PCSK9. Frovocimab inhibits PCSK9 binding to LDL receptor (LDLR) while permitting the normal proteolytic cleavage of the bound intact PCSK9 .
|
- HY-P990204
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse LAG-3 (D265A) Antibody (C9B7W-CP013) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to mouse LAG-3.
|
- HY-P9918
-
Ticilimumab; CP-675206
|
CTLA-4
|
Inflammation/Immunology
Cancer
|
Tremelimumab (Ticilimumab) is a fully human monoclonal antibody specific for cytotoxic T-lymphocyte antigen-4 (CTLA-4) and can be used for metastatic melanoma research .
|
- HY-P99307
-
AMG-203; Anti-Human CSF2 Recombinant Antibody
|
c-Fms
|
Inflammation/Immunology
|
Namilumab (AMG203) is a human IgG1 monoclonal antibody that binds with high affinity to the GM-CSF ligand, potently neutralizing GM-CSF. Namilumab can be used for the research of rheumatoid arthritis .
|
- HY-P990269
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD40L/CD154 (LALA-PG) Antibody (MR-1-CP034) is a mouse-derived IgG2a, κ type antibody inhibitor, targeting to mouse CD40L/CD154.
|
- HY-P99141
-
- HY-P99039
-
MEDI9447
|
CD73
|
Cancer
|
Oleclumab (MEDI9447) is a human IgG1λ monoclonal antibody targeting CD73 and inhibits the exonuclease activity of the extracellular enzyme CD73. Oleclumab can adjust the composition of bone marrow and lymphoid infiltrating leukocyte populations in the tumor microenvironment and has anti-tumor activity .
|
- HY-P99179
-
|
Inhibitory Antibodies
|
Cancer
|
CTX-2026 is a fully human antibody that binds to CD277. CTX-2026 shows an anti-tumor effect on ovarian tumor models. CTX-2026 can be used for the research of cancer .
|
- HY-P990193
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse MHC Class I (H-2Kd, H-2Dd) Antibody (34-1-2S) is a mouse-derived IgG2a, κ type antibody inhibitor, targeting to mouse MHC Class I.
|
- HY-P990185
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse/Rat MHC Class II (I-Ek/RT1-D) Antibody (14-4-4S) is a mouse-derived IgG2a, κ type antibody inhibitor, targeting to mouse/rat MHC Class II.
|
- HY-P99424
-
RG 7624; RO 5553110; NI-1401
|
Interleukin Related
|
Inflammation/Immunology
|
Afasevikumab (RG 7624; RO 5553110; NI-1401) is a fully human monoclonal IgG1κ antibody neutralizing both IL-17A and IL-17F. Afasevikumab has anti-inflammatory activities .
|
- HY-P99618
-
IBI-315; BH2950
|
EGFR
PD-1/PD-L1
|
Inflammation/Immunology
Cancer
|
Fidasimtamab (IBI-315; BH2950) is a recombinant human IgG1 bispecific antibody that targets, binds and inhibits both HER2 and PD-1 and their downstream signalling pathways, and links PD-1 expressing T cells to HER2 expressing tumour cells. Fidasimtamab has potential immunosuppressive and antitumor activity .
|
- HY-P990256
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CTLA-4/CD152 (LALA-PG) Antibody (9D9-CP008) is a mouse-derived IgG2a, κ type antibody inhibitor, targeting to mouse CTLA-4/CD152.
|
- HY-P990270
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD40L/CD154 (D265A) Antibody (MR-1-CP032) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to mouse CD40L/CD154.
|
- HY-P99571
-
INH-H 2002
|
Inhibitory Antibodies
|
Infection
|
Tefibazumab is a humanized IgG1κ monoclonal antibody that binds to the surface-expressed adhesion protein clumping factor A. Tefibazumab can be used for the research of serious Staphylococcus aureus infections .
|
- HY-P990114
-
|
Inhibitory Antibodies
|
Others
|
Anti-Canine PD-L1/B7-H1 Antibody (JC071) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to canine PD-L1/B7-H1.
|
- HY-P99955
-
AMG 451; KHK4083
|
Inhibitory Antibodies
|
Infection
Inflammation/Immunology
|
Rocatinlimab (AMG 451) (KHK4083) is a fully human, non-fucosylated, immunoglobulin G1 (IgG1) anti-OX40 monoclonal antibody. Rocatinlimab can be used for the research of atopic dermatitis (AD) .
|
- HY-P99301
-
Anti-Canine IL31 Recombinant Antibody
|
Interleukin Related
|
Inflammation/Immunology
|
Lokivetmab (Anti-Canine IL31 Recombinant Antibody) is an anti-canine IL-31 monoclonal antibody that can be used for the research of atopic dermatitis (AD) in dogs .
|
- HY-P9988
-
BA301
|
ADC Antibody
TAM Receptor
|
Cancer
|
Mecbotamab is a humanized IgG1-κ antibody targeting to AXL receptor tyrosine kinase (AXL). Mecbotamab can serves as a conditionally active biologic (CAB), which can be conjugated with MMAE (HY-15162) via a cleavable linker, to form ADC Mecbotamab vedotin (BA3011) .
|
- HY-P990221
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse IL-17F Antibody (MM17F8F5.1A9) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to mouse IL-17F.
|
- HY-P99119A
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse 4-1BB/CD137 (LALA-PG) Antibody (LOB12.3-CP038) is a mouse-derived IgG2a, κ type antibody inhibitor, targeting to mouse 4-1BB/CD137.
|
- HY-P99877
-
AMG592
|
Inhibitory Antibodies
|
Others
|
Efavaleukin alfa (AMG592) is a human monoclonal antibody. Efavaleukin alfa is composed of the IGHG1 Fc fragment fused to IL-2. The expression system of Efavaleukin alfa is usually CHO (Chinese Hamster Ovary) cells .
|
- HY-P99484
-
AGEN 1181
|
CTLA-4
|
Cancer
|
Botensilimab (AGEN 1181), a human anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4) monoclonal antibody, is an innate and adaptive immune activator. Botensilimab can be used for the research of cancer .
|
- HY-P99351
-
Anti-MMP9 Reference Antibody (andecaliximab)
|
MMP
|
Cancer
|
Andecaliximab is a recombinant chimeric IgG4 monoclonal antibody (mAb) targets matrix metalloproteinase 9 (MMP9). Andecaliximab shows the antifibrotic efficacy in idiopathic pulmonary fibrosis mouse models. Andecaliximab can be used for the research of gastric adenocarcinoma and idiopathic pulmonary fibrosis (IPF) .
|
- HY-P99414
-
AMG 557
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Prezalumab (AMG 557) is a humanized IgG2 monoclonal antibody targets ICOSL and BAFF. Prezalumab demonstrates beneficial activities on the arthritis of systemic lupus erythematosus. Prezalumab can be used for the research of sjogren's syndrome cutaneous lupus erythematosus, psoriasis and systemic lupus erythematosus (SLE) .
|
- HY-P99323
-
BTT 1023; Anti-Human AOC3 Recombinant Antibody
|
AP-1
|
Inflammation/Immunology
|
Timolumab (BTT1023 ), a recombinant fully human monoclonal antibody that specifically binds VAP-1. Timolumab (BTT1023 ) could be used in the study of chronic inflammatory diseases .
|
- HY-P99309
-
BSYX-A 110; Anti-S. Epidermidis LTA Recombinant Antibody
|
Bacterial
|
Infection
|
Pagibaximab is a chimeric IgG1 antibody recognizing the surface component lipoteichoic acid of S. aureus and S. epidermidis. Pagibaximab can be used to prevent staphylococcal sepsis .
|
- HY-P990290
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse CD16/CD32 (LALA-PG) Antibody (2.4G2-CP026) is a mouse-derived IgG2a, κ type antibody inhibitor, targeting to mouse CD16/CD32.
|
- HY-P99016B
-
- HY-P99195
-
- HY-P99966
-
|
RANKL/RANK
|
Cancer
|
Narlumosbart (JMT103) is an IgG4κ antibody targeting receptor activator of nuclear factor-κB ligand (RANKL) .
|
- HY-P99320
-
OMP 59R5; Anti-Human NOTCH2 Recombinant Antibody
|
Notch
|
Cancer
|
Tarextumab (OMP-59R5) is an anti-Notch2/3 fully human IgG2 monoclonal antibody. Tarextumab shows anti-tumor activity .
|
- HY-P99370
-
LY2495655; Anti-GDF8 / Myostatin Reference Antibody (landogrozumab)
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Landogrozumab (LY2495655) is an humanized anti-myostatin monoclonal antibody. Landogrozumab effectively improves muscle volume, hand grip strength and function. Landogrozumab can be used for the research of muscle wasting disease .
|
- HY-P99318
-
LT 1009; Anti-Human S1P Recombinant Antibody
|
LPL Receptor
|
Cancer
|
Sonepcizumab (LT 1009) is a fully human anti-S1P monoclonal antibody. Sonepcizumab has the potential for the research of metastatic renal cell carcinoma (mRCC) .
|
- HY-P9952
-
LymphoStat B
|
TNF Receptor
|
Inflammation/Immunology
|
Belimumab (LymphoStat B) is a human IgG1λ monoclonal antibody that inhibits B-cell activating factor (BAFF). Belimumab can be used for systemic lupus erythematosus (SLE) research .
|
- HY-P99052
-
|
PD-1/PD-L1
|
Inflammation/Immunology
Cancer
|
Tislelizumab, a monoclonal antibody with high binding affinity to the PD-1 receptor, minimizes Fcγ receptor binding on macrophages, thereby abrogating antibody-dependent phagocytosis, a mechanism of T cell clearance and potential resistance to anti-PD-1 research. Tislelizumab can be used for the research of advanced squamous non-small-cell lung cancer .
|
- HY-P99507
-
MCLA-128; PB4188; R040517
|
EGFR
|
Cancer
|
Zenocutuzumab (MCLA-128) is a bispecific humanized IgG1 antibody containing two different Fab arms, targeting extracellular domains of HER2 and HER3 .
|
- HY-P99475
-
MSB-2311
|
PD-1/PD-L1
|
Cancer
|
Betifisolimab (MSB-2311) is a humanized monoclonal antibody directed against the immunosuppressive ligand PD-L1. Betifisolimab has the potential for advanced solid tumors and hematological malignancies research .
|
- HY-P9924
-
LY2439821
|
Interleukin Related
|
Inflammation/Immunology
|
Ixekizumab (LY2439821) is a humanized IgG4 monoclonal antibody that selectively binds and neutralizes interleukin IL-17A (KD<3 pM). Ixekizumab directly blocks IL-17A binding to IL-17RA (IL-17A receptor) but does not bind to other IL-17 family members. Ixekizumab is used for the research of moderate-to-severe plaque psoriasis .
|
- HY-P99020
-
GC1008
|
TGF-β Receptor
|
Inflammation/Immunology
Cancer
|
Fresolimumab (GC1008) is a high-affinity fully human monoclonal antibody that neutralizes the active form of human TGFβ1, TGFβ2, and TGFβ3. Fresolimumab can be used for the research of cancer and fibrotic diseases .
|
- HY-P99110
-
SHP643; DX-2930
|
Ser/Thr Protease
|
Inflammation/Immunology
|
Lanadelumab (SHP643) is a human IgG1 monoclonal antibody against plasma kallikrein (pKal) with an Ki value of 0.12 nM. Lanadelumab inhibits both free and HMWK (high molecular weight kininogen)-bound pKal. Lanadelumab has the potential for the research of hereditary angioedema .
|
- HY-P99206
-
Naxitamab-gqgk; Humanized 3F8; Hu3F8
|
Inhibitory Antibodies
|
Cancer
|
Naxitamab (Hu3F8) is a humanized monoclonal antibody targeting the disialoganglioside GD2. Naxitamab can be used in research of neuroblastoma, osteosarcoma and other GD2-positive cancers .
|
- HY-P990191
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse MHC Class I (H-2Kk, H-2Dk) Antibody (15-3-1S (HB-13)) is a mouse-derived IgG2a, κ type antibody inhibitor, targeting to mouse MHC Class I.
|
- HY-P99322
-
LFG316; Anti-Human C5 Recombinant Antibody
|
Complement System
|
Inflammation/Immunology
|
Tesidolumab (LFG316) is a fully-human IgG1/λ anti-C5 monoclonal antibody of 143 kDa (without glycosylation). Tesidolumab (LFG316) blocks cleavage of C5 and prevents subsequent formation of the membrane attack complex .
|
- HY-P99273
-
Anti-Human CD70 Recombinant Antibody
|
Inhibitory Antibodies
|
Cancer
|
Vorsetuzumab (Anti-Human CD70 Recombinant Antibody) is a human anti-CD70 antibody. Vorsetuzumab enhances macrophage-related phagocytosis of renal carcinoma cells, shows inhibitory efficacy against Burkitt’s lymphoma .
|
- HY-P9931
-
CNTO 1959
|
Interleukin Related
|
Inflammation/Immunology
|
Guselkumab is a recombinant human IgG1 monoclonal antibody against the IL-23p19 subunit. Guselkumab binds to human and cynomolgus monkey IL-23 with Kd values of 3.3 and 1.9 pmol/L, respectively. Guselkumab inhibits production of cytokines lying downstream of the IL-23 signaling pathway and can be used for psoriatic arthritis research .
|
- HY-P9933
-
Unituxin; APN-311
|
Inhibitory Antibodies
|
Cancer
|
Dinutuximab (Unituxin; APN-311) is a chimeric, human-murine, anti-GD2 monoclonal antibody. Dinutuximab potently enlongs event-free survival and overall survival, in high-risk neuroblastoma treatment, in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), aldesleukin (interleukin-2 [IL-2]), and isotretinoin (13-cis-retinoic acid [RA]) .
|
- HY-P99400
-
ALXN 6000
|
Inhibitory Antibodies
|
Cancer
|
Samalizumab (ALXN 6000) is a humanized monoclonal antibody that specifically binds to CD200 and blocks its ligation to the CD200 receptor (CD200R). Samalizumab can be used for multiple myeloma and B-cell chronic lymphocytic leukemia research .
|
- HY-P99261
-
OMP 21M18; Human Anti-TNFRSF10B Recombinant Antibody
|
Notch
|
Cancer
|
Demcizumab (OMP 21M18) is an anti-DLL4 monoclonal antibody. Demcizumab is a potent inhibitor of the Notch pathway. Demcizumab alone or in combination with chemotherapy is effective in various cancer models .
|
- HY-P99272
-
BMS 936564; MDX 1338; Anti-Human CXCR4 Recombinant Antibody
|
CXCR
|
Cancer
|
Ulocuplumab (Anti-Human CXCR4 Recombinant Antibody/BMS-936564/MDX1338) is a fully human IgG4 anti-CXCR4 antibody. Ulocuplumab induces apoptosis and inhibits CXCL12 mediated CXCR4 activation-migration of chronic lymphocytic leukemia (CLL). Ulocuplumab exhibits antitumor activity in established tumors including acute myeloid leukemia (AML), non-Hodgkin lymphoma (NHL), and multiple myeloma xenograft models .
|
- HY-P99524
-
GBR500
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Vatelizumab (GBR500) is a monoclonal antibody targeting the α2 subunit (CD49b) of very late antigen-2 (VLA-2). Vatelizumab can be used for the research of multiple sclerosis .
|
- HY-P99444
-
MSTT 1041A; RG 6149
|
Interleukin Related
|
Inflammation/Immunology
|
Astegolimab (MSTT 1041A; RG 6149) is a human IgG2 monoclonal antibody that blocks IL-33 signaling by targeting ST2, the IL-33 receptor. Astegolimab has the potential for chronic obstructive pulmonary disease (COPD) research .
|
- HY-P9907A
-
Anti-Human HER2, Humanized Antibody (PBS)
|
ADC Antibody
EGFR
|
Cancer
|
Trastuzumab (PBS) is a humanized IgG1 monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab (PBS) has the potential for HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer research.
|
- HY-P9951
-
RG-6321
|
VEGFR
|
Cardiovascular Disease
|
Ranibizumab (RG-6321) is a humanized anti-VEGF monoclonal antibody fragment and can recognize all VEGF-A isoforms (VEGF110, VEGF121, and VEGF165) . Ranibizumab slows vision loss in vivo and is used for wet age-related macular degeneration (AMD) research .
|
- HY-P99238
-
|
Interleukin Related
|
Inflammation/Immunology
Cancer
|
Rolinsatamab is a potent dual IL-4 and IL-13 inhibitor as a fully humanized bispecific monoclonal antibody. Rolinsatamab chimeric antigen receptor sequence T cell. Rolinsatamab can be used in research of immune disease .
|
- HY-P99704
-
OCS-02
|
TNF Receptor
|
Inflammation/Immunology
|
Licaminlimab (OCS-02) is a single-chain anti-TNF alpha antibody fragment. TNF alpha is an inflammatory cytokine produced by macrophages and monocytes during inflammation .
|
- HY-P990186
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse MHC Class II (I-Ak, I-Ar, I-Af, I-As,I-Ag7) Antibody (10-3.6.2) is a mouse-derived IgG2c, κ type antibody inhibitor, targeting to mouse MHC Class II.
|
- HY-P99153
-
MORAb-003
|
Antibiotic
|
Cancer
|
Farletuzumab (MORAb-003) is a potent folate receptor-alpha (FRα) inhibitor. Farletuzumab is a humanized monoclonal antibody with high affinity for FRα. Farletuzumab possesses growth-inhibitory functions on cells overexpressing FRα. Farletuzumab can be used in research of cancer .
|
- HY-P9915A
-
Anti-Human CD38, Human Antibody (PBS)
|
ADC Antibody
CD38
|
Cancer
|
Daratumumab (PBS) (Anti-Human CD38) is the first-in-class human-specific anti-CD38 monoclonal antibody (IgG1). Daratumumab (PBS) has anti-multiple myeloma (MM) effect. Daratumumab (PBS) impairs MM cell adhesion, which results in an increased sensitivity of MM to proteasome inhibition .
|
- HY-P99820
-
NV-01
|
TNF Receptor
|
Inflammation/Immunology
|
Ranevetmab (NV-01) is a caninised anti-NGF monoclonal antibody (mAb). Ranevetmab can alleviate pain, and is used for the research of degenerative joint disease (DJD) pain .
|
- HY-P99265
-
HGS-ETR1; Anti-Human TNFRSF10A Recombinant Antibody
|
Inhibitory Antibodies
|
Cancer
|
Mapatumumab (HGS-ETR1) is a fully human IgG1 agonistic monoclonal antibody that targets tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1). Mapatumumab can be used for the research of cancer .
|
- HY-P99317
-
Immunoglobulin G1, anti-(human β-amyloid) (human-mouse monoclonAnti-Human Abeta Recombinant Antibody
|
Amyloid-β
|
Neurological Disease
|
Solanezumab is a humanized monoclonal IgG1 antibody directed against the mid-domain of the amyloid-β (Aβ) peptide. Solanezumab has the potential for the research of Alzheimer’s disease .
|
- HY-P99155
-
|
EGFR
|
Cancer
|
Zalutumumab is a high affinity, completely human IgG1 monoclonal antibody targeting EGFR. Zalutumumab binds to domain III of the EGF receptor and acts by blocking the binding of EGF and by sterically interfering with the active conformation of the receptor. Zalutumumab binds with IgG and its Fab fragment with EC50s of 7 and 19 nM, respectively. Zalutumumab can be used for the research of cancer .
|
- HY-P99353
-
Anti-ACVRL1 / ALK-1 Reference Antibody (ascrinvacumab); PF-03446962
|
Anaplastic lymphoma kinase (ALK)
|
Cancer
|
Ascrinvacumab (PF-03446962) is a human IgG2 monoclonal antibody targets ALK-1. Ascrinvacumab shows binding efficiency with human ALK1 with a Kd value of 7 nM. Ascrinvacumab can be used for the research of hepatocellular carcinoma (HCC) .
|
- HY-P99224
-
IMMU-106; hA20
|
Integrin
|
Cancer
|
Veltuzumab (IMMU-106) is a humanized anti-CD20 monoclonal antibody. Veltuzumab has low EC50 value of 0.08-0.09 μg/mL in the Daudi cell line. Veltuzumab can be used for the research of cancer including non-Hodgkin lymphoma (NHL) .
|
- HY-P9951A
-
RG-6321 (anti-VEGF)
|
VEGFR
|
Cardiovascular Disease
|
Ranibizumab (RG-6321) (anti-VEGF) is a humanized anti-VEGF monoclonal antibody fragment and can recognize all VEGF-A isoforms (VEGF110, VEGF121, and VEGF165) . Ranibizumab (anti-VEGF) slows vision loss in vivo and is used for wet age-related macular degeneration (AMD) research .
|
- HY-P99041
-
ABX-EGF
|
EGFR
|
Cancer
|
Panitumumab (ABX-EGF) is a fully human IgG2 anti-EGFR monoclonal antibody with anti-tumor activity. Panitumumab inhibits tumor cell proliferation, survival and angiogenesis. Panitumumab can be used in the research of cancers, such as colon cancer .
|
- HY-P99291
-
LM 609; MEDI 523; Anti-αvβ3 Integrin Recombinant Antibody
|
Integrin
|
Cancer
|
Etaracizumab (LM 609) is an αvβ3 integrin IgG1 monoclonal antibody. Etaracizumab inhibits angiogenesis and melanoma tumor growth. Etaracizumab can be used to research anticancer .
|
- HY-P99375
-
IMC-RON8; LY3012219; Anti-MSPR/RON/CD136 Reference Antibody (narnatumab)
|
Inhibitory Antibodies
|
Cancer
|
Narnatumab (IMC-RON8) is a neutralizing human monoclonal antibody that blocks RON binding to its ligand, macrophage-stimulating protein (MSP), with a Kd of 32 pM. Narnatumab can be used for the research of cancer .
|
- HY-P990190
-
|
Inhibitory Antibodies
|
Others
|
Anti-Swine MHC Class I (SLAd) Antibody (74-11-10) is a mouse-derived IgG2b, κ type antibody inhibitor, targeting to Swine MHC Class I.
|
- HY-P99199
-
NI-0401
|
CD3
|
Inflammation/Immunology
|
Foralumab (NI-0401) is a potent, orally active human monoclonal antibody targeting the CD3. Foralumab modulates immune responses by human cells in NSG mice that were reconstituted with human hematopoietic stem cells .
|
- HY-P990021
-
|
Inhibitory Antibodies
|
Others
|
Calpurbatug is an immunoglobulin G1 antibody. Calpurbatug has activity with anti-bacterial DNA-binding protein DNABII family and anti-human monoclonal TRL1068 γ1-chain .
|
- HY-P99437
-
KN-026
|
EGFR
|
Cancer
|
Anbenitamab (KN-026) is a bispecific antibody simultaneously targeting the extracellular domains II and IV of the human HER2. Anbenitamab blocks both ligand-dependent and ligand-independent HER2 signaling pathway. The IgG1 Fc fragment of Anbenitamab binds FcRγIIIa mediates potent antibody dependent cell-mediated cytotoxicity (ADCC) and inhibits tumor cell proliferation. Anbenitamab has the potential for HER2-positive metastatic breast cancer (MBC) research .
|
- HY-P99193
-
MEDI-528
|
Interleukin Related
|
Inflammation/Immunology
|
Enokizumab (MEDI-528) is a monoclonal antibody targeting to interleukin (IL)-9. IL-9 regulates the development of airway inflammation, mucus production, airway hyperresponsiveness, and airway fibrosis largely by increasing mast cell numbers and activity in the airways .
|
- HY-P99258
-
OMP 52M51; Anti-Human NOTCH1 Recombinant Antibody
|
Notch
|
Cancer
|
Brontictuzumab (OMP 52M51) is a monoclonal antibody (MAb) that inhibits Notch1 signal. Brontictuzumab selectively binds the negative regulatory region of the Notch1. Brontictuzumab inhibits tumor cell proliferation. Brontictuzumab can be used in the research of leukemia and lymphoma .
|
- HY-P9972
-
PDR001
|
PD-1/PD-L1
|
Cancer
|
Spartalizumab (PDR001) is a humanized immunoglobulin 4 monoclonal antibody that binds PD-1 with subnanomolar activity and blocks interaction with PD-L1 and PD-L2. Spartalizumab can be used for the research of anaplastic thyroid carcinoma (ATC) .
|
- HY-108810
-
Ilaris; ACZ 885
|
Interleukin Related
|
Inflammation/Immunology
|
Canakinumab (ACZ885) is a recombinant human anti-IL-1β monoclonal antibody. Canakinumab shows IC50 values of 43.6 and 40.8 pM for human and marmoset IL-1β, respectively. The mode of action of canakinumab is based on the neutralization of IL-1β signaling, resulting in suppression of inflammation related to disorders of autoimmune origin .
|
- HY-P99286
-
PRO 95780; rhuMAb-DR 5; Anti-Human DR5 Recombinant Antibody
|
Apoptosis
|
Cancer
|
Drozitumab (PRO 95780) is a human agonistic monoclonal antibody which binds the death receptor DR5. Drozitumab has potent antitumor activity against rhabdomyosarcoma .
|
- HY-P99145A
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse PD-L1/B7-H1 Antibody (10F.9G2?-CP168) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to mouse PD-L1/B7-H1.
|
- HY-P99184
-
|
Integrin
|
Infection
Inflammation/Immunology
Cancer
|
Abrilumab is a fully human monoclonal antibody directed against α4β7. Abrilumab selectively binds the α4β7 integrin heterodimer. Abrilumab can be used for the research of inflammatory bowel disease (IBD) .
|
- HY-P99041A
-
|
EGFR
|
Cancer
|
Panitumumab (anti-EGFR) is a fully human IgG2 anti-EGFR monoclonal antibody with anti-tumor activity. Panitumumab (anti-EGFR) inhibits tumor cell proliferation, survival and angiogenesis. Panitumumab (anti-EGFR) can be used in the research of cancers, such as colon cancer .
|
- HY-P99257
-
ASKP 1240; Anti-Human CD40 Recombinant Antibody
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Bleselumab (ASKP 1240) is a human anti-CD40 monoclonal antibody (mAb). Bleselumab binds to human CD40 with high affinity (Kd: 0.24 nM). Bleselumab inhibits immune responses by blocking the interaction of CD40 with its ligand CD40L. Bleselumab prevents organ transplant rejection .
|
- HY-P99283
-
NN 7415; mAb 2021; Anti-TFPI Recombinant Antibody
|
Inhibitory Antibodies
|
Others
|
Concizumab is an anti-TFPI monoclonal antibody (IgG4 type) that binds to the Kunitz-type protease inhibitor (KPI) 2 structural domain of TFPI, thereby blocking the interaction of this structural domain with the FXa active site. Concizumab can be used in the study of haemophilia .
|
- HY-P99152
-
|
CD3
|
Inflammation/Immunology
Cancer
|
Muromonab is a monoclonal antibody targeting the CD3 receptor. Muromonab can block all cytotoxic T cell function. Muromonab also as an immunosuppressant agent given to reduce acute solid organ transplant rejection .
|
- HY-P99938
-
HX008
|
PD-1/PD-L1
|
Cancer
|
Pucotenlimab (HX008) is a humanized immunoglobulin G4 (IgG4) anti programmed cell death protein 1 (anti-PD-1) monoclonal antibody. Pucotenlimab can be used for the research of tumor .
|
- HY-P9962
-
|
Fungal
|
Infection
|
Efungumab is a monoclonal antibody with antifungal activity. Efungumab binds to HSP 90, preventing a conformational change needed for fungal viability. Efungumab can be used for research on invasive candidiasis (IC) .
|
- HY-P99031
-
CAM 3001
|
c-Fms
|
Cardiovascular Disease
Inflammation/Immunology
|
Mavrilimumab (CAM 3001) is a monoclonal antibody that binds to the α subunit of the granulocyte-macrophage colony stimulating factor (GM-CSF) receptor and blocks intracellular signalling downstream of GM-CSF. GM-CSF might be a mediator of the hyperactive inflammatory response associated with respiratory failure and death .
|
- HY-P99377
-
OMP-305B83; Anti-DLL4 Reference Antibody (navicixizumab)
|
Notch
|
Cancer
|
Navicixizumab (OMP-305B83) is a bispecific anti-VEGF and anti-DLL4 inhibitory antibody. Navicixizumab can combine with Paclitaxel (HY-B0015) for cancer research. Navicixizumab can be used in the research of ovarian, primary peritoneal, or fallopian tube cancer .
|
- HY-P9954
-
|
CD3
|
Cancer
|
Catumaxomab, a trifunctional IgG2 antibody, is composed of mouse and rat heavy and light chains and binds to human EpCAM and human CD 3 receptors. The Fc region of Catumaxomab region has binding affinity for FcγR1 (CD 64), FcγRIIA (CD 32a), and FcγRIII (CD 16). Catumaxomab can be used for anti-tumor research, especially epithelial cancers .
|
- HY-P9957
-
ABthrax
|
Bacterial
|
Infection
|
Raxibacumab (ABthrax) is a human IgG1 monoclonal antibody against Bacillus anthracis protective antigen (PA). Raxibacumab blocks the toxin’s deleterious effects by preventing binding of the protective antigen component of the anthrax toxin to its receptors in host cells, thereby blocking the toxin’s deleterious effects. Raxibacumab can be used for anti-anthrax research .
|
- HY-P990171
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse PD-L1/B7-H1 (LALA-PG) Antibody (10F.9G2?-CP154) is a mouse-derived IgG2a, κ type antibody inhibitor, targeting to mouse PD-L1/B7-H1.
|
- HY-P99941
-
|
PD-1/PD-L1
|
Cancer
|
Retifanlimab is an anti-programmed cell death protein 1 (anti-PD-1) monoclonal antibody (mAb). Retifanlimab can be used for the research of gastroesophageal adenocarcinoma (GEA) .
|
- HY-P99613
-
MK-4280
|
LAG-3
|
Cancer
|
Favezelimab (MK-4280) is a humanized anti-LAG-3 monoclonal antibody that blocks the interaction between LAG-3 and its ligand MHC class II. Favezelimab has the potential for colorectal cancer (CRC) research combined with the PD-L1 inhibitor Pembrolizumab (HY-P9902) .
|
- HY-P99044
-
MBG453
|
Tim3
|
Inflammation/Immunology
|
Sabatolimab (MBG453) is a high-affinity, humanized, IgG4 (S228P) antibody targeting TIM-3, an inhibitory receptor that regulates adaptive and innate immune responses. Sabatolimab is a potential immunosuppression agent that can target TIM-3 on immune and myeloid cells .
|
- HY-P99335
-
Anti-Human IL17A Recombinant Antibody
|
Interleukin Related
|
Inflammation/Immunology
|
Vunakizumab (Anti-Human IL17A Recombinant Antibody) is a recombinant human IgGκ monoclonal antibody that targets IL-17A and inhibits its interaction with the IL-17 receptor. Vunakizumab can be used to study autoimmune diseases such as psoriatic arthritis, ankylosing spondylitis, multiple sclerosis and inflammatory arthritis .
|
- HY-P99024
-
RO7082859
|
CD20
|
Cancer
|
Glofitamab (RO7082859) is a T-cell-engaging bispecific antibody possessing a novel 2:1 structure with bivalency for CD20 on B cells and monovalency for CD3 on T cells. Glofitamab leads to T-cell activation, proliferation, and tumor cell killing upon binding to CD20 on malignant cells. Glofitamab induces durable complete remissions in relapsed or refractory B-Cell lymphoma .
|
- HY-P99962
-
BGB-A425
|
Mucin
|
Cancer
|
Surzebiclimab (BGB-A425) is a humanized IgG1-variant monoclonal antibody against T-cell immunoglobulin and mucin-domain containing-3 (TIM-3). Surzebiclimab binds to the extracellular domain of human Tim-3 with high affinity (KD=0.36 nM) and specificity. Surzebiclimab can be used in research of cancer .
|
- HY-P990172
-
|
Inhibitory Antibodies
|
Others
|
Anti-Mouse PD-L1/B7-H1 (D265A) Antibody (10F.9G2?-CP001) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to mouse PD-L1/B7-H1.
|
- HY-P99614
-
BFKB8488A
|
FGFR
|
Metabolic Disease
|
Fazpilodemab (BFKB8488A) is a humanized, agonistic, bispecific antibody targeting fibroblast growth factor receptor 1c (FGFR1c) and Klothoβ. Fazpilodemab can be used for the research of type 2 diabetes mellitus (T2DM) or nonalcoholic fatty liver disease (NAFLD) .
|
- HY-P99201
-
UC-961; Cirmtuzumab
|
ROR
|
Cancer
|
Zilovertamab (UC-961) is a humanised monoclonal antibody against ROR1 that blocks Wnt5a-induced ROR1 signalling .
|
- HY-P99321
-
BMS 224819; Chi220; Anti-Human CD40 Recombinant Antibody
|
TNF Receptor
|
Inflammation/Immunology
Cancer
|
Teneliximab (BMS-224819) is a chimeric monoclonal antibody, blocks the CD40-CD40L interaction. Teneliximab (BMS-224819) has partial agonist activity resulting in some signaling through CD40 and peripheral B cell depletion .
|
- HY-P99688
-
AL001
|
Neurotensin Receptor
|
Cancer
|
Latozinemab (AL001) is a recombinant human anti-Sortilin monoclonal antibody. Latozinemab effectively binds Sortilin with a high affinity and blocks the interaction between progranulin protein (PGRN) and Sortilin receptor. Latozinemab has the potential for progranulin gene (GRN) mutations causative of Frontotemporal dementia (FTD) (FTD-GRN) research .
|
- HY-P99057A
-
|
TNF Receptor
|
Cancer
|
Varlilumab (anti-CD27) is a first-in-class human IgG1 anti-CD27 monoclonal antibody. Varlilumab has an anti-tumor activity .
|
- HY-P99172
-
|
Interleukin Related
|
Cancer
|
CC-90002 is a humanized anti-CD47 monoclonal antibody (mAb). CC-90002 has a high affinity for binding to CD47 with a subnanomolar Kd value. CC-90002 can be used for the research of hematologic malignancies and solid tumors .
|
- HY-P9978
-
|
PD-1/PD-L1
|
Cancer
|
Toripalimab is the first domestic anti-tumor PD-1 antibody in China. Toripalimab is a selective, recombinant, humanized monoclonal antibody against PD-1. Toripalimab is able to bind to PD-1 and block the interaction with its ligands. Toripalimab has exhibited primary anti-tumor effects in tumors such as melanoma, lung cancer, digestive tract tumors, hepatobiliary and pancreatic tumors, neuroendocrine neoplasms, nasopharyngeal carcinoma and urothelial carcinoma .
|
- HY-P9804
-
MERS-2E6; MERS Antibody-2E6
|
SARS-CoV
|
Infection
|
Anti-MERS-2E6 mAb (MERS-2E6; MERS Antibody-2E6), a human neutralizing antibody IgG1 (CHO expressed) that can compete for the binding of the virus Spike protein to the receptor (CD26), thereby inhibiting virus invasion into host cells.
|
- HY-P99259
-
FPA 008; Anti-Human CSF1R Recombinant Antibody
|
c-Fms
|
Inflammation/Immunology
Cancer
|
Cabiralizumab (FPA 008) is an anti-CSF1R monoclonal antibody (MAb). Cabiralizumab enhances T cell infiltration and antitumor T cell immune responses. Cabiralizumab inhibits the activation of osteoclasts and blocks bone destruction, and can be used in the research of rheumatoid arthritis (RA). Cabiralizumab can combine with Nivolumab (HY-P9903) for lung cancer research .
|
- HY-P99431
-
Alomfilimab; SAR 445256
|
Inhibitory Antibodies
|
Inflammation/Immunology
Cancer
|
KY-1044 (Alomfilimab; SAR 445256) is a fully human IgG1 antibody targeting inducible costimulatory receptor (ICOS). KY-1044 depletes ICOS high cells via antibody-dependent cellular cytotoxicity (ADCC) through the engagement of FcgRIIIa. KY-1044 act as a costimulatory molecule on cells expressing lower ICOS levels, such as CD8 + TEff cells (through FcgR-dependent clustering). KY-1044 exploit the differential expression of ICOS on T-cell subtypes to improve the intratumoral immune contexture and restore an antitumor immune response .
|
- HY-P99178
-
|
Interleukin Related
|
Inflammation/Immunology
Cancer
|
CTX-471 is a fully human monoclonal antibody of CD137. CTX-471 has bind affinity for recombinant human, cynomolgus macaque CD137 and mouse CD137 with Kd values of 50 nM, 61 nM and 748 nM, respectively. CTX-471 can be used for the research of immunomodulation and cancer .
|
- HY-P99963
-
HS636
|
PD-1/PD-L1
|
Cancer
|
Sudubrilimab (HS636) is an Ig G1-kappa monoclonal antibody against PDL1. Sudubrilimab is fused at the C terminus of the heavy chain to a TGF-β1 receptor Ⅱ ectodomain (TGFBR2-ECD), and which can sequester the PD-1/PD-L1 pathway and TGF-β bioactivity in the immunosuppressive tumor microenvironment .
|
- HY-P9945
-
SB 240563
|
Interleukin Related
|
Cardiovascular Disease
Inflammation/Immunology
|
Mepolizumab (SB 240563) is a humanized monoclonal antibody that binds to and neutralizes interleukin-5 (IL-5), the major cytokine involved in eosinophil proliferation, activation, and survival. Mepolizumab can be used for the research of eosinophilic granulomatosis with polyangiitis (EGPA) and severe eosinophilic asthma .
|
- HY-P9947
-
|
Integrin
|
Others
|
Efalizumab is a targeted T cell modulator, and is a humanized monoclonal antibody of CD11a, the α subunit of LFA-1. Efalizumab inhibits T cell activation, cutaneous T cell trafficking, and T cell adhesion to keratinocytes, can be used for plaque psoriasis research .
|
- HY-P99260
-
AMG 655; TRAIL-R2 mAb; Human Anti-TNFRSF10B Recombinant Antibody
|
TNF Receptor
|
Cancer
|
Conatumumab (AMG 655) is a human monoclonal agonist antibody against human death receptor 5 (DR5, TRAILR2) (Kd: 1 nM for the long form of DR5, 0.8 nM for the short form of DR5). Conatumumab induces apoptosis via caspase activation. Conatumumab can be used in the research of cancers.
.
|
- HY-P99203
-
|
PD-1/PD-L1
|
Cancer
|
Cemiplimab (Anti-Human PD-1) is a high-affinity programmed death receptor-1 (PD-1) monoclonal IgG4 antibody that blocks PD-1/PD-L1-mediated T-cell suppression. Cemiplimab is commonly used in squamous cell skin cancer research .
|
- HY-P99403
-
GSK249320
|
Inhibitory Antibodies
|
Neurological Disease
|
Refanezumab (GSK249320) is an IgG1-type humanized monoclonal antibody directed against myelin-associated glycoprotein (MAG). Refanezumab binds to MAG and blocks MAG-mediated inhibition of axonal regeneration. Refanezumab can cross the blood-brain barrier (BBB) in animal stroke models. Refanezumab has the potential for the enhancement of recovery of function poststroke .
|
- HY-P99112
-
|
Interleukin Related
|
Inflammation/Immunology
Cancer
|
Satralizumab, a humanized monoclonal antibody, is a potent Interleukine-6 (IL-6) inhibitor. Satralizumab prevents dTAA formation and progression in rattus norvegicus. Satralizumab can be used for neuromyelitis optica spectrum disorder (NMOSD) and descending thoracic aorta aneurysm (dTAA) research .
|
- HY-P99687
-
AMG 256
|
PD-1/PD-L1
|
Cancer
|
Latikafusp (AMG 256) is a bifunctional fusion protein comprising a PD-1-targeting antibody and IL-21 mutein designed to deliver IL-21 pathway stimulation to PD-1+ cells. Latikafusp is designed to prime and extend the activity of cytotoxic and memory T cells and induce anti-tumor immunity. Latikafusp has the potential for solid tumors research .Latikafusp may lead to the development of immunogenicity-mediated responses .
|
- HY-P9945A
-
|
Interleukin Related
|
Inflammation/Immunology
|
Mepolizumab (anti-IL5) is a humanized monoclonal antibody that binds to and neutralizes interleukin-5 (IL-5), the major cytokine involved in eosinophil proliferation, activation, and survival. Mepolizumab can be used for the research of eosinophilic granulomatosis with polyangiitis (EGPA) and severe eosinophilic asthma .
|
- HY-P99033
-
BTCT-4465A
|
CD20
CD3
|
Inflammation/Immunology
Cancer
|
Mosunetuzumab (BTCT-4465A) is a full-length, fully humanized immunoglobulin G1 (IgG1) T-cell-dependent bispecific (TDB) antibody targeting CD20 (B cells) and CD3 (T cells). Mosunetuzumab redirects T cells to engage and eliminate malignant B cells and can be used for the research of relapsed or refractory (R/R) B-cell non-Hodgkin lymphomas (B-NHLs) .
|
- HY-P9984
-
rhuMAb Beta7; RG7413; PRO145223
|
Integrin
|
Cancer
|
Etrolizumab (rhuMAb Beta7) is a gut-selective, anti-β7 integrin monoclonal antibody. Etrolizumab is specific targeting of the β7 subunit of α4β7 and αEβ7 integrins with Ki values of 18 nM and 1800 pM for Human α4β7 and Human αEβ7-293, respectively. Etrolizumab can be used in research of inflammatory bowel disease (IBD) .
|
- HY-P99744
-
TAK-573
|
CD38
|
Cancer
|
Modakafusp alfa (TAK-573) is a humanized, anti-CD38 IgG4 monoclonal antibody fused to 2 attenuated IFNα2b molecules. Modakafusp alfa can be used in the research of multiple myeloma .
|
- HY-108831A
-
|
Integrin
|
Inflammation/Immunology
|
Natalizumab (Solution) is a recombinant, humanized IgG4 monoclonal antibody, binds to α4β1-integrin and blocks its interaction with vascular cell adhesion molecule-1 (VCAM-1). Natalizumab can be used for the treatment of relapsing remitting multiple sclerosis and Crohn's disease. Natalizumab is also the first targeted therapy which blocks an essential mechanism for lymphocyte entry to the CNS and thus prevents acute demyelinating relapses .
|
- HY-P99268
-
SAR 256212; MM 121; Anti-Human ERBB3/ErbB 3 Recombinant Antibody
|
EGFR
Apoptosis
|
Cancer
|
Seribantumab (MM 121) is a fully human IgG2 monoclonal antibody that targets HER3. Seribantumab blocks the activation of epidermal growth factor receptor (ErbB) family members and its downstream signal. Seribantumab inhibits neuregulin 1 (NRG1) fusion-dependent tumorigenesis in vitro and in vivo in breast, lung and ovarian patient-derived cancer models .
|
- HY-P99359
-
ABT-555; AE12-1Y-QL; Anti-RGMA Reference Antibody (elezanumab)
|
TGF-beta/Smad
|
Metabolic Disease
|
Elezanumab (ABT-555; AE12-1Y-QL) is a human monoclonal antibody that selectively targets repulsive guidance molecule A (RGMa). Elezanumab potently inhibited RGMa mediated BMP signalling via the SMAD1/5/8 pathway, with an IC50 around 97 pM. Elezanumab promotes neuroregeneration and neuroprotection in neuronal injury and demyelination models binds N-terminal RGMa, blocks BMP signaling and lacks RGMc cross-reactivity. elezanumab has neuroregenerative and neuroprotective activities without impact on iron metabolism .
|
- HY-P99009
-
HBM9161; IMVT-1401
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Batoclimab is a human anti-FcRn monoclonal antibody. Batoclimab can be used for the research of autoimmune diseases mediated by pathogenic IgG antibodies .
|
- HY-P9975
-
TGN1412
|
CD28
|
Inflammation/Immunology
|
Theralizumab (TGN1412) is a humanized lgG4 superagonistic anti-CD28 monoclonal antibody that directly stimulates T cells. Theralizumab can cause cytokine release syndrome (CRS). Theralizumab can be used for the research of rheumatoid arthritis .
|
- HY-P9977
-
JNJ-61186372
|
EGFR
|
Cancer
|
Amivantamab (JNJ-61186372) is a human EGFR-MET bispecific antibody with immune anticancer activity. Amivantamab inhibits ligand binding, promotes endocytosis and degradation of receptor-antibody complexes, and induces Fc-dependent cytokinesis in macrophages and antibody-dependent cytotoxicity in natural killer cells .
|
- HY-P99055
-
|
Inhibitory Antibodies
|
Inflammation/Immunology
Cancer
|
Urelumab, a fully human, non-ligand binding, CD137 agonist IgG4 monoclonal antibody, enhances T-cell and natural killer-cell antitumor activity, and may enhance cytotoxic activity of Rituximab (HY-P9913). Urelumab can be used for the research of diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), and other types of non-Hodgkin lymphoma (NHL) .
|
- HY-P9960
-
Ocrevus
|
CD20
|
Inflammation/Immunology
|
Ocrelizumab is an anti-CD20 antibody that depletes circulating immature and mature B cells but spares CD20-negative plasma cells. The effector mechanisms of Ocrelizumab are complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity. Ocrelizumab is the first monoclonal antibody for secondary primary progressive multiple sclerosis (PPMS) .
|
- HY-P99048
-
IBI308
|
PD-1/PD-L1
|
Inflammation/Immunology
Cancer
|
Sintilimab (IBI308) is a fully human IgG4 monoclonal antibody that binds to PD-1, thereby blocking the interaction of PD-1 with its ligands (PD-L1 and PL-L2) and consequently helping to restore the endogenous antitumour T-cell response. Sintilimab can be used for the research of classical Hodgkin's lymphoma, non-small cell lung cancer and oesophageal cancer .
|
- HY-P99718
-
BAY 1112623
|
ADC Antibody
|
Cancer
|
Lupartumab (BAY 1112623) is an anti-LYPD3 (C4.4A) monoclonal antibody that can be used for the synthesis of antibody-drug conjugate BAY 1129980 .
|
- HY-P99496
-
RPC 4046; ABT 308; CC-93538
|
Interleukin Related
|
Inflammation/Immunology
|
Cendakimab (RPC4046; ABT 308; CC-93538) is a selective, humanized, recombinant monoclonal antibody against the IL-13 molecule. Cendakimab has a high affinity and potency for both human wild-type and variant IL-13 and blocks binding of IL-13 to both IL-13Rα1 and IL-13Rα2 with IC50s of 352 pM and 631 pM by ELISA, respectively. Cendakimab recognizes both wild-type human IL-13 and the common polymorphic variant R110Q, with binding affinities of 52 and 50 pM, respectively. Cendakimab has the potential for IL-13-related allergic/inflammatory diseases (e.g., asthma and eosinophilic esophagitis) .
|
- HY-108730A
-
- HY-P99245
-
RG 7155; RO 5509554
|
c-Fms
|
Cancer
|
Emactuzumab(RG 7155) is a specific monoclonal antibody that inhibits colonystimulating factor 1 receptor (CSF1R) activation. Emactuzumab has high affinity for CSF-1R with Ki value of 0.2 nM to blocks CSF-1R dimerization. Emactuzumab can be used for the research of several diseases, such as diffuse-type tenosynovial giant cell tumour (dt-GCT) .
|
- HY-P9976A
-
|
CD38
|
Cancer
|
Isatuximab (anti-CD38) is a monoclonal antibody targeting the transmembrane receptor and extracellular enzyme CD38.Isatuximab induces tumor cell killing via fragment crystallizable (Fc)-dependent or Fc-independent mechanisms, including antibody-dependent cellular cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP), and complement-dependent cytotoxicity (CDC) .
|
- HY-P99113
-
|
ADC Antibody
CD19
|
Inflammation/Immunology
|
Inebilizumab is an anti-CD19 monoclonal antibody (mAb) with enhanced antibody-dependent cell-mediated cytotoxicity against B cells. Inebilizumab can be used for multiple sclerosis and neuromyelitis optica research .
|
- HY-P99712
-
hz208F2-4
|
IGF-1R
ADC Antibody
|
Cancer
|
Lonigutamab (hz208F2-4) is a humanized anti-IGF-1R monoclonal antibody that can be used for the synthesis of antibody–agent conjugates (ADC) .
|
- HY-P99990
-
- HY-P9928
-
REGN 727; SAR 236553
|
Ser/Thr Protease
|
Cardiovascular Disease
|
Alirocumab (REGN 727) is a human monoclonal antibody inhibitor of PCSK9. Alirocumab is a monoclonal antibody. Alirocumab has anti-inflammatory, antiangiogenic and antioxidant effects. Alirocumab can be used in the study of hypercholesterolemia .
|
- HY-P99634
-
PankoMab
|
Mucin
|
Cancer
|
Gatipotuzumab (PankoMab) is a humanized monoclonal antibody which recognizes the tumor-specific epitope of mucin-1 (TA-MUC1). Gatipotuzumab reveals a potent tumor-specific antibody-dependent cell cytotoxicity (ADCC) .
|
- HY-P99788
-
|
ADC Antibody
ALCAM/CD166
|
Cancer
|
Praluzatamab is a monoclonal antibody targeting the activated leukocyte cell adhesion molecule (ALCAM/CD116). Praluzatamab can be used to synthesize Praluzatamab ravtansine (antibody-drug conjugates). Praluzatamab can be used for research of cancers .
|
- HY-P99953
-
|
Bacterial
|
Infection
|
Rivabazumab is a recombinant antibody against Pseudomonas aeruginosa pcrV .
|
- HY-P990038
-
- HY-P990071
-
- HY-P99978
-
- HY-P99977
-
- HY-P99985
-
- HY-P99250
-
MetMAb
|
c-Met/HGFR
|
Cancer
|
Onartuzumab (MetMAb) is a unique, humanized and affinity-matured monovalent (one-armed) monoclonal antibody against the MET receptor. Onartuzumab potently inhibits HGF binding and receptor phosphorylation and signaling. Onartuzumab has antibody-like pharmacokinetics and antitumor activity .
|
- HY-P99971
-
|
ADC Antibody
|
Cancer
|
Gemtuzumab is a monoclonal IgG4-κ antibody targeting CD33 antigen, which present on leukemic myeloblasts of acute myeloid leukemia (AML). Gemtuzumab can be used for synthesis of antibody-drug conjugate (ADC), Gemtuzumab ozogamicin (HY-109539). Gemtuzumab ozogamicin consists of a cytotoxic derivative of Calicheamicin (a cytotoxic antibiotic), and a monoclonal antibody. Gemtuzumab ozogamicin can be used for the research of acute myeloid leukemia .
|
- HY-P99013
-
GC33; RO5137382
|
Inhibitory Antibodies
|
Cancer
|
Codrituzumab is a monoclonal antibody targeting GPC3 (glypican-3). GPC3 is an oncofetal protein expressed on the cell surface of hepatocellular carcinoma (HCC). Codrituzumab induces antibody-dependent cellular cytotoxicity (ADCC) and inhibits tumor growth .
|
- HY-P990012
-
- HY-P99967
-
|
ADC Antibody
|
Cancer
|
Cantuzumab is a monoclonal antibody that can binds the CanAg antigen. Cantuzumab is typically linked to one of several cytotoxic agents, yielding antibody-drug conjugates (ADC), such as Cantuzumab mertansine (HY-P99492) and Cantuzumab ravtansine (HY-P99493) .
|
- HY-P99992
-
- HY-P99981
-
- HY-P99982
-
- HY-P99470
-
GEN1029
|
TNF Receptor
Apoptosis
|
Cancer
|
Benufutamab (GEN1029) is a death receptor 5 (DR5)-specific agonistic antibody. Benufutamab is a mixture of 2 noncompeting DR5-specific IgG1 antibodies, each with an E430G mutation in the Fc domain. Benufutamab has antitumor effects .
|
- HY-P99986
-
- HY-P99382
-
JTX 2011
|
Inhibitory Antibodies
|
Inflammation/Immunology
Cancer
|
Vopratelimab (JTX-2011) is a humanized immunoglobulin G1-kappa agonist monoclonal antibody that pecifically binds to the Inducible CO-Stimulator of T cells (ICOS). Vopratelimab retains species cross-reactivity with affinities of 0.93 nM to hICOS, 0.46 nM to cynomolgus ICOS, 3.7 nM to rat ICOS, and 0.64 nM to mICOS. Vopratelimab has antitumor immune response .
|
- HY-P99734
-
ADCT-601
|
TAM Receptor
|
Cancer
|
Mipasetamab uzoptirine (ADCT-601) is an AXL-targeted antibody-drug conjugates (ADCs). Mipasetamab uzoptirine consists of a humanized anti-AXL antibody, a cleavable linker and the potent pyrrolobenzodiazepine (PBD) dimer cytotoxin SG3199. Mipasetamab uzoptirine can be used for the research of cancers .
|
- HY-P99733
-
|
ADC Antibody
TAM Receptor
|
Cancer
|
Mipasetamab is an IgG1κ antibody targeting to AXL, a tyrosine kinase receptor and an TAM Receptor. Mipasetamab involves in synthesis of ADCT-601 (Mipasetamab uzoptirine), an AXL-targeted antibody-drug conjugate (ADC). ADCT-601 has anti-tumor activity .
|
- HY-P990083
-
|
Inhibitory Antibodies
|
Cancer
|
Tegoprubart is a monoclonal antibody directed against CD40 ligand (CD40L), a key mediator of costimulation. Inhibition of CD40L reduces cellular and antibody-mediated immunity and creates a more tolerant immune environment. Tegoprubart was demonstrated to have in vivo efficacy in transplantation animal models.
|
- HY-P99175
-
|
Inhibitory Antibodies
|
Cancer
|
KWAR23 is an anti-human SIRPα antibody. KWAR23 binds human SIRPα with high affinity and disrupts its binding to CD47. KWAR23 shows antitumor activity in combination with tumor-opsonizing antibodies and can be used in cancer immunotherapy research .
|
- HY-P99108
-
- HY-P99635
-
- HY-P99903
-
- HY-P99899
-
- HY-P990057
-
- HY-P99800
-
- HY-P99809
-
MK-1308
|
CTLA-4
|
Cancer
|
Quavonlimab (MK-1308) is a novel anti-CTLA-4 antibody .
|
- HY-P99868
-
MGD 011
|
CD19
|
Others
|
Duvortuxizumab (MGD 011) is a chimeric humanized IG antibody targeting CD19 and CD3E .
|
- HY-P99994
-
- HY-P99996
-
- HY-P99998
-
- HY-P99014
-
|
Apoptosis
|
Inflammation/Immunology
|
Cusatuzumab is a human αCD70 monoclonal antibody. Cusatuzumab shows cytotoxicity activity with enhanced antibody-dependent cellular. Cusatuzumab reduces leukemia stem cells (LSCs) and triggers gene signatures related to myeloid differentiation and apoptosis. Cusatuzumab has the potential for the research of Acute myeloid leukemia (AML) .
|
- HY-P99806
-
|
Inhibitory Antibodies
|
Cancer
|
Pritumumab is a natural human IgG1kappa mAb originally isolated from a regional draining lymph node of a patient with cervical carcinoma. Pritumumab recognizes vimentin expressing on the cell surface of the malignant tumor. Pritumumab can be used for glioblastoma research .
|
- HY-P99526
-
- HY-P99709
-
LY3300054
|
PD-1/PD-L1
|
Cancer
|
Lodapolimab (LY3300054) is an IgGλ anti-PD-1 monoclonal antibody .
|
- HY-P990024
-
- HY-P990056
-
- HY-P990085
-
- HY-P99883
-
SAR156597
|
Interleukin Related
|
Others
|
Romilkimab (SAR156597) is a chimeric humanized IG antibody that specifically targets IL-4 and IL13 .
|
- HY-P99922
-
|
Inhibitory Antibodies
|
Cancer
|
Encelimab is an anti-LAG3 antibody. Encelimab blocks the interaction between LAG-3 and MHC II, and enhances T-cell activation. Encelimab alone or in combination with an anti-PD-1 antibody reduces tumor size in a lymphoma mice model (A20 cell xenograft) .
|
- HY-P99995
-
- HY-P99997
-
- HY-P99988
-
- HY-P99225
-
M9346A
|
Antifolate
|
Cancer
|
Mirvetuximab (M9346A) is an anti-FOLR1 (folate receptor 1) monoclonal antibody. Mirvetuximab is the antibody moiety of novel folate receptor alpha (FRα)-targeting ADC (Mirvetuximab soravtansine). Mirvetuximab soravtansine can be used in ovarian and other FRα-positive cancer research .
|
- HY-P99896
-
- HY-P99237
-
- HY-P99532
-
- HY-P99451
-
- HY-P99663
-
|
TNF Receptor
|
Cancer
|
Inezetamab is a bispecific anti-CD40 and anti-MSLN IgG1 monoclonal antibody .
|
- HY-P99699
-
- HY-P99723
-
BCD-135
|
PD-1/PD-L1
|
Cancer
|
Manelimab is a monoclonal antibody that inhibits programmed death-ligand 1 (PD-L1) .
|
- HY-P99862
-
PEG sTNF-RI
|
TNF Receptor
|
Others
|
Pegsunercept (PEG sTNF-RI) is a monoclonal antibody that specifically targets TNFA and is conjugated to a pegol structure .
|
- HY-P990058
-
- HY-P990011
-
- HY-P99983
-
- HY-P99984
-
- HY-P9923
-
MEDI-563; BIW-8405
|
Interleukin Related
Apoptosis
|
Inflammation/Immunology
Cancer
|
Benralizumab (MEDI-563) is an interleukin-5 receptor α (IL-5Rα)-directed cytolytic monoclonal antibody that induces direct, rapid and nearly complete depletion of eosinophils via enhanced antibody-dependent cell-mediated cytotoxicity. Benralizumab can be used for severe eosinophilic asthma .
|
- HY-P99015
-
|
TNF Receptor
|
Cancer
|
Dacetuzumab (SGN-40) is a humanized IgG1, anti-CD40 monoclonal antibody with anti-lymphoma activity. Dacetuzumab kills tumor cells via immune effector functions (antibody-dependent cellular cytotoxicity and phagocytosis [ADCC/ADCP]). Dacetuzumab ((SGN-40) can be used for multiple myeloma research .
|
- HY-P99253
-
KW-0761
|
CCR
|
Inflammation/Immunology
Cancer
|
Mogamulizumab (KW-0761) is a recombinant anti-CCR4 monoclonal antibody (MAb). Mogamulizumab can eliminate tumor cells by antibody-dependent cellular cytotoxicity (ADCC). Mogamulizumab can be used in the research of cancers, adult T-cell leukemia/lymphoma (ATLL), cutaneous T-cell lymphoma (CTCL) .
|
- HY-P99604
-
AZD-1061; COV2-2130
|
SARS-CoV
|
Infection
|
Cilgavimab (AZD-1061; COV2-2130) is a human SARS-CoV-2-neutralizing monoclonal antibody, can compose monoclonal-antibody combination AZD7442 with Tixagevimab (HY-P99556). Cilgavimab shows protective action on mouse models of SARS-CoV-2 infection .
|
- HY-P99653
-
VAY-736
|
Inhibitory Antibodies
|
Cancer
|
Ianalumab (VAY-736) is a human, decarboxylated antibody against BAFF-R. Ianalumab can block the interaction between BAFF and BAFF-R and antagonize the apoptosis protection mediated by BAFF. Ianalumab exerts antibody-dependent cytotoxic (ADCC), depending on effector cell activation mediated by immune receptor tyrosine activation motif (ITAM) .
|
- HY-P99682
-
hLIV22
|
Inhibitory Antibodies
|
Cancer
|
Ladiratuzumab (hLIV22) is an anti-LIV-1/ZIP6 humanized monoclonal antibody. Ladiratuzumab, conjugated with the microtubule disrupting agent, MMAE (HY-15162) to compose SGN-LIV1A, an antibody-drug conjugate (ADC). Ladiratuzumab can be used for research of breast cancer .
|
- HY-P99843
-
|
TROP2
ADC Antibody
|
Cancer
|
Datopotamab (CDP7657) is an antibody targeting to TROP2. Datopotamab can be used to synthesize Datopotamab deruxtecan (HY-141598), TROP2-directed antibody-drug conjugate (ADC). Datopotamab deruxtecan consists of DNA topoisomerase I inhibitor Deruxtecan (HY-13631E) and Datopotamab .
|
- HY-P99730
-
TAK-079
|
CD38
|
Cancer
|
Mezagitamab (TAK-079) is a IgG1λ anti-CD38 monoclonal antibody. Mezagitamab depletes tumor cells expressing CD38 through antibody and complement dependent cytotoxicity. Mezagitamab has potential application in relapsed/refractory multiple myeloma (RRMM) and idiopathic thrombocytopenic purpura (ITP) .
|
- HY-P99254
-
1E10
|
Inhibitory Antibodies
|
Inflammation/Immunology
Cancer
|
Racotumomab (Anti-Human NGcGM3 Recombinant Antibody) is an anti-idiotype monoclonal antibody (MAb). Racotumomab reacts to Neu-glycolyl (NeuGc)-containing gangliosides, sulfatides, and other antigens expressed in tumors. Racotumomab is an active anticancer agent for lung cancer .
|
- HY-P99987
-
- HY-P99211
-
ChAglyCD3; TRX 4
|
CD3
|
Metabolic Disease
|
Otelixizumab (ChAglyCD3) is an anti-human CD3 monoclonal antibody and can be used for the research of type 1 diabetes .
|
- HY-P990027
-
|
ADC Antibody
|
Cancer
|
Izeltabart is a high-affinity humanized antibody targeting ADAM9. Izeltabart can be used as ADC Antibody for site-specific conjugation with Maytansinoid-based DM21-C (a Drug-Linker Conjugates for ADC), to synthesize IMGC936 (Antibody-Drug Conjugates (ADCs)) with strong anti-cancer activity. DM21-C is composed of Maytansinoid (microtubule inhibitor) and a stable tripeptide linker. IMGC936 exhibits cytotoxicity against ADAM9-positive human tumor cell lines and potent antitumor activity in xenograft tumor models .
|
- HY-P99457
-
- HY-P99582
-
ONC-005, OTSA101
|
Inhibitory Antibodies
|
Cancer
|
Tabituximab (OTSA101) is a humanized monoclonal antibody against frizzled class receptor 10 (FZD10) .
|
- HY-P99937
-
|
HIV
|
Infection
|
Elipovimab is a potent broadly neutralizing HIV-1 antibody for the targeted elimination of HIV-infected cells
|
- HY-P990053
-
- HY-P990020
-
- HY-P9806
-
MERS-D12; MERS Antibody-D12
|
SARS-CoV
|
Infection
|
Anti-MERS-D12 mAb (MERS-D12; MERS Antibody-D12) is a human monoclonal IgG1. Anti-MERS-D12 mAb binds directly to the DPP4 interacting region of the MERS-CoV Spike receptor binding domain (RBD) and effect neutralization by directly blocking receptor binding .
|
- HY-P99640
-
ABBV-927
|
Inhibitory Antibodies
|
Cancer
|
Giloralimab (ABBV-927) is a potent antiCD40 agonistic monoclonal antibody. Giloralimab has the potential for the research of cancer .
|
- HY-P990018
-
MK-5890
|
TNF Receptor
|
Cancer
|
Boserolimab (MK-5890) is a chimeric humanized IgG1κ antibody targeting the mouse signaling regulatory protein CD27.
|
- HY-P99675
-
AK112
|
PD-1/PD-L1
VEGFR
|
Cancer
|
Ivonescimab (AK112) is a PD-1/VEGF Bispecific Antibody. Ivonescimab can be used for cancer research .
|
- HY-P99679
-
- HY-P99558
-
GEXMab73; GT-MAb7.3-GEX; TrastuzuMab-GEX
|
EGFR
|
Cancer
|
Timigutuzumab (GEXMab73) is a humanized monoclonal antibody that targets ErbB2. Timigutuzumab can be used for the research of cancer .
|
- HY-P99495
-
- HY-P99898
-
- HY-P990010
-
- HY-P990036
-
|
IFNAR
|
Infection
|
Dazukibart is a mouse-derived, humanized IgG1κ antibody targeting interferon beta 1 (IFNB1) .
|
- HY-P990043
-
- HY-P990062
-
|
Inhibitory Antibodies
|
Others
|
Freneslerbart is an IgG4κ antibody targeting Felcat allergen 1. Felcat allergen 1 is an allergen protein .
|
- HY-P990082
-
|
VEGFR
|
Cancer
|
Suvemcitug is a humanized IgG1κ antibody targeting VEGF derived from the African hare (Oryctolagus cuniculus) .
|
- HY-P990063
-
|
Inhibitory Antibodies
|
Others
|
Mevonlerbart is an IgG4κ antibody targeting human Felcat allergen 1. Felcat allergen 1 is an allergen protein.
|
- HY-P990039
-
|
Inhibitory Antibodies
|
Cancer
|
Falbikitug is a humanized immunoglobulin G1-kappa, anti-LIF monoclonal antibody. Falbikitug is an antineoplastic .
|
- HY-P990045
-
- HY-P99194
-
REGN1500
|
Inhibitory Antibodies
|
Cardiovascular Disease
Metabolic Disease
|
Evinacumab (REGN1500) is a human anti-ANGPTL3 (angiopoietin-like protein 3) monoclonal antibody (IgG4 class antibody). Evinacumab reduces plasma lipids in dyslipidemic mice by blocking ANGPTL3. Evinacumab can be used in studies of homozygous familial hypercholesterolaemia (HoFH), refractory hypercholesterolaemia (both familial and non-familial) and severe hypertriglyceridaemia .
|
- HY-P99655
-
KB004
|
Ephrin Receptor
Apoptosis
|
Cancer
|
Ifabotuzumab (KB004) is an IgG1κ antibody targeting EphA3 (KD=610 pM). Ifabotuzumab induces tumor cell apoptosis, activates Antibody-dependent cell mediated cytotoxicity (ADCC), and damages tumor vasculature. Ifabotuzumab reduces human idiopathic pulmonary fibrosis (IPF) CCR10 + cells and improves pulmonary fibrosis .
|
- HY-P99566
-
ST2146
|
Inhibitory Antibodies
|
Cancer
|
Tenatumomab (ST2146) is a murine monoclonal antibody against tenascin-C. And tenascin-C, the large extracellular glycoprotein, is overexpressed in cancer. Tenatumomab has been used for Pretargeted Antibody Guided Radioimmunoresearch (PAGRIT), and delivering radionuclides to tumors via PAGRIT and direct 131Iodine labeling approach .
|
- HY-P9908A
-
- HY-P99200
-
- HY-P99347
-
- HY-P99684
-
J2898A
|
EGFR
|
Cancer
|
Laprituximab (J2898A) is a humanized IgG1 anti-EGFR antibody that can be used for the synthesis of ADC IMGN289 .
|
- HY-P99968
-
|
Mucin
|
Cancer
|
Clivatuzumab is a humanized anti-mucin monoclonal antibody targeting an epitope in the MUC1 antigen expressed in most pancreatic cancers .
|
- HY-P99867
-
MEDI 573
|
IGF-1R
|
Others
|
Dusigitumab (MEDI 573) is a human IgG2λ monoclonal antibody that specifically targets IGF2 and IGF1 .
|
- HY-P990065
-
- HY-P99167
-
HCD122
|
TNF Receptor
|
Cancer
|
Lucatumumab (HCD122) is a fully human anti-CD40 antagonist monoclonal antibody, which blocks CD40/CD40L-mediated signaling. Lucatumumab efficiently mediates antibody-dependent cell-mediated cytotoxicity (ADCC) and clearance of tumor cells, can be used for refractory lymphomas, CLL and multiple myeloma research .
|
- HY-P99622
-
IMC-20D7S
|
Tyrosinase
|
Cancer
|
Flanvotumab (IMC-20D7S) is a human monoclonal antibody targeting to tyrosinase-related protein (TYRP1), specifically expressed in melanocytes and melanoma cells. Flanvotumab acts function via natural killing-mediated antibody-dependent cell-mediated cytotoxicity (ADCC). Flanvotumab has potent anti-tumor activity and good tolerance .
|
- HY-P99393
-
MEDI 0562; Tavolimab
|
Inhibitory Antibodies
|
Cancer
|
Tavolixizumab (MEDI 0562; Tavolimab) is a human monoclonal antibody to TNFRSF4 (TNF receptor superfamily member 4) for use in cancer immunology research .
|
- HY-P99481
-
NEOD001
|
Amyloid-β
|
Neurological Disease
|
Birtamimab (NEOD001) is an investigational monoclonal antibody that specifically and selectively target and clear the amyloid. Birtamimab can be used for the research of light chain amyloidosis .
|
- HY-P99892
-
PR-1594407; DC-1630423
|
EGFR
|
Others
|
Serclutamab is a humanized chimeric antibody targeting EGFR IgG1-κ. Mainly expressed by CHO (Chinese Hamster Ovary) cells .
|
- HY-P990019
-
- HY-P99975
-
- HY-P99740
-
|
CD276/B7-H3
|
Cancer
|
Mirzotamab is an IgG1κ antibody targeting to CD276/B7-H3. Mirzotamab can conjugates with Clezutoclax (HY-137774), an BCL inhibitor to form Mirzotamab clezutoclax (HY-P99741), involving in research with taxane research in relapsed/refractory solid tumors. Mirzotamab clezutoclax (ABBV-155) is a targeted antibody drug conjugate (ADC) .
|
- HY-P99801
-
- HY-P99954
-
|
Bacterial
|
Infection
|
Rivabazumab pegol is a PcrV protein antibody that can be used to study the phase II pegylated Fab of chronic Pseudomonas aeruginosa infection .
|
- HY-P9964
-
|
EGFR
|
Cancer
|
Necitumumab is a human IgG monoclonal antibody directed against EGFR. Necitumumab can be used for research of NSCLC, colorectal cancer, etc .
|
- HY-P990030
-
AB-308
|
Inhibitory Antibodies
|
Infection
|
Ralzapastotug (AB-308) is a monoclonal antibody targeting amino acids 106-126 of the cellular prion protein PrP C .
|
- HY-P990089
-
- HY-P990047
-
|
GLP Receptor
|
Metabolic Disease
|
Maridebart is a human immunoglobulin G1-kappa, anti-GIPR (gastric inhibitory polypeptide receptor) monoclonal antibody .
|
- HY-P990028
-
|
Inhibitory Antibodies
|
Cancer
|
Raludotatug is a humanized immunoglobulin G1-kappa, anti-CDH6 monoclonal antibody. Raludotatug is an antineoplastic .
|
- HY-P99539
-
REGN4018
|
CD3
|
Cancer
|
Ubamatamab (REGN4018) is a humanized bispecific antibody targeted against Mucin 16 (MUC16) and CD3. Ubamatamab demonstrates potent antitumor activity .
|
- HY-P99517
-
JNJ-63898081
|
CD3
|
Cancer
|
Voxalatamab (JNJ-63898081) is a bispecific IgG4 antibody that binds PSMA and CD3 and has anti-cancer activity for use in prostate cancer research .
|
- HY-P9912A
-
|
EGFR
|
Cancer
|
Pertuzumab (PBS), a humanized monoclonal antibody, is a HER2 dimerization inhibitor for the treatment of metastatic HER2-positive breast cancer.
|
- HY-P99408
-
- HY-145645
-
- HY-P99615
-
SB 209763; RSHZ19
|
RSV
|
Infection
|
Felvizumab (SB 209763) is a humanized IgG1κ monoclonal antibody directed to distinct neutralizing epitopes on the F glycoprotein of RSV .
|
- HY-P99781
-
MLN-1202
|
CCR
|
Cancer
|
Plozalizumab (MLN-1202) is a specific humanized anti-CCR2 antibody. Plozalizumab can be used for malignant melanoma research .
|
- HY-P990035
-
|
PD-1/PD-L1
|
Cancer
|
Benmelstobart is an IgG1κ antibody targeting PD-L1/CD274, derived from mice .
|
- HY-P990044
-
- HY-P990016
-
- HY-P990074
-
- HY-P990048
-
|
CTLA-4
|
Cancer
|
Muzastotug is a humanized immunoglobulin G1-kappa, anti-CTLA4 monoclonal antibody. Muzastotug is an immunostimulant and antineoplastic .
|
- HY-P99577
-
|
CD19
|
Cancer
|
Taplitumomab paptox is an anti-CD19 monoclonal antibody. Taplitumomab paptox can be used in cancer research.
|
- HY-P990031
-
M-6223
|
Inhibitory Antibodies
|
Inflammation/Immunology
Cancer
|
Dargistotug (M-6223) is a fully human IgG1 monoclonal antibody targeting TIGIT (T cell immune receptor with Ig domain and ITIM). TIGIT is an inhibitory immune checkpoint that promotes NK cell depletion and reduces the secretion of cytokines by binding to CD155 and other antibodies. It can also directly or indirectly inhibit effector T cells and upregulate Tregs cells, thereby exerting immunosuppression. Function .
|
- HY-P990033
-
CC-95251; BMS-986351
|
Inhibitory Antibodies
|
Cancer
|
Anzurstobart (CC-95251; BMS-986351) is a high-affinity, fully human monoclonal anti-SIRPα antibody that blocks the binding of CD47 to SIRPα. Anzurstobart enhances macrophage phagocytic activity against DLBCL cell lines in co-culture models when combined with the antibody Rituximab (HY-P9913). Anzurstobart has the potential for solid and hematologic malignancies research .
|
- HY-P990306
-
|
c-Met/HGFR
ADC Antibody
|
Cancer
|
ABBV-303 is a multi-specific NK cell antibody targeting c-Met designed based on TriNKET technology for natural killer (NK) cell redirection therapy. The ABBV-303 antibody consists of three functional arms, a single-chain variable fragment (scFV) targeting c-Met, a Fab arm targeting NKG2D, and an Fc fragment targeting NK cell CD16a .
|
- HY-P99619
-
SCT-I10A
|
PD-1/PD-L1
|
Cancer
|
Finotonlimab (SCT-I10A) is a recombinant humanised IgG PD-1 antibody. Finotonlimab has the potential for solid tumors or lymphomas research .
|
- HY-P99754
-
|
Interleukin Related
|
Inflammation/Immunology
|
Netakimab is an anti-IL-17 monoclonal antibody. Nerelimomab can be used for research of ankylosing spondylitis, psoriatic arthritis, moderate-to-severe plaque psoriasis .
|
- HY-P9912
-
|
EGFR
|
Cancer
|
Pertuzumab, a humanized IgG1 monoclonal antibody, is a HER2 dimerization inhibitor for the treatment of metastatic HER2-positive breast cancer.
|
- HY-P99198
-
- HY-P99402
-
REGN 2176
|
PDGFR
|
Metabolic Disease
|
Rinucumab (REGN 2176), a monoclonal antibody, is a PDGF inhibitor. Rinucumab (REGN 2176) could be used for the study of neovascular age-related macular degeneration .
|
- HY-P99501
-
HS006
|
CD20
|
Cancer
|
Zuberitamab (HS006) is a monoclonal antibody that targets CD20 and can be used in cancer research, including diffuse large B-cell lymphoma .
|
- HY-P99533
-
SRF-231; SRF231
|
Interleukin Related
|
Cancer
|
Urabrelimab (SRF231) is a fully human anti-CD47 monoclonal antibody that blocks the CD47-SIRP interaction .
|
- HY-P99724
-
- HY-P99725
-
PF-06741086
|
Inhibitory Antibodies
|
Metabolic Disease
|
Marstacimab (PF-06741086) is an anti-tissue factor pathway inhibitor (TFPI) monoclonal antibody. Marstacimab can be used for the research of hemophilia .
|
- HY-P99512
-
UCB-7858
|
Glutaminase
|
Inflammation/Immunology
|
Zampilimab (UCB-7858) is a monoclonal antibody against transglutaminase 2 (TG2). Zampilimab has potential application in renal transplant .
|
- HY-P99866
-
MEHD-7945A; RG 7597
|
EGFR
|
Others
|
Duligotuzumab (MEHD-7945A; RG 7597) is a humanized IgG-κ monoclonal antibody that specifically targets Her3 (ErbB3) .
|
- HY-P990040
-
LVGN-6051
|
TNF Receptor
|
Cancer
|
Exlinkibart (LVGN-6051) targets TNFRSF9 and is an IgG1κ antibody humanized through complementarity-determining region (CDR) grafting technology.
|
- HY-P99993
-
- HY-P9913A
-
|
CD20
|
Inflammation/Immunology
Cancer
|
Rituximab (anti-CD20) is an anti-CD20 chimeric monoclonal antibody used to treat certain autoimmune diseases and types of cancer .
|
- HY-P99160
-
|
Inhibitory Antibodies
|
Cancer
|
Labetuzumab is a humanised anti-carcinoembryonic antigen (CEA) monoclonal antibody that inhibits tumour growth and sensitises human medullary thyroid cancer xenografts to Dacarbazine chemotherapy .
|
- HY-P99343
-
REGN3470
|
Filovirus
|
Infection
|
Atoltivimab (REGN3470), or maftivimab/odesivimab (Inmazeb) is the first Food and agent Administration (FDA)-approved monoclonal antibody to target Zaire ebolavirus (EBOVs) infection .
|
- HY-P99383
-
REMD-477; AMG-477
|
GCGR
|
Metabolic Disease
|
Volagidemab is an antagonistic glucagon receptor (GCGR) monoclonal antibody (mAb). Volagidemab can be used in the research of type 1 diabetes (T1D) .
|
- HY-P99617
-
REGN3767
|
LAG-3
|
Cancer
|
Fianlimab (REGN3767) is a human monoclonal antibody that targets the immune checkpoint receptor LAG-3 on T cells and has anti-tumour activity .
|
- HY-P99578
-
HL036337; HBM9036
|
TNF Receptor
|
Others
|
Tanfanercept (HL036337) is an anti-TNF-α monoclonal antibody. Tanfanercept is effective in ameliorating corneal erosions in a dry eye (DE) mouse model .
|
- HY-P99674
-
GEN-3009
|
Inhibitory Antibodies
|
Cancer
|
Ivicentamab (GEN-3009) is an IgG1κ anti-CD37 humanized monoclonal antibody. Ivicentamab can be used for cancer research .
|
- HY-P99658
-
PRX-003
|
Inhibitory Antibodies
|
Cancer
|
Imaprelimab (PRX-003) is a humanized IgG1κ anti-melanoma cell adhesion molecule (MCAM) monoclonal antibody. Imaprelimab is an antineoplastic agent .
|
- HY-P99780
-
- HY-P99775
-
ART621; CEP-37247; PN0621
|
TNF Receptor
|
Inflammation/Immunology
|
Placulumab (ART621) is an anti-TNF α monoclonal antibody. Placulumab has anti-inflammatory activity and has potential applications in inflammatory diseases such as arthritis .
|
- HY-P99865
-
AK-119
|
CD73
|
Others
|
Dresbuxelimab (AK-119) is an IgG-κ monoclonal antibody targeting CD73. The expression system is usually CHO (Chinese Hamster Ovary) cells .
|
- HY-P990051
-
|
Inhibitory Antibodies
|
Cancer
|
Delpacibart is a humanized, mouse IgG1κ antibody targeting TFRC. TFRC is the most important membrane protein that regulates intracellular iron transport processes .
|
- HY-P990080
-
|
CTLA-4
|
Cancer
|
Sovipostobart is an immunoglobulin G1-kappa, anti-CTLA-4 human monoclonal antibody with cleavable prodomain. Sovipostobart is an immunostimulant and antineoplastic .
|
- HY-P99177
-
|
SARS-CoV
|
Infection
Cardiovascular Disease
|
Enibarcimab is a humanised murine monoclonal immunoglobulin G1 (IgG1) antibody, could be used for acute heart failure, COVID-19 infections and septic shock research .
|
- HY-P99404
-
|
CXCR
|
Inflammation/Immunology
Cancer
|
Quetmolimab is a humanized anti-CX3CL1 monoclonal antibody. However, CX3CL1 is a chemokine with a modulating effect on chemotaxis and adhesion .
|
- HY-P99115
-
ASC 22; KN 035
|
PD-1/PD-L1
|
Cancer
|
Envafolimab (ASC 22; KN 035) is a recombinant protein of a humanized single-domain anti- PD-L1 antibody. Envafolimab is created by a fusion of the of anti-PD-L1 domain with Fc fragment of human IgG1 antibody. Envafolimab blocks interaction between PD-L1 and PD-1 with an IC50 value of 5.25 nM. Envafolimab has the potential for the research of solid tumors .
|
- HY-P99746
-
3C23K; GM102
|
Inhibitory Antibodies
|
Inflammation/Immunology
Cancer
|
Murlentamab (3C23K; GM102) is a humanized anti-AMHRII antibody. AMHRII is the anti-Müllerian hormone receptor. Murlentama significantly promotes macrophage-mediated antibody-dependent cell-mediated cytotoxicity (ADCC). Murlentama stimulates pro-inflammatory and anti-tumor internal environment, recruits and activates T cells. Murlentama suppresses tumors growth by inducing naïve macrophage orientation and promoting tumor-associated macrophage (TAM) reprogramming .
|
- HY-P9904
-
MPDL3280A
|
PD-1/PD-L1
Apoptosis
Autophagy
|
Cancer
|
Atezolizumab (MPDL3280A) is a selective humanized monoclonal IgG1 antibody against programmed death ligand 1 (PD-L1), used for cancer research.
|
- HY-P99187
-
- HY-P99213
-
GSK1223249
|
Inhibitory Antibodies
|
Neurological Disease
|
Ozanezumab (GSK1223249) is an anti-Nogo-A (neurite outgrowth inhibitor A) monoclonal antibody. Ozanezumab can be used in amyotrophic lateral sclerosis (ALS) and multiple sclerosis research .
|
- HY-P9982
-
|
Inhibitory Antibodies
|
Endocrinology
|
Romosozumab is a humanized monoclonal anti-sclerostin antibody, it promotes bone formation and inhibits bone resorption by inhibiting sclerostin. Romosozumab can be used for the research of osteoporosis .
|
- HY-P99555
-
- HY-P99625
-
SAR441344; INX-021
|
TNF Receptor
|
Inflammation/Immunology
|
Frexalimab (SAR441344; INX-021) is a monoclonal antibody targeting the CD40 ligand (CD40L). Frexalimab has the potential for multiple sclerosis research .
|
- HY-P99643
-
UCB6114
|
Inhibitory Antibodies
|
Cancer
|
Ginisortamab (UCB6114) is a fully human IgG4P antiGremlin-1 monoclonal antibody. Ginisortamab has the potential for the research of gastrointestinal (GI) tumors .
|
- HY-P99646
-
MEDI6570
|
Inhibitory Antibodies
|
Metabolic Disease
|
Golocdacimab (MEDI6570) is a fully human anti-LOX-1 monoclonal antibody. Golocdacimab (MEDI6570) has the potential for the research of type 2 diabetes .
|
- HY-P99686
-
c4G7-N
|
Filovirus
|
Infection
|
Larcaviximab (c4G7-N) is an IgG1 kappa anti-Ebola virus glycoprotein chimeric monoclonal antibody .
|
- HY-P99758
-
CS1003
|
PD-1/PD-L1
|
Cancer
|
Nofazinlimab (CS1003) is a humanised IgG4 anti-PD-1 monoclonal antibody. Nofazinlimab can be used for unresectable hepatocellular carcinoma (uHCC) research .
|
- HY-P99761
-
XmAb5871
|
CD19
|
Inflammation/Immunology
|
Obexelimab (XmAb5871) is a humanized anti-CD19 antibody Fc-engineered for increased affinity to FcγRIIb. Obexelimab can be used in research of autoimmune .
|
- HY-P9948
-
Campath-IH
|
Apoptosis
|
Cancer
|
Alemtuzumab (Campath-IH) is a humanized monoclonal antibody against CD52. Alemtuzumab does not cross-react with murine CD52. Alemtuzumab selectively targets the CD52 antigen to induce profound lymphocyte depletion, followed by recovery of T and B cells with regulatory phenotypes. Alemtuzumab is capable of complement-dependent cytotoxicity and antibody-dependent cell-mediated cytotoxicity (ADCC), as well as induction of apoptosis. Alemtuzumab has the potential for B-cell chronic lymphocytic leukaemia research .
|
- HY-P990025
-
ARGX-117
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Empasiprubart (ARGX-117) a humanized inhibitory monoclonal antibody against complement C2. Empasiprubart prevents the formation of the C3 proconvertase and inhibits classical and lectin pathway activation upstream of C3 activation through binding to the Sushi-2 domain of C2. Empasiprubart exhibits pH- and calcium-dependent target binding. Empasiprubart prevents complement-mediated cytotoxicity in in vitro models for autoimmune hemolytic anemia and antibody-mediated rejection of organ transplants .
|
- HY-P9903
-
BMS-936558; ONO-4538; MDX-1106
|
PD-1/PD-L1
|
Cancer
|
Nivolumab is a programmed death receptor-1 (PD-1) blocking human IgG4 antibody to treat advanced (metastatic) non-small cell lung cancer.
|
- HY-P99603
-
SEA-CD40
|
Inhibitory Antibodies
|
Cancer
|
Cifurtilimab (SEA-CD40) is an agonistic nonfucosylated, human IgG1 monoclonal antibody directed against CD40. Cifurtilimab shows antitumor activities .
|
- HY-P9939
-
KRN23
|
Inhibitory Antibodies
|
Others
|
Burosumab is a human fibroblast growth factor 23 (FGF23) neutralizing antibody that can be used for the research of X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia .
|
- HY-P99570
-
GBR-830
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Telazorlimab (GBR-830) is a humanized monoclonal antibody against OX40 costimulatory receptor on activated T cells. Telazorlimab can be used for the research of autoimmune diseases .
|
- HY-P99642
-
- HY-P9929
-
|
Bacterial
|
Infection
Inflammation/Immunology
|
Bezlotoxumab is a human monoclonal antibody directed against C. difficile toxin B. Bezlotoxumab binds to C. difficile toxin B preventing intestinal epithelial damage and colitis .
|
- HY-P990041
-
|
CTLA-4
|
Inflammation/Immunology
Cancer
|
Firastotug is an IgG1κ antibody targeting CTLA4. CTLA4 is a cytotoxic T lymphocyte-associated protein and a key immune checkpoint in the fields of autoimmunity and cancer .
|
- HY-P990068
-
|
Inhibitory Antibodies
|
Cancer
|
Perenostobart is a human immunoglobulin G4-kappa, anti-ENTPD1/CD39 monoclonal antibody. Perenostobart is an immunostimulant and antineoplastic .
|
- HY-P990081
-
- HY-P990015
-
|
HBV
|
Infection
|
Tobevibart is an IgG1-lambda, anti-HBV (hepatitis B virus) surface envelope protein human monoclonal antibody. Tobevibart shows antiviral activity .
|
- HY-P990042
-
ONC-392; BNT 316
|
CTLA-4
|
Cancer
|
Gotistobart (ONC-392) is a humanized anti-CTLA-4 antibody that confers immunotherapeutic effect by selective depletion of regulatory T cells (Treg) in the tumor microenvironment .
|
- HY-P99676
-
SI-B001
|
EGFR
|
Cancer
|
Izalontamab (SI-B001) is a bispecific anti-EGFR/HER3 monoclonal antibody with high selectivity for EGFR/HER3 heterodimer. Izalontamab can be used for the research of cancer .
|
- HY-P99807
-
BCD-100
|
PD-1/PD-L1
|
Cancer
|
Prolgolimab (BCD-100) is a human IgG1 anti-PD-1 monoclonal antibody containing the Fc-silencing 'LALA' mutation. Prolgolimab can be used for the research of advanced melanoma .
|
- HY-P99851
-
SPECIFID
|
Inhibitory Antibodies
|
Cancer
|
Detumomab is a mouse monoclonal antibody targeting human B-cell lymphoma. Detumomab can be used in the research of cancers such as non-Hodgkin's lymphoma (NHL).
|
- HY-P99856
-
|
RABV
|
Infection
|
Docaravimab is an antibody, targeting ERA (Evelyn-Rockitniki-Abelseth) glycoprotein ectodomain epitope G-III. Docaravimab can be used in research of Rabies .
|
- HY-P99863
-
4197X-RA; MDX-RA (ricin A chain) immunotoxin
|
Inhibitory Antibodies
|
Others
|
Dorlimomab aritox (4197X-RA; MDX-RA (ricin A chain) immunotoxin) is a mouse-derived monoclonal antibody conjugated to ricin A .
|
- HY-P99186
-
|
Inhibitory Antibodies
|
Others
|
Blosozumab (LY2541546) is an anti-Human sclerostin (SOST) antibody inhibitor. Blosozumab stimulates bone formation and reduces bone resorption. Blosozumab can be used in the research of Osteoporosis .
|
- HY-P99188
-
CNTO 888
|
CCR
|
Cancer
|
Carlumab (CNTO 888) is a human anti-CCL2 (chemokine ligand 2) antibody with high affinity. Carlumab can be used in cancer research, particularly in prostate cancer .
|
- HY-108852
-
CHI 621
|
Interleukin Related
|
Inflammation/Immunology
|
Basiliximab (CHI 621) is a recombinant chimeric murine/human IgG1 monoclonal anti-interleukin-2 receptor antibody. Basiliximab can be used for the research of renal transplantation .
|
- HY-P99208
-
IPH2102
|
Inhibitory Antibodies
|
Cancer
|
Lirilumab (IPH2102) is an anti-KIR monoclonal antibody, and shows antitumor activity. Lirilumab can be used in Leukemia, squamous cell carcinoma of the head and neck (SCCHN) research .
|
- HY-P99804
-
MK1654
|
RSV
|
Infection
|
Clesrovimab (MK1654) is a fully human, anti-RSV fusion (RSV F) glycoprotein monoclonal antibody. Clesrovimab has the potential for the research of respiratory syncytial virus infection .
|
- HY-P99494
-
TRC105; DE-122
|
TGF-beta/Smad
|
Cancer
|
Carotuximab (TRC105) is a IgG1 monoclonal antibody that blocks endoglin (CD105) and its downstream Smad signaling pathway. Carotuximab has immunomodulatory and antineoplastic actions .
|
- HY-P99703
-
17.1.41
|
HBV
|
Infection
|
Libivirumab (17.1.41) is a human anti-HBV monoclonal antibody. Libivirumab shows neutralization activity with IC50s of 35, 130 ng/mL for HBsAg, HBeAg, respectively .
|
- HY-P99812
-
INCAGN-1876
|
TNF Receptor
|
Cancer
|
Ragifilimab (INCAGN-1876) is an agonist monoclonal antibody targeting the glucocorticoid-induced TNFR-related protein (GITR). Ragifilimab can be used for advanced or metastatic solid tumors research .
|
- HY-P99835
-
MABT 5102A; RG 7412
|
Amyloid-β
|
Neurological Disease
|
Crenezumab (MABT 5102A; RG 7412) is a fully humanized anti-Aβ monoclonal antibody that binds multiple forms of Aβ, such as soluble, oligomeric and fibrillar, for use in Alzheimer's disease research .
|
- HY-P99105
-
- HY-P99104
-
COVI-AMG; STI-2020
|
SARS-CoV
|
Infection
|
Plutavimab a human IgG1-κ anti-SARS-CoV-2 antibody, targeting to Spike (S) glycoprotein receptor binding domain (RBD) .
|
- HY-P99884
-
PF-06801591
|
PD-1/PD-L1
|
Others
|
Sasanlimab (PF-06801591) is a humanized IgG4-κ antibody targeting PD-1. Mainly expressed by CHO (Chinese Hamster Ovary) cells .
|
- HY-P990049
-
JMT-101
|
EGFR
|
Cancer
|
Becotatug (JMT-101) is an IgG1 antibody targeting EGFR that can also be conjugated to Afatinib (HY-10261) and Osimertinib (HY-15772) as a synthetic ADC .
|
- HY-P99849
-
ABT-806
|
EGFR
|
Cancer
|
Depatuxizumab is a brain-penetrant and humanized tumor-specific anti EGFR monoclonal antibody. Depatuxizumab inhibits the growth of xenograft models of mutant EGFRvIII and wild-type EGFR. Depatuxizumab can be used for research on cancer .
|
- HY-P990183
-
|
Inhibitory Antibodies
|
Others
|
Mouse IgG2a (D265A) kappa, isotype control is a mouse-derived IgG2a type antibody inhibitor, targeting to mouse IgG2a.
|
- HY-P9905
-
Cetuximab
Maximum Cited Publications
25 Publications Verification
C225
|
EGFR
|
Cancer
|
Cetuximab (C225) is a human IgG1 monoclonal antibody that inhibits epidermal growth factor receptor (EGFR), with a Kd of 0.201 nM for EGFR by SPR. Cetuximab has potent antitumor activity .
|
- HY-P99214
-
KBPA101
|
Bacterial
|
Infection
|
Panobacumab (KBPA101) is a fully human IgM/κ monoclonal antibody generated by immortalizing human B lymphocytes against the LPS O polysaccharide of serotype O11 of P. aeruginosa .
|
- HY-P99209
-
MEDI-524
|
RSV
|
Infection
|
Motavizumab (MEDI-524) is an anti-human RSV (respiratory syncytial virus) monoclonal antibody. Motavizumab can be used in respiratory syncytial virus infection in high-risk infants research .
|
- HY-P99537
-
PBP1510
|
Inhibitory Antibodies
|
Cancer
|
Ulenistamab (PBP1510) is a first-in-class hunamised IgG1 monoclonal antibody targeting pancreatic adenocarcinoma upregulated factor (PAUF). Ulenistamab can be used for pancreatic cancer (PC) research .
|
- HY-P99438
-
KIND-030
|
Inhibitory Antibodies
|
Infection
|
Anivovetmab (KIND-030) is an anti-VP2 (parvovirus major capsid protein) monoclonal antibody (IgG2 type). Anivovetmab has the potential to study canine parvovirus infection.
|
- HY-P99473
-
BI-505
|
Integrin
|
Cancer
|
Bersanlimab (BI-505) is a fully human monoclonal antibody that targets intercellular adhesion molecule-1 (ICAM-1 or CD54). Bersanlimab has anticancer effects .
|
- HY-P99576
-
OG1953
|
VEGFR
|
Others
|
Tarcocimab (OG1953) is a humanized anti-VEGFA monoclonal antibody (IgG1 type). Tarcocimab is available for research in retinal vein occlusion (RVO) and wet age-related macular degeneration (AMD).
|
- HY-P99832
-
c13C6-FR1
|
Filovirus
|
Infection
|
Cosfroviximab (c13C6-FR1) is a mouse/human chimeric monoclonal antibody against Ebola virus glycoprotein (EBOV-GP) .
|
- HY-P99831
-
GB-221
|
EGFR
|
Others
|
Coprelotamab (GB-221) is an IgG-κ monoclonal antibody targeting EGFR2. The commonly used expression system for Coprelotamab is CHO DG44 (Chinese Hamster Ovary) cells .
|
- HY-P99870
-
ASLAN004; CSL-334
|
Interleukin Related
|
Others
|
Eblasakimab (ASLAN004; CSL-334) is a human IgG4 antibody that specifically targets IL13RA1 and is primarily expressed by CHO-K1 cells .
|
- HY-P990052
-
MAD-0004J08
|
SARS-CoV
|
Infection
|
Simaravibart (MAD-0004J08) is an IgG1κ antibody targeting the SARS-CoV2 spike (S) glycoprotein receptor binding domain .
|
- HY-P990073
-
REGN-5093
|
c-Met/HGFR
|
Cancer
|
Davutamig (REGN-5093) is a human immunoglobulin G4-kappa, anti-MET monoclonal antibody targeting two different nonoverlapping epitopes on MET. Davutamig is an antineoplastic .
|
- HY-P990092
-
|
Inhibitory Antibodies
|
Cancer
|
Rolistobart is a humanized immunoglobulin G4-kappa, anti-LILRB4/CD85k monoclonal antibody. Rolistobart is an immunostimulant and antineoplastic .
|
- HY-P990084
-
|
IGF-1R
|
Cancer
|
Veligrotug is an IgG1-kappa, anti-IGF1R (insulin-like growth factor 1 receptor, CD221) chimeric monoclonal antibody .
|
- HY-P99572
-
BNT-312; DuoBody-CD40x-4-1BB; GEN1042
|
TNF Receptor
|
Inflammation/Immunology
Cancer
|
Tecaginlimab (BNT-312) is a Fc-inert bispecific antibody for dual targeting and conditional stimulation of CD40 and 4-1BB. Tecaginlimab can enhance priming and reactivation of tumor-specific immunity .
|
- HY-P99959
-
MT-3921; rH116A3
|
Inhibitory Antibodies
|
Neurological Disease
|
Unasnemab (MT-3921) is a humanised IgG1 monoclonal antibody that binds to repulsive guidance molecule A (RGMa). Unasnemab improves locomotor function and promotes neuroregeneration and can be used for the research of spinal cord injury .
|
- HY-P99736
-
BI-754111
|
LAG-3
|
Cancer
|
Miptenalimab (BI-754111) is an anti-human LAG-3 antibody (KD: 88.6 nM for h LAG-3). Miptenalimab blocks the interaction of LAG-3 with its ligand MHC-II .
|
- HY-P99778
-
MORAb-004
|
Inhibitory Antibodies
|
Cancer
|
Ontuxizumab (MORAb-004) is a humanized IgG1/κ anti-endosialin (TEM-1 or CD248) monoclonal antibody with antitumor effects. Ontuxizumab can be used for the research of cancer .
|
- HY-P99707
-
HH1
|
Apoptosis
|
Cancer
|
Lilotomab (HH1) is a murine anti-CD37 monoclonal antibody. Lilotomab reduces clonogenic survival. Lilotomab shows anti-tumor activity .
|
- HY-P99047
-
AB 0024; GS 6624
|
Monoamine Oxidase
|
Inflammation/Immunology
|
Simtuzumab (AB 0024; GS 6624) is a monoclonal antibody directed against Lysyl oxidase like-2 (LOXL2). Simtuzumab can be used for the research of primary sclerosing cholangitis (PSC) .
|
- HY-P99644
-
ACT017
|
Inhibitory Antibodies
|
Cardiovascular Disease
|
Glenzocimab (ACT017) is a Fab fragment of humanized anti-GPVI monoclonal antibody. Glenzocimab inhibits collagen-induced platelet aggregation. Glenzocimab has the potential for the research of acute ischemic stroke .
|
- HY-P99706
-
AK 117
|
Interleukin Related
|
Cancer
|
Ligufalimab (AK 117) is a humanized IgG4 anti-CD47 monoclonal antibody. Ligufalimab does not induce RBC hemagglutination, and induces phagocytosis. Ligufalimab shows anti-tumor activity .
|
- HY-P99858
-
AB154
|
Inhibitory Antibodies
|
Cancer
|
Domvanalimab (AB154) is an anti-TIGIT humanized monoclonal antibody. Domvanalimab binds human TIGIT9 and blocks the TIGIT-CD155 interaction. Domvanalimab can be used in research of cancer .
|
- HY-P99748
-
|
TGF-β Receptor
|
Inflammation/Immunology
|
Nadecnemab is an IgG4κ antibody targeting to GFRA3, glial cell derived neurotrophic factor family receptor alpha 3. Nadecnemab can be used for research of osteoarthritis of the knee/pain .
|
- HY-P99828
-
PF-06523435; hu24
|
Inhibitory Antibodies
|
Others
|
Cofetuzumab (PF-06523435) is a humanized IgG1-κ monoclonal antibody targeting PTK7. The expression system of Cofetuzumab is usually CHO (Chinese Hamster Ovary) cells .
|
- HY-P99871
-
AK102
|
Ser/Thr Protease
|
Others
|
Ebronucimab (AK102) is an IgG1-λ2 antibody targeting PCSK9 and is primarily expressed by CHO DG44 (Chinese Hamster Ovary) cells .
|
- HY-P99873
-
KM 871; KW 2871
|
Inhibitory Antibodies
|
Others
|
Ecromeximab (KM 871; KW 2871) is a mouse-derived IgG-κ chimeric antibody targeting ganglioside GD3. Ecromeximab is expressed by YB2/0 rat hybridoma cells .
|
- HY-P990032
-
EOS-448; EOS884448; GSK4428859A
|
Inhibitory Antibodies
|
Cancer
|
Belrestotug (EOS-448) is an antagonistic anti-TIGIT (VSIG9, VSTM3) human immunoglobulin G1 kappa (hIgG1 kappa) antibody. Belrestotug shows antineoplastic activity .
|
- HY-P9925
-
AMG 827; KHK4827
|
Interleukin Related
|
Inflammation/Immunology
|
Brodalumab (AMG 827) is a human anti-interleukin-17-receptor IgG2 monoclonal antibody that can be used for the research of moderate-to-severe plaque psoriasis and rheumatoid arthritis .
|
- HY-P99649
-
MEDI3902
|
Bacterial
|
Infection
|
Gremubamab (MEDI3902) is a humanized IgG1 kappa anti-PcrV/Psl monoclonal antibody. Gremubamab binds to the PA PcrV protein and Psl exopolysaccharide. Gremubamab has the potential for the research of pseudomonas aeruginosa infections .
|
- HY-P990013
-
|
GCGR
|
Metabolic Disease
|
Gulgafafusp alfa is a human IgG2κ antibody targeting the glucagon-like peptide 1 receptor GLP1R .
|
- HY-P990054
-
|
CD20
|
Cancer
|
Eramkafusp Alfa is a human IgG1 antibody targeting the mouse B lymphocyte CD20 antigen MS4A1 .
|
- HY-P9923A
-
MEDI-563 (anti-IL5RA ); BIW-8405 (anti-IL5RA )
|
Interleukin Related
|
Inflammation/Immunology
|
Benralizumab (anti-IL5RA ) (MEDI-563 (anti-IL5RA ); BIW-8405 (anti-IL5RA )) is an interleukin-5 receptor α (IL-5Rα)-directed cytolytic monoclonal antibody that induces direct, rapid and nearly complete depletion of eosinophils via enhanced antibody-dependent cell-mediated cytotoxicity. Benralizumab can be used for severe eosinophilic asthma study .
|
- HY-P99045
-
|
ADC Antibody
|
Cancer
|
Sacituzumab is a humanized IgG1 monoclonal antibody for anti-trophoblast cell-surface antigen 2 (anti-Trop-2). Sacituzumab has the potential for metastatic triple-negative breast cancer research .
|
- HY-P9958
-
Immunoglobulin G2; Ranmark
|
NF-κB
|
Cancer
|
Denosumab is a human monoclonal antibody binding to, and inhibiting, the receptor activator of RANKL (TNFSF11). Denosumab can reduce the risk of vertebral, nonvertebral and hip fractures , also has anti-cancer activity .
|
- HY-P99168
-
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Anifrolumab is a type I interferon (IFN) receptor antagonist, a human monoclonal antibody. Anifrolumab blocks the activity of type I interferon. Anifrolumab can be used in systemic lupus erythematosus (SLE) research .
|
- HY-P99181
-
CPI-006
|
CD73
|
Infection
Inflammation/Immunology
|
Mupadolimab (CPI-006) is an IgG1κ humanized FcγR binding-deficient anti-CD73 monoclonal antibody (mAb) that activates CD73 POS B cells .
|
- HY-P9966
-
MGA271
|
Inhibitory Antibodies
|
Cancer
|
Enoblituzumab (MGA271) is a humanized IgG1κ monoclonal antibody recognizing human B7-H3 protein, a member of the B7 family of immune regulators .
|
- HY-P99337
-
Ansuvimab-zyk; mAb114
|
Filovirus
|
Infection
|
Ansuvimab (Ansuvimab-zyk) is a recombinant human monoclonal IgG1 antibody that exhibits antiviral activity against Zaire ebolavirus. Ansuvimab binds to the glycoprotein on Zaire ebolavirus to block its entry into host cells .
|
- HY-P99366
-
AMG 157; MEDI 19929; Tezepelumab-ekko
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Tezepelumab (AMG 157) is human monoclonal antibody (IgG2λ) that binds specifically to TSLP, blocking it from interacting with its heterodimeric receptor. Tezepelumab can be used for the research of severe, uncontrolled asthma .
|
- HY-P99423
-
ADG 20
|
SARS-CoV
|
Infection
|
Adintrevimab (ADG 20) is a human IgG1 monoclonal SARS-CoV (SARS-CoV) antibody. Adintrevimab inhibits SARS-CoV-2 variants and other SARS-like coronaviruses with pandemic potential .
|
- HY-P99469
-
PB 2452; MEDI 2452
|
Inhibitory Antibodies
|
Metabolic Disease
|
Bentracimab (PB 2452) is a neutralizing monoclonal antibody that binds Ticagrelor (HY-1006) and its major active circulating metabolite with high affinity. Bentracimab can rapidly reverse the antiplatelet effect of Ticagrelor .
|
- HY-P99670
-
- HY-P99857
-
PF-06252616
|
Inhibitory Antibodies
|
Metabolic Disease
|
Domagrozumab is an anti-myostatin humanized monoclonal antibody with a KD value of 2.6 pM for human myostatin. Domagrozumab induces muscle anabolic activity. Domagrozumab can be used in research of duchenne muscular dystrophy (DMD) .
|
- HY-P99947
-
XVR011
|
SARS-CoV
|
Infection
|
Rimteravimab (XVR011) is a bivalent VHH-Fc antibody with potent neutralizing activity with high stability, broad coverage and silenced Fc effector functions against the disease caused by SARS-CoV-2 .
|
- HY-145641
-
BMS-986413; C-144-LS
|
SARS-CoV
|
Infection
|
Crexavibart (BMS-986413; C-144-LS) is an IgG1λ2 antibody that targets the SARS-CoV2 spike (S) glycoprotein receptor-binding domain .
|
- HY-P990077
-
CT-011; MDV9300
|
PD-1/PD-L1
|
Cancer
|
Pidilizumab (CT-011) is a humanized IgG1k anti-PD-1 monoclonal antibody. Pidilizumab acts as a DLL1 antagonist. Pidilizumab has the potential for hematologic malignancies research .
|
- HY-P99453
-
|
ADC Antibody
|
Cancer
|
Azintuxizumab is a monoclonal, targeting to B-cell maturation antigen (BCMA) and SLAMF7/CRACC/CD319, IgG1 bispecific antibody. Azintuxizumab has the potential for the research of relapsed/refractory multiple myeloma (RRMM) .
|
- HY-P99671
-
M-6495
|
ADAMTS
|
Inflammation/Immunology
|
Isecarosmab (M-6495) is an anti-ADAMTS monoclonal antibody (mAb) with a KD value of 3.65 pM. Isecarosmab has chondroprotective and anti-inflammatory activities. Isecarosmab can bind albumin to extend plasma half-life .
|
- HY-P9903A
-
|
PD-1/PD-L1
|
Cancer
|
Nivolumab (anti-PD-1) is a programmed death receptor-1 (PD-1) blocking human IgG4 antibody to treat advanced (metastatic) non-small cell lung cancer .
|
- HY-P9956
-
CNTO-328
|
Interleukin Related
|
Cancer
|
Siltuximab is an anti-IL-6 (interleukin-6) monoclonal antibody, and shows antitumor activity. Siltuximab can be used in Multicentric Castleman's Disease (MCD) and COVID-19 research .
|
- HY-P99401
-
OMP-131R10
|
Inhibitory Antibodies
|
Cancer
|
Rosmantuzumab (OMP-131R10) is an anti-R-spondin 3 (RSPO3) humanized monoclonal antibody. Rosmantuzumab can be used for the research of advanced telapsed and refractory solid tumors .
|
- HY-P99411
-
SHP647
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Ontamalimab (SHP647) is a fully-human IgG2 monoclonal antibody targeting mucosal addressin cell adhesion molecule-1 (MAdCAM-1). Ontamalimab can be used for the research of Crohn's disease .
|
- HY-P99461
-
ISU-104
|
EGFR
|
Cancer
|
Barecetamab (ISU-104) is a fully human anti-ErbB3 monoclonal antibody. Barecetamab can be used for the research of recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) .
|
- HY-P99629
-
FHTR 2163; RG 6147; RO 7171009
|
Ser/Thr Protease
|
Neurological Disease
|
Galegenimab (FHTR 2163; RG 6147; RO 7171009), an anti-High-temperature requirement A1 (HTRA1) antibody fragment. Galegenimab can be used for age-related macular degeneration (AMD) research .
|
- HY-P99900
-
MSL-109
|
CMV
|
Infection
|
Sevirumab (MSL-109) is a human IgG1 neutralizing monoclonal antibody against cytomegalovirus (CMV). Sevirumab recognizes CMV gH complexes and inhibits CMV replication with an EC50 of 0.3 μg/mL .
|
- HY-P99811
-
CR57
|
RABV
|
Infection
|
Rafivirumab (CR57) is an anti-rabies virus monoclonal antibody for the prophylaxis of rabies. Rafivirumab has neutralizing potency against a broad spectrum of RABV variants. Rafivirumab can be used for research of cocktails .
|
- HY-P9927A
-
- HY-P990009
-
NIS-793
|
TGF-beta/Smad
|
Cancer
|
Nisevokitug (NIS-793) is a human, IgG2λ antibody targeting TGF-β (TGFB1/TGFB2). Nisevokitug is expressed by CHO-K1 cells .
|
- HY-P99739
-
- HY-P99732
-
CC-49
|
Inhibitory Antibodies
|
Cancer
|
Minretumomab (CC-49) is a murine monoclonal antibody against TAG-72 (tumor-associated glycoprotein 72). Minretumomab is used in cancer and immunity research .
|
- HY-P99743
-
|
Inhibitory Antibodies
|
Cancer
|
Mitumomab is an anti-idiotypic mouse IgG2b monoclonal antibody that mimics the ganglioside GD3. Mitumomab can be used for the research of small-cell lung carcinoma .
|
- HY-P99979
-
- HY-P99980
-
- HY-P99489
-
ABBV 181; PR 1648817
|
PD-1/PD-L1
|
Cancer
|
Budigalimab (ABBV 181; PR 1648817) is a humanized IgG1 monoclonal antibody targeting programmed cell death 1 (PD-1) receptor. Budigalimab is Fc mutated thus to reduce Fc receptor interactions and limit effector function .
|
- HY-P99652
-
AK 111
|
Interleukin Related
|
Inflammation/Immunology
|
Gumokimab (AK 111) is a monoclonal antibody targeting IL-17A, which can be used in the study of psoriasis, ankylosing spondylitis. Gumokimab competitively blocks the binding of human IL-17A to IL-17R.
|
- HY-P99223
-
MEDI-575
|
PDGFR
|
Cancer
|
Tovetumab (MEDI-575) is an anti-PDGFRα monoclonal antibody that selectively blocks the PDGFRα signal transduction. Tovetumab can be used in the research of glioblastoma and non-small cell lung cancer (NSCLC) .
|
- HY-P99540
-
PSB-205; QL1706 (iparomlimab/tuvonralimab); PBS105
|
PD-1/PD-L1
CTLA-4
|
Cancer
|
Tuvonralimab (PSB-205; QL1706) is a dual immune checkpoint blockade containing a mixture of anti-PD-1 IgG4 and anti-CTLA-4 IgG1 antibodies, Iparomlimab and Tuvonralimab .
|
- HY-P99550
-
MEDI-3506
|
Interleukin Related
|
Inflammation/Immunology
|
Tozorakimab (MEDI-3506) is a human immunoglobulin G1 monoclonal antibody targeting interleukin-33. Tozorakimab reduces inflammation and epithelial dysfunction. Tozorakimab can be used to research chronic obstructive pulmonary disease .
|
- HY-P99491
-
AVTX-007; CERC-007; MEDI 2338
|
Interleukin Related
|
Inflammation/Immunology
|
Camoteskimab (AVTX-007) is a fully human, high-affinity anti-IL-18 monoclonal antibody. Camoteskimab has the potential for the autoinflammatory diseases research, including adult-onset Still’s disease (AOSD) .
|
- HY-P99895
-
|
PD-1/PD-L1
|
Inflammation/Immunology
Cancer
|
Rulonilimab is a human IgG1 monoclonal antibody against PD-1 that targets, binds and inhibits PD-1 and its downstream signalling pathways with potential immune checkpoint inhibition and anti-tumour activity .
|
- HY-P99591
-
AS1402; huHMFG-1
|
Inhibitory Antibodies
|
Cancer
|
Sontuzumab (AS1402) is a humanizedised IgG1κ MUC1 specific monoclonal antibody. Sontuzumab binds the extracellular MUC1 peptide sequence PDTR with a Kd of ~1 nM. Sontuzumab can be used for the research of breast cancer .
|
- HY-P99792
-
NM57; rhRIG
|
RABV
|
Infection
|
Ormutivimab (rhRIG) is a recombinant human monoclonal antibody, targeting rabies virus. Ormutivimab neutralizes a variety of rabies virus strains. Ormutivimab exhibits potent potency against rabies post-exposure prophylaxis (PEP) model .
|
- HY-P99853
-
CR6261
|
Influenza Virus
|
Infection
|
Diridavumab is a monoclonal anti-HA stalk antibody. Diridavumab stabilizes the prefusion HA structure and prevents pH-dependent fusion of cellular and viral membranes in endosomes. Diridavumab can be used in research of H2 influenza virus .
|
- HY-P99949
-
OMP-313M32
|
Inhibitory Antibodies
|
Cancer
|
Etigilimab (OMP-313M32), a humanized IgG1 monoclonal antibody, blocks TIGIT interaction with PVR (CD155; poliovirus receptor) and inhibits downstream signalling with target cell killing .
|
- HY-P990034
-
MLTA3698A; RG7415; PRO283698
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Pateclizumab (MLTA3698A) is a humanized antibody against lymphotoxin α (LTα), a transiently expressed cytokine on activated B and T cells (Th1, Th17), which are implicated in rheumatoid arthritis (RA) pathogenesis .
|
- HY-P99569
-
T101-ricin A chain immunotoxin; T101-RTA
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Telimomab aritox (T101-ricin A chain immunotoxin) is a mouse monoclonal antibody that linked to the A chain of the ricin protein. Telimomab aritox can be used as an immunosuppressive agent .
|
- HY-P990182
-
|
Inhibitory Antibodies
|
Others
|
Mouse IgG2b (LALA-PG) kappa, isotype control is a mouse-derived IgG2b, κ type antibody inhibitor, targeting to mouse IgG2b.
|
- HY-P99727
-
SYN023
|
RABV
|
Infection
|
Mazorelvimab (SYN023) is a combination of CTB011 and CTB012 humanized monoclonal antibodies cocktail against rabies virus (RABV). Mezagitamab binds to non-overlapping epitopes on RABV glycoprotein (G). Mezagitamab has potential application in the prevention of rabies .
|
- HY-P9901
-
MDX-010; BMS-734016
|
CTLA-4
|
Cancer
|
Ipilimumab is a fully human monoclonal antibody IgG1κ that blocks the inhibitory receptor cytotoxic T lymphocyte antigen 4 (CTLA-4) on T cells. Ipilimumab can be used in unresectable or metastatic melanoma (MM) studies .
|
- HY-P99196
-
|
c-Met/HGFR
|
Cancer
|
Ficlatuzumab is a monoclonal antibody (McAb) targeting human hepatocyte growth factor (HGF). Ficlatuzumab blocks the activation of the HGF/c-Met signaling pathway, and inhibits c-Met receptor-mediated cancer cell proliferation, migration, and invasion .
|
- HY-P99365
-
ALXN1210
|
Complement System
|
Metabolic Disease
|
Ravulizumab (ALXN1210) is a humanized monoclonal antibody that specifically binds with high affinity to the human complement protein C5. Ravulizumab can be used for the research of paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis .
|
- HY-P99452
-
SNDX-6352
|
c-Fms
|
Inflammation/Immunology
Cancer
|
Axatilimab (SNDX-6352) is a humanized IgG4 antibody with high affinity to CSF-1R. Axatilimab can be used for the research of chronic graft versus host disease (cGVHD) and neoplastic diseases .
|
- HY-P99560
-
C4G1; YM-337
|
Integrin
|
Cardiovascular Disease
|
Tadocizumab (C4G1; YM-337) is a humanized monoclonal antibody tageting integrin αIIbβ3. Tadocizumab has antiplatelet and antithrombotic effects, and can be used for cardiovascular disease research .
|
- HY-P99485
-
AMG 139; MEDI2070
|
Interleukin Related
|
Inflammation/Immunology
|
Brazikumab (AMG 139) is a human IgG2 monoclonal antibody, selectively binds the p19 subunit of IL-23, with a KD of 0.138 nM for human IL-23. Brazikumab can be used for the research of Crohn's disease .
|
- HY-P99795
-
GSK 3196165; MOR103
|
c-Fms
|
Inflammation/Immunology
|
Otilimab (GSK 3196165) is an anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) human monoclonal antibody. Otilimab neutralises the biological function of GM-CSF by blocking the interaction of GM-CSF with its cell surface receptor .
|
- HY-P99764
-
REGN-3471
|
Influenza Virus
|
Infection
|
Odesivimab is a human monoclonal antibody, targeting Ebola virus glycoprotein with a KD value of 7.74 nM for recombinant histidine-tagged Makona strain Ebola virus glycoprotein ectodomain protein. Odesivimab can be used in research of Ebola virus infection .
|
- HY-P99880
-
LFB-R593
|
Inhibitory Antibodies
|
Others
|
Roledumab (LFB-R593) is a human IgG1-κ antibody targeting RHD/CD240D. Roledumab is expressed by YB2/0 rat hybridoma cells .
|
- HY-P990095
-
|
CD3
TNF Receptor
|
Cancer
|
Vonsetamig is a humanised immunoglobulin G4-kappa, anti-TNFRSF17 and CD3E monoclonal antibody. Vonsetamig is an antineoplastic .
|
- HY-P99931
-
GEN3013
|
CD3
CD20
|
Cancer
|
Epcoritamab (GEN3013) is an bispecific IgG1 antibody redirecting T-cells toward CD3×CD20 + tumor cells. Epcoritamab induces potent T-cell-mediated cytotoxicity towards B-cell NHL cell lines .
|
- HY-P99796
-
ATN-103
|
TNF Receptor
|
Inflammation/Immunology
|
Ozoralizumab (ATN-103) is an anti-TNFα humanized antibody. Ozoralizumab is a humanized trivalent nanobody compound that consists of two anti-human TNFα nanobodies and an anti-human serum albumin (HSA) nanobody. Ozoralizumab can be used in research of arthritis .
|
- HY-P9950
-
Olizumab; rhuMab-E25
|
Inhibitory Antibodies
|
Inflammation/Immunology
Cancer
|
Omalizumab is a recombinant, humanized, monoclonal antibody against human immunoglobulin E (IgE) with a KD of 0.393 nM. Omalizumab binds to the human FcγRIIb receptors with a KD of 6.37 uM. Omalizumab has the potential for persistent allergic asthma research .
|
- HY-P99183
-
EMD 525797; DI17E6
|
Integrin
|
Cancer
|
Abituzumab (DI17E6) is a humanised anti-integrin αV monoclonal antibody (IgG2 type). Abituzumab effectively reduces the phosphorylation of FAK, Akt and ERK. Abituzumab can be used in cancer research, particularly in prostate cancer .
|
- HY-P99222
-
MGA-031; PRV-031
|
CD3
|
Metabolic Disease
|
Teplizumab (MGA-031) is a Fc receptor non-binding anti-human CD3 monoclonal antibody. Teplizumab reduces the loss of beta-cell function. Teplizumab can be used in the research of type 1 diabetes .
|
- HY-P99648
-
BMS-986168; IPN007; BIIB092
|
Tau Protein
|
Neurological Disease
|
Gosuranemab (BMS-986168) is a humanised IgG4 anti-tau monoclonal antibody. Gosuranemab binds to human N-terminal tau residues 15-22. Gosuranemab has the potential for the research of alzheimer’s disease (AD) .
|
- HY-P99830
-
KH902
|
VEGFR
|
Others
|
Conbercept (KH902) is a monoclonal antibody targeting VEGFRA fused to the IGHG1 Fc fragment. Conbercept is produced by the fusion of the second C-LIKE of FLT1 and the third and fourth C-LIKE of KDR with IGHG1 Fc. Conbercept .
|
- HY-P990008
-
|
TNF Receptor
Apoptosis
|
Inflammation/Immunology
|
Atrosab is a humanized IgG1 antagonistic anti-TNFR1 antibody. Atrosab inhibits TNF-mediated apoptosis induction and IL-6 and IL-8 production. Atrosab can be used for research of inflammatory disease .
|
- HY-P990072
-
|
PD-1/PD-L1
|
Cancer
|
Lipustobart is an IgG4-kappa, anti-PDCD1 (programmed cell death 1, PD1, PD-1, CD279) humanized monoclonal antibody. Lipustobart shows immunostimulant and antineoplastic activity .
|
- HY-P99007
-
BAY 1179470
|
FGFR
|
Cancer
|
Aprutumab (BAY 1179470) is a fully human FGFR2 monoclonal antibody, which binds to the FGFR2 isoforms FGFR2-IIIb and FGFR2-IIIc. Aprutumab has the potential for solid tumors research .
|
- HY-P99010
-
|
FGFR
|
Cancer
|
Bemarituzumab is a first-in-class, humanized IgG1 monoclonal antibody against FGFR2b (a FGF receptor). Bemarituzumab blocks fibroblast growth factors from binding and activating FGFR2b. Bemarituzumab has the potential for cancer research .
|
- HY-P99030
-
|
EGFR
|
Cancer
|
Margetuximab (MGAH22) is a chimeric anti-HER2 monoclonal antibody optimized Fc domain, with an EC50 value of 39.33 ng/mL. Margetuximab can be used for researching metastatic HER2-positive breast cancer .
|
- HY-P9911A
-
|
Integrin
|
Inflammation/Immunology
|
Vedolizumab (anti-α4β7-integrin) is a humanized IgG1 monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease .
|
- HY-P9934
-
C7E3
|
Integrin
|
Cardiovascular Disease
|
Abciximab (C7E3), a chimeric mouse/human monoclonal antibody, is a glycoprotein (GP) IIb/IIIa inhibitor. Abciximab inhibits platelet aggregation and leucocyte adhesion by binding to the glycoprotein IIb/IIIa, vitronectin and Mac-1 receptors .
|
- HY-P99219
-
MEDI-545; MDX 1103
|
IFNAR
|
Inflammation/Immunology
|
Sifalimumab (MEDI-545) is an anti-IFNα monoclonal antibody. Sifalimumab suppresses the abnormal immune activity by binding to multiple interferon-alpha (IFNα) subtypes. Sifalimumab can be used in systemic lupus erythematosus (SLE) research .
|
- HY-P99354
-
Anti-Human CTLA4xLAG3
|
LAG-3
|
Inflammation/Immunology
Cancer
|
Bavunalimab (Anti-Human CTLA4xLAG3) is a bispecific human anti-CTLA-4/LAG-3 monoclonal antibody. Bavunalimab activates T cells in NSG mice. Bavunalimab can be used for the research of cancer .
|
- HY-P99516
-
HLX-06
|
VEGFR
|
Cancer
|
Vulinacimab (HLX-06) is an anti-VEGFR-2 monoclonal antibody (mAb). Vulinacimab can be used in the research of cancers. VEGFR-2, overexpressed in certain tumors, is critical in angiogenesis and the proliferation, survival, migration and differentiation of endothelial cells .
|
- HY-P99439
-
IMA-638
|
Interleukin Related
|
Inflammation/Immunology
|
Anrukinzumab (IMA-638) is a humanized anti-IL-13 monoclonal antibody. Anrukinzumab effectively reduces lung inflammation in a cynomolgus monkey model. Anrukinzumab can be used in studies of ulcerative colitis (UC) as well as asthma .
|
- HY-P99945
-
- HY-P99842
-
CDP 7657
|
Inhibitory Antibodies
|
Cancer
|
Dapirolizumab pegol (CDP 7657) is a Fab'-IgG-κ class monoclonal antibody targeting CD40LG/TNFSF5 conjugated to a pegol moiety. Dapirolizumab pegol was originally cloned from the Norway rat (Rattus norvegicus).
|
- HY-P990067
-
ATOR-1017
|
TNF Receptor
|
Cancer
|
Evunzekibart (ATOR-1017) is an Fc-γ receptor conditional 4-1BB agonist and IgG4-type antibody. Evunzekibart can be used as monotherapy or in combination with anti-PD1 to exert anticancer activity.
|
- HY-P990014
-
IMC-001; STI-3031
|
PD-1/PD-L1
|
Inflammation/Immunology
Cancer
|
Danburstotug (IMC-001) is an IgG1-lambda anti-CD274 (PDL1, B7 homologue 1, B7H1) human monoclonal antibody. Danburstotug also is immunostimulant and antineoplastic .
|
- HY-P99661
-
|
Interleukin Related
|
Cancer
|
Inbakicept is a dimeric human IL-15 receptor alpha (IL-15 Ra) sushi domain/human IgG1 Fc fusion protein and is an IL-15 superagonist complex. Inbakicept is able to form complex N-803 (Nogapendekin alfa inbakicept) with the IL-15 antibody Nogapendekin alfa in a 1:2 ratio. N-803 mimics the function of IL-15 and amplifies anti-CD20 mAb-mediated NK cell responses and antibody-dependent cellular cytotoxicity (ADCC). N-803 also increases degranulation and IFNγ production in cells .
|
- HY-P9953
-
Certolizumab; CDP870
|
TNF Receptor
|
Inflammation/Immunology
|
Certolizumab pegol (Certolizumab) is a recombinant, polyethylene glycolylated, antigen-binding fragment of a humanized monoclonal antibody that selectively targets and neutralizes tumour necrosis factor-α (TNF-α). Certolizumab pegol can be used for rheumatoid arthritis and Crohn disease research .
|
- HY-P99159
-
|
Inhibitory Antibodies
|
Cancer
|
Ivuxolimab is an OX40 (also known as CD134; TNFRSF4) agonist monoclonal antibody. OX40 is a costimulatory receptor expressed on activated CD4 + and CD8 + T cells. Ivuxolimab shows antitumor activity, with potential immunostimulatory activity .
|
- HY-P99226
-
MEDI7734; VIB7734
|
SARS-CoV
|
Cancer
|
Daxdilimab is an anti-ILT7 monoclonal antibody, ILT7 is a cell surface molecule specific to the pDC type of dendritic cells. Daxdilimab can be used in acute lung injury (ALI) in patients with COVID-19 infection research .
|
- HY-P99216
-
PF-04360365; RN 1219
|
EGFR
|
Neurological Disease
|
Ponezumab (PF-04360365) is a humanised anti-amyloid IgG2 monoclonal antibody. Ponezumab reduces Aβ levels in the central nervous system and improves performance in mice in various models of learning and memory. Ponezumab can be used in study of Alzheimer's disease .
|
- HY-P99197
-
CP-751871
|
IGF-1R
|
Cancer
|
Figitumumab (CP-751871) is a potent and fully human monoclonal anti–insulin-like growth factor 1 receptor (IGF1R) antibody. Figitumumab prevents IGF1 from binding to IGF1R with an IC50 of 1.8 nM .
|
- HY-P99388
-
REGN-1033
|
Inhibitory Antibodies
|
Metabolic Disease
|
Trevogrumab (REGN-1033) is a monoclonal antibody targeting GDF8 (growth differentiation factor 8, also known as muscle growth inhibitor). Trevogrumab is used in studies of sarcopenia, including wasting atrophy, chronic diseases, and changes in food and nutritional intake .
|
- HY-P99346
-
CT-P59
|
SARS-CoV
Angiotensin-converting Enzyme (ACE)
|
Infection
|
Regdanvimab (CT-P59) is a human monoclonal antibody that targets the receptor-binding domain of SARS-CoV-2 spike protein, blocking interaction with ACE2 for viral entry. Regdanvimab can be used for the research of COVID-19 .
|
- HY-P99434
-
KY1005; SAR445229
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Alvircept sudotox is an anti-OX40 Ligand (OX40L) monoclonal antibody (mAb). Alvircept sudotox inhibits OX40-OX40L interaction, and can be used in the research of atopic dermatitis .
|
- HY-P990046
-
Incagn-02385
|
LAG-3
|
Inflammation/Immunology
|
Tuparstobart (Incagn-02385) is an IgG1κ antibody targeting LAG-3. LAG-3 is an immune checkpoint receptor protein mainly expressed on activated T cells, NK cells, B cells and plasmacytoid dendritic cells .
|
- HY-P990070
-
BION-1301
|
TNF Receptor
|
Inflammation/Immunology
|
Zigakibart (BION-1301) is an IgG4-kappa, anti-TNFSF13 (tumor necrosis factor (TNF) superfamily member 13, APRIL, CD256) humanized monoclonal antibody. Zigakibart shows anti-inflammatory activity .
|
- HY-P99392
-
|
CD3
|
Cancer
|
Teclistamab is a human bispecific antibody to BCMA and CD3 that recognizes BCMA on target cells and CD3 on T cells and induces T cell-mediated cytotoxicity leading to T cell activation and subsequent target cell lysis. Teclistamab can be used in studies of diseases related to multiple myeloma (MM) .
|
- HY-P99659
-
ANB 019
|
Interleukin Related
|
Inflammation/Immunology
|
Imsidolimab (ANB 019) is a high-affinity, humanized monoclonal antibody of anti-IL-36R. Imsidolimab antagonizes IL-36 cytokine signal transduction. Imsidolimab has potential application in generalized pustular psoriasis (GPP) and other inflammatory skin diseases .
|
- HY-P990096
-
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Human IgG1-Lambda2, Isotype Control is a human monoclonal antibody that is the isotype control of human IgG1κ antibody. Isotype control antibodies can help remove non-specific signals from experimental results and assess the accuracy and reliability of the experiment .
|
- HY-P9927
-
AIN457
|
Interleukin Related
|
Inflammation/Immunology
Cancer
|
Secukinumab (AIN457) is a high affinity, human monoclonal antibody targeted against interleukin (IL)-17A. Secukinumab is the first-in-class anti-IL-17 agent used for the research of plaque psoriasis, ankylosing spondylitis and psoriatic arthritis .
|
- HY-P99217
-
AMG 102
|
c-Met/HGFR
|
Cancer
|
Rilotumumab (AMG 102) is an anti-HGF (anti-hepatocyte growth factor) monoclonal antibody, inhibits HGF/MET-driven signaling. Rilotumumab shows anti-tumor activity, and can be used in castration-resistant prostate cancer (CRPC) and solid tumor research .
|
- HY-P99476
-
|
VEGFR
|
Cancer
|
ABP 215 (Bevacizumab-awwb), a Bevacizumab (Bevacizumab (HY-P9906)) biosimilar, is a humanized IgG1 monoclonal antibody targeting VEGFA (VEGFR). ABP 215 has anticancer effects, and can be used metastatic colorectal cancer (mCRC) research .
|
- HY-P99654
-
INT-001
|
Inhibitory Antibodies
|
Cancer
|
Idactamab (INT-001) is an IgG1-κ antibody with in vivo activity across a spectrum of hematological malignancies. Idactamab can be used for prepare MEDI7247, a potent and specific ADC, targeting ASCT2 (SLC1A5) .
|
- HY-P99701
-
BMS-986004
|
TNF Receptor
|
Inflammation/Immunology
|
Letolizumab (BMS-986004) is a monoclonal antibody targeting CD40L, which is produced to express mutant IgG1 lacking effector function, including Fc binding and complement fixation. Letolizumab reduces rejection, thromboembolism and prolongs the survival time .
|
- HY-P99768
-
TTAC-0001
|
VEGFR
|
Cancer
|
Olinvacimab (TTAC-0001) is a fully human anti-VEGFR2 monoclonal antibody. Olinvacimab inhibits VEGF binds to KDR with a Kd value of 0.23 nM. Olinvacimab has antiangiogenic activity. Olinvacimab can be used for the research of recurrent glioblastoma and breast cancer .
|
- HY-P99770
-
514-G3
|
Bacterial
|
Infection
|
Omodenbamab is an anti-SpA (Staphylococcal protein A) human monoclonal antibody with a KD value of 0.0467 nM. Omodenbamab circumvents a key S. aureus evasion mechanism by targeting the cell wall moiety Protein A (SpA). Omodenbamab can be used in research of S. aureus bloodstream infection .
|
- HY-P990007
-
PRA023; PRA-023
|
TNF Receptor
|
Inflammation/Immunology
|
Tulisokibart (PRA023) is a humanized IgG1-κ monoclonal antibody targeting to TNFSF15/TL1A. Tulisokibart can be used to study a variety of inflammatory/fibrotic diseases, such as Crohn's Disease (CD) .
|
- HY-P99872
-
CSJ-117; NVP-CSJ117
|
Inhibitory Antibodies
|
Others
|
Ecleralimab (CSJ-117; NVP-CSJ117) is a Fab-IgG1-λ2 antibody targeting the thymic stromal lymphopoietin TSLP. The expression system of Ecleralimab is usually CHO (Chinese Hamster Ovary) cells .
|
- HY-P990037
-
|
CD38
|
Cancer
|
Erzotabart is an IgG1-kappa, anti-CD38 (ADP-ribosyl cyclase 1, cyclic ADP-ribose hydrolase 1, cADPr hydrolase 1, cADPR1) Homo sapiens monoclonal antibody. Erzotabart shows antineoplastic activity .
|
- HY-P99058
-
IMAB362
|
Inhibitory Antibodies
|
Cancer
|
Zolbetuximab (IMAB362) is a monoclonal antibody targeting Claudin-18.2. Zolbetuximab mediates specific killing of Claudin-18.2-positive cells through immune effector mechanisms. Zolbetuximab can be used for the research of gastrointestinal adenocarcinomas and pancreatic tumors .
|
- HY-P99192
-
LY2875358
|
c-Met/HGFR
|
Cancer
|
Emibetuzumab (LY2875358) is a humanized bivalent MET antibody (IgG4 type). Emibetuzumab shows high neutralization and internalization activities, resulting in inhibition of both HGF-dependent and HGF-independent MET pathway activation and tumor growth. Emibetuzumab can be used in study of cancer .
|
- HY-P99523
-
AMG 199
|
CD3
|
Cancer
|
Vepsitamab (AMG 199) is an anti-MUC17/CD3 BiTE antibody that binds to CD3 on T cells and MUC17 expressed on tumor cells, mediates redirected tumor cell lysis, and induces T cell activation and proliferation .
|
- HY-P99559
-
GEN-1029; HexaBody-DR5/DR5; Hx-DR5-01/05
|
Inhibitory Antibodies
|
Cancer
|
Tilogotamab (GEN-1029) is an agonistic hexamer formation-enhanced mixture of two antibodies that target two separate epitopes on death receptor type 5 (DR5). Tilogotamab specifically binds to and activates DR5. Tilogotamab can be used for the research of multiple myeloma (MM) .
|
- HY-P99886
-
h5G1. 1-SC
|
Complement System
Apoptosis
|
Cardiovascular Disease
Neurological Disease
|
Pexelizumab (h5G1. 1-SC) is a humanized scFv monoclonal antibody directed against the C5 complement component. Pexelizumab inhibits apoptosis and leukocyte infiltration. Pexelizumab can be used for the research of cerebral IR injury and myocardial infarction .
|
- HY-P99790
-
CEN 000029; cM-T412
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Priliximab (CEN 000029) is an anti-CD4 humanized monoclonal antibody. Priliximab binds to CD4 on the surface of T cells, resulting in a significant and sustained reduction in circulating CD4 + T cells. Priliximab can be used in research of rheumatoid arthritis (RA) .
|
- HY-P99827
-
TSR-022; GSK4069889
|
Tim3
|
Cancer
|
Cobolimab (TSR-022) is an anti-TIM-3 monoclonal antibody. Cobolimab mediates the internalization of TIM3 with an IC50 value of 0.4464 nM. Cobolimab has potential application in solid tumors and non-small cell lung cancer (NSCLC) .
|
- HY-P990078
-
LY3372993
|
Amyloid-β
|
Neurological Disease
|
Remternetug is a human immunoglobulin G1-kappa, anti-APP (amyloid beta A4 precursor protein) Aβ42 N3pGlu peptide monoclonal antibody. Remternetug recognizes a pyroglutamated form of Aβ that aggregates into amyloid plaques .
|
- HY-P99231
-
Panorex; CO17-1A
|
Inhibitory Antibodies
|
Cancer
|
Edrecolomab (Panorex) is a murine monoclonal antibody to the cell-surface glycoprotein 17-1A, expressed on epithelial tissues and on various carcinomas. Edrecolomab shows anti-tumor activity and can be used in colorectal carcinoma research .
|
- HY-P99714
-
MGD019
|
PD-1/PD-L1
CTLA-4
|
Cancer
|
Lorigerlimab (MGD019) is a bispecific IgG4 dual-affinity re-targeting antibody (DART). Lorigerlimab can block PD-1 and CTLA-4, and improves T-cell responses. Lorigerlimab can be used for research of metastatic castration-resistant prostate cancer (mCRPC) .
|
- HY-P99757
-
Hu3F8-BsAb
|
CD2
CD3
|
Cancer
|
Nivatrotamab (Hu3F8-BsAb) is a humanized anti-GD2/CD3 bispecific antibody. Nivatrotamab is a CD3- and GD2-specific bsAb-based T-cell engager. Nivatrotamab can be used in research of neuroblastoma .
|
- HY-P9970
-
- HY-P99019
-
TEV-48125
|
CGRP Receptor
|
Neurological Disease
|
Fremanezumab (TEV-48125) is a humanized IgG2a monoclonal antibody that selectively and potently binds to calcitonin gene-related peptide (CGRP). CGRP is a 37-amino acid neuropeptide involved in central and peripheral pathophysiological events of migraine. Fremanezumab has the potential for chronic migraine research .
|
- HY-P99114
-
|
PD-1/PD-L1
|
Cancer
|
Sugemalimab is a fully human, full length, anti-programmed death ligand 1 (PD-L1) immunoglobulin G4 (IgG4) monoclonal antibody (mAb). Sugemalimab shows anticancer activities and can be used for non-small cell lung cancer research .
|
- HY-P99327
-
BT-061
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Tregalizumab is a humanized anti-human CD4 monoclonal antibody (IgG1 type) that selectively activates the suppressive properties of regulatory T cells (Tregs) in vitro. Tregalizumab can be used in the research of autoimmune diseases (resulting from insufficient Treg activity) and allergies .
|
- HY-P99519
-
KPL-716
|
Interleukin Related
|
Inflammation/Immunology
|
Vixarelimab (KPL-716) is a human anti-oncostatin M (OSM) monoclonal antibody that binds to the beta chain of the OSM receptor and inhibits IL-31 and OSM signalling. Vixarelimab can be used in studies of inflammatory skin diseases such as atopic dermatitis and itchy nodular rash .
|
- HY-P99450
-
IPH 5401; Anti-C5aR1 mAb
|
Complement System
|
Inflammation/Immunology
Cancer
|
Avdoralimab (IPH 5401) is a fully human IgGκ monoclonal antibody that targets the complement C5a receptor 1 (C5aR1) that prevents its binding to C5a. Avdoralimab can be used for complement-driven inflammatory diseases and solid tumours research .
|
- HY-P99711
-
RB4v1.2
|
CD19
|
Cancer
|
Loncastuximab (RB4v1.2) is an anti-CD19 monoclonal antibody. Loncastuximab shows antitumor activity and has potential application in non-Hodgkin's lymphoma (NHL), including diffuse large B-cell lymphoma (DLBCL) .
|
- HY-P99794
-
BAY 1213790
|
Factor Xa
|
Cardiovascular Disease
|
Osocimab (BAY 1213790), an anti-FXIa antibody (Ki=2.4 nM; EC50=0.2 nM). FXI inhibition may reduce the risk of thrombosis. Osocimab inhibits thrombin generation, and prolongs activated partial thromboplastin time. Osocimab exhibits anticoagulant effects .
|
- HY-P99466
-
SAND-26
|
Dipeptidyl Peptidase
|
Inflammation/Immunology
|
Begelomab (SAND-26) is a murine IgG2b monoclonal antibody against DPP-4/CD26. Begelomab can be used for the research of severe refractory idiopathic inflammatory myopathy .
|
- HY-P99636
-
ABX-CBL
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Gavilimomab (ABX-CBL) is an IgM murine monoclonal antibody that recognizes CD147 on the cell surface and initiates cell killing through complement-mediated lysis. Gavilimomab can be used for the research of graft-versus-host disease (GVHD) .
|
- HY-P99220
-
LY2127399
|
TNF Receptor
|
Inflammation/Immunology
|
Tabalumab (LY2127399) is a human anti-BAFF (B-cell activating factor) monoclonal antibody (IgG4 type) with neutralising activity against membrane bound and soluble BAFF. Tabalumab can be used in studies of autoimmune diseases such as rheumatoid arthritis, renal failure and systemic lupus erythematosus .
|
- HY-P99215
-
Anti-EGFL7; RG 7414
|
VEGFR
|
Cancer
|
Parsatuzumab (Anti-EGFL7; RG 7414) is a humanized monoclonal antibody, acts as an immunomodulator and binds to EGFL7. Parsatuzumab selectively blocks the interaction between EGFL7 and endothelial cells, potentially inhibiting vascular regrowth and reducing vascular endothelial growth factor (VEGF) inhibition .
|
- HY-P99368
-
MCS110; Anti-Human B7-H3
|
c-Fms
|
Metabolic Disease
Cancer
|
Lacnotuzumab (MCS110) is a neutralizing humanized IgG1/κ monoclonal antibody targeting CSF-1 that prevents CSF-1 from activating the CSF-1R. Lacnotuzumab can be used for the research of pigmented villonodular synovitis .
|
- HY-P99490
-
hzVSF-v13
|
Interleukin Related
SARS-CoV
|
Infection
Inflammation/Immunology
|
Burfiralimab (hzVSF-v13) is a monoclonal IgG4 antibody against vimentin expressed on the surface of virus-infected cells, with broad-spectrum antiviral activity and anti-inflammatory effects against virus-induced inflammation. Burfiralimab can be used in severe COVID-19 studies .
|
- HY-P99633
-
BGB-A333
|
PD-1/PD-L1
Apoptosis
|
Cancer
|
Garivulimab (BGB-A333) is a humanized IgG1-variant monoclonal antibody that specifically targets and binds to PD-L1. Garivulimab selectively blocks the interaction of PD-L1 and PD-1. Garivulimab has antitumor activity .
|
- HY-P99756
-
MEDI8897
|
RSV
|
Infection
|
Nirsevimab (MEDI8897) is a recombinant human respiratory syncytial virus (RSV) monoclonal antibody with modified Fc region, which can prolong its half-life. Nirsevimab has an affinity for RSV-B with an Kd value of 1.5 nM. Nirsevimab can be used for RSV research .
|
- HY-P99763
-
BGB-A1217
|
Inhibitory Antibodies
|
Cancer
|
Ociperlimab is a humanized IgG1 anti-TIGIT antibody. Ociperlimab binds to the extracellular domain of human TIGIT with high affinity (KD = 0.135 nM). Ociperlimab blocks the interaction between TIGIT and its ligands PVR or PVR-L2. Ociperlimab can be used in research of cancer .
|
- HY-P99776
-
XmAb-13676
|
CD20
CD3
|
Cancer
|
Plamotamab (XmAb-13676) is a human bispecific antibody (bsAb) that binds CD3 and CD20. Plamotamab recruits cytotoxic T cells to kill CD20 + expressing tumor cells. Plamotamab induces a mild hematologic reaction (MR), and results in tumor regression in vivo .
|
- HY-P9987
-
|
P-selectin
|
Cardiovascular Disease
|
Crizanlizumab is an anti-P-selectin monoclonal antibody. Crizanlizumab binds to P-selectin and blocks its interaction with P-selectin glycoprotein ligand 1 (PSGL-1). Crizanlizumab prevents vaso-occlusive crises (VOCs) and can be used for research of sickle cell disease .
|
- HY-P990086
-
|
Interleukin Related
|
Cancer
|
Vopikitug is an IgG1-kappa, anti-IL2RA (interleukin 2 receptor alpha subunit, IL-2RA, TAC, p55, CD25) homo sapiens monoclonal antibody. Vopikitug shows antineoplastic activity .
|
- HY-P99396
-
BI 655130
|
Interleukin Related
|
Inflammation/Immunology
|
Spesolimab (BI 655130) is an anti-IL-36R antibody. IL-36 involves in immune system, as Spesolimab can be used for palmoplantar pustulosis (PPP) research. Spesolimab is associated with the reduction of biomarkers linked to innate, Th1/Th17, and neutrophilic pathways .
|
- HY-P99488
-
JSP-191
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Briquilimab (JSP-191) is a non-toxic humanized monoclonal antibody targeting CD117 (c-Kit) to deplete hematopoietic stem cell (HSC). Briquilimab has safety to clear host marrow niche space to enable sufficient donor HSC engraftment and immune reconstitution as primary method of severe combined immunodeficiency (SCID) .
|
- HY-P99650
-
WT1
|
Inhibitory Antibodies
|
Cancer
|
Grisnilimab (WT1), a IgG2a monoclonal antibody anti-CD7, is a tumor suppressor involved in the etiology of Wilms' tumor. Grisnilimab regulates the transcription of multiple target genes and may participate in the post-transcriptional processing of RNA .
|
- HY-P99664
-
|
Interleukin Related
|
Inflammation/Immunology
|
Inolimomab is an anti-interleukin-2 receptor (IL-2R) α chain monoclonal antibody. Inolimomab improves the survival rate in the early research of treating acute graft-versus-host disease (aGVHD) .
|
- HY-P99562
-
XmAb-18087
|
CD3
|
Cancer
|
Tidutamab (XmAb-18087) is a humanized and affinity-optimized bispecific antibody (bsAb) targeting SSTR2 binding domain and T-cell binding domain (CD3). Tidutamab possesses a full Fc domain to maintain long serum half-life.Tidutamab eliminates SSTR+ tumor cells by stimulating redirected T cellmediated cytotoxicity (RTcC) .
|
- HY-P9919
-
MEDI 4736
|
PD-1/PD-L1
|
Cancer
|
Durvalumab (MEDI 4736) is an human anti-PD-L1 monoclonal antibody . Durvalumab (MEDI4736) completely blocks the binding of PD-L1 to both PD-1 and CD80, with IC50s of 0.1 and 0.04 nM, respectively .
|
- HY-P99218
-
Sch 717454; 19D12
|
IGF-1R
|
Cancer
|
Robatumumab (Sch 717454) is an anti-human IGF-1R (insulin-like growth factor receptor-1) antibody. Robatumumab shows anti-tumor activity and anti-proliferative activity to cancer cells. Robatumumab can be used in osteosarcoma and Ewing sarcoma research .
|
- HY-P99544
-
HBM-9167; KL-A167
|
PD-1/PD-L1
|
Cancer
|
Tagitanlimab (HBM-9167) is a humanized anti-PD-L1 antibody (IgG1κ type). Tagitanlimab selectively blocks the interaction of PD-L1 and PD-1. Tagitanlimab has the potential to be studied in recurrent or metastatic nasopharyngeal carcinoma (NPC) .
|
- HY-P99541
-
anti-hepatitis B; OST 577; SDZ-OST 577
|
HBV
|
Infection
|
Tuvirumab (OST 577; SDZ-OST 577) is a human IgG1 subclass monoclonal antibody directed against HBV surface antigen (HBsAg). Tuvirumab binds specifically and with high affinity (K=3.6 nM) to HBsAg. Tuvirumab has the potential for chronic hepatitis B research .
|
- HY-P99672
-
MM 141; MM-005
|
IGF-1R
EGFR
|
Cancer
|
Istiratumab (M-6495) is bispecific monoclonal antibody targeting IGF-1R and ErbB3. Istiratumab induces IGF-1R and ErbB3 receptor degradation through the proteasome pathway Istiratumab can be used for research of cancers .
|
- HY-P99669
-
MDX-060
|
TNF Receptor
|
Cancer
|
Iratumumab (MDX-060) a human anti-CD30 IgG1κ monoclonal antibody. Iratumumab inhibits the growth of CD30-expressing tumor cells. Iratumumab can be used for research of Hodgkin's lymphoma (HL) and anaplastic large-cell lymphoma (ALCL) .
|
- HY-P990022
-
DS-6016A
|
Inhibitory Antibodies
|
Metabolic Disease
|
Prafnosbart (DS-6016A) is an IgG1-kappa, anti-ACVR1 (activin A receptor type 1, ACVRLK2, ALK2, ACVR1A, SKR1) humanized monoclonal antibody. Prafnosbart can be used for bone metabolism disorders research .
|
- HY-P9942
-
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Sulesomab (IMMU-MN3) is a murine monoclonal antibody fragment of the IgG1 class that binds to Normal Cross-Reactive Antigen-90 present on leukocytes. Sulesomab is cleared into infection nonspecifically through increased capillary membrane permeability .
|
- HY-P990060
-
Mim8
|
Factor Xa
|
Cardiovascular Disease
|
Denecimig (Mim8) is a novel activated coagulation factor VIII-mimetic human bispecific antibody with anti-FIXa and anti-FX arms that potently stimulates FX activation resulting in efficacious haemostasis in vitro and in vivo .
|
- HY-P99822
-
SHR-1209
|
Ser/Thr Protease
|
Metabolic Disease
|
Recaticimab (SHR-1209) is a humanized monoclonal antibody that inhibits PCSK9. Receticimab mediates the degradation of PCSK9 by binding to PCSK9, increasing the level of low-density lipoprotein (LDL) receptors on the surface of hepatocytes, reducing the level of LDL in plasma, and achieving the goal of lowering blood lipids. Recaticimab has potential application in hypercholesterolemia .
|
- HY-P99299
-
HGS-ETR 2; ETR2-ST01
|
Apoptosis
|
Cancer
|
Lexatumumab (HGS-ETR 2) is a human agonistic TRAIL receptor 2 (TRAIL-R2, DR5, APO-2) IgG4κ type monoclonal antibody. Lexatumumab induces apoptosis in malignant mesothelioma. Lexatumumab can be used for malignant pleural mesothelioma (MPM) research .
|
- HY-P99486
-
ABT-874
|
Interleukin Related
|
Inflammation/Immunology
|
Briakinumab (ABT-874) is a fully human anti-IL-12/23p40 monoclonal antibody. Briakinumab targets and neutralizes IL-12 and IL-23. Briakinumab can be used for the research of rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis .
|
- HY-P99680
-
SB-210396; IDEC CE9.1
|
Interleukin Related
|
Cancer
|
Keliximab (SB-210396) is a chimeric human/macaque IgG1 anti-CD4 monoclonal antibody with a Ki value of 1.0 nM for soluble CD4. Keliximab blocks T cell proliferation and inhibits IL-2 production. Keliximab can be used for cancer research .
|
- HY-P99697
-
PRO 140
|
CCR
HIV
|
Infection
Cancer
|
Leronlimab (PRO 140) is a humanized IgG4 anti-CCR5 monoclonal antibody. Leronlimab inhibits CCR5-mediated HIV-1 viral and lung metastasis in mouse tumor models. Leronlimab can be used for the research of HIV nonalcoholic steatohepatitis (NASH) and cancer .
|
- HY-P99793
-
MLDL1278A
|
LDLR
|
Inflammation/Immunology
|
Orticumab (MLDL1278A) is an antibody targeting to oxidized or malondialdehyde-modified lipoprotein (LDL). Orticumab specifically inhibits oxidized low-density lipoproteins (oxLDL). Orticumab involves in modulation of autoimmune responses against oxLDL, improves atherosclerosis in animal model. Orticumab also can be used for research of psoriasis improvement .
|
- HY-P99836
-
IBI101
|
Orexin Receptor (OX Receptor)
|
Inflammation/Immunology
Cancer
|
Cudarolimab (IBI101) is a completely human anti-OX40 (CD134, a co stimulating molecule expressed by activated immune cells) antibody. Cudarolimab inhibits the binding of OX40 to its ligand OX40L. Cudarolimab has antitumor activity and can be used in cancer related research .
|
- HY-P99844
-
ALPN-202; CD80 vIgD-Fc
|
CTLA-4
|
Others
|
Davoceticept (ALPN-202; CD80 vIgD-Fc) is a monoclonal antibody targeting CTLA-4. Davoceticept consists of the (1-107) fragment of CD80 linked to IGHG1 Fc via a peptidyl linker. The expression system of Davoceticept is usually CHO (Chinese Hamster Ovary) cells .
|
- HY-P9920
-
|
VEGFR
|
Cancer
|
Ramucirumab is a human VEGFR-2 antagonist for the treatment of solid tumors. Ramucirumab is a recombinant human immunoglobulin G1 monoclonal antibody that binds to the extracellular binding domain of VEGFR-2 and prevents the binding of VEGFR ligands: VEGF-A, VEGF-C, and VEGF-D. Ramucirumab is also an angiogenesis inhibitor .
|
- HY-P99412
-
OSE-127
|
Interleukin Related
|
Cancer
|
Lusvertikimab (OSE-127) is a humanized IL7R monoclonal antibody. Lusvertikimab is not internalized by target cells and prevents IL7R heterodimerization and subsequent downstream signaling. Lusvertikimab has anti-leukemic efficacy and has the potential for B cell precursor acute lymphoblastic leukemia (BCP-ALL) research .
|
- HY-P99913
-
|
c-Fms
|
Inflammation/Immunology
|
Eflapegrastim is a human IgG4 monoclonal antibody, is also a granulocyte colony-stimulating factor (G-CSF). Eflapegrastim targets to G-CSF receptor (c-Fms). Eflapegrastim stimulates proliferation and differentiation of neutrophil progenitor cells and maintains stable numbers of mature and functional neutrophils. Eflapegrastim also shortens the duration of neutropenia .
|
- HY-P99673
-
REGN-3500; SAR-440340
|
Interleukin Related
NF-κB
|
Inflammation/Immunology
|
Itepekimab (REGN-3500) is an IgG4 monoclonal antibody against IL-33. Itepekimab reduced airway inflammation and related tissue damage in preliminary clinical studies. Itepekimab has potential effects in asthma, chronic obstructive pulmonary disease (COPD), and atopic dermatitis (AD) .
|
- HY-P99011
-
|
CD3
|
Cancer
|
Cibisatamab (CEA-TCB), a T cell bispecific antibody, binds Carcino-Embryonic Antigen (CEA) on cancer cells and CD3 on T cells. Cibisatamab (CEA-TCB) triggers T cell killing of cancer cell lines expressing moderate to high levels of CEA at the cell surface. Cibisatamab (CEA-TCB) can be used for colorectal cancer research .
|
- HY-P99765
-
anti-LFA1
|
Integrin
|
Inflammation/Immunology
|
Odulimomab (anti-LFA1) is an anti-LFA-1 monoclonal antibody. Odulimomab inhibits proliferation of T lymphocyte and shows protective effects against ischemia and reperfusion injury. Odulimomab can be used for the research of transplant rejection and immunological disease .
|
- HY-P99342
-
REGN10987
|
SARS-CoV
|
Infection
|
Imdevimab (REGN10987) is a human monoclonal antibody to target SARS-CoV-2 virus, which causes COVID-19. Imdevimab lacks efficacy against COVID-19 variants. Imdevimab can be used in combination with Casirivimab (HY-P99341), it reduces viral load and improves diseases .
|
- HY-P99341
-
REGN10933
|
SARS-CoV
|
Infection
|
Casirivimab (REGN10933) is a human monoclonal antibody to target SARS-CoV-2 virus, which causes COVID-19. Casirivimab lacks efficacy against COVID-19 variants. Casirivimab can be used in combination with Imdevimab (HY-P99342), it reduces viral load and improves diseases .
|
- HY-P99637
-
MHAA4549A; RG7745
|
Influenza Virus
|
Infection
|
Gedivumab (MHAA4549A; RG7745) is a human monoclonal antibody that targets influenza A virus (IAV) with high specificity and binds to the highly conserved stem region of the IAV haemagglutinin protein, thereby preventing haemagglutinin maturation and blocking haemagglutinin-mediated membrane fusion in the intranucleosome. Gedivumab can be used in IAV infection disease studies .
|
- HY-P99791
-
SYNT001
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Orilanolimab (SYNT001) is a humanized, de-immunized and FcRn-blocking monoclonal antibody. Orilanolimab blocks the interaction between FcRn and the Fc portion of IgG molecules. Orilanolimab impedes IgG IC activation of the FcRn-mediated adaptive immune function. And Orilanolimab disrupts the associated pathways related to IgG homeostasis and innate and adaptive immunity .
|
- HY-P99956
-
VLS-101; MK-2140
|
Antibody-Drug Conjugates (ADCs)
Apoptosis
|
Cancer
|
Zilovertamab vedotin (VLS-101) is a novel antibody-drug conjugate comprising the humanized monoclonal antibody zilovertamab and and the anti-microtubule cytotoxin monomethyl vedotin. Zilovertamab vedotin binding to tumor cell ROR1 results in rapid internalization, trafficking to lysosomes, antibody–agent conjugate cleavage, and monomethyl vedotin release. Zilovertamab vedotin induces apoptosis. Zilovertamab vedotin can be used in research of cancer .
|
- HY-P99407
-
VX 15/2503
|
Inhibitory Antibodies
|
Neurological Disease
|
Pepinemab (VX 15/2503) is a human monoclonal antibody against SEMA4D, a signalling protein 4D (SEMA4D), also known as CD100, which is a regulator of neuronal development and plays a role in a variety of cellular processes. Pepinemab can be used in the study of various neurodegenerative diseases such as Alzheimer's disease by blocking the activity of SEMA4D .
|
- HY-P99176
-
ATG-031
1 Publications Verification
|
Inhibitory Antibodies
|
Cancer
|
ATG-031 is a humanised anti-CD24 monoclonal antibody. ATG-031 effectively stimulates macrophage-mediated phagocytosis and induces cancer cell destruction by blocking the "don't eat me" signals that characterize the growth of many cancers. ATG-031 can be used in the study of haematological malignancies as well as solid tumours.
|
- HY-P99163
-
ABBV-8E12; C2N-8E12
|
Microtubule/Tubulin
|
Neurological Disease
|
Tilavonemab (ABBV-8E12) is a humanised anti-tau antibody that binds amino acids 25-30 near the N-terminal end of the tau protein. Tilavonemab blocks the ability of human and mouse neurons to take up tau aggregates and reduces brain atrophy. Tilavonemab can be used in the study of Alzheimer's disease .
|
- HY-P99344
-
Anti-Human SARS-CoV-2
|
SARS-CoV
|
Infection
|
Bamlanivimab (Anti-Human SARS-CoV-2) is the first COVID-19 monoclonal antibody (mAb) to be granted Emergency Use Authorization (EUA) in November 2020 by the U.S. Food and agent Administration (FDA). However, Bamlanivimab is withdrawn in April 2021 following the rise of SARS-CoV-2 virus variants resistant to Bamlanivimab .
|
- HY-P99345
-
TSR-042
|
PD-1/PD-L1
|
Cancer
|
Dostarlimab (TSR-042) is a humanized anti-PD-1 monoclonal antibody. Dostarlimab binds with high affinity to human PD-1 and competitively inhibits its interaction with its ligands, PD-L1 and PD-L2, with IC50s of 1.8 and 1.5 nM, respectively .
|
- HY-P99385
-
ALX-0061
|
Interleukin Related
|
Inflammation/Immunology
|
Vobarilizumab (ALX-0061) is an anti-IL-6R monoclonal antibody (mAb) (Kd: 0.19 pM). Vobarilizumab consists of an anti-IL-6R domain and an anti-human serum albumin domain. Vobarilizumab can be used in the research of inflammatory autoimmune diseases, such as rheumatoid arthritis .
|
- HY-P99487
-
BR 3FC
|
ADC Antibody
|
Inflammation/Immunology
|
Briobacept (BR 3FC) is a selective human monoclonal antibody targeting to BLyS (BAFF), induces B cells apoptosis. Briobacept is a recombinant glucoprotein, consists of 2 molecules from the BLyS receptor (BR3)and a Fc domain of human IgG1. Briobacept can be used in studies of rheumatoid arthritis (RA) .
|
- HY-P99594
-
ZKAB001; STI-1014; STI-A1014
|
PD-1/PD-L1
|
Cancer
|
Socazolimab (ZKAB001) is an anti-PD-L1 monoclonal antibody. Socazolimab has lasting safety and efficacy in the treatment of recurrent or metastatic cervical cancer. Socazolimab also has potential applications in small cell lung cancer, esophageal squamous cell carcinoma (ESCC), advanced urothelial carcinoma and osteosarcoma .
|
- HY-P99767
-
ALXN1007
|
Complement System
|
Infection
|
Olendalizumab (ALXN1007) is a mouse-derived and humanized IgG2-G4-κ antibody, targeting to Complement protein C5a (Ki=60 pM). Olendalizumab targets the complement inflammatory pathway. Moreover, Olendalizumab can be used for research of complement mediated disorder caused by corona virus .
|
- HY-P990006
-
|
TNF Receptor
|
Inflammation/Immunology
|
Duvakitug is a humanized IgG1-λ2 monoclonal antibody targeting to TNFSF15/TL1A. Duvakitug' main expression system is CHOK1SV cells endogenously expressing glutamine synthetase (GS). Duvakitug can be used in the study of Crohn's Disease (CD) .
|
- HY-P99430
-
- HY-P99419
-
GEN1046
|
PD-1/PD-L1
|
Cancer
|
Acasunlimab (GEN1046) is a bispecific antibody (bsAb) targeting PD-L1 and 4-1BB. Acasunlimab enhances T-cell and NK-cell function through conditional 4-1BB stimulation while constitutively blocking the PD-1/PD-L1 inhibitory axis. Acasunlimab can be used in research of cancer .
|
- HY-P99668
-
|
PD-1/PD-L1
|
Cancer
|
Iparomlimab is an anti-human PD-1/CD279/PDCD1 IgG4κ antibody. Iparomlimab also targets to human monoclonal PSB103 γ4-chain, disulfided with human monoclonal PSB103 κ-chain to form a dimer. Iparomlimab can be used for Oncology research .
|
- HY-P99715
-
ABT-806
|
EGFR
|
Cancer
|
Losatuxizumab (ABT-806) is an anti-EGFR monoclonal antibody. Losatuxizumab binds to EGFR with EC50s of 0.96 nM for EGFR wild-type, 0.09 nM for EGFR C271A,C283A, 0.12 nM for EGFRvIII, 0.66 nM for EGFR1-501. Losatuxizumab can be used for research of EGFR-expressing cancers .
|
- HY-P99161
-
BGB149
|
TAM Receptor
|
Cancer
|
Tilvestamab (BGB149) is a humanized anti-AXL antibody that blocks AXL-mediated cell signaling. Tilvestamab significantly inhibits Gas6-induced AXL activation in 786-0-Luc RCC cells and inhibits downstream AKT phosphorylation. Tilvestamab can be used in cancer research, particularly in AXL overexpressing renal cell carcinomas .
|
- HY-P99239
-
HUJ-591
|
PSMA
|
Cancer
|
Rosopatamab (HuJ591) is a humanized antiPSMA IgG1 monoclonal antibody that can be used in cancer research, especially prostate cancer. Rosopatamab can be linked to the low-energy beta-emitting radioisotope lutetium-177 ( 177Lu) through the bifunctional chelator DOTA-NHS ester to obtain a radioimmunoconjugate that targets malignant prostate cells with high efficiency .
|
- HY-P99406
-
MCLA 158
|
EGFR
|
Cancer
|
Petosemtamab (MCLA 158) is an anti- EGFR (Kd: 0.22 nM) and anti-LGR5 (Kd: 0.86 nM) monoclonal antibody (mAb). Petosemtamab leads to EGFR signaling blockade and receptor degradation in LGR5+ cancer cells. Petosemtamab can be used in the research of solid tumors, such as head and neck squamous cell carcinoma (HNSCC), metastatic colorectal cancer (CRC) .
|
- HY-P99552
-
IBI-306
|
Ser/Thr Protease
|
Cardiovascular Disease
|
Tafolecimab (IBI-306) is a human lgG2 monoclonal antibody that specifically binds PCSK-9 and reduces LDL-C levels by inhibiting PCSK-9-mediated endocytosis of the LDL receptor, which in turn enhances clearance of LDL-C and leads to a reduction in LDL-C levels. Tafolecimab may be used in studies of hypercholesterolaemia .
|
- HY-P9920A
-
|
VEGFR
|
Cancer
|
Ramucirumab (anti-VEGFR) is a human VEGFR-2 antagonist for the treatment of solid tumors. Ramucirumab (anti-VEGFR) is a recombinant human immunoglobulin G1 monoclonal antibody that binds to the extracellular binding domain of VEGFR-2 and prevents the binding of VEGFR ligands: VEGF-A, VEGF-C, and VEGF-D. Ramucirumab (anti-VEGFR) is also an angiogenesis inhibitor .
|
- HY-P99101
-
AEX-4089
|
ADC Antibody
|
Cancer
|
Vobramitamab is a humanized B7-H3 monoclonal antibody (mAb). Vobramitamab conjugated with prodrug seco-DUBA (HY-132180A) via a cleavable linker, to form antibody-drug conjugate (ADC), the MGC018 .
|
- HY-P99395
-
JNJ 56022473; CSL 362
|
Interleukin Related
|
Cancer
|
Talacotuzumab (JNJ 56022473; CSL 362) is an IgG1-type fully humanized, CD123-neutralizing monoclonal antibody containing a modified Fc structure. Talacotuzumab has KDs of 0.43 nM, 188 nM, 46 nM, 16.8 nM for CD123, CD32b/c, CD16-158F, CD16-158V, respectively. Talacotuzumab inhibits IL-3 binding to CD123, antagonizing IL-3 signaling in target cells. Talacotuzumab has mutated the Fc region to increase affinity for CD16 (FcγRIIIa), thereby enhancing antibody-dependent cell-mediated cytotoxicity (ADCC). Talacotuzumab is highly effective in vivo reducing leukemic cell growth in acute myeloid leukemia (AML) xenograft mouse models .
|
- HY-P99762
-
MGD009
|
CD3
|
Cancer
|
Obrindatamab is a humanized anti-B7-H3/CD3 bispecific antibody. Obrindatamab binds to B7-H3 and CD3, thereby mediating redirected cytotoxic T-lymphocyte (CTL) activity against B7-H3-expressing cancer cells. Obrindatamab can be used in research of cancer .
|
- HY-P9902A
-
|
PD-1/PD-L1
|
Cancer
|
Pembrolizumab (anti-PD-1) is a humanized IgG4 antibody and PD-1 inhibitor. Pembrolizumab produces PD-1 blockade, preventing PD-L1 and PD-L2 from connecting to PD-1. This avoids the uncontrolled regulation of T cells on cells that normally express PD-1 .
|
- HY-P9974
-
OMP-18R5
|
Wnt
|
Cancer
|
Vantictumab (OMP-18R5) is a fully human IgG2 monoclonal antibody. Vantictumab inhibits Wnt pathway signaling by binding to FZD1/2/5/7/8 receptors. Vantictumab is being studied against cancers such as metastatic HER2-negative breast cancer and metastatic pancreatic adenocarcinoma .
|
- HY-P990093
-
CM310
|
Interleukin Related
|
Inflammation/Immunology
|
Stapokibart (CM310) is a humanised monoclonal antibody targeting IL-4Rα and efficiently blocks the interaction of cytokines IL-4 and IL-13 with their co-receptor subunit IL-4Rα. Stapokibart has the capacity to interact with IL-4Rα in humans, cynomolgus monkeys, and rats .
|
- HY-P9919A
-
MEDI 4736 (anti-PD-L1)
|
PD-1/PD-L1
|
Others
|
Durvalumab (anti-PD-L1)(MEDI 4736) is a human anti-PD-L1 protein monoclonal antibody . Durvalumab (anti-PD-L1) completely blocks PD-L1 binding to PD-1 and CD80, IC 50 are 0.1 and 0.04 nM respectively .
|
- HY-P99593A
-
DMUC5754A (solution)
|
Antibody-Drug Conjugates (ADCs)
|
Cancer
|
Sofituzumab vedotin (DMUC5754A) (solution) is an antibody-drug conjugate (ADC) that contains the humanized IgG1 anti-MUC16 monoclonal antibody and a potent anti-mitotic agent, monomethyl auristatin E (MMAE), linked through a protease-cleavable linker .
|
- HY-P99837
-
SPV-T3a
|
CD3
|
Infection
|
Dafsolimab (SPV-T3a) is an IgG2a murine monoclonal antibody (anti-CD3). Dafsolimab can induce cell death through modulation and activation of the CD3/T cell receptor complex. Dafsolimab can be used for the research of graft-versus-host disease (GVHD) .
|
- HY-P9949
-
Sch 55700
|
Interleukin Related
|
Inflammation/Immunology
|
Reslizumab (Sch 55700) is humanized monoclonal antibodies that target interleukin-5 (IL-5) for the treatment of eosinophilic asthma. Reslizumab is effective in neutralizing the function of IL-5. Reslizumab has high binding affinity for human IL-5, with KD values of 109 pM and 4.3 pM in the the Biacore surface plasmon resonance and Kinetic Exclusion Assay, respectively .
|
- HY-108738
-
Zenapax; Ro 24-7375
|
Interleukin Related
|
Inflammation/Immunology
|
Daclizumab (Zenapax) is a humanized, monoclonal antibody that blocks CD25 (α-subunit of the high-affinity interleukin-2 receptor (IL-2R-HA)). Daclizumab (Zenapax) reversibly binds to CD25and prevents the interaction of IL-2 with the IL-2R-HA. Daclizumab (Zenapax) can be used for multiple sclerosis research .
|
- HY-P99190
-
BMS-936557; MDX-1100
|
CXCR
|
Inflammation/Immunology
|
Eldelumab (BMS-936557) is a human anti-CXCL10 (IP-10) monoclonal antibody (IgG1 type). Eldelumab selectively binds to CXCL10 and blocks CXCL10-induced calcium flux and cell migration. Eldelumab can be used in studies of autoimmune and auto-inflammatory diseases such as rheumatoid arthritis, ulcerative colitis and crohn's disease .
|
- HY-P99386
-
MNRP-1685A
|
Complement System
|
Cancer
|
Vesencumab (MNRP-1685A) is IG1 antibody against neuropilin-1 (NRP-1). Vesencumab binds to NRP-1 and prevents the subsequent coupling of NRP-1 to VEGFR-2. Vesencumab has anti-angiogenic and anti-neoplastic activities. Vesencumab can be used in the research of metastatic solid tumors, including ovarian cancer .
|
- HY-P99394
-
JNJ-64407564
|
CD3
|
Cancer
|
Talquetamab (JNJ-64407564) is a humanized bispecific antibody that binds to GPRC5D (member of G protein-coupled receptor family C5 group D) and CD3 to induce T cell-mediated killing of GPRC5D-expressing MM cells through T cell recruitment and activation. Talquetamab (JNJ-64407564) has antitumor activity .
|
- HY-P99810
-
AVTX-002; AEVI 002; SAR 252067
|
SARS-CoV
|
Cardiovascular Disease
|
Quisovalimab (AVTX-002; AEVI 002; SAR 252067) is a human monoclonal antibody against LIGHT, a tumor necrosis factor (TNF)-related cytokine (TNFSF14) that plays an important role in acute respiratory distress syndrome (ARDS) and cytokine release syndrome (CRS) COVID-19. Quisovalimab can be used in COVID-19 acute respiratory distress syndrome and other studies .
|
- HY-P99588
-
MYO-029
|
TGF-β Receptor
|
Metabolic Disease
|
Stamulumab (MYO-029) is a recombinant human IgG1λ antibody that binds to myostatin and neutralizes its activity by preventing binding to its endogenous high-affinity receptor ActRIIB. Stamulumab leads to muscle fiber hypertrophy and not hyperplasia in SCID mice. Stamulumab has the potential for Becker muscular dystrophy (BMD), facioscapulohumeral dystrophy (FSHD), and limb-girdle muscular dystrophy (LGMD) research .
|
- HY-P99612
-
MORAb-202
|
Antibody-Drug Conjugates (ADCs)
|
Cancer
|
Farletuzumab ecteribulin (MORAb-202) is an antibody-drug conjugate (ADC), consisting of the humanized anti-human folate receptor alpha (FRA) antibody Farletuzumab (HY-P99153) conjugated via reduced interchain disulfide bonds to Mal-PEG2-Val-Cit-PAB-eribulin. Farletuzumab ecteribulin has a agent-to-antibody ratio of 4.0. Farletuzumab ecteribulin is highly cytotoxic to FRA-positive cells in vitro. Farletuzumab ecteribulin has potent antitumor activity.
|
- HY-P9928A
-
REGN 727(anti-PCSK9); SAR 236553(anti-PCSK9)
|
Ser/Thr Protease
|
Cardiovascular Disease
|
Alirocumab (anti-PCSK9) is a human monoclonal antibody inhibiting proprotein convertase subtilisin/kexin type 9 (PCSK9). Alirocumab specifically binds PCSK9, a down regulator of liver low-density lipoprotein (LDL)-receptors, thereby increasing the ability of the liver to bind LDL-cholesterol (LDL-C) and reducing levels of LDL-C in blood. Alirocumab can be used for the research of hypercholesterolemia .
|
- HY-P99248
-
Risankizumab rzaa; BI 655066
|
Interleukin Related
|
Inflammation/Immunology
|
Risankizumab (BI 655066) is a humanised IgG monoclonal antibody, targeting IL-23 p19 subunit (Kd <10 pM) and inhibiting IL-17 production induced by human IL-23 in mouse splenocytes (IC50 = 2 pM). Risankizumab can be used to research immunological and inflammatory disorders such as psoriasis vulgaris, psoriatic arthritis, generalized pustular psoriasis and erythrodermic psoriasis .
|
- HY-P99387
-
|
LAG-3
|
Cancer
|
TSR-033 is a high affinity human IgG4 antibody targeting LAG-3 (lymphocyte activation gene-3), a co-receptor associated with impaired T cell function and often co-expressed with PD-1, that enhances T cell function and PD-1 blocking activity in vitro and in vivo. TSR-033 has anti-tumor activity .
|
- HY-P99520
-
CaCP-29, IFX-1
|
Complement System
SARS-CoV
|
Infection
Inflammation/Immunology
|
Vilobelimab (CaCP-29, IFX-1) is a monoclonal anti-C5a antibody to the allergen C5a, a pro-inflammatory complement division product that plays a central role in mediating organ dysfunction. Vilobelimab acts as a C5a inhibitor, inhibiting neutrophil activation, chemotaxis, and reducing inflammatory signalling, and may be used in studies related to sepsis, COVID-19, etc .
|
- HY-P99731
-
hLL1; MEDI-115
|
CD74
|
Cancer
|
Milatuzumab (hLL1; MEDI-115) is a humanized anti-CD74 monoclonal antibody. CD74, a integral membrane protein, is associated with the promotion of B-cell growth and survival. Milatuzumab causes free radical oxygen generation, and loss of mitochondrial membrane potential. Milatuzumaba also decreases CD20/CD74 aggregates and cell adhesion, to lead to cell death .
|
- HY-P990094
-
CSL311
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Trabikibart (CSL311), a βc-specific, fully human monoclonal antibody, binds to a unique epitope that is specific to the cytokine-binding site of the human βc receptor. Trabikibart has picomolar binding affinity for the human βc receptor. Trabikibart is a potent inhibitor of the combined effects of IL-3, GM-CSF and IL-5 on the survival of eosinophils. Trabikibart has the potential for chronic inflammatory diseases research .
|
- HY-P99333
-
M200; Eos 200-4
|
Integrin
|
Cardiovascular Disease
Cancer
|
Volociximab (M200) is a chimeric human/murine IgG4 antibody IIA1 targeting integrin α5β1 (EC50=0.2 nM). Integrin α5β1 is a major fibronectin receptor involved in angiogenesis. Volociximab has antiangiogenic and antitumor activities and inhibits the proliferation of human umbilical vein vascular endothelial cells (HUVECs) .
|
- HY-P99623
-
MGD006; S80880
|
CD3
|
Cancer
|
Flotetuzumab (MGD006; S80880) is an investigational CD123/CD3 bispecific dual-affinity retargeting antibody (DART) molecule. Flotetuzumab reactivates T cells by simultaneously binding to CD123 in target cells and CD3 in effector T cells, leading to T-cell-mediated cytotoxicity in target cells. Flotetuzumab shows inhibitory effect on a mouse model of patient-derived xenograft (PDX) in acute myeloid leukemia (AML) .
|
- HY-P99189
-
IMC-A12; NSC742460
|
Inhibitory Antibodies
|
Cancer
|
Cixutumumab (IMC-A12) is a human anti-IGF-1R monoclonal antibody with high affinity that inhibits ligand-dependent receptor activation and downstream signaling. Cixutumumab also mediates the internalization and degradation of IGF-IR. Cixutumumab shows broad-spectrum anti-tumour activity and can be used in studies of cancers such as lung cancer, malignancies, leukaemia, non-small cell lung cancer and prostate cancer .
|
- HY-P99390
-
MCLA 117
|
CD3
|
Cancer
|
Tepoditamab (MCLA-117) is a bispecific monoclonal antibody that binds to CLEC12A of myeloid cells and CD3 of cytotoxic T cells. Among others, CLEC12A is a myeloid differentiation antigen. Tepoditamab (MCLA-117) kills AML leukaemia mother cells and AML leukaemia stem cells, induces T cell-mediated proliferative lysis of AML cells and can be used in acute myeloid leukaemia (AML) research .
|
- HY-145644
-
C-135-LS; BMS-986414
|
SARS-CoV
|
Infection
|
Ogalvibart (C-135-LS) is a human anti-SARS-CoV-2 monoclonal antibody (IgG1 type). Ogalvibart binds to the spike (S) glycoprotein receptor-binding domain (RBD) of SARS-CoV-2. Ogalvibart in combination with C144LS (1:1 ratio) shows good preventive activity and can effectively block the development of COVID19 in a rhesus monkey disease model .
|
- HY-P99551
-
KBSA301; AR-301
|
Antibiotic
|
Infection
|
Tosatoxumab (AR-301; KBSA301) is a human immunoglobulin G1 monoclonal antibody that specifically neutralizes alpha-toxin (alpha-hemolysin; Hla) of S. aureus. Tosatoxumab binds to an N-terminal epitope of alpha-toxin, thereby preventing functional toxin pore oligomerisation. Tosatoxumab has the potential for passive immunotherapy in the S. aureus pneumonia as an adjunctive therapy to standard antibiotic agent .
|
- HY-P990091
-
SAR 445088
|
Complement System
|
Inflammation/Immunology
|
Riliprubart (SAR445088) is an anti-C1s humanized monoclonal antibody that inhibits activated C1s in the proximal portion of the classical complement system. Riliprubart selectively inhibits activated C1s and prevents the enzymatic action of C1 on its substrates C4 and C2, thus inhibiting the formation of the classical pathway C3 convertase, C4b2a .
|
- HY-P990061
-
JTX 8064
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Polzastobart (JTX-8064) is a humanized IgG4 monoclonal antagonist antibody that selectively binds LILRB2 and prevents it from binding its ligands, classical and non-classical MHC I molecules. Polzastobart enhances pro-inflammatory cytokine production in macrophages by blocking the ability of LILRB2 to bind HLA-A/B and/or HLA-G, a marker of immunotolerance on cancer cells. Polzastobart is a macrophage immune checkpoint inhibitor .
|
- HY-P99157
-
|
CD276/B7-H3
|
Cancer
|
Omburtamab is an anti-CD276 (also known as B7-H3) monoclonal antibody, CD276 is a B7/CD28 immunoglobulin superfamily member expressed among solid human tumours. Omburtamab can bind tumor tissues and be used in various cancers research .
|
- HY-P99008
-
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Atibuclimab, is a chimeric monoclonal antibody directed against CD14 and is composed of murine variable and human IgG4 Fc regions. Atibuclimab can be used for the research of amyotrophic lateral sclerosis . Atibuclimab attenuates LPS-induced symptoms and strongly inhibits LPS-induced proinflammatory cytokine release, while only delaying the release of the anti-inflammatory cytokines soluble TNF receptor type I and IL-1 receptor antagonist .
|
- HY-P99340
-
VIR 7831
|
SARS-CoV
|
Infection
|
Sotrovimab (VIR 7831) is a human IgG1κ pan-sarbecovirus monoclonal antibody (mAb), neutralizes SARS-CoV-2, SARS-CoV-1, and multiple other sarbecoviruses. Sotrovimab is developed based on S309, exhibits a long half-life and great bioavailability in the respiratory mucosa. Sotrovimab could result in immune-mediated viral clearance and prevent progression of Covid-19 early in the course of disease .
|
- HY-P99583
-
MEDI4893
|
Bacterial
|
Infection
Inflammation/Immunology
|
Suvratoxumab (MEDI4893) is a long-acting, high-affinity human anti-α-toxin monoclonal antibody (IgG1κ type). Suvratoxumab potently neutralizes α-toxin, a key S. aureus virulence factor. Suvratoxumab improves survival and reduces lung injury in an immunocompromised mice model of pneumonia. Suvratoxumab also enhances the antibacterial activity of Vancomycin (HY-B0671) or Linezolid (HY-10394) .
|
- HY-P99506
-
SC-003 mAb; SC-Mab003; SC34.28ss1
|
ADC Antibody
|
Cancer
|
Tamrintamab (SC-003 mAb, SC-Mab003, SC34.28ss1) is an ADC Antibody targeting to dipeptidase 3 (DPEP3 or MBD3). DPEP3 is a glycosyl phosphatidylinositol anchored metallopeptidase that is overexpressed in ovarian tumors. Tamrintamab can specifically bind DPEP3-expressing cells to produce cytotoxicity. Tamrintamab can be used in ovarian cancer research .
|
- HY-P99833
-
CK-301; TG-1501
|
PD-1/PD-L1
|
Cancer
|
Cosibelimab (CK-301; TG-1501) is a high-affinity, fully human PD-L1-blocking monoclonal antibody that binds PD-L1 and blocks its interaction with PD-1. Cosibelimab has a functional Fc domain and is capable of inducing ADCC and complement-dependent cytotoxicity (CDC)-mediated killing of PD-L1 + cell lines, including lymphoma cells .
|
- HY-P99677
-
- HY-P99708
-
ABBV-151; ARGX-115
|
TGF-beta/Smad
|
Cancer
|
Livmoniplimab (ABBV-151; ARGX-115) is a potent, humanized monoclonal antibody against the LRRC32 (GARP)/TGFβ1 complex. Livmoniplimab blocks LRRC32-mediated latent TGFβ1 activation and release. Livmoniplimab has potential in cancer research as a single anticancer agent or in combination with an anti-PD-1 mAb to inhibit locally advanced or metastatic solid tumors (NCT03821935) .
|
- HY-132253
-
|
Antibody-Drug Conjugates (ADCs)
|
Cancer
|
Polatuzumab vedotin is an antibody-drug conjugate targeting CD79b. It contains a humanized anti-CD79b IgG1 monoclonal antibody linked to monomethyl auristatin E (MMAE), a potent microtubule inhibitor. Polatuzumab vedotin has the potential for the research of Large B-cell lymphomas (LBCL) .
|
- HY-P990304
-
- HY-108831
-
|
Integrin
|
Inflammation/Immunology
|
Natalizumab is a recombinant, humanized IgG4 monoclonal antibody, binds to α4β1-integrin and blocks its interaction with vascular cell adhesion molecule-1 (VCAM-1). Natalizumab can be used for the treatment of relapsing remitting multiple sclerosis and Crohn's disease. Natalizumab is also the first targeted therapy which blocks an essential mechanism for lymphocyte entry to the CNS and thus prevents acute demyelinating relapses .
|
- HY-P99111
-
CNTO-148
|
TNF Receptor
Apoptosis
Interleukin Related
Caspase
|
Inflammation/Immunology
Cancer
|
Golimumab (CNTO-148) is a potent human IgG1 TNFα antagonist monoclonal antibody. Golimumab has anti-inflammation activitity and inhibits IL-6 and IL-1β production. Golimumab acts via targeting and neutralizing TNF to prevent inflammation and destruction of cartilage and bone. Golimumab has the anticancer activity and induces cell apoptosis. Golimumab can be used for rheumatoid arthritis, Crohn's disease and cancer research .
|
- HY-P99171
-
|
Interleukin Related
|
Inflammation/Immunology
|
Gevokizumab is a potent anti-IL-1β antibody, negatively modulates IL-1β signaling through an allosteric mechanism. Gevokizumab selectively decreases the binding affinity of IL-1β for the IL-1 receptor type I (IL-1RI) signaling receptor instead of IL-1 counter-regulatory decoy receptor (IL-1 receptor type II) .
|
- HY-P99165
-
|
IGF-1R
TSH Receptor
|
Endocrinology
|
Teprotumumab is an IGF-1 receptor (IGF-1R) blocking human monoclonal antibody. Teprotumumab binds to the ligand binding extracellular α-subunit domain of IGF-1R. Teprotumumab inhibits TSH and IGF-1 action in fibrocytes. Teprotumumab attenuates TSH-dependent IL-6 and IL-8 expression and Akt phosphorylation. Teprotumumab can be used for thyroid-associated ophthalmopathy research .
|
- HY-P99410
-
AMG 714; PRV-015
|
Interleukin Related
|
Inflammation/Immunology
|
Ordesekimab (AMG 714; PRV-015) is a fully human IgG1κ anti-IL-15 (Interleukin Related) monoclonal antibody. The binding of Ordesekimab to IL-15 inhibits the interaction of IL-15 with the IL-2Rβ and common γ chain of the IL-15 receptor complex, but not with the IL-15Rα chain. Ordesekimab has the potential for study of nonresponsive celiac disease (NRCD) .
|
- HY-P99584
-
KD-247
|
HIV
|
Infection
|
Suvizumab (KD-247) is an neutralizing antibody anti-HIV-1. Suvizumab effectively neutralizes HIV-1MN, HIV-1SF2 and HIV-189.6 with IC50 values of 0.1 µg/mL, 1.0 µg/mL and 0.2 µg/mL, respectively. Suvizumab reduces the viral load of HIV. Suvizumab has good tolerance and can be used to prevent HIV infection .
|
- HY-P9991
-
TST001
|
Inhibitory Antibodies
|
Cancer
|
Osemitamab is an IgG1 antibody targeting to human claudin-18.2. Osemitamab consists of human-Mus musculus monoclonal TST001 γ1-chain, disulfide with human-Mus musculus monoclonal TST001 κ-chain, dimer (ACI). Osemitamab in combination with Capecitabine (HY-B0016) and Oxaliplatin (HY-17371), can be used for G/GEJ cancer study .
|
- HY-P99464
-
IMMU-LL 2
|
CD22
|
Cancer
|
Bectumomab (IMMU-LL 2) is an humanized IgG2a mAb against human CD22 (antigen). Bectumomab is also an anti-lymphoma antibody fragment. Bectumomab can be used for imaging in combination with technetium 99 (Tc99m LL2 Fab). Moreover, Bectumomab examines in the staging of recurrent or newly diagnosed non-Hodgkin's lymphoma (NHL) and to assess targeting before radioimmunoresearch (RIT) .
|
- HY-P99813
-
HER3-DXd
|
Antibody-Drug Conjugates (ADCs)
|
Cancer
|
Patritumab deruxtecan (HER3-DXd) is an antibody-drug conjugate (ADC) consisting of a fully human anti-HER3 IgG1 monoclonal antibody Patritumab (HY-P99275) attached to a topoisomerase I inhibitor payload via a tetrapeptide-based cleavable linker. Patritumab deruxtecan shows anticancer activity .
|
- HY-P99911
-
- HY-P99284
-
MK-0646; h7C10
|
IGF-1R
Apoptosis
|
Cancer
|
Dalotuzumab (MK-0646) is a recombinant humanized monoclonal antibody (IgG1 type) targeting IGF-1R. Dalotuzumab acts by inhibiting IGF-1- and IGF-2-mediated tumor cell proliferation, IGF-1R autophosphorylation, and Akt phosphorylation. Dalotuzumab also induces apoptosis and cycle arrest. Dalotuzumab in combination with other anticancer agents such as statins can enhance the antitumor activity of Dalotuzumab in vitro and in vivo .
|
- HY-P99212
-
TRU-016
|
Inhibitory Antibodies
|
Cancer
|
Otlertuzumab (TRU-016) is a humanized anti-CD37 monoclonal antibody that can be used for cancer research .
|
- HY-P99957
-
AMG-404
|
PD-1/PD-L1
|
Cancer
|
Zeluvalimab (AMG-404) is a monoclonal antibody targeting the PD-1 receptor that can be used for the research of cancer .
|
- HY-P990017
-
CD19-4-1BBL; RO7227166; RG6076
|
CD19
|
Cancer
|
Englumafusp alfa (CD19-4-1BBL; RO7227166) is a fusion construct comprised of a CD19-specific antibody domain fused to a trimerized extracellular domains of human 41BBL. Englumafusp alfa promotes CD19-specific 4-1BB cross-linking on the surface of T and NK cells .
|
- HY-P99575
-
AMG-757
|
Notch
|
Inflammation/Immunology
Cancer
|
Tarlatamab (AMG-757) is a bispecific T-cell engager (BiTE) antibody targeting delta-like ligand 3 (DLL3). DLL3 is a target that is selectively expressed in small-cell lung cancer (SCLC) tumors, but with minimal normal tissue expression. Tarlatamab has the KDs of 0.64 nM and 0.50 nM for human and nonhuman primate (NHP) DLL3, respectively. Tarlatamab has the KDs of 14.9 nM and 12 nM for human and NHP CD3, respectively. Tarlatamab is a first-in-class HLE BiTE immuno-oncology therapy targeting DLL3 and has the potential for SCLC research .
|
- HY-P990304A
-
- HY-P9930
-
AMG 145
|
NF-κB
Ser/Thr Protease
Toll-like Receptor (TLR)
|
Cardiovascular Disease
Metabolic Disease
Inflammation/Immunology
Cancer
|
Evolocumab (AMG 145) is a human monoclonal antibody that inhibits PCSK9. Evolocumab is used in the study of hypercholesterolemia and atherosclerotic cardiovascular disease. Evolocumab binds to circulating PCSK9 protein and inhibits its binding to LDLR. Evolocumab has antioxidant and cytoprotective activities against H2O2-induced oxidative damage to endothelial cells. Evolocumab may also negatively regulate activation of the TLR-4/NF-κB signaling pathway to prevent inflammation .
|
- HY-145642
-
ZRC3308-A7
|
SARS-CoV
|
Infection
|
Masavibart (ZRC3308-A7) is an anti-SARS-CoV-2 monoclonal antibody (IgG1 type). Masavibart shows good binding affinity to a non-competing epitope on the RBD of the SARS-CoV-2 spike protein. Masavibart can be used in combination with ZRC3308-B10 (HY-145643) at a ratio of 1:1, which is effective for the prevention of COVID-19 and the early stage of COVID-19 before the development of severe disease .
|
- HY-145643
-
ZRC3308-B10
|
SARS-CoV
|
Infection
|
Nepuvibart (ZRC3308-B10) is an anti-SARS-CoV-2 monoclonal antibody (IgG1 type). Nepuvibart shows good binding affinity to a non-competing epitope on the RBD of the SARS-CoV-2 spike protein. Nepuvibart can be used in combination with ZRC3308-A7 (HY-145642) at a ratio of 1:1, which is effective for the prevention of COVID-19 and the early stage of COVID-19 before the development of severe disease .
|
- HY-P99620
-
CT-P22; CT120
|
Influenza Virus
|
Infection
|
Firivumab (CT-P22; CT120) is a human IgG1 monoclonal influenza A virus hemagglutinin (Anti-IAV HA) antibody. Firivumab is capable of neutralizing H1N1, H5N1, H6N1, H6N2, H8N4, H8N8, H9N2 and H12N7. Firivumab shows protection against H1N1 virus in mice .
|
- HY-P99483
-
AT 004; VT 007
|
CD20
|
Cancer
|
Blontuvetmab (AT 004)is a caninized CD20 monoclonal antibody. Blontuvetmab can be used for the research of Canine B-cell lymphoma .
|
- HY-P99542
-
SAR-408701; HuMAb2-3-SPDB-DM4
|
Antibody-Drug Conjugates (ADCs)
Microtubule/Tubulin
|
Cancer
|
Tusamitamab ravtansine (SAR-408701) is a targeted ADC against tumor cells expressing CEACAM5, composed of a humanized anti-CEACAM5 monoclonal antibody covalently linked to the potent cytotoxic agent, maytansinoid DM4 (HY-12454), via a cleavable linker. Tusamitamab ravtansine has an average drug-to-antibody ratio (DAR) of 3.8 .
|
- HY-P99932
-
|
Inhibitory Antibodies
|
Others
|
Eftansomatropin alfa is an antibody targeting the growth hormone receptor (GSH). Eftansomatropin alfa is a fusion protein of GH1 and IGHG4 Fc .
|
- HY-P9971
-
SHR-1210
|
PD-1/PD-L1
|
Cancer
|
Camrelizumab (SHR-1210) is a potent humanied high-affinity IgG4-κ monoclonal antibody (mAb) to PD-1. Camrelizumab binds PD-1 at a high affinity of 3 nM and inhibits the binding interaction of PD-1 and PD-L1 with an IC50 of 0.70 nM. Camrelizumab acts as anti-PD-1/PD-L1 agent and can be used for cancer research, including NSCLC, ESCC, Hodgkin lymphoma, and advanced HCC et,al .
|
- HY-P99109
-
GLS-010; AB-122; WBP-3055
|
PD-1/PD-L1
|
Cancer
|
Zimberelimab (GLS-010) is a fully human IgG4 anti-PD-1 monoclonal antibody with an EC50 of 210 pM for human PD-1. Zimberelimab effectively blocks the binding of PD-L1 and PD-L2 to cell-surface PD-1 in CHO-S cells, with IC50 values of 580 pM and 670 pM, respectively. Zimberelimab shows antitumor activities, and can be used for various cancers research, including cervical cancer, non-small cell lung cancer and classical Hodgkin’s lymphoma .
|
- HY-P99925
-
REGN421
|
Notch
|
Metabolic Disease
Cancer
|
Enoticumab (REGN421, SAR153192) is an IgG1κ antibody targeting human Dll4. DLL4 is a ligand of the Notch signaling pathway and regulates fatty acid uptake through non-transcriptional regulation of macropinocytosis-dependent long-chain fatty acid uptake. Specific in vivo activity of Enoticumab in an ovarian xenograft model. EGN421 (2.5 mg/kg once weekly) resulted in 86% and 83% tumor growth inhibition in mouse subcutaneous TOV-112D or intraperitoneal A2780 human tumor xenograft models, respectively .
|
- HY-P990090
-
CBP-201
|
Interleukin Related
|
Inflammation/Immunology
|
Rademikibart (CBP-201) is a human monoclonal antibody targeting IL-4Rα with a KD of 20.7 pM when binding to human IL-4Rα epitopes. Rademikibart does not bind to IL-4Rα from other species. Rademikibart inhibits IL-4 and IL-13-mediated STAT6 signaling, TF-1 cell proliferation and TARC production in PBMCs. Rademikibart has the potential for moderate-to-severe Th2 inflammatory diseases research .
|
- HY-P99249
-
Pogalizumab; MOXR 0916
|
Inhibitory Antibodies
|
Cancer
|
Vonlerolizumab (MOXR 0916) is a humanized IgG agonistic monoclonal OX40-specific antibody. Vonlerolizumab can be used for the research of cancer .
|
- HY-P99978A
-
|
Inhibitory Antibodies
|
Others
|
Mouse IgG2a (LALA-PG), Isotype Control is a mouse-derived IgG2a, κ type antibody inhibitor, targeting to mouse IgG2a.
|
- HY-P99797
-
JR-141
|
Transferrin Receptor
|
Neurological Disease
|
Pabinafusp alfa (JR-141) is a transferrin receptor-targeting antibody consisting of Iduronate 2-sulfatase (HY-P76399) and an anti-human transferrin receptor antibody. Pabinafusp alfa is blood-brain permeable and prevents heparan sulfate (HS) deposition in the central nervous system of mucopolysaccharidosis II (MPS II) mice. Pabinafusp alfa improves learning and prevents central nervous system neuronal damage in mice .
|
- HY-P990304C
-
- HY-P99164
-
LY33003560
|
Microtubule/Tubulin
|
Neurological Disease
|
Zagotenemab (LY3303560) is a humanised anti-tau antibody that selectively binds and neutralises tau deposits in the brain. Zagotenemab can be used in Alzheimer's disease research .
|
- HY-P99515
-
- HY-P99606
-
ZTS-00521426
|
TGF-beta/Smad
|
Inflammation/Immunology
|
Cirevetmab (ZTS-00521426) is an immunoglobulin G2-kappa, Canis lupus familiaris TGFB1 caninized monoclonal antibody. Cirevetmab is an immunomodulator .
|
- HY-P99641
-
|
PD-1/PD-L1
|
Cancer
|
Gilvetmab is a potent caninized antiPD-1 monoclonal antibody. gilvetmab blocks the interaction between PD-1 and its ligand PDL-1 .
|
- HY-P99841
-
AGEN-1423; GS-1423
|
CD73
TGF-β Receptor
|
Inflammation/Immunology
|
Dalutrafusp alfa (AGEN-1423; GS-1423) is a specific bifunctional antibody against CD73 and TGF-β, which is involved in the immunosuppressive pathway .
|
- HY-P99573
-
MGD-013
|
LAG-3
|
Inflammation/Immunology
Cancer
|
Tebotelimab (MGD-013) is a humanized IgG4κ bispecific PD-1/LAG-3 dual-affinity re-targeting (DART) antibody. Tebotelimab binds cell-surface expressed PD-1 and LAG-3 with EC50s of 1.65 nM and 0.41 nM in NS0 cells, respectively. Tebotelimab blocks PD-1/PD-L1, PD-1/PD-L2 and LAG-3/HLA (MHC-II) interactions and PD-1 signaling. Tebotelimab restores exhausted T-cell responses and and enhances antitumour immunity .
|
- HY-P990304B
-
- HY-P99864
-
ZTS-00521505
|
Interleukin Related
|
Others
|
Dovanvetmab (ZTS-00521505) is an IgG1-κ antibody targeting Felcat IL31. Mainly expressed by CHO (Chinese Hamster Ovary) cells .
|
- HY-P99965
-
SKY59; RO7112689
|
Complement System
|
Cardiovascular Disease
Metabolic Disease
|
Crovalimab (SKY59; RO7112689) is a novel humanized antibody against C5 in a pH-dependent manner with KDs of 15.2 nM and 16.8 μM at pH 7.4 and 5.8, respectively. Crovalimab binds human FcRn with great affinity (KD: 17 μM at pH 6.0). Crovalimab can block cleavage of C5 by the C5 convertase and inhibite the activity of a C5 variant (p.Arg885His). Crovalimab inhibits C5b-9 formation significantly in all three complement pathways, the classical pathway (CP), lectin pathway (LP), and alternative pathway (AP). Crovalimab has the potential for paroxysmal nocturnal hemoglobinuria (PNH) and complement-mediated diseases research .
|
- HY-P99845
-
MEDI 4920; VIB 4920
|
Inhibitory Antibodies
|
Others
|
Dazodalibep (MEDI 4920; VIB 4920) is a monoclonal antibody targeting CD40LG/TNFSF5 fused to human serum albumin ALB/HSA .
|
- HY-P99876
-
OMP-336B11
|
Inhibitory Antibodies
|
Others
|
Efaprimermin alfa (OMP-336B11) is a human monoclonal antibody targeting TNFRSF18. Efaprimermin alfa is a GITR ligand-Fc fusion protein .
|
- HY-P3239
-
GSK2857916; Belantamab mafodotin-blm
|
Antibody-Drug Conjugates (ADCs)
|
Cancer
|
Belantamab mafodotin (GSK2857916) is composed of humanized and focused monoclonal antibody against B cell maturation antigen (BCMA) and McMMAF. Belantamab mafodotin has anti-myeloma activity .
|
- HY-P99627
-
NV-02
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Frunevetmab (NV-02) is a felinized anti-nerve growth factor (NGF) monoclonal antibody with a Kd of 20 pM. Frunevetmab can effectively decrease osteoarthritis (OA) pain in cats .
|
- HY-P9973
-
DLX1008; ESBA 1008; RTH258
|
VEGFR
|
Cancer
|
Brolucizumab (DLX1008) is a single-chain anti-VEGF-A antibody fragment with low picomolar affinity (KD=1.05 pM). Brolucizumab can be used for the research of cancer .
|
- HY-P99593
-
DMUC5754A
|
Antibody-Drug Conjugates (ADCs)
|
Cancer
|
Sofituzumab vedotin (DMUC5754A) is a MMAE-containing anti-MUC16 antibody-drug conjugate (ADC) with a protease-cleavable linker. Sofituzumab vedotin can be used for the research of cancer .
|
- HY-P99202
-
|
Inhibitory Antibodies
|
Cancer
|
Vibostolimab is an anti-TIGIT (T cell immunoglobulin and ITIM domain) monoclonal antibody. Vibostolimab shows antitumor activity, and can be used in non-small cell lung cancer (NSCLC) and melanoma research .
|
- HY-P99510
-
LY-3127804
|
Tie
|
Inflammation/Immunology
|
Zansecimab (LY-3127804) is an immunoglobulin G4-kappa, a monoclonal antibody against angiopoietin 2 (Ang 2). Zansecimab has potential applications in angiogenesis and immune regulation .
|
- HY-P99772
-
L19TNF
|
TNF Receptor
|
Cancer
|
Onfekafusp alfa (L19TNF) is a homotrimer that forms from engineered peptides for the L19 antibody in scFv format fused to human TNF. Onfekafusp alfa can be used for malignant glioma research .
|
- HY-P99384
-
B-701; MFGR-1877S; RG-7444
|
FGFR
|
Cancer
|
Vofatamab (B-701) is an anti-FGFR3 monoclonal antibody (mAb). Vofatamab blocks activation of both the wildtype and genetically activated receptor. Vofatamab can be used in the research of metastatic urothelial carcinoma (mUC) .
|
- HY-P99630
-
MM-302
|
EGFR
|
Cancer
|
Gancotamab (MM-302) is a HER2-targeted antibody-liposomal Doxorubicin conjugate with antitumor activity. Gancotamab encapsulates Doxorubicin to facilitate its delivery to HER2-overexpressing tumor cells .
|
- HY-P99581
-
OTSA101-DTPA; OTSA101-DTPA-90Y; OTSA101-SS01
|
Wnt
|
Cancer
|
Tabituximab barzuxetan (exclude Y90) is a radioimmunoconjugate composed of a humanized monoclonal antibody targeting FZD-10 (OTSA-101). Tabituximab barzuxetan shows antineoplastic activity. Tabituximab barzuxetan can be used for synovial sarcoma research .
|
- HY-P990076
-
14.18 mAb; hu14.18-IL2; EMD 273063
|
Inhibitory Antibodies
|
Cancer
|
Lorukafusp alfa (14.18 mAb; hu14.18-IL2) is an immunocytokine consisting of the humanized 14.18 anti-GD2 mAb linked to IL210. Lorukafusp alfa has activity mediated by activation of antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity via the binding of hu14.18-IL2 to GD2 on the tumor cell surface, followed by binding to Fc receptors on effector cells along with activation of NK and T cells via IL2 receptor binding. Lorukafusp alfa has anti-tumor activity .
|
- HY-P99505
-
COR-001
|
Interleukin Related
|
Cardiovascular Disease
Inflammation/Immunology
|
Ziltivekimab (COR-001) is a human anti-IL-6 monoclonal antibody that is effective in reducing serum CRP. Ziltivekimab has anti-inflammatory activity and may be used in studies of chronic systemic inflammation and cardiovascular disease associated with CKD .
|
- HY-P99530
-
AGT-181; HIRMAb-IDUA
|
Insulin Receptor
|
Metabolic Disease
|
Valanafusp alfa (AGT-181) is a brain penetrating recombinant fusion protein of a chimeric monoclonal antibody against the human insulin receptor (HIR) and human iduronidase (IDUA). Valanafusp alfa can be used for the research of Mucopolysaccharidosis type I (MPS I) .
|
- HY-P99902
-
FAP-IL2v
|
Interleukin Related
|
Cancer
|
Simlukafusp alfa (FAP-IL2v) is an immunocytokine comprising an antibody against fibroblast activation protein α (FAPα) and an IL-2 variant that only binds IL-2Rβγ. Isotype: human IgG1 .
|
- HY-P99513
-
CTB011; SYN023
|
RABV
|
Infection
|
Zamerovimab (CTB011; SYN023) is a mixture of human monoclonal antibodies consisting of CTB011 and CTB012. Zamerovimab binds to non-overlapping epitopes on rabies virus (RABV) glycoprotein, where CTB011 binds to antigenic site III. Zamerovimab can be used in rabies studies .
|
- HY-P99297
-
ZTS-00508841
|
Trk Receptor
|
Inflammation/Immunology
|
Bedinvetmab (ZTS-00508841) is a canine monoclonal antibody (mAb) targeting nerve growth factor (NGF). Bedinvetmab inhibits NGF interaction with tropomyosin receptor kinase A (trkA) and p75 neurotrophin receptor (p75NTR) receptors. Bedinvetmab can be used for the research of osteoarthritis pain in dogs .
|
- HY-P99479
-
L19-IL2
|
Inhibitory Antibodies
|
Cancer
|
Bifikafusp alfa (L19-IL2) is an immunoresearch fusion protein consisting of human L19 antibodies fused to the human cytokine interleukin 2 (IL2).Bifikafusp alfa is specific to the EDB domain of fibronectin. Bifikafusp alfa has anticancer activity .
|
- HY-P99518
-
BMS 986089; RG 6206; RO 7239361
|
Inhibitory Antibodies
|
Others
|
Taldefgrobep alfa (BMS 986089; RG 6206; RO 7239361) is a potent inhibitory antibody targeting to human myostatin. Taldefgrobep alfa is a fusion protein composed of a human IgG1-Fc domain and Adnectin domain. Taldefgrobep alfa can be used for spinal muscular atrophy (SMA) research .
|
- HY-P99349
-
Loncastuximab tesirine-lpyl; ADCT-402
|
Antibody-Drug Conjugates (ADCs)
Apoptosis
|
Cancer
|
Loncastuximab tesirine is a human cluster of differentiation 19 (CD19)-directed antibody-drug conjugate (ADC). Once bound to CD19 on the cell membrane, loncastuximab tesirine is rapidly internalised and triggers cell death. Loncastuximab tesirin induces cell apoptosis, it can be used for the research of diffuse large B-cell lymphoma .
|
- HY-P99493
-
IMGN242; huC242-DM4
|
Antibody-Drug Conjugates (ADCs)
Microtubule/Tubulin
|
Cancer
|
Cantuzumab ravtansine (IMGN242; huC242-DM4), an ADC, is a humanized monoclonal antibody, huC242, covalently linked via a disulfide bond to DM4 (DM4 (HY-12454)). Cantuzumab ravtansine has broad antitumor efficacy against a range of CanAg-positive human tumor xenografts .
|
- HY-P99492
-
SB-408075; huC242-DM1
|
Antibody-Drug Conjugates (ADCs)
Microtubule/Tubulin
|
Cancer
|
Cantuzumab mertansine (SB-408075; huC242-DM1), an ADC, is an immunoconjugate of the potent maytansine derivative (DM1; HY-19792) and the humanized monoclonal antibody (huC242) directed to CanAg. Cantuzumab mertansine has cytotoxic toward colon cancer cells and has broad antitumor efficacy against a range of CanAg-positive human tumor xenografts .
|
- HY-P99803
-
VAL-1221
|
Glucosidase
|
Others
|
Clervonafusp alfa (VAL-1221) is a fusion protein targeting both cytosolic and lysosomal glycogen. Clervonafusp alfa is comprised of the Fab portion of a cell-penetrating antibody and recombinant human acid alpha glucosidase (rhGAA), the former utilizing the nucleoside transporter ENT-2 to gain access to the cytosol, and the latter enters lysosomes via mannose-6-phosphate receptors (M6PRs). Clervonafusp alfa can be used for late-onset Pompe disease research .
|
- HY-P99601
-
BFCR 4350A; RG 6160; RO 7187797
|
CD3
|
Neurological Disease
Cancer
|
Cevostamab (BFCR4350A; RG6160; RO7187797) is a humanized IgG1-based BsAb that targets membrane-proximal extracellular domain of FcRH5 on multiple myeloma (MM) cells as well as CD3 on T cells. Moreover, Cevostamab facilitates efficient synapse formation, improves killing activity of T cells against MM tumor cells .
|
- HY-P99958
-
AMV-564; TandAb T564
|
Inhibitory Antibodies
|
Cancer
|
Vixtimotamab (AMV-564; TandAb T564) is a bispecific tetravalent tandem diabody (TandAb) that targets human CD33 and human CD3 antigens. Vixtimotamab can be used for the research of acute myeloid leukemia (AML) .
|
- HY-P99050
-
- HY-P99852
-
ABT165; PR1283233
|
VEGFR
|
Cancer
|
Dilpacimab (ABT165) is a potent dual-variable domain immunoglobulin, targets both delta-like ligand 4 (DLL4) and VEGF pathways.. Dilpacimab can be used in research of cancer .
|
- HY-P99834
-
89Zr-Df-IAB22M2C
|
Inhibitory Antibodies
|
Cancer
|
Crefmirlimab (89Zr-Df-IAB22M2C) is an anti-human CD8 probe targeting CD8 antigen, which can be used in the diagnosis of various cancers .
|
- HY-108829
-
CTLA4lg; BMS-188667
|
CTLA-4
|
Inflammation/Immunology
Cancer
|
Abatacept (CTLA4lg) is a soluble fusion protein consisting of the extra-cellular domain of human CTLA4 and a fragment of the Fc portion of human IgG1 (hinge and CH2 and 3 domains) . Abatacept is a selective T-cell co-stimulation modulator and a protein agent for the autoimmune diseases .
|
- HY-P9926
-
REGN-668; SAR-231893
|
Interleukin Related
|
Inflammation/Immunology
Cancer
|
Dupilumab (REGN-668) is a fully human mAb to IL-4 receptor α (IL-4Rα) that inhibits both IL-4 and IL-13 signaling, markedly improved moderate-to-severe atopic dermatitis .
|
- HY-108847
-
|
TNF Receptor
Bacterial
|
Inflammation/Immunology
Cancer
|
Etanercept, a dimeric fusion protein that binds TNF, acts as a TNF inhibitor. Etanercept competitively inhibits the binding of both TNF-α and TNF-β to cell surface TNF receptors, rendering TNF biologically inactive. Etanercept shows efficacy against rheumatoid arthritis, juvenile idiopathic arthritis, and plaque psoriasis .
|
- HY-P99006
-
MORab-009
|
Mesothelin
|
Cancer
|
Amatuximab (MORab-009) is a chimeric, humanized IgG1/k MAb that targets the cell surface mesothelin (MSLN). Mesothelin is a glycosylphosphatidyl inositol (GPI)-anchored membrane glycoprotein, which is present in a restricted set of normal adult tissues such as the mesothelium .
|
- HY-P99032
-
IPH2201
|
Checkpoint Kinase (Chk)
IFNAR
|
Inflammation/Immunology
Cancer
|
Monalizumab (IPH2201) is an immune checkpoint inhibitor targeting Natural Killer Group 2A (NKG2A). Monalizumab, a humanized anti-NKG2A blocking mAb, increases IFN-γ production, thereby promoting NK cell effector functions. Monalizumab can be used for the research of head and neck squamous cell carcinoma (HNSCC) .
|
- HY-P99056
-
PF 05082566
|
TNF Receptor
|
Inflammation/Immunology
Cancer
|
Utomilumab (PF 05082566) is a fully human IgG2 mAb agonist of the T-cell costimulatory receptor 4-1BB/CD137. Utomilumab can be used for the research of relapsed/refractory follicular lymphoma (FL) and other CD20 + non-Hodgkin lymphomas (NHL) .
|
- HY-P9986
-
|
Inhibitory Antibodies
|
Inflammation/Immunology
Cancer
|
Tiragolumab is an immune checkpoint inhibitor binding to T-cell immunoglobulin and ITIM domain (TIGIT). Tiragolumab, alone or in combination with the PD-L1 inhibitor Atezolizumab (HY-P9904), may be effective against multiple solid malignancies-most notably non-small cell lung cancer (NSCLC) .
|
- HY-114134
-
rhEPO; EPOCH; Genetical recombination
|
Inhibitory Antibodies
|
Metabolic Disease
Cancer
|
Epoetin beta (rhEPO) is a recombinant form of erythropoietin. Epoetin beta is responsible for the maintenance of erythropoiesis and can be used for anaemia research .
|
- HY-P99227
-
ALX-0681; ALX-0081
|
Inhibitory Antibodies
|
Inflammation/Immunology
Cancer
|
Caplacizumab (ALX-0681) is a humanized anti-von Willebrand factor (vWF) nanobody. Caplacizumab inhibits the vWF-mediated platelet adhesion and prevents further microthrombi formation. Caplacizumab can be used for the research of thrombotic thrombocytopenic purpura (TTP) .
|
- HY-P99221
-
RN-624; PF 4383119
|
Inhibitory Antibodies
|
Neurological Disease
Inflammation/Immunology
|
Tanezumab (RN-624) is a humanized anti-NGF mAb with high affinity and specificity. Tanezumab blocks NGF binding to its receptors, p75 and TrkA, in the peripheral nervous system. Tanezumab can be used in studies of acute and chronic pain such as osteoarthritis, knee and neuralgia, as well as post-herpetic neuralgia .
|
- HY-108801
-
VEGF Trap; VEGF-TRAPR1R2; VEGF-trapR1
|
VEGFR
|
Cardiovascular Disease
Metabolic Disease
|
Aflibercept (VEGF Trap) is a soluble decoy VEGFR constructed by fusing the Ig domains of VEGFR1 and VEGFR2 with the Fc region of human IgG1. Aflibercept inhibits VEGF signaling by reducing VEGF-regulated processes. Aflibercept can be used for thr research of age-related macular degeneration (AMD) and cardiovascular disease .
|
- HY-145633
-
OPT 302; VGX-300
|
VEGFR
|
Cardiovascular Disease
|
Sozinibercept (OPT 302; VGX-300) is a soluble form of VEGFR-3, potently inhibits the activity of VEGF-C/D, which are the proangiogenic factors, inhibiting angiogenesis and vascular leakage. Sozinibercept also inhibits diabetic retinal edema in rats .
|
- HY-P99367
-
- HY-P99413
-
ASP1650
|
Inhibitory Antibodies
|
Cancer
|
IMAB027 (ASP1650) is a specific anti-CLDN6 mAb, while CLDN6 (Claudin 6) is a tight junction membrane protein, aberrantly expressed in various human cancer types, ovarian cancers particularly. IMAB 027 shows anti-tumor activity, and induces apoptosis in CLDN6 + ovarian and testicular cancer cell lines .
|
- HY-P99420
-
ALPN-101
|
CD28
|
Inflammation/Immunology
|
Acazicolcept (ALPN-101), an Fc fusion protein, is a dual inducible T cell costimulator (ICOS)/CD28 antagonist. Acazicolcept has anti-inflammatory activities .
|
- HY-P99397
-
ALX 0761; M 1095
|
Interleukin Related
|
Inflammation/Immunology
|
Sonelokimab (ALX 0761; M 1095) is a trivalent nanobody comprised of monovalent camelid-derived nanobodies specific to human interleukin (IL)-17A, IL-17F, and human serum albumin VHHs. Sonelokimab has the potential for plaque-type psoriasis research .
|
- HY-145629
-
- HY-P99433
-
U 85855
|
HIV
|
Infection
|
Alvircept sudotox is a recombinant CD4 derived from Pneumonas aeruginosa exotoxin A. Alvircept sudotox can be used in the research of HIV infections .
|
- HY-P99527
-
ACC-001; PF 05236806
|
Inhibitory Antibodies
|
Neurological Disease
|
Vanutide cridificar (ACC-001) is an aminoterminal Aβ1-7 peptide conjugate. Vanutide cridificar can be used for Alzheimer's disease (AD) research .
|
- HY-P99446
-
TACI-Ig; TACI-Fc 5
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Atacicept (TACI-Ig) is a is a recombinant fusion protein containing the extracellular, ligand-binding portion of the TACI receptor and the Fc portion of human IgG. Atacicept inhibits B cell stimulation by binding to B lymphocyte stimulator and a proliferation-inducing ligand. Atacicept can be used in research of B-cell autoimmune disease .
|
- HY-P99456
-
- HY-P99553
-
42-89-glycoprotein; WAY164339; pMT21:PL85
|
Inhibitory Antibodies
|
Others
|
Torapsel (42-89-glycoprotein; WAY164339) is a fusion protein with immunoglobiln. Torapsel can be used to research the prevention of ischemia reperfusion injury.
|
- HY-P99568
-
RC18
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Telitacicept (RC18) is a fully human TACI-Fc fusion protein. Telitacicept is a dual B lymphocyte stimulator (BLyS)/APRIL (a proliferation-inducing ligand) inhibitor that effectively blocks proliferation of B lymphocytes. Telitacicept can be used in research of B-cell autoimmune disease .
|
- HY-P99458
-
CG 10639
|
Inhibitory Antibodies
|
Cancer
|
Balugrastim (CG 10639) is a novel long-acting recombinant granulocyte colony-stimulating factor (G-CSF) obtained by means of a genetic fusion between recombinant human serum albumin and granulocyte colony-stimulating factor. Balugrastim can be used for the research of breast cancer .
|
- HY-P99529
-
BAX1810; TAK-752
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Valziflocept (BAX1810; TAK-752) is a recombinant soluble human FcγRIIb receptor that targets Fc and FcγR. FcγRs bind and neutralize pathogenic IgG, thus forming a "decoy" or "scavenger" receptor that can reduce the severity of autoimmune diseases. Valziflocept can be used in studies of autoimmune diseases such as systemic lupus erythematosus (SLE) .
|
- HY-P99435
-
BRII-196
|
SARS-CoV
|
Infection
|
Amubarvimab (BRII-196) is a human IgG1 mAb that bind to non-competing epitopes on the receptor binding domain (RBD) of spike protein, with a KD of 5.88 nM. Amubarvimab can effectively neutralize SARS-CoV-2 variants .
|
- HY-P99443
-
HuDreg-55
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Aselizumab (HuDreg-55) is an humanized IgG4 mAb against L-selectin. However, L-selectin (CD62L) is a cell adhesion molecule expressed on circulating neutrophils. It regulates migrating cells to chemotaxis towards the site of injury. Aselizumab may be account for a high rate of infections and leucopenia after truma .
|
- HY-P99440
-
CSL-324
|
c-Fms
|
Inflammation/Immunology
|
Anumigilimab (CSL-324) is an human IgG2a mAb against human granulocyte colony-stimulating factor (G-CSF) receptor. Anumigilimab can be used for increasing numbers of neutrophils at sites of inflammation .
|
- HY-P99428
-
NGM282
|
Inhibitory Antibodies
|
Metabolic Disease
|
Aldafermin (NGM282) is an analog of fibroblast growth factor 19. Aldafermin can be used for the research of nonalcoholic steatohepatitis (NASH) .
|
- HY-P99445
-
APG101; CAN008
|
TNF Receptor
|
Inflammation/Immunology
Cancer
|
Asunercept (APG101; CAN008) is a soluble CD95-Fc fusion protein targeting CD95L. Asunercept disrupts CD95/CD95L signaling by selectively binding to CD95L. Asunercept can be used in the research of glioblastoma multiforme (GBM), myelodysplastic syndrome (MDS), and graft-versus-host disease (GvHD) .
|
- HY-P99565
-
ARENEGYR; NGR-TNF; NGR-hTNF
|
TNF Receptor
|
Cancer
|
Tengonermin (ARENEGYR) is a vascular-targeting agent consisting of the human Tumour Necrosis Factor-α (TNF-α) conjugated with the CNGRCG peptide. Tengonermin increases penetration of intratumoral chemotherapy and T-cell infiltration by modifying the tumour microenvironment .
|
- HY-P99887
-
JTX-4014
|
PD-1/PD-L1
|
Cancer
|
Pimivalimab (JTX-4014) is a PD-1 inhibitor. Pimivalimab can be used for the research of solid tumor .
|
- HY-P99621
-
NPC-21; EV2038
|
CMV
|
Infection
|
Fiztasovimab (NPC-21; EV2038) is a fully human IgG1λ mAb against human cytomegalovirus (hCMV). Fiztasovimab acts neutralizing activity by binding to the antigenic domain 1 of glycoprotein B on hCMV envelope. Fiztasovimab inhibits cell-to-cell transmission of hCMV .
|
- HY-P99610
-
BI-754091
|
PD-1/PD-L1
|
Cancer
|
Ezabenlimab (BI-754091) is an anti-PD-1 mAb with binding constant Kd value of 6 nM (CHO cells). Ezabenlimab blocks the interaction of PD-1 with PD-L1 and PD-L2. Ezabenlimab increases interferon-γ secretion in T cells, and inhibits tumor growth in vivo .
|
- HY-P99608
-
|
HBV
|
Infection
|
Exbivirumab is an anti-HBV mAb. Exbivirumab enhances the antiviral activity of hepatitis B immunoglobulin (HBIG) .
|
- HY-P99536
-
SL-401
|
Interleukin Related
|
Cancer
|
Tagraxofusp (SL-401) is a potent IL-3 receptor inhibitor to inhibits plasmacytoid dendritic cells (pDCs) growth in multiple myeloma (MM) bone marrow (BM) microenvironment. Tagraxofusp has synergistic effect with Bortezomib (HY-10227) and Pomalidomide (HY-10984) to suppress multiple myeloma (MM) .
|
- HY-P99499
-
JNJ 63723283; JNJ 3283
|
PD-1/PD-L1
Interleukin Related
TNF Receptor
|
Cancer
|
Cetrelimab (JNJ 63723283; JNJ 3283) is a human IgG4κ mAb targeting PD-1. Cetrelimab binds PD-1 (Kd=1.72 nM, HEK293) to block the interaction of PD-1 with PD-L1 and PD-L2 (IC50s=111.7 ng/mL and 138.6 ng/mL, respectively). Cetrelimab stimulates peripheral T cells, increases IFN-γ, IL-2, TNF-α level and inhibits tumor growth in vivo .
|
- HY-P99498
-
CEA-IL2v; RG 7813; RO 6895882
|
Interleukin Related
|
Inflammation/Immunology
Cancer
|
Cergutuzumab amunaleukin (CEA-IL2v) is a monomeric carcinoembryonic antigen (CEA)-targeted IL-2 variant-based immunocytokine. Cergutuzumab amunaleukin has immunostimulating and antineoplastic activities .
|
- HY-P99459
-
BG 9924; TT-47
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Baminercept (BG 9924) is a lymphotoxin β receptor IgG fusion protein (LTβR-Ig). Baminercept can be used for the research of many autoimmune diseases including primary Sjögren's syndrome (SS) and rheumatoid arthritis (RA) .
|
- HY-P99429
-
BG 9273; Human LFA 3IgG fusion protein; LFA 3TIP
|
Inhibitory Antibodies
|
Others
|
Alefacept (BG 9273) is a human lymphocyte function-associated antigen 3/immunoglobulin 1 fusion protein. Alefacept can be used for the research of chronic plaque psoriasis .
|
- HY-P99924
-
- HY-P99897
-
BCD-054
|
Inhibitory Antibodies
|
Others
|
Sampeginterferon beta-1a (BCD-054) is a pegylated IFNβ-1a. Sampeginterferon beta-1a can be used for research against remitting multiple sclerosis .
|
- HY-108822
-
Arcalyst; IL 1 Trap; Interleukin 1 Trap
|
Interleukin Related
|
Inflammation/Immunology
|
Rilonacept (Arcalyst), a dimeric fusion protein, is a interleukin 1 inhibitor. Rilonacept consists of the ligand-binding domains of the extracellular portions of the IL-1R components linked to the Fc portion of human IgG1. Rilonacept can be used for the research of cryopyrin-associated periodic syndromes .
|
- HY-P99906
-
- HY-P99930
-
|
FGFR
|
Metabolic Disease
|
Efruxifermin is an Fc-FGF21 fusion protein (human IgG1 Fc domain linked to a modified human FGF21). Efruxifermin has prolonged half-life and enhanced receptor affinity compared with native human FGF21. Efruxifermin can be used for the research of non-alcoholic steatohepatitis .
|
- HY-P99940
-
ABT-122
|
TNF Receptor
Interleukin Related
|
Inflammation/Immunology
|
Remtolumab (ABT-122) is a dual-variable domain immunoglobulin that neutralises both tumor necrosis factor α (TNFα) and IL-17A. Remtolumab shows dual inhibition of TNFα and IL-17A. Remtolumab can be used for rheumatoid arthritis (RA) research .
|
- HY-P99463
-
AVB-S6-500
|
TAM Receptor
|
Cancer
|
Batiraxcept (AVB-S6-500) is a highly potent and specific AXL inhibitor, a recombinant fusion protein dimer containing the extracellular domain of human AXLM and human immunoglobulin G1 heavy chain (Fc). Batiraxcept binds to GAS6 and inhibits the interaction of GAS6 with AXL, thereby substantially reducing AXL signaled invasion and migration of highly metastatic cells in vitro and inhibiting metastatic disease in nonclinical models of aggressive human cancers. Batiraxcept is available for studies in advanced or metastatic clear cell renal cell carcinoma (ccRCC) and platinum sensitive recurrent ovarian cancer .
|
- HY-P99935
-
PRS-060; AZD1402
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Elarekibep (PRS-060) (AZD1402) is a high affinity, slowly dissociating, long-acting full antagonist of IL-4Ra. Elarekibep can be used for the research of T2 endotype asthma .
|
- HY-P99645
-
- HY-P99952
-
SCT400
|
CD20
|
Cancer
|
Ripertamab (SCT400) is a recombinant, human-mouse chimeric anti-CD20 IgG1κ mAb. Ripertamab can be used for the research of hematological malignancies, including non-Hodgkin’s lymphoma (NHL) .
|
- HY-P99692
-
p55TNF-R:Ig; Ro 45-2081; TNFR55-IgG1
|
TNF Receptor
|
Inflammation/Immunology
|
Lenercept (Ro 45-2081) is a recombinant fusion protein that consists of the soluble TNF-receptor (p55) linked to the Fc portion of human IgG1 .
|
- HY-P99722
-
REGN3470-3471-3479
|
Filovirus
|
Infection
|
Maftivimab (REGN3470-3471-3479), the inhibitor of Filovirus, is an Food and agent Administration (FDA)-approved agent. Maftivimab, also named as Atoltivimab, Odesivimab (Inmazeb), can be used for research of Zaire ebolavirus infection .
|
- HY-P99721
-
ABT-981
|
Interleukin Related
|
Inflammation/Immunology
|
Lutikizumab (ABT-981) is an anti-IL-1α and IL-1β dual variable domain immunoglobulin. Lutikizumab binds and inhibits IL-1α and IL-1β. Lutikizumab can be used for the research of osteoarthritis .
|
- HY-P99693
-
GC1102
|
HBV
|
Infection
|
Lenvervimab (GC1102) is a IgG1-type recombinant human hepatitis B Immunoglobulin. Lenvervimab can be used for research of hepatitis B virus infection .
|
- HY-P99720
-
ACE-536; luspatercept–aamt
|
TGF-beta/Smad
|
Metabolic Disease
|
Luspatercept (ACE-536) is a recombinant modified ActRIIB fusion protein that binds with transforming growth factor β superfamily ligands. Luspatercept increases the erythrocyte numbers and promotes maturation of erythroid precursors. Luspatercept binds with GDF11 and inhibits Smad2/3 signaling. Luspatercept can be used for the research of anemia .
|
- HY-P99667
-
OMP-54F28; FZD8-Fc
|
Wnt
|
Cancer
|
Ipafricept (OMP-54F28; FZD8-Fc) is the first class of recombinant fusion proteins, consisting of the extracellular portion of the human fried-8 receptor fused to the Fc fragment of human IgG1 binding to the Wnt ligand. Ipafricept shows solid tumor inhibition activity, with well tolerance .
|
- HY-P99590
-
ACE-011
|
TGF-β Receptor
|
Inflammation/Immunology
Cancer
|
Sotatercept (ACE-011) is a soluble activin receptor 2A (ACVR2A) type IgG Fc fusion protein. Sotatercept combines activin and growth differentiation factor to try to restore the balance between growth promotion and growth inhibition signal pathways. Sotatercept has potential application in pulmonary arterial hypertension, anemia, bone loss, erythropoiesis, multiple myeloma (MM) osteolytic lesions .
|
- HY-P99782
-
- HY-P99771
-
- HY-P99818
-
|
TGF-β Receptor
|
Metabolic Disease
|
Ramatercept is a soluble ActRIIB receptor and can be used as a soluble activin receptor 2 (ACVR2) antagonist. Ramatercept inhibits the signal pathway of muscle growth inhibition and has potential application in muscle atrophy .
|
- HY-P99821
-
- HY-P99798
-
AMG 420; BI-836909
|
CD3
|
Cancer
|
Pacanalotamab (AMG 420; BI-836909) is a bispecific T-cell engager (BiTE) targeting to BCMA and CD3ɛ. BCMA refers to B cell maturation antigen, as Pacanalotamab redirecting T cells to BCMA expressing cells on the cell surface. Pacanalotamab conducts T-cell redirected lysis of human multiple myeloma (MM) cell lines .
|
- HY-P99823
-
TA-46; sFGFR3
|
FGFR
|
Others
|
Recifercept (TA-46) is a soluble, recombinant fibroblast growth factor receptor 3 (FGFR3) molecule. Recifercept can be used as a decoy/ligand trap to decrease the amount of fibroblast growth factors that can bind to mutant FGFR3 receptors. Recifercept can be used for the research of achondroplasia .
|
- HY-P99802
-
BAY 2010112; AMG 212
|
CD3
|
Cancer
|
Pasotuxizumab (BAY 2010112) is a PSMA and CD3 bispecific T-cell engager (BiTE). Pasotuxizumab binds to CD3 and PSMA with KDs of 9.4 nM and 47.0 nM for human CD3 and PSMA. Pasotuxizumab can be used for research of metastatic castration-resistant prostate cancer (mCRPC) .
|
- HY-P99816
-
- HY-P99799
-
CX-072
|
PD-1/PD-L1
|
Cancer
|
Pacmilimab (CX-072) is a potent PD-L1 inhibitor. Pacmilimab shows antitumor activity .
|
- HY-P99814
-
AMG-701
|
CD3
|
Inflammation/Immunology
Cancer
|
Pavurutamab (AMG-701) is a bispecific T cell engager molecule that anti-CD3 and anti-B cell maturation antigens (BCMA). Pavurutamab has an extended half-life based on Pacanalotamab (HY-P99798). The Fc of Pavurutamab is coupled to molecules to improve pharmacokinetic parameters. Pavurutamab has potential applications in immune regulation and multiple myeloma (MM) .
|
- HY-P99817
-
|
Interleukin Related
HIV
|
Infection
|
Pegaldesleukin is a conjugate of polyethylene glycol and interleukin-2 (PEG-IL2). Pegaldeslukin has antiviral activity and has potential applications in HIV, possibly delaying the progression of HIV infection by retaining the immune repertoire .
|
- HY-P99777
-
TTI-621
|
Inhibitory Antibodies
|
Cancer
|
Ontorpacept (TTI-621) is a soluble fusion protein that consists of the human SIRPα N-terminal (1-118) linked to the Fc region of human IgG1. The N-terminal (1-118)-fragment of ontorpacept is a binding domain for CD47 which is an inhibitor of phagocytosis by macrophages. Ontorpacept is a CD47-blocking checkpoint inhibitor with antitumor activity .
|
- HY-P99742
-
ADC-1013; JNJ-64457107
|
TNF Receptor
|
Cancer
|
Mitazalimab (ADC-1013; JNJ-64457107) is FcγR-dependent CD40 agonist with tumor-directed activity. Mitazalimab activates antigen-presenting cells, e.g. dendritic cells (DC), to initiate tumor-reactive T cells. Therefore, Mitazalimab induces tumor-specific T cells to infiltrate and kill tumors. Mitazalimab remodels the tumor-infiltrating myeloid microenvironment .
|
- HY-P99100
-
CTL-002
|
PD-1/PD-L1
|
Cancer
|
Visugromab is aGDF-15 neutralizing IgG4 mAb. Visugromab exhibits potent effecicacy in PD-1/PD-L1 relapsed/refractory metastatic solid tumors .
|
- HY-P9958A
-
|
RANKL/RANK
|
Cancer
|
Denosumab (anti-TNFSF11) is a RANKL inhibitor that is effective against giant cell tumor of bone (GCTB).Denosumab eliminates RANK-positive tumor giant cells and reduces the relative content of proliferative, dense-cell tumor stromal cells .
|
- HY-108801A
-
|
VEGFR
|
Cardiovascular Disease
Metabolic Disease
|
Aflibercept (VEGF Trap) is a soluble decoy VEGFR constructed by fusing the Ig domains of VEGFR1 and VEGFR2 with the Fc region of human IgG1. Aflibercept inhibits VEGF signaling by reducing VEGF-regulated processes. Aflibercept can be used for thr research of age-related macular degeneration (AMD) and cardiovascular disease .
|
- HY-P990026
-
- HY-P990064
-
- HY-P990087
-
- HY-P990111
-
- HY-P99034
-
- HY-P99611
-
- HY-P990029
-
|
PD-1/PD-L1
|
Infection
Cancer
|
Eciskafusp alfa is a programmed cell death 1 (PDCD1, best known as PD-1) cis-targeted IL2v immunocytokine. Eciskafusp alfa preferentially targets antigen-specific stem-like PD-1+ TCF-1+ CD8+ T cells and differentiates them towards a novel population of better effectors. Eciskafusp alfa can be used for the research of cancer and chronic infections .
|
- HY-P990088
-
|
VEGFR
PD-1/PD-L1
|
Cardiovascular Disease
|
Sotiburafusp alfa is a bispecific fusion protein, which is a humanized VEGFR-1 extracellular domain fragment (129-228, 1-100 in the current sequence) fused via the peptide linker 101GGSGGSGGSGGSGGS 115 to the N-terminus of the heavy chain (116-564) of a humanized IgG1-kappa anti-human PD-L1 heavy chain variant L352>A, L353>A. Sotiburafusp alfa is also an angiogenesis inhibitor .
|
- HY-P990005
-
|
Inhibitory Antibodies
|
Others
|
Mouse IgG2a Fc, Isotype Control, is a Fc fragment of mouse IgG2a only and does not contain the Fab fragments. The molecular mass is about 34 kDa.
|
- HY-108841
-
AMG-719; Anakinra
|
Interleukin Related
|
Inflammation/Immunology
Cancer
|
Raleukin (AMG-719) is a recombinant, nonglycosylated human interleukin-1 receptor (IL-1R) antagonist. Raleukin (AMG-719) is the first biological agent to block the pro-inflammatory effects .
|
- HY-119810A
-
Ucb 44212 lithium
|
HIV
|
Neurological Disease
|
Seletracetam (Ucb 44212) lithium, as an analog of the antiepileptic agent Levetiracetam, is a SV2A modulator for the research of epilepsy .
|
- HY-103415
-
YM-09151-2; Emonapride
|
Dopamine Receptor
5-HT Receptor
|
Neurological Disease
|
Nemonapride is a highly potent dopamine D2 receptor antagonist with a Ki of 0.06 nM. Nemonapride also activates 5-HT1A receptor with an IC50 of 34 nM. Nemonapride is an antipsychotic that readily passes through the blood brain barrier and exhibits potent neuroleptic effects in animals .
|
- HY-145771
-
|
PD-1/PD-L1
|
Cancer
|
PD-1/PD-L1-IN-20 (Example 21) is a small-molecule inhibitor of the PD-1/PD-L1 protein-protein interaction. PD-1/PD-L1-IN-20 blocks PD-1/PD-L1 with the IC50 of 5.29 nM. PD-1/PD-L1-IN-20 can be used for the research of cancers, infectious diseases and autoimmune diseases .
|
- HY-P99035
-
|
Inhibitory Antibodies
|
Inflammation/Immunology
Cancer
|
Naptumomab estafenatox, a tumor targeting superantigen (TTS), is a fusion protein containing. Naptumomab estafenatox stimulates the immune system to identify and kill tumour cells. Naptumomab estafenatox can be used for the research of refractory solid tumors such as renal cell carcinoma .
|
- HY-108794
-
BMN 110; Chondrosulfatase; Chondroitinase; Chondrosulfatases; Chondroitin sulfatase
|
Inhibitory Antibodies
|
Others
|
Elosulfase alfa (BMN 110) is a recombinant form of human N-acetylgalactosamine-6-sulfatase (GALNS). Elosulfase alfa is used as an enzyme replacement therapy for mucopolysaccharidosis IVA (MPS IVA), also known as Morquio A syndrome .
|
- HY-108786
-
ENB-0040
|
Inhibitory Antibodies
|
Metabolic Disease
|
Asfotase alfa (ENB-0040) is a bone-targeted genetically engineered glycoprotein. Asfotase alfa increases the survival rate, bone mineralization and bone length and prevents mineralization defects of the feet, rib cage, lower limbs, jaw bones in Akp2 −/− knockout mice. Asfotase alfa can be used for the research of perinatal, infantile, and juvenile-onset hypophosphatasia (HPP) .
|
- HY-112935
-
BAX326; Coagulation Factor IX [Recombinant]
|
Inhibitory Antibodies
|
Others
|
Nonacog alfa (BAX326) is a recombinant human factor IX that can be used for the research of haemophilia B .
|
- HY-118860
-
Org 36286; MK-8962
|
Estrogen Receptor/ERR
|
Endocrinology
|
Corifollitropin alfa (Org 36286) is a long-acting recombinant follicle-stimulating hormone (FSH) analog. Corifollitropin alfa is a FSH Receptor agonist with an EC50 of 5.0 pM. Corifollitropin alfa stimulates ovulation and can be used in the research of infertility .
|
- HY-112998
-
|
Factor VIII
|
Others
|
Efmoroctocog alfa is a recombinant human coagulation factor VIII-Fc fusion protein (rFVIIIFc) that can be used for the research of haemophilia A .
|
- HY-P99255
-
CAT 8015; HA 22
|
Antibody-Drug Conjugates (ADCs)
CD22
|
Cancer
|
Moxetumomab pasudotox (CAT 8015) is anti-CD22 immunotoxin containing an anti-CD22 Fv and Pseudomonas exotoxin. CD22 is a cell surface receptor expressed on a variety of malignant B-cells. Moxetumomab pasudotox can be used in the research of hairy cell leukemia (HCL) .
|
- HY-P99338
-
CTL019
|
CD19
|
Inflammation/Immunology
Cancer
|
Tisagenlecleucel (CTL019) is an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy. Tisagenlecleucel targets and eliminates CD19-expressing B cells. Tisagenlecleucel can be used for the research of refractory aggressive diffuse large B-cell lymphoma .
|
- HY-P99339
-
IMCgp100
|
Interleukin Related
TNF Receptor
|
Cancer
|
Tebentafusp (IMCgp100) is a bispecific fusion protein to target gp100 peptide-HLA-A*02:01 (a melanoma-associated antigen). Tebentafusp guides T cells to kill gp100-expressing tumor cells via a high affinity T-cell receptor (TCR) binding domain and an anti-CD3 T-cell engaging domain. Tebentafusp leads to inflammatory cytokines and cytolytic proteins production, resulting in the direct lysis of tumour cells .
|
- HY-P99348
-
Ropeginterferon alfa-2b-njft; PEG-proline-interferon alpha-2b
|
Apoptosis
|
Cancer
|
Ropeginterferon alfa-2b (Ropeginterferon alfa-2b-njft) is a monopegylated IFN-α that can be used for the research of myeloproliferative neoplasms .
|
- HY-P99416
-
AGN-150998; MP0112
|
VEGFR
|
Cardiovascular Disease
Inflammation/Immunology
|
Abicipar pegol (AGN-150998, MP0112) is an anti-VEGF DARPin molecule, a novel class of small proteins containing ankyrin repeat domains engineered to bind with high specificity and affinity to target proteins. Abicipar pegol effectively inhibits angiogenesis and vascular permeability and is used in the study of diseases related to ocular inflammation by intravitreal injection, reducing mean retinal thickness and leakage area .
|
- HY-P99547
-
(vic)-Trastuzumab duocarmazine
|
Antibody-Drug Conjugates (ADCs)
|
Cancer
|
Trastuzumab duocarmazine ((vic)-Trastuzumab duocarmazine) is a HER2-targeting ADC that is recognized and cleaved by histone B in tumor cells and selectively targets tumor cells. Trastuzumab duocarmazine has anti-tumor activity and can be used in cancer research related to uterine and ovarian sarcomas .
|
- HY-P99436
-
ABR-214936
|
Inhibitory Antibodies
|
Inflammation/Immunology
Cancer
|
Anatumomab mafenatox (ABR-214936) is a 73 KDa recombinant protein to recognize the tumor-associated antigen 5T4, which is widely expressing in malignancy. Anatumomab mafenatox is between a modified form of SEA and a murine Fab. The main side effects of Anatumomab mafenatox are reported to include fever, low blood pressure, pain, nausea and drowsiness .
|
- HY-P99554
-
PRX-302
|
Inhibitory Antibodies
|
Cancer
|
Topsalysin is a PSA-activated protoxin, a pore-forming protein (synthetic proaerolysin) fusion protein with human prostate-specific antigen. Topsalysin has tumor suppression effect in mice modle .
|
- HY-P99497
-
|
Integrin
HCV
|
Infection
|
Cepeginterferon alfa-2b is a pegylated interferon. And Cepeginterferon alfa-2b has PEG with molecular weight of 20 kDa as a pegylated base. Cepeginterferon alfa-2b can be used for research of various diseases, such as hepatitis C virus (HCV), polycythemia vera (PV) and essential thrombocythemia (ET) .
|
- HY-P99879
-
Benegrastim; Bineuta; F 627
|
Inhibitory Antibodies
|
Inflammation/Immunology
|
Efbemalenograstim alfa (F 627) is a recombinant fusion protein. Efbemalenograstim alfa is a long acting dimeric granulocyte colony-stimulating factor (G-CSF) that contains two human G-CSF fused to a human immunoglobulin G2 (hIgG2)-Fc fragment with a peptide linker. Efbemalenograstim alfa induces the production of white blood cells .
|
- HY-P99427
-
alb-IFN
|
Inhibitory Antibodies
|
Infection
Inflammation/Immunology
|
Albinterferon alfa-2B (alb-IFN) is a recombinant protein consisting of interferon alfa-2b genetically fused to human albumin. Albinterferon alfa-2B can be used for the research of chronic hepatitis C .
|
- HY-P99477
-
- HY-P99579
-
AT-005; AT005
|
Inhibitory Antibodies
|
Cancer
|
Tamtuvetmab (AT-005) is a caninised blontuvetmab against CD52. Tamtuvetmab increases progression-free survival (PFS), exhibits in vivo efficacy in dogs with naïve T-cell lymphoma (LSA). Tamtuvetmab has been approved by veterinary .
|
- HY-P3393
-
- HY-P99917
-
|
STAT
|
Inflammation/Immunology
|
Eflepedocokin alfa is a recombinant fusion protein with potential cell protective activity. Eflepedocokin alfa consists of human IL-22 fused to human IgG2-Fc domain. Eflepedocokin alfa leads to the activation of IL-22/IL-22R-mediated signal transduction pathways as well as STAT3. Eflepedocokin alfa plays a role in immune response and bacterial infection, enhancing intestinal barrier function, intestinal immunity, and tissue repair .
|
- HY-P99920
-
ACE083
|
Inhibitory Antibodies
|
Others
|
Efmitermant alfa (ACE-083) is a locally acting, follistatin-based fusion protein. Efmitermant alfa also is a muscle-promoting agent. Efmitermant alfa can be used for the research of muscle disorders .
|
- HY-P99905
-
|
VEGFR
|
Cardiovascular Disease
Neurological Disease
|
Efdamrofusp alfa is a bispecific fusion protein. Efdamrofusp alfa is capable of neutralizing both VEGF isoforms and C3b/C4b. Efdamrofusp alfa can be used for the research of neovascular age-related macular degeneration (nAMD) and other complement-related ocular conditions .
|
- HY-P99907
-
- HY-P99919
-
|
Interleukin Related
|
Infection
|
Efmarodocokin alfa is a fusion protein of human IL-22 and the IgG4 crystallizable fragment. Efmarodocokin alfa activates IL-22 signaling. Efmarodocokin alfa can be used for the research of severe COVID-19 pneumonia .
|
- HY-P99928
-
- HY-P99908
-
NT-17
|
Interleukin Related
|
Cancer
|
Efineptakin alfa (NT-17) is a long-acting recombinant human IL-7. Efineptakin alfa supports the proliferation and survival CD4 + and CD8 + cells in both human and mice. Efineptakin alfa can be used for glioblastoma research .
|
- HY-152228
-
|
Histone Methyltransferase
Autophagy
|
Cancer
|
SMYD3-IN-2 is a SMYD3 inhibitor against gastric cancer via inducing lethal autophagy. SMYD3-IN-2 has inhibitory for SMYD3 and BGC823 cells with IC50 values of 0.81 μM and 0.75 μM, respectively. SMYD3-IN-2 can be used for the research of cancer .
|
- HY-P99690
-
- HY-P99647
-
ALX-0171; VR-465
|
RSV
|
Infection
|
Gontivimab (ALX-0171; VR-465) is a poent anti-RSV prefusion F protein nanobody with a KD value of 0.113 nM. Gontivimab shows antiviral activity. Gontivimab reduces the RSV load in the nose and lung .
|
- HY-P99666
-
|
IFNAR
|
Infection
|
Albinterferon alfa-2b is a type I interferon that activates novel genes and exerts potent antiviral and antiproliferative activity on target cells. Signaling by Albinterferon alfa-2b requires receptor-dependent activation of Stat1 and Stat2 to form a heterodimeric STAT that binds to the DNA-binding protein IRF-9 (p48) and forms ISGF-3 (IFN-stimulated gene factor 3). The driver genes are then further activated by ISGF-3 to achieve antiviral function .
|
- HY-P99696
-
LIB003
|
Ser/Thr Protease
|
Cardiovascular Disease
Metabolic Disease
|
Lerodalcibep (LIB003) is a recombinant fusion protein of a PCSK9-binding domain (adnectin) and human serum albumin. Lerodalcibep is a Lipid-lowering agent. Lerodalcibep can be used for the research of hypercholesterolemia and cardiovascular diseases .
|
- HY-P99665
-
LY-3209590
|
Insulin Receptor
|
Metabolic Disease
|
Insulin efsitora alfa (LY-3209590) is a selective agonist of insulin receptor (IR). Insulin efsitora alfa is a fusion protein composed of human IR agonists fused with the crystallizable (Fc) domain of human immunoglobulin G2 (IgG2) fragment, with a molecular weight of 64.1 kDa. Insulin efsitora alfa is well tolerated and has potential applications in diabetes .
|
- HY-P99694
-
JR-171
|
Inhibitory Antibodies
|
Neurological Disease
|
Lepunafusp alfa (JR-171) is a BBB-penetrable fusion protein consisting of J-Brain Cargo and IDUA (a lysosomal enzyme, α-L-iduronidase). Lepunafusp alfa can reduce concentration of heparan sulfate (HS) and dermatan sulfate (DS). Lepunafusp alfa can be used for research of mucopolysaccharidosis type I .
|
- HY-P99728
-
RG7835; RO7049665
|
Interleukin Related
|
Inflammation/Immunology
|
Melredableukin alfa (RO-7049665) is a fusion protein that consists of a human IgG1-κ fused to a mutated human interleukin 2 (IL2 mutein) via a peptide linker. Melredableukin alfa can be used for the research of autoimmune hepatitis and ulcerative colitis .
|
- HY-P99735
-
|
IFNAR
|
Infection
|
Mipeginterferon alfa-2b is an interferon alpha-2b (IFNA2b) analogue, with an average number of 5 substituted among 11 amino groups (one N-terminal and 10 lysine N6). Mipeginterferon alfa-2b has the relative molecular mass of 40 kDa .
|
- HY-P99769
-
SCT-800
|
Factor VIII
|
Metabolic Disease
|
Omfiloctocog alfa (SCT-800) is a recombinant factor VIII (FVIII). FVIII is an essential blood coagulation protein and a key component of the fluid phase blood coagulation system. Omfiloctocog alfa can be used for the research of Hemophilia A .
|
- HY-P99933
-
IMP321; LAG-3Ig
|
LAG-3
|
Cancer
|
Eftilagimod alfa (IMP321) is a recombinant LAG-3Ig fusion protein that binds to MHC class II. Eftilagimod alfa mediates antigen-presenting cell (APC) activation followed by CD8 T-cell activation. Eftilagimod alfa can be used for metastatic melanoma and metastatic breast carcinoma research .
|
- HY-P99934
-
ABBV-621
|
Apoptosis
|
Cancer
|
Eftozanermin alfa (ABBV-621) is a second-generation tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) agonist. Eftozanermin alfa induces apoptosis in tumor cells by activation of death receptors 4/5. Eftozanermin alfa can be used for the research of multiple solid and heme malignancies .
|
- HY-P99944
-
Retlirafusp alfa
|
PD-1/PD-L1
TGF-β Receptor
|
Cancer
|
SHR-1701 (Retlirafusp alfa) is a bifunctional fusion protein targeting PD-L1 and TGF-β for cancer research .
|
- HY-P99951
-
- HY-P99752
-
ALKS 4230; RDB-1450
|
Interleukin Related
|
Inflammation/Immunology
Cancer
|
Nemvaleukin alfa (ALKS 4230) is a IL-2 fusion protein that selectively binds to intermediate-affinity IL-2R. Nemvaleukin alfa is an activator of NK and effector T cells. Nemvaleukin alfa can be used for research of cancer .
|
- HY-108798
-
|
VEGFR
|
Cardiovascular Disease
Cancer
|
Ziv-aflibercept is a soluble inhibitor of vascular endothelial growth factor (VEGF). Ziv-aflibercept is an adaptive variant of Aflibercept (HY-108801), Ziv-aflibercept has a low PH value and high osmotic pressure when compared to Aflibercept. Ziv-aflibercept has potential applications in metastatic colorectal carcinoma and retinal diseases .
|
- HY-P99605
-
PRS 343
|
EGFR
TNF Receptor
|
Cancer
|
Cinrebafusp alfa (PRS 343) is a high affinity CD137/HER2 bispecfic anticalin-based drug. Cinrebafusp alfa binds to recombinant human HER2 (Kd=0.3 nM) and human monomeric CD137 (4-1BB; Kd=5 nM). Cinrebafusp alfa facilitates T-cell costimulation by tumor-localized, HER2-dependent 4-1BB clustering and activation, further enhancing T-cell receptor-mediated activity and leading to tumor destruction. Cinrebafusp alfa has the potential for HER2+ solid tumors research .
|
- HY-P99480
-
M7824; MSB0011359C
|
TGF-β Receptor
|
Cancer
|
Bintrafusp alfa (M 7824) is a first-in-class bifunctional fusion protein composed of the extracellular domain of TGF-βRII fused to a human IgG1 mAb blocking programmed cell death ligand. Bintrafusp alfa can be used for the research of cancer .
|
- HY-P99840
-
CB-2679d; DalcA; ISU-304
|
Inhibitory Antibodies
|
Others
|
Dalcinonacog alfa is a recombinant FIX factor that can be used in the study of Haemophilia B .
|
- HY-P99974
-
|
Microtubule/Tubulin
Apoptosis
Autophagy
|
Cancer
|
Nab-Paclitaxel is an albumin-bound nanoparticle formulation of Paclitaxel (HY-B0015). Nab-Paclitaxel is composed of albumin and the active pharmaceutical ingredient Paclitaxel (Paclitaxel: human albumin=1:9), in which human albumin is used as an excipient to disperse and stabilize particles and carry the main drug. Nab-Paclitaxel was associated with higher response rates and better tolerability, with favorable pharmacokinetic properties .
|
- HY-119594
-
|
Parasite
|
Infection
|
Melarsoprol, a melaminophenylarsine-type trivalent organic arsenical, is an important drug for African trypanosomiasis. Melarsoprol is also active against leukemia cell lines and plasma cells from myeloma patients. Melarsoprol increases the biliary output of GSH in rats .
|
- HY-108829A
-
CTLA4lg (powder); BMS-188667 (powder)
|
CTLA-4
|
Inflammation/Immunology
Cancer
|
Abatacept (CTLA4lg; BMS-188667) powder is a soluble fusion protein consisting of the extra-cellular domain of human CTLA4 and a fragment of the Fc portion of human IgG1 (hinge and CH2 and 3 domains). Abatacept powder is a selective T-cell co-stimulation modulator and a protein agent for the autoimmune diseases .
|
- HY-P99590A
-
|
Inhibitory Antibodies
|
Cardiovascular Disease
|
Sotatercept (mIgG2a) has direct cardioprotective actions, which reduces right ventricular (RV) remodeling and improves function in a pulmonary artery banding (PAB) mouse model .
|
- HY-P99829
-
PF-06647020; ABBV-647; h6M24-vc0101
|
Antibody-Drug Conjugates (ADCs)
Microtubule/Tubulin
|
Cancer
|
Cofetuzumab pelidotin (PF-06647020) is a PTK7-targeting ADC comprising a humanized anti-PTK7 mAb (hu6M024, IgG1) joined to an auristatin microtubule inhibitor payload, auristatin-0101 (Aur0101; HY-12522), by a cleavable valine-citrulline (vc)-based linker. Cofetuzumab pelidotin has a DAR of 4. Cofetuzumab pelidotin binds to cell-surface PTK7 with an EC50 of 1153 pM by flow cytometry. Cofetuzumab pelidotin has the potential for solid tumors research .
|
- HY-P990305
-
- HY-P3385
-
SCB-313
|
Inhibitory Antibodies
|
Others
|
Rilunermin alfa (SCB-313) is an active compound. Rilunermin alfa can be used for various biochemical studies .
|
Cat. No. |
Product Name |
Category |
Target |
Chemical Structure |
Cat. No. |
Compare |
Product Name |
Species |
Source |
Compare Products
|
Products |
|
Cat. No. |
|
Species |
|
Source |
|
Tag |
|
Accession |
|
Gene ID |
|
Molecular Weight |
|
Purity |
|
Endotoxin Level |
|
Biological Activity |
|
Appearance |
|
Formulation |
|
Storage & Stability |
|
Shipping |
|
Free Sample |
Yes
No
|
Size |
* This product has been "discontinued".
Optimized version of product available:
|
Cat. No. |
Product Name |
Chemical Structure |
-
- HY-12454S
-
|
DM4-d6 is deuterium labeled DM4. DM4 is is an antitubulin agent that inhibit cell division. DM4 can be used in the preparation of antibody agent conjugate.
|
-
-
- HY-B0199S
-
|
Mycophenolate Mofetil-d4 is the deuterium labeled Mycophenolate Mofetil. Mycophenolate mofetil (RS 61443) is the morpholinoethylester proagent of Mycophenolic acid. Mycophenolate mofetil inhibits de novo purine synthesis via the inhibition of inosine monophosphate dehydrogenase (IMPDH). Mycophenolate mofetil shows selective lymphocyte antiproliferative effects involve both T and B cells, preventing antibody formation[1].
|
-
-
- HY-P5168S
-
|
GPSVFPLAPSSK- 13C6 is the 13C labeled GPSVFPLAPSSK. GPSVFPLAPSSK is an IgG1 signature peptide of anti-SARS-CoV-2 antibodies. GPSVFPLAPSSK can be used for the quantification of the specific isolation of anti-SARS-CoV-2 antibodies .
|
-
-
- HY-P5201S
-
|
VTSEGAGLQLQK- 13C6, 15N2 is the 13C and 15N labeled VTSEGAGLQLQK. VTSEGAGLQLQK is an amino acid sequence in the C-terminal region of recombinant human alpha-acid glucosidase (rhGAA). VTSEGAGLQLQK can be used to bind anti-drug antibodies (ADA) in plasma and quantitatively analyze the therapeutic effect .
|
-
-
- HY-P5201S1
-
|
VTSEGAGLQLQK- 13C6, 15N2 (TFA) is the 13C- and 15N-labeled VTSEGAGLQLQK. VTSEGAGLQLQK is an amino acid sequence in the C-terminal region of recombinant human alpha-acid glucosidase (rhGAA), which can be used to bind anti-drug antibodies in plasma and quantitatively analyze the therapeutic effect .
|
-
-
- HY-15583S
-
|
Auristatin F-d8 is deuterium labeled Auristatin F (HY-15583). Auristatin F is a potent cytotoxin in antibo-conjugated agents and an analogue of MMAF. Auristatin F is a potent microtubule inhibitor and vascular damaging agent (VDA). Auristatin F inhibits cell division by preventing tubulin aggregation.Auristatin F can be used in antibody-drug conjugates (ADC) .
|
-
-
- HY-114816S
-
|
N-butyryl-L-Homoserine lactone-d5 is the deuterium labeled N-Butanoyl-L-homoserine lactone. N-Butanoyl-L-homoserine lactone (C4-HSL) is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N-Butanoyl-L-homoserine lactone has antibacterial activity and is used in antibacterial biofilm[1]. N-Butanoyl-L-homoserine lactone aptamers blocks qurom sensing and inhibits biofilm formation in Pseudomonas aeruginosa[2][3].
|
-
-
- HY-161022S1
-
|
FL118-C3-O-C-amide-C-NH2-d5 formate is a deuterium labeled FL118-C3-O-C-amide-C-NH2 formate. FL118-C3-O-C-amide-C-NH2 formate is an ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
Cat. No. |
Product Name |
Application |
Reactivity |
-
- HY-P80276
-
AKT 1 Antibody; AKT Antibody; AKT1 Antibody; AKT1_HUMAN Antibody; MGC99656 Antibody; PKB Antibody; PKB-ALPHA Antibody; PRKBA Antibody; Protein Kinase B Alpha Antibody; Protein kinase B Antibody; Proto-oncogene c-Akt Antibody; RAC Alpha Antibody; RAC Antibody; RAC-alpha serine/threonine-protein kinase Antibody; RAC-PK-alpha Antibody;
|
WB, ICC/IF, IHC-P
|
Human, Mouse |
Phospho-Akt1(Ser473) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 56 kDa, targeting to Phospho-Akt1(Ser473). It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.
|
-
- HY-P81248
-
SN-38 Antibody,SN38 Antibody
|
ELISA
|
Species independent |
-
- HY-P80879
-
Antibody; Ig gamma chain C region; Ig kappa-b4 chain C region; Ig kappa-b5 chain C region; Ig kappa-b9 chain C region; Ig lambda chain C region; K-BAS.
|
WB, ELISA
|
Rabbit |
Rabbit IgG Antibody (YA680) is a non-conjugated and Mouse origined monoclonal antibody about 55,25 kDa.Rabbit IgG (5B2). It can be used for WB,ELISA assays with tag free, in the background of Rabbit.
|
-
- HY-P83658
-
CATE Antibody; CATE_HUMAN Antibody; Cathepsin E Antibody; Cathepsin E form II Antibody; CTSE Antibody; Erythrocyte membrane aspartic proteinase Antibody; Slow moving proteinase Antibody
|
WB, IHC-P
|
Human, Mouse, Rat |
-
- HY-P81242
-
GCG Antibody; Glucagon
|
WB; IF-Cell; IHC-P; FC;
|
Human, Mouse, Rat |
-
- HY-P81060
-
Quinolones Antibody
|
ELISA
|
Species independent |
Quinolones Antibody (YA903) is an unconjugated, rabbit-derived, anti-Quinolones (YA903) monoclonal antibody. Quinolones Antibody (YA903) can be used for: ELISA expriments in species-independent background without labeling.
|
-
- HY-P81061
-
Clenbuterol Antibody
|
ELISA
|
|
Clenbuterol Antibody (YA904) is an unconjugated, rabbit-derived, anti-Clenbuterol (YA904) monoclonal antibody. Clenbuterol Antibody (YA904) can be used for: ELISA expriments in background without labeling.
|
-
- HY-P80464
-
Hormone sensitive lipase Antibody; Hormone sensitive lipase testicular isoform Antibody; Hormone-sensitive lipase Antibody; HSL Antibody; LHS; Lipase hormone sensitive Antibody; LIPE Antibody; LIPS_HUMAN Antibody; Phospho-Hormonesensitivelipase(S853); PhosphoHormonesensitivelipase(S853)
|
WB, IHC-P
|
Human, Mouse, Rat |
Phospho-Hormone sensitive lipase (Ser853) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 117 kDa, targeting to Phospho-Hormone sensitive lipase (S853). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
-
- HY-P80010
-
|
WB, IHC-P
|
Human, Mouse |
Albumin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 69 kDa, targeting to Albumin. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
|
-
- HY-P80011
-
|
WB, IHC-P, FC
|
Human, Rat |
ALIX Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 96 kDa, targeting to ALIX. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Rat.
|
-
- HY-P80016
-
|
WB, ICC, IP
|
Human, Mouse |
APC Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 312 kDa, targeting to APC. It can be used for WB,ICC,IP assays with tag free, in the background of Human, Mouse.
|
-
- HY-P80023
-
|
WB, ICC/IF, IHC-P
|
Human |
ATM Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 351 kDa, targeting to ATM. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human.
|
-
- HY-P80024
-
|
ICC, IHC-P
|
Mouse |
ATRX Antibody is a non-conjugated and Mouse origined monoclonal antibody about 280 kDa, targeting to ATRX. It can be used for ICC,IHC-P assays with tag free, in the background of Mouse.
|
-
- HY-P80025
-
|
WB, ICC/IF, IHC-P, FC, IP
|
Human |
Bad Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 18 kDa, targeting to Bad. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human.
|
-
- HY-P80031
-
|
WB, ICC/IF, IHC-P, FC, IP
|
Human |
Bid Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 22 kDa, targeting to Bid. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human.
|
-
- HY-P80032
-
|
WB, ICC, IHC-P, IP
|
Human, Mouse |
Bim Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 22 kDa, targeting to Bim. It can be used for WB,ICC,IHC-P,IP assays with tag free, in the background of Human, Mouse.
|
-
- HY-P80040
-
|
WB, ICC/IF, IHC-P
|
Human, Mouse, Rat |
Calbindin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 30 kDa, targeting to Calbindin. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
-
- HY-P80042
-
|
WB, ICC, IHC-P
|
Human |
Calpastatin Antibody is a non-conjugated and Mouse origined monoclonal antibody about 120 kDa, targeting to Calpastatin. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human.
|
-
- HY-P80043
-
|
WB, ICC, IHC-P, FC, IP
|
Human, Mouse |
Calreticulin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 48 kDa, targeting to Calreticulin. It can be used for WB,ICC,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse.
|
-
- HY-P80087
-
|
WB, ICC, IHC-P, FC
|
Human, Mouse, Rat |
CNPase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 48 kDa, targeting to CNPase. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
-
- HY-P80088
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human, Mouse |
Cortactin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 62 kDa, targeting to Cortactin. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
|
-
- HY-P80092
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human, Mouse |
CREB Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 35 kDa, targeting to CREB. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
|
-
- HY-P80103
-
|
WB, ICC/IF, IHC-P, FC
|
Human, Mouse, Rat |
Desmin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to Desmin. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
-
- HY-P80108
-
|
WB, FC
|
Human, Mouse, Rat |
Doublecortin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 41 kDa, targeting to Doublecortin. It can be used for WB,FC assays with tag free, in the background of Human, Mouse, Rat.
|
-
- HY-P80110
-
|
WB, ICC, IF, IHC-P, FC
|
Human |
Drosha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 159 kDa, targeting to Drosha. It can be used for WB,ICC,IF,IHC-P,FC assays with tag free, in the background of Human.
|
-
- HY-P80115
-
|
WB, IHC-P, IP
|
Human |
EGF Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 130/10 kDa, targeting to EGF. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human.
|
-
- HY-P80116
-
|
WB, ICC/IF, IHC-P, IP
|
Human, Mouse, Rat |
EGFR Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 134 kDa, targeting to EGFR. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
|
-
- HY-P80125
-
|
WB, ICC/IF, IHC-P, FC, IP
|
Human, Mouse |
FAK Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 119 kDa, targeting to FAK. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse.
|
-
- HY-P80131
-
|
WB, IHC-P, IP
|
Human, Mouse |
FosB Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to FosB. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse.
|
-
- HY-P80136
-
|
WB, IHC-P, FC
|
Human, Mouse, Rat |
GABARAP Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 14 kDa, targeting to GABARAP. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
-
- HY-P80137
-
|
WB, ICC/IF, IHC-P, FC, IP
|
Human, Mouse, Rat, Chicken |
GAPDH Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to GAPDH. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse, Rat, Chicken.
|
-
- HY-P80141
-
|
WB, ICC/IF, IHC-P, IP
|
|
GFP Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 27 kDa, targeting to GFP. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of .
|
-
- HY-P80188
-
|
WB, IHC-P, FC
|
Human, Mouse, Rat |
Huntingtin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 348 kDa, targeting to Huntingtin. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
-
- HY-P80190
-
|
WB, IHC-P, ELISA
|
Human |
Insulin Antibody is a non-conjugated and Mouse origined monoclonal antibody about 12 kDa, targeting to Insulin. It can be used for WB,IHC-P,ELISA assays with tag free, in the background of Human.
|
-
- HY-P80200
-
|
WB, ICC/IF, IHC-P, IP
|
Human |
JunB Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to JunB. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human.
|
-
- HY-P80216
-
|
WB, FC
|
Human |
MCU Antibody is a non-conjugated and Mouse origined monoclonal antibody about 40 kDa, targeting to MCU. It can be used for WB,FC assays with tag free, in the background of Human.
|
-
- HY-P80224
-
|
WB, IHC-P
|
Human |
MGMT Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 22 kDa, targeting to MGMT. It can be used for WB,IHC-P assays with tag free, in the background of Human.
|
-
- HY-P80225
-
|
WB, ICC, FC
|
Human, Mouse, Rat |
MiTF Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 59 kDa, targeting to MiTF. It can be used for WB,ICC,FC assays with tag free, in the background of Human, Mouse, Rat.
|
-
- HY-P80227
-
|
WB, IHC-P
|
Human, Mouse |
MLKL Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to MLKL. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
|
-
- HY-P80228
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human, Mouse |
Moesin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 68 kDa, targeting to Moesin. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
|
-
- HY-P80237
-
|
WB, ICC/IF, FC, IHC-P
|
Human, Mouse |
Nanog Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 35 kDa, targeting to Nanog. It can be used for WB,ICC/IF,FC,IHC-P assays with tag free, in the background of Human, Mouse.
|
-
- HY-P80241
-
|
WB, ICC/IF, IHC-P, FC
|
Human, Mouse, Rat |
NeuN Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 34 kDa, targeting to NeuN. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
-
- HY-P80249
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human, Mouse, Rat |
nNOS Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 161 kDa, targeting to nNOS. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
|
-
- HY-P80252
-
|
WB, ICC, IHC-P
|
Human, Mouse, Rat |
Nucleolin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 77 kDa, targeting to Nucleolin. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
-
- HY-P80253
-
|
WB, ICC, IHC-P
|
Human, Mouse, Rat |
NUMB Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 71 kDa, targeting to NUMB. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
-
- HY-P80254
-
|
WB, ICC, IF, IHC-P, FC
|
Human, Mouse, Rat |
OGT Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 117 kDa, targeting to OGT. It can be used for WB,ICC,IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
-
- HY-P80266
-
|
WB, ICC/IF, IHC-P, IP
|
Human, Mouse |
Paxillin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 65 kDa, targeting to Paxillin. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse.
|
-
- HY-P80268
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human, Mouse |
PCNA Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 29 kDa, targeting to PCNA. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
|
-
- HY-P80283
-
|
WB, ICC/IF, IHC-P, IP
|
Human |
PKR Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 62 kDa, targeting to PKR. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human.
|
-
- HY-P80286
-
|
WB, ICC/IF, IHC-P
|
Human, Mouse |
PTEN Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to PTEN. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80289
-
|
WB, ICC/IF, IHC-P, FC
|
Human, Mouse |
PUMA Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 21 kDa, targeting to PUMA. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80298
-
|
WB, ICC/IF, IP
|
Human, Rat |
Ras Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 21 kDa, targeting to Ras. It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Rat.
|
- HY-P80300
-
|
WB, ICC/IF, IHC-P, IP
|
Human, Mouse |
Rb Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 106 kDa, targeting to Rb. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse.
|
- HY-P80305
-
|
WB
|
Human |
RBPJK Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 56 kDa, targeting to RBPJK. It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80306
-
|
WB, ICC/IF, IHC-P, IP
|
Human |
RelB Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 62 kDa, targeting to RelB. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human.
|
- HY-P80307
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human, Mouse |
Ret Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 124 kDa, targeting to Ret. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80310
-
|
WB, ICC, IF, IHC-P, FC
|
Human, Mouse |
RHEB Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 20 kDa, targeting to RHEB. It can be used for WB,ICC,IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80312
-
|
WB, IHC-P, ICC, FC
|
Human, Mouse |
RICTOR Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 192 kDa, targeting to RICTOR. It can be used for WB,IHC-P,ICC,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80313
-
|
WB, FC
|
Human |
RIP Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 76 kDa, targeting to RIP. It can be used for WB,FC assays with tag free, in the background of Human.
|
- HY-P80318
-
|
WB, ICC/IF, IHC-P, FC
|
Human, Mouse |
SDHA Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 73 kDa, targeting to SDHA. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80338
-
|
WB, ICC/IF, IHC-P, FC
|
Human, Mouse, Rat |
Src Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 60 kDa, targeting to Src. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80358
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human, Mouse, Rat |
TrkA Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 87 kDa, targeting to TrkA. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80360
-
|
WB, IHC-P
|
Mouse, Rat |
TrkB Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 92 kDa, targeting to TrkB. It can be used for WB,IHC-P assays with tag free, in the background of Mouse, Rat.
|
- HY-P80361
-
|
WB, ICC/IF, IHC-P, FC
|
Human, Mouse, Rat |
TXNIP Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 44 kDa, targeting to TXNIP. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80368
-
|
WB, IP
|
Human |
VASP Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 46 kDa, targeting to VASP. It can be used for WB,IP assays with tag free, in the background of Human.
|
- HY-P80371
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human, Mouse, Rat |
Vimentin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to Vimentin. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80372
-
|
WB, ICC/IF, IP, IHC
|
Human, Mouse, Rat |
Vinculin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 124 kDa, targeting to Vinculin. It can be used for WB,ICC/IF,IP,IHC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80493
-
|
WB, ICC/IF, IHC-P
|
Human, Mouse |
Fibronectin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 272 kDa, targeting to Fibronectin. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80498
-
|
WB, ICC, IHC-P, FC
|
Human, Mouse |
Hamartin Antibody is a non-conjugated and Mouse origined monoclonal antibody about 130 kDa, targeting to Hamartin. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80517
-
|
IHC-P
|
Human |
pVHL Antibody is a non-conjugated and Mouse origined monoclonal antibody about 24 kDa, targeting to pVHL. It can be used for IHC-P assays with tag free, in the background of Human.
|
- HY-P80986
-
|
WB, IHC-P, IP
|
Human |
Villin Antibody is an unconjugated, rabbit-derived, anti-Villin monoclonal antibody. Villin Antibody can be used for: WB, IHC-P, IP expriments in human background without labeling.
|
- HY-P81249
-
CLR19.3 Antibody; FCAS2 Antibody; Monarch 1 Antibody; Monarch-1 Antibody; NACHT, leucine rich repeat and PYD containing 12 Antibody; NACHT, LRR and PYD containing protein 12 Antibody; NACHT, LRR and PYD domains-containing protein 12 Antibody; NAL12_HUMAN Antibody; NLR family, pyrin domain containing 12 Antibody; NLRP12 Antibody; Nucleotide-binding oligomerization domain, leucine rich repeat and pyrin domain containing 12 Antibody; OTTHUMP00000067227 Antibody; PAN6 Antibody; PYPAF7 Antibody; PYRIN containing APAF1 like protein 7 Antibody; PYRIN-containing APAF1-like protein 7 Antibody; Regulated by nitric oxide Antibody; RNO Antibody; RNO2 Antibody;
|
ELISA; IHC-P; IHC-F; IF;
|
Human, Rat, Mouse, Dog, Pig, Cow, Horse, Rabbit, Sheep |
- HY-P83202
-
FLJ13874 Antibody; Heat shock 70 kDa protein 12A Antibody; heat shock 70kD protein 12A Antibody; heat shock 70kDa protein 12A Antibody; HS12A_HUMAN Antibody; Hspa12a Antibody; KIAA0417 Antibody
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P80948B
-
HA epitope tag Antibody; HA1; HA2; hemagglutinin Antibody
|
WB, IF-Cell, IP
|
Species independent |
Anti-HA tag Antibody is a non-conjugated and Rabbit origined monoclonal antibody. It can be used for WB, IF-Cell, IP assays in the background of .
|
- HY-P80427
-
PLC gamma 1 Antibody; PLC II Antibody; PLC-148 Antibody; PLCgamma1 Antibody; PLCG1; NCKAP3
|
WB, ICC, IP
|
Human |
Phospholipase C gamma 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 149 kDa, targeting to Phospholipase C gamma 1. It can be used for WB,ICC,IP assays with tag free, in the background of Human.
|
- HY-P80148A
-
Glutathione S Transferase Antibody
|
WB, IF-Cell, IP
|
|
The glutathione S-transferase (GST) family of enzymes comprises a long list of cytosolic, mitochondrial, and microsomal proteins that are capable of multiple reactions with a multitude of substrates, both endogenous and xenobiotic. Mammalian cytosolic GSTs are dimeric both subunits being from the same class of GSTs. The monomers are in the range of 22–29 kDa. Glutathione S-transferase is used to create the “GST gene fusion system” in genetic engineering. Here, GST is used to purify and detect proteins of interest.
|
- HY-P80347
-
12S1644 Antibody; D12S1644 Antibody; IL 4 STAT Antibody; IL-4 Stat Antibody; IL4 STAT Antibody; Interleukin 4 Induced Antibody; Interleukin 4 Induced Transcription Factor IL4 STAT Antibody; Signal transducer and activator of transcription 6 Antibody; Signal Transducer And Activator Of Transcription 6 Interleukin 4 Induced Antibody; Signal Transducer And Activator Of Transcription 6 Nirs Variant 1 Antibody; Signal transducer and activator of transcription 6, interleukin 4 induced Antibody;
STAT 6 Antibody; STAT interleukin4 induced Antibody; STAT, interleukin4 induced Antibody; Stat6 Antibody; STAT6_HUMAN Antibody; STAT6B Antibody; STAT6C Antibody; Transcription factor IL 4 STAT Antibody;
|
WB, ICC/IF, IHC-P, IP
|
Human, Mouse |
STAT6 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 94 kDa, targeting to STAT6. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse.
|
- HY-P81048
-
Alpha 1 (VI) chain (61 AA) Antibody; CO6A1_HUMAN Antibody; COL6A1 Antibody; Collagen alpha-1(VI) chain Antibody; Collagen type VI alpha 1 Antibody; Collagen VI alpha 1 polypeptide Antibody; Collagen VI Antibody; Human mRNA for collagen VI alpha 2 C terminal globular domain Antibody; OPLL Antibody; PP3610 Antibody
|
WB, IF-Cell, IF-Tissue, IHC-P
|
Human, Mouse, Rat |
Collagen VI Antibody (YA893) is an unconjugated, approximately 109 kDa, rabbit-derived, anti-Collagen VI (YA893) monoclonal antibody. Collagen VI Antibody (YA893) can be used for: WB, IF-Cell, IF-Tissue, IHC-P expriments in human, mouse, rat background without labeling.
|
- HY-P83646
-
Goat Anti-Rabbit IgG Antibody
|
WB;ELISA
|
Rabbit |
- HY-P80002
-
|
WB, ICC/IF, IHC-P, FC
|
Human, Mouse |
ABCG2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 72 kDa, targeting to ABCG2. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80012
-
|
WB, ICC, IHC-P, IP, FC
|
Human, Mouse |
Alkaline Phosphatase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 57 kDa, targeting to Alkaline Phosphatase. It can be used for WB,ICC,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80013
-
|
WB, IHC-P
|
Human |
ALKBH1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 44 kDa, targeting to ALKBH1. It can be used for WB,IHC-P assays with tag free, in the background of Human.
|
- HY-P80014
-
|
WB, ICC/IF
|
Human |
Androgen receptor Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 99 kDa, targeting to Androgen receptor. It can be used for WB,ICC/IF assays with tag free, in the background of Human.
|
- HY-P80017
-
|
WB, ICC/IF
|
Human, Rat |
APC6 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 72 kDa, targeting to APC6. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Rat.
|
- HY-P80018
-
|
WB, ICC/IF, IHC-P, FC
|
Human, Mouse |
A-RAF Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 68 kDa, targeting to A-RAF. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80019
-
|
WB, IHC-P
|
Human |
Arginase-1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 35 kDa, targeting to Arginase-1. It can be used for WB,IHC-P assays with tag free, in the background of Human.
|
- HY-P80021
-
|
WB, IHC-P, ICC
|
Human, Mouse, Rat |
Atg12 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 15 kDa, targeting to Atg12. It can be used for WB,IHC-P,ICC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80022
-
|
WB, ICC/IF, IHC-P, IP
|
Human, Rat, Mouse, Monkey |
ATG5 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 32 kDa, targeting to ATG5. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Rat, Mouse, Monkey.
|
- HY-P80029
-
|
WB, ICC/IF, IHC-P, FC
|
Human, Mouse, Rat |
Bcl-2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 26 kDa, targeting to Bcl-2. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80030
-
|
WB, ICC/IF, IHC-P, FC, IP
|
Human |
Bcl-XL Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 26 kDa, targeting to Bcl-XL. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human.
|
- HY-P80033
-
|
WB, ICC/IF
|
Human, Mouse, Rat |
BMAL1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 69 kDa, targeting to BMAL1. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80034
-
|
WB, ICC, IHC-P, FC
|
Human, Mouse, Rat |
Bmi1 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 37 kDa, targeting to Bmi1. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80035
-
|
WB, ICC/IF, IHC-P
|
Human, Mouse |
BNIP3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 22 kDa, targeting to BNIP3. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80036
-
|
WB, IHC-P, ICC
|
Human, Mouse, Rat |
B-Raf Antibody is a non-conjugated and Mouse origined monoclonal antibody about 84 kDa, targeting to B-Raf. It can be used for WB,IHC-P,ICC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80037
-
|
WB, ICC, IHC-P, FC
|
Human |
BRD2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 88 kDa, targeting to BRD2. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human.
|
- HY-P80039
-
|
WB, ICC/IF, IHC-P, IP
|
Human, Mouse, Rat |
BRG1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 185 kDa, targeting to BRG1. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80044
-
|
WB, IHC-P, FC, IP
|
Human |
Caspase-10 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 59 kDa, targeting to Caspase-10. It can be used for WB,IHC-P,FC,IP assays with tag free, in the background of Human.
|
- HY-P80045
-
|
WB, ICC/IF, IHC-P, FC, IP
|
Human, Mouse |
Caspase-14 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 28 kDa, targeting to Caspase-14. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse.
|
- HY-P80046
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human |
Caspase-3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 32 kDa, targeting to Caspase-3. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human.
|
- HY-P80047
-
|
WB, ICC/IF, IHC-P, IP
|
Human, Mouse, Rat |
Caspase-6 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 33 kDa, targeting to Caspase-6. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80049
-
|
WB, ICC/IF, IHC-P
|
Human |
Caspase-8 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 55 kDa, targeting to Caspase-8. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human.
|
- HY-P80050
-
|
WB, ICC/IF, IHC-P, IP
|
Human, Mouse |
Caspase-9 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 46 kDa, targeting to Caspase-9. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse.
|
- HY-P80053
-
|
WB, ICC/IF, IHC-P
|
Human, Mouse |
Caveolin-1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 20 kDa, targeting to Caveolin-1. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80054
-
|
WB, IHC-P, FC
|
Human, Mouse |
CD133 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 97 kDa, targeting to CD133. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80055
-
|
WB, ICC/IF, IHC-P
|
Human |
CD4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 51 kDa, targeting to CD4. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human.
|
- HY-P80056
-
|
WB, ICC, IHC-P
|
Human |
CD40 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 31 kDa, targeting to CD40. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human.
|
- HY-P80058
-
|
WB, IHC-P
|
Human |
CD41 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 113 kDa, targeting to CD41. It can be used for WB,IHC-P assays with tag free, in the background of Human.
|
- HY-P80061
-
|
WB, IHC-P, FC
|
Human |
CD43 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 40 kDa, targeting to CD43. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human.
|
- HY-P80062
-
|
WB, IHC-P, FC
|
Human, Mouse |
CD44 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 82 kDa, targeting to CD44. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80064
-
|
WB, ICC, IHC-P
|
Human, Rat |
CD46 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 44 kDa, targeting to CD46. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Rat.
|
- HY-P80065
-
|
IHC-P
|
Human |
CD47 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 35 kDa, targeting to CD47. It can be used for IHC-P assays with tag free, in the background of Human.
|
- HY-P80069
-
|
WB, IHC-P
|
Human, Rat |
CD90 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 18 kDa, targeting to CD90. It can be used for WB,IHC-P assays with tag free, in the background of Human, Rat.
|
- HY-P80070
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human |
CD99 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 25 kDa, targeting to CD99. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human.
|
- HY-P80071
-
|
WB, ICC/IF
|
Human |
CDC23 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 69 kDa, targeting to CDC23. It can be used for WB,ICC/IF assays with tag free, in the background of Human.
|
- HY-P80073
-
|
WB, IHC-P
|
Human |
Cdc27 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 92 kDa, targeting to Cdc27. It can be used for WB,IHC-P assays with tag free, in the background of Human.
|
- HY-P80074
-
|
WB, IHC-P, IP, FC
|
Human, Mouse |
CDC42 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 21 kDa, targeting to CDC42. It can be used for WB,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80077
-
|
WB, ICC/IF, IHC-P, IP
|
Human, Mouse |
Cdk4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 34 kDa, targeting to Cdk4. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse.
|
- HY-P80078
-
|
WB, IHC-P, FC, IP
|
Human, Mouse, Rat |
Cdk5 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 33 kDa, targeting to Cdk5. It can be used for WB,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80079
-
|
WB, ICC/IF, IHC-P, FC
|
Human |
Cdk6 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 37 kDa, targeting to Cdk6. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human.
|
- HY-P80080
-
|
WB, IHC-P, IP
|
Human |
CDT1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 60 kDa, targeting to CDT1. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human.
|
- HY-P80083
-
|
WB, ICC/IF, IHC-P, IP
|
Human |
Chk2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 61 kDa, targeting to Chk2. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human.
|
- HY-P80084
-
|
WB, ICC, IHC-P, IP
|
Human, Mouse, Rat |
c-Jun Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to c-Jun. It can be used for WB,ICC,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80089
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human, Mouse, Rat |
COX IV Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 20 kDa, targeting to COX IV. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80090
-
|
WB, IHC-P, FC
|
Human, Rat |
COX2 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 69 kDa, targeting to COX2. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Rat.
|
- HY-P80093
-
|
WB, IHC-P, IP
|
Human |
c-Rel Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 69 kDa, targeting to c-Rel. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human.
|
- HY-P80094
-
|
WB, IHC-P, FC
|
Human |
Ctip1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 91 kDa, targeting to Ctip1. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human.
|
- HY-P80095
-
|
WB, ICC, IHC-P, FC
|
Human, Mouse |
Ctip2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 100/110kDa, targeting to Ctip2. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80101
-
|
WB, IHC-P
|
Human, Mouse |
Cyclophilin A Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 18 kDa, targeting to Cyclophilin A. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80102
-
|
WB, ICC/IF, IHC-P, IP
|
Human, Mouse, Rat |
Cytochrome C Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 12 kDa, targeting to Cytochrome C. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80109
-
|
WB, IP, IHC-P, FC
|
Human |
DR5 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 48 kDa, targeting to DR5. It can be used for WB,IP,IHC-P,FC assays with tag free, in the background of Human.
|
- HY-P80114
-
|
WB, IHC-P
|
Human, Mouse, Rat |
EEA1 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 162 kDa, targeting to EEA1. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80117
-
|
WB, IHC-P
|
Human |
EGR1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 58 kDa., targeting to EGR1. It can be used for WB,IHC-P assays with tag free, in the background of Human.
|
- HY-P80120
-
|
WB, IHC-P, IP, ICC/IF
|
Human, Mouse |
Epac1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 104 kDa, targeting to Epac1. It can be used for WB,IHC-P,IP,ICC/IF assays with tag free, in the background of Human, Mouse.
|
- HY-P80122
-
|
WB, ICC/IF, IP, FC
|
Human, Mouse |
ERK5 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 115 kDa, targeting to ERK5. It can be used for WB,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80123
-
|
WB, IHC-P, ICC, FC
|
Human, Mouse, Rat |
ERp72 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 73 kDa, targeting to ERp72. It can be used for WB,IHC-P,ICC,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80124
-
|
WB, ICC/IF, IHC-P
|
Human, Mouse, Rat |
FABP4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to FABP4. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80128
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human, Mouse, Rat |
Fatty Acid Synthase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 273 kDa, targeting to Fatty Acid Synthase. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80129
-
|
WB, ICC/IF, IHC-P, FC
|
Human, Mouse |
Filamin A Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 281 kDa, targeting to Filamin A. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80130
-
|
WB
|
Human, Mouse |
FIP200 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 183 kDa, targeting to FIP200. It can be used for WB assays with tag free, in the background of Human, Mouse.
|
- HY-P80134
-
|
WB, ICC/IF, IHC-P, FC, IP
|
Human |
FOXO4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to FOXO4. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human.
|
- HY-P80135
-
|
WB, ICC, FC
|
Human |
FOXP3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 47 kDa, targeting to FOXP3. It can be used for WB,ICC,FC assays with tag free, in the background of Human.
|
- HY-P80138
-
|
WB, ICC, IHC-P, FC
|
Human |
GCN2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 187 kDa, targeting to GCN2. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human.
|
- HY-P80142
-
|
WB, IHC-P
|
Mouse, Rat |
Gli1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 118 kDa, targeting to Gli1. It can be used for WB,IHC-P assays with tag free, in the background of Mouse, Rat.
|
- HY-P80146
-
|
WB, IHC-P, FC
|
Human |
GPX1 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 22 kDa, targeting to GPX1. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human.
|
- HY-P80147
-
|
WB, IHC-P, ICC
|
Human, Rat |
GRB2 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 25 kDa, targeting to GRB2. It can be used for WB,IHC-P,ICC assays with tag free, in the background of Human, Rat.
|
- HY-P80149
-
|
WB, IHC-P, ICC
|
Human, Mouse |
HDAC1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 55 kDa, targeting to HDAC1. It can be used for WB,IHC-P,ICC assays with tag free, in the background of Human, Mouse.
|
- HY-P80150
-
|
WB, ICC, IP
|
Human |
HDAC10 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 43 kDa, targeting to HDAC10. It can be used for WB,ICC,IP assays with tag free, in the background of Human.
|
- HY-P80151
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human, Mouse, Rat |
HDAC2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 55 kDa, targeting to HDAC2. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80152
-
|
WB, ICC/IF, IHC-P, IP
|
Human, Mouse, Rat |
HDAC3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 49 kDa, targeting to HDAC3. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80153
-
|
WB, ICC/IF
|
Human |
HDAC4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 120 kDa, targeting to HDAC4. It can be used for WB,ICC/IF assays with tag free, in the background of Human.
|
- HY-P80154
-
|
WB, ICC/IF, IHC-P, IP
|
Human |
HDAC6 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 131 kDa, targeting to HDAC6. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human.
|
- HY-P80155
-
|
WB, ICC/IF, IHC-P, FC
|
Human, Mouse, Rat |
Hes1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 30 kDa, targeting to Hes1. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80183
-
|
WB, ICC/IF, IHC-P, FC
|
Human, Mouse, Rat |
HMGB1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 25 kDa, targeting to HMGB1. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80184
-
|
WB, ICC, IHC-P
|
Human, Mouse, Rat |
HSP60 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 61 kDa, targeting to HSP60. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80194
-
|
WB
|
Human |
ISG15 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 18 kDa, targeting to ISG15. It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80195
-
|
WB, IHC-P
|
Human, Mouse, Rat |
Jagged1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 134 kDa, targeting to Jagged1. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80196
-
|
WB, IHC-P, FC
|
Human, Mouse, Rat |
JAK1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 133 kDa, targeting to JAK1. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80199
-
|
WB, ICC, IHC-P, IP, FC
|
Human, Mouse |
JNK2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 46/54 kDa, targeting to JNK2. It can be used for WB,ICC,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80201
-
|
WB, ICC/IF, IHC-P
|
Human, Mouse |
KLF4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 55 kDa, targeting to KLF4. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80203
-
|
WB, ICC/IF, IHC-P, IP
|
Human |
Ku80 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 83 kDa, targeting to Ku80. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human.
|
- HY-P80206
-
|
WB, IHC-P
|
Human |
LAMP1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 45 kDa, targeting to LAMP1. It can be used for WB,IHC-P assays with tag free, in the background of Human.
|
- HY-P80212
-
|
WB, IHC-P
|
Human |
LRP6 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 180 kDa, targeting to LRP6. It can be used for WB,IHC-P assays with tag free, in the background of Human.
|
- HY-P80213
-
|
WB, ICC, IHC-P
|
Human, Mouse |
MAPK14 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 41 kDa, targeting to MAPK14. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80215
-
|
WB, IHC-P, ICC, FC
|
Human |
MCM2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 102 kDa, targeting to MCM2. It can be used for WB,IHC-P,ICC,FC assays with tag free, in the background of Human.
|
- HY-P80217
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human, Mouse |
MEK1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 43 kDa, targeting to MEK1. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80223
-
|
WB, IHC-P, FC
|
Human, Mouse |
METTL3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 64 kDa, targeting to METTL3. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80226
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human, Mouse, Rat |
MLH1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 85 kDa, targeting to MLH1. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80229
-
|
WB, IHC-P
|
Human, Mouse, Rat |
Mre11 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 81 kDa, targeting to Mre11. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80230
-
|
WB, IHC-P, IP
|
Human, Mouse |
Mst2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 56 kDa, targeting to Mst2. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse.
|
- HY-P80232
-
|
WB, ELISA, IP
|
|
Myc-tag Antibody is a non-conjugated and Mouse origined monoclonal antibody, targeting to Myc-tag. It can be used for WB,ELISA,IP assays with Myc-tag, in the background of .
|
- HY-P80238
-
|
WB, ICC, IHC-P
|
Human, Mouse |
N-Cadherin Antibody is a non-conjugated and Mouse origined monoclonal antibody about 100 kDa, targeting to N-Cadherin. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80239
-
|
WB, ICC/IF, IHC-P, IP
|
Human, Mouse |
NDRG1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 43 kDa, targeting to NDRG1. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse.
|
- HY-P80240
-
|
WB, ICC/IF, IHC-P, IP
|
Human, Rat |
NEDD8 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 9 kDa, targeting to NEDD8. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Rat.
|
- HY-P80242
-
|
WB, ICC/IF, IHC-P, FC
|
Human |
NFAT1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 100 kDa, targeting to NFAT1. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human.
|
- HY-P80243
-
|
WB, ICC, IHC-P, FC
|
Human |
NFAT2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 101 kDa, targeting to NFAT2. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human.
|
- HY-P80246
-
|
WB, ICC/IF, IHC-P, FC, IP
|
Human, Mouse, Rat |
NLRP3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 118 kDa, targeting to NLRP3 . It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80247
-
|
WB, ICC/IF, IHC-P, FC
|
Human, Mouse, Rat |
NMDAR1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 105 kDa, targeting to NMDAR1. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80255
-
|
WB, ICC/IF, IHC-P, FC
|
Human, Mouse, Rat |
OPA1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 112 kDa, targeting to OPA1. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80261
-
|
WB, IHC-P
|
Human, Mouse, Rat |
Pan-Actin Antibody is a non-conjugated and Mouse origined monoclonal antibody about 42kDa, targeting to Pan-Actin. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80262
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human, Mouse, Rat |
Pan-Cadherin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 100 kDa, targeting to Pan-Cadherin. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80265
-
|
WB, FC
|
Human |
PARP2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 66 kDa, targeting to PARP2. It can be used for WB,FC assays with tag free, in the background of Human.
|
- HY-P80267
-
|
ICC, IHC-P, WB
|
Human |
PCK1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 69 kDa, targeting to PCK1. It can be used for ICC,IHC-P,WB assays with tag free, in the background of Human.
|
- HY-P80269
-
|
WB, ICC, IHC-P, FC
|
Human, Mouse |
PDCD4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 52 kDa, targeting to PDCD4. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80270
-
|
WB, FC
|
Human, Mouse, Rat |
PDIA2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 57 kDa, targeting to PDIA2. It can be used for WB,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80271
-
|
WB, ICC/IF, FC
|
Human, Mouse |
PDIA6 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 48 kDa, targeting to PDIA6. It can be used for WB,ICC/IF,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80272
-
|
WB, IHC-P, IP, FC
|
Human, Mouse, Rat |
PDK1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 49 kDa, targeting to PDK1. It can be used for WB,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80274
-
|
WB, IHC-P, ICC/IF
|
Human |
PDX1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 31 kDa, targeting to PDX1. It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human.
|
- HY-P80275
-
|
WB, ICC, IHC-P, FC, IP
|
Human, Mouse, Rat |
PFKFB3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 60 kDa, targeting to PFKFB3. It can be used for WB,ICC,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80285
-
|
WB, ICC/IF, IHC-P, FC, IP
|
Human, Mouse, Rat |
PSD95 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 80 kDa, targeting to PSD95. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80293
-
|
WB, IHC-P
|
Human, Mouse |
Rab5 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 24 kDa, targeting to Rab5. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80295
-
|
WB, ICC/IF, IHC-P, FC
|
Human, Mouse |
RAB7 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 23 kDa, targeting to RAB7. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80297
-
|
WB, ICC/IF, IHC-P, FC, IP
|
Human, Mouse, Rat |
Rad51 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 37 kDa, targeting to Rad51. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80299
-
|
WB, ICC
|
Human, Mouse |
RASA1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 116 kDa, targeting to RASA1. It can be used for WB,ICC assays with tag free, in the background of Human, Mouse.
|
- HY-P80301
-
|
WB, ICC, IHC-P, FC, IP
|
Human, Mouse, Rat |
RbAP48 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 48 kDa, targeting to RbAP48. It can be used for WB,ICC,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80302
-
|
WB
|
Human, Mouse, Rat |
RbBP5 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 59 kDa, targeting to RbBP5. It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80303
-
|
ICC, IHC-P, FC
|
Mouse, Human, Rat |
RBM3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 17 kDa, targeting to RBM3. It can be used for ICC,IHC-P,FC assays with tag free, in the background of Mouse, Human, Rat.
|
- HY-P80304
-
|
WB, IHC-P
|
Human |
RBP4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 23 kDa, targeting to RBP4. It can be used for WB,IHC-P assays with tag free, in the background of Human.
|
- HY-P80314
-
|
WB, ICC/IF, IHC-P, IP
|
Human, Mouse |
ROCK1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 158 kDa, targeting to ROCK1. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse.
|
- HY-P80316
-
|
ICC/IF, IHC-P, WB
|
Human, Mouse |
RUNX2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 57 kDa, targeting to RUNX2. It can be used for ICC/IF,IHC-P,WB assays with tag free, in the background of Human, Mouse.
|
- HY-P80319
-
|
WB, ICC/IF, IHC-P, IP
|
Human, Mouse |
SIRT1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 82 kDa, targeting to SIRT1. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse.
|
- HY-P80320
-
|
WB, ICC/IF, IP, FC
|
Human, Rat |
SIRT2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 43 kDa, targeting to SIRT2. It can be used for WB,ICC/IF,IP,FC assays with tag free, in the background of Human, Rat.
|
- HY-P80321
-
|
WB
|
Human |
SIRT5 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 34 kDa, targeting to SIRT5. It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80322
-
|
WB, ICC/IF, IHC-P, FC
|
Human, Mouse |
SIRT6 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 39 kDa, targeting to SIRT6. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80323
-
|
WB, ICC/IF, IHC-P
|
Human, Mouse |
Smad1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 52 kDa, targeting to Smad1. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80324
-
|
WB, ICC, IHC-P, IP, FC
|
Human, Mouse, Rat |
Smad2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 52 kDa, targeting to Smad2. It can be used for WB,ICC,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80325
-
|
WB, ICC/IF, IHC-P, FC
|
Human, Mouse, Rat |
Smad3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 58 kDa, targeting to Smad3. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80326
-
|
WB, ICC/IF, IHC-P, FC
|
Human, Mouse, Rat |
Smad4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 60 kDa, targeting to Smad4. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80327
-
|
WB, ICC, IHC-P, FC
|
Human, Mouse |
Smad5 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 52 kDa, targeting to Smad5. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80328
-
|
WB, ICC, IF, IP, IHC-P
|
Human |
SOCS2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 22 kDa, targeting to SOCS2. It can be used for WB,ICC,IF,IP,IHC-P assays with tag free, in the background of Human.
|
- HY-P80330
-
|
WB, ICC/IF, IHC-P
|
Human, Mouse, Rat |
SOX1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 39 kDa, targeting to SOX1. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80331
-
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
SOX10 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 50 kDa, targeting to SOX10. It can be used for WB,IHC-P,ICC/IF,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80332
-
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
SOX11 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 47 kDa, targeting to SOX11. It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80333
-
|
WB
|
Human |
SOX18 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 41 kDa, targeting to SOX18. It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80334
-
|
IHC-P
|
Human |
SOX2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 34 kDa, targeting to SOX2. It can be used for IHC-P assays with tag free, in the background of Human.
|
- HY-P80335
-
|
WB, ICC/IF, IHC-P, IP, FC, ChIP, CUT&Tag-seq
|
Human, Mouse |
SOX9 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 56 kDa, targeting to SOX9. It can be used for WB,ICC/IF,IHC-P,IP,FC,ChIP,CUT&Tag-seq assays with tag free, in the background of Human, Mouse.
|
- HY-P80336
-
|
WB, ICC/IF, IHC-P
|
Human |
SP1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 81 kDa, targeting to SP1. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human.
|
- HY-P80337
-
|
WB, IHC-P, FC
|
Human |
SPHK1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 42 kDa, targeting to SPHK1. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human.
|
- HY-P80339
-
|
WB, IHC-P, IP
|
Human |
SRC1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 157 kDa, targeting to SRC1. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human.
|
- HY-P80353
-
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
SUZ12 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 83 kDa, targeting to SUZ12. It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80356
-
|
WB, FC
|
Human |
TIMP2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 24 kDa, targeting to TIMP2. It can be used for WB,FC assays with tag free, in the background of Human.
|
- HY-P80357
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human, Mouse |
TRAF2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 56 kDa, targeting to TRAF2. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80362
-
|
WB, ICC, IHC-P, FC, IF
|
Human, Mouse, Rat |
Tyrosine Hydroxylase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 59 kDa, targeting to Tyrosine Hydroxylase. It can be used for WB,ICC,IHC-P,FC,IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80364
-
|
WB, ICC, IHC-P
|
Human, Mouse, Rat |
Ubiquitin D Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 18 kDa, targeting to Ubiquitin D. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80366
-
|
WB, IHC-P
|
Human, Mouse, Rat |
ULK1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 113 kDa, targeting to ULK1. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80369
-
|
WB, ICC, IHC-P
|
Human, Mouse, Rat |
VDAC1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 31 kDa, targeting to VDAC1. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80373
-
|
WB, IHC-P, FC
|
Human, Mouse, Rat |
WDR5 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 37 kDa, targeting to WDR5. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80374
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human |
YAP1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to YAP1. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human.
|
- HY-P80383
-
|
WB, ICC/IF, IHC-P
|
Human |
Cathepsin B Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 38 kDa, targeting to Cathepsin B. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human.
|
- HY-P80384
-
|
WB, ICC, IHC-P, IP
|
Human, Mouse |
Cathepsin D Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 45/28 kDa, targeting to Cathepsin D. It can be used for WB,ICC,IHC-P,IP assays with tag free, in the background of Human, Mouse.
|
- HY-P80385
-
|
WB, IHC-P, IP, FC
|
Human, Mouse |
CCR2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 42 kDa, targeting to CCR2. It can be used for WB,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80386
-
|
WB, IHC-P, ICC
|
Human |
CD38 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 34 kDa, targeting to CD38. It can be used for WB,IHC-P,ICC assays with tag free, in the background of Human.
|
- HY-P80391
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human, Mouse |
ERK1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 43 kDa, targeting to ERK1. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80394
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human, Mouse, Rat |
ERK2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 41 kDa, targeting to ERK2. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80395
-
|
WB, ICC/IF
|
Human |
FGFR1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 100,140 kDa, targeting to FGFR1. It can be used for WB,ICC/IF assays with tag free, in the background of Human.
|
- HY-P80397
-
|
WB, IP
|
Human |
FGFR2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 92 kDa, targeting to FGFR2. It can be used for WB,IP assays with tag free, in the background of Human.
|
- HY-P80399
-
|
WB, ICC/IF, IHC-P
|
Human, Mouse |
FGFR3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 88 kDa, targeting to FGFR3. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80400
-
|
WB, ICC/IF
|
Human, Mouse |
FKBP12 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 12 kDa, targeting to FKBP12. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse.
|
- HY-P80401
-
|
WB, IHC-P, IP, FC
|
Human, Rat |
FKBP51 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 51 kDa, targeting to FKBP51. It can be used for WB,IHC-P,IP,FC assays with tag free, in the background of Human, Rat.
|
- HY-P80402
-
|
WB, ICC, IHC-P, FC
|
Human, Mouse |
FKBP52 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 52 kDa, targeting to FKBP52. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80406
-
|
WB, IHC-P, FC
|
Human |
GLUT2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 57 kDa, targeting to GLUT2. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human.
|
- HY-P80411
-
|
WB, ICC, IHC-P, FC
|
Human, Mouse, Rat |
Glutathione Synthetase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 52 kDa, targeting to Glutathione Synthetase. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80413
-
|
WB, ICC/IF, IHC-P, FC, IP
|
Human, Mouse |
IKK alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 85 kDa, targeting to IKK alpha. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse.
|
- HY-P80415
-
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
IKK gamma Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 48 kDa, targeting to IKK gamma. It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80420
-
|
WB, IHC-P
|
Human, Mouse |
IRAK-1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 77 kDa, targeting to IRAK-1. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80422
-
|
WB, ICC/IF, IHC-P, FC, IP
|
Human, Mouse |
Lactate Dehydrogenase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 37 kDa, targeting to Lactate Dehydrogenase. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse.
|
- HY-P80423
-
|
WB, ICC, IHC-P, FC
|
Human, Mouse, Rat |
LXR alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 50 kDa, targeting to LXR alpha. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80424
-
|
WB, IHC-P
|
Human, Mouse, Rat |
MMP3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to MMP3. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80430
-
|
WB, ICC/IF, IHC-P, FC, IP
|
Human, Mouse, Rat |
PKC alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 77 kDa, targeting to PKC alpha. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80433
-
|
WB, ICC/IF, IHC-P
|
Human, Mouse, Rat |
PKC delta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 78 kDa, targeting to PKC delta. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80434
-
|
WB, ICC, IHC-P, FC
|
Human, Mouse, Rat |
PKC epsilon Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 84 kDa, targeting to PKC epsilon. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80435
-
|
WB, IHC-P
|
Human, Mouse, Rat |
PKC gamma Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 78 kDa, targeting to PKC gamma. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80438
-
|
WB, ICC, IHC-P, FC
|
Human, Mouse, Rat |
Beta Actin Antibody is a non-conjugated and Mouse origined monoclonal antibody about 42 kDa, targeting to Beta Actin. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80447
-
|
WB, IHC-P, FC, IP
|
Human |
CD31 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 83 kDa, targeting to CD31. It can be used for WB,IHC-P,FC,IP assays with tag free, in the background of Human.
|
- HY-P80448
-
|
WB, ICC, IP, FC
|
Human |
Cleaved PARP Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 89 kDa, targeting to Cleaved PARP. It can be used for WB,ICC,IP,FC assays with tag free, in the background of Human.
|
- HY-P80450
-
|
WB, IHC-P, ICC
|
Human, Mouse, Rat |
GPX4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 22 kDa, targeting to GPX4. It can be used for WB,IHC-P,ICC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80487
-
|
WB, ICC, IHC-P, FC
|
Human, Mouse, Rat |
beta Tubulin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 50 kDa, targeting to beta Tubulin. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80500
-
|
IHC-P, WB, ICC
|
Human |
HER2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 138 kDa, targeting to HER2. It can be used for IHC-P,WB,ICC assays with tag free, in the background of Human.
|
- HY-P80501
-
|
WB, IHC-P, FC, IP, ICC/IF
|
Human, Mouse, Rat |
Iba1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 17 kDa, targeting to Iba1. It can be used for WB,IHC-P,FC,IP,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80504
-
|
WB, ICC/IF, IHC-P, FC
|
Human, Mouse |
IRF3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 47 kDa, targeting to IRF3. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80508
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human, Mouse |
MCL1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 37 kDa, targeting to MCL1. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80509
-
|
WB, IHC-P
|
Human, Mouse |
MMP2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 72 kDa, targeting to MMP2. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80510
-
|
WB, ICC, IHC-P, FC
|
Human, Mouse |
PDGFR alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 123 kDa, targeting to PDGFR alpha. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80957
-
|
WB
|
Human, Mouse, Rat |
VGluT1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 62 kDa. It can be used for WB assays in the background of Human, Mouse, Rat.
|
- HY-P80958
-
|
WB, IF-Cell, IF-Tissue, IHC-P, FC
|
Human, Mouse, Rat |
SATB2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 83 kDa, targeting to SATB2. It can be used for WB,IF-Cell,IF-Tissue,IHC-P,FC assays in the background of Human, Mouse, Rat.
|
- HY-P80960
-
|
WB, IHC-P, IP, FC
|
Human, Mouse, Rat |
CDC37 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 44 kDa, targeting to Hsp90 co-chaperone Cdc37 (CDC37). It can be used for WB,IHC-P,IP,FC assays in the background of Human, Mouse, Rat.
|
- HY-P80966
-
|
WB, IHC-P, FC
|
Human |
CD161 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 25 kDa, targeting to CD161. It can be used for WB, IHC-P, FC assays with tag free, in the background of Human.
|
- HY-P80968
-
|
WB, IHC-P
|
Human, Mouse, Rat |
HMGCS2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 57 kDa, targeting to HMGCS2. It can be used for WB, IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80974
-
|
WB, IHC-P
|
Human |
FOXA2 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 48 kDa, targeting to FOXA2. It can be used for WB,IHC-P assays with tag free, in the background of Human.
|
- HY-P80983
-
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
CDX2 Antibody is an unconjugated, approximately 34 kDa, rabbit-derived, anti-CDX2 monoclonal antibody. CDX2 Antibody can be used for: WB, IHC-P, ICC/IF, FC expriments in human, mouse, rat background without labeling.
|
- HY-P80989
-
|
IHC-P
|
Human |
Gastric Mucin Antibody is an unconjugated, mouse-derived, anti-Gastric Mucin monoclonal antibody. Gastric Mucin Antibody can be used for: IHC-P expriments in human background without labeling.
|
- HY-P80992
-
|
WB, IHC-P
|
Human |
p16 Antibody is an unconjugated, approximately 16 kDa, rabbit-derived, anti-p16 monoclonal antibody. p16 Antibody can be used for: WB, IHC-P expriments in human background without labeling.
|
- HY-P80995
-
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
IDH1 Antibody is an unconjugated, approximately 47 kDa, rabbit-derived, anti-IDH1 monoclonal antibody. IDH1 Antibody can be used for: WB, IHC-P, IP expriments in human, mouse, rat background without labeling.
|
- HY-P81023
-
|
WB, IHC-P
|
Human, Rat |
CHRNA9 Antibody is an unconjugated, approximately 55 kDa, rabbit-derived, anti-CHRNA9 polyclonal antibody. CHRNA9 Antibody can be used for: WB, IHC-P expriments in human, rat background without labeling.
|
- HY-P80001
-
|
WB, ICC/IF, IHC-P, FC
|
Human, Mouse, Rat |
53BP1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 214 kDa, targeting to TP53BP1. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80006
-
|
WB, ICC, IHC-P, IP, FC
|
Human, Mouse |
AIF Antibody (YA636) is a non-conjugated and Rabbit origined monoclonal antibody about 67 kDa, targeting to AIF. It can be used for WB,ICC,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80015
-
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse |
Annexin A2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 39 kDa, targeting to Annexin A2. It can be used for WB,IHC-P,ICC/IF,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80026
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human, Mouse |
Bak Antibody (YA592) is a non-conjugated and Rabbit origined monoclonal antibody about 23 kDa, targeting to Bak. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80028
-
|
WB, IF, IP, FC
|
Human, Mouse, Rat |
Bax Antibody (YA591) is a non-conjugated and Rabbit origined monoclonal antibody about 21 kDa, targeting to Bax. It can be used for WB,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80038
-
|
IHC-P, ICC/IF, FC
|
All |
BrdU Antibody (YA578) is a non-conjugated and Rabbit origined monoclonal antibody, targeting to BrdU. It can be used for IHC-P,ICC/IF,FC assays with tag free, in the background of .
|
- HY-P80041
-
|
WB, ICC/IF, IHC-P, FC
|
Human, Rat |
Calnexin Antibody (YA573) is a non-conjugated and Rabbit origined monoclonal antibody about 68 kDa, targeting to Calnexin. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Rat.
|
- HY-P80051
-
|
WB, IHC-P
|
Human, Mouse, Rat |
Catalase Antibody (YA552) is a non-conjugated and Rabbit origined monoclonal antibody about 60 kDa, targeting to Catalase. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80052
-
|
WB, ICC, IHC-P, FC
|
Human, Mouse, Rat |
Catalase Antibody (YA811) is a non-conjugated and Mouse origined monoclonal antibody about 60kDa, targeting to Catalase. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80057
-
|
WB, ICC/IF, IHC-P, FC
|
Human, Mouse, Rat |
CD40L Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 29 kDa, targeting to CD40L. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80059
-
|
WB, IHC
|
Human, Mouse |
CD42a Antibody is a non-conjugated and Mouse origined monoclonal antibody about 19 kDa, targeting to CD42a. It can be used for WB,IHC assays with tag free, in the background of Human, Mouse.
|
- HY-P80060
-
|
IHC-P, FC
|
Human |
CD42b Antibody is a non-conjugated and Mouse origined monoclonal antibody about 72 kDa, targeting to CD42b. It can be used for IHC-P,FC assays with tag free, in the background of Human.
|
- HY-P80072
-
|
WB, IP
|
Human |
Cdc25B Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 65 kDa, targeting to Cdc25B. It can be used for WB,IP assays with tag free, in the background of Human.
|
- HY-P80086
-
|
WB, IHC-P
|
Human, Mouse, Rat |
Clathrin heavy chain Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 191/187 kDa, targeting to Clathrin heavy chain. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80096
-
|
WB, ICC/IF, IHC-P
|
Human, Mouse, Rat |
Cyclin A2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 49 kDa, targeting to Cyclin A2. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80099
-
|
WB, ICC/IF, FC
|
Human, Mouse |
Cyclin D3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 33 kDa, targeting to Cyclin D3. It can be used for WB,ICC/IF,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80104
-
|
WB, ICC, IHC-P
|
Human |
DNA-PKcs/PRKDC Antibody is a non-conjugated and Mouse origined monoclonal antibody about 469 kDa, targeting to DNA-PKcs/PRKDC. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human.
|
- HY-P80107
-
|
WB, ICC/IF
|
Human, Mouse |
Dnmt3a Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 102 kDa, targeting to Dnmt3a. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse.
|
- HY-P80118
-
|
WB, IHC-P, ICC, FC
|
Human, Mouse |
eIF4E Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 25 kDa, targeting to eIF4E. It can be used for WB,IHC-P,ICC,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80121
-
|
WB, ICC, IHC-P
|
Human, Mouse |
EpCAM Antibody (YA772) is a non-conjugated and Mouse origined monoclonal antibody about 35 kDa, targeting to EpCAM. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80126
-
|
WB, ICC/IF, IHC-P, FC
|
Human |
Fas/CD95 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 37 kDa, targeting to Fas(CD95). It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human.
|
- HY-P80127
-
|
WB, ICC/IF, IHC-P, FC, IP
|
Human, Mouse, Rat |
Fascin Antibody (YA445) is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to Fascin. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80132
-
|
WB, ICC, IHC-P
|
Human, Mouse |
FOXO1A Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 70 kDa, targeting to FOXO1A. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80139
-
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
GFAP Antibody (YA755) is a non-conjugated and Mouse origined monoclonal antibody about 50 kDa, targeting to GFAP. It can be used for WB,IHC-P,ICC/IF,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80140
-
|
WB, IHC-P, IP, IF
|
Human, Mouse, Rat |
GFAP Antibody (YA416) is a non-conjugated and Rabbit origined monoclonal antibody about 50 kDa, targeting to GFAP. It can be used for WB,IHC-P,IP,IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80143
-
|
WB, IHC-P, FC, ICC
|
Human, Mouse |
Glucocorticoid Receptor alpha Antibody is a non-conjugated and Mouse origined monoclonal antibody about 86 kDa, targeting to Glucocorticoid Receptor alpha. It can be used for WB,IHC-P,FC,ICC assays with tag free, in the background of Human, Mouse.
|
- HY-P80144
-
|
WB
|
|
Glu-Glu Tag Antibody is a non-conjugated and Mouse origined monoclonal antibody, targeting to Glu-Glu Tag. It can be used for WB assays with Glu-Glu-tag, in the background of Species independent.
|
- HY-P80166
-
|
WB, ICC/IF, IHC-P, IP, ChIP
|
Human, Mouse, Rat |
Histone H3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Histone H3. It can be used for WB,ICC/IF,IHC-P,IP,ChIP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80178
-
|
WB, ICC/IF, IHC-P
|
Human, Mouse, Rat |
Histone H4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 11 kDa, targeting to Histone H4. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80186
-
|
WB, ICC/IF, IHC-P
|
Human, Mouse, Monkey |
Hsp90 alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 85 kDa, targeting to Hsp90 alpha. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse, Monkey.
|
- HY-P80187
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human, Mouse, Rat |
Hsp90 beta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 83 kDa, targeting to Hsp90 beta. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80191
-
|
WB, IHC-P
|
Human, Mouse |
Insulin degrading enzyme Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 118 kDa, targeting to Insulin degrading enzyme. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80192
-
|
WB, ICC/IF
|
Human, Rat |
Insulin Receptor Beta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 156 kDa, targeting to Insulin Receptor Beta. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Rat.
|
- HY-P80193
-
|
WB, IHC-P
|
Human, Mouse |
Insulin Receptor R Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 144 kDa, targeting to Insulin Receptor R. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80204
-
|
WB, ICC, IHC-P, FC
|
Human, Mouse, Rat |
Lamin A/C Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 74 kDa, targeting to Lamin A/C. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80205
-
|
WB, ICC/IF, IHC-P, IP
|
Human, Mouse, Rat |
Lamin B1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 66 kDa, targeting to Lamin B1. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80208
-
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
LAMP2a Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 45 kDa, targeting to LAMP2a. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80210
-
|
WB, ICC, IHC-P
|
Human, Mouse |
LIN28A Antibody is a non-conjugated and Mouse origined monoclonal antibody about 23 kDa, targeting to LIN28A. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80211
-
|
WB, ICC, IHC-P
|
Human |
Lin28B Antibody is a non-conjugated and Mouse origined monoclonal antibody about ~27 kDa, targeting to Lin28B. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human.
|
- HY-P80218
-
|
WB, ICC/IF, IHC-P, IP
|
Human, Mouse, Rat |
MEK1/2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 44 kDa, targeting to MEK1/2. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80219
-
|
WB, ICC/IF, IHC-P, FC
|
Human |
Met (C-Met) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 156 kDa, targeting to Met (C-Met). It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human.
|
- HY-P80231
-
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
mTOR Antibody (YA281) is a non-conjugated and Rabbit origined monoclonal antibody about 289 kDa, targeting to mTOR. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80234
-
|
WB, IHC-P, IF
|
Human, Mouse, Rat |
Myosin heavy chain Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 224 kDa, targeting to Myosin heavy chain. It can be used for WB,IHC-P,IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80248
-
|
WB, IHC-P, IF
|
Human, Mouse, Rat |
NMDAR2A Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 165 kDa, targeting to NMDAR2A. It can be used for WB,IHC-P,IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80273
-
|
WB, IHC-P
|
Human |
PD-L1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 33 kDa, targeting to PD-L1. It can be used for WB,IHC-P assays with tag free, in the background of Human.
|
- HY-P80294
-
|
WB, IHC-P
|
Human |
RAB5C Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 23 kDa, targeting to RAB5C. It can be used for WB,IHC-P assays with tag free, in the background of Human.
|
- HY-P80296
-
|
WB
|
Human |
RAB8A Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 24 kDa, targeting to RAB8A. It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80308
-
|
WB, FC
|
Human |
Retinoic Acid Receptor alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 51 kDa, targeting to Retinoic Acid Receptor alpha. It can be used for WB,FC assays with tag free, in the background of Human.
|
- HY-P80311
-
|
WB, ICC/IF, FC
|
Human, Mouse |
RhoA Antibody (YA093) is a non-conjugated and Rabbit origined monoclonal antibody about 22 kDa, targeting to RhoA. It can be used for WB,ICC/IF,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80342
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human |
STAT1 alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 87 kDa, targeting to STAT1 alpha. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human.
|
- HY-P80345
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human, Mouse |
STAT5a Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 91 kDa, targeting to STAT5a. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80346
-
|
WB, ICC/IF, IHC-P, IP
|
Human, Mouse, Rat |
STAT5b Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 90 kDa, targeting to STAT5b. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80350
-
|
WB, FC
|
Human |
STING Antibody (YA048) is a non-conjugated and Rabbit origined monoclonal antibody about 42 kDa, targeting to STING. It can be used for WB,FC assays with tag free, in the background of Human.
|
- HY-P80352
-
|
WB, ICC/IF, IHC-P, FC
|
Human, Mouse |
Survivin Antibody (YA045) is a non-conjugated and Rabbit origined monoclonal antibody about 16 kDa, targeting to Survivin. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80354
-
|
WB, IHC
|
Human, Mouse, Rat |
Synaptophysin Antibody (YA043) is a non-conjugated and Rabbit origined monoclonal antibody about 38 kDa, targeting to Synaptophysin. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80359
-
|
WB, ICC, IHC-P
|
Human, Mouse, Rat |
TrkA+B+C Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 92 kDa, targeting to TrkA+B+C. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80363
-
|
WB, ICC/IF, IHC-P, FC
|
Human, Mouse |
Ubiquitin Antibody (YA022) is a non-conjugated and Rabbit origined monoclonal antibody about 77 kDa, targeting to Ubiquitin. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80367
-
|
WB, ELISA
|
|
V5-tag Antibody is a non-conjugated and Mouse origined monoclonal antibody, targeting to V5-tag. It can be used for WB,ELISA assays with V5-tag, in the background of .
|
- HY-P80380
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human, Mouse |
ATP citrate lyase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 121 kDa, targeting to ATP citrate lyase. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80382
-
|
WB, IHC-P
|
Human, Mouse, Rat |
Carbonic Anhydrase I is a non-conjugated and Rabbit origined monoclonal antibody about 29 kDa, targeting to Carbonic Anhydrase I . It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80393
-
|
WB, ICC/IF, IP, FC
|
Human, Mouse, Rat |
ERK1/2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 43/41 kDa, targeting to ERK1/2. It can be used for WB,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80417
-
|
WB, ICC, FC
|
Human |
Integrin alpha V Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 116 kDa, targeting to Integrin alpha V. It can be used for WB,ICC,FC assays with tag free, in the background of Human.
|
- HY-P80429
-
|
WB, IHC-P, IP
|
Human |
PKA R2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 46 kDa., targeting to PKA R2. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human.
|
- HY-P80488
-
|
WB, IHC-P, IF, IP
|
Human, Mouse |
Beta-Catenin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 85 kDa, targeting to Beta-Catenin. It can be used for WB,IHC-P,IF,IP assays with tag free, in the background of Human, Mouse.
|
- HY-P80490
-
|
WB, FC, IP
|
Human, Rat |
C/EBP Beta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to C/EBP Beta. It can be used for WB,FC,IP assays with tag free, in the background of Human, Rat.
|
- HY-P80492
-
|
WB, IHC-P
|
Human |
EIF2A Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 65 kDa, targeting to EIF2A. It can be used for WB,IHC-P assays with tag free, in the background of Human.
|
- HY-P80496
-
|
WB, ICC, IHC-P
|
Human, Mouse |
GRP78 BiP Antibody is a non-conjugated and Mouse origined monoclonal antibody about 72kDa, targeting to GRP78 BiP. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80523
-
|
WB, IHC-P, ICC, FC
|
Human, Mouse |
xCT Antibody (YA652) is a non-conjugated and Mouse origined monoclonal antibody about 55 kDa, targeting to xCT. It can be used for WB,IHC-P,ICC,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80923
-
TRKB
|
WB
|
Rat |
Trk B Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 92 kDa, targeting to Trk B. It can be used for WB assays with tag free, in the background of Rat.
|
- HY-P80971
-
|
WB ; IF ; IHC-P ; FC
|
Human, Mouse, Rat |
Anti-Aurora A Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 46 kDa, targeting to Aurora. It can be used for WB, IF, IHC-P, FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80990
-
|
IHC-P, FC, ELISA
|
Human |
Mucin 5B Antibody is an unconjugated, mouse-derived, anti-Mucin 5B monoclonal antibody. Mucin 5B Antibody can be used for: IHC-P, FC, ELISA expriments in human background without labeling.
|
- HY-P80998
-
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
Cyclin B2 Antibody is an unconjugated, approximately 45 kDa, anti-Cyclin B2 monoclonal antibody. Cyclin B2 Antibody can be used for: WB, IHC-P, ICC/IF, IP expriments in human, mouse, rat background without labeling.
|
- HY-P80007
-
|
WB, ICC, IHC-P, FC
|
Human |
AKT1 Antibody (YA834) is a non-conjugated and Mouse origined monoclonal antibody about 56 kDa, targeting to AKT1. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human.
|
- HY-P80020
-
|
WB, ICC/IF, IHC-P, FC
|
Human, Mouse |
ASK1 Antibody (YA609) is a non-conjugated and Rabbit origined monoclonal antibody about 155 kDa, targeting to ASK1. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80048
-
|
WB, IP
|
Human |
Caspase-6 p18 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 33 kDa, targeting to Caspase-6 p18. It can be used for WB,IP assays with tag free, in the background of Human.
|
- HY-P80063
-
|
WB, IHC-P, FC
|
Human |
CD45 Antibody (YA533) is a non-conjugated and Rabbit origined monoclonal antibody about 147 kDa., targeting to CD45. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human.
|
- HY-P80066
-
|
WB, IHC-P, FC
|
Human |
CD68 Antibody (YA798) is a non-conjugated and Mouse origined monoclonal antibody about 37 kDa., targeting to CD68. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human.
|
- HY-P80067
-
|
WB
|
Human |
CD68 Antibody (YA529) is a non-conjugated and Rabbit origined monoclonal antibody about 37 kDa, targeting to CD68. It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80068
-
|
WB, ICC/IF, IHC-P, IP
|
Human, Mouse |
CD9 Antibody (YA524) is a non-conjugated and Rabbit origined monoclonal antibody about 25 kDa, targeting to CD9. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse.
|
- HY-P80075
-
|
WB
|
Human |
CDC42EP1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 40 kDa, targeting to CDC42EP1. It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80081
-
|
WB, IHC-P, FC
|
Mouse |
c-Fos Antibody (YA506) is a non-conjugated and Rabbit origined monoclonal antibody about 41 kDa, targeting to c-Fos. It can be used for WB,IHC-P,FC assays with tag free, in the background of Mouse.
|
- HY-P80082
-
|
WB, ICC/IF, IHC-P, FC
|
Human, Mouse |
Chk1 Antibody (YA505) is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to Chk1. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80085
-
|
WB, IHC-P
|
Human |
c-Kit Antibody (YA502) is a non-conjugated and Rabbit origined monoclonal antibody about 110 kDa, targeting to c-Kit. It can be used for WB,IHC-P assays with tag free, in the background of Human.
|
- HY-P80105
-
|
WB, IHC-P, FC
|
Human |
DNMT1 Antibody (YA781) is a non-conjugated and Mouse origined monoclonal antibody about 183 kDa, targeting to DNMT1. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human.
|
- HY-P80106
-
|
WB, ICC/IF, IHC-P
|
Human, Mouse |
Dnmt1 Antibody (YA476) is a non-conjugated and Rabbit origined monoclonal antibody about 183 kDa, targeting to Dnmt1. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80112
-
|
WB, ICC, IHC-P, FC
|
Human, Mouse |
E-Cadherin Antibody (YA778) is a non-conjugated and Mouse origined monoclonal antibody about 97 kDa, targeting to E-Cadherin. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80113
-
|
WB, ICC/IF, IHC-P, FC, IP
|
Human |
E-Cadherin Antibody (YA470) is a non-conjugated and Rabbit origined monoclonal antibody about 97 kDa, targeting to E-Cadherin. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human.
|
- HY-P80119
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human, Mouse, Rat |
eIF4EBP1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 13 kDa, targeting to eIF4EBP1. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80145
-
GYS1
|
WB, ICC/IF, IHC-P, FC, IP
|
Human, Mouse |
Glycogen synthase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 84 kDa, targeting to Glycogen synthase. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse.
|
- HY-P80148
-
|
WB
|
|
GST-Tag Antibody is a HRP-conjugated and Rabbit origined monoclonal antibody, targeting to GST-Tag. It can be used for WB assays with GST-tag, in the background of .
|
- HY-P80157
-
|
WB, ICC/IF, IHC-P
|
Human, Mouse |
Histone H1.0 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 21 kDa, targeting to Histone H1.0. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80158
-
|
WB, ICC/IF, IHC-P, ChIP
|
Human, Mouse, Rat |
Histone H1.2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 21 kDa, targeting to Histone H1.2. It can be used for WB,ICC/IF,IHC-P,ChIP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80163
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human, Mouse, Rat |
Histone H2B Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 14 kDa, targeting to Histone H2B. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80177
-
|
WB, ICC/IF, IHC-P, ChIP
|
Human, Mouse |
Histone H3.3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Histone H3.3. It can be used for WB,ICC/IF,IHC-P,ChIP assays with tag free, in the background of Human, Mouse.
|
- HY-P80185
-
|
WB, ICC/IF, IHC-P, FC
|
Human, Mouse |
Hsp70 Antibody (YA359) is a non-conjugated and Rabbit origined monoclonal antibody about 70 kDa, targeting to Hsp70. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80189
-
|
WB, IHC-P, ICC, ELISA
|
Human, Mouse |
IL-6 Antibody (YA724) is a non-conjugated and Mouse origined monoclonal antibody about 24 kDa, targeting to IL-6. It can be used for WB,IHC-P,ICC,ELISA assays with tag free, in the background of Human, Mouse.
|
- HY-P80198
-
|
WB, IP
|
Mouse, Rat |
JNK1+JNK3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 48/53 kDa, targeting to JNK1+JNK3. It can be used for WB,IP assays with tag free, in the background of Mouse, Rat.
|
- HY-P80202
-
|
WB, IHC-P
|
Human, Mouse |
Ku70 Antibody (YA715) is a non-conjugated and Mouse origined monoclonal antibody about 70 kDa, targeting to Ku70. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80207
-
|
WB, ICC, IHC-P, FC
|
Human |
LAMP2 Antibody (YA713) is a non-conjugated and Mouse origined monoclonal antibody about 45 kDa, targeting to LAMP2. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human.
|
- HY-P80222
-
|
WB, IHC-P
|
Human, Mouse, Rat |
Methylmalonyl Coenzyme A mutase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 83 kDa, targeting to Methylmalonyl Coenzyme A mutase. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80233
-
|
WB, ICC/IF, IHC-P, FC
|
Human |
MyD88 Antibody (YA280) is a non-conjugated and Rabbit origined monoclonal antibody about 33 kDa, targeting to MyD88. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human.
|
- HY-P80236
-
|
WB, ICC/IF, IHC-P, FC
|
Human, Mouse, Rat |
Myosin light chain kinase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 211 kDa, targeting to Myosin light chain kinase. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80245
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human, Mouse |
NF-κB p65 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 65 kDa, targeting to NF-κB p65. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80250
-
|
WB, IHC-P
|
Human, Rat |
NQO1 Antibody (YA697) is a non-conjugated and Mouse origined monoclonal antibody about 31 kDa, targeting to NQO1. It can be used for WB,IHC-P assays with tag free, in the background of Human, Rat.
|
- HY-P80251
-
|
WB, ICC/IF, IP, FC
|
Human, Mouse |
NQO1 Antibody (YA261) is a non-conjugated and Rabbit origined monoclonal antibody about 31 kDa, targeting to NQO1. It can be used for WB,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80257
-
|
WB, ICC/IF, IHC-P, IP
|
Human |
p53 Antibody (YA250) is a non-conjugated and Rabbit origined monoclonal antibody about 44 kDa, targeting to p53. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human.
|
- HY-P80259
-
|
WB, ICC/IF
|
Human, Mouse, Rat |
p53 DINP1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 27 kDa, targeting to p53 DINP1. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80287
-
|
WB, IHC-P
|
Human |
SPI1 Antibody (YA118) is a non-conjugated and Rabbit origined monoclonal antibody about 31 kDa, targeting to PU.1. It can be used for WB,IHC-P assays with tag free, in the background of Human.
|
- HY-P80288
-
|
WB, IHC-P, FC
|
Human |
SpI1 Antibody (YA117) is a non-conjugated and Rabbit origined monoclonal antibody about 31 kDa, targeting to PU.1/Spi1. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human.
|
- HY-P80290
-
|
WB, ICC/IF, IHC-P
|
Human, Mouse |
PYK2 Antibody (YA115) is a non-conjugated and Rabbit origined monoclonal antibody about 116 kDa, targeting to PYK2. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80292
-
|
WB, IHC-P
|
Human, Mouse, Rat |
Pyruvate Dehydrogenase E2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 69 kDa, targeting to Pyruvate Dehydrogenase E2. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80309
-
|
WB, ICC, IHC-P, IP
|
Human, Rat |
Retinoid X Receptor alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 51 kDa, targeting to Retinoid X Receptor alpha. It can be used for WB,ICC,IHC-P,IP assays with tag free, in the background of Human, Rat.
|
- HY-P80317
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human, Mouse |
S100A4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 12 kDa, targeting to S100A4. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80329
-
|
WB, IHC-P
|
Human, Mouse |
SOD2 Antibody (YA071) is a non-conjugated and Rabbit origined monoclonal antibody about 25 kDa, targeting to SOD2. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80340
-
|
WB, IP, FC
|
Human, Mouse |
STAT1 Antibody (YA059) is a non-conjugated and Rabbit origined monoclonal antibody about 87 kDa, targeting to STAT1. It can be used for WB,IP,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80341
-
|
WB, ICC
|
Human, Mouse |
STAT1 Antibody (YA667) is a non-conjugated and Mouse origined monoclonal antibody about 87kDa, targeting to STAT1. It can be used for WB,ICC assays with tag free, in the background of Human, Mouse.
|
- HY-P80343
-
|
WB, ICC, IHC-P
|
Human, Mouse, Rat |
STAT2 Antibody (YA057) is a non-conjugated and Rabbit origined monoclonal antibody about 98 kDa, targeting to STAT2. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80344
-
|
WB, ICC/IF, IHC-P, IP
|
Human, Mouse, Rat |
STAT3 Antibody (YA056) is a non-conjugated and Rabbit origined monoclonal antibody about 88 kDa, targeting to STAT3. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80351
-
|
WB, ICC/IF, IHC-P, IP, FC, ChIP
|
Human, Mouse |
SUMO1 Antibody (YA046) is a non-conjugated and Rabbit origined monoclonal antibody about 12 kDa, targeting to SUMO-1. It can be used for WB,ICC/IF,IHC-P,IP,FC,ChIP assays with tag free, in the background of Human, Mouse.
|
- HY-P80355
-
|
WB, ICC/IF, IHC-P, FC
|
Human, Mouse |
TAK1 Antibody (YA042) is a non-conjugated and Rabbit origined monoclonal antibody about 67 kDa, targeting to TAK1. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80375
-
|
WB, ICC/IF, IHC-P, FC, IP
|
Human, Mouse |
YB1 Antibody (YA004) is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to YB1. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse.
|
- HY-P80379
-
|
WB, IHC-P, FC
|
Human, Mouse, Rat |
ATF6 Antibody (YA831) is a non-conjugated and Mouse origined monoclonal antibody about 75 kDa, targeting to ATF6. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80387
-
|
WB, IHC-P
|
Human |
CD73 Antibody (YA528) is a non-conjugated and Rabbit origined monoclonal antibody about 63 kDa, targeting to CD73. It can be used for WB,IHC-P assays with tag free, in the background of Human.
|
- HY-P80388
-
|
WB, IHC-P, IF, FC
|
Human |
CD73 Antibody (YA797) is a non-conjugated and Mouse origined monoclonal antibody about 63 kDa, targeting to CD73. It can be used for WB,IHC-P,IF,FC assays with tag free, in the background of Human.
|
- HY-P80390
-
|
WB, IHC-P, ICC
|
Human, Mouse, Rat |
Dynamin 1 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 97 kDa, targeting to Dynamin 1. It can be used for WB,IHC-P,ICC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80396
-
|
WB, IHC-P
|
Human, Mouse, Rat |
FGFR1 Oncogene Partner Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 43 kDa, targeting to FGFR1 Oncogene Partner. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80398
-
|
WB, ICC, IHC-P
|
Human, Mouse |
FGFR2/CD332 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 92 kDa, targeting to FGFR2/CD332. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80403
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human, Mouse, Rat |
Galectin 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Galectin 1. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80408
-
|
WB, IHC-P, FC
|
Human, Mouse |
Glutamine Synthetase Antibody (YA751) is a non-conjugated and Mouse origined monoclonal antibody about 42 kDa, targeting to Glutamine Synthetase. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80412
-
|
WB, IHC-P, IF
|
Human, Mouse, Rat |
HSP70 Antibody (YA728) is a non-conjugated and Mouse origined monoclonal antibody about 70 kDa, targeting to HSP70. It can be used for WB,IHC-P,IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80421
-
|
WB, ICC, IHC-P, FC
|
Human, Mouse, Rat |
JAK2 Antibody (YA721) is a non-conjugated and Mouse origined monoclonal antibody about ~130kDa, targeting to JAK2. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80425
-
|
WB, ICC/IF, IHC-P, FC
|
Human, Rat |
MMP9 Antibody (YA285) is a non-conjugated and Rabbit origined monoclonal antibody about 78 kDa, targeting to MMP9. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Rat.
|
- HY-P80426
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human, Mouse |
Notch 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 125 kDa, targeting to Notch 1. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80436
-
|
WB
|
Human, Rat |
PPAR gamma Antibody (YA122) is a non-conjugated and Rabbit origined monoclonal antibody about 58 kDa, targeting to PPAR gamma. It can be used for WB assays with tag free, in the background of Human, Rat.
|
- HY-P80443
-
|
ICC, IHC-P, FC
|
Human, Mouse, Rat |
Calpain 1 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 82 kDa, targeting to Calpain 1. It can be used for ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80444
-
|
WB, ICC, IHC-P, FC
|
Human, Rat |
Calpain 2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 80 kDa, targeting to Calpain 2. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Rat.
|
- HY-P80453
-
|
WB, ICC/IF, IHC-P, IP
|
Human |
Phospho-ATM (S1981) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 351 kDa, targeting to Phospho-ATM (S1981). It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human.
|
- HY-P80457
-
|
WB, ICC, IHC-P, IP, FC
|
Human, Mouse |
Phospho-Creb (Ser133) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 35 kDa, targeting to Phospho-Creb (S133). It can be used for WB,ICC,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80460
-
|
WB, ICC/IF
|
Human, Mouse |
Phospho-FAK (Tyr397) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 119 kDa, targeting to Phospho-FAK (Y397). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse.
|
- HY-P80468
-
|
WB, IHC-P
|
Mouse |
Phospho-MLKL (Ser345) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to Phospho-MLKL (S345). It can be used for WB,IHC-P assays with tag free, in the background of Mouse.
|
- HY-P80475
-
|
WB, ICC
|
Human |
Phospho-PTEN (Ser380) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 47 kDa, targeting to Phospho-PTEN(S380). It can be used for WB,ICC assays with tag free, in the background of Human.
|
- HY-P80476
-
|
WB, ICC/IF, IHC-P
|
Human, Mouse |
Phospho-Rb (Ser807) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 106 kDa, targeting to Phospho-Rb(S807). It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80480
-
|
WB, ICC/IF, IHC-P
|
Mouse, Rat, Human |
Phospho-Tau (Ser396) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 79 kDa, targeting to Phospho-Tau(S396). It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Mouse, Rat, Human.
|
- HY-P80486
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human, Mouse, Rat |
ATF4 Antibody (YA605) is a non-conjugated and Rabbit origined monoclonal antibody about 39 kDa, targeting to ATF4. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80489
-
|
IHC-P
|
Human, Mouse |
BRCA1 Antibody (YA819) is a non-conjugated and Mouse origined monoclonal antibody about 208 kDa, targeting to BRCA1. It can be used for IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80491
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human, Mouse |
E2F1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 47 kDa, targeting to E2F1. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80494
-
|
WB, ICC/IF, IHC-P, FC
|
Human, Mouse |
Glucose Transporter GLUT1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to Glucose Transporter GLUT1. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80502
-
|
WB, ICC, IHC-P
|
Human |
ICAM1 Antibody (YA725) is a non-conjugated and Mouse origined monoclonal antibody about 58 kDa, targeting to ICAM1. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human.
|
- HY-P80505
-
|
IHC-P
|
Human, Mouse |
Ki67 Antibody (YA717) is a non-conjugated and Mouse origined monoclonal antibody about 359 kDa, targeting to Ki67. It can be used for IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80506
-
|
IHC, IF
|
Human, Mouse, Rat |
Ki67 Antibody (YA322) is a non-conjugated and Rabbit origined monoclonal antibody about 345-395 kDa, targeting to Ki67. It can be used for IHC,IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80507
-
|
WB, ICC/IF, IHC-P
|
Human |
KMT6/EZH2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 85 kDa, targeting to KMT6/EZH2. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human.
|
- HY-P80512
-
|
WB, IHC-P
|
Human |
Phospho-Met Antibody (YA175) is a non-conjugated and Rabbit origined monoclonal antibody about 156 kDa, targeting to Phospho-Met (pY1349). It can be used for WB,IHC-P assays with tag free, in the background of Human.
|
- HY-P80514
-
|
WB, FC
|
Human |
Phospho-Src (Tyr419) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 60 kDa, targeting to Phospho-Src(Y419). It can be used for WB,FC assays with tag free, in the background of Human.
|
- HY-P80519
-
|
WB
|
Human, Mouse, Rat |
TBK1 Antibody (YA662) is a non-conjugated and Mouse origined monoclonal antibody about 84 kDa, targeting to TBK1. It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80524
-
|
WB, ICC, IHC-P, FC, IP
|
Human |
ZAP70 Antibody (YP4051) is a non-conjugated and Rabbit origined monoclonal antibody about 70 kDa, targeting to ZAP70. It can be used for WB,ICC,IHC-P,FC,IP assays with tag free, in the background of Human.
|
- HY-P80574
-
Bromodeoxyuridine
|
ICC/IF
|
All |
BrdU Antibody (YA818) is a non-conjugated and Mouse origined monoclonal antibody, targeting to BrdU. It can be used for ICC/IF assays with tag free, in the background of Species independent.
|
- HY-P80748
-
LZM; LYZF1
|
WB, IHC-P
|
Human |
Lysozyme Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 17 kDa, targeting to Lysozyme. It can be used for WB,IHC-P assays with tag free, in the background of Human.
|
- HY-P80948
-
|
WB, IP
|
Species independent |
Anti-HA tag Antibody is a non-conjugated and Rabbit origined monoclonal antibody. It can be used for WB,IP assays in the background of .
|
- HY-P80963
-
|
IHC-P, FC
|
Human |
Anoctamin 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody, targeting to Anoctamin-1 (ANO1). It can be used for IHC-P, FC assays in the background of Human.
|
- HY-P80975
-
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
RPA32 Antibody (YA679) is a non-conjugated and Rabbit origined monoclonal antibody about 32 kDa, targeting to RPA32. It can be used for WB, IHC-P, ICC/IF, IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80982
-
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Rat |
Cytokeratin 20 Antibody is an unconjugated, approximately 44 kDa, rabbit-derived, anti-Cytokeratin 20 monoclonal antibody. Cytokeratin 20 Antibody can be used for: WB, IHC-P, ICC/IF, IP, FC expriments in human, rat background without labeling.
|
- HY-P80987
-
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Rat |
Mucin 2 Antibody is an unconjugated, rabbit-derived, anti-Mucin 2 monoclonal antibody. Mucin 2 Antibody can be used for: WB, IHC-P, ICC/IF, IP, FC expriments in human, rat background without labeling.
|
- HY-P80991
-
|
WB, IHC-P
|
Human |
Mucin 16 Antibody is an unconjugated, rabbit-derived, anti-Mucin 16 monoclonal antibody. Mucin 16 Antibody can be used for: WB, IHC-P expriments in human background without labeling.
|
- HY-P80993
-
|
WB
|
Human, Mouse, Rat, Zebrafish, Monkey, Hamster, Plant |
Beta Actin Antibody HRP Conjugated is a rabbit-derived HRP-conjugated antibody targeting beta-Actin with a molecular weight of approximately 42 KDa. Beta Actin Antibody HRP Conjugated can be used for WB experiments in human, mouse, rat, zebrafish, monkey, hamster, plant backgrounds.
|
- HY-P80994
-
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
Anti-Lactate Dehydrogenase A Antibody is an unconjugated, approximately 37 kDa, rabbit-derived, anti-Lactate Dehydrogenase A monoclonal antibody. Anti-Lactate Dehydrogenase A Antibody can be used for: WB, IHC-F, IHC-P, ICC/IF, IP expriments in human, mouse, rat background without labeling.
|
- HY-P81024
-
|
WB
|
Species-independent |
AmCyan Tag Antibody (YA864) is an unconjugated, approximately 55 kDa, mouse-derived, anti-AmCyan Tag (YA864) monoclonal antibody. AmCyan Tag Antibody (YA864) can be used for: WB expriments in species-independent background without labeling.
|
- HY-P81025
-
|
WB, IHC-F, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat, Hamster, Goat, Monkey |
COX IV Antibody (YA867) is an unconjugated, approximately 20 kDa, mouse-derived, anti-COX IV (YA867) monoclonal antibody. COX IV Antibody (YA867) can be used for: WB, IHC-F, IHC-P, ICC/IF, IP, FC expriments in human, mouse, rat, hamster, goat, monkey background without labeling.
|
- HY-P81026
-
|
WB
|
Escherichia Coli |
DsbA Tag Antibody (YA868) is an unconjugated, approximately 23 kDa, mouse-derived, anti-DsbA Tag (YA868) monoclonal antibody. DsbA Tag Antibody (YA868) can be used for: WB expriments in Escherichia coli background without labeling.
|
- HY-P81029
-
|
WB
|
Species-independent |
ECFP Tag Antibody (YA871) is an unconjugated, mouse-derived, anti-ECFP Tag (YA871) monoclonal antibody. ECFP Tag Antibody (YA871) can be used for: WB expriments in species-independent background without labeling.
|
- HY-P81030
-
|
WB
|
Species-independent |
EYFP Tag Antibody (YA872) is an unconjugated, mouse-derived, anti-EYFP Tag (YA872) monoclonal antibody. EYFP Tag Antibody (YA872) can be used for: WB expriments in species-independent background without labeling.
|
- HY-P80954A
-
|
WB, ELISA
|
Human, Mouse, Rat |
GAPDH Antibody (HRP) (YA874) is a mouse-derived, anti-GAPDH (HRP) (YA874) monoclonal antibody. GAPDH Antibody (HRP) (YA874) can be used for: WB, ELISA expriments in human, mouse, rat background with HRP labeling.
|
- HY-P81032
-
|
WB
|
Species-independent |
HSV Tag Antibody (YA878) is an unconjugated, mouse-derived, anti-HSV Tag (YA878) monoclonal antibody. HSV Tag Antibody (YA878) can be used for: WB expriments in species-independent background without labeling.
|
- HY-P81033
-
- HY-P81034
-
|
WB
|
Species-independent |
mOrange Tag Antibody (YA880) is an unconjugated, mouse-derived, anti-mOrange Tag (YA880) monoclonal antibody. mOrange Tag Antibody (YA880) can be used for: WB expriments in species-independent background without labeling.
|
- HY-P81035
-
|
WB
|
Oryza sativa L,Brassica napus |
Plant Actin Antibody (YA881) is an unconjugated, approximately 42 kDa, mouse-derived, anti-Plant Actin (YA881) monoclonal antibody. Plant Actin Antibody (YA881) can be used for: WB expriments in Oryza sativa L, Brassica napus background without labeling.
|
- HY-P81036
-
|
WB
|
Species-independent |
RFP Tag Antibody (YA882) is an unconjugated, mouse-derived, anti-RFP Tag (YA882) monoclonal antibody. RFP Tag Antibody (YA882) can be used for: WB expriments in species-independent background without labeling.
|
- HY-P81037
-
|
WB
|
Species-independent |
S Tag Antibody (YA883) is an unconjugated, mouse-derived, anti-S Tag (YA883) monoclonal antibody. S Tag Antibody (YA883) can be used for: WB expriments in species-independent background without labeling.
|
- HY-P81038
-
|
WB
|
Species-independent |
SRT Tag Antibody (YA884) is an unconjugated, mouse-derived, anti-SRT Tag (YA884) monoclonal antibody. SRT Tag Antibody (YA884) can be used for: WB expriments in species-independent background without labeling.
|
- HY-P81041
-
|
WB
|
Species-independent |
TAP Tag Antibody (YA887) is an unconjugated, mouse-derived, anti-TAP Tag (YA887) monoclonal antibody. TAP Tag Antibody (YA887) can be used for: WB expriments in species-independent background without labeling.
|
- HY-P81042
-
|
WB
|
Species-independent |
Trx Tag Antibody (YA888) is an unconjugated, mouse-derived, anti-Trx Tag (YA888) monoclonal antibody. Trx Tag Antibody (YA888) can be used for: WB expriments in species-independent background without labeling.
|
- HY-P81058
-
Salbutamol
|
ELISA
|
|
Salbutamol Antibody (YA901) is an unconjugated, rabbit-derived, anti-Salbutamol (YA901) monoclonal antibody. Salbutamol Antibody (YA901) can be used for: ELISA expriments in background without labeling.
|
- HY-P81064
-
Neomycin
|
ELISA
|
|
Neomycin Antibody (YA907) is an unconjugated, rabbit-derived, anti-Neomycin (YA907) monoclonal antibody. Neomycin Antibody (YA907) can be used for: ELISA expriments in background without labeling.
|
- HY-P81833
-
- HY-P81965
-
Neurofascin
|
WB
|
Human, Mouse, Rat |
- HY-P82166
-
Scinderin
|
WB, IHC-P
|
Human |
- HY-P82236
-
HBP
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P82761
-
- HY-P83075
-
- HY-P83119
-
LCAT
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P83356
-
- HY-P83538
-
TPMTD
|
WB, IHC-P, IP
|
Human |
- HY-P81847A
-
|
WB, IHC-P, ELISA
|
Human, Rat |
- HY-P80097
-
|
WB, ICC/IF, IHC-P, IP
|
Human |
Cyclin B1 Antibody (YA486) is a non-conjugated and Rabbit origined monoclonal antibody about 48 kDa, targeting to Cyclin B1. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human.
|
- HY-P80098
-
|
WB, ICC/IF, IHC-P, IP
|
Human, Mouse, Rat |
Cyclin D1 Antibody (YA485) is a non-conjugated and Rabbit origined monoclonal antibody about 34 kDa, targeting to Cyclin D1. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80100
-
|
WB, ICC/IF, IHC-P
|
Human, Mouse |
Cyclin E1 Antibody (YA483) is a non-conjugated and Rabbit origined monoclonal antibody about 47 kDa, targeting to Cyclin E1. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80161
-
|
WB, IF, IHC-P, IP
|
Human, Mouse, Rat |
Histone H2A.X Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Histone H2A.X. It can be used for WB,IF,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80162
-
|
WB, IHC-P, ICC/IF
|
Human, Mouse |
Histone H2A.Z Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 14 kDa, targeting to Histone H2A.Z. It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse.
|
- HY-P80209
-
|
WB, IP
|
Human |
LC3B Antibody (YA308) is a non-conjugated and Rabbit origined monoclonal antibody about 14/16 kDa, targeting to LC3B. It can be used for WB,IP assays with tag free, in the background of Human.
|
- HY-P80214
-
|
WB, IP
|
Human, Mouse |
MAPKAP Kinase 2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 46 kDa, targeting to MAPKAP Kinase 2. It can be used for WB,IP assays with tag free, in the background of Human, Mouse.
|
- HY-P80221
-
|
WB, ICC, IF, IHC-P, FC
|
Human, Mouse, Rat |
Methionine Aminopeptidase 2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 53 kDa, targeting to Methionine Aminopeptidase 2. It can be used for WB,ICC,IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80258
-
|
WB, ICC, IHC-P
|
Human |
p53 (acetyl K382) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 53 kDa, targeting to p53 (acetyl K382). It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human.
|
- HY-P80260
-
|
WB, ICC/IF, IP
|
Human |
p53 (acetyl K370)Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 53 kDa, targeting to p53(acetyl K370). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human.
|
- HY-P80278
-
|
WB, ICC/IF
|
Human, Rat |
Phospho-PDGFR beta (Y740) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 124 kDa, targeting to Phospho-PDGFR beta (Y740). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Rat.
|
- HY-P80279
-
|
WB, ICC/IF, IHC-P, IP
|
Human, Mouse, Rat |
Phospho-PKC alpha (T638) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 77 kDa, targeting to Phospho-PKC alpha (T638). It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80280
-
|
WB, IHC-P
|
Human, Mouse |
Phospho-PKC zeta (T560) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 68 kDa, targeting to Phospho-PKC zeta(T560). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80281
-
|
WB, ICC/IF, IHC-P, IP
|
Human, Rat, Mouse |
Phospho-STAT3 (Ser727) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 88 kDa, targeting to Phospho-STAT3 (S727). It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Rat, Mouse.
|
- HY-P80370
-
|
WB, ICC, IHC-P, IP
|
Human, Rat |
VEGF Receptor 2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 152 kDa, targeting to VEGF Receptor 2. It can be used for WB,ICC,IHC-P,IP assays with tag free, in the background of Human, Rat.
|
- HY-P80381
-
|
WB, IHC-P
|
Human |
Carbonic anhydrase 9 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 50 kDa, targeting to Carbonic anhydrase 9. It can be used for WB,IHC-P assays with tag free, in the background of Human.
|
- HY-P80407
-
|
WB, IHC-P, IP
|
Mouse, Rat |
Glutamate receptor 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 102 kDa, targeting to Glutamate receptor 1. It can be used for WB,IHC-P,IP assays with tag free, in the background of Mouse, Rat.
|
- HY-P80414
-
|
WB, ICC/IF, IP
|
Human, Mouse |
IKK alpha + IKK beta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 87 kDa, targeting to IKK alpha + IKK beta. It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse.
|
- HY-P80437
-
|
WB, ICC, IF, IHC-P, FC
|
Human, Mouse, Rat |
Proteasome 20S LMP7 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 30 kDa, targeting to Proteasome 20S LMP7. It can be used for WB,ICC,IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80455
-
|
WB, IHC-P
|
Human |
Phospho-Chk1 (Ser296) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to Phospho-Chk1 (S296). It can be used for WB,IHC-P assays with tag free, in the background of Human.
|
- HY-P80456
-
|
WB, ICC, IHC-P
|
Human |
Phospho-c-Jun(Ser63) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to Phospho-c-Jun(S63). It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human.
|
- HY-P80472
-
|
WB, IHC-P, IP
|
Human, Mouse |
Phospho-p53 (Ser392) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 53 kDa, targeting to Phospho-p53 (S392). It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse.
|
- HY-P80474
-
|
WB, ICC/IF, FC
|
Human |
Phospho-PLK1 (Thr210) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 68 kDa, targeting to Phospho-PLK1(T210). It can be used for WB,ICC/IF,FC assays with tag free, in the background of Human.
|
- HY-P80485
-
|
WB
|
Human |
alpha Tubulin (acetyl K40) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 50 kDa, targeting to alpha Tubulin (acetyl K40). It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80497
-
|
WB, ICC/IF, IHC-P, FC
|
Human, Mouse, Rat |
GSK3 beta Antibody (YA397) is a non-conjugated and Rabbit origined monoclonal antibody about 47 kDa, targeting to GSK3 beta. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80499
-
|
WB, IHC-P, IP, FC
|
Human |
Heme Oxygenase 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 33 kDa, targeting to Heme Oxygenase 1(HO-1). It can be used for WB,IHC-P,IP,FC assays with tag free, in the background of Human.
|
- HY-P80503
-
|
WB, ICC/IF, IHC-P, FC
|
Human |
IL-1 beta Antibody (YA345) is a non-conjugated and Rabbit origined monoclonal antibody about 31 kDa, targeting to IL-1 beta. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human.
|
- HY-P80511
-
|
WB, ICC/IF, IHC-P, IP
|
Human |
Phospho-c-Myc(Ser62) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 57 kDa, targeting to Phospho-c-Myc(S62). It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human.
|
- HY-P80513
-
|
WB, ICC, IP
|
Mouse |
Phospho-SHP2 (Tyr542) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 68 kDa, targeting to Phospho-SHP2(Y542). It can be used for WB,ICC,IP assays with tag free, in the background of Mouse.
|
- HY-P80621
-
SMTCK
|
WB
|
Rat |
CKMT2 Antibody (YA793) is a non-conjugated and Mouse origined monoclonal antibody about 48 kDa, targeting to CKMT2 (3F4). It can be used for WB assays with tag free, in the background of Rat.
|
- HY-P80703
-
HKII; HXK2
|
WB, IHC-P, IP
|
Human, Rat, Hamster |
Hexokinase II Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 102 kDa, targeting to Hexokinase II. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Rat, Hamster.
|
- HY-P80904
-
MGF; STAT5
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
STAT5 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 91 kDa, targeting to STAT5. It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80961
-
|
WB, IP
|
Human, Mouse, Rat |
Phospho-CDC37 (Ser13) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 44 kDa, targeting to Hsp90 co-chaperone Cdc37 (CDC37). It can be used for WB,IP assays in the background of Human, Mouse, Rat.
|
- HY-P81000
-
|
WB, IHC-P, IP, FC
|
Human, Mouse, Rat |
Transferrin Receptor 1 Antibody is an unconjugated, approximately 85 kDa, rabbit-derived, anti-Transferrin Receptor 1 monoclonal antibody. Transferrin Receptor 1 Antibody can be used for: WB, IHC-P, IP, FC expriments in human, mouse, rat background without labeling.
|
- HY-P81022
-
|
WB, ICC/IF
|
Human |
Phospho-IRF3 (Ser386) Antibody is an unconjugated, approximately 47 kDa, rabbit-derived, anti-IRF3 (Ser386) polyclonal antibody. Phospho-IRF3 (Ser386) Antibody can be used for: WB, ICC/IF expriments in human background without labeling.
|
- HY-P80955A
-
|
WB
|
Human, Mouse, Monkey, Hamster, Rat |
beta Tubulin Antibody (HRP) (YA865) is an approximately 50-55 kDa, mouse-derived, anti-beta Tubulin (HRP) (YA865) monoclonal antibody. beta Tubulin Antibody (HRP) (YA865) can be used for: WB expriments in human, mouse, monkey, hamster, rat background with HRP labeling.
|
- HY-P81028
-
|
WB
|
Species-independent |
E2 Tag Antibody (YA870) is an unconjugated, mouse-derived, anti-E2 Tag (YA870) monoclonal antibody. E2 Tag Antibody (YA870) can be used for: WB expriments in species-independent background without labeling.
|
- HY-P80111A
-
|
WB
|
Species-independent |
Flag Tag Antibody (HRP) (YA873) is a Flag tag-conjugated, mouse-derived monoclonal antibody. Flag Tag Antibody (HRP) (YA873) can be used for: WB expriments in species-independent background.
|
- HY-P80948A
-
|
WB, ELISA
|
Species-independent |
HA Tag Antibody (HRP) (YA876) is a HA-conjugated, mouse-derived monoclonal antibody. HA Tag Antibody (HRP) (YA876) can be used for: WB, ELISA expriments in species-independent background.
|
- HY-P80947A
-
|
WB
|
Species-independent |
His Tag Antibody (HRP) (YA877) is a HRP-conjugated, mouse-derived monoclonal antibody. His Tag Antibody (HRP) (YA877) can be used for: WB expriments in species-independent background.
|
- HY-P81040
-
|
WB
|
Species-independent |
T7 Tag Antibody (YA886) is an unconjugated, mouse-derived, anti-T7 Tag (YA886) monoclonal antibody. T7 Tag Antibody (YA886) can be used for: WB expriments in species-independent background without labeling.
|
- HY-P81031
-
|
WB, IP, ICC/IF
|
Species-independent |
VSV G tag Antibody (YA875) is an unconjugated, anti-VSV G tag (YA875) monoclonal antibody. VSV G tag Antibody (YA875) can be used for: expriments in background without labeling.
|
- HY-P81059
-
BiotinConjugatedAntiMalachitegreen
|
ELISA
|
|
Malachite green Antibody (YA902) is an unconjugated, mouse-derived, anti-Malachite green (YA902) monoclonal antibody. Malachite green Antibody (YA902) can be used for: ELISA expriments in background without labeling.
|
- HY-P81062
-
SudanI
|
ELISA
|
|
Sudan I Antibody (YA905) is an unconjugated, rabbit-derived, anti-Sudan I (YA905) monoclonal antibody. Sudan I Antibody (YA905) can be used for: ELISA expriments in background without labeling.
|
- HY-P81414
-
- HY-P81430
-
MB; Myoglobin
|
IHC-P
|
Human |
- HY-P81561
-
- HY-P81579
-
- HY-P81580
-
- HY-P81665
-
HTX5
|
WB
|
Human, Mouse, Rat |
- HY-P81930
-
Endopeptidase Clp
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P81989
-
SBIDDS
|
WB
|
Human, Mouse, Rat |
- HY-P82065
-
RDX; Radixin
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P82410
-
Enovin; Neublastin
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P82454
-
Thyroglobulin (Tg)
|
WB, IP
|
Human |
- HY-P82474
-
PDCD12
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P82601
-
TAGLN; Transgelin
|
WB, IHC-P
|
Human |
- HY-P82637
-
- HY-P82640
-
FIGF; VEGFD
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82743
-
Involucrin; IVL
|
WB, IHC-P, FC
|
Human, Rat |
- HY-P82795
-
SDPIII
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P82839
-
ApoD; ApolipoproteinD
|
WB, IHC-P
|
Human |
- HY-P82844
-
MAL; Wyatt
|
WB
|
Human, Mouse, Rat |
- HY-P82962
-
- HY-P82992
-
BDK; BCKDKD
|
WB
|
Human, Mouse, Rat |
- HY-P83098
-
- HY-P83163
-
- HY-P83302
-
TYK1
|
WB, IHC-P
|
Human, Rat |
- HY-P83437
-
- HY-P83467
-
- HY-P83513
-
MTHFR; Methylenetetrahydrofolate reductase
|
WB, ICC/IF, IP
|
Human, Mouse |
- HY-P83550
-
SYLD
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Mouse, Rat |
- HY-P80111
-
FLAG Tag; flag
|
WB, IF; IP
|
|
DYKDDDDK Tag (FLAG) Antibody is a non-conjugated and Mouse origined monoclonal antibody, targeting to DYKDDDDK Tag(FLAG). It can be used for WB,IP,IF assays with DYKDDDDK-tag, in the background of .
|
- HY-P80009
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human, Mouse |
AKT1/2/3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 56 kDa, targeting to AKT1/2/3. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80167
-
|
WB, ICC/IF, IHC-P, IP, SNAP-ChIP, CUT&Tag-seq
|
Human, Mouse, Rat |
Histone H3 (acetyl K14) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Histone H3 (acetyl K14). It can be used for WB,ICC/IF,IHC-P,IP,SNAP-ChIP,CUT&Tag-seq assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80168
-
|
WB, IHC-P
|
Human, Rat |
Histone H3 (acetyl K18) Antibody is a non-conjugated and Mouse origined monoclonal antibody about 15 kDa, targeting to Histone H3 (acetyl K18). It can be used for WB,IHC-P assays with tag free, in the background of Human, Rat.
|
- HY-P80169
-
|
WB, ICC, IHC-P, FC
|
Human, Mouse, Rat |
Histone H3 (acetyl K27) Antibody is a non-conjugated and Mouse origined monoclonal antibody about 15 kDa, targeting to Histone H3 (acetyl K27). It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80170
-
|
WB, ICC/IF, IHC-P, ChIP, CUT&Tag-seq
|
Human, Mouse |
Histone H3 (acetyl K56) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Histone H3 (acetyl K56). It can be used for WB,ICC/IF,IHC-P,ChIP,CUT&Tag-seq assays with tag free, in the background of Human, Mouse.
|
- HY-P80179
-
|
WB, IHC-P, FC, ICC/IF
|
Human, Mouse, Rat |
Histone H4 (acetyl K16) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 11 kDa, targeting to Histone H4 (acetyl K16). It can be used for WB,IHC-P,FC,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80180
-
|
WB, ICC, IHC-P
|
Human, Mouse, Rat |
Histone H4 (acetyl K8) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 11 kDa, targeting to Histone H4 (acetyl K8). It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80182
-
|
WB, ICC/IF, IHC-P, IP, ChIP, CUT&Tag-seq
|
Human, Mouse, Rat |
Histone H4 (acetyl K5) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 11 kDa, targeting to Histone H4(acetyl K5). It can be used for WB,ICC/IF,IHC-P,IP,ChIP,CUT&Tag-seq assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80197
-
|
WB, ICC/IF, IHC-P, IP
|
Human, Mouse, Rat |
JNK1+JNK2+JNK3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 48/53 kDa, targeting to JNK1+JNK2+JNK3. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80220
-
|
WB, ICC/IF, IHC-P, FC, IP
|
Human, Mouse, Rat |
Metabotropic glutamate receptor 5 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 132 kDa, targeting to Metabotropic glutamate receptor 5. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80235
-
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
Myosin Light Chain 2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 19 kDa, targeting to Myosin Light Chain 2. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80244
-
|
WB, ICC, IHC-P
|
Human, Mouse |
NF-κB p105/p50 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 50 kDa, targeting to NF-κB p105/p50. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80256
-
|
WB, ICC/IF, IHC-P, FC, IP
|
Human, Mouse, Rat |
p27 KIP 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 22 kDa, targeting to p27 KIP 1. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80284
-
|
WB, ICC, IHC-P, IP
|
Human, Mouse, Rat |
PP2A alpha + beta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to PP2A alpha + beta. It can be used for WB,ICC,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80291
-
|
WB, IHC-P, FC, IP
|
Human, Mouse, Rat |
Pyruvate Dehydrogenase E1 beta subunit Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 39 kDa, targeting to Pyruvate Dehydrogenase E1 beta subunit. It can be used for WB,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80315
-
|
WB, IF-Cell, IHC-P, FC
|
Human, Mouse, Rat |
RSK1 p90 Antibody (YA088) is a non-conjugated and Rabbit origined monoclonal antibody about 83 kDa, targeting to RSK1 p90. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80348
-
|
IHC-P
|
Human |
Stathmin 1 Antibody (YA049) is a non-conjugated and Rabbit origined monoclonal antibody about 17 kDa, targeting to Stathmin. It can be used for IHC-P assays with tag free, in the background of Human.
|
- HY-P80349
-
|
WB, ICC/IF, IHC-P, FC, IP
|
Human, Mouse, Rat |
Stathmin 1 Antibody (YA050) is a non-conjugated and Rabbit origined monoclonal antibody about 18 kDa, targeting to Stathmin 1. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80405
-
|
WB, IHC-P, ICC/IF
|
Human |
Glucosidase 2 subunit beta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 59 kDa., targeting to Glucosidase 2 subunit beta. It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human.
|
- HY-P80416
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human, Mouse |
Integrin alpha 5 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 115 kDa, targeting to Integrin alpha 5. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80418
-
|
WB, IHC-P, FC
|
Human, Mouse |
Integrin beta 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 88 kDa, targeting to Integrin beta 1. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80419
-
|
WB, IHC-P, ICC/IF
|
Human, Mouse |
Integrin beta 3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 87 kDa, targeting to Integrin beta 3. It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse.
|
- HY-P80431
-
|
WB, IHC-P, FC
|
Human, Mouse |
PKC beta 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 77 kDa, targeting to PKC beta 1. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80432
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human, Mouse |
PKC beta 2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 77 kDa, targeting to PKC beta 2. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80439
-
|
WB, IHC-P, FC
|
Human, Mouse |
Laminin beta 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 198 kDa, targeting to Laminin beta 1. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80441
-
|
WB, ICC/IF, IHC-P, FC, IP
|
Human, Mouse |
Argonaute 2 Antibody (YA612) is a non-conjugated and Rabbit origined monoclonal antibody about 97 kDa, targeting to Argonaute 2. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse.
|
- HY-P80449
-
|
WB, ICC, IF, IHC-P, FC
|
Human, Mouse, Rat |
Cytochrome P450 17A1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 57 kDa, targeting to Cytochrome P450 17A1. It can be used for WB,ICC,IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80452
-
|
WB, ICC/IF, IHC-P
|
Human, Mouse |
Phospho-AMPK alpha 2(Ser345) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 62 kDa, targeting to Phospho-AMPK alpha 2(S345). It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80458
-
|
WB, ICC/IF, IP, FC
|
Human |
Phospho-EGFR Antibody (YA204) is a non-conjugated and Rabbit origined monoclonal antibody about 134 kDa, targeting to Phospho-EGFR(Y1068). It can be used for WB,ICC/IF,IP,FC assays with tag free, in the background of Human.
|
- HY-P80459
-
|
WB, ICC
|
Human |
Phospho-eIF4G (Ser1108) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 175 kDa, targeting to Phospho-eIF4G (S1108). It can be used for WB,ICC assays with tag free, in the background of Human.
|
- HY-P80461
-
|
WB, IHC-P
|
Human, Mouse, Rat |
Phospho-FOXO3a(Ser253) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 71 kDa, targeting to Phospho-FOXO3a(S253). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80469
-
|
WB, IHC
|
Human, Mouse |
Phospho-mTOR (Ser2448) Antibody (YA691) is a non-conjugated and Mouse origined monoclonal antibody about 289 kDa, targeting to Phospho-mTOR (S2448). It can be used for WB,IHC assays with tag free, in the background of Human, Mouse.
|
- HY-P80495
-
|
WB, ICC, IHC-P
|
Human, Mouse |
Glucose Transporter GLUT4 Antibody (YA753) is a non-conjugated and Mouse origined monoclonal antibody about 55 kDa, targeting to Glucose Transporter GLUT4. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80518
-
|
WB, IHC-P, FC
|
Human, Mouse, Rat |
SQSTM1/p62 Antibody (YA669) is a non-conjugated and Mouse origined monoclonal antibody about 62 kDa, targeting to SQSTM1 / p62. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80520
-
|
WB, ICC/IF, IHC-P, IP, FC
|
Human, Mouse |
TCF7L2/TCF4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 68 kDa, targeting to TCF7L2/TCF4. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80521
-
|
WB, IHC-P
|
Human, Mouse, Rat |
TGF beta 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 44 kDa, targeting to TGF beta 1. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80568
-
BECN1
|
WB, IP
|
Human, Mouse, Rat |
Beclin 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 52 kDa, targeting to Beclin 1. It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80584
-
CARS1; CYSRS; MGC:11246
|
WB, IHC-P
|
Human, Rat |
CARS Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 85 kDa, targeting to CARS. It can be used for WB,IHC-P assays with tag free, in the background of Human, Rat.
|
- HY-P80595
-
CD146; MUC18
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Rat |
CD146 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 72 kDa, targeting to CD146. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Rat.
|
- HY-P80652
-
p220
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
eIF4G1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 175 kDa, targeting to eIF4G1. It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80672
-
Fumarate hydratase; mitochondrial; Fumarase
|
WB, ICC/IF
|
Human, Mouse, Rat |
FH Antibody (YA763) is a non-conjugated and Mouse origined monoclonal antibody about 55 kDa, targeting to FH (2A3). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80682
-
GAD65
|
WB
|
Human, Rat |
GAD65 Antibody (YA758) is a non-conjugated and Mouse origined monoclonal antibody about 65 kDa, targeting to GAD65 (6D5). It can be used for WB assays with tag free, in the background of Human, Rat.
|
- HY-P80697
-
DFNA5; ICERE-1; GSDME
|
WB, IP
|
Human |
GSDME Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 55 kDa, targeting to GSDME. It can be used for WB,IP assays with tag free, in the background of Human.
|
- HY-P80732
-
INrf2; KLHL19
|
WB, IHC-P
|
Human, Mouse |
Keap1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 70 kDa, targeting to Keap1. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80863
-
VIM; Vimentin
|
WB, ICC/IF, IP
|
Human |
Phospho-Vimentin (Ser56) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to Phospho-Vimentin (Ser56). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human.
|
- HY-P80892
-
SIR2L3
|
WB, IHC-P
|
Human |
SIRT3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 44 kDa, targeting to SIRT3. It can be used for WB,IHC-P assays with tag free, in the background of Human.
|
- HY-P80896
-
ZMYND21.
|
WB
|
Human |
SMYD4 Antibody (YA671) is a non-conjugated and Mouse origined monoclonal antibody about 89 kDa, targeting to SMYD4 (7C8). It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80959
-
|
WB, IP
|
|
His Tag Antibody is a non-conjugated and Rabbit origined polyclonal antibody with His-tag. It can be used for WB,IP assays.
|
- HY-P80964
-
|
WB , IP
|
Human, Mouse |
Cleaved-Caspase 9 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 46 kDa, targeting to Cleaved-Caspase 9. It can be used for WB, IP assays with tag free, in the background of Human, Mouse.
|
- HY-P80973
-
TS; TMS; HST422
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
Thymidylate Synthase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to thymidylate synthase. It can be used for WB, IHC-F, IHC-P, ICC/IF, IP assays with tag free, in the background of Human.
|
- HY-P80996
-
|
WB, IF-Cell, IF-Tissue
|
Human, Mouse, Rat |
p38 alpha/MAPK14 Antibody is an unconjugated, approximately 41 kDa, anti-p38 alpha/MAPK14 monoclonal antibody. p38 alpha/MAPK14 Antibody can be used for: WB, IF-Cell, IF-Tissue expriments in human, mouse, rat background without labeling.
|
- HY-P80232A
-
|
WB, ELISA, IHC-P, IP
|
Species-independent |
c-Myc Tag Antibody(HRP) (YA866) is a c-Myc tag-conjugated, mouse-derived monoclonal antibody. c-Myc Tag Antibody(HRP) (YA866) can be used for: WB, ELISA, IHC-P, IP expriments in species-independent background.
|
- HY-P81087
-
advanced glycosylation end products; AGE.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, Mouse, Rat, |
AGEs Antibody is an unconjugated, rabbit-derived, anti-AGEs polyclonal antibody. AGEs Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, background without labeling.
|
- HY-P81291
-
B23; NPM
|
WB, ChIP
|
Human, Mouse |
- HY-P81291A
-
B23; NPM
|
WB, IHC-P, IP
|
Human |
- HY-P81332
-
neomycin phosphotransferase II
|
WB
|
Transfected |
- HY-P81394
-
Gem; Geminin; GMNN
|
IHC-P
|
Human |
- HY-P81403
-
cytidine deaminase; CDD
|
IHC-P
|
Human |
- HY-P81450
-
SMSMO; SMTN; Smoothelin
|
IHC-P
|
Human |
- HY-P81504
-
Parvalbumin alpha; PVALB
|
IHC-P
|
Human |
- HY-P81548
-
Siglec-1
|
IHC-P, ICC/IF, FC
|
Human |
- HY-P81563
-
- HY-P81564
-
LOG15
|
IHC-P, ICC/IF, FC
|
Human |
- HY-P81568
-
CALLA, NEP
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P81676
-
Nova-1
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P81708
-
NUDT10
|
WB, ICC/IF
|
Human, Rat |
- HY-P81951
-
Phe-4-monooxygenase
|
WB
|
Human, Mouse, Rat |
- HY-P82025
-
- HY-P82038
-
MLASA1
|
WB, ICC/IF, IP
|
Human, Hamster, Rat |
- HY-P82044
-
RAB10
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82201
-
- HY-P82224
-
SCAD; ACAD3
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82302
-
ABH2
|
WB
|
Human, Mouse, Rat |
- HY-P82305
-
- HY-P82363
-
Homeobox protein goosecoid
|
WB, IP
|
Human |
- HY-P82392
-
SRP54
|
WB, IHC-P, IP, FC
|
Mouse, Rat, Human |
- HY-P82403
-
HIP4; CBS
|
WB, IHC-P, ICC/IF
|
Human |
- HY-P82462
-
TIM44
|
WB, ICC/IF, IP
|
Human |
- HY-P82778
-
CAD; CAD protein
|
WB, ICC/IF, IP, FC
|
Human |
- HY-P82922
-
CTRL; CTRL1
|
WB
|
Human, Mouse, Rat |
- HY-P82972
-
HLRC1; hDOHH
|
WB, IP
|
Human |
- HY-P83025
-
ARPP-19e
|
WB
|
Human, Mouse, Rat |
- HY-P83036
-
- HY-P83040
-
- HY-P83048
-
Mort1/FADD
|
WB, IHC-P
|
Human, Mouse |
- HY-P83118
-
FRAT-1
|
WB, ICC/IF, IP
|
Human |
- HY-P83160
-
- HY-P83175
-
FKBP36
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P83207
-
- HY-P83245
-
Hepatic leukemia factor
|
WB
|
Human |
- HY-P83278
-
LOR; Loricrin; LRN
|
WB, IHC-P
|
Human |
- HY-P83286
-
HNRNPGT
|
WB
|
Human, Mouse, Rat |
- HY-P83310
-
ODS1
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P83328
-
- HY-P83331
-
- HY-P83380
-
- HY-P83389
-
KCASH2
|
WB
|
Human, Mouse, Rat |
- HY-P83432
-
- HY-P83475
-
S8
|
WB, ICC/IF, IP
|
Human, Mouse, Rat, Hamster |
- HY-P83507
-
- HY-P83516
-
- HY-P83544
-
CAPH2
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P83610
-
Kl; Klotho peptide
|
WB, IHC-P
|
Human, Mouse |
- HY-P83642
-
DM4
|
ELISA
|
Species independent |
Ravtansine (DM4) is a maytansinoid, a chemical derivative of maytansine being investigated as the cytotoxic payload of a number of antibody-drug conjugates (ADCs). Microtubules are dynamic cytoskeletal polymers that switch stochastically between states of growing and shortening, called “dynamic instability”. They function in the precise segregation of chromosomes during cell division, transport of cellular cargos, and positioning and movement of intracellular organelles. Inhibition of microtubule function leads to cell cycle arrest and cell death. Microtubule-targeted drugs including the Vinca alkaloids, taxanes, and epothilones suppress the dynamic instability of microtubules, induce mitotic arrest, inhibit cell proliferation and induce apoptosis. The anticancer properties of maytansinoids have been attributed to their ability to disrupt microtubule function. The maytansinoid emtansine (DM1), for example, binds at the ends of microtubules and thereby suppress their dynamic instability. It is synthesized in order to link maytansinoids to antibodies via disulfide bonds. Maytansinoids inhibit tubulin polymerization and microtubule assembly and enhance microtubule destabilization, so there is potent suppression of microtubule dynamics resulting in a mitotic block and subsequent apoptotic cell death. DM4 can be used in the preparation of antibody drug conjugate. Although S-methyl DM1 and S-methyl DM4 inhibited microtubule assembly more weakly than maytansine, they suppressed dynamic instability more strongly than maytansine. Like vinblastine, the maytansinoids potently suppress microtubule dynamic instability by binding to a small number of high affinity sites, most likely at microtubule ends. Thus, the maytansine derivatives that result from cellular metabolism of the antibody conjugates are themselves potent microtubule poisons, interacting with microtubules as effectively as or more effectively than the parent molecule.
|
- HY-P80159
-
|
WB, ICC/IF, IHC-P, ChIP, CUT&Tag-seq
|
Human, Mouse |
Histone H2A(acetyl K9) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 14 kDa, targeting to Histone H2A(acetyl K9). It can be used for WB,ICC/IF,IHC-P,ChIP,CUT&Tag-seq assays with tag free, in the background of Human, Mouse.
|
- HY-P80160
-
|
WB, IHC-P
|
Human, Mouse |
Histone H2A (hydroxyl Y39) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 14 kDa, targeting to Histone H2A(hydroxyl Y39). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80164
-
|
WB, ICC/IF, IHC-P, FC, IP, ChIP, CUT&Tag-seq
|
Human, Mouse |
Histone H2B (acetyl K20) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 14 kDa, targeting to Histone H2B(acetyl K20). It can be used for WB,ICC/IF,IHC-P,FC,IP,ChIP,CUT&Tag-seq assays with tag free, in the background of Human, Mouse.
|
- HY-P80171
-
|
WB, ICC/IF, IHC-P
|
Human, Mouse, Rat |
Histone H3 (di methyl K9) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Histone H3 (di methyl K9). It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80172
-
|
WB, ICC/IF, IHC-P
|
Human, Mouse |
Histone H3 (mono methyl K18) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Histone H3 (mono methyl K18). It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80173
-
|
WB, ICC/IF
|
Human, Mouse |
Histone H3 (mono methyl K36)Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Histone H3 (mono methyl K36). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse.
|
- HY-P80174
-
|
WB, ICC/IF
|
Human, Mouse |
Histone H3 (mono methyl R2)Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Histone H3 (mono methyl R2). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse.
|
- HY-P80181
-
|
WB, IHC-P
|
Human, Mouse |
Histone H4 (tri methyl K20) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 11 kDa, targeting to Histone H4 (tri methyl K20). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80282
-
|
WB, IHC-P, IP
|
Human, Mouse |
Phospho-STAT3 (Tyr705) Antibody (YA146) is a non-conjugated and Rabbit origined monoclonal antibody about 88 kDa, targeting to Phospho-STAT3(Tyr705). It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse.
|
- HY-P80409
-
|
WB, ICC, FC
|
Human, Mouse |
Glutathione peroxidase 1 Antibody (YA750) is a non-conjugated and Mouse origined monoclonal antibody about 22 kDa, targeting to Glutathione peroxidase 1. It can be used for WB,ICC,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80410
-
|
WB, ICC/IF, IHC-P, IP
|
Human, Rat |
Glutathione Peroxidase 1 Antibody (YA404) is a non-conjugated and Rabbit origined monoclonal antibody about 22 kDa, targeting to Glutathione Peroxidase 1. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Rat.
|
- HY-P80428
-
|
WB, IP, ICC/IF, IHC-P, FC
|
Human, Mouse, Rat |
PKA 2 beta (regulatory subunit)Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 46 kDa, targeting to PKA 2 beta (regulatory subunit). It can be used for WB,IP,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80462
-
|
WB, ICC/IF, IHC-P
|
Human |
Phospho-GSK3 beta(Ser 9) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 47 kDa, targeting to Phospho-GSK3 beta(Ser 9). It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human.
|
- HY-P80465
-
|
WB, IP
|
Human |
Phospho-Hsp27 (Ser82) Antibody (YA187) is a non-conjugated and Rabbit origined monoclonal antibody about 23 kDa, targeting to Phospho-Hsp27(S82). It can be used for WB,IP assays with tag free, in the background of Human.
|
- HY-P80466
-
|
WB, ICC, IP
|
Human, Mouse |
Phospho-IKB alpha (Ser32) Antibody (YA183) is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to Phospho-IKB alpha(S32). It can be used for WB,ICC,IP assays with tag free, in the background of Human, Mouse.
|
- HY-P80467
-
|
WB, ICC, IHC-P, IP
|
Human, Mouse, Rat |
Phospho-JAK2 (Tyr1007+Tyr1008) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 131 kDa, targeting to Phospho-JAK2(Y1007+Y1008). It can be used for WB,ICC,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80470
-
|
WB, IP, FC, IHC-P
|
Human |
Phospho-NF-κB p65 (Ser529) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 60 kDa, targeting to Phospho-NF-κB p65(S529). It can be used for WB,IP,FC,IHC-P assays with tag free, in the background of Human.
|
- HY-P80473
-
|
WB, ICC/IF, IHC-P, IP
|
Human, Mouse |
Phospho-p95/NBS1 (Ser343) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 85 kDa, targeting to Phospho-p95/NBS1 (S343). It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse.
|
- HY-P80477
-
|
WB, ICC/IF, IHC-P
|
Human, Mouse |
Phospho-Smad3 (Ser423/Ser425) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 48 kDa, targeting to Phospho-Smad3(S423/S425). It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80478
-
|
WB, IHC-P
|
Human, Mouse |
Phospho-STAT1 (Ser727) Antibody (YA148) is a non-conjugated and Rabbit origined monoclonal antibody about 87 kDa, targeting to Phospho-STAT1(S727). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80481
-
|
WB, IHC-P
|
Human, Mouse |
Phospho-YAP1 (Ser127) Antibody (YA137) is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to Phospho-YAP1 (S127). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80543
-
AMPKG
|
WB, ICC/IF, IP
|
Human |
AMPK gamma 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 38 kDa, targeting to AMPK gamma 1. It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human.
|
- HY-P80604
-
CD63 antigen; CD63
|
WB, IHC-P
|
Human, Mouse |
CD63 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 26 kDa, targeting to CD63. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80634
-
KIAK0002.
|
WB
|
Human |
Cyclin D2 Antibody (YA789) is a non-conjugated and Mouse origined monoclonal antibody about 33 kDa, targeting to Cyclin D2 (6E11). It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80687
-
GR; GCR; GRL; GCCR; GCRST
|
WB, ICC/IF
|
Human, Mouse, Rat |
Glucocorticoid Receptor Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 87 kDa, targeting to Glucocorticoid Receptor. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80767
-
SYM1; SYNS1.
|
WB, ICC/IF
|
Transfected(Human, Mouse, Rat) |
Noggin Antibody (YA698) is a non-conjugated and Mouse origined monoclonal antibody about 26 kDa, targeting to Noggin (1D2). It can be used for WB,ICC/IF assays with tag free, in the background of Transfected.
|
- HY-P80962
-
|
WB, IP
|
Human, Mouse, Rat |
Phospho-CDC37 (Ser13) Antibody (YA219) is a non-conjugated and Rabbit origined monoclonal antibody about 44 kDa, targeting to Hsp90 co-chaperone Cdc37 (CDC37). It can be used for WB,IP assays in the background of Human, Mouse, Rat.
|
- HY-P81027
-
|
WB, IP
|
Human |
Dynactin Subunit 1 Antibody (YA869) is an unconjugated, approximately 142 kDa, mouse-derived, anti-Dynactin Subunit 1 (YA869) monoclonal antibody. Dynactin Subunit 1 Antibody (YA869) can be used for: WB, IP expriments in human background without labeling.
|
- HY-P81067
-
Core antigen ; Core protein
|
IHC-P
|
Human |
HBcAg Antibody (YA910) is an unconjugated, mouse-derived, anti-HBcAg (YA910) monoclonal antibody. HBcAg Antibody (YA910) can be used for: IHC-P expriments in human background without labeling.
|
- HY-P81315
-
Protective antigen
|
ELISA
|
Bacillusanthracis |
- HY-P81327
-
PURH; AICAR; AICARFT; IMPCHASE
|
WB
|
Human, Mouse, Rat |
- HY-P81329
-
HKMT1098; KIAA1949.
|
WB
|
Human |
- HY-P81471
-
calpastatin; BS-17; CAST
|
IHC-P
|
Human |
- HY-P81487
-
Inhibin alpha chain
|
IHC-P
|
Human |
- HY-P81543
-
- HY-P81545
-
JCHAIN, IGCJ, IGJ
|
IHC-P
|
Human, Mouse, Rat |
- HY-P81569
-
CREBBP, CREB-binding protein
|
WB, ICC/IF
|
Human |
- HY-P81576
-
- HY-P81577
-
IHABP, RHAMM, HMMR
|
WB
|
Human, Mouse, Rat, Monkey |
- HY-P81590
-
AGGG; CI-AGGG
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P81672
-
LRP; MVP; VAULT1
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P81719
-
PERB11.1; MICA
|
FC, ELISA
|
Human |
- HY-P81878
-
- HY-P81890
-
DOD; UBL5
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P81891
-
Microsomal GST-I
|
WB, IHC-P
|
Human, Rat |
- HY-P81967
-
Sorting nexin-5
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P81982
-
6-phosphogluconate dehydrogenase; decarboxylating
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82016
-
CAP1; PROSTASIN
|
WB, IP
|
Human |
- HY-P82039
-
- HY-P82053
-
- HY-P82064
-
glypican
|
WB, ICC/IF
|
Human |
- HY-P82089
-
CENP-34; RASFADIN
|
WB
|
Human |
- HY-P82092
-
Protein raver-2
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P82263
-
CEDNIK; SNAP-29
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82269
-
Catechol O methyltransferase; COMT
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P82436
-
Tyrosine-protein kinase Tec
|
WB, ICC/IF
|
Human |
- HY-P82455
-
STEF; TIAM-2
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
- HY-P82458
-
Apof; Apolipoprotein F; LTIP
|
WB, ICC/IF
|
Human |
- HY-P82512
-
TRAX
|
WB
|
Human, Mouse, Rat |
- HY-P82547
-
C13orf34
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82564
-
APACD; PHLP3
|
WB, IHC-P
|
Human |
- HY-P82576
-
TRAP; SPENCDI; TrATPase
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82602
-
NEDSG; HSPC155
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P82607
-
- HY-P82779
-
- HY-P82786
-
GPCR; Lgr6
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82807
-
ATDC; TRIM29
|
WB
|
Human, Mouse, Rat |
- HY-P82862
-
ada; ADA1
|
WB, ICC/IF, IP
|
Human, Rat |
- HY-P82867
-
HLA B; HLAB
|
WB, IHC-P
|
Human |
- HY-P82891
-
- HY-P82995
-
BCLG
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P83020
-
STA; EDMD; LEMD5
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse |
- HY-P83068
-
Oncostatin-M (OSM)
|
WB
|
Human, Mouse, Rat |
- HY-P83072
-
FPS; FPPS; POROK9
|
WB, IHC-P
|
Human, Hamster |
- HY-P83122
-
- HY-P83200
-
CSNB1H
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P83220
-
AGS1; ATIP; Atrip
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P83224
-
HBP; VGL; PRO2900
|
WB
|
Human |
- HY-P83266
-
BDA1; HHG2
|
WB, IHC-P
|
Human, Mouse |
- HY-P83348
-
MVK; Mevalonate kinase; MK
|
WB, IP
|
Human |
- HY-P83369
-
NMMHCB; NMMHC-IIB
|
WB, IP
|
Human, Mouse |
- HY-P83383
-
- HY-P83397
-
HSET; KNSL2
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse |
- HY-P83402
-
CAM; CCM1
|
WB
|
Human, Mouse, Rat |
- HY-P83430
-
CMS22; Prolylendopeptidase-like
|
WB, IHC-P, IP
|
Human, Mouse, Rat, Hamster |
- HY-P83482
-
SDS; SWDS; CGI-97
|
WB, ICC/IF, IP
|
Human |
- HY-P83484
-
CLCRP2
|
WB
|
Human, Mouse, Rat |
- HY-P83508
-
MASK; MST4
|
WB, ICC/IF, IP
|
Human, Rat |
- HY-P83572
-
CAHL; hYTHDC2
|
WB, IP
|
Human |
- HY-P80608
-
CD81; TAPA1; TSPAN28; CD81 antigen; 26 kDa cell surface protein TAPA-1; Target of the antiproliferative Antibody 1; Tetraspanin-28; Tspan-28; CD81
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse |
CD81 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 26 kDa, targeting to CD81. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse.
|
- HY-P80165
-
|
WB, ICC/IF, IHC-P
|
Human, Mouse |
Histone H2B (mono methyl R79) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 14 kDa, targeting to Histone H2B(mono methyl R79). It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80277
-
|
WB, ICC, IHC-P, IP
|
Human, Mouse, Rat |
Phospho-Glycogen synthase 1 (S641) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 84 kDa, targeting to Phospho-Glycogen synthase 1(S641). It can be used for WB,ICC,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80365
-
|
WB, ICC/IF, IHC-P, FC
|
Human, Mouse |
Ubiquitin-like modifier-activating enzyme 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 118 kDa, targeting to Ubiquitin-like modifier-activating enzyme 1. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80376
-
|
WB, ICC/IF, FC, IP
|
Human, Rat |
AMPK alpha 1 Antibody (YA624) is a non-conjugated and Rabbit origined monoclonal antibody about 64 kDa, targeting to AMPK alpha 1. It can be used for WB,ICC/IF,FC,IP assays with tag free, in the background of Human, Rat.
|
- HY-P80377
-
|
WB, ICC, IHC-P
|
Human, Mouse, Rat |
AMPK alpha 2 Antibody (YA833) is a non-conjugated and Mouse origined monoclonal antibody about 62 kDa, targeting to AMPK alpha 2. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80482
-
|
WB, IHC-P
|
Human, Mouse |
Acetyl CoA Carboxylase 1 (ACC1) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 266 kDa, targeting to Acetyl CoA Carboxylase 1(ACC1). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80566
-
BCL2; Apoptosis regulator Bcl-2
|
WB, IHC-P
|
Human, Mouse |
Bcl2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 26 kDa, targeting to Bcl2. It can be used for WB, IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80583
-
PRMT4; CARM1
|
WB, IP
|
Human, Mouse |
CARM1 Antibody (YA812) is a non-conjugated and Mouse origined monoclonal antibody about 66 kDa, targeting to CARM1 (2B9). It can be used for WB,IP assays with tag free, in the background of Human, Mouse.
|
- HY-P80612
-
PCTK1; PCTAIRE; PCTAIRE1; PCTGAIRE
|
WB
|
Human |
CDK16 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 56 kDa, targeting to CDK16. It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80631
-
CCNA1; Cyclin-A1
|
WB, IHC-F, IHC-P, ICC/IF, ELISA
|
Human, Mouse, Rat, Monkey |
Cyclin A1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 52 kDa, targeting to Cyclin A1. It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Mouse, Rat, Monkey.
|
- HY-P80651
-
EIF-4B; PRO1843
|
WB, IHC-P
|
Human |
eIF4B Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 69 kDa, targeting to eIF4B. It can be used for WB,IHC-P assays with tag free, in the background of Human.
|
- HY-P80668
-
FASN; FAS; Fatty acid synthase
|
WB, ICC/IF, IP
|
Human, Mouse, Rat, Monkey |
Fatty Acid Synthase Antibody (YA766) is a non-conjugated and Mouse origined monoclonal antibody about 273 kDa, targeting to Fatty Acid Synthase (2F9). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat, Monkey.
|
- HY-P80675
-
Flotillin-1
|
WB
|
Mouse, Rat |
Flotillin 1 Antibody (YA760) is a non-conjugated and Mouse origined monoclonal antibody about 47 kDa, targeting to Flotillin 1 (6H9). It can be used for WB assays with tag free, in the background of Mouse, Rat.
|
- HY-P80693
-
GR; HEL-75; HEL-S-122m
|
WB
|
Human, Mouse |
Glutathione Reductase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 56 kDa, targeting to Glutathione Reductase. It can be used for WB assays with tag free, in the background of Human, Mouse.
|
- HY-P80739
-
CT32; LDH3; LDHX
|
WB
|
Human |
Lactate Dehydrogenase C Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to Lactate Dehydrogenase C. It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80742
-
MAP1LC3B
|
WB, ICC/IF, IHC-F, IHC-P
|
Human, Mouse, Rat |
LC3B Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 15 kDa, targeting to LC3B. It can be used for WB,ICC/IF,IHC-F,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80745
-
Liver-type arginase; Type I arginase
|
WB, IHC-P
|
Mouse, Rat |
Liver Arginase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 35 kDa, targeting to Liver Arginase. It can be used for WB,IHC-P assays with tag free, in the background of Mouse, Rat.
|
- HY-P80901
-
La; LARP3; La/SSB
|
WB
|
Human |
SSB Antibody (YA668) is a non-conjugated and Mouse origined monoclonal antibody about 47 kDa, targeting to SSB (4B10). It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80934
-
Wnt5b
|
WB
|
Transfected |
Wnt5b Antibody (YA653) is a non-conjugated and Mouse origined monoclonal antibody about 40 kDa, targeting to Wnt5b (3D1). It can be used for WB assays with tag free, in the background of Transfected.
|
- HY-P80947
-
|
WB, IP
|
|
Anti-6X His-tag (C-terminal) Antibody is a non-conjugated and Mouse origined monoclonal antibody. It can be used for WB,IP assays in the background of .
|
- HY-P81341
-
RM; RACE; CBAS4; AMACRD
|
WB, ICC/IF
|
Rat, Human |
- HY-P81342
-
RAD9; hRAD9
|
WB, IP
|
Human, Mouse, Rat, Monkey |
- HY-P81376
-
- HY-P81386
-
TPS2; tryptaseB; tryptaseC
|
IHC-P
|
Human |
- HY-P81393
-
SNX; ANX7; SYNEXIN
|
IHC-P
|
Human |
- HY-P81465
-
Dek; DEK oncogene; Protein DEK
|
IHC-P
|
Human |
- HY-P81540
-
- HY-P81556
-
CALD, CAD, CALD1
|
IHC-P
|
Human, Mouse, Rat |
- HY-P81560
-
Ag3, LFA3
|
WB, ICC/IF, FC
|
Human |
- HY-P81567
-
RP8, ZMYND7
|
WB
|
Human, Mouse, Rat |
- HY-P81652
-
APH2; Ncstn; NCT; Nicastrin
|
WB, IP
|
Human, Mouse, Rat |
- HY-P81701
-
- HY-P81720
-
NWASP; WASPB; N-WASP
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse |
- HY-P81721
-
MIC-B; PERB11.2
|
FC, ELISA
|
Human |
- HY-P81729
-
Olfactory marker protein
|
WB, IP
|
Mouse, Rat |
- HY-P81734
-
PSCA; Prostate stem cell antigen
|
FC, ELISA
|
Human |
- HY-P81741
-
ROR1; NTRKR1
|
FC, ELISA
|
Human |
- HY-P81752
-
TIGIT; VSIG9; VSTM3
|
FC, ELISA
|
Human |
- HY-P81771
-
APOE; Apolipoprotein E; Apo-E
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse |
- HY-P81814
-
Alpi; Glycerophosphatase; IAP
|
WB, IHC-P
|
Human |
- HY-P81825
-
ADF; AGEL; Brevin; Gelsolin; Gsn
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse |
- HY-P81841
-
GHA1; Mammotropin; PRL; Prolactin
|
WB
|
Human |
- HY-P81877
-
PLN; PLB; Cardiac phospholamban; PLB
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P81926
-
HNUP153; Nup153
|
WB, ICC/IF, FC
|
Human |
- HY-P81928
-
MEN1; SCG2; Menin
|
WB, IP
|
Human, Rat |
- HY-P81974
-
Prealbumin; TBPA; Amyloidosis I; Transthyretin
|
WB
|
Rat |
- HY-P81986
-
HRMT1L3
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P81992
-
hat1; KAT1
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P82008
-
Cf2; FII; Cf-2
|
WB, IHC-P
|
Mouse, Rat |
- HY-P82071
-
Ras-related protein Ral-B
|
WB, IP
|
Human, Mouse |
- HY-P82101
-
UHX1; USP11
|
WB, IP
|
Human, Rat |
- HY-P82155
-
SD; Fug1; RANGAP
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82157
-
HEX; HHEX; HMPH; PRH; PRHX
|
WB, IP
|
Human |
- HY-P82170
-
SENP1; SuPr2
|
WB, IHC-P, ICC/IF, FC
|
Human |
- HY-P82188
-
HUR; Hua; MelG; ELAV1
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82194
-
ERLEC2; Os9
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82218
-
Angio-associated migratory cell protein
|
WB
|
Human, Mouse, Rat |
- HY-P82239
-
CMM6; XRCC3
|
WB, FC
|
Human, Mouse, Rat |
- HY-P82280
-
FRIGG; UNC84B
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82298
-
SRS; SpS; MRSR; SPMSY
|
WB
|
Human |
- HY-P82320
-
ADIP; hMsd1
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Rat |
- HY-P82332
-
STAU; PPP1R150
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P82365
-
BAF57; SMARCE1
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82411
-
PGAM1; PGAMA; PGAMB
|
WB, FC
|
Human, Mouse, Rat |
- HY-P82425
-
AS160; NIDDM5
|
WB, IP
|
Human |
- HY-P82529
-
LTF; LF; Lactotransferrin; Lactoferrin; Talalactoferrin
|
WB, ICC/IF, IP
|
Human |
- HY-P82544
-
BOKL; BCL2L9
|
WB
|
Human, Rat |
- HY-P82591
-
Calretinin; CR; 29 kDa calbindin
|
WB, ICC/IF
|
Rat |
- HY-P82609
-
- HY-P82644
-
TAP; VDP; P115
|
WB, IP
|
Mouse |
- HY-P82691
-
Bcl2 modifying factor; Bmf
|
WB, FC
|
Human, Mouse, Rat |
- HY-P82762
-
- HY-P82775
-
- HY-P82993
-
DRCC1; MUC-13
|
IHC-P
|
Human |
- HY-P82999
-
- HY-P83011
-
PRTN3; ACPA; CANCA
|
WB, IHC-P
|
Human |
- HY-P83016
-
MO25; CGI-66
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P83031
-
- HY-P83046
-
DF; ADN; PFD; ADIPSIN
|
WB
|
Human |
- HY-P83094
-
HMG17; HMGN2
|
WB, IHC-P
|
Human |
- HY-P83107
-
DOC2; DOC-2
|
WB, IHC-P, IP
|
Human |
- HY-P83116
-
DAGK; DAGK1; DGK-alpha
|
WB, IHC-P, IP
|
Human |
- HY-P83125
-
- HY-P83127
-
Acid maltase; GAA; Glucosidase alpha acid; LYAG
|
WB
|
Human, Mouse, Rat |
- HY-P83130
-
napA; SNAP alpha; SNAPA
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P83213
-
GDH2; GPDM; mGPDH
|
WB, IP
|
Human, Mouse, Rat |
- HY-P83229
-
Pitx3; PTX3
|
WB, IP, FC
|
Human, Mouse, Rat |
- HY-P83242
-
FAKTS; URLC9; hFLEG1
|
WB, IHC-P
|
Human |
- HY-P83270
-
IL-26; AK155
|
WB, IHC-P, IP
|
Human |
- HY-P83338
-
PXN; Paxillin
|
WB
|
Human, Mouse, Rat |
- HY-P83353
-
CK 6A
|
WB, IHC-P, ICC/IF
|
Human |
- HY-P83360
-
NgR3; NGRH2
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P83378
-
N155; ATFB15
|
WB, ICC/IF
|
Human |
- HY-P83491
-
- HY-P83549
-
NCK; nck-1; NCKalpha
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P83590
-
DHFR; DHFRP1; Dihydrofolate reductase; DYR
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P80175
-
|
WB, IHC-P
|
Human, Mouse, Rat |
Histone H3 (mono+di+tri methyl K79) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Histone H3 (mono+di+tri methyl K79). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80516
-
|
WB, ICC/IF, IHC-P, FC
|
Human, Mouse |
PI 3 Kinase p85 alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 84 kDa, targeting to PI 3 Kinase p85 alpha. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80538
-
ALS22; TUBA1; H2-ALPHA
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat, Hamster |
alpha Tubulin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 50 kDa, targeting to alpha Tubulin. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat, Hamster.
|
- HY-P80552
-
Phospho-ATF2-T69/T71
|
WB
|
Human, Mouse, Rat |
ATF2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 52 kDa, targeting to ATF2. It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80591
-
ENG; END; Endoglin; CD antigen CD105
|
WB, IHC-P, IP
|
Human |
CD105 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 71 kDa, targeting to CD105. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human.
|
- HY-P80673
-
FIB; FLRN; Nop1; RNU3IP1
|
WB, IP
|
Human, Mouse, Rat |
Fibrillarin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 34 kDa, targeting to Fibrillarin. It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80686
-
GFAP; FLJ45472; cb345; ALXDRD
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse |
GFAP Antibody (YA756) is a non-conjugated and Mouse origined monoclonal antibody about 50 kDa, targeting to GFAP (9A2). It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse.
|
- HY-P80734
-
MKI67; Antigen KI-67
|
IHC-P, ICC/IF
|
Human, Mouse |
Ki67 Antibody (YA001) is a non-conjugated and Rat origined monoclonal antibody, targeting to Ki67. It can be used for IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse.
|
- HY-P80784
-
PGKA; MIG10; HEL-S-68p
|
WB, ICC/IF, FC
|
Human, Mouse, Rat |
PGK1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 45 kDa, targeting to PGK1. It can be used for WB,ICC/IF,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P81283
-
LMN2; LAMB2
|
WB, IP
|
Human, Mouse |
- HY-P81283A
-
LMN2; LAMB2
|
WB
|
Human, Mouse, Rat |
- HY-P81317
-
Ig mu chain C region
|
ELISA, IHC-P
|
Human |
- HY-P81331
-
DDIT1; GADD45
|
WB
|
Transfected |
- HY-P81338
-
AR; ADR; ALR2; ALDR1
|
WB
|
Human, Mouse, Rat |
- HY-P81373
-
- HY-P81422
-
CALBL; Scgn; SECRET; Secretagogin; SEGN; Setagin
|
IHC-P
|
Human |
- HY-P81555
-
OLR1, CLEC8A
|
WB, ICC/IF, FC
|
Human |
- HY-P81557
-
Dipeptidase 1, hRDP, MDP, RDP
|
IHC-P
|
Human, Rat |
- HY-P81562
-
CR2, C3DR
|
IHC-P
|
Human, Mouse, Rat |
- HY-P81588
-
AITR; GITR; TNFRSF18; CD357
|
FC, ELISA
|
Human |
- HY-P81593
-
B15; CI-B15
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P81640
-
CD267; TACI; TNFRSF13B
|
FC, ELISA
|
Human |
- HY-P81656
-
Nitrilase homolog 1
|
WB, IP
|
Human, Mouse, Rat |
- HY-P81699
-
C1orf57; HCR-NTPase
|
WB, IP
|
Human |
- HY-P81777
-
RAX; PACT; DYT16; HSD14
|
WB
|
Human, Mouse, Rat |
- HY-P81799
-
CLSD; sec23a
|
WB, FC
|
Human |
- HY-P81806
-
HIWI; MIWI; PIWI; PIWIL1
|
WB
|
Human, Mouse, Rat |
- HY-P81831
-
LPL; LIPD; Lipoprotein lipase; LPL
|
WB, IHC-P
|
Human |
- HY-P81894
-
ARP; Arp1; ARL18
|
WB, IP
|
Rat |
- HY-P81896
-
EPVH; PAR14; PAR17
|
WB, IP
|
Human, Rat, Hamster |
- HY-P81906
-
DAP12; KARAP; PLOSL; TYROBP
|
WB, IHC-P, ICC/IF, FC
|
Human |
- HY-P81932
-
Activin beta B; INHBB
|
WB
|
Human, Mouse, Rat |
- HY-P82047
-
Ras-related protein Rab-45
|
WB, ICC/IF
|
Human, Mouse |
- HY-P82110
-
Prorelaxin H2
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P82140
-
R2; RR2M
|
WB, ICC/IF, IP
|
Human |
- HY-P82150
-
Clec3b; Tetranectin; TN; TNA
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82151
-
FGG; Fibrinogen gamma chain
|
WB, FC
|
Human |
- HY-P82161
-
NET40; C9orf126
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82179
-
Sep15; 9430015P09Rik
|
WB
|
Human |
- HY-P82202
-
ASHI; CI-ASHI; NDUFB8
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82226
-
T2; MAT; ACAT; THIL
|
WB, IP
|
Human |
- HY-P82227
-
EOPA; MITAP1; NDEL1; NUDEL
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P82248
-
SMAC; DFNA64; DIABLO; SMAC3
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82265
-
JARD2; JARID2; JMJ
|
WB, ICC/IF
|
Human |
- HY-P82277
-
Sun1; UNC84A
|
WB, IHC-P, ICC/IF, FC
|
Human |
- HY-P82281
-
SMD3; Sm-D3
|
WB
|
Human, Rat |
- HY-P82299
-
SNX1; Sorting nexin-1
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82301
-
NS; NETS; LEKTI; LETKI; VAKTI
|
WB
|
Human |
- HY-P82318
-
BMFF; BMFS1; HEL103
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
- HY-P82369
-
SDCN; SYND3
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82475
-
- HY-P82481
-
AZ2; NAP1; TILP
|
WB
|
Human, Rat |
- HY-P82598
-
- HY-P82676
-
WNT16; Protein Wnt-16
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82728
-
MAO C; mMAO C; Renalase; RNLS
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P82740
-
CENTB2; CNT-B2
|
WB
|
Human, Hamster, Rat |
- HY-P82759
-
MNLL; CI-MNLL; CI-SGDH
|
WB, IHC-P
|
Human |
- HY-P82765
-
RPF1; NEDD4-1
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82768
-
OR17-7
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82820
-
Lactogen-like; Chorionic somatomammotropin-like
|
WB, IHC-P
|
Human |
- HY-P82824
-
magoh; MAGOHA; Protein mago nashi homolog
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82826
-
BAMS; FSHD2; Smchd1
|
WB, IHC-P
|
Human |
- HY-P82829
-
CTPS; GATD5; IMD24
|
WB
|
Human |
- HY-P82877
-
B23; NPM
|
WB, IHC-P, IP
|
Human, Rat |
- HY-P82905
-
Adam15; MDC15; Metargidin
|
WB, IHC-P
|
Human |
- HY-P82938
-
PSAP; GLBA; SAP1; Proactivator polypeptide
|
WB, IHC-P
|
Human |
- HY-P82971
-
Rad52; RAD52 homolog
|
WB
|
Human |
- HY-P83007
-
BDR2; HPCA; P23K
|
WB
|
Human, Mouse, Rat |
- HY-P83009
-
BPIFE; HDLCQ9; OD107; Pltp
|
WB
|
Human, Rat |
- HY-P83056
-
Protein FAM98B
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
- HY-P83086
-
FBLN; FIBL1
|
WB, IP
|
Human, Mouse |
- HY-P83096
-
FPTA; PTAR2; PGGT1A
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Rat |
- HY-P83113
-
DENN; IG20; RAB3GEP
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
- HY-P83129
-
CDC8; TMPK; TYMK; PP3731
|
WB, IHC-P, IP
|
Human |
- HY-P83152
-
H-Vps28; Vps28
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P83156
-
CKN1; CSA; ERCC8
|
WB, IP
|
Human |
- HY-P83194
-
LAK1; Nemo like kinase; Nlk
|
WB, FC
|
Human |
- HY-P83197
-
PIF96; P96PIF
|
WB, IP
|
Human |
- HY-P83219
-
RAIG2; RAIG-2
|
WB, IP
|
Human, Mouse, Rat |
- HY-P83233
-
GTA3; GSTA3-3
|
WB
|
Human, Mouse, Rat |
- HY-P83381
-
NPAP60; NPAP60L
|
WB, ICC/IF, IP
|
Human |
- HY-P83479
-
BMD; CMD3B; DMD; Dystrophin
|
WB
|
Human, Mouse, Rat |
- HY-P83552
-
MWFE; ZNF183; CI-MWFE
|
WB, IHC-P, IP
|
Human |
- HY-P83633
-
POLB; DNA polymerase beta
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P83076
-
AURA17; Dardarin Antibody; ; Leucine rich repeat kinase 2; LRRK 2 Antibody; LRRK2; LRRK2_HUMAN; PARK 8; PARK8; RIPK7; ROCO 2; ROCO2
|
WB, IHC-P, ICC/IF
|
Human, Mouse |
- HY-P80463
-
|
WB, IHC-P
|
Human, Mouse, Rat |
Phospho-Histone H2A.X (Ser139) Antibody (YA190) is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Phospho-Histone H2A.X(S139). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80528
-
ACC; ACAC; ACC1; ACCA; ACACAD
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
Acetyl Coenzyme A Carboxylase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 277 kDa, targeting to Acetyl Coenzyme A Carboxylase. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human.
|
- HY-P80550
-
TS11; ASNSD; ASNS; Asparagine synthetase [glutamine-hydrolyzing]
|
WB, IHC-P
|
Human, Rat |
Asparagine Synthetase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 64 kDa, targeting to Asparagine Synthetase. It can be used for WB,IHC-P assays with tag free, in the background of Human, Rat.
|
- HY-P80565
-
BCL2; Apoptosis regulator Bcl-2
|
WB
|
Human, Rat, Mouse |
Bcl2 Antibody (YA824) is a non-conjugated and Mouse origined monoclonal antibody about 26 kDa, targeting to Bcl2 (1D8). It can be used for WB assays with tag free, in the background of Human, Rat, Mouse.
|
- HY-P80933
-
WNT5A; Protein Wnt-5a
|
WB, ICC/IF
|
Human |
Wnt5a Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 42 kDa, targeting to Wnt5a. It can be used for WB,ICC/IF assays with tag free, in the background of Human.
|
- HY-P80942
-
Aldoketomutase; glo1; GLOD1; Glx I; GLYI
|
WB, FC
|
Human, Mouse, Rat |
GLO1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 21 kDa, targeting to Lactoylglutathione lyase (GLO1). It can be used for WB,FC assays in the background of Human, Mouse, Rat.
|
- HY-P80985
-
BGP-1; BGPI; CD66a; CEACAM1
|
WB, IHC-P, ICC/IF, IP
|
Human |
CEACAM1 Antibody is an unconjugated, approximately 120-150 kDa, rabbit-derived, anti-CEACAM1 monoclonal antibody. CEACAM1 Antibody can be used for: WB, IHC-P, ICC/IF, IP expriments in human background without labeling.
|
- HY-P81004
-
FXR1; FXR1P; hFXR1p
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
FXR1 Antibody is an unconjugated, approximately 70 kDa, rabbit-derived, anti-FXR1 monoclonal antibody. FXR1 Antibody can be used for: WB, IHC-P, ICC/IF, FC expriments in human, mouse, rat background without labeling.
|
- HY-P81039
-
Strep-Tag II;Strep Tag
|
WB, IF-Cell, IP
|
Species-independent |
Strep-Tag II Antibody (YA885) is an unconjugated, rabbit-derived, anti-Strep-Tag II (YA885) monoclonal antibody. Strep-Tag II Antibody (YA885) can be used for: WB、IF、IP expriments in species-independent background without labeling.
|
- HY-P81045
-
CD141; Fetomodulin; THBD; THRM; thrombomodulin; TM
|
WB, ICC/IF, IP
|
Human |
Thrombomodulin Antibody (YA891) is an unconjugated, approximately 95 kDa, rabbit-derived, anti-Thrombomodulin (YA891) monoclonal antibody. Thrombomodulin Antibody (YA891) can be used for: WB, ICC/IF, IP expriments in human background without labeling.
|
- HY-P81046
-
CD141; Fetomodulin; THBD; THRM; thrombomodulin; TM
|
WB
|
Mouse, Rat |
Thrombomodulin Antibody (YA892) is an unconjugated, approximately 95 kDa, rabbit-derived, anti-Thrombomodulin (YA892) monoclonal antibody. Thrombomodulin Antibody (YA892) can be used for: WB expriments in mouse, rat background without labeling.
|
- HY-P81063
-
sulfamethazine; Sulfadimidine; 57-68-1; Sulphamethazine; Sulfadimethyldiazine;
|
ELISA
|
|
Sulfadimidine Antibody (YA906) is an unconjugated, rabbit-derived, anti-Sulfadimidine (YA906) monoclonal antibody. Sulfadimidine Antibody (YA906) can be used for: ELISA expriments in background without labeling.
|
- HY-P81187
-
Brucella bacterial; 布鲁氏菌; 布鲁氏杆菌; 布鲁氏杆菌病; 布鲁氏病; 布鲁氏病菌; 布氏杆菌菌体蛋白; 布病
|
ELISA
|
|
Brucella Antibody is an unconjugated, approximately N/A kDa, rabbit-derived, anti-Brucella polyclonal antibody. Brucella Antibody can be used for: ELISA expriments in background without labeling.
|
- HY-P81216
-
NO tyrosine; nTyr; Nitrotyrosine; nitro-Tyrosine; nitro Tyrosine.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, Rat(predicted: Mouse) |
3-Nitrotyrosine Antibody is an unconjugated, rabbit-derived, anti-3-Nitrotyrosine polyclonal antibody. 3-Nitrotyrosine Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, rat, and predicted: mouse background without labeling.
|
- HY-P81253
-
MYO; MB; MGC13548; PVALB; MYG_HUMAN.
|
WB, IHC-P, IHC-F, ICC, IF, ELISA
|
Human, Mouse, Rat |
- HY-P81278
-
HRS; CMT2W; USH3B
|
WB
|
Human, Mouse, Monkey |
- HY-P81278B
-
HRS; CMT2W; USH3B
|
WB, IP
|
Human |
- HY-P81334
-
4EBP2; PHASII
|
WB
|
Transfected |
- HY-P81340
-
PMI; PMI1; CDG1B
|
WB, ICC/IF
|
Human, Rat |
- HY-P81350
-
CGB4; hLHB; LSH-B
|
IHC-P
|
Human |
- HY-P81362
-
HFH4; HFH-4; FKHL13
|
IHC-P
|
Human |
- HY-P81412
-
CAK1; Mesothelin; MPF; Msln; SMR; SMRP
|
IHC-P
|
Human |
- HY-P81442
-
- HY-P81454
-
SOX17; Transcription factor SOX-17
|
IHC-P
|
Human |
- HY-P81463
-
VASA; MGC111074; DDX4; MVH
|
IHC-P
|
Human |
- HY-P81477
-
DAGK5; DAGK6; DGK-ZETA; hDGKzeta
|
IHC-P
|
Human |
- HY-P81485
-
OTCase; Ornithine carbamoyltransferase; mitochondrial; OCTD
|
IHC-P
|
Human |
- HY-P81503
-
Pancreatic lipase; PL; PNLIP; PNLIPD; PTL
|
IHC-P
|
Human |
- HY-P81558
-
Bp35, MS4A1
|
IHC-P
|
Human, Mouse, Rat |
- HY-P81559
-
MAPK1, MAPK3
|
WB
|
Human, Mouse, Rat |
- HY-P81566
-
p18, CFL1
|
WB
|
Human, Mouse, Rat |
- HY-P81571
-
ICAM-3, CDw50, ICAM-R
|
IHC-P, ICC/IF, FC
|
Human |
- HY-P81578
-
Cyclin-dependent kinase 8
|
IHC-P
|
Human, Mouse |
- HY-P81581
-
CGL1, CSPB, CTLA1,GRB
|
IHC-P
|
Human |
- HY-P81613
-
NRK2; STK2; pp12301
|
WB
|
Human |
- HY-P81653
-
BAG 2; Bag2
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P81654
-
HE1; EDDM1
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P81658
-
- HY-P81683
-
CORD9; MCMP; MDC9; Mltng
|
FC, ELISA
|
Human |
- HY-P81684
-
C20orf21; DF1
|
WB, IP
|
Human, Hamster |
- HY-P81695
-
- HY-P81696
-
FUR; FURIN; PACE; PCSK3; SPC1
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P81704
-
HES 5; Hes5
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P81711
-
CD162; CLA; PSGL1; SELPLG
|
WB, IHC-P, ICC/IF, IP
|
Human |
- HY-P81735
-
MSA; TDH2A; TPO; TPX
|
WB, IHC-P, IP
|
Human |
- HY-P81767
-
TNFSF14; CD258; HVEML; LIGHT; LTg
|
FC, ELISA
|
Human |
- HY-P81807
-
VAMP8; EDB; Endobrevin; VAMP-8
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P81821
-
LIM mineralization protein; LMP; Protein enigma
|
WB
|
Human |
- HY-P81852
-
6-phosphofructokinase type B; PFK-B; Phosphohexokinase
|
WB, ICC/IF
|
Mouse, Rat |
- HY-P81853
-
Angiopoietin-2 (ANG-2)
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P81869
-
CTSS; Cathepsin S; Cat-s; CATS
|
WB, IHC-P, ICC/IF
|
Human |
- HY-P81905
-
Autophagy-related protein 13
|
WB, IP
|
Human, Mouse, Rat |
- HY-P81924
-
gb110; MOV 10
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P81931
-
ATP2B1; PMCA1
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P81935
-
p38; POLD4; PDIP38
|
WB, IP
|
Human |
- HY-P81966
-
MAPE; OIP4; CT130; OIP-4
|
WB, IHC-P, IP
|
Human, Mouse |
- HY-P82003
-
TORC3; FLJ21868; CRTC3
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P82018
-
GINS complex subunit 1
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82056
-
DTR; DTS; DTSF; HB-EGF; HBEGF; HEGFL
|
WB
|
Human, Rat |
- HY-P82098
-
NURF55; RBAP48; lin-53
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat, Hamster |
- HY-P82107
-
RELB; Transcription factor RelB; I-Rel
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82189
-
HI95; SES2; SEST2
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82195
-
PSF; POMP100; PPP1R140
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82198
-
FRP4; FrpHE; PYL; Sfrp4
|
WB
|
Human, Mouse, Rat |
- HY-P82219
-
ABAT; GABA transaminase; GABA transferase; GABAT; LAIBAT
|
WB, IP
|
Rat |
- HY-P82260
-
ADX; FDX; LOH11CR1D
|
WB, IHC-P, IP
|
Human, Mouse |
- HY-P82262
-
ARM1; ARM-1; GP110
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P82267
-
C2orf33; GL004; Mff
|
WB
|
Human, Mouse, Rat |
- HY-P82270
-
Extracellular O-linked N-acetylglucosamine transferase
|
WB
|
Human, Rat |
- HY-P82296
-
HEXC; MEA5; Mgea5; NCOAT; OGA
|
WB, IHC-P, IP
|
Human, Mouse |
- HY-P82313
-
APBB1; Protein Fe65; RIR
|
WB, IHC-P, ICC/IF
|
Human |
- HY-P82315
-
PC; Pyruvate carboxylase; mitochondrial; Pyruvic carboxylase; PCB
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P82397
-
AQP-CD; WCH-CD
|
WB, IHC-P, IP
|
Human |
- HY-P82427
-
ALS10; TDP-43
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82434
-
CGI65; CIA30; Ndufaf1
|
WB, IHC-P, ICC/IF, IP, FC
|
Human |
- HY-P82464
-
Transmembrane protein 161B
|
WB, IP
|
Human |
- HY-P82483
-
C11orf15
|
WB
|
Human, Mouse, Rat |
- HY-P82524
-
ARD1; ARFD1; RNF46
|
WB
|
Human, Mouse, Rat |
- HY-P82536
-
TF6; HMSNP; SPG57; TRKT3
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82539
-
CAT2; ECAC1; OTRPC3
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82541
-
Mitochondrial mRNA pseudouridine synthase TRUB2
|
WB
|
Human |
- HY-P82580
-
- HY-P82585
-
MTH1; NUDT 1
|
WB, IHC-P, ICC/IF, IP, FC
|
Human |
- HY-P82590
-
GOLPH5; GORASP1; GRASP65
|
WB, IHC-P, ICC/IF, IP, FC
|
Human |
- HY-P82625
-
NPHS2; PDCN; Podocin; SRN1
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P82626
-
HNUDC; MNUDC; NPD011; nudC; SIG92
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82633
-
CUL1; Cullin1
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82652
-
FOE; WAPAL; WAPL; Wings apart like homolog
|
WB, ICC/IF, IP
|
Human |
- HY-P82700
-
hVPS18; PEP3; vps18
|
WB, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82714
-
ESP2; HED2; ZYX; Zyxin2
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Rat |
- HY-P82720
-
ERV29
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P82722
-
CRABP; Crabp1; CRABPI; RBP5
|
WB, IP
|
Human, Mouse |
- HY-P82744
-
Ddx17; P72; RH70
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse |
- HY-P82760
-
hPAF1; PAF1; PD2
|
WB
|
Human, Mouse, Rat |
- HY-P82785
-
COD2; SHNS; CDG2L
|
WB
|
Human, Mouse |
- HY-P82787
-
CLN80; COIL; Coilin; Coilin p80
|
WB
|
Human |
- HY-P82798
-
Kaiso; Zbtb33; ZNF Kaiso; ZNF348
|
WB
|
Human, Mouse, Rat |
- HY-P82821
-
APOB; Apolipoprotein B-100; Apo B-100
|
WB, IP, FC
|
Human |
- HY-P82832
-
Crk L; Crk like protein; Crkl; Crkol
|
WB, IHC-P, ICC/IF
|
Human |
- HY-P82855
-
CCNT; CYCT1; HIVE1
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82944
-
ADK; Adenosine kinase; AK; Adenosine 5'-phosphotransferase
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P82957
-
MST104; MSTP104; PRO1472
|
WB, IP
|
Human, Rat |
- HY-P82965
-
DOCK 2; IMD40
|
WB, IHC-P
|
Human |
- HY-P82968
-
MRD2; ZIR8; HEL-205
|
WB
|
Human |
- HY-P82978
-
ZABC1; ZN217; ZNF217
|
WB
|
Human |
- HY-P82982
-
Angiotensinogenase; HNFJ2; REN; Ren1; Renin
|
WB, FC
|
Human |
- HY-P82987
-
LPA; Apolipoprotein(a; Apo(a); Lp(a)
|
WB
|
Human |
- HY-P82988
-
UCHL2; hucep-6; HUCEP-13
|
WB
|
Human |
- HY-P83013
-
ETS domain-containing protein Elk-1
|
WB, IHC-P, IP, ChIP
|
Human |
- HY-P83033
-
Epsin 1
|
WB
|
Human, Mouse, Rat |
- HY-P83057
-
Citrate synthase; Citrate synthase; mitochondrial; Cs
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Rat |
- HY-P83083
-
UNR; D1S155E
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P83097
-
ERG; erg-3; p55; KCNH2
|
WB, IHC-P, ICC/IF, ChIP
|
Human, Mouse, Rat |
- HY-P83117
-
KAT4; KATIV; KYAT4; mitAAT
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P83172
-
NM; DMRV; IBM2; Uae1; GLCNE
|
WB, IP
|
Human |
- HY-P83185
-
GTP-binding protein 1
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
- HY-P83193
-
GAQ; SWS; CMC1; G-ALPHA-q
|
WB
|
Mouse, Rat |
- HY-P83214
-
HCE; HCE1; hCAP; CAP1A
|
WB, ICC/IF, IP
|
Human, Rat |
- HY-P83262
-
CD102; Ly-60; Icam-2
|
WB, IHC-P, IP
|
Human, Mouse |
- HY-P83264
-
CD50; CDW50; ICAM-R
|
WB, IHC-P, IP
|
Human, Rat |
- HY-P83279
-
3-hydroxymethyl-3-methylglutaryl-CoA lyase; HL
|
WB
|
Human |
- HY-P83349
-
EOPA; MITAP1; NDEL1; NUDEL
|
WB
|
Human, Mouse |
- HY-P83392
-
Renal carcinoma antigen NY-REN-45
|
WB
|
Human |
- HY-P83463
-
RAP80; X2HRIP110
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
- HY-P83489
-
SEP2; SEPT8
|
WB, IP
|
Hamster, Rat |
- HY-P83495
-
Matrix metalloproteinase-26; Endometase; Matrilysin-2
|
WB
|
Human, Hamster, Rat |
- HY-P83541
-
C81621; AI481586
|
WB, IP
|
Human |
- HY-P83543
-
AAC1; MNAT; NATI; NAT-1
|
WB
|
Human, Mouse, Rat |
- HY-P83636
-
Beta 1B glycoprotein; HEMO; Hemopexin; Hpx
|
WB, IHC-P, ICC/IF, IP
|
Human |
- HY-P80451
-
|
WB, ICC/IF, IP
|
Human |
Phospho-AMPK alpha 1 (Ser496) Antibody (YA226) is a non-conjugated and Rabbit origined monoclonal antibody about 64 kDa, targeting to Phospho-AMPK alpha 1 (S496). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human.
|
- HY-P80596
-
HT-7; CD147; EMMPRIN; AI115436; AI325119
|
WB, IHC-P, FC, IP
|
Human, Mouse |
CD147 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 42 kDa, targeting to CD147. It can be used for WB,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse.
|
- HY-P80605
-
CD68; Macrosialin; Gp110; CD68
|
IHC-P, ICC/IF
|
Human, Mouse |
CD68 Antibody (YA799) is a non-conjugated and Mouse origined monoclonal antibody, targeting to CD68 (9H5). It can be used for IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse.
|
- HY-P80620
-
CKMT; CKMT1; UMTCK; CKMT1A
|
WB
|
Human, Mouse |
CKMT1 Antibody (YA794) is a non-conjugated and Mouse origined monoclonal antibody about 47 kDa, targeting to CKMT1 (1A6). It can be used for WB assays with tag free, in the background of Human, Mouse.
|
- HY-P80642
-
DBX; DDX3; HLP2; DDX14.
|
WB, ICC/IF, IP, ChIP
|
Human, Rat, Mouse, Monkey |
DDX3 Antibody (YA784) is a non-conjugated and Mouse origined monoclonal antibody about 73 kDa, targeting to DDX3 (6G8). It can be used for WB,ICC/IF,IP,ChIP assays with tag free, in the background of Human, Rat, Mouse, Monkey.
|
- HY-P80760
-
MYD88; Myeloid differentiation primary response protein MyD88
|
ICC/IF, WB, IHC-F, IHC-P, ELISA
|
Human, Mouse, Rat |
MyD88 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 33 kDa, targeting to MyD88. It can be used for ICC/IF,WB,IHC-F,IHC-P,ELISA assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80907
-
SYP; Synaptophysin; Major synaptic vesicle protein p38
|
WB, IHC-P
|
Human, Mouse, Rat |
Synaptophysin Antibody (YA664) is a non-conjugated and Mouse origined monoclonal antibody about 34 kDa, targeting to Synaptophysin (10C8). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80954
-
G3PD; GAPD; HEL-S-162eP
|
WB
|
Human, Monkey, Rat, Mouse, Saccharomyces cerevisiae, Pichia pastoris, Hamster |
GAPDH Antibody (YA848) is a non-conjugated and Mouse origined monoclonal antibody about 36 kDa. It can be used for WB assays with tag free, in the background of Human, Monkey, Rat, Mouse, Hamster, Saccharomyces cerevisiae, Pichia pastoris.
|
- HY-P80955
-
Human,Mouse,Monkey,Goat,Hamster,Rat,ChlamydomonasReinhardtii
|
WB, ICC/IF
|
Human, Mouse, Monkey, Goat, Hamster, Rat, Chlamydomonas Reinhardtii |
beta Tubulin Antibody (YA839) is a non-conjugated and Mouse origined monoclonal antibody about 50-55 kDa, targeting to Tubulin beta chain (TUBB). It can be used for WB,ICC/IF assays in the background of Human, Mouse, Monkey, Goat, Hamster, Rat, Chlamydomonas Reinhardtii.
|
- HY-P81002
-
DGPT; ERG9; FDFT1; SQS; Squalene synthase; SS
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
FDFT1 Antibody is an unconjugated, approximately 48 kDa, rabbit-derived, anti-FDFT1 monoclonal antibody. FDFT1 Antibody can be used for: WB, IHC-P, ICC/IF, IP expriments in human, mouse, rat background without labeling.
|
- HY-P80784A
-
PGKA; MIG10; HEL-S-68p
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P81057
-
Monomethylauristatin F, Monomethyl Auristatin F, 745017-94-1
|
ELISA; Sandwich ELISA; Competitive ELISA
|
|
MMAF Antibody (YA900) is an unconjugated, mouse-derived, anti-MMAF (YA900) monoclonal antibody. MMAF Antibody (YA900) can be used for: ELISA, Sandwich ELISA, Competitive ELISA expriments in background without labeling.
|
- HY-P81262
-
CRP; PTX1; C-reactive protein
|
ELISA
|
Human |
- HY-P81262A
-
CRP; PTX1; C-reactive protein
|
ELISA
|
Human |
- HY-P81262B
-
CRP; PTX1; C-reactive protein
|
WB, IHC-P, IP
|
Human |
- HY-P81271A
-
CAM 120/8, E-cadherin, CD324
|
WB
|
Human, Mouse, Rat |
- HY-P81336
-
Proto-oncogene Wnt-3; INT4; TETAMS
|
WB
|
Transfected |
- HY-P81418
-
SCD1; FADS5; SCDOS; MSTP008
|
IHC-P
|
Human |
- HY-P81421
-
MRP4; MOATB; MOAT-B; EST170205
|
IHC-P
|
Human |
- HY-P81453
-
HOXB13; Homeobox protein Hox-B13
|
IHC-P
|
Human |
- HY-P81519
-
FBP; FBP1; FBPase 1
|
IHC-P
|
Human |
- HY-P81572
-
- HY-P81592
-
AMHR; AMHR2; MISR2; MISRII; MRII
|
FC, ELISA
|
Human |
- HY-P81597
-
ATAR; CD270; HVEA; HVEM; LIGHTR; TR2
|
FC, ELISA
|
Human |
- HY-P81607
-
TYKY; CI-23k; CI23KD
|
WB
|
Mouse, Rat |
- HY-P81617
-
NC; APUG; NERCC; LCCS10; NERCC1
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Rat |
- HY-P81698
-
AOE37-2; PRX-4
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P81750
-
Luciferase; Firefly; Luciferin 4 monooxygenase
|
WB, ICC/IF
|
Firefly |
- HY-P81773
-
CLDN 18.2,Claudin 18.2
|
FC, ELISA
|
Human |
- HY-P81774
-
RPTOR; KOG1; KIAA1303; RAPTOR; Mip1
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P81784
-
EndoG; EndonucleaseG; Mitochondrial endonuclease G; NUCG_HUMAN
|
WB
|
Human, Mouse, Rat |
- HY-P81794
-
MXRA2; CH-ILKBP
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P81798
-
HNRPE2; HNRNPE2; hnRNP-E2
|
WB, IP
|
Mouse, Rat |
- HY-P81817
-
CD156b; ADAM17; CSVP; TACE
|
WB, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P81849
-
PEX14B; PEX11-BETA
|
WB
|
Human, Mouse |
- HY-P81873
-
PLN; PLB; Cardiac phospholamban; PLB
|
WB
|
Human, Mouse |
- HY-P81882
-
HHCPA78; THIF; TXNIP; VDUP1
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P81887
-
PICK 1; Pick1; PRKCABP
|
WB, IP
|
Human |
- HY-P81904
-
Ncf2; NOXA2; P67 PHOX
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P81908
-
Centromere autoantigen A; Centromere protein A; CENP-A
|
WB
|
Human |
- HY-P81929
-
KCP1; KRTCAP1; Perp; PIGPC1; THW
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P81971
-
Protein regulator of cytokinesis 1
|
WB, IHC-P, IP
|
Human, Rat |
- HY-P82037
-
CAV1; CAV; Caveolin-1
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P82043
-
QK; Hqk; QK1; QK3; hqkI
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82046
-
Ras-related protein Rab-22A
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82105
-
Receptor expression-enhancing protein 2
|
WB
|
Human |
- HY-P82127
-
CEB; Cellubrevin; Synaptobrevin 3; VAMP3
|
WB, ICC/IF, IP, FC
|
Human |
- HY-P82130
-
AAG11; DRAL; Fhl2; SLIM3
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82156
-
SAM domain-containing protein 9
|
WB, ICC/IF
|
Human |
- HY-P82168
-
hHIPk2; Hipk2; Nbak1; Stank
|
WB, ICC/IF, IP, FC
|
Human, Mouse |
- HY-P82203
-
ADH; ADH1; ADH1A; Aldehyde reductase
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82223
-
CBP; Csk binding protein; PAG; PAG1
|
WB, IHC-P, IP, FC
|
Human, Mouse, Rat |
- HY-P82240
-
AGC1; ARALAR; EIEE39
|
WB, IP
|
Mouse, Rat |
- HY-P82266
-
ADEH; ADSS 2
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P82304
-
DIL1; DIL-1; MINDIN; M-SPONDIN
|
WB
|
Human, Mouse, Rat |
- HY-P82308
-
ADAS; ADPS; RCDP3; ADAP-S; ADHAPS; ALDHPSY
|
WB, IHC-P, IP
|
Human |
- HY-P82321
-
HEL-S-49; TIM; TPI1; TPID
|
WB, FC
|
Human, Mouse, Rat |
- HY-P82373
-
PEN 2; PSEN2; psenen
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82379
-
Pantophysin; SYPL1
|
WB, IHC-P
|
Human |
- HY-P82396
-
FKSG15; IDDM21; TAGAP1; ARHGAP47
|
WB, IP
|
Human, Rat |
- HY-P82435
-
BUB3; Mitotic checkpoint protein BUB3
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82469
-
ATP5B; ATPMB; ATPSB; HEL-S-271
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat, Monkey |
- HY-P82480
-
PIG17; TMEM85
|
WB, IP
|
Human, Mouse, Rat, Hamster |
- HY-P82491
-
ALC1; chd1l; CHDL
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse |
- HY-P82501
-
Domain E; Domain G; GEPH; GPH; GPHN; GPHRYN
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82506
-
BAG6; BAT 3; Scythe
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P82507
-
DDX6; HLR2; P54; RCK
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P82521
-
Cell surface A33 antigen; Gpa33
|
WB, IHC-P, IP
|
Human |
- HY-P82534
-
Demethylase; DMTase; Mbd2; MBD2a
|
WB, IHC-P, ICC/IF
|
Human |
- HY-P82542
-
QR2; DHQV; DIA6; NMOR2
|
WB, FC
|
Human, Mouse, Rat |
- HY-P82546
-
ESG; ESG1; GRG1; TLE1
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82550
-
alpha 1-adaptin; ADTAA; CLAPA1
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82627
-
hSMURF2; SMUF2_HUMAN; Smurf2
|
WB
|
Human, Mouse, Rat |
- HY-P82645
-
TIM50; TIM50L; TIMM50
|
WB, IHC-P
|
Human, Mouse |
- HY-P82664
-
HVPS41; HVSP41; hVps41p
|
WB
|
Human, Mouse, Rat |
- HY-P82671
-
WAVE; SCAR1; WAVE1
|
WB
|
Human, Mouse, Rat |
- HY-P82672
-
AIP1; NORI-1; HEL-S-52
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
- HY-P82690
-
Neuronatin; NNAT; Peg 5; Peg5
|
WB
|
Human, Mouse |
- HY-P82713
-
MAG; GMA; Myelin-associated glycoprotein; Siglec-4a
|
WB, IP, FC
|
Human, Mouse, Rat |
- HY-P82752
-
CRAM; DPYSL5; DRP5; Ulip6
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P82758
-
STP; CIP4; HSTP; STOT; TRIP-10
|
WB
|
Human, Mouse, Rat |
- HY-P82794
-
WAS; IMD2; Wiskott-Aldrich syndrome protein; WASp
|
WB, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82808
-
APR; ATL-derived; NOXA; Pmaip1; Protein Noxa
|
WB
|
Human |
- HY-P82817
-
CGI149; CHMP3; hVps24; NEDF
|
WB, IHC-P, IP, FC
|
Human, Mouse, Rat |
- HY-P82842
-
B5R; DIA1
|
WB, IHC-P
|
Human, Rat |
- HY-P82874
-
CPR; CYPOR; P450R; por
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82880
-
HSP75; HSP90L; Trap1
|
WB, IHC-P, ICC/IF
|
Human |
- HY-P82916
-
DDAH; DDAHI; DDAH-1; HEL-S-16
|
WB, IP
|
Human |
- HY-P82970
-
CPT1; CPT2; IIAE4; CPTASE
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82986
-
DLG1; DLGH1; hDlg; SAP97
|
WB
|
Human, Mouse, Rat |
- HY-P83019
-
T2-cadherin; CDH10
|
WB
|
Human, Mouse, Rat |
- HY-P83023
-
enolase 3; MSE; GSD13
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P83073
-
PAX2; Paired box protein Pax-2
|
WB, IHC-P, FC
|
Human, Mouse |
- HY-P83090
-
C-terminal-binding protein 2
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P83106
-
K9; CK-9; EPPK
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P83112
-
Myh7b; Myosin-7B
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P83120
-
TAJ alpha; TAJ; TNFRSF19; TRADE; TROY
|
WB, IHC-P, FC
|
Human, Mouse, Rat |
- HY-P83150
-
CEH; SEH; ABHD20
|
WB
|
Human, Mouse |
- HY-P83169
-
GFAT; GFAT2; GFAT 2
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P83210
-
G-rich sequence factor 1
|
WB, ICC/IF
|
Human |
- HY-P83227
-
- HY-P83235
-
GBP; ECHA; HADH; LCEH; MTPA; LCHAD; TP-ALPHA
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P83243
-
Hexokinase domain-containing protein 1
|
WB, IP
|
Human |
- HY-P83248
-
ADTG; AP1G1; CLAPG1
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P83255
-
HPRT1; HPRT; Hypoxanthine-guanine phosphoribosyltransferase; HGPRT; HGPRTase
|
WB, IP
|
Human, Rat |
- HY-P83263
-
Histone H2A.2
|
WB
|
Human, Rat |
- HY-P83277
-
Ras GTPase-activating-like protein IQGAP2
|
WB, IHC-P
|
Human |
- HY-P83316
-
UPS; PBGD; PORC; PBG-D; HMBS; Hydroxymethylbilane synthase
|
WB
|
Human, Mouse, Rat |
- HY-P83371
-
DKCB1; NOLA3; NOP10P
|
WB, IHC-P
|
Human |
- HY-P83384
-
Homeobox protein OTX1 (Orthodenticle homolog 1)
|
WB
|
Human, Mouse, Rat |
- HY-P83393
-
BTB/POZ domain-containing protein KCTD9
|
WB, ICC/IF
|
Human |
- HY-P83400
-
Paired box protein Pax-9; PAX9
|
WB
|
Human, Mouse, Rat |
- HY-P83418
-
P47; Platelet 47 kDa protein
|
WB
|
Human |
- HY-P83438
-
PHB1; HEL-215; HEL-S-54e
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Rat |
- HY-P83481
-
NSP; SARA; MADHIP; SMADIP; PPP1R173
|
WB, IHC-P, IP
|
Human |
- HY-P83502
-
MS2; CD156; CD156a
|
WB, IP
|
Human, Mouse |
- HY-P83527
-
EPI; TFI; LACI; TFPI1
|
WB, IP
|
Human |
- HY-P83532
-
BTN6; BTNL11; MOGIG2; NRCLP7
|
WB, ICC/IF
|
Rat |
- HY-P83539
-
MYH-1c; MMI-alpha; MMIa
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P83595
-
LIS2; PRO1598; Reeler; Reelin; RELN; RL
|
WB
|
Human, Rat |
- HY-P80263
-
PARP-1; ARTD1; ADPRT 1; PARP1
|
WB, ICC/IF, IHC-P, FC
|
Human, Mouse |
PARP1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 113 kDa, targeting to PARP. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80582
-
Caspase recruitment domain-containing protein 9; hCARD9
|
WB
|
Human |
CARD9 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 62 kDa, targeting to CARD9. It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80601
-
CD3 gamma; CD3g; T3G
|
WB, IHC-P, IP
|
Human |
CD3G Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 20 kDa, targeting to CD3G. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human.
|
- HY-P80661
-
ERCC1; DNA excision repair protein ERCC-1
|
WB
|
Human |
ERCC1 Antibody (YA770) is a non-conjugated and Mouse origined monoclonal antibody about 33 kDa, targeting to ERCC1 (7F6). It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80664
-
EZR; VIL2; Ezrin; Cytovillin; Villin-2; p81
|
WB
|
Human, Mouse, Rat |
Ezrin Antibody (YA767) is a non-conjugated and Mouse origined monoclonal antibody about 69 kDa, targeting to Ezrin (2C12). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80674
-
FN1; FN; Fibronectin; FN; Cold-insoluble globulin; CIG
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
Fibronectin Antibody (YA762) is a non-conjugated and Mouse origined monoclonal antibody about 272 kDa, targeting to Fibronectin (1E2). It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80694
-
GYS1; GYS; Glycogen [starch] synthase; muscle
|
WB, ICC/IF, IP
|
Human, Rat |
Glycogen Synthase 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 84 kDa, targeting to Glycogen Synthase 1. It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Rat.
|
- HY-P80813
-
MAPK1/MAPK3
|
WB, IP
|
Human, Hamster, Rat |
Phospho-ERK1/2 (Thr202/Thr185) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 44,42 kDa, targeting to Phospho-ERK1/2 (Thr202/Thr185). It can be used for WB,IP assays with tag free, in the background of Human, Hamster, Rat.
|
- HY-P80815
-
MAPK1/MAPK3
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
Phospho-ERK1/2 (Tyr204/Tyr187) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 42,44 kDa, targeting to Phospho-ERK1/2 (Tyr204/Tyr187). It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80875
-
HRMT1L6; PRMT 6
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
PRMT6 Antibody (YA685) is a non-conjugated and Mouse origined monoclonal antibody about 42 kDa, targeting to PRMT6 (2C3). It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human.
|
- HY-P80895
-
BOP; KMT3D; ZMYND18; ZMYND22
|
WB
|
Rat |
SMYD1 Antibody (YA672) is a non-conjugated and Mouse origined monoclonal antibody about 57 kDa, targeting to SMYD1 (2E11). It can be used for WB assays with tag free, in the background of Rat.
|
- HY-P80945
-
p68; p70; ANX6; CBP68; CPB-II
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
Annexin VI Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 76 kDa, targeting to Annexin A6 (ANXA6). It can be used for WB,IHC-P,IP assays in the background of Human, Mouse, Rat.
|
- HY-P80977
-
ACS4; FACL4; LACS4; MRX63; MRX68
|
WB, IF-Cell, IHC-P, FC
|
Human, Mouse, Rat |
FACL4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 79 kDa, targeting to FACL4. It can be used for WB, IF-Cell, IHC-P, FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P81313
-
Np95; hNP95; ICBP90; RNF106
|
WB
|
Human, Mouse |
- HY-P81361
-
PRKCT; PRKCQ; nPKC-theta; Protein kinase C theta type
|
IHC-P
|
Human |
- HY-P81439
-
Cone rod homeobox; CORD 2; CRD; CRX
|
IHC-P
|
Human |
- HY-P81464
-
nfe2 ; Nuclear factor; p45 NFE2
|
IHC-P
|
Human |
- HY-P81505
-
TRP-2; TRP2; TYRP2; DCT; DT
|
IHC-P
|
Human |
- HY-P81512
-
U-PAR; Monocyte activation antigen Mo3; CD87
|
IHC-P
|
Human |
- HY-P81541
-
Cytokeratin 5, CK-5, K5
|
WB, IHC-P, ICC/IF
|
Huamn |
- HY-P81547
-
HspB5, CRYAB, CRYA2, HSPB5
|
WB, IHC-P
|
Mouse, Rat |
- HY-P81553
-
ASGP-R 1, HL-1, CLEC4H1
|
WB, IHC-P, ICC/IF, FC, IP
|
Human |
- HY-P81611
-
BAFFR; CD268; CVID4; BAFF-R; BROMIX; prolixin
|
FC, ELISA
|
Human |
- HY-P81620
-
RD; RDP; RDBP; D6S45; NELF-E
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P81636
-
ANF; ANP; PND; ATFB6; CDD-ANF
|
WB, IP
|
Human |
- HY-P81639
-
RING finger protein 109; RNF109
|
WB, ICC/IF
|
Human |
- HY-P81661
-
P54; NMT55; NRB54; P54NRB
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P81690
-
FAP3; NTH1; OCTS3; hNTH1
|
WB, ICC/IF
|
Human |
- HY-P81703
-
HAVcr-2; TIMD-3; TIM-3; CD366
|
FC, ELISA
|
Human |
- HY-P81770
-
TNFSF18; AITRL; TL6; hGITRL; GITR Ligand
|
FC, ELISA
|
Human |
- HY-P81776
-
OPMD; PAB2; PABII; PABP2; PABP-2
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse |
- HY-P81859
-
hSPRY2; Sprouty2; SPRY2
|
WB, IHC-P, ICC/IF, IP
|
Human, Rat |
- HY-P81867
-
PHD3; HIFPH3; HIFP4H3
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P81876
-
Transcription initiation factor TFIID subunit 3
|
WB, IHC-P
|
Human |
- HY-P81902
-
GOPC; CAL; CFTR-associated ligand; GOPC1; FIG; PIST
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse |
- HY-P81907
-
Cellular retinoic acid-binding protein II; CRABP-II
|
WB, ICC/IF
|
Human |
- HY-P81918
-
HpaII tiny fragments locus 9c protein
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
- HY-P81973
-
CDC2; CRCS10; MDPL; POLD; POLD1
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P81995
-
BAF; BANF1; BCRG1; BCRP1; NGPS
|
WB
|
Human |
- HY-P82022
-
LMP10; MECL1; beta2i
|
WB
|
Human, Rat |
- HY-P82068
-
COREST; Nr2b2; RCOR; Rcor1; Rxrb
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82084
-
PP4; ANX5; ENX2; RPRGL3.
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P82125
-
LKP; RHA; DDX9; NDH2; NDHII
|
WB
|
Rat |
- HY-P82138
-
RRM1; R1; RIR1; RR1
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P82164
-
Lipin-1; Lpin1; PAP1
|
WB, IHC-P, ICC/IF, IP, FC
|
Human |
- HY-P82199
-
ILF 2; MGC8391; NF45
|
WB, IHC-P, IP, FC
|
Human, Mouse, Rat |
- HY-P82217
-
CDX1; Homeobox protein CDX 1
|
WB, ICC/IF
|
Human |
- HY-P82222
-
ACADM; Medium-chain specific acyl-CoA dehydrogenase; mitochondrial; MCAD
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P82234
-
AOX; Acox; Paox; D130055E20Rik
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82286
-
FDH; FTHFD; 10-fTHF; 10-FTHFDH
|
WB
|
Mouse, Rat |
- HY-P82294
-
Adrenalin oxidase; MAO; brain; MAO; platelet; MAOB
|
WB, IHC-P
|
Human |
- HY-P82311
-
SYB1; Synaptobrevin 1; Vamp1
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82333
-
Alpha gal A; GALA; Galactosidase; alpha; GLA; Melibiase
|
WB, IHC-P, ICC/IF, IP, FC
|
Human |
- HY-P82337
-
MDH s; mdh1; MDHA; MDHs; MOR2
|
WB, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82374
-
syntaxin 16; SYN16
|
WB
|
Human, Mouse, Rat |
- HY-P82378
-
Dodc1; ODC; Odc1; ODC2; RNODC
|
WB
|
Human, Mouse, Rat |
- HY-P82391
-
Khdrbs1; p62; p68; Sam68
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82393
-
AOA; AOA1; AXA1; EAOH; EOAHA; FHA-HIT
|
WB, ICC/IF
|
Human |
- HY-P82423
-
MYB; Transcriptional activator Myb; Proto-oncogene c-Myb
|
WB, IHC-P
|
Human |
- HY-P82461
-
GS2; RAM; RAB27; HsT18676
|
WB, ICC/IF, IP, FC
|
Human |
- HY-P82470
-
Transmembrane protein 192
|
WB
|
Human |
- HY-P82488
-
EMI1; FBX5; Fbxo31; fbxo5
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82489
-
CTEN; C-terminal tensin-like protein
|
WB
|
Human, Mouse, Rat |
- HY-P82518
-
TRIF; IIAE6; MyD88-3; PRVTIRB; TICAM-1
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82522
-
DYT4; TUBB4; beta-5
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82531
-
AA930854; TNFR1 associated DEATH domain protein; tradd
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82558
-
HuF2; ZGRF6
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Rat |
- HY-P82574
-
Uncharacterized protein C3orf38
|
WB
|
Human |
- HY-P82587
-
CDM; HCAD; LCAD; H-CAD; L-CAD; NAG22
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P82615
-
OT R; OTR; OTR1; OXT R; Oxtr
|
WB
|
Human, Mouse, Rat |
- HY-P82617
-
Deubiquitinating enzyme 10; UBPO; USP10
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P82623
-
HGFL; MSP; MST1; NF15S2
|
WB, IHC-P, FC
|
Human, Mouse, Rat |
- HY-P82646
-
ALSPDC; CHAK; CHAK1; LTrpC7; TRPM7
|
WB, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82678
-
CBX2; Chromobox protein homolog 2
|
WB, FC
|
Human, Mouse, Rat |
- HY-P82679
-
WNT13; Wnt2b; XWNT2
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P82719
-
DNM2; DYN2; Dynamin-2
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82745
-
CBX4; hPc2; NBP16; PC2
|
WB
|
Human, Mouse, Rat |
- HY-P82747
-
NRP; NAP1; NAP1L
|
WB, FC
|
Human, Mouse, Rat |
- HY-P82757
-
PIM1; Serine/threonine-protein kinase pim-1
|
WB, IHC-P
|
Human |
- HY-P82801
-
V; RASGRP; hRasGRP1; CALDAG-GEFI; CALDAG-GEFII
|
WB
|
Human |
- HY-P82802
-
Cathepsin; CTSL; CTSV; CTSK; CTSH
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82804
-
BHMT; Betaine--homocysteine S-methyltransferase 1
|
WB, IHC-P, IP
|
Human |
- HY-P82840
-
CUL-5; VACM1; VACM-1
|
WB
|
Human, Mouse, Rat |
- HY-P82841
-
PUM2; PUMH2; Pumilio2; PUML2
|
WB, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82896
-
Death-associated protein 1; DAP-1
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82901
-
Deleted in azoospermia-associated protein 1
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82918
-
GUA; GURDB; RH-II/GU; RH-II/GuA
|
WB, ICC/IF
|
Human |
- HY-P82919
-
WNT inhibitory factor 1; WIF-1
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82941
-
PC3; ARP1B; CTRN2
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P82945
-
Stanniocalcin; STC; STC-1; Stc1
|
WB, IP
|
Human |
- HY-P82990
-
Homeobox protein BarH-like 1
|
WB, IP
|
Human, Rat, Hamster |
- HY-P82996
-
GTB; NAGAT; A3GALNT; A3GALT1
|
WB, IP
|
Human, Mouse, Rat |
- HY-P83034
-
hly9; mLY9; CD229; SLAMF3
|
WB
|
Human |
- HY-P83065
-
RSN; CLIP; CYLN1; CLIP170; CLIP-170
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P83091
-
ADP ribosylation factor 5; Arf5
|
WB, FC
|
Human, Mouse, Rat |
- HY-P83102
-
Activin binding protein; Follistatin; FS; fst; Human follistatin gene
|
WB
|
Rat |
- HY-P83108
-
GUSB; Beta-glucuronidase; Beta-G1
|
WB, IHC-P, ICC/IF, FC
|
Human |
- HY-P83141
-
HTATSF1; HTSF1; TAT SF1
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse |
- HY-P83149
-
C10orf63; ENKUR; Enkurin
|
WB
|
Human, Mouse |
- HY-P83180
-
Gal-1-P uridylyltransferase; UDP-glucose--hexose-1-phosphate uridylyltransferase
|
WB, IP
|
Human, Mouse, Rat |
- HY-P83191
-
NET1; GLYT2; HKPX3; GLYT-2
|
WB
|
Human, Rat |
- HY-P83226
-
Serine/threonine-protein kinase GSK3A
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P83291
-
DYSF; Dysferlin; Fer-1-like protein 1
|
WB, IHC-P, ICC/IF
|
Human, Mouse |
- HY-P83297
-
4-hydroxyphenylpyruvate dioxygenase like; GLOXD1; 4-HPPD-L
|
WB, IP
|
Human |
- HY-P83308
-
RALBP1; RIP1; RLIP1; RLIP76
|
WB, IHC-P, FC
|
Human, Mouse, Rat |
- HY-P83309
-
HMN5; CMT2D; DSMAV; GlyRS; SMAD1
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P83312
-
MKS3; JBTS6; NPHP11; TNEM67; MECKELIN
|
WB, ICC/IF
|
Human |
- HY-P83315
-
Huc; mHuC; PLE21; 2600009P04Rik
|
WB, IP
|
Rat |
- HY-P83335
-
NS11; M-RAs; RRAS3; R-RAS3
|
WB, IP
|
Human, Mouse, Rat |
- HY-P83363
-
Integrin beta-5
|
WB
|
Human, Hamster, Rat |
- HY-P83420
-
Polyamine-modulated factor 1
|
WB, IP
|
Human, Mouse, Rat |
- HY-P83428
-
MDS; LIS1; LIS2; MDCR; NudF; PAFAH
|
WB, IP
|
Hamster, Rat |
- HY-P83468
-
Formimidoyltetrahydrofolate cyclodeaminase; FTCD; Glutamate formiminotransferase; LCHC 1
|
WB, IHC-P, FC
|
Human |
- HY-P83474
-
RPS20; 40S ribosomal protein S20
|
WB, IHC-P
|
Human, Mouse, Rat, Hamster |
- HY-P83488
-
CHO1; KNSL5; MKLP1; MKLP-1
|
WB
|
Human |
- HY-P83494
-
TERF1; PIN2; TRBF1; TRF1
|
WB, ICC/IF
|
Human, Mouse |
- HY-P83501
-
S31mt; IMOGN38; MRP-S31
|
WB
|
Rat |
- HY-P83504
-
Testis development protein NYD-SP21
|
WB
|
Human, Rat |
- HY-P83511
-
Large T antigen; LT; LT-AG
|
WB, ICC/IF, IP
|
All |
- HY-P83512
-
Alglucerase; betaGC; GBA1; GCase; GCB; GLUC; Glucosylceramidase; Imiglucerase
|
WB, IHC-P
|
Human, Rat |
- HY-P83537
-
Myosin head domain-containing protein 1
|
WB
|
Human, Mouse |
- HY-P83569
-
hVPS35; MEM3; PARK17; VPS35
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P83596
-
ADORA1; Adenosine receptor A1
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82553
-
C6.1A; BRCC36; CXorf53
|
WB, IP
|
Human, Mouse, Rat |
- HY-P81237
-
FLJ14301; OODD; Protein Wnt-10a ; SSPS; STHAG4; Wingless type MMTV integration site family member 10A Antibody; WN10A_HUMAN; wnt10a;
|
WB; IF-Cell:; IHC-P;
|
Human, Mouse |
- HY-P80076
-
Cdc2 related protein kinase; CDC28; CDC2A; Cdk 2; CDK1; CDK2; CDK2_HUMAN ; CDKN2; MPF; p33(CDK2) Antibody
|
WB, ICC/IF, IHC-P, IP, FC
|
Human, Mouse, Rat |
Cdk2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 34 kDa, targeting to Cdk2. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse,Rat.
|
- HY-P80532
-
P53; BCC7; LFS1; TRP53
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
Acetyl-p53 (Lys370) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 44 kDa, targeting to Acetyl-p53 (Lys370). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80554
-
activating transcription factor 6; ATF6A
|
WB, IHC-P, IP
|
Human |
ATF6 Antibody (YA604) is a non-conjugated and Rabbit origined monoclonal antibody about 75 kDa, targeting to ATF6. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human.
|
- HY-P80556
-
APG3; APG3L; PC3-96; APG3-LIKE
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
ATG3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to ATG3. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80581
-
CAP 2; Adenylyl cyclase-associated protein 2
|
WB, IP
|
Human |
CAP2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 53 kDa, targeting to CAP2. It can be used for WB,IP assays with tag free, in the background of Human.
|
- HY-P80588
-
Caspl; ich-3; CASP-4; Casp11; CASP-11
|
WB, IP
|
Human, Mouse, Rat |
Caspase 11 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 43 kDa, targeting to Caspase 11. It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80614
-
TAK; C-2k; CTK1; CDC2L4; PITALRE
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
CDK9 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 43 kDa, targeting to CDK9. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80632
-
CCNB1; CCNB; G2/mitotic-specific cyclin-B1
|
WB, IHC-F, IHC-P, ICC/IF, ELISA
|
Human, Mouse, Rat |
Cyclin B1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 48 kDa, targeting to Cyclin B1. It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80635
-
CCNE1; CCNE; G1/S-specific cyclin-E1
|
WB, IHC-F, IHC-P, ICC/IF, ELISA
|
Human, Mouse, Rat |
Cyclin E1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 47 kDa, targeting to Cyclin E1. It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80637
-
CCNH; Cyclin-H; MO15-associated protein; p34; p37
|
WB
|
Human |
Cyclin H Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 38 kDa, targeting to Cyclin H. It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80646
-
Dual specificity protein phosphatase VHR; VHR; Vaccinia H1-related phosphatase
|
WB, IHC-F, IHC-P, ICC/IF, FC, IP
|
Human, Mouse, Rat |
DUSP3 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 20 kDa, targeting to DUSP3. It can be used for WB,IHC-F,IHC-P,ICC/IF,FC,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80699
-
HDAC2; Histone deacetylase 2; HD2
|
WB, ICC/IF
|
Human, Mouse, Rat, Monkey |
HDAC2 Antibody (YA742) is a non-conjugated and Mouse origined monoclonal antibody about 55 kDa, targeting to HDAC2 (2D9). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat, Monkey.
|
- HY-P80888
-
RUNX1; AML1; RUNX2; OSF2; RUNX3; CBFA3
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
RUNX Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 49 kDa, targeting to RUNX. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80903
-
STAT4; Signal transducer and activator of transcription 4
|
WB, IHC-P, IP
|
Human |
STAT4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 86 kDa, targeting to STAT4. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human.
|
- HY-P80921
-
SSA; RO52; SSA1; RNF81; Ro/SSA
|
WB
|
Human |
TRIM21 Antibody (YA658) is a non-conjugated and Mouse origined monoclonal antibody about 54 kDa, targeting to TRIM21 (5B9). It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80943
-
Translationally-controlled tumor protein; TCTP; Fortilin; Histamine-releasing factor; HRF; p23
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
TCTP Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 20 kDa, targeting to TCTP. It can be used for WB,ICC/IF,IP assays in the background of Human, Mouse, Rat.
|
- HY-P80981
-
Fc-gamma RI; FcRI; Fc-gamma RIA; FcgammaRIa; CD64
|
WB, IHC-P, FC
|
Human |
FCGR1A Antibody is an unconjugated, approximately 43 kDa, rabbit-derived, anti-FCGR1A monoclonal antibody. FCGR1A Antibody can be used for: WB, IHC-P, FC expriments in human background without labeling.
|
- HY-P81055
-
Mertansine, Maytansinoid DM1, DM 1, 139504-50-0
|
ELISA; Sandwich ELISA; Competitive ELISA
|
|
DM1 Antibody (YA898) is an unconjugated, mouse-derived, anti-DM1 (YA898) monoclonal antibody. DM1 Antibody (YA898) can be used for: ELISA, Sandwich ELISA, Competitive ELISA expriments in background without labeling.
|
- HY-P81240
-
IL-19; MDA1; NG.1; ZMDA1; IL-10C
|
WB, IHC-P
|
Human |
- HY-P81302
-
Rb2; P130
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
- HY-P81302A
-
- HY-P81322
-
P62; BTF2; TFB1; TFIIH.
|
WB, ICC/IF, IP
|
Human |
- HY-P81335
-
4EBP3; 4E-BP3
|
WB
|
Transfected |
- HY-P81383
-
CD79B; AGM6; B29; IGB
|
IHC-P
|
Human |
- HY-P81411
-
GYPC; CD236; CD236R; GE; GPC; GYPD
|
IHC-P
|
Human |
- HY-P81434
-
BANK1; B-cell scaffold protein with ankyrin repeats
|
IHC-P
|
Human |
- HY-P81470
-
CDHF6; Desmoglein3; DSG3; PVA
|
IHC-P
|
Human |
- HY-P81538
-
FOXP1; HSPC215; Forkhead box protein P1
|
IHC-P
|
Human |
- HY-P81615
-
NEK7; NimA related protein kinase 7
|
WB, IP
|
Mouse, Rat |
- HY-P81638
-
neurogranin (protein kinase C substrate; RC3); RC3; hng
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P81666
-
PERC; PGC1; PPARGC1; Ppargc1b
|
WB, IP
|
Human, Mouse, Rat |
- HY-P81688
-
LOQS; Prbp; tarbp2; TRBP; TRBP1; TRBP2
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P81732
-
ORP1; OSBP8; OSBPL1; OSBPL1B
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P81733
-
Grp170; HSP12A; Hyou1; Orp150
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P81745
-
SDC1; SDC; Syndecan-1; SYND1; CD138
|
FC, ELISA
|
Human |
- HY-P81747
-
SLAM7 (19A; CD319; CRACC; CS1)
|
FC, ELISA
|
Human |
- HY-P81783
-
poly(A) binding protein interacting protein 1
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P81804
-
PTPRQ; EC-PTP; PCPTP1; PTP-SL; PTPBR7
|
WB
|
Rat |
- HY-P81826
-
CAP70; CLAMP; PDZD1; NHERF3; NHERF-3
|
WB, IP
|
Human |
- HY-P81900
-
MC4R; Melanocortin 4 receptor
|
WB
|
Human, Mouse, Rat |
- HY-P81936
-
RAD50; DNA repair protein RAD50; hRAD50
|
WB
|
Human |
- HY-P81963
-
B56E; B56epsilon
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P81975
-
stomatin like 2; SLP-2; HSPC108
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82021
-
PA28A; IFI5111; REGalpha; PA28alpha
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82049
-
ANCCA; Atad2; CT137; L16; PRO2000
|
WB, ICC/IF, FC
|
Human |
- HY-P82100
-
HFE3; TfR2; TFRC2
|
WB, IHC-P
|
Human |
- HY-P82111
-
ACRV1; Msa63; Sp10; SPACA2
|
WB
|
Human |
- HY-P82115
-
NR1B3; RAR gamma; RARC; Rarg
|
WB, ICC/IF
|
Human, Rat |
- HY-P82128
-
C4BP; C4BPB; PRP
|
WB, IHC-P, ICC/IF, IP
|
Human, Rat |
- HY-P82134
-
EAA1; GluK4; GRIK; Grik4; KA1
|
WB
|
Human, Mouse, Rat |
- HY-P82165
-
HsPK21; NEK2; NEK2A; NLK1
|
WB
|
Human |
- HY-P82173
-
E2IG3; GNL3; NNP47; NS; Nucleostemin
|
WB, ICC/IF, FC
|
Human |
- HY-P82178
-
Irf9; ISGF3; ISGF3G; p48
|
WB, ICC/IF, FC
|
Human |
- HY-P82255
-
DPYD; Dihydropyrimidine dehydrogenase [NADP(+)]; DHPDHase; DPD; Dihydrothymine dehydrogenase; Dihydrouracil dehydrogenase
|
WB, IHC-P, ICC/IF, FC
|
Human |
- HY-P82327
-
AQDQ; CI 18; CI AQDQ; NDUFS4
|
WB, IHC-P, IP, FC
|
Human, Mouse, Rat |
- HY-P82330
-
ALS2CR8; NYD-SP24
|
WB
|
Human |
- HY-P82340
-
STK33; Serine/threonine-protein kinase 33
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
- HY-P82343
-
ZIN; PPP2R6C; zinedin
|
WB, ICC/IF, IP
|
Human |
- HY-P82394
-
SL1; TAFI95; TAFI110; MGC:39976
|
WB, IP
|
Human |
- HY-P82400
-
PH domain-containing family A member 1
|
WB, IP
|
Human |
- HY-P82401
-
BIG2; PVNH2; dJ1164I10.1
|
WB
|
Human, Mouse, Rat |
- HY-P82404
-
Rho GTPase activating protein 25; KAIA0053
|
WB, IHC-P
|
Human, Rat |
- HY-P82406
-
Aconitate hydratase; mitochondrial; Aconitase; Citrate hydro-lyase
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82407
-
ARC34; PRO2446; p34-Arc; PNAS-139
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82413
-
SII; TCEA; TF2S; GTF2S; TFIIS
|
WB
|
Human, Mouse, Rat, Monkey |
- HY-P82482
-
CENP-C; CENPC1; hcp-4; ICEN7; MIF2
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82484
-
bHLHc13; mxd3; Myx
|
WB, IHC-P, FC
|
Human, Mouse, Rat |
- HY-P82499
-
CLN2; GIG1; LPIC; SCAR7; TPP-1
|
WB, IHC-P
|
Human |
- HY-P82578
-
CAMP GEFII; CAMPGEFII; CGEF2; EPAC2; Rapgef4
|
WB
|
Human, Mouse, Rat |
- HY-P82600
-
ActR IIB; ACVR 2B; HTX4
|
WB
|
Human, Mouse, Rat |
- HY-P82611
-
Epitheliasin; PRSS10; TMPRSS2
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82657
-
VTN; Vitronectin; VN; S-protein; Serum-spreading factor; V75
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
- HY-P82662
-
NR1F2; ROR BETA; Rorb; RZR BETA; RZRB
|
WB
|
Human, Mouse |
- HY-P82707
-
CTH; Cystathionine gamma lyase; Cysteine desulfhydrase; Gamma cystathionase; Homoserine deaminase
|
WB, IP
|
Human |
- HY-P82711
-
- HY-P82729
-
CDW1; DCAF2; Dtl; L2DTL; RAMP
|
WB, IHC-P
|
Human |
- HY-P82739
-
HNRNPA 1; HNRNPA1; HNRPA1
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82776
-
Cleft lip and palate transmembrane protein 1
|
WB, IP
|
Human |
- HY-P82809
-
CFIM; CFIM68; CFIM72; HPBRII-4; HPBRII-7
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82854
-
LIPE; Hormone-sensitive lipase; HSL
|
WB
|
Human |
- HY-P82860
-
SHYC; SRA1; SRA-1; P140SRA-1
|
WB
|
Human, Mouse, Rat |
- HY-P82866
-
cytochrome c oxidase subunit 6C
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P82958
-
ALOX 5AP; ALOX5 AP; ALOX5AP; FLAP
|
WB
|
Human |
- HY-P83026
-
Tropomodulin 2; NTMOD; TMOD2
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P83037
-
DGCR1; HIR; HIRA; TUP 1; TUPLE1
|
WB, ICC/IF, IP, FC
|
Human |
- HY-P83039
-
Elf3; EPR1; ERT; ESE-1; ESX; jen
|
WB, FC
|
Human, Mouse, Rat |
- HY-P83081
-
eIF3e; EIF3S6; eIFe
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P83089
-
Glycerophosphatase; PLA2P; Plaa; PLAP
|
WB, IHC-P, ICC/IF, IP
|
Human |
- HY-P83139
-
HDAC11; HD11; Histone deacetylase 11
|
WB, IP
|
Human |
- HY-P83148
-
ARG2; Arginase-2; Type II arginase
|
WB, ICC/IF, FC
|
Human |
- HY-P83154
-
GK; Glycerol kinase; GK; Glycerokinase; ATP:glycerol 3-phosphotransferase
|
WB, IP, FC
|
Human, Mouse, Rat |
- HY-P83171
-
ETV6; Tel; TEL oncogene; TEL/ABL; TEL1
|
WB, ICC/IF, FC
|
Human |
- HY-P83190
-
TOR1A; DQ2; DYT1; TorsinA
|
WB, FC
|
Human |
- HY-P83203
-
Golgin subfamily A member 1 (Golgin-97)
|
WB
|
Human |
- HY-P83208
-
LIM domain only protein 4; LMO4
|
WB, IP
|
Human, Mouse |
- HY-P83252
-
IBSN; MGC841; NUP62; p62; SNDI
|
WB
|
Human |
- HY-P83268
-
Renilla-type luciferase; Renilla luciferin 2 monooxygenase
|
WB, ICC/IF
|
Renilla Luciferase |
- HY-P83282
-
HBO1; HBOA; MYST2; ZC2HC7
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P83340
-
BDMF; MSAP; DMSFH; LGMBF; DMSMFH; c86fus; HEL-249
|
WB
|
Human, Mouse |
- HY-P83375
-
H105E3; XAP104; SDR31E1
|
WB, IP
|
Human |
- HY-P83396
-
KNS; KINH; KNS1; UKHC; HEL-S-61
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P83399
-
killin; p53-regulated DNA replication inhibitor; CWS4; KILLIN
|
WB
|
Human, Mouse, Rat |
- HY-P83408
-
lox; LYOX; Lysyl oxidase; Protein lysine 6 oxidase
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P83417
-
PRKCQ; PRKCT; Protein kinase C theta type; nPKC-theta
|
WB
|
Human, Rat |
- HY-P83422
-
PNK; AOA4; MCSZ; CMT2B2; EIEE10
|
WB, IHC-P, IP
|
Human |
- HY-P83453
-
MRG; MAS-L; dJ994E9.2
|
WB, IP
|
Human, Mouse, Rat |
- HY-P83462
-
MDH; MOR1; M-MDH; EIEE51; MGC:3559
|
WB, IHC-P
|
Human, Rat |
- HY-P83464
-
mef2; ADCAD1; RSRFC4; RSRFC9
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P83497
-
Histone lysine demethylase MINA; MDIG; MINA; NO52; ROX
|
WB, ICC/IF
|
Human, Mouse |
- HY-P83526
-
Myelin membrane encephalitogenic protein; Myelin A1 protein
|
WB
|
Human, Rat |
- HY-P83534
-
- HY-P83547
-
CDw156; CD156c; ADAM10; KUZ; MADM
|
WB, IP
|
Human, Mouse, Rat |
- HY-P83567
-
VAV2; Vav 2 oncogene; VAV-2
|
WB, ICC/IF, IP
|
Human |
- HY-P81234
-
Antigen identified by monoclonal Antibody Ki 67; Antigen KI67; KIA; Ki67; MKI67; Proliferation related Ki 67 antigen; Antigen KI-67; KI67_MOUSE.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; ICC; IF
|
Human, Mouse, |
Ki-67 Antibody is an unconjugated, approximately 358 kDa, rabbit-derived, anti-Ki-67 polyclonal antibody. Ki-67 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, background without labeling.
|
- HY-P80392
-
|
WB, IP, IHC-P
|
Human |
Erk1 (pT202/pY204)+Erk2 (pT185/pY187) Antibody (YA455) is a non-conjugated and Rabbit origined monoclonal antibody about 41/43 kDa, targeting to Erk1 (pT202/pY204) + Erk2 (pT185/pY187). It can be used for WB,IP,IHC-P assays with tag free, in the background of Human.
|
- HY-P80535
-
AKT1,AKT2,AKT3
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat, Hamster |
AKT Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 56 kDa, targeting to AKT. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat, Hamster.
|
- HY-P80559
-
hAGP7; Ubiquitin-activating enzyme E1-like protein; APG7L
|
WB
|
Human, Mouse, Rat |
ATG7 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 78 kDa, targeting to ATG7. It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80567
-
BDNF; MGC34632; Abrineurin; ANON2; Brain Derived Neurotrophic Factor; Neurotrophin; BULN2
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
BDNF Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 28 kDa, targeting to BDNF. It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80641
-
XPE; DDBA; XAP1; XPCE; XPE-BF; UV-DDB1
|
WB
|
Human, Mouse, Rat, Monkey |
DDB1 Antibody (YA785) is a non-conjugated and Mouse origined monoclonal antibody about 127 kDa, targeting to DDB1 (2D6). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat, Monkey.
|
- HY-P80683
-
JUP; CTNNG; DP3; Junction plakoglobin; Catenin gamma; Desmoplakin III; Desmoplakin-3
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
gamma Catenin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 82 kDa, targeting to gamma Catenin. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human.
|
- HY-P80691
-
GLNA; GS; GLUL; GLNS; PIG43; PIG59; Glutamine synthetase
|
WB
|
Mouse, Rat |
Glutamine Synthetase Antibody (YA405) is a non-conjugated and Rabbit origined monoclonal antibody about 42 kDa, targeting to Glutamine Synthetase. It can be used for WB assays with tag free, in the background of Mouse, Rat.
|
- HY-P80754
-
MMP1; CLG; Interstitial collagenase; Fibroblast collagenase; Matrix metalloproteinase-1; MMP-1
|
WB, IP
|
Human |
MMP1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 54 kDa, targeting to MMP1. It can be used for WB,IP assays with tag free, in the background of Human.
|
- HY-P80898
-
IPOB; IPO-B; MNSOD; MVCD6; Mn-SOD; SOD2
|
WB
|
Human |
SOD2 Antibody (YA670) is a non-conjugated and Mouse origined monoclonal antibody about 25 kDa, targeting to SOD2 (4C4). It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80929
-
VEGFA; VEGF; Vascular endothelial growth factor A; VEGF-A; Vascular permeability factor; VPF
|
WB
|
Human, Mouse, Rat |
VEGFA Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 27 kDa, targeting to VEGFA. It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80956
-
Apotransferrin; beta 1 metal binding globulin; serotransferrin; TF
|
WB, IHC-P, ICC/IF
|
Human |
Transferrin Antibody (YA840) is a non-conjugated and Mouse origined monoclonal antibody about 77 kDa. It can be used for WB,IHC-P,ICC/IF assays in the background of Human.
|
- HY-P80967
-
EDG6; LPC1; S1P4; SLP4
|
WB, IHC-P
|
Rat |
S1PR4 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 42 kDa, targeting to S1PR4. It can be used for WB, IHC-P assays with tag free, in the background of Rat.
|
- HY-P81070
-
DLAT; DLTA; E2; PBC; PDCE2; Pyruvate Dehydrogenase E2
|
WB, ICC/IF, IP
|
Human, Mouse |
DLAT Antibody (YA912) is an unconjugated, approximately 69 kDa, mouse-derived, anti-DLAT (YA912) monoclonal antibody. DLAT Antibody (YA912) can be used for: WB, ICC/IF, IP expriments in human, mouse background without labeling.
|
- HY-P81152
-
erythropoietin receptor; EPO R; EPO Receptor; Erythropoietin receptor precursor; EPOR_HUMAN; MGC138358.
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human, Rat(predicted: Mouse, Dog, Cow, Horse) |
EPOR Antibody is an unconjugated, approximately 56 kDa, rabbit-derived, anti-EPOR polyclonal antibody. EPOR Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, rat, and predicted: mouse, dog, cow, horse background without labeling.
|
- HY-P81236
-
autophagy related 10; APG10; APG10L; pp12616
|
WB;IHC
|
Human, Mouse |
ATG10 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 25 kDa, targeting to ATG10. It can be used for WB,IHC assays with tag free, in the background of Human and mouse.
|
- HY-P81276
-
ADAP; Fyb; FYN binding protein; p120/p130; SLAP130
|
WB
|
Human |
- HY-P81276B
-
ADAP; Fyb; FYN binding protein; p120/p130; SLAP130
|
WB, IHC-P, ICC/IF
|
Mouse, Human |
- HY-P81288
-
NPPB; Natriuretic peptides B; Gamma-brain natriuretic peptide
|
ELISA
|
Human |
- HY-P81288A
-
NPPB; Natriuretic peptides B; Gamma-brain natriuretic peptide
|
ELISA
|
Human |
- HY-P81288B
-
NPPB; Natriuretic peptides B; Gamma-brain natriuretic peptide
|
ELISA
|
Human |
- HY-P81364
-
HIP8; HYPD; CT1.3; MAGE3; MAGEA6
|
IHC-P
|
Human |
- HY-P81382
-
galectin 9; HUAT; LGALS9A
|
IHC-P
|
Human |
- HY-P81387
-
GCAT2; Gcet; Gcsam; hGAL; M17; M17 L
|
IHC-P
|
Human |
- HY-P81395
-
CDC46; MCM5; MGC5315; P1 CDC46
|
IHC-P
|
Human |
- HY-P81424
-
CLDN8; UNQ779/PRO1573 ; Claudin-8
|
IHC-P
|
Human |
- HY-P81459
-
PCTT; PSTI; SPINK1; Spink3; TaTI; TCP; P12
|
IHC-P
|
Human |
- HY-P81490
-
DPEP3; UNQ834/PRO1772; Dipeptidase 3
|
IHC-P
|
Human |
- HY-P81493
-
TRBC1 ; T cell receptor beta constant 1
|
IHC-P
|
Human |
- HY-P81514
-
UPK2; Uroplakin-2; UP2; Uroplakin II (UPII)
|
IHC-P
|
Human |
- HY-P81544
-
SSEA1, FUT4, ELFT, FCT3A
|
IHC-P
|
Human, Mouse, Rat |
- HY-P81570
-
Gabra1, Gabra-1
|
WB, IHC-P
|
Mouse, Rat |
- HY-P81599
-
C3HC4 type zinc finger protein; RNF8
|
WB
|
Human, Rat |
- HY-P81602
-
CI-13kA; CI13KDA; CI-13kD-A
|
WB, IP
|
Human, Mouse, Rat, Hamster |
- HY-P81671
-
P130; NOPP130; NOPP140; NS5ATP13
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
- HY-P81693
-
MEF2C; Myocyte-specific enhancer factor 2C
|
WB, IHC-P
|
Human, Rat |
- HY-P81715
-
ODG6; NUP84; NPHS11; ODG6; GAMOS7
|
WB
|
Human, Rat |
- HY-P81742
-
HLA-Drb1; DW2.2/DR2.2
|
WB, IHC-P, ICC/IF
|
Human |
- HY-P81766
-
p60 katanin; Katanin p60 subunit A1
|
WB
|
Human |
- HY-P81789
-
CSPG2; ERVR; GHAP; PGM; VCAN; Versican; WGN1
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P81822
-
Bub1; BUB1A; BUB1L; hBUB1
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P81832
-
Ubiquitin-fold modifier 1; C13orf20
|
WB, IHC-P, IP
|
Human, Mouse |
- HY-P81836
-
CAMPATH 1; CD52; CDw52; He5
|
WB, IP
|
Mouse |
- HY-P81837
-
MDK; FLJ27379; MK1; NEGF2; Midkine; NEGF2; ARAP
|
WB, IP
|
Human |
- HY-P81847
-
ANGPT1; KIAA0003; Angiopoietin-1; ANG-1
|
WB
|
Human, Rat |
- HY-P81850
-
ALP; hALP; N acetyltransferase like protein; NAT10; NET43
|
WB, ICC/IF, IP
|
Human, Rat |
- HY-P81883
-
ABCD3; ABC43; PMP70; PXMP1; ZWS2
|
WB, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P81892
-
ATH1; ATOH1; bHLHa14; hATH1; MATH1
|
WB
|
Human, Mouse, Rat |
- HY-P81899
-
AI115456; AI835305; Pip5kIgamma
|
WB, IP
|
Human, Mouse |
- HY-P81909
-
CCBP1; CD234; DARC; Dfy; FY; GPD; GpFy; WBCQ1
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse |
- HY-P81927
-
Phospholipid scramblase 3; PL scramblase 3
|
WB
|
Human, Mouse, Rat |
- HY-P81944
-
MRD5; p135 SynGAP; RASA1; RASA5; SYNGAP1
|
WB
|
Rat |
- HY-P81961
-
5' -NT; 5' -nucleotidase; ACP3; PAP; Prostatic acid phosphatase; TMPase
|
WB, IHC-P, ICC/IF, IP
|
Human |
- HY-P81968
-
Protein regulator of cytokinesis 1
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
- HY-P81994
-
PDS; PGD2; PGDS; LPGDS; PGDS2; L-PGDS
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82042
-
LRG1; LRG; Leucine-rich alpha-2-glycoprotein; LRG
|
WB, IHC-P, IP
|
Human |
- HY-P82051
-
Epididymis tissue protein Li 184a; Profilin I
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82052
-
AAP1; APAP1; cb337; DEDAF; RYBP; rybpa; YEAF1
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82061
-
Dnmt3b; DNA methyltransferase HsaIIIB; DNMT3B
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P82069
-
HTRP1; Mtrp1; TRP1; TRPC1; Trrp1
|
WB
|
Human, Mouse, Rat |
- HY-P82085
-
NS6; CMNS; NCMS; ALPS4; N-ras; NRAS1
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82088
-
NS6; CMNS; NCMS; ALPS4; N-ras; NRAS1
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82117
-
Serine/threonine-protein kinase GSK3A
|
WB
|
Human, Rat, Hamster |
- HY-P82162
-
FIH 1; FIH1; HIF1AN
|
WB, IHC-P, ICC/IF, FC
|
Human |
- HY-P82192
-
5-LO; 5-LOX; 5LPG; LOG5; MGC163204
|
WB, IHC-F, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82220
-
ecat9; GDF3; KFS3; MCOP7; Vgr2
|
WB
|
Human, Mouse, Rat |
- HY-P82242
-
61E3.4; ATX; hSMG1; LIP; smg1
|
WB
|
Human, Mouse, Rat |
- HY-P82268
-
ISWI; SNF2H; hISWI; hSNF2H; WCRF135
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P82275
-
AGT; PH1; SPT; AGT1; SPAT; TLH6; AGXT1
|
WB
|
Mouse, Rat |
- HY-P82306
-
CT1.1; MAGE1; MAGE1A; MAGEA1
|
WB, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82307
-
Frizzled-8; FZ8; FZD8; hFz8
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P82324
-
Fba5e; FGA; Fib; Fib2; Fibrinopeptide A
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82331
-
CMTRIB; KARS; KARS1; KARS2; KRS; Lysine tRNA ligase; LysRS
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82346
-
IMPD2; IMPDH 2; IMPDH II; Impdh2
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82349
-
ACE; Dipeptidyl carboxypeptidase I; Kininase II
|
WB, IHC-P
|
Mouse, Rat |
- HY-P82357
-
Stx3; STX3A; Syntaxin 3A
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82362
-
SP-D; Sfpd; Sftp4; AI573415
|
WB, IHC-P
|
Rat |
- HY-P82399
-
Brachyury homolog; Bry; Protein T; SAVA; TFT
|
WB, IHC-P, ICC/IF, IP, FC
|
Mouse, Rat, Human |
- HY-P82412
-
ATP2A; ATP2A1; SERCA1
|
WB, IHC-P, IP
|
Human |
- HY-P82433
-
Arginyltransferase 1; R-transferase 1
|
WB, IHC-P
|
Human, Rat |
- HY-P82443
-
GST; GST class kappa; GST13; Gstk1; hGSTK1
|
WB, IHC-P, ICC/IF, IP, FC
|
Human |
- HY-P82447
-
TXN; MTRX; TRX2; MT-TRX; COXPD29
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82478
-
LUMA; ARVC5; ARVD5; EDMD7
|
WB, IHC-P
|
Human, Rat |
- HY-P82487
-
CCT A; CCT alph; CTPCT; PCYT1; Pcyt1a
|
WB, ICC/IF, IP, FC
|
Human |
- HY-P82492
-
TOP1; DNA topoisomerase 1; DNA topoisomerase I
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82513
-
APRIL; CD256; TALL2; TNFSF13; TRDL1; ZTNF2
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P82560
-
NACB; BTF3a; BTF3b; BETA-NAC
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P82569
-
PRCA1; Ribonuclease4; RibonucleaseL; RNase L; Rnasel; RNS4
|
WB
|
Human |
- HY-P82570
-
TR; TR1; TXNR; TRXR1; GRIM-12
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse |
- HY-P82586
-
Na+/Ca2+ exchanger; NCX1; SLC8A1
|
WB
|
Human, Mouse, Rat |
- HY-P82594
-
UCH37; CGI-70; INO80R; UCH-L5
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82606
-
Ring1A; Ring1; RING1A; Rnf1
|
WB, IHC-P, ICC/IF
|
Human |
- HY-P82618
-
Kinesin2; KLC; Klc1; KNS2; KNS2A
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82619
-
CD280 antigen; MRC2; ENDO180; KIAA0709; UPARAP
|
WB
|
Human |
- HY-P82634
-
Desmoplakin I; Desmoplakin II; DPI; DPII; DSP; KPPS2; PPKS2
|
WB, ICC/IF, FC
|
Human, Rat |
- HY-P82648
-
BCL2 like 12; BCL2L12; BPR
|
WB, IHC-P, ICC/IF, IP, FC
|
Human |
- HY-P82655
-
LTA4; LTA4 hydrolase; LTA4H
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82681
-
hOCT1; OCT1; Slc22a1
|
WB, FC
|
Human |
- HY-P82695
-
CD55; CR; DAF; Complement decay-accelerating factor; CD55
|
WB
|
Human |
- HY-P82710
-
F2RL1; GPR11; PAR 2
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82724
-
AEP; cysteine 1; Legumain; LGMN; LGMN1; PRSC1
|
WB
|
Human, Mouse, Rat |
- HY-P82741
-
Carboxypeptidase A1+A2+B
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82746
-
ATF1; ATF2; gdnf; HFB1 GDNF; hGDNF; HSCR3
|
WB, FC
|
Human, Mouse, Rat |
- HY-P82749
-
ETS1; EWSR2; Protein C-ets-1; p54
|
WB
|
Human, Mouse |
- HY-P82750
-
Acry 1; CRYA1; CRYAA; HspB4
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P82788
-
OPLL; BTHLM1; UCHMD1
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
- HY-P82799
-
NUP62L; Nucleoporin-62 C-terminal-like protein
|
WB, IP
|
Human |
- HY-P82827
-
CDKN2; p33(CDK2)
|
WB, IHC-P, IP
|
Human |
- HY-P82833
-
CUL3; KIAA0617; Cullin-3; CUL-3
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82849
-
CCNE2; G1/S-specific cyclin-E2
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
- HY-P82856
-
EXP; EXP35; EXP40; EXP42; MBNL; MBNL1
|
WB
|
Human, Mouse |
- HY-P82865
-
CHRM2; HM2; AChR; Acm2
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P82870
-
CARD11; CARMA1; Carma 1; BIMP3
|
WB, ICC/IF
|
Human, Mouse |
- HY-P82903
-
hTll; nr2e1; Tll; TLX; XTLL
|
WB
|
Human, Mouse, Rat |
- HY-P82932
-
AP3A hydrolase; AP3Aase; Dinucleosidetriphosphatase; FRA3B
|
WB
|
Human, Rat |
- HY-P82936
-
FKHL5; foxf1; FREAC1; HFH 8
|
WB, ICC/IF, FC
|
Human |
- HY-P82984
-
hK2; hGK-1; KLK2A2
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P82994
-
PA26; sesn1; SEST1; sestrin 1
|
WB, FC
|
Human, Mouse, Rat |
- HY-P83015
-
CSTA; STF1; STFA; Cystatin-A; Cystatin-AS; Stefin-A
|
WB, FC
|
Human, Mouse, Rat |
- HY-P83030
-
ECL; SLC; CKb9; TCA4; 6Ckine; SCYA21
|
WB
|
Human |
- HY-P83047
-
BIRC1; Birc1a; NAIP; Naip1; NLRB1; psiNAIP
|
WB
|
Human |
- HY-P83055
-
SSTR5; SS5R; Sstr5
|
WB, FC
|
Human, Mouse, Rat |
- HY-P83069
-
ATP-dependent Clp protease ATP-binding subunit clpX-like; mitochondrial; CLPX
|
WB, ICC/IF
|
Human, Mouse, Rat, Hamster |
- HY-P83136
-
CYK4; GAP; Gap1; ID GAP; MgcRacGAP; Racgap1
|
WB, IHC-P, ICC/IF
|
Human |
- HY-P83162
-
HOX1; HOX1.3; HOX1C; HOXA5
|
WB
|
Human, Mouse, Rat |
- HY-P83164
-
HOX1; ABD-B; HOX1G; HOX1.7
|
WB
|
Human |
- HY-P83179
-
TRM82; WD repeat protein 4; wdr4
|
WB, IHC-P, ICC/IF, FC
|
Human |
- HY-P83186
-
Pancreatic anionic trypsinogen; Protease; serine; 2; PRSS2; TRYP8
|
WB
|
Human, Mouse, Rat |
- HY-P83236
-
BPIFF; HDLCQ10; CETP; Lipid transfer protein I; Cholesteryl ester transfer protein
|
WB, IP
|
Human |
- HY-P83246
-
EGVEGF; Mambakine; PK1; PRK1; PROK1; Prokineticin-1
|
WB, FC
|
Human, Mouse |
- HY-P83247
-
HMG4; HMG-4; HMG2A; HMG-2a
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P83332
-
MRG1; PEMP; AAG12; EMP55; DXS552E
|
WB
|
Human |
- HY-P83373
-
IRF1; Interferon regulatory factor 1; IRF-1
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P83385
-
Interferon regulatory factor 2; IRF 2
|
WB, IHC-P, ICC/IF
|
Human, Mouse |
- HY-P83394
-
NCF; CGD3; P40PHOX; SH3PXD4
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P83403
-
CRSBP 1; CRSBP-1; CRSBP1; hyaluronic acid receptor
|
WB
|
Human, Mouse, Rat |
- HY-P83425
-
MDP1; PEO; PolG alpha; POLG; POLG1; POLGA; SANDO; SCAE
|
WB
|
Human |
- HY-P83445
-
REV7; FANCV; MAD2B; POLZ2
|
WB, ICC/IF, IP
|
Human |
- HY-P83451
-
MRS; ILLD; CMT2U; ILFS2; METRS; MTRNS; SPG70
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Rat |
- HY-P83454
-
MAT; SAMS; MATA1; SAMS1; MAT1A
|
WB, IP
|
Human, Mouse, Rat |
- HY-P83476
-
NG2; MCSP; MCSPG; MSK16; HMW-MAA; MEL-CSPG
|
WB, IHC-P, FC
|
Human |
- HY-P83503
-
Urokinase-type plasminogen activator; U-plasminogen activator; Upa; PLAU; ATF uPA
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P83530
-
TSP; THBS; TSP1; TSP-1; THBS-1
|
WB, IHC-P, IP
|
Human, Mouse |
- HY-P83564
-
UEF; FCHL; MLTF; FCHL1; MLTFI; HYPLIP1; bHLHb11
|
WB
|
Human, Mouse |
- HY-P83580
-
Estrogen-induced tag 6; HPH-3; PHD1
|
WB
|
Human, Rat |
- HY-P82551
-
CLGN; MEG 1 antigen; Calnexin-T; Calmegin precursor; Calmegin
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P80636
-
CCNH; Cyclin-H; MO15-associated protein; p34; p37
|
WB
|
Human, Mouse |
Cyclin H Antibody (YA788) is a non-conjugated and Mouse origined monoclonal antibody about 38 kDa, targeting to Cyclin H (1A7). It can be used for WB assays with tag free, in the background of Human, Mouse.
|
- HY-P80655
-
NNE; PPH; MPB1; ENO1L1; HEL-S-17
|
WB
|
Human, Mouse, Rat, Monkey |
ENO1 Antibody (YA773) is a non-conjugated and Mouse origined monoclonal antibody about 47 kDa, targeting to ENO1 (3F7). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat, Monkey.
|
- HY-P80678
-
FOXP3; IPEX; JM2; Forkhead box protein P3; Scurfin
|
WB, ICC/IF
|
Transfected |
FOXP3 Antibody (YA759) is a non-conjugated and Mouse origined monoclonal antibody about 47 kDa, targeting to FOXP3. It can be used for WB,ICC/IF assays with tag free, in the background of Transfected.
|
- HY-P80688
-
G6PD; Glucose-6-phosphate 1-dehydrogenase; G6PD
|
WB, IHC-P, IP
|
Human, Rat |
Glucose 6 Phosphate Dehydrogenase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 59 kDa, targeting to Glucose 6 Phosphate Dehydrogenase. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Rat.
|
- HY-P80873
-
PP4; PPX; PP4C; PPH3; PPP4
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
PPP4C Antibody (YA687) is a non-conjugated and Mouse origined monoclonal antibody about 35 kDa, targeting to PPP4C (2F11). It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human.
|
- HY-P80911
-
ETGF; TFGA; TGF A; TGF-alpha; Tgfa; Wa1; Waved 1
|
WB, IHC-P, IP
|
Human |
TGF alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 17 kDa, targeting to TGF alpha. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human.
|
- HY-P80925
-
FLJ25987; MGC8385; ubiquitin B; Ubiquitin; UBCEP1; UBCEP2; RPS27A
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
Ubiquitin Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 26 kDa, targeting to Ubiquitin. It can be used for WB,IHC-P,ICC/IF,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80965
-
FOXP3; IPEX; JM2; Forkhead box protein P3; Scurfin
|
WB, IHC-P
|
Human |
Anti-FOXP3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 47 kDa, targeting to FOXP3. It can be used for WB, IHC-P assays with tag free, in the background of Human.
|
- HY-P81056
-
MMAE; Monomethyl auristatin E; Monomethylauristatin E; Monomethylauristatin norephedrine; Toxin MMAE; MMAE toxin
|
ELISA;
|
Species independent |
MMAE Antibody (YA899) is an unconjugated, rabbit-derived, anti-MMAE (YA899) monoclonal antibody. MMAE Antibody (YA899) can be used for: ELISA, Sandwich ELISA, Competitive ELISA expriments in background without labeling.
|
- HY-P81194
-
Eosinophil peroxidase; Eosinophil peroxidase heavy chain; EPER; EPO; EPP; EPX PEN; PERE; PERE_HUMAN.
|
ELISA; IHC-P; IHC-F; IF
|
Human, Mouse(predicted: Rat) |
EPX Antibody is an unconjugated, approximately 79 kDa, rabbit-derived, anti-EPX polyclonal antibody. EPX Antibody can be used for: ELISA, IHC-P, IHC-F, IF expriments in human, mouse, and predicted: rat background without labeling.
|
- HY-P81285
-
LPP; Lipoma-preferred partner; LIM domain-containing preferred translocation partner in lipoma
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat, Monkey, Hamster |
- HY-P81285A
-
LPP; Lipoma-preferred partner; LIM domain-containing preferred translocation partner in lipoma
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P81316
-
CKM; CKMM; Creatine kinase M-type; Creatine kinase M chain; M-CK
|
ELISA
|
Human |
- HY-P81396
-
AML2; CBFA3; PEBP2aC; FLJ34510; MGC16070
|
IHC-P
|
Human |
- HY-P81416
-
CENPF; Centromere protein F; CENP-F; AH antigen; Kinetochore protein CENPF; Mitosin
|
IHC-P
|
Human |
- HY-P81440
-
HMG R; HMG-I(Y); HMGA1; HMGA1A; HMGIY
|
IHC-P
|
Human |
- HY-P81473
-
IGJ; Immunoglobulin J Chain; IGJ; Joining chain of multimeric IgA and IgM
|
IHC-P
|
Human |
- HY-P81489
-
CDHP; HJMD; PCAD; CDH3 ; Cadherin-3; Placental cadherin (P-cadherin)
|
IHC-P
|
Human |
- HY-P81549
-
ATX3, MJD, MJD1, SCA3, ATXN3
|
IHC-P
|
Human, Mouse, Rat |
- HY-P81551
-
BLAST-2, CD23A, CLEC4J, FCE2, IGEBF
|
IHC-P, ICC/IF, FC
|
Human |
- HY-P81552
-
FLK-1, VEGFR-2, CD309, KRD1, Ly73
|
WB, IF-Cell, IHC-P, IP
|
Human, Rat |
- HY-P81565
-
CK-15, Cytokeratin-15, Keratin-15, KRT15, KRTB
|
WB, IHC-P, ICC/IF, FC
|
Human |
- HY-P81631
-
KMT5A; PR-Set7; SET07; SET8
|
WB, FC
|
Human, Mouse, Rat |
- HY-P81645
-
CD30; D1S166E; KI1; Tnfrsf8
|
WB, IHC-P
|
Human |
- HY-P81687
-
NRG3; Pro-neuregulin-3; membrane-bound isoform; Pro-NRG3
|
WB
|
Human, Rat |
- HY-P81731
-
CDH16; Cadherin-16; Kidney-specific cadherin; Ksp-cadherin
|
WB, IHC-P, IP
|
Human, Mouse |
- HY-P81761
-
TNFRSF9; 4-1BB; CD137; CDw137; ILA
|
FC, ELISA
|
Human |
- HY-P81810
-
DNA nucleotidylexotransferase; DNTT; TDT; Terminal addition enzyme; Terminal deoxynucleotidyltransferase; Terminal transferase
|
WB
|
Human |
- HY-P81819
-
JARID1A; Kdm5a; RBBP2; RBP2
|
WB, ICC/IF, IP, FC
|
Human, Mouse |
- HY-P81828
-
KIAA0723; Matr3; Matrin3; MPD2; VCPDM
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
- HY-P81858
-
Phosphoglucomutase-1; PGM 1; Glucose phosphomutase 1
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P81897
-
Netrin1; NTN1; NTN1L; Unc6
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P81943
-
A esterase 2; Paraoxonase 2; PON2
|
WB, IHC-P, IP
|
Human |
- HY-P81960
-
B56D; MRD35; B56delta
|
WB, IP
|
Human, Mouse, Rat |
- HY-P81984
-
Prolactin regulatory element-binding protein; Mammalian guanine nucleotide exchange factor mSec12
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P82007
-
DBA; DBA1; Ribosomal protein S19; rps19; S19
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P82030
-
EB3; EBF3; MAPRE3; RP/EB Family; RP3
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82055
-
RAB9A; DmRab9; Ras related protein Rab 9A
|
WB, IHC-P
|
Human, Mouse |
- HY-P82079
-
Ras-related protein Rap-1b; K-REV; RAL1B
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82136
-
RAB25; CATX8; Ras-related protein Rab-25; CATX-8
|
WB
|
Human |
- HY-P82141
-
p7; RRP4; SHRF; Rrp4p; hRrp4p
|
WB
|
Human, Mouse, Rat |
- HY-P82154
-
Zinc finger protein 797; Zinc finger protein SALL4
|
WB, IHC-P
|
Human |
- HY-P82207
-
B16.6; CDA016; CGI-39; GRIM19; GRIM-19
|
WB, IHC-P, ICC/IF
|
Human |
- HY-P82212
-
Xanthine dehydrogenase; Xanthine oxidase; Xanthine oxidoreductase; XD; XDH; xdha; XO; xor
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P82276
-
Exonuclease WRN; RecQ3; RECQL2; RECQL3; Werner syndrome helicase; WRN
|
WB
|
Human |
- HY-P82283
-
ASB; ANH1; XLSA; ALASE; XLDPP; XLEPP; ALAS-E; SIDBA1
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82316
-
BACH 1; BRIP 1; BRIP1; FANCJ
|
WB
|
Human |
- HY-P82359
-
EMK1; Mark2; PAR 1; Par1b
|
WB, FC
|
Human, Mouse, Rat |
- HY-P82380
-
tnnc1a; TNC; Tnnc1; TNNI3; Troponin C
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P82430
-
Aspartate aminotransferase; cytoplasmic; Glutamate oxaloacetate transaminase 1; Transaminase A
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82432
-
ATX1; SCA1; D6S504E
|
WB, IP
|
Mouse |
- HY-P82465
-
OTX2; Homeobox protein OTX2; Orthodenticle homolog 2
|
WB
|
Human |
- HY-P82508
-
BAT5; NG26; PP199; D6S82E
|
WB
|
Human, Rat |
- HY-P82545
-
Niemann Pick C1 protein precursor; NPC; NPC1
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82559
-
Terf2; TRBF2; TRF2
|
WB, IHC-P, ICC/IF
|
Human |
- HY-P82562
-
BGN; Biglycan; DSPG1; PG S1; PGI; SEMDX; SLRR1A
|
WB, IP, FC
|
Human, Mouse, Rat |
- HY-P82628
-
Bat8; Ehmt2; G9A; GAT8; NG36
|
WB, IHC-P
|
Human |
- HY-P82651
-
NEK6; NimA related protein kinase 6; SID61512
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82659
-
MYB; Transcriptional activator Myb; Proto-oncogene c-Myb
|
WB, IHC-P, IP, ChIP
|
Human |
- HY-P82717
-
AHC2; Atp1a3; DYT12; RDP
|
WB
|
Human, Mouse, Rat |
- HY-P82732
-
haloacid dehalogenase like hydrolase domain containing 5; CECR5
|
WB, IP
|
Human |
- HY-P82770
-
RGD1565941; VAV 3; Vav3; VAV3 oncogene
|
WB, ICC/IF, IP, FC
|
Human, Mouse |
- HY-P82781
-
SDC1; SDC; Syndecan-1; SYND1; CD138
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82897
-
RCC1; RCC1-I; SNHG3-RCC1; CHC1
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82933
-
ddx20; DP103; Gemin3; SMN interacting protein
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse |
- HY-P82943
-
DSH homolog 2
|
WB
|
Human, Mouse |
- HY-P82946
-
adenylate kinase 2; ADK2; AK 2
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82997
-
CSK; Tyrosine-protein kinase CSK; C-Src kinase; Protein-tyrosine kinase CYL
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P83005
-
PIM2; Serine/threonine-protein kinase pim-2; Pim-2h
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P83018
-
p43; HLD3; EMAP2; SCYE1; EMAPII; AIMP1
|
WB
|
Human, Rat |
- HY-P83032
-
CRMP4; DPYSL3; DRP3; LCRMP; TUC4; ULIP1
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P83050
-
ACTR2; ACTRII; ACTRIIA; Acvr2; ACVR2A
|
WB
|
Human, Mouse, Rat |
- HY-P83103
-
PP7910; PYGO2; Pygo2 protein; Pygopus 2
|
WB, IHC-P, ICC/IF
|
Human, Mouse |
- HY-P83121
-
Cubilin; Cubn; IFCR; MGA1; Cubilin precursor; megaloblastic anemia 1
|
WB, IHC-P
|
Human |
- HY-P83155
-
GCN5; hGCN5; GCN5L2; PCAF-b
|
WB, IP
|
Human |
- HY-P83165
-
D5D; TU12; FADS6; FADSD5; LLCDL1
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P83196
-
HJ2; JAG2; Jagged2; SER2; Syndactylism
|
WB
|
Human, Mouse |
- HY-P83201
-
HUK5; Lysophospholipase homolog; Lysophospholipase like; MAGL; MGL; MGLL; Monoacylglycerol lipase
|
WB
|
Human |
- HY-P83215
-
CMTX; CMTX1; Connexin32; Cx32; GJB1
|
WB, IHC-P, FC
|
Human |
- HY-P83225
-
AUTS15; CDFE; CNTNAP2; CNTP2; NRXN4; PTHSL1
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P83254
-
alpha synuclein; beta synuclein; NACP; PD1; SNCA; SNCB
|
WB, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P83261
-
Histone H1c; Histone H1s-2
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P83321
-
9-27; CD225; IFI17; LEU13; DSPA2a
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P83323
-
rBPI; BPIFD1; CAP 57; BPI; Bactericidal permeability-increasing protein
|
WB, ICC/IF, FC
|
Human |
- HY-P83377
-
AI1H; Integrin beta-6
|
WB, IP
|
Human, Mouse, Rat |
- HY-P83398
-
MMP13; Collagenase 3; Matrix metalloproteinase-13; MMP-13
|
WB
|
Human, Mouse |
- HY-P83406
-
PHA; LMN2R; TDRD18; DHCR14B; LBR
|
WB, IHC-P, IP
|
Human |
- HY-P83407
-
Paired box protein Pax-7; HuP1; PAX7; HUP1
|
WB, FC
|
Human, Mouse, Rat |
- HY-P83449
-
ERK3; PRKM6; p97MAPK; HsT17250; ERK-3
|
WB, IHC-P, IP
|
Human, Mouse |
- HY-P83461
-
TPA; T-PA; TPA1; PLAT; Tissue plasminogen activator
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P83490
-
MLD; DEGS; DES1; Des-1; FADS7; MIG15; DEGS-1
|
WB
|
Human |
- HY-P80551
-
Argininosuccinate synthase 1; ASS; ass1; ASSA; Citrulline aspartate ligase; CTLN1
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Rat |
ASS1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 47 kDa, targeting to ASS1. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Rat.
|
- HY-P80555
-
autophagy related 10; APG10; APG10L; pp12616
|
WB, IP
|
Human |
ATG10 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 25 kDa, targeting to ATG10. It can be used for WB,IP assays with tag free, in the background of Human.
|
- HY-P80666
-
FAS; ALPS1A; APO-1; APT1; CD95; FAS1; FASTM; TNFRSF6
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
Fas Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 38 kDa, targeting to Fas. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human.
|
- HY-P80680
-
FTO; KIAA1752; Alpha-ketoglutarate-dependent dioxygenase FTO; Fat mass and obesity-associated protein
|
WB, IHC-P
|
Human |
FTO Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 58 kDa, targeting to FTO. It can be used for WB,IHC-P assays with tag free, in the background of Human.
|
- HY-P80685
-
GATA6; Transcription factor GATA-6; GATA-binding factor 6
|
WB
|
Human |
GATA6 Antibody (YA757) is a non-conjugated and Mouse origined monoclonal antibody about 60 kDa, targeting to GATA6 (3H3). It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80702
-
HK1; Hexokinase-1; Brain form hexokinase; Hexokinase type I; HK I
|
WB
|
Human, Mouse, Rat |
Hexokinase I Antibody (YA739) is a non-conjugated and Mouse origined monoclonal antibody about 102 kDa, targeting to Hexokinase I (6B8). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80721
-
IL-18; IL18; IGIF; IL-1g; IL1F4; interleukin-18
|
WB, IHC-P
|
Human |
IL-18 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 22 kDa, targeting to IL-18. It can be used for WB,IHC-P assays with tag free, in the background of Human.
|
- HY-P80765
-
NFKB3; RELA; TF65; Transcription factor p65; p65; NFkB
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse |
NF-KB p65 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 60 kDa, targeting to NF-KB p65. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse.
|
- HY-P80779
-
AR-JP; LPRS2; PARK2; parkin; parkin 2; PDJ; PRKN; PRKN2
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
Parkin Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 52 kDa, targeting to Parkin. It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80797
-
CDC2; CDC28A; P34CDC2
|
WB, IP
|
Human, Hamster |
Phospho-CDK1/2/3 (Thr14) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 34 kDa, targeting to Phospho-CDK1/2/3 (Thr14). It can be used for WB,IP assays with tag free, in the background of Human, Hamster.
|
- HY-P80806
-
CCNB1; CCNB; G2/mitotic-specific cyclin-B1
|
WB, IP
|
Human |
Phospho-Cyclin B1 (Ser126) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 48 kDa, targeting to Phospho-Cyclin B1 (Ser126). It can be used for WB,IP assays with tag free, in the background of Human.
|
- HY-P80807
-
CCNE1; CCNE; G1/S-specific cyclin-E1
|
WB
|
Human |
Phospho-Cyclin E1 (Thr395) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 47 kDa, targeting to Phospho-Cyclin E1 (Thr395). It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80814
-
MAPK1/MAPK3
|
WB
|
Human, Mouse, Rat |
Phospho-ERK1/2 (Thr202/Tyr204)/(Thr185/Tyr187) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 44,42 kDa, targeting to Phospho-ERK1/2 (Thr202/Tyr204)/(Thr185/Tyr187). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80869
-
nPKC eta; PKC h; PKC L; PKCh; PKCL; Prkch; PRKCL; Protein kinase C eta
|
WB, IP
|
Human, Mouse, Rat |
PKC eta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 78 kDa, targeting to PKC eta. It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80930
-
GC; Vitamin D-binding protein; DBP; VDB; Gc-globulin; Group-specific component
|
WB, ICC/IF
|
Human, Mouse, Rat |
Vitamin D Binding Protein Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 53 kDa, targeting to Vitamin D Binding Protein. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80976
-
Brd4; CAP; HUNK1; MCAP; Bromodomain containing 4; chromosome associated protein
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
BRD4 Antibody is an antibody about 152 kDa, targeting to BRD4.
|
- HY-P80978
-
PAX6; AN2; Paired box protein Pax-6; Aniridia type II protein; Oculorhombin
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
PAX6 Antibody is an antibody targeting to PAX6.
|
- HY-P81065
-
ATG1; ATG1A; hATG1; ULK1; UNC51
|
WB
|
Human, Mouse |
Phospho-ULK1 (Ser556) Antibody is an unconjugated, approximately 113 kDa (Calculated)/130 kDa (Observed), rabbit-derived, anti-ULK1 (Ser556) monoclonal antibody. Phospho-ULK1 (Ser556) Antibody can be used for: WB expriments in human, mouse background without labeling.
|
- HY-P81091
-
Beta-casein; CASB; CASB_SHEEP; Casein beta; CSN 2; Csn2.
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human, Cow, Sheep, Goat, |
Beta casein Antibody is an unconjugated, approximately 23 kDa, rabbit-derived, anti-Beta casein polyclonal antibody. Beta casein Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, cow, sheep, goat, background without labeling.
|
- HY-P81155
-
OCLN_HUMAN; Occludin; Ocl; BLCPMG; PPP1R115; PTORCH1; Tight junction protein occludin
|
WB; ELISA; Flow-Cyt
|
Human(predicted: Mouse, Rat, Dog, Pig, Cow, Horse, Guinea Pig) |
OCLN Antibody is an unconjugated, approximately 57 kDa, rabbit-derived, anti-OCLN polyclonal antibody. OCLN Antibody can be used for: WB, ELISA, Flow-Cyt expriments in human, and predicted: mouse, rat, dog, pig, cow, horse, guinea pig background without labeling.
|
- HY-P81308
-
BAF155; CRACC1; Rsc8; SMARCC1; SRG3; SWI3
|
WB
|
Human |
- HY-P81308A
-
BAF155; CRACC1; Rsc8; SMARCC1; SRG3; SWI3
|
WB, ICC/IF, IP, FC
|
Human, Rat |
- HY-P81325
-
MECT1; TORC1; WAMTP1; FLJ14027; KIAA0616; CRTC1
|
WB, ICC/IF, IP, FC
|
Human |
- HY-P81328
-
HSPC321; SWAP-70; FLJ39540; KIAA0640
|
WB, IP
|
Human, Mouse, Rat, Monkey |
- HY-P81351
-
15-PGDH; Hpgd; PGDH; PGDH1; PHOAR1; SDR36C1
|
IHC-P
|
Human |
- HY-P81371
-
SPI1; Transcription factor PU.1; 31 kDa-transforming protein
|
IHC-P
|
Human |
- HY-P81389
-
ANXA10; ANX14; Annexin A10; Annexin-10; Annexin-14
|
IHC-P
|
Human |
- HY-P81392
-
MCM3; HCC5; P1-MCM3; P1.h; RLFB
|
IHC-P
|
Human |
- HY-P81400
-
Aquaporin 3; AQP-3; Aquaglyceroporin-3; AQP3
|
IHC-P
|
Human |
- HY-P81409
-
DNA-binding protein SATB1 (Special AT-rich sequence-binding protein 1)
|
IHC-P
|
Human |
- HY-P81417
-
Acrogranin; CLN11; GEP; GP88; Granulins; GRN; PCDGF; PEPI; PGRN; Proepithelin; Progranulin
|
IHC-P
|
Human |
- HY-P81425
-
S100A8; CAGA; CFAG; MRP8; P8
|
IHC-P
|
Human |
- HY-P81456
-
CCND3 ; G1/S-specific cyclin-D3
|
IHC-P
|
Human |
- HY-P81467
-
ICOS; AILIM; CD278; Inducible T-cell costimulator; Activation-inducible lymphocyte immunomediatory molecule
|
IHC-P
|
Human |
- HY-P81499
-
ISL1; Insulin gene enhancer protein ISL-1; Islet-1
|
IHC-P
|
Human |
- HY-P81530
-
AYTL2; lpcat; AGPAT9; PFAAP3; AGPAT10; LPCAT-1; lysoPAFAT
|
IHC-P
|
Human |
- HY-P81532
-
Edr; HB-1; Mar2; MEF3L; Mart2; RGAG3
|
IHC-P
|
Human |
- HY-P81542
-
ASGP, Mucin-4 alpha chain, ASGP-1, Testis mucin, Pancreatic adenocarcinoma mucin
|
IHC-P
|
Human |
- HY-P81546
-
DRY6, CD196, CKRL3, CMKBR6, GPR29, STRL22
|
WB, IHC-P
|
Human |
- HY-P81589
-
Ubiquitin carboxyl terminal hydrolase 22; Usp22; USP3L
|
WB, ICC/IF, IP, FC
|
Human |
- HY-P81627
-
CNR1; CNR; Cannabinoid receptor 1; CB-R; CB1; CANN6
|
WB, IHC-P, IHC-F, IF, ELISA
|
Human, Rat |
- HY-P81646
-
BKSR1; dKsr; EK31; KSR; KSR1; RSU2; SR31
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse |
- HY-P81709
-
IL2; Interleukin-2; IL-2; T-cell growth factor; TCGF; Aldesleukin
|
FC, ELISA
|
Human |
- HY-P81726
-
NCR3; CD337; NKp30; 1C7; LY117; MALS
|
FC, ELISA
|
Human |
- HY-P81802
-
PCK2; PEPCK2; Phosphoenolpyruvate carboxykinase [GTP]; mitochondrial; PEPCK-M; Phosphoenolpyruvate carboxylase
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P81808
-
PDE1B1; PDES1B; HEL-S-79p
|
WB
|
Human, Mouse, Rat |
- HY-P81816
-
Calmitin; Calmitine; Calsequestrin; Calsequestrin-1; CASQ; Casq1; PDIB1
|
WB, IHC-P, FC
|
Human, Mouse, Rat |
- HY-P81823
-
GATA4; Transcription factor GATA-4; GATA-binding factor 4
|
WB, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P81855
-
TNF alpha-induced protein 8; NDED; SCC-S2
|
WB, IP
|
Human |
- HY-P81860
-
AD3LP; AD5; E5-1; STM-2
|
WB, IP
|
Human, Mouse, Rat |
- HY-P81863
-
Gamma2; hWRS; IFI53; IFP53; TrpRS; WARS; WRS
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P81865
-
ANP32B; PAL31; PHAPI2; PHAPI2a; Ssp29
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Rat |
- HY-P81913
-
ADAR; Adar1; AGS6; DRADA; Dsh; Dsrad; IFI4; P136
|
WB, IHC-P, ICC/IF, FC
|
Human |
- HY-P81915
-
Alpha RLC; ITGA4L; ITGA9; RLC
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P81916
-
Cps1; CPSase 1; CPSase I; CPSASE1; MS738
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P81919
-
DBK; PKN; PAK1; PRK1; PAK-1; PRKCL1; PKN-ALPHA
|
WB
|
Rat |
- HY-P81957
-
Cadherin family member 3; Desmocollin-4; HT-CP
|
WB, ICC/IF
|
Human |
- HY-P81970
-
GSD7; PFK1; PFKA; PFKX; PFK-1; Phosphohexokinase
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P81981
-
PRKACG; cAMP-dependent protein kinase catalytic subunit gamma; PKA C-gamma
|
WB, IP
|
Human, Mouse, Rat |
- HY-P81987
-
AGS1; AGS5; CRV; DNase III; DRN3; HERNS; TREX1
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
- HY-P82000
-
ARF GAP GIT1; CAT 1; CaT1; GIT1
|
WB, FC
|
Human, Mouse, Rat |
- HY-P82015
-
Mud1; snRNP A; SNRPA; U1-A; U1A
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82029
-
DNA mismatch repair protein Msh2; MutS protein homolog 2
|
WB
|
Human, Rat |
- HY-P82063
-
TRAD; R51H3; BROVCA4; RAD51L3
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82070
-
CRADD; MGC9163; RAIDD; Death adaptor molecule RAIDD; Death domain containing protein CRADD
|
WB, IP
|
Human |
- HY-P82087
-
TNNI2; Troponin I; fast skeletal muscle; Troponin I; fast-twitch isoform
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82097
-
FEX; GPR49; GPR67; GRP49; LGR5; HG38; 8
|
WB, IP, FC
|
Human, Mouse, Rat |
- HY-P82144
-
AMPA4; GluA4; GluR4; GLUR4C; GLURD; Gria4
|
WB, FC
|
Human, Mouse, Rat |
- HY-P82185
-
CD349; frizzled-9; Fz-9; FZD3; FzE6
|
WB
|
Human, Mouse, Rat |
- HY-P82191
-
ASF; SF2; SFRS1; SF2p33; SRp30a
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82208
-
SDP1; WISP; SH3PX1; SH3PXD3A
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse |
- HY-P82215
-
FCAR; CD89; Immunoglobulin alpha Fc receptor; IgA Fc receptor; CD89
|
WB, IHC-P, ICC/IF, IP, FC
|
Human |
- HY-P82238
-
ACSS2; ACSA; ACAS2; AceCS; MYH7B; Acetyl CoA synthetase
|
WB
|
Human |
- HY-P82253
-
FDH; ADHX; ADH-3; FALDH; GSNOR; GSH-FDH; HEL-S-60p
|
WB, IHC-P, IP
|
Human |
- HY-P82282
-
FOSL1; FRA1; Fos-related antigen 1; FRA-1
|
WB, ICC/IF
|
Human |
- HY-P82284
-
ATP7B; PWD; WC1; WD; WND; WND/140 kDa
|
WB, ICC/IF, FC
|
Human |
- HY-P82285
-
CTBP1; CTBP; C-terminal-binding protein 1; CtBP1
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82295
-
GCK; Glucokinase; Hexokinase type IV; HK IV; Hexokinase-4; HK4; Hexokinase-D
|
WB
|
Human |
- HY-P82326
-
CD66b; CD67; CEACAM8; CGM6; NCA95
|
WB
|
Human |
- HY-P82351
-
STUB1; CHIP; HSPABP2; NY-CO-7; SDCCAG7; UBOX1
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82355
-
Exp5; Exportin 5; Ranbp21; xpo5
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82364
-
AP-2; BOFS; AP2TF; TFAP2; AP-2alpha
|
WB, IP
|
Rat |
- HY-P82444
-
CRFG; GTP binding protein 4; Gtpbp4; NGB; NOG1
|
WB, IHC-P, IP, FC
|
Human |
- HY-P82459
-
hTIM; TIM; TIM1; Timeless; timeless circadian clock 1; TIMELESS1
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
- HY-P82473
-
CD39L4; Entpd5; mNTPase; NTPDase 5; PCPH
|
WB
|
Human, Mouse, Rat |
- HY-P82526
-
Insulin receptor substrate 2; IRS 2; IRS-2
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82604
-
EGR alpha; EGRA; Egral; EGRalpha; Gdnfif; KLF10; mGIF; TIEG; TIEG1
|
WB
|
Human, Mouse, Rat |
- HY-P82612
-
CEBP; CPE-BP1; CPEB1; h CEBP; hCPEB 1
|
WB, IP
|
Human |
- HY-P82635
-
LL37; CAP18; CRAMP; HSD26; CAP-18; FALL39; FALL-39
|
WB, IHC-P, IP
|
Human |
- HY-P82661
-
VWF; von Willebrand factor; von Willebrand antigen II; F8VWF
|
WB, IHC-P
|
Rat |
- HY-P82692
-
END1; hVPS11; PEP5; PP3476; RNF108; vps11
|
WB, IHC-P, FC
|
Human, Mouse |
- HY-P82696
-
CXXC 3; Mbd1; MECP1 COMPLEX; PCM1; RFT
|
WB, IHC-P, ICC/IF, IP
|
Human |
- HY-P82697
-
DER12; ei-type; HNP36; Nucleoside transporter; SLC29A2
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82736
-
ERK 3; JTK5; JTK5A; Ryk; RYK1; Vik
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P82793
-
Lipid droplet associated protein; PERI; Perilipin-1; PerilipinA; LIN1
|
WB, ICC/IF
|
Human, Mouse |
- HY-P82825
-
CTCF; Transcriptional repressor CTCF; 11-zinc finger protein; CCCTC-binding factor; CTCFL paralog
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82882
-
VEGFB; VRF; Vascular endothelial growth factor B; VEGF-B; VEGF-related factor; VRF
|
WB
|
Human, Mouse |
- HY-P82960
-
EAA4; GLR6; MRT6; GLUK6; GLUR6; GluK2
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P82973
-
FOSL2; FRA2; Fos-related antigen 2; FRA-2
|
WB, IP, FC
|
Human, Mouse, Rat |
- HY-P82980
-
ACTR2; ARP2; ARP2/3 COMPLEX
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P83000
-
eIF3b; EIF3S9; hPrt1; PRT1
|
WB, IHC-P
|
Human |
- HY-P83001
-
ALL; CML; PHL; BCR1; D22S11; D22S662
|
WB, IHC-P, IP
|
Human, Rat |
- HY-P83010
-
RPS3; OK/SW-cl.26; 40S ribosomal protein S3
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P83038
-
MDP1; PEO; PolG alpha; POLG; POLG1; POLGA; SANDO; SCAE
|
WB
|
Human, Mouse, Rat |
- HY-P83059
-
Fanconi anemia complementation group B; FA2; FAB; FACB; FAAP90; FAAP95
|
WB
|
Human, Mouse |
- HY-P83101
-
NCAN; CSPG3; NEUR; Neurocan core protein; Chondroitin sulfate proteoglycan 3
|
WB, IHC-P, IP
|
Human |
- HY-P83124
-
CAV3; M-caveolin; Caveolin 3; VIP21
|
WB, IP
|
Human, Mouse, Rat |
- HY-P83182
-
Alpha-CP1; hnRNP E1; HNRPE1; HNRPX; PCBP1
|
WB, IP
|
Human, Mouse, Rat |
- HY-P83189
-
Atp1a2; FHM2; KIAA0778; MHP2
|
WB
|
Human, Mouse, Rat |
- HY-P83204
-
GRK2; BARK1; FLJ16718; BETA-ARK1; ADRBK1
|
WB, IP
|
Human |
- HY-P83271
-
ADP ribosylation factor 6; ARF6; Small GTP binding protein
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P83289
-
CEAR; HNRPM; HTGR1; NAGR1; HNRPM4; HNRNPM4; hnRNP M
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P83298
-
DLG4; HUGL; LLGL; Lgl1; Mgl1; HUGL1; HUGL-1
|
WB, IP
|
Human |
- HY-P83320
-
IDH; IDP; IDHM; IDPM; ICD-M; D2HGA2; mNADP-IDH
|
WB
|
Human, Rat |
- HY-P83382
-
NRP; FIP2; HIP7; HYPL; ALS12; GLC1E; TFIIIA-INTP
|
WB, IHC-P
|
Human |
- HY-P83413
-
CDC45L; CDC45L2; PORC-PI-1; CDC45
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P83478
-
Glutathione peroxidase MGST3; LTC4 synthase MGST3; Microsomal GST-III
|
WB, IHC-P, IP
|
Human |
- HY-P83483
-
TGN38; TGN46; TGN48; TGN51; TGOLN2; TTGN2
|
WB, IHC-P, IP
|
Human |
- HY-P83517
-
CSC21K; TIMP 2; TIMP2
|
WB, FC
|
Human |
- HY-P83518
-
CW-1; TCTEL1; tctex-1
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P83551
-
NAE2; UBE1C; hUBA3
|
WB
|
Human, Mouse |
- HY-P83582
-
IGG4; Ig gamma 4 chain C region
|
WB, IHC-P
|
Human |
- HY-P83585
-
BAP1; DING; BAP-1; HIPI3; RING2; RING1B
|
WB, IHC-P
|
Human |
- HY-P83637
-
Elongation protein 3 homolog; elp3; hELP3; Kat9
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P80578
-
CANX; Calnexin; IP90; Major histocompatibility complex class I antigen-binding protein p88; p90
|
WB, IHC-F, IHC-P, ICC/IF, ELISA
|
Human, Mouse, Rat |
Calnexin Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 68 kDa, targeting to Calnexin. It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80589
-
Mch3; CMH-1; mCASP-7; AI314680; ICE-IAP3; caspase-7
|
WB, ICC/IF, IP
|
Mouse, Rat |
Caspase 7 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 34 kDa, targeting to Caspase 7. It can be used for WB,ICC/IF,IP assays with tag free, in the background of Mouse, Rat.
|
- HY-P80594
-
Prominin-1; Antigen AC133; Prominin-like protein 1; CD133.
|
WB
|
Human |
CD133 Antibody (YA809) is a non-conjugated and Mouse origined monoclonal antibody about 97 kDa, targeting to CD133 (8F2). It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80639
-
CST3; Cystatin-C; Cystatin-3; Gamma-trace; Neuroendocrine basic polypeptide; Post-gamma-globulin
|
WB, IHC-P
|
Human, Mouse, Rat |
Cystatin C Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 16 kDa, targeting to Cystatin C. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80690
-
Glutaminase kidney isoform; GLS; GLS1; KGA; K-glutaminase; GAM; GAC; Glutaminase C; L-glutamine amidohydrolase
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
Glutaminase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 73 kDa, targeting to Glutaminase. It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80701
-
HDAC6; KIAA0901; JM21; Histone deacetylase 6; HD6
|
WB
|
Human, Rat |
HDAC6 Antibody (YA740) is a non-conjugated and Mouse origined monoclonal antibody about 131 kDa, targeting to HDAC6 (3B2). It can be used for WB assays with tag free, in the background of Human, Rat.
|
- HY-P80720
-
IL1B; IL1F2; Interleukin-1 beta; IL-1 beta; Catabolin
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
IL-1 beta Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 31 kDa, targeting to IL-1 beta. It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80750
-
CSF1; Macrophage colony-stimulating factor 1; CSF-1; M-CSF; MCSF; Lanimostim
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
M-CSF Antibody is a non-conjugated and Rabbit origined monoclonal antibody, targeting to M-CSF. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human.
|
- HY-P80766
-
FCU; MWS; FCAS; Cias1; Mmig1; NLRP3; Pypaf1; AII/AVP; AGTAVPRL; Cryopyrin
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
NLRP3 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 118 kDa, targeting to NLRP3. It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Mouse, Rat.
|
- HY-P80884
-
RPA1; HSSB; MST075; REPA1; RF-A; RP-A; RPA70
|
WB, ICC/IF, IP
|
Human, Monkey, Mouse, Rat |
RPA70 Antibody (YA678) is a non-conjugated and Mouse origined monoclonal antibody about 68 kDa, targeting to RPA70 (8C3). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Monkey, Mouse, Rat.
|
- HY-P80924
-
TSG101; Tumor susceptibility gene 101 protein; ESCRT-I complex subunit TSG101
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
TSG101 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 44 kDa, targeting to TSG101. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80940
-
ERIS; MITA; MPYS; SAVI; NET23; STING; hMITA; hSTING; STING-beta; Transmembrane Protein 173
|
WB
|
Human, Mouse |
STING Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 42 kDa, targeting to STING. It can be used for WB assays with N-6*His-tag, in the background of Human, Mouse.
|
- HY-P81053
-
Microtubule associated protein 2; MAP2A; MAP2B; MAP2C
|
WB, IF-Cell, IHC-P
|
Human, Mouse, Rat |
MAP2 Antibody is an unconjugated, approximately 60 kDa, rabbit-derived, anti-MAP2 polyclonal antibody. MAP2 Antibody can be used for: WB, IF-Cell, IHC-P expriments in human, mouse, rat background without labeling.
|
- HY-P81116
-
IRS1_HUMAN; Insulin receptor substrate 1; IRS-1; IRS 1
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human, Mouse, Rat, Pig(predicted: Chicken) |
IRS1 Antibody is an unconjugated, approximately 137 kDa, rabbit-derived, anti-IRS1 polyclonal antibody. IRS1 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, pig, and predicted: chicken background without labeling.
|
- HY-P81258
-
ACTA1; ACTA; Actin; alpha skeletal muscle; Alpha-actin-1
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P81258A
-
ACTA1; ACTA; Actin; alpha skeletal muscle; Alpha-actin-1
|
IHC-P
|
Human |
- HY-P81318
-
MRXJ; SMCX; MRXSJ; XE169; MRXSCJ; JARID1C; DXS1272E
|
WB, ICC/IF
|
Human |
- HY-P81347
-
CD28; T-cell-specific surface glycoprotein CD28; TP44; CD28
|
IHC-P
|
Human |
- HY-P81391
-
GDA; KIAA1258; Guanine deaminase; Guanase; Guanine aminase; Guanine aminohydrolase (GAH); p51-nedasin
|
IHC-P
|
Human |
- HY-P81406
-
GYPA; GPA; Glycophorin-A; MN sialoglycoprotein; PAS-2; Sialoglycoprotein alpha; CD235a
|
IHC-P
|
Human |
- HY-P81446
-
CSH2; Chorionic somatomammotropin hormone 2; Choriomammotropin; Lactogen; Placental lactogen (PL)
|
IHC-P
|
Human |
- HY-P81488
-
PP14434; CTEN; TNS4; Tensin-4; C-terminal tensin-like protein
|
IHC-P
|
Human |
- HY-P81507
-
LGR3; TSHR; Thyrotropin Receptor; Thyroid-stimulating hormone receptor (TSH-R)
|
IHC-P
|
Human |
- HY-P81539
-
Cell death protein RIP,Receptor-interacting protein 1
|
WB, IHC-F, IHC-P, FC, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P81554
-
CSF-1R, M-CSF-R, CD115, CSF1R, FMS
|
IHC-P
|
Human, Mouse |
- HY-P81586
-
ESSS; Np15; P17.3; NP17.3; CI-ESSS; LSDMCA3
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P81598
-
HLC-1; B14.5b; NADHDH2; CI-B14.5b
|
WB, IHC-P
|
Human |
- HY-P81664
-
CD70; CD27LG; TNFSF7; TNFSF7G; CD27L
|
FC, ELISA
|
Human |
- HY-P81673
-
vesicle-associated membrane protein 2 (synaptobrevin 2); SYB2; VAMP-2
|
WB, IP
|
Human, Mouse, Rat |
- HY-P81702
-
DDAH; DDAH II; DDAH2; DDAHII; Dimethylargininase 2; G6a
|
WB, IP
|
Human, Mouse, Rat |
- HY-P81705
-
nudix (nucleoside diphosphate linked moiety X)-type motif 19; RP2
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Rat |
- HY-P81723
-
DmNXF1; MEX67; Mex67p; Mvb1; NXF1; Sbr; TAP
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P81727
-
NTB-A; SLAMF6; Ly108; NK-T-B-antigen; CD352; KALI
|
FC, ELISA
|
Human |
- HY-P81787
-
Blastokinin; CC10; CC16; CCPBP; CCSP; SCGB1A; UGB; UP1; Uteroglobin
|
WB, FC
|
Human, Mouse, Rat |
- HY-P81815
-
Interferon beta; Interferon β; IFN-beta; IFN-β; IFNβ; Fibroblast interferon; IFB; IFNB
|
WB, IP
|
Human |
- HY-P81827
-
penta-EF-hand domain containing 1; ABP32; PEF1A
|
WB, IP
|
Human, Mouse, Rat |
- HY-P81889
-
C1qb; Complement component 1 q subcomponent B chain
|
WB, IHC-P, ICC/IF
|
Human |
- HY-P81934
-
COP9 signalosome subunit 8; COP9; CSN8; SGN8
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P81976
-
ATG18; ATG18A; WIPI 1; WIPI-1; WIPI49
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P81978
-
ASH2; Bre2; ASH2L1; ASH2L2
|
WB, ICC/IF, IP
|
Human, Rat |
- HY-P82001
-
AFP regulator 1; Zinc finger and homeodomain protein 2
|
WB, ICC/IF
|
Human, Rat |
- HY-P82020
-
proteasome subunit alpha 4; HC9; PSC9; HsT17706
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82035
-
Sprouty homolog 4; SPRY 4; Spry-4
|
WB, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82040
-
TSPO; BZRP; MBR; Translocator protein; Mitochondrial benzodiazepine receptor; PKBS; Peripheral-type benzodiazepine receptor; PBR
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse |
- HY-P82041
-
PP; PP1; IOPPP; HEL-S-66p; SID6-8061
|
WB, IP
|
Human, Mouse |
- HY-P82050
-
GABATHG; GABATR; GABT1; GAT1; Slc6a1
|
WB
|
Human, Mouse, Rat |
- HY-P82059
-
H12.3; HLC-7; PIG21; RACK1; Gnb2-rs1
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P82119
-
SYN1; Synapsin-1; Brain protein 4.1; Synapsin I
|
WB, IHC-P
|
Human, Rat |
- HY-P82132
-
ARHG2; ARHGEF2; GEF; GEFH1; Lbcl1; Lfc; LFP40
|
WB, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82142
-
SEC6; Sec6p; SEC6L1
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82174
-
GATOR complex protein SEH1; Nup107-160 subcomplex subunit SEH1
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82221
-
GATAD2A; Hp66alpha; P66 alpha; p66alpha
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse |
- HY-P82232
-
NTB-A; SLAMF6; Ly108; NK-T-B-antigen; CD352; KALI
|
WB, ICC/IF, IP
|
Human |
- HY-P82251
-
HCAK1; Ig kappa chain C region; IGKC; IMMUNOGLOBULIN InV; Km
|
WB, IHC-P, ICC/IF
|
Human |
- HY-P82291
-
MAOA; Amine oxidase [flavin-containing] A; Monoamine oxidase type A; MAO-A
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82309
-
Speckle-type POZ protein; HIB homolog 1; Roadkill homolog 1
|
WB
|
Human |
- HY-P82310
-
EN1; Engrailed 1; Engrailed; Hu-En-1; Mo-en.1
|
WB, IP, FC
|
Human, Mouse, Rat |
- HY-P82319
-
FA2H; FAAH; FAAH-1; Oleamide hydrolase 1; Oleamide hydrolase
|
WB, IHC-P
|
Human, Mouse |
- HY-P82358
-
Azgp1; ZA2G; ZAG; ZNGP1
|
WB, IHC-P, IP
|
Human |
- HY-P82360
-
Alpha COP; Alpha COPI; AlphaCOP; COP A; copA; HEP COP; Proxenin; Xenin
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P82367
-
FA 1; FA; FA H; FA1; FAA; FACA; FAH; Fanca; FANCH
|
WB, IP
|
Human |
- HY-P82382
-
DDB p48 subunit; Ddb2; DDBb; UV-DDB 2
|
WB, IHC-P, ICC/IF, FC
|
Human |
- HY-P82437
-
ARHQ; RASL7A; Rho related GTP binding protein RhoQ; Rhoq; TC10A
|
WB, ICC/IF
|
Human, Rat |
- HY-P82567
-
Txl; TXNL; TRP32; TXL-1; HEL-S-114
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82582
-
CAS2; CATB; GP75; OCA3; TRP1; TYRP; TYRP1; TYRRP
|
WB, IHC-P, IP
|
Human |
- HY-P82589
-
Claudin 11; CLD11_HUMAN; Cldn11; OSP; OTM
|
WB, FC
|
Human, Mouse, Rat |
- HY-P82638
-
SISd; eoCP; SCYA5; RANTES; TCP228; D17S136E; SIS-delta
|
WB, ICC/IF
|
Human |
- HY-P82643
-
IQGAP1; KIAA0051; Ras GTPase-activating-like protein IQGAP1; p195
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse |
- HY-P82650
-
CBR3; Carbonyl reductase [NADPH] 3; NADPH-dependent carbonyl reductase 3
|
WB
|
Human |
- HY-P82726
-
F3; Tissue factor; TF; Coagulation factor III; Thromboplastin; CD antigen CD142
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P82815
-
BCAR 1; CAS; CAS1; Cass1; CRKAS; p130cas
|
WB
|
Human, Mouse, Rat |
- HY-P82852
-
PAX5; Paired box protein Pax-5; B-cell-specific transcription factor; BSAP
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse |
- HY-P82876
-
IDDM5; SMT3H4; SUMO-4; dJ281H8.4
|
WB, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82885
-
DD5; EDD; EDD1; hHYD; HYD; Rat100; Ubiquitin protein ligase; UBR5
|
WB
|
Human, Mouse |
- HY-P82894
-
SLAMF1; SLAM; Signaling lymphocytic activation molecule; CDw150; IPO-3; CD150
|
WB, IP, FC
|
Human |
- HY-P82904
-
innexin; MRS1; Pannexin 1; Panx1; PX1
|
WB, IP
|
Human |
- HY-P82934
-
PRKCZ; PKC2; Protein kinase C zeta type; nPKC-zeta
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P82989
-
UBCH 10; UbcH10; Ube2c
|
WB
|
Human |
- HY-P82991
-
CD MPR; M6pr; Man6PR; MPR46; MPRD; SMPR
|
WB, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P83058
-
FKBP 38; Fkbp8; FKBPR38; hFKBP38; Rotamase; Sam11
|
WB, ICC/IF, FC
|
Human |
- HY-P83067
-
FBL7; CXXC8; FBL11; FBXL11; JHDM1A; LILINA
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P83077
-
CFL1; CFL; Cofilin-1; 18 kDa phosphoprotein; p18; Cofilin; non-muscle isoform
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
- HY-P83133
-
guanine nucleotide binding protein (G protein); alpha 13; G13
|
WB, IHC-P
|
Human |
- HY-P83137
-
ATG8; GEF2; ATG8C; GEF-2; GATE16; GATE-16
|
WB
|
Human, Rat |
- HY-P83140
-
ADLTE; ADPAEF; ADPEAF; Epitempin 1; EPITEMPIN; EPT; ETL1; LGI1
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P83159
-
hSPT5; SPT5; SPT5H; supt5h; Tat CT1
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P83184
-
CCL23; CKB8; Hmrp-2a; MIP3; MPIF1; SCYA23
|
WB, ICC/IF
|
Human |
- HY-P83221
-
MERTK; MER; Tyrosine-protein kinase Mer; Proto-oncogene c-Mer; Receptor tyrosine kinase MerTK
|
WB, IHC-P, IP
|
Human |
- HY-P83249
-
HDAC8; HDACL1; CDA07; Histone deacetylase 8; HD8
|
WB, IP
|
Human |
- HY-P83250
-
HMG 2; HMG B2; HMG-2; HMG2; HMGB2
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat, Hamster |
- HY-P83274
-
MHC; HLAC; HLC-C; D6S204; PSORS1; HLA-JY3
|
WB, IP
|
Human, Mouse |
- HY-P83352
-
NADH dehydrogenase (ubiquinone) Fe-S protein 2; 49kDa; CI-49
|
WB, IHC-P, IP
|
Human |
- HY-P83376
-
ICSBP; IRF-8; ICSBP1; IMD32A; IMD32B; H-ICSBP
|
WB, IHC-P, IP
|
Human |
- HY-P83387
-
KOR; R21; KOR-1; MSL-1; Oprk2; K-OR-1
|
WB, IP
|
Rat |
- HY-P83424
-
Charcot-Leyden crystal protein 2; CLC2; Galectin-14; Gal-14
|
WB, ICC/IF
|
Rat |
- HY-P83435
-
CASP14; Caspase-14; Caspase 14; MICE; CASP-14
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P83436
-
ATM; Serine-protein kinase ATM; Ataxia telangiectasia mutated; A-T mutated
|
WB, IHC-P, ICC/IF, IP
|
Human |
- HY-P83466
-
regulator of G protein signaling 6; GAP; S914; HA117
|
WB
|
Human |
- HY-P83480
-
HLA G antigen; MHC class I antigen G; HLA-G; HLA60; HLAG
|
WB
|
Human |
- HY-P83510
-
Endothelin B receptor; ET-B; ET-BR; Endothelin receptor non-selective type
|
WB, IP
|
Human |
- HY-P83531
-
Fgf21; FGFL; Fibroblast growth factor 21; PRO10196; UNQ3115
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P83553
-
ADFP; Adipophilin; Adipose differentiation related protein; ADRP; Perilipin-2; PLIN2
|
WB, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P83554
-
L40; CEP52; RPL40; HUBCEP52
|
WB, ICC/IF, IP
|
Human |
- HY-P83575
-
Centerin; GCET1; Seprin A9; SERPINA11; SERPINA11b; Serpina9
|
WB
|
Human, Mouse, Rat |
- HY-P80560
-
ACLY; ATP-citrate synthase; ATP-citrate; pro-S-)-lyase; ACL; Citrate cleavage enzyme
|
WB, ICC/IF, FC
|
Human, Mouse, Monkey |
ATP Citrate Lyase Antibody (YA829) is a non-conjugated and Mouse origined monoclonal antibody about 121 kDa, targeting to ATP Citrate Lyase (3D9). It can be used for WB,ICC/IF,FC assays with tag free, in the background of Human, Mouse, Monkey.
|
- HY-P80629
-
BCK; Ckb; CKBB; HEL 211; HEL S 29
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
Creatine Kinase B type Antibody (YA492) is a non-conjugated and Rabbit origined monoclonal antibody about 43 kDa, targeting to Creatine Kinase B type. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80653
-
EIF-5A; EIF5A1; eIF5AI; Eukaryotic initiation factor 5A
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
eIF5A Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 17 kDa, targeting to eIF5A. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80708
-
Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8)
|
WB, IHC-P, IP
|
Human, Mouse, Rat, Hamster |
Hsc70 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 71 kDa, targeting to Hsc70. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat, Hamster.
|
- HY-P80713
-
Hsp70; hsp68; HSP70B1; Hsp70-1; Hsp70.1
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
Hsp70 1B Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 70 kDa, targeting to Hsp70 1B. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80727
-
JAK2; Tyrosine-protein kinase JAK2; Janus kinase 2; JAK-2
|
WB
|
Human, Mouse |
JAK2 Antibody (YA330) is a non-conjugated and Rabbit origined monoclonal antibody about 131 kDa, targeting to JAK2. It can be used for WB assays with tag free, in the background of Human, Mouse.
|
- HY-P80761
-
CDH2; CDHN; NCAD; Cadherin-2; CDw325; Neural cadherin; N-cadherin; CD antigen CD325
|
WB, IP
|
Human, Mouse, Rat |
N Cadherin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 100 kDa, targeting to N Cadherin. It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80988
-
Apomucin; Gastric mucin; LeB; MUC5AC; Mucin 5AC oligomeric mucus/gel forming; TBM
|
WB, IHC-P, ICC/IF
|
Human |
Mucin 5AC Antibody is an unconjugated, approximately 220-600 kDa, rabbit-derived, anti-Mucin 5AC monoclonal antibody. Mucin 5AC Antibody can be used for: WB, IHC-P, ICC/IF expriments in human background without labeling.
|
- HY-P81104
-
Calcitonin receptor precursor; Calcr; CRT; CT R; CTR; CTR1; CALCR_MOUSE; CT-R; CALCR_HUMAN.
|
ELISA; IHC-P; IHC-F; ICC; IF
|
Rat(predicted: Mouse) |
Calcitonin receptor Antibody is an unconjugated, approximately 53 kDa, rabbit-derived, anti-Calcitonin receptor polyclonal antibody. Calcitonin receptor Antibody can be used for: ELISA, IHC-P, IHC-F, ICC, IF expriments in rat, and predicted: mouse background without labeling.
|
- HY-P81107
-
GH receptor; GHBP; GHR; Growth hormone receptor precursor; Serum binding protein; Somatotropin receptor; GHR_HUMAN.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, Mouse, Rat(predicted: Chicken, Dog, Pig, Cow, Sheep) |
Growth hormone receptor Antibody is an unconjugated, approximately 68 kDa, rabbit-derived, anti-Growth hormone receptor polyclonal antibody. Growth hormone receptor Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: chicken, dog, pig, cow, sheep background without labeling.
|
- HY-P81261
-
CTNNB1; CTNNB; OK/SW-cl.35; Catenin beta-1; Beta-catenin
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P81261A
-
CTNNB1; CTNNB; OK/SW-cl.35; Catenin beta-1; Beta-catenin
|
WB
|
Human, Mouse, Rat |
- HY-P81261B
-
CTNNB1; CTNNB; OK/SW-cl.35; Catenin beta-1; Beta-catenin
|
WB, IHC-P, IP
|
Human, Mouse, Rat, Hamster |
- HY-P81272
-
EEF2; EF2; Elongation factor 2; EF-2
|
WB, ICC/IF, ChIP
|
Human |
- HY-P81272A
-
EEF2; EF2; Elongation factor 2; EF-2
|
WB, ICC/IF
|
Human, Mouse, Monkey, Rat |
- HY-P81272B
-
EEF2; EF2; Elongation factor 2; EF-2
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P81301
-
RB1; Retinoblastoma-associated protein; p105-Rb; pRb; Rb; pp110
|
WB, IHC-P, IP
|
Human, Rat |
- HY-P81301A
-
RB1; Retinoblastoma-associated protein; p105-Rb; pRb; Rb; pp110
|
WB, IP
|
Human, Rat |
- HY-P81301B
-
RB1; Retinoblastoma-associated protein; p105-Rb; pRb; Rb; pp110
|
WB
|
Human, Hamster |
- HY-P81301C
-
RB1; Retinoblastoma-associated protein; p105-Rb; pRb; Rb; pp110
|
WB, IHC-P
|
Human, Rat |
- HY-P81301D
-
RB1; Retinoblastoma-associated protein; p105-Rb; pRb; Rb; pp110
|
WB, IHC-P
|
Human, Rat |
- HY-P81313A
-
Np95; hNP95; ICBP90; RNF106; TDRD22; hUHRF1; huNp95
|
IHC-P
|
Human |
- HY-P81375
-
aldehyde dehydrogenase 3 family; member A1; ALDH3; ALDHIII
|
IHC-P
|
Human |
- HY-P81401
-
minichromosome maintenance complex component 6; Mis5; P105MCM; MCG40308
|
IHC-P
|
Human |
- HY-P81419
-
CLDN5; AWAL; TMVCF; Claudin-5; Transmembrane protein deleted in VCFS; TMDVCF
|
IHC-P
|
Human |
- HY-P81432
-
19A; CS1; SLAMF7; SLAM family member 7
|
IHC-P
|
Human |
- HY-P81433
-
MAF; Transcription factor Maf; Proto-oncogene c-Maf; V-maf musculoaponeurotic fibrosarcoma oncogene homolog
|
IHC-P
|
Human |
- HY-P81449
-
HNRNPK; HNRPK; Heterogeneous nuclear ribonucleoprotein K; hnRNP K; Transformation up-regulated nuclear protein; TUNP
|
IHC-P
|
Human |
- HY-P81574
-
Cytokeratin-6C, KRT6C, CK-6C, CK-6E
|
WB
|
Human, Mouse, Rat |
- HY-P81630
-
CD200; MOX1; MOX2; My033; OX-2 membrane glycoprotein; CD200
|
FC, ELISA
|
Human |
- HY-P81648
-
CD37; TSPAN26; Leukocyte antigen CD37; Tetraspanin-26; Tspan-26; CD37
|
FC, ELISA
|
Human |
- HY-P81649
-
PRKCA; PKCA; PRKACA; Protein kinase C alpha type; PKC-A; PKC-alpha
|
WB, IHC-P
|
Human, Rat |
- HY-P81728
-
Protein lin-28 homolog A; LIN28A; CSDD1; LIN28; ZCCHC1
|
WB, IHC-P, ICC/IF, IP, FC
|
Human |
- HY-P81740
-
PVR; PVS; Poliovirus receptor; Nectin-like protein 5; NECL-5; CD155
|
FC, ELISA
|
Human |
- HY-P81796
-
ANPC; ANPRC; GUCY2B; NPR 3; NPR C; Npr3; NPRC
|
WB, FC
|
Human, Mouse, Rat |
- HY-P81800
-
RING finger protein 134; Mel18 and Bmi1-like RING finger
|
WB, ICC/IF, IP
|
Mouse, Rat |
- HY-P81812
-
CASP6; MCH2; Caspase-6; CASP-6; Apoptotic protease Mch-2
|
WB
|
Human, Rat |
- HY-P81824
-
PDPK1; PDK1; 3-phosphoinositide-dependent protein kinase 1; hPDK1
|
WB
|
Human, Mouse, Rat |
- HY-P81838
-
ABC29; Abcc1; GSX; Leukotriene C(4) transporter; LTC4 transporter; MRP1
|
WB, FC
|
Human |
- HY-P81848
-
NOV; NOVP; Plexin-A1; Plexin1; PlexinA1; PLXN1; Plxna1
|
WB, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P81868
-
Gnb2; Gnb2l1; RACK1; Transducin beta chain 2
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P81881
-
Plcb; AI132408; mKIAA0581; 3110043I21Rik
|
WB
|
Rat |
- HY-P81940
-
exo/endonuclease G; ENGL; ENGLA; ENGLB; ENGL-a; ENGL-b; ENDOGL1; ENDOGL2
|
WB
|
Human |
- HY-P81941
-
LIMK1; LIMK; LIM domain kinase 1; LIMK-1
|
WB
|
Human, Mouse |
- HY-P81949
-
Diaphorase; Dihydrolipoamide dehydrogenase; DLDD; DLDH; GCSL; LAD; lipoamide dehydrogenase; Lipoamide reductase; Lipoyl dehydrogenase; PHE3
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P81954
-
ABC38; ABCE1; HuHP68; OABP; RLI; RNASEL1; RNASELI; RNS4I
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82012
-
PRP4; RP70; HPRP4; Prp4p; HPRP4P; SNRNP60
|
WB, IP
|
Human, Mouse |
- HY-P82014
-
HPRP8; p220; PRP8; PRPC8; Prpf8; RP13; SNRNP220
|
WB, IHC-P
|
Human |
- HY-P82019
-
FGCP; FOLH 1; GCP 2; GCPII; mGCP; NAALADase I; PSM; PSMA
|
WB
|
Human |
- HY-P82143
-
Double minute 2 protein; Hdm2; Oncoprotein Mdm2
|
WB, IHC-P
|
Human, Rat |
- HY-P82152
-
YES1; YES; Tyrosine-protein kinase Yes; Proto-oncogene c-Yes; p61-Yes
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82196
-
CRMP 1; Crmp1; DPYSL1; DRP1; ULIP-3; Ulip3
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82256
-
STX1A; STX1; Syntaxin-1A; Neuron-specific antigen HPC-1
|
WB, IP, FC
|
Human, Mouse, Rat |
- HY-P82258
-
KMT3E; ZMYND1; ZNFN3A1; bA74P14.1
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P82287
-
SS3R; SS3-R; SS-3-R; SSR-28
|
WB
|
Human |
- HY-P82292
-
ALDOA; ALDA; Fructose-bisphosphate aldolase A; Lung cancer antigen NY-LU-1; Muscle-type aldolase
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82300
-
Myf5; Class C basic helix loop helix protein 2; bHLHc2
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82353
-
CGI135; FIS1; hFis1; TTC 11
|
WB, IHC-P, ICC/IF
|
Human, Cow |
- HY-P82381
-
DKCA3; Tin 2; TIN2; TINF 2; Tinf2
|
WB
|
Human, Mouse, Rat |
- HY-P82395
-
BDK; Bradykinin; HMWK; Kallidin I; Kallidin II; KNG; KNG1; WILLIAMS FACTOR
|
WB, IHC-P, IP
|
Human |
- HY-P82420
-
BRE 1B; BRE1 B; BRE1B; RBP95; Rnf40; STARING
|
WB, IHC-P, IP
|
Mouse, Rat, Human |
- HY-P82457
-
Cul2; CUL 2; CUL2; cullin 2
|
WB, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82476
-
hU2AF65; U2af2; U2AF65
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82500
-
CRGF; Cripto 1; cripto; Cripto1 growth factor; TDGF1
|
WB, ICC/IF, IP, FC
|
Human |
- HY-P82520
-
AGX; AGX1; AntigenX; SPAG2; Sperm associated antigen 2; uap1
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82532
-
GUD; AWT1; WAGR; WT33; NPHS4; WIT-2; EWS-WT1
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse |
- HY-P82556
-
NU; HC2; PROS30; psmA1; PSC2; Proteasome 20S C2
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82581
-
U1 small nuclear ribonucleoprotein C; U1 snRNP C; U1-C
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Rat |
- HY-P82622
-
Deubiquitinating enzyme 13; Isopeptidase T3; ISOT3; UBP13; USP13
|
WB, ICC/IF, IP
|
Human |
- HY-P82629
-
pdhB; DHBD; PDHE1 B; PDHE1-B; PHE1B
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82639
-
HC3; PMSA2; Proteasome component C3; PSC2; PSC3; psmA2
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82677
-
CCB peptide; CgB; Chgb; ChromograninB; SCG1; Secretogranin 1; Secretogranin B; SgI
|
WB
|
Human, Mouse, Rat |
- HY-P82683
-
AADC; Aromatic L Amino Acid Decarboxylase; DDC; DOPA decarboxylase (aromatic L-amino acid decarboxylase); DOPA decarboxylase
|
WB
|
Human, Mouse, Rat |
- HY-P82684
-
API3; ILP1; MIHA; XLP2; BIRC4; IAP-3; hIAP3; hIAP-3
|
WB
|
Human, Mouse, Rat |
- HY-P82731
-
AFCP; Capg; gCap39; HEL S 66; mbh1; MCP
|
WB
|
Human, Mouse, Rat |
- HY-P82735
-
ETR3; ETR-3; NAPOR; CELF-2; CUGBP2; BRUNOL3; CUG-BP2
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82803
-
E1BAP5; E1B-AP5; HNRPUL1
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
- HY-P82811
-
PVR; PVS; Poliovirus receptor; Nectin-like protein 5; NECL-5; CD155
|
WB, IP
|
Human |
- HY-P82838
-
CUL4B; KIAA0695; Cullin-4B; CUL-4B
|
WB, IHC-P
|
Human, Hamster, Rat |
- HY-P82883
-
Protein kinase C delta type; Tyrosine-protein kinase PRKCD; nPKC-delta
|
WB, IHC-P, IP
|
Human |
- HY-P82912
-
B61; EFL1; ECKLG; EPLG1; LERK1; LERK-1; TNFAIP4
|
WB
|
Human |
- HY-P82930
-
AKR1C1; AKR1C2
|
WB, FC
|
Human, Mouse, Rat |
- HY-P83002
-
GOLPH2; GP73; GOLM1; Golgi protein 73kD; C9orf155
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P83024
-
KAP3; KIF3AP; Kifap3; Kinesin associated protein 3; SMAP
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P83045
-
CHX 10; HOX10; MCOP2; MCOPCB3; RET1; Vsx2
|
WB, FC
|
Human, Mouse, Rat |
- HY-P83070
-
RNA-binding protein Musashi homolog 1; Musashi-1; MSI1
|
WB, IHC-P, ICC/IF, IP, FC
|
Human |
- HY-P83084
-
PMEL; ME20-M; Premelanosome protein; Silver locus protein homolog; PMEL17; SILV
|
WB, IHC-P
|
Human |
- HY-P83104
-
CSTB; CST6; STFB; Cystatin-B; CPI-B; Liver thiol proteinase inhibitor; Stefin-B
|
WB, IHC-P
|
Human, Rat |
- HY-P83110
-
ALS17; CHMP2b; DMT1; hVps2-2; VPS2B
|
WB, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P83138
-
DHRD; DRAD; FBNL; MLVT; MTLV; S1-5; FBLN3; FIBL-3; Fibulin-3
|
WB, IHC-P, IP
|
Human |
- HY-P83168
-
AMDM; ANPB; ANPRB; GCB; GUC2B; GUCY2B; Npr2; NPRB; NPRBi
|
WB
|
Human, Mouse, Rat |
- HY-P83198
-
ACTRI; Acvr1; ACVR1A; ACVRLK2; ALK2; FOP; SKR1; TSRI
|
WB, IP
|
Human, Mouse, Rat |
- HY-P83205
-
SML1; SP; Spasmolysin; TFF2; Trefoil factor 2
|
WB
|
Human |
- HY-P83216
-
AMR; 7TMR; ADMR; AM-R; G10D; L1-R; gamrh; hrhAMR
|
WB
|
Human, Mouse, Rat |
- HY-P83237
-
HSD18; MCJ; Methylation controlled J protein; DNAJC15; DNAJD1; GIG22; DJC1
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P83239
-
C3/C5 convertase; Complement factor B; PBF2; Properdin factor B
|
WB
|
Human |
- HY-P83241
-
CD1C; T-cell surface glycoprotein CD1c; CD1c
|
WB
|
Human |
- HY-P83290
-
HOMER; SYN47; Ves-1; HOMER1A; HOMER1B; HOMER1C
|
WB, IP
|
Mouse, Rat |
- HY-P83300
-
MSI2; RNA-binding protein Musashi homolog 2; Musashi-2
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P83304
-
Histone H1b; Histone H1s-4
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P83305
-
MTK1; MEKK4; MEKK 4; MAPKKK4; PRO0412
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
- HY-P83368
-
MHA; FTNS; EPSTS; BDPLT6; DFNA17; MATINS; NMMHCA; NMHC-II-A; NMMHC-IIA
|
WB, IHC-P, IP
|
Human, Rat |
- HY-P83374
-
G-protein coupled receptor 28; GPR-9-6; CDw199; CCR9
|
WB, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P83499
-
HHF7; MCT 1; MCT; Slc16a1
|
WB
|
Human |
- HY-P83519
-
Mucin-4; Ascites sialoglycoprotein; ASGP; Pancreatic adenocarcinoma mucin; Testis mucin; Tracheobronchial mucin
|
WB
|
Human |
- HY-P83559
-
C20orf7; dJ842G6.1; bA526K24.2
|
WB, IHC-P, IP
|
Human, Mouse |
- HY-P83608
-
FerH; Ferritin; Ferritin H subunit; Ferritin; mitochondrial; Fth3; FTMT; mitochondrial; Mitochondrial ferritin; MTF
|
WB
|
Human |
- HY-P82554
-
desmoglein-2; DSG2; HDGC; ARVD10; CDHF5; CMD1BB
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P80533
-
ATGL; Desnutrin; plpl; plpl2; Pnpla2; TTS 2.2; TTS2; TTS2.2; ZETA
|
WB
|
Human, Mouse, Rat |
Adipose Triglyceride Lipase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 55 kDa, targeting to Adipose Triglyceride Lipase. It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80585
-
CSNK1A1; Casein kinase I isoform alpha; CKI-alpha; CK1
|
WB, IP
|
Human, Rat |
Casein Kinase 1 alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 39 kDa, targeting to Casein Kinase 1 alpha. It can be used for WB,IP assays with tag free, in the background of Human, Rat.
|
- HY-P80599
-
Platelet endothelial cell adhesion molecule; PECAM-1; EndoCAM; GPIIA'; PECA1; CD antigen CD31
|
WB, IF-Cell, IF-Tissue, IHC-P, FC, mIHC
|
Human |
CD31 Antibody (YA806) is a non-conjugated and Mouse origined monoclonal antibody about 83 kDa, targeting to CD31 (2D3). It can be used for WB,IP assays with tag free, in the background of Human.
|
- HY-P80627
-
Collagen alpha-2(I) chain (Alpha-2 type I collagen)
|
WB, IHC-F, IHC-P, ICC/IF, ELISA
|
Human, Mouse, Rat |
Collagen I alpha 2 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 129 kDa, targeting to Collagen I alpha 2. It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80649
-
EIF1A; EIF4C; eIF-1A; eIF-4C; EIF1AP1
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
eIF1A Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 16 kDa, targeting to eIF1A. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80656
-
NOS3; Nitric oxide synthase; endothelial; Constitutive NOS; cNOS; EC-NOS; Endothelial NOS; eNOS; NOS type III; NOSIII
|
WB, IHC-F, IHC-P, ICC/IF, ELISA
|
Human, Mouse, Rat |
eNOS Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 133 kDa, targeting to eNOS. It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80839
-
NFKB3; RELA; TF65; Transcription factor p65; p65; NFkB
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
Phospho-NF-KB p65 (Ser536) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 60 kDa, targeting to Phospho-NF-KB p65 (Ser536). It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80840
-
NFKB3; RELA; TF65; Transcription factor p65; p65; NFkB
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
Phospho-NF-KB p65 (Thr254) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 60 kDa, targeting to Phospho-NF-KB p65 (Thr254). It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80880
-
RAF1; RAF; RAF proto-oncogene serine/threonine-protein kinase; Proto-oncogene c-RAF; cRaf; Raf-1
|
WB, ICC/IF
|
Human, Mouse, Rat |
Raf1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 73 kDa, targeting to Raf1. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80881
-
RHOA; ARH12; ARHA; RHO12; Transforming protein RhoA; Rho cDNA clone 12; h12
|
ICC/IF, WB, IHC-F, IHC-P, ELISA
|
Human, Mouse, Rat |
RhoA Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 22 kDa, targeting to RhoA. It can be used for ICC/IF,WB,IHC-F,IHC-P,ELISA assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80885
-
RPS6; OK/SW-cl.2; 40S ribosomal protein S6; Phosphoprotein NP33
|
WB, ICC/IF, IP
|
Human, Mouse, Rat, Monkey |
RPS6 Antibody (YA677) is a non-conjugated and Mouse origined monoclonal antibody about 29 kDa, targeting to RPS6 (7B10). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat, Monkey.
|
- HY-P80909
-
MAPT; MAPTL; MTBT1; TAU; Microtubule-associated protein tau; Neurofibrillary tangle protein; Paired helical filament-tau; PHF-tau
|
WB
|
Human, Mouse, Rat |
Tau Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 79 kDa, targeting to Tau. It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80918
-
TLR4; Toll-like receptor 4; hToll; CD antigen CD284
|
WB, FC
|
Human |
Toll-Like Receptor 4 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 96 kDa, targeting to Toll-Like Receptor 4. It can be used for WB,FC assays with tag free, in the background of Human.
|
- HY-P80935
-
CCBR1; Cysteine/glutamate transporter; SLC7A11; solute carrier family 7; xCT
|
WB, IP
|
Human, Mouse |
xCT Antibody (YA006) is a non-conjugated and Rabbit origined monoclonal antibody about 55 kDa, targeting to xCT. It can be used for WB,IP assays with tag free, in the background of Human, Mouse.
|
- HY-P80944
-
S100 calcium binding protein A11; MLN70; S100C; HEL-S-43
|
WB, IHC-P
|
Human, Mouse, Rat |
S100A11 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 12 kDa, targeting to Protein S100-A11 (S100A11). It can be used for WB,IHC-P assays in the background of Human, Mouse, Rat.
|
- HY-P81109
-
LDLR_HUMAN; Low-density lipoprotein receptor; LDL receptor; FH; FHC; FHCL1; LDLCQ2; low density lipoprotein receptor
|
WB; ELISA; Flow-Cyt; ICC
|
Human, Mouse(predicted: Rat, Dog, Pig, Cow, Horse, Rabbit, Guinea Pig) |
LDLR Antibody is an unconjugated, approximately 92 kDa, rabbit-derived, anti-LDLR polyclonal antibody. LDLR Antibody can be used for: WB, ELISA, Flow-Cyt, ICC expriments in human, mouse, and predicted: rat, dog, pig, cow, horse, rabbit, guinea pig background without labeling.
|
- HY-P81159
-
L glycoprotein; L-HBsAg; LHB; Large S protein; Large surface protein; Major surface antigen; S; HBSAG_HBVC5.
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human(predicted: Bee) |
HBsAg Antibody is an unconjugated, approximately 44 kDa, goat-derived, anti-HBsAg polyclonal antibody. HBsAg Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, and predicted: Bee background without labeling.
|
- HY-P81219
-
Myeloperoxidase; MPO; 89 kDa myeloperoxidase; 84 kDa yeloperoxidase; Myeloperoxidase heavy chain; EC 1.11.1.7; PERM_HUMAN.
|
ELISA; IHC-P; IHC-F; ICC; IF
|
Human, Mouse(predicted: Rat, Dog, Horse, Rabbit, Guinea Pig) |
MPO Antibody is an unconjugated, approximately 84 kDa, rabbit-derived, anti-MPO polyclonal antibody. MPO Antibody can be used for: ELISA, IHC-P, IHC-F, ICC, IF expriments in human, mouse, and predicted: rat, dog, horse, rabbit, guinea pig background without labeling.
|
- HY-P81257
-
ALDH2; ALDM; Aldehyde dehydrogenase; mitochondrial; ALDH class 2; ALDH-E2; ALDHI
|
WB
|
Human, Mouse, Rat, Monkey, Hamster |
- HY-P81257A
-
ALDH2; ALDM; Aldehyde dehydrogenase; mitochondrial; ALDH class 2; ALDH-E2; ALDHI
|
WB, IHC-P, IP
|
Human, Mouse |
- HY-P81298
-
PRKCA; PKCA; PRKACA; Protein kinase C alpha type; PKC-A; PKC-alpha
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P81298A
-
PRKCA; PKCA; PRKACA; Protein kinase C alpha type; PKC-A; PKC-alpha
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P81321
-
ECTO; PTC7; RFG7; TF1G; TIF1G; TIFGAMMA; TIF1GAMMA
|
WB
|
Human |
- HY-P81333
-
P38; GADS; GRID; GRPL; GrbX; Mona; GRB2L; GRBLG; Grf40; GRAP-2
|
WB
|
Human |
- HY-P81363
-
ABHD5; Abhydrolase domain containing 5; CDS; CGI58; IECN2; NCIE2
|
IHC-P
|
Human |
- HY-P81428
-
HBA1; HBA2; Hemoglobin subunit alpha; Alpha-globin; Hemoglobin alpha chain; Hemopressin
|
IHC-P
|
Human |
- HY-P81431
-
BAF180; hPB1; PB1; Pbrm1; polybromo 1; Polybromo-1D
|
IHC-P
|
Human |
- HY-P81462
-
Protein NNX3; RMP; URI; NNX3; C19orf2; PPP1R19
|
IHC-P
|
Human |
- HY-P81486
-
DPEP1; MDP; RDP; Dipeptidase 1; Dehydropeptidase-I; Microsomal dipeptidase; Renal dipeptidase
|
IHC-P
|
Human |
- HY-P81502
-
CAS2; CATB; GP75; OCA3; TRP1; TYRP; TYRP1; TYRRP; DHICA oxidase
|
IHC-P
|
Human |
- HY-P81517
-
CD205; CLEC13B; DEC-205; gp200-MR6; Ly-75; LY75
|
IHC-P
|
Human |
- HY-P81619
-
BTLA; B- and T-lymphocyte attenuator; B- and T-lymphocyte-associated protein; CD antigen CD272
|
FC, ELISA
|
Human |
- HY-P81669
-
NgBR; MRD55; CDG1AA; C6orf68; TANGO14; MGC:7199
|
WB
|
Human, Mouse, Rat |
- HY-P81674
-
CLEC12A; MICL; CLL-1; CLL1; DCAL2; DCAL-2; CD371
|
FC, ELISA
|
Human |
- HY-P81697
-
FAP; Seprase; 170 kDa melanoma membrane-bound gelatinase; Fibroblast activation protein alpha; Integral membrane serine protease
|
FC, ELISA
|
Human |
- HY-P81725
-
CDH13; CDHH; H-cadherin; Heart cadherin; P105; T cad; T Cadherin; Truncated cadherin
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P81781
-
NMP 22; NUMA; NUMA1; SP H antigen
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P81791
-
PAR6; PAR6C; TAX40; PAR-6A; TIP-40; PAR6alpha
|
WB, IP
|
Human, Mouse, Rat |
- HY-P81888
-
ATP synthase lipid-binding protein; ATP synthase membrane subunit c locus 1
|
WB, ICC/IF
|
Human |
- HY-P81903
-
serine threonine kinase 3/4; KRS1; MST2/KRS2; MST1; YSK3; TIIAC
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P81952
-
UP3a; UPIII; UPIIIA; UPK3; UPK3A; Uroplakin3A; UroplakinIII
|
IHC-P, FC
|
Human |
- HY-P81985
-
PRKD2; PKD2; HSPC187; Serine/threonine-protein kinase D2; nPKC-D2
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse |
- HY-P82023
-
S8; p45; SUG1; SUG-1; TBP10; TRIP1; p45/SUG
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82066
-
DFFRX; FAF; Fafl; Fam; hFAM; MRX99; Usp9x; X chromosome; X-linked
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82082
-
CALM; CALM1; CALM2; CALM3; CAM; CAM1; CAM2; CAM3; CAMB; CAMC
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82106
-
DKK3; REIC; Dickkopf-related protein 3; Dickkopf-3; Dkk-3; hDkk-3
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82114
-
ACTDP; ADF; corn1; Destrin; DSN; Dstn; HEL32; Sid 23; sid23p
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82177
-
CD100; COLL4; SEMAJ; coll-4; C9orf164; M-sema-G
|
WB, ICC/IF
|
Human |
- HY-P82193
-
COE1; EBF; Ebf1; O/E 1; OE1; OLF1
|
WB
|
Human, Mouse |
- HY-P82200
-
Galectin-7; Gal-7; HKL-14; PI7; LGALS7; PIG1
|
WB, IHC-P, ICC/IF, IP
|
Human |
- HY-P82206
-
MAP3K7IP1; TAB1; TAK1 binding protein 1
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82225
-
EHD1; H PAST; hPAST1; PAST; PAST homolog 1; PAST1; Tilin
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82230
-
Axonin1; AXT; Cntn2; Contactin2; TAG 1; TAG564; TAX1
|
WB, ICC/IF, FC
|
Human, Mouse |
- HY-P82245
-
DCTN5; Dynactin 4; Dynactin 5 (p25)
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82289
-
aldehyde dehydrogenase 7 family member A1; EPD; PDE; ATQ1
|
WB, ICC/IF, IP
|
Human, Mouse |
- HY-P82339
-
Adenosinetriphosphatase; ATP1B; ATP1B1; Atpb 1; ATPBS
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P82354
-
Cyclophilin40; CyclophilinD; CYP40; CYPD; PPIase; PPIase D; Ppid; Rotamase; Rotamase D
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82356
-
Capsulin; Epicardin; POD 1; POD1; TCF-21; tcf21
|
WB, IP, FC
|
Human |
- HY-P82419
-
AP-A; Aminopeptidase A; APA; bp1; CD249; EAP; Enpep; Gp160; Ly51
|
WB, IHC-P
|
Human |
- HY-P82460
-
ATP synthase lipid-binding protein; ATP synthase membrane subunit c locus 1
|
WB, IHC-P, IP
|
Human, Rat |
- HY-P82477
-
Axil; Axin like protein; Axin2; Axis inhibition protein 2; Conductin
|
WB
|
Human, Mouse, Rat |
- HY-P82479
-
baz1b; hWALP2; WALP2; WBRS9; WBSC10; WBSCR10; WBSCR9; WSTF
|
WB, FC
|
Human, Mouse, Rat |
- HY-P82494
-
GIMPc; golim4; GOLPH 4; GPP130; P 138; P138
|
WB, IHC-P
|
Human |
- HY-P82496
-
MPL; TPOR; Thrombopoietin receptor; TPO-R; Myeloproliferative leukemia protein; Proto-oncogene c-Mpl; CD110
|
WB
|
Human, Mouse, Rat |
- HY-P82624
-
bHLHa1; NDR2; NDRF; neuroD related factor; NeuroD2; neurogenic differentiation 2
|
WB
|
Human, Mouse, Rat |
- HY-P82716
-
PROC; Vitamin K-dependent protein C; Anticoagulant protein C; Autoprothrombin IIA; Blood coagulation factor XIV
|
WB
|
Human |
- HY-P82748
-
Leptin receptor; LEP-R; HuB219 OB receptor; OB-R; CD295; LEPR; DB; OBR
|
WB
|
Human, Mouse, Rat |
- HY-P82751
-
beta Granin; Chromogranin A; ChrA; SP-I; Vasostatin I; Vasostatin-2; Vasostatin II; Pancreastatin; CHGA
|
WB
|
Rat |
- HY-P82756
-
FBI1; LRF; Pokemon; TIP21; ZBTB7; ZBTB7A; ZNF857A
|
WB, IHC-P, ICC/IF, IP
|
Human |
- HY-P82767
-
RVP1; HRVP1; C7orf1; CPE-R2; CPETR2
|
WB, ICC/IF, IP
|
Human |
- HY-P82777
-
ATN; CMM8; LB24 AB; SHEP3; SK29 AB; Tumor rejection antigen AB; TYR
|
WB, IHC-P, ICC/IF
|
Human |
- HY-P82800
-
Binding peptide; Haptoglobin alpha chain; Haptoglobin beta chain; HP2ALPHA2; HPA1S; Zonulin
|
WB
|
Human, Mouse, Rat |
- HY-P82830
-
NCF1; NCF1A; NOXO2; SH3PXD1A; p47phox
|
WB, IP
|
Human |
- HY-P82908
-
Chromokinesin; KIF4; KIF4 G1; KIF4A; KIF4G1
|
WB, FC
|
Human, Mouse |
- HY-P82935
-
DGCR8; DGCRK6; Gy1; C22orf12; D16Wis2; pasha
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82937
-
MMP11; STMY3; Stromelysin-3; SL-3; ST3; Matrix metalloproteinase-11; MMP-11
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82961
-
DKK1; Dickkopf-related protein 1; Dickkopf-1; Dkk-1; hDkk-1; SK
|
WB, IHC-P, ICC/IF, FC
|
Human, Rat |
- HY-P82981
-
BHLH B6; BHLHB 6; bHLHb6; bHLHe21; Olig1; Oligo1
|
WB, FC
|
Human, Mouse, Rat |
- HY-P82985
-
DIP; MIZ; MIZ1; SIZ2; ARIP3; PIASX; ZMIZ4; PIASX-BETA; PIASX-ALPHA
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P83006
-
A3a; DAG; AGRNR; 156DAG; MDDGA9; MDDGC7; MDDGC9; LGMDR16
|
WB
|
Human |
- HY-P83035
-
INHBA; Inhibin beta A chain; Activin beta-A chain; Erythroid differentiation protein; EDF
|
WB
|
Human, Mouse, Rat |
- HY-P83099
-
FNTB; Protein farnesyltransferase subunit beta; FTase-beta; CAAX farnesyltransferase subunit beta; Ras proteins prenyltransferase subunit beta
|
WB, IP
|
Human |
- HY-P83176
-
TACC3; ERIC1; Transforming acidic coiled-coil-containing protein 3; ERIC-1
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P83212
-
RDC1; CXCR7; RDC-1; CMKOR1; CXC-R7; CXCR-7; GPR159
|
WB
|
Human, Mouse, Rat |
- HY-P83232
-
GLUR3; GPRC1C; GRM3; MGlu3; mGluR3
|
WB
|
Human, Mouse, Rat |
- HY-P83285
-
HNC; CLG1; MMP-8; PMNL-CL; COLLAGENASE I; NEUTROPHIL; matrix metalloproteinase 8
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P83288
-
GCN2-like protein; GCN2; KIAA1338; EIF2AK4
|
WB
|
Human |
- HY-P83346
-
JAG1; JAGL1; Protein jagged-1; Jagged1; hJ1; CD339
|
WB, IHC-P
|
Human |
- HY-P83447
-
C11orf43; IGF 2; IGF II; IGF2; INSIGF; Somatomedin A
|
WB, ICC/IF
|
Human |
- HY-P83450
-
GRM1; GPRC1A; MGLUR1; Metabotropic glutamate receptor 1; mGluR1
|
WB
|
Human, Mouse, Rat |
- HY-P83457
-
SLC9A3R1; EBP50; NPHLOP2; NHERF; NHERF-1; NHERF1
|
WB, IHC-P
|
Human, Rat |
- HY-P83459
-
AQP4; Aquaporin-4; AQP-4; Mercurial-insensitive water channel; MIWC; WCH4
|
IHC-P
|
Human, Rat |
- HY-P83486
-
HMP; P87; P89; PIG4; Mic60; PIG52; MINOS2; P87/89
|
WB
|
Human |
- HY-P83509
-
MT-CO2; COX2; CO2; Cytochrome c oxidase II; MTCO2; COII; COXII
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P83557
-
My013; C6orf66; HRPAP20; HSPC125; bA22L21.1
|
WB, ICC/IF, IP
|
Human |
- HY-P83558
-
E2-F1; L-UBC; UBCH7; UbcM4
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P83563
-
E4; UFD2; HDNB1; UBOX3; UFD2A
|
WB, ICC/IF
|
Human, Rat |
- HY-P83568
-
alternate SOS1; GF1; GGF1; GINGF; gingival fibromatosis; HGF; NS4; Sos1
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P83588
-
PAK4; PAK5; PAK6
|
WB
|
Human, Mouse, Rat |
- HY-P83593
-
Protein 61K; hPrp31; U4/U6 snRNP 61 kDa protein
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P83605
-
C17; RCP; RCP9; RPC9; POLR3I; POLR3J; CGRPRCP; CGRP-RCP
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P80479
-
STAT5A; STAT5; Signal transducer and activator of transcription 5A
|
WB, IHC-P, IF-Cell
|
Human, Rat, Mouse |
Phospho-Stat5 (Tyr694) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 91 kDa, targeting to Phospho-Stat5(Y694). It can be used for WB,IHC-P assays with tag free, in the background of Human.
|
- HY-P80573
-
BRCA1; RNF53; Breast cancer type 1 susceptibility protein; RING finger protein 53
|
WB, IHC-F, IHC-P, ICC/IF, ELISA
|
Human, Rat |
BRCA1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 208 kDa, targeting to BRCA1. It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Rat.
|
- HY-P80681
-
FYN; Tyrosine-protein kinase Fyn; Proto-oncogene Syn; Proto-oncogene c-Fyn; Src-like kinase; SLK; p59-Fyn
|
WB
|
Human, Mouse, Rat |
FYN Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 61 kDa, targeting to FYN. It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80738
-
LDHA; LDH-M; LDH1; PIG19; GSD11; TRG5; Proliferation inducing gene 19
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Rat |
Lactate Dehydrogenase A Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 37 kDa, targeting to Lactate Dehydrogenase A. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Rat.
|
- HY-P80753
-
MLH1; COCA2; DNA mismatch repair protein Mlh1; MutL protein homolog 1
|
WB, ICC/IF
|
Human, Monkey |
MLH1 Antibody (YA703) is a non-conjugated and Mouse origined monoclonal antibody about 85 kDa, targeting to MLH1 (4C1). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Monkey.
|
- HY-P80775
-
EP300; P300; Histone acetyltransferase p300; p300 HAT; E1A-associated protein p300
|
ICC/IF, WB, IHC-F, IHC-P, ELISA
|
Human, Mouse, Rat |
p300 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 264 kDa, targeting to p300. It can be used for ICC/IF,WB,IHC-F,IHC-P,ELISA assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80829
-
JAK2; Tyrosine-protein kinase JAK2; Janus kinase 2; JAK-2
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
Phospho-JAK2 (Tyr1007/1008) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 131 kDa, targeting to Phospho-JAK2 (Tyr1007/1008). It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80864
-
YAP1; YAP65; Yorkie homolog; 65 kDa Yes-associated protein; YAP65
|
WB, IHC-P
|
Human, Mouse, Rat |
Phospho-YAP1 (Ser127) Antibody (YA136) is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to Phospho-YAP1 (Ser127). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80902
-
STAT3; APRF; Signal transducer and activator of transcription 3; Acute-phase response factor
|
WB, IHC-P
|
Human, Rat, Mouse |
STAT3 Antibody (YA666) is a non-conjugated and Mouse origined monoclonal antibody about 88 kDa, targeting to STAT3 (6H10). It can be used for WB,IHC-P assays with tag free, in the background of Human, Rat, Mouse.
|
- HY-P80980
-
DNA topoisomerase II; DNA topoisomerase II-alpha; TOP2; TP2A; alpha isozyme, Topoisomerase II alpha
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
TOP2A Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 174 kDa, targeting to TOP2A. It can be used for WB, IHC-P, IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P81120
-
ESTM 46; FLJ 21841; FLJ21841; Intermediate filament protein; Nbla00170; Nes; NEST_RAT; Nestin.
|
ELISA; IHC-P; IHC-F; Flow-Cyt; ICC; IF
|
Human, Mouse, Rat, |
Nestin Antibody is an unconjugated, approximately 209 kDa, rabbit-derived, anti-Nestin polyclonal antibody. Nestin Antibody can be used for: ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, rat, background without labeling.
|
- HY-P81125
-
SP7_HUMAN; Transcription factor Sp7; OSX; Zinc finger protein osterix; Sp7 transcription factor; Osterix
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human, Mouse(predicted: Rat, Dog, Pig, Cow, Horse, Rabbit) |
SP7/Osterix Antibody is an unconjugated, approximately 45 kDa, rabbit-derived, anti-SP7/Osterix polyclonal antibody. SP7/Osterix Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, and predicted: rat, dog, pig, cow, horse, rabbit background without labeling.
|
- HY-P81145
-
OXYR_HUMAN; Oxytocin receptor; OXTR; OTR1; OT-R; OTR; OT R; OTR 1; OXT R
|
WB; ELISA; IHC-P
|
Human, Mouse, Rat(predicted: Dog, Pig, Cow, Horse) |
Oxytocin R Antibody is an unconjugated, approximately 43 kDa, rabbit-derived, anti-Oxytocin R polyclonal antibody. Oxytocin R Antibody can be used for: WB, ELISA, IHC-P expriments in human, mouse, rat, and predicted: dog, pig, cow, horse background without labeling.
|
- HY-P81269
-
DBC1; DBC-1; NET35; p30DBC; p30 DBC; KIAA1967
|
WB, ICC/IF, IP
|
Human, Mouse, Rat, Monkey |
- HY-P81269A
-
DBC1; DBC-1; NET35; p30DBC; p30 DBC; KIAA1967
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P81277
-
GSTP1; FAEES3; GST3; Glutathione S-transferase P; GST class-pi; GSTP1-1
|
WB, IHC-F, IHC-P, ICC/IF, FC
|
Human |
- HY-P81277A
-
GSTP1; FAEES3; GST3; Glutathione S-transferase P; GST class-pi; GSTP1-1
|
IHC-P
|
Human |
- HY-P81314
-
XRCC1; DNA repair protein XRCC1; X-ray repair cross-complementing protein 1
|
WB
|
Human |
- HY-P81314A
-
XRCC1; DNA repair protein XRCC1; X-ray repair cross-complementing protein 1
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P81369
-
CT10,MAGE-C2 antigen,MAGE-E1 antigen,MAGEC2,HCA587, MAGEE1
|
IHC-P
|
Human |
- HY-P81397
-
ERF1; TFAP2G; hAP-2g; AP2-GAMMA
|
IHC-P
|
Human |
- HY-P81405
-
SAGE; SAGE1; Sarcoma antigen 1; Cancer/testis antigen 14 (CT14)
|
IHC-P
|
Human |
- HY-P81420
-
B47; Epidermal growth factor receptor GRB 7; GRB7 adapter protein; GRB7
|
IHC-P
|
Human |
- HY-P81447
-
natural cytotoxicity triggering receptor 1; LY94; CD335; NKP46; NK-p46
|
IHC-P
|
Human |
- HY-P81492
-
Tenascin X; TNXB; XB; TNX; XBS; HXBL; TENX; TN-X; TNXB1; TNXB2; Tenascin-X
|
IHC-P
|
Human |
- HY-P81583
-
C3BR,Complement receptor type 1,C3b/C4b receptor,CD35
|
IHC-P
|
Human |
- HY-P81591
-
KIAA1515; Ubiquitin carboxyl terminal hydrolase 28; Ubiquitin thioesterase 28; UBP28
|
WB, ICC/IF, FC
|
Human |
- HY-P81604
-
Activated factor Xa heavy chain; Coagulation factor X; F10; factor Xa; FXA; Prothrombinase; Stuart factor
|
WB, IHC-P
|
Human |
- HY-P81609
-
B7-H6; NCR3LG1; B7 Homolog 6
|
FC, ELISA
|
Human |
- HY-P81621
-
BTN3A1; BTF5; CD277; BTN3.1; BT3.1
|
FC, ELISA
|
Human |
- HY-P81680
-
NEFL; NF68; NFL; Neurofilament light polypeptide; NF-L; 68 kDa neurofilament protein; Neurofilament triplet L protein
|
FC, ELISA
|
Human |
- HY-P81710
-
CDCA1; CT106; hNuf2; hNuf2R; hsNuf2; NUF2; NUF2R
|
WB
|
Human |
- HY-P81716
-
LAG3; FDC; Lymphocyte activation gene 3 protein; LAG-3; Protein FDC; CD223
|
FC, ELISA
|
Human |
- HY-P81764
-
GPRC1E; GRM5; Metabotropic glutamate receptor 5 precursor; MGLUR5; MGR5
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P81768
-
STAT5A; STAT5; Signal transducer and activator of transcription 5A
|
WB, IHC-P
|
Human, Mouse |
- HY-P81780
-
SGK1; SGK; Serine/threonine-protein kinase Sgk1; Serum/glucocorticoid-regulated kinase 1
|
WB, IHC-P, IP, FC
|
Human, Mouse, Rat |
- HY-P81790
-
CDHP; CDHE; HJMD; PCAD; CDHN; P-cadherin; E-cadherin; N-cadherin; Cadherin-1; Cadherin-2; Cadherin-3
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat, Hamster |
- HY-P81801
-
HB58; Hbeta58; hVPS26; PEP8A; VPS 26; VPS26A
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P81809
-
XPO1; CRM1; Exportin-1; Exp1; Chromosome region maintenance 1 protein homolog
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P81843
-
FGFR4; JTK2; TKF; Fibroblast growth factor receptor 4; FGFR-4; CD334
|
WB
|
Human, Mouse, Rat |
- HY-P81864
-
LTrpC6; MGC2849; Transient receptor potential p8; Trp p8; Trpm8; TRPP8
|
WB, ICC/IF
|
Human, Mouse |
- HY-P81880
-
importin 9; Imp9; Ran-binding protein 9; RanBP9
|
WB, ICC/IF, IP
|
Human |
- HY-P81911
-
NPC1 LIKE 1; NPC1L1
|
WB
|
Human |
- HY-P81912
-
hFL(2)D; WT1-associated protein; Wilms tumor 1-associating protein; Pre-mRNA-splicing regulator WTAP
|
WB, IHC-P, IP
|
Human |
- HY-P81920
-
DFNA11; DFNB2; Myo7a; MYU7A; NSRD2; Ush1b
|
WB, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P81939
-
RPB5; XAP4; RPABC1; hRPB25; hsRPB5
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P81950
-
MBD3; Methyl-CpG-binding domain protein 3; Methyl-CpG-binding protein MBD3
|
WB, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P81962
-
Pancreas-specific transcription factor 1a; bHLH transcription factor p48; PTF1-p48
|
WB, IP
|
Human, Rat |
- HY-P81972
-
EIG 1; Eig1; MM1; PFD5; PFDN5; Prefoldin 5
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P81997
-
D(3) dopamine receptor; Dopamine D3 receptor; DRD3; ETM1; FET1
|
WB
|
Human, Mouse, Rat |
- HY-P82026
-
E2F6; Transcription factor E2F6; E2F-6
|
WB, ICC/IF, FC
|
Human |
- HY-P82048
-
ERp28; ERP29_HUMAN; ERp31; HEL S 107; PDI-DB; PDIA9
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82054
-
PARK7; Protein DJ-1; Oncogene DJ1; Parkinson disease protein 7
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82091
-
CYP1B1; Cytochrome P450 1B1; CYPIB1
|
WB, IHC-P, FC
|
Human, Mouse, Rat |
- HY-P82099
-
cadherin 4; type 1; R-cadherin (retinal); CAD4; RCAD; R-CAD
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82109
-
p16 Arc; ARPC5; ARC16; Arp2/3 protein complex subunit p16
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P82120
-
petC; PGR1; RIP1; RIS1; RISP; UQCR5; UQCRFS1
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82122
-
Interleukin 1 receptor associated kinase 2; IRAK 2; Irak2
|
WB, IP, FC
|
Human |
- HY-P82133
-
AD3LP; AD5; E5-1; STM-2
|
WB
|
Human, Mouse, Rat |
- HY-P82148
-
APOL1; APOL; Apolipoprotein L1; Apolipoprotein L; Apo-L; ApoL; Apolipoprotein L-I; ApoL-I
|
WB, ICC/IF, IP, FC
|
Human |
- HY-P82149
-
S100 alpha9; Calgranulin-B; Leukocyte L1 complex heavy chain
|
WB, IHC-F, IHC-P, ICC/IF
|
Mouse |
- HY-P82249
-
ACTRI; Acvr1; ACVR1A; ACVRLK2; ALK2; FOP; SKR1; TSRI
|
WB, IP
|
Human, Mouse |
- HY-P82297
-
APC inhibitor; APOH; Apolipoprotein H; B2G1; B2GP1; B2GPI; BG
|
WB, ICC/IF, IP
|
Human, Rat |
- HY-P82312
-
Catenin alpha-1; Alpha E-catenin; Cadherin-associated protein; Renal carcinoma antigen NY-REN-13
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82335
-
Hop; P60; STI1; STI1L; STIP1; Stress induced phosphoprotein 1
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P82345
-
NL2; ARP4; FIAF; HARP; PGAR; HFARP; TGQTL; UNQ171; pp1158
|
WB
|
Human |
- HY-P82347
-
GOK; TAM; TAM1; IMD10; STRMK; D11S4896E
|
WB
|
Human, Mouse, Rat |
- HY-P82350
-
GSTO1 1; Gsto1; GSTTLp28; GSTX; Gtsttl; p28; SPG-R
|
WB, IHC-P, ICC/IF
|
Human, Rat |
- HY-P82352
-
Angiotensinogen; Serpin A8; AGT; SERPINA8; Des-Asp[1]-angiotensin II; Serine (or cysteine) proteinase inhibitor
|
WB, IHC-P, IP
|
Mouse |
- HY-P82370
-
PSMD4; AF; AF-1; ASF; MCB1; Rpn10; S5A; pUB-R5
|
WB, IP, FC
|
Human, Mouse, Rat |
- HY-P82415
-
DIAPH1; DFNA1; DIA1; DIAP1; DIAPH1; DRF1; hDIA1; LFHL1
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82440
-
p24; p25; p25alpha; TPPP; TPPP/p25; TPPP1; Tubulin polymerization promoting protein
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82450
-
EC 2.7.1.21; KITH; TK-1; TK1; Thymidine kinase 1; cytosolic
|
WB, IP
|
Human |
- HY-P82453
-
4T2HC; CD98; CD98HC; MDU1; NACAE; Slc3a2
|
WB, IHC-P, IP
|
Human |
- HY-P82463
-
P39; VATX; VMA6; ATP6D; ATP6DV; VPATPD
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82471
-
SAA4; CSAA; Serum amyloid A-4 protein; Constitutively expressed serum amyloid A protein; C-SAA
|
WB, IHC-P, ICC/IF, FC
|
Human |
- HY-P82498
-
ELMO1; KIAA0281; Engulfment and cell motility protein 1; Protein ced-12 homolog
|
WB, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82579
-
Histone lysine demethylase PHF8; MRXSSD; PHD finger protein 8; PHF8; ZNF422
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82593
-
DD3; DDX; HA1753; HAKRB; HAKRe; HSD17B5; KIAA0119; hluPGFS
|
WB, ICC/IF, IP, FC
|
Human |
- HY-P82596
-
AHC; AHX; DSS; GTD; HHG; AHCH; DAX1; DAX-1; NROB1; SRXY2
|
WB, IHC-P, ICC/IF, FC
|
Human |
- HY-P82666
-
CPRLP; HPRL; hPRL receptor; Lactogen receptor; MFAB; OPR; Pr-1; Pr-3; PRLR; Prolactin receptor a
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82685
-
C1orf136; DISC1; KIAA0457; RP4-730B13.1; SCZD9
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82699
-
Bravo; hBravo; Neuronal cell adhesion molecule; Ng CAM related; NgCAM related cell adhesion molecule; Nr CAM; Nrcam
|
WB, IP
|
Human |
- HY-P82708
-
Zinc finger protein 160; Zinc finger protein HZF5; Zinc finger protein Kr18
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82718
-
IRF7; Interferon regulatory factor 7; IRF-7; IRF7A; IRF-7H
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Rat |
- HY-P82730
-
PIAS1; PIAS2; PIAS3; Protein inhibitor of activated STAT protein 1
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82771
-
YVS; BTOP; SAC3; ALS11; CMT4J; KIAA0274; dJ249I4.1
|
WB, IP
|
Human |
- HY-P82772
-
CLIC4; Chloride intracellular channel protein 4; Intracellular chloride ion channel protein p64H1
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82774
-
Endoplasmin; GRP-94; gp96 homolog; HSP90B1; GRP 94; TRA1
|
WB, IHC-P, ICC/IF
|
Human, Mouse |
- HY-P82782
-
Atoh4; bHLHa8; Math4A; MGC; NEUROG2; Neurogenin2; NGN2
|
WB
|
Human, Mouse, Rat |
- HY-P82805
-
COX5B; Cytochrome c oxidase subunit 5B; mitochondrial; Cytochrome c oxidase polypeptide Vb
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82806
-
SMC protein 3; Bamacan; SMC3; BAM; BMH; CSPG6; SMC3L1
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82813
-
Alpha amylase; AMY1; AMY1C; AMY2; AMY2B; AMY3; HXA
|
WB
|
Human |
- HY-P82835
-
APOM; G3A; NG20; HSPC336; Apolipoprotein M; Apo-M; ApoM; Protein G3a
|
WB, IHC-P, FC
|
Human |
- HY-P82847
-
Apo AIV; APOA 4; ApoA IV; APOA4; Apolipoprotein A IV; Apolipoprotein A4
|
WB, IP
|
Human |
- HY-P82853
-
DGU; HIGM4; HIGM5; Uracil-DNA glycosylase; UNG1; UNG2; UDG; UNG15
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82857
-
PPIF; CYP3; Peptidyl-prolyl cis-trans isomerase F; mitochondrial; PPIase F; Cyclophilin F; Rotamase F
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P82886
-
PRKCG; PKCG; Protein kinase C gamma type; PKC-gamma
|
WB, IHC-P
|
Human, Mouse |
- HY-P82910
-
doublecortin-like kinase 1; CL1; DCLK; CLICK1; DCDC3A; DCAMKL1
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82927
-
FGF15; FGF19; Fibroblast growth factor 15; Fibroblast growth factor 19
|
WB
|
Human |
- HY-P82948
-
AK3; AK 4; AK3L1; AK3L2
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P82953
-
CPHD3; LHX3; Lim3; M2 LHX3; mLim-3; mLIM3; P LIM
|
WB, IP, FC
|
Human, Mouse, Rat |
- HY-P82964
-
Myosin regulatory light chain 2; ventricular/cardiac muscle isoform; MLC-2; MLC-2v
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P82979
-
LC8; PIN; DLC1; DLC8; LC8a; DNCL1; hdlc1; DNCLC1
|
WB, IHC-P, IP
|
Human, Mouse |
- HY-P82983
-
E2F4; Transcription factor E2F4; E2F-4
|
WB
|
Human |
- HY-P83042
-
ECM1; Extracellular matrix protein 1; Secretory component p85
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P83066
-
UCH-L3; Ubiquitin thiolesterase L3; Ubiquitin carboxyl-terminal hydrolase isozyme L3; UCHL3
|
WB
|
Human, Mouse, Rat |
- HY-P83071
-
GLB1; ELNR1; Beta-galactosidase; Acid beta-galactosidase; Lactase; Elastin receptor 1
|
WB, FC
|
Human, Mouse, Rat |
- HY-P83230
-
PH4; PH-4; PHD4; EGLN4; HIDEA; HIFPH4; P4H-TM
|
WB, IHC-P, IP
|
Human |
- HY-P83234
-
DNM3; Dyn3; DynaIII; dynamin 2; Dynamin; Dynamin3; T dynamin
|
WB
|
Human, Mouse |
- HY-P83259
-
K12; Keratin 12; KRT12; type I cytoskeletal 12
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P83272
-
Homeobox protein Hox-B9; Hox-2E; Hox-2.5; HOXB9; HOX2E
|
WB, ICC/IF, IP
|
Human |
- HY-P83283
-
NBLST2; NBPhox; PHOX 2B; PHOX2B; PMX 2B; PMX2B
|
WB, IHC-P, ICC/IF
|
Human, Mouse |
- HY-P83293
-
LIG1; DNA ligase 1; DNA ligase I; Polydeoxyribonucleotide synthase [ATP] 1
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Rat |
- HY-P83294
-
L1ORF1p; L1RE1; LRE1
|
WB, IP
|
Human |
- HY-P83359
-
My049; ITPase; NTPase; C20orf37; dJ794I6.3; HLC14-06-P
|
WB, IHC-P
|
Human |
- HY-P83444
-
PTB; PTB2; PTB3; PTB4; pPTB; HNRPI; PTB-1; PTB-T; HNRNPI; HNRNP-I
|
WB, IHC-P
|
Human, Mouse, Hamster |
- HY-P83487
-
JMH; CD108; SEMAL; CDw108; SEMAK1; H-Sema-L; H-SEMA-K1
|
WB, IHC-P, IP
|
Human |
- HY-P83542
-
SEDL; SEDT; MIP2A; TRS20; ZNF547L; hYP38334; TRAPPC2P1
|
WB
|
Human |
- HY-P83581
-
35DAG; CMD1L; DAGD; Delta-sarcoglycan; LGMD2F; SG delta; SGCD; SGCDP
|
WB, IHC-P, IP
|
Human |
- HY-P83606
-
CD66c; CEACAM6; CEAL; NCA; Non specific cross reacting antigen; Normal cross reacting antigen
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P80570
-
TUBB3; TUBB4; Tubulin beta-3 chain; Tubulin beta-4 chain; Tubulin beta-III
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
beta III Tubulin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 50 kDa, targeting to beta III Tubulin. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80577
-
AHUS5; ARMD9; ASP; Complement C3; Complement factor 3; CPAMD1; HEL S 62p
|
WB, IHC-P
|
Human |
C3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 187 kDa, targeting to C3. It can be used for WB,IHC-P assays with tag free, in the background of Human.
|
- HY-P80580
-
CaM K1; CaM KI; CaMK 1; CAMK I; CaMK1 alpha; CAMK1 PEN; CaMKI alpha
|
WB
|
Mouse, Rat |
CaMK1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 41 kDa, targeting to CaMK1. It can be used for WB assays with tag free, in the background of Mouse, Rat.
|
- HY-P80630
-
Adapter molecule crk; avian sarcoma virus CT10 (v-crk) oncogene homolog; CRK; CRKII; Proto-oncogene c-Crk
|
WB
|
Human |
CRK Antibody (YA790) is a non-conjugated and Mouse origined monoclonal antibody about 34 kDa, targeting to CRK (3H7). It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80633
-
CCND1; BCL1; D11S287E; PRAD1; U21B31; Cyclin D1
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
Cyclin D1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 34 kDa, targeting to Cyclin D1. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80665
-
Emr1; Ly71; Gpf480; TM7LN3; DD7A5-7; EGF-TM7
|
IHC-P, ICC/IF, FC
|
Mouse |
F4/80 Antibody is a non-conjugated and Rat origined monoclonal antibody, targeting to F4/80. It can be used for IHC-P,ICC/IF,FC assays with tag free, in the background of Mouse.
|
- HY-P80733
-
Fgf7; Fibroblast growth factor 7; HBGF7; Heparin binding growth factor 7; Keratinocyte growth factor
|
WB
|
Human, Mouse, Rat |
KGF Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 23 kDa, targeting to KGF. It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80751
-
HR2; mKIAA4032; D3Ertd265e; 2310002F04Rik; 6330416C07Rik
|
WB, IP
|
Mouse, Rat, Hamster |
Mitofusin 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 84 kDa, targeting to Mitofusin 1. It can be used for WB,IP assays with tag free, in the background of Mouse, Rat, Hamster.
|
- HY-P80755
-
Macrophage metalloelastase; MME; 3.4.24.65; Macrophage elastase; ME; hME; Matrix metalloproteinase-12; MMP-12; MMP12; HME
|
WB, IP
|
Human, Rat, Hamster |
MMP12 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to MMP12. It can be used for WB,IP assays with tag free, in the background of Human, Rat, Hamster.
|
- HY-P80819
-
Serine/threonine-protein kinase GSK3A; Serine/threonine-protein kinase GSK3B
|
WB, IP
|
Mouse, Rat |
Phospho-GSK3 (Tyr216/Tyr279) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 51 kDa, targeting to Phospho-GSK3 (Tyr216/Tyr279). It can be used for WB,IP assays with tag free, in the background of Mouse, Rat.
|
- HY-P80857
-
STAT3; APRF; Signal transducer and activator of transcription 3; Acute-phase response factor
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
Phospho-STAT3 (Tyr705) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 88 kDa, targeting to Phospho-STAT3 (Tyr705). It can be used for WB,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P81054
-
Dxd, OQM5SD32BQ, UNII-OQM5SD32BQ, Exatecan derivative, Exatecan derivative for ADC
|
ELISA
|
Species independent |
DXd Antibody (YA897) is an unconjugated, mouse-derived, anti-DXd (YA897) monoclonal antibody. DXd Antibody (YA897) can be used for: ELISA expriments in species-independent background without labeling.
|
- HY-P81076
-
L glycoprotein; L-HBsAg; LHB; Large S protein; Large surface protein; Major surface antigen; S; HBSAG_HBVC5.
|
ELISA;
|
Human, Rat, |
HBsAg Antibody (YA913) is an unconjugated, approximately 44 kDa, mouse-derived, anti-HBsAg (YA913) monoclonal antibody. HBsAg Antibody (YA913) can be used for: ELISA, expriments in human, rat, background without labeling.
|
- HY-P81136
-
Aquaporin 5; AQP5; AQP 5; AQP-5; AQP5_HUMAN; Aquaporin-5.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, Mouse, Rat(predicted: Dog, Pig, Cow, Horse, Sheep) |
Aquaporin 5 Antibody is an unconjugated, approximately 29 kDa, rabbit-derived, anti-Aquaporin 5 polyclonal antibody. Aquaporin 5 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: dog, pig, cow, horse, sheep background without labeling.
|
- HY-P81263
-
CAMK4; CAMK; CAMK-GR; CAMKIV; Calcium/calmodulin-dependent protein kinase type IV; CaMK IV; CaM kinase-GR
|
WB
|
Human |
- HY-P81263A
-
CAMK4; CAMK; CAMK-GR; CAMKIV; Calcium/calmodulin-dependent protein kinase type IV; CaMK IV; CaM kinase-GR
|
WB, IHC-P, ICC/IF, IP, FC
|
Human |
- HY-P81346
-
LOG15; LOG15; Polyunsaturated fatty acid lipoxygenase ALOX15; Polyunsaturated fatty acid lipoxygenase ALOX15
|
IHC-P
|
Human |
- HY-P81374
-
DNA helicase V; FBP; FUBP; Fubp1; Fubp4; FUSE-binding protein 1; HDH V
|
IHC-P
|
Human |
- HY-P81458
-
PTK6; BRK; Protein-tyrosine kinase 6; Breast tumor kinase; Tyrosine-protein kinase BRK
|
IHC-P
|
Human |
- HY-P81460
-
AHC; Nuclear receptor DAX-1; HHG; AHCH; DAX1; DAX-1; NROB1
|
IHC-P
|
Human |
- HY-P81495
-
TP73; P73; Tumor protein p73; p53-like transcription factor; p53-related protein
|
IHC-P
|
Human |
- HY-P81513
-
CD163b; CD163L1; CD164L1; M160; Scart1
|
IHC-P
|
Human |
- HY-P81535
-
Fasciclin-I like; OSF2; Periostin; Periostin osteoblast specific factor; PN; POSTN; RP11 412K4.1
|
IHC-P
|
Human |
- HY-P81682
-
ERGIC5; F5F8D; FMFD1; Gp58; Lman1; MCFD1; MR60
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P81686
-
CSF3R; GCSFR; Granulocyte colony-stimulating factor receptor; G-CSF receptor; G-CSF-R; CD114
|
FC, ELISA
|
Human |
- HY-P81714
-
APO A2; Apo AII; APOA 2; ApoA II; APOA2; APOAII; Apolipoprotein A II
|
WB, ICC/IF, FC
|
Human, Rat |
- HY-P81795
-
CD220; HHF5; human insulin receptor; Insr; Insulin receptor subunit beta; IR 1; IR
|
WB, ICC/IF
|
Human, Rat |
- HY-P81797
-
SAMHD1; AGS5; CHBL2; DCIP; HDDC1; MOP-5; MOP5; SBBI88; Mg11
|
WB, IHC-P, ICC/IF, FC
|
Human |
- HY-P81834
-
E3 ubiquitin-protein ligase RNF115; Rabring 7; Zinc finger protein 364
|
WB
|
Human, Rat |
- HY-P81835
-
SDHB; SDH; SDH1; Succinate dehydrogenase [ubiquinone] iron-sulfur subunit; mitochondrial; Iron-sulfur subunit of complex II; Ip
|
WB, IHC-P, IP, FC
|
Human, Mouse, Rat |
- HY-P81946
-
P2ry6; P2Y6; P2Y6 receptor; PP2891
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P81964
-
Cadherin 17; Cdh17; HPT 1; LI-cadherin; Liver Cadherin; liver inTine cadherin
|
WB, IHC-P, IP
|
Human |
- HY-P81977
-
PSEN1; AD3; PS1; PSNL1; Presenilin-1; PS-1; Protein S182
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P81990
-
bHLHe74; mNRC 1; NCoA 1; RIP160; SRC 1
|
WB, IHC-P, IP
|
Human |
- HY-P82004
-
proteasome subunit alpha 6; IOTA; p27K; PROS27
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P82024
-
betaR; CXC11; CXCL11; H174; I TAC; IP9; ITAC; SCYB11; SCYB9B
|
WB, ICC/IF
|
Human |
- HY-P82036
-
HsPUM; PUM L1; Pum1; PUMH 1; PUMH; PUMH1; Pumilio1; PUML1
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse |
- HY-P82045
-
LIG1; DNA ligase 1; DNA ligase I; Polydeoxyribonucleotide synthase [ATP] 1
|
WB, IHC-P, ICC/IF
|
Human, Rat |
- HY-P82073
-
CRLR activity-modifying protein 1; Calcitonin-receptor-like receptor activity-modifying protein 1
|
WB
|
Human, Mouse, Rat |
- HY-P82129
-
HNRNPC; HNRPC; Heterogeneous nuclear ribonucleoproteins C1/C2; hnRNP C1/C2
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82182
-
septin 7; CDC3; CDC10; SEPT7; SEPT7A; NBLA02942
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P82183
-
C53; IC53; LZAP; HSF-27; MST016; PP1553; OK/SW-cl.114
|
WB, IHC-P, IP
|
Human, Mouse |
- HY-P82197
-
CP64; L plastin; LC64P; LCP1; LPL; Lplastin; Plastin 2; PLS2
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82216
-
NFL; NF-L; NF68; CMT1F; CMT2E; CMTDIG; PPP1R110
|
WB, IHC-P, IP
|
Mouse |
- HY-P82231
-
COL11A1; COLL6; Collagen alpha-1(XI) chain
|
WB
|
Human |
- HY-P82272
-
MLLT10; AF10; Protein AF-10; ALL1-fused gene from chromosome 10 protein
|
WB, IHC-P
|
Human |
- HY-P82290
-
TMEFF2; HPP1; TPEF; TR-2; Tomoregulin; TENB2; Tomoregulin-2; CT120.2
|
WB, IHC-P, ICC/IF, FC
|
Human |
- HY-P82384
-
CEND1; BM88; Cell cycle exit and neuronal differentiation protein 1; BM88 antigen
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82387
-
AP17; AP17 delta; Ap2s1; CLAPS2; Sigma2 adaptin
|
WB, IP, FC
|
Human, Mouse, Rat |
- HY-P82417
-
Ah receptor; AhR; Class E basic helix-loop-helix protein 76; bHLHe76; AHR
|
WB
|
Human |
- HY-P82452
-
APT1; hAPT1; LPL1; LYPLA1; Lysophospholipase 1; LYSOPLA; LysoPLA I
|
WB, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82519
-
CSE1L; CAS; CSE1; Exp2; Importin-alpha re-exporter; Exportin-2; XPO2
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse |
- HY-P82525
-
EWSR1; EWS; RNA-binding protein EWS; EWS oncogene; Ewing sarcoma breakpoint region 1 protein
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82527
-
Rab4; RAB4A; HRES 1; RAB4; Ras related protein Rab 4A
|
WB, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82528
-
PTC6; TF1A; TIF1; RNF82; TIF1A; hTIF1; TIF1ALPHA
|
WB
|
Human |
- HY-P82535
-
HH19; MKP3; PYST1; DUSP6; DUSP6a; Dual specificity phosphatase 6
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82555
-
Cernunno; Nhej1; Non homologous end joining factor 1; Protein cernunnos; XLF; XRCC4 like factor
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82568
-
CAF; GCN5; GCN5L; GCN5L1; KAT2B; P/CAF; Pcaf
|
WB, IP, FC
|
Human, Mouse, Rat |
- HY-P82603
-
APO C1; Apo CI; APOC 1; ApoC I; APOC1; APOC1B; ApolipoproteinCI
|
WB, IHC-P, ICC/IF, IP, FC
|
Human |
- HY-P82608
-
FASPS; FASPS1; hPER 2; hPER2; KIAA0347; PER2; Period 2
|
WB, ICC/IF, FC
|
Human |
- HY-P82632
-
hP1.A; HP1A; HPS2; pNR2; pS2; TFF1
|
WB, IHC-P, ICC/IF, IP, FC
|
Human |
- HY-P82660
-
NgR; Nogo 66 receptor; Nogo receptor; Nogor; Reticulon 4 receptor; Rtn4r
|
WB, IP
|
Human, Mouse |
- HY-P82689
-
BTF2 p80; COFS2; CXPD; EM9; ERCC2; MAG; TFIIH p80; TTD; XPD; XPDC
|
WB, ICC/IF
|
Human |
- HY-P82702
-
hRPB33; hsRPB3; Polr2c; RPB3; RPB31; RPB33
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P82706
-
GPC3; OCI5; Glypican-3; GTR2-2; Intestinal protein OCI-5; MXR7
|
WB, FC
|
Human |
- HY-P82754
-
GATA3; Trans-acting T-cell-specific transcription factor GATA-3; GATA-binding factor 3
|
WB, IHC-P, ICC/IF, ChIP, FC
|
Human |
- HY-P82780
-
Cli; ApoJ; Sgp2; SP-40; Sgp-2; Sugp-2; AI893575; D14Ucla3
|
WB, IP
|
Rat |
- HY-P82789
-
Keratin; type I cytoskeletal 17; Cytokeratin-17; CK-17; Keratin-17; K17
|
WB, IHC-P, IP
|
Human |
- HY-P82879
-
CDC25C; M-phase inducer phosphatase 3; Dual specificity phosphatase Cdc25C
|
WB, IHC-P, ICC/IF, IP, FC
|
Human |
- HY-P82914
-
CHRNA5; NACHRA5; Neuronal acetylcholine receptor subunit alpha-5
|
WB, IP, FC
|
Human, Mouse, Rat |
- HY-P82915
-
DPK; JIK; hKFC-A; MAP3K18
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P82954
-
LIG4; DNA ligase 4; DNA ligase IV; Polydeoxyribonucleotide synthase [ATP] 4
|
WB
|
Human |
- HY-P82963
-
MCM4; CDC21; DNA replication licensing factor MCM4; CDC21 homolog; P1-CDC21
|
WB, IP, FC
|
Human, Mouse |
- HY-P83074
-
ARHGAP5; p190 B; p190 RhoGAP; Rho GTPase activating protein 5; RhoGAP; RhoGAP5
|
WB, IHC-P, FC
|
Human, Mouse, Rat |
- HY-P83092
-
FLI1; Friend leukemia integration 1 transcription factor; Proto-oncogene Fli-1; Transcription factor ERGB
|
WB, IHC-P
|
Human, Rat |
- HY-P83143
-
HK33; PBD12A; Peroxin 19; PEX19; PMP1; PMPI; PXF; PXMP1
|
WB, ICC/IF, IP, FC
|
Human, Rat |
- HY-P83153
-
GCLC; GLCL; GLCLC; Glutamate--cysteine ligase catalytic subunit; GCS heavy chain; Gamma-ECS; Gamma-glutamylcysteine synthetase
|
WB
|
Human, Mouse, Rat |
- HY-P83188
-
DKFZp451B1011; ILWEQ; Talin-2; talin2; TLN 2; TLN2
|
WB
|
Human, Mouse, Rat |
- HY-P83287
-
WVS; ENX1; KMT6; WVS2; ENX-1; EZH2b; KMT6A; EZH2
|
WB
|
Human |
- HY-P83292
-
TSC2; Tuberous sclerosis 2 homolog protein; Tuberous sclerosis 2 protein; Tuberin; TSC4
|
WB, IHC-P, FC
|
Human, Mouse, Rat |
- HY-P83339
-
MLRW; HLA-DRA1; MHC class II antigen DRA; HLA class II histocompatibility antigen; DR alpha chain
|
WB, IHC-P, ICC/IF, FC
|
Human |
- HY-P83429
-
HSPB6; HEL55; Hsp20; Heat-shock 20 kDa like-protein p20
|
WB, IHC-P, FC
|
Human, Mouse, Rat |
- HY-P83477
-
NCAM1; NCAM; Neural cell adhesion molecule 1; N-CAM-1; NCAM-1; CD56
|
WB, IHC-P, ICC/IF, IP, FC
|
Human |
- HY-P83514
-
PSK2; TAO1; KFC-B; MARKK; PSK-2; hKFC-B; hTAOK1; MAP3K16
|
WB, IP
|
Human, Mouse, Rat |
- HY-P83573
-
D0S117E; DBN1; Drebrin 1; Drebrin; Drebrin E2; Drebrin1; DrebrinE
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P83640
-
Efnb2; ephrin B2; EPLG5; Htk L; HTK ligand; HTK-L; HTKL; LERK5
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P83072A
-
FPPS_HUMAN; Farnesyl pyrophosphate synthase; FPP synthase; FPS; (2E,6E)-farnesyl diphosphate synthase; Dimethylallyltranstransferase; Farnesyl diphosphate synthase; Geranyltranstransferase.
|
IHC-P, IHC-F, ICC, IF, ELISA
|
Rat, Mouse (predicted: Human) |
- HY-P81219A
-
Myeloperoxidase; MPO; 89 kDa myeloperoxidase; 84 kDa yeloperoxidase; Myeloperoxidase heavy chain; EC 1.11.1.7; PERM_HUMAN.
|
WB, IHC-P, IF-Cell, IF-Tissue
|
Human, Mouse, Rat |
MPO Antibody is an unconjugated, approximately 84 kDa, mouse-derived, anti-MPO monoclonal antibody. MPO Antibody can be used for: WB, IHC-P, IF-Cell, IF-Tissue expriments in human, mouse, rat background without labeling.
|
- HY-P80534
-
AIFM1; AIF; PDCD8; Apoptosis-inducing factor 1; mitochondrial; Programmed cell death protein 8
|
WB, ICC/IF
|
Human |
AIF Antibody (YA835) is a non-conjugated and Mouse origined monoclonal antibody about 67 kDa, targeting to AIF (8H1). It can be used for WB,ICC/IF assays with tag free, in the background of Human.
|
- HY-P80716
-
ICAM1; Intercellular adhesion molecule 1; ICAM-1; Major group rhinovirus receptor; CD antigen CD54
|
WB, IHC-P, IP
|
Human |
ICAM1 Antibody (YA352) is a non-conjugated and Rabbit origined monoclonal antibody about 58 kDa, targeting to ICAM1. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human.
|
- HY-P80787
-
ACACA; ACAC; ACC1; ACCA; Acetyl-CoA carboxylase 1; ACC1; ACC-alpha
|
WB
|
Human |
Phospho-Acetyl Coenzyme A Carboxylase (Ser79) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 266 kDa, targeting to Phospho-Acetyl Coenzyme A Carboxylase (Ser79). It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80847
-
PRKAR2A; PKR2; PRKAR2; cAMP-dependent protein kinase type II-alpha regulatory subunit
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat, Pig |
Phospho-PKA RII alpha (Ser99) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 46 kDa, targeting to Phospho-PKA RII alpha (Ser99). It can be used for WB,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat, Pig.
|
- HY-P80859
-
MAPT; MAPTL; MTBT1; TAU; Microtubule-associated protein tau; Neurofibrillary tangle protein; Paired helical filament-tau; PHF-tau
|
WB, IP
|
Human |
Phospho-Tau (Ser198) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 79 kDa, targeting to Phospho-Tau (Ser198). It can be used for WB,IP assays with tag free, in the background of Human.
|
- HY-P80860
-
MAPT; MAPTL; MTBT1; TAU; Microtubule-associated protein tau; Neurofibrillary tangle protein; Paired helical filament-tau; PHF-tau
|
WB
|
Human, Rat |
Phospho-Tau (Ser404) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 79 kDa, targeting to Phospho-Tau (Ser404). It can be used for WB assays with tag free, in the background of Human, Rat.
|
- HY-P80861
-
MAPT; MAPTL; MTBT1; TAU; Microtubule-associated protein tau; Neurofibrillary tangle protein; Paired helical filament-tau; PHF-tau
|
WB, IP
|
Human |
Phospho-Tau (Thr181) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 79 kDa, targeting to Phospho-Tau (Thr181). It can be used for WB,IP assays with tag free, in the background of Human.
|
- HY-P80938
-
TP53; P53; Cellular tumor antigen p53; Antigen NY-CO-13; Phosphoprotein p53; Tumor suppressor p53
|
WB, IHC, IF, ELISA
|
Human, Mouse, Rat, Monkey |
p53 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 44 kDa, targeting to p53 tumor protein. It can be used for WB,IHC,IF, ELISA assays in the background of Human, Mouse, Rat, Monkey.
|
- HY-P80939
-
Myb-like; SWIRM and MPN domains 1; 2ADUB; 2A-DUB; RP4-592A1.1
|
WB, IHC-P
|
Human, Mouse |
MYSM1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 95 kDa, targeting to MYSM1. It can be used for WB,IHC-P assays in the background of Human, Mouse.
|
- HY-P80970
-
CREB1; Cyclic AMP-responsive element-binding protein 1; CREB-1; cAMP-responsive element-binding protein 1
|
WB, IF-Cell, IF-Tissue, IHC-P
|
Human, Mouse, Rat |
FMRP Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 71 kDa, targeting to FMRP. It can be used for WB, IF-Cell, IF-Tissue, IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P81074
-
FOXO1; FKHR; FOXO1A; Forkhead box protein O1; Forkhead box protein O1A; Forkhead in rhabdomyosarcoma
|
WB, IHC-F, IHC-P, ICC/IF, ELISA, ChIP
|
Human, Mouse, Rat, Pig |
- HY-P81271
-
CDH1; CDHE; UVO; Cadherin-1; CAM 120/80; Epithelial cadherin; E-cadherin; Uvomorulin; CD antigen CD324
|
WB, IHC-P
|
Human, Mouse |
- HY-P81345
-
FAP; Seprase; 170 kDa melanoma membrane-bound gelatinase; Fibroblast activation protein alpha; Integral membrane serine protease
|
IHC-P
|
Human |
- HY-P81355
-
PODXL; PCLP; PCLP1; Podocalyxin; GCTM-2 antigen; Gp200; Podocalyxin-like protein 1; PC; PCLP-1
|
IHC-P
|
Human |
- HY-P81438
-
Nicotinamide phosphoribosyltransferase; NAmPRTase; Nampt; Pre-B-cell colony-enhancing factor 1; Pre-B cell-enhancing factor; Visfatin
|
IHC-P
|
Human |
- HY-P81441
-
HMGA2; HMGIC; High mobility group protein HMGI-C; High mobility group AT-hook protein 2
|
IHC-P
|
Human |
- HY-P81474
-
NKX6-1; NKX6A; Homeobox protein Nkx-6.1; Homeobox protein NK-6 homolog A
|
IHC-P
|
Human |
- HY-P81476
-
Calpain4; CalpainS1; CANP; CANPS; CAPN4; CAPNS; Capns1; CDPS; CSS1
|
IHC-P
|
Human |
- HY-P81515
-
SIGLEC1; SN; Sialoadhesin; Sialic acid-binding Ig-like lectin 1 (Siglec-1); CD169
|
IHC-P
|
Human |
- HY-P81521
-
CD207; CD207 antigen; langerin; CD207 molecule; CLEC4K; Langerhans cell specific c type lectin; Langerin
|
IHC-P
|
Human |
- HY-P81533
-
CD27; CD27L receptor; LPFS2; S152; T14; TNFRSF7; TNFSF7; Tp55
|
IHC-P
|
Human |
- HY-P81594
-
EPHA2; ECK; Ephrin type-A receptor 2; Epithelial cell kinase; Tyrosine-protein kinase receptor ECK
|
FC, ELISA
|
Human |
- HY-P81596
-
MALT1; MLT; Mucosa-associated lymphoid tissue lymphoma translocation protein 1; MALT lymphoma-associated translocation; Paracaspase
|
WB, ICC/IF, FC
|
Human |
- HY-P81626
-
KASH3; NET53; Nesp3; C14orf49; C14orf139; LINC00341; NCRNA00341
|
WB
|
Human |
- HY-P81633
-
NEFH; KIAA0845; NFH; Neurofilament heavy polypeptide; NF-H; 200 kDa neurofilament protein; Neurofilament triplet H protein
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P81677
-
2F1 Ag; CLEC15A; KLRG1; MAFA 2F1; MAFA L; MAFA like; MAFAL
|
FC, ELISA
|
Human |
- HY-P81756
-
TNFRSF17; BCM; BCMA; Tumor necrosis factor receptor superfamily member 17; B-cell maturation protein; CD269
|
FC, ELISA
|
Human |
- HY-P81778
-
HIP 1; hip1; HIP1/PDGFRB fusion gene; HIPI; Huntingtin interacting protein 1
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P81792
-
KLK3; APS; Prostate-specific antigen; PSA; Gamma-seminoprotein; Seminin; Kallikrein-3; P-30 antigen; Semenogelase
|
WB, IHC-P
|
Human |
- HY-P81830
-
Pellino-related intracellular-signaling molecule; RING-type E3 ubiquitin transferase pellino homolog 1
|
WB, IP
|
Human, Rat |
- HY-P81917
-
PRKD2; PKD2; HSPC187; Serine/threonine-protein kinase D2; nPKC-D2
|
WB, IP
|
Human |
- HY-P81921
-
A esterase 1; Arylesterase 1; ESA; MVCD5; Paraoxonase 1; PON1
|
WB, IHC-P, IP
|
Human |
- HY-P81945
-
POT1; Protection of telomeres protein 1; hPot1; POT1-like telomere end-binding protein
|
WB
|
Human, Mouse, Rat |
- HY-P81953
-
Protein phosphatase 1G; PP2C-gamma; Protein phosphatase magnesium-dependent 1 gamma
|
WB
|
Human, Mouse, Rat |
- HY-P81969
-
cAMP-specific 3' ; 5' -cyclic phosphodiesterase 4D; DPDE3; PDE43; PDE4D; DPDE3
|
WB
|
Human |
- HY-P81999
-
HC3; PMSA2; Proteasome component C3; PSC2; PSC3; psmA2
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82017
-
Keratin4; Cytokeratin 4; Keratin-4; CK-4; CK4; KRT14; CYK4
|
WB, IP
|
Human, Rat |
- HY-P82033
-
Meis homeobox 2; Meis1 related gene 1; MEIS2; MGC2820; MRG1
|
WB, FC
|
Human, Mouse, Rat |
- HY-P82062
-
Glutamate decarboxylase 1; 67 kDa glutamic acid decarboxylase; GAD 67; GAD1; GAD; GAD67
|
WB, IP
|
Human |
- HY-P82116
-
HST; ST2; STD; hSTa; DHEAS; ST2A1; ST2A3; DHEA-ST
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82118
-
ARHGDIA; GDIA1; Rho GDP-dissociation inhibitor 1; Rho GDI 1; Rho-GDI alpha
|
WB
|
Human, Mouse, Rat |
- HY-P82163
-
CLA1; SRB1; CLA-1; SR-BI; CD36L1; HDLQTL6; Scavenging Receptor SR-BI
|
WB, IP
|
Human, Mouse |
- HY-P82190
-
2PP2A; IGAAD; TAF-I; I2PP2A; IPP2A2; PHAPII; TAF-IBETA
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P82233
-
BLU; HEL-S-71; Ubc13; UbCH ben; UbcH13; UBCHBEN; Ube2n
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82246
-
OATPJ; OATP-J; OATP5A1; OATPRP4; OATP-RP4; SLC21A15
|
WB, IHC-P
|
Human, Mouse |
- HY-P82371
-
IKZF3; ZNFN1A3; Zinc finger protein Aiolos; Ikaros family zinc finger protein 3
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82449
-
SMN1; SMN; SMNT; SMN2; SMNC; Survival motor neuron protein; Component of gems 1; Gemin-1
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P82451
-
IGHG2; immunoglobulin Gm2; immunoglobulin heavy constant gamma 2 (G2m marker)
|
WB, IHC-P, ICC/IF
|
Human |
- HY-P82504
-
GAA 5; GAA5; GABRA 5; Gabra5
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P82505
-
26S proteasome non-ATPase regulatory subunit 14; PAD1; POH1; Psmd14; RPN11
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82509
-
DIFF6; hNEDD5; KIAA0158; NEDD5; Pnutl3; SEPT2; septin 2
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82595
-
CAPC; hCAP C; hCAP-C; SMC 4; SMC4; SMC4L1; XCAP C homolog
|
WB, ICC/IF, FC
|
Human, Mouse |
- HY-P82597
-
Distal less homeo box 5; Dlx 5; Homeo box protein DLX 5
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82605
-
CNR1; CNR; Cannabinoid receptor 1; CB-R; CB1; CANN6
|
WB
|
Human |
- HY-P82613
-
QPC; QCR7; QP-C; UQBC; UQBP; UQPC; UQCR6; MC3DN3
|
WB, IHC-P, IP
|
Human, Rat |
- HY-P82705
-
GNRP; GRF1; CDC25; GRF55; CDC25L; H-GRF55; PP13187; ras-GRF1
|
WB
|
Rat |
- HY-P82709
-
Il1rak; IRAK; Irak1; IRAK1-S; mPLK; Pelle; Pelle homolog; Pelle-like protein kinase; Plpk
|
WB, ICC/IF, IP
|
Human |
- HY-P82783
-
IL25; IL27; SF20; IL27w; C19orf10; R33729_1; EUROIMAGE1875335
|
WB
|
Human |
- HY-P82790
-
NDUFS1; NADH-ubiquinone oxidoreductase 75 kDa subunit; mitochondrial; Complex I-75kD; CI-75kD
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82812
-
NOTCH4; INT3; Neurogenic locus notch homolog protein 4; Notch 4; hNotch4
|
WB
|
Human |
- HY-P82846
-
RAD23A; UV excision repair protein RAD23 homolog A; HR23A; hHR23A
|
WB, FC
|
Human, Mouse, Rat |
- HY-P82858
-
PAWR; PAR4; PRKC apoptosis WT1 regulator protein; Prostate apoptosis response 4 protein; Par-4
|
WB
|
Human, Mouse, Rat |
- HY-P82909
-
SFN; HME1; 14-3-3 protein sigma; Epithelial cell marker protein 1; Stratifin
|
WB, IHC-P
|
Human, Rat |
- HY-P82923
-
YWHAG; 14-3-3 protein gamma; Protein kinase C inhibitor protein 1; KCIP-1
|
WB
|
Human, Mouse, Rat |
- HY-P82959
-
DJ4; MRJ; DnaJ; HSJ2; HHDJ1; HSJ-2; MSJ-1; LGMD1D; LGMD1E
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P82974
-
TNNT2; Cardiac muscle troponin T; Troponin T; cardiac muscle; troponin T type 2 (cardiac)
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P83079
-
16G2; A2HS; AHS; Ahsg; FETUA; FETUB; FetuinA; FetuinB; Gugu; HSGA; IRL685; PRO2743
|
WB, IP
|
Human, Mouse |
- HY-P83088
-
CSNK2A1; CK2A1; Casein kinase II subunit alpha; CK II alpha
|
WB
|
Human, Mouse, Rat |
- HY-P83142
-
Enactin; Ent; Entactin 1; Entactin; NID 1; NID; Nid1; Nidogen 1; Nidogen
|
WB, IHC-P
|
Human |
- HY-P83244
-
CGS PDE; cGSPDE; PDE2A; PDE2A1; PDE2A4; phosphodiesterase 2A
|
WB
|
Human, Mouse, Rat |
- HY-P83253
-
DNA methyltransferase 1 associated protein 1; DNMAP1; DNMTAP1; EAF2; SWC4
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P83256
-
Alpha T catenin; Cadherin associated protein; Catenin alpha 3; Catna3; CTNNA3; VR22
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P83275
-
ITGA6; CD49 antigen-like family member F; VLA-6; CD49f
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P83388
-
KMLS; KRP; MLCK; MYLK; myosin light chain kinase; smooth muscle and non-muscle isozymes; myosin light polypeptide kinase; telokin
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P83415
-
CDC5; CEF1; PCDC5RP; CDC5-LIKE; dJ319D22.1; CDC5L
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P83426
-
90K; M2BP; gp90; CyCAP; BTBD17B; MAC-2-BP; TANGO10B
|
WB
|
Human |
- HY-P83452
-
FUS; FUS-CHOP; TLS; 75 kDa DNA-pairing protein; Oncogene FUS; Oncogene TLS; POMP75; Translocated in liposarcoma protein
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P83562
-
G-CSF; CSF beta; CSF3; CSF3OS; Csfg; Filgrastim; GCSA; GCSF; MGI 2; Pluripoietin
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P83604
-
APOC3; APO C3; Apo CIII; ApoC III; APOC3; ApoCIII; Apolipoprotein C III; Apolipoprotein C3
|
WB, IHC-P
|
Human |
- HY-P83628
-
CSF3R; GCSFR; Granulocyte colony-stimulating factor receptor; G-CSF receptor; G-CSF-R; CD114
|
WB, FC
|
Human |
- HY-P83629
-
DNAI1; ICS; Immotile cilia syndrome 1; ICS1; CILD1; PCD
|
WB
|
Human, Mouse, Rat |
- HY-P83632
-
L36LBP; Lactose binding lectin 4; Lectin galactoside binding soluble 4; LGALS4
|
WB, IHC-P
|
Human, Rat |
- HY-P83635
-
NRSF; RE1 silencing transcription factor; Repressor binding to the X2 box; rest; X2 box repressor; XBR
|
WB
|
Human |
- HY-P80617
-
CHEK1; CHK1; Serine/threonine-protein kinase Chk1; CHK1 checkpoint homolog; Cell cycle checkpoint kinase; Checkpoint kinase-1
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
Chk1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 54 kDa, targeting to Chk1. It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80640
-
CPT7; CYP17; P450C17; S17AH; CYP17A1
|
WB
|
Human |
Cytochrome P450 17A1 Antibody (YA786) is a non-conjugated and Mouse origined monoclonal antibody about 57 kDa, targeting to Cytochrome P450 17A1 (6E1). It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80698
-
GSK3B; Glycogen synthase kinase-3 beta; GSK-3 beta; Serine/threonine-protein kinase GSK3B
|
WB, IHC-P, FC
|
Human, Mouse, Rat |
GSK3 beta Antibody (YA744) is a non-conjugated and Mouse origined monoclonal antibody about 47 kDa, targeting to GSK3 beta. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80712
-
HSP72; HSPA1; HSP70I; HSPA1B; HSP70-1; HSP70-1A.
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
Hsp70 1A Antibody (YA727) is a non-conjugated and Mouse origined monoclonal antibody about 70 kDa, targeting to Hsp70 1A (1D9). It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80756
-
MMP9; CLG4B; Matrix metalloproteinase-9; MMP-9; 92 kDa gelatinase; 92 kDa type IV collagenase; Gelatinase B; GELB
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
MMP9 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 78 kDa, targeting to MMP9. It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80882
-
ARH12; ARH6; ARH9; ARHA; ARHA2; H12; RHO12; Transforming protein RhoA; RHOA; RHOB; RHOC
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
RhoA/B/C Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 22 kDa, targeting to RhoA/B/C. It can be used for WB,IHC-P,ICC/IF,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80914
-
TNF; TNFA; TNFSF2; Tumor necrosis factor; Cachectin; TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a
|
WB, IHC-F, IHC-P, ICC/IF, ELISA
|
Human, Mouse, Rat |
TNF alpha Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 26 kDa, targeting to TNF alpha. It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80937
-
ZAP70; SRK; Tyrosine-protein kinase ZAP-70; 70 kDa zeta-chain associated protein; Syk-related tyrosine kinase
|
WB, IP
|
Human |
ZAP70 Antibody (YA651) is a non-conjugated and Mouse origined monoclonal antibody about 70 kDa, targeting to ZAP70 (4B2). It can be used for WB,IP assays with tag free, in the background of Human.
|
- HY-P81092
-
DRD2_HUMAN; D(2) dopamine receptor; Dopamine D2 receptor; dopamine receptor D2; D2R; D2DR
|
WB; ELISA; IHC-P; IHC-F; IF
|
Rat(predicted: Human, Mouse) |
DRD2 Antibody is an unconjugated, approximately 51 kDa, rabbit-derived, anti-DRD2 polyclonal antibody. DRD2 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in rat, and predicted: human, mouse background without labeling.
|
- HY-P81093
-
Bone morphogenetic protein 2; BMP 2; BMP 2A; BMP2A; BMP-2; BMP2_HUMAN.
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human, Mouse, Rat(predicted: Chicken, Dog, Cow, Horse, Rabbit, Sheep) |
BMP2 Antibody is an unconjugated, approximately 13/44 kDa, rabbit-derived, anti-BMP2 polyclonal antibody. BMP2 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, and predicted: chicken, dog, cow, horse, rabbit, sheep background without labeling.
|
- HY-P81254
-
ACT1_DROME; Dro-actin; Actin 5C; Act5C; Fruit Fly Actin; β-actin; β actin
|
WB
|
Fruit Fly |
- HY-P81287A
-
H3K14me; H3.4; H3/g; H3FT; H3t
|
WB, ICC/IF
|
Human, Mouse |
- HY-P81304
-
ALPP; PLAP; Alkaline phosphatase; placental type; Alkaline phosphatase Regan isozyme; Placental alkaline phosphatase 1; PLAP-1
|
WB
|
Human |
- HY-P81304A
-
ALPP; PLAP; Alkaline phosphatase; placental type; Alkaline phosphatase Regan isozyme; Placental alkaline phosphatase 1; PLAP-1
|
WB
|
Human |
- HY-P81337
-
X ray repair cross complementing protein 4; DNA repair protein XRCC4; DNA double strand break repair
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P81380
-
EL2; Elliptocytosis2; erythrocyte; Erythroid alpha spectrin; HS3; SPH3; SPTA; SPTA1
|
IHC-P
|
Human |
- HY-P81390
-
NTRKR; ROR2; Tyrosine-protein kinase transmembrane receptor ROR2; Neurotrophic tyrosine kinase, receptor-related 2
|
IHC-P
|
Human |
- HY-P81457
-
SPARC; ON; SPARC; Basement-membrane protein 40; BM-40; Osteonectin; ON; Secreted protein acidic and rich in cysteine
|
IHC-P
|
Human |
- HY-P81506
-
SLC29A1; solute carrier family 29 (equilibrative nucleoside transporter); member 1; ENT1
|
IHC-P
|
Human |
- HY-P81550
-
MIG-C4, Matrigel-induced gene C4 protein, LYPD3, C4.4A
|
WB, IHC-P, ICC/IF, IP
|
Human |
- HY-P81612
-
BCSG1; Breast cancer specific gene 1 protein; Gamma synuclein; Persyn; PRSN; SNCG; SR; Synoretin; Synuclein gamma
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Rat |
- HY-P81629
-
CD126; gp80; IL-6R-1; IL-6RA; IL6Q; IL6RA; IL6RQ
|
IHC-P, IHC-F, Flow-Cyt, IF, ELISA
|
Human, Mouse, Rat |
- HY-P81657
-
DOT 1; DOT1L; KMT4; Histone methyltransferase DOT1L; H3 lysine-79 specific
|
WB, IHC-P
|
Human, Mouse |
- HY-P81691
-
CD226; DNAM1; CD226 antigen; DNAX accessory molecule 1; DNAM-1; CD antigen CD226
|
FC, ELISA
|
Human |
- HY-P81775
-
NBN; NBS; NBS1; P95; Nibrin; Cell cycle regulatory protein p95; Nijmegen breakage syndrome protein 1
|
WB, ICC/IF, IP
|
Human |
- HY-P81856
-
HEP; Heparanase; Heparanase1; Hpa 1; HPA; Hpa1 HPR1; HPSE1; HSE1
|
WB, IP
|
Human, Mouse, Rat |
- HY-P81862
-
CD265; FEO; LOH18CR1; mRANK; ODFR; OFE; OPTB7; OSTS; PDB2; RANK; TNFRSF11A; TRANCER
|
WB
|
Human |
- HY-P81871
-
PQ-rich protein; PQR protein; Proline- and histidine-rich protein; T-cell death-associated gene 51 protein
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
- HY-P81885
-
ASP4; KAP; Kdap; NAP1; NAPA; Napsa; Napsin-1; Napsin-A; Pronapsin A; SNAPA; TA01/TA02
|
WB, IHC-P, IP
|
Human |
- HY-P82009
-
Homeobox prospero like protein; Prospero homeobox protein 1; prospero-related homeobox gene 1; PROX1
|
WB
|
Rat |
- HY-P82027
-
DNA mismatch repair gene; DNA mismatch repair protein PMS2; HNPCC4; PMS1 protein homolog 2
|
WB, IHC-P, ICC/IF
|
Human |
- HY-P82057
-
ras-related C3 botulinum toxin substrate 3 (rho family; small GTP binding protein Rac3)
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P82108
-
HRMT1L5; IBP72; JBP1; SKB1; SKB1Hs; PRMT5; Skb1Hs Methyltransferase
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82131
-
KRT14; Keratin; type I cytoskeletal 14; Cytokeratin-14; CK-14; Keratin-14; K14
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82167
-
MIF; GLIF; MMIF; Macrophage migration inhibitory factor; MIF; Glycosylation-inhibiting factor; GIF; L-dopachrome isomerase; L-dopachrome tautomerase; Phenylpyruvate tautomerase
|
WB, IP, FC
|
Human, Mouse, Rat |
- HY-P82171
-
MOM1; PLA2; PLA2B; PLA2L; PLA2S; PLAS1; sPLA2
|
WB
|
Human, Mouse, Rat |
- HY-P82228
-
LHX2; LH2; LIM/homeobox protein Lhx2; Homeobox protein LH-2; LIM homeobox protein 2
|
WB
|
Human, Mouse, Rat |
- HY-P82271
-
ANG5; Angiopoietin 5; Angiopoietin like 3; ANGPT5; ANGPTL3; ANL3; FHBL2
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P82274
-
MC1R; MSHR; Melanocyte-stimulating hormone receptor; MSH-R; Melanocortin receptor 1; MC1-R
|
WB, IHC-P
|
Human |
- HY-P82317
-
Alpha-actinin-4 ,Non-muscle alpha-actinin 4 ,ACTN4
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82325
-
HEL S 281; LDH B; LDH H; LDH-B; LDH-H; LDHB; LDHBD; LDHH; TRG5
|
WB, IHC-P, ICC/IF, IP, FC
|
Human |
- HY-P82497
-
BRST2; GCDGP15; gp17; GPIP4; PIP; Prolactin induced protein; SABP; Secretory actin binding protein
|
WB, ICC/IF, IP
|
Human |
- HY-P82516
-
GABA-A receptor; beta-1 polypeptide; Gabrb-1; GABRB1; GARB1
|
WB
|
Human, Mouse, Rat |
- HY-P82571
-
TNFSF9; Tumor necrosis factor ligand superfamily member 9; 4-1BB ligand; 4-1BBL
|
WB, IP
|
Human |
- HY-P82658
-
groN; nitB; rif; RNA pol beta; RNA polymerase subunit beta; ron; rpoB; stl; stv; tabD; Transcriptase subunit beta
|
WB, IP
|
Escherichia Coli |
- HY-P82667
-
CD226; DNAM1; CD226 antigen; DNAX accessory molecule 1; DNAM-1; CD antigen CD226
|
WB
|
Human |
- HY-P82721
-
JAK3; Tyrosine-protein kinase JAK3; Janus kinase 3; JAK-3; Leukocyte janus kinase; L-JAK
|
WB, ICC/IF
|
Human |
- HY-P82810
-
Bmp7; Bone morphogenetic protein 7; Eptotermin alfa; OP 1; Osteogenic protein 1
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82836
-
EEF2; EF2; Elongation factor 2; EF-2
|
WB
|
Human |
- HY-P83123
-
DOK1; Docking protein 1; Downstream of tyrosine kinase 1; p62(dok); pp62
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P83144
-
HK5; Kallikrein 5; Kallikrein L2; KLK 5; KLK L2; SCTE
|
WB, ICC/IF, FC
|
Human, Mouse |
- HY-P83157
-
brPTB; MIBP; nPTB; Polypyrimidine tract binding protein 2; PTB like protein; PTBP 2Ptbp2; Splicing regulator
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P83265
-
class II beta tubulin isotype; Beta2; Tubulin beta 2 chain; TUBB; TUBB2
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P83267
-
NFKBIE; IKBE; NF-kappa-B inhibitor epsilon; NF-kappa-BIE; I-kappa-B-epsilon; IkB-E; IkB-epsilon; IkappaBepsilon
|
WB, IP
|
Human |
- HY-P83269
-
IL-1 Receptor Accessory Protein; IL1R3; C3orf13; IL-1RAcP
|
WB, IP
|
Human |
- HY-P83284
-
RBMX; HNRPG; RBMXP1; RNA-binding motif protein; X chromosome; Glycoprotein p43; Heterogeneous nuclear ribonucleoprotein G; hnRNP G
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
- HY-P83307
-
IRAK3; Interleukin-1 receptor-associated kinase 3; IRAK-3; IL-1 receptor-associated kinase M; IRAK-M
|
WB, IP
|
Human |
- HY-P83351
-
CTNNB1; CTNNB; OK/SW-cl.35; Catenin beta-1; Beta-catenin
|
WB
|
Human, Rat |
- HY-P83365
-
NDPKC; NDPK-C; NM23H3; DR-nm23; NM23-H3; c371H6.2
|
WB, IHC-P, IP
|
Human |
- HY-P83401
-
HDAC7; HDAC7A; Histone deacetylase 7; HD7; Histone deacetylase 7A; HD7a
|
WB, FC
|
Human, Mouse, Rat |
- HY-P83460
-
M-CSF Receptor; CSF-1-R; CSF-1R; M-CSF-R; Proto-oncogene c-Fms; CD115
|
WB
|
Human |
- HY-P83521
-
TFEB; BHLHE35; Transcription factor EB; Class E basic helix-loop-helix protein 35; bHLHe35
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P83522
-
GH1; Somatotropin; Growth hormone; GH; GH-N; Growth hormone 1; Pituitary growth hormone
|
WB, IHC-P, IP
|
Human |
- HY-P83528
-
HLA class II histocompatibility antigen; DP beta 1 chain; HLADPB1; HLADP1B; HLADM
|
WB, IHC-P, ICC/IF, IP
|
Human |
- HY-P83611
-
8 hydroxyguanine DNA glycosylase; AP lyase; HMMH; HOGG1; MMH; MUTM; N glycosylase; Ogg1; OGH 1
|
WB
|
Human |
- HY-P83623
-
Histone deacetylase complex subunit Sin 3a; Paired amphipathic helix protein Sin 3a; SIN3 homolog A
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P83647
-
7 dehydrocholesterol reductase; 7 DHC reductase; Delta 7 dehydrocholesterol reductase; Putative sterol reductase SR 2; Sterol Delta; DHCR7_HUMAN.
|
WB; ELISA
|
Human, Mouse, Rat |
- HY-P80527
-
ABCB5 P-gp; ATP binding cassette sub family B (MDR/TAP) member 5; P glycoprotein ABCB5
|
WB, ICC/IF
|
Human |
ABCB5 Antibody (YA836) is a non-conjugated and Mouse origined monoclonal antibody about 139 kDa, targeting to ABCB5 (8D2). It can be used for WB,ICC/IF assays with tag free, in the background of Human.
|
- HY-P80547
-
CYP19A1; ARO1; CYAR; CYP19; Cytochrome P450 19A1; Aromatase; CYPXIX; Cytochrome P-450AROM; Estrogen synthase
|
WB, IP
|
Human, Mouse, Rat |
Aromatase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 58 kDa, targeting to Aromatase. It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80553
-
Cyclic AMP-dependent transcription factor ATF-4; CREB-2; cAMP-responsive element-binding protein 2; DNA-binding protein TAXREB67
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
ATF4 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 39 kDa, targeting to ATF4. It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80576
-
BTK; AGMX1; ATK; BPK; Tyrosine-protein kinase BTK; Agammaglobulinaemia tyrosine kinase; ATK; B-cell progenitor kinase; BPK; Bruton tyrosine kinase
|
WB, IP
|
Human |
BTK Antibody (YA816) is a non-conjugated and Mouse origined monoclonal antibody about 76 kDa, targeting to BTK (5B12). It can be used for WB,IP assays with tag free, in the background of Human.
|
- HY-P80603
-
PTPRC; CD45; Receptor-type tyrosine-protein phosphatase C; Leukocyte common antigen; L-CA; T200; CD antigen CD45
|
WB, IHC-P
|
Human, Mouse |
CD45 Antibody (YA800) is a non-conjugated and Mouse origined monoclonal antibody about 147 kDa, targeting to CD45. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80616
-
FOS; G0S7; Proto-oncogene c-Fos; Cellular oncogene fos; G0/G1 switch regulatory protein 7
|
ICC/IF, WB, IHC-F, IHC-P, ELISA
|
Human, Mouse, Rat |
c-Fos Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 41 kDa, targeting to c-Fos. It can be used for ICC/IF,WB,IHC-F,IHC-P,ELISA assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80638
-
PPIB; CYPB; Peptidyl-prolyl cis-trans isomerase B; PPIase B; CYP-S1; Cyclophilin B; Rotamase B; S-cyclophilin; SCYLP
|
WB, IHC-P
|
Human, Rat, Mouse |
Cyclophilin B Antibody (YA787) is a non-conjugated and Mouse origined monoclonal antibody about 24 kDa, targeting to Cyclophilin B (5F10). It can be used for WB,IHC-P assays with tag free, in the background of Human, Rat, Mouse.
|
- HY-P80648
-
EGFR; ERBB; ERBB1; HER1; Epidermal growth factor receptor; Proto-oncogene c-ErbB-1; Receptor tyrosine-protein kinase erbB-1
|
WB, ICC/IF, IP
|
Human, Monkey |
EGFR Antibody (YA775) is a non-conjugated and Mouse origined monoclonal antibody about 134 kDa, targeting to EGFR (6H11). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Monkey.
|
- HY-P80676
-
FOXO1; FKHR; FOXO1A; Forkhead box protein O1; Forkhead box protein O1A; Forkhead in rhabdomyosarcoma
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
FOXO1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 70 kDa, targeting to FOXO1. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human.
|
- HY-P80684
-
TUBG1; TUBG; Tubulin gamma-1 chain; Gamma-1-tubulin; Gamma-tubulin complex component 1; GCP-1
|
WB, ICC/IF, IP
|
Human, Mouse, Rat, Hamster |
gamma Tubulin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 51 kDa, targeting to gamma Tubulin. It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat, Hamster.
|
- HY-P80726
-
JAK1; JAK1A; JAK1B; Tyrosine-protein kinase JAK1; Janus kinase 1; JAK-1
|
WB, ICC/IF, IP
|
Human, Rat |
JAK1 Antibody (YA722) is a non-conjugated and Mouse origined monoclonal antibody about 133 kDa, targeting to JAK1 (8B8). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Rat.
|
- HY-P80746
-
A2MR; alpha 2MR; Alpha 2 macroglobulin receptor; CD91; APR; LRP1; LRP85; TGFBR5
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
LRP1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 505 kDa, targeting to LRP1. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80820
-
GSK3B; Glycogen synthase kinase-3 beta; GSK-3 beta; Serine/threonine-protein kinase GSK3B
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
Phospho-GSK3 beta (Ser9) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 47 kDa, targeting to Phospho-GSK3 beta (Ser9). It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80899
-
p60; p62; A170; DMRV; OSIL; PDB3; ZIP3; p62B; NADGP; FTDALS3
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse |
SQSTM1/p62 Antibody (YA062) is a non-conjugated and Rabbit origined monoclonal antibody about 48 kDa, targeting to SQSTM1/p62. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse.
|
- HY-P80912
-
TXN; ADF; ATL-derived factor; SASP; Thioredoxin; TRX1; Thioredoxin delta 3; TRX; TXN delta 3; TRDX
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
Thioredoxin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 12 kDa, targeting to Thioredoxin. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human.
|
- HY-P80920
-
TREM2; TREM-2; Trem2a; Trem2b; Trem2c; triggering receptor expressed on myeloid cells 2
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
TREM2 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 25 kDa, targeting to TREM2. It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80931
-
WD repeat domain 77; p44; MEP50; MEP-50; HKMT1069; Nbla10071; p44/Mep50
|
WB, ICC/IF
|
Human, Mouse, Rat |
WDR77 Antibody (YA655) is a non-conjugated and Mouse origined monoclonal antibody about 37 kDa, targeting to WDR77 (8A10). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P81098
-
CD34 antigen; CD34 molecule; Cluster designation 34; Hematopoietic progenitor cell antigen CD34; HPCA1; CD34_HUMAN.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, Mouse(predicted: Rat, Dog, Pig, Cow, Rabbit) |
CD34 Antibody is an unconjugated, approximately 39 kDa, rabbit-derived, anti-CD34 polyclonal antibody. CD34 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, and predicted: rat, dog, pig, cow, rabbit background without labeling.
|
- HY-P81259
-
BAG1; HAP; BAG family molecular chaperone regulator 1; BAG-1; Bcl-2-associated athanogene 1
|
WB
|
Transfected |
- HY-P81259A
-
BAG1; HAP; BAG family molecular chaperone regulator 1; BAG-1; Bcl-2-associated athanogene 1
|
WB, IHC-P, IP
|
Human |
- HY-P81270
-
PRKDC; HYRC; HYRC1; DNA-dependent protein kinase catalytic subunit; DNA-PK catalytic subunit; DNA-PKcs; DNPK1; p460
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P81270A
-
PRKDC; HYRC; HYRC1; DNA-dependent protein kinase catalytic subunit; DNA-PK catalytic subunit; DNA-PKcs; DNPK1; p460
|
WB, ICC/IF, IP
|
Human |
- HY-P81270B
-
PRKDC; HYRC; HYRC1; DNA-dependent protein kinase catalytic subunit; DNA-PK catalytic subunit; DNA-PKcs; DNPK1; p460
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P81290
-
ENO2; Gamma-enolase; 2-phospho-D-glycerate hydro-lyase; Enolase 2; Neural enolase; Neuron-specific enolase; NSE
|
WB, ELISA
|
Human, Mouse, Rat |
- HY-P81290A
-
ENO2; Gamma-enolase; 2-phospho-D-glycerate hydro-lyase; Enolase 2; Neural enolase; Neuron-specific enolase; NSE
|
WB, ELISA
|
Human, Mouse, Rat |
- HY-P81290B
-
ENO2; Gamma-enolase; 2-phospho-D-glycerate hydro-lyase; Enolase 2; Neural enolase; Neuron-specific enolase; NSE
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P81290C
-
ENO2; Gamma-enolase; 2-phospho-D-glycerate hydro-lyase; Enolase 2; Neural enolase; Neuron-specific enolase; NSE
|
WB, ELISA
|
Human, Mouse, Rat |
- HY-P81415
-
CLA1; SRB1; CLA-1; SR-BI; CD36L1; HDLQTL6; Scavenging Receptor SR-BI
|
IHC-P
|
Human |
- HY-P81484
-
Nucleolysin TIA 1 isoform p40; p40 TIA 1; TIA1 protein; TIAL1; TIAR
|
IHC-P
|
Human |
- HY-P81494
-
S1PR1; EDG1; S1P1; ECGF1; EDG-1; CHEDG1; D1S3362
|
IHC-P
|
Human |
- HY-P81496
-
INSL3; RLF, RLNL; Insulin-like 3; Leydig insulin-like peptide (Ley-I-L); Relaxin-like factor
|
IHC-P
|
Human |
- HY-P81584
-
TNFSF9; Tumor necrosis factor ligand superfamily member 9; 4-1BB ligand; 4-1BBL
|
FC, ELISA
|
Human |
- HY-P81603
-
PD-1 ligand 2; PD-L2; PDCD1 ligand 2; B7-DC; CD273
|
FC, ELISA
|
Human |
- HY-P81641
-
ACN; BANF; Merlin; Moesin ezrin radixin like protein; Neurofibromatosis 2; Neurofibromin 2; Nf2; SCH; Schwannomerlin
|
WB, IP
|
Human, Mouse, Rat |
- HY-P81650
-
PDK2; PDHK2; [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 2; mitochondrial; Pyruvate dehydrogenase kinase isoform 2
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P81659
-
CD5; LEU1; T-cell surface glycoprotein CD5; Lymphocyte antigen T1/Leu-1; CD antigen CD5
|
IHC-P, IHC-F, Flow-Cyt, IF
|
Human (predicted: Mouse, Rat) |
- HY-P81663
-
SLC31A1; COPT1; CTR1; solute carrier family 31 member 1
|
WB
|
Human, Mouse, Rat, Hamster |
- HY-P81886
-
Coagulation factor XIIIa; F13A; F13a1; Fibrin stabilizing factor; A subunit; Fibrinoligase; TGase; Transglutaminase A chain
|
WB, IHC-P
|
Human |
- HY-P81937
-
SCGB2A2; MGB1; UGB2; Mammaglobin-A; Mammaglobin-1; Secretoglobin family 2A member 2
|
WB, IHC-P
|
Human, Rat |
- HY-P81938
-
Cas9; CRISPR-associated endonuclease Cas9/Csn1; CRISPR-Cas9/Csn1; csn1; SpyCas9
|
WB, IHC-P, ICC/IF, IP, FC
|
Staphylococcus aureus |
- HY-P81958
-
PPP1CB; Serine/threonine-protein phosphatase PP1-beta catalytic subunit; PP-1B; PPP1CD
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P81980
-
CJD; GSS; PrP; PRNP; ASCR; KURU; PRIP; PrPc; CD230; AltPrP; Prion protein; PrP27-30; PrP33-35C
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P82010
-
ACTR3; ARP3; Actin-related protein 3; Actin-like protein 3
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82058
-
CACH; CLE; EIF 2B; EIF2B; EIF2B5; EIF2BE; EIF2Bepsilon
|
WB, IHC-P, ICC/IF
|
Human |
- HY-P82075
-
Golgin subfamily A member 2; 130 kDa cis-Golgi matrix protein; GM130; GM130 autoantigen; Golgin-95
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat, Monkey, Cow, Dog |
- HY-P82103
-
BAP; Bap37; BCAP 37; D prohibitin; p22; Phb2; PNAS 141; Prohibitin 2
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82112
-
KRT10; KPP; Keratin; type I cytoskeletal 10; Cytokeratin-10; CK-10; Keratin-10; K10
|
WB, IHC-P
|
Human, Hamster, Mouse, Rat |
- HY-P82121
-
PGR; NR3C3; Progesterone receptor; PR; Nuclear receptor subfamily 3 group C member 3
|
WB, IHC-P, ICC/IF, IP
|
Human |
- HY-P82153
-
SYN 2; SYN II; SYN IIa; SYN IIb; SYN2; Synapsin2; SynapsinII; SYNII; SYNIIa; SYNIIb
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P82158
-
Actin binding protein; Actinin alpha 2; ACTN2; Alpha actinin 2; CMD1AA
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P82184
-
Core protein II; QCR2; mitochondrial; Ubiquinol cytochrome c reductase core protein II; UQCR2; Uqcrc2
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82252
-
ACTN3; Alpha-actinin-3; Alpha-actinin skeletal muscle isoform 3; F-actin cross-linking protein
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82293
-
12 LOX; 12LO; 12S LOX; 12S-lipoxygenase; 12S-LOX; Alox12; LOG12; P-12LO
|
WB
|
Human, Rat |
- HY-P82303
-
BMP6; VGR; Bone morphogenetic protein 6; BMP-6; VG-1-related protein; VG-1-R; VGR-1
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82323
-
SGCA; ADL; DAG2; Alpha-sarcoglycan; Alpha-SG; 50 kDa dystrophin-associated glycoprotein; 50DAG; Adhalin; Dystroglycan-2
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P82426
-
MCM7; CDC47; MCM2; DNA replication licensing factor MCM7; CDC47 homolog; P1.1-MCM3
|
WB, ICC/IF, FC
|
Human |
- HY-P82448
-
GdA; GdF; GdS; Glycodelin A; Glycodelin; Glycodelin F; Glycodelin S; PAEG; PAEP; PEG; PEP; Placental protein 14; PP14
|
WB
|
Human |
- HY-P82515
-
CD83; CD83 antigen; hCD83; B-cell activation protein; Cell surface protein HB15; CD antigen CD83
|
WB
|
Human, Mouse, Rat |
- HY-P82543
-
GC1; GW112; hGC 1; hOLfD; olfactomedin 4; OlfD; OLFM4; OLM4
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82549
-
BRCA1-associated ATM activator 1; BRCA1-associated protein required for ATM activation protein 1
|
WB, ICC/IF, IP
|
Human |
- HY-P82575
-
CCT2; 99D8.1; CCTB; T-complex protein 1 subunit beta; TCP-1-beta; CCT-beta
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82704
-
hMAD1; HsMAD1; MAD1; MAD1L1; PIG9; TP53I9; TXBP181
|
WB
|
Human, Mouse, Rat |
- HY-P82733
-
splicing factor 3a subunit 3; PRP9; PRPF9; SAP61; SF3a60
|
WB
|
Human, Mouse, Rat, Hamster |
- HY-P82831
-
53BP2; ASPP2; p53BP2; PPP1R13A; Tp53bp2
|
WB, IHC-P, ICC/IF
|
Human |
- HY-P82837
-
CollagenX; COL10A1; COAA1; Collagen type X alpha 1
|
WB
|
Human, Mouse, Rat |
- HY-P82848
-
GATA3; Trans-acting T-cell-specific transcription factor GATA-3; GATA-binding factor 3
|
WB, IHC-P, IP
|
Human |
- HY-P82863
-
CBP1; CBP2; OI10; gp46; AsTP3; HSP47; PIG14; PPROM; RA-A47; SERPINH2
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P82869
-
MSN; Moesin; Membrane-organizing extension spike protein; RDX; Radixin; EZR; VIL2; Ezrin; Cytovillin; Villin-2; p81
|
WB, IHC-P
|
Human, Rat |
- HY-P82871
-
ACH4; AChR; Acra4; BFNC; CHRNA4; EBN; EBN1; NACHR; NACRA4
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82942
-
HOXB4; HOX2F; Homeobox protein Hox-B4; Homeobox protein Hox-2.6; Homeobox protein Hox-2F
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P83028
-
C10orf7; CDC123; Cell division cycle 123; D123; HT 1080; PZ32
|
WB, IP, FC
|
Human, Mouse, Rat |
- HY-P83114
-
PLA X polypeptide; RP23-414L19.4; RPL7A; SURF3; surfeit 3; TRUP
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P83146
-
GAP43; Neuromodulin; Axonal membrane protein GAP-43; Growth-associated protein 43; Neural phosphoprotein B-50; pp46
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P83167
-
GFA; GFAT; GFPT; MSLG; CMS12; GFAT1; CMSTA1; GFAT 1; GFAT1m; GFPT1L
|
WB, IHC-P, IP
|
Human |
- HY-P83173
-
MOM1; PLA2; PLA2B; PLA2L; PLA2S; PLAS1; sPLA2
|
WB
|
Human, Mouse, Rat |
- HY-P83276
-
ALAS1; ALAS-H; 5-aminolevulinic acid synthase 1; Delta-ALA synthase 1; ALAS3; ALASH
|
WB, ICC/IF
|
Human |
- HY-P83281
-
GDH; Gdh-X; GDH1; GLUD; Glud1; Glud1a; Glud1b; Gludl; MRG-2
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P83324
-
Recessive polycystic kidney disease protein Tg737 homolog; Tetratricopeptide repeat protein 10; TPR repeat protein 10
|
WB
|
Human, Mouse, Rat |
- HY-P83434
-
AKT1S1; PRAS40; Proline-rich AKT1 substrate 1; 40 kDa proline-rich AKT substrate
|
WB, IP
|
Human, Rat |
- HY-P83485
-
MRPL11; CGI-113; 39S ribosomal protein L11; mitochondrial; L11mt; MRP-L11
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
- HY-P83493
-
ubiquitin conjugating enzyme E2 D1; SFT; UBCH5; UBC4/5; UBCH5A; E2(17)KB1
|
WB, IHC-P, IP
|
Human, Mouse |
- HY-P83579
-
ADCAD1; MEF2; MEF2A; Myocyte enhancer factor 2A; RSRFC4; RSRFC9
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P83591
-
CCN1; CCNA; CCNA1; CCNA2; CT146; Cyclin-A; Cyclin-A1; Cyclin-A2
|
WB, IP
|
Human |
- HY-P80546
-
Ago 2; Argonaute 2; dAgo2; eIF2C 2; hAgo2; PPD
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
Argonaute 2 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 97 kDa, targeting to Argonaute 2. It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80692
-
Phospholipid hydroperoxide glutathione peroxidase; mitochondrial; PHGPx; EC 1.11.1.12; Glutathione peroxidase 4; GPx-4; GSHPx-4
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
Glutathione Peroxidase 4 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 22 kDa, targeting to Glutathione Peroxidase 4. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80771
-
SPP1; BNSP; OPN; PSEC0156; Osteopontin; Bone sialoprotein 1; Nephropontin; Secreted phosphoprotein 1; SPP-1; Urinary stone protein; Uropontin
|
WB, IHC-P, ELISA
|
Human, Mouse, Rat |
Osteopontin Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 35 kDa, targeting to Osteopontin. It can be used for WB,IHC-P,ELISA assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80808
-
EGFR; ERBB; ERBB1; HER1; Epidermal growth factor receptor; Proto-oncogene c-ErbB-1; Receptor tyrosine-protein kinase erbB-1
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
Phospho-EGFR (Tyr1068) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 134 kDa, targeting to Phospho-EGFR (Tyr1068). It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human.
|
- HY-P80809
-
EGFR; ERBB; ERBB1; HER1; Epidermal growth factor receptor; Proto-oncogene c-ErbB-1; Receptor tyrosine-protein kinase erbB-1
|
WB, IHC-P
|
Human, Mouse, Rat |
Phospho-EGFR (Tyr1092) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 134 kDa, targeting to Phospho-EGFR (Tyr1092). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80810
-
EGFR; ERBB; ERBB1; HER1; Epidermal growth factor receptor; Proto-oncogene c-ErbB-1; Receptor tyrosine-protein kinase erbB-1
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
Phospho-EGFR (Tyr1173) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 134 kDa, targeting to Phospho-EGFR (Tyr1173). It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human.
|
- HY-P80843
-
TP53; P53; Cellular tumor antigen p53; Antigen NY-CO-13; Phosphoprotein p53; Tumor suppressor p53
|
WB, ICC/IF
|
Human, Mouse, Rat |
Phospho-p53 (Ser37) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 44 kDa, targeting to Phospho-p53 (Ser37). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80844
-
TP53; P53; Cellular tumor antigen p53; Antigen NY-CO-13; Phosphoprotein p53; Tumor suppressor p53
|
WB, IHC-P, IP
|
Human |
Phospho-p53 (Ser6) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 44 kDa, targeting to Phospho-p53 (Ser6). It can be used for WB,IHC-P,IP assays with tag free, in the background of Human.
|
- HY-P80856
-
STAT1; Signal transducer and activator of transcription 1-alpha/beta; Transcription factor ISGF-3 components p91/p84
|
ICC/IF, WB, IHC-F, IHC-P, IP, ELISA
|
Human, Mouse, Rat, Monkey |
Phospho-STAT1 (Tyr701) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 87 kDa, targeting to Phospho-STAT1 (Tyr701). It can be used for ICC/IF,WB,IHC-F,IHC-P,IP,ELISA assays with tag free, in the background of Human, Mouse, Rat, Monkey.
|
- HY-P80906
-
BIRC5; API4; IAP4; Baculoviral IAP repeat-containing protein 5; Apoptosis inhibitor 4; Apoptosis inhibitor survivin
|
WB, IHC-P
|
Human, Rat |
Survivin Antibody (YA665) is a non-conjugated and Mouse origined monoclonal antibody about 16 kDa, targeting to Survivin (8B9). It can be used for WB,IHC-P assays with tag free, in the background of Human, Rat.
|
- HY-P80979
-
Hod; Hop; Ob1; Obl; Hdop; Toto; Cameo; AI848177; AW490897; 1110018K11Rik; 1200015P04Rik; 2300002F06Rik
|
WB, IP
|
Human |
HOPX Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 8 kDa, targeting to HOPX. It can be used for WB, IP assays with tag free, in the background of Human.
|
- HY-P81069
-
CYP7A1; CYP7; Cholesterol 7-alpha-monooxygenase; CYPVII; Cholesterol 7-alpha-hydroxylase; Cytochrome P450 7A1
|
WB; ELISA; IHC-P; IHC-F; ICC; IF;
|
Human, Mouse |
CYP7A1 Antibody is an unconjugated, approximately 55 kDa, rabbit-derived, anti-CYP7A1 polyclonal antibody. CYP7A1 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, ICC, IF, expriments in human, mouse background without labeling.
|
- HY-P81358
-
SERPINA3; AACT; GIG24; GIG25; Alpha-1-antichymotrypsin; ACT; Cell growth-inhibiting gene 24/25 protein; Serpin A3
|
IHC-P
|
Human |
- HY-P81377
-
SERPINA1; AAT; PI; Alpha-1-antitrypsin; Alpha-1 protease inhibitor; Alpha-1-antiproteinase; Serpin A1
|
IHC-P
|
Human |
- HY-P81407
-
CDC7 ; CDC7L1; Cell division cycle 7-related protein kinase; CDC7-related kinase; HsCdc7; huCdc7
|
IHC-P
|
Human |
- HY-P81520
-
PDCD6; ALG2; Programmed cell death protein 6; Apoptosis-linked gene 2 protein homolog
|
IHC-P
|
Human |
- HY-P81573
-
Collectin-4, COLEC4, Collectin-5, COLEC5, PSAP, SFTP1, SFTPA, SFTPA1B, SFTPA2B
|
WB
|
Human, Mouse, Rat |
- HY-P81608
-
Coagulation factor IX; Christmas factor; Plasma thromboplastin component; PTC [Cleaved into: Coagulation factor IXa light chain; Coagulation factor IXa heavy chain]
|
WB
|
Human |
- HY-P81628
-
CY6; TER1; CCR-8; CKRL1; CDw198; CMKBR8; GPRCY6; CMKBRL2; CC-CKR-8; TER1
|
FC, ELISA
|
Human |
- HY-P81651
-
NFYA; Nuclear transcription factor Y subunit alpha; CAAT box DNA-binding protein subunit A; Nuclear transcription factor Y subunit A; NF-YA
|
WB, IP
|
Human, Mouse, Rat |
- HY-P81689
-
Pgf; PGFL; PIGF; Placenta growth factor; Placental growth factor; vascular endothelial growth factor related protein; PlGF; PlGF2; SHGC 10760
|
FC, ELISA
|
Human |
- HY-P81700
-
bHLHe73; ECYT4; EPAS 1; EPAS1; HIF2A; HLF; MOP 2; PASD2
|
WB, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P81718
-
Interleukin-23 subunit alpha; IL-23 subunit alpha; IL-23-A; Interleukin-23 subunit p19; IL-23p19
|
WB
|
Human |
- HY-P81755
-
p40; RAB9p40; RABEPK; RGD1310612; RP11 65N13.1; RP23-446N16.2
|
WB
|
Human |
- HY-P81757
-
T bet; T box 21; T PET; TBET; TBLYM; Tbx21; TPET; Transcription factor TBLYM
|
IHC-P, FC
|
Human |
- HY-P81839
-
PD-1 ligand 2; PD-L2; PDCD1 ligand 2; B7-DC; CD273
|
WB
|
Human, Rat |
- HY-P81854
-
PFKP; PFKF; 6-phosphofructokinase type C; 6-phosphofructokinase; platelet type; Phosphofructo-1-kinase isozyme C; PFK-C; Phosphofructokinase 1; Phosphohexokinase
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P81884
-
Chymase 1; Chymase; CMA1; CYH; CYM; Mcp-5; MCP3P; Mcpt5; MCT1; MMCP-5
|
WB, IHC-P
|
Human |
- HY-P81893
-
SLC6A4; 5HTT; 5HT transporter; 5-HTT; 5-HTTLPR; OCD1; SERT; Serotonin transporter; HSERT; SERT1
|
WB
|
Human, Mouse, Rat |
- HY-P81923
-
FHL1; FHL1A; FHL1B; FLH1A; RBMX1A; RBMX1B; SLIM1; SLIMMER; XMPMA
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P82002
-
Beta1i; LMP2; PSMB 9; PSMB6i; PSMB9; RING12
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P82067
-
Pgf; PGFL; PIGF; Placenta growth factor; Placental growth factor; vascular endothelial growth factor related protein; PlGF; PlGF2; SHGC 10760
|
WB, IF-Cell, IHC-P
|
Human, Mouse, Rat |
- HY-P82094
-
ITGA2B; GP2B; ITGAB; Integrin alpha-IIb; GPalpha IIb; GPIIb; Platelet membrane glycoprotein IIb; CD41
|
WB
|
Human, Rat |
- HY-P82104
-
p35 2; PLACENTAL; Stx4; STX4A; Syntaxin 4; syntaxin 4A
|
WB
|
Human, Mouse, Rat |
- HY-P82123
-
PSEN1; AD3; PS1; PSNL1; Presenilin-1; PS-1; Protein S182
|
WB
|
Human |
- HY-P82139
-
Interferon regulatory factor 5; Interferon regulatory factor 5 bone marrow variant; IRF 5; SLEB10
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82204
-
YWHAB; 14-3-3 protein beta/alpha; Protein 1054; Protein kinase C inhibitor protein 1; KCIP-1
|
WB
|
Human, Rat |
- HY-P82205
-
LYP; SAP; XLP; DSHP; EBVS; IMD5; XLPD; MTCP1; XLPD1; SAP/SH2D1A
|
WB
|
Human, Mouse, Rat |
- HY-P82259
-
EEF1G; EF1G; Elongation factor 1-gamma; EF-1-gamma; eEF-1B gamma
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82279
-
Axam2; Senp2; Sentrin specific protease 2; SMT3 specific isopeptidase 2; Smt3ip2
|
WB, IHC-P, ICC/IF
|
Human |
- HY-P82322
-
INA; NEF5; Alpha-internexin; Alpha-Inx; 66 kDa neurofilament protein; NF-66; Neurofilament-66; Neurofilament 5
|
WB
|
Human, Mouse, Rat |
- HY-P82383
-
LRP8; APOER2; Low-density lipoprotein receptor-related protein 8; LRP-8; Apolipoprotein E receptor 2
|
WB, IP
|
Human, Rat, Hamster |
- HY-P82386
-
NEDD8 activating enzyme E1 subunit 1; HPP1; ula-1; APPBP1; A-116A10.1
|
WB, IP
|
Human |
- HY-P82485
-
hMOF; MOF; MOZ; MYST1; SAS2; SAS3; YBF2; YBF2/SAS3; ZC2HC8; KAT8
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82493
-
TCP1; CCT1; CCTA; T-complex protein 1 subunit alpha; TCP-1-alpha; CCT-alpha
|
WB, IHC-P, ICC/IF, IP
|
Human |
- HY-P82572
-
NKX3-1; NKX3.1; NKX3A; Homeobox protein Nkx-3.1; Homeobox protein NK-3 homolog A
|
WB, IHC-P
|
Human |
- HY-P82636
-
BMP15; GDF9B; Bone morphogenetic protein 15; BMP-15; Growth/differentiation factor 9B; GDF-9B
|
WB, FC
|
Human, Mouse, Rat |
- HY-P82668
-
vacuolar protein sorting 4 homolog A; SKD1; SKD2; VPS4; SKD1A; VPS4-1
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82669
-
KIF2C; KNSL6; Kinesin-like protein KIF2C; Kinesin-like protein 6; Mitotic centromere-associated kinesin; MCAK
|
WB, ICC/IF, FC
|
Human |
- HY-P82701
-
YY1; Delta transcription factor; INO80 complex subunit S; NF-E1; Yin and yang 1; YY-1
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82715
-
BCHE; Butyrylcholine esterase; CHE1; CHE2; Choline esterase II; Cholinesterase (serum) 2; Cholinesterase 1; Cholinesterase; E1
|
WB
|
Human |
- HY-P82742
-
CFP1; CGBP; SPP1; PCCX1; PHF18; hCGBP; ZCGPC1; HsT2645; 2410002I16Rik; 5830420C16Rik
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82784
-
NEFM; NEF3; NFM; Neurofilament medium polypeptide; NF-M; 160 kDa neurofilament protein; Neurofilament 3; Neurofilament triplet M protein
|
WB, IHC-P, ICC/IF, IP
|
Human |
- HY-P82859
-
CDC42; CDC42Hs; G25K; TKS; MIG5; Ras like protein TC25
|
WB
|
Human |
- HY-P82864
-
CDCA5; Cell division cycle associated protein 5; Cell division cycle-associated protein 5; p35; Sororin
|
WB, IHC-P, ICC/IF, FC
|
Human |
- HY-P82925
-
TBXAS1; CYP5; CYP5A1; Thromboxane-A synthase; TXA synthase; TXS; Cytochrome P450 5A1
|
WB
|
Human, Mouse |
- HY-P82956
-
HRH3; GPCR97; Histamine H3 receptor; H3R; HH3R; G-protein coupled receptor 97
|
WB, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82977
-
APLP2; APPL2; Amyloid-like protein 2; APLP-2; APPH; Amyloid protein homolog; CDEI box-binding protein; CDEBP
|
WB
|
Human, Rat |
- HY-P83004
-
TPH1; MGC119994; TPRH; TRPH; Tryptophan 5-hydroxylase 1; Tryptophan Hydroxylase
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P83054
-
family with sequence similarity 50 member A; 9F; XAP5; HXC26; HXC-26; DXS9928E
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat, Hamster |
- HY-P83131
-
Low-density lipoprotein receptor-related protein 2; LRP-2; Glycoprotein 330; gp330; Megalin; LRP2; DBS
|
WB
|
Human, Mouse, Rat |
- HY-P83134
-
HS1; STN; EF1A; STNL; MRD38; EEF1AL; EIEE33; EF-1-alpha-2
|
WB, IP
|
Human, Mouse, Rat |
- HY-P83135
-
BRE1-A; hBRE1; RING finger protein 20; E3 ubiquitin-protein ligase BRE1A; RNF20
|
WB, ICC/IF, IP, FC
|
Human, Mouse |
- HY-P83187
-
DPDE4; PDE 4B; PDE IVB; PDE32; Pde4b; PDE4B5; PDEIVB; Phosphodiesterase 4B
|
WB, FC
|
Human, Mouse |
- HY-P83217
-
HMX3; MNAR; P160; PELP1; PELP1 proline glutamic acid leucine rich protein 1; PELP1 proline- glutamic
|
WB, IHC-P, ICC/IF, FC
|
Human |
- HY-P83303
-
hydroxysteroid (17-beta) dehydrogenase 1; HSD17; EDHB17; EDH17B2; SDR28C1
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P83306
-
Integrin alpha-E; HML-1 antigen; Integrin alpha-IEL; Mucosal lymphocyte 1 antigen; CD103; ITGAE
|
IHC-P
|
Human |
- HY-P83419
-
LEF1; Lymphoid enhancer-binding factor 1; LEF-1; T cell-specific transcription factor 1-alpha; TCF1-alpha
|
WB, ICC/IF
|
Human |
- HY-P83442
-
DLG2; Disks large homolog 2; Channel-associated protein of synapse-110; Chapsyn-110; Postsynaptic density protein PSD-93
|
WB, IP
|
Human, Rat |
- HY-P83446
-
E3 ubiquitin-protein ligase ZNRF2; ZNRF2; Zinc/RING finger protein 2; RNF202; Protein Ells2
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P83465
-
S100P; S100E; Protein S100-P; Protein S100-E; S100 calcium-binding protein P
|
WB, IHC-P, ICC/IF, IP
|
Human |
- HY-P83525
-
D(1A) dopamine receptor; DADR; Dopamine D1 receptor; DR D1Al; DRD1; DRD1A
|
WB
|
Human, Mouse, Rat |
- HY-P83594
-
HEC; HsHec1; hsNDC80; Kinetochore protein Hec1; Kinetochore-associated protein 2; KNTC2; ndc80; TID3
|
WB, IP
|
Human, Mouse, Rat |
- HY-P83612
-
Bone marrow stromal antigen 2; BST2; CD317; HM1.24 antigen; NPC A 7; Tetherin
|
WB, IHC-P, FC
|
Human |
- HY-P83618
-
Fletcher factor; kallikrein B plasma; Kallikrein B1; Kininogenin; KLK3; KLKB1; PKK; PKKD; Plasma kallikrein light chain; PPK; Prekallikrein
|
WB, IHC-P, IP
|
Human, Rat |
- HY-P83624
-
A1M; alpha 1 microglobulin bikunin; Alpha 1 microglycoprotein; AMBP; Bikunin; EDC1; HI30
|
WB, IHC-P
|
Human |
- HY-P83631
-
11-DH; 11-beta-HSD1; HSD11B1; HSD11; HSD11L; 11 beta HSD1
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P83638
-
AOF1; KDM1B; LSD2; Lysine-specific histone demethylase 1B; Lysine-specific histone demethylase 2
|
WB, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P80768
-
NOTCH1; TAN1; Neurogenic locus notch homolog protein 1; Notch 1; hN1; Translocation-associated notch protein TAN-1
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
Notch1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 273 kDa, targeting to Notch1. It can be used for WB,IHC-P,ICC/IF,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80798
-
CDK2; CDKN2; Cyclin-dependent kinase 2; Cell division protein kinase 2; p33 protein kinase
|
WB, IP
|
Human, Hamster, Rat |
Phospho-CDK2 (Tyr15) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 34 kDa, targeting to Phospho-CDK2 (Tyr15). It can be used for WB,IP assays with tag free, in the background of Human, Hamster, Rat.
|
- HY-P81043
-
WFDC2; Epididymis-specific he4; Epididymal protein 4; DJ461P17.6; EDDM4; HE4; WAP5
|
WB, IF-Cell, IF-Tissue, IHC-P, IP, FC
|
Human, Mouse |
HE4 Antibody (YA889) is an unconjugated, approximately 13-19 kDa, rabbit-derived, anti-HE4 (YA889) monoclonal antibody. HE4 Antibody (YA889) can be used for: WB, IF-Cell, IF-Tissue, IHC-P, IP, FC expriments in human, mouse background without labeling.
|
- HY-P81044
-
MUC16; CA125; Mucin-16; MUC-16; Ovarian cancer-related tumor marker CA125; CA-125; Ovarian carcinoma antigen CA125
|
WB, IF-Cell, IF-Tissue, IHC-P, FC
|
Human |
MUC16 Antibody (YA890) is an unconjugated, approximately 1519 kDa, anti-MUC16 (YA890) monoclonal antibody. MUC16 Antibody (YA890) can be used for: WB, IF-Cell, IF-Tissue, IHC-P, FC expriments in human background without labeling.
|
- HY-P81241
-
LEP; Leptin Murine Obesity Homolog; Leptin Precursor Obesity Factor; OB; Obese Protein; Obesity; Obesity factor; Obesity homolog mouse; Obesity Murine Homolog Leptin; OBS; LEP_HUMAN.
|
WB; ELISA; IHC-P; IHC-F; IF;
|
Human, Mouse, Rat, Pig, Sheep |
- HY-P81266
-
KRT16; KRT16A; Keratin; type I cytoskeletal 16; Cytokeratin-16; CK-16; Keratin-16; K16
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P81266A
-
KRT16; KRT16A; Keratin; type I cytoskeletal 16; Cytokeratin-16; CK-16; Keratin-16; K16
|
WB, IHC-P
|
Human |
- HY-P81284
-
LCN2; 24p3; MSFI; NGAL; Lipocalin-2; p25; Siderocalin; SV40 induced 24P3 protein; Uterocalin
|
ELISA
|
Human, Rat |
- HY-P81284A
-
LCN2; 24p3; MSFI; NGAL; Lipocalin-2; p25; Siderocalin; SV40 induced 24P3 protein; Uterocalin
|
WB, IHC-P, ICC/IF
|
Human |
- HY-P81344
-
Lymphocyte-specific protein 1; Protein pp52; 52 kDa phosphoprotein; Lymphocyte-specific antigen WP34; 47 kDa actin-binding protein
|
IHC-P
|
Human |
- HY-P81370
-
CD53; MOX44; TSPAN25; Leukocyte surface antigen CD53; Cell surface glycoprotein CD53; Tetraspanin-25; Tspan-25; CD53
|
IHC-P
|
Human |
- HY-P81372
-
MFAP5; MAGP2; Microfibrillar-associated protein 5; MFAP-5; MP25; Microfibril-associated glycoprotein 2 (MAGP-2)
|
IHC-P
|
Human |
- HY-P81410
-
MEF2B; XMEF2; Myocyte-specific enhancer factor 2B; RSRFR2; Serum response factor-like protein 2
|
IHC-P
|
Human |
- HY-P81642
-
cb486; Mybbp1a; P160; p160MBP; p67MBP; PAP2; RP23 48A2.3
|
WB, IHC-P, ICC/IF, FC
|
Human |
- HY-P81667
-
Synaptosomal-associated protein 25; SNAP-25; Super protein; SUP; Synaptosomal-associated 25 kDa protein; SNAP25; SNAP
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P81763
-
TFE3; BHLHE33; Transcription factor E3; Class E basic helix-loop-helix protein 33; bHLHe33
|
IHC-P, ICC/IF, FC
|
Human |
- HY-P81779
-
SERPINE1; PAI1; PLANH1; Plasminogen activator inhibitor 1; PAI; PAI-1; Endothelial plasminogen activator inhibitor; Serpin E1
|
WB
|
Human, Mouse |
- HY-P81805
-
HCHOLA3; LDLCQ1; NARC1; Neural apoptosis regulated convertase 1; PC9; PCSK9; Proprotein convertase 9
|
WB, IP
|
Human |
- HY-P81845
-
MMP-14; MMP-X1; MT-MMP; MT1MMP; MTMMP1; WNCHRS; MT1-MMP; MT-MMP 1
|
WB, IHC-P, IP
|
Human, Hamster |
- HY-P81870
-
Fc fragment of IgG; low affinity IIb; receptor (CD32); CD32; FCG2; CD32B; FCGR2; IGFR2
|
WB, IHC-P
|
Human, Rat |
- HY-P81942
-
SERPINF1; PEDF; PIG35; Pigment epithelium-derived factor; PEDF; Cell proliferation-inducing gene 35 protein; EPC-1; Serpin F1
|
WB, FC
|
Human |
- HY-P82083
-
Alpha 1 syntrophin; LQT12; SNT1; Snta1; Syntrophin 1; TACIP1
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse |
- HY-P82210
-
YWHAQ; 14-3-3 protein theta; 14-3-3 protein T-cell; 14-3-3 protein tau; Protein HS1
|
WB
|
Human, Mouse, Rat |
- HY-P82237
-
CA1; Carbonic anhydrase 1; Carbonate dehydratase I; Carbonic anhydrase B; CAB; Carbonic anhydrase I; CA-I
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat, Zebrafish |
- HY-P82264
-
ERR 3; ERR gamma 2; ERR3; ERRG2; ERRgamma; ESRRG; NR3B3
|
WB
|
Human, Mouse, Rat |
- HY-P82328
-
SNCA; NACP; PARK1; Alpha-synuclein; Non-A beta component of AD amyloid; Non-A4 component of amyloid precursor; NACP
|
WB, IHC-P, IP
|
Human, Rat |
- HY-P82338
-
STK3; Mess1; MST-2; MST2; Serine/threonine kinase 3; KRS1; STE20-like kinase MST2
|
WB, IHC-P, IP
|
Human, Mouse, Rat, Hamster |
- HY-P82408
-
GI GPx; GPRP; GPRP-2; GPx-GI; GPX2; GSHPx 2; GSHPx GI; GSHPx-2; GSHPx-GI
|
WB, IHC-P
|
Human |
- HY-P82409
-
T box 3; T-box protein 3; Tbx3; TBX3 ISO; UMS; XHL
|
WB, IP
|
Mouse |
- HY-P82438
-
TPM1; C15orf13; TMSA; Tropomyosin alpha-1 chain; Alpha-tropomyosin; Tropomyosin-1
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82441
-
LGALS8; Galectin-8g; Galectin-8; Po66-CBP; PCTA-1; Gal-8; Galectin 8; PCTA1
|
WB, IHC-P, ICC/IF, IP, FC
|
Human |
- HY-P82442
-
ATG16L1; APG16L; Autophagy-related protein 16-1; APG16-like 1
|
WB
|
Human, Mouse, Rat |
- HY-P82514
-
CP26; CYP26; cyp26a1; hP450RAI; P450RAI; P450RAI1
|
WB, IHC-P
|
Human, Rat |
- HY-P82548
-
Activator protein 1; AP 1; Jun D; jun D proto oncogene; Jund; JunD FL isoform; Transcription factor jun D
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82675
-
EC SOD; Extracellular superoxide dismutase [Cu Zn]; Extracellular superoxide dismutase precursor; SOD3; Superoxide dismutase 3 extracellular
|
WB, IHC-P
|
Human |
- HY-P82686
-
EGLN1; C1orf12; ECYT3; HIFPH2; HPH2; PHD2; SM-20; SM20; ZMYND6; PHD2
|
WB, IP
|
Human |
- HY-P82796
-
Cyclooxygenase-2; COX-2; Glucocorticoid-regulated inflammatory cyclooxygenase; Gripghs; PES-2; PHS II; Prostaglandin H2 synthase 2
|
WB, ICC/IF, IP
|
Mouse |
- HY-P82884
-
14-3-3 epsilon; 14-3-3E; 143E; KCIP-1; MDCR; Protein kinase C inhibitor protein-1; YWHAE
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82893
-
Rho GDP dissociation inhibitor (GDI) beta; D4; GDIA2; GDID4; LYGDI; Ly-GDI; RAP1GN1; RhoGDI2
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
- HY-P82911
-
SRC; SRC1; Proto-oncogene tyrosine-protein kinase Src; Proto-oncogene c-Src; pp60c-src; p60-Src
|
WB, IP
|
Rat |
- HY-P82917
-
Interferon regulatory factor 6; IRF 6; LPS; OFC 6; PIT; PPS; PPS1; VWS; VWS1
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82955
-
Adiponectin receptor protein 1; Progestin and adipoQ receptor family member I; CGI-45; PAQR1; ADIPOR1
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P83022
-
DCML; GATA binding protein 2; GATA binding protein 3; HDR; HDRS; IMD21; MONOMAC; NFE1B
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P83051
-
5 HT 7; 5 HT X; 5-HT-7; 5-HT-X; 5-HT7; 5HT7; htr7
|
WB
|
Human, Mouse, Rat |
- HY-P83062
-
Chloride intracellular channel protein 1; Chloride channel ABP; Nuclear chloride ion channel 27; NCC27; Regulatory nuclear chloride ion channel protein; hRNCC
|
WB, ICC/IF, IP
|
Human, Mouse, Rat, Hamster |
- HY-P83080
-
KIAA0057; TRAM like protein; Tram2; Translocating chain associating membrane protein 2; Translocation associated membrane protein 2
|
WB
|
Human, Mouse, Rat |
- HY-P83126
-
KCNJ2; ATFB9; HHBIRK1; IRK1; KIR2.1; LQT7; HIRK1; IRK-1; HHIRK1; SQT3
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P83174
-
Preproprotein S; PROS; proS1; PS21; PS22; PS23; PS24; PS25; PS26; PSA; THPH5; THPH6
|
WB
|
Human |
- HY-P83251
-
TNC; HXB; Tenascin; TN; Cytotactin; GMEM; GP 150-225; Glioma-associated-extracellular matrix antigen; Hexabrachion; JI; Myotendinous antigen; Neuronectin; Tenascin-C; TN-C
|
WB
|
Human |
- HY-P83257
-
Coiled coil and C2 domain containing 1A; FREUD 1; Freud 1/Aki1; MRT3
|
WB, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P83296
-
Tubulin alpha-1B chain; Alpha-tubulin ubiquitous; Tubulin K-alpha-1; Tubulin alpha-ubiquitous chain
|
WB, ICC/IF
|
Human |
- HY-P83337
-
PTD017; S18amt; C6orf14; HSPC183; MRPS18-2; HumanS18a; MRP-S18-2
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P83416
-
LAT; Linker for activation of T-cells family member 1; 36 kDa phospho-tyrosine adapter protein; pp36; p36-38
|
WB, IHC-P, IP
|
Human |
- HY-P83561
-
Ubiquitin-protein ligase E3A; UBE3A; E6AP; EPVE6AP; HPVE6A
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P83570
-
FOR; WOX1; EIEE28; FRA16D; SCAR12; HHCMA56; PRO0128; SDR41C1; D16S432E
|
WB, IHC-P, IP
|
Human, Mouse |
- HY-P83615
-
MtTF1; mtTFA; TCF6; TCF6L1; TCF6L2; TCF6L3; TFAM; Transcription factor 6
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P83617
-
CA2; Carbonic anhydrase 2; Carbonate dehydratase II; Carbonic anhydrase C; CAC; Carbonic anhydrase II; CA-II
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P83626
-
Caspr; Caspr1; CNTNAP; Cntnap1; Contactin associated protein 1; MHDNIV; NCP1; Neurexin-4; Nrxn4; p190; Paranodin
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P83627
-
ZIC; Zic protein member 1; Zinc finger protein 201; Zinc finger protein ZIC1; ZNF201
|
WB, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P83630
-
Lysophosphatidic acid receptor 1; LPA receptor 1; LPA-1; Lysophosphatidic acid receptor Edg-2; LPAR1; EDG2; LPA1
|
WB, IHC-P, IP
|
Human |
- HY-P80027
-
Apoptosis regulator BAX; BAX; Bcl-2-like protein 4; BCL2-associated X protein; Bcl2-L-4; BCL2L4
|
WB, IHC-P
|
Human, Mouse, Rat |
BAX Antibody (YA825) is a non-conjugated and Mouse origined monoclonal antibody about 21 kDa, targeting to BAX. It can be used for WB, IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80564
-
Apoptosis regulator BAX; BAX; Bcl-2-like protein 4; BCL2-associated X protein; Bcl2-L-4; BCL2L4
|
WB
|
Human, Monkey |
Bax Antibody (YA826) is a non-conjugated and Mouse origined monoclonal antibody about 21 kDa, targeting to Bax (2B12). It can be used for WB assays with tag free, in the background of Human, Monkey.
|
- HY-P80572
-
BRAF; BRAF1; RAFB1; Serine/threonine-protein kinase B-raf; Proto-oncogene B-Raf; p94; v-Raf murine sarcoma viral oncogene homolog B1
|
WB
|
Human, Mouse, Rat |
BRAF Antibody is a non-conjugated and Mouse origined monoclonal antibody about 84 kDa, targeting to BRAF (4E1). It can be used for WB assays with tag free, in the background of Human, Mouse.
|
- HY-P80671
-
FGF2; FGFB; Fibroblast growth factor 2; FGF-2; Basic fibroblast growth factor; bFGF; Heparin-binding growth factor 2; HBGF-2
|
WB, IP, FC, IHC-P
|
Human, Mouse |
FGF2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 31 kDa, targeting to FGF2. It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80677
-
FOXO3; FKHRL1; FOXO3A; Forkhead box protein O3; AF6q21 protein; Forkhead in rhabdomyosarcoma-like 1
|
WB
|
Human |
FOXO3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 71 kDa, targeting to FOXO3. It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80717
-
IGF1R; Insulin-like growth factor 1 receptor; Insulin-like growth factor I receptor; IGF-I receptor; CD antigen CD221
|
WB, IHC-P
|
Human |
IGF1 Receptor Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 155 kDa, targeting to IGF1 Receptor. It can be used for WB,IHC-P assays with tag free, in the background of Human.
|
- HY-P80718
-
NFKBIA; IKBA; MAD3; NFKBI; NF-kappa-B inhibitor alpha; I-kappa-B-alpha; IkB-alpha; IkappaBalpha; Major histocompatibility complex enhancer-binding protein MAD3
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
IKB alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to IKB alpha. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80722
-
IL4; Interleukin-4; IL-4; B-cell stimulatory factor 1; BSF-1; Binetrakin; Lymphocyte stimulatory factor 1; Pitrakinra
|
WB
|
Transfected |
IL-4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 17 kDa, targeting to IL-4. It can be used for WB assays with tag free, in the background of Transfected.
|
- HY-P80805
-
CREB1; Cyclic AMP-responsive element-binding protein 1; CREB-1; cAMP-responsive element-binding protein 1
|
WB, IHC-P, IP
|
Human, Rat |
Phospho-CREB (Ser133) Antibody (YA209) is a non-conjugated and Rabbit origined monoclonal antibody about 35 kDa, targeting to Phospho-CREB (Ser133). It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Rat.
|
- HY-P80855
-
STAT1; Signal transducer and activator of transcription 1-alpha/beta; Transcription factor ISGF-3 components p91/p84
|
WB, IHC-P
|
Human, Mouse, Rat |
Phospho-STAT1 (Ser727) Antibody (YA149) is a non-conjugated and Rabbit origined monoclonal antibody about 87 kDa, targeting to Phospho-STAT1 (Ser727). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80871
-
PPARA; NR1C1; PPAR; Peroxisome proliferator-activated receptor alpha; PPAR-alpha; Nuclear receptor subfamily 1 group C member 1
|
WB, IHC-F, IHC-P, ICC/IF, ELISA
|
Human, Mouse, Rat |
PPAR alpha Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 52 kDa, targeting to PPAR alpha. It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80890
-
S100 alpha6; Protein S100-A6; Calcyclin; MLN 4; PRA; CACY; CABP; 5B10
|
WB
|
Human |
S100A6 Antibody (YA674) is a non-conjugated and Mouse origined monoclonal antibody about 10 kDa, targeting to S100A6 (3E11). It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80910
-
TBK1; NAK; Serine/threonine-protein kinase TBK1; NF-kappa-B-activating kinase; T2K; TANK-binding kinase 1
|
WB
|
Human, Mouse, Rat, Hamster |
TBK1 Antibody (YA040) is a non-conjugated and Rabbit origined monoclonal antibody about 84 kDa, targeting to TBK1. It can be used for WB assays with tag free, in the background of Human, Mouse, Rat, Hamster.
|
- HY-P81072
-
HUSSY 01; LAS; LIP 1; Lip syn; LIP1; Lipoate synthase; Lipoic acid synthetase; Lipoic acid synthetase mitochondrial; Lipoyl synthase, mitochondrial; LS; MGC23245.
|
ELISA; IHC-P ; ICC; IF;
|
Mouse(predicted: Human, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit, Sheep) |
LIAS Antibody is an unconjugated, rabbit-derived, anti-LIAS polyclonal antibody. LIAS Antibody can be used for: ELISA, IHC-P, ICC, IF, expriments in mouse and predicted: human, rat, chicken, dog, pig, cow, horse, rabbit, sheep background without labeling.
|
- HY-P81222
-
CLD1_HUMAN; Claudin-1; Claudin 1; Claudin1; CLD1; SEMP1; Senescence-associated epithelial membrane protein; UNQ481/PRO944; ILVASC
|
WB; ELISA; IHC-; IHC-; IF
|
Human, Mouse(predicted: Rat, Pig, Cow, Horse, Rabbit, Sheep, Guinea Pig) |
CLDN1 Antibody is an unconjugated, approximately 23 kDa, rabbit-derived, anti-CLDN1 polyclonal antibody. CLDN1 Antibody can be used for: WB, ELISA, IHC-, IHC-, IF expriments in human, mouse, and predicted: rat, pig, cow, horse, rabbit, sheep, guinea pig background without labeling.
|
- HY-P81244
-
CYP2E1; CYP2E; Cytochrome P450 2E1; 4-nitrophenol 2-hydroxylase; CYPIIE1; Cytochrome P450-J
|
WB, IF-Cell, IF-Tissue, IHC-P
|
Human, Mouse, Rat |
- HY-P81287
-
H3K79me; H3 histone; HIST1H3A; Histone cluster 1; H3a
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P81388
-
C33; CD82; IA4; Inducible membrane protein; KAI1; Kangai1; SAR2; ST6; Tetraspanin 27; Tspan27
|
IHC-P
|
Human |
- HY-P81455
-
CDC73; C1orf28, HRPT2; Parafibromin; Cell division cycle protein 73 homolog; Hyperparathyroidism 2 protein
|
IHC-P
|
Human |
- HY-P81481
-
DMT1; DMRT1; DM domain expressed in testis protein 1; Doublesex- and mab-3-related transcription factor 1
|
IHC-P
|
Human |
- HY-P81483
-
IL-5 Receptor alpha; interleukin 5 receptor; alpha; IL5R; CD125; CDw125; HSIL5R3
|
IHC-P
|
Human |
- HY-P81498
-
Integrin alpha-E; HML-1 antigen; Integrin alpha-IEL; Mucosal lymphocyte 1 antigen; CD103; ITGAE; Integrin alpha E
|
IHC-P
|
Human |
- HY-P81523
-
FABP1; FABPL; Fatty acid-binding protein, liver; Fatty acid-binding protein 1; Liver-type fatty acid-binding protein (L-FABP)
|
IHC-P
|
Human |
- HY-P81660
-
CD7; T-cell antigen CD7; GP40; T-cell leukemia antigen; T-cell surface antigen Leu-9; TP41; CD7
|
FC, ELISA
|
Human |
- HY-P81679
-
XBP1; TREB5; XBP2; X-box-binding protein 1; XBP-1; Tax-responsive element-binding protein 5
|
WB, IP
|
Human, Mouse |
- HY-P81758
-
P4HB; DSI; ERBA2L; GIT; P4Hbeta; PDI; PDIA1; PHDB; PO4DB; PO4HB; PROHB
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P81813
-
ELOVL FA elongase 5; Fatty acid elongase 1; hELO1; Very long chain 3-ketoacyl-CoA synthase 5
|
WB, ICC/IF
|
Human |
- HY-P81818
-
CDKN2A; CDKN2; MLM; Alternative reading frame (ARF); Cyclin-dependent kinase inhibitor 2A; P14arf
|
WB, ICC/IF, IP, FC
|
Human |
- HY-P81910
-
BD1; beta 1; DEFB1; DEFB101; Defensin; Defensin beta 1; HBD1
|
WB
|
Human |
- HY-P81922
-
p164 ROCK 2; Rho kinase 2; ROCK 2; Rock II; Rock2m; ROK alpha; ROKalpha
|
WB, ICC/IF
|
Human, Rat |
- HY-P81991
-
PGR; NR3C3; Progesterone receptor; PR; Nuclear receptor subfamily 3 group C member 3
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P82031
-
PTPN1; PTP1B; Tyrosine-protein phosphatase non-receptor type 1; Protein-tyrosine phosphatase 1B; PTP-1B
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
- HY-P82032
-
GPI; Glucose-6-phosphate isomerase; GPI; Autocrine motility factor; AMF; Neuroleukin; NLK; Phosphoglucose isomerase; PGI; Phosphohexose isomerase; PHI; Sperm antigen 36; SA-36
|
WB, IHC-P, ICC/IF, FC
|
Human |
- HY-P82077
-
DDX48; EIF4A3; eIF4AIII; hNMP 265; NMP 265; NMP265; NUK34
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82078
-
PRKDC; HYRC; HYRC1; DNA-dependent protein kinase catalytic subunit; DNA-PK catalytic subunit; DNA-PKcs; DNPK1; p460
|
WB, IHC-P, ICC/IF
|
Human |
- HY-P82086
-
NRP1; NRP; VEGF165R; Neuropilin-1; Vascular endothelial cell growth factor 165 receptor; CD antigen CD304
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82096
-
ATP-binding cassette transporter 8; White protein homolog; ABC8; WHT1; ABCG1; ABC transporter 8; WHITE1
|
WB
|
Human |
- HY-P82124
-
PEBP1; PBP; PEBP; Phosphatidylethanolamine-binding protein 1; PEBP-1; HCNPpp; Neuropolypeptide h3; Prostatic-binding protein; Raf kinase inhibitor protein; RKIP
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P82160
-
Protein PR264; Splicing component; 35 kDa; Splicing factor SC35; SC-35; Splicing factor; arginine/serine-rich 2
|
WB, IHC-P, IP
|
Human, Rat |
- HY-P82213
-
BAG4; SODD; BAG family molecular chaperone regulator 4; BAG-4; Bcl-2-associated athanogene 4; Silencer of death domains
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
- HY-P82257
-
ADAMTS13; ADAM-TS; ADAM-TS13; ADAMTS-13; ADAM-TS 13; C9orf8; TTP; VWF-CP; VWFCP
|
WB, FC
|
Human |
- HY-P82344
-
MT-ND1; MTND1; NADH1; ND1; NADH-ubiquinone oxidoreductase chain 1; NADH dehydrogenase subunit 1
|
WB
|
Human, Mouse, Rat |
- HY-P82416
-
p95; p95vav; Protein vav 1; Protein vav 2; Protein vav 3; VAV; vav-T
|
WB, ICC/IF, IP, FC
|
Human |
- HY-P82445
-
HSPE1; 10 kDa heat shock protein; mitochondrial; Hsp10; 10 kDa chaperonin; Chaperonin 10; CPN10; Early-pregnancy factor; EPF
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82540
-
BMP4; BMP2B; DVR4; Bone morphogenetic protein 4; BMP-4; Bone morphogenetic protein 2B; BMP-2B
|
WB, ICC/IF, IP
|
Human |
- HY-P82682
-
HsT17016; LS-B8340; SNAP23A; SNAP23B; Synaptosomal associated protein 23; Vesicle membrane fusion protein SNAP23
|
WB
|
Human, Mouse, Rat |
- HY-P82822
-
AMRF; CD36; CD36L2; EPM4; HLGP85; LGP85; LIMP2; LIMPII; Scarb2; SRBII
|
WB, IHC-P, IP, FC
|
Human, Mouse, Rat |
- HY-P82828
-
AR7; CHNG6; EAR7; ERB-T-1; ERBA; ERBA1; NR1A1; THRA; THRA1; THRA2
|
WB
|
Human |
- HY-P82834
-
CDH1; CDHE; UVO; Cadherin-1; CAM 120/80; Epithelial cadherin; E-cadherin; Uvomorulin; CD antigen CD324
|
WB, IHC-P, IP
|
Human, Mouse |
- HY-P82850
-
NR3C1; GRL; Glucocorticoid receptor; GR; Nuclear receptor subfamily 3 group C member 1
|
WB, IHC-P
|
Human, Rat |
- HY-P82898
-
DAPK2; Death-associated protein kinase 2; DAP kinase 2; DAP-kinase-related protein 1; DRP-1
|
WB, IHC-P
|
Rat |
- HY-P83043
-
FABP2; FABPI; Fatty acid-binding protein; intestinal; Fatty acid-binding protein 2; Intestinal-type fatty acid-binding protein; I-FABP
|
WB
|
Human, Mouse, Rat |
- HY-P83115
-
IFITM3; Interferon-induced transmembrane protein 3; Dispanin subfamily A member 2b; DSPA2b; Interferon-inducible protein 1-8U
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
- HY-P83166
-
IL-32; IL 32alpha; IL 32beta; IL 32delta; IL 32gamma; IL32; NK4; TAIF; TAIFa; TAIFb; TAIFc; TAIFd
|
WB
|
Human |
- HY-P83170
-
EBS1; EBSO; HD1; Hemidesmosomal protein 1; PCN; pleC; PLEC1; Plectin 1; Plectin 6; Plectin; PLTN
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P83209
-
CDKN1C; KIP2; Cyclin-dependent kinase inhibitor 1C; Cyclin-dependent kinase inhibitor p57; p57Kip2
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P83211
-
BA2R; CCG1; CCGS; DYT3; N TAF1; NSCL2; p250; TAF1; TAF2A; TAFII250; XDP
|
WB
|
Human, Mouse, Rat |
- HY-P83273
-
p33; p47; p33ING1; p24ING1c; p33ING1b; p47ING1a
|
WB
|
Human, Mouse, Rat |
- HY-P83358
-
NBN; NBS; NBS1; P95; Nibrin; Cell cycle regulatory protein p95; Nijmegen breakage syndrome protein 1
|
WB, ICC/IF, IP
|
Human |
- HY-P83366
-
ILK; ILK1; ILK2; Integrin-linked protein kinase; 59 kDa serine/threonine-protein kinase; ILK-1; ILK-2; p59ILK
|
WB, IP
|
Human, Mouse, Rat |
- HY-P83409
-
Peroxiredoxin-6; Antioxidant protein 2; Liver 2D page spot 40; NSGPx; PRDX6; AOP2; KIAA
|
WB, IP
|
Human |
- HY-P83520
-
Toll-Like Receptor 5; SLEB1; TIL3; Tlr5; Toll like receptor 5 precursor
|
WB
|
Human, Mouse, Rat |
- HY-P83524
-
CSNBAD1; OPN2; opsd; Opsin 2 rod pigment; Opsin2; Retinitis pigmentosa 4 autosomal dominant; RHO; Rhodopsin; RP4
|
WB, IHC-P
|
Human, Rat |
- HY-P83546
-
NCE2; NEDD8 carrier protein UBE2F; NEDD8 protein ligase UBE2F; NEDD8-conjugating enzyme 2
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
- HY-P83565
-
LCA2; mRPE65; p63; rd12; Retinal pigment epithelium specific 61 kDa protein; RP20; RPE65; sRPE65
|
WB, IP
|
Human, Mouse, Rat |
- HY-P83603
-
ECP51; Reptin 52; REPTIN; RUVB2; RUVBL2; RVB2; TAP54-beta; TIH2; TIP48; TIP49b; zreptin
|
WB
|
Human, Mouse |
- HY-P83656
-
Interleukin-23 receptor; IL23 Receptor; IL23R; IL 23R; interleukin 23 receptor; IL-23 receptor; IL23R_HUMAN.
|
WB, IHC-P, IHC-F, IF, ELISA
|
Rat, Mouse, Human |
- HY-P80586
-
CSNK2B; CK2N; G5A; Casein kinase II subunit beta; CK II beta; Phosvitin; Protein G5a
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
Casein Kinase 2 beta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 25 kDa, targeting to Casein Kinase 2 beta. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80607
-
CD8A; MAL; T-cell surface glycoprotein CD8 alpha chain; T-lymphocyte differentiation antigen T8/Leu-2; CD antigen CD8a
|
WB, IHC-P
|
Human, Hamster |
CD8 alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 26 kDa, targeting to CD8 alpha. It can be used for WB,IHC-P assays with tag free, in the background of Human, Hamster.
|
- HY-P80643
-
H3K27me2; H3 histone; HIST1H3A; Histone cluster 1; H3a
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
DiMethyl-Histone H3 Antibody (YA783) is a non-conjugated and Mouse origined monoclonal antibody about 15 kDa, targeting to DiMethyl-Histone H3 (Lys27) (5F6). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80650
-
Eukaryotic initiation factor 4A-I; eIF-4A-I; eIF4A-I; ATP-dependent RNA helicase eIF4A-1
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
eIF4A1 Antibody (YA774) is a non-conjugated and Mouse origined monoclonal antibody about 46 kDa, targeting to eIF4A1 (6D7). It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80663
-
ESR1; Era; Eralpha; Estrogen receptor; Estradiol receptor; ER-alpha; Estrogen receptor 1; NR3A1; ER; ESR; ESRA; Estrogen receptor alpha
|
WB, IHC-F, IHC-P, ICC/IF, IP, ChIP
|
Human |
Estrogen Receptor alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 66 kDa, targeting to Estrogen Receptor alpha. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP,ChIP assays with tag free, in the background of Human.
|
- HY-P80670
-
FTH1; FTH; FTHL6; OK/SW-cl.84; PIG15; Ferritin heavy chain; Ferritin H subunit; Cell proliferation-inducing gene 15 protein
|
WB, ICC/IF
|
Human, Mouse, Rat, Hamster |
Ferritin Heavy Chain Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 21 kDa, targeting to Ferritin Heavy Chain. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat, Hamster.
|
- HY-P80695
-
GRB2; ASH; Growth factor receptor-bound protein 2; Adapter protein GRB2; Protein Ash; SH2/SH3 adapter GRB2
|
WB
|
Human, Mouse, Rat |
GRB2 Antibody (YA748) is a non-conjugated and Mouse origined monoclonal antibody about 25 kDa, targeting to GRB2 (5G3). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80752
-
HSG; MARF; CMT2A; CPRP1; CMT2A2; HMSN6A; CMT2A2A; CMT2A2B
|
WB, IHC-P, ELISA
|
Human, Mouse, Rat |
Mitofusin 2 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 86 kDa, targeting to Mitofusin 2. It can be used for WB,IHC-P,ELISA assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80781
-
EIF2AK3; PEK; PERK; Eukaryotic translation initiation factor 2-alpha kinase 3; PRKR-like endoplasmic reticulum kinase; Pancreatic eIF2-alpha kinase; HsPEK
|
WB
|
Human, Mouse, Rat |
PERK Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 125 kDa, targeting to PERK. It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80803
-
MET; Hepatocyte growth factor receptor; HGF receptor; HGF/SF receptor; Proto-oncogene c-Met; Scatter factor receptor; SF receptor; Tyrosine-protein kinase Met
|
WB, IP
|
Human |
Phospho-c-Met (Tyr1349) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 156 kDa, targeting to Phospho-c-Met (Tyr1349). It can be used for WB,IP assays with tag free, in the background of Human.
|
- HY-P80922
-
H3K27me3; H3 histone; HIST1H3A; Histone cluster 1; H3a
|
WB, IHC-F, IHC-P, ICC/IF, IP, ChIP
|
Human, Rat |
TriMethyl-Histone H3 (Lys27) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to TriMethyl-Histone H3 (Lys27). It can be used for WB,IHC-F,IHC-P,ICC/IF,IP,ChIP assays with tag free, in the background of Human, Rat.
|
- HY-P80927
-
VCAM1; L1CAM; Vascular cell adhesion protein 1; V-CAM 1; VCAM-1; INCAM-100; CD antigen CD106
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
VCAM1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 81 kDa, targeting to VCAM1. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80972
-
PLK1; PLK; Serine/threonine-protein kinase PLK1; Polo-like kinase 1; PLK-1; Serine/threonine-protein kinase 13; STPK13
|
WB, ICC/IF, IP
|
Human, Rat |
PLK1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 68 kDa, targeting to PLK1. It can be used for WB, ICC/IF, IP assays with tag free, in the background of Human, Rat.
|
- HY-P81164
-
pan-cytokeratin; pan-CK; pan CK; P-CK; CK-PAN; wide spectrum Cytokeratin; Cytokeratins; [cytokeratins 1,2,4,5,6,7,8,71,72,75,78].
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; ICC; IF
|
Human, Mouse, Rat, Cow(predicted: Chicken, Dog, Pig, Horse, Rabbit) |
Pan Cytokeratin Antibody is an unconjugated, approximately 42-64 kDa, rabbit-derived, anti-Pan Cytokeratin polyclonal antibody. Pan Cytokeratin Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, rat, cow, and predicted: chicken, dog, pig, horse, rabbit background without labeling.
|
- HY-P81357
-
FOXA1; Forkhead box A1; Forkhead box protein A1; HNF-3-alpha; TCF3A; HNF3A; Transcription factor 3A
|
IHC-P
|
Human |
- HY-P81384
-
MST1R; PTK8; RON; Macrophage-stimulating protein receptor; MSP receptor; CDw136; Protein-tyrosine kinase 8; p185-Ron; CD136
|
IHC-P
|
Human |
- HY-P81399
-
ADGRE5; Adhesion G protein-coupled receptor E5; CD97 antigen; Leukocyte antigen CD97; Seven span transmembrane protein; TM7LN1
|
IHC-P
|
Human |
- HY-P81402
-
SA 2; SA-2; SA2; SCC3 homolog 2; SCC3B; stag2; Stromal antigen 2
|
IHC-P
|
Human |
- HY-P81461
-
TAGLN; Transgelin; SM22; WS3-10; 22 kDa actin-binding protein; Protein WS3-10; Smooth muscle protein 22-alpha (SM22-alpha)
|
IHC-P
|
Human |
- HY-P81585
-
NDUFB10; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10; Complex I-PDSW; CI-PDSW; NADH-ubiquinone oxidoreductase PDSW subunit
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P81625
-
L1CAM; CAML1; MIC5; Neural cell adhesion molecule L1; N-CAM-L1; NCAM-L1; CD antigen CD171
|
FC, ELISA
|
Human |
- HY-P81634
-
IL17RA; IL17R; Interleukin-17 receptor A; IL-17 receptor A; IL-17RA; CDw217; CD antigen CD217
|
FC, ELISA
|
Human |
- HY-P81647
-
CTF; HMGIC/NFIB; NF-I/B; NF1-B; NF1B; NF1B2; NFI-B; NFI-RED; Nfib; NFIB2; NFIB3
|
WB, IP
|
Human, Rat |
- HY-P81753
-
G0/G1 switch regulatory protein 3; G0S3; Protein fosB; GOSB; Oncogene FOSB; Activator protein 1
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P81786
-
EEC3; KET; LMS; SHFM4; TA p63 alpha; TP63; p51; p73H; p73L; tumor protein p63
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P81933
-
PML; MYL; RNF71; TRIM19; Protein PML; Promyelocytic leukemia protein; RING finger protein 71; Tripartite motif-containing protein 19
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P81993
-
HIP; HOP; P48; AAG2; SNC6; HSPABP; FAM10A1; FAM10A4; HSPABP1; ST13
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse |
- HY-P82013
-
GABA; GABA(A) receptor beta 2; GABA(A) receptor subunit beta-2; GABRB2
|
WB
|
Human, Mouse, Rat |
- HY-P82102
-
SAE1; AOS1; SUA1; UBLE1A; SUMO-activating enzyme subunit 1; Ubiquitin-like 1-activating enzyme E1A
|
WB, ICC/IF, IP, FC
|
Human, Rat |
- HY-P82398
-
KHSRP; FUBP2; Far upstream element-binding protein 2; FUSE-binding protein 2; KH type-splicing regulatory protein; KSRP; p75
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82429
-
C20orf97; NIPK; SINK; SKIP3; TRB3; Trib3; Tribbles homolog 3; Tribbles pseudokinase 3; Tribbles3
|
WB
|
Human |
- HY-P82561
-
Atp5a1; ATP5AL2; ATPM; hATP1; HEL-S-123m; MC5DN4; MOM2
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82642
-
CAV2; Caveolae protein 20 Kd; Caveolin 2; Caveolin 2 isoform a and b; Caveolin-2
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P82703
-
FBLN5; DANCE; Fibulin-5; FIBL-5; Developmental arteries and neural crest EGF-like protein; Dance; Urine p50 protein; UP50
|
WB
|
Human, Mouse |
- HY-P82753
-
KIF22; KID; KNSL4; Kinesin-like protein KIF22; Kinesin-like DNA-binding protein; Kinesin-like protein 4
|
WB
|
Human |
- HY-P82899
-
PPP1R1B; DARPP32; Protein phosphatase 1 regulatory subunit 1B; DARPP-32; Dopamine- and cAMP-regulated neuronal phosphoprotein
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P82928
-
ARAF; ARAF1; PKS; PKS2; Serine/threonine-protein kinase A-Raf; Proto-oncogene A-Raf; Proto-oncogene A-Raf-1; Proto-oncogene Pks
|
WB, IHC-P
|
Human |
- HY-P82929
-
De2f2; E2F transcription factor 2; E2F-2; Transcription factor E2F2
|
WB, FC
|
Human, Mouse, Rat |
- HY-P82976
-
Trans-prenyltransferase 1; TPT 1; Solanesyl-diphosphate synthase subunit 1; Decaprenyl-diphosphate synthase subunit 1
|
WB, IP
|
Human |
- HY-P83014
-
BP180; BPA 2; BPAG2; COL17A1; Collagen 17; CollagenXVII; LAD1
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P83060
-
Hyaluronan and proteoglycan link protein 1; Cartilage-linking protein 1; Cartilage-link protein; Proteoglycan link protein; HAPLN1; CRTL1
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P83082
-
STK39; SPAK; STE20/SPS1-related proline-alanine-rich protein kinase; Ste-20-related kinase; DCHT; Serine/threonine-protein kinase 39
|
WB, IHC-P, FC
|
Human |
- HY-P83147
-
EPHB4; HTK; MYK1; TYRO11; Ephrin type-B receptor 4; Hepatoma transmembrane kinase; Tyrosine-protein kinase TYRO11
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P83181
-
AMS2; MAT 2; MAT 2A; MAT II; Mat2a; MATA2; MATII; SAMS 2; SAMS2
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P83318
-
MAD2L1BP; CMT2; KIAA0110; MAD2L1-binding protein; Caught by MAD2 protein
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P83391
-
Cyclic AMP-dependent transcription factor ATF-1; cAMP-dependent transcription factor ATF-1; Activating transcription factor 1 Protein TREB36; ATF1
|
WB, ICC/IF, IP
|
Human |
- HY-P83427
-
HSPA4; APG2; Heat shock 70 kDa protein 4; HSP70RY; Heat shock 70-related protein APG-2
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P83472
-
T box brain 1; T-brain-1; TBR 1; Tbr1; TES 56
|
WB
|
Human, Mouse, Rat |
- HY-P83500
-
GI008; MRPS13; RPMS13; MRP-S13; MRP-S26; NY-BR-87; C20orf193; dJ534B8.3
|
WB, ICC/IF
|
Human |
- HY-P83533
-
P0; CHM; DSS; MPP; CMT1; CMT1B; CMT2I; CMT2J; CMT4E; CMTDI3; CMTDID; HMSNIB
|
WB
|
Rat |
- HY-P83535
-
CD104; gp150; Integrin beta 4 subunit; ITG B4; ITGB 4; Itgb4
|
WB, IHC-P
|
Human, Mouse |
- HY-P83555
-
ERp57; ERp60; ERp61; Glucose Regulated Protein 58 Kd; HsT17083; p58; PDIA3; Phospholipase C alpha; PI PLC
|
WB, IHC-P, IP
|
Human |
- HY-P83583
-
TGT; tRNA guanine transglycosylase 60 kD subunit; Ubiquitin carboxyl terminal hydrolase 14; Ubiquitin specific peptidase 14; USP14
|
WB, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P83589
-
LTalpha; DIF; LT alpha; Lta; Lymphotoxin alpha; TNF B; TNF superfamily member 1; TNF-beta; TNFB; TNFbeta; TNFSF1; TNLG1E
|
WB
|
Human |
- HY-P81215
-
Bone Marrow Serine Protease; ELA 2; ELA2; ELANE; Elastase 2; Elastase-2; Elastase 2 neutrophil; Elastase neutrophil expressed; Elastase-2; ELNE_HUMAN; GE Antibody Granulocyte derived elastase; HLE; HNE; Human leukocyte elastase; Leukocyte elastase; Leukocyte Elastase Precursor; Medullasin; NE; Neutrophil elastase; Neutrophill elastase; PMN E; PMN Elastase; Polymorphonuclear elastase; SCN1; Serine protease; SERP1.
|
WB; ELISA; Flow-Cyt;
|
Human, Mouse, Rat(predicted: Dog) |
Neutrophil Elastase Antibody is an unconjugated, approximately 26 kDa, rabbit-derived, anti-Neutrophil Elastase polyclonal antibody. Neutrophil Elastase Antibody can be used for: WB, ELISA, Flow-Cyt, expriments in human, mouse, rat, and predicted: dog background without labeling.
|
- HY-P80378
-
Ah receptor; Aromatic hydrocarbon receptor; Aryl hydrocarbon receptor; Aryl hydrocarbon receptor precursor; BHLHE76; Class E basic helix loop helix protein 76; HGNC:348; AHR_HUMAN.
|
WB, ICC/IF
|
Human |
Aryl hydrocarbon Receptor Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 96 kDa, targeting to Aryl hydrocarbon Receptor. It can be used for WB,ICC/IF assays with tag free, in the background of Human.
|
- HY-P80563
-
BAK1; BAK; BCL2L7; CDN1; Bcl-2 homologous antagonist/killer; Apoptosis regulator BAK; Bcl-2-like protein 7; Bcl2-L-7
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse |
Bak Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 23 kDa, targeting to Bak. It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80592
-
CD11 antigen-like family member B; CR-3 alpha chain; Cell surface glycoprotein MAC-1 subunit alpha; CD11b; Leukocyte adhesion receptor MO1
|
WB, IP
|
Mouse |
CD11b Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 127 kDa, targeting to CD11b. It can be used for WB,IP assays with tag free, in the background of Mouse.
|
- HY-P80597
-
CD19; B-lymphocyte antigen CD19; B-lymphocyte surface antigen B4; Differentiation antigen CD19; T-cell surface antigen Leu-12; CD19
|
ICC/IF, FC
|
Human |
CD19 Antibody (YA807) is a non-conjugated and Mouse origined monoclonal antibody, targeting to CD19 (3G7). It can be used for ICC/IF,FC assays with tag free, in the background of Human.
|
- HY-P80600
-
CD3D; T3D; T-cell surface glycoprotein CD3 delta chain; T-cell receptor T3 delta chain; CD antigen CD3d
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
CD3D Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 19 kDa, targeting to CD3D. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human.
|
- HY-P80626
-
MYC; BHLHE39; Myc proto-oncogene protein; Class E basic helix-loop-helix protein 39; bHLHe39; Proto-oncogene c-Myc; Transcription factor p64
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
c-Myc Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 49 kDa, targeting to c-Myc. It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80659
-
ERBB3; HER3; Receptor tyrosine-protein kinase erbB-3; Proto-oncogene-like protein c-ErbB-3; Tyrosine kinase-type cell surface receptor HER3
|
WB
|
Human |
ErbB 3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 148 kDa, targeting to ErbB 3. It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80707
-
CBX3; Chromobox protein homolog 3; HECH; Heterochromatin protein 1 homolog gamma; HP1 gamma; Modifier 2 protein
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Mouse, Human, Monkey, Hamster, Rat |
HP1 gamma Antibody (YA733) is a non-conjugated and Mouse origined monoclonal antibody about 21 kDa, targeting to HP1 gamma (5G10). It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Mouse, Human, Monkey, Hamster, Rat.
|
- HY-P80725
-
NOS2; NOS2A; Nitric oxide synthase; inducible; Hepatocyte NOS; HEP-NOS; Inducible NO synthase; Inducible NOS; iNOS; NOS type II; Peptidyl-cysteine S-nitrosylase NOS2
|
ICC/IF, WB, IHC-F, IHC-P, ELISA
|
Human, Mouse, Rat |
iNOS Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 131 kDa, targeting to iNOS. It can be used for ICC/IF,WB,IHC-F,IHC-P,ELISA assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80928
-
VEGFR-1; VEGF Receptor 1; FLT-1; FLT; FRT; VEGFR1; Fms-like tyrosine kinase 1; Tyrosine-protein kinase FRT
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
VEGF Receptor 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 151 kDa, targeting to VEGF Receptor 1. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P81231
-
Occludin, Occludin-1; Occludin1; Occludin 1; FLJ08163; BLCPMG; FLJ18079; FLJ77961; FLJ94056; MGC34277; Occludin; OCLN; OCLN_HUMAN; Tight junction protein occludin.
|
WB; IF-Cell; IHC-P; FC
|
Human, Mouse, Rat(predicted: Dog, Pig, Cow, Sheep) |
Occludin Antibody is an unconjugated, approximately 59 kDa, rabbit-derived, anti-Occludin polyclonal antibody. Occludin Antibody can be used for: 0 expriments in human, mouse, rat, and predicted: dog, pig, cow, sheep background without labeling.
|
- HY-P81256
-
H4K5ac; H4; H4/n; H4F2; H4FN; FO108; HIST2H4
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P81280
-
CBX5; HP1A; Chromobox protein homolog 5; Antigen p25; Heterochromatin protein 1 homolog alpha; HP1 alpha
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P81280A
-
CBX5; HP1A; Chromobox protein homolog 5; Antigen p25; Heterochromatin protein 1 homolog alpha; HP1 alpha
|
WB, IHC-P
|
Human, Rat, Mouse |
- HY-P81280B
-
CBX5; HP1A; Chromobox protein homolog 5; Antigen p25; Heterochromatin protein 1 homolog alpha; HP1 alpha
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P81296
-
CAS; p120; BCDS2; CTNND; P120CAS; P120CTN; p120(CAS); p120(CTN)
|
WB, ICC/IF, IP
|
Rat, Hamster |
- HY-P81296A
-
CAS; p120; BCDS2; CTNND; P120CAS; P120CTN; p120(CAS); p120(CTN)
|
WB
|
Human, Mouse |
- HY-P81296B
-
CAS; p120; BCDS2; CTNND; P120CAS; P120CTN; p120(CAS); p120(CTN)
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse |
- HY-P81297
-
LAT; Linker for activation of T-cells family member 1; 36 kDa phospho-tyrosine adapter protein; pp36; p36-38
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P81297A
-
LAT; Linker for activation of T-cells family member 1; 36 kDa phospho-tyrosine adapter protein; pp36; p36-38
|
WB
|
Human |
- HY-P81359
-
FOXC1; FKHL7, FREAC3; Forkhead box protein C1; Forkhead-related protein FKHL7; Forkhead-related transcription factor 3 (FREAC-3)
|
IHC-P
|
Human |
- HY-P81427
-
B7X; B7H4; B7S1; B7-H4; B7h.5; VCTN1; PRO1291
|
IHC-P
|
Human |
- HY-P81452
-
SSTR2; somatostatin receptor 2; SS 2 R; SS2R; SRIF 1; SS2 R
|
IHC-P
|
Human |
- HY-P81575
-
BCAP31; DXS1357E; 6C6 AG; CDM; DXS1357E; p28; p28 Bap31; RP23-329M9.5
|
WB, IF, ICC IHC-P, FC
|
Human, Mouse |
- HY-P81610
-
SPTAN1; NEAS; SPTA2; Spectrin alpha chain; non-erythrocytic 1; Alpha-II spectrin; Fodrin alpha chain; Spectrin; non-erythroid alpha subunit
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P81614
-
BCL2L1; BCL2L; BCLX; Bcl-2-like protein 1; Bcl2-L-1; Apoptosis regulator Bcl-X
|
FC, ELISA
|
Human |
- HY-P81618
-
PAK1; Serine/threonine-protein kinase PAK 1; Alpha-PAK; p21-activated kinase 1; PAK-1; p65-PAK
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P81624
-
ARCA1; C6orf98; CPG2; EDMD4; Enaptin; Myne-1; MYNE1; Nesp1; Nesprin-1; SCAR8; Syne-1; SYNE1
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P81635
-
TOMM20; KIAA0016; Mitochondrial import receptor subunit TOM20 homolog; Mitochondrial 20 kDa outer membrane protein; Outer mitochondrial membrane receptor Tom20
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Hamster |
- HY-P81662
-
GCLM; GLCLR; Glutamate--cysteine ligase regulatory subunit; GCS light chain; Gamma-ECS regulatory subunit; Gamma-glutamylcysteine synthetase regulatory subunit; Glutamate--cysteine ligase modifier subunit
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P81670
-
KPNA2; RCH1; SRP1; Importin subunit alpha-2; Karyopherin subunit alpha-2; RAG cohort protein 1; SRP1-alpha
|
WB, FC
|
Human, Mouse, Rat |
- HY-P81678
-
MELK; KIAA0175; Maternal embryonic leucine zipper kinase; hMELK; Protein kinase Eg3; pEg3 kinase; Protein kinase PK38; hPK38; Tyrosine-protein kinase MELK
|
WB
|
Human |
- HY-P81694
-
epidermal surface antigen; ESA; flotillin-2; Membrane component chromosome 17 surface marker 1; ESA1; M17S1
|
WB, IP
|
Human, Mouse, Rat |
- HY-P81739
-
SNCA; NACP; PARK1; Alpha-synuclein; Non-A beta component of AD amyloid; Non-A4 component of amyloid precursor; NACP
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P81788
-
TPS1; TPS2; TPSAB1; TPSB1; MCP 7; Mast cell protease 7; Tryptase alpha 1
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P81844
-
IGFBP2; BP2; IBP2; Insulin-like growth factor-binding protein 2; IBP-2; IGF-binding protein 2; IGFBP-2
|
WB, IHC-P
|
Human |
- HY-P81846
-
ACR1; AOEB166; B166; Peroxiredoxin V; Peroxiredoxin-5; PLP; PMP20; PRDX5; PRDX6; Prx-V; PRXV; SBBI10; Thioredoxin reductase
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P81861
-
LOR2; LOX L2; LOXL2; Lysyl oxidase homolog 2; Lysyl oxidase like 2; WS9 14
|
WB, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P81914
-
PRKD1; PKD; PKD1; PRKCM; Serine/threonine-protein kinase D1; Protein kinase C mu type; Protein kinase D; nPKC-D1; nPKC-mu
|
WB
|
Human, Rat |
- HY-P81996
-
PGES; MPGES; PIG12; PP102; PP1294; MGST-IV; MGST1L1; TP53I12; mPGES-1; MGST1-L1
|
WB
|
Human, Mouse, Rat |
- HY-P82081
-
RAP1GAP; KIAA0474; RAP1GA1; Rap1 GTPase-activating protein 1; Rap1GAP; Rap1GAP1
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82147
-
ESR2; ESTRB; NR3A2; Estrogen receptor beta; ER-beta; Nuclear receptor subfamily 3 group A member 2
|
WB, IHC-P
|
Human |
- HY-P82175
-
CLOCK; BHLHE8; KIAA0334; Circadian locomoter output cycles protein kaput; hCLOCK; Class E basic helix-loop-helix protein 8; bHLHe8
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82211
-
GLI3; Transcriptional activator GLI3; GLI3 form of 190 kDa; GLI3-190; GLI3 full length protein; GLI3FL
|
WB, ICC/IF
|
Human |
- HY-P82214
-
SA; LBP; LRP; p40; 67LR; ICAS; lamR; 37LRP; LAMBR; LAMR1; LRP/LR; LBP/p40; NEM/1CHD4
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82439
-
ATF5; ATFX; Cyclic AMP-dependent transcription factor ATF-5; cAMP-dependent transcription factor ATF-5; Activating transcription factor 5; Transcription factor ATFx
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P82517
-
DFFA; DFF1; DFF45; H13; DNA fragmentation factor subunit alpha; DNA fragmentation factor 45 kDa subunit; DFF-45; Inhibitor of CAD; ICAD
|
WB, IHC-P, ICC/IF, IP, FC
|
Human |
- HY-P82641
-
PSMA3; HC8; PSC8; Proteasome subunit alpha type-3; Macropain subunit C8; Multicatalytic endopeptidase complex subunit C8; Proteasome component C8
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82738
-
CENP E; Centromere associated protein E; Centromere protein E 312kDa; KIF10; Kinesin family member 10; Kinesin related protein; PPP1R61
|
WB
|
Human |
- HY-P82868
-
Antigen NY-CO-25; Heat shock protein 105 kDa; HS105; HSP105; HSP105A; HSP105B; HSP110; HSPH1
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82895
-
RAD17; R24L; Cell cycle checkpoint protein RAD17; hRad17; RF-C/activator 1 homolog
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
- HY-P82900
-
IL17RA; IL17R; Interleukin-17 receptor A; IL-17 receptor A; IL-17RA; CDw217; CD antigen CD217
|
WB, IP
|
Human |
- HY-P82951
-
AKAP8; AKAP95; A-kinase anchor protein 8; AKAP-8; A-kinase anchor protein 95 kDa; AKAP 95
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P83017
-
DCNT22; DCTN22; Dctn3; dynactin 3 (p22); dynactin light chain; Dynactin subunit 3; p22
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P83052
-
CEP55; C10orf3; URCC6; Centrosomal protein of 55 kDa; Cep55; Up-regulated in colon cancer 6
|
WB, ICC/IF
|
Human, Rat |
- HY-P83128
-
Desmoglein-1; Desmosomal glycoprotein 1; DG1; DGI; Pemphigus foliaceus antigen; Cadherin family member 4; DSG1; CDHF4
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P83161
-
gemin2; SIP 1; SIP1; SIP1 delta; SMN interacting protein 1; Survival interacting protein 1
|
WB, IP
|
Human, Mouse, Rat |
- HY-P83199
-
guanine nucleotide binding protein (G protein); alpha inhibiting activity polypeptide 2; GIP; GNAI2B; H_LUCA15.1; H_LUCA16.1
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P83218
-
HCK; Tyrosine-protein kinase HCK; Hematopoietic cell kinase; Hemopoietic cell kinase; p59-HCK/p60-HCK; p59Hck; p61Hck
|
WB, ICC/IF, IP
|
Human |
- HY-P83295
-
MLANA; MART1; Melanoma antigen recognized by T-cells 1; MART-1; Antigen LB39-AA; Antigen SK29-AA; Protein Melan-A
|
WB, IHC-P, ICC/IF, FC
|
Human |
- HY-P83301
-
H4K16me; H4; H4/n; H4F2; H4FN; FO108; HIST2H4
|
WB, ICC/IF
|
Human, Mouse |
- HY-P83342
-
Activator protein 1; AP 1; Jun D; jun D proto oncogene; Jund; JunD FL isoform; Transcription factor jun D
|
WB, IP
|
Human, Mouse, Rat |
- HY-P83404
-
L1CAM; CAML1; MIC5; Neural cell adhesion molecule L1; N-CAM-L1; NCAM-L1; CD antigen CD171
|
WB, IHC-P
|
Human |
- HY-P83455
-
MYH6; MYH7; MYHC; MYHCA; MYHCB; Myosin heavy chain 6; Myosin heavy chain; Myosin-6; Myosin heavy chain; cardiac muscle alpha isoform
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P80008
-
AKT 1; AKT; AKT1; AKT1_HUMAN ; MGC99656; PKB; PKB-ALPHA; PRKBA; Protein Kinase B Alpha ; Proto-oncogene c-Akt; RAC Alpha;
|
WB, IHC-P, IP, FC
|
Human, Mouse |
AKT1 Antibody (YA634) is a non-conjugated and Rabbit origined monoclonal antibody about 56 kDa, targeting to AKT1. It can be used for WB,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80598
-
CD3E; T3E; T-cell surface glycoprotein CD3 epsilon chain; T-cell surface antigen T3/Leu-4 epsilon chain; CD3e
|
WB, IHC-P, IP
|
Human |
CD3 epsilon Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 23 kDa, targeting to CD3 epsilon. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human.
|
- HY-P80662
-
ESR1; Era; Eralpha; Estrogen receptor; Estradiol receptor; ER-alpha; Estrogen receptor 1; NR3A1; ER; ESR; ESRA; Estrogen receptor alpha
|
WB
|
Transfected |
Estrogen Receptor alpha Antibody (YA768) is a non-conjugated and Mouse origined monoclonal antibody about 66 kDa, targeting to Estrogen Receptor alpha (6F11). It can be used for WB assays with tag free, in the background of Transfected.
|
- HY-P80667
-
55 kDa actin bundling protein; Actin bundling protein; FAN1; Fascin 1; Fascin; Singed (Drosophila) like (sea urchin fascin homolog like); Fascin homolog 1; Fascin
|
WB, IHC-F, IHC-P, ICC/IF, FC, IP
|
Human, Mouse, Rat, Monkey |
Fascin Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 55 kDa, targeting to Fascin. It can be used for WB,IHC-F,IHC-P,ICC/IF,FC,IP assays with tag free, in the background of Human, Mouse, Rat, Monkey.
|
- HY-P80758
-
Macrophage scavenger receptor types I and II; Macrophage acetylated LDL receptor I and II; Scavenger receptor class A member 1; CD204; MSR1; SCARA1
|
WB
|
Human, Mouse, Rat |
MSR1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 50 kDa, targeting to MSR1. It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80762
-
NADPH oxidase 4; Kidney oxidase-1; KOX-1; KOX1; Kidney superoxide-producing NADPH oxidase; Renal NAD(P)H-oxidase; NOX4; RENOX
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
NADPH Oxidase 4 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 67 kDa, targeting to NADPH Oxidase 4. It can be used for WB,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80794
-
BRAF; BRAF1; RAFB1; Serine/threonine-protein kinase B-raf; Proto-oncogene B-Raf; p94; v-Raf murine sarcoma viral oncogene homolog B1
|
WB, IP
|
Human, Mouse, Rat |
Phospho-BRAF (Thr401) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 84 kDa, targeting to Phospho-BRAF (Thr401). It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80825
-
IGF1R; Insulin-like growth factor 1 receptor; Insulin-like growth factor I receptor; IGF-I receptor; CD antigen CD221
|
WB, IP
|
Human, Mouse, Rat |
Phospho-IGF1 Receptor (Tyr1166) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 155 kDa, targeting to Phospho-IGF1 Receptor (Tyr1166). It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80827
-
NFKBIA; IKBA; MAD3; NFKBI; NF-kappa-B inhibitor alpha; I-kappa-B-alpha; IkB-alpha; IkappaBalpha; Major histocompatibility complex enhancer-binding protein MAD3
|
WB
|
Human, Mouse |
Phospho-IKB alpha (Ser36) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to Phospho-IKB alpha (Ser36). It can be used for WB assays with tag free, in the background of Human, Mouse.
|
- HY-P80830
-
JNK 46; JNK 55; MAPK10; MAPK9; MAPK8; SAPK1b; SAPK1; SAPK; PRKM10; PRKM9; PRKM8
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
Phospho-JNK (Thr183) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 48 kDa, targeting to Phospho-JNK (Thr183). It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80919
-
TRAF6; RNF85; TNF receptor-associated factor 6; E3 ubiquitin-protein ligase TRAF6; Interleukin-1 signal transducer; RING finger protein 85
|
WB
|
Human, Rat |
TRAF6 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 60 kDa, targeting to TRAF6. It can be used for WB assays with tag free, in the background of Human, Rat.
|
- HY-P81052
-
HSF1; HSTF1; Heat shock factor protein 1; HSF 1; Heat shock transcription factor 1; HSTF 1
|
WB, IHC-P, ICC/IF, IP, FC
|
Human |
HSF1 Antibody (YA896) is an unconjugated, approximately 57-80 kDa, rabbit-derived, anti-HSF1 (YA896) monoclonal antibody. HSF1 Antibody (YA896) can be used for: WB, IHC-P, ICC/IF, IP, FC expriments in human background without labeling.
|
- HY-P81300
-
PTPN1; PTP1B; Tyrosine-protein phosphatase non-receptor type 1; Protein-tyrosine phosphatase 1B; PTP-1B
|
WB, ICC/IF, IP
|
Human |
- HY-P81300A
-
PTPN1; PTP1B; Tyrosine-protein phosphatase non-receptor type 1; Protein-tyrosine phosphatase 1B; PTP-1B
|
WB, IHC-P
|
Human |
- HY-P81404
-
AQP1; CHIP28; Aquaporin-1; AQP-1; Aquaporin-CHIP; Urine water channel; Water channel protein for red blood cells and kidney proximal tubule
|
IHC-P
|
Human |
- HY-P81423
-
Amyloid fibril protein AA; Amyloid fibrils; Amyloid protein A; Fibrils; PIG4; SAA 1; SAA 2; Serum amyloid A protein precursor
|
IHC-P
|
Human |
- HY-P81472
-
T bet; T box 21; T PET; TBET; TBLYM; Tbx21; TPET; Transcription factor TBLYM; T Box Protein 21
|
IHC-P
|
Human |
- HY-P81509
-
TNFRSF4; OX40L receptor; ACT35 antigen; CD134; TXGP1L; TAX transcriptionally-activated glycoprotein 1 receptor
|
IHC-P
|
Human |
- HY-P81525
-
FBXW7; FBW7 ; FBX30; SEL10 ; F-box/WD repeat-containing protein 7; F-box protein FBX30; SEL-10; hCdc4
|
IHC-P
|
Human |
- HY-P81537
-
CD74; DHLAG; HLA class II histocompatibility antigen gamma chain; HLA-DR antigens-associated invariant chain; Ia antigen-associated invariant chain; Ii; p33; CD74
|
IHC-P
|
Human |
- HY-P81582
-
ELFT,FCT3A,4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase,ELAM-1 ligand fucosyltransferase,Fucosyltransferase 4,Fuc-TIV; FucT-IV,Galactoside 3-L-fucosyltransferase
|
IHC-P
|
Human |
- HY-P81622
-
PAK3; OPHN3; Serine/threonine-protein kinase PAK 3; Beta-PAK; Oligophrenin-3; p21-activated kinase 3; PAK-3
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P81803
-
LAMA3; Laminin 5 alpha3; E170; LAMNA; LOCS; laminin alpha 3; Laminin A3
|
WB, ICC/IF
|
Human |
- HY-P81948
-
PPP2CA; Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform; PP2A-alpha; Replication protein C; RP-C
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat, Hamster |
- HY-P82074
-
AE1; BND3; CD233; DI; EMPB3; EPB3; FR; RTA1A; SLC4A1; SW; WD; WD1; WR
|
WB, IHC-P, ICC/IF
|
Human |
- HY-P82172
-
PTTG1; EAP1; PTTG; TUTR1; Securin; Esp1-associated protein; Pituitary tumor-transforming gene 1 protein; Tumor-transforming protein 1; hPTTG
|
WB, IHC-P, IP
|
Human, Mouse |
- HY-P82254
-
CAF 1A; CAF IP60; CAF-1; CAF1; CAF1A; CAF1P60; CHAF1B; MPHOSPH7; MPP7
|
WB, IHC-P, ICC/IF, IP, FC
|
Human |
- HY-P82278
-
AHSA1; C14orf3; HSPC322; Activator of 90 kDa heat shock protein ATPase homolog 1; AHA1; p38
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82421
-
CPC9; CYP2C; CYP2C10; CYP2C9; CYPIIC9; P450 PB1; P450MP
|
WB, ICC/IF, FC
|
Human |
- HY-P82466
-
HO68; VA68; VPP2; Vma1; ARCL2D; ATP6A1; IECEE3; ATP6V1A1
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P82490
-
HSF2; HSTF2; Heat shock factor protein 2; HSF 2; Heat shock transcription factor 2; HSTF 2
|
WB, ICC/IF, FC
|
Human |
- HY-P82573
-
RIG-I-like receptor 1; RLR-1; RLR1; Retinoic acid-inducible gene 1 protein; RIG-1; RIG1; RIG-I; RIGI
|
WB, IP
|
Human |
- HY-P82610
-
Serine/threonine-protein kinase ULK3; Ulk3; unc 51 like kinase 3 (C. elegans); Unc-51-like kinase 3
|
WB
|
Human |
- HY-P82630
-
15S Mg(2+) ATPase p97 subunit; ALS14; ATPase p97; CDC48; IBMPFD; p97; TER ATPase; TERA; VCP; Yeast Cdc48p homolog
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82670
-
HB9; HLXB9; Homeobox HB9; Homeobox protein HB9; HOXHB9; MNX1; Motor neuron and pancreas homeobox protein 1; SCRA1
|
WB, IP
|
Human, Mouse |
- HY-P82763
-
PPP3CA; CALNA; CNA; Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform; CAM-PRP catalytic subunit; Calmodulin-dependent calcineurin A subunit alpha isoform
|
WB, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82769
-
Toll-Like Receptor 7; PRO285; TLR 7; Tlr7; Toll like receptor 7; UNQ248
|
WB, IHC-P
|
Human |
- HY-P82851
-
CITED2; MRG1; MRG-1; MSG-related protein 1; ASD8; VSD2; MSG1-related gene 1; p35SRJ
|
WB
|
Human, Mouse |
- HY-P82878
-
ITCH; E3 ubiquitin-protein ligase Itchy homolog; Itch; Atrophin-1-interacting protein 4; AIP4; NFE2-associated polypeptide 1; NAPP1
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P82906
-
ATF7; ATFA; Cyclic AMP-dependent transcription factor ATF-7; cAMP-dependent transcription factor ATF-7; Activating transcription factor 7; Transcription factor ATF-A
|
WB
|
Human, Mouse, Rat |
- HY-P82921
-
DDX5; G17P1; HELR; HLR1; Probable ATP-dependent RNA helicase DDX5; DEAD box protein 5; RNA helicase p68
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82950
-
Keratin; type I cytoskeletal 13; Krt1-13; Cytokeratin 13; CK13; Keratin 13; KRT13; WSN2
|
WB, IHC-P, ICC/IF
|
Human, Mouse |
- HY-P82967
-
ABC27; ABC50; ABCF1; ATP-binding cassette 50; ATP-binding cassette 50 (TNF-alpha stimulated); TNF-alpha-stimulated ABC protein
|
WB, IHC-P, ICC/IF
|
Human, Rat |
- HY-P83021
-
TFDP1; DP1; Transcription factor Dp-1; DRTF1-polypeptide 1; DRTF1; E2F dimerization partner 1
|
WB, FC
|
Human, Mouse, Rat |
- HY-P83095
-
Abelson interactor 2; ABI2; ABI2B; Abl binding protein 3; AblBP3; ArgBP1; ARGBPIA; ArgBPIB; SSH3BP2
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P83151
-
Histone H3-K4 methyltransferase SETD7; Lysine N-methyltransferase 7; SET domain-containing protein 7; SET7; SET9
|
WB, IP
|
Human, Mouse, Rat |
- HY-P83260
-
KRT8; CYK8; Keratin; type II cytoskeletal 8; Cytokeratin-8; CK-8; Keratin-8; K8; Type-II keratin Kb8
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse |
- HY-P83322
-
E3 ubiquitin-protein ligase RAD18; hHR18; hRAD18; RAD18; RAD18; S. cerevisiae; homolog; RING finger protein 73; RNF73
|
WB, FC
|
Human, Mouse, Rat |
- HY-P83326
-
insulin-like growth factor 2 mRNA binding protein 1; IMP1; ZBP1; CRDBP; IMP-1; CRD-BP; VICKZ1
|
WB, IHC-P, IP
|
Human, Mouse |
- HY-P83333
-
A-kinase anchor protein 14; A-kinase anchor protein 14; A-kinase anchor protein 28 kDa; AKAP14; AKAP28
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P83355
-
3-dioxygenase; IDO 1; IDO; IDO1; INDO; indolamine 2; 3 dioxygenase; Indole 2 3 dioxygenase
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P83536
-
NEUROD1; BHLHA3; NEUROD; Neurogenic differentiation factor 1; NeuroD; NeuroD1; Class A basic helix-loop-helix protein 3; bHLHa3
|
WB, IP
|
Human, Mouse, Rat |
- HY-P83602
-
SPTAN1; NEAS; SPTA2; Spectrin alpha chain; non-erythrocytic 1; Alpha-II spectrin; Fodrin alpha chain; Spectrin; non-erythroid alpha subunit
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P81839A
-
PD-1 ligand 2; PD-L2; PDCD1 ligand 2; B7-DC; CD273; PD L2; PDL2
|
WB, ICC/IF, FC, ELISA
|
Human, Mouse, Rat |
- HY-P81097
-
VE-cadherin; 7B4 antigen; VECD; Vascular endothelial cell cadherin; 7B 4; 7B4; 7B4 antigen; Cadherin 5; Cadherin 5 type 2; Cadherin-5; Cadherin5; CD 144; CD144 antigen; CDH 5; CDH5; CDH5 protein; Vascular endothelial cadherin; VE Cad Antibody VEC; CADH5_HUMAN.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; ICC; IF
|
Human, Mouse, Rat, |
CD144/VE Cadherin Antibody is an unconjugated, approximately 86 kDa, rabbit-derived, anti-CD144/VE Cadherin polyclonal antibody. CD144/VE Cadherin Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, rat, background without labeling.
|
- HY-P81203
-
Vitamin D3 receptor; 125 dihydroxyvitamin D3 receptor; 1 Antibody 1,25-@dihydroxyvitamin D3 receptor; 125 dihydroxyvitamin D3 receptor; 25-dihydroxyvitamin D3 receptor; NR1I1; Nuclear receptor subfamily 1 group I member 1; VDR; VDR_HUMAN; Vitamin D (1,25- dihydroxyvitamin D3) receptor; Vitamin D hormone receptor; Vitamin D receptor; Vitamin D3 receptor,
|
IHC-P; IHC-F; ICC; IF
|
Human, Rat(predicted: Mouse, Chicken, Pig, Cow, Horse, Rabbit) |
Vitamin D Receptor Antibody is an unconjugated, approximately 47 kDa, rabbit-derived, anti-Vitamin D Receptor polyclonal antibody. Vitamin D Receptor Antibody can be used for: IHC-P, IHC-F, ICC, IF expriments in human, rat, and predicted: mouse, chicken, pig, cow, horse, rabbit background without labeling.
|
- HY-P80618
-
cIAP2; AIP1; API2; BIRC3; CIAP2; HAIP1; IAP homolog C; RNF49; MIHC; MALT2; Apoptosis inhibitor 2; IAP2
|
WB
|
Human, Monkey |
cIAP2 Antibody (YA795) is a non-conjugated and Mouse origined monoclonal antibody about 68 kDa, targeting to cIAP2 (1F12). It can be used for WB assays with tag free, in the background of Human, Monkey.
|
- HY-P80749
-
MCM2; BM28; CCNL1; CDCL1; KIAA0030; DNA replication licensing factor MCM2; Minichromosome maintenance protein 2 homolog; Nuclear protein BM28
|
WB, IHC-F, IHC-P, ICC/IF, FC, IP
|
Human, Mouse |
MCM2 Antibody (YA705) is a non-conjugated and Mouse origined monoclonal antibody about 102 kDa, targeting to MCM2 (2B5). It can be used for WB,IHC-F,IHC-P,ICC/IF,FC,IP assays with tag free, in the background of Human, Mouse.
|
- HY-P80789
-
AKT1; PKB; RAC; RAC-alpha serine/threonine-protein kinase; Protein kinase B; PKB; Protein kinase B alpha; PKB alpha; Proto-oncogene c-Akt; RAC-PK-alpha
|
ICC/IF, WB, IHC-F, IHC-P, ELISA
|
Human, Mouse, Rat |
Phospho-AKT (Thr308) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 56 kDa, targeting to Phospho-AKT (Thr308). It can be used for ICC/IF,WB,IHC-F,IHC-P,ELISA assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80817
-
FOXO3; FKHRL1; FOXO3A; Forkhead box protein O3; AF6q21 protein; Forkhead in rhabdomyosarcoma-like 1
|
WB
|
Human, Mouse, Rat |
Phospho-FOXO3A (Ser253) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 71 kDa, targeting to Phospho-FOXO3A (Ser253). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80845
-
EIF2AK3; PEK; PERK; Eukaryotic translation initiation factor 2-alpha kinase 3; PRKR-like endoplasmic reticulum kinase; Pancreatic eIF2-alpha kinase; HsPEK
|
ICC/IF, WB, IHC-F, IHC-P, ELISA
|
Human, Mouse, Rat |
Phospho-PERK (Thr982) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 125 kDa, targeting to Phospho-PERK (Thr982). It can be used for ICC/IF,WB,IHC-F,IHC-P,ELISA assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80865
-
PI3K; PIK3; PI3CG; PI3Kgamma; p110gamma; p120-PI3K
|
WB
|
Human |
PI3 Kinase p110 gamma Antibody (YA690) is a non-conjugated and Mouse origined monoclonal antibody about 126 kDa, targeting to PI3 Kinase p110 gamma (2D10). It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80889
-
S100A10; 42C; ANX2L; ANX2LG; CAL1L; CLP11; Ca[1]; GP11; P11; p10
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
S100A10 Antibody (YA675) is a non-conjugated and Mouse origined monoclonal antibody about 11 kDa, targeting to S100A10 (6F4). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P81066
-
PRDX3; AOP1; Thioredoxin-dependent peroxide reductase; mitochondrial; Antioxidant protein 1; AOP-1; HBC189; Peroxiredoxin III; Prx-III; Peroxiredoxin-3; Protein MER5 homolog
|
WB, IF-Cell, IHC-P, FC, IP
|
Human |
PRDX3 Antibody (YA909) is an unconjugated, approximately 28 kDa, human-derived, anti-PRDX3 (YA909) monoclonal antibody. PRDX3 Antibody (YA909) can be used for: WB, IF-Cell, IHC-P, FC, IP expriments in human background without labeling.
|
- HY-P81111
-
IFNG; IFG; IFI; IFN Gamma; IFN Immune; IFN-gamma; IFNG; IFNG_HUMAN; Immune Interferon; Interferon gamma; Interferon Gamma Precursor; Macrophage Activating Factor; MAF; T Cell Interferon; Type II Interferon.
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human, |
IFN gamma Antibody is an unconjugated, approximately 15 kDa, rabbit-derived, anti-IFN gamma polyclonal antibody. IFN gamma Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, background without labeling.
|
- HY-P81166
-
ox-LDL: LDL (Copper oxidized); Cu2SO4 oxidized low density lipoprotein; oxidized low density lipoprotein; Low density lipoprotein; MDA oxidized LDL; MDA oxidized low density lipoprotein. 氧化型低密度脂蛋白;
|
ELISA; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, |
ox-LDL Antibody is an unconjugated, approximately 31 kDa, rabbit-derived, anti-ox-LDL polyclonal antibody. ox-LDL Antibody can be used for: ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, background without labeling.
|
- HY-P81286
-
MTDH; AEG1; LYRIC; Protein LYRIC; 3D3/LYRIC; Astrocyte elevated gene-1 protein; AEG-1; Lysine-rich CEACAM1 co-isolated protein; Metadherin; Metastasis adhesion protein
|
WB, IHC-P, FC
|
Human |
- HY-P81286A
-
MTDH; AEG1; LYRIC; Protein LYRIC; 3D3/LYRIC; Astrocyte elevated gene-1 protein; AEG-1; Lysine-rich CEACAM1 co-isolated protein; Metadherin; Metastasis adhesion protein
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P81348
-
PHLPP2; KIAA0931, PHLPPL; PH domain leucine-rich repeat-containing protein phosphatase 2; PH domain leucine-rich repeat-containing protein phosphatase-like (PHLPP-like)
|
IHC-P
|
Human |
- HY-P81365
-
PCANAP6; PRST; Slc45a3; Solute carrier family 45 member 3; Prostate cancer-associated protein 6; Prostein
|
IHC-P
|
Human |
- HY-P81366
-
CD48; BCM1; BLAST1; CD48 antigen; B-lymphocyte activation marker BLAST-1; BCM1 surface antigen; Leukocyte antigen MEM-102; TCT.1; CD48
|
IHC-P
|
Human |
- HY-P81379
-
ROC1; RNF75; RBX1; E3 ubiquitin-protein ligase RBX1; RING finger protein 75; RING-box protein 1 (Rbx1)
|
IHC-P
|
Human |
- HY-P81482
-
GHRL; MTLRP; UNQ524/PRO1066; Appetite-regulating hormone; Growth hormone secretagogue; Growth hormone-releasing peptide; Motilin-related peptide; Protein M46; Ghrelin-27Ghrelin-28 (Ghrelin); Obestatin
|
IHC-P
|
Human |
- HY-P81600
-
Glutaminase interacting protein 3; Tax interaction protein 1; Tax1 binding protein 3; Tax1bp3; TIP1
|
WB, IHC-P, FC
|
Human, Mouse, Rat |
- HY-P81601
-
NDUFS3; NADH dehydrogenase [ubiquinone] iron-sulfur protein 3; mitochondrial; Complex I-30kD; CI-30kD; NADH-ubiquinone oxidoreductase 30 kDa subunit
|
WB
|
Human, Mouse |
- HY-P81722
-
B2BKR; B2BRA; B2R; BDKRB2; BK2 receptor; BK2R; BKR2; BR B2; BRB2; Kinin B2
|
WB, IP
|
Human, Mouse |
- HY-P81762
-
TNFSF12; APO3L; DR3LG; Tumor necrosis factor ligand superfamily member 12; APO3 ligand; TNF-related weak inducer of apoptosis; TWEAK
|
FC, ELISA
|
Human |
- HY-P81842
-
GATA1; ERYF1; GF1; Erythroid transcription factor; Eryf1; GATA-binding factor 1; GATA-1; GF-1; NF-E1 DNA-binding protein
|
WB, ICC/IF, IP, ChIP
|
Human |
- HY-P81959
-
Anti TCL1A; P14 TCL1; T cell leukemia 1; TCL1; TCL1 PEN; Tcl1a
|
WB, IHC-P, ICC/IF, FC
|
Human |
- HY-P82006
-
PRKAR1A; PKR1; PRKAR1; TSE1; cAMP-dependent protein kinase type I-alpha regulatory subunit; Tissue-specific extinguisher 1; TSE1
|
WB
|
Human, Rat |
- HY-P82060
-
Cenexin 1; Cenexin; CT134; KKT4; ODF 2; ODF 84; odf2; ODF2/1; ODF2/2; ODF84
|
WB, FC
|
Human |
- HY-P82080
-
fb62c11; HSEC61; SEC 61; SEC 61A; Sec61 alpha 1; SEC61; SEC61A1
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82241
-
TNPO 3; Imp12; Importin 12; IPO12; MTR10A; TNPO3; Transportin 3; Transportin SR; TRN-SR2; TRNSR
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82446
-
COPS3; CSN3; COP9 signalosome complex subunit 3; SGN3; Signalosome subunit 3; JAB1-containing signalosome subunit 3
|
WB, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82467
-
BOB 1; BOB-1; OBF 1; OBF1; OCA B; OCA-B; OCAB; OCT binding factor 1; Pou2af1
|
WB, IHC-P, ICC/IF, FC
|
Human |
- HY-P82557
-
CYP2E1; CYP2E; Cytochrome P450 2E1; 4-nitrophenol 2-hydroxylase; CYPIIE1; Cytochrome P450-J
|
WB
|
Human, Mouse, Rat |
- HY-P82563
-
MU; H-B; GST1; GTH4; GTM1; MU-1; GSTM1-1; MGC26563; GSTM1a-1a; GSTM1b-1b
|
WB
|
Human, Mouse, Rat |
- HY-P82588
-
ubiquitin conjugating enzyme E2D 3; UBC4/5; UBCH5C; E2(17)KB3
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82693
-
Homeo box protein Meis1; Leukemogenic homolog protein; MEIS 1; Meis homeo box 1; Meis1; Meis1 mouse homolog; MEIS1 protein
|
WB, IP, FC
|
Human, Mouse, Rat |
- HY-P82887
-
PML; MYL; RNF71; TRIM19; Protein PML; Promyelocytic leukemia protein; RING finger protein 71; Tripartite motif-containing protein 19
|
WB, IHC-P
|
Human |
- HY-P82931
-
CD266 antigen; FGF inducible 14; Fibroblast growth factor inducible immediate early response protein 14; FN14; TNFRSF 12A; Tweak receptor; TweakR
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P82940
-
ECP54; Pontin 52; PONTIN; RuvB like 1; RUVBL1; RVB1; TAP54 alpha; TIP49; TIP49a
|
WB, FC
|
Human, Mouse, Rat |
- HY-P82952
-
DLX4; BP1; DLX7; DLX8; DLX9; Homeobox protein DLX-4; Beta protein 1; Homeobox protein DLX-7; Homeobox protein DLX-8
|
WB, ICC/IF, IP
|
Human, Rat |
- HY-P83109
-
DAXX; BING2; DAP6; Death domain-associated protein 6; Daxx; hDaxx; ETS1-associated protein 1; EAP1; Fas death domain-associated protein
|
WB, ICC/IF
|
Human |
- HY-P83111
-
PPP2CA; Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform; PP2A-alpha; Replication protein C; RP-C
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P83195
-
Aw-68; HLA class I histocompatibility antigen; A-28 alpha chain; MHC class I antigen A*68; HLA-A; MHC class I antigen HLA A heavy chain
|
WB, IHC-P, ICC/IF, IP, FC
|
Human |
- HY-P83329
-
Wolf Hirschhorn syndrome candidate 1 like 1; WHSC1L1; NSD3; pp14328; Histone-lysine N-methyltransferase NSD3; Protein whistle
|
WB, FC
|
Human, Mouse, Rat |
- HY-P83347
-
IL11RA; Interleukin-11 receptor subunit alpha; IL-11 receptor subunit alpha; IL-11R subunit alpha; IL-11R-alpha; IL-11RA
|
WB, IHC-P
|
Human |
- HY-P83412
-
CRACM1; Orai 1; ORAI calcium release activated calcium modulator 1; orai1; ORAT1; Protein orai 1; TMEM142A
|
WB
|
Human |
- HY-P83423
-
cell division cycle 40; EH-binding protein 3; EHB3; pre-mRNA splicing factor 17; PRP17; PRPF17; Cdc40
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P83439
-
CDP; CUX; p75; CASP; CDP1; COY1; Clox; GDDI; p100; p110; p200; CUTL1; GOLIM6; CDP/Cut; Cux/CDP; Nbla10317
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P83540
-
DIL2; p100; DIL-2; HCTP4; FLS353; HCA519; REPP86; C20orf1; C20orf2; GD:C20orf1
|
WB, ICC/IF
|
Human |
- HY-P83566
-
Frizzled related protein 1; FRP1; FrzA; SARP2; Secreted apoptosis related protein 2; Secreted frizzled related protein 1; SFRP1
|
WB, IHC-P, ICC/IF
|
Human |
- HY-P83592
-
DAZ homolog; DAZ like autosomal; DAZH; DAZL; DAZL1; DAZLA; Deleted in azoospermia like 1; Germline specific RNA binding protein; SPGY like autosomal; SPGYLA; Tpx2
|
WB
|
Human |
- HY-P83609
-
AGP 1; AGP A; AGP1; Alpha 1 acid glycoprotein; alpha-1-AGP; HEL S 153w; ORM; Orosomucoid 1
|
WB, IHC-P
|
Human |
- HY-P83625
-
DRP2; CRMP-2; N2A3; Unc-33-like phosphoprotein 2; ULIP-2; DPYSL2; CRMP2; ULIP2; Musunc33; TOAD64
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P80740
-
LAMP2; Lysosome-associated membrane glycoprotein 2; LAMP-2; Lysosome-associated membrane protein 2; CD107 antigen-like family member B; CD107b
|
WB, IHC-P
|
Human |
LAMP2 Antibody (YA310) is a non-conjugated and Rabbit origined monoclonal antibody about 45 kDa, targeting to LAMP2. It can be used for WB,IHC-P assays with tag free, in the background of Human.
|
- HY-P80747
-
LYN; JTK8; Tyrosine-protein kinase Lyn; Lck/Yes-related novel protein tyrosine kinase; V-yes-1 Yamaguchi sarcoma viral related oncogene homolog; p53Lyn; p56Lyn
|
WB
|
Human |
Lyn Antibody (YA707) is a non-conjugated and Mouse origined monoclonal antibody about 59 kDa, targeting to Lyn (1C8). It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80788
-
AKT1; PKB; RAC; RAC-alpha serine/threonine-protein kinase; Protein kinase B; PKB; Protein kinase B alpha; PKB alpha; Proto-oncogene c-Akt; RAC-PK-alpha
|
WB
|
Human, Mouse, Rat |
Phospho-AKT1 (Ser473) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 56 kDa, targeting to Phospho-AKT (Ser473). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80800
-
Transcription factor AP-1; Activator protein 1; AP1; Proto-oncogene c-Jun; V-jun avian sarcoma virus 17 oncogene homolog; p39
|
WB, IHC-P
|
Human, Mouse, Rat |
Phospho-c-Jun (Ser243) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 36 kDa, targeting to Phospho-c-Jun (Ser243). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80801
-
Transcription factor AP-1; Activator protein 1; AP1; Proto-oncogene c-Jun; V-jun avian sarcoma virus 17 oncogene homolog; p39
|
WB, IHC-P
|
Human, Mouse, Rat |
Phospho-c-Jun (Ser63) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to Phospho-c-Jun (Ser63). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80802
-
Transcription factor AP-1; Activator protein 1; AP1; Proto-oncogene c-Jun; V-jun avian sarcoma virus 17 oncogene homolog; p39
|
WB, IHC-P
|
Human, Mouse, Rat |
Phospho-c-Jun (Ser73) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 36 kDa, targeting to Phospho-c-Jun (Ser73). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80804
-
MYC; BHLHE39; Myc proto-oncogene protein; Class E basic helix-loop-helix protein 39; bHLHe39; Proto-oncogene c-Myc; Transcription factor p64
|
WB, ICC/IF, IP
|
Mouse, Rat |
Phospho-c-Myc (Ser62) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 49 kDa, targeting to Phospho-c-Myc (Ser62). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Mouse, Rat.
|
- HY-P80826
-
NFKBIA; IKBA; MAD3; NFKBI; NF-kappa-B inhibitor alpha; I-kappa-B-alpha; IkB-alpha; IkappaBalpha; Major histocompatibility complex enhancer-binding protein MAD3
|
WB, IP
|
Human, Mouse |
Phospho-IKB alpha (Ser32) Antibody (YA185) is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to Phospho-IKB alpha (Ser32). It can be used for WB,IP assays with tag free, in the background of Human, Mouse.
|
- HY-P80917
-
CD283; CD283 antigen; IIAE2; TLR 3; Tlr3; TLR3_HUMAN; Toll Like Receptor 3; Toll-like receptor 3.
|
WB, IHC-P, IHC-F, IF, ELISA
|
Human, Mouse, Rat |
Toll-Like Receptor 3 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 105 kDa, targeting to Toll-Like Receptor 3 . It can be used for WB, IHC-P, IHC-F, IF, ELISA assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P81003
-
CDKN2C; CDKN6; Cyclin-dependent kinase 4 inhibitor C; Cyclin-dependent kinase 6 inhibitor; p18-INK4c; p18-INK6
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
CDKN2C Antibody is an unconjugated, approximately 15 kDa, rabbit-derived, anti-CDKN2C monoclonal antibody. CDKN2C Antibody can be used for: WB, IHC-P, ICC/IF, IP expriments in background without labeling.
|
- HY-P81077
-
Alpha Fetoprotein; Alpha-fetoprotein; alpha 1 fetoprotein; Alpha-1-fetoprotein; Alpha-fetoglobulin; alpha fetoglobulin; alpha Fetoprotein; Alpha fetoprotein precursor; FETA; HPAFP; FETA_HUMAN.
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human, Rat, |
AFP Antibody (YA914) is an unconjugated, approximately 65 kDa, mouse-derived, anti-AFP (YA914) monoclonal antibody. AFP Antibody (YA914) can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, rat, background without labeling.
|
- HY-P81078
-
Alpha Fetoprotein; Alpha-fetoprotein; alpha 1 fetoprotein; Alpha-1-fetoprotein; Alpha-fetoglobulin; alpha fetoglobulin; alpha Fetoprotein; Alpha fetoprotein precursor; FETA; HPAFP; FETA_HUMAN.
|
WB; ELISA
|
Human, |
AFP Antibody (YA915) is an unconjugated, approximately 65 kDa, mouse-derived, anti-AFP (YA915) monoclonal antibody. AFP Antibody (YA915) can be used for: WB, ELISA expriments in human, background without labeling.
|
- HY-P81123
-
MGC29565; OCIF; OPG; Osteoclastogenesis Inhibitory Factor; TNFRSF 11B; TNFRSF11B; TR 1; TR1; Tumor Necrosis Factor Receptor Superfamily Member 11b; TR11B_HUMAN.
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human, Mouse, Rat(predicted: Dog, Cow) |
OPG Antibody is an unconjugated, approximately 43 kDa, rabbit-derived, anti-OPG polyclonal antibody. OPG Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, and predicted: dog, cow background without labeling.
|
- HY-P81265
-
CHD4; Chromodomain-helicase-DNA-binding protein 4; CHD-4; ATP-dependent helicase CHD4; Mi-2 autoantigen 218 kDa protein; Mi2-beta
|
WB, IP
|
Human |
- HY-P81265A
-
CHD4; Chromodomain-helicase-DNA-binding protein 4; CHD-4; ATP-dependent helicase CHD4; Mi-2 autoantigen 218 kDa protein; Mi2-beta
|
WB, ICC/IF, FC
|
Human |
- HY-P81360
-
MAGEA1; MAGE1, MAGE1A; Melanoma-associated antigen 1; Antigen MZ2-E; Cancer/testis antigen 1.1 (CT1.1); MAGE-1 antigen
|
IHC-P
|
Human |
- HY-P81436
-
HLA DPA1; major histocompatibility complex; class II; DP alpha 1; PLT1; HLADP; HLASB; DP(W3); DP(W4); HLA-DP1A
|
IHC-P
|
Human |
- HY-P81497
-
hITF; hP1.B; InTinal trefoil factor; ITF; mITF; P1B; Polypeptide P1.B; TFF3; TFI; TREFOIL; Trefoil factor 3
|
IHC-P
|
Human |
- HY-P81606
-
CLDN4; CPER; CPETR1; WBSCR8; Claudin-4; Clostridium perfringens enterotoxin receptor; CPE-R; CPE-receptor; Williams-Beuren syndrome chromosomal region 8 protein
|
WB, IHC-P, IP
|
Human |
- HY-P81655
-
Fibroblast growth factor receptor substrate 2; FGFR substrate 2; FGFR-signaling adaptor SNT; Suc1-associated neurotrophic factor target 1; SNT-1
|
WB, IP
|
Human |
- HY-P81749
-
CDKN1B; KIP1; Cyclin-dependent kinase inhibitor 1B; Cyclin-dependent kinase inhibitor p27; p27Kip1
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P81820
-
PDLIM1; CLIM1; CLP36; PDZ and LIM domain protein 1; C-terminal LIM domain protein 1; Elfin; LIM domain protein CLP-36
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P81895
-
CD2; SRBC; T-cell surface antigen CD2; Erythrocyte receptor; LFA-2; LFA-3 receptor; Rosette receptor; T-cell surface antigen T11/Leu-5; CD2
|
WB, IHC-P, ICC/IF, IP, FC
|
Human |
- HY-P82011
-
MSH6; GTBP; DNA mismatch repair protein Msh6; hMSH6; G/T mismatch-binding protein; GTBP; GTMBP; MutS-alpha 160 kDa subunit; p160
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82090
-
CEBPB; LAP; TCF5; PP9092; CCAAT/enhancer-binding protein beta; C/EBP beta; Liver activator protein; Nuclear factor NF-IL6; Transcription factor 5; TCF-5
|
WB, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82135
-
RPL10A; NEDD6; 60S ribosomal protein L10a; CSA-19; Neural precursor cell expressed developmentally down-regulated protein 6; NEDD-6
|
WB
|
Human, Mouse, Rat |
- HY-P82137
-
H3 K9 HMTase 2; KMT1B; Su(var)3 9 homolog 2; Suv39h2
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P82273
-
SMARCB1; BAF47; hSNF5; INI1; RDT; RTPS1; Sfh1p; SMARCB1; SNF5 homolog; SNF5L1; Snr1; SWI/SNF comp
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse |
- HY-P82329
-
IFNGR1; Interferon gamma receptor 1; IFN-gamma receptor 1; IFN-gamma-R1; CDw119; CD antigen CD119
|
WB, IHC-P, ICC/IF, FC
|
Human |
- HY-P82342
-
cytochrome P450 family 4 subfamily A member 11; CP4Y; CYP4A2; CYP4AII; CYPIVA11
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P82377
-
DTEF 1; NTEF 1; TCF13; TEAD1; TEAD2; TEAD3; TEAD4; TEAD5; TEF1; TEF4; TEF5
|
WB
|
Human |
- HY-P82502
-
Alcadein alpha 1; alcalpha1; alcalpha2; Calsyntenin 1; CDHR12; Clstn1; CS1; CSTN1; PIK3CD; XB31alpha
|
WB, IHC-P, ICC/IF
|
Human, Mouse |
- HY-P82584
-
UBA2; SAE2; UBLE1B; HRIHFB2115; SUMO-activating enzyme subunit 2; Anthracycline-associated resistance ARX; Ubiquitin-like 1-activating enzyme E1B
|
WB, ICC/IF, IP
|
Human, Rat |
- HY-P82674
-
MmTRA1a; MmTRA1b; Nor1; PLSCR 1; Scramblase1; Tra1; Tra1a; Tra1b; Tras1; Tras2
|
WB, ICC/IF, IP, FC
|
Human |
- HY-P82737
-
Excitatory amino acid transporter 2; Glutamate/aspartate transporter II; Sodium-dependent glutamate/aspartate transporter 2; Solute carrier family 1 member 2
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82755
-
cIAP1; C-IAP1; IAP homolog B; Inhibitor of apoptosis protein 2; IAP-2; hIAP-2; hIAP2; API1; IAP2; MIHB; RNF48
|
WB, ICC/IF
|
Human |
- HY-P82814
-
ACT2; G-26; HC21; LAG1; LAG-1; MIP1B; SCYA2; SCYA4; MIP1B1; AT744.1; MIP-1-beta
|
WB, ICC/IF, IP
|
Human, Mouse |
- HY-P83206
-
GPR37; Probable G-protein coupled receptor 37; Endothelin B receptor-like protein 1; ETBR-LP-1; Parkin-associated endothelin receptor-like receptor; PAELR
|
WB
|
Rat |
- HY-P83330
-
KCNA1; Potassium voltage-gated channel subfamily A member 1; Voltage-gated K(+) channel HuKI; Voltage-gated potassium channel HBK1; Voltage-gated potassium channel subunit Kv1.1
|
WB, IP
|
Human |
- HY-P83372
-
Delta type opioid receptor; Delta type opioid receptor DOR1; DOR 1; mDOR; Nbor; Opioid receptor delta 1; OPRD 1
|
WB, FC
|
Human, Mouse, Rat |
- HY-P83458
-
ABL2; ABLL; ARG; Abelson tyrosine-protein kinase 2; Abelson murine leukemia viral oncogene homolog 2; Abelson-related gene protein; Tyrosine-protein kinase ARG
|
WB, FC
|
Human, Mouse, Rat |
- HY-P83498
-
100 kDa NT receptor; Glycoprotein 95; Gp95; LDLCQ6; Neurotensin receptor 3; NT3; NTR3; SORT 1; Sortilin 1
|
WB, IHC-P
|
Human, Rat |
- HY-P83577
-
Aw-68; HLA class I histocompatibility antigen; A-28 alpha chain; MHC class I antigen A*68; HLA-A; MHC class I antigen HLA A heavy chain
|
WB, IHC-P
|
Human |
- HY-P83621
-
KIF 3; KIF 3A; Kifl; Kinesin family member 3A; Kinesin like protein KIF 3A; Kinesin-like protein KIF3A; Kns3
|
WB, IP
|
Human, Mouse, Rat |
- HY-P83634
-
CD1A; T-cell surface glycoprotein CD1a; T-cell surface antigen T6/Leu-6; hTa1 thymocyte antigen; CD antigen CD1a
|
WB, IHC-P
|
Human |
- HY-P83639
-
CYP2D6; CYP2DL1; Cytochrome P450 2D6; CYPIID6; Cytochrome P450-DB1; Debrisoquine 4-hydroxylase
|
WB, IHC-P, ICC/IF, FC
|
Human |
- HY-P80541
-
PRKAA2; AMPK; AMPK2; 5'-AMP-activated protein kinase catalytic subunit alpha-2; AMPK subunit alpha-2; Acetyl-CoA carboxylase kinase; ACACA kinase; Hydroxymethylglutaryl-CoA reductase kinase; HMGCR kinase
|
WB, IP
|
Human |
AMPK alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 62 kDa, targeting to AMPK alpha. It can be used for WB,IP assays with tag free, in the background of Human .
|
- HY-P80544
-
ANXA1; ANX1; LPC1; Annexin A1; Annexin I; Annexin-1; Calpactin II; Calpactin-2; Chromobindin-9; Lipocortin I; Phospholipase A2 inhibitory protein; p35
|
WB
|
Human, Mouse, Rat, Monkey |
Annexin A1 Antibody (YA832) is a non-conjugated and Mouse origined monoclonal antibody about 39 kDa, targeting to Annexin A1 (5E4D8). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat, Monkey.
|
- HY-P80593
-
IL7R; Interleukin-7 receptor subunit alpha; IL-7 receptor subunit alpha; IL-7R subunit alpha; IL-7R-alpha; IL-7RA; CDw127; CD antigen CD127
|
WB
|
Human |
CD127 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 52 kDa, targeting to CD127. It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80623
-
CASP3; CPP32; Caspase-3; CASP-3; Apopain; Cysteine protease CPP32; CPP-32; Protein Yama; SREBP cleavage activity 1; SCA-1
|
WB, ICC/IF
|
Human, Mouse, Rat |
Cleaved-Caspase 3 p12 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 32 kDa, targeting to Cleaved-Caspase 3 p12. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80660
-
ERBB4; HER4; Receptor tyrosine-protein kinase erbB-4; Proto-oncogene-like protein c-ErbB-4; Tyrosine kinase-type cell surface receptor HER4; p180erbB4
|
WB
|
Human, Rat |
ErbB 4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 147 kDa, targeting to ErbB 4. It can be used for WB assays with tag free, in the background of Human, Rat.
|
- HY-P80669
-
FEN1; RAD2; Flap endonuclease 1; FEN-1; DNase IV; Flap structure-specific endonuclease 1; Maturation factor 1; MF1; hFEN-1
|
WB, IP
|
Human, Mouse, Rat |
FEN1 Antibody (YA765) is a non-conjugated and Mouse origined monoclonal antibody about 43 kDa, targeting to FEN1 (1E7). It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80689
-
SLC2A4; GLUT4; Solute carrier family 2; facilitated glucose transporter member 4; Glucose transporter type 4; insulin-responsive; GLUT-4
|
WB, IHC-P, ELISA
|
Human, Mouse, Rat |
Glucose Transporter GLUT4 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 55 kDa, targeting to Glucose Transporter GLUT4. It can be used for WB,IHC-P,ELISA assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80723
-
IL6; IFNB2; Interleukin-6; IL-6; B-cell stimulatory factor 2; BSF-2; CTL differentiation factor; CDF; Hybridoma growth factor; Interferon beta-2; IFN-beta-2
|
WB, IHC-P, ELISA
|
Human |
IL-6 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 24 kDa, targeting to IL-6. It can be used for WB,IHC-P,ELISA assays with tag free, in the background of Human.
|
- HY-P80818
-
GAB1; GRB2-associated-binding protein 1; GRB2-associated binder 1; Growth factor receptor bound protein 2-associated protein 1
|
WB; IHC-P; IHC-F; ICC; IF; ELISA;
|
Human, Mouse, Rat |
Phospho-GAB1 (Tyr627) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 77 kDa, targeting to Phospho-GAB1 (Tyr627). It can be used for WB、IHC-P、IHC-F、ICC、IF、ELISA assays with tag free, in the background of Human, Mouse and Rat.
|
- HY-P80822
-
HSF1; HSTF1; Heat shock factor protein 1; HSF 1; Heat shock transcription factor 1; HSTF 1
|
WB, IHC-P
|
Human |
Phospho-HSF1 (Ser303/Ser307) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 57 kDa, targeting to Phospho-HSF1 (Ser303/Ser307). It can be used for WB,IHC-P assays with tag free, in the background of Human.
|
- HY-P80941
-
H2A.X; H2AFX; H2a/x; HIST5-2AX; Histone H2A.X; gamma H2A.X
|
WB, ICC/IF
|
Human, Mouse |
Phospho-Histone H2A.X (Ser139) Antibody is a non-conjugated and Mouse origined monoclonal antibody about 15 kDa, targeting to Histone H2AX. It can be used for WB,ICC/IF assays with N-6*His-tag, in the background of Human, Mouse.
|
- HY-P80969
-
integrin binding sialoprotein; BSP; BNSP; SP-II; BSP-II;IBSP; Bone sialoprotein II; Cell binding sialoprotein; Integrin binding sialoprotein; SIAL_HUMAN; Bone sialoprotein 2; Cell-binding sialoprotein; Integrin-binding sialoprotein.
|
WB, IHC-P, IHC-F, IF, ELISA
|
Mouse, Rat (predicted: Human) |
IBSP Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 35 kDa, targeting to IBSP. It can be used for WB, IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P81050
-
HSF1; HSTF1; Heat shock factor protein 1; HSF 1; Heat shock transcription factor 1; HSTF 1
|
WB, IF-Cell, IHC-P, IP, FC
|
Human |
Phospho-HSF1 (Ser326) Antibody(YA894) is an unconjugated, approximately 57 kDa, rabbit-derived, anti-HSF1 (Ser326)(YA894) monoclonal antibody. Phospho-HSF1 (Ser326) Antibody(YA894) can be used for: WB, IF-Cell, IHC-P, IP, FC expriments in human background without labeling.
|
- HY-P81256A
-
H4K16ac; H4F2; HIST; HIST1H4A; Histone H4.AC-H4K5; H4K5
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P81326
-
ALDH3A2; ALDH10; FALDH; Fatty aldehyde dehydrogenase; Aldehyde dehydrogenase 10; Aldehyde dehydrogenase family 3 member A2; Microsomal aldehyde dehydrogenase
|
WB
|
Human |
- HY-P81468
-
C1qa; Complement C1q subcomponent subunit A; Complement component 1 q subcomponent A chain; Complement component 1 q subcomponent alpha polypeptide
|
IHC-P
|
Human |
- HY-P81469
-
Homeobox protein Nkx 2.2; NK 2 homolog B; NK2 homeobox 2; NKX2 2; NKX22; Nkx2b
|
IHC-P
|
Human |
- HY-P81675
-
ASY; Foocen; NI220/250; NOGO; NOGOC; NSP; rat N; RTN X; Rtn4; RTN4-A; RTN4-B1; RTN4-B2; RTN4-C; Vp20
|
WB, IHC-P, ICC/IF, IP, FC
|
Human |
- HY-P81829
-
RARB; HAP; NR1B2; Retinoic acid receptor beta; RAR-beta; HBV-activated protein; Nuclear receptor subfamily 1 group B member 2; RAR-epsilon
|
WB, IHC-P, ICC/IF
|
Human |
- HY-P82076
-
RAN; ARA24; OK/SW-cl.81; GTP-binding nuclear protein Ran; Androgen receptor-associated protein 24; GTPase Ran; Ras-like protein TC4; Ras-related nuclear protein
|
WB, ICC/IF, IP
|
Human, Mouse , Monkey |
- HY-P82390
-
APPL1; APPL; DIP13A; KIAA1428; DCC-interacting protein 13-alpha; Dip13-alpha; Adapter protein containing PH domain; PTB domain and leucine zipper motif 1
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P82495
-
BAG3; BIS; BAG family molecular chaperone regulator 3; BAG-3; Bcl-2-associated athanogene 3; Bcl-2-binding protein Bis; Docking protein CAIR-1
|
WB
|
Human, Rat |
- HY-P82530
-
BIN1; AMPHL; Myc box-dependent-interacting protein 1; Amphiphysin II; Amphiphysin-like protein; Box-dependent myc-interacting protein 1; Bridging integrator 1
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82631
-
BCAM; LU; MSK19; Basal cell adhesion molecule; Auberger B antigen; B-CAM cell surface glycoprotein; F8/G253 antigen; Lutheran antigen; Lutheran blood group glycoprotein; CD239
|
WB, IHC-P, IP, FC
|
Human, Mouse, Rat |
- HY-P82654
-
Helicard; Hlcd; IDDM19; IFIH1; MDA-5; RH116; RIG I like receptor 2; RLR 2; RNA helicase DEAD box protein 116
|
WB, ICC/IF
|
Human |
- HY-P82656
-
MAP3K7IP 3; NAP1; NFkB activating protein 1; Tab3; TAK1 binding protein 3
|
WB, ICC/IF
|
Human, Mouse |
- HY-P82819
-
Gamma 1 globin; Gamma 2 globin; Gamma A hemoglobin; Gamma globin; Hb F Agamma; Hb F Ggamma; HBG1; HBG2; HBGA; HBGR
|
WB
|
Human |
- HY-P82845
-
FLN; FMD; MNS; OPD; ABPX; CSBS; CVD1; FGS2; FLN1; NHBP; OPD1; OPD2; XLVD; XMVD; FLN-A; ABP-280
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Rat |
- HY-P82881
-
CDC6; CDC18L; Cell division control protein 6 homolog; CDC6-related protein; Cdc18-related protein; HsCdc18; p62(cdc6); HsCDC6
|
WB, IHC-P, ICC/IF
|
Human |
- HY-P83085
-
SLC22A3; EMTH; OCT3; Solute carrier family 22 member 3; Extraneuronal monoamine transporter; EMT; Organic cation transporter 3
|
WB, IHC-P, FC
|
Human |
- HY-P83223
-
NME2; NM23B; Nucleoside diphosphate kinase B; NDK B; NDP kinase B; C-myc purine-binding transcription factor PUF; Histidine protein kinase NDKB; nm23-H2
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P83240
-
RAD21; HR21; KIAA0078; NXP1; Double-strand-break repair protein rad21 homolog; hHR21; Nuclear matrix protein 1; NXP-1; SCC1 homolog
|
WB, FC
|
Human, Mouse, Rat |
- HY-P83414
-
COPS5; CSN5; JAB1; COP9 signalosome complex subunit 5; SGN5; Signalosome subunit 5; Jun activation domain-binding protein 1
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P83601
-
ITK; EMT; LYK; Tyrosine-protein kinase ITK/TSK; Interleukin-2-inducible T-cell kinase; IL-2-inducible T-cell kinase; Kinase EMT; T-cell-specific kinase; Tyrosine-protein kinase Lyk
|
WB, IHC-P, FC
|
Human |
- HY-P80569
-
ARB1; ARR1; ARRB1; ARRB1_HUMAN; Arrestin 2; Arrestin beta 1; Arrestin beta-1; Beta-arrestin-1.
|
WB
|
Human |
beta Arrestin 1 Antibody (YA822) is a non-conjugated and Mouse origined monoclonal antibody about 47 kDa, targeting to beta Arrestin 1 (6A1). It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80654
-
EEF1A1; CCS-3; CCS3; EEF-1; EEF1A; EF-Tu; EF1A; GRAF-1EF; LENG7; PTI1; eEF1A-1
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
Elongation Factor 1A1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 50 kDa, targeting to Elongation Factor 1A1. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80932
-
MGC119418; MGC119419; MGC119420; Protein Wnt 3a Precursor; Protein Wnt-3a; Wingless type MMTV integration site family member 3A; Wnt 3a; WNT3A protein.
|
WB, IHC-P, IHC-F, IF, ELISA
|
Human, Mouse, Rat (predicted: Pig) |
Wnt3a Antibody is a non-conjugated and Rabbit origined Polyclonal antibody about 39 kDa, targeting to Wnt3a . It can be used for WB, IHC-P, IHC-F, IF, ELISA assays with tag free, in the background of Human.
|
- HY-P81119
-
MTR1A_HUMAN; Melatonin receptor type 1A; Melatonin Receptor 1A; Mel-1A-R; Mel1a receptor; MT1; MT 1; Mel 1A R
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human, Mouse, Rat(predicted: Chicken, Dog, Pig, Cow, Sheep, Guinea Pig) |
MTNR1A Antibody is an unconjugated, approximately 39 kDa, rabbit-derived, anti-MTNR1A polyclonal antibody. MTNR1A Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, and predicted: chicken, dog, pig, cow, sheep, guinea pig background without labeling.
|
- HY-P81141
-
Casein; alpha-S1-casein; CASA; CASA1_Cow; Casein alpha s1; casein, alpha; casein, alpha-S1, included; Casoxin-D; CSN1; CSN1S1; MGC149368.
|
WB; ELISA
|
Mouse, Cow |
Alpha casein Antibody is an unconjugated, approximately 23 kDa, rabbit-derived, anti-Alpha casein polyclonal antibody. Alpha casein Antibody can be used for: WB, ELISA expriments in (predicted) mouse, cow background without labeling.
|
- HY-P81306
-
SAFB; HAP; HET; SAFB1; Scaffold attachment factor B1; SAF-B; SAF-B1; HSP27 estrogen response element-TATA box-binding protein; HSP27 ERE-TATA-binding protein
|
WB, ICC/IF, ChIP
|
Human |
- HY-P81306A
-
SAFB; HAP; HET; SAFB1; Scaffold attachment factor B1; SAF-B; SAF-B1; HSP27 estrogen response element-TATA box-binding protein; HSP27 ERE-TATA-binding protein
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse |
- HY-P81330
-
RAD23B; UV excision repair protein RAD23 homolog B; HR23B; hHR23B; XP-C repair-complementing complex 58 kDa protein; p58
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat, Monkey, Hamster |
- HY-P81385
-
APP; A4; AD1; Amyloid beta A4 protein; ABPP; APPI; APP; Alzheimer disease amyloid protein; Cerebral vascular amyloid peptide; CVAP; PreA4; Protease nexin-II; PN-II
|
IHC-P
|
Human |
- HY-P81466
-
TARC; CCL17; SCYA17; C-C motif chemokine 17; C-C motif chemokine 17; Small-inducible cytokine A17; Thymus and activation-regulated chemokine
|
IHC-P
|
Human |
- HY-P81508
-
ANPEP; APN; CD13; PEPN; Aminopeptidase N; AP-N; hAPN; Alanyl aminopeptidase; Aminopeptidase M; AP-M; Microsomal aminopeptidase; Myeloid plasma membrane glycoprotein CD13; gp150; CD antigen CD13
|
IHC-P
|
Human |
- HY-P81685
-
FGF1; FGFA; Fibroblast growth factor 1; FGF-1; Acidic fibroblast growth factor; aFGF; Endothelial cell growth factor; ECGF; Heparin-binding growth factor 1; HBGF-1
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P81713
-
IL3RA; IL3R; Interleukin-3 receptor subunit alpha; IL-3 receptor subunit alpha; IL-3R subunit alpha; IL-3R-alpha; IL-3RA; CD123
|
FC, ELISA
|
Human |
- HY-P82072
-
UBA1; A1S9T; UBE1; Ubiquitin-like modifier-activating enzyme 1; Protein A1S9; Ubiquitin-activating enzyme E1
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82235
-
SERPING1; C1IN; C1NH; Plasma protease C1 inhibitor; C1 Inh; C1Inh; C1 esterase inhibitor; C1-inhibiting factor; Serpin G1
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82341
-
HIP116; HIP116A; HLTF 1; Hltf; HLTF1; p113; RNF80; SMARC A3; SMARCA 3; SMARCA3; SNF2L3; ZBU1
|
WB, IHC-P, ICC/IF
|
Human, Rat |
- HY-P82424
-
SRSF3; SFRS3; SRP20; Serine/arginine-rich splicing factor 3; Pre-mRNA-splicing factor SRP20; Splicing factor; arginine/serine-rich 3
|
WB, IHC-P, ICC/IF, FC
|
Mouse, Rat, Human |
- HY-P82503
-
CALCOCO3; D6Ertd404e; D6Ertd772e; PRO0105; T6BP; TAX1BP1; tax1bp1b; TXBP151
|
WB, IHC-P
|
Human |
- HY-P82647
-
CBL; CBL2; RNF55; E3 ubiquitin-protein ligase CBL; Casitas B-lineage lymphoma proto-oncogene; Proto-oncogene c-Cbl; RING finger protein 55; Signal transduction protein CBL
|
WB, ICC/IF, IP
|
Human |
- HY-P82665
-
IGFBP1; IBP1; Insulin-like growth factor-binding protein 1; IBP-1; IGF-binding protein 1; IGFBP-1; Placental protein 12; PP12
|
WB
|
Human, Mouse, Rat |
- HY-P82816
-
Homeobox1J; HomeoboxA13; HOX 1; HOX 1J; HOX A13; HOX1; HOX1J; HOXA 13; HOXA13; Transcription factor HOXA13
|
WB
|
Human, Mouse, Rat |
- HY-P82873
-
Protein NDRG1; Differentiation-related gene 1 protein; DRG-1; RTP; Rit42; NDRG1; CAP43; DRG1; RTP; targ1; TDD5; tdds
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse |
- HY-P82890
-
KRT8; CYK8; Keratin; type II cytoskeletal 8; Cytokeratin-8; CK-8; Keratin-8; K8; Type-II keratin Kb8
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P82924
-
liver; Glucose Transporter 2; Glucose Transporter GLUT2; Glucose transporter type 2; Glucose transporter; liver/islet; GLUT2; GTT2; SLC2A2
|
WB
|
Human |
- HY-P83049
-
Transcription factor 7-like 1; HMG box transcription factor 3; TCF-3; TCF7L1; TCF3
|
WB, FC
|
Human |
- HY-P83064
-
E2-2; ITF2; PTHS; SEF2; ITF-2; SEF-2; TCF-4; SEF2-1; SEF2-1A; SEF2-1B; bHLHb19
|
WB, IHC-P, FC, ChIP
|
Human |
- HY-P83100
-
DNA-binding protein inhibitor ID-1; Class B basic helix-loop-helix protein 24; bHLHb24; Inhibitor of DNA binding 1; ID1; BHLHB24; ID
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P83145
-
PKN2; PRK2; PRKCL2; Serine/threonine-protein kinase N2; PKN gamma; Protein kinase C-like 2; Protein-kinase C-related kinase 2
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P83177
-
SLC2A3; GLUT3; Solute carrier family 2; facilitated glucose transporter member 3; Glucose transporter type 3; brain; GLUT-3
|
WB
|
Human, Mouse, Rat |
- HY-P83258
-
HSPA14; HSP60; HSP70L1; Heat shock 70 kDa protein 14; HSP70-like protein 1; Heat shock protein HSP60
|
WB, ICC/IF, IP
|
Human, Mouse |
- HY-P83313
-
PRPF19; NMP200; PRP19; SNEV; Pre-mRNA-processing factor 19; Nuclear matrix protein 200; PRP19/PSO4 homolog; hPso4; Senescence evasion factor
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P83319
-
inducible T-cell co-stimulator ligand; B7H2; GL50; B7-H2; B7RP1; CD275; ICOSL; LICOS; B7RP-1; ICOS-L
|
WB, IP
|
Human |
- HY-P83364
-
I 1; I1; Inhibitor 1; IPP1; Ppp1r1a; Protein phosphatase 1 regulatory (inhibitor) subunit 1A
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P83441
-
H2A.y; H2A/y; mH2A1; H2AF12M; MACROH2A1.1; macroH2A1.2
|
WB, ICC/IF
|
Mouse, Rat |
- HY-P83545
-
Cell migration-inducing gene 5 protein; EN-7; GX; p21-Rac1; p21-Rac2; p21-Rac3; RAC1; RAC2; RAC3; TC25
|
WB
|
Human, Mouse, Rat |
- HY-P83600
-
21 kDa TBP-like protein; Second TBP of unique DNA protein; STUD; TATA box-binding protein-related factor 2; TBPL1; TLF; TLP; TLP21
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P80571
-
Adenovirus E1B19k binding protein B5; BNIP3a; BNIP3H; BNIP3L; BNIP3L protein; NIP3 like protein X; NIP3L; NIX
|
WB, IHC-P
|
Human, Mouse, Rat |
BNIP3L Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 24 kDa, targeting to BNIP3L. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80743
-
LCK; Tyrosine-protein kinase Lck; Leukocyte C-terminal Src kinase; LSK; Lymphocyte cell-specific protein-tyrosine kinase; Protein YT16; Proto-oncogene Lck; T cell-specific protein-tyrosine kinase; p56-LCK
|
WB
|
Human |
Lck Antibody (YA712) is a non-conjugated and Mouse origined monoclonal antibody about 58 kDa, targeting to Lck (3E5). It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80778
-
PAK2; Serine/threonine-protein kinase PAK 2; Gamma-PAK; PAK65; S6/H4 kinase; p21-activated kinase 2; PAK-2; p58
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Monkey |
PAK2 Antibody (YA695) is a non-conjugated and Mouse origined monoclonal antibody about 58 kDa, targeting to PAK2 (7H3). It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Monkey.
|
- HY-P80799
-
CHEK2; CDS1; CHK2; RAD53; Serine/threonine-protein kinase Chk2; CHK2 checkpoint homolog; Cds1 homolog; Hucds1; hCds1; Checkpoint kinase 2
|
WB, ICC/IF, IHC-P
|
Human, Mouse, Rat |
Phospho-Chk2 (Thr68) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 61 kDa, targeting to Phospho-Chk2 (Thr68). It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80821
-
H2A.X; H2AFX; H2a/x; HIST5-2AX; Histone H2A.X; gamma H2A.X
|
WB, IP
|
Human, Mouse, Rat |
Phospho-Histone H2A.X (Ser139) Antibody (YA191) is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Phospho-Histone H2A.X (Ser139). It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80908
-
MAP3K7; TAK1; Mitogen-activated protein kinase kinase kinase 7; Transforming growth factor-beta-activated kinase 1; TGF-beta-activated kinase 1
|
WB
|
Human, Mouse, Rat, Monkey |
TAK1 Antibody (YA663) is a non-conjugated and Mouse origined monoclonal antibody about 67 kDa, targeting to TAK1 (3G1). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat, Monkey.
|
- HY-P81068
-
Cell Death Activator; Cell death activator CIDE-3; Cell death inducing DFFA like effector protein C; CIDE 3; CIDE C; CIDEC_HUMAN; FLJ20871; FPLD5; FSP27; CIDE-3
|
WB, ICC/IF, FC
|
Human |
CIDEC Antibody (YA911) is an unconjugated, approximately 27 kDa, mouse-derived, anti-CIDEC (YA911) monoclonal antibody. CIDEC Antibody (YA911) can be used for: WB, ICC/IF, FC expriments in human background without labeling.
|
- HY-P81068A
-
Cell Death Activator; Cell death activator CIDE-3; Cell death inducing DFFA like effector protein C; CIDE 3; CIDE C; CIDEC_HUMAN; FLJ20871; FPLD5; FSP27; CIDE-3
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, Mouse, Rat(predicted: Pig, ) |
CIDEC/FSP27 Antibody is an unconjugated, approximately 27 kDa, rabbit-derived, anti-CIDEC/FSP27 polyclonal antibody. CIDEC/FSP27 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: pig backgrounds without labeling.
|
- HY-P81189
-
MYOG_HUMAN; MYOG; BHLHC3; MYF4; Class C basic helix-loop-helix protein 3 (bHLHc3); Myogenic factor 4 (Myf-4); BHLHC3; MYF4; MYF 4
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human, Mouse, Rat, Pig, Cow, Horse, Rabbit, Sheep |
Myogenin Antibody is an unconjugated, approximately 25 kDa, rabbit-derived, anti-Myogenin polyclonal antibody. Myogenin Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in (predicted) human, mouse, rat, pig, cow, horse, rabbit, sheep background without labeling.
|
- HY-P81221
-
ARHP; ARHR; AV020965; Dentin matrix acidic phosphoprotein 1; Dentin matrix protein 1; DENTMAT; DMP 1; Dmp; MGC130441; PP; Serine rich acidic phosphoprotein; DMP1_HUMAN.
|
WB; ELISA; IHC-P; IHC-F; ICC; IF
|
Human |
DMP1 Antibody is an unconjugated, approximately 54 kDa, rabbit-derived, anti-DMP1 polyclonal antibody. DMP1 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, ICC, IF expriments in (predicted) human background without labeling.
|
- HY-P81279
-
Heterogeneous nuclear ribonucleoprotein U; hnRNP U protein; HNRNPU; hnRNPU protein; HNRPU; HNRPU_HUMAN; p120; p120 nuclear protein; SAF A; SAF-A; SAFA; Scaffold attachment factor A; U21.1.
|
WB
|
Human |
- HY-P81279A
-
Heterogeneous nuclear ribonucleoprotein U; hnRNP U protein; HNRNPU; hnRNPU protein; HNRPU; HNRPU_HUMAN; p120; p120 nuclear protein; SAF A; SAF-A; SAFA; Scaffold attachment factor A; U21.1.
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P81354
-
FOLR1; FOLR; Folate receptor alpha; FR-alpha; Adult folate-binding protein; FBP; Folate receptor 1; Folate receptor; adult; KB cells FBP; Ovarian tumor-associated antigen MOv18
|
IHC-P
|
Human |
- HY-P81534
-
CD276; B7H3; PSEC0249; CD276 antigen; 4Ig-B7-H3; B7 homolog 3; B7-H3; Costimulatory molecule; CD276
|
IHC-P
|
Human |
- HY-P81644
-
NFATC1; NFAT2; NFATC; Nuclear factor of activated T-cells; cytoplasmic 1; NF-ATc1; NFATc1; NFAT transcription complex cytosolic component; NF-ATc; NFATc
|
WB
|
Human, Mouse |
- HY-P81712
-
IL2RA; Interleukin-2 receptor subunit alpha; IL-2 receptor subunit alpha; IL-2-RA; IL-2R subunit alpha; IL2-RA; TAC antigen; p55; CD25
|
FC, ELISA
|
Human |
- HY-P82034
-
Anterior gradient protein 2 homolog; AG-2; hAG-2; HPC8; Secreted cement gland protein XAG-2 homolog; AGR2; AG2; GOB4; XAG2
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Rat |
- HY-P82146
-
Dip1; LVNC7; MIB; mib1; ZZANK2; ZZZ6; DAPK-interacting protein 1; Mind bomb homolog 1; RING-type E3 ubiquitin transferase MIB1
|
WB, IHC-P, ICC/IF
|
Human, Mouse |
- HY-P82187
-
Toll-Like Receptor 2; TLR2; CD282; TIL4; Toll-like receptor 2; Toll/interleukin-1 receptor-like protein 4
|
WB, IHC-F, IHC-P, ICC/IF
|
Mouse |
- HY-P82334
-
ALYREF; ALY; BEF; THOC4; THO complex subunit 4; Tho4; Ally of AML-1 and LEF-1; Aly/REF export factor; Transcriptional coactivator Aly/REF; bZIP-enhancing factor BEF
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82456
-
atp1b3; ATPB3; CD298; FLJ29027; NKAB3S; Sodium pump subunit beta 3; Sodium/potassium dependent ATPase subunit beta 3
|
WB
|
Mouse, Rat |
- HY-P82510
-
TGM2; Protein-glutamine gamma-glutamyltransferase 2; Tissue transglutaminase; Transglutaminase C; TG(C); TGC; TGase C; Transglutaminase H; TGase H; Transglutaminase-2; TGase-2
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P82538
-
ESRRA; ERRa; ERR1; HERR1; NR3B1; Steroid hormone receptor ERR1; ERR-alpha; ERRalpha; ESRL1; Estrogen receptor-like 1; Estrogen-related receptor alpha
|
WB, IP, FC
|
Human, Mouse, Rat |
- HY-P82592
-
CAM kinase 2 delta; CAM kinase II delta; CaM kinase II delta subunit; CaM kinase II subunit delta; CAMK 2d; CaMK-II delta subunit; CAMK2D; CAMKI
|
WB
|
Human, Rat |
- HY-P82663
-
IRF4; MUM1; Interferon regulatory factor 4; IRF-4; Lymphocyte-specific interferon regulatory factor; LSIRF; Multiple myeloma oncogene 1; NF-EM5
|
WB, IHC-P, ICC/IF, IP, FC
|
Human |
- HY-P82764
-
PA2G4; EBP1; Proliferation-associated protein 2G4; Cell cycle protein p38-2G4 homolog; hG4-1; ErbB3-binding protein 1
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82791
-
KDM4B; JHDM3B; JMJD2B; KIAA0876; Lysine-specific demethylase 4B; JmjC domain-containing histone demethylation protein 3B; Jumonji domain-containing protein 2B
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82907
-
DBF4; ASK; DBF4A; ZDBF1; Protein DBF4 homolog A; Activator of S phase kinase; Chiffon homolog A; DBF4-type zinc finger-containing protein 1
|
WB
|
Human |
- HY-P82949
-
PLCB3; 1-phosphatidylinositol 4; 5-bisphosphate phosphodiesterase beta-3; Phosphoinositide phospholipase C-beta-3; Phospholipase C-beta-3; PLC-beta-3
|
WB, IHC-P
|
Human |
- HY-P83078
-
P150; Phosphoinositide 3 kinase regulatory subunit 4; PI3 kinase p150 subunit; PIK3R4; VPS15
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P83386
-
PTGES3; P23; TEBP; Prostaglandin E synthase 3; Cytosolic prostaglandin E2 synthase; cPGES; Hsp90 co-chaperone; Progesterone receptor complex p23; Telomerase-binding protein p23
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P83411
-
C-X-C motif chemokine 4; CXCL4; Iroplact; OncostatinA; PF4; Platelet factor 4; SCYB4; short form; Small inducible cytokine subfamily member 4
|
WB, IHC-P, IP
|
Human, Rat |
- HY-P83421
-
AD4BP; ELP; FTZ1; FTZF1; hSF 1; NR5A1; POF7; SF1; SPGF8; SRXY3; STF1; SF-1
|
WB
|
Human, Mouse, Rat |
- HY-P83456
-
ITGA4; CD49D; Integrin alpha-4; CD49 antigen-like family member D; Integrin alpha-IV; VLA-4 subunit alpha; CD49d
|
WB
|
Human |
- HY-P83471
-
RNF14; ARA54; HRIHFB2038; E3 ubiquitin-protein ligase RNF14; Androgen receptor-associated protein 54; HFB30; RING finger protein 14; Triad2 protein
|
WB
|
Human, Mouse, Rat |
- HY-P83515
-
TBP; GTF2D1; TF2D; TFIID; TATA-box-binding protein; TATA sequence-binding protein; TATA-binding factor; TATA-box factor; Transcription initiation factor TFIID TBP subunit
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse |
- HY-P83571
-
S100A1; S100A; Protein S100-A1; S-100 protein alpha chain; S-100 protein subunit alpha; S100 calcium-binding protein A1
|
WB, IHC-P, IP, FC
|
Human, Mouse |
- HY-P83574
-
DAPK3; ZIPK; Death-associated protein kinase 3; DAP kinase 3; DAP-like kinase; Dlk; MYPT1 kinase; Zipper-interacting protein kinase; ZIP-kinase
|
WB
|
Human |
- HY-P80609
-
CD86; CD28LG2; T-lymphocyte activation antigen CD86; Activation B7-2 antigen; B70; BU63; CTLA-4 counter-receptor B7.2; FUN-1; CD antigen CD86
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Rat |
CD86 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 38 kDa, targeting to CD86. It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Human, Rat.
|
- HY-P80772
-
p-pg; ABCB1; MDR1; PGY1; Multidrug resistance protein 1; ATP-binding cassette sub-family B member 1; P-glycoprotein 1; CD antigen CD243
|
WB
|
Human |
P Glycoprotein Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 141 kDa, targeting to P Glycoprotein. It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80858
-
MAP3K7; TAK1; Mitogen-activated protein kinase kinase kinase 7; Transforming growth factor-beta-activated kinase 1; TGF-beta-activated kinase 1
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
Phospho-TAK1 (Ser439) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 67 kDa, targeting to Phospho-TAK1 (Ser439). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80862
-
NTRK2; TRKB; BDNF/NT-3 growth factors receptor; GP145-TrkB; Trk-B; Neurotrophic tyrosine kinase receptor type 2; TrkB tyrosine kinase; Tropomyosin-related kinase B
|
WB
|
Human, Mouse, Rat |
Phospho-TrkA/B (Tyr490/Tyr516) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 92 kDa, targeting to Phospho-TrkA/B (Tyr490/Tyr516). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P81110
-
Telomerase catalytic subunit; EST2; hEST2; TCS1; Telomerase associated protein 2; Telomere Reverse Transcriptase; TP2; TRT; Telomerase reverse transcriptase; Telomerase Catalytic Subunit; Telomerase-associated protein 2; TERT_HUMAN.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; ICC; IF
|
Human, Mouse, Rat, |
TERT Antibody is an unconjugated, approximately 125 kDa, rabbit-derived, anti-TERT polyclonal antibody. TERT Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, rat, background without labeling.
|
- HY-P81260
-
B2MG; Beta 2 microglobin; Beta 2 microglobulin; Beta-2-microglobulin form pI 5.3; CDABP0092; Hdcma22p
|
ELISA
|
Human |
- HY-P81260A
-
B2MG; Beta 2 microglobin; Beta 2 microglobulin; Beta-2-microglobulin form pI 5.3; CDABP0092; Hdcma22p
|
WB, IP
|
Human, Mouse, Rat |
- HY-P81264
-
CHD3; Chromodomain-helicase-DNA-binding protein 3; CHD-3; ATP-dependent helicase CHD3; Mi-2 autoantigen 240 kDa protein; Mi2-alpha; Zinc finger helicase; hZFH
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P81264A
-
CHD3; Chromodomain-helicase-DNA-binding protein 3; CHD-3; ATP-dependent helicase CHD3; Mi-2 autoantigen 240 kDa protein; Mi2-alpha; Zinc finger helicase; hZFH
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P81295
-
CDC6; CDC18L; Cell division control protein 6 homolog; CDC6-related protein; Cdc18-related protein; HsCdc18; p62(cdc6); HsCDC6
|
WB
|
Human, Rat |
- HY-P81295A
-
CDC6; CDC18L; Cell division control protein 6 homolog; CDC6-related protein; Cdc18-related protein; HsCdc18; p62(cdc6); HsCDC6
|
WB, ICC/IF
|
Human |
- HY-P81413
-
ARID1A; BAF250; C1orf4; ELD; HOSA1; Osa homolog 1; OSA1 nuclear protein; SMARCF1; MRD14; p270; B120; BM029
|
IHC-P
|
Human |
- HY-P81480
-
IL4I1; FIG1 ; UNQ636/PRO1265 ; L-amino-acid oxidase ; Interleukin-4-induced protein 1; hIL4I1 ; Protein Fig-1 ; LAAO; LAO
|
IHC-P
|
Human |
- HY-P81706
-
inducible T-cell co-stimulator ligand; B7H2; GL50; B7-H2; B7RP1; CD275; ICOSL; LICOS; B7RP-1; ICOS-L
|
FC, ELISA
|
Human |
- HY-P81811
-
PDGFB; PDGF2; SIS; Platelet-derived growth factor subunit B; PDGF subunit B; PDGF-2; Platelet-derived growth factor B chain; Platelet-derived growth factor beta polypeptide; Proto-oncogene c-Sis; Becaplermin
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P81875
-
AAT4; FAA4; MYH11; Myosin 11; Myosin heavy chain 11; Myosin heavy chain smooth muscle isoform; Myosin heavy polypeptide 11 smooth muscle; SMHC; SMMHC
|
WB, IHC-P
|
Human, Mouse |
- HY-P81901
-
P2Y15; Alpha-ketoglutarate receptor 1; G-protein coupled receptor 80; G-protein coupled receptor 99; P2Y purinoceptor 15
|
WB
|
Human, Rat |
- HY-P82093
-
SYNCRIP; HNRPQ; NSAP1; Heterogeneous nuclear ribonucleoprotein Q; hnRNP Q; Glycine- and tyrosine-rich RNA-binding protein; GRY-RBP; NS1-associated protein 1; Synaptotagmin-binding; cytoplasmic RNA-interacting protein
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82348
-
MLC2; CMH10; MLC-2C; Myosin RLC; Myosin regulatory light chain 2; smooth muscle isoform; Myosin regulatory light chain 9; Myosin regulatory light chain MRLC1
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P82366
-
1C9 2; hTom 22; hTom22; MST065; MSTP 065; MSTP065; TOM 22; TOM22; TOMM 22
|
WB, IHC-P, ICC/IF, IP, FC
|
Human |
- HY-P82372
-
AP-3 adaptor complex mu3A subunit; Adaptor-related protein complex 3 subunit mu-1; Mu-adaptin 3A; Mu3A-adaptin
|
WB
|
Human, Mouse, Rat |
- HY-P82389
-
TAF15; RBP56; TAF2N; TATA-binding protein-associated factor 2N; 68 kDa TATA-binding protein-associated factor; TAF(II)68; TAFII68; RNA-binding protein 56
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82616
-
IL2RA; Interleukin-2 receptor subunit alpha; IL-2 receptor subunit alpha; IL-2-RA; IL-2R subunit alpha; IL2-RA; TAC antigen; p55; CD25
|
IHC-P, ICC/IF
|
Human |
- HY-P82680
-
CD247; CD3Z; T3Z; TCRZ; T-cell surface glycoprotein CD3 zeta chain; T-cell receptor T3 zeta chain; CD antigen CD247
|
WB, IP
|
Human |
- HY-P82712
-
ACVRL1; ACVRLK1; ALK1; Serine/threonine-protein kinase receptor R3; SKR3; Activin receptor-like kinase 1; ALK-1; TGF-B superfamily receptor type I; TSR-I
|
WB
|
Human, Mouse, Rat |
- HY-P82797
-
CXCL10; INP10; SCYB10; C-X-C motif chemokine 10; 10 kDa interferon gamma-induced protein; Gamma-IP10; IP-10; Small-inducible cytokine B10
|
WB
|
Human |
- HY-P82818
-
DPYSL4; CRMP3; ULIP4; Dihydropyrimidinase-related protein 4; DRP-4; Collapsin response mediator protein 3; CRMP-3; UNC33-like phosphoprotein 4; ULIP-4
|
WB
|
Rat |
- HY-P82947
-
EBI3; IL27B; Interleukin-27 subunit beta; IL-27 subunit beta; IL-27B; Epstein-Barr virus-induced gene 3 protein; EBV-induced gene 3 protein
|
WB
|
Human, Mouse, Rat |
- HY-P83350
-
IL-1 Receptor Antagonist Protein; DIRA; IRAP; IL1F3; IL1RA; MVCD4; IL-1RN; IL-1ra; IL-1ra3; ICIL-1RA
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse |
- HY-P83431
-
Cell division cycle-associated protein 3; Trigger of mitotic entry protein 1; TOME-1; Gene-rich cluster protein C8; CDCA3; C8; GRCC8; TOME1
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P83548
-
NCK2; GRB4; Cytoplasmic protein NCK2; Growth factor receptor-bound protein 4; NCK adaptor protein 2; Nck-2; SH2/SH3 adaptor protein NCK-beta
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P83578
-
MEK6; MKK6; MAPKK6; PRKMK6; SAPKK3; MAP2K6; MEK3; MAP kinase kinase 3; MAPKK3; MAPK/ERK kinase 3
|
WB, ICC/IF, IP
|
Human, Mouse |
- HY-P83607
-
Antithrombin; Antithrombin III; AT 3; AT III; AT3; AT3D; ATIII; Heparin cofactor I; Serpin C1; Serpin family C member 1; SERPINC1; THPH7
|
WB, ICC/IF
|
Human |
- HY-P83655
-
bA540M5.1; Nuclear FMRP interacting protein 1; Nuclear fragile X mental retardation interacting protein 1; nuclear fragile X mental retardation protein interacting protein 1; NUFIP.
|
WB, IHC-P, IHC-F, ICC, IF, ELISA
|
Human, Mouse, Rat |
- HY-P81096
-
CD14 antigen; CD14 molecule; Lipopolysaccharide receptor; LPSR; Monocyte Differentiation Antigen 14; Monocyte differentiation antigen CD14; Myeloid cell specific leucine rich glycoprotein; CD14_MOUSE; Myeloid cell-specific leucine-rich glycoprotein.
|
WB; ELISA; IHC-P; IHC-F; ICC; IF
|
Human, Mouse(predicted: Rat, Dog, Pig, Cow, Rabbit, Sheep) |
CD14 Antibody is an unconjugated, approximately 35/40 kDa, rabbit-derived, anti-CD14 polyclonal antibody. CD14 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, ICC, IF expriments in human, mouse, and predicted: rat, dog, pig, cow, rabbit, sheep background without labeling.
|
- HY-P81113
-
Interleukin-10 precursor; Cytokine synthesis inhibitory factor; CSIF; Cytokine Synthesis Inhibitory Factor; IL 10; IL10A; Interleukin 10; Interleukin10; MGC126450; MGC126451; TGIF; IL10_HUMAN. 白介素10
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human, Mouse(predicted: Rat, Chicken, Pig, Rabbit, Sheep, Guinea Pig) |
IL-10 Antibody is an unconjugated, approximately 18 kDa, rabbit-derived, anti-IL-10 polyclonal antibody. IL-10 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, and predicted: rat, chicken, pig, rabbit, sheep, guinea pig background without labeling.
|
- HY-P81138
-
activated leukocyte cell adhesion molecule; ALCAM protein; ALCAM; CD 166; CD166 antigen; FLJ38514; MEMD; MGC71733; FLJ3851; AI853494; BEN; DM-GRASP; MGC27910; MuSC; SC1; CD166_HUMAN.
|
WB; ELISA; IHC-F; Flow-Cyt; IF
|
Human(predicted: Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit) |
CD166 Antibody is an unconjugated, approximately 62 kDa, rabbit-derived, anti-CD166 polyclonal antibody. CD166 Antibody can be used for: WB, ELISA, IHC-F, Flow-Cyt, IF expriments in human, and predicted: mouse, rat, chicken, dog, pig, cow, horse, rabbit background without labeling.
|
- HY-P81151
-
MT2; melatonin receptor type 1B; melatonin receptor; MEL1B; MEL-1B-R; Mtnr1b; MGC129286; MGC129287; MTNR-1B; Melatonin receptor 1B; MTR1B_HUMAN.
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human, Mouse, Rat(predicted: Dog) |
MTNR1B Antibody is an unconjugated, approximately 40 kDa, rabbit-derived, anti-MTNR1B polyclonal antibody. MTNR1B Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, and predicted: dog background without labeling.
|
- HY-P81294
-
CBL; CBL2; RNF55; E3 ubiquitin-protein ligase CBL; Casitas B-lineage lymphoma proto-oncogene; Proto-oncogene c-Cbl; RING finger protein 55; Signal transduction protein CBL
|
WB, IP
|
Human, Rat |
- HY-P81294A
-
CBL; CBL2; RNF55; E3 ubiquitin-protein ligase CBL; Casitas B-lineage lymphoma proto-oncogene; Proto-oncogene c-Cbl; RING finger protein 55; Signal transduction protein CBL
|
WB
|
Human |
- HY-P81408
-
ZEB1; TCF8; AREB6; Zinc finger E-box-binding homeobox 1; NIL-2-A zinc finger protein; Negative regulator of IL2; Transcription factor 8 (TCF-8)
|
IHC-P
|
Human |
- HY-P81444
-
CSF1R; FMS; Macrophage colony-stimulating factor 1 receptor; CSF-1 receptor; CSF-1-R; CSF-1R; M-CSF-R; Proto-oncogene c-Fms; CD antigen CD115
|
IHC-P
|
Human |
- HY-P81528
-
LMO2; RBTN2, RBTNL1, RHOM2, TTG2; Rhombotin-2; Cysteine-rich protein TTG-2; LIM domain only protein 2 (LMO-2); T-cell translocation protein 2
|
IHC-P
|
Human |
- HY-P81605
-
CD276; B7H3; PSEC0249; CD276 antigen; 4Ig-B7-H3; B7 homolog 3; B7-H3; Costimulatory molecule; CD276
|
WB, IP, FC
|
Human, Mouse |
- HY-P81759
-
TNFRSF4; TXGP1L; Tumor necrosis factor receptor superfamily member 4; ACT35 antigen; OX40L receptor; TAX transcriptionally-activated glycoprotein 1 receptor; CD antigen CD134
|
FC, ELISA
|
Human |
- HY-P81866
-
IKBKE; IKKE; IKKI; KIAA0151; Inhibitor of nuclear factor kappa-B kinase subunit epsilon; I-kappa-B kinase epsilon; IKK-E; IKK-epsilon; IkBKE; Inducible I kappa-B kinase; IKK-i
|
WB, IHC-P, ICC/IF, FC
|
Human |
- HY-P81979
-
FJHN; HNF 1B; HNF 2; HNF1 beta; HNF1B; HNF2; HPC11; LFB3; MODY5; TCF 2; TCF2; vHNF1
|
WB
|
Human |
- HY-P82388
-
CLASP1; KIAA0622; MAST1; CLIP-associating protein 1; Cytoplasmic linker-associated protein 1; Multiple asters homolog 1; Protein Orbit homolog 1; hOrbit1
|
WB, IHC-P, ICC/IF, FC
|
Mouse, Rat, Human |
- HY-P82688
-
HLA-DQA1; CD; CELIAC1; DQ-A1; GSE; HLA-DQA; DQ alpha 1 chain; DC-1 alpha chain; DC-alpha; HLA-DCA; MHC class II DQA1
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P82823
-
APP; A4; AD1; Amyloid beta A4 protein; ABPP; APPI; APP; Alzheimer disease amyloid protein; Cerebral vascular amyloid peptide; CVAP; PreA4; Protease nexin-II; PN-II
|
WB, ICC/IF, IP
|
Human, Rat |
- HY-P83183
-
MU; H-B; GST1; GTH4; GTM1; MU-1; GSTM1-1; MGC26563; GSTM1a-1a; GSTM1b-1b
|
WB
|
Human, Hamster |
- HY-P83327
-
WASF2; WAVE2; Wiskott-Aldrich syndrome protein family member 2; WASP family protein member 2; Protein WAVE-2; Verprolin homology domain-containing protein 2
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P83379
-
EIF2C3; Argonaute3; Argonaute 3; AGO3; EIF-2C 3; HAgo3; EIF2C 3; Protein argonaute-3
|
WB
|
Human, Mouse, Rat |
- HY-P83433
-
Paired box 8; Paired box gene 8; paired box homeotic gene 8; Paired box protein Pax 8; Paired domain gene 8; PAX8
|
WB, IHC-P, ICC/IF
|
Human |
- HY-P83470
-
MAP3K2; MAPKKK2; MEKK2; Mitogen-activated protein kinase kinase kinase 2; MAPK/ERK kinase kinase 2; MEK kinase 2; MEKK 2
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P83586
-
KDM4A; JHDM3A; JMJD2; JMJD2A; KIAA0677; Lysine-specific demethylase 4A; JmjC domain-containing histone demethylation protein 3A; Jumonji domain-containing protein 2A
|
WB, IP
|
Human |
- HY-P80548
-
PYCARD; ASC; CARD5; TMS1; Apoptosis-associated speck-like protein containing a CARD; hASC; Caspase recruitment domain-containing protein 5; PYD and CARD domain-containing protein; Target of methylation-induced silencing 1
|
WB, IHC-F, IHC-P, ICC/IF, ELISA
|
Human, Mouse, Rat |
ASC Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 22 kDa, targeting to ASC. It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80579
-
CALU; CALU_HUMAN; Calumenin 1; Calumenin 2; Calumenin; Crocalbin; crocalbin-like protein; FLJ90608; IEF SSP 9302; multiple EF-hand protein; OTTHUMP00000212712; OTTHUMP00000212713; OTTHUMP00000212714; OTTHUMP00000212715.
|
WB
|
Human, Mouse |
Calumenin Antibody (YA813) is a non-conjugated and Mouse origined monoclonal antibody about 37 kDa, targeting to Calumenin (4C6). It can be used for WB assays with tag free, in the background of Human, Mouse.
|
- HY-P80587
-
CASP1; IL1BC; IL1BCE; Caspase-1; CASP-1; Interleukin-1 beta convertase; IL-1BC; Interleukin-1 beta-converting enzyme; ICE; IL-1 beta-converting enzyme; p45
|
WB, IHC-P, ELISA
|
Human, Mouse, Rat |
Caspase 1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 45 kDa, targeting to Caspase 1. It can be used for WB,IHC-P,ELISA assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80606
-
CD79A; IGA; MB1; B-cell antigen receptor complex-associated protein alpha chain; Ig-alpha; MB-1 membrane glycoprotein; Membrane-bound immunoglobulin-associated protein; Surface IgM-associated protein; CD antigen CD79a
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
CD79a Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 25 kDa, targeting to CD79a. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human.
|
- HY-P80764
-
NFKB1; Nuclear factor NF-kappa-B p105 subunit; DNA-binding factor KBF1; EBP-1; Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
WB
|
Human, Mouse, Rat |
NF-KB p105 Antibody (YA700) is a non-conjugated and Mouse origined monoclonal antibody about 105 kDa, targeting to NF-KB p105 (5E3). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80782
-
PRDX1; PAGA; PAGB; TDPX2; Peroxiredoxin-1; Natural killer cell-enhancing factor A; NKEF-A; Proliferation-associated gene protein; PAG; Thioredoxin peroxidase 2; Thioredoxin-dependent peroxide reductase 2
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
Peroxiredoxin 1 Antibody (YA692) is a non-conjugated and Mouse origined monoclonal antibody about 22 kDa, targeting to Peroxiredoxin 1 (6A6). It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80795
-
ITGB2; CD18; MFI7; Integrin beta-2; Cell surface adhesion glycoproteins LFA-1/CR3/p150; 95 subunit beta; Complement receptor C3 subunit beta; CD antigen CD18
|
WB, IP
|
Human, Mouse, Rat |
Phospho-CD18 (Ser745) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 85 kDa, targeting to Phospho-CD18 (Ser745). It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80897
-
SOCS1; SSI1; TIP3; Suppressor of cytokine signaling 1; SOCS-1; JAK-binding protein; JAB; STAT-induced STAT inhibitor 1; SSI-1; Tec-interacting protein 3; TIP-3
|
ICC/IF, WB, IHC-F, IHC-P, ELISA
|
Human, Mouse, Rat |
SOCS1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 24 kDa, targeting to SOCS1. It can be used for ICC/IF,WB,IHC-F,IHC-P,ELISA assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P81163
-
Cathepsin K; Procathepsin K; Cathepsin K precursor; Cathepsin O; Cathepsin O1; Cathepsin O2; Cathepsin X; CathepsinK; CTS02; CTSK; CTSK protein; CTSO; CTSO1; CTSO2; MGC23107; PKND; PYCD; Pycnodysostosis; cath-K; CK.
|
WB; ELISA; IHC-P; IHC-F; IF
|
Rat(predicted: Human, Mouse, Dog, Pig, Cow, Horse, Guinea Pig) |
Cathepsin K Antibody is an unconjugated, approximately 36 kDa, rabbit-derived, anti-Cathepsin K polyclonal antibody. Cathepsin K Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in rat, and predicted: human, mouse, dog, pig, cow, horse, guinea pig background without labeling.
|
- HY-P81289
-
NME1; NDPKA; NM23; Nucleoside diphosphate kinase A; NDK A; NDP kinase A; Granzyme A-activated DNase; GAAD; Metastasis inhibition factor nm23; Tumor metastatic process-associated protein; nm23-H1
|
WB
|
Human, Mouse, Rat |
- HY-P81289A
-
NME1; NDPKA; NM23; Nucleoside diphosphate kinase A; NDK A; NDP kinase A; Granzyme A-activated DNase; GAAD; Metastasis inhibition factor nm23; Tumor metastatic process-associated protein; nm23-H1
|
WB
|
Human |
- HY-P81303
-
SIRT1; SIR2L1; NAD-dependent protein deacetylase sirtuin-1; hSIRT1; Regulatory protein SIR2 homolog 1; SIR2-like protein 1; hSIR2
|
WB, IHC-P, ICC/IF
|
Human |
- HY-P81303A
-
SIRT1; SIR2L1; NAD-dependent protein deacetylase sirtuin-1; hSIRT1; Regulatory protein SIR2 homolog 1; SIR2-like protein 1; hSIR2
|
WB
|
Human |
- HY-P81320
-
TBL1X; TBL1; F-box-like/WD repeat-containing protein TBL1X; SMAP55; Transducin beta-like protein 1X; Transducin-beta-like protein 1; X-linked
|
WB, ICC/IF
|
Human |
- HY-P81352
-
TPBG,5T4,5T4 oncofetal antigen,5T4 oncofetal trophoblast glycoprotein (5T4 oncotrophoblast glycoprotein),M6P1,Wnt-activated inhibitory factor 1 (WAIF1)
|
IHC-P
|
Human |
- HY-P81368
-
AKR1B10; AKR1B11; Aldo-keto reductase family 1 member B10; ARL-1; Aldose reductase-like; Aldose reductase-related protein (ARP; hARP); Small intestine reductase (SI reductase)
|
IHC-P
|
Human |
- HY-P81381
-
ASCL1; ASH1, BHLHA46; HASH1; Achaete-scute homolog 1; ASH-1; hASH1 ; Class A basic helix-loop-helix protein 46
|
IHC-P
|
Human |
- HY-P81518
-
LRE1; L1RE1; LINE-1 retrotransposable element ORF1 protein; L1ORF1p; LINE retrotransposable element 1; LINE1 retrotransposable element 1
|
IHC-P
|
Human |
- HY-P81681
-
NR1D1; EAR1; HREV; THRAL; Nuclear receptor subfamily 1 group D member 1; Rev-erbA-alpha; V-erbA-related protein 1; EAR-1
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P81692
-
Death domain containing protein p84N5; HPR1; hTREX84; Nuclear matrix protein p84; p84N5; THO complex 1; Tho1; Thoc1
|
WB, ICC/IF
|
Human |
- HY-P81707
-
PTH1R; PTHR; PTHR1; Parathyroid hormone/parathyroid hormone-related peptide receptor; PTH/PTHrP type I receptor; PTH/PTHr receptor; Parathyroid hormone 1 receptor; PTH1 receptor
|
WB, IP
|
Human |
- HY-P81730
-
TNFSF4; TXGP1; Tumor necrosis factor ligand superfamily member 4; Glycoprotein Gp34; OX40 ligand; OX40L; TAX transcriptionally-activated glycoprotein 1; CD antigen CD252
|
FC, ELISA
|
Human |
- HY-P81736
-
APAF; APAF-1; APAF1; apoptotic peptidase activating factor 1; apoptotic protease activating factor 1; Apoptotic protease-activating factor 1; CED4; DKFZp781B1145; KIAA0413
|
WB, IHC-P, ICC/IF
|
Human, Mouse |
- HY-P81840
-
PRDX2; NKEFB; TDPX1; Peroxiredoxin-2; Natural killer cell-enhancing factor B; NKEF-B; PRP; Thiol-specific antioxidant protein; TSA; Thioredoxin peroxidase 1; Thioredoxin-dependent peroxide reductase 1
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P81947
-
MAD2L1; MAD2; Mitotic spindle assembly checkpoint protein MAD2A; HsMAD2; Mitotic arrest deficient 2-like protein 1; MAD2-like protein 1
|
WB
|
Human |
- HY-P82577
-
COUP-TF1; EAR3; ERBAL3; NR2F1; NR2F2; Nuclear receptor subfamily 2 group F member 1; SVP44; TCFCOUP1; TFCOUP1
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82889
-
GGT1; GGT; Gamma-glutamyltranspeptidase 1; GGT 1; Gamma-glutamyltransferase 1; Glutathione hydrolase 1; Leukotriene-C4 hydrolase; CD224
|
WB, IHC-P
|
Human |
- HY-P83192
-
GUCY1A3; GC-S-alpha-1; GUC1A3; GUCA3; GCS-alpha-3; GUCY1A1; GC-SA3; GCS-alpha-1; GUCSA3
|
WB
|
Human |
- HY-P83299
-
H2AK9ac; H2A; H2A1B; H2AFM; HIST1H2A; Histone H2A.2; Histone H2A/a
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P83311
-
HSPA2; Heat shock 70kD protein 2; HSP70-2; HSP70-3; Heat shock 70 kDa protein 2; Heat shock 70kDa protein 2
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P83362
-
ITGA2; CD49B; Integrin alpha-2; CD49 antigen-like family member B; Collagen receptor; Platelet membrane glycoprotein Ia; GPIa; VLA-2 subunit alpha; CD49b
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P83473
-
GRM2; GPRC1B; MGLUR2; Metabotropic glutamate receptor 2; mGluR2; GRM3; GPRC1C; MGLUR3; Metabotropic glutamate receptor 3; mGluR3
|
WB, IHC-P
|
Human, Mouse |
- HY-P83620
-
HLP; CP33; CP34; CYP3A; NF-25; CYP3A3; P450C3; CYPIIIA3; CYPIIIA4; P450PCN1; CYP3A4
|
WB, IHC-P, IP
|
Human |
- HY-P83657
-
Myelin Protein Zero Rabbit pAb; peripheral myelin prothein Zero; MPZ; MPP; Myelin P0 protein; CHM; CMT1; CMT1B; DSS; MYELIN GLYCOPROTEIN P-ZERO; MYELIN PROTEIN PERIPHERAL; Myelin protein zero; P0; MYP0_HUMAN.
|
WB, IHC-P, IHC-F, IF, ELISA
|
Mouse, Rat, Dog |
- HY-P80522
-
PYCARD; ASC; CARD5; TMS1; Apoptosis-associated speck-like protein containing a CARD; hASC; Caspase recruitment domain-containing protein 5; PYD and CARD domain-containing protein; Target of methylation-induced silencing 1
|
WB, ICC/IF, FC
|
Human |
TMS1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 22 kDa, targeting to TMS1. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human.
|
- HY-P80536
-
ALDH1A1; ALDC; ALDH1; PUMB1; Retinal dehydrogenase 1; RALDH 1; RalDH1; ALDH-E1; ALHDII; Aldehyde dehydrogenase family 1 member A1; Aldehyde dehydrogenase; cytosolic
|
WB, IHC-P, IP
|
Human, Mouse |
ALDH1A1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 55 kDa, targeting to ALDH1A1. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse.
|
- HY-P80540
-
PRKAA2; AMPK; AMPK2; 5'-AMP-activated protein kinase catalytic subunit alpha-2; AMPK subunit alpha-2; Acetyl-CoA carboxylase kinase; ACACA kinase; Hydroxymethylglutaryl-CoA reductase kinase; HMGCR kinase
|
WB, IP
|
Human, Rat |
AMPK alpha 2 Antibody (YA623) is a non-conjugated and Rabbit origined monoclonal antibody about 62 kDa, targeting to AMPK alpha 2. It can be used for WB,IP assays with tag free, in the background of Human, Rat.
|
- HY-P80561
-
AIK; ARK1; AYK1; Aurora-A; Aurora-related kinase 1; BTAK; IAK1; Ipl1- and aurora-related kinase 1; STK15; STK6; Serine/threonine kinase 15
|
WB, ICC/IF
|
Human, Monkey |
Aurora A Antibody (YA827) is a non-conjugated and Mouse origined monoclonal antibody about 46 kDa, targeting to Aurora A (2E3). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Monkey.
|
- HY-P80622
-
CASP1; IL1BC; IL1BCE; Caspase-1; CASP-1; Interleukin-1 beta convertase; IL-1BC; Interleukin-1 beta-converting enzyme; ICE; IL-1 beta-converting enzyme; p45
|
WB, ICC/IF, IHC-F, IHC-P, ELISA
|
Human, Mouse |
Cleaved-Caspase 1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 45 kDa, targeting to Cleaved-Caspase 1. It can be used for WB,ICC/IF,IHC-F,IHC-P,ELISA assays with tag free, in the background of Human, Mouse.
|
- HY-P80679
-
AIFM2; AMID; PRG3; Apoptosis-inducing factor 2; Apoptosis-inducing factor homologous mitochondrion-associated inducer of death; Apoptosis-inducing factor-like mitochondrion-associated inducer of death; p53-responsive gene 3 protein
|
WB, IHC-F, IHC-P, ICC/IF, ELISA
|
Human, Mouse, Monkey |
FSP1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 41 kDa, targeting to FSP1. It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Mouse, Monkey.
|
- HY-P80700
-
EC 3.5.1.98; HA6116; HD 4; HD4; HDAC 4; HDAC A; HDAC4; HDAC4_HUMAN; HDACA; Histone Deacetylase 4; Histone Deacetylase A; KIAA0288.
|
WB, IP
|
Human, Mouse, Rat, Monkey |
HDAC4 Antibody (YA741) is a non-conjugated and Mouse origined monoclonal antibody about 119 kDa, targeting to HDAC4 (4A3). It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Rat, Monkey.
|
- HY-P80705
-
ARNT; BHLHE2; Aryl hydrocarbon receptor nuclear translocator; ARNT protein; Class E basic helix-loop-helix protein 2; bHLHe2; Dioxin receptor; nuclear translocator; Hypoxia-inducible factor 1-beta; HIF-1-beta; HIF1-beta
|
WB, IHC-P
|
Human, Mouse, Rat, Hamster |
HIF1 beta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 87 kDa, targeting to HIF1 beta. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat, Hamster.
|
- HY-P80731
-
KDM1A; AOF2; KDM1; KIAA0601; LSD1; Lysine-specific histone demethylase 1A; BRAF35-HDAC complex protein BHC110; Flavin-containing amine oxidase domain-containing protein 2
|
WB
|
Human, Mouse, Monkey |
KDM1A Antibody (YA718) is a non-conjugated and Mouse origined monoclonal antibody about 93 kDa, targeting to KDM1A (1B2). It can be used for WB assays with tag free, in the background of Human, Mouse, Monkey.
|
- HY-P80744
-
CSDD1; FLJ12457; LIN 28; Lin-28A; LIN28; LIN28A; LN28A_HUMAN; Protein lin-28 homolog A; ZCCHC1; Zinc finger CCHC domain-containing protein 1.
|
WB
|
Human, Mouse |
LIN28A Antibody (YA711) is a non-conjugated and Mouse origined monoclonal antibody about 23 kDa, targeting to LIN28A (2C1). It can be used for WB assays with tag free, in the background of Human, Mouse.
|
- HY-P80783
-
PPARGC1A; LEM6; PGC1; PGC1A; PPARGC1; Peroxisome proliferator-activated receptor gamma coactivator 1-alpha; PGC-1-alpha; PPAR-gamma coactivator 1-alpha; PPARGC-1-alpha; Ligand effect modulator 6
|
WB
|
Human, Mouse, Rat |
PGC1 alpha Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 91 kDa, targeting to PGC1 alpha. It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80791
-
PRKAA2; AMPK; AMPK2; 5'-AMP-activated protein kinase catalytic subunit alpha-2; AMPK subunit alpha-2; Acetyl-CoA carboxylase kinase; ACACA kinase; Hydroxymethylglutaryl-CoA reductase kinase; HMGCR kinase
|
WB
|
Human, Mouse, Rat |
Phospho-AMPK alpha 2 (Thr172) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 62 kDa, targeting to Phospho-AMPK alpha 2 (Thr172). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80828
-
ERN1; IRE1; Serine/threonine-protein kinase/endoribonuclease IRE1; Endoplasmic reticulum-to-nucleus signaling 1; Inositol-requiring protein 1; hIRE1p; Ire1-alpha; IRE1a
|
WB, IP
|
Human |
Phospho-IRE1 (Ser724) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 110 kDa, targeting to Phospho-IRE1 (Ser724). It can be used for WB,IP assays with tag free, in the background of Human.
|
- HY-P80900
-
SREBF1; BHLHD1; SREBP1; Sterol regulatory element-binding protein 1; SREBP-1; Class D basic helix-loop-helix protein 1; bHLHd1; Sterol regulatory element-binding transcription factor 1
|
WB, ELISA
|
Human, Mouse, Rat |
SREBP1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 122 kDa, targeting to SREBP1. It can be used for WB,ELISA assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P81088
-
Aggrecan; Aggrecan core protein; Cartilage-specific proteoglycan core protein; CSPCP; Chondroitin sulfate proteoglycan core protein 1; Chondroitin sulfate proteoglycan 1; Aggrecan core protein 2; AGC1; CSPG1; MSK16; PGCA_HUMAN.
|
ELISA; IHC-P; IHC-F; IF
|
Mouse, Rat(predicted: Human, Chicken, Dog, Pig, Cow, Horse, Rabbit) |
ACAN Antibody is an unconjugated, approximately 208/248 kDa, rabbit-derived, anti-ACAN polyclonal antibody. ACAN Antibody can be used for: ELISA, IHC-P, IHC-F, IF expriments in mouse, rat, and predicted: human, chicken, dog, pig, cow, horse, rabbit background without labeling.
|
- HY-P81117
-
Matrilysin; Matrilysin uterine; Matrin; Matrix Metalloproteinase 7; MMP-7; MMP 7; MMP7; MPSL1; PUMP 1; Pump 1 protease; PUMP1; Uterine Matrilysin; Uterine metalloproteinase; MMP7_HUMAN.
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human, Mouse(predicted: Rat) |
MMP7 Antibody is an unconjugated, approximately 30 kDa, rabbit-derived, anti-MMP7 polyclonal antibody. MMP7 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, and predicted: rat background without labeling.
|
- HY-P81128
-
Stem Cell Factor; C kit ligand; Ckit ligand; DKFZp686F2250; KIT ligand; Kitl; KITLG; KL 1; KL1; Mast cell growth factor; MGF; SF; SHEP7; Steel factor; Stem cell factor precursor; SCF_HUMAN.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, Mouse, Rat, |
SCF Antibody is an unconjugated, approximately 31 kDa, rabbit-derived, anti-SCF polyclonal antibody. SCF Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, background without labeling.
|
- HY-P81137
-
Apo-AI; ApoA I; ApoA-I; APOA1_HUMAN; Apolipoprotein A-I(1-242); Apolipoprotein A1; Apolipoprotein A 1; Apolipoprotein AI; Apolipoprotein A I; Brp14; Ltw1; Lvtw1; Sep1; Sep2.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, Mouse, Rat, Chicken(predicted: Pig, Cow) |
APOA1 Antibody is an unconjugated, approximately 28 kDa, rabbit-derived, anti-APOA1 polyclonal antibody. APOA1 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, chicken, and predicted: pig, cow background without labeling.
|
- HY-P81147
-
ZO1_HUMAN; Tight junction protein ZO-1; TJP1; ZO1; Tight junction protein 1; Zona occludens protein 1; Zonula occludens protein 1; ZO1 tight junction protein
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, Pig(predicted: Mouse, Rat, Chicken, Dog, Cow, Rabbit, Guinea Pig) |
ZO-1/TJP1 Antibody is an unconjugated, approximately 191 kDa, rabbit-derived, anti-ZO-1/TJP1 polyclonal antibody. ZO-1/TJP1 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, pig, and predicted: mouse, rat, chicken, dog, cow, rabbit, guinea pig background without labeling.
|
- HY-P81181
-
K1C18_HUMAN; Keratin, type I cytoskeletal 18; KRT18; CYK18; Cell proliferation-inducing gene 46 protein; Cytokeratin-18 (CK-18); Keratin-18 (K18); PIG46; Keratin 18
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; ICC; IF
|
Human, Mouse, Rat(predicted: Dog, Pig, Cow, Horse, Rabbit) |
CK18 Antibody is an unconjugated, approximately 48 kDa, rabbit-derived, anti-CK18 polyclonal antibody. CK18 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, rat, and predicted: dog, pig, cow, horse, rabbit background without labeling.
|
- HY-P81275
-
Ferritin L chain; Ferritin L subunit; Ferritin light chain; Ferritin light polypeptide; Ferritin light polypeptide like 3; FRIL; FRIL_HUMAN; FTL; L apoferritin; LFTD; MGC71996; NBIA 3; NBIA3.
|
ELISA
|
Human |
- HY-P81275A
-
Ferritin L chain; Ferritin L subunit; Ferritin light chain; Ferritin light polypeptide; Ferritin light polypeptide like 3; FRIL; FRIL_HUMAN; FTL; L apoferritin; LFTD; MGC71996; NBIA 3; NBIA3.
|
ELISA
|
Human |
- HY-P81307
-
PTPN6; HCP; PTP1C; Tyrosine-protein phosphatase non-receptor type 6; Hematopoietic cell protein-tyrosine phosphatase; Protein-tyrosine phosphatase 1C; PTP-1C; Protein-tyrosine phosphatase SHP-1; SH-PTP1
|
WB, IP
|
Human |
- HY-P81307A
-
PTPN6; HCP; PTP1C; Tyrosine-protein phosphatase non-receptor type 6; Hematopoietic cell protein-tyrosine phosphatase; Protein-tyrosine phosphatase 1C; PTP-1C; Protein-tyrosine phosphatase SHP-1; SH-PTP1
|
WB, IHC-P
|
Human |
- HY-P81349
-
CD39; ENTPD1; Ectonucleoside triphosphate diphosphohydrolase 1; NTPDase 1; Ecto-ATP diphosphohydrolase 1 (Ecto-ATPDase 1; Ecto-ATPase 1); Ecto-apyrase; Lymphoid cell activation antigen
|
IHC-P
|
Human |
- HY-P81398
-
GRIA2; GLUR2; Glutamate receptor 2; GluR-2; AMPA-selective glutamate receptor 2; GluR-B; GluR-K2; Glutamate receptor ionotropic; AMPA 2; GluA2
|
IHC-P
|
Human |
- HY-P81524
-
vasoactive inTinal peptide receptor 1; II; HVR1; RDC1; V1RG; VIPR; VIRG; VAPC1; VPAC1; VPAC1R; VIP-R-1; VPCAP1R; PACAP-R2; PACAP-R-2
|
IHC-P
|
Human |
- HY-P81529
-
ADCP2, CD26; DPP4; Dipeptidyl peptidase 4; ADABP; Adenosine deaminase complexing protein 2 (ADCP-2); Dipeptidyl peptidase IV (DPP IV); T-cell activation antigen CD26; TP103
|
IHC-P
|
Human |
- HY-P81738
-
OTUB1; OTB1; OTU1; HSPC263; Ubiquitin thioesterase OTUB1; Deubiquitinating enzyme OTUB1; OTU domain-containing ubiquitin aldehyde-binding protein 1; Otubain-1; hOTU1; Ubiquitin-specific-processing protease OTUB1
|
WB, IP
|
Human, Mouse, Rat |
- HY-P81744
-
NTRK1; MTC; TRK; TRKA; High affinity nerve growth factor receptor; Neurotrophic tyrosine kinase receptor type 1; TRK1-transforming tyrosine kinase protein; Tropomyosin-related kinase A; Tyrosine kinase receptor; Tyrosine kinase receptor A
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P81746
-
MYOD1; BHLHC1; MYF3; MYOD; Myoblast determination protein 1; Class C basic helix-loop-helix protein 1; bHLHc1; Myogenic factor 3; Myf-3
|
WB, IHC-P
|
Human |
- HY-P81748
-
CK-15; CK15; cytokeratin15; K15; K1C15; K1CO; keratin 15; Keratin-15; keratin-15; beta; KRT15; KRTB; type I cytoskeletal 15
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse |
- HY-P81785
-
PAK3; OPHN3; Serine/threonine-protein kinase PAK 3; Beta-PAK; Oligophrenin-3; p21-activated kinase 3; PAK-3
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P81983
-
MMP17; MT4MMP; Matrix metalloproteinase-17; MMP-17; Membrane-type matrix metalloproteinase 4; MT-MMP 4; MTMMP4; Membrane-type-4 matrix metalloproteinase; MT4-MMP; MT4MMP
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82113
-
UPF1; KIAA0221; RENT1; Regulator of nonsense transcripts 1; ATP-dependent helicase RENT1; Nonsense mRNA reducing factor 1; NORF1; Up-frameshift suppressor 1 homolog; hUpf1
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P82181
-
EGR2; KROX20; E3 SUMO-protein ligase EGR2; AT591; E3 SUMO-protein transferase ERG2 Curated; Early growth response protein 2 (EGR-2); Zinc finger protein Krox-20;
|
WB
|
Human, Mouse, Rat |
- HY-P82243
-
SLC27A4; ACSVL4; FATP4; Long-chain fatty acid transport protein 4; FATP-4; Fatty acid transport protein 4; Solute carrier family 27 member 4
|
WB, ICC/IF, IP
|
Human |
- HY-P82361
-
CXCR5; BLR1; MDR15; C-X-C chemokine receptor type 5; CXC-R5; CXCR-5; Burkitt lymphoma receptor 1; Monocyte-derived receptor 15; MDR-15; CD185
|
WB, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82376
-
CYP24A1; CYP24; 1; 25-dihydroxyvitamin D(3) 24-hydroxylase; mitochondrial; 24-OHase; Vitamin D(3) 24-hydroxylase; Cytochrome P450 24A1; Cytochrome P450-CC24
|
WB
|
Human |
- HY-P82621
-
CASP10; MCH4; Caspase-10; CASP-10; Apoptotic protease Mch-4; FAS-associated death domain protein interleukin-1B-converting enzyme 2; FLICE2; ICE-like apoptotic protease 4
|
WB, IHC-P, IP
|
Human |
- HY-P82649
-
SHC1; SHC; SHCA; SHC-transforming protein 1; SHC-transforming protein 3; SHC-transforming protein A; Src homology 2 domain-containing-transforming protein C1; SH2 domain protein C1
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82694
-
BOV1; BOV1A; BOV1B; BOV1C; HSPC114; MDS014; RBM 8; RBM 8A; RBM 8B; RBM8; rbm8a; RBM8B; ZNRP; ZRNP1
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82725
-
4F2-LC6; BAT1; Bat1a; D17H6S81E; D6S81E; D6S81Eh; DDX39B; p47; UAP56
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82734
-
SLC1A3; EAAT1; GLAST; GLAST1; Excitatory amino acid transporter 1; Sodium-dependent glutamate/aspartate transporter 1; GLAST-1; Solute carrier family 1 member 3
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P82766
-
DPP4; ADCP2; CD26; Dipeptidyl peptidase 4; ADABP; Adenosine deaminase complexing protein 2; ADCP-2; Dipeptidyl peptidase IV; DPP IV; T-cell activation antigen CD26; TP103; CD26
|
WB
|
Human, Mouse, Rat |
- HY-P82913
-
ECI1; DCI; Enoyl-CoA delta isomerase 1; mitochondrial; 3; 2-trans-enoyl-CoA isomerase; Delta(3); Delta(2)-enoyl-CoA isomerase; D3; D2-enoyl-CoA isomerase; Dodecenoyl-CoA isomerase
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P83027
-
Caspase-2; Caspase 2; Caspase2; CASP-2; Neural precursor cell expressed developmentally down-regulated protein 2; NEDD-2; Protease ICH-1; CASP2; ICH1; NEDD2
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P83029
-
NGFR; TNFRSF16; Tumor necrosis factor receptor superfamily member 16; Gp80-LNGFR; Low affinity neurotrophin receptor p75NTR; Low-affinity nerve growth factor receptor; NGF receptor; p75 ICD; CD antigen CD271
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P83041
-
CDC34; UBCH3; UBE2R1; Ubiquitin-conjugating enzyme E2 R1; Ubiquitin-conjugating enzyme E2-32 kDa complementing; Ubiquitin-conjugating enzyme E2-CDC34; Ubiquitin-protein ligase R1
|
WB, IP
|
Human, Mouse, Rat |
- HY-P83238
-
HINT1; HINT; PKCI1; PRKCNH1; Histidine triad nucleotide-binding protein 1; Adenosine 5'-monophosphoramidase; Protein kinase C inhibitor 1; Protein kinase C-interacting protein 1; PKCI-1
|
WB, ICC/IF, IP
|
Human |
- HY-P83343
-
NFKBIB; IKBB; TRIP9; NF-kappa-B inhibitor beta; NF-kappa-BIB; I-kappa-B-beta; IkB-B; IkB-beta; IkappaBbeta; Thyroid receptor-interacting protein 9; TR-interacting protein 9; TRIP-9
|
WB, IHC-P, IP
|
Human, Mouse |
- HY-P83390
-
HORK3; P2Y12; ADPG-R; BDPLT8; SP1999; P2T(AC); P2Y(AC); P2Y(12)R; P2Y(ADP); P2Y(cyc)
|
WB, IP
|
Human |
- HY-P83492
-
MAP3K11; MLK3; PTK1; SPRK; Mitogen-activated protein kinase kinase kinase 11; Mixed lineage kinase 3; Src-homology 3 domain-containing proline-rich kinase
|
WB, ICC/IF
|
Human |
- HY-P83584
-
BCL2 adenovirus E1B 19kD interacting protein 1; BNIP1; Nip1; sec20; SEC20L; Transformation-related gene 8 protein; TRG8; Vesicle transport protein SEC20
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P83597
-
EP2; PGE2 receptor EP2 subtype; Prostaglandin E receptor 2 subtype EP2 53kDa; Prostaglandin E2 receptor EP2 subtype; Prostanoid EP2 receptor; Ptger2
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat, Cow |
- HY-P83599
-
Mata1l1; Metastasis associated gene 1 like 1; Metastasis associated gene family member 2; Mmta2; MTA1L1; p53 target protein in deacetylase complex; PID
|
WB, IHC-P, ICC/IF, FC
|
Human |
- HY-P83616
-
AHUS1; AMBP1; ARMD4; ARMS1; beta1H; CFH; CFHL3; complement factor H; isoform b; Factor H; factor H like 1; FHL1; HF1; HF2; HUS
|
WB, ICC/IF
|
Human |
- HY-P80537
-
A1A1; AT1A1; ATP1A1; Na+/K+ transporting; alpha 1 polypeptide; Na+/K+ ATPase 1; Na; K-ATPase 1; Sodium pump 1
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
alpha 1 Sodium Potassium ATPase Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 113 kDa, targeting to alpha 1 Sodium Potassium ATPase. It can be used for WB,IHC-P,ICC/IF,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80539
-
PRKAA1; AMPK1; 5'-AMP-activated protein kinase catalytic subunit alpha-1; AMPK subunit alpha-1; Acetyl-CoA carboxylase kinase; ACACA kinase; Hydroxymethylglutaryl-CoA reductase kinase; HMGCR kinase; Tau-protein kinase PRKAA1
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
AMPK alpha 1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 64 kDa, targeting to AMPK alpha 1. It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80542
-
5' ' -AMP-activated protein kinase subunit beta-1; AMP-activated; noncatalytic; beta-1; AMPK; AMPK beta 1 chain; AMPK subunit beta-1; AMPK-BETA-1; AMPKb; HAMPKb; PRKAB1
|
WB, IHC-P, FC, IP
|
Human, Mouse, Rat |
AMPK beta 1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 30 kDa, targeting to AMPK beta 1. It can be used for WB,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80602
-
CD44; LHR; MDU2; MDU3; MIC4; CD44 antigen; CDw44; Epican; Extracellular matrix receptor III; ECMR-III; GP90 lymphocyte homing/adhesion receptor; HUTCH-I; Heparan sulfate proteoglycan; Hermes antigen; Hyaluronate receptor; Phagocytic glycopr
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
CD44 Antibody (YA801) is a non-conjugated and Mouse origined monoclonal antibody about 82 kDa, targeting to CD44 (2H12). It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human.
|
- HY-P80611
-
CDK1; CDC2; CDC28A; CDKN1; P34CDC2; Cyclin-dependent kinase 1; CDK1; Cell division control protein 2 homolog; Cell division protein kinase 1; p34 protein kinase
|
WB, IP
|
Human |
CDK1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 34 kDa, targeting to CDK1. It can be used for WB,IP assays with tag free, in the background of Human.
|
- HY-P80696
-
HSPA5; GRP78; 78 kDa glucose-regulated protein; GRP-78; Endoplasmic reticulum lumenal Ca(2+)-binding protein grp78; Heat shock 70 kDa protein 5; Immunoglobulin heavy chain-binding protein; BiP
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
GRP78 BiP Antibody (YA746) is a non-conjugated and Mouse origined monoclonal antibody about 72 kDa, targeting to GRP78 BiP (4F11). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80719
-
IKBKB; IKKB; Inhibitor of nuclear factor kappa-B kinase subunit beta; I-kappa-B-kinase beta; IKK-B; IKK-beta; IkBKB; I-kappa-B kinase 2; IKK2; Nuclear factor NF-kappa-B inhibitor kinase beta; NFKBIKB
|
WB, ICC/IF
|
Human, Mouse, Rat |
IKK beta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 87 kDa, targeting to IKK beta. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80759
-
MTOR; FRAP; FRAP1; FRAP2; RAFT1; RAPT1; Serine/threonine-protein kinase mTOR; FK506-binding protein 12-rapamycin complex-associated protein 1; FKBP12-rapamycin complex-associated protein; Mammalian target of rapamycin; mTOR; Mechanistic tar
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
mTOR Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 289 kDa, targeting to mTOR. It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80811
-
EIF2S1; EIF2A; Eukaryotic translation initiation factor 2 subunit 1; Eukaryotic translation initiation factor 2 subunit alpha; eIF-2-alpha; eIF-2A; eIF-2alpha
|
WB
|
Human, Mouse, Rat |
Phospho-eIF2A (Ser51) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to Phospho-eIF2A (Ser51). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80812
-
EIF4E; EIF4EL1; EIF4F; Eukaryotic translation initiation factor 4E; eIF-4E; eIF4E; eIF-4F 25 kDa subunit; mRNA cap-binding protein
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
Phospho-eIF4E (Ser209) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 25 kDa, targeting to Phospho-eIF4E (Ser209). It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P81079
-
Carcinoembryonic antigen; Carcinoembryonic antigen related cell adhesion molecule 5; Carcinoembryonic antigen-related cell adhesion molecule 5; CD66e; CD66e antigen; CEACAM5; CEAM5_HUMAN; DKFZp781M2392; Meconium antigen 100.
|
ELISA; IHC-P; IHC-F; IF
|
Human, |
CEA Antibody (YA916) is an unconjugated, approximately 150-200 kDa, mouse-derived, anti-CEA (YA916) monoclonal antibody. CEA Antibody (YA916) can be used for: ELISA, IHC-P, IHC-F, IF expriments in human, background without labeling.
|
- HY-P81080
-
Carcinoembryonic antigen; Carcinoembryonic antigen related cell adhesion molecule 5; Carcinoembryonic antigen-related cell adhesion molecule 5; CD66e; CD66e antigen; CEACAM5; CEAM5_HUMAN; DKFZp781M2392; Meconium antigen 100.
|
ELISA; IHC-P; IHC-F; IF
|
Human, |
CEA Antibody (YA917) is an unconjugated, approximately 150-200 kDa, mouse-derived, anti-CEA (YA917) monoclonal antibody. CEA Antibody (YA917) can be used for: ELISA, IHC-P, IHC-F, IF expriments in human, background without labeling.
|
- HY-P81089
-
C-X-C chemokine receptor type 4; CXC-R4; CXCR-4; Stromal cell-derived factor 1 receptor; SDF-1 receptor; Fusin; Leukocyte-derived seven transmembrane domain receptor; LESTR; CD184 antigen; CXCR4_HUMAN.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, Mouse, Rat(predicted: Cow, Rabbit) |
CXCR4 Antibody is an unconjugated, approximately 40 kDa, rabbit-derived, anti-CXCR4 polyclonal antibody. CXCR4 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: cow, rabbit background without labeling.
|
- HY-P81100
-
Choline O acetyltransferase; Choline O acetyltransferase; Acetyl CoA choline O acetyltransferase; Acetyl CoA:choline O acetyltransferase; ChAT; CHOACTase; Choline acetylase; choline acetyltransferase; CMS1A; CMS1A2; EC 2.3.1.6; OTTHUMP00000019583; OTTHUMP00000019584; CLAT_HUMAN.
|
ELISA; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, Mouse, Rat(predicted: Dog, Pig) |
ChAT Antibody is an unconjugated, approximately 82 kDa, rabbit-derived, anti-ChAT polyclonal antibody. ChAT Antibody can be used for: ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: dog, pig background without labeling.
|
- HY-P81108
-
HGF alpha; HGFA; F TCF; Hepatocyte growth factor; Fibroblast derived tumor cytotoxic factor; Hepatocyte growth factor precursor; Hepatopoietin A; HPTA; Lung fibroblast derived mitogen; Scatter factor; SF; hepatocyte growth factor alpha-chain; Hepatocyte growth factor alpha chain; HGF_HUMAN.
|
ELISA; IHC-P; IHC-F; IF
|
Human, Mouse(predicted: Rat, Dog, Pig, Cow, Horse, Rabbit, Sheep, Guinea Pig) |
HGF Antibody is an unconjugated, approximately 54/80 kDa, rabbit-derived, anti-HGF polyclonal antibody. HGF Antibody can be used for: ELISA, IHC-P, IHC-F, IF expriments in human, mouse, and predicted: rat, dog, pig, cow, horse, rabbit, sheep, guinea pig background without labeling.
|
- HY-P81135
-
SNAI1_HUMAN; Zinc finger protein SNAI1; SNAI1; SNAH; SNAI 1; SNA; SNAIL1; dJ710H13.1; Protein snail homolog 1 (Protein sna); Protein snail homolog 1; Protein sna
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; IF
|
Human(predicted: Mouse, Rat) |
SNAI1 Antibody is an unconjugated, approximately 29 kDa, rabbit-derived, anti-SNAI1 polyclonal antibody. SNAI1 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, and predicted: mouse, rat background without labeling.
|
- HY-P81170
-
Uncoupling Protein-1; UCP1; UCP 1; Mitochondrial brown fat uncoupling protein 1; mitochondrial brown fat uncoupling protein; SLC25A7; Thermogenin; UCP 1; UCP; Uncoupling protein 1; UCP1_HUMAN.
|
WB; ELISA; Flow-Cyt
|
Mouse(predicted: Human, Rat, Dog, Cow, Horse, Rabbit, Sheep) |
UCP-1 Antibody is an unconjugated, approximately 33 kDa, rabbit-derived, anti-UCP-1 polyclonal antibody. UCP-1 Antibody can be used for: WB, ELISA, Flow-Cyt expriments in mouse, and predicted: human, rat, dog, cow, horse, rabbit, sheep background without labeling.
|
- HY-P81177
-
Scavenger receptor cysteine-rich type 1 protein M130; CD 163; CD163 antigen; CD163 molecule; Hemoglobin Scavenger Receptor; M130; M130 antigen precursor; Macrophage associated antigen; MM130; C163A_HUMAN.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; ICC; IF
|
Human, Mouse(predicted: Rat, Dog, Pig, Horse) |
CD163 Antibody is an unconjugated, approximately 130 kDa, rabbit-derived, anti-CD163 polyclonal antibody. CD163 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, and predicted: rat, dog, pig, horse background without labeling.
|
- HY-P81200
-
Glucose Transporter 8; Glucose transporter type 8; Glucose transporter type X1; GLUT-8; GLUT 8; GLUTX1; SLC2A8; solute carrier family 2 (facilitated glucose transporter) member 8.
|
WB; ELISA
|
Mouse, Rat(predicted: Human) |
GLUT8 Antibody is an unconjugated, approximately 52 kDa, rabbit-derived, anti-GLUT8 polyclonal antibody. GLUT8 Antibody can be used for: WB, ELISA expriments in mouse, rat, and predicted: human background without labeling.
|
- HY-P81205
-
Calcium/calmodulin dependent protein kinase beta; Calcium/calmodulin dependent protein kinase kinase 2; Calcium/calmodulin dependent protein kinase kinase beta; CaM kinase kinase beta; CaM KK beta; CAMKK 2; CAMKK; CaMKK beta; CAMKK beta protein; CAMKKB.
|
WB; IHC-P; IHC-F; Flow-Cyt;
|
Human, Mouse, Rat, Sheep(predicted: Pig, Cow, Horse) |
CAMKK2 Antibody is an unconjugated, approximately 55 kDa, rabbit-derived, anti-CAMKK2 polyclonal antibody. CAMKK2 Antibody can be used for: WB, IHC-P, IHC-F, Flow-Cyt, expriments in human, mouse, rat, sheep, and predicted: pig, cow, horse background without labeling.
|
- HY-P81217
-
Osteocalcin Propeptide; Gamma-carboxyglutamic acid-containing protein; Bone Gla-protein; BGLAP; Bone gamma carboxyglutamate protein; BGLAP; BGP; Bone gamma carboxyglutamate gla protein osteocalcin; Bone gamma carboxyglutamate protein; Bone Gla protein; Gamma carboxyglutamic acid containing protein; OC; PMF1; OSTCN_HUMAN.
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human, Mouse(predicted: Rat) |
Osteocalcin Antibody is an unconjugated, approximately 11 kDa, rabbit-derived, anti-Osteocalcin polyclonal antibody. Osteocalcin Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, and predicted: rat background without labeling.
|
- HY-P81243
-
Des-gamma-carboxy (abnormal)prothrombin; Des-Gamma-carboxy-prothrombin; coagulation factor II (thrombin); Coagulation factor II; DCP; Factor II; Prepro coagulation factor II; Prothrombin; prothrombin B-chain; PT; RPRGL2; serine protease; THPH1; THRB; THRB_HUMAN; Thrombin heavy chain.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, Mouse, Rat |
- HY-P81281
-
ALB; ALBU_HUMAN; Albumin (32 AA); Albumin (AA 34); Albumin; Analbuminemia; Bisalbuminemia; Cell growth inhibiting protein 42; DKFZp779N1935; Dysalbuminemic hyperthyroxinemia; Growth inhibiting protein 20; HSA; Hyperthyroxinemia dysalbuminemic; Serum albumin.
|
LFIA, ELISA
|
Human |
- HY-P81281A
-
ALB; ALBU_HUMAN; Albumin (32 AA); Albumin (AA 34); Albumin; Analbuminemia; Bisalbuminemia; Cell growth inhibiting protein 42; DKFZp779N1935; Dysalbuminemic hyperthyroxinemia; Growth inhibiting protein 20; HSA; Hyperthyroxinemia dysalbuminemic; Serum albumin.
|
WB, ELISA
|
Human |
- HY-P81281B
-
ALB; ALBU_HUMAN; Albumin (32 AA); Albumin (AA 34); Albumin; Analbuminemia; Bisalbuminemia; Cell growth inhibiting protein 42; DKFZp779N1935; Dysalbuminemic hyperthyroxinemia; Growth inhibiting protein 20; HSA; Hyperthyroxinemia dysalbuminemic; Serum albumin.
|
WB, ELISA
|
Human |
- HY-P81353
-
LYPD3; C4.4A; UNQ491/PRO1007; Ly6/PLAUR domain-containing protein 3; GPI-anchored metastasis-associated protein C4.4A homolog; Matrigel-induced gene C4 protein (MIG-C4)
|
IHC-P
|
Human |
- HY-P81445
-
TCF; HNF4; MODY; FRTS4; MODY1; NR2A1; TCF14; HNF4a7; HNF4a8; HNF4a9; NR2A21; TCF-14; HNF4alpha
|
IHC-P
|
Human |
- HY-P81451
-
NECTIN2; HVEB, PRR2, PVRL2; CD112; Nectin-2; Herpes virus entry mediator B (Herpesvirus entry mediator B; HveB); Nectin cell adhesion molecule 2; Poliovirus receptor-related protein 2
|
IHC-P
|
Human |
- HY-P81511
-
PBK; TOPK; Lymphokine-activated killer T-cell-originated protein kinase; Cancer/testis antigen 84; CT84; MAPKK-like protein kinase; Nori-3; PDZ-binding kinase; Spermatogenesis-related protein kinase; SPK; T-LAK cell-originated protein kinas
|
IHC-P
|
Human |
- HY-P81516
-
LILRB1; ILT2; LIR1 ; MIR7; Leukocyte immunoglobulin-like receptor subfamily B member 1; LIR-1 ; Leukocyte immunoglobulin-like receptor 1; CD85j ; CD85 antigen-like family member J
|
IHC-P
|
Human |
- HY-P81522
-
CD22; SIGLEC2; B-cell receptor CD22; B-lymphocyte cell adhesion molecule; BL-CAM; Sialic acid-binding Ig-like lectin 2; Siglec-2; T-cell surface antigen Leu-14; CD antigen CD22
|
IHC-P
|
Human |
- HY-P81587
-
SKP2; FBXL1; S-phase kinase-associated protein 2; Cyclin-A/CDK2-associated protein p45; F-box protein Skp2; F-box/LRR-repeat protein 1; p45skp2
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P81595
-
NDUFB9; LYRM3; UQOR22; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9; Complex I-B22; CI-B22; LYR motif-containing protein 3; NADH-ubiquinone oxidoreductase B22 subunit
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P81637
-
CD244; 2B4; Natural killer cell receptor 2B4; NK cell activation-inducing ligand; NAIL; NK cell type I receptor protein 2B4; NKR2B4; h2B4; CD244
|
FC, ELISA
|
Human |
- HY-P81643
-
KDR; FLK1; VEGFR2; Vascular endothelial growth factor receptor 2; VEGFR-2; Fetal liver kinase 1; FLK-1; Kinase insert domain receptor; KDR; Protein-tyrosine kinase receptor flk-1; CD antigen CD309
|
FC, ELISA
|
Human |
- HY-P81668
-
CD80; CD28LG; CD28LG1; LAB7; T-lymphocyte activation antigen CD80; Activation B7-1 antigen; BB1; CTLA-4 counter-receptor B7.1; B7; CD antigen CD80
|
FC, ELISA
|
Human |
- HY-P81724
-
ALDH1A2; RALDH2; Retinal dehydrogenase 2; RALDH 2; RalDH2; Aldehyde dehydrogenase family 1 member A2; Retinaldehyde-specific dehydrogenase type 2; RALDH(II)
|
WB
|
Human, Mouse, Rat |
- HY-P81793
-
CD36; GP3B; GP4; Platelet glycoprotein 4; Fatty acid translocase; FAT; Glycoprotein IIIb; GPIIIB; Leukocyte differentiation antigen CD36; PAS IV; PAS-4; Platelet collagen receptor; Platelet glycoprotein IV; GPIV; Thrombospondin receptor; CD36
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P82176
-
AIV; AnnexinA4; AnnexinIV; ANX 4; ANX A4; ANX4; ANXA4; Chromobindin4; EndonexinI; LipocortinIV; P32.5; P33/41; PAPII; PIG28; PP4X; Protein II; Xanx-4; ZAP36
|
WB, ICC/IF, FC
|
Human |
- HY-P82180
-
PDGFRB; PDGFR; PDGFR1; Platelet-derived growth factor receptor beta; PDGF-R-beta; PDGFR-beta; Beta platelet-derived growth factor receptor; Beta-type platelet-derived growth factor receptor; CD140 antigen-like family member B; Platelet-deri
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82209
-
TEAD1; TCF13; TEF1; Transcriptional enhancer factor TEF-1; NTEF-1; Protein GT-IIC; TEA domain family member 1; TEAD-1; Transcription factor 13; TCF-13
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P82247
-
FMO3; Dimethylaniline monooxygenase [N-oxide-forming] 3; Dimethylaniline oxidase 3; FMO II; FMO form 2; Hepatic flavin-containing monooxygenase 3; FMO 3; Trimethylamine monooxygenase
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82314
-
ADRA1A; ADRA1C; Alpha-1A adrenergic receptor; Alpha-1A adrenoreceptor; Alpha-1A adrenoceptor; Alpha-1C adrenergic receptor; Alpha-adrenergic receptor 1c
|
WB, IHC-P
|
Rat |
- HY-P82375
-
APEX1; APE; APE1; APEX; APX; HAP1; REF1; DNA-(apurinic or apyrimidinic site) lyase; APEX nuclease; APEN; Apurinic-apyrimidinic endonuclease 1; AP endonuclease 1; APE-1; REF-1; Redox factor-1
|
WB
|
Human, Mouse, Rat |
- HY-P82402
-
GCbeta1; GCS beta 1; GCS beta 3; GUC1B3; GUCSB3; GUCY1B1; Gucy1b1; GUCY1B3; SGC
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P82414
-
ERAP1; APPILS; ARTS1; KIAA0525; Endoplasmic reticulum aminopeptidase 1; ARTS-1; Adipocyte-derived leucine aminopeptidase; A-LAP; Aminopeptidase PILS; Puromycin-insensitive leucyl-specific aminopeptidase; PILS-AP; Type 1 tumor necrosis facto
|
WB, IHC-P
|
Human, Rat |
- HY-P82472
-
PIAS1; DDXBP1; E3 SUMO-protein ligase PIAS1; DEAD/H box-binding protein 1; Gu-binding protein; GBP; Protein inhibitor of activated STAT protein 1; RNA helicase II-binding protein
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82523
-
Beta ig; Beta ig h3; Beta ig-h3; BGH3_HUMAN; Big h3; BIGH3; CDB1; CDG2; CDGG1; CSD; CSD1; CSD2; CSD3; EBMD; Kerato epithelin; Kerato-epithelin; LCD1
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P82653
-
ITGAL; CD11A; Integrin alpha-L; CD11 antigen-like family member A; Leukocyte adhesion glycoprotein LFA-1 alpha chain; LFA-1A; Leukocyte function-associated molecule 1 alpha chain; CD11a
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P82687
-
G3BP1; G3BP; Ras GTPase-activating protein-binding protein 1; G3BP-1; ATP-dependent DNA helicase VIII; hDH VIII; GAP SH3 domain-binding protein 1
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82861
-
JUN; Transcription factor AP-1; Activator protein 1; AP1; Proto-oncogene c-Jun; V-jun avian sarcoma virus 17 oncogene homolog; p39; JUND; Transcription factor jun-D
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82892
-
Alpha 1 (VI) chain (61 AA); COL6A1; COL6A2; COL6A3; Collagen alpha 2(VI) chain; Collagen alpha 3(VI) chain; OPLL; PP3610
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P83012
-
BUB1B; BUBR1; MAD3L; SSK1; Mitotic checkpoint serine/threonine-protein kinase BUB1 beta; MAD3/BUB1-related protein kinase; hBUBR1; Mitotic checkpoint kinase MAD3L; Protein SSK1
|
WB, ICC/IF, IP
|
Human |
- HY-P83053
-
DAK1; DAP K1; DAP kinase 1; DAPK 1; DAPK; DAPK1; DAPK1_HUMAN; Death Associated Protein Kinase 1; Death-associated protein kinase 1
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P83105
-
ACO1; IREB1; Cytoplasmic aconitate hydratase; Aconitase; Citrate hydro-lyase; Ferritin repressor protein; Iron regulatory protein 1; IRP1; Iron-responsive element-binding protein 1; IRE-BP 1
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P83222
-
Histone deacetylase 9; HD9; Histone deacetylase 7B; HD7; HD7b; Histone deacetylase-related protein; MEF2-interacting transcription repressor MITR; HDAC9; HDAC7; HDAC7B; HDRP; KIAA0744; MITR
|
WB, IHC-P
|
Human |
- HY-P83280
-
F11R; JAM1; JCAM; Junctional adhesion molecule A; JAM-A; Junctional adhesion molecule 1; JAM-1; Platelet F11 receptor; Platelet adhesion molecule 1; PAM-1; CD321
|
WB, ICC/IF, IP
|
Human |
- HY-P83325
-
MAPKAPK3; MAP kinase-activated protein kinase 3; MAPK-activated protein kinase 3; MAPKAP kinase 3; MAPKAP-K3; MAPKAPK-3; MK-3; Chromosome 3p kinase; 3pK
|
WB, IP
|
Human |
- HY-P83370
-
IL-1 receptor-associated kinase 4; Interleukin 1 receptor associated kinase 4 mutant form 1; IPD1; IRAK4; LOC 51135; NY REN 64; REN64
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
- HY-P83410
-
HSPA9; GRP75; HSPA9B; Stress-70 protein; mitochondrial; 75 kDa glucose-regulated protein; GRP-75; Heat shock 70 kDa protein 9; Mortalin; MOT; Peptide-binding protein 74; PBP74
|
WB
|
Human, Mouse, Rat |
- HY-P83448
-
protein tyrosine phosphatase type IVA; member 2; HH13; OV-1; PRL2; HH7-2; PRL-2; PTP4A; HU-PP-1; PTPCAAX2; ptp-IV1a; ptp-IV1b
|
WB, IP
|
Human |
- HY-P83576
-
Toll-Like Receptor 9; CD289; TLR9; Toll like receptor 9; Toll like receptor 9 isoform A precursor; Toll like receptor 9 isoform B
|
WB
|
Human |
- HY-P83614
-
CD209; CLEC4L; CD209 antigen; C-type lectin domain family 4 member L; Dendritic cell-specific ICAM-3-grabbing non-integrin 1; DC-SIGN; DC-SIGN1; CD209
|
WB
|
Human |
- HY-P83653
-
p150/95 integrin alpha chain; Leu M5; SLEB6; ITGAX; CD11c; p150; Myeloid membrane antigen alpha subunit; Leukocyte surface antigen p150 95 alpha subunit; Integrin alpha-X;Integrin alpha X
|
WB, IHC-P, ICC/IF, IP
|
Human |
- HY-P80446
-
CD19_HUMAN; B-lymphocyte antigen CD19; B-lymphocyte surface antigen B4; Differentiation antigen CD19; T-cell surface antigen Leu-12; CD_antigen: CD19; B-lymphocyte surface antigen B4; Leu 12; Leu12
|
WB, ICC/IF, IHC-P; FC
|
Human |
CD19 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 61 kDa, targeting to CD19. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human.
|
- HY-P80545
-
APG 5L; APG5; APG5 autophagy 5 like; APG5 like; APG5-like; Apoptosis specific protein; ASP; ATG 5; ATG5 autophagy related 5 homolog; Autophagy protein 5; hAPG5
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
APG5L Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 32 kDa, targeting to APG5L. It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80557
-
ATG4A; APG4A; AUTL2; Cysteine protease ATG4A; AUT-like 2 cysteine endopeptidase; Autophagin-2; Autophagy-related cysteine endopeptidase 2; Autophagy-related protein 4 homolog A; hAPG4A
|
WB, IHC-P, IP
|
Human |
ATG4A Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 45 kDa, targeting to ATG4A. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human .
|
- HY-P80558
-
ATG4C; APG4C; AUTL1; AUTL3; Cysteine protease ATG4C; AUT-like 3 cysteine endopeptidase; Autophagin-3; Autophagy-related cysteine endopeptidase 3; Autophagy-related protein 4 homolog C
|
WB, IHC-P
|
Human |
ATG4C Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 52 kDa, targeting to ATG4C. It can be used for WB,IHC-P assays with tag free, in the background of Human.
|
- HY-P80610
-
CD9; MIC3; TSPAN29; GIG2; CD9 antigen; 5H9 antigen; Cell growth-inhibiting gene 2 protein; Leukocyte antigen MIC3; Motility-related protein; MRP-1; Tetraspanin-29; Tspan-29; p24; CD antigen CD9
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
CD9 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 25 kDa, targeting to CD9. It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80711
-
HSPD1; HSP60; 60 kDa heat shock protein; mitochondrial; 60 kDa chaperonin; Chaperonin 60; CPN60; Heat shock protein 60; HSP-60; Hsp60; HuCHA60; Mitochondrial matrix protein P1; P60 lymphocyte protein
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
Hsp60 Antibody (YA730) is a non-conjugated and Mouse origined monoclonal antibody about 61 kDa, targeting to Hsp60 (6C8). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80774
-
CDKN1A; CAP20; CDKN1; CIP1; MDA6; PIC1; SDI1; WAF1; Cyclin-dependent kinase inhibitor 1; CDK-interacting protein 1; Melanoma differentiation-associated protein 6; MDA-6; p21
|
WB, ICC/IF
|
Human, Mouse, Rat |
p21 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 18 kDa, targeting to p21. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80838
-
MTOR; FRAP; FRAP1; FRAP2; RAFT1; RAPT1; Serine/threonine-protein kinase mTOR; FK506-binding protein 12-rapamycin complex-associated protein 1; FKBP12-rapamycin complex-associated protein; Mammalian target of rapamycin; mTOR; Mechanistic tar
|
WB
|
Human, Mouse, Rat |
Phospho-mTOR (Ser2481) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 289 kDa, targeting to Phospho-mTOR (Ser2481). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80926
-
Deubiquitinating enzyme 7; HAUSP; herpes virus associated; Herpes virus associated ubiquitin specific protease; Herpesvirus-associated ubiquitin-specific protease; TEF 1; tef-1; TEF1; Ubiquitin carboxyl terminal hydrolase 7; Ubiquitin carboxyl-terminal hy
|
WB
|
Human |
USP7 Antibody (YA657) is a non-conjugated and Mouse origined monoclonal antibody about 128 kDa, targeting to USP7 (3E4). It can be used for WB assays with tag free, in the background of Human.
|
- HY-P81146
-
Follicle-stimulating hormone receptor precursor; Follicle stimulating hormone receptor; Follicle stimulating hormone receptor isoform 1; Follitropin receptor; FSHRO; LGR1; ODG1; Follicle-stimulating hormone receptor; FSH-R; FSH R; Fshr; FSHR_HUMAN; MGC141667; MGC141668; ovarian dysgenesis 1.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, Mouse, Rat(predicted: Dog, Pig, Cow, Horse, Sheep, Guinea Pig) |
FSH receptor Antibody is an unconjugated, approximately 78 kDa, rabbit-derived, anti-FSH receptor polyclonal antibody. FSH receptor Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: dog, pig, cow, horse, sheep, guinea pig background without labeling.
|
- HY-P81192
-
StARD1; Cholesterol trafficker; Luteinizing hormone induced protein; Mitochondrial steroid acute regulatory protein; StAR related lipid transfer (START) domain containing 1; StARD1; START domain containing protein 1; Steroidogenic Acute Regulatory Protein; Steroidogenic acute regulatory protein mitochondrial; STAR_HUMAN.
|
WB; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, Mouse, Rat(predicted: Dog, Cow, Horse) |
StAR Antibody is an unconjugated, approximately 32 kDa, rabbit-derived, anti-StAR polyclonal antibody. StAR Antibody can be used for: WB, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: dog, cow, horse background without labeling.
|
- HY-P81208
-
4-Hydroxy-2-Nonenal; 4Hydroxynonenal; 4-Hydroxynonenal; HNE; 4HNE; 4-HNE; (E)-4-Hydroxy-2-nonenal; 2-Nonenal, 4-hydroxy-, (2E)-; (2E)-4-Hydroxy-2-nonenal; 4-Hydroxy-2(E)-nonenal; (E)-4-羟基-2-壬烯醛; 4-羟基壬醛
|
WB; ELISA; IHC-P; IF
|
|
4 Hydroxynonenal Antibody is an unconjugated, approximately 0.156 kDa, rabbit-derived, anti-4 Hydroxynonenal polyclonal antibody. 4 Hydroxynonenal Antibody can be used for: WB, ELISA, IHC-P, IF expriments in background without labeling.
|
- HY-P81310
-
SDCBP; MDA9; SYCL; Syntenin-1; Melanoma differentiation-associated protein 9; MDA-9; Pro-TGF-alpha cytoplasmic domain-interacting protein 18; TACIP18; Scaffold protein Pbp1; Syndecan-binding protein 1
|
WB
|
Human |
- HY-P81310A
-
SDCBP; MDA9; SYCL; Syntenin-1; Melanoma differentiation-associated protein 9; MDA-9; Pro-TGF-alpha cytoplasmic domain-interacting protein 18; TACIP18; Scaffold protein Pbp1; Syndecan-binding protein 1
|
WB, IHC-P, ICC/IF, IP, FC
|
Human |
- HY-P81312
-
General transcription factor IIB; General transcription factor TFIIB; gtf2b; RNA polymerase II transcription factor IIB; S300 II; S300-II; TF IIB; TF2B; TF2B_HUMAN; TFIIB; Transcription initiation factor IIB.
|
WB
|
Human, Mouse, Monkey |
- HY-P81312A
-
General transcription factor IIB; General transcription factor TFIIB; gtf2b; RNA polymerase II transcription factor IIB; S300 II; S300-II; TF IIB; TF2B; TF2B_HUMAN; TFIIB; Transcription initiation factor IIB.
|
WB, IP
|
Human, Mouse, Rat |
- HY-P81319
-
JMJD6; KIAA0585; PTDSR; Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6; Histone arginine demethylase JMJD6; JmjC domain-containing protein 6; Jumonji domain-containing protein 6; Lysyl-hydroxylase JMJD6; Peptide-lysine 5-diox
|
WB, ICC/IF
|
Human |
- HY-P81479
-
THO Complex Subunit 1; Death domain containing protein p84N5; HPR1; hTREX84; Nuclear matrix protein p84; p84N5; THO complex 1; Tho1; Thoc1
|
IHC-P
|
Human |
- HY-P81500
-
NGFR; TNFRSF16; Tumor necrosis factor receptor superfamily member 16; Gp80-LNGFR; Low affinity neurotrophin receptor p75NTR; Low-affinity nerve growth factor receptor; NGF receptor; p75 ICD; CD antigen CD271
|
IHC-P
|
Human |
- HY-P81526
-
VIP2R; VIPR2; Vasoactive intestinal polypeptide receptor 2; VIP-R-2; Helodermin-preferring VIP receptor; Pituitary adenylate cyclase-activating polypeptide type III receptor (PACAP type III receptor; PACAP-R-3; PACAP-R3); VPAC2
|
IHC-P
|
Human |
- HY-P81623
-
CA9; G250; MN; Carbonic anhydrase 9; Carbonate dehydratase IX; Carbonic anhydrase IX; CA-IX; CAIX; Membrane antigen MN; P54/58N; Renal cell carcinoma-associated antigen G250; RCC-associated antigen G250; pMW1
|
FC, ELISA
|
Human |
- HY-P81737
-
SELP; GMRP; GRMP; P-selectin; CD62 antigen-like family member P; Granule membrane protein 140; GMP-140; Leukocyte-endothelial cell adhesion molecule 3; LECAM3; Platelet activation dependent granule-external membrane protein; PADGEM; CD62P
|
FC, ELISA
|
Human |
- HY-P81851
-
5-trisphosphate receptor; Inositol 1; InsP3R1; IP3; IP3 receptor; IP3R 1; IP3R; IP3R1; Itpr1; SCA15; SCA16; SCA29
|
WB
|
Human, Mouse, Rat |
- HY-P82244
-
ACVR1B; ACVRLK4; ALK4; Activin receptor type-1B; Activin receptor type IB; ACTR-IB; Activin receptor-like kinase 4; ALK-4; Serine/threonine-protein kinase receptor R2; SKR2
|
WB
|
Human, Mouse, Rat |
- HY-P82261
-
CBFB; Core-binding factor subunit beta; CBF-beta; Polyomavirus enhancer-binding protein 2 beta subunit; PEA2-beta; PEBP2-beta; SL3-3 enhancer factor 1 subunit beta; SL3/AKV core-binding factor beta subunit
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82486
-
TNFAIP3; OTUD7C; Tumor necrosis factor alpha-induced protein 3; TNF alpha-induced protein 3; OTU domain-containing protein 7C; Putative DNA-binding protein A20; Zinc finger protein A20
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
- HY-P82583
-
ACAT; CE 1; CEH; CES1; CES2; CESDD1; Egasyn; ES-HTEL; ES-x; Es22; Esterase 22; hCE 1; HMSE; HMSE1; REH; SES1; TGH; Triacylglycerol hydrolase
|
WB, IP, FC
|
Human, Mouse, Rat |
- HY-P82888
-
MAP/ERK kinase kinase 3; MAP3K3; MAPK/ERK kinase kinase 3; MAPKKK3; MEK kinase 3; MEKK 3; MEKK3; Mitogen activated protein kinase kinase kinase 3
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P82920
-
67 kDa cytokeratin; CK1; EHK; Epidermolytic hyperkeratosis 1; EPPK; Hair alpha protein; K1; Keratin; KRT 1; KRT1A; NEPPK; type II cytoskeletal 1; Type-II keratin Kb1
|
WB
|
Human, Mouse, Rat |
- HY-P82969
-
AIV; AnnexinA4; AnnexinIV; ANX 4; ANX A4; ANX4; ANXA4; Chromobindin4; EndonexinI; LipocortinIV; P32.5; P33/41; PAPII; PIG28; PP4X; Protein II; Xanx-4; ZAP36
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat, Hamster |
- HY-P83008
-
IL12B; NKSF2; Interleukin-12 subunit beta; IL-12B; Cytotoxic lymphocyte maturation factor 40 kDa subunit; CLMF p40; IL-12 subunit p40; NK cell stimulatory factor chain 2; NKSF2
|
WB
|
Human |
- HY-P83345
-
AGTR2; Angiotensin ii receptor type 2; Angiotensin II type-2 receptor; AT2 receptor; AT2; At2r; MRX88; Angiotensin ii at2; Angiotensin receptor 2; Type-2 angiotensin II receptor; ATGR2
|
WB, IP
|
Human, Mouse, Rat |
- HY-P83361
-
AP-2 complex subunit mu; AP-2 mu chain; Adapter-related protein complex 2 subunit mu; Adaptin-mu2; Clathrin assembly protein complex 2 mu medium chain; Clathrin coat assembly protein AP50
|
WB
|
Human, Mouse, Rat |
- HY-P83395
-
MAP2K5; MEK5; MKK5; PRKMK5; Dual specificity mitogen-activated protein kinase kinase 5; MAP kinase kinase 5; MAPKK 5; MAPK/ERK kinase 5; MEK 5
|
WB, ICC/IF
|
Human |
- HY-P83505
-
FCGR2A; CD32; FCG2; FCGR2A1; IGFR2; Low affinity immunoglobulin gamma Fc region receptor II-a; IgG Fc receptor II-a; CDw32; Fc-gamma RII-a; Fc-gamma-RIIa; FcRII-a; CD32
|
WB, IHC-P
|
Human |
- HY-P83556
-
UBE2I; UBC9; UBCE9; SUMO-conjugating enzyme UBC9; SUMO-protein ligase; Ubiquitin carrier protein 9; Ubiquitin carrier protein I; Ubiquitin-conjugating enzyme E2 I; Ubiquitin-protein ligase I; p18
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P83613
-
AGTR1; AGTR1A; AGTR1B; AT2R1; AT2R1B; Type-1 angiotensin II receptor; AT1AR; AT1BR; Angiotensin II type-1 receptor; AT1
|
WB
|
Human |
- HY-P82552
-
NKX2-1; NKX2A; TITF1; TTF1; Homeobox protein Nkx-2.1; Homeobox protein NK-2 homolog A; Thyroid nuclear factor 1; Thyroid transcription factor 1; TTF-1
|
WB, ICC/IF
|
Human, Hamster |
- HY-P83459A
-
aquaporin 4; WCH4; Mercurial-insensitive water channel; MIWC; AQP 4; AQP4; Aquaporin4; HMIWC 2; HMIWC2; Mercurial insensitive water channel; MGC22454; MIWC; AQP4_HUMAN; Aquaporin-4; AQP-4.
|
WB, IHC-P, IHC-F, Flow-Cyt, IF
|
Human, Mouse, Rat, Pig, Cow, Rabbit, Sheep |
- HY-P80005
-
ACDCR1; ADIPO R1; Adiponectin receptor protein 1; ADIPOR 1; ADIPOR1; CGI-45; CGI-45 protein; FLJ25385; PAQR1; Progestin and adipoQ receptor family member I; TESBP1A; ADR1_HUMAN.
|
ICC/IF, IHC-P, FC
|
Human, Mouse |
Adiponectin receptor protein 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 43 kDa, targeting to Adiponectin receptor protein 1. It can be used for ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80525
-
14-3-3 protein eta; 1433F_HUMAN; Brain protein 14-3-3; eta isoform; HGNC:12853; Protein AS1; Tyrosine 3/tryptophan 5 monooxygenase activation protein eta polypeptide; YWHA 1; YWHA1; Ywhah.
|
WB
|
Human, Mouse, Rat |
14-3-3 eta Antibody (YA838) is a non-conjugated and Mouse origined monoclonal antibody about 28 kDa, targeting to 14-3-3 eta (5F2). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80526
-
EIF4EBP1; Eukaryotic translation initiation factor 4E-binding protein 1; 4E-BP1; eIF4E-binding protein 1; Phosphorylated heat- and acid-stable protein regulated by insulin 1; PHAS-I
|
WB, IHC-P, IP
|
Human, Mouse, Rat, Hamster |
4E BP1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 13 kDa, targeting to 4E BP1. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat, Hamster.
|
- HY-P80549
-
MAP3K5; ASK1; MAPKKK5; MEKK5; Mitogen-activated protein kinase kinase kinase 5; Apoptosis signal-regulating kinase 1; ASK-1; MAPK/ERK kinase kinase 5; MEK kinase 5; MEKK 5
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse |
ASK1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 155 kDa, targeting to ASK1. It can be used for WB,IHC-P,ICC/IF,FC assays with tag free, in the background of Human, Mouse.
|
- HY-P80590
-
15 hydroxyprostaglandin dehydrogenase [NADP ]; 15-hydroxyprostaglandin dehydrogenase [NADP ]; Carbonyl reductase [NADPH] 1; CBR 1; CBR1; CBR1_HUMAN; CRN; NADPH dependent carbonyl reductase 1; NADPH-dependent carbonyl reductase 1; Prostaglandin 9 ketoreduc
|
WB, ICC/IF
|
Human |
CBR1 Antibody (YA810) is a non-conjugated and Mouse origined monoclonal antibody about 30 kDa, targeting to CBR1 (2C9). It can be used for WB,ICC/IF assays with tag free, in the background of Human.
|
- HY-P80619
-
KIT; SCFR; Mast/stem cell growth factor receptor Kit; SCFR; Piebald trait protein; PBT; Proto-oncogene c-Kit; Tyrosine-protein kinase Kit; p145 c-kit; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; CD antigen CD117
|
WB, IHC-F, IHC-P, ICC/IF, ELISA
|
Human, Mouse, Rat, Monkey |
c-Kit Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 110 kDa, targeting to c-Kit. It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Mouse, Rat, Monkey.
|
- HY-P80625
-
PARP1; ADPRT; PPOL; Poly [ADP-ribose] polymerase 1; PARP-1; ADP-ribosyltransferase diphtheria toxin-like 1; ARTD1; NAD(+) ADP-ribosyltransferase 1; ADPRT 1; Poly[ADP-ribose] synthase 1
|
WB
|
Human |
Cleaved-PARP1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 113 kDa, targeting to Cleaved-PARP1. It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80645
-
DUSP1; CL100; MKP1; PTPN10; VH1; Dual specificity protein phosphatase 1; Dual specificity protein phosphatase hVH1; Mitogen-activated protein kinase phosphatase 1; MAP kinase phosphatase 1; MKP-1; Protein-tyrosine phosphatase CL100
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
DUSP1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 39 kDa, targeting to DUSP1. It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80769
-
alpha pal; alpha palindromic binding protein; Alpha palindromic-binding protein; Alpha-pal; locus control region factor 1; NFE2 related factor 1; NRF-1; Nrf1; NRF1_HUMAN; Nuclear respiratory factor 1; transcription factor 11.
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
Nrf1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to Nrf1. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80773
-
CDKN1A; CAP20; CDKN1; CIP1; MDA6; PIC1; SDI1; WAF1; Cyclin-dependent kinase inhibitor 1; CDK-interacting protein 1; Melanoma differentiation-associated protein 6; MDA-6; p21
|
WB
|
Human, Mouse |
p21 Antibody (YA254) is a non-conjugated and Rabbit origined monoclonal antibody about 18 kDa, targeting to p21. It can be used for WB assays with tag free, in the background of Human, Mouse.
|
- HY-P80780
-
PARP1; ADPRT; PPOL; Poly [ADP-ribose] polymerase 1; PARP-1; ADP-ribosyltransferase diphtheria toxin-like 1; ARTD1; NAD(+) ADP-ribosyltransferase 1; ADPRT 1; Poly[ADP-ribose] synthase 1
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
PARP1 Antibody (YA245) is a non-conjugated and Rabbit origined monoclonal antibody about 113 kDa, targeting to PARP1. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80790
-
PRKAA1; AMPK1; 5'-AMP-activated protein kinase catalytic subunit alpha-1; AMPK subunit alpha-1; Acetyl-CoA carboxylase kinase; ACACA kinase; Hydroxymethylglutaryl-CoA reductase kinase; HMGCR kinase; Tau-protein kinase PRKAA1
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
Phospho-AMPK alpha 1 (Ser496) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 64 kDa, targeting to Phospho-AMPK alpha 1 (Ser496). It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80793
-
ATF2; CREB2; CREBP1; Cyclic AMP-dependent transcription factor ATF-2; cAMP-dependent transcription factor ATF-2; Activating transcription factor 2; Cyclic AMP-responsive element-binding protein 2; CREB-2; cAMP-responsive element-binding pro
|
WB, ICC/IF, IP
|
Human, Mouse |
Phospho-ATF2 (Thr71) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 55 kDa, targeting to Phospho-ATF2 (Thr71). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse.
|
- HY-P80796
-
CDK1; CDC2; CDC28A; CDKN1; P34CDC2; Cyclin-dependent kinase 1; CDK1; Cell division control protein 2 homolog; Cell division protein kinase 1; p34 protein kinase
|
WB
|
Human, Mouse, Rat |
Phospho-CDK1 (Tyr15) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 34 kDa, targeting to Phospho-CDK1 (Tyr15). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80837
-
MTOR; FRAP; FRAP1; FRAP2; RAFT1; RAPT1; Serine/threonine-protein kinase mTOR; FK506-binding protein 12-rapamycin complex-associated protein 1; FKBP12-rapamycin complex-associated protein; Mammalian target of rapamycin; mTOR; Mechanistic tar
|
WB, IHC-P
|
Human, Mouse |
Phospho-mTOR (Ser2448) Antibody (YA171) is a non-conjugated and Rabbit origined monoclonal antibody about 289 kDa, targeting to Phospho-mTOR (Ser2448). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P80915
-
CD120b; p75 TNF receptor; p80 TNF alpha receptor; Soluble TNFR1B variant 1; TBP-2; TBPII; TNF R75; TNFBR; TNFR-II; TNFR1B; TNFR2; TNFR80; TNFRII; Tnfrsf1b
|
WB, IHC-F, IHC-P, ICC/IF, FC, IP
|
Human, Mouse, Rat |
TNF Receptor 2 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 48 kDa, targeting to TNF Receptor 2. It can be used for WB,IHC-F,IHC-P,ICC/IF,FC,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P81094
-
Basic calponin; Calponin-1; Calponin 1 basic smooth muscle; Calponin H1 smooth muscle; Calponin1; Calponins basic; CNN 1; CNN1; Sm Calp; SMCC; CNN1_HUMAN; Calponin H1; Calponin1; Sm Calp; smooth muscle.
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human, Mouse, Rat(predicted: Chicken, Dog, Pig, Cow, Sheep) |
Calponin 1 Antibody is an unconjugated, approximately 33 kDa, rabbit-derived, anti-Calponin 1 polyclonal antibody. Calponin 1 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, and predicted: chicken, dog, pig, cow, sheep background without labeling.
|
- HY-P81175
-
Myogenic differentiation 1; AI503393; bHLHc1; MD1; MGC156574; MYF3; MYOD; MYOD1; PUM; MYOD1_HUMAN; Class C basic helix-loop-helix protein 1; bHLHc1; Myogenic factor 3; Myf-3.
|
WB; ELISA
|
Mouse, Rat(predicted: Human, Chicken, Dog, Pig, Cow, Horse, Rabbit, Zebrafish, Sheep) |
MyoD1/Myf3 Antibody is an unconjugated, approximately 35 kDa, rabbit-derived, anti-MyoD1/Myf3 polyclonal antibody. MyoD1/Myf3 Antibody can be used for: WB, ELISA expriments in mouse, rat, and predicted: human, chicken, dog, pig, cow, horse, rabbit, zebrafish, sheep background without labeling.
|
- HY-P81180
-
MIG; CMK; C-X-C motif chemokine 9; CXCL9; chemokine (C-X-C motif) ligand 9; crg-10; Humig; monokine induced by gamma interferon; SCYB9; Small inducible cytokine B9; small inducible cytokine subfamily B member 9.
|
ELISA; IHC-P; IHC-F; IF
|
Human, Mouse(predicted: Rat, Pig, Cow, Horse) |
CXCL9 Antibody is an unconjugated, approximately 14 kDa, rabbit-derived, anti-CXCL9 polyclonal antibody. CXCL9 Antibody can be used for: ELISA, IHC-P, IHC-F, IF expriments in human, mouse, and predicted: rat, pig, cow, horse background without labeling.
|
- HY-P81198
-
Adhesion related kinase; AI323647; Ark; Axl; AXL oncogene; AXL receptor tyrosine kinase; AXL transforming gene; AXL transforming sequence/gene; EC 2.7.10.1; JTK11; Oncogene AXL; Tyro7; Tyrosine protein kinase receptor UFO; Tyrosine-protein kinase receptor UFO; UFO; UFO_HUMAN.
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human, Mouse(predicted: Rat, Dog, Horse, Rabbit) |
AXL Antibody is an unconjugated, approximately 95 kDa, rabbit-derived, anti-AXL polyclonal antibody. AXL Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, and predicted: rat, dog, horse, rabbit background without labeling.
|
- HY-P81324
-
FLJ36922; FLJ55954; OTTHUMP00000165834; PP-T; PP5; PPP5; PPP5_HUMAN; PPP5C; PPT; Protein phosphatase 5; catalytic subunit; Protein phosphatase T; Serine/threonine protein phosphatase 5; Serine/threonine-protein phosphatase 5.
|
WB
|
Human |
- HY-P81491
-
4-bisphosphate 4-phosphatase; Inositol polyphosphate 4 phosphatase type II 105kDa; Inositol polyphosphate 4-phosphatase type II; Inpp4b; MGC132014; Type II inositol 3; 4 bisphosphate 4 phosphatase; Type II inositol-3
|
IHC-P
|
Human |
- HY-P81531
-
VSIR; PP2135, UNQ730/PRO1412; C10orf54, SISP1; VISTA; V-type immunoglobulin domain-containing suppressor of T-cell activation; Platelet receptor Gi24; Stress-induced secreted protein-1; V-set domain-containing immunoregulatory receptor; V-set immunoregulatory receptor
|
IHC-P
|
Human |
- HY-P81751
-
TACSTD2; GA733-1; M1S1; TROP2; Tumor-associated calcium signal transducer 2; Cell surface glycoprotein Trop-2; Membrane component chromosome 1 surface marker 1; Pancreatic carcinoma marker protein GA733-1
|
FC, ELISA
|
Human |
- HY-P81898
-
PTPN11; PTP2C; SHPTP2; Tyrosine-protein phosphatase non-receptor type 11; Protein-tyrosine phosphatase 1D; PTP-1D; Protein-tyrosine phosphatase 2C; PTP-2C; SH-PTP2; SHP-2; Shp2; SH-PTP3
|
WB, IHC-P, IP
|
Human |
- HY-P82005
-
DKC1; NOLA4; H/ACA ribonucleoprotein complex subunit 4; CBF5 homolog; Dyskerin; Nopp140-associated protein of 57 kDa; Nucleolar protein NAP57; Nucleolar protein family A member 4; snoRNP protein DKC1
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82336
-
GRIA1; GLUH1; GLUR1; Glutamate receptor 1; GluR-1; AMPA-selective glutamate receptor 1; GluR-A; GluR-K1; Glutamate receptor ionotropic; AMPA 1; GluA1
|
WB
|
Human, Rat |
- HY-P82368
-
AP-2 complex subunit mu; AP-2 mu chain; Adapter-related protein complex 2 subunit mu; Adaptin-mu2; Clathrin assembly protein complex 2 mu medium chain; Clathrin coat assembly protein AP50
|
WB
|
Human |
- HY-P82385
-
TACSTD2; GA733-1; M1S1; TROP2; Tumor-associated calcium signal transducer 2; Cell surface glycoprotein Trop-2; Membrane component chromosome 1 surface marker 1; Pancreatic carcinoma marker protein GA733-1
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
- HY-P82565
-
SORL1; C11orf32; Sortilin-related receptor; Low-density lipoprotein receptor relative with 11 ligand-binding repeats; LDLR relative with 11 ligand-binding repeats; LR11; SorLA-1; Sorting protein-related receptor containing LDLR class A repe
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P82599
-
CAMK2B; CAM2; CAMK2; CAMKB; Calcium/calmodulin-dependent protein kinase type II subunit beta; CaM kinase II subunit beta; CaMK-II subunit beta; CAMK2G; CAMK; CAMK-II; CAMKG; Calcium/calmodulin-dependent protein kinase type II subunit gamma
|
WB
|
Mouse |
- HY-P82673
-
GABA-B receptor 1; GABA-B-R1; GABAB R1; GABAB subunit 1c; GABABR1; GABBR1 3; Gamma aminobutyric acid (GABA) B receptor 1; Gb1; GPRC3A
|
WB
|
Human, Mouse, Rat |
- HY-P82792
-
PTGS1; COX1; Prostaglandin G/H synthase 1; Cyclooxygenase-1; COX-1; Prostaglandin H2 synthase 1; PGH synthase 1; PGHS-1; PHS 1; Prostaglandin-endoperoxide synthase 1
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82875
-
STXBP1; UNC18A; Syntaxin-binding protein 1; MUNC18-1; N-Sec1; Protein unc-18 homolog 1; Unc18-1; Protein unc-18 homolog A; Unc-18A; p67
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P83317
-
PDGFRB; PDGFR; PDGFR1; Platelet-derived growth factor receptor beta; PDGF-R-beta; PDGFR-beta; Beta platelet-derived growth factor receptor; Beta-type platelet-derived growth factor receptor; CD140 antigen-like family member B; Platelet-deri
|
WB, ICC/IF
|
Mouse, Rat |
- HY-P83334
-
IGFBP7; MAC25; PSF; Insulin-like growth factor-binding protein 7; IBP-7; IGF-binding protein 7; IGFBP-7; IGFBP-rP1; MAC25 protein; PGI2-stimulating factor; Prostacyclin-stimulating factor; Tumor-derived adhesion factor; TAF
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P83341
-
MUC1; PUM; Mucin-1; MUC-1; Breast carcinoma-associated antigen DF3; Carcinoma-associated mucin; Episialin; H23AG; Krebs von den Lungen-6; KL-6; PEMT; Peanut-reactive urinary mucin; PUM; Polymorphic epithelial mucin; PEM; Tumor-associated ep
|
WB, IHC-P, ICC/IF, IP, FC
|
Human |
- HY-P83354
-
BAD; BBC6; BCL2L8; Bcl2 antagonist of cell death; BAD; Bcl-2-binding component 6; Bcl-2-like protein 8; Bcl2-L-8; Bcl-XL/Bcl-2-associated death promoter
|
WB, IP
|
Human, Mouse, Rat |
- HY-P83357
-
FA D2; FA4; FAC D2; FACD 2; FACD; FACD2; FAD; FAD2; FANCD 2; FANCD; FANCD2; Fanconi anemia group D2 protein; FLJ23826; Protein FACD2; Type 4 Fanconi pancytopenia
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P83440
-
SUZ12; CHET9; JJAZ1; KIAA0160; Polycomb protein SUZ12; Chromatin precipitated E2F target 9 protein; ChET 9 protein; Joined to JAZF1 protein; Suppressor of zeste 12 protein homolog
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P83443
-
CXCL12; SDF1; SDF1A; SDF1B; Stromal cell-derived factor 1; SDF-1; hSDF-1; C-X-C motif chemokine 12; Intercrine reduced in hepatomas; IRH; hIRH; Pre-B cell growth-stimulating factor; PBSF
|
WB, ICC/IF
|
Human |
- HY-P83529
-
SELP; GMRP; GRMP; P-selectin; CD62 antigen-like family member P; Granule membrane protein 140; GMP-140; Leukocyte-endothelial cell adhesion molecule 3; LECAM3; Platelet activation dependent granule-external membrane protein; PADGEM; CD62P
|
WB, IHC-P
|
Human |
- HY-P83560
-
Alpha-2-Macroglobulin; A2m; Alpha 2M; Alpha-2-macroglobulin; C3 and PZP-like alpha-2-macroglobulin domain-containing protein 5; CPAMD5; FWP007; S863 7
|
WB, IHC-P
|
Human |
- HY-P80624
-
CASP8; MCH5; Caspase-8; CASP-8; Apoptotic cysteine protease; Apoptotic protease Mch-5; CAP4; FADD-homologous ICE/ced-3-like protease; FADD-like ICE; FLICE; ICE-like apoptotic protease 5; MORT1-associated ced-3 homolog; MACH
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
Cleaved-Caspase 8 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 55 kDa, targeting to Cleaved-Caspase 8. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80644
-
DNM1L; DLP1; DRP1; Dynamin-1-like protein; Dnm1p/Vps1p-like protein; DVLP; Dynamin family member proline-rich carboxyl-terminal domain less; Dymple; Dynamin-like protein; Dynamin-like protein 4; Dynamin-like protein IV; HdynIV; Dynamin-rela
|
WB, IHC-P
|
Human, Mouse, Rat |
DRP1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 82 kDa, targeting to DRP1. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80657
-
EPCAM; GA733-2; M1S2; M4S1; MIC18; TACSTD1; TROP1; Epithelial cell adhesion molecule; Ep-CAM; Adenocarcinoma-associated antigen; Cell surface glycoprotein Trop-1; Epithelial cell surface antigen; Epithelial glycoprotein; EGP; Epithelial glycoprotein 314;
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
EpCAM Antibody (YA458) is a non-conjugated and Rabbit origined monoclonal antibody about 35 kDa, targeting to EpCAM. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human.
|
- HY-P80735
-
Endothelial Kruppel like zinc finger protein; Epithelial zinc finger protein EZF; EZF; GKLF; Gut-enriched krueppel-like factor; KLF; KLF4; KLF4_HUMAN; Krueppel-like factor 4; Kruppel like factor 4; Epithelial zinc finger protein EZF; Gut enriched Krueppel
|
WB
|
Transfected |
KLF4 Antibody (YA716) is a non-conjugated and Mouse origined monoclonal antibody about 55 kDa, targeting to KLF4 (3B3). It can be used for WB assays with tag free, in the background of Transfected.
|
- HY-P80741
-
LC3; LC3A; ATG8E; MAP1ALC3; MAP1BLC3; MAP1LC3A; LC3B; ATG8F; MAP1LC3B-a; MAP1A/1BLC3; MAP1LC3B
|
WB
|
Human, Mouse, Rat |
LC3A/B Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 14 kDa, targeting to LC3A/B. It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80786
-
EIF4EBP1; Eukaryotic translation initiation factor 4E-binding protein 1; 4E-BP1; eIF4E-binding protein 1; Phosphorylated heat- and acid-stable protein regulated by insulin 1; PHAS-I
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
Phospho-4E BP1 (Thr46) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 13 kDa, targeting to Phospho-4E BP1 (Thr46). It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80872
-
CIMT1; GLM1; NR1C3; Nuclear receptor subfamily 1 group C member 3; Peroxisome proliferator activated nuclear receptor gamma variant 1; Peroxisome proliferator activated receptor gamma 1; Peroxisome Proliferator Activated Receptor gamma; Peroxisome prolife
|
ICC/IF, WB, IHC-F, IHC-P, ELISA
|
Human, Mouse, Rat |
PPAR gamma Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 58 kDa, targeting to PPAR gamma. It can be used for ICC/IF,WB,IHC-F,IHC-P,ELISA assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80874
-
ANM 1; ANM1; ANM1_HUMAN; complete cds; HCP 1; HCP1; Heterogeneous nuclear ribonucleoprotein methyltransferase 1 like 2; Heterogeneous nuclear ribonucleoproteins methyltransferase like 2; Heterogeneous nuclear ribonucleoproteins methyltransferase like2; Hi
|
WB
|
Human |
PRMT1 Antibody (YA686) is a non-conjugated and Mouse origined monoclonal antibody about 42 kDa, targeting to PRMT1 (4E9). It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80877
-
PTK2B; FAK2; PYK2; RAFTK; Protein-tyrosine kinase 2-beta; Calcium-dependent tyrosine kinase; CADTK; Calcium-regulated non-receptor proline-rich tyrosine kinase; Cell adhesion kinase beta; CAK-beta; CAKB; Focal adhesion kinase 2; FADK 2; Pro
|
WB, IHC-P
|
Human |
PYK2 Antibody (YA682) is a non-conjugated and Mouse origined monoclonal antibody about 116 kDa, targeting to PYK2 (4B4). It can be used for WB,IHC-P assays with tag free, in the background of Human.
|
- HY-P80883
-
POLR2A; POLR2; DNA-directed RNA polymerase II subunit RPB1; RNA polymerase II subunit B1; DNA-directed RNA polymerase II subunit A; DNA-directed RNA polymerase III largest subunit; RNA-directed RNA polymerase II subunit RPB1
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
RNA Polymerase II Subunit B1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 217 kDa, targeting to RNA Polymerase II Subunit B1. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human.
|
- HY-P81051
-
NFE2L2; NRF2; Nuclear factor erythroid 2-related factor 2; NF-E2-related factor 2; NFE2-related factor 2; HEBP1; Nuclear factor; erythroid derived 2; like 2
|
WB, IHC-P, ICC/IF, IP, ChIP
|
Human, Mouse |
Nrf2 Antibody(YA895) is an unconjugated, approximately 68 kDa, rabbit-derived, anti-Nrf2(YA895) monoclonal antibody. Nrf2 Antibody(YA895) can be used for: WB, IHC-P, ICC/IF, IP, ChIP expriments in human, mouse background without labeling.
|
- HY-P81167
-
CPT 1; CPT1A; CPTI-L; CPT1-L; carnitine palmitoyl transferase 1; Carnitine O-palmitoyltransferase 1, liver isoform; CPT I; Carnitine palmitoyltransferase 1A; carnitine O-palmitoyltransferase 1, liver isoform isoform 1; CPT1A_HUMAN.
|
WB; ELISA
|
Mouse(predicted: Human, Rat) |
CPT1A Antibody is an unconjugated, approximately 86 kDa, rabbit-derived, anti-CPT1A polyclonal antibody. CPT1A Antibody can be used for: WB, ELISA expriments in mouse, and predicted: human, rat background without labeling.
|
- HY-P81185
-
C5; C6; C7; C8; C9; Complement component 5; Complement component 6; Complement component 7; Complement component 8; Complement component 9; MAC; Membrane attack complex; TCC; Terminal complement complex.
|
WB; IHC-P; IHC-F; IF
|
Human, Rat(predicted: Mouse) |
C5b-9 Antibody is an unconjugated, rabbit-derived, anti-C5b-9 polyclonal antibody. C5b-9 Antibody can be used for: WB, IHC-P, IHC-F, IF expriments in human, rat, and predicted: mouse background without labeling.
|
- HY-P81207
-
BRICD4; BRICHOS domain containing 4; CHM1 LIKE; CHM1L; Chondromodulin I like; Chondromodulin I like protein; Chondromodulin-1-like protein; Chondromodulin-I-like protein; hChM1L; hTeM; Myodulin; TEM; Tendin; Tenomodulin; Tenomodulin protein; TNMD; TNMD_HUMAN; UNQ771/PRO1565.
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human, Mouse, Rat(predicted: Dog, Pig, Cow, Horse, Rabbit, Sheep) |
TNMD Antibody is an unconjugated, approximately 37 kDa, rabbit-derived, anti-TNMD polyclonal antibody. TNMD Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, and predicted: dog, pig, cow, horse, rabbit, sheep background without labeling.
|
- HY-P81213
-
Fibronectin type III domain containing 5; Fibronectin type III domain-containing protein 5; Fibronectin type III repeat containing protein 2; Fibronectin type III repeat-containing protein 2; FNDC 5; FNDC5_HUMAN; FRCP2; Irisin.
|
WB; ELISA; IHC-P; IHC-F; ICC; IF
|
Human, Mouse(predicted: Rat, Chicken, Dog, Rabbit) |
FNDC5 Antibody is an unconjugated, approximately 12/20 kDa, rabbit-derived, anti-FNDC5 polyclonal antibody. FNDC5 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, ICC, IF expriments in human, mouse, and predicted: rat, chicken, dog, rabbit background without labeling.
|
- HY-P81268
-
58 kDa cytokeratin; CK 5; CK-5; CK5; Cytokeratin-5; Cytokeratin5; DDD; DDD1; EBS 2; EBS2; epidermolysis bullosa simplex 2 Dowling-Meara/Kobner/Weber-Cockayne types; K2C5_HUMAN; K5
|
WB
|
Human, Mouse, Rat |
- HY-P81268A
-
58 kDa cytokeratin; CK 5; CK-5; CK5; Cytokeratin-5; Cytokeratin5; DDD; DDD1; EBS 2; EBS2; epidermolysis bullosa simplex 2 Dowling-Meara/Kobner/Weber-Cockayne types; K2C5_HUMAN; K5
|
IHC-P, ICC/IF
|
Human |
- HY-P81309
-
SUMO2; HSMT3; SMT3 homolog 2; SMT3A; Sentrin 2; Smt3B; SMT3H2; SUMO-2; SUMO-3; Sentrin-2; Ubiquitin-like protein SMT3A; Ubiquitin-like protein SMT3B
|
WB
|
Human |
- HY-P81309A
-
SUMO2; HSMT3; SMT3 homolog 2; SMT3A; Sentrin 2; Smt3B; SMT3H2; SUMO-2; SUMO-3; Sentrin-2; Ubiquitin-like protein SMT3A; Ubiquitin-like protein SMT3B
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P81743
-
CHAF1A; CAF; CAF1P150; Chromatin assembly factor 1 subunit A; CAF-1 subunit A; Chromatin assembly factor I p150 subunit; CAF-I 150 kDa subunit; CAF-I p150; hp150
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human |
- HY-P81782
-
POU2F2; OCT2; OTF2; POU domain; class 2; transcription factor 2; Lymphoid-restricted immunoglobulin octamer-binding protein NF-A2; Octamer-binding protein 2; Oct-2; Octamer-binding transcription factor 2; OTF-2
|
WB, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P81857
-
CLU; APOJ; CLI; KUB1; AAG4; Clusterin; Aging-associated gene 4 protein; Apolipoprotein J; Apo-J; Complement cytolysis inhibitor; CLI; Complement-associated protein SP-40; 40; Ku70-binding protein 1; NA1/NA2; Testosterone-repressed prostate m
|
WB, IHC-P
|
Human, Mouse |
- HY-P81998
-
RCHY1; ARNIP; CHIMP; PIRH2; RNF199; ZNF363; RING finger and CHY zinc finger domain-containing protein 1; Androgen receptor N-terminal-interacting protein; CH-rich-interacting match with PLAG1; E3 ubiquitin-protein ligase Pirh2; RING finger
|
WB
|
Human |
- HY-P82095
-
EPIM; Epimorphin; EPM; HPC 1; P35 1; STX1A; Stx1b; STX1B1; STX1B2; STX2; STX2A; STX2B; STX2C; STX3; STX3A
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82422
-
TCF7L2; HMG box transcription factor 4; HTCF-4; T-cell factor-4 variant X2; T-cell factor 4; Transcription factor 7-like 2; TCF-4
|
WB, IHC-P, IP
|
Human |
- HY-P82468
-
WNK1; HSN2; KDP; KIAA0344; PRKWNK1; Serine/threonine-protein kinase WNK1; Erythrocyte 65 kDa protein; p65; Kinase deficient protein; Protein kinase lysine-deficient 1; Protein kinase with no lysine 1; hWNK1
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P82511
-
SF3B1; SAP155; Splicing factor 3B subunit 1; Pre-mRNA-splicing factor SF3b 155 kDa subunit; SF3b155; Spliceosome-associated protein 155; SAP 155
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82614
-
S1PR3; EDG3; Sphingosine 1-phosphate receptor 3; S1P receptor 3; S1P3; Endothelial differentiation G-protein coupled receptor 3; Sphingosine 1-phosphate receptor Edg-3; S1P receptor Edg-3
|
WB
|
Human, Mouse, Rat |
- HY-P82620
-
SLC1A1; EAAC1; EAAT3; Excitatory amino acid transporter 3; Excitatory amino-acid carrier 1; Neuronal and epithelial glutamate transporter; Sodium-dependent glutamate/aspartate transporter 3; Solute carrier family 1 member 1
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P82698
-
CA9; G250; MN; Carbonic anhydrase 9; Carbonate dehydratase IX; Carbonic anhydrase IX; CA-IX; CAIX; Membrane antigen MN; P54/58N; Renal cell carcinoma-associated antigen G250; RCC-associated antigen G250; pMW1
|
IHC-P
|
Human |
- HY-P82723
-
ATG4B; APG4B; AUTL1; KIAA0943; Cysteine protease ATG4B; AUT-like 1 cysteine endopeptidase; Autophagin-1; Autophagy-related cysteine endopeptidase 1; Autophagy-related protein 4 homolog B; hAPG4B
|
WB, FC
|
Human, Mouse, Rat |
- HY-P82872
-
HSPB8; CRYAC; E2IG1; HSP22; PP1629; Heat shock protein beta-8; HspB8; Alpha-crystallin C chain; E2-induced gene 1 protein; Protein kinase H11; Small stress protein-like protein HSP22
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P83132
-
EPHB3; ETK2; HEK2; TYRO6; Ephrin type-B receptor 3; EPH-like tyrosine kinase 2; EPH-like kinase 2; Embryonic kinase 2; EK2; hEK2; Tyrosine-protein kinase TYRO6
|
WB, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P83405
-
Mitogen-activated protein kinase 10; MAP kinase 10; MAPK 10; MAP kinase p49 3F12; Stress-activated protein kinase 1b; SAPK1b; MAPK10; JNK3; JNK3A; PRKM10; SAPK1B
|
WB, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P83619
-
5-HT-1C; 5-HT-2C; 5-HT1C; 5-HT2C; 5-HTR2C; 5HT1C; 5HT2C; 5HTR2C; 5Hydroxytryptamine 2C receptor; Htr1c; HTR2C
|
WB
|
Human, Mouse, Rat |
- HY-P80471
-
NFE2L2; NRF2; Nuclear factor erythroid 2-related factor 2; NF-E2-related factor 2; NFE2-related factor 2; HEBP1; Nuclear factor; erythroid derived 2; like 2
|
WB, ICC/IF, IHC-P, FC, IP
|
Human |
Phospho-Nrf2 (Ser40) Antibody (YA168) is a non-conjugated and Rabbit origined monoclonal antibody about 68 kDa, targeting to Phospho-Nrf2(S40). It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human.
|
- HY-P80647
-
KIF11; EG5; KNSL1; TRIP5; Kinesin-like protein KIF11; Kinesin-like protein 1; Kinesin-like spindle protein HKSP; Kinesin-related motor protein Eg5; Thyroid receptor-interacting protein 5; TR-interacting protein 5; TRIP-5
|
WB, ICC/IF, IP
|
Human |
Eg5 Antibody (YA776) is a non-conjugated and Mouse origined monoclonal antibody about 119 kDa, targeting to Eg5 (4H3). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human.
|
- HY-P80709
-
HSPB1; HSP27; HSP28; Heat shock protein beta-1; HspB1; 28 kDa heat shock protein; Estrogen-regulated 24 kDa protein; Heat shock 27 kDa protein; HSP 27; Stress-responsive protein 27; SRP27
|
WB, ICC/IF
|
Human, Monkey |
Hsp27 Antibody (YA732) is a non-conjugated and Mouse origined monoclonal antibody about 23 kDa, targeting to Hsp27 (7E5). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Monkey.
|
- HY-P80710
-
DNAJB1; DNAJ1; HDJ1; HSPF1; DnaJ homolog subfamily B member 1; DnaJ protein homolog 1; Heat shock 40 kDa protein 1; HSP40; Heat shock protein 40; Human DnaJ protein 1; hDj-1
|
WB
|
Human |
Hsp40 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 38 kDa, targeting to Hsp40. It can be used for WB assays with tag free, in the background of Human.
|
- HY-P80777
-
MAPK14; CSBP; CSBP1; CSBP2; CSPB1; MXI2; SAPK2A; Mitogen-activated protein kinase 14; MAP kinase 14; MAPK 14; Cytokine suppressive anti-inflammatory drug-binding protein; CSAID-binding protein; CSBP; MAP kinase MXI2; MAX-interacting protein
|
WB, IP
|
Human |
p38 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 41 kDa, targeting to p38. It can be used for WB,IP assays with tag free, in the background of Human.
|
- HY-P80792
-
MAP3K5; ASK1; MAPKKK5; MEKK5; Mitogen-activated protein kinase kinase kinase 5; Apoptosis signal-regulating kinase 1; ASK-1; MAPK/ERK kinase kinase 5; MEK kinase 5; MEKK 5
|
WB, IHC-P
|
Human, Mouse, Rat |
Phospho-ASK1 (Ser966) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 155 kDa, targeting to Phospho-ASK1 (Ser966). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80835
-
RPS6KA5; MSK1; Ribosomal protein S6 kinase alpha-5; S6K-alpha-5; 90 kDa ribosomal protein S6 kinase 5; Nuclear mitogen- and stress-activated protein kinase 1; RSK-like protein kinase; RSKL
|
WB, ICC/IF, IP
|
Human, Mouse, Rat, Hamster |
Phospho-MSK1 (Ser360) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 90 kDa, targeting to Phospho-MSK1 (Ser360). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat, Hamster.
|
- HY-P80836
-
RPS6KA5; MSK1; Ribosomal protein S6 kinase alpha-5; S6K-alpha-5; 90 kDa ribosomal protein S6 kinase 5; Nuclear mitogen- and stress-activated protein kinase 1; RSK-like protein kinase; RSKL
|
WB, IHC-P, IP
|
Human, Rat |
Phospho-MSK1 (Ser376) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 90 kDa, targeting to Phospho-MSK1 (Ser376). It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Rat.
|
- HY-P80841
-
NFE2L2; NRF2; Nuclear factor erythroid 2-related factor 2; NF-E2-related factor 2; NFE2-related factor 2; HEBP1; Nuclear factor; erythroid derived 2; like 2
|
WB, IHC-P
|
Human |
Phospho-Nrf2 (Ser40) Antibody (YA169) is a non-conjugated and Rabbit origined monoclonal antibody about 68 kDa, targeting to Phospho-Nrf2 (Ser40). It can be used for WB,IHC-P assays with tag free, in the background of Human.
|
- HY-P80854
-
SMAD3; MADH3; Mothers against decapentaplegic homolog 3; MAD homolog 3; Mad3; Mothers against DPP homolog 3; hMAD-3; JV15-2; SMAD family member 3; SMAD 3; Smad3; hSMAD3
|
WB, IHC-P, ICC/IF
|
Human, Mouse |
Phospho-Smad3 (Ser423/425) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 48 kDa, targeting to Phospho-Smad3 (Ser423/425). It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse.
|
- HY-P80866
-
GRB1; P85A; PI3-kinase p85-alpha subunit; PI3K; PI3K p85-alpha; P55G; PI3-kinase p85-gamma subunit; PI3K p85-gamma
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
PI3 Kinase p55 gamma Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 54 kDa, targeting to PI3 Kinase p55 gamma. It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80870
-
PKM; OIP3; PK2; PK3; PKM2; Pyruvate kinase isozymes M1/M2; Cytosolic thyroid hormone-binding protein; CTHBP; Opa-interacting protein 3; OIP-3; Pyruvate kinase 2/3; Pyruvate kinase muscle isozyme; Thyroid hormone-binding protein 1; THBP1; Tu
|
WB
|
Human, Mouse, Rat, Monkey |
PKM2 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 58 kDa, targeting to PKM2. It can be used for WB assays with tag free, in the background of Human, Mouse, Rat, Monkey.
|
- HY-P80936
-
YBX1; NSEP1; YB1; Nuclease-sensitive element-binding protein 1; CCAAT-binding transcription factor I subunit A; CBF-A; DNA-binding protein B; DBPB; Enhancer factor I subunit A; EFI-A; Y-box transcription factor; Y-box-binding protein 1; YB-
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
YB1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 36 kDa, targeting to YB1. It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P81126
-
SAR; PAR-1; PAR 1; BXR; CF2R; F2R; HTR; TR; Proteinase-activated receptor 1 precursor; Proteinase activated receptor 1; Thrombin receptor; Coagulation factor II receptor; Prader-Willi/Angelman region-1; Coagulation factor II (thrombin) receptor; PAR1_HUMAN
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human, Mouse, Rat, |
PAR1 Antibody is an unconjugated, approximately 42 kDa, rabbit-derived, anti-PAR1 polyclonal antibody. PAR1 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, background without labeling.
|
- HY-P81168
-
CGRPR; CRLR; calcitonin receptor like precursor; Calcitonin gene related peptide type 1 receptor; Calcitonin receptor like; CGRP type 1 receptor; Calcitonin gene related peptide type 1 receptor; Calcitonin receptor like; Calcitonin Receptor Like Receptor; CGRP type 1 receptor; CALRL_HUMAN.
|
WB; ELISA
|
Human, Mouse(predicted: Rat) |
CALCRL Antibody is an unconjugated, approximately 50 kDa, rabbit-derived, anti-CALCRL polyclonal antibody. CALCRL Antibody can be used for: WB, ELISA expriments in human, mouse, and predicted: rat background without labeling.
|
- HY-P81197
-
3 hydroxy 3 methylglutaryl CoA reductase; 3 hydroxy 3 methylglutaryl Coenzyme A reductase; 3 hydroxymethylglutaryl CoA reductase; 3-hydroxy-3-methylglutaryl CoA reductase (NADPH); 3-hydroxy-3-methylglutaryl-coenzyme A reductase; 3H3M; HMDH_HUMAN; HMG CoA reductase; HMG CoAR; HMG-CoA reductase; Hydroxymethylglutaryl CoA reductase; LDLCQ3; MGC103269; Red.
|
ELISA; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, Mouse, Rat(predicted: Dog, Pig, Cow, Rabbit) |
HMGCR Antibody is an unconjugated, approximately 97 kDa, rabbit-derived, anti-HMGCR polyclonal antibody. HMGCR Antibody can be used for: ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: dog, pig, cow, rabbit background without labeling.
|
- HY-P81378
-
MAP4K4; HGK, KIAA0687, NIK; Mitogen-activated protein kinase kinase kinase kinase 4; HPK/GCK-like kinase HGK; MAPK/ERK kinase kinase kinase 4 (MEK kinase kinase 4; MEKKK 4); Nck-interacting kinase
|
IHC-P
|
Human |
- HY-P81510
-
LAMC1; LAMB2; Laminin subunit gamma-1; Laminin B2 chain; Laminin-1 subunit gamma; Laminin-10 subunit gamma; Laminin-11 subunit gamma; Laminin-2 subunit gamma; Laminin-3 subunit gamma; Laminin-4 subunit gamma; Laminin-6 subunit gamma; Lamini
|
IHC-P
|
Human |
- HY-P81616
-
SIRPA; BIT; MFR; MYD1; PTPNS1; SHPS1; SIRP; Tyrosine-protein phosphatase non-receptor type substrate 1; SHP substrate 1; SHPS-1; Brain Ig-like molecule with tyrosine-based activation motifs; Bit; CD172 antigen-like family member A; Inhibito
|
FC, ELISA
|
Human |
- HY-P81874
-
Pro-opiomelanocortin; POMC; Corticotropin-lipotropin; NPP; Melanotropin gamma (Gamma-MSH); Potential peptide; Corticotropin (Adrenocorticotropic hormone; ACTH); Melanotropin alpha (Alpha-MSH); Corticotropin-like intermediary peptide (CLIP); Lipotropin beta (Beta-LPH); Lipotropin gamma (Gamma-LPH); Melanotropin beta (Beta-MSH); Beta-endorphin; Met-enkephalin
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P82028
-
PTN; HBNF1; NEGF1; Pleiotrophin; PTN; Heparin-binding brain mitogen; HBBM; Heparin-binding growth factor 8; HBGF-8; Heparin-binding growth-associated molecule; HB-GAM; Heparin-binding neurite outgrowth-promoting factor 1; HBNF-1; Osteoblast-specific factor 1; OSF-1
|
WB, IP
|
Human, Rat |
- HY-P82533
-
TRIM25; EFP; RNF147; ZNF147; E3 ubiquitin/ISG15 ligase TRIM25; Estrogen-responsive finger protein; RING finger protein 147; Tripartite motif-containing protein 25; Ubiquitin/ISG15-conjugating enzyme TRIM25; Zinc finger protein 147
|
WB, ICC/IF, IP
|
Human, Rat |
- HY-P82537
-
BLNK; BASH; SLP65; B-cell linker protein; B-cell adapter containing a SH2 domain protein; B-cell adapter containing a Src homology 2 domain protein; Cytoplasmic adapter protein; Src homology 2 domain-containing leukocyte protein of 65 kDa
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82939
-
ACTL6A; BAF53; BAF53A; INO80K; Actin-like protein 6A; 53 kDa BRG1-associated factor A; Actin-related protein Baf53a; ArpNbeta; BRG1-associated factor 53A; BAF53A; INO80 complex subunit K
|
WB, ICC/IF, IP
|
Human |
- HY-P82966
-
ANXA2; ANX2; ANX2L4; CAL1H; LPC2D; Annexin A2; Annexin II; Annexin-2; Calpactin I heavy chain; Calpactin-1 heavy chain; Chromobindin-8; Lipocortin II; Placental anticoagulant protein IV; PAP-IV; Protein I; p36
|
WB, IP
|
Human |
- HY-P83063
-
TRAF4; CART1; MLN62; RNF83; TNF receptor-associated factor 4; Cysteine-rich domain associated with RING and Traf domains protein 1; Metastatic lymph node gene 62 protein; MLN 62; RING finger protein 83
|
WB, ICC/IF, FC
|
Human, Mouse |
- HY-P83228
-
Int 1 related protein; INT1L 1; INT1L1; IRP; IRP protein; ONCOGENE INT1 LIKE 1; Protein Wnt-2; Secreted growth factor; Wingless type MMTV integration site family member 2; WNT2
|
WB
|
Human, Mouse, Rat |
- HY-P83314
-
MAP2K2; MEK2; MKK2; PRKMK2; Dual specificity mitogen-activated protein kinase kinase 2; MAP kinase kinase 2; MAPKK 2; ERK activator kinase 2; MAPK/ERK kinase 2; MEK 2
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse |
- HY-P83336
-
ATG9A; APG9-like 1; Autophagy 9-like 1 protein; Autophagy-related protein 9A; MGD3208; MATG9; APG9 autophagy 9-like 1; APG9L1; Autophagy related 9A
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P83523
-
GTF2I; BAP135; WBSCR6; General transcription factor II-I; GTFII-I; TFII-I; Bruton tyrosine kinase-associated protein 135; BAP-135; BTK-associated protein 135; SRF-Phox1-interacting protein; SPIN; Williams-Beuren syndrome chromosomal region
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
- HY-P83622
-
DDR2; NTRKR3; TKT; TYRO10; Discoidin domain-containing receptor 2; Discoidin domain receptor 2; CD167 antigen-like family member B; Discoidin domain-containing receptor tyrosine kinase 2; Neurotrophic tyrosine kinase; receptor-related 3; Re
|
WB
|
Human, Mouse, Rat |
- HY-P80715
-
High temperature requirement protein A2; HTRA 2; HtrA like serine protease; HtrA serine peptidase 2; HtrA; E. coli; homolog of; 2; HtrA2; HTRA2_HUMAN; mitochondrial; Omi stress regulated endoprotease; Omi stress-regulated endoprotease; PARK 13; PARK13; Pr
|
WB, IP
|
Human |
HtrA2 Antibody (YA726) is a non-conjugated and Mouse origined monoclonal antibody about 49 kDa, targeting to HtrA2 (8G11). It can be used for WB,IP assays with tag free, in the background of Human.
|
- HY-P80763
-
NFKB2; LYT10; Nuclear factor NF-kappa-B p100 subunit; DNA-binding factor KBF2; H2TF1; Lymphocyte translocation chromosome 10 protein; Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2; Oncogene Lyt-10; Lyt10
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
NF-KB p100 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 97 kDa, targeting to NF-KB p100. It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80776
-
MAPK14; CSBP; CSBP1; CSBP2; CSPB1; MXI2; SAPK2A; Mitogen-activated protein kinase 14; MAP kinase 14; MAPK 14; Cytokine suppressive anti-inflammatory drug-binding protein; CSAID-binding protein; CSBP; MAP kinase MXI2; MAX-interacting protein
|
WB
|
Human, Mouse, Rat, Monkey |
p38 Antibody (YA696) is a non-conjugated and Mouse origined monoclonal antibody about 41 kDa, targeting to p38 (5A1). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat, Monkey.
|
- HY-P80816
-
PTK2; FAK; FAK1; Focal adhesion kinase 1; FADK 1; Focal adhesion kinase-related nonkinase; FRNK; Protein phosphatase 1 regulatory subunit 71; PPP1R71; Protein-tyrosine kinase 2; p125FAK; pp125FAK
|
WB
|
Human, Mouse |
Phospho-FAK (Tyr576) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 119 kDa, targeting to Phospho-FAK (Tyr576). It can be used for WB assays with tag free, in the background of Human, Mouse.
|
- HY-P80823
-
HSPB1; HSP27; HSP28; Heat shock protein beta-1; HspB1; 28 kDa heat shock protein; Estrogen-regulated 24 kDa protein; Heat shock 27 kDa protein; HSP 27; Stress-responsive protein 27; SRP27
|
WB, IHC-P, ICC/IF
|
Human |
Phospho-Hsp27 (Ser78) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 23 kDa, targeting to Phospho-Hsp27 (Ser78). It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human.
|
- HY-P80824
-
HSPB1; HSP27; HSP28; Heat shock protein beta-1; HspB1; 28 kDa heat shock protein; Estrogen-regulated 24 kDa protein; Heat shock 27 kDa protein; HSP 27; Stress-responsive protein 27; SRP27
|
WB, IHC-P
|
Human |
Phospho-Hsp27 (Ser82) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 23 kDa, targeting to Phospho-Hsp27 (Ser82). It can be used for WB,IHC-P assays with tag free, in the background of Human.
|
- HY-P80832
-
MAP2K1; MEK1; PRKMK1; Dual specificity mitogen-activated protein kinase kinase 1; MAP kinase kinase 1; MAPKK 1; MKK1; ERK activator kinase 1; MAPK/ERK kinase 1; MEK 1
|
WB, ICC/IF
|
Human, Mouse, Rat |
Phospho-MEK1 (Ser298) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 43 kDa, targeting to Phospho-MEK1 (Ser298). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80833
-
MAP2K1; MEK1; PRKMK1; Dual specificity mitogen-activated protein kinase kinase 1; MAP kinase kinase 1; MAPKK 1; MKK1; ERK activator kinase 1; MAPK/ERK kinase 1; MEK 1
|
WB
|
Mouse, Rat |
Phospho-MEK1 (Thr292) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 43 kDa, targeting to Phospho-MEK1 (Thr292). It can be used for WB assays with tag free, in the background of Mouse, Rat.
|
- HY-P80913
-
mitochondrial; selenoprotein Z; SELZ; Thioredoxin reductase 2; Thioredoxin reductase 2 mitochondrial; thioredoxin reductase 3; thioredoxin reductase beta; Thioredoxin reductase TR3; TR 3; TR; TR beta; TR-beta; TRXR 2; TRXR2; TRXR2_HUMAN; TXNRD 2; Txnrd2.
|
WB
|
Human |
Thioredoxin Reductase 2 Antibody (YA661) is a non-conjugated and Mouse origined monoclonal antibody about 57 kDa, targeting to Thioredoxin Reductase 2 (3F2). It can be used for WB assays with tag free, in the background of Human.
|
- HY-P81095
-
UNQ9415; Apoptosis related cysteine protease; CASP 12; casp12; CASP12P1; Caspase 12 pseudogene 1; CASP-12; casp12; caspase 12 (gene/pseudogene); Caspase12; CASPC_HUMAN; OTTHUMP00000207026; OTTHUMP00000207028; OTTHUMP00000207031; OTTHUMP00000207032; OTTHUMP00000219058; UNQ9415.
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human, Mouse, Rat, |
Caspase-12 Antibody is an unconjugated, approximately 46 kDa, rabbit-derived, anti-Caspase-12 polyclonal antibody. Caspase-12 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, background without labeling.
|
- HY-P81124
-
OPGL; CD254; hRANKL2; ODF; OPGL; Osteoclast differentiation factor; Osteoprotegerin ligand; RANKL; Receptor activator of nuclear factor kappa B ligand; sOdf; SOFA; TNF related activation induced cytokine; TNFSF 11; TNFSF11; TRANCE; Tumor necrosis factor ligand superfamily member 11; Osteoprotegerin Ligand; TNF11_HUMAN.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, Mouse(predicted: Rat, Dog) |
RANKL/CD254 Antibody is an unconjugated, approximately 35 kDa, rabbit-derived, anti-RANKL/CD254 polyclonal antibody. RANKL/CD254 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, and predicted: rat, dog background without labeling.
|
- HY-P81176
-
Integrin alpha-X; integrin alpha-X precursor; ITGAX; SLEB6; CD11C (p150) alpha polypeptide; complement receptor 4; integrin aX; CD11 antigen-like family member C; leukocyte adhesion receptor p150,95; leukocyte adhesion glycoprotein p150,95 alpha chain; ITAX_HUMAN.
|
ELISA; Flow-Cyt; IF
|
Human, Rat(predicted: Mouse, Dog) |
CD11c Antibody is an unconjugated, approximately 126 kDa, rabbit-derived, anti-CD11c polyclonal antibody. CD11c Antibody can be used for: ELISA, Flow-Cyt, IF expriments in human, rat, and predicted: mouse, dog background without labeling.
|
- HY-P81299
-
EIF2AK2; PKR; PRKR; Interferon-induced; double-stranded RNA-activated protein kinase; Eukaryotic translation initiation factor 2-alpha kinase 2; eIF-2A protein kinase 2; Interferon-inducible RNA-dependent protein kinase; P1/eIF-2A protein k
|
WB
|
Human |
- HY-P81299A
-
EIF2AK2; PKR; PRKR; Interferon-induced; double-stranded RNA-activated protein kinase; Eukaryotic translation initiation factor 2-alpha kinase 2; eIF-2A protein kinase 2; Interferon-inducible RNA-dependent protein kinase; P1/eIF-2A protein k
|
WB, IHC-P, IP, ChIP
|
Human |
- HY-P81426
-
SF3B3; KIAA0017; SAP130; Splicing factor 3B subunit 3; Pre-mRNA-splicing factor SF3b 130 kDa subunit; SF3b130; STAF130; Spliceosome-associated protein 130; SAP 130
|
IHC-P
|
Human |
- HY-P81429
-
CLEC4C; BDCA2, CLECSF11, CLECSF7, DLEC, HECL; UNQ9361/PRO34150; C-type lectin domain family 4 member C; CD303; Blood dendritic cell antigen 2 (BDCA-2); C-type lectin superfamily member 7; Dendritic lectin
|
IHC-P
|
Human |
- HY-P81437
-
SLC34A2; Sodium-dependent phosphate transport protein 2B; Sodium-phosphate transport protein 2B; Na(+)-dependent phosphate cotransporter 2B; NaPi3b; Sodium/phosphate cotransporter 2B (Na(+)/Pi cotransporter 2B; NaPi-2b); Solute carrier family 34 member 2
|
IHC-P
|
Human |
- HY-P81443
-
BCL10; CIPER; CLAP; B-cell lymphoma/leukemia 10; B-cell CLL/lymphoma 10; Bcl-10; CARD-containing molecule enhancing NF-kappa-B; CARD-like apoptotic protein; hCLAP; CED-3/ICH-1 prodomain homologous E10-like regulator; CIPER; Cellular homolog
|
IHC-P
|
Human |
- HY-P81478
-
NR2F2; ARP1; TFCOUP2; COUP transcription factor 2; COUP-TF2; Apolipoprotein A-I regulatory protein 1; ARP-1; COUP transcription factor II; COUP-TF II; Nuclear receptor subfamily 2 group F member 2
|
IHC-P
|
Human |
- HY-P81536
-
BCL6; BCL5; LAZ3; ZBTB27; ZNF51; B-cell lymphoma 6 protein; BCL-6; B-cell lymphoma 5 protein; BCL-5; Protein LAZ-3; Zinc finger and BTB domain-containing protein 27; Zinc finger protein 51
|
IHC-P
|
Human |
- HY-P81765
-
TNFSF13B; BAFF; BLYS; TALL1; TNFSF20; ZTNF4; Tumor necrosis factor ligand superfamily member 13B; B lymphocyte stimulator; BLyS; B-cell-activating factor; BAFF; Dendritic cell-derived TNF-like molecule; TNF- and APOL-related leukocyte expressed ligand 1; TALL-1; CD257
|
FC, ELISA
|
Human |
- HY-P81772
-
EPHA3; ETK; ETK1; HEK; TYRO4; Ephrin type-A receptor 3; EPH-like kinase 4; EK4; hEK4; HEK; Human embryo kinase; Tyrosine-protein kinase TYRO4; Tyrosine-protein kinase receptor ETK1; Eph-like tyrosine kinase 1
|
FC, ELISA
|
Human |
- HY-P81988
-
GABBR2; GPR51; GPRC3B; Gamma-aminobutyric acid type B receptor subunit 2; GABA-B receptor 2; GABA-B-R2; GABA-BR2; GABABR2; Gb2; G-protein coupled receptor 51; HG20
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82126
-
CHUK; IKKA; TCF16; Inhibitor of nuclear factor kappa-B kinase subunit alpha; I-kappa-B kinase alpha; IKK-A; IKK-alpha; IkBKA; IkappaB kinase; Conserved helix-loop-helix ubiquitous kinase; I-kappa-B kinase 1; IKK1; Nuclear factor NF-kappa-B
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P82418
-
CYP27A1; CYP27; Sterol 26-hydroxylase; mitochondrial; 5-beta-cholestane-3-alpha; 7-alpha; 12-alpha-triol 27-hydroxylase; Cytochrome P-450C27/25; Cytochrome P450 27; Sterol 27-hydroxylase; Vitamin D(3) 25-hydroxylase
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P82428
-
PTX3; TNFAIP5; TSG14; Pentraxin-related protein PTX3; Pentaxin-related protein PTX3; Tumor necrosis factor alpha-induced protein 5; TNF alpha-induced protein 5; Tumor necrosis factor-inducible gene 14 protein; TSG-14
|
WB, FC
|
Human, Mouse |
- HY-P82431
-
EPHB1; ELK; EPHT2; HEK6; NET; Ephrin type-B receptor 1; ELK; EPH tyrosine kinase 2; EPH-like kinase 6; EK6; hEK6; Neuronally-expressed EPH-related tyrosine kinase; NET; Tyrosine-protein kinase receptor EPH-2
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82773
-
Ly-6A.2/Ly-6E.1; Ly6a; Ly6al; Lymphocyte antigen 6A-2/6E-1; Lymphocyte antigen Ly 6A.2/Ly 6E.1; SCA-1; Stem cell antigen 1; T cell activating protein; TAP
|
WB, IHC-P
|
Mouse |
- HY-P82843
-
TNFRSF10D; DCR2; TRAILR4; TRUNDD; Tumor necrosis factor receptor superfamily member 10D; Decoy receptor 2; DcR2; TNF-related apoptosis-inducing ligand receptor 4; TRAIL receptor 4; TRAIL-R4; TRAIL receptor with a truncated death domain; CD
|
WB, IHC-P, ICC/IF
|
Human |
- HY-P82998
-
BCL2A1; ACC-1; ACC-2; Bcl-2-like protein 5; Bcl-2-related protein A1; BCL2-related protein A1; BFL1; Bcl2-L-5; BCL2L5; GRS; HBPA1; Protein BFL-1; Protein GRS
|
WB, IHC-P, FC
|
Human, Mouse, Rat |
- HY-P83158
-
GDF15; MIC1; PDF; PLAB; PTGFB; Growth/differentiation factor 15; GDF-15; Macrophage inhibitory cytokine 1; MIC-1; NSAID-activated gene 1 protein; NAG-1; NSAID-regulated gene 1 protein; NRG-1; Placental TGF-beta; Placental bone morphogenetic
|
WB
|
Human |
- HY-P83598
-
HSD17B10; ERAB; HADH2; MRPP2; SCHAD; XH98G2; 3-hydroxyacyl-CoA dehydrogenase type-2; 17-beta-hydroxysteroid dehydrogenase 10; 17-beta-HSD 10; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase; 3-hydroxyacyl-CoA dehydrogenase type II; Endoplasmic
|
WB, IHC-P, ICC/IF, FC
|
Human, Mouse, Rat |
- HY-P80613
-
Cdk 5; Cdk5; CDK5_HUMAN; Cell division protein kinase 5; Crk6; Cyclin dependent kinase 5; Cyclin-dependent kinase 5; Protein kinase CDK5 splicing; PSSALRE; Serine threonine protein kinase PSSALRE; Serine/threonine-protein kinase PSSALRE; Tau protein kinas
|
WB, ICC/IF
|
Human, Mouse, Rat, Monkey |
CDK5 Antibody (YA796) is a non-conjugated and Mouse origined monoclonal antibody about 33 kDa, targeting to CDK5 (2E8). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat, Monkey.
|
- HY-P80615
-
CDKN2A; CDKN2; MTS1; Cyclin-dependent kinase inhibitor 2A; isoforms 1/2/3; Cyclin-dependent kinase 4 inhibitor A; CDK4I; Multiple tumor suppressor 1; MTS-1; p16-INK4a; p16-INK4; p16INK4A
|
WB, IP
|
Human, Mouse |
CDKN2A Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 17 kDa, targeting to CDKN2A. It can be used for WB,IP assays with tag free, in the background of Human, Mouse.
|
- HY-P80658
-
ERBB2; HER2; MLN19; NEU; NGL; Receptor tyrosine-protein kinase erbB-2; Metastatic lymph node gene 19 protein; MLN 19; Proto-oncogene Neu; Proto-oncogene c-ErbB-2; Tyrosine kinase-type cell surface receptor HER2; p185erbB2; CD antigen CD340
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
ErbB 2 Antibody (YA771) is a non-conjugated and Mouse origined monoclonal antibody about 138 kDa, targeting to ErbB 2 (1C4). It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80730
-
TRIM28; KAP1; RNF96; TIF1B; Transcription intermediary factor 1-beta; TIF1-beta; E3 SUMO-protein ligase TRIM28; KRAB-associated protein 1; KAP-1; KRAB-interacting protein 1; KRIP-1; Nuclear corepressor KAP-1; RING finger protein 96; Tripart
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
KAP1 Antibody (YA719) is a non-conjugated and Mouse origined monoclonal antibody about 89 kDa, targeting to KAP1 (4E1). It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human.
|
- HY-P80876
-
PSMB8; LMP7; PSMB5i; RING10; Y2; Proteasome subunit beta type-8; Low molecular mass protein 7; Macropain subunit C13; Multicatalytic endopeptidase complex subunit C13; Proteasome component C13; Proteasome subunit beta-5i; Really interesting
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Rat |
Proteasome beta 8 Antibody (YA684) is a non-conjugated and Mouse origined monoclonal antibody about 30 kDa, targeting to Proteasome beta 8 (3G3). It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Rat.
|
- HY-P80893
-
SMAD2; MADH2; MADR2; Mothers against decapentaplegic homolog 2; MAD homolog 2; Mothers against DPP homolog 2; JV18-1; Mad-related protein 2; hMAD-2; SMAD family member 2; SMAD 2; Smad2; hSMAD2
|
WB, ICC/IF, FC, IP, ChIP
|
Human, Mouse, Rat |
Smad2/3 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 52 kDa, targeting to Smad2/3. It can be used for WB,ICC/IF,FC,IP,ChIP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P81081
-
SARS-CoV-2 Nucleocapsid Protein; SARS-CoV-2 NP; nucleocapsid protein [Severe acute respiratory syndrome coronavirus 2]; novel coronavirus N Protein; novel coronavirus Nucleocapsid Protein; 2019-nCoV Nucleoprotein; 2019-nCoV N; 2019nCoV N; 2019-nCoV N Protein; 2019 ncov N Protein; 2019-nCoV nucleocapsid protein.
|
WB; ELISA
|
|
SARS-CoV-2 (2019-nCoV) Nucleocapsid Antibody (YA918) is an unconjugated, approximately 46 kDa, mouse-derived, anti-SARS-CoV-2 (2019-nCoV) Nucleocapsid (YA918) monoclonal antibody. SARS-CoV-2 (2019-nCoV) Nucleocapsid Antibody (YA918) can be used for: WB, ELISA expriments in background without labeling.
|
- HY-P81085
-
Beta 2-adrenergic receptor; beta 2 Adrenergic Receptor; ADRB2R; ADRBR; ADRB2_HUMAN; Adrenergic beta 2 receptor surface; B2AR; BAR; Beta 2 adrenoreceptor; BETA2AR; Catecholamine receptor; beta2-adrenergic receptor. β2-adrenergic receptor
|
WB; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, Mouse, Rat(predicted: Dog, Rabbit) |
ADRB2 Antibody is an unconjugated, approximately 46 kDa, rabbit-derived, anti-ADRB2 polyclonal antibody. ADRB2 Antibody can be used for: WB, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: dog, rabbit background without labeling.
|
- HY-P81140
-
8-hydroxy-2'-deoxyguanosine; 2'-Deoxy-8-oxoguanosine; 7,8-Dihydro-8-oxo-2'-deoxyguanosine; 8-Oxo-7,8-dihydro-2'-deoxyguanosine; 8-Oxo-7,8-dihydrodeoxyguanosine; 2'-Deoxy-8-oxo-D-guanosine; 8-Oxo-7,8-dihydro-2μ-deoxyguanosine,8-Oxo-dG; 2'-Deoxy-8-hydroxyguanosine;
|
ELISA; IHC-P; IHC-F; IF
|
Human |
8-OHdG (DNA/RNA Damage) Antibody is an unconjugated, approximately 0.283 kDa, rabbit-derived, anti-8-OHdG (DNA/RNA Damage) polyclonal antibody. 8-OHdG (DNA/RNA Damage) Antibody can be used for: ELISA, IHC-P, IHC-F, IF expriments in human, background without labeling.
|
- HY-P81225
-
GPCR GPR43; FFA2R; Ffar2; FFAR2_HUMAN; free fatty acid activated receptor 2; Free fatty acid receptor 2; G protein coupled receptor 43; G protein-coupled receptor 43; G-protein coupled receptor 43; GPR 43; GPCR 43.
|
ELISA; IHC-P; IHC-F; ICC; IF
|
Human, Mouse(predicted: Rat) |
GPR43 Antibody is an unconjugated, approximately 37 kDa, rabbit-derived, anti-GPR43 polyclonal antibody. GPR43 Antibody can be used for: ELISA, IHC-P, IHC-F, ICC, IF expriments in human, mouse, and predicted: rat background without labeling.
|
- HY-P81356
-
PRDM1; BLIMP1; PR domain zinc finger protein 1; BLIMP-1; Beta-interferon gene positive regulatory domain I-binding factor; PR domain-containing protein 1; Positive regulatory domain I-binding factor 1 (PRDI-BF1; PRDI-binding factor 1)
|
IHC-P
|
Human |
- HY-P81527
-
FCRL4; FCRH4, IFGP2, IRTA1; Fc receptor-like protein 4; CD307d; FcR-like protein 4; FcRL4; Fc receptor homolog 4 (FcRH4); IFGP family protein 2 (hIFGP2); Immune receptor translocation-associated protein 1
|
IHC-P
|
Human |
- HY-P81717
-
NR4A1; GFRP1; HMR; NAK1; Nuclear receptor subfamily 4 group A member 1; Early response protein NAK1; Nuclear hormone receptor NUR/77; Nur77; Orphan nuclear receptor HMR; Orphan nuclear receptor TR3; ST-59; Testicular receptor 3
|
WB
|
Rat |
- HY-P82566
-
C1QBP; GC1QBP; HABP1; SF2P32; Complement component 1 Q subcomponent-binding protein; mitochondrial; GC1q-R protein; Glycoprotein gC1qBP; C1qBP; Hyaluronan-binding protein 1; Mitochondrial matrix protein p32; p33
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82727
-
B1-binding factor; B1F2; CPF; CYP7A promoter-binding factor; FTF; FTZ F1; FTZ F1beta; FTZ-F1; FTZ-F1beta; hB1F 2; hB1F-2; LRH1; Nr5a2
|
WB
|
Human, Mouse, Rat |
- HY-P83003
-
DNAJA1; DNAJ2; HDJ2; HSJ2; HSPF4; DnaJ homolog subfamily A member 1; DnaJ protein homolog 2; HSDJ; Heat shock 40 kDa protein 4; Heat shock protein J2; HSJ-2; Human DnaJ protein 2; hDj-2
|
WB, IP, FC
|
Human, Mouse, Rat |
- HY-P80529
-
H3K14ac; H3/j; H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3FJ; H3C10; H3C11; HIST1H3J
|
WB, ICC/IF, IP
|
Human, Rat |
Acetyl-Histone H3 (Lys14) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Acetyl-Histone H3 (Lys14). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Rat.
|
- HY-P80530
-
H3K27ac; H3/j; H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3FJ; H3C10; H3C11; HIST1H3J
|
WB, IHC-F, IHC-P, ICC/IF, IP, ChIP
|
Human |
Acetyl-Histone H3 (Lys27) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Acetyl-Histone H3 (Lys27). It can be used for WB,IHC-F,IHC-P,ICC/IF,IP,ChIP assays with tag free, in the background of Human.
|
- HY-P80531
-
H3K4ac; H3/j; H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3FJ; H3C10; H3C11; HIST1H3J
|
WB, ICC/IF
|
Human, Mouse |
Acetyl-Histone H3 (Lys4) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Acetyl-Histone H3 (Lys4). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse.
|
- HY-P80575
-
SMARCA4; BAF190A; BRG1; SNF2B; SNF2L4; Transcription activator BRG1; ATP-dependent helicase SMARCA4; BRG1-associated factor 190A; BAF190A; Mitotic growth and transcription activator; Protein BRG-1; Protein brahma homolog 1; SNF2-beta; SWI/S
|
WB, ICC/IF, IP
|
Human, Mouse |
BRG1 Antibody (YA817) is a non-conjugated and Mouse origined monoclonal antibody about 185 kDa, targeting to BRG1 (6D7). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse.
|
- HY-P80704
-
HIF1A; BHLHE78; MOP1; PASD8; Hypoxia-inducible factor 1-alpha; HIF-1-alpha; HIF1-alpha; ARNT-interacting protein; Basic-helix-loop-helix-PAS protein MOP1; Class E basic helix-loop-helix protein 78; bHLHe78; Member of PAS protein 1; PAS doma
|
ICC/IF, WB, IHC-F, IHC-P, ELISA
|
Human, Mouse, Rat |
HIF1 alpha Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 93 kDa, targeting to HIF1 alpha. It can be used for ICC/IF,WB,IHC-F,IHC-P,ELISA assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80842
-
MAPK14; CSBP; CSBP1; CSBP2; CSPB1; MXI2; SAPK2A; Mitogen-activated protein kinase 14; MAP kinase 14; MAPK 14; Cytokine suppressive anti-inflammatory drug-binding protein; CSAID-binding protein; CSBP; MAP kinase MXI2; MAX-interacting protein
|
WB
|
Human, Mouse, Rat |
Phospho-p38 (Thr180/Tyr182) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 41 kDa, targeting to Phospho-p38 (Thr180/Tyr182). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80853
-
SMAD2; MADH2; MADR2; Mothers against decapentaplegic homolog 2; MAD homolog 2; Mothers against DPP homolog 2; JV18-1; Mad-related protein 2; hMAD-2; SMAD family member 2; SMAD 2; Smad2; hSMAD2
|
WB
|
Human, Mouse, Rat, Hamster |
Phospho-Smad2 (Ser250) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 52 kDa, targeting to Phospho-Smad2 (Ser250). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat, Hamster.
|
- HY-P80867
-
PIK3R1; GRB1; Phosphatidylinositol 3-kinase regulatory subunit alpha; PI3-kinase regulatory subunit alpha; PI3K regulatory subunit alpha; PtdIns-3-kinase regulatory subunit alpha; Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha; PI3-kinase s
|
WB, IHC-P
|
Human, Mouse, Rat |
PI3 Kinase p85 alpha Antibody (YA689) is a non-conjugated and Mouse origined monoclonal antibody about 84 kDa, targeting to PI3 Kinase p85 alpha (1C8). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80868
-
p85; p85 beta; p85-BETA; P85B; P85B_HUMAN; Phosphatidylinositol 3 kinase; Phosphatidylinositol 3 kinase regulatory beta subunit; Phosphatidylinositol 3 kinase regulatory subunit beta; Phosphatidylinositol 3 kinase regulatory subunit polypeptide 2; Phospha
|
WB
|
Human, Mouse, Rat |
PI3 Kinase p85 beta Antibody (YA688) is a non-conjugated and Mouse origined monoclonal antibody about 82 kDa, targeting to PI3 Kinase p85 beta (8D9). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80878
-
mitochondrial; ODPA_HUMAN; PDH; PDHA; PDHA1; PDHCE1A; PDHE1 A type I; PDHE1-A type I; PHE1A; Pyruvate Dehydrogenase (lipoamide) alpha 1; Pyruvate dehydrogenase complex; E1 alpha polypeptide 1; Pyruvate Dehydrogenase E1 alpha; Pyruvate dehydrogenase E1 com
|
WB, ICC/IF
|
Human, Mouse |
Pyruvate Dehydrogenase E1 alpha Antibody (YA681) is a non-conjugated and Mouse origined monoclonal antibody about 43 kDa, targeting to Pyruvate Dehydrogenase E1 alpha (3H2). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse.
|
- HY-P80891
-
NEF; Protein S100 B; Protein S100-B; S 100 calcium binding protein beta chain; S 100 protein beta chain; S-100 protein beta chain; S-100 protein subunit beta; S100; S100 calcium binding protein beta (neural); S100 calcium-binding protein B; S100 protein b
|
WB, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat, Goat |
S100B Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 11 kDa, targeting to S100B. It can be used for WB,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat, Goat.
|
- HY-P80894
-
Chromosome segregation protein SmcB; DXS423E; KIAA0178; MGC138332; Sb1.8; Segregation of mitotic chromosomes 1; SMC protein 1A; SMC-1-alpha; SMC-1A; SMC1 (structural maintenance of chromosomes 1 yeast) like 1; SMC1; SMC1 structural maintenance of chromoso
|
WB, ICC/IF
|
Human |
SMC1A Antibody (YA673) is a non-conjugated and Mouse origined monoclonal antibody about 143 kDa, targeting to SMC1A (4C5). It can be used for WB,ICC/IF assays with tag free, in the background of Human.
|
- HY-P80916
-
Fas like protein; Apoptosis inducing protein TRICK2A/2B; Apoptosis inducing receptor TRAIL R2; CD 262; CD262; CD262 antigen; Cytotoxic TRAIL receptor 2; Death domain containing receptor for TRAIL/Apo 2L; Death domain containing receptor for TRAIL/Apo2L; D
|
WB, ICC/IF
|
Human, Mouse |
TNFRSF10B Antibody (YA660) is a non-conjugated and Mouse origined monoclonal antibody about 48 kDa, targeting to TNFRSF10B (7F4). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse.
|
- HY-P81121
-
NGF; Beta nerve growth factor; NGF-beta; Beta nerve growth factor precursor; Beta NGF; HSAN5; MGC161426; MGC161428; Nerve growth factor beta; Nerve growth factor beta polypeptide; Nerve growth factor beta subunit; NGF B; NID67; NGF beta; NGF-B; NGF_HUMAN. NGF-β; NGF β; NGFβ; β NGF; β-NGF; .
|
ELISA; IHC-P; IHC-F; ICC; IF
|
Human, Rat, Dog(predicted: Mouse, Chicken, Pig, Cow, Horse, Rabbit) |
NGFB Antibody is an unconjugated, approximately 13/32 kDa, rabbit-derived, anti-NGFB polyclonal antibody. NGFB Antibody can be used for: ELISA, IHC-P, IHC-F, ICC, IF expriments in human, rat, dog, and predicted: mouse, chicken, pig, cow, horse, rabbit background without labeling.
|
- HY-P81130
-
Hs.2563; Neurokinin 1; Neurokinin 2; Neurokinin A; Neurokinin alpha; Neuromedin L; Neuropeptide gamma; NKA; NKNA; PPT; Protachykinin 1 precursor; Substance K; Substance P; TAC1; TAC2; Tachykinin 1; Tachykinin 2; Tachykinin precursor 1; Tachykinin1; TACI; TKN1_HUMAN.
|
ELISA; IHC-P; IHC-F; Flow-Cyt; ICC; IF
|
Human, Mouse, Rat, Guinea Pig(predicted: Pig, Cow, Horse, Rabbit, Sheep) |
Substance P Antibody is an unconjugated, approximately 1.4/13 kDa, rabbit-derived, anti-Substance P polyclonal antibody. Substance P Antibody can be used for: ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, rat, guinea pig, and predicted: pig, cow, horse, rabbit, sheep background without labeling.
|
- HY-P81169
-
Programmed cell death protein 1; CD279; CD279 antigen; hPD 1; hPD-1; hSLE1; PD 1; PD1; PDCD 1; PDCD1; PDCD1_HUMAN; Programmed cell death 1; Protein PD 1; Protein PD-1; SLEB2; Systemic lupus erythematosus susceptibility 2.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, Mouse, Rat(predicted: Cow, Horse, Rabbit) |
PD-1 Antibody is an unconjugated, approximately 32 kDa, rabbit-derived, anti-PD-1 polyclonal antibody. PD-1 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: cow, horse, rabbit background without labeling.
|
- HY-P81202
-
FCG3A_HUMAN; Low affinity immunoglobulin gamma Fc region receptor III-A; CD16a antigen; Fc-gamma RIII-alpha; Fc-gamma RIII; Fc-gamma RIIIa; FcRIII; FcRIIIa; FcR-10; IgG Fc receptor III-2; CD_antigen: D16a; FCGR3A; CD16A; FCG3; FCGR3; IGFR3.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, Mouse, Rat(predicted: Pig, Cow, Rabbit, Sheep) |
CD16 Antibody is an unconjugated, approximately 27 kDa, rabbit-derived, anti-CD16 polyclonal antibody. CD16 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: pig, cow, rabbit, sheep background without labeling.
|
- HY-P81273
-
FABP 1; FABP1; FABP1; FABPL; FABPL_HUMAN; Fatty Acid Binding Protein 1; Fatty acid binding protein 1 liver; Fatty Acid Binding Protein; Fatty acid-binding protein 1; Fatty acid-binding protein; Fatty acid-binding protein liver; L FABP; L-FABP; liver; Liver-type fatty acid-binding protein.
|
ELISA
|
Human |
- HY-P81273B
-
FABP 1; FABP1; FABP1; FABPL; FABPL_HUMAN; Fatty Acid Binding Protein 1; Fatty acid binding protein 1 liver; Fatty Acid Binding Protein; Fatty acid-binding protein 1; Fatty acid-binding protein; Fatty acid-binding protein liver; L FABP; L-FABP; liver; Liver-type fatty acid-binding protein.
|
WB, IHC-F, IHC-P, ICC/IF
|
Mouse |
- HY-P81292
-
96 kDa nucleoporin; 98 kDa nucleoporin; ADAR2; ADIR2; GLFG-repeat containing nucleoporin; Nuclear pore complex protein Nup96; Nuclear pore complex protein Nup98 Nup96; Nucleoporin 98kD; nucleoporin 98kDa; Nucleoporin Nup96; Nucleoporin Nup98; NUP196; NUP96; Nup98; Nup98-Nup96; NUP98_HUMAN.
|
WB, IP
|
Human |
- HY-P81292A
-
96 kDa nucleoporin; 98 kDa nucleoporin; ADAR2; ADIR2; GLFG-repeat containing nucleoporin; Nuclear pore complex protein Nup96; Nuclear pore complex protein Nup98 Nup96; Nucleoporin 98kD; nucleoporin 98kDa; Nucleoporin Nup96; Nucleoporin Nup98; NUP196; NUP96; Nup98; Nup98-Nup96; NUP98_HUMAN.
|
WB
|
Human |
- HY-P81435
-
SLC1A5 ; ASCT2; M7V1, RDR, RDRC; Neutral amino acid transporter B(0); ATB(0); Baboon M7 virus receptor; RD114/simian type D retrovirus receptor; Sodium-dependent neutral amino acid transporter type 2; Solute carrier family 1 member 5
|
IHC-P
|
Human |
- HY-P81925
-
CCL19; ELC; MIP3B; SCYA19; C-C motif chemokine 19; Beta-chemokine exodus-3; CK beta-11; Epstein-Barr virus-induced molecule 1 ligand chemokine; EBI1 ligand chemokine; ELC; Macrophage inflammatory protein 3 beta; MIP-3-beta; Small-inducible
|
WB, FC
|
Human |
- HY-P82169
-
BACE1; BACE; KIAA1149; Beta-secretase 1; Aspartyl protease 2; ASP2; Asp 2; Beta-site amyloid precursor protein cleaving enzyme 1; Beta-site APP cleaving enzyme 1; Memapsin-2; Membrane-associated aspartic protease 2
|
WB, IP
|
Human, Mouse, Rat |
- HY-P82186
-
ATP2A2; ATP2B; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2; SERCA2; SR Ca(2+)-ATPase 2; Calcium pump 2; Calcium-transporting ATPase sarcoplasmic reticulum type; slow twitch skeletal muscle isoform; Endoplasmic reticulum class 1/2 Ca(2+) ATPase
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Rat |
- HY-P82229
-
SKP1; EMC19; OCP2; SKP1A; TCEB1L; S-phase kinase-associated protein 1; Cyclin-A/CDK2-associated protein p19; Organ of Corti protein 2; OCP-2; Organ of Corti protein II; OCP-II; RNA polymerase II elongation factor-like protein; SIII; Transcr
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P82288
-
IGF2BP2; IMP2; VICKZ2; Insulin-like growth factor 2 mRNA-binding protein 2; IGF2 mRNA-binding protein 2; IMP-2; Hepatocellular carcinoma autoantigen p62; IGF-II mRNA-binding protein 2; VICKZ family member 2
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P83087
-
INPP5D; SHIP; SHIP1; Phosphatidylinositol 3; 4; 5-trisphosphate 5-phosphatase 1; Inositol polyphosphate-5-phosphatase of 145 kDa; SIP-145; SH2 domain-containing inositol 5'-phosphatase 1; SH2 domain-containing inositol phosphatase 1; SHIP-1
|
WB, IHC-P, IP, FC
|
Human |
- HY-P83178
-
CCL19; ELC; MIP3B; SCYA19; C-C motif chemokine 19; Beta-chemokine exodus-3; CK beta-11; Epstein-Barr virus-induced molecule 1 ligand chemokine; EBI1 ligand chemokine; ELC; Macrophage inflammatory protein 3 beta; MIP-3-beta; Small-inducible
|
WB
|
Human |
- HY-P83231
-
MGC1490; Rab 11; Rab 11A; Rab-11; RAB11 A; RAB11; Rab11a; RAB11A member RAS oncogene family; Ras related protein Rab 11A; Ras related protein Rab11A; Ras-related protein Rab-11A; RB11A; YL 8; YL8
|
WB, IP
|
Human, Mouse, Rat |
- HY-P83506
-
CD59; MIC11; MIN1; MIN2; MIN3; MSK21; CD59 glycoprotein; 1F5 antigen; 20 kDa homologous restriction factor; HRF-20; HRF20; MAC-inhibitory protein; MAC-IP; MEM43 antigen; Membrane attack complex inhibition factor; MACIF; Membrane inhibitor of reactive lysis; MIRL; Protectin; CD59
|
WB, ICC/IF, IP, FC
|
Human |
- HY-P80562
-
AURKB; AIK2; AIM1; AIRK2; ARK2; STK1; STK12; STK5; Aurora kinase B; Aurora 1; Aurora- and IPL1-like midbody-associated protein 1; AIM-1; Aurora/IPL1-related kinase 2; ARK-2; Aurora-related kinase 2; STK-1; Serine/threonine-protein kinase 12
|
WB, IP
|
Human |
Aurora B Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 39 kDa, targeting to Aurora B. It can be used for WB,IP assays with tag free, in the background of Human.
|
- HY-P80706
-
H2BK5ac; H2B 1A; H2B; H2B histone family; H2B2f; H2Ba; H2Bf; HIST2H2BF; histone H2B; histone H2B type 1; Histone H2B type 2-F
|
WB, IHC-P
|
Human, Mouse, Rat |
Histone H2B Antibody (YA737) is a non-conjugated and Mouse origined monoclonal antibody about 14 kDa, targeting to Histone H2B (7E2). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80736
-
XRCC6; G22P1; X-ray repair cross-complementing protein 6; 5'-deoxyribose-5-phosphate lyase Ku70; 5'-dRP lyase Ku70; 70 kDa subunit of Ku antigen; ATP-dependent DNA helicase 2 subunit 1; ATP-dependent DNA helicase II 70 kDa subunit; CTC box-
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
Ku70 Antibody (YA319) is a non-conjugated and Rabbit origined monoclonal antibody about 70 kDa, targeting to Ku70. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human.
|
- HY-P80737
-
XRCC5; G22P2; X-ray repair cross-complementing protein 5; 86 kDa subunit of Ku antigen; ATP-dependent DNA helicase 2 subunit 2; ATP-dependent DNA helicase II 80 kDa subunit; CTC box-binding factor 85 kDa subunit; CTC85; CTCBF; DNA repair pr
|
WB, ICC/IF, IP, ChIP
|
Human, Monkey |
Ku80 Antibody (YA714) is a non-conjugated and Mouse origined monoclonal antibody about 83 kDa, targeting to Ku80 (8H1). It can be used for WB,ICC/IF,IP,ChIP assays with tag free, in the background of Human, Monkey.
|
- HY-P80785
-
UCHL1 / PGP9.5; UCHL1; B220; CD 45; CD45; cd45 antigen; ec3.1.3.48; GP 180; GP180; Human homolog of severe combined immunodeficiency due to PTPRC deficiency; L CA; L-CA; lca; Leukocyte common antigen; LY 5; LY5; Protein tyrosine phosphatase receptor type
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
PGP9.5 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 25 kDa, targeting to PGP9.5. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80846
-
PIK3R1; GRB1; Phosphatidylinositol 3-kinase regulatory subunit alpha; PI3-kinase regulatory subunit alpha; PI3K regulatory subunit alpha; PtdIns-3-kinase regulatory subunit alpha; Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha; PI3-kinase s
|
WB, IHC-F, IHC-P, ICC/IF, ELISA
|
Human, Mouse, Rat, Monkey |
Phospho-PI3 Kinase p85/p55 (Tyr467/Tyr199) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 84 kDa, targeting to Phospho-PI3 Kinase p85/p55 (Tyr467/Tyr199). It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Mouse, Rat, Monkey.
|
- HY-P80851
-
RPS6KA6; RSK4; Ribosomal protein S6 kinase alpha-6; S6K-alpha-6; 90 kDa ribosomal protein S6 kinase 6; p90-RSK 6; p90RSK6; Ribosomal S6 kinase 4; RSK-4; pp90RSK4
|
WB, ICC/IF
|
Human |
Phospho-RSK4 (Ser232) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 84 kDa, targeting to Phospho-RSK4 (Ser232). It can be used for WB,ICC/IF assays with tag free, in the background of Human.
|
- HY-P80905
-
SUMO1; SMT3C; SMT3H3; UBL1; OK/SW-cl.43; Small ubiquitin-related modifier 1; SUMO-1; GAP-modifying protein 1; GMP1; SMT3 homolog 3; Sentrin; Ubiquitin-homology domain protein PIC1; Ubiquitin-like protein SMT3C; Smt3C; Ubiquitin-like protein
|
WB, IHC-P
|
Human, Mouse, Rat |
SUMO1 Antibody (YA047) is a non-conjugated and Rabbit origined monoclonal antibody, targeting to SUMO1. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P81090
-
Activating transcription factor 3; ATF3deltaZip2; ATF3deltaZip2c; ATF3deltaZip3; cAMP dependent transcription factor ATF3; Cyclic AMP dependent transcription factor ATF3; Cyclic AMP-dependent transcription factor ATF-3; TF3_HUMAN; cAMP-dependent transcription factor ATF-3; cyclic AMP-dependent transcription factor ATF-3 isoform 1.
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human, Mouse(predicted: Rat, Chicken, Dog, Cow) |
ATF3 Antibody is an unconjugated, approximately 20 kDa, rabbit-derived, anti-ATF3 polyclonal antibody. ATF3 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, and predicted: rat, chicken, dog, cow background without labeling.
|
- HY-P81114
-
Interleukin-17A; CTLA-8; CTLA 8; CTLA8; Cytotoxic T lymphocyte associated antigen 8; Cytotoxic T lymphocyte associated serine esterase 8; IL 17A; IL-17A; IL-17; Interleukin 17; Interleukin-17; Interleukin 17A; Interleukin17; Interleukin17A; IL17_HUMAN; IL17_MOUSE.
|
WB; ELISA; IHC-P; IHC-F; IF
|
Mouse, Rat, |
IL17A Antibody is an unconjugated, approximately 15 kDa, rabbit-derived, anti-IL17A polyclonal antibody. IL17A Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in mouse, rat, background without labeling.
|
- HY-P81157
-
Sonic hedgehog; Vhh-1; Sonic hedgehog protein; SHH; HHG 1; HHG1; HLP 3; HLP3; Holoprosencephaly 3; HPE 3; HPE3; MCOPCB5; SMMC I; SMMCI; Sonic Hedgehog (Drosophila) homolog; sonic hedgehog homolog (Drosophila); Sonic hedgehog homolog; Sonic hedgehog protein; TPT; TPTPS; Sonic hedgehog protein N-product; SHH_HUMAN.
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human, Mouse, Rat(predicted: Chicken, Cow, Horse, Rabbit) |
Shh Antibody is an unconjugated, approximately 19/47 kDa, rabbit-derived, anti-Shh polyclonal antibody. Shh Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, and predicted: chicken, cow, horse, rabbit background without labeling.
|
- HY-P81212
-
Gonadotropin receptor; CGR; hCG receptor; FLJ41504; Gpcr19-rs1; GTHR-II; HHG; LCGR; LGR2; LH-R; LH/CG R; LH/CG-R; LH RECEPTOR; LH/CGR; LHCGR; LHRHR; LSH R; LSH-R; LSHR_HUMAN; Luteinizing hormone receptor; Luteinizing hormone/choriogonadotropin receptor; luteinizing hormone/choriogonadotropin receptor; Lutropin choriogonadotropic hormone receptor; Lutropin choriogonadotropic receptor; Lutropin-choriogonadotropic hormone receptor; ULG5.
|
ELISA; IHC-P; IHC-F; IF
|
Human, Rat(predicted: Mouse, Pig, Cow, Horse, Rabbit, Sheep) |
LHR Antibody is an unconjugated, approximately 74 kDa, rabbit-derived, anti-LHR polyclonal antibody. LHR Antibody can be used for: ELISA, IHC-P, IHC-F, IF expriments in human, rat, and predicted: mouse, pig, cow, horse, rabbit, sheep background without labeling.
|
- HY-P81218
-
Ferroportin 1; Ferroportin-1; FPN1; HFE4; IREG1; Iron regulated transporter 1; Iron-regulated transporter 1; MTP1; S40A1_HUMAN; SLC40A1; Solute carrier family 40 member 1; MST079; MSTP079; MTP1; SLC11A3.
|
WB; ELISA
|
Human(predicted: Mouse, Rat, Dog, Pig, Rabbit) |
SLC40A1 Antibody is an unconjugated, approximately 63 kDa, rabbit-derived, anti-SLC40A1 polyclonal antibody. SLC40A1 Antibody can be used for: WB, ELISA expriments in human, and predicted: mouse, rat, dog, pig, rabbit background without labeling.
|
- HY-P81247
-
DGAT2_HUMAN; Diacylglycerol O acyltransferase like protein 2; Diacylglycerol O-acyltransferase 2; Diacylglycerol O-acyltransferase homolog 2 (mouse); Diacylglycerol O-acyltransferase homolog 2; Diacylglycerol O-acyltransferase-like protein 2 isoform 1; Diglyceride acyltransferase 2; DKFZp686A15125; GS1999full; HMFN1045.
|
WB; ELISA
|
Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Sheep |
- HY-P81293
-
Basic domain helix loop helix protein class B 1; Basic helix loop helix protein class B 1; BHLHB; bHLHB1; bHLHe19; Class B basic helix loop helix protein 1; Class B basic helix-loop-helix protein 1; class E basic helix loop helix protein 19
|
WB
|
Transfected |
- HY-P81293A
-
Basic domain helix loop helix protein class B 1; Basic helix loop helix protein class B 1; BHLHB; bHLHB1; bHLHe19; Class B basic helix loop helix protein 1; Class B basic helix-loop-helix protein 1; class E basic helix loop helix protein 19
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P81448
-
SLC7A5; CD98LC, LAT1; MPE16; Large neutral amino acids transporter small subunit 1; 4F2 light chain (4F2 LC; 4F2LC); CD98 light chain; Integral membrane protein E16; Solute carrier family 7 member 5
|
IHC-P
|
Human |
- HY-P81632
-
IL13RA1; IL13R; IL13RA; Interleukin-13 receptor subunit alpha-1; IL-13 receptor subunit alpha-1; IL-13R subunit alpha-1; IL-13R-alpha-1; IL-13RA1; Cancer/testis antigen 19; CT19; CD antigen CD213a1
|
FC, ELISA
|
Human |
- HY-P82405
-
MARK3; CTAK1; EMK2; MAP/microtubule affinity-regulating kinase 3; C-TAK1; cTAK1; Cdc25C-associated protein kinase 1; ELKL motif kinase 2; EMK-2; Protein kinase STK10; Ser/Thr protein kinase PAR-1; Par-1a; Serine/threonine-protein kinase p78
|
WB, ICC/IF, IP, FC
|
Mouse, Human |
- HY-P83061
-
CELF1; BRUNOL2; CUGBP; CUGBP1; NAB50; CUGBP Elav-like family member 1; CELF-1; 50 kDa nuclear polyadenylated RNA-binding protein; Bruno-like protein 2; CUG triplet repeat RNA-binding protein 1; CUG-BP1; CUG-BP- and ETR-3-like factor 1; Dead
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P83344
-
INPP5D; SHIP; SHIP1; Phosphatidylinositol 3; 4; 5-trisphosphate 5-phosphatase 1; Inositol polyphosphate-5-phosphatase of 145 kDa; SIP-145; SH2 domain-containing inositol 5'-phosphatase 1; SH2 domain-containing inositol phosphatase 1; SHIP-1
|
WB, ICC/IF, IP
|
Human |
- HY-P83367
-
IFNAR1; IFNAR; Interferon alpha/beta receptor 1; IFN-R-1; IFN-alpha/beta receptor 1; Cytokine receptor class-II member 1; Cytokine receptor family 2 member 1; CRF2-1; Type I interferon receptor 1
|
WB, IP
|
Human |
- HY-P83496
-
SMARCA2; BAF190B; BRM; SNF2A; SNF2L2; Probable global transcription activator SNF2L2; ATP-dependent helicase SMARCA2; BRG1-associated factor 190B; BAF190B; Protein brahma homolog; hBRM; SNF2-alpha; SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
- HY-P80852
-
SMAD1; BSP1; MADH1; MADR1; Mothers against decapentaplegic homolog 1; MAD homolog 1; Mothers against DPP homolog 1; JV4-1; Mad-related protein 1; SMAD family member 1; SMAD 1; Smad1; hSMAD1; Transforming growth factor-beta-signaling protein
|
WB, IP
|
Human, Rat |
Phospho-Smad1 (Ser463/Ser465) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 52 kDa, targeting to Phospho-Smad1 (Ser463/Ser465). It can be used for WB,IP assays with tag free, in the background of Human, Rat.
|
- HY-P81073
-
Neurokinin 1; Neurokinin 1 Receptor; NK 1 receptor; NK 1R; NK1 receptor; NK-1R; NK1R; NKIR; SPR; Substance P receptor; TAC 1R; TAC1R; Tachykinin 1 receptor; Tachykinin receptor 1; Tachykinin receptor 1; TACR1; NK1-R; NK1R
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, Rat, Guinea Pig (predicted: Mouse, Dog, Pig, Cow, Horse ) |
NK1R Antibody is an unconjugated, approximately 48 kDa, rabbit-derived, anti-NK1R polyclonal antibody. NK1R Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, rat, guinea pig, and predicted: mouse, dog, pig, cow, horse background without labeling.
|
- HY-P81122
-
Na(+)/I(-) cotransporter; Na(+)/I(-) symporter; Na(+)/I(-) cotransporter; Na(+)/I(-) symporter; Na+/I- cotransporter; Na+/I-symporter; NIS; SC5A5_HUMAN; SLC5A5; sodium iodide symporter; Sodium-iodide symporter; Sodium/iodide cotransporter; Solute carrier family 5 (sodium iodide symporter) member 5; Solute carrier family 5; Solute carrier family 5 member 5.
|
WB; ELISA; IHC-P; IHC-F; IF
|
Mouse, Rat(predicted: Human) |
NIS Antibody is an unconjugated, approximately 68 kDa, rabbit-derived, anti-NIS polyclonal antibody. NIS Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in mouse, rat, and predicted: human background without labeling.
|
- HY-P81142
-
Muscarinic Acetylcholine receptor M3; cholinergic receptor, muscarinic 3; CHRM 3; CHRM3; HM 3; HM3; HM3; EGBRS; M3 muscarinic receptor; muscarinic 3; m3 muscarinic acetylcholine receptor; ACM3_HUMAN; muscarinic receptor M3; muscarinic cholinergic m3 receptor; muscarinic m3 receptor; Acetylcholine receptor(M3).
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human(predicted: Mouse, Rat) |
Muscarinic Acetylcholine receptor M3 Antibody is an unconjugated, approximately 65 kDa, rabbit-derived, anti-Muscarinic Acetylcholine receptor M3 polyclonal antibody. Muscarinic Acetylcholine receptor M3 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, and predicted: mouse, rat background without labeling.
|
- HY-P81160
-
Glucagon like peptide-1 receptor; GLP 1 R; GLP 1 receptor; GLP 1R; Glp1r; GLP; glp1r; Glucagon like peptide 1 receptor; RATGL1RCP; Glip; MGC138331; GLP-1-R; GLP1R_HUMAN; Glucagon-like peptide 1 receptor; GLP-1 receptor; GLP-1-R; GLP-1R; Precursor.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; ICC; IF
|
Human, Mouse, Rat(predicted: Dog) |
GLP-1R Antibody is an unconjugated, approximately 51 kDa, rabbit-derived, anti-GLP-1R polyclonal antibody. GLP-1R Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, rat, and predicted: dog background without labeling.
|
- HY-P81233
-
GADD153; CHOP; Growth arrest and DNA damage-inducible 153; C/EBP homologous protein; C/EBP Homology Protein; CEBPZ; CHOP10; DDIT 3; DNA Damage Inducible Transcript 3; GADD 153; Growth Arrest and DNA Damage Inducible Protein 153; Growth arrest and DNA damage inducible protein GADD153; MGC4154; DDIT3_HUMAN.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, Mouse, Rat(predicted: Dog, Pig, Cow, Horse, Rabbit, Sheep) |
DDIT3 Antibody is an unconjugated, approximately 19 kDa, rabbit-derived, anti-DDIT3 polyclonal antibody. DDIT3 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: dog, pig, cow, horse, rabbit, sheep background without labeling.
|
- HY-P81267
-
CK 7; CK-7; ck7; Cytokeratin 7; Cytokeratin-7; Cytokeratin7; D15Wsu77e; K2C7; K2C7_HUMAN; K7; Keratin 55k type ii cytoskeletal; Keratin 7; Keratin simple epithelial type 1 k7; Keratin type II cytoskeletal 7
|
WB, ICC/IF
|
Human |
- HY-P81267A
-
CK 7; CK-7; ck7; Cytokeratin 7; Cytokeratin-7; Cytokeratin7; D15Wsu77e; K2C7; K2C7_HUMAN; K7; Keratin 55k type ii cytoskeletal; Keratin 7; Keratin simple epithelial type 1 k7; Keratin type II cytoskeletal 7
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P81267B
-
CK 7; CK-7; ck7; Cytokeratin 7; Cytokeratin-7; Cytokeratin7; D15Wsu77e; K2C7; K2C7_HUMAN; K7; Keratin 55k type ii cytoskeletal; Keratin 7; Keratin simple epithelial type 1 k7; Keratin type II cytoskeletal 7
|
WB, ICC/IF, IP
|
Human |
- HY-P81343
-
MAP2K6; MEK6; MKK6; PRKMK6; SKK3; Dual specificity mitogen-activated protein kinase kinase 6; MAP kinase kinase 6; MAPKK 6; MAPK/ERK kinase 6; MEK 6; Stress-activated protein kinase kinase 3; SAPK kinase 3; SAPKK-3; SAPKK3
|
WB, IP
|
Human, Rat |
- HY-P81367
-
FOXM1; FKHL16, HFH11, MPP2, WIN; Forkhead box protein M1; Forkhead-related protein FKHL16; Hepatocyte nuclear factor 3 forkhead homolog 11 (HFH-11; HNF-3/fork-head homolog 11); M-phase phosphoprotein 2; MPM-2 reactive phosphoprotein 2; Transcription factor Trident; Winged-helix factor from INS-1 cells
|
IHC-P
|
Human |
- HY-P81475
-
TCF3; BHLHB21, E2A, ITF1; Transcription factor E2-alpha; Class B basic helix-loop-helix protein 21 (bHLHb21); Immunoglobulin enhancer-binding factor E12/E47; Immunoglobulin transcription factor 1; Kappa-E2-binding factor; Transcription factor 3 (TCF-3); Transcription factor ITF-1
|
IHC-P
|
Human |
- HY-P81754
-
IGF2R; MPRI; Cation-independent mannose-6-phosphate receptor; CI Man-6-P receptor; CI-MPR; M6PR; 300 kDa mannose 6-phosphate receptor; MPR 300; Insulin-like growth factor 2 receptor; Insulin-like growth factor II receptor; IGF-II receptor; M6P/IGF2 receptor; M6P/IGF2R; CD222
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P81879
-
IL13RA1; IL13R; IL13RA; Interleukin-13 receptor subunit alpha-1; IL-13 receptor subunit alpha-1; IL-13R subunit alpha-1; IL-13R-alpha-1; IL-13RA1; Cancer/testis antigen 19; CT19; CD antigen CD213a1
|
WB
|
Human |
- HY-P81956
-
CK 6A; CK 6B; CK 6C; CK 6D; CK 6E; CK-6C; CK-6E; K6a keratin; K6b keratin; K6C; K6c keratin; K6d keratin; K6e keratin; Keratin; KRT6A; KRT6B; KRT6C; KRT6D; KRT6E
|
WB, IHC-P, ICC/IF
|
Human |
- HY-P82159
-
ILF3; DRBF; MPHOSPH4; NF90; Interleukin enhancer-binding factor 3; Double-stranded RNA-binding protein 76; DRBP76; M-phase phosphoprotein 4; MPP4; Nuclear factor associated with dsRNA; NFAR; Nuclear factor of activated T-cells 90 kDa; NF-AT-90; Translational control protein 80; TCP80
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse |
- HY-P83044
-
Phosphatidylinositol 3-kinase catalytic subunit type 3 (EC:2.7.1.137); PI3-kinase type 3; PI3K type 3; PtdIns-3-kinase type 3; Phosphatidylinositol 3-kinase p100 subunit; Phosphoinositide-3-kinase class 3; hVps34; VPS34 AntibodyPIK3C3;
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P80004
-
30 kDa adipocyte complement related protein; ACDC; ACRP 30; ACRP30; ADIPO_HUMAN; Adipocyte; AdipoQ; Adipose most abundant gene transcript 1; Adipose specific collagen like factor; ADIPQTL1; ADPN; APM 1; apM-1; ApM1; C1q and collagen domain-containing protein; GBP 28; GBP28; Gelatin binding protein; Gelatin binding protein 28; Gelatin-binding protein.
|
WB, ICC, IHC-P
|
Mouse |
Adiponectin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 27 kDa, targeting to Adiponectin. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Mouse.
|
- HY-P80389
-
CDK7_HUMAN; Cyclin-dependent kinase 7; EC:2.7.11.22; EC:2.7.11.23; CDK7; CAK; CAK1; CDKN7; MO15; STK1; 39 kDa protein kinase (p39 Mo15); CDK-activating kinase 1; Cell division protein kinase 7; Serine/threonine-protein kinase 1; TFIIH basal transcription factor complex kinase subunit
|
WB;ELISA;IHC-P;IHC-F;ICC;IF
|
Human, Mouse, Rat |
Cdk7 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 39 kDa, targeting to Cdk7. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human.
|
- HY-P80440
-
MGC22487; Oct 3; Oct 4; Oct-3; Oct-4; OCT3; Oct4; Octamer binding protein 3; Octamer binding protein 4; Octamer binding transcription factor 3; Octamer-binding protein 3; Octamer-binding protein 4; Octamer-binding transcription factor 3; OTF 3; OTF 4; OTF
|
WB, ICC
|
Human, Mouse |
Oct-4 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 39 kDa, targeting to POU5F1. It can be used for WB,ICC assays with tag free, in the background of Human, Mouse.
|
- HY-P80628
-
Connexin 43; Connexin-43; Cx 43; Cx43; CXA1_HUMAN; DFNB38; Gap junction 43 kDa heart protein; Gap junction alpha-1 protein; Gap junction protein alpha 1 43kDa (connexin 43); Gap junction protein alpha 1 43kDa; Gap junction protein alpha like; GJA 1; Gja1
|
WB, IHC-F, IHC-P, ICC/IF, ELISA
|
Human, Mouse, Rat |
Connexin 43 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 43 kDa, targeting to Connexin 43. It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80770
-
MGC22487; Oct 3; Oct 4; Oct-3; Oct-4; OCT3; Oct4; Octamer binding protein 3; Octamer binding protein 4; Octamer binding transcription factor 3; Octamer-binding protein 3; Octamer-binding protein 4; Octamer-binding transcription factor 3; OTF 3; OTF 4; OTF
|
WB, IHC-P, ICC/IF, IP, ChIP
|
Human, Mouse |
Oct-4 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 39 kDa, targeting to POU5F1. It can be used for WB,IHC-P,ICC/IF,IP,ChIP assays with tag free, in the background of Human, Mouse.
|
- HY-P80834
-
MAP2K4; JNKK1; MEK4; MKK4; PRKMK4; SEK1; SERK1; SKK1; Dual specificity mitogen-activated protein kinase kinase 4; MAP kinase kinase 4; MAPKK 4; JNK-activating kinase 1; MAPK/ERK kinase 4; MEK 4; SAPK/ERK kinase 1; SEK1; Stress-activated pro
|
WB, IP
|
Human |
Phospho-MEK4 (Ser80) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 44 kDa, targeting to Phospho-MEK4 (Ser80). It can be used for WB,IP assays with tag free, in the background of Human.
|
- HY-P80850
-
RPS6KA3; ISPK1; MAPKAPK1B; RSK2; Ribosomal protein S6 kinase alpha-3; S6K-alpha-3; 90 kDa ribosomal protein S6 kinase 3; p90-RSK 3; p90RSK3; Insulin-stimulated protein kinase 1; ISPK-1; MAP kinase-activated protein kinase 1b; MAPK-activated
|
WB, IP
|
Human, Mouse, Rat |
Phospho-RSK2 (Ser227) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 84 kDa, targeting to Phospho-RSK2 (Ser227). It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80887
-
RPS6KA2; MAPKAPK1C; RSK3; Ribosomal protein S6 kinase alpha-2; S6K-alpha-2; 90 kDa ribosomal protein S6 kinase 2; p90-RSK 2; p90RSK2; MAP kinase-activated protein kinase 1c; MAPK-activated protein kinase 1c; MAPKAP kinase 1c; MAPKAPK-1c; Ri
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Hamster |
RSK3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 83 kDa, targeting to RSK3. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Hamster.
|
- HY-P81086
-
Advanced glycosylation end product specific receptor; Advanced glycosylation end product-specific receptor; AGER; EC 2.7.11.22; LE 9211 A antigen; LE-9211-A antigen; MGC22357; MOK; RAGE 1; RAGE1; MOK protein kinase; Receptor for advanced glycation endproducts; Renal tumor antigen 1; Renal tumor antigen; Renal cell carcinoma antigen (MOK protein kinase); Renal tumor antigen 1; RAGE_HUMAN.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, Mouse, Rat, |
RAGE Antibody is an unconjugated, approximately 42 kDa, rabbit-derived, anti-RAGE polyclonal antibody. RAGE Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, background without labeling.
|
- HY-P81133
-
Clgi; Collagenase inhibitor; EPA; EPO; Erythroid Potentiating Activity; Fibroblast collagenase inhibitor; FLJ90373; HC; Human Collagenase Inhibitor; Metalloproteinase inhibitor 1; Metalloproteinase inhibitor 1 precursor; OTTHUMP00000023214; TIMP 1; TIMP; TIMP metallopeptidase inhibitor 1; TIMP1 protein; Tissue Inhibitor of Metalloproteinase 1; Tissue inhibitor of metalloproteinases; Ttissue inhibitor of metalloproteinase 1 erythroid potentiating activity collagenase inhibitor.
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human, Mouse, Rabbit(predicted: Rat, Dog, Pig, Cow, Sheep) |
TIMP-1 Antibody is an unconjugated, approximately 21 kDa, rabbit-derived, anti-TIMP-1 polyclonal antibody. TIMP-1 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rabbit, and predicted: rat, dog, pig, cow, sheep background without labeling.
|
- HY-P81150
-
G Protein Coupled Receptor 30; G-protein coupled receptor 30; G-protein coupled estrogen receptor 1; Membrane estrogen receptor; mER; Chemokine receptor-like 2; IL8-related receptor DRY12; Flow-induced endothelial G-protein coupled receptor 1; FEG-1; Lymphocyte-derived G-protein coupled receptor; LYGPR; GPCR-BR; CEPR; CMKRL2; DRY12; GPER.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; ICC; IF
|
Human, Mouse, Rat(predicted: Chicken, Cow, Horse, Rabbit) |
GPR30 Antibody is an unconjugated, approximately 42 kDa, rabbit-derived, anti-GPR30 polyclonal antibody. GPR30 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, rat, and predicted: chicken, cow, horse, rabbit background without labeling.
|
- HY-P81158
-
CXC-chemokine receptor 2; CD 182; CD182; CD182 antigen; CDw128b; Chemokine (CXC) receptor 2; CMKAR2; CXCR 2; CXC R2; CXC-R2; CXCR2_HUMAN; C-X-C chemokine receptor type 2; CXCR-2; GRO/MGSA receptor; High affinity interleukin-8 receptor B; IL-8R B; IL-8 receptor type 2.
|
WB; ELISA
|
Human, Mouse(predicted: Rat, Dog, Pig, Cow, Horse, Rabbit, Guinea Pig) |
CXCR2 Antibody is an unconjugated, approximately 41 kDa, rabbit-derived, anti-CXCR2 polyclonal antibody. CXCR2 Antibody can be used for: WB, ELISA expriments in human, mouse, and predicted: rat, dog, pig, cow, horse, rabbit, guinea pig background without labeling.
|
- HY-P81190
-
p-PERK(Thr980); PERK(Phospho Thr980); PERK(Phospho T980); mo(Thr980)/hu (Thr982)/rat (Thr974); HRI; HsPEK; Pancreatic eIF2-alpha kinase; PEK; PRKR like endoplasmic reticulum kinase; WRS; DKFZp781H1925; EC 2.7.11.1; EIF2AK3; Eukaryotic translation initiation factor 2 alpha kinase 3; Heme regulated EIF2 alpha kinase.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, Mouse, Rat(predicted: Dog, Pig, Cow, Rabbit) |
Phospho-PERK (Thr980) Antibody is an unconjugated, approximately 119 kDa, rabbit-derived, anti-PERK (Thr980) polyclonal antibody. Phospho-PERK (Thr980) Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: dog, pig, cow, rabbit background without labeling.
|
- HY-P81230
-
DF 5L; DF5L; DFNA 5L; DFNA5L; FKSG 10; FKSG10; FLJ12150; Gasdermin D; Gasdermin domain containing 1; Gasdermin domain containing protein 1; Gasdermin domain-containing protein 1; Gasdermin-D; GasderminD; GSDMD_HUMAN; GSDMDC 1; GSDMDC1; Gasdermin-D, N-terminal; GSDMD-NT; hGSDMD-NTD; Gasdermin-D, C-terminal; GSDMD-CT; hGSDMD-CTD.
|
WB; ELISA; IHC-P; IHC-F; ICC; IF
|
Human(predicted: Mouse, Rat) |
GSDMD Antibody is an unconjugated, approximately 53 kDa, rabbit-derived, anti-GSDMD polyclonal antibody. GSDMD Antibody can be used for: WB, ELISA, IHC-P, IHC-F, ICC, IF expriments in human, and predicted: mouse, rat background without labeling.
|
- HY-P81252
-
Caspase-5 subunit p20; Apoptosis related cysteine protease; CASP 5; CASP5; Caspase-5; Caspase5; Caspase 5 apoptosis related cysteine peptidase; caspase 5 apoptosis related cysteine protease; ICE; ICE(rel) III; ICE(rel)III; ICEREL III; ICERELIII; ICH 3; ICH 3 protease; ICH3; ICH3 protease; MGC141966; TY; TY protease.
|
WB, IHC-P, IHC-F, IF, ELISA
|
Human, Mouse (predicted: Rat, Rabbit, Pig, Cow, Dog, Horse) |
- HY-P81760
-
Acidic C4; Acidic complement C4; Basic C4; Basic complement C4; C4A; C4A2; C4A3; C4A4; C4A6; C4AD; C4B1; C4B12; C4B2; C4B3; C4BD; C4F; C4S; CPAMD2; CPAMD3
|
WB, IHC-P, FC
|
Human |
- HY-P81872
-
PIK3CD; Phosphatidylinositol 4; 5-bisphosphate 3-kinase catalytic subunit delta isoform; PI3-kinase subunit delta; PI3K-delta; PI3Kdelta; PtdIns-3-kinase subunit delta; Phosphatidylinositol 4; 5-bisphosphate 3-kinase 110 kDa catalytic subunit delta; PtdIns-3-kinase subunit p110-delta; p110delta
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P82902
-
MAP2K7; JNKK2; MEK7; MKK7; PRKMK7; SKK4; Dual specificity mitogen-activated protein kinase kinase 7; MAP kinase kinase 7; MAPKK 7; JNK-activating kinase 2; MAPK/ERK kinase 7; MEK 7; Stress-activated protein kinase kinase 4; SAPK kinase 4; S
|
WB, IHC-P, ICC/IF, IP, FC
|
Human, Mouse, Rat |
- HY-P83650
-
C2orf31; DKFZP434E2135; Frizzled homolog 5; Frizzled-5; Frizzled5; Fz 5; Fz-5; Fz5; FZD 5; hFz5; FZD5; FZD5_HUMAN; FzE 5; FzE5; HFZ 5; HFZ5; MGC129692; Seven transmembrane receptor frizzled 5; Uncharacterized protein C2orf31; Wnt receptor.
|
WB, IHC-P, IHC-F, Flow-Cyt, IF, ELISA
|
Human, Mouse , Rat |
- HY-P80714
-
HSP90AA1; HSP90A; HSPC1; HSPCA; Heat shock protein HSP 90-alpha; Heat shock 86 kDa; HSP 86; HSP86; Renal carcinoma antigen NY-REN-38; HSP90AB1; HSP90B; HSPC2; HSPCB; Heat shock protein HSP 90-beta; HSP 90; Heat shock 84 kDa; HSP 84; HSP84
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
Hsp90 alpha/beta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 85 kDa, targeting to Hsp90 alpha/beta. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80724
-
Cancer/testis antigen 98; CT98; DKFZp686F1078; hKOC; IF2B3_HUMAN; IGF II mRNA binding protein 3; IGF-II mRNA-binding protein 3; IGF2 mRNA binding protein 3; IGF2 mRNA-binding protein 3; IGF2BP3; IMP 3; IMP-3; Insulin like growth factor 2 mRNA binding prot
|
WB, ICC/IF, IP, FC
|
Human, Mouse, Rat |
IMP3 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 64 kDa, targeting to IMP3. It can be used for WB,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P80848
-
RPS6KA1; MAPKAPK1A; RSK1; Ribosomal protein S6 kinase alpha-1; S6K-alpha-1; 90 kDa ribosomal protein S6 kinase 1; p90-RSK 1; p90RSK1; p90S6K; MAP kinase-activated protein kinase 1a; MAPK-activated protein kinase 1a; MAPKAP kinase 1a; MAPKAP
|
WB, ICC/IF, IP
|
Human, Rat, Mouse |
Phospho-RSK1 p90 (Ser380) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 83 kDa, targeting to Phospho-RSK1 p90 (Ser380). It can be used for WB, ICC/IF, IP assays with tag free, in the background of Human, Mouse and Rat.
|
- HY-P80886
-
RPS6KA1; MAPKAPK1A; RSK1; Ribosomal protein S6 kinase alpha-1; S6K-alpha-1; 90 kDa ribosomal protein S6 kinase 1; p90-RSK 1; p90RSK1; p90S6K; MAP kinase-activated protein kinase 1a; MAPK-activated protein kinase 1a; MAPKAP kinase 1a; MAPKAP
|
WB, IP
|
Human, Mouse, Monkey |
RSK1 p90 Antibody (YA676) is a non-conjugated and Mouse origined monoclonal antibody about 83 kDa, targeting to RSK1 p90 (6B9). It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Monkey.
|
- HY-P81112
-
IBP1; IGF 1; IGF I; IGF-1; IGF IA; IGF IB; IGF1; IGFI; IGFIA; Insulin like growth factor 1 (somatomedin C); Full=Insulin-like growth factor I; Insulin Like Growth Factor 1; Insulin like growth factor IA; Insulin like growth factor IB; Mechano growth factor; MGF; Mechano growth factor; MGF; Somatomedia C; Somatomedin C; IGF1_HUMAN. IGF-I;
|
WB; ELISA; IP; IHC-P; IHC-F; IF
|
Human, Mouse, Rat, Dog(predicted: Pig, Cow, Rabbit, Sheep) |
IGF 1 Antibody is an unconjugated, approximately 7.7/21 kDa, rabbit-derived, anti-IGF 1 polyclonal antibody. IGF 1 Antibody can be used for: WB, ELISA, IP, IHC-P, IHC-F, IF expriments in human, mouse, rat, dog, and predicted: pig, cow, rabbit, sheep background without labeling.
|
- HY-P81139
-
CD 62E; CD26E; CD62E antigen; CD62 antigen-like family member E; E selectin; ELAM 1; ELAM; ELAM-1; ELAM1; Endothelial adhesion molecule 1; Endothelial leukocyte adhesion molecule 1; ESEL; LECAM 2; LECAM2; Leukocyte endothelial cell adhesion molecule 2; Leukocyte-endothelial cell adhesion molecule 2; LYAM2_HUMAN; SELE; Selectin E; SelectinE.
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human, Mouse, Pig(predicted: Rat, Chicken, Dog, Horse, Rabbit) |
E-Selectin Antibody is an unconjugated, approximately 65 kDa, rabbit-derived, anti-E-Selectin polyclonal antibody. E-Selectin Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, pig, and predicted: rat, chicken, dog, horse, rabbit background without labeling.
|
- HY-P81148
-
CD8 antigen, alpha polypeptide (p32); CD8a; CD8a antigen; CD8a molecule; CD8A_MOUSE; CD8A_HUMAN; Leu2; Leu2 T lymphocyte antigen; MAL; OKT8 T cell antigen; p32; T cell antigen Leu2; T cell co receptor; T-cell surface glycoprotein CD8 alpha chain; T-lymphocyte differentiation antigen T8/Leu-2; T8 T cell antigen.
|
WB; IHC-P; IHC-F; IF
|
Human, Mouse, |
CD8 Antibody is an unconjugated, approximately 27 kDa, rabbit-derived, anti-CD8 polyclonal antibody. CD8 Antibody can be used for: WB, IHC-P, IHC-F, IF expriments in human, mouse, background without labeling.
|
- HY-P81161
-
Apoptotic cysteine protease; Apoptotic protease Mch 5; C/EBP alpha; CAP4; Caspase 8 precursor; CCAAT Enhancer Binding Protein alpha; CEBP; CEBP A; CEBP alpha; CEBPA; FADD homologous ICE/CED 3 like protease; FADD like ICE; FLICE; ICE like apoptotic protease 5; ICE8; MACH; MCH5; MORT1 associated CED 3 homolog; CEBP α, CEBP-α.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; ICC; IF
|
Human, Rat(predicted: Mouse, Dog, Pig, Cow, Rabbit, Sheep, Goat) |
CEBP-alpha Antibody is an unconjugated, approximately 39 kDa, rabbit-derived, anti-CEBP-alpha polyclonal antibody. CEBP-alpha Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, rat, and predicted: mouse, dog, pig, cow, rabbit, sheep, goat background without labeling.
|
- HY-P81173
-
ACS3; B-HLH DNA binding protein; bHLHa38; BPES2; BPES3; Class A basic helix-loop-helix protein 38; CRS1; H-twist; OTTHUMP00000116043; SCS; Twist basic helix loop helix transcription factor 1; Twist homolog 1 (Drosophila); Twist homolog 1; TWIST homolog of drosophila; Twist related protein 1; Twist-related protein 1; Twist1; TWST1_HUMAN.
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human, Mouse, Rat, |
TWIST Antibody is an unconjugated, approximately 23 kDa, rabbit-derived, anti-TWIST polyclonal antibody. TWIST Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, background without labeling.
|
- HY-P81186
-
HAVCR; HAVCR 1; HA; Vcr-1; hepatitis A virus cellular receptor 1; HKIM-1; Kidney Injury Molecule1; KIM1; KIM 1; KIM-1; TIM-1; TIMD 1; TIMD1; KM-1; TIMD1_HUMAN; T cell immunoglobin domain and mucin domain protein 1; T-cell immunoglobulin and mucin domain-containing protein 1; T-cell membrane protein 1. 肾脏损伤分子1
|
WB; ELISA; Flow-Cyt;
|
Human, Mouse(predicted: Rat, Dog, Pig, Cow) |
HAVCR1 Antibody is an unconjugated, approximately 39 kDa, rabbit-derived, anti-HAVCR1 polyclonal antibody. HAVCR1 Antibody can be used for: WB, ELISA, Flow-Cyt, expriments in human, mouse, and predicted: rat, dog, pig, cow background without labeling.
|
- HY-P81115
-
interleukin-1 alpha; Hematopoietin 1; IL 1 alpha; IL1 alpha; IL 1; IL 1A; Il-1a; IL1; IL1A; IL1F1; ilia; Interleukin 1 alpha; Interleukin 1 alpha precursor; Interleukin1 alpha; Preinterleukin 1 alpha; Pro interleukin 1 alpha; Prointerleukin 1 alpha; IL1A_HUMAN.
|
WB; ELISA; IHC-P; HC-F; Flow-Cyt; IF
|
Human, Mouse (predicted: Rat) |
- HY-P81274
-
422 protein; Cardiac Fatty Acid Binding Protein; FABP 11; FABP 3; FABP11; FABP3; FABPH_HUMAN; fatty acid binding protein 11; Fatty acid binding protein 3; Fatty acid binding protein 3 muscle and heart; Fatty acid binding protein 3 muscle and heart mammary derived growth inhibitor; Fatty acid binding protein 3 muscle; Fatty acid binding protein 3
|
ELISA
|
Human |
- HY-P81274A
-
422 protein; Cardiac Fatty Acid Binding Protein; FABP 11; FABP 3; FABP11; FABP3; FABPH_HUMAN; fatty acid binding protein 11; Fatty acid binding protein 3; Fatty acid binding protein 3 muscle and heart; Fatty acid binding protein 3 muscle and heart mammary derived growth inhibitor; Fatty acid binding protein 3 muscle; Fatty acid binding protein 3
|
ELISA
|
Human |
- HY-P81274B
-
422 protein; Cardiac Fatty Acid Binding Protein; FABP 11; FABP 3; FABP11; FABP3; FABPH_HUMAN; fatty acid binding protein 11; Fatty acid binding protein 3; Fatty acid binding protein 3 muscle and heart; Fatty acid binding protein 3 muscle and heart mammary derived growth inhibitor; Fatty acid binding protein 3 muscle; Fatty acid binding protein 3
|
WB, IHC-P
|
Human, Mouse, Rat |
- HY-P80454
-
BTK(Y223); BTK (phospho Y223); p-BTK (phospho Y223); Agammaglobulinaemia tyrosine kinase; AGMX 1; AGMX1; AT; ATK; B cell progenitor kinase; B-cell progenitor kinase; BPK; Bruton agammaglobulinemia tyrosine kinase; Bruton tyrosine kinase; Bruton’s Tyrosine Kinase; Btk; BTK_HUMAN; IMD 1; IMD1; MGC126261; MGC126262; OTTHUMP00000063593; PSCTK 1; PSCTK1; Tyrosine protein kinase BTK; Tyrosine-protein kinase BTK; XLA.
|
WB, IHC-P, IHC-F, ICC, IF
|
Human |
Phospho-BTK(Y223) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 76 kDa, targeting to Phospho-BTK(Y223). It can be used for WB, IHC-P, IHC-F, ICC, IF assays with tag free, in the background of Human.
|
- HY-P80849
-
RPS6KA1; MAPKAPK1A; RSK1; Ribosomal protein S6 kinase alpha-1; S6K-alpha-1; 90 kDa ribosomal protein S6 kinase 1; p90-RSK 1; p90RSK1; p90S6K; MAP kinase-activated protein kinase 1a; MAPK-activated protein kinase 1a; MAPKAP kinase 1a; MAPKAP
|
WB, IP
|
Human, Mouse, Rat |
Phospho-RSK1 p90 (Thr359/Ser363) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 83 kDa, targeting to Phospho-RSK1 p90 (Thr359/Ser363). It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P81082
-
Fbx32; 4833442G10Rik; AI430017; Atrogin 1; Atrogin-1; ATROGIN1; Atrophy gene 1; F box only protein 32; F-box only protein 32; F-box protein 32; FBX32_HUMAN; fbxo25; FBXO32; FLJ32424; MAFbx; MGC108443; MGC137646; MGC33610; Muscle atrophy F box; Muscle atrophy F box protein; Muscle atrophy F-box protein.
|
WB; ICC
|
Mouse, Rat(predicted: Human) |
Fbx32 Antibody (YA919) is an unconjugated, approximately 42 kDa, rabbit-derived, anti-Fbx32 (YA919) monoclonal antibody. Fbx32 Antibody (YA919) can be used for: WB, ICC expriments in mouse, rat, and predicted: human background without labeling.
|
- HY-P81165
-
DA transporter; DAT 1; DAT; DAT1; SC6A3_HUMAN; SLC6A3; Sodium dependent dopamine transporter; Sodium-dependent dopamine transporter; Solute carrier family 6 (neurotransmitter transporter dopamine), member 3; Solute carrier family 6 member 3; Variable number tandem repeat (VNTR); dopamine transporter; ADAT 1; Adenosine deaminase tRNA specific 1; HADAT1; tRNA specific adenosine deaminase 1.
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human, Mouse, Rat(predicted: Dog, Cow) |
Dopamine Transporter Antibody is an unconjugated, approximately 68 kDa, rabbit-derived, anti-Dopamine Transporter polyclonal antibody. Dopamine Transporter Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, and predicted: dog, cow background without labeling.
|
- HY-P81172
-
Lectin-type oxidized LDL receptor 1; OLR1; lectin-like low density lipoprotein receptor-1; Oxidized low-density lipoprotein receptor 1; Ox-LDL receptor 1; Lectin-like oxidized LDL receptor 1; Lectin-like oxLDL receptor 1; LOX-1; BLOX1; Contains: Oxidized low-density lipoprotein receptor 1, soluble form A; Oxidized low-density lipoprotein receptor 1, soluble form B; OLR1_HUMAN.
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human, Rat, Rabbit(predicted: Mouse, Cow) |
LOX 1 Antibody is an unconjugated, approximately 31/50 kDa, rabbit-derived, anti-LOX 1 polyclonal antibody. LOX 1 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, rat, rabbit, and predicted: mouse, cow background without labeling.
|
- HY-P81183
-
40 kDa keratin intermediate filament; CK 19; ck19; CK19; CK-19; KRT19; Cytokeratin19; Cytokeratin-19; k19; k1cs; Keratin 19; Keratin-19; Keratin type I 40 kD; Keratin type i 40kD; Keratin type I cytoskeletal 19; krt19; mgc15366; K1C19_HUMAN; Keratin, type I cytoskeletal 19; Keratin, type I, 40 kd.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, Mouse(predicted: Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit) |
Cytokeratin 19 Antibody is an unconjugated, approximately 44 kDa, rabbit-derived, anti-Cytokeratin 19 polyclonal antibody. Cytokeratin 19 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, and predicted: rat, chicken, dog, pig, cow, horse, rabbit background without labeling.
|
- HY-P81214
-
Mannose Receptor; C-type lectin domain family 13 member D; CD 206; CD206; CD206 antigen; CLEC13D; CLEC13DL; Macrophage mannose receptor; Mannose receptor C type 1; MMR; MRC 1; MRC-1; MRC1_HUMAN; Macrophage mannose receptor 1; MRC1L1; C-type lectin domain family 13 member D-like; Macrophage mannose receptor 1-like protein 1.
|
WB; ELISA; Flow-Cyt
|
Human(predicted: Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Sheep, Guinea Pig) |
MRC1 Antibody is an unconjugated, approximately 160 kDa, rabbit-derived, anti-MRC1 polyclonal antibody. MRC1 Antibody can be used for: WB, ELISA, Flow-Cyt expriments in human, and predicted: mouse, rat, chicken, dog, pig, cow, horse, sheep, guinea pig background without labeling.
|
- HY-P80728
-
AI849689; c Jun N terminal kinase 1; C-JUN kinase 1; c-Jun N-terminal kinase 1; EC 2.7.11.24; JAK 1A; JAK1A; JNK 1; JNK 46; JNK; JNK-46; JNK1A2; JNK21B1/2; MAP kinase 8; MAPK 8; MAPK8; Mitogen activated protein kinase 8; Mitogen-activated protein kinase 8
|
WB, IP
|
Human, Mouse, Rat, Hamster |
JNK Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 48 kDa, targeting to JNK. It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Rat, Hamster.
|
- HY-P81099
-
CGRP-I + CGRP-II; CGRP-1/2; Procalcitonin; Beta type CGRP; CALC2; CALCB; Calcitonin 1; Calcitonin 2; Calcitonin gene related peptide; Calcitonin gene related peptide II; Calcitonin related polypeptide beta; CGRP; CGRP II; CGRP2; CT; Calcitonin/calcitonin related polypeptide alpha; Katacalcin; MGC126648; CALCA_HUMAN; CALCB_HUMAN; Calcitonin gene-related peptide 2; Beta-type CGRP; Beta-CGRP; Calcitonin gene-related peptide II; CGRP-II; CGRP-I.
|
ELISA; IHC-P; IHC-F; IF
|
Human, Rat(predicted: Mouse, Chicken, Pig, Cow) |
CGRP-1/2 Antibody is an unconjugated, approximately 3.8/14 kDa, rabbit-derived, anti-CGRP-1/2 polyclonal antibody. CGRP-1/2 Antibody can be used for: ELISA, IHC-P, IHC-F, IF expriments in human, rat, and predicted: mouse, chicken, pig, cow background without labeling.
|
- HY-P81132
-
CD90 / Thy1; CD7; CD90 antigen; CDw90; FLJ33325; MGC128895; T25; Theta antigen; Thy-1; Thy 1; Thy 1 cell surface antigen; Thy-1 membrane glycoprotein; Thy 1 membrane glycoprotein precursor; Thy 1.2; Thy-1 T-cell antigen; Thy1 antigen; Thy1 T cell antigen; Thy1.1; Thy1.2; Thymus cell antigen 1, theta; THY1_RAT; THY1_HUMAN.
|
WB; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, Mouse, Rat(predicted: Dog, Pig, Horse, Sheep) |
CD90/Thy-1 Antibody is an unconjugated, approximately 12 kDa, rabbit-derived, anti-CD90/Thy-1 polyclonal antibody. CD90/Thy-1 Antibody can be used for: WB, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: dog, pig, horse, sheep background without labeling.
|
- HY-P81182
-
C9orf15; FLJ14038; Gamma interferon activated transcriptional element binding factor 1; GATE binding factor 1; GBF 1; GBF1; Membrane associated prostaglandin E synthase 2; MGC11289; Microsomal prostaglandin E synthase 2; mPGES 2; mPGES-2; PGES2; PGES2_HUMAN; Prostaglandin E synthase 2; Prostaglandin E synthase 2 truncated form; PTGES 2; PGES2_MOUSE.
|
ELISA; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, Mouse, Rat(predicted: Chicken, Dog, Pig, Cow) |
PTGES2 Antibody is an unconjugated, approximately 43 kDa, rabbit-derived, anti-PTGES2 polyclonal antibody. PTGES2 Antibody can be used for: ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: chicken, dog, pig, cow background without labeling.
|
- HY-P81204
-
Alpha ENaC 2; Alpha ENaC; Alpha NaCH; Alpha-NaCH; Amiloride sensitive epithelial sodium channel alpha subunit; Amiloride sensitive sodium channel subunit alpha; Amiloride-sensitive sodium channel subunit alpha; ENaCa; ENaCalpha; Epithelial Na(+) channel subunit alpha; Epithelial Na+ channel subunit alpha; FLJ21883; Nonvoltage gated sodium channel 1 subunit alpha; Nonvoltage-gated sodium channel 1 subunit alpha; SCNEA; SCNN 1; SCNN1; SCNN1A; SCNNA_HUMAN; Sodium channel nonvoltage gated 1 alpha.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, Mouse, Rat(predicted: Dog, Pig, Cow, Horse, Sheep) |
Alpha-ENaC Antibody is an unconjugated, approximately 76 kDa, rabbit-derived, anti-Alpha-ENaC polyclonal antibody. Alpha-ENaC Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: dog, pig, cow, horse, sheep background without labeling.
|
- HY-P81246
-
ACAT related gene product 1; ACAT-related gene product 1; Acyl coenzyme A:cholesterol acyltransferase related gene 1; Acyl-CoA retinol O-fatty-acyltransferase; Acyl-CoA:diacylglycerol acyltransferase; ARAT; ARGP1; C75990; D15Ertd23e; Dgat; DGAT1; DGAT1_HUMAN; Diacylglycerol O acyltransferase 1; Diacylglycerol O-acyltransferase 1; Diglyceride acyltransferase; EC 2.3.1.20; hCG_24006; MGC139064; Retinol O fatty acyltransferase.
|
WB; ELISA; IHC-P; IHC-F; IF;
|
Human, Mouse, Rat, Dog, Pig, Horse |
- HY-P81250
-
40 kDa keratin intermediate filament; CK 19; ck19; CK19; CK-19; KRT19; Cytokeratin19; Cytokeratin-19; k19; k1cs; Keratin 19; Keratin-19; Keratin type I 40 kD; Keratin type i 40kD; Keratin type I cytoskeletal 19; krt19; mgc15366; K1C19_HUMAN; Keratin, type I cytoskeletal 19; Keratin, type I, 40 kd
|
WB, IHC-P, IHC-F, ICC, IF
|
Rat, Mouse, Human |
Cytokeratin 19 Antibody is an unconjugated, approximately 44 kDa, mouse-derived, anti-Cytokeratin 19 monoclonal antibody. Cytokeratin 19 Antibody can be used for: WB, IHC-P, IHC-F,ICC, IF expriments in human, mouse, rat background without labeling.
|
- HY-P81305
-
Alpha isoform serine threonine protein phosphatase PP1alpha 1 catalytic subunit; Catalytic subunit; PP1A; PP1A_HUMAN; PP1alpha; PP2C ALPHA; PP2CA; Ppp1ca; Protein Phosphatase 2C Alpha Isoform; Serine threonine protein phosphatase PP1 alpha catalytic subunit; Serine threonine protein phosphatase PP1 alpha catalytic subunit protein phosphatase 1; Serine/threonine-protein phosphatase PP1-alpha catalytic subunit.
|
WB, IHC-F, IHC-P, ICC/IF
|
Human |
- HY-P81305A
-
Alpha isoform serine threonine protein phosphatase PP1alpha 1 catalytic subunit; Catalytic subunit; PP1A; PP1A_HUMAN; PP1alpha; PP2C ALPHA; PP2CA; Ppp1ca; Protein Phosphatase 2C Alpha Isoform; Serine threonine protein phosphatase PP1 alpha catalytic subunit; Serine threonine protein phosphatase PP1 alpha catalytic subunit protein phosphatase 1; Serine/threonine-protein phosphatase PP1-alpha catalytic subunit.
|
WB, ICC/IF
|
Human |
- HY-P83587
-
H2A.1; H2A/c; H2A1; H2AFC:; H2AFD; H2AFI; H2AFN; H2AFP; HIST1H2AG; HIST1H2AI; HIST1H2AK; HIST1H2AL; HIST1H2AM; histone cluster 1; H2ai; Histone H2A type 1; Histone H2A/p
|
WB, IHC-P
|
Human, Mouse |
- HY-P80003
-
ACE-2; ACE 2; Angiotensin converting enzyme 2; ACE related carboxypeptidase; ACEH; Angiotensin converting enzyme homolog; Angiotensin converting enzyme like protein; Angiotensin I Converting Enzyme (peptidyl dipeptidase A) 2; Angiotensin I converting enzyme 2; DKFZP434A014; EC 3.4.17; angiotensin-converting enzyme 2 precursor; ACE2_HUMAN; Angiotensin-converting enzyme 2; ACE-related carboxypeptidase; Angiotensin-converting enzyme homolog; Metalloprotease MPROT15; Processed angiotensin-converting enzyme 2.
|
WB, ICC, IHC-P, IP
|
Human, Mouse, Hamster |
ACE2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 92 kDa, targeting to ACE2. It can be used for WB,ICC,IHC-P,IP assays with tag free, in the background of Human, Mouse, Hamster.
|
- HY-P80729
-
AI849689; c Jun N terminal kinase 1; C-JUN kinase 1; c-Jun N-terminal kinase 1; EC 2.7.11.24; JAK 1A; JAK1A; JNK 1; JNK 46; JNK; JNK-46; JNK1A2; JNK21B1/2; MAP kinase 8; MAPK 8; MAPK8; Mitogen activated protein kinase 8; Mitogen-activated protein kinase 8
|
WB, ICC/IF
|
Human, Mouse, Rat |
JNK1 (1A4) Antibody is a non-conjugated and Mouse origined monoclonal antibody about 48 kDa, targeting to JNK1 (1A4). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P81118
-
multidrug resistance-associated protein2; ABC30; ABCC2; ATP binding cassette sub family C (CFTR/MRP) member 2; ATP binding cassette subfamily C member 2; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; CMOAT; CMOAT1; cMRP; DJS; KIAA1010; MRP 2; MRP-2; MRP2; Multidrug resistance associated protein 2; MRP2_HUMAN; ATP-binding cassette sub-family C member 2; Multidrug resistance-associated protein 2.
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human, Mouse, Rat, |
MRP2/ABCC2 Antibody is an unconjugated, approximately 174 kDa, rabbit-derived, anti-MRP2/ABCC2 polyclonal antibody. MRP2/ABCC2 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, background without labeling.
|
- HY-P81134
-
Toll-like receptor 2; Toll like receptor 2; Toll like receptor 2 precursor; Toll-like receptor 2; TLR 2; TLR-2; Toll/interleukin-1 receptor-like protein 4; CD282 antigen; CD282; TIL 4; TIL4; TLR2_HUMAN; Toll/interleukin 1 receptor like 4; Toll/interleukin 1 receptor like protein 4; Toll/interleukin receptor like protein 4.
|
WB; IHC-P; IHC-F
|
Human, Mouse, Rat(predicted: Chicken, Dog, Pig, Cow, Sheep) |
TLR2 Antibody is an unconjugated, approximately 84 kDa, rabbit-derived, anti-TLR2 polyclonal antibody. TLR2 Antibody can be used for: WB, IHC-P, IHC-F expriments in human, mouse, rat, and predicted: chicken, dog, pig, cow, sheep background without labeling.
|
- HY-P81323
-
PP 1G; PP-1G; PP1G; PP1G_HUMAN; PP1gamma; PPP 1G; PPP1CC; PPP1CC protein; PPP1G; Protein phosphatase 1 catalytic subunit gamma isoform; Protein phosphatase 1C catalytic subunit; Protein phosphatase 1C subunit; Protein phosphatase 2C gamma isoform; Serine/threonine phosphatase 1 gamma; Serine/threonine protein phosphatase PP1 gamma catalytic subunit; Serine/threonine-protein phosphatase PP1-gamma catalytic subunit.
|
WB
|
Human |
- HY-P81501
-
KIR2DL3 ; CD158B2, KIRCL23, NKAT2; CD158b2; Killer cell immunoglobulin-like receptor 2DL3 ; CD158 antigen-like family member B2; KIR-023GB; Killer inhibitory receptor cl 2-3; NKAT2a; NKAT2b; Natural killer-associated transcript 2 (NKAT-2); p58 natural killer cell receptor clone CL-6 (p58 NK receptor CL-6); p58.2 MHC class-I-specific NK receptor
|
IHC-P
|
Human |
- HY-P81769
-
RPS6KB2; STK14B; Ribosomal protein S6 kinase beta-2; S6K-beta-2; S6K2; 70 kDa ribosomal protein S6 kinase 2; P70S6K2; p70-S6K 2; S6 kinase-related kinase; SRK; Serine/threonine-protein kinase 14B; p70 ribosomal S6 kinase beta; S6K-beta; p70
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P81955
-
Alpha isoform serine threonine protein phosphatase PP1alpha 1 catalytic subunit; Catalytic subunit; PP1A; PP1A_HUMAN; PP1alpha; PP2C ALPHA; PP2CA; Ppp1ca; Protein Phosphatase 2C Alpha Isoform; Serine threonine protein phosphatase PP1 alpha catalytic subunit; Serine threonine protein phosphatase PP1 alpha catalytic subunit protein phosphatase 1; Serine/threonine-protein phosphatase PP1-alpha catalytic subunit.
|
WB, IHC-P, IP
|
Human, Mouse, Rat |
- HY-P82145
-
RPS6KB2; STK14B; Ribosomal protein S6 kinase beta-2; S6K-beta-2; S6K2; 70 kDa ribosomal protein S6 kinase 2; P70S6K2; p70-S6K 2; S6 kinase-related kinase; SRK; Serine/threonine-protein kinase 14B; p70 ribosomal S6 kinase beta; S6K-beta; p70
|
WB
|
Human, Mouse, Rat |
- HY-P80091
-
PTGS2; COX 2; COX2; COX-2; Cyclooxygenase; Cyclooxygenase2; Cyclooxygenase-2; hCox 2; PGG/HS; PGH synthase 2; PGHS 2; PGHS2; PHS 2; PHS II; PHS2 ; Prostaglandin endoperoxide synthase 2; Prostaglandin G/H synthase 2 precursor; Prostaglandin G/H synthase and cyclooxygenase; Prostaglandin G/H synthase 2; Prostaglandin H2 synthase 2; TIS10II; PGH2_HUMAN.
|
WB, ICC/IF, IHC-P
|
Human, Rat |
COX2/Cyclooxygenase 2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 69 kDa, targeting to COX2/Cyclooxygenase 2. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Rat.
|
- HY-P80831
-
AI849689; c Jun N terminal kinase 1; C-JUN kinase 1; c-Jun N-terminal kinase 1; EC 2.7.11.24; JAK 1A; JAK1A; JNK 1; JNK 46; JNK; JNK-46; JNK1A2; JNK21B1/2; MAP kinase 8; MAPK 8; MAPK8; Mitogen activated protein kinase 8; Mitogen-activated protein kinase 8
|
WB, IP
|
Human, Rat |
Phospho-JNK1 (Thr183/Tyr185) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 48 kDa, targeting to Phospho-JNK1 (Thr183/Tyr185). It can be used for WB,IP assays with tag free, in the background of Human, Rat.
|
- HY-P80984
-
CK-5; CK5; Cytokeratin-5; Cytokeratin5; DDD; DDD1; EBS2; epidermolysis bullosa simplex 2 Dowling-Meara/Kobner/Weber-Cockayne types; K2C5_HUMAN; K5; keratin 5 (epidermolysis bullosa simplex, Dowling-Meara/Kobner/Weber-Cockayne types); Keratin 5; Keratin ; keratin complex 2, basic, gene 5; keratin, type II cytoskeletal 5 ; Keratin-5; Keratin5; KRT 5; Krt5; KRT5A; type II cytoskeletal 5 ; Type-II keratin Kb5;
|
WB, IHC-P, IF-Tissue, IF-Cell, FC
|
Human, Mouse, Rat |
Cytokeratin 5 Antibody is an unconjugated, approximately 62 kDa, rabbit-derived, anti-Cytokeratin 5 monoclonal antibody. Cytokeratin 5 Antibody can be used for: WB, IHC-P, IF-Tissue, IF-Cell, FC expriments in human, mouse, rat background without labeling.
|
- HY-P81071
-
2-oxoglutarate dehydrogenase complex component E2; Dihydrolipoamide S succinyltransferase (E2 component of 2 oxo glutarate complex); Dihydrolipoamide S succinyltransferase; Dihydrolipoamide succinyltransferase component of 2 oxoglutarate dehydrogenase complex; Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex; Dihydrolipoyllysine residue succinyltransferase component of 2 oxoglutarate dehydrogenase complex; Dihydrolipoyllysine residue succinyltransferase component of 2 oxoglutarate dehydrogenase complex mitochondrial; Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex; Dlst; DLTS; E2; E2K; mitochondrial; ODO2_HUMAN; OGDC-E2.
|
WB; ELISA; IHC-P; IHC-F; ICC; IF;
|
Human, Mouse (predicted: Rat, Rabbit, Pig, Sheep, Cow, Dog, Horse) |
DLST Antibody is an unconjugated, approximately 41 kDa, rabbit-derived, anti-DLST polyclonal antibody. DLST Antibody can be used for: WB, ELISA, IHC-P, IHC-F, ICC, IF, expriments in mouse and predicted: human, rat, dog, pig, cow, horse, rabbit, sheep background without labeling.
|
- HY-P81106
-
Interleukin 8; Interleukin8; (Ala-IL-8)77; (Ser-IL-8)72; 3 10C; 310C; AMCF1; b ENAP; CXC chemokine ligand 8; CXCL 8; CXCL8; Emoctakin; GCP-1; GCP1; IL 8; IL-8; IL-8(1-77); IL-8(9-77); IL8; LYNAP; MDNCF; MDNCF-b; MDNCF-c; MONAP; NAF; NAP-1; NAP1; Protein 3 10C; Protein 3-10C; SCYB 8; SCYB8; TSG1.
|
ELISA; IHC-P; IHC-F; IF
|
Human, Rabbit(predicted: Pig, Cow, Sheep) |
IL-8/CXCL8 Antibody is an unconjugated, approximately 8/9 kDa, rabbit-derived, anti-IL-8/CXCL8 polyclonal antibody. IL-8/CXCL8 Antibody can be used for: ELISA, IHC-P, IHC-F, IF expriments in human, rabbit, and predicted: pig, cow, sheep background without labeling.
|
- HY-P81144
-
troponin I type 3 (cardiac); Cardiac troponin I; Troponin I, cardiac muscle; Cardiomyopathy, familial hypertrophic, 7, included; CMD1FF; CMD2A; CMH7; cTnI; Familial hypertrophic cardiomyopathy 7; MGC116817; RCM1; Tn1; Tni; TNN I3; TNNC 1; TNNC-1; TNNC1; TNNI3; Troponin I cardiac; Troponin I cardiac muscle; Troponin I cardiac muscle isoform; Troponin I type 3 cardiac; troponin I, cardiac 3; TroponinI; Troponin I; TNNI3_HUMAN.
|
ELISA; IHC-P; IHC-F; IF
|
Mouse(predicted: Human, Rat, Dog, Pig, Cow, Rabbit) |
Cardiac Troponin I/TNNC1 Antibody is an unconjugated, approximately 23 kDa, rabbit-derived, anti-Cardiac Troponin I/TNNC1 polyclonal antibody. Cardiac Troponin I/TNNC1 Antibody can be used for: ELISA, IHC-P, IHC-F, IF expriments in mouse, and predicted: human, rat, dog, pig, cow, rabbit background without labeling.
|
- HY-P81174
-
AXOR 12; AXOR12; G protein coupled receptor 54; G-protein coupled receptor 54; G-protein coupled receptor OT7T175; GPCR 54; GPCR54; GPR 54; GPR54; HOT7T175; Hypogonadotropin 1; Hypogonadotropin-1; Hypogonadotropin1; KISS 1 receptor; KISS 1R; KiSS-1 receptor; KiSS1R; KiSS-1R; KISS1 receptor; KISS1R; Kisspeptins receptor; KISSR_HUMAN; Metastin receptor; OT7T175.
|
WB; ELISA
|
Human, Mouse, Rat(predicted: Dog, Pig, Sheep, Guinea Pig) |
KiSS1 receptor Antibody is an unconjugated, approximately 44 kDa, rabbit-derived, anti-KiSS1 receptor polyclonal antibody. KiSS1 receptor Antibody can be used for: WB, ELISA expriments in human, mouse, rat, and predicted: dog, pig, sheep, guinea pig background without labeling.
|
- HY-P81179
-
AMCFII; C-X-C motif chemokine 5; Cxcl5; CXCL5_HUMAN; ENA-78(1-78); ENA-78(9-78); ENA78; Epithelial derived neutrophil activating peptide 78; Epithelial derived neutrophil activating protein 78; Epithelial-derived neutrophil-activating protein 78; GCP2; LIX; Neutrophil activating peptide ENA 78; Neutrophil-activating peptide ENA-78; SCYB5; Scyb6; Small inducible cytokine B5; Small inducible cytokine subfamily B member 5; Small-inducible cytokine B5.
|
ELISA; IHC-P; IHC-F; IF
|
Rat(predicted: Mouse) |
CXCL5 Antibody is an unconjugated, approximately 8/9 kDa, rabbit-derived, anti-CXCL5 polyclonal antibody. CXCL5 Antibody can be used for: ELISA, IHC-P, IHC-F, IF expriments in rat, and predicted: mouse background without labeling.
|
- HY-P81184
-
Activation B7-1 antigen; B lymphocyte activation antigen B7; B7; B7-1; B7-1 antigen; BB1; CD28 antigen ligand 1; CD28LG; CD28LG1; CD80; CD80 antigen (CD28 antigen ligand 1, B7-1 antigen); CD80 antigen; CD80 molecule; CD80_HUMAN; Costimulatory factor CD80; costimulatory molecule variant IgV-CD80; CTLA-4 counter-receptor B7.1; LAB7; T-lymphocyte activation antigen CD80; CD80_RAT.
|
WB, IHC-P, Flow-Cyt, ICC
|
Human, Mouse (predicted: Rat) |
CD80 Antibody is an unconjugated, approximately 30 kDa, mouse-derived, anti-CD80 monoclonal antibody. CD80 Antibody can be used for: WB, IHC-P,FC ICC expriments in mouse,human, and predicted: rat background without labeling.
|
- HY-P81191
-
eNOS (phospho S1177); eNOS(phospho S1177); p-eNOS (phospho S1177); eNOS (Phospho-Ser1177); cNOS; Constitutive NOS; EC NOS; ecNOS; Endothelial nitric oxidase synthase; Endothelial nitric oxide synthase; Endothelial nitric oxide synthase 3; Endothelial NOS; Nitric oxide synthase 3 (endothelial cell); Nitric oxide synthase 3; Nitric oxide synthase 3 endothelial cell; Nitric oxide synthase endothelial; nitric oxide synthase, endothelial; NOS 3; NOS III; NOS type III; NOS3; NOSIII; NOS3_HUMAN.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, Mouse(predicted: Rat, Dog, Pig, Cow, Rabbit, Sheep, Guinea Pig) |
Phospho-eNOS (Ser1177) Antibody is an unconjugated, approximately 133 kDa, rabbit-derived, anti-eNOS (Ser1177) polyclonal antibody. Phospho-eNOS (Ser1177) Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, and predicted: rat, dog, pig, cow, rabbit, sheep, guinea pig background without labeling.
|
- HY-P81193
-
A disintegrin and metalloproteinase with thrombospondin motifs 5; A disintegrin like and metalloprotease (reprolysin type) with thrombospondin type 1 motif 5; A Disintigrin And Metalloproteinase with ThromboSpondin motif-5; ADAM metallopeptidase with thrombospondin type 1 motif 5; ADAM TS 11; ADAM TS 5; ADAM TS5; ADAMTS 11; ADAMTS 5; ADAMTS11; ADMP 2; ADMP2; Aggrecanase 2; aggrecanase-2; FLJ36738; Implantin; ThromboSpondin motif-5.
|
WB; ELISA; IHC-P
|
Human, Mouse, Rat(predicted: Dog, Pig, Cow, Horse, Rabbit) |
ADAMTS5 Antibody is an unconjugated, approximately 102 kDa, rabbit-derived, anti-ADAMTS5 polyclonal antibody. ADAMTS5 Antibody can be used for: WB, ELISA, IHC-P expriments in human, mouse, rat, and predicted: dog, pig, cow, horse, rabbit background without labeling.
|
- HY-P81195
-
AMCBX2; CGD; CGD91-phox; CY24B_HUMAN; CYBB; Cytochrome b 245, beta polypeptide; Cytochrome b(558) beta chain; Cytochrome b(558) subunit beta; Cytochrome b-245 heavy chain; Cytochrome b558 subunit beta; GP91 PHOX; gp91-1; gp91-phox; GP91PHOX; Heme-binding membrane glycoprotein gp91phox; NADPH oxidase 2; Neutrophil cytochrome b 91 kDa polypeptide; p22 phagocyte B-cytochrome; P91 PHOX; p91-PHOX; Superoxide-generating NADPH oxidase heavy chain subunit.
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human, Mouse, Rat(predicted: Chicken, Dog, Pig, Cow, Horse, Rabbit) |
NOX2 Antibody is an unconjugated, approximately 65 kDa, rabbit-derived, anti-NOX2 polyclonal antibody. NOX2 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, and predicted: chicken, dog, pig, cow, horse, rabbit background without labeling.
|
- HY-P81224
-
Bile Acid Receptor NR1H4; BAR; FXR; Farnesoid X activated receptor; Farnesoid X receptor; Farnesoid X-activated receptor; Farnesol receptor HRR 1; Farnesol receptor HRR-1; Farnesol receptor HRR1; FXR; HRR 1; HRR1; NR1H4_HUMAN; Nuclear receptor subfamily 1 group H member 4; Retinoid X receptor interacting protein 14; Retinoid X receptor-interacting protein 14; RIP 14; RIP14; RXR interacting protein 14; RXR-interacting protein 14.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; ICC; IF
|
Human, Mouse(predicted: Rat, Dog, Pig, Cow, Horse, Sheep) |
NR1H4 Antibody is an unconjugated, approximately 56 kDa, rabbit-derived, anti-NR1H4 polyclonal antibody. NR1H4 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, and predicted: rat, dog, pig, cow, horse, sheep background without labeling.
|
- HY-P81227
-
Collagen type I; Alpha 1 type I collagen; Alpha 2 type I collagen; COL1A1; COL1A2; Collagen I alpha 1 polypeptide; Collagen I alpha 2 polypeptide; Collagen Of Skin Tendon And Bone; Collagen Type 1; Collagen type I alpha 1; Collagen type I alpha 2; OI4; Osteogenesis Imperfecta Type IV; Pro alpha 1(I) collagen; Type I procollagen; CO1A1_HUMAN.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, Mouse, Rat, Rabbit(predicted: Chicken, Dog, Cow, Sheep) |
Collagen I Antibody is an unconjugated, approximately 130 kDa, rabbit-derived, anti-Collagen I polyclonal antibody. Collagen I Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, rabbit, and predicted: chicken, dog, cow, sheep background without labeling.
|
- HY-P81255
-
EK4; End3; Eph receptor A3; EPH-like kinase 4; EPH-like tyrosine kinase 1; EphA3; Ephrin receptor EphA3; Ephrin type-A receptor 3; ETK 1; ETK; ETK1; HEK 4; HEK; Hek4; Human embryo kinase; Mek4; MGC109882; Receptor tyrosine kinase HEK; Tyro 4; Tyro4; Tyrosine protein kinase receptor ETK 1; Tyrosine-protein kinase TYRO4; AW492086; Cek4; EC 2.7.10.1; EPHA3_HUMAN.
|
WB; IHC-P; IHC-F; ICC; IF; ELISA;
|
Mouse, Rat (predicted: Human, Sheep, Cow, Dog, Horse) |
- HY-P81282
-
CLL associated antigen KW 6; DNA-binding protein Ikaros; hIk 1; hIk-1; Hs.54452; IK1; Ikaros (zinc finger protein); IKAROS; IKAROS family zinc finger 1 (Ikaros); Ikaros family zinc finger protein 1; Ikzf1; IKZF1_HUMAN; LYF1; Lymphoid transcription factor LyF-1; PRO0758; Zinc finger protein subfamily 1A 1 (Ikaros); zinc finger protein subfamily 1A 1; Zinc finger protein; subfamily 1A; member 1; ZNFN1A1.
|
WB, IP
|
Human |
- HY-P81282A
-
CLL associated antigen KW 6; DNA-binding protein Ikaros; hIk 1; hIk-1; Hs.54452; IK1; Ikaros (zinc finger protein); IKAROS; IKAROS family zinc finger 1 (Ikaros); Ikaros family zinc finger protein 1; Ikzf1; IKZF1_HUMAN; LYF1; Lymphoid transcription factor LyF-1; PRO0758; Zinc finger protein subfamily 1A 1 (Ikaros); zinc finger protein subfamily 1A 1; Zinc finger protein; subfamily 1A; member 1; ZNFN1A1.
|
IHC-P
|
Human |
- HY-P82250
-
B cell antigen receptor Ig beta associated protein 1; BPM 90; BPM L; BPM-L; BPM90; BPML; IBAP 1; Imp 9; Importin 9; Novel centrosomal protein RanBPM; RAN binding protein 9; Ran binding protein centrosomal; Ran Binding Protein in the Microtubule organizing center; Ran binding protein M; Ran BP9; Ran-binding protein 9; Ran-binding protein M; RANB9_HUMAN; RanBP 7; RANBP 9; RanBP7; RanBP9; RanBPM.
|
WB, ICC/IF
|
Human, Mouse, Rat |
- HY-P81101
-
COL 3A1; COL3A1; Collagen alpha 1(III) chain; Collagen III alpha 1 chain precursor; Collagen III alpha 1 polypeptide; Collagen type III alpha 1 (Ehlers Danlos syndrome type IV autosomal dominant); Collagen type III alpha 1; Collagen type III alpha; EDS4A; Ehlers Danlos syndrome type IV, autosomal dominant; Fetal collagen; Type III collagen; CO3A1_HUMAN; Collagen alpha-1(III) chain; Type III collagen; type III preprocollagen alpha 1 chain.
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human, Dog, Rabbit(predicted: Mouse, Rat, Chicken, Cow) |
Collagen III Antibody is an unconjugated, approximately 117 kDa, rabbit-derived, anti-Collagen III polyclonal antibody. Collagen III Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, dog, rabbit, and predicted: mouse, rat, chicken, cow background without labeling.
|
- HY-P81103
-
CCN 2; CCN-2; CCN2; Connective Tissue Growth Factor; Hcs 24; Hcs24; Hypertrophic chondrocyte specific protein 24; Hypertrophic chondrocyte-specific gene product 24; Insulin-like Growth Factor-Binding Protein 8; MGC102839; NOV 2; NOV2; Connective tissue growth factor; CCN family member 2; Hypertrophic chondrocyte-specific protein 24; Insulin-like growth-binding protein 8; IBP-8; IGF-binding protein 8; IGFBP8; IGFBP-8; connective tissue growth factor precursor; CTGF_HUMAN.
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human, Mouse, Rat(predicted: Chicken, Dog, Pig, Cow) |
CTGF Antibody is an unconjugated, approximately 36 kDa, rabbit-derived, anti-CTGF polyclonal antibody. CTGF Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, and predicted: chicken, dog, pig, cow background without labeling.
|
- HY-P81105
-
Tumor necrosis factor ligand superfamily member 6; FASLG; APO1L; Apoptosis (APO 1) antigen ligand 1; Fas-L; Apoptosis antigen ligand 1; APTL; CD178; CD-178; CD 178; CD95L; CD95 ligand; CD95-L; CD95L protein; FAS antigen ligand; Fas L; FASL; Fas ligand (TNF superfamily member 6); Generalized lymphoproliferative disease; TNF superfamily member 6; TNFSF6; TNFL6_HUMAN; Apoptosis antigen ligand; Tumor necrosis factor ligand superfamily member 6, membrane form; Tumor necrosis factor ligand superfamily member 6, soluble form; FASLG.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; ICC; IF
|
Human, Mouse, Rat(predicted: Cow) |
Fas Ligand Antibody is an unconjugated, approximately 31 kDa, rabbit-derived, anti-Fas Ligand polyclonal antibody. Fas Ligand Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, rat, and predicted: cow background without labeling.
|
- HY-P81131
-
TGF-beta receptor type-2; TGF beta R2; TGFBR2; AAT 3; AAT3; FAA 3; FAA3; HNPCC6; MFS 2; MFS2; RIIC; TAAD 2; TAAD2; TbetaR II; TGF beta receptor type 2; TGF beta receptor type II; TGF beta type II receptor; TGFB R2; TGFbeta RII; TGFBR 2; TGFR 2; TGFR2; Transforming growth factor beta receptor II; Transforming growth factor beta receptor type II. TGF-βRⅡ; TGFβRⅡ; TGF βRⅡ; TGFβ RⅡ.
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human, Mouse, Rat, Cow(predicted: Chicken, Pig, Horse, Rabbit, Sheep) |
TGF beta Receptor II Antibody is an unconjugated, approximately 62 kDa, rabbit-derived, anti-TGF beta Receptor II polyclonal antibody. TGF beta Receptor II Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, cow, and predicted: chicken, pig, horse, rabbit, sheep background without labeling.
|
- HY-P81178
-
MTrim63; uRF 1; MuRF-1; Muscle-specific RING finger protein 1; Muscle-specific RING finger protein 1; E3 ubiquitin-protein ligase TRIM63; FLJ32380; IRF; MURF1; MURF 1; MURF2; RNF28; SMRZ; Iris ring finger protein; Muscle specific ring finger protein 2; Ring finger protein 28; RNF28; SMRZ; Striated muscle RING zinc finger protein; TRIM 63; TRIM63; Tripartite motif containing 63; Tripartite motif containing protein 63; Ubiquitin ligase TRIM63.
|
ELISA; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, Mouse(predicted: Rat, Pig, Cow, Horse, Rabbit) |
MuRF1 Antibody is an unconjugated, approximately 39 kDa, rabbit-derived, anti-MuRF1 polyclonal antibody. MuRF1 Antibody can be used for: ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, and predicted: rat, pig, cow, horse, rabbit background without labeling.
|
- HY-P81188
-
CXCR3_HUMAN; Interferon-inducible protein 10 receptor; IP-10 receptor; C-X-C chemokine receptor type 3; CD 183; CD183; CD183 antigen; G protein-coupled receptor 9; G Protein Coupled Receptor 9; Chemokine (C X C motif) receptor 3; Chemokine (C X C) receptor 3; C-X-C Chemokine receptor; CXC Motif Receptor 3; Chemokine CXC Motif Receptor 3; CKRL2; CKR L2; CKR-L2; GPR9; CXC-R3; CXCR-3; IP10 receptor.
|
WB
|
Human, Mouse, Rat(predicted: Dog, Pig, Cow, Rabbit, Guinea Pig) |
CXCR3 Antibody is an unconjugated, approximately 40 kDa, rabbit-derived, anti-CXCR3 polyclonal antibody. CXCR3 Antibody can be used for: WB expriments in human, mouse, rat, and predicted: dog, pig, cow, rabbit, guinea pig background without labeling.
|
- HY-P81210
-
LATS1 +LATS2 (phospho T1079 + T1041); Serine/threonine protein kinase LATS2; KPM; Large tumor supressor, homolog 1; LATS, large tumor suppressor, homolog 1 (Drosophila); LATS, large tumor suppressor, homolog 2 (Drosophila); LATS1 +LATS2 (phospho T1079 + T1041); p-LATS1 +LATS2(Thr1079 +Thr1041); RGD1564085; Serine/threonine protein kinase LATS1; WARTS; WARTS protein kinase; wts; 4932411G09Rik; AV277261; AW208599; AW228608; FLJ13161; LATS1_HUMAN.
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human, Mouse(predicted: Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit) |
phospho-LATS1+LATS2 (Thr1079 +Thr1041) Antibody is an unconjugated, approximately 124 kDa, rabbit-derived, anti-phospho-LATS1+LATS2 (Thr1079 +Thr1041) polyclonal antibody. phospho-LATS1+LATS2 (Thr1079 +Thr1041) Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, and predicted: rat, chicken, dog, pig, cow, horse, rabbit background without labeling.
|
- HY-P81223
-
Cholesterol 20 22 desmolase; Cholesterol desmolase; Cholesterol monooxygenase (side chain cleaving); Cholesterol side chain cleavage enzyme; Cholesterol side chain cleavage enzyme mitochondrial; Cholesterol side-chain cleavage enzyme; CP11A_HUMAN; CYP11A; CYPXIA1; Cytochrome P450 11A1; Cytochrome P450 11A1 mitochondrial; Cytochrome P450 family 11 subfamily A polypeptide 1; Cytochrome P450 subfamily XIA; Cytochrome P450(scc); Cytochrome P450C11A1; mitochondrial; P450SCC; Steroid 20 22 lyase
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; ICC; IF
|
Human, Mouse, Rat(predicted: Dog, Pig, Cow, Horse, Rabbit, Sheep) |
CYP11A1 Antibody is an unconjugated, approximately 53/57 kDa, rabbit-derived, anti-CYP11A1 polyclonal antibody. CYP11A1 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, rat, and predicted: dog, pig, cow, horse, rabbit, sheep background without labeling.
|
- HY-P81228
-
Superoxide Dismutase 1; ALS 1; ALS; ALS1; Amyotrophic lateral sclerosis 1 adult; Amyotrophic lateral sclerosis 1; Cu/Zn SOD; Cu/Zn superoxide dismutase; Homodimer; Indophenoloxidase A; IPOA; Mn superoxide dismutase; SOD 1; SOD; SOD soluble; SOD2; SODC; Soluble indophenoloxidase A; Superoxide dismutase 1; Superoxide dismutase 1 soluble; Superoxide dismutase Cu Zn; Superoxide dismutase cystolic; SODC_HUMAN; Superoxide dismutase [Cu-Zn]; hSod1; Ipo1; SODC; Ipo-1; Sod-1; CuZnSOD; Cu/Zn-SOD; MGC107553; B430204E11Rik; superoxide-dimuta se-1.
|
WB, IHC-P, IHC-F, ICC, IF, Flow-Cyt, ELISA
|
Human, Mouse, Rat(predicted: Pig, Cow, Horse) |
SOD1 Antibody is an unconjugated, approximately 17 kDa, rabbit-derived, anti-SOD1 polyclonal antibody. SOD1 Antibody can be used for: 0 expriments in human, mouse, rat, and predicted: pig, cow, horse background without labeling.
|
- HY-P81047
-
Collagen II alpha 1; COL2A1; COL2A1 protein; collagen, type II, alpha 1; collagen alpha-1(II); type II collagen; alpha-1 type II collagen; alpha1 type II collagen; Col2a1; AOM; Cartilage collagen; Chondrocalcin; COL11A3; Collagen alpha 1(II) chain precursor; Collagen II alpha 1 polypeptide; Collagen type II alpha 1 (primary osteoarthritis spondyloepiphyseal dysplasia congenital); MGC131516; SEDC; Collagen alpha-1(II) chain; Alpha-1 type II collagen; CO2A1_HUMAN.; CollagenII;
|
WB, ELISA, IHC-P, IF
|
Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Rabbit, Guinea Pig |
Collagen II Antibody is an unconjugated, approximately 117 KDa, rabbit-derived, anti-Collagen II polyclonal antibody. Collagen II Antibody can be used for: WB, ELISA, IHC-P, IF expriments in human, mouse, rat, chicken, dog, pig, cow, rabbit, guinea pig background without labeling.
|
- HY-P81049
-
NFKB1; NF-KB; Nuclear factor NF-kappa-B p105 subunit; DNA-binding factor KBF1; EBP-1; Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; DNA-binding factor KBF1; EBP-1; Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; Nuclear factor NF-kappa-B p50 subunit; NFkB p105 / p50; NFkB p105/p50; nuclear factor kappa B subunit 1; NF-kB; CVID12; NF-kB1; NFKB-p50; NFkappaB; NF-kappaB; NFKB-p105; NF-kappa-B1; NF-kappabeta
|
WB, IHC-P, IHC-F, Flow-Cyt, IF, ELISA
|
Human, Mouse (predicted: Rat, Pig, Cow) |
Phospho-NFKB1 p105/p50 (Ser337) Antibody is an unconjugated, approximately 50&120 kDa, rabbit-derived, anti-NFKB1 p105/p50 (Ser337) polyclonal antibody. Phospho-NFKB1 p105/p50 (Ser337) Antibody can be used for: WB, IHC-P, ICC/IF expriments in human, mouse, rat background without labeling.
|
- HY-P81075
-
CD 152; CD152; CD152 antigen; Celiac disease 3; CELIAC3; CTLA 4; CTLA-4; Cytotoxic T cell associated 4; Cytotoxic T lymphocyte associated 4; Cytotoxic T lymphocyte associated antigen 4; Cytotoxic T lymphocyte associated protein 4; Cytotoxic T lymphocyte associated serine esterase 4; Cytotoxic T lymphocyte protein 4; Cytotoxic T-lymphocyte-associated antigen 4; Cytotoxic T-lymphocyte-associated protein 4; GSE; IDDM12; CD152 isoform; CTLA4_HUMAN; GRD4; ICOS; Ligand and transmembrane spliced cytotoxic T lymphocyte associated antigen 4.
|
WB; ELISA; Flow-Cyt;
|
Human, Mouse, Rat |
- HY-P81084
-
Angiotensin Converting Enzyme 1; ACE; ACE-T; Angiotensin-converting enzyme isoform 1precursor; Dipeptidyl carboxy peptidase 1; Kininase II; ACE-1; testis-specific isoform precursor. ACE 1; ACE T; ACE1; Angiotensin converting enzyme somatic isoform; Angiotensin converting enzyme testis specific isoform; Angiotensin I converting enzyme; Angiotensin I converting enzyme 1; Angiotensin I converting enzyme peptidyl dipeptidase A 1; Carboxycathepsin; CD 143; CD143; CD143 antigen; DCP 1; DCP; DCP1; Dipeptidyl carboxypeptidase 1; MVCD3; Peptidase P; Peptidyl dipeptidase A; Testicular ECA; ACE_HUMAN.
|
WB; ELISA; IHC-P; IHC-F; ICC; IF
|
Human, Mouse, Rat(predicted: Dog, Pig, Cow, Sheep) |
ACE Antibody is an unconjugated, approximately 147 kDa, rabbit-derived, anti-ACE polyclonal antibody. ACE Antibody can be used for: WB, ELISA, IHC-P, IHC-F, ICC, IF expriments in human, mouse, rat, and predicted: dog, pig, cow, sheep background without labeling.
|
- HY-P81102
-
Collagen type X; Col10a 1; Collagen alpha 1(X) chain; Collagen type X alpha 1 (Schmid metaphyseal chondrodysplasia); Collagen type X alpha 1; Collagen X alpha 1 polypeptide; CollagenX; fa66d11; fb10c08; OTTHUMP00000040411; Procollagen type X alpha 1; Schmid metaphyseal chondrodysplasia; wu:fa66d11; wu:fb10c08; COAA1_HUMAN; COL10A1; Collagen alpha-1(X) chain; collagen alpha-1(X) chain precursor; Schmid metaphyseal chondrodysplasia; collagen X, alpha-1 polypeptide.
|
WB; ELISA; IHC-P; IHC-F; IF
|
Mouse, Rat(predicted: Human, Chicken, Dog, Cow, Rabbit) |
Collagen X Antibody is an unconjugated, approximately 73 kDa, rabbit-derived, anti-Collagen X polyclonal antibody. Collagen X Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in mouse, rat, and predicted: human, chicken, dog, cow, rabbit background without labeling.
|
- HY-P81245
-
Cytochrome P450 1A2; cytochrome P450, family 1, subfamily a, polypeptide 2; Cytochrome P450 family 1 polypeptide 2; Cytochrome P450 subfamily I aromatic compound inducible polypeptide 2; Cyp1a2; CYPD45; P-450d; RATCYPD45; CP12; CP 12; P3-450; Aryl hydrocarbon hydroxylase; Dioxin inducable P3 45; Flavoprotein linked monooxygenase; Microsomal monooxygenase; P450 4; P450 form 4; P450 P3; P450(PA); Xenobiotic monooxygenase; P450 1A2.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, Mouse, Rat |
- HY-P81251
-
Caspase-4 subunit 2; Caspase-4 subunit p10; Caspase-11; CASP-11; Protease ICH-3; Apoptosis related cysteine peptidase; Apoptotic cysteine protease Mih1/TX; CASP 4; CASP 4; CASP-4; CASP4; CASP4_HUMAN; CASP4_MOUSE; Caspase 4 apoptosis related cysteine peptidase; Caspase-4 subunit 2; Caspase4; ICE(rel) II; ICE(rel)-II; ICE(rel)II; ICEREL II; ICERELII; ICH 2; ICH 2 protease; ICH2; Mih1/TX; Mih1/TX; Protease ICH-2; Protease TX; TX; TX protease; EC:3.4.22.64.
|
WB, ELISA
|
Rat (predicted: Mouse) |
- HY-P81311
-
C21; DC42; F box like/WD repeat containing protein TBL1XR1; F-box-like/WD repeat-containing protein TBL1XR1; FLJ12894; IRA1; Nuclear receptor corepressor/HDAC3 complex subunit; Nuclear receptor corepressor/HDAC3 complex subunit TBLR1; TBL1 related protein 1; TBL1-related protein 1; TBL1R_HUMAN; TBL1XR1; Transducin (beta) like 1 X linked receptor 1; Transducin beta like 1X related protein 1; Transducin beta-like 1X-related protein 1.
|
WB, IHC-F, IHC-P, ICC/IF
|
Human, Mouse |
- HY-P81311A
-
C21; DC42; F box like/WD repeat containing protein TBL1XR1; F-box-like/WD repeat-containing protein TBL1XR1; FLJ12894; IRA1; Nuclear receptor corepressor/HDAC3 complex subunit; Nuclear receptor corepressor/HDAC3 complex subunit TBLR1; TBL1 related protein 1; TBL1-related protein 1; TBL1R_HUMAN; TBL1XR1; Transducin (beta) like 1 X linked receptor 1; Transducin beta like 1X related protein 1; Transducin beta-like 1X-related protein 1.
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P81339
-
C21; DC42; F box like/WD repeat containing protein TBL1XR1; F-box-like/WD repeat-containing protein TBL1XR1; FLJ12894; IRA1; Nuclear receptor corepressor/HDAC3 complex subunit; Nuclear receptor corepressor/HDAC3 complex subunit TBLR1; TBL1 related protein 1; TBL1-related protein 1; TBL1R_HUMAN; TBL1XR1; Transducin (beta) like 1 X linked receptor 1; Transducin beta like 1X related protein 1; Transducin beta-like 1X-related protein 1.
|
WB, IHC-P, ICC/IF
|
Human, Monkey |
- HY-P83093
-
DKFZp781C1895; DKFZp781O1323; Dwfc; hSmad 5; hSmad5; JV5 1; JV5-1; MAD homolog 5; MAD mothers against decapentaplegic homolog 5; MAD; mothers against decapentaplegic homolog 5; MADH 5; MADH5; Mothers against decapentaplegic homolog 5; Mothers against DPP homolog 5; MusMLP; SMA and MAD related protein 5; SMAD 5; SMAD family member 5; SMAD mothers against DPP homolog 5; Smad5; Smad5; SMAD5_HUMAN.
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
- HY-P83645
-
ACTFS; Double minute 2 protein; E3 ubiquitin-protein ligase Mdm2; Hdm 2; Hdm2; HDMX; MDM 2; MDM2; MDM2 oncogene E3 ubiquitin protein ligase; Mdm2 p53 E3 ubiquitin protein ligase homolog; Mdm2 transformed 3T3 cell double minute 2 p53 binding protein (mouse) binding protein 104kDa; MDM2_HUMAN; MDM2BP; Mouse Double Minute 2; MTBP; Murine Double Minute Chromosome 2; Oncoprotein Mdm2; p53 Binding Protein Mdm2; Ubiquitin protein ligase E3 Mdm2;
|
WB, IP, IF, IHC-P
|
Human, Mouse, Rat |
- HY-P81129
-
MAD (mothers against decapentaplegic Drosophila) homolog 7; MAD; Mad homolog 7; MAD mothers against decapentaplegic homolog 7; MADH 7; MADH 8; MADH8; Mothers Against Decapentaplegic Drosophila Homolog of 7; Mothers against decapentaplegic homolog 7; Mothers against decapentaplegic homolog 8; Mothers against DPP homolog 7; Mothers against DPP homolog 8; SMA- AND MAD-RELATED PROTEIN 7; SMAD 7; SMAD; SMAD family member 7; SMAD, mothers against DPP homolog 7 (Drosophila); SMAD, mothers against DPP homolog 7; SMAD7_HUMAN.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; ICC; IF
|
Human, Mouse, Rat(predicted: Pig, Cow) |
SMAD7 Antibody is an unconjugated, approximately 46 kDa, rabbit-derived, anti-SMAD7 polyclonal antibody. SMAD7 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, rat, and predicted: pig, cow background without labeling.
|
- HY-P81149
-
NKG2-D type II integral membrane protein; KLRK1; natural killer cell group 2D; NKG2-D isoform b; Klrk1; Nkrp2; NKG2-D-activating NK receptor; NK cell receptor D; Killer cell lectin-like receptor subfamily K; NK lectin-like receptor; CD314; CD 314; CD314 antigen; D12S2489E; Killer cell lectin like receptor subfamily K member 1; Killer cell lectin-like receptor subfamily K member 1; KLR; Klrk1; NKG2 D activating NK receptor; NKG2 D type II integral membrane protein; NKG2-D-activating NK receptor; NKG2D_HUMAN; NKLLR; NKR P2; Nkrp2.
|
WB; ELISA; IHC-P; Flow-Cyt; IF
|
Human, Mouse(predicted: Rat) |
NKG2D Antibody is an unconjugated, approximately 25 kDa, rabbit-derived, anti-NKG2D polyclonal antibody. NKG2D Antibody can be used for: WB, ELISA, IHC-P, Flow-Cyt, IF expriments in human, mouse, and predicted: rat background without labeling.
|
- HY-P81154
-
10 kDa interferon gamma induced protein; C7; Chemokine (C X C motif) ligand 10; Chemokine CXC motif ligand 10; Crg 2; CRG2; CXCL 10; CXCL10; Gamma IP10; gIP 10; GIP10; IFI 10; IFI10; INP 10; INP10; Interferon activated gene 10; Interferon gamma induced cell line; Interferon inducible cytokine IP 10; MOB1; SCYB 10; SCYB10; Small inducible cytokine B10; Small inducible cytokine B10 precursor; Small inducible cytokine subfamily B (Cys X Cys) member 10; Gamma-IP-10.
|
ELISA; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, Mouse, Rat, |
CXCL10/IP10 Antibody is an unconjugated, approximately 10 kDa, rabbit-derived, anti-CXCL10/IP10 polyclonal antibody. CXCL10/IP10 Antibody can be used for: ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, background without labeling.
|
- HY-P81196
-
3BHS1_HUMAN; 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1; beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type I; 3-beta-HSD I; 3-beta-hydroxy-5-ene steroid dehydrogenase 1; 3-beta-hydroxy-Delta(5)-steroid dehydrogenase 1; EC:1.1.1.145; 3-beta-hydroxysteroid 3-dehydrogenase 1; EC:1.1.1.270; Delta-5-3-ketosteroid isomerase; Dihydrotestosterone oxidoreductase. EC:1.1.1.210; Steroid Delta-isomerase 1; EC:5.3.3.1; Trophoblast antigen FDO161G; 3BH; HSDB3A
|
WB; ELISA; IHC-P; IHC-F; IF
|
Mouse, Rat(predicted: Human, Dog, Cow, Horse) |
HSD3B1 Antibody is an unconjugated, approximately 41 kDa, rabbit-derived, anti-HSD3B1 polyclonal antibody. HSD3B1 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in mouse, rat, and predicted: human, dog, cow, horse background without labeling.
|
- HY-P81201
-
Arresten; Canstatin; COL4A1; HANAC; ICH; POREN1; Collagen Alpha 1(IV) Chain; Collagen IV Alpha 1 Polypeptide; Collagen Of Basement Membrane Alpha 1 Chain; Collagen Of Basement Membrane Alpha 2 Chain; Collagen Type IV Alpha 1; DKFZp686I14213; FLJ22259; collagen alpha-1(IV) chain preproprotein; collagen alpha-1(IV) chain preproprotein; Col4a1 protein; collagen of basement membrane, alpha-1 chain; collagen IV, alpha-1 polypeptide; collagen alpha-1(IV) chain; COL4A1 NC1 domain; CO4A1_HUMAN; Collagen Ⅳ; Collagen Type Ⅳ.
|
ELISA; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, Mouse, Rat(predicted: Chicken, Dog, Pig, Cow, Horse, Rabbit) |
Collagen IV Antibody is an unconjugated, approximately 165 kDa, rabbit-derived, anti-Collagen IV polyclonal antibody. Collagen IV Antibody can be used for: ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: chicken, dog, pig, cow, horse, rabbit background without labeling.
|
- HY-P81232
-
caspase-1 isoform alpha p20 subunit; CASP1; ICE; IL1BC; Caspase-1 subunit p20; CASP 1; Caspase 1 apoptosis related cysteine peptidase; Caspase 1 apoptosis related cysteine protease; Caspase1; IL 1 beta converting enzyme; IL 1BC; IL1B convertase; IL1BCE; Interleukin 1 beta convertase; Interleukin 1 beta convertase precursor; Interleukin 1 beta converting enzyme; CASP-1; Interleukin-1 beta convertase; IL-1BC; Interleukin-1 beta-converting enzyme; ICE; IL-1 beta-converting enzyme; p45; CASP1_HUMAN; CASP1_MOUSE.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; ICC; IF
|
Human, Mouse, Rat, |
Caspase-1 p20 Antibody is an unconjugated, approximately 20/46 kDa, rabbit-derived, anti-Caspase-1 p20 polyclonal antibody. Caspase-1 p20 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, rat, background without labeling.
|
- HY-P81235
-
Interleukin-4; IL4; IL 4; B cell growth factor 1; B cell IgG differentiation factor; B Cell Stimulatory Factor 1; BCGF 1; BCGF1; Binetrakin; BSF 1; BSF1; HCGF; Hodgkin’s Cell Growth Factor; IA Inducing Factor; IGG1 induction factor; Il4e12; Interleukin 4; Interleukin 4, isoform 1; Interleukin4; Lymphocyte stimulatory factor 1; Macrophage fusion factor; Mast cell growth factor 2; MCGF2; MFF; MGC79402; Pitrakinra; T cell growth factor 2; TCGF2; IL4_MOUSE; B-cell stimulatory factor 1; BSF-1.
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human, Mouse, Rat |
IL-4 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 14 kDa, targeting to IL-4. It can be used for WB、ELISA、IHC-P、IHC-F、IF assays with tag free, in the background of Transfected.
|
- HY-P82926
-
KRT2; KRT76; KRT3; KRT5; KRT6A; KRT6B; KRT6C; KRT71; KRT72; KRT73; KRT74; KRT75; KRT79; KRT8; KRT84; Keratin; type II cytoskeletal 2 epidermal; Keratin; type II cytoskeletal 2 oral; Keratin; type II cytoskeletal 3; Keratin; type II cytoskeletal 5; Keratin; type II cytoskeletal 6A; Keratin; type II cytoskeletal 6B; Keratin; type II cytoskeletal 6C; Keratin; type II cytoskeletal 71; Keratin; type II cytoskeletal 72; Keratin; type II cytoskeletal 73; Keratin; type II cytoskeletal 74
|
WB, IHC-P
|
Human |
- HY-P83654
-
CD3 epsilon; CD3e; CD3e antigen epsilon polypeptide (TiT3 complex); CD3E antigen epsilon polypeptide; CD3E antigen, epsilon subunit; CD3e molecule epsilon; CD3e molecule, epsilon (CD3 TCR complex); CD3e molecule, epsilon (CD3-TCR complex); CD3E_HUMAN; IMD18; T cell antigen receptor complex epsilon subunit of T3; T cell surface antigen T3/Leu 4 epsilon chain; T cell surface glycoprotein CD3 epsilon chain; T-cell surface antigen T3/Leu-4 epsilon chain; T-cell surface glycoprotein CD3 epsilon chain; T3E; TCRE.
|
Flow-Cyt
|
Human |
- HY-P80445
-
Alpha CaMKII; Calcium calmodulin dependent protein kinase II; Calcium/calmodulin dependent protein kinase II alpha B subunit; Calcium/calmodulin dependent protein kinase type II alpha chain; Calcium/calmodulin-dependent protein kinase (CaM kinase) II alpha; Calcium/calmodulin-dependent protein kinase II alpha; Calcium/calmodulin-dependent protein kinase II-alpha; Calcium/calmodulin-dependent protein kinase type II subunit alpha; Calcium/calmodulin-dependent protein kinase type IIA; CaM kinase II alpha chain; CaM kinase II alpha subunit; CaM kinase II subunit alpha; CaMK II alpha subunit; CaMK-II subunit alpha; Camk2a; CAMKA; CaMKII; CaMKIINalpha; EC2.7.11.17; KCC2A_HUMAN; KIAA0968; MGC123320; MGC139375; MGC155201; mKIAA0968; PK2CDD; PKCCD; R74975; zgc:112538; zgc:123320;
|
WB, IP, FC, IHC-P
|
Human, Mouse, Rat |
CaMKII alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to CaMKII alpha. It can be used for WB,IP,FC,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P81220
-
F4/80; Adhesion G protein-coupled receptor E1; Cell surface glycoprotein EMR1; Cell surface glycoprotein F4/80; DD7A5 7; Egf like module containing mucin like hormone receptor like 1; Egf like module containing mucin like hormone receptor like sequence 1; EGF like module receptor 1; EGF TM7; EGF-like module receptor 1; EGF-like module-containing mucin-like hormone receptor-like 1; EGFTM7; EMR 1; EMR1; EMR-1; EMR1 hormone receptor; EMR1_HUMAN; AGRE1_HUMAN; Gpf480; Ly71; Lymphocyte antigen 71; TM7LN3.
|
WB; ELISA; Flow-Cyt
|
Human, Mouse(predicted: Rat, Pig, Guinea Pig) |
ADGRE1 Antibody is an unconjugated, approximately 95 kDa, rabbit-derived, anti-ADGRE1 polyclonal antibody. ADGRE1 Antibody can be used for: WB, ELISA, Flow-Cyt expriments in human, mouse, and predicted: rat, pig, guinea pig background without labeling.
|
- HY-P81083
-
F4/80 (mouse); Adhesion G protein-coupled receptor E1; Cell surface glycoprotein EMR1; Cell surface glycoprotein F4/80; DD7A5 7; Egf like module containing mucin like hormone receptor like 1; Egf like module containing mucin like hormone receptor like sequence 1; EGF like module receptor 1; EGF TM7; EGF-like module receptor 1; EGF-like module-containing mucin-like hormone receptor-like 1; EGFTM7; EMR 1; EMR1; EMR-1; EMR1 hormone receptor; EMR1_HUMAN; AGRE1_HUMAN; Gpf480; Ly71; Lymphocyte antigen 71; TM7LN3.
|
WB; IP
|
Human(predicted: Mouse, Rat) |
ADGRE1 (F4/80) Antibody (YA920) is an unconjugated, approximately 95 kDa, mouse-derived, anti-ADGRE1 (F4/80) (YA920) monoclonal antibody. ADGRE1 (F4/80) Antibody (YA920) can be used for: WB, IP expriments in human, and predicted: mouse, rat background without labeling.
|
- HY-P81162
-
PI3 kinase p110 subunit alpha; caPI3K; MGC142161; MGC142163; p110 alpha; Phosphatidylinositol 3 kinase catalytic alpha polypeptide; Phosphatidylinositol 3 kinase catalytic 110 KD alpha; Phosphatidylinositol 4 5 bisphosphate 3 kinase catalytic subunit alpha isoform; Phosphoinositide 3 kinase catalytic alpha polypeptide; PI3 kinase p110 subunit alpha; PI3K; PI3KC A; PIK3C A; PK3CA; PtdIns 3 kinase p110; PI3-kinase P110α; PI3-kinase p110 subunit alpha; PI 3 Kinase catalytic subunit alpha; PK3CA_HUMAN; PI3 kinase P110α.
|
WB; ELISA; IHC-P; IHC-F; ICC; IF
|
Human, Mouse, Rat(predicted: Chicken, Cow, Rabbit) |
PIK3CA Antibody is an unconjugated, approximately 117 kDa, rabbit-derived, anti-PIK3CA polyclonal antibody. PIK3CA Antibody can be used for: WB, ELISA, IHC-P, IHC-F, ICC, IF expriments in human, mouse, rat, and predicted: chicken, cow, rabbit background without labeling.
|
- HY-P81206
-
5 alpha SR2; EC; SR type 2; Steroid 5 alpha reductase 2; 3 oxo 5 alpha steroid 4 dehydrogenase 2; 3-oxo-5-alpha-steroid 4-dehydrogenase 2; 5 alpha-SR2; 5ART2; e II 5 alpha reductase; EC; MGC138457; Micropenis, included; S5A2_HUMAN; S5AR 2; SR type 2; SRD5A2; Steroid 5 alpha reductase 2; Steroid 5-alpha-reductase 2; Steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2); Type II 5-alpha reductase.
|
ELISA; IHC-P; IHC-F; IF
|
Human, Mouse, Rat, Pig, Horse |
SRD5A2 Antibody is an unconjugated, approximately 28 kDa, rabbit-derived, anti-SRD5A2 polyclonal antibody. SRD5A2 Antibody can be used for: ELISA, IHC-P, IHC-F, IF expriments in (predicted) human, mouse, rat, pig, horse background without labeling.
|
- HY-P80404
-
Galectin-3; 35 kDa lectin; Carbohydrate binding protein 35; CBP 35; CBP35; GAL 3; GAL3; GAL-3; Galactose specific lectin 3; Galactose-specific lectin 3; Galactoside binding protein; Galactoside-binding protein; GALBP; Galectin3 internal gene,included; Galectin3; GALIG; GBP; IgE binding protein; IgE-binding protein; L 31; L 34; L-34 galactoside-binding lectin; L31; Laminin binding protein; Laminin-binding protein; Lectin galactose binding soluble 3; Lectin galactoside binding soluble 3; Lectin L 29; Lectin L-29; Lectin, galactose binding, soluble 3; LGALS 3; LGALS2; LGALS3; LGALS3 protein; MAC 2 antigen; Mac-2; MAC2; Macrophage galactose-specific lectin; MGC105387; LEG3_HUMAN.
|
WB, ICC/IF, FC, IHC-P
|
Human, Mouse |
Galectin 3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 26 kDa, targeting to Galectin 3. It can be used for WB,ICC/IF,FC,IHC-P assays with tag free, in the background of Human, Mouse.
|
- HY-P81127
-
PRKACA/PRKACB; PRKACA + PRKACB; PKA alpha + beta; PKA alpha; PKA beta; cAMP dependent protein kinase alpha catalytic subunit; cAMP dependent protein kinase beta catalytic subunit; cAMP dependent protein kinase catalytic subunit alpha; cAMP dependent protein kinase catalytic subunit beta; DKFZp781I2452; MGC102831; MGC41879; MGC48865; MGC9320; PKA C alpha; PKA C beta; PKACA; PKACB; PRKACA; PRKACB; Protein kinase A catalytic subunit alpha; Protein kinase A catalytic subunit; Protein kinase A catalytic subunit beta; Protein kinase cAMP dependent catalytic alpha; Protein kinase cAMP dependent catalytic beta; cAMP dependent protein kinase catalytic subunit alpha isoform 1; cAMP-dependent protein kinase catalytic subunit alpha; KAPCA_HUMAN; KAPCB_HUMAN; PKA C alpha; PKA C-alpha; PKACA; PRKACA; Protein kinase A catalytic subunit; Protein kinase cAMP dependent catalytic alpha.
|
WB; ELISA; IHC-P; IHC-F; ICC; IF
|
Human, Mouse(predicted: Rat) |
PKA alpha + beta Antibody is an unconjugated, approximately 40 kDa, rabbit-derived, anti-PKA alpha + beta polyclonal antibody. PKA alpha + beta Antibody can be used for: WB, ELISA, IHC-P, IHC-F, ICC, IF expriments in human, mouse, and predicted: rat background without labeling.
|
- HY-P81143
-
CCR7_HUMAN; BLR 2; BLR2; C C chemokine receptor type 7; C C CKR 7; CC chemokine receptor 7; CC chemokine receptor type 7; CC CKR 7; CCCKR7; CCR 7; CD 197; CD197; CD197 antigen; CDW197; Chemokine C C motif receptor 7; Chemokine C C receptor 7; Chemokine receptor 7-like protein; EBI 1; EBI1; Ebi1h; EBV Induced G Protein Coupled Receptor 1; Epstein Barr virus induced G protein coupled receptor; Epstein Barr virus induced gene 1; EVI 1; EVI1; Lymphocyte Specific G Protein Coupled Peptide Receptor; MGC108519; MIP 3 beta receptor; MIP3 Beta Receptor.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; ICC; IF
|
Human, Mouse, Rat(predicted: Dog) |
CCR7 Antibody is an unconjugated, approximately 42 kDa, rabbit-derived, anti-CCR7 polyclonal antibody. CCR7 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, rat, and predicted: dog background without labeling.
|
- HY-P81153
-
Basic helix loop helix PAS protein MOP2; Basic-helix-loop-helix-PAS protein MOP2; bHLHe73; Class E basic helix-loop-helix protein 73; ECYT4; Endothelial PAS domain containing protein 1; Endothelial pas domain protein 1; Endothelial PAS domain-containing protein 1; EPAS 1; EPAS-1; EPAS1; EPAS1_HUMAN; HIF 1 alpha like factor; HIF-1-alpha-like factor; HIF-2-alpha; HIF2-alpha; HIF2A; HLF; Hypoxia inducible factor 2 alpha; Hypoxia inducible factor 2 alpha subunit; Hypoxia-inducible factor 2-alpha; Member of PAS protein 2; Member of pas superfamily 2; MOP 2; MOP2; PAS domain-containing protein 2; PASD2.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, Mouse, Rat(predicted: Pig, Cow, Horse) |
HIF 2 alpha Antibody is an unconjugated, approximately 96 kDa, rabbit-derived, anti-HIF 2 alpha polyclonal antibody. HIF 2 alpha Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: pig, cow, horse background without labeling.
|
- HY-P81199
-
PIK3CA(phospho Y317); PI3 kinase p110 subunit alpha; caPI3K; MGC142161; MGC142163; p110 alpha; Phosphatidylinositol 3 kinase catalytic alpha polypeptide; Phosphatidylinositol 3 kinase catalytic 110 KD alpha; Phosphatidylinositol 4 5 bisphosphate 3 kinase catalytic subunit alpha isoform; Phosphoinositide 3 kinase catalytic alpha polypeptide; PI3 kinase p110 subunit alpha; PI3K; PI3KC A; PIK3C A; PIK3CA; PK3CA; PtdIns 3 kinase p110; PI3-kinase P110α; PI3-kinase p110 subunit alpha; PI 3 Kinase catalytic subunit alpha; PK3CA_HUMAN; PI3 kinase P110α.
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human, Mouse(predicted: Rat) |
phospho-PI3KCA (Tyr317) Antibody is an unconjugated, approximately 117 kDa, rabbit-derived, anti-phospho-PI3KCA (Tyr317) polyclonal antibody. phospho-PI3KCA (Tyr317) Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, and predicted: rat background without labeling.
|
- HY-P81209
-
p70(S6K)-alpha; ribosomal protein S6 kinase; p70 S6 Kinase; P70 Beta1; KS6B1_HUMAN; Ribosomal protein S6 kinase beta-1; 70 kDa ribosomal protein S6 kinase 1; P70S6K1; p70-S6K 1; Ribosomal protein S6 kinase I; Serine/threonine-protein kinase 14A; p70 ribosomal S6 kinase alpha; p70 S6 kinase alpha; p70 S6K-alpha; p70 S6KA; S6K; PS6K; S6K1; STK14A; p70-S6K; p70 S6KA; p70-alpha; S6K-beta-1; p70(S6K)-alpha.
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human, Rat(predicted: Mouse, Chicken, Dog, Pig, Cow, Horse, Rabbit, Goat) |
RPS6KB1 Antibody is an unconjugated, approximately 70 kDa, rabbit-derived, anti-RPS6KB1 polyclonal antibody. RPS6KB1 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, rat, and predicted: mouse, chicken, dog, pig, cow, horse, rabbit, goat background without labeling.
|
- HY-P80484
-
alpha sarcomeric Actin; alpha smooth muscle Actin; Actin alpha; ASMA; ASM-A; alpha-SMA; alpha SMA; AAT6; ACTA2; Actin alpha 2 smooth muscle aorta; Actin aortic smooth muscle; ACTSA; ACTVS; Alpha 2 actin; Alpha-actin 2; Cell growth inhibiting gene 46 protein; Growth inhibiting gene 46; ACTA_HUMAN; Actin alpha 2 smooth muscle aorta; Actin aortic smooth muscle; Actin, aortic smooth muscle; Alpha 2 actin; Alpha actin 2; Alpha cardiac actin; Alpha-actin 2; Alpha-actin-2; Cell growth inhibiting gene 46 protein; Cell growth-inhibiting gene 46 protein; Growth inhibiting gene 46; MYMY5 α-Smooth Muscle Actin; α Smooth Muscle Actin
|
WB, IHC-P, FC, IP
|
Human, Mouse |
alpha smooth muscle ActinAntibody is a non-conjugated and Rabbit origined monoclonal antibody about 42 kDa, targeting to alpha smooth muscle Actin. It can be used for WB,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse.
|
- HY-P81171
-
MCP-1/CCL2; C-C motif chemokine 2; CCL 2; CCL2; CCL2_HUMAN; Chemokine (C C motif) ligand 2; Chemokine C C motif ligand 2; Chemokine CC Motif Ligand 2; GDCF 2; GDCF 2 HC11; GDCF-2; GDCF2; HC11; HSMCR30; HSMCR30; JE; MCAF; MCP 1; MCP-1; MGC9434; Monocyte chemoattractant protein 1; Monocyte chemotactic and activating factor; Monocyte chemotactic protein 1; Monocyte secretory protein JE; SCYA2; Small inducible cytokine A2 (monocyte chemotactic protein 1, homologous to mouse Sig je); Small inducible cytokine A2; Small inducible cytokine subfamily A (Cys Cys), member 2; Small inducible cytokine subfamily A Cys Cys member 2; Small-inducible cytokine A2; SMC CF; SMC-CF; SMCCF.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, Rat(predicted: Mouse, Dog, Pig, Horse, Rabbit) |
MCP1 Antibody is an unconjugated, approximately 11 kDa, rabbit-derived, anti-MCP1 polyclonal antibody. MCP1 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, rat, and predicted: mouse, dog, pig, horse, rabbit background without labeling.
|
- HY-P83643
-
PKM2 (Phospho Tyr148); PKM2 (Phospho Y148); PK 1; PK 2; PK 3; PK Muscle type; PK1; PK2; Pk3; PKL; PKLR; PKM 2; PKM; PYKM; Pyruvate kinase 1; Pyruvate kinase 2/3; Pyruvate kinase 3; Pyruvate kinase isozyme R/L; Pyruvate kinase isozymes M1/M2; Pyruvate kinase liver and blood cell; Pyruvate kinase liver and RBC; Pyruvate kinase liver and RBC type; Pyruvate kinase M2; Pyruvate kinase muscle; Pyruvate kinase muscle isozyme; Pyruvate kinase type L; R type/L type pyruvate kinase; Red cell/liver pyruvate kinase; RPK; TCB; THBP 1; THBP1; Thyroid hormone binding protein cytosolic; CTHBP; Cytosolic thyroid hormone binding protein; MGC3932; OIP 3; Oip3; Tumor M2-PK; p58; OIP-3; KPYM_HUMAN.
|
WB, IHC-P, IHC-F, ICC, IF, Flow-Cyt, ELISA
|
Human (predicted: Mouse, Rat, Pig, Cow, Rabbit, Sheep, GuineaPig) |
- HY-P83644
-
PKM2 (Phospho Tyr105); PKM2 (Phospho Y105); PK 1; PK 2; PK 3; PK Muscle type; PK1; PK2; Pk3; PKL; PKLR; PKM 2; PKM; PYKM; Pyruvate kinase 1; Pyruvate kinase 2/3; Pyruvate kinase 3; Pyruvate kinase isozyme R/L; Pyruvate kinase isozymes M1/M2; Pyruvate kinase liver and blood cell; Pyruvate kinase liver and RBC; Pyruvate kinase liver and RBC type; Pyruvate kinase M2; Pyruvate kinase muscle; Pyruvate kinase muscle isozyme; Pyruvate kinase type L; R type/L type pyruvate kinase; Red cell/liver pyruvate kinase; RPK; TCB; THBP 1; THBP1; Thyroid hormone binding protein cytosolic; CTHBP; Cytosolic thyroid hormone binding protein; MGC3932; OIP 3; Oip3; Tumor M2-PK; p58; OIP-3.
|
IHC-P, IHC-F, IF, Flow-Cyt, ELISA
|
Human, Rat (predicted: Mouse, Dog, Pig, Cow, Horse, Rabbit, GuineaPig) |
- HY-P80176
-
H3K9me3; H3 histone family member E pseudogene; H3 histone family, memberA; H3/A; H31_HUMAN; H3F3; H3FA; Hist1h3a; HIST1H3B; HIST1H3C; HIST1H3D; HIST1H3E; HIST1H3F; HIST1H3G; HIST1H3H; HIST1H3I; HIST1H3J; HIST3H3; histone 1, H3a; Histone cluster 1, H3a; Histone H3 3 pseudogene; Histone H3.1; Histone H3/a; Histone H3/b; Histone H3/c; Histone H3/d; Histone H3/f; Histone H3/h; Histone H3/i; Histone H3/j; Histone H3/k; HistoneH3/l; H3K9me2; HistoneH3(trimethylK9)
|
WB, ICC, IHC-P
|
Human, Mouse, Rat |
Histone H3 (tri methyl K9) Antibody is a non-conjugated and Mouse origined monoclonal antibody about 15 kDa, targeting to Histone H3 (tri methyl K9). It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
- HY-P81229
-
PI3-kinase p110 subunit beta; p110 BETA; p110Beta; PI3K beta; Phosphatidylinositol 3 kinase catalytic beta polypeptide; Phosphatidylinositol 4 5 bisphosphate 3 kinase 110 kDa catalytic subunit beta; Phosphatidylinositol 4 5 bisphosphate 3 kinase catalytic subunit beta isoform; Phosphatidylinositol-4; Phosphoinositide 3 kinase catalytic beta polypeptide; PI3 kinase p110 subunit beta; PI3-kinase subunit beta; PI3K; PI3K beta; PI3K-beta; PI3Kbeta; PI3KCB; PIK3C1; Pik3cb; PK3CB_HUMAN; PtdIns 3 kinase p110; PtdIns-3-kinase subunit beta; PtdIns-3-kinase subunit p110-beta; 5-bisphosphate 3-kinase 110 kDa catalytic subunit beta; 5-bisphosphate 3-kinase catalytic subunit beta isoform.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; ICC; IF
|
Human, Mouse, Rat(predicted: Dog, Cow, Horse, Rabbit) |
PI3 Kinase p110 beta Antibody is an unconjugated, approximately 123 kDa, rabbit-derived, anti-PI3 Kinase p110 beta polyclonal antibody. PI3 Kinase p110 beta Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, rat, and predicted: dog, cow, horse, rabbit background without labeling.
|
- HY-P81239
-
NF-kB p65 (phospho S276); p-NF-kB p65 (phospho S276); RELA(phospho S276); NF kB P65; NF-kB p65; NF kB P65; NF-κBp65; p65 NF kappaB; p65 NFkB; RELA; Transcription Factor p65; v rel avian reticuloendotheliosis viral oncogene homolog A (nuclear factor of kappa light polypeptide gene enhancer in B cells 3 (p65)); V Rel Avian Reticuloendotheliosis Viral Oncogene Homolog A; v rel reticuloendotheliosis viral oncogene homolog A (avian); v-rel reticuloendotheliosis viral oncogene homolog A; p65NFKB; Avian reticuloendotheliosis viral (v rel) oncogene homolog A; MGC131774; NFKB 3; NFKB3; Nuclear Factor NF Kappa B p65 Subunit; Nuclear factor of kappa light polypeptide gene enhancer in B cells 3; Nuclear Factor Of Kappa Light Polypeptide Gene Enhancer In B Cells. NFκB-p65; NFκB p65; NF κB-p65; NFκBp65
|
ELISA; IHC-P; IHC-F; Flow-Cyt; ICC; IF;
|
Human, Mouse, Rat, (predicted: Dog, Pig, Cow, Horse, ) |
- HY-P81211
-
PI3-kinase p110 subunit beta; p-PI3Kβ(Ser1070); PI 3-kinase C2β; p110 BETA; p110Beta; Phosphatidylinositol 3 kinase catalytic beta polypeptide; Phosphatidylinositol 4 5 bisphosphate 3 kinase 110 kDa catalytic subunit beta; Phosphatidylinositol 4 5 bisphosphate 3 kinase catalytic subunit beta isoform; Phosphatidylinositol-4; Phosphoinositide 3 kinase catalytic beta polypeptide; PI3 kinase p110 subunit beta; PI3-kinase subunit beta; PI3K; PI3K beta; PI3K-beta; PI3Kbeta; PI3KCB; PIK3C1; Pik3cb; PK3CB_HUMAN; PtdIns 3 kinase p110; PtdIns-3-kinase subunit beta; PtdIns-3-kinase subunit p110-beta; 5-bisphosphate 3-kinase 110 kDa catalytic subunit beta; 5-bisphosphate 3-kinase catalytic subunit beta isoform.
|
WB; ELISA; IHC-P; IHC-F; IF
|
Human, Mouse, Rat(predicted: Chicken, Dog, Pig, Cow, Horse, Guinea Pig) |
phospho-PI3 Kinase p110 beta (Ser1070) Antibody is an unconjugated, approximately 110-123 kDa, rabbit-derived, anti-phospho-PI3 Kinase p110 beta (Ser1070) polyclonal antibody. phospho-PI3 Kinase p110 beta (Ser1070) Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, and predicted: chicken, dog, pig, cow, horse, guinea pig background without labeling.
|
- HY-P81226
-
Autophagy related protein LC3 A; Autophagy related protein LC3 B; Autophagy related ubiquitin like modifier LC3 A; Autophagy related ubiquitin like modifier LC3 B; MAP1 light chain 3 like protein 1; MAP1 light chain 3 like protein 2; MAP1A/1B light chain 3 A; MAP1A/1B light chain 3 B; MAP1A/1BLC3; MAP1A/MAP1B LC3 A; MAP1A/MAP1B LC3 B; MAP1ALC3; MAP1BLC3; MAP1LC3A; MAP1LC3B; Microtubule associated protein 1 light chain 3 alpha; Microtubule associated protein 1 light chain 3 beta; Microtubule associated proteins 1A/1B light chain 3; Microtubule associated proteins 1A/1B light chain 3A; Microtubule associated proteins 1A/1B light chain 3B; MLP3A_HUMAN.
|
WB; ELISA; IHC-P; IHC-F; Flow-Cyt; IF
|
Human, Rat(predicted: Mouse, Chicken, Dog, Pig, Cow, Horse, Sheep, Goat) |
LC3 Antibody is an unconjugated, approximately 14/16 kDa, rabbit-derived, anti-LC3 polyclonal antibody. LC3 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, rat, and predicted: mouse, chicken, dog, pig, cow, horse, sheep, goat background without labeling.
|
- HY-P81238
-
NF-kB p65 (phospho S536); p-NF-κB p65(Phospho-Ser536); RELA(phospho S536); NF kB P65; NF-kB p65; NFKBp65; NF-κBp65; p65 NF kappaB; p65 NFkB; NFKBp65; RELA; Transcription Factor p65; v rel avian reticuloendotheliosis viral oncogene homolog A (nuclear factor of kappa light polypeptide gene enhancer in B cells 3 (p65)); V Rel Avian Reticuloendotheliosis Viral Oncogene Homolog A; v rel reticuloendotheliosis viral oncogene homolog A (avian); v-rel reticuloendotheliosis viral oncogene homolog A; p65NFKB; Avian reticuloendotheliosis viral (v rel) oncogene homolog A; MGC131774; NFKB 3; NFKB3; Nuclear Factor NF Kappa B p65 Subunit; Nuclear factor of kappa light polypeptide gene enhancer in B cells 3; Nuclear Factor Of Kappa Light Polypeptide Gene Enhancer In B Cells; TF65_HUMAN. NFκB-p65; NFκB p65; NF κB-p65; NFκBp65
|
WB; IHC; Flow-Cyt;
|
Human, Mouse, Rat, (predicted: Chicken, Dog, Cow, Horse, ) |
- HY-P82975
-
60S acidic ribosomal protein P1; AA409079; AI325195; AU020965; HSSB; ik:tdsubc_2g1; M(2)21C; MGC137236; OTTHUMP00000004008; p32; p34; RCJMB04_6d17 replication protein A2; 32kDa; REPA 2; REPA1; REPA2; Replication factor A protein 2; Replication protein A 32 kDa subunit; Replication protein A 32kDa subunit; Replication protein A 34 kDa subunit; Replication protein A; replication protein A1 (70kD); Replication Protein A2 (32kDa); Replication protein A2 32kD; Replication protein A2 32kDa; Replication protein A2; Replication protein A2; 32kDa; RF A; RF-A protein 2; Rf-A2; RFA; RFA2_HUMAN; RP A; RP-A p32; RP-A p34; RP21C; RPA 2; RPA 32; RPA; RPA2; RPA32; RPA34; RPA70; RpLP1; RpP2; xx:tdsubc_2g1; zgc:109822.
|
WB, IP
|
Human, Mouse, Rat |
- HY-P83469
-
AW212142; dual specificity mitogen activated protein kinase kinase 3; Dual specificity mitogen activated protein kinase kinase 6; Dual specificity mitogen-activated protein kinase kinase 3; MAP kinase kinase 3; MAP kinase kinase 6; map2k3; MAP2K6; MAPK ERK kinase 3; MAPK/ERK kinase 3; MAPK/ERK kinase 6; MAPKK 3; MAPKK 6; MAPKK3; MAPKK6; MEK 3; MEK 6; MEK3; Mitogen activated protein kinase kinase 3; Mitogen activated protein kinase kinase 6; MKK 3; MKK3; MKK6; mMKK3b; MP2K3_HUMAN; PRKMK 3; PRKMK3; PRKMK6; Protein kinase; mitogen activated; kinase 6 (MAP kinase kinase 6); protein kinase; mitogen-activated; kinase 3; SAPK kinase 2; SAPKK 2; SAPKK 3; SAPKK-2; SAPKK2; SAPKK3; Stress activated protein kinase kinase 2; Stress activated protein kinase kinase 3; Stress-activated protein kinase kinase 2.
|
WB, ICC/IF, IP
|
Human, Mouse, Rat |
- HY-P80776A
-
p38 (phospho T180 + Y182); p-p38 (phospho T180 + Y182); p38 (phospho T180/Y182); CSAID Binding Protein 1; CSAID binding protein; CSAID-binding protein; Csaids binding protein; CSBP 1; CSBP 2; CSBP; CSBP1; CSBP2; CSPB 1; CSPB1; Cytokine suppressive anti inflammatory drug binding protein; Cytokine suppressive anti-inflammatory drug-binding protein; EXIP; MAP kinase 14; MAP kinase MXI2; MAP kinase p38 alpha; MAPK 14; MAPK14; MAX interacting protein 2; MAX-interacting protein 2; Mitogen Activated Protein Kinase 14; Mitogen activated protein kinase p38 alpha; Mitogen-activated protein kinase 14; Mitogen-activated protein kinase p38 alpha; MK14_HUMAN; Mxi 2; Mxi2; p38 ALPHA; p38; p38 MAP kinase; p38 MAPK; p38 mitogen activated protein kinase; p38ALPHA; p38alpha Exip; PRKM14; PRKM15; RK; SAPK 2A; SAPK2A; Stress Activated Protein Kinase 2A.
|
WB, IHC-P, Flow-Cyt, ICC, ELISA
|
Human, Mouse (predicted: Rat, Rabbit, Pig, Chicken, Dog, Horse) |
- HY-P81156
-
ERK1 + ERK2 (phospho Thr183/Tyr185); phospho-ERK1/MAPK-1/2(Thr183/Tyr185); ERK 1; ERK 2; ERK-2; ERK1; ERK2; ERT1; ERT2; Extracellular signal regulated kinase 1; Extracellular signal regulated kinase 1; Extracellular signal regulated kinase 2; Extracellular signal regulated kinase 2; Extracellular signal-regulated kinase 2; HS44KDAP; HUMKER1A; Insulin stimulated MAP2 kinase; MAP kinase 1; MAP kinase 2; MAP kinase isoform p42; MAP kinase isoform p44; MAPK 1; MAPK 2; MAPK1; MAPK2; MGC20180; Microtubule associated protein 2 kinase; Mitogen activated protein kinase 1; Mitogen activated protein kinase 1; Mitogen activated protein kinase 2; Mitogen-activated protein kinase 1; Mitogen-activated protein kinase 2; MK01_MOUSE; p38; p40; p41; p41mapk; p42 MAPK; p42-MAPK; p42MAPK; p42MAPK; p44 ERK1; p44 MAPK; p44ERK1; p44ERK1; p44MAPK; p44MAPK; PRKM 1; PRKM 1; PRKM 2; PRKM 2; PRKM1; PRKM2; Protein kinase mitogen activated 1; Protein kinase mitogen activated 1; Protein kinase mitogen activated 2; Protein kinase mitogen activated 2; Protein tyrosine kinas.
|
WB; ELISA; IHC-P; IHC-F; ICC; IF
|
Human, Mouse(predicted: Rat, Chicken, Dog, Cow, Horse, Rabbit, Guinea Pig) |
phospho-ERK1 + 2 (Thr183/Tyr185) Antibody is an unconjugated, approximately 42/44 kDa, rabbit-derived, anti-phospho-ERK1 + 2 (Thr183/Tyr185) polyclonal antibody. phospho-ERK1 + 2 (Thr183/Tyr185) Antibody can be used for: WB, ELISA, IHC-P, IHC-F, ICC, IF expriments in human, mouse, and predicted: rat, chicken, dog, cow, horse, rabbit, guinea pig background without labeling.
|
Cat. No. |
Product Name |
|
Classification |
-
- HY-120903
-
|
|
DBCO
ADC Synthesis
|
DBCO-C3-Acid is a Click Chemistry intermediate used in the synthesis of antibody-drug conjugate (ADC) linker .
|
-
- HY-145066
-
|
|
Azide
ADC Synthesis
|
Gly-Gly-Gly-PEG4-azide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-157275
-
|
|
ADC Synthesis
Azide
|
Gly-Gly-Gly-PEG2-azide is an ADC linker that can be used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-163045
-
|
|
Azide
|
4-Azidophenylarsonic acid, a Hapten that contains a diazonium group, is a probes of antibody response and immunorecognition .
|
-
- HY-151640
-
|
|
Azide
|
Fmoc-DAP-N3 is a click chemistry reagent containing an azide group. Fmoc-DAP-N3 is a short, linear spacer molecule with Fmoc protected amino function. Fmoc-DAP-N3 can be used in click conjugation and amid bond formation either with small molecules or for bioconjugation with proteins and antibodies .
|
-
- HY-141284
-
|
|
Tetrazine
ADC Synthesis
|
Gly-Gly-Gly-PEG4-methyltetrazine is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-141190
-
|
|
ADC Synthesis
TCO
|
Gly-Gly-Gly-PEG3-TCO is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-141150
-
|
|
Azide
ADC Synthesis
|
Azido-PEG5-Ala-Ala-Asn-PAB is a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-131157
-
|
|
ADC Synthesis
Azide
|
Lys(MMT)-PAB-oxydiacetamide-PEG8-N3 is a cleavable antibody agent conjugate linker used in the synthesis of antibody-drug conjugates (ADCs) . Lys(MMT)-PAB-oxydiacetamide-PEG8-N3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
-
- HY-151752
-
|
|
Alkynes
|
Mal-AMCHC-N-Propargylamide is a click chemistry reagent containing an azide group. Mal-AMCHC-N-Propargylamide can be a bio-conjugation reagent for antibody-agent-conjugate synthesis using Click-Chemistry .
|
-
- HY-151764
-
|
|
ADC Synthesis
Azide
|
N3-D-Orn(Boc)-OH is a Boc-protected pentanoic amino acid derivative, can be used as a click chemistry reagent and has been used to synthesis antibody-drug conjugates (ADC) .
|
-
- HY-151764A
-
|
|
Azide
ADC Synthesis
|
N3-D-Orn(Boc)-OH (CHA) is a Boc-protected pentanoic amino acid derivative, can be used as a click chemistry reagent and has been used to synthesis antibody-drug conjugates (ADC) .
|
-
- HY-136261
-
|
|
DBCO
|
DM1-(PEG)4-DBCO is a agent-linker conjugate composed of a potent microtubulin inhibitor DM1 and a linker DBCO-PEG4-Ahx to make antibody agent conjugate (ADC). Mertansine (DM1) is a microtubulin inhibitor and is an antibody-conjugatable maytansinoid that is developed to overcome systemic toxicity associated with maytansine and to enhance tumor-specific delivery. DM1-PEG4-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-136260
-
|
|
DBCO
|
DBCO-PEG4-Ahx-DM1 is a agent-linker conjugate composed of a potent microtubulin inhibitor DM1 and a linker DBCO-PEG4-Ahx to make antibody agent conjugate (ADC). Mertansine (DM1) is a microtubulin inhibitor and is an antibody-conjugatable maytansinoid that is developed to overcome systemic toxicity associated with maytansine and to enhance tumor-specific delivery. DBCO-PEG4-Ahx-DM1 is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-141167
-
|
|
ADC Synthesis
TCO
PROTAC Synthesis
|
TCO-PEG4-NHS ester is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. TCO-PEG4-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-141170
-
|
|
ADC Synthesis
TCO
PROTAC Synthesis
|
TCO-PEG12-NHS ester is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. TCO-PEG12-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
|
-
- HY-116270
-
|
|
DBCO
ADC Synthesis
|
DBCO-Maleimide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-Maleimide is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-42973
-
|
|
DBCO
ADC Synthesis
|
DBCO-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-NHS ester is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-W000423
-
|
|
DBCO
ADC Synthesis
|
DBCO-amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-amine is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-79584
-
|
|
Alkynes
ADC Synthesis
|
Propargyl-Tos is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-Tos is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-157182
-
|
|
DBCO
|
DNP-PEG2-NHCO-C2-DBCO is a clickable hapten that bears a dinitrophenyl (DNP) moiety as the antibody‐recruiting motif at one end, a polyethylene glycol chain as a spacer and a dibenzocyclooctene at the other end for the SPAAC chemistry .
|
-
- HY-126851
-
|
|
DBCO
ADC Synthesis
|
Fluorescein-DBCO is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Fluorescein-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-136095
-
|
|
Tetrazine
ADC Synthesis
|
Tetrazine-biotin is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-biotin is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
-
- HY-136104
-
|
|
ADC Synthesis
Tetrazine
|
Methyltetrazine-Maleimide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Methyltetrazine-Maleimide is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
-
- HY-123687
-
|
|
ADC Synthesis
DBCO
|
DBCO-Sulfo-NHS ester sodium is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-Sulfo-NHS ester (sodium) is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-140306
-
|
|
ADC Synthesis
DBCO
|
Mal-Sulfo-DBCO is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Mal-Sulfo-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-135977
-
|
|
ADC Synthesis
DBCO
|
DBCO-SS-aldehyde is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-SS-aldehyde is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-135972
-
|
|
BCN
ADC Synthesis
|
BCN-SS-amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-SS-amine is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-135973
-
|
|
BCN
ADC Synthesis
|
BCN-SS-NHS is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-SS-NHS is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-138506
-
|
|
DBCO
ADC Synthesis
|
DBCO-S-S-acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-S-S-acid is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-136032
-
|
|
Tetrazine
ADC Synthesis
|
Tetrazine-SS-NHS is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-SS-NHS is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
-
- HY-136033
-
|
|
Tetrazine
ADC Synthesis
|
Methyltetrazine-SS-NHS is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Methyltetrazine-SS-NHS is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
-
- HY-136039
-
|
|
ADC Synthesis
TCO
|
TCO-SS-amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . TCO-SS-amine is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
|
-
- HY-130928
-
|
|
Tetrazine
ADC Synthesis
|
Tetrazine-Ph-OPSS is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-Ph-OPSS is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
-
- HY-136031
-
|
|
Tetrazine
ADC Synthesis
|
Tetrazine-SS-Biotin is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-SS-Biotin is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
-
- HY-151696
-
|
|
TCO
|
TCO-PEG3-maleimide (TCO-PEG3-NEM) is a click chemistry reagent. TCO-PEG3-maleimide efficiently binds TCO (trans-cyclooctene) moiety to thiol-containing molecules (such as antibodies, cysteine-containing peptides) .
|
-
- HY-126511
-
|
|
Alkynes
ADC Synthesis
|
Propargyl-C1-NHS ester is a nonclaevable linker for antibody-agent-conjugation (ADC). Propargyl-C1-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-126512
-
|
|
Alkynes
ADC Synthesis
|
Propargyl-C2-NHS ester is a nonclaevable linker for antibody-agent-conjugation (ADC). Propargyl-C2-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-130810
-
|
|
DBCO
ADC Synthesis
|
DBCO-Sulfo-Link-biotin is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-Sulfo-Link-biotin is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-130935
-
|
|
DBCO
ADC Synthesis
|
DBCO-Val-Cit-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-Val-Cit-OH is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-133504
-
|
|
ADC Synthesis
Tetrazine
|
Tetrazine-Ph-SS-amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-Ph-SS-amine is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
-
- HY-130936
-
|
|
DBCO
ADC Synthesis
|
DBCO-Val-Cit-PABC-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-Val-Cit-PABC-OH is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-130937
-
|
|
ADC Synthesis
DBCO
|
DBCO-Val-Cit-PABC-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-Val-Cit-PABC-PNP is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-133412
-
|
|
ADC Synthesis
DBCO
|
DBCO-NHCO-S-S-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-NHCO-S-S-NHS ester is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-133413
-
|
|
DBCO
ADC Synthesis
|
DBCO-CONH-S-S-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-CONH-S-S-NHS ester is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-126513
-
|
|
Alkynes
ADC Synthesis
|
Propargyl-PEG1-NHS ester is a nonclaevable 1-unit PEG linker for antibody-agent-conjugation (ADC). Propargyl-PEG1-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-126516
-
|
|
ADC Synthesis
Alkynes
|
Propargyl-PEG4-NHS ester is a nonclaevable 4-unit PEG linker for antibody-agent-conjugation (ADC). Propargyl-PEG4-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-120770
-
|
|
DBCO
ADC Synthesis
|
DBCO-PEG4-Maleimide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG4-Maleimide is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-135971
-
|
|
BCN
ADC Synthesis
|
BCN-PEG4-acid is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-PEG4-acid is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
-
- HY-136125
-
|
|
BCN
ADC Synthesis
|
BCOT-PEF3-OPFP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCOT-PEF3-OPFP is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-145593
-
|
|
ADC Synthesis
BCN
|
Aminooxy-PEG2-BCN is a cleavable PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Aminooxy-PEG2-BCN is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-136046
-
|
|
Alkynes
ADC Synthesis
|
PTAD-PEG4-alkyne is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . PTAD-PEG4-alkyne is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-136049
-
|
|
ADC Synthesis
DBCO
|
APN-PEG4-DBCO is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . APN-PEG4-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-136044
-
|
|
BCN
ADC Synthesis
|
APN-PEG4-BCN is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . APN-PEG4-BCN is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-136061
-
|
|
BCN
ADC Synthesis
|
BCN-PEG4-HyNic is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-PEG4-HyNic is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-136067
-
|
|
DBCO
ADC Synthesis
|
DBCO-PEG4-HyNic is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG4-HyNic is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-136075
-
|
|
Alkynes
ADC Synthesis
|
HyNic-PEG4-alkyne is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . HyNic-PEG4-alkyne is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-136101
-
|
|
ADC Synthesis
Alkynes
|
Bocaminooxyacetamide-PEG3-alkyne is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Bocaminooxyacetamide-PEG3-alkyne is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-147325
-
|
|
ADC Synthesis
Azide
|
bisSP1 is an antibody agent conjugates linker . bisSP1 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-115524
-
|
|
ADC Synthesis
DBCO
|
DBCO-NHS ester 2 is a cleavable linker that is used for making antibody-drug conjugate (ADC). DBCO-NHS ester 2 is a derivative of Dibenzylcyclooctyne (DBCO) used in copper-free click chemistry . DBCO-NHS ester 2 is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-140136
-
|
|
DBCO
ADC Synthesis
|
PC DBCO-PEG3-biotin is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . PC DBCO-PEG3-biotin is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-140930
-
|
|
DBCO
ADC Synthesis
|
Diazo Biotin-PEG3-DBCO is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Diazo Biotin-PEG3-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-140108
-
|
|
ADC Synthesis
Alkynes
|
Propargyl-PEG1-SS-alcohol is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG1-SS-alcohol is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-140078
-
|
|
ADC Synthesis
BCN
|
bis-PEG2-endo-BCN is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . bis-PEG2-endo-BCN is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-140139
-
|
|
Alkynes
ADC Synthesis
|
PC Alkyne-PEG4-NHS ester is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . PC Alkyne-PEG4-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-140130
-
|
|
Alkynes
ADC Synthesis
|
PC Biotin-PEG3-alkyne is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . PC Biotin-PEG3-alkyne is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-140152
-
|
|
BCN
ADC Synthesis
|
BCN-PEG3-VC-PFP ester is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-PEG3-VC-PFP ester is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-135979
-
|
|
ADC Synthesis
DBCO
|
DBCO-SS-PEG4-Biotin is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-SS-PEG4-Biotin is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-136052
-
|
|
Tetrazine
ADC Synthesis
|
Tetrazine-PEG4-oxyamine (hydrochloride) is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-PEG4-oxyamine (hydrochloride) is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
- HY-136050
-
|
|
ADC Synthesis
TCO
|
TCO-PEG3-Biotin is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . TCO-PEG3-Biotin is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
|
- HY-136053
-
|
|
Tetrazine
ADC Synthesis
|
Tetrazine-PEG4-biotin is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-PEG4-biotin is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
- HY-136056
-
|
|
Tetrazine
ADC Synthesis
|
Methyltetrazine-PEG4-oxyamine is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Methyltetrazine-PEG4-oxyamine is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
- HY-136045
-
|
|
Tetrazine
ADC Synthesis
|
APN-PEG4-tetrazine is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . APN-PEG4-tetrazine is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
- HY-133431
-
|
|
ADC Synthesis
DBCO
|
DBCO-PEG3-SS-NHS ester is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG3-SS-NHS ester is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-130924
-
|
|
BCN
ADC Synthesis
|
BCN-PEG3-Biotin is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-PEG3-Biotin is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-130925
-
|
|
ADC Synthesis
BCN
|
BCN-PEG4-OH is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-PEG4-OH is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-130926
-
|
|
ADC Synthesis
BCN
|
BCN-PEG3-oxyamine is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-PEG3-oxyamine is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-133427
-
|
|
ADC Synthesis
Alkynes
|
Propargyl-PEG4-hydrazide is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG4-hydrazide is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-133429
-
|
|
ADC Synthesis
DBCO
|
DBCO-PEG3-oxyamine is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG3-oxyamine is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-133430
-
|
|
DBCO
ADC Synthesis
Alkynes
|
DBCO-PEG4-alkyne is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG4-alkyne is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-130927
-
|
|
ADC Synthesis
BCN
|
BCN-PEG4-Ts is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-PEG4-Ts is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-130972
-
|
|
DBCO
ADC Synthesis
|
Amino-bis-PEG3-DBCO is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Amino-bis-PEG3-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-130977
-
|
|
ADC Synthesis
Tetrazine
|
Tetrazine-PEG4-amine (hydrochloride) is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-PEG4-amine (hydrochloride) is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
- HY-136074
-
|
|
ADC Synthesis
Tetrazine
|
Methyltetrazine-PEG4-aldehyde is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Methyltetrazine-PEG4-aldehyde is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
- HY-136077
-
|
|
TCO
ADC Synthesis
|
TCO-PEG3-aldehyde is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . TCO-PEG3-aldehyde is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
|
- HY-136085
-
|
|
ADC Synthesis
BCN
|
Amino-bis-PEG3-BCN is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Amino-bis-PEG3-BCN is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-136086
-
|
|
Tetrazine
ADC Synthesis
|
Tetrazine-PEG6-amine (hydrochloride) is a cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-PEG6-amine (hydrochloride) is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
- HY-136087
-
|
|
ADC Synthesis
DBCO
|
Mal-bis-PEG3-DBCO is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Mal-bis-PEG3-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-136096
-
|
|
DBCO
ADC Synthesis
|
DBCO-PEG3 acetic-EVCit-PAB is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG3 acetic-EVCit-PAB is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-148211
-
|
|
Tetrazine
|
Tetrazine-PEG7-amine hydrochloride is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-PEG7-amine (hydrochloride) is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
- HY-121805
-
|
|
ADC Synthesis
DBCO
|
DBCO-C6-acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). DBCO-C6-acid can be used in the synthesis of carmaphycin analogues . DBCO- C6- acid is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-140309
-
|
|
ADC Synthesis
DBCO
|
Gly-Gly-Gly-PEG4-DBCO is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Gly-Gly-Gly-PEG4-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-136040
-
|
|
Tetrazine
ADC Synthesis
|
Tetrazine-PEG4-SS-NHS is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-PEG4-SS-NHS is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
- HY-130922
-
|
|
BCN
ADC Synthesis
|
BCN-PEG1-Val-Cit-OH is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-PEG1-Val-Cit-OH is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-130945
-
|
|
ADC Synthesis
Tetrazine
|
Tetrazine-PEG5-SS-amine is a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-PEG5-SS-amine is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
- HY-130947
-
|
|
ADC Synthesis
Tetrazine
|
Tetrazine-PEG4-SS-Py is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-PEG4-SS-Py is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
- HY-130955
-
|
|
ADC Synthesis
TCO
|
Amino-bis-PEG3-TCO is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Amino-bis-PEG3-TCO is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
|
- HY-133432
-
|
|
DBCO
TCO
ADC Synthesis
|
DBCO-PEG4-SS-TCO is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG4-SS-TCO is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
|
- HY-133466
-
|
|
ADC Synthesis
Tetrazine
|
Methyltetrazine-PEG4-SS-NHS ester is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Methyltetrazine-PEG4-SS-NHS ester is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
- HY-133435
-
|
|
ADC Synthesis
Alkynes
|
Aminooxy-amido-PEG4-propargyl is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Aminooxy-amido-PEG4-propargyl is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-136035
-
|
|
ADC Synthesis
Tetrazine
|
Methyltetrazine-SS-PEG4-Biotin is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Methyltetrazine-SS-PEG4-Biotin is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
- HY-136036
-
|
|
ADC Synthesis
Tetrazine
|
Tetrazine-SS-PEG4-Biotin is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-SS-PEG4-Biotin is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
- HY-136078
-
|
|
Tetrazine
ADC Synthesis
|
Tetrazine-diazo-PEG4-biotin is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-diazo-PEG4-biotin is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
- HY-136141
-
|
|
DBCO
ADC Synthesis
|
DBCO-PEG3-propionic EVCit-PAB is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG3-propionic EVCit-PAB is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-D1052
-
|
|
Labeling and Fluorescence Imaging
Alkynes
|
Cy7-YNE is a fluorescence labeling agent (Ex=700-770 nm,Em=790 nm). Cyanine dyes are used to label proteins, antibodies, and peptides. Cy7-YNE is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-140104
-
|
|
ADC Synthesis
Azide
|
Azidoethyl-SS-ethylamine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azidoethyl-SS-ethylamine is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-140100
-
|
|
ADC Synthesis
Azide
|
Azidoethyl-SS-propionic acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azidoethyl-SS-propionic acid is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-140105
-
|
|
ADC Synthesis
Azide
|
Azidoethyl-SS-ethylazide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azidoethyl-SS-ethylazide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-133426
-
Ald-benzyl-amide-PEG4-propargyl
|
|
Alkynes
ADC Synthesis
|
Ald-Ph-amido-PEG4-propargyl is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Ald-Ph-amido-PEG4-propargyl is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-133436
-
|
|
Alkynes
ADC Synthesis
|
Boc-aminooxy-amide-PEG4-propargyl is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Boc-aminooxy-amide-PEG4-propargyl is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-130923
-
|
|
BCN
ADC Synthesis
|
BCN-PEG1-Val-Cit-PABC-OH is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-PEG1-Val-Cit-PABC-OH is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-130934
-
|
|
ADC Synthesis
TCO
|
TCO-PEG1-Val-Cit-OH is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . TCO-PEG1-Val-Cit-OH is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
|
- HY-136103
-
|
|
DBCO
ADC Synthesis
|
DBCO-PEG4-Propionic-Val-Cit-PAB is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG4-Propionic-Val-Cit-PAB is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-136098
-
|
|
DBCO
ADC Synthesis
|
DBCO-PEG4-acetic-Val-Cit-PAB is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG4-acetic-Val-Cit-PAB is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-124386
-
|
|
PROTAC Synthesis
DBCO
ADC Synthesis
|
DBCO-NHCO-PEG4-amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. DBCO-NHCO-PEG4-amine is a cleavable ADC linker used to conjugate MMAE (HY-15162) and antibody (e.g., DBCO-VCpAB−MMAE and DBCO-TRX−MMAE with EC50s of 280 nM and 22 nM in SKBR3 cells, respectively) .
|
- HY-130383
-
|
|
PROTAC Synthesis
ADC Synthesis
Alkynes
|
Propargyl-PEG7-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG7-acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG7-acid is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-130386
-
|
|
ADC Synthesis
Alkynes
PROTAC Synthesis
|
Propargyl-PEG6-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG6-acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG6-acid is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-140109
-
|
|
ADC Synthesis
Alkynes
|
Propargyl-PEG1-SS-PEG1-acid is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG1-SS-PEG1-acid is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-140102
-
|
|
ADC Synthesis
Azide
|
Azidoethyl-SS-propionic NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azidoethyl-SS-propionic NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-141155
-
|
|
BCN
ADC Synthesis
|
endo-BCN-PEG4-Val-Cit-PAB-MMAE is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . endo-BCN-PEG4-Val-Cit-PAB-MMAE is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-130966
-
|
|
TCO
ADC Synthesis
|
TCO-PEG1-Val-Cit-PABC-OH is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . TCO-PEG1-Val-Cit-PABC-OH is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
|
- HY-136100
-
|
|
ADC Synthesis
TCO
|
TCO-PEG1-Val-Cit-PABC-PNP is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . TCO-PEG1-Val-Cit-PABC-PNP is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
|
- HY-136131
-
|
|
DBCO
ADC Synthesis
|
NH2-PEG4-hydrazone-DBCO is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . NH2-PEG4-hydrazone-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-138387
-
|
|
ADC Synthesis
Azide
|
6-Azido-hexylamine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . 6-Azido-hexylamine is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-D2242
-
|
|
DBCO
|
Sulfo-Cy7.5 DBCO is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) bearing a DBCO group. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Sulfo-Cy7.5 DBCO can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples .
|
- HY-128930
-
|
|
ADC Synthesis
Alkynes
|
6-O-2-Propyn-1-yl-D-galactose is a nonclaevable glycolinker for the functionalization of cytotoxic agents and applications in antibody-agent conjugation. 6-O-2-Propyn-1-yl-D-galactose is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-115545
-
|
|
ADC Synthesis
DBCO
|
DBCO-NHS ester 3 (Compound 12) is a cleavable linker that is used for making antibody-drug conjugate (ADC). DBCO-NHS ester 3 is a derivative of Dibenzylcyclooctyne (DBCO) obtained by activation of N-hydroxysuccinimide by the carboxylic acid moiety of both methyl-oxanorbornadiene (MeOND) and dibenzoazacyclooctyne (DIBAC) . DBCO-NHS ester 3 is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-140111
-
|
|
ADC Synthesis
Alkynes
|
Propargyl-PEG1-SS-PEG1-propargyl is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG1-SS-PEG1-propargyl is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-140110
-
|
|
ADC Synthesis
Alkynes
|
Propargyl-PEG1-SS-PEG1-PFP ester is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG1-SS-PEG1-PFP ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-140313
-
|
|
DBCO
ADC Synthesis
Tetrazine
|
Methyltetrazine-DBCO is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Methyltetrazine-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups. Methyltetrazine-DBCO also contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
- HY-135970
-
|
|
Alkynes
ADC Synthesis
|
Alkyne-PEG4-SS-PEG4-alkyne is a cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Alkyne-PEG4-SS-PEG4-alkyne is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-130968
-
|
|
Alkynes
ADC Synthesis
|
Amino-PEG4-bis-PEG3-propargyl is a cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Amino-PEG4-bis-PEG3-propargyl is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-130971
-
|
|
DBCO
ADC Synthesis
|
Mal-PEG4-bis-PEG3-DBCO is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Mal-PEG4-bis-PEG3-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-130973
-
|
|
Alkynes
ADC Synthesis
|
Mal-PEG4-bis-PEG4-propargyl is a cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Mal-PEG4-bis-PEG4-propargyl is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-136060
-
|
|
BCN
ADC Synthesis
|
Mal-PEG2-bis-PEG3-BCN is a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Mal-PEG2-bis-PEG3-BCN is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-136076
-
|
|
ADC Synthesis
TCO
|
TCO-PEG3-CH2-aldehyde is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . TCO-PEG3-CH2-aldehyde is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
|
- HY-136088
-
|
|
ADC Synthesis
BCN
|
Acid-PEG1-bis-PEG3-BCN is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Acid-PEG1-bis-PEG3-BCN is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-136089
-
|
|
ADC Synthesis
BCN
|
Aminooxy-PEG2-bis-PEG3-BCN is a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Aminooxy-PEG2-bis-PEG3-BCN is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-47018
-
|
|
BCN
|
BCN-HS-PEG2-VA-PABC-SG3199 (Compound 4) is a pyrrolobenzodiazepine that can be used as a agent linker of antibody-drug conjugates (ADC) . BCN-HS-PEG2-VA-PABC-SG3199 is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-126524
-
|
|
ADC Synthesis
Azide
|
N3-Ph-NHS ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N3-Ph-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-125541
-
|
|
ADC Synthesis
DBCO
PROTAC Synthesis
|
DBCO-Amide-PEG5-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. DBCO-Amide-PEG5-acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-NHCO-PEG4-acid is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-130346
-
|
|
ADC Synthesis
DBCO
PROTAC Synthesis
|
DBCO-PEG4-DBCO is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. DBCO-PEG4-DBCO is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG4-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-126976
-
|
|
PROTAC Synthesis
Alkynes
ADC Synthesis
|
Propargyl-PEG5-amine is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Propargyl-PEG5-amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs . Propargyl-PEG5-amine is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-130372
-
|
|
PROTAC Synthesis
Alkynes
ADC Synthesis
|
Propargyl-PEG9-bromide is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG9-bromide is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG9-bromide is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-130377
-
|
|
PROTAC Synthesis
ADC Synthesis
Alkynes
|
Propargyl-PEG8-bromide is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG8-bromide is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG8-bromide is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-130591
-
|
|
PROTAC Synthesis
Alkynes
ADC Synthesis
|
Propargyl-PEG4-Br is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG4-Br is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG4-Br is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-116427
-
|
|
Alkynes
ADC Synthesis
PROTAC Synthesis
|
Propargyl-PEG4-thiol is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG4-thiol is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG4-thiol is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-118808
-
|
|
Alkynes
PROTAC Synthesis
ADC Synthesis
|
Propargyl-PEG2-NHBoc is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Propargyl-PEG2-NHBoc is a PEG-based PROTAC linker can be used in the synthesis of PROTACs . Propargyl-PEG2-NHBoc is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-130387
-
|
|
ADC Synthesis
Alkynes
PROTAC Synthesis
|
Propargyl-PEG4-Tos is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG4-Tos is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG4-Tos is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-130943
-
|
|
ADC Synthesis
Tetrazine
|
Methyltetrazine-PEG4-SS-PEG4-methyltetrazine is a cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Methyltetrazine-PEG4-SS-PEG4-methyltetrazine is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
- HY-130953
-
|
|
ADC Synthesis
Tetrazine
|
Mal-PEG4-bis-PEG3-methyltetrazine is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Mal-PEG4-bis-PEG3-methyltetrazine is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
- HY-130931
-
|
|
Alkynes
ADC Synthesis
|
Propargyl-NH-PEG3-C2-NHS ester is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-NH-PEG3-C2-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-130967
-
|
|
ADC Synthesis
Alkynes
|
Ald-Ph-PEG4-bis-PEG4-propargyl is a cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Ald-Ph-PEG4-bis-PEG4-propargyl is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-130970
-
|
|
ADC Synthesis
Tetrazine
|
Amino-PEG4-bis-PEG3-methyltetrazine is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Amino-PEG4-bis-PEG3-methyltetrazine is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
- HY-133539
-
|
|
ADC Synthesis
Alkynes
|
Propargyl-C8-amido-PEG2-NHS ester is a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-C8-amido-PEG2-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-138521
-
|
|
ADC Synthesis
Azide
|
Azido-C6-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-C6-OH is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-138535
-
|
|
ADC Synthesis
Azide
|
Azide-C2-Azide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azide-C2-Azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-126525
-
|
|
ADC Synthesis
Azide
|
4-N3Pfp-NHS ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . 4-N3Pfp-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-118764
-
|
|
Alkynes
PROTAC Synthesis
ADC Synthesis
|
Propargyl-PEG2-acid is a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Propargyl-PEG2-acid is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Propargyl-PEG2-acid is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-111456
-
|
|
ADC Synthesis
PROTAC Synthesis
DBCO
|
DBCO-NHCO-PEG4-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. DBCO-NHCO-PEG4-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-NHCO-PEG4-NHS ester is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-126885
-
|
|
DBCO
PROTAC Synthesis
ADC Synthesis
|
DBCO-PEG5-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. DBCO-PEG5-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG5-NHS ester is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-126974
-
|
|
Alkynes
ADC Synthesis
PROTAC Synthesis
|
Propargyl-PEG3-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG3-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG3-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-130376
-
|
|
ADC Synthesis
Alkynes
PROTAC Synthesis
|
Propargyl-PEG8-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG8-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG8-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-130381
-
|
|
Alkynes
ADC Synthesis
PROTAC Synthesis
|
Propargyl-PEG7-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG7-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG7-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-130385
-
|
|
ADC Synthesis
Alkynes
PROTAC Synthesis
|
Propargyl-PEG6-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG6-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG6-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-130388
-
|
|
PROTAC Synthesis
ADC Synthesis
Alkynes
|
Propargyl-PEG5-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG5-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG5-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-W051634
-
|
|
Alkynes
ADC Synthesis
PROTAC Synthesis
|
Propargyl-PEG2-amine is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Propargyl-PEG2-amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs . Propargyl-PEG2-amine is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-115374
-
|
|
ADC Synthesis
Azide
|
m-PEG6-azide is a non-cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). m-PEG6-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-140352
-
|
|
Azide
ADC Synthesis
|
Azide-PEG5-Tos is a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azide-PEG5-Tos is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-133434
-
|
|
ADC Synthesis
Azide
|
Aminoxyacetamide-PEG3-azide is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Aminoxyacetamide-PEG3-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-136038
-
|
|
ADC Synthesis
Azide
|
Azido-PEG3-SSPy is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG3-SSPy is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-130974
-
|
|
ADC Synthesis
Tetrazine
|
Ald-Ph-PEG4-bis-PEG3-methyltetrazine is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Ald-Ph-PEG4-bis-PEG3-methyltetrazine is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
- HY-136099
-
|
|
Azide
ADC Synthesis
|
Bocaminooxyacetamide-PEG2-Azido is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Bocaminooxyacetamide-PEG2-Azido is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-W096133
-
|
|
Azide
ADC Synthesis
|
Biotin-PEG1-azide is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Biotin-PEG1-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-138745
-
|
|
Azide
ADC Synthesis
|
Bis-sulfone-PEG3-Azide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Bis-sulfone-PEG3-Azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-139107
-
|
|
Azide
ADC Synthesis
|
Biotin-PEG4-SS-azide is a cleavable, biotin-labeled, ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Biotin-PEG4-SS-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-139859
-
|
|
ADC Synthesis
Tetrazine
|
APN-PEG36-tetrazine is an analogue of APN-PEG4-tetrazine. APN-PEG4-tetrazine is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . APN-PEG36-tetrazine is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
- HY-126520
-
|
|
Azide
ADC Synthesis
|
N3-C2-NHS ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N3-C2-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-126521
-
|
|
Azide
ADC Synthesis
|
N3-C3-NHS ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N3-C3-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-126522
-
|
|
Azide
ADC Synthesis
|
N3-C4-NHS ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N3-C4-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-126523
-
|
|
Azide
ADC Synthesis
|
N3-C5-NHS ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N3-C5-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-126514
-
|
|
Alkynes
ADC Synthesis
|
Propargyl-O-C1-amido-PEG2-C2-NHS ester is a nonclaevable 2-unit PEG linker for antibody-agent-conjugation (ADC). Propargyl-O-C1-amido-PEG2-C2-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-126515
-
|
|
ADC Synthesis
Alkynes
|
Propargyl-O-C1-amido-PEG4-C2-NHS ester is a nonclaevable 4-unit PEG linker for antibody-agent-conjugation (ADC). Propargyl-O-C1-amido-PEG4-C2-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-126884
-
|
|
DBCO
PROTAC Synthesis
ADC Synthesis
|
DBCO-NHCO-PEG4-NH-Boc is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. DBCO-NHCO-PEG4-NH-Boc is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-NHCO-PEG4-NH-Boc is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-130379
-
|
|
Alkynes
PROTAC Synthesis
ADC Synthesis
|
Propargyl-PEG8-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG8-acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). The ADCs can be used in bacterial infections caused by Gram-negative bacteria . Propargyl-PEG8-acid is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-140132
-
|
|
ADC Synthesis
Azide
|
PC Biotin-PEG3-azide is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . PC Biotin-PEG3-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-140944
-
|
|
Azide
ADC Synthesis
|
Biotin-PEG3-SS-azide is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Biotin-PEG3-SS-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-135966
-
|
|
Azide
ADC Synthesis
|
Azido-PEG3-SS-NHS is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG3-SS-NHS is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-130940
-
|
|
Azide
ADC Synthesis
|
PTAD-PEG4-N3 is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . PTAD-PEG4-N3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-130954
-
|
|
Azide
ADC Synthesis
|
Hynic-PEG3-N3 is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Hynic-PEG3-N3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-136034
-
|
|
Azide
ADC Synthesis
|
Azido-PEG1-Val-Cit-OH is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG1-Val-Cit-OH is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-136084
-
|
|
ADC Synthesis
TCO
|
Mal-PEG4-(PEG3-DBCO)-(PEG3-TCO) is a cleavable 10 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Mal-PEG4-(PEG3-DBCO)-(PEG3-TCO) is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
|
- HY-136130
-
|
|
ADC Synthesis
Alkynes
|
N,N-Bis(PEG2-alkyne)-N-amido-PEG2-thiol is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . N,N-Bis(PEG2-alkyne)-N-amido-PEG2-thiol is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-D1860
-
|
|
Alkynes
|
Cy3 alkyne chloride is a dye derivative of Cyanine 3 (Cy3) (HY-D0822) containing a sulfonate ion and an alkyne functional group. Cy3 is a fluorescent dye with a fluorescence spectrum typically in the green to orange wavelength range. The alkyne functional group of Cy3 alkyne chloride can react with molecules containing the azide functional group to form covalent bonds. Cy3 alkyne chloride can bind to biological molecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
|
- HY-126690
-
|
|
DBCO
|
DBCO-(PEG2-VC-PAB-MMAE)2 is made by MMAE conjugated to the cleavable DBCO-(PEG2-VC-PAB)2 linker. Monomethyl auristatin E (MMAE), a potent tubulin inhibitor, is a toxin payload in antibody agent conjugate . DBCO-(PEG2-VC-PAB-MMAE)2 is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-126676
-
|
|
PROTAC Synthesis
ADC Synthesis
DBCO
|
DBCO-(PEG2-Val-Cit-PAB)2 is a dual cleavable ADC linker for antibody-drug conjugates (ADCs). DBCO-(PEG2-Val-Cit-PAB)2 is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. DBCO-(PEG2-Val-Cit-PAB)2 is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-130182
-
|
|
PROTAC Synthesis
ADC Synthesis
Alkynes
|
Propargyl-PEG8-NH2 (compound 3b) is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG8-NH2 is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG8-NH2 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-140127
-
|
|
Azide
ADC Synthesis
|
Azide-C2-SS-C2-biotin is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azide-C2-SS-C2-biotin is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-140148
-
|
|
Azide
ADC Synthesis
|
Azido-PEG3-Val-Cit-PAB-OH is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG3-Val-Cit-PAB-OH is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-140634
-
|
|
ADC Synthesis
Azide
|
Ald-CH2-PEG5-azide is a non-cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Ald-CH2-PEG5-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-140081
-
|
|
BCN
PROTAC Synthesis
ADC Synthesis
|
Boc-gly-PEG3-endo-BCN is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Boc-gly-PEG3-endo-BCN is also a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Boc-gly-PEG3-endo-BCN is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-136054
-
|
|
Azide
ADC Synthesis
|
N3-PEG5-aldehyde is a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . N3-PEG5-aldehyde is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-133428
-
|
|
ADC Synthesis
DBCO
TCO
|
DBCO-PEG3-TCO is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG3-TCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups. DBCO-PEG3-TCO also contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
|
- HY-136105
-
|
|
ADC Synthesis
Azide
|
Azido-PEG1-Val-Cit-PABC-PNP is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG1-Val-Cit-PABC-PNP is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-136137
-
|
|
Azide
ADC Synthesis
|
Azide-PEG1-Val-Cit-PABC-OH is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azide-PEG1-Val-Cit-PABC-OH is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-136155
-
|
|
Azide
ADC Synthesis
|
Fmoc-NH-Azide-PEG4-L-Lysine-PFP ester is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Fmoc-NH-Azide-PEG4-L-Lysine-PFP ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-131082
-
|
|
ADC Synthesis
Azide
|
(R)-8-Azido-2-(Fmoc-amino)octanoic acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . (R)-8-Azido-2-(Fmoc-amino)octanoic acid is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-133583
-
|
|
Alkynes
ADC Synthesis
|
Propargyl-O-C1-amido-PEG3-C2-NHS ester is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-O-C1-amido-PEG3-C2-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-126526
-
|
|
Azide
ADC Synthesis
|
N3-PEG2-C2-NHS ester is a nonclaevable 2-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs). N3-PEG2-C2-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-126527
-
|
|
Azide
ADC Synthesis
|
N3-PEG2-C2-PFP ester is a nonclaevable 2-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs). N3-PEG2-C2-PFP ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-126528
-
|
|
Azide
ADC Synthesis
|
N3-PEG3-C2-NHS ester is a nonclaevable 3-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs). N3-PEG3-C2-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-126529
-
|
|
ADC Synthesis
Azide
|
N3-PEG3-C2-PFP ester is a nonclaevable 3-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs). N3-PEG3-C2-PFP ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-130108
-
|
|
ADC Synthesis
Azide
|
N3-PEG4-C2-Pfp ester is a nonclaevable 4-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs). N3-PEG4-C2-Pfp ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-130109
-
|
|
Azide
ADC Synthesis
|
N3-PEG4-C2-NHS ester is a nonclaevable 4-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs). N3-PEG4-C2-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-101157
-
|
|
PROTAC Synthesis
ADC Synthesis
Alkynes
|
Propargyl-PEG5-acid is a non-cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Propargyl-PEG5-acid can used to synthesize ADC inhibitors of Galectin-3. Propargyl-PEG5-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Propargyl-PEG5-acid is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-130475
-
|
|
PROTAC Synthesis
ADC Synthesis
Azide
|
Azido-PEG9-acid is a non-cleavable 9 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG9-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Azido-PEG9-acid is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-140454
-
|
|
PROTAC Synthesis
Azide
ADC Synthesis
|
Azido-PEG8-acid is a non-cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG8-acid is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG8-acid is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-140133
-
|
|
ADC Synthesis
Azide
|
PC-Biotin-PEG4-PEG3-azide is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . PC-Biotin-PEG4-PEG3-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-136058
-
|
|
ADC Synthesis
Azide
|
N3-PEG4-amido-Lys(Fmoc)-acid is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . N3-PEG4-amido-Lys(Fmoc)-acid is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-136079
-
|
|
Tetrazine
DBCO
ADC Synthesis
|
Methyltetrazine-PEG4-hydrazone-DBCO is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Methyltetrazine-PEG4-hydrazone-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups. Methyltetrazine-PEG4-hydrazone-DBCO also contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
|
- HY-136318
-
|
|
ADC Synthesis
Azide
|
β-D-tetraacetylgalactopyranoside-PEG1-N3 is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . β-D-tetraacetylgalactopyranoside-PEG1-N3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-136288
-
|
|
Azide
|
Azide-PEG4-VC-PAB-Doxorubicin is a agent-linker conjugate composed of a cytotoxic anthracycline antibiotic Doxorubicin and a linker Azide-PEG4-VC-PAB to make antibody agent conjugate (ADC) . Azide-PEG4-VC-PAB-Doxorubicin is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-147363
-
|
|
DBCO
ADC Synthesis
|
DIBAC-GGFG-NH2CH2-Dxd (compound LP4), a Camptothecin (HY-16560) derivative, is a linker-payload of protein-agent conjugates . Dxd (HY-13631D) can be used as a payload for the antibody-coupling drug ADC (DS-8201a).DIBAC-GGFG-NH2CH2-Dxd is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-130990
-
|
|
DBCO
|
DBCO-PEG4-Val-Cit-PAB-MMAF consists a cleavable 4 unit PEG ADC linker (DBCO-PEG4-Val-Cit-PAB) and a potent tubulin polymerization inhibitor (MMAF). DBCO-PEG4-Val-Cit-PAB-MMAF can be used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG4-Val-Cit-PAB-MMAF is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-130169
-
|
|
Azide
PROTAC Synthesis
ADC Synthesis
|
Azido-PEG9-amine is a non-cleavable 9 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG9-amine is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG9-amine is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-130324
-
|
|
Azide
ADC Synthesis
PROTAC Synthesis
|
Azido-PEG7-amine is a non-cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG7-amine is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG7-amine is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-130435
-
|
|
ADC Synthesis
DBCO
PROTAC Synthesis
|
DBCO-PEG4-amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. DBCO-PEG4-amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). DBCO-PEG4-amine can be used in the synthesis of FPM-PEG4-DBCO (a homobifunctional azide-to-azide cross-linker) . DBCO-PEG4-amine is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-113931
-
|
|
ADC Synthesis
PROTAC Synthesis
Azide
|
Aminooxy-PEG2-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Aminooxy-PEG2-azide is also a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Aminooxy-PEG2-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-130211
-
|
|
PROTAC Synthesis
ADC Synthesis
Azide
|
Azido-PEG5-alcohol is a non-cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG5-alcohol is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG5-alcohol is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-130537
-
|
|
ADC Synthesis
PROTAC Synthesis
Azide
|
Azido-PEG6-alcohol is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG6-alcohol is also a non-cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG6-alcohol is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-140004
-
|
|
Azide
PROTAC Synthesis
ADC Synthesis
|
Azide-PEG3-Tos is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azide-PEG3-Tos is also a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azide-PEG3-Tos is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-140215
-
|
|
PROTAC Synthesis
ADC Synthesis
Azide
|
Azido-PEG6-amine is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG6-amine is also a non-cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG6-amine is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-140101
-
|
|
ADC Synthesis
Azide
|
Azido-C2-SS-PEG2-C2-acid is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-C2-SS-PEG2-C2-acid is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-130957
-
|
|
ADC Synthesis
Azide
|
Amino-PEG6-amido-bis-PEG5-N3 is a cleavable 11 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Amino-PEG6-amido-bis-PEG5-N3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-130969
-
|
|
ADC Synthesis
Azide
|
Ald-Ph-PEG4-bis-PEG3-N3 is a cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Ald-Ph-PEG4-bis-PEG3-N3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-136090
-
|
|
Azide
ADC Synthesis
|
Amino-PEG4-bis-PEG3-N3 is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Amino-PEG4-bis-PEG3-N3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-D1862
-
|
|
Alkynes
|
Cy7.5 alkyne chloride is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) containing a sulfonate ion and an alkyne functional group. Cy7.5 is a near-infrared fluorescent dye commonly used for biolabeling and cell imaging. The alkyne functional group of Cy7.5 alkyne chloride can react with molecules containing the azide functional group to form covalent bonds. Cy7.5 alkyne chloride can bind to biological molecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
|
- HY-136314
-
|
|
DBCO
|
DBCO-PEG4-VC-PAB-MMAE consists a ADC linker (DBCO-PEG4-VC-PAB) and a tubulin polymerization inhibitor MMAE (HY-15162). DBCO-PEG4-VC-PAB-MMAE can be used in the synthesis of antibody-agent conjugates (ADCs). MMAE is a synthetic derivative of dolastatin 10 and functions as a potent mitotic inhibitor by inhibiting tubulin polymerization. DBCO-PEG4-VC-PAB-MMAE is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
|
- HY-130572
-
|
|
Azide
ADC Synthesis
PROTAC Synthesis
|
Azido-PEG5-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs, such as the conjugate CPT-APO (CPT: Camptothecin (HY-16560)). Azido-PEG5-acid is a non-cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG5-acid is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-126949
-
|
|
ADC Synthesis
PROTAC Synthesis
Azide
|
Aminooxy-PEG3-azide is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Aminooxy-C2-PEG3-azide is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Aminooxy-PEG3-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-130184
-
|
|
PROTAC Synthesis
Azide
ADC Synthesis
|
Azido-PEG8-NHS ester is a cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG8-NHS ester is also a PEG- and Alkyl/ether-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG8-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-130474
-
|
|
PROTAC Synthesis
ADC Synthesis
Azide
|
Azido-PEG6-NHS ester is a cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG6-NHS ester is also a PEG- and Alkyl/ether based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG6-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-140310
-
|
|
TCO
DBCO
ADC Synthesis
PROTAC Synthesis
|
TCO-PEG4-DBCO is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. TCO-PEG4-DBCO is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . TCO-PEG4-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups. TCO-PEG4-DBCO also contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
|
- HY-140149
-
|
|
Azide
PROTAC Synthesis
ADC Synthesis
|
Azido-PEG4-Val-Cit-PAB-OH is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG4-Val-Cit-PAB-OH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG4-Val-Cit-PAB-OH is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-140150
-
|
|
ADC Synthesis
Azide
PROTAC Synthesis
|
Azido-PEG3-Val-Cit-PAB-PNP is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG3-Val-Cit-PAB-PNP is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG3-Val-Cit-PAB-PNP is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-130690
-
|
|
PROTAC Synthesis
ADC Synthesis
Alkynes
|
Propargyl-PEG1-SS-PEG1-C2-Boc is a Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG1-SS-PEG1-C2-Boc is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG1-SS-PEG1-C2-Boc is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
- HY-130485
-
|
|
ADC Synthesis
Azide
PROTAC Synthesis
|
Bromo-PEG2-C2-azide is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Bromo-PEG2-C2-azide is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Bromo-PEG2-C2-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-136129
-
|
|
Azide
ADC Synthesis
|
N,N-Bis(PEG2-N3)-N-amido-PEG2-thiol is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . N,N-Bis(PEG2-N3)-N-amido-PEG2-thiol is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-D1859
-
|
|
Alkynes
|
Sulfo-Cy7.5 alkyne is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) containing a sulfonate ion and an alkyne functional group. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy7.5 is a near-infrared fluorescent dye commonly used for biolabeling and cell imaging. The alkyne functionality of Sulfo-Cy7.5 alkyne can react with molecules containing the azide functionality to form covalent bonds. Sulfo-Cy7.5 alkyne can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
|
- HY-130653
-
|
|
Azide
PROTAC Synthesis
ADC Synthesis
|
Azido-PEG4-C2-acid a PEG-based PROTAC linker can be used in the synthesis of vRucaparib-TP4. Azido-PEG4-C2-acid is also a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG4-C2-acid is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-130144
-
|
|
PROTAC Synthesis
ADC Synthesis
Azide
|
Ald-CH2-PEG3-azide is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Ald-CH2-PEG3-azide is a PEG-based PROTAC linker can be used in the synthesis of PROTACs . Ald-CH2-PEG3-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-151769
-
|
|
TCO
Labeling and Fluorescence Imaging
|
TCO-PEG2-Sulfo-NHS ester-EDC Urea is a click chemistry reagent containing an azide group. TCO-PEG2-Sulfo-NHS ester is a PEG linker containing a TCO moiety and a sulfo-NHS ester moiety. The sulfo group makes this molecule soluble in waqueous buffer. This reagent can be used to label antibodies, proteins and other primary amine-containing macromolecules with TCO moiety. Reagent grade, for research use only . TCO-PEG2-Sulfo-NHS ester-EDC Urea is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
|
- HY-D1850
-
|
|
Azide
|
Sulfo-Cy7.5 azide is a Cyanine 7.5 (Cy7.5) (HY-D0926) dye derivative with azide and sulfonate functional groups. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy7.5 is a near-infrared fluorescent dye commonly used for biolabeling and cell imaging. The azide group of Sulfo-Cy7.5 azide can react chemically with molecules containing alkyne functionality, such as alkyne or cyclooctyne, to form covalent bonds. Therefore, Sulfo-Cy7.5 azide can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
|
- HY-42618
-
|
|
ADC Synthesis
PROTAC Synthesis
Azide
|
Azido-PEG4-CH2-Boc is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG4-CH2-Boc is also a PEG- and Alkyl/ether-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG4-CH2-Boc is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-130946
-
|
|
Azide
ADC Synthesis
|
NH2-C5-PEG4-N3-L-Lysine-PEG3-N3 is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . NH2-C5-PEG4-N3-L-Lysine-PEG3-N3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-130194
-
|
|
ADC Synthesis
PROTAC Synthesis
Azide
|
Azido-PEG5-CH2CO2H is a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG5-CH2CO2H is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG5-CH2CO2H is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-42490
-
|
|
ADC Synthesis
PROTAC Synthesis
Azide
|
N3-PEG3-CH2CH2COOH a PEG-based PROTAC linker can be used in the synthesis of BI-3663 (HY-111546), BI-4216 and BI-0319. Azido-PEG3-acid is also a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N3-PEG3-CH2CH2COOH is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-42489
-
|
|
ADC Synthesis
PROTAC Synthesis
Azide
|
N3-PEG3-CH2CH2-Boc is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . N3-PEG3-CH2CH2-Boc is also a PEG- and Alkyl/ether-based PROTAC linker that can be used in the synthesis of PROTACs . N3-PEG3-CH2CH2-Boc is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
- HY-140213
-
N3-PEG2-CH2CH2NH2
|
|
ADC Synthesis
Azide
PROTAC Synthesis
|
Azido-PEG2-C2-amine (N3-PEG2-CH2CH2NH2) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG2-C2-amine is also a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG2-C2-amine is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
|
Your information is safe with us. * Required Fields.
Inquiry Information
- Product Name:
- Cat. No.:
- Quantity:
- MCE Japan Authorized Agent: